<SUBMISSION>
<ACCESSION-NUMBER>0000950134-08-016803
<TYPE>S-1/A
<PUBLIC-DOCUMENT-COUNT>14
<FILING-DATE>20080918
<DATE-OF-FILING-DATE-CHANGE>20080918
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>FLUIDIGM CORP
<CIK>0001162194
<ASSIGNED-SIC>3826
<IRS-NUMBER>770513190
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>S-1/A
<ACT>33
<FILE-NUMBER>333-150227
<FILM-NUMBER>081077519
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7000 SHORELINE COURT
<STREET2>SUITE 100
<CITY>SOUTH SAN FRANCISCO
<STATE>CA
<ZIP>94080
<PHONE>6502666000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7000 SHORELINE COURT
<STREET2>SUITE 100
<CITY>SOUTH SAN FRANCISCO
<STATE>CA
<ZIP>94080
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>f39432xsv1za.htm
<DESCRIPTION>AMENDMENT TO FORM S-1
<TEXT>
<HTML>
<HEAD>
<TITLE>sv1za</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->
</DIV><!-- END PAGE WIDTH -->
<DIV style="width: 94%; margin-left: 3%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B> As filed with the Securities and Exchange Commission on
    September&#160;18, 2008</B>
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="right" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B> Registration
    <FONT style="white-space: nowrap">No.&#160;333-150227</FONT></B>
</DIV>

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 2pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 14pt">UNITED STATES SECURITIES AND
    EXCHANGE COMMISSION</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">Washington,&#160;D.C.
    20549</FONT></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 1pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 17%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=96 -->

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 1pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">AMENDMENT NO. 10 TO</FONT></B>
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 18pt">
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT></FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">REGISTRATION
    STATEMENT</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">UNDER</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 12pt">THE SECURITIES ACT OF
    1933</FONT></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 1pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 17%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=96 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 1pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 24pt">FLUIDIGM CORPORATION</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I><FONT style="font-size: 8pt">(Exact name of Registrant as
    specified in its charter)</FONT></I>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 1pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 17%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=96 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 1pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="34%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="32%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="32%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD nowrap align="center" valign="top">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    <B>Delaware</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    <B>3826</B>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    <B>77-0513190</B>
</TD>
</TR>
<TR valign="bottom">
<TD align="center" valign="top">
    <I><FONT style="font-size: 8pt">(State or other jurisdiction
    of<BR>
    incorporation or organization)</FONT></I>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    <I><FONT style="font-size: 8pt">(Primary Standard Industrial<BR>
    Classification Code Number)</FONT></I>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    <I><FONT style="font-size: 8pt">(I.R.S. Employer<BR>
    Identification Number)</FONT></I><FONT style="font-size: 8pt">
    </FONT>
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 9pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>7000 Shoreline Court, Suite 100</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>South San&#160;Francisco, CA 94080</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>(650) 266-6000</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I><FONT style="font-size: 8pt">(Address, including zip code,
    and telephone number,<BR>
    including area code, of Registrant&#146;s principal executive
    offices)</FONT></I>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 17%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=96 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Gajus V. Worthington</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>President and Chief Executive Officer</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>7000 Shoreline Court, Suite&#160;100</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>South San&#160;Francisco, CA 94080</B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="white-space: nowrap">(650)&#160;266-6000</FONT></B>
</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I><FONT style="font-size: 8pt">(Name, address, including zip
    code, and telephone number,<BR>
    including area code, of agent for service)</FONT></I>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 17%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=96 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><I>Copies to:</I></B>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="34%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="32%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="32%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="center" valign="top">
    <B>David J. Segre<BR>
    Robert F. Kornegay<BR>
    Asaf H. Kharal<BR>
    Wilson Sonsini Goodrich &#038; Rosati P.C.<BR>
    650 Page&#160;Mill Road<BR>
    Palo Alto, CA 94304<BR>
    Telephone:
    <FONT style="white-space: nowrap">(650)&#160;493-9300</FONT><BR>
    Telecopy:
    <FONT style="white-space: nowrap">(650)&#160;493-6811</FONT></B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    <B>William M. Smith<BR>
    Vice President, Legal Affairs<BR>
    and General Counsel<BR>
    7000 Shoreline Court, Suite 100<BR>
    South San&#160;Francisco, CA 94080<BR>
    Telephone: (650) 266-6000<BR>
    Telecopy: (650) 871-7152</B>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    <B>Charles K. Ruck<BR>
    B. Shayne Kennedy<BR>
    Latham &#038; Watkins LLP<BR>
    650 Town Center Drive,
    20<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>&#160;Floor<BR>
    Costa Mesa, CA 92626<BR>
    Telephone: (714) 540-1235<BR>
    Telecopy: (714) 755-8290</B>
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>Approximate date of commencement of proposed sale to the
    public:</B>&#160;&#160;As soon as practicable after the
    effective date of this Registration Statement.
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If any of the securities being registered on this Form are to be
    offered on a delayed or continuous basis pursuant to
    Rule&#160;415 under the Securities Act, as amended, check the
    following
    box.&#160;&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;
    </FONT>
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If this Form is filed to register additional securities for an
    offering pursuant to Rule&#160;462(b) under the Securities Act,
    please check the following box and list the Securities Act
    registration statement number of the earlier effective
    registration statement for the same
    offering.&#160;&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;</FONT>&#160;<FONT style="word-spacing: 60pt; white-space: nowrap; font-size: 1pt"><U>&#173;
    &#173;</U></FONT><!-- callerid=128 iwidth=540 length=60 -->
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If this Form is a post-effective amendment filed pursuant to
    Rule&#160;462(c) under the Securities Act, check the following
    box and list the Securities Act registration statement number of
    the earlier effective registration statement for the same
    offering.&#160;&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;</FONT>&#160;<FONT style="word-spacing: 60pt; white-space: nowrap; font-size: 1pt"><U>&#173;
    &#173;</U></FONT><!-- callerid=128 iwidth=540 length=60 -->
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    If this Form is a post-effective amendment filed pursuant to
    Rule&#160;462(d) under the Securities Act, check the following
    box and list the Securities Act registration statement number of
    the earlier effective registration statement for the same
    offering.&#160;&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;</FONT>&#160;<FONT style="word-spacing: 60pt; white-space: nowrap; font-size: 1pt"><U>&#173;
    &#173;</U></FONT><!-- callerid=128 iwidth=540 length=60 -->
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Indicate by check mark whether the registrant is a large
    accelerated filer, an accelerated filer, a non-accelerated
    filer, or a smaller reporting company. See the definitions of
    &#147;large accelerated filer,&#148; &#147;accelerated
    filer&#148; and &#147;smaller reporting company&#148; in Ruler
    <FONT style="white-space: nowrap">12b-2</FONT> of the
    Exchange Act. (Check one):
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="24%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="22%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="24%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="24%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom">
<TD align="center" valign="top">
<DIV style="text-indent: -9pt; margin-left: 9pt">
    Large accelerated
    filer&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;
    </FONT>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Accelerated
    filer&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;
    </FONT>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Non-accelerated
    filer&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;
    </FONT>
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Smaller reporting
    company&#160;<FONT style="font-family: Wingdings; font-variant: normal">&#111;
    </FONT>
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="center" valign="top">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="center" valign="top">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD colspan="5" align="center" valign="top">
    (Do not check if a smaller reporting company)
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 17%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=96 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B><FONT style="font-size: 8pt">CALCULATION OF REGISTRATION
    FEE</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="70%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutterleft -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutterright -->
    <TD width="13%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutterleft -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=03 type=gutterright -->
    <TD width="13%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-top: 3px double #000000">
    <B>Proposed Maximum<BR>
    </B>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-top: 3px double #000000">
    <B>Amount of<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
    <B>Title of Each Class of<BR>
    </B>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Aggregate<BR>
    </B>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Registration<BR>
    </B>
</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD nowrap align="center" valign="bottom">
    <B>Securities to be Registered</B>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Offering Price(1)</B>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
    <B>Fee(2)(3)</B>
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom" style="border-top: 1px solid #000000">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Common Stock $0.001 par value per share
</DIV>
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-top: 1px solid #000000">
    97,520,000
</TD>
<TD style="border-right: 1px solid #000000; padding-right: 2pt; border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom" style="border-top: 1px solid #000000">
    $3,832.54
</TD>
</TR>
<TR style="font-size: 1pt">
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD style="border-top: 3px double #000000">
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom" style="border-top: 3px double #000000">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="1%"></TD>
    <TD width="1%"></TD>
    <TD width="98%"></TD>
</TR>

<TR>
    <TD align="right" valign="top">
    <FONT style="font-size: 8pt">(1)
    </FONT></TD>
    <TD></TD>
    <TD valign="bottom">
    <FONT style="font-size: 8pt">Estimated solely for the purpose of
    computing the amount of the registration fee pursuant to Rule
    457(o) under the Securities Act. Includes $12,720,000 of shares
    that the underwriters have the option to purchase to cover
    over-allotments, if any.
    </FONT></TD>
</TR>

<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>

<TR>
    <TD align="right" valign="top">
    <FONT style="font-size: 8pt">(2)
    </FONT></TD>
    <TD></TD>
    <TD valign="bottom">
    <FONT style="font-size: 8pt">Calculated pursuant to Rule 457(o)
    under the Securities Act based on an estimate of the proposed
    maximum offering price.
    </FONT></TD>
</TR>

</TABLE>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="1%"></TD>
    <TD width="1%"></TD>
    <TD width="98%"></TD>
</TR>

<TR>
    <TD align="right" valign="top">
    <FONT style="font-size: 8pt">(3)
    </FONT></TD>
    <TD></TD>
    <TD valign="bottom">
    <FONT style="font-size: 8pt">$3,832.54 previously paid.
    </FONT></TD>
</TR>

</TABLE>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 3%; font-size: 9pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>The Registrant hereby amends this Registration Statement on
    such date or dates as may be necessary to delay its effective
    date until the Registrant shall file a further amendment that
    specifically states that this Registration Statement shall
    thereafter become effective in accordance with Section&#160;8(a)
    of the Securities Act of 1933, as amended, or until the
    Registration Statement shall become effective on such date as
    the Securities and Exchange Commission, acting pursuant to such
    Section&#160;8(a), may determine.</B>
</DIV>

<DIV style="margin-top: 4pt; font-size: 1pt">&nbsp;</DIV>

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<CENTER style="font-size: 1pt; width: 100%; border-bottom: 2pt solid #000000"></CENTER><!-- callerid=999 iwidth=540 length=0 -->

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">EXPLANATORY
    NOTE</FONT></B>
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Fluidigm Corporation has prepared this Amendment No.&#160;10 to
    the Registration Statement on
    <FONT style="white-space: nowrap">Form&#160;S-1</FONT>
    <FONT style="white-space: nowrap">(File&#160;No.&#160;333-150227)</FONT>
    for the purpose of refiling Exhibits&#160;4.2 and 10.19 to the
    Registration Statement. This Amendment No.&#160;10 does not
    modify any provision of the prospectus that forms a part of the
    Registration Statement, and accordingly such prospectus has not
    been included herein.
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">PART&#160;II<BR>
    </FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">INFORMATION
    NOT REQUIRED IN PROSPECTUS</FONT></B>
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="9%"></TD>
    <TD width="91%"></TD>
</TR>

<TR valign="top">
    <TD>
    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;13.<I>&#160;&#160;</I></FONT></B>
</TD>
    <TD>
    <B><I><FONT style="font-family: 'Times New Roman', Times">Other
    Expenses of Issuance and Distribution.</FONT></I></B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The following table sets forth all expenses to be paid by the
    registrant, other than estimated underwriting discounts and
    commissions, in connection with this offering. All amounts shown
    are estimates except for the SEC registration fee, the NASD
    filing fee and the NASDAQ Global Market listing fee.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>


<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="88%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=02 type=lead -->
    <TD width="8%" align="right">&nbsp;</TD>	<!-- colindex=02 type=body -->
    <TD width="1%" align="left">&nbsp;</TD>	<!-- colindex=02 type=hang1 -->
</TR>
<!-- Table Width Row END -->
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    SEC registration fee
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    3,833
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NASD filing fee
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    9,700
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    NASDAQ Global Market listing fee
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    105,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Printing and engraving
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    390,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Legal fees and expenses
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    1,700,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Accounting fees and expenses
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    850,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Blue sky fees and expenses (including legal fees)
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    10,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Transfer agent and registrar fees
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    2,500
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="background: #CCEEFF">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 10pt">
    Miscellaneous
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
<TD nowrap align="right" valign="bottom">
    28,967
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
<TR valign="bottom" style="font-size: 1pt">
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD style="border-top: 1px solid #000000">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="left" valign="bottom">
<DIV style="text-indent: -10pt; margin-left: 20pt">
    Total
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="left" valign="bottom">
    $
</TD>
<TD nowrap align="right" valign="bottom">
    3,100,000
</TD>
<TD nowrap align="left" valign="bottom">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>


<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="9%"></TD>
    <TD width="91%"></TD>
</TR>

<TR valign="top">
    <TD>
    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;14.<I>&#160;&#160;</I></FONT></B>
</TD>
    <TD>
    <B><I><FONT style="font-family: 'Times New Roman', Times">Indemnification
    of Directors and Officers.</FONT></I></B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Section&#160;145 of the Delaware General Corporation Law
    authorizes a corporation&#146;s board of directors to grant, and
    authorizes a court to award, indemnity to officers, directors
    and other corporate agents.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    As permitted by Section&#160;102(b)(7) of the Delaware General
    Corporation Law, the registrant&#146;s certificate of
    incorporation includes provisions that eliminate the personal
    liability of its directors and officers for monetary damages for
    breach of their fiduciary duty as directors and officers.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In addition, as permitted by Section&#160;145 of the Delaware
    General Corporation Law, the bylaws of the registrant provide
    that:
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    The registrant shall indemnify its directors and officers for
    serving the registrant in those capacities or for serving other
    business enterprises at the registrant&#146;s request, to the
    fullest extent permitted by Delaware law. Delaware law provides
    that a corporation may indemnify such person if such person
    acted in good faith and in a manner such person reasonably
    believed to be in or not opposed to the best interests of the
    registrant and, with respect to any criminal proceeding, had no
    reasonable cause to believe such person&#146;s conduct was
    unlawful.
</TD>
</TR>


<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    The registrant may, in its discretion, indemnify employees and
    agents in those circumstances where indemnification is not
    required by law.
</TD>
</TR>


<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    The registrant is required to advance expenses, as incurred, to
    its directors and officers in connection with defending a
    proceeding, except that such director or officer shall undertake
    to repay such advances if it is ultimately determined that such
    person is not entitled to indemnification.
</TD>
</TR>


<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    The registrant will not be obligated pursuant to the bylaws to
    indemnify a person with respect to proceedings initiated by that
    person, except with respect to proceedings authorized by the
    registrant&#146;s Board of Directors or brought to enforce a
    right to indemnification.
</TD>
</TR>


<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    The rights conferred in the bylaws are not exclusive, and the
    registrant is authorized to enter into indemnification
    agreements with its directors, officers, employees and agents
    and to obtain insurance to indemnify such persons.
</TD>
</TR>


<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    The registrant may not retroactively amend the bylaw provisions
    to reduce its indemnification obligations to directors,
    officers, employees and agents.
</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-1
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The registrant&#146;s policy is to enter into separate
    indemnification agreements with each of its directors and
    officers that provide the maximum indemnity allowed to directors
    and executive officers by Section&#160;145 of the Delaware
    General Corporation Law and also provides for certain additional
    procedural protections. The registrant also maintains directors
    and officers insurance to insure such persons against certain
    liabilities.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    These indemnification provisions and the indemnification
    agreements entered into between the registrant and its officers
    and directors may be sufficiently broad to permit
    indemnification of the registrant&#146;s officers and directors
    for liabilities (including reimbursement of expenses incurred)
    arising under the Securities Act.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The underwriting agreement filed as Exhibit&#160;1.1 to this
    registration statement provides for indemnification by the
    underwriters of the registrant and its officers and directors
    for certain liabilities arising under the Securities Act and
    otherwise.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="9%"></TD>
    <TD width="91%"></TD>
</TR>

<TR valign="top">
    <TD>
    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;15.<I>&#160;&#160;</I></FONT></B>
</TD>
    <TD>
    <B><I><FONT style="font-family: 'Times New Roman', Times">Recent
    Sales of Unregistered Securities.</FONT></I></B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    In the three years prior to the filing of this registration
    statement, the registrant has issued the following unregistered
    securities:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;From March 2005 through July&#160;17, 2007, Fluidigm
    Corporation, a California corporation, issued and sold an
    aggregate of 134,561&#160;shares of its common stock upon the
    exercise of options issued to certain employees, directors and
    consultants under the registrant&#146;s 1999 Stock Option Plan,
    as amended, at exercise prices ranging from $1.05 to $2.90, for
    aggregate consideration of $188,442. From July&#160;18, 2007
    through May&#160;22,&#160;2008, the registrant issued and sold
    an aggregate of 71,634&#160;shares of its common stock upon the
    exercise of options issued to certain employees, directors and
    consultants under the registrant&#146;s 1999 Stock Option Plan,
    as amended, at exercise prices ranging from $1.05 to $4.76 per
    share, for aggregate consideration of $123,346.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;From March 2005 through July&#160;17, 2007, Fluidigm
    Corporation, a California corporation, granted to certain of its
    employees, directors and consultants under the registrant&#146;s
    1999 Stock Option Plan, as amended, options to purchase an
    aggregate of 1,138,869&#160;shares of its common stock at
    exercise prices ranging from $1.05 to $4.76 per share. From
    July&#160;18, 2007 through May&#160;22, 2008, the registrant
    granted to certain of its employees, directors and consultants
    under the registrant&#146;s 1999 Stock Option Plan, as amended,
    options to purchase an aggregate of 129,200&#160;shares of the
    registrant&#146;s common stock at exercise prices ranging from
    $4.83 to $8.40 per share.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (c)&#160;In March and December 2005, Fluidigm Corporation, a
    California corporation, pursuant to a loan and security
    agreement, issued and sold warrants to purchase
    106,122&#160;shares of its Series&#160;D Preferred Stock to one
    accredited investor at an exercise price of $9.80 per share. In
    connection with the registrant&#146;s reincorporation into the
    State of Delaware on July&#160;18, 2007, the warrant was
    converted into a warrant to purchase an equal number of shares
    of the registrant&#146;s Series&#160;D Preferred Stock.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (d)&#160;In November 2005, Fluidigm Corporation, a California
    corporation, issued and sold 20,000&#160;shares of its common
    stock to one accredited investor at an issuance price of $1.96
    per share for aggregate monetary consideration of $39,200, which
    amount was deemed paid by the transfer of certain rights granted
    to registrant pursuant to the terms of a licensing agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (e)&#160;In December 2005, Fluidigm Corporation, a California
    corporation, issued 237,895&#160;shares of its Series&#160;D
    Preferred Stock to one accredited investor in connection with
    the conversion of a convertible promissory note at a conversion
    price per share of $9.80.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (f)&#160;In June 2006, Fluidigm Corporation, a California
    corporation, issued to one accredited investor a convertible
    promissory notes in an aggregate principal amount of $3,000,000
    convertible into shares of its Series&#160;D Preferred Stock. In
    July 2007, the notes were converted into 330,612&#160;shares of
    Series&#160;D Preferred Stock at a conversion price per share of
    $9.80.
</DIV>


<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (g)&#160;In April 2006, Fluidigm Corporation, a California
    corporation, issued an aggregate of 61,223&#160;shares of its
    Series&#160;D Preferred Stock to UAB Research Foundation
    pursuant to the terms of a Master Closing Agreement by and among
    UAB Research Foundation, Oculus Pharmaceuticals, Inc. and
    Fluidigm Corporation, at an issuance price of $9.80 per share,
    for aggregate monetary consideration of $599,998, which
</DIV>


<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-2
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    amount was deemed paid by the transfer of certain rights granted
    to registrant pursuant to the terms of such agreement and the
    achievement of certain milestones thereunder; at the request of
    UAB, 26,530 of such shares were issued to Oculus
    Pharmaceuticals, Inc., 10,204 of such shares were issued to
    Athersys, Inc. and 24,489 of such shares were issued to UAB
    Research Foundation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (h)&#160;In June 2006, Fluidigm Corporation, a California
    corporation, issued 76,530&#160;shares of its Series&#160;D
    Preferred Stock to one accredited investor in connection with
    the exercise of a warrant to purchase shares of its
    Series&#160;D Preferred Stock at an exercise price per share of
    $9.80.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;From August 2006 through April 2007, Fluidigm
    Corporation, a California corporation, issued three convertible
    promissory notes to one accredited investor in an aggregate
    principal amount of $15,000,000, all of which were convertible
    into shares of its Series&#160;E Preferred Stock. In March 2007,
    two of the notes were converted into an aggregate of
    844,095&#160;shares of the Series&#160;E Preferred Stock of
    Fluidigm Corporation, a California corporation. In connection
    with the registrant&#146;s reincorporation into the State of
    Delaware on July&#160;18, 2007, the remaining outstanding
    convertible promissory note was made convertible into shares of
    the registrant&#146;s Series&#160;E Preferred Stock.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (j)&#160;In March 2007, Fluidigm Corporation, a California
    corporation, issued 28,571&#160;shares of its common stock to
    one accredited investor at an issuance price of $2.90 per share,
    for aggregate monetary consideration of $83,000, which amount
    was deemed paid by the transfer of certain rights granted to
    registrant pursuant to the terms of a licensing agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (k)&#160;In May 2007, Fluidigm Corporation, a California
    corporation, granted to seven of its employees and directors
    under the registrant&#146;s 1999 Stock Option Plan, as amended,
    options to purchase an aggregate of 219,142&#160;shares of its
    common stock at an exercise price of $4.76 per share.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (l)&#160;In connection with the registrant&#146;s
    reincorporation into the State of Delaware on July&#160;18,
    2007, the registrant issued an aggregate of
    2,770,285&#160;shares of common stock to a total of 128
    stockholders in exchange for the outstanding shares of common
    stock Fluidigm Corporation, a California corporation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (m)&#160;In connection with the registrant&#146;s
    reincorporation into the State of Delaware on July&#160;18,
    2007, the registrant issued an aggregate of 779,220&#160;shares
    of the registrant&#146;s Series&#160;A Preferred Stock to a
    total of 41 investors in exchange for the outstanding shares of
    Series&#160;A Preferred Stock of Fluidigm Corporation, a
    California corporation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (n)&#160;In connection with the registrant&#146;s
    reincorporation into the State of Delaware on July&#160;18,
    2007, the registrant issued an aggregate of
    1,845,907&#160;shares of the registrant&#146;s Series&#160;B
    Preferred Stock to a total of 35 investors in exchange for the
    outstanding shares of Series&#160;B Preferred Stock of Fluidigm
    Corporation, a California corporation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (o)&#160;In connection with the registrant&#146;s
    reincorporation into the State of Delaware on July&#160;18,
    2007, the registrant issued an aggregate of
    4,675,666&#160;shares of the registrant&#146;s Series&#160;C
    Preferred Stock to a total of 62 investors in exchange for the
    outstanding shares of Series&#160;C Preferred Stock of Fluidigm
    Corporation, a California corporation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (p)&#160;In connection with the registrant&#146;s
    reincorporation into the State of Delaware on July&#160;18,
    2007, the registrant issued an aggregate of
    3,484,626&#160;shares of the registrant&#146;s Series&#160;D
    Preferred Stock to a total of 52 investors in exchange for the
    outstanding shares of Series&#160;D Preferred Stock of Fluidigm
    Corporation, a California corporation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (q)&#160;In connection with the registrant&#146;s
    reincorporation into the State of Delaware on July&#160;18,
    2007, the registrant issued an aggregate of
    2,562,810&#160;shares of the registrant&#146;s Series&#160;E
    Preferred Stock to a total of 35 investors in exchange for the
    outstanding shares of Series&#160;E Preferred Stock of Fluidigm
    Corporation, a California corporation.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (r)&#160;From October 2007 through December 2007, the registrant
    issued and sold an aggregate of 2,512,841&#160;shares of
    Series&#160;E Preferred Stock to a total of seven investors at
    $14.00 per share, for aggregate proceeds of $35,179,780.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-3
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (s)&#160;In December 2007, the registrant issued
    1,714&#160;shares of its common stock to one accredited investor
    at an issuance price of $4.76 per share for aggregate monetary
    consideration of $8,160, which amount was deemed paid by the
    transfer of certain rights granted to registrant pursuant to the
    terms of a licensing agreement.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (t)&#160;In December 2007, the registrant granted to one of its
    directors under the registrant&#146;s 1999 Stock Option Plan, as
    amended, options to purchase an aggregate of 28,571&#160;shares
    of the registrant&#146;s common stock at an exercise price of
    $8.40 per share.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (u)&#160;In February and June 2008, the registrant issued a
    warrant to purchase 28,572 and 57,142&#160;shares of the
    registrant&#146;s Series&#160;E Preferred Stock to one
    accredited investor at an exercise price of $14.00 per share.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (v)&#160;In February 2008, the registrant granted to one of its
    executive officers under the registrant&#146;s 1999 Stock Option
    Plan, as amended, options to purchase an aggregate of
    171,427&#160;shares of the registrant&#146;s common stock at an
    exercise price of $8.40 per share.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (w)&#160;In April 2008, the registrant granted to 110 of its
    employees, consultants and directors under the registrant&#146;s
    1999 Stock Option Plan, as amended, options to purchase an
    aggregate of 546,711&#160;shares of its common stock at an
    exercise price of $11.16 per share.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (x)&#160;On May&#160;12, 2008, the registrant issued
    4,692&#160;shares of its Series&#160;C Preferred Stock to
    Imperial Bank pursuant to Imperial Bank&#146;s net exercise of
    its warrant to purchase up to 11,795&#160;shares of
    Series&#160;C Preferred Stock. The remainder of the warrant was
    cancelled pursuant to the terms of the net exercise.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (y)&#160;In June 2008, the registrant granted to seven of its
    employees and consultants under the registrant&#146;s 1999 Stock
    Option Plan, as amended, options to purchase an aggregate of
    24,426&#160;shares of its common stock at an exercise price of
    $11.97 per share.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (z)&#160;In August 2008, the registrant granted to eight of its
    employees under the registrant&#146;s 1999 Stock Option Plan, as
    amended, options to purchase an aggregate of 18,426&#160;shares
    of its common stock at an exercise price of $12.71 per share.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    None of the foregoing transactions involved any underwriters,
    underwriting discounts or commissions, or any public offering,
    and the registrant believes that each transaction was exempt
    from the registration requirements of the Securities Act in
    reliance on the following exemptions:
</DIV>

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="4%"></TD>
    <TD width="2%"></TD>
    <TD width="94%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to the transactions described in paragraphs
    (a)&#160;and (b), Rule&#160;701 promulgated under the Securities
    Act as transactions pursuant to a compensatory benefit plan
    approved by the registrant&#146;s Board of Directors;
</TD>
</TR>


<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to the transactions described in paragraphs (1)
    through (q), Rule&#160;145(a)(2) promulgated under the
    Securities Act as transactions pursuant to a plan or agreement
    for statutory merger or similar plan or acquisition in which
    securities of the registrant were exchanged for the securities
    of Fluidigm Corporation, a California corporation, the sole
    purpose of which was to change the registrant&#146;s domicile
    solely within the United States, and a Permit granted pursuant
    to Section 25121 of the California Corporations Code;&#160;and
</TD>
</TR>


<TR style="line-height: 3pt; font-size: 1pt"><TD>&nbsp;</TD></TR>


<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    &#149;&#160;
</TD>
    <TD align="left">
    with respect to the transactions described in paragraphs
    (c)&#160;through (k) and paragraphs (r) through (z),
    Section&#160;4(2) of the Securities Act, or Rule&#160;506 of
    Regulation&#160;D promulgated thereunder, as transactions by an
    issuer not involving a public offering. Each recipient of the
    securities in this transaction represented his or her intention
    to acquire the securities for investment only and not with a
    view to, or for resale in connection with, any distribution
    thereof, and appropriate legends were affixed to the share
    certificates issued in each such transaction. In each case, the
    recipient received adequate information about the registrant or
    had adequate access, through his or her relationship with the
    registrant, to information about the registrant.
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

<TR>
    <TD width="9%"></TD>
    <TD width="91%"></TD>
</TR>

<TR valign="top">
    <TD>
    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;16.<I>&#160;&#160;</I></FONT></B>
</TD>
    <TD>
    <B><I><FONT style="font-family: 'Times New Roman', Times">Exhibits
    and Financial Statement Schedules.</FONT></I></B>
</TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (a)&#160;<I>Exhibits.</I>&#160;&#160;The following exhibits are
    included herein or incorporated herein by reference:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="6%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="85%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Exhibit Number</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Description</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    1
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Underwriting Agreement.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Certificate of Incorporation of the Registrant, as currently in
    effect.<FONT size="1">

</FONT>
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-4
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left"><FONT size="1">

</FONT></DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="6%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="85%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Exhibit Number</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Description</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .2<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Restated Certificate of Incorporation of the Registrant,
    to be in effect upon the completion of this offering.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .3<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Bylaws of the Registrant.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .4<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Amended and Restated Bylaws of the Registrant, to be in
    effect upon completion of this offering.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Specimen Common Stock Certificate of the Registrant.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .2<SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Series&#160;E Preferred Stock Purchase Agreement dated
    June&#160;13, 2006 through December&#160;31, 2007 between the
    Registrant and the Purchasers set forth therein, as amended.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .3<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Eighth Amended and Restated Investor Rights Agreement between
    the Registrant and certain holders of the Registrant&#146;s
    common stock named therein, including amendments No.&#160;1 and
    No.&#160;2.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .4<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Loan and Security Agreement No.&#160;4561 between the Registrant
    and Lighthouse Capital Partners&#160;V, L.P. dated
    March&#160;29, 2005, including amendments Nos. 1 through 4.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .4A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Preferred Stock Purchase Warrant issued to Lighthouse Capital
    Partners&#160;V, L.P. effective March&#160;29, 2005.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .4B<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Negative Pledge Agreement by and between the Registrant and
    Lighthouse Capital Partners&#160;V, L.P. dated March&#160;29,
    2005.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .5<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Convertible Note Purchase Agreement by and between Biomedical
    Sciences Investment Fund&#160;Pte Ltd and the Registrant dated
    August&#160;7, 2006.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .5A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Convertible Promissory Note issued to Biomedical Sciences
    Investment Fund&#160;Pte Ltd dated April&#160;19, 2007, as
    amended.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .6<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Action By Written Consent of the holders of Preferred Stock of
    the Registrant effective as of August&#160;25, 2008 consenting
    to the Conversion of all Preferred Stock.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    5
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Opinion of Wilson Sonsini Goodrich&#160;&#038; Rosati,
    Professional Corporation.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Indemnification Agreement between the Registrant and its
    directors and officers.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .2<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    1999 Stock Plan of the Registrant, as amended April&#160;24,
    2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .2A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Forms of agreements under the 1999 Stock Plan.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .3<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    2008 Equity Incentive Plan.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .3A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Forms of agreements under the 2008 Equity Incentive Plan.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .4<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Second Amended and Restated License Agreement by and between
    California Institute of Technology and the Registrant effective
    as of May&#160;1, 2004.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .4A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    First Addendum, effective as of March&#160;29, 2007, to Second
    Amended and Restated License Agreement by and between California
    Institute of Technology and the Registrant effective as of
    May&#160;1, 2004.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .5<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Co-Exclusive License Agreement between President and Fellows of
    Harvard College and the Registrant effective as of
    October&#160;15, 2000.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .5A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    First Amendment to Co-Exclusive License Agreement between
    President and Fellows of Harvard College and the Registrant
    effective as of October&#160;15, 2000.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .6<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Co-Exclusive License Agreement between President and Fellows of
    Harvard College and the Registrant effective as of
    October&#160;15, 2000.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .7<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Co-Exclusive License Agreement between President and Fellows of
    Harvard College and the Registrant effective as of
    October&#160;15, 2000.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .8<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Patent License Agreement by and between Gyros AB and the
    Registrant dated January&#160;9, 2003.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .8A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amendment No.&#160;1 dated January&#160;9, 2005 to Patent
    License Agreement by and between Gyros AB and the Registrant
    dated January&#160;9, 2003.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .9<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Master Closing Agreement by and between UAB Research Foundation,
    Oculus Pharmaceuticals, Inc. and the Registrant dated
    March&#160;7, 2003.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .9A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    License Agreement by and between UAB Research Foundation and the
    Registrant dated March&#160;7,
    2003.<FONT size="1">

</FONT>
</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-5
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left"><FONT size="1">

</FONT></DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="6%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="85%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Exhibit Number</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Description</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .10<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated Letter Agreement Regarding Application for
    Incentives Under the Research Incentive Scheme for Companies
    (RISC) dated March&#160;27, 2008 (originally dated
    October&#160;7, 2005), by and between Singapore Economic
    Development Board and Fluidigm Singapore Pte. Ltd.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .10A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Supplement Dated January&#160;11, 2006 to Letter Agreement
    Relating to Application for Incentives under the Research
    Incentive Scheme for Companies (RISC), dated October&#160;7,
    2005 between Singapore Economic Development Board and Fluidigm
    Singapore Pte. Ltd.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .11<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated Letter Agreement Regarding Application for
    Incentives Under the Research Incentive Scheme for Companies
    (RISC) dated March&#160;27, 2008 (originally dated
    February&#160;12, 2007), by and between Singapore Economic
    Development Board and Fluidigm Singapore Pte. Ltd.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .12<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Distribution Agreement by and between Eppendorf AG and the
    Registrant effective as of April&#160;1, 2005.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .12A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    First Amendment, effective as of December&#160;1, 2007, to the
    Distribution Agreement by and between Eppendorf AG and the
    Registrant effective as of April&#160;1, 2005.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .13<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Employment and Severance Agreement between the
    Registrant and each of its executive officers.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .14<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Consulting Agreement by and between the Registrant and Richard
    DeLateur dated February&#160;29, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .15<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Employee Loan Agreement with Gajus Worthington dated
    January&#160;20, 2004.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .15A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Stock Repurchase Agreement between the Registrant and Gajus V.
    Worthington dated April&#160;10, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .16<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Offer Letter to Vikram Jog dated January&#160;29, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .17<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Settlement Agreement and General Release of all Claims by and
    between Michael Ybarra Lucero and the Registrant dated
    March&#160;20, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .18<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Letter Agreement between President and Fellows of Harvard
    College and the Registrant dated December&#160;22, 2004.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .19
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Sublease, dated March&#160;25, 2004, between Genome Therapeutics
    Corporation as Sublessor and Fluidigm Corporation as Sublessee
    and amendment thereto, and related master lease agreements and
    amendments thereto.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .20<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Tenancy for Flatted Factory Space in Singapore between JTC
    Corporation and the Registrant dated July 27, 2005 and August
    12, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    21
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    List of subsidiaries of Registrant.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    23
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Consent of Independent Registered Public Accounting Firm.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    23
</TD>
<TD nowrap align="left" valign="top">
    .2<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Consent of Wilson Sonsini Goodrich&#160;&#038; Rosati,
    Professional Corporation (included in Exhibit&#160;5.1).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    24
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Power of Attorney.
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 12pt; margin-left: 0%; width: 10%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=455 length=48 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="2%"></TD>
    <TD width="1%"></TD>
    <TD width="97%"></TD>
</TR>

<TR>
    <TD valign="top">
    <FONT style="font-size: 8pt">(1)
    </FONT></TD>
    <TD></TD>
    <TD valign="bottom">
    <FONT style="font-size: 8pt">To be filed by amendment.
    </FONT></TD>
</TR>




<TR>
    <TD valign="top">
    <FONT style="font-size: 8pt">(2)
    </FONT></TD>
    <TD></TD>
    <TD valign="bottom">
    <FONT style="font-size: 8pt">Confidential treatment has been
    requested with respect to certain portions of this exhibit.
    Omitted portions have been filed separately with the Securities
    and Exchange Commission.
    </FONT></TD>
</TR>



<TR>
    <TD valign="top">
    <FONT style="font-size: 8pt">(3)
    </FONT></TD>
    <TD></TD>
    <TD valign="bottom">
    <FONT style="font-size: 8pt">Previously filed.
    </FONT></TD>
</TR>

</TABLE>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (b)&#160;<I>Financial Statement Schedules.</I>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    All schedules have been omitted because the information required
    to be presented in them is not applicable or is shown in the
    consolidated financial statements or related notes.
</DIV>

<DIV style="margin-top: 12pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">Item&#160;17.&#160;&#160;<I>Undertakings.</I></FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The undersigned registrant hereby undertakes to provide to the
    underwriters at the closing specified in the underwriting
    agreement certificates in such denominations and registered in
    such names as required by the underwriters to permit prompt
    delivery to each purchaser.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    II-6
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Insofar as indemnification for liabilities arising under the
    Securities Act of 1933&#160;may be permitted to directors,
    officers and controlling persons of the registrant pursuant to
    the foregoing provisions, or otherwise, the registrant has been
    advised that in the opinion of the Securities and Exchange
    Commission such indemnification is against public policy as
    expressed in the Act and is, therefore, unenforceable. In the
    event that a claim for indemnification against such liabilities
    (other than the payment by the registrant of expenses incurred
    or paid by a director, officer or controlling person of the
    registrant in the successful defense of any action, suit or
    proceeding) is asserted by such director, officer or controlling
    person in connection with the securities being registered, the
    registrant will, unless in the opinion of its counsel the matter
    has been settled by controlling precedent, submit to a court of
    appropriate jurisdiction the question whether such
    indemnification by it is against public policy as expressed in
    the Act and will be governed by the final adjudication of such
    issue.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    The undersigned registrant hereby undertakes that:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (1)&#160;For purposes of determining any liability under the
    Securities Act of 1933, the information omitted from the form of
    prospectus filed as part of this registration statement in
    reliance upon Rule&#160;430A and contained in a form of
    prospectus filed by the registrant pursuant to
    Rule&#160;424(b)(1) or (4)&#160;or 497(h) under the Securities
    Act shall be deemed to be part of this registration statement as
    of the time it was declared effective.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (2)&#160;For the purpose of determining any liability under the
    Securities Act of 1933, each post effective amendment that
    contains a form of prospectus shall be deemed to be a new
    registration statement relating to the securities offered
    therein, and the offering of such securities at that time shall
    be deemed to be the initial bona fide offering thereof.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (3)&#160;For the purpose of determining liability under the
    Securities Act of 1933 to any purchaser, if the registrant is
    subject to Rule&#160;430C, each prospectus filed pursuant to
    Rule&#160;424(b) as part of a registration statement relating to
    an offering, other than registration statements relying on
    Rule&#160;430B or other than prospectuses filed in reliance on
    Rule 430A, shall be deemed to be part of and included in the
    registration statement as of the date it is first used after
    effectiveness; provided, however, that no statement made in a
    registration statement or prospectus that is part of the
    registration statement or made in a document incorporated or
    deemed incorporated by reference into the registration statement
    or prospectus that is part of the registration statement will,
    as to a purchaser with a time of contract of sale prior to such
    first use, supersede or modify any statement that was made in
    the registration statement or prospectus that was part of the
    registration statement or made in any such document immediately
    prior to such date of first use.
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 4%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (4)&#160;For the purpose of determining liability of the
    registrant under the Securities Act of 1933 to any purchaser to
    the initial distribution of the securities, the undersigned
    registrant undertakes that in a primary offering of securities
    of the undersigned registrant pursuant to this registration
    statement, regardless of the underwriting method used to sell
    the securities to the purchaser, if the securities are offered
    or sold to such purchaser by means of any of the following
    communications, the undersigned registrant will be a seller to
    the purchasers and will be considered to offer or sell such
    securities to such purchaser:
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (i)&#160;Any preliminary prospectus or prospectus of the
    undersigned registrant relating to the offering required to be
    filed pursuant to Rule&#160;424;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (ii)&#160;Any free writing prospectus relating to the offering
    prepared by or on behalf of the undersigned registrant or used
    or referred to by the undersigned registrant;
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (iii)&#160;The portion of any other free writing prospectus
    relating to the offering containing material information about
    the undersigned registrant or its securities provided by or on
    behalf of the undersigned registrant;&#160;and
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 8%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    (iv)&#160;Any other communication that is an offer in the
    offering made by the undersigned registrant to the purchaser.
</DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-7
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">SIGNATURES</FONT></B>
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, the
    Registrant has duly caused this Amendment No.&#160;10 to the
    registration statement to be signed on its behalf by the
    undersigned, thereunto duly authorized, in the City of South San
    Francisco, State of California, on the 18th day of September
    2008.
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 24pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 49%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <B>FLUIDIGM CORPORATION</B>
</DIV>

<DIV style="margin-top: 36pt; font-size: 1pt">&nbsp;</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0">

<TR>
    <TD width="49%"></TD>
    <TD width="4%"></TD>
    <TD width="47%"></TD>
</TR>

<TR valign="top" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <TD>&nbsp;</TD>
    <TD>    By:&#160;
</TD>
    <TD align="center">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Gajus
    V. Worthington</FONT></DIV>
</TD>
</TR>

</TABLE>

<DIV style="font-size: 2pt; margin-left: 53%; width: 100%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=455 length=0 -->

<DIV align="center" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Gajus V. Worthington
</DIV>

<DIV align="center" style="margin-left: 53%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <I>President and Chief Executive Officer</I>
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    Pursuant to the requirements of the Securities Act of 1933, this
    Amendment No. 10 to the registration statement has been signed
    by the following persons in the capacities indicated on the 18th
    day of September&#160;2008.
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="6%">&nbsp;</TD>	<!-- colindex=01 type=maindata -->
    <TD width="1%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="38%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=03 type=gutter -->
    <TD width="32%">&nbsp;</TD>	<!-- colindex=03 type=maindata -->
    <TD width="3%">&nbsp;</TD>	<!-- colindex=04 type=gutter -->
    <TD width="17%">&nbsp;</TD>	<!-- colindex=04 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 10pt">Signature</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 10pt">Title</FONT></B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B><FONT style="font-size: 10pt">Date</FONT></B>
</DIV>
</TD>
</TR>
<TR style="line-height: 12pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Gajus
    V. Worthington</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=198 length=0 -->Gajus
    V. Worthington
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    President, Chief Executive Officer and Director (Principal
    Executive Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    September&#160;18, 2008
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Vikram
    Jog</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=198 length=0 -->Vikram
    Jog
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    Chief Financial Officer (Principal Accounting and Financial
    Officer)
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    September&#160;18, 2008
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%"><FONT style="font-variant: SMALL-CAPS">*</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=198 length=0 -->Samuel
    Colella
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    September&#160;18, 2008
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%"><FONT style="font-variant: SMALL-CAPS">*</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=198 length=0 -->Michael
    W. Hunkapiller
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    September&#160;18, 2008
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%"><FONT style="font-variant: SMALL-CAPS">*</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=198 length=0 -->Elaine
    V. Jones
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    September&#160;18, 2008
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%"><FONT style="font-variant: SMALL-CAPS">*</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=198 length=0 -->Kenneth
    Nussbacher
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    September&#160;18, 2008
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD colspan="3">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD colspan="3" align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%"><FONT style="font-variant: SMALL-CAPS">*</FONT></DIV><BR>
    <DIV style="font-size: 2pt; margin-left: 0%; width: 100%; border-bottom: 1pt solid #000000"></DIV><!-- callerid=201 iwidth=198 length=0 -->John
    A. Young
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    Director
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
    September&#160;18, 2008
</TD>
</TR>
<TR valign="bottom" style="line-height: 6pt">
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="center" valign="top">
    *By:
</TD>
<TD>
&nbsp;
</TD>
<TD align="center" valign="top">
    <DIV style="display:inline; text-align:center; width:90%">/s/&#160;&#160;<FONT style="font-variant: SMALL-CAPS">Gajus
    V. Worthington</FONT></DIV><BR>
    <CENTER style="font-size: 1pt; width: 100%; border-bottom: 1pt solid #000000"></CENTER><!-- callerid=208 iwidth=174 length=0 -->Gajus
    V. Worthington<BR>
    Attorney-in-Fact
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
&nbsp;
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="top">
&nbsp;
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<P align="center" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
    <BR>
    II-8
</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: #FFFFFF">

    <B><FONT style="font-family: 'Times New Roman', Times">EXHIBIT&#160;INDEX</FONT></B>
</DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="6%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="85%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Exhibit Number</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Description</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    1
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Underwriting Agreement.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Certificate of Incorporation of the Registrant, as currently in
    effect.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .2<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Restated Certificate of Incorporation of the Registrant,
    to be in effect upon the completion of this offering.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .3<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Bylaws of the Registrant.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    3
</TD>
<TD nowrap align="left" valign="top">
    .4<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Amended and Restated Bylaws of the Registrant, to be in
    effect upon completion of this offering.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Specimen Common Stock Certificate of the Registrant.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .2<SUP style="font-size: 85%; vertical-align: text-top">(2)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Series&#160;E Preferred Stock Purchase Agreement dated
    June&#160;13, 2006 through December&#160;31, 2007 between the
    Registrant and the Purchasers set forth therein, as amended.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .3<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Eighth Amended and Restated Investor Rights Agreement between
    the Registrant and certain holders of the Registrant&#146;s
    common stock named therein, including amendments No.&#160;1 and
    No.&#160;2.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .4<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Loan and Security Agreement No.&#160;4561 between the Registrant
    and Lighthouse Capital Partners&#160;V, L.P. dated
    March&#160;29, 2005, including amendments Nos. 1 through 4.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .4A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Preferred Stock Purchase Warrant issued to Lighthouse Capital
    Partners&#160;V, L.P. effective March&#160;29, 2005.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .4B<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Negative Pledge Agreement by and between the Registrant and
    Lighthouse Capital Partners&#160;V, L.P. dated March&#160;29,
    2005.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .5<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Convertible Note Purchase Agreement by and between Biomedical
    Sciences Investment Fund&#160;Pte Ltd and the Registrant dated
    August&#160;7, 2006.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .5A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Convertible Promissory Note issued to Biomedical Sciences
    Investment Fund&#160;Pte Ltd dated April&#160;19, 2007, as
    amended.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    4
</TD>
<TD nowrap align="left" valign="top">
    .6<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Action By Written Consent of the holders of Preferred Stock of
    the Registrant effective as of August&#160;25, 2008 consenting
    to the Conversion of all Preferred Stock.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    5
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Opinion of Wilson Sonsini Goodrich&#160;&#038; Rosati,
    Professional Corporation.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Indemnification Agreement between the Registrant and its
    directors and officers.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .2<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    1999 Stock Plan of the Registrant, as amended April&#160;24,
    2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .2A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Forms of agreements under the 1999 Stock Plan.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .3<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    2008 Equity Incentive Plan.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .3A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Forms of agreements under the 2008 Equity Incentive Plan.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .4<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Second Amended and Restated License Agreement by and between
    California Institute of Technology and the Registrant effective
    as of May&#160;1, 2004.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .4A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    First Addendum, effective as of March&#160;29, 2007, to Second
    Amended and Restated License Agreement by and between California
    Institute of Technology and the Registrant effective as of
    May&#160;1, 2004.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .5<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Co-Exclusive License Agreement between President and Fellows of
    Harvard College and the Registrant effective as of
    October&#160;15, 2000.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .5A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    First Amendment to Co-Exclusive License Agreement between
    President and Fellows of Harvard College and the Registrant
    effective as of October&#160;15, 2000.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .6<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Co-Exclusive License Agreement between President and Fellows of
    Harvard College and the Registrant effective as of
    October&#160;15, 2000.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .7<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Co-Exclusive License Agreement between President and Fellows of
    Harvard College and the Registrant effective as of
    October&#160;15, 2000.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .8<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Patent License Agreement by and between Gyros AB and the
    Registrant dated January&#160;9, 2003.
</TD>
</TR>
</TABLE>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="width: 87%; margin-left: 6%"><!-- BEGIN PAGE WIDTH -->

<DIV align="left"><FONT size="1">

</FONT></DIV>

<TABLE border="0" width="100%" align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">
<!-- Table Width Row BEGIN -->
<TR style="font-size: 1pt" valign="bottom">
    <TD width="6%" align="right">&nbsp;</TD>	<!-- colindex=01 type=lead -->
    <TD width="1%" align="right">&nbsp;</TD>	<!-- colindex=01 type=body -->
    <TD width="6%" align="left">&nbsp;</TD>	<!-- colindex=01 type=align1 -->
    <TD width="2%">&nbsp;</TD>	<!-- colindex=02 type=gutter -->
    <TD width="85%">&nbsp;</TD>	<!-- colindex=02 type=maindata -->
</TR>
<!-- Table Width Row END -->
<TR style="font-size: 8pt" valign="bottom" align="center">
<TD colspan="3" nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Exhibit Number</B>
</DIV>
</TD>
<TD>
&nbsp;
</TD>
<TD nowrap align="center" valign="bottom">
<DIV style="border-bottom: 1px solid #000000; width: 1%; padding-bottom: 1px">
    <B>Description</B>
</DIV>
</TD>
</TR>
<TR style="line-height: 3pt; font-size: 1pt">
<TD>&nbsp;
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .8A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amendment No.&#160;1 dated January&#160;9, 2005 to Patent
    License Agreement by and between Gyros AB and the Registrant
    dated January&#160;9, 2003.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .9<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Master Closing Agreement by and between UAB Research Foundation,
    Oculus Pharmaceuticals, Inc. and the Registrant dated
    March&#160;7, 2003.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .9A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    License Agreement by and between UAB Research Foundation and the
    Registrant dated March&#160;7, 2003.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .10<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated Letter Agreement Regarding Application for
    Incentives Under the Research Incentive Scheme for Companies
    (RISC) dated March&#160;27, 2008 (originally dated
    October&#160;7, 2005), by and between Singapore Economic
    Development Board and Fluidigm Singapore Pte. Ltd.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .10A<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Supplement Dated January&#160;11, 2006 to Letter Agreement
    Relating to Application for Incentives under the Research
    Incentive Scheme for Companies (RISC), dated October&#160;7,
    2005 between Singapore Economic Development Board and Fluidigm
    Singapore Pte. Ltd.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .11<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Amended and Restated Letter Agreement Regarding Application for
    Incentives Under the Research Incentive Scheme for Companies
    (RISC) dated March&#160;27, 2008 (originally dated
    February&#160;12, 2007), by and between Singapore Economic
    Development Board and Fluidigm Singapore Pte. Ltd.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .12<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Distribution Agreement by and between Eppendorf AG and the
    Registrant effective as of April&#160;1, 2005.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .12A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    First Amendment, effective as of December&#160;1, 2007, to the
    Distribution Agreement by and between Eppendorf AG and the
    Registrant effective as of April&#160;1, 2005.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .13<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Form of Employment and Severance Agreement between the
    Registrant and each of its executive officers.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .14<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Consulting Agreement by and between the Registrant and Richard
    DeLateur dated February&#160;29, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .15<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Employee Loan Agreement with Gajus Worthington dated
    January&#160;20, 2004.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .15A<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Stock Repurchase Agreement between the Registrant and Gajus V.
    Worthington dated April&#160;10, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .16<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Offer Letter to Vikram Jog dated January&#160;29, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .17<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Settlement Agreement and General Release of all Claims by and
    between Michael Ybarra Lucero and the Registrant dated
    March&#160;20, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .18<SUP style="font-size: 85%; vertical-align: text-top">(2)(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Letter Agreement between President and Fellows of Harvard
    College and the Registrant dated December&#160;22, 2004.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .19
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Sublease, dated March&#160;25, 2004, between Genome Therapeutics
    Corporation as Sublessor and Fluidigm Corporation as Sublessee
    and amendment thereto, and related master lease agreements and
    amendments thereto.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    10
</TD>
<TD nowrap align="left" valign="top">
    .20<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Tenancy for Flatted Factory Space in Singapore between JTC
    Corporation and the Registrant dated July 27, 2005 and August
    12, 2008.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    21
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    List of subsidiaries of Registrant.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    23
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Consent of Independent Registered Public Accounting Firm.
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    23
</TD>
<TD nowrap align="left" valign="top">
    .2<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Consent of Wilson Sonsini Goodrich&#160;&#038; Rosati,
    Professional Corporation (included in Exhibit&#160;5.1).
</TD>
</TR>
<TR valign="bottom">
<TD nowrap align="right" valign="top">
&nbsp;
</TD>
<TD nowrap align="right" valign="top">
    24
</TD>
<TD nowrap align="left" valign="top">
    .1<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP>
</TD>
<TD>
&nbsp;
</TD>
<TD align="left" valign="top">
    Power of Attorney.
</TD>
</TR>
</TABLE>

<DIV align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV style="margin-top: 6pt; font-size: 1pt">&nbsp;</DIV>

<DIV style="font-size: 12pt; margin-left: 0%; width: 10%;  align: left; border-bottom: 1pt solid #000000"></DIV><!-- callerid=999 iwidth=455 length=48 -->

<DIV style="margin-top: 3pt; font-size: 1pt">&nbsp;</DIV>



<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

<TR>
    <TD width="2%"></TD>
    <TD width="1%"></TD>
    <TD width="97%"></TD>
</TR>

<TR>
    <TD valign="top">
    <FONT style="font-size: 8pt">(1)
    </FONT></TD>
    <TD></TD>
    <TD valign="bottom">
    <FONT style="font-size: 8pt">To be filed by amendment.
    </FONT></TD>
</TR>




<TR>
    <TD valign="top">
    <FONT style="font-size: 8pt">(2)
    </FONT></TD>
    <TD></TD>
    <TD valign="bottom">
    <FONT style="font-size: 8pt">Confidential treatment has been
    requested with respect to certain portions of this exhibit.
    Omitted portions have been filed separately with the Securities
    and Exchange Commission.
    </FONT></TD>
</TR>



<TR>
    <TD valign="top">
    <FONT style="font-size: 8pt">(3)
    </FONT></TD>
    <TD></TD>
    <TD valign="bottom">
    <FONT style="font-size: 8pt">Previously filed.
    </FONT></TD>
</TR>

</TABLE>

<P align="left" style="font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: #FFFFFF">

</DIV><!-- END PAGE WIDTH -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>f39432xexv4w2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
<TITLE>exv4w2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;4.2</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FLUIDIGM CORPORATION</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>SERIES E PREFERRED STOCK PURCHASE AGREEMENT</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>First Closing: June&nbsp;13, 2006<BR>
Second Closing: December&nbsp;22, 2006<BR>
Third Closing: March&nbsp;30, 2007<BR>
Fourth Extended Closing: October&nbsp;10, 2007<BR>
Fifth Extended Closing: October&nbsp;26, 2007<BR>
Sixth Extended Closing: December&nbsp;31, 2007</B>

</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD>1.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Purchase and Sale of Preferred Stock</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Authorization of the Shares</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Purchase and Sale of the Shares</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Closing Date</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Delivery</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>2.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Representations and Warranties of the Company</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Organization, Good Standing and Qualification</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Corporate Power</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Subsidiaries</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Capitalization</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Authorization</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Valid Issuance of Preferred and Common Stock</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Governmental Consents</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Litigation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employees</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Patents and Other Intangible Assets</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.11</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Compliance with Other Instruments</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.12</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Permits</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.13</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Environmental and Safety Laws</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.14</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title to Property and Assets</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.15</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Agreements; Action</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.16</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Financial Statements</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.17</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Changes</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.18</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Brokers or Finders</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.19</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Qualified Small Business Stock</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.20</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee Benefit Plans</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.21</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Matters</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.22</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Insurance</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.23</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Corporate Documents</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.24</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Disclosure</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.25</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Offering</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.26</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Returns and Complaints</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>3.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Representations and Warranties of the Purchasers</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Experience</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Investment</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rule&nbsp;144</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Legends</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Public Market</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Access to Data</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-i-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS<BR>
(continued)</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Authorization</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Accredited Investor</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Public Solicitation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Advisors</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.11</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Purchaser Counsel</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.12</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Brokers or Finders</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.13</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Non-United States Persons</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>4.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Conditions of Purchaser&#146;s Obligations at Closing</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Representations and Warranties</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Performance</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Compliance Certificate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Blue Sky</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Company Counsel</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Investor Rights Agreement</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Restated Articles</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Corporate Proceedings; Waivers and Consents</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>5.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Conditions of the Company&#146;s Obligations at Closing</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Representations and Warranties</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Payment of Purchase Price</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Blue Sky</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Investor Rights Agreements</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Restated Articles</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proceedings and Documents</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD>6.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Miscellaneous</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Governing Law; Jurisdiction</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Indemnification</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Survival</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Successors and Assigns</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Entire Agreement; Amendment</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notices, Etc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Delays or Omissions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">California Corporate Securities Law</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Finder&#146;s Fee</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Expenses</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.11</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Waiver of Conflict</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.12</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Severability</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.13</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Counterparts; Facsimile</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.14</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Titles and Subtitles</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-ii-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS<BR>
(continued)</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.15</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exculpation Among Purchasers</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.16</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Like Treatment of Holders</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.17</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jury Trial</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" align="left"><B>EXHIBITS</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" align="left">Exhibit&nbsp;A</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Schedule of Purchasers</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" align="left">Exhibit&nbsp;B</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Amended and Restated Articles of Incorporation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" align="left">Exhibit&nbsp;C</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Schedule of Exceptions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" align="left">Exhibit&nbsp;D</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Eighth Amended and Restated Investor Rights Agreement</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" align="left">Exhibit&nbsp;E</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Legal Opinion</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-iii-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>SERIES E PREFERRED STOCK PURCHASE AGREEMENT</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS SERIES E PREFERRED STOCK PURCHASE AGREEMENT is made as of June&nbsp;13, 2006, by and among
Fluidigm Corporation, a California corporation (the &#147;<B>Company</B>&#148;), and the purchasers listed on the
Schedule of Purchasers attached hereto as <U>EXHIBIT A</U> (the &#147;<B>Schedule of Purchasers</B>&#148;). The
persons or entities listed thereon are hereinafter referred to collectively as the &#147;<B>Purchasers</B>&#148; and
individually as a &#147;<B>Purchaser</B>.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE PARTIES HEREBY AGREE AS FOLLOWS:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Purchase and Sale of Preferred Stock</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 <U>Authorization of the Shares</U>. The Company will on or before the Closing
(as defined below) authorize the sale and issuance pursuant to this Agreement of up
to 5,000,000 shares (the &#147;<B>Shares</B>&#148;) of its Series&nbsp;E Preferred Stock (the &#147;<B>Series&nbsp;E
Preferred</B>&#148;), having the rights, preferences and privileges as set forth in the
Amended and Restated Articles of Incorporation attached hereto as <U>EXHIBIT B</U>
(the &#147;<B>Restated Articles</B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2 <U>Purchase and Sale of the Shares</U>. Subject to the terms and conditions
hereof and in reliance upon the representations, warranties and agreements contained
herein, the Company will issue and sell to each Purchaser, severally and not jointly,
and each Purchaser will purchase from the Company, severally and not jointly, at the
Closing, the number of Shares set forth opposite the Purchaser&#146;s name on the Schedule
of Purchasers, at a purchase price of Four Dollars ($4.00) per Share. The Company
shall be entitled to sell any unpurchased Shares to any Purchaser or to a person who
is not a Purchaser and to amend the Schedule of Purchasers to include the information
relating to such sales, and such purchasers shall be considered &#147;Purchasers&#148; and
parties to this Agreement; provided that (i)&nbsp;such sales are made pursuant to this
Agreement or an agreement identical to this one except for the Closing Date and
exhibits, and (ii)&nbsp;such sales are completed within 120&nbsp;days of the Initial Closing
(as defined below). The Company&#146;s agreement with each Purchaser is a separate
agreement, and the sale of the Shares to each Purchaser is a separate sale.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.3 <U>Closing Date</U>. The first closing of the purchase and sale of the Shares
hereunder (the &#147;<B>Initial Closing</B>&#148;) shall be held at the offices of Wilson Sonsini
Goodrich &#038; Rosati, 650 Page Mill Road, Palo Alto, California 94304 on June&nbsp;13, 2006
(the &#147;<B>Closing Date</B>&#148;) or such other date as the Company and a majority-in-interest of
the Purchasers may agree. Subject to Section&nbsp;1.2 above, subsequent closings under
this Agreement may be held from time to time after the Initial Closing at such time
and place as the Company and the relevant Purchasers agree (&#147;<B>Subsequent Closings</B>&#148;).
For the purposes of this Agreement, the term &#147;<B>Closing</B>&#148; and &#147;<B>Closing Date</B>&#148; unless
otherwise indicated, refers to the closing or date of closing
of the purchase and sale of the Shares with respect to a particular Purchaser or
group of Purchasers, whether such closing occurs at the Initial Closing or at a
Subsequent Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.4 <U>Delivery</U>. At Closing, the Company shall deliver to each Purchaser a
certificate, in such denomination and registered in Purchaser&#146;s name as set forth on
the Schedule of Purchasers, representing the number of Shares which Purchaser is
purchasing from the Company
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">against delivery to the Company of a check or wire
transfer payable to the order of the Company in the amount of the purchase price of
the Shares to be purchased by such Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Representations and Warranties of the Company</U>. The Company hereby represents
and warrants to Purchaser that, except as set forth in the Schedule of Exceptions attached
hereto as <U>EXHIBIT C</U> (the &#147;<B>Schedule of Exceptions</B>&#148;), which has been delivered to each
Purchaser prior to Purchaser&#146;s execution hereof, each of the representations, warranties and
statements contained in this Section&nbsp;2 is true and correct as of the date of this Agreement and
will be true and correct on and as of the Closing Date. For all purposes of this Agreement,
the statements contained in the Schedule of Exceptions shall also be deemed to be
representations and warranties made and given by Company under this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 <U>Organization, Good Standing and Qualification</U>. The Company is a
corporation duly organized, validly existing and in good standing under the laws of
the State of California and has all requisite corporate power and authority to carry
on its business as currently conducted. The Company is duly qualified to transact
business and is in good standing in each jurisdiction in which the failure to so
qualify, individually or in the aggregate, would have a material adverse effect on
its business (as now conducted), properties, or financial condition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 <U>Corporate Power</U>. The Company will have at the Closing all requisite
legal and corporate power and authority to (i)&nbsp;execute and deliver this Agreement;
(ii)&nbsp;sell and issue the Shares hereunder; (iii)&nbsp;issue the Common Stock issuable upon
conversion of the Shares (the &#147;<B>Conversion Shares</B>&#148;); and (iv)&nbsp;carry out and perform
its obligations under the terms of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 <U>Subsidiaries</U>. The Company does not presently own or control, directly or
indirectly, any interest in any other corporation, association, or other business
entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4 <U>Capitalization</U>. The authorized capital stock of the Company consists, or
immediately prior to the Initial Closing will consist, of 77,857,144 shares of Common
Stock (&#147;<B>Common Stock</B>&#148;), of which 9,274,356 shares are issued and outstanding
immediately prior to the Initial Closing and 51,687,948 shares of Preferred Stock
(&#147;<B>Preferred Stock</B>&#148;), 2,727,273 of which are designated Series&nbsp;A Preferred Stock of
which 2,727,273 are outstanding immediately prior to the Initial Closing; 6,460,675
of which are designated Series&nbsp;B Preferred Stock of which 6,460,675 are outstanding
immediately prior to the Initial Closing; 17,000,000 of which are designated Series&nbsp;C
Preferred Stock, 16,364,832 of which are issued and outstanding immediately prior to
the Initial Closing; and 15,500,000 of which are designated Series&nbsp;D Preferred Stock,
11,714,048 of which are issued and outstanding immediately prior to the Initial
Closing; and 10,000,000 of which are designated Series&nbsp;E Preferred Stock, none of
which will be outstanding immediately prior to the Initial Closing. All such issued
and outstanding shares have been duly authorized and validly issued in compliance
with applicable laws, and are fully paid and nonassessable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has reserved: (i)&nbsp;5,000,000 shares of Series&nbsp;E Preferred for issuance hereunder
and 5,000,000 shares of Common Stock for issuance upon conversion of such shares of Series&nbsp;E
Preferred; (ii)&nbsp;11,714,048 shares of Common Stock for issuance upon conversion of the outstanding
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shares of Series&nbsp;D Preferred; (iii)&nbsp;916,335 shares of Series&nbsp;D Preferred for issuance upon exercise
of outstanding warrants and 916,335 shares of Common Stock for issuance upon conversion of such
Series&nbsp;D Preferred; (iv)&nbsp;16,364,832 shares of Common Stock for issuance upon conversion of the
outstanding shares of Series&nbsp;C Preferred Stock; (v)&nbsp;294,868 shares of Series&nbsp;C Preferred Stock for
issuance upon exercise of outstanding warrants and 294,868 shares of Common Stock for issuance upon
conversion of such Series&nbsp;C Preferred Stock; (vi)&nbsp;6,460,675 shares of Common Stock for issuance
upon conversion of the outstanding Series&nbsp;B Preferred Stock; (vii)&nbsp;2,727,273 shares of Common Stock
for issuance upon conversion of the outstanding Series&nbsp;A Preferred Stock; and (viii)&nbsp;an aggregate
of 10,800,000 shares of Common Stock for issuance to employees and consultants of the Company
pursuant to the Company&#146;s 1999 Stock Option Plan, pursuant to which options to purchase 5,597,763
shares are granted and outstanding and 1,554,643 shares are available for future grant. Other than
with respect to the shares reserved for issuance in the preceding sentence, or as set forth in the
Ancillary Agreements (as defined below), there are no outstanding rights, options, warrants,
conversion rights, preemptive rights, rights of first refusal or similar rights for the purchase or
acquisition from the Company of any securities of the Company. There are no outstanding
obligations of the Company to repurchase or redeem any of its securities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as contemplated in the Investor Rights Agreement (as defined below), the Company has
not granted or agreed to grant any registration rights, including piggyback rights, to any person
or entity. Except as contemplated in the Second Amended and Restated Voting Agreement dated as of
August&nbsp;16, 2005, the Company is not a party or subject to any agreement or understanding, and to
the Company&#146;s knowledge, there is no agreement or understanding between any person or entities,
which relates to the voting or the giving of written consents with respect to any security of the
Company or by a director of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5 <U>Authorization</U>. All corporate action on the part of the Company, its
officers, directors and shareholders necessary for the authorization, execution and
delivery of this Agreement, the Eighth Amended and Restated Investor Rights Agreement
in the form attached hereto as <U>EXHIBIT D</U> (the &#147;<B>Investor Rights Agreement</B>&#148;),
the performance of all obligations of the Company under this Agreement and the
Investor Rights Agreement (other than those registration obligations contained in
Section&nbsp;1 of the Investor Rights Agreement), and any other agreements to which the
Company is a party, the execution and delivery of which is a contemplated hereby (the
&#147;<B>Ancillary
Agreements</B>&#148;) and the authorization, issuance (or reservation for issuance), sale and
delivery of the Shares and the Conversion Shares has been taken or will be taken
prior to the Closing. This Agreement and the Investor Rights Agreement constitute
valid and legally binding obligations of the Company, enforceable against the Company
in accordance with their respective terms, subject to: (i)&nbsp;judicial principles
limiting the availability of specific performance, injunctive relief, and other
equitable remedies; (ii)&nbsp;bankruptcy, insolvency, reorganization, moratorium or other
similar laws now or hereafter in effect generally relating to or affecting creditors&#146;
rights; and (iii)&nbsp;limitations on the enforceability of the indemnification provisions
of the Investor Rights Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.6 <U>Valid Issuance of Preferred and Common Stock</U>. The Shares that are being purchased by the Purchasers hereunder, when issued, sold and
delivered in accordance with the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">terms of this Agreement for the consideration expressed herein,
will be duly and validly issued, fully paid, and nonassessable, and will be free of restrictions on
transfer other than restrictions on transfer under this Agreement and the Investor Rights Agreement
and under applicable state and federal securities laws. The Conversion Shares have been duly and
validly reserved for issuance, and, upon issuance in accordance with the terms of the Restated
Articles, will be duly and validly issued, fully paid, and nonassessable and will be free of
restrictions on transfer other than restrictions on transfer under this Agreement and the Investor
Rights Agreement and under applicable state and federal securities laws. The Conversion Shares may
be issued without any registration or qualification under state and federal securities laws as such
laws are currently in effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.7 <U>Governmental Consents</U>. No consent, approval, order or authorization of,
or registration, qualification, designation, declaration or filing with, any federal,
state or local governmental authority on the part of the Company is required in
connection with the offer, sale or issuance of the Shares or the Conversion Shares or
the consummation of any other transaction contemplated hereby, except for (a)&nbsp;the
filing of the Restated Articles with the Secretary of State of the State of
California prior to the Closing and (b)&nbsp;filings required pursuant to applicable
federal and state securities laws and blue sky laws, which filings, the Company
covenants to complete within the required statutory period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.8 <U>Litigation</U>. There is no action, suit, proceeding or investigation
pending or, to the Company&#146;s knowledge, currently threatened against the Company
before any court, administrative agency or other governmental body which questions
the validity of this Agreement or the Investor Rights Agreement or the right of the
Company to enter into any of them, or to consummate the transactions contemplated
hereby or thereby, or which could result, either individually or in the aggregate, in
any material adverse change in the condition (financial or otherwise), business,
property, assets or liabilities of the Company, nor is the Company aware that there
is any basis for the foregoing. The Company is not a party or subject to, and none
of its assets is bound
by, the provisions of any order, writ, injunction, judgment or decree of any court or
government agency or instrumentality. There is no action, suit, proceeding or
investigation by or involving the Company currently pending or that the Company
intends to initiate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.9 <U>Employees</U>. Each employee of the Company has executed a proprietary
information and invention assignment agreement substantially in the form or forms
made available to the Purchasers. To the Company&#146;s knowledge, no officer or key
employee is in violation of any prior employee contract or proprietary information
agreement. No employees of the Company are represented by any labor union or covered
by any collective bargaining agreement. There is no pending or, to the Company&#146;s
knowledge, threatened labor dispute involving the Company and any group of its
employees. The Company is not aware that any officer or key employee intends to
terminate his or her employment with the Company within the six months after Closing.
The Company does not have a present intention to terminate the employment of any
officer or key employee. Each officer and key employee is devoting 100% of his or
her business time to the conduct of the business of the Company. The Company is not
aware that any officer or key employee intends to work less than full time during the
six months after Closing. Subject to general
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">principles related to wrongful
termination of employees, the employment of each officer and employee of the Company
is terminable at will.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.10 <U>Patents and Other Intangible Assets</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company owns, or is licensed or otherwise has the legally enforceable right to use,
all copyrights, domain names, maskworks, applications for the issuance or registration of any of
the foregoing, trade secrets, confidential or proprietary know-how, data and information, ideas,
inventions, designs, developments, algorithms, processes, schematics, techniques, computer
programs, applications and other software, works of authorship, creative effort and, to the
Company&#146;s knowledge after such investigation as the Company deemed reasonable, patents, patent
applications, trademarks (including service marks and design marks) and applications therefor,
tradenames (all of the foregoing generically, &#147;<B>Intellectual Property Rights</B>&#148;) utilized in, or
necessary for, its business as now conducted (collectively, the &#147;<B>Company Intellectual Property</B>&#148;)
without infringing upon the right of any person, corporation or other entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;2.10 of the Schedule of Exceptions lists (i)&nbsp;all patents and patent applications
and all registered and unregistered trademarks, trade names, copyrights and maskworks and
registered domain names included in the Company Intellectual Property, including the jurisdictions
in which each such intellectual property right has been issued or registered or in which any
application for such issuance or registration has been filed, (ii)&nbsp;all licenses, sublicenses,
collaborations and other agreements (or options for any of the foregoing) to which the Company is a
party and pursuant to which any person, corporation or other entity is authorized to use any of the
Company Intellectual Property, and (iii)&nbsp;all licenses, sublicenses, collaborations and other
agreements (or options for any of the foregoing) to which the Company is a party and pursuant
to which the Company is authorized to use any Intellectual Property Right of any third party (other
than standard licenses for commercially available software). Each of the agreements in (ii)&nbsp;and
(iii)&nbsp;above remain in full force and effect and, to the Company&#146;s knowledge, no party to any such
agreement is in material breach or default under such agreement, and the Company is not aware of
any act or failure to act by a party which would constitute a material breach or default under any
such agreement, give rise to a right of the licensor to terminate any such agreement or otherwise
result in termination of, or suspension or loss of exclusive rights under, any such agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the Company&#146;s knowledge, the Company has not infringed or misappropriated any
Intellectual Property Right of any other person, corporation or other entity. The Company has not
received any communication or otherwise received any information alleging any such conduct by the
Company or asserting a claim by any third party to the ownership of, or right to use, any of the
Company Intellectual Property, and the Company does not know of any basis for any such claim. The
Company is not aware of any action, suit, proceeding or investigation pending or currently
threatened against the Company (or any third party owner or licensor of rights to the Company of
any of the Company Intellectual Property) which would have a material impact on the Company&#146;s
ownership of or exclusive or co-exclusive rights to use, the Company Intellectual Property.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-5-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company is not aware that any of its employees is obligated under any agreement, or
subject to any judgment, decree or order of any court or administrative agency, that would
materially interfere with his or her ability to fully and freely perform their duties to the
Company or that would conflict with the Company&#146;s business. To the Company&#146;s knowledge, neither
the filing of the Restated Articles nor the execution and delivery of this Agreement or the
Investor Rights Agreement, nor the carrying on of the Company&#146;s business by the employees of the
Company, will conflict with or result in a material breach of the terms, conditions, or provisions
of, or constitute a default under, any agreement under which any such employee is now obligated.
The Company does not utilize, and will not be required to utilize, any invention, development or
work of authorship of any of its employees (or persons it currently intends to hire) made prior to
their employment by the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Except as described in Schedule&nbsp;2.10, (i)&nbsp;the Company is not obligated, or under any
liability whatsoever to make any payments by way of royalties, fees or otherwise, to any owner or
licensor of, or other claimant to, any Company Intellectual Property, and (ii)&nbsp;the Company is not a
party to any agreement concerning the Company Intellectual Property or any other Intellectual
Property Right used or to be used by the Company in its business as conducted. No founder,
director, officer or employee of the Company, or, to the Company&#146;s knowledge, no shareholder of the
Company has any interest in the Company Intellectual Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Except with respect to any rights granted under the agreements described in Schedule&nbsp;2.10,
the Company owns exclusively all rights arising from or associated with the research and
development efforts of the Company, its founders, employees and independent contractors relating to
the Company&#146;s business as now conducted, and all such rights form part of
the Company Intellectual Property. The Company has secured valid written assignments from all
employees and independent contractors who contributed to the creation or development of any of the
Company Intellectual Property of the rights to such contributions that the Company does not already
own by operation of law. The Company has not received notice of any claim being asserted by any
current or former employee, independent contractor or other third party to the ownership, of or
right to use, any of the Company Intellectual Property, or challenging or questioning the validity
of any of the Company Intellectual Property, and the Company is not aware of any basis for any such
claim.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;The Company has taken reasonable steps to protect and preserve the confidentiality of all
material trade secrets included in Company Intellectual Property not otherwise protected by patents
or copyright (&#147;<B>Confidential Information</B>&#148;). All disclosure of Confidential Information to a third
party has been pursuant to the terms of a written confidentiality or non-disclosure agreement
between the Company and such third party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) The Company hereby represents and warrants that the data, written and oral reports and
other representations and information that the Company provided to its investors (or their counsel)
pertaining to the Company Intellectual Property, when taken as a whole, were truthful and, to the
Company&#146;s knowledge, accurate in all material respects, and there was no omission therefrom which
made such information misleading, or incomplete in any material way<B>.</B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-6-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.11 <U>Compliance with Other Instruments</U>. The Company is not in violation or default of any provision of its Articles of
Incorporation or Bylaws, each as amended and in effect on and as of the Closing. The Company is
not in violation or default of any material provision of any instrument, mortgage, deed of trust,
loan, contract, commitment, judgment, decree, order or obligation to which it is a party or by
which it or any of its properties or assets are bound or, to the best of its knowledge, of any
provision of any federal, state or local statute, rule or governmental regulation. The execution,
delivery and performance of and compliance with this Agreement and the Investor Rights Agreement,
and the issuance and sale of the Shares, will not result in any such violation, be in conflict with
or constitute, with or without the passage of time or giving of notice, a default under any such
provision, license, indenture, instrument, mortgage, deed of trust, loan, contract, commitment,
judgment, decree, order or obligation; or require any consent or waiver under any such provision,
license, indenture, instrument, mortgage, deed of trust, loan, contract, commitment, judgment,
decree, order or obligation (other than any consents or waivers that have been obtained); or result
in the creation of any mortgage, pledge, lien, encumbrance or charge upon any of the properties or
assets of the Company pursuant to any such provision, license, indenture, instrument, mortgage,
deed of trust, loan, contract, commitment, judgment, decree, order or obligation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.12 <U>Permits</U>. The Company has all franchises, permits, licenses, and any
similar authority necessary for the conduct of its business as now being conducted by
it. The Company is not in default in any material respect under any of such
franchises, permits, licenses, or other similar authority.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.13 <U>Environmental and Safety Laws</U>. To its knowledge, the Company is not in violation of any applicable statute, law, or regulation
relating to the environment or occupational health and safety, and to its knowledge, no material
expenditures by the Company are or will be required in order to comply with any such existing
statute, law, or regulation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.14 <U>Title to Property and Assets</U>. The Company has good and marketable title
to all of its properties and assets free and clear of all pledges, mortgages, liens
security interests, charges and encumbrances, except liens for current taxes and
assessments not yet due and possible minor liens and encumbrances which do not, in
any case, individually or in the aggregate, materially detract from the value of the
property subject thereto or materially impair the ownership or use of said property
or assets, or the operations of the Company. With respect to the property and assets
it leases, the Company is in compliance with such leases and, to the best of its
knowledge, holds a valid leasehold interest free of all liens, claims or
encumbrances. The Company&#146;s properties and assets are in good condition and repair
in all material respects.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.15 <U>Agreements; Action</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Except for agreements contemplated by this Agreement, there are no agreements,
understandings or proposed transactions between the Company and any of its officers, directors,
affiliates, or any affiliate thereof other than standard option grants and stock purchase
agreements entered into prior to the date of this Agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-7-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;There are no agreements, understandings, instruments, contracts, proposed transactions,
judgments, orders, writs or decrees to which the Company is a party or by which it is bound that
may involve (i)&nbsp;obligations (contingent or otherwise) of, or payments by the Company in excess of,
$100,000, other than in the ordinary course of business, (ii)&nbsp;the license of any patent, copyright,
trade secret or other proprietary right to or from the Company other than standard commercial
software licenses, (iii)&nbsp;provisions restricting or adversely affecting the development, manufacture
or distribution of the Company&#146;s products or services, or (iv)&nbsp;indemnification by the Company with
respect to infringements of proprietary rights other than indemnifications entered into in the
ordinary course of business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;For the purposes of subsection (b)&nbsp;above, all indebtedness, liabilities, agreements,
understandings, instruments, contracts and proposed transactions involving the same person or
entity (including persons or entities the Company has reason to believe are affiliated therewith)
shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such
subsection.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company is not a party to and is not bound by any contract, agreement or instrument,
or subject to any restriction under its Restated Articles or its Bylaws that adversely affects its
business as now conducted, its properties or its financial condition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company is not a guarantor or indemnitor of any indebtedness of any other person or
entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The Company has not engaged in the past three months in any discussion (i)&nbsp;with any
representative of any entity or entities regarding the merger of the Company with or into any such
entity or entities or any affiliate thereof, (ii)&nbsp;with any representative of any entity or any
individual regarding the sale, conveyance or disposition of all or substantially all of the assets
of the Company or a transaction or series of related transactions in which more than fifty percent
(50%) of the voting power of the Company would be disposed of, or (iii)&nbsp;regarding any other form of
liquidation, dissolution or winding up of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.16 <U>Financial Statements</U>. The Company has made available to each Purchaser
its unaudited balance sheet dated as of December&nbsp;31, 2005 and the unaudited statement
of operations for the fiscal year then ended, its unaudited balance sheet as of March
31, 2006, and its unaudited statement of operations and cash flow statement covering
the three month period then ended (collectively, the &#147;<B>Financial Statements</B>&#148;). The
Financial Statements are complete and correct in all material respects and have been
prepared in accordance with generally accepted accounting principles applied on a
consistent basis throughout the periods indicated. The Financial Statements
accurately set out and describe the financial condition and operating results of the
Company as of the date, and during the periods, indicated therein. Except as set
forth in the Financial Statements, the Company has no material liabilities,
contingent or otherwise, other than (i)&nbsp;liabilities incurred in the ordinary course
of business subsequent to March&nbsp;31, 2006 and (ii)&nbsp;obligations under contracts and
commitments incurred in the ordinary course of business and not required under
generally accepted accounting principles to be reflected in the Financial Statements,
which, in both cases, individually or in the aggregate are not material to the
financial condition or operating results of the Company.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-8-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.17 <U>Changes</U>. Since March&nbsp;31 2006:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;the Company has not (i)&nbsp;declared or paid any dividends or authorized or made any
distribution upon or with respect to any class or series of its capital stock, (ii)&nbsp;incurred any
indebtedness for money borrowed or any other liabilities outside the ordinary course of its
business individually in excess of $100,000 or, in the case of indebtedness and/or liabilities
individually less than $100,000, in excess of $200,000 in the aggregate, (iii)&nbsp;made any loans or
advances to any person, other than ordinary advances for reimbursable businesses expenses,
(iv)&nbsp;sold, exchanged, assigned, transferred, licensed or otherwise disposed of any of its assets or
rights (including Company Intellectual Property), other than the sale of its inventory in the
ordinary course of business, (v)&nbsp;waived or compromised a valuable right or a material debt owed to
it, (vi)&nbsp;materially changed any compensation arrangement or agreement with any employee, officer,
director or shareholder, or (vii)&nbsp;arranged or committed to do any of the things described in this
subsection (a); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;there has not been (i)&nbsp;a loss of, or a material order cancellation by, any major customer
of the Company, (ii)&nbsp;any damage, destruction or loss, whether or not covered by insurance,
materially and adversely affecting the business, properties, or financial condition of the Company,
(iii)&nbsp;any change in the assets, liabilities, financial condition or operating results of the
Company from that reflected in the Financial Statements, except changes in the ordinary course of
business that have not been, in the aggregate, materially adverse, (iv)&nbsp;any resignation or
termination of any officer or key employee of the Company, and the Company is not aware of the
impending resignation or termination of employment of any such officer, or (v)&nbsp;to the best of the
Company&#146;s knowledge, any other event or condition of any character that would materially and
adversely affect the business, properties, or financial condition of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.18 <U>Brokers or Finders</U>. The Company has not agreed to incur, directly or
indirectly, any liability for brokerage or finders&#146; fees, agents&#146; commissions or
other similar charges in connection with this Agreement or any of the transactions
contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.19 <U>Qualified Small Business Stock</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of and immediately following the Closing, the Shares will meet each of the requirements
for qualification as &#147;qualified small business stock&#148; set forth in Section 1202(c) of the Internal
Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;), including without limitation the following: (i)&nbsp;the
Company will be a domestic C corporation, (ii)&nbsp;the Company will not have made any purchases of its
own stock described in Code Section&nbsp;1202(c)(3)(B) during the one-year period preceding the Closing,
and (iii)&nbsp;the Company&#146;s (and any predecessor&#146;s) aggregate gross assets, as defined by Code Section
1202(d)(2), at no time from the date of incorporation of the Company and through the Closing have
exceeded or will exceed $50&nbsp;million, taking into account the assets of any corporations required to
be aggregated with the Company in accordance with Code Section&nbsp;1202(d)(3).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the Closing, at least 80% (by value) of the assets of the Company are used by it in
the active conduct of one or more qualified trades or businesses, as defined by Code
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-9-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Section
1202(e)(3), and the Company is an eligible corporation, as defined by Code Section&nbsp;1202(e)(4).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.20 <U>Employee Benefit Plans</U>. The Company does not have any Employee Benefit
Plan as defined in the Employee Retirement Income Security Act of 1974 other than the
Company&#146;s 401(k) Plan. The Company is in material compliance with the terms of the
Company&#146;s 401(k) Plan and has not received notice of any material increase in the
costs of such plans.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.21 <U>Tax Matters</U>. The Company has filed all tax returns and reports as
required by law. These returns and reports are true and correct in all material
respects. The Company has paid all taxes and other assessments due. The Company has
not elected
pursuant to the Code, to be treated as a Subchapter S corporation or a collapsible
corporation pursuant to Section 1362(a) or Section 341(f) of the Code, nor has it
made any other elections pursuant to the Code (other than elections that relate
solely to methods of accounting, depreciation or amortization) that would have a
material effect on the business, properties or condition (financial or otherwise) of
the Company. None of the Company&#146;s tax returns have ever been audited by any
governmental authorities. The Company has withheld or collected from each payment
made to its employees the amount of all taxes (including without limitation, federal
income taxes, Federal Insurance Contribution Act taxes and Federal Unemployment Tax
Act taxes) required to be withheld or collected therefrom, and has paid the same to
the proper tax receiving officers or authorized depositories.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.22 <U>Insurance</U>. The Company has in full force and effect fire and casualty
insurance policies, with extended coverage, sufficient in amount (subject to
reasonable deductibles) to allow it to replace any of its properties that might be
damaged or destroyed. The Company has obtained term life insurance payable to the
Company on the lives of Stephen Quake and Gajus Worthington in the amount of
$500,000. The Company has in full force and effect directors and officers liability
insurance, covering all of its directors, with aggregate coverage in the amount of
$2,000,000.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.23 <U>Corporate Documents</U>. The Restated Articles and Bylaws of the Company
are in the form made available to the Purchasers. The copy of the minute books of
the Company made available to the Purchasers&#146; counsel contains true and correct
minutes of all meetings of directors (including any committees thereof) and
shareholders and all actions by written consent taken without a meeting by the
directors and shareholders since December&nbsp;18, 2003.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.24 <U>Disclosure</U>. The Company has fully provided each Purchaser with all the
information which such Purchaser has requested in connection with the purchase of the
Shares hereunder, as well as all information which the Company in its judgment
believes is reasonably necessary to enable such Purchaser to make a decision as to
whether to invest in the Company. Neither this Agreement with the Exhibits hereto,
nor any other statements, certificates or documents made or delivered in connection
herewith or therewith, contains any untrue statement of a material fact or omits to
state a material fact necessary to make the statements herein or therein not
misleading in light of the circumstances under which they were made. The financial
projections made available to the Purchasers (the &#147;<B>Projections</B>&#148;) were prepared in
good faith and based upon assumptions that the Company believes are reasonable, and
represent the Company&#146;s good faith
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-10-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">estimate of its future plans and results; provided
however that the Company does not represent or warrant that it will achieve any of
the Projections.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.25 <U>Offering</U>. Subject in part to the truth and accuracy of each Purchaser&#146;s representations set forth in
this Agreement, the offer, sale and issuance of the Shares as contemplated by this Agreement is
exempt from the registration requirements of the Securities Act of 1933, as amended (the
&#147;<B>Securities Act</B>&#148;), and from the registration or qualification requirements of applicable state
securities laws or blue sky laws, and neither the Company nor any authorized agent acting on its
behalf will take any action hereafter that would cause the loss of such exemption.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.26 <U>Returns and Complaints</U>. The Company has not received customer
complaints concerning alleged defects in the design of its products that, if true,
would have, individually or in the aggregate, a material adverse effect on its
business, properties, or financial condition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, individually
and not jointly, hereby represents and warrants as of the Closing Date that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 <U>Experience</U>. Such Purchaser is experienced in evaluating start-up
companies such as the Company, is able to evaluate and represent its own interests in
transactions such as the one contemplated by this Agreement, has such knowledge and
experience in financial and business matters such that Purchaser is capable of
evaluating the merits and risks of Purchaser&#146;s prospective investment in the Company,
and has the ability to bear the economic risks of its investment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 <U>Investment</U>. Such Purchaser is acquiring the Shares, and the Conversion
Shares, for investment for such Purchaser&#146;s own account and not with the view to, or
for resale in connection with, any distribution thereof. Such Purchaser understands
that the Shares, and the Conversion Shares have not been registered under the
Securities Act by reason of a specific exemption from the registration provisions of
the Securities Act which depends upon, among other things, the bona fide nature of
the investment intent as expressed herein. Such Purchaser further represents that it
does not have any contract, undertaking, agreement or arrangement with any person to
sell, transfer or grant participation to any third person with respect to any of the
Shares, or the Conversion Shares, other than a transfer not involving a change of
beneficial ownership. Such Purchaser understands and acknowledges that the offering
of the Shares pursuant to this Agreement will not be registered under the Securities
Act on the ground that the sale provided for in this Agreement is exempt from the
registration requirements of the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3 <U>Rule&nbsp;144</U>. Such Purchaser acknowledges that the Shares and the Conversion
Shares must be held indefinitely unless subsequently registered under the Securities
Act or an exemption from such registration is available. Such Purchaser is aware of
the provisions of Rule&nbsp;144 promulgated under the Securities Act which permit limited
resale of shares purchased in a private placement subject to the satisfaction of
certain conditions. Such Purchaser covenants that, in the absence of an effective
registration statement covering the stock in question, such Purchaser will sell,
transfer, or otherwise dispose of the Shares or the Conversion Shares only in a
manner consistent
with applicable securities laws and such Purchaser&#146;s representations and covenants
set forth in this Section&nbsp;3. In connection therewith, such Purchaser acknowledges
that the Company
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-11-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">will make a notation on its stock books regarding the restrictions
on transfers set forth in this Section&nbsp;3 and will transfer securities on the books of
the Company only to the extent not inconsistent therewith.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4 <U>Legends</U>. Purchaser understands and acknowledges that the certificate
evidencing its Shares and the Conversion Shares will be imprinted with legends in the
form set forth in Section&nbsp;1.3 of the Investor Rights Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5 <U>No Public Market</U>. Such Purchaser understands that no public market now
exists for any of the securities issued by the Company, and that the Company has made
no assurances that a public market will ever exist for the Shares or the Conversion
Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.6 <U>Access to Data</U>. Such Purchaser has received and reviewed information
about the Company and has had an opportunity to discuss the Company&#146;s business,
management and financial affairs with its management and to review the Company&#146;s
facilities. The foregoing, however, does not limit or modify the representations and
warranties of the Company in Section&nbsp;2 of this Agreement or the right of the
Purchasers to rely thereon.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.7 <U>Authorization</U>. This Agreement when executed and delivered by such
Purchaser will constitute a valid and legally binding obligation of the Purchaser,
enforceable against the Purchaser in accordance with its terms, subject to:
(i)&nbsp;judicial principles respecting election of remedies or limiting the availability
of specific performance, injunctive relief, and other equitable remedies;
(ii)&nbsp;bankruptcy, insolvency, reorganization, moratorium or other similar laws now or
hereafter in effect generally relating to or affecting creditors&#146; rights; and
(iii)&nbsp;limitations on the enforceability of the indemnification provisions of the
Investor Rights Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.8 <U>Accredited Investor</U>. Such Purchaser acknowledges that it is an
&#147;accredited investor&#148; as defined in Rule&nbsp;501 of Regulation&nbsp;D as promulgated by the
Securities and Exchange Commission under the Securities Act and shall submit to the
Company such further assurances of such status as may be reasonably requested by the
Company. The principal address of such Purchaser is as set forth on the Schedule of
Purchasers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.9 <U>Public Solicitation</U>. Purchaser knows of no public solicitation or
advertisement of an offer in connection with the proposed issuance and sale of the
Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.10 <U>Tax Advisors</U>. Purchaser has reviewed with Purchaser&#146;s own tax advisors
the federal, state and local tax consequences of this investment, where applicable,
and the transactions contemplated by this Agreement. Each Purchaser is relying
solely on
such advisors and not on any statements or representations of the Company or any of
its agents and understands that each Purchaser (and not the Company) shall be
responsible for the Purchaser&#146;s own tax liability that may arise as a result of this
investment or the transactions contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.11 <U>Purchaser Counsel</U>. Purchaser acknowledges that it has had the
opportunity to review this Agreement, the exhibits and the schedules attached hereto
and the transactions contemplated by this Agreement with Purchaser&#146;s own legal
counsel. Each Purchaser is relying
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-12-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">solely on such counsel and not on any statements
or representations of the Company or any of its agents for legal advice with respect
to this investment or the transactions contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.12 <U>Brokers or Finders</U>. The Company has not incurred and will not incur,
directly or indirectly, as a result of any action taken by such Purchaser, any
liability for brokerage or finders&#146; fees or agents&#146; commissions or any similar
changes in connection with this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.13 <U>Non-United States Persons</U>. If Purchaser is not a United States person, such Purchaser hereby represents that such
Purchaser is satisfied as to the full observance of the laws of such Purchaser&#146;s jurisdiction in
connection with any invitation to subscribe for the Shares and the Conversion Shares or any use of
this Agreement, the Investor Rights Agreement and the Voting Agreement, including (i)&nbsp;the legal
requirements within such Purchaser&#146;s jurisdiction for the purchase of Shares and the Conversion
Shares, (ii)&nbsp;any foreign exchange restrictions applicable to such purchase, (iii)&nbsp;any governmental
or other consents that may need to be obtained and (iv)&nbsp;the income tax and other tax consequences,
if any, that may be relevant to the purchase, holding, redemption, sale or transfer of such
securities. Such Purchaser&#146;s subscription and payment for, and such Purchaser&#146;s continued
beneficial ownership of, the Shares and the Conversion Shares will not violate any applicable
securities or other laws of such Purchaser&#146;s jurisdiction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Conditions of Purchaser&#146;s Obligations at Closing</U>. The obligations of each
Purchaser under this Agreement are subject to the fulfillment on or before the Closing of each
of the following conditions, the waiver of which shall not be effective against any Purchaser
who does not consent in writing thereto:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 <U>Representations and Warranties</U>. The representations and warranties of
the Company contained in Section&nbsp;2 shall be true on and as of the Closing with the
same effect as though such representations and warranties had been made on and as of
the date of the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 <U>Performance</U>. The Company shall have performed and complied with all
agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by it on or before the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 <U>Compliance Certificate</U>. The President of the Company shall deliver to
each Purchaser at the Closing a certificate stating that the conditions specified in
Sections&nbsp;4.1 and 4.2 have been fulfilled and stating that as of the Closing there
shall have been no adverse change in the business, affairs, operations, properties,
assets or condition of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4 <U>Blue Sky</U>. The Company shall have obtained all necessary permits and
qualifications, if any, or secured an exemption therefrom, required by any state or
country prior to the offer and sale of the Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.5 <U>Opinion of Company Counsel</U>. Each Purchaser in the Initial Closing shall
have received from Wilson Sonsini Goodrich &#038; Rosati, Professional Corporation,
counsel for the Company, an opinion, dated as of the Initial Closing, in the form
attached hereto as <U>EXHIBIT E</U>.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-13-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.6 <U>Investor Rights Agreement</U>. The Company and each Purchaser shall have
entered into the Investor Rights Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.7 <U>Restated Articles</U>. The Restated Articles shall have been accepted for
filing by the California Secretary of State and shall be in full force and effect as
of the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.8 <U>Corporate Proceedings; Waivers and Consents</U>. All corporate and other
proceedings to be taken and all waivers, consents and permits necessary or
appropriate for the consummation of the transactions contemplated by this Agreement
will have been taken or obtained.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Conditions of the Company&#146;s Obligations at Closing</U>. The obligations of the
Company to each Purchaser under this Agreement are subject to the fulfillment on or before the
Closing of each of the following conditions by that Purchaser:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 <U>Representations and Warranties</U>. The representations and warranties of
the Purchasers contained in Section&nbsp;3 shall be true on and as of the Closing with the
same effect as though such representations and warranties had been made on and as of
the Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 <U>Payment of Purchase Price</U>. Each Purchaser shall have delivered the
purchase price against delivery of the Shares as set forth in Section&nbsp;1.4 by the
Company to such Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 <U>Blue Sky</U>. The Company shall have obtained all necessary permits and
qualifications, if any, or secured an exemption therefrom, required by any state or
country for the offer and sale of the Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4 <U>Investor Rights Agreements</U>. The Company and each Purchaser shall have
entered into the Investor Rights Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.5 <U>Restated Articles </U>. The Restated Articles shall have been accepted for
filing by the California Secretary of State and shall be in full force and effect as
of the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.6 <U>Proceedings and Documents</U>. All corporate and other proceedings in
connection with the transactions contemplated at the Closing hereby, and all
documents and instruments incident to these transactions, shall be reasonably
satisfactory in substance to the Company and its counsel.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Miscellaneous</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 <U>Governing Law; Jurisdiction</U>. This Agreement and all acts and
transactions pursuant hereto and the rights and obligations of the parties hereto
shall be governed in all respects by the laws of the State of California, without
regard to any provisions thereof relating to conflicts of laws among different
jurisdictions. The parties hereto agree to submit to the exclusive jurisdiction of
the federal and state courts of San Mateo County, California with respect to the
breach or interpretation of this Agreement or the enforcement of any and all rights,
duties, liabilities, obligations, powers, and other relations between the parties
arising under this Agreement.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-14-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 <U>Indemnification</U>. The Company shall indemnify, defend and hold each
Purchaser harmless against all liability, loss or damage (collectively, &#147;<B>Losses</B>&#148; and
individually, a &#147;<B>Loss</B>&#148;) arising from any litigation, proceeding or dispute arising
from such Purchaser&#146;s status as a shareholder of the Company other than Losses
arising from such Purchaser&#146;s gross negligence or willful misconduct, provided that
such indemnification shall apply only to litigation, proceedings or disputes arising
prior to the Company&#146;s Initial Public Offering (as defined in the Investor Rights
Agreement) and the Company&#146;s obligation to indemnify any Purchaser shall be limited
in amount to the amount paid by such Purchaser for the purchase of such Purchaser&#146;s
Shares as set forth on <U>EXHIBIT A</U>. The foregoing indemnity is not intended to
supercede or replace the indemnification obligations of the parties set forth in
Section&nbsp;1.10 of the Investor Rights Agreement nor shall it be construed to limit any
other rights and remedies of the Purchasers under this Agreement or any other
indemnification to which such Purchaser may be entitled under any other agreement of
the Company. The foregoing indemnification rights are transferable only to
Affiliates (as defined in the Investor Rights Agreement) of a Purchaser.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 <U>Survival</U>. The representations, warranties, covenants and agreements made
herein shall survive any investigation made by any Purchaser or the Company and the
Closing of the transactions contemplated hereby; provided, however, that such
representations and warranties are only made as of the date of such execution and
delivery and as of such Closing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 <U>Successors and Assigns</U>. Except as otherwise provided herein, the
provisions hereof shall inure to the benefit of, and be binding upon, the successors,
assigns, heirs, executors and administrators of the parties hereto; provided,
however, that the rights of a Purchaser to purchase Shares at the Closing shall not
be assignable without the consent of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5 <U>Entire Agreement; Amendment</U>. This Agreement and the other documents
delivered pursuant hereto constitute the full and entire understanding and agreement
among the parties with regard to the subjects hereof and thereof relating to the
purchase of the Shares. Neither this Agreement nor any term hereof may be amended,
waived, discharged or terminated other than by a written instrument signed by the
Company and the holder or holders of greater than fifty percent (50%) of the
then-outstanding Shares or the Conversion Shares. Notwithstanding the foregoing, any
additional purchaser pursuant to Section&nbsp;1.2 may become a party to this Agreement by
executing and delivering an additional counterpart signature page to this Agreement
and such purchaser shall be deemed a Purchaser hereunder. The parties agree that the
Schedule of Purchasers attached hereto as <U>Exhibit&nbsp;A</U> shall be updated
automatically without any formal amendment to reflect the addition of any such
additional Purchaser. Any amendment or waiver effected in accordance with this
Section&nbsp;6.5 shall be binding upon the Purchasers and each transferee of the Shares
(or the Common Stock issuable upon conversion thereof), each future holder of all
such securities, and the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6 <U>Notices, Etc</U>. All notices and other communications required or permitted
hereunder, shall be in writing and shall be personally delivered, sent by facsimile,
mailed by registered or certified mail, postage prepaid, return receipt requested, or
delivered by a nationally recognized overnight courier, addressed (a)&nbsp;if to a
Purchaser, at such Purchaser&#146;s address or
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-15-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">facsimile number set forth on the Schedule
of Purchasers, or at such other address or facsimile number as such Purchaser shall
have furnished to the Company in writing, or (b)&nbsp;if to the Company, at its address or
facsimile number set forth on the signature page to this Agreement addressed to the
attention of the Corporate Secretary, or at such other address or facsimile number as
the Company shall have furnished to the Purchasers. Any such notice or communication
shall be deemed to have been received (A)&nbsp;in the case of personal delivery or
delivery by telecopier, on the date of such delivery, (B)&nbsp;in the case of a commercial
overnight courier, on the next business day after the date when sent and (C)&nbsp;in the
case of mailing, on the fifth business day following that on which the piece of mail
containing such communication is posted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.7 <U>Delays or Omissions</U>. No delay or omission to exercise any right, power
or remedy accruing to any holder of any Shares upon any breach or default of the
Company under this Agreement shall impair any such right, power or remedy of such
holder, nor shall it be construed to be a waiver of any such breach or default, or an
acquiescence therein, or of or in any similar breach or default thereafter occurring;
nor shall any waiver of any single breach or default be deemed a waiver of any other
breach or default theretofore or thereafter occurring. Any waiver, permit, consent
or approval of any kind or character on the part of any holder of any breach or
default under this Agreement, or any waiver on the part of any holder of any
provisions or conditions of this Agreement, must be in writing and shall be effective
only to the extent specifically set forth in such writing or as provided in this
Agreement. All remedies, either under this Agreement or by law or otherwise afforded
to any holder, shall be cumulative and not alternative.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.8 <U>California Corporate Securities Law</U>. THE SALE OF THE SECURITIES WHICH
ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF
CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE
PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH
QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM THE
QUALIFICATION BY SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE.
THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH
QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.9 <U>Finder&#146;s Fee</U>. The Company and each Purchaser shall each indemnify and
hold the other harmless from any liability for any commission or compensation in the
nature of a finder&#146;s fee (including the costs, expenses and legal fees of defending
against such liability) for which the Company or the Purchasers, or any of their
respective partners, employees, or representatives, as the case may be, is
responsible.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.10 <U>Expenses</U>. The Company and each Purchaser shall bear its own expenses
and legal fees incurred on its behalf with respect to this Agreement and the
transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.11 <U>Waiver of Conflict</U>. Each of the Purchasers and the Company acknowledges
that Wilson Sonsini Goodrich &#038; Rosati, Professional Corporation (&#147;<B>WSGR</B>&#148;) may have
represented and may currently represent Purchasers. In the course of such
representation, WSGR may have
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-16-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">come into possession of confidential information
relating to such Purchasers. Each of the Purchasers and the Company acknowledges
that WSGR is representing only the Company in this transaction. Pursuant to Rule
3-310 of the Rules of Professional Conduct promulgated by the State Bar of
California, an attorney must avoid representations in which the attorney has or had a
relationship with another party interested in the representation without the informed
written consent of all parties affected. By executing this Agreement, each of the
Purchasers
and the Company hereby waives any actual or potential conflict of interest that may
arise in this financing as a result of WSGR&#146;s representation of such persons or
entities, WSGR&#146;s possession of such confidential information and the participation by
WSGR&#146;s affiliate in the financing. Each of the Purchasers and the Company represents
that it has had the opportunity to consult with independent counsel concerning the
giving of this waiver.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.12 <U>Severability</U>. In the event that any provision of this Agreement becomes
or is declared by a court of competent jurisdiction to be illegal, unenforceable or
void, this Agreement shall continue in full force and effect without said provision;
provided that no such severability shall be effective if it materially changes the
economic benefit of this Agreement to any party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.13 <U>Counterparts; Facsimile</U>. This Agreement may be executed in any number
of counterparts, each of which may be executed by less than all Purchasers, each of
which shall be enforceable against the parties actually executing such counterparts,
and all of which together shall constitute one instrument. This Agreement may be
executed by facsimile signature.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.14 <U>Titles and Subtitles</U>. The titles and subtitles used in this Agreement
are used for convenience only and are not to be considered in construing or
interpreting this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.15 <U>Exculpation Among Purchasers</U>. Each Purchaser acknowledges that it is
not relying upon any person, firm or corporation (including without limitation any
other Purchaser), other than the Company and its officers and directors (acting in
their capacity as representatives of the Company), in deciding to invest and in
making its investment in the Company. Each Purchaser agrees that no other Purchaser
nor the respective controlling persons, officers, directors, partners, agents or
employees of any other Purchaser shall be liable to such Purchaser for any losses
incurred by such Purchaser in connection with its investment in the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.16 <U>Like Treatment of Holders</U>. The Company shall not directly or indirectly
pay or cause to be paid any consideration, whether by way of interest, fee, payment
for the redemption or exchange of Preferred Stock, or otherwise to any holder of
Preferred Stock for or as inducement to, any consent, waiver or amendment of any term
or provision of the Preferred Stock, this Agreement or the Investor Rights Agreement
unless equivalent consideration is offered on equivalent terms and conditions to all
Purchasers of Preferred Stock under this Agreement bound by such consent, waiver or
amendment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.17 <U>Jury Trial</U>. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO
THE FULLEST EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING (WHETHER
SOUNDING IN CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS AGREEMENT.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-17-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>FLUIDIGM CORPORATION</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Gajus Worthington
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Gajus Worthington&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer<br><br>
7100 Shoreline Court<br>
South San Francisco, CA 94080<br>
FAX: (650) 871-7195&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;FLUIDIGM CORPORATION SERIES E PREFERRED STOCK PURCHASE AGREEMENT&#093;</I></B>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="50%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>PURCHASER:</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>AllianceBernstein L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Adam Spilka</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Adam Spilka</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SVP, Counsel, Secretary</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;FLUIDIGM CORPORATION SERIES E PREFERRED STOCK PURCHASE AGREEMENT&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT A</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>SCHEDULE OF PURCHASERS</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="23%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="13%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name and Address</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Shares of Series E</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Purchase Price</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>AllianceBernstein L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,250,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">5,000,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>TOTALS</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>1,250,000</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>$</B></TD>
    <TD align="right"><B>5,000,000.00</B></TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FLUIDIGM CORPORATION</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>AMENDMENT NO. 1 TO<BR>
SERIES E PREFERRED STOCK PURCHASE AGREEMENT</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment No.&nbsp;1 (the &#147;<B>Amendment</B>&#148;) to that certain Series&nbsp;E Preferred Stock Purchase
Agreement, dated as of June&nbsp;13, 2006 (the &#147;<B>Purchase Agreement</B>&#148;), is made and entered into effective
as of December&nbsp;22, 2006 (the &#147;<B>Effective Date</B>&#148;) by and among Fluidigm Corporation, a California
corporation (the &#147;<B>Company</B>&#148;), and the Purchasers named therein. Capitalized terms used in this
Amendment that are not otherwise defined herein shall have the respective meanings assigned to them
in the Purchase Agreement.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>RECITALS</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, the Company previously sold and issued an aggregate of 1,250,000 shares of Series&nbsp;E
Preferred Stock of the Company (the &#147;<B>Series&nbsp;E Preferred</B>&#148;) pursuant to the terms of the Purchase
Agreement at the Initial Closing held on June&nbsp;13, 2006;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, the Company and the Purchaser now desire to amend the terms of the Purchase Agreement
to provide that the Company may sell and issue additional shares of Series&nbsp;E Preferred pursuant to
the Purchase Agreement, at one or more additional Subsequent Closings, provided that any such
additional Subsequent Closings shall take place no later than March&nbsp;31, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, pursuant to Section&nbsp;6.5 of the Purchase Agreement, the terms of the Purchase
Agreement may be amended upon the written consent of the Company and the holder or holders of
greater than fifty percent (50%) of the outstanding Shares or the Conversion Shares; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, the Purchaser who has signed below holds greater than fifty percent (50%) of the
outstanding Shares purchased under the Purchase Agreement as of the Effective Date and consents to
the changes as set forth in this Amendment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>NOW, THEREFORE, </B>in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
mutually agree as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>AGREEMENT</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Amendment to Section&nbsp;1.1</U>. Section&nbsp;1.1 (Authorization of the Shares) of the
Purchase Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;1.1 <U>Authorization of the Shares</U>. The Company will on or
before the Closing (as defined below) authorize the sale and issuance
pursuant to this Agreement of up to 6,318,333 shares (the &#147;<B>Shares</B>&#148;) of its
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 1 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">Series&nbsp;E Preferred Stock (the &#147;<B>Series&nbsp;E Preferred</B>&#148;), having the rights,
preferences and privileges as set forth in the Amended and Restated Articles
of Incorporation attached hereto as <U>EXHIBIT B</U> (the &#147;<B>Restated
Articles</B>&#148;).&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Amendment to Section&nbsp;1.2</U>. Section&nbsp;1.2 (Purchase and Sale of the Shares) of the
Purchase Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;1.2 <U>Purchase and Sale of the Shares</U>. Subject to the terms and
conditions hereof and in reliance upon the representations, warranties and
agreements contained herein, the Company will issue and sell to each
Purchaser, severally and not jointly, and each Purchaser will purchase from
the Company, severally and not jointly, at the Closing, the number of Shares
set forth opposite the Purchaser&#146;s name on the Schedule of Purchasers, at a
purchase price of Four Dollars ($4.00) per Share. The Company shall be
entitled to sell any unpurchased Shares to any Purchaser or to a person who
is not a Purchaser and to amend the Schedule of Purchasers to include the
information relating to such sales, and such purchasers shall be considered
&#147;Purchasers&#148; and parties to this Agreement; provided that (i)&nbsp;such sales are
made pursuant to this Agreement or an agreement identical to this one except
for the Closing Date and exhibits, and (ii)&nbsp;such sales are completed on or
prior to March&nbsp;31, 2007. The Company&#146;s agreement with each Purchaser is a
separate agreement, and the sale of the Shares to each Purchaser is a
separate sale.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Governing Law</U>. This Amendment shall be governed in all respects by the laws of the
State of California, without regard to any provisions thereof relating to conflicts of laws among
different jurisdictions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Purchase Agreement</U>. Wherever necessary, all other terms of the Purchase Agreement
are hereby amended to be consistent with the terms of this Amendment. Except as specifically set
forth herein, the Purchase Agreement shall remain in full force and effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Counterparts; Facsimile</U>. This Amendment may be executed in any number of
counterparts, each of which shall be an original, and all of which together shall constitute one
instrument. Executed signatures transmitted via facsimile will be accepted and considered duly
executed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Effect of Execution of Amendment by Certain Purchaser</U>. This Amendment, when
executed and delivered by the Company and a Purchaser purchasing shares of Series&nbsp;E Preferred at a
Subsequent Closing held on or after the date hereof, shall also constitute and shall be deemed a
counterpart signature page to the Purchase Agreement. Consequently, each undersigned Purchaser
purchasing shares of Series&nbsp;E Preferred at a Subsequent Closing held on or after the date hereof
acknowledges and agrees that he, she or it is bound by the terms and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 2 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">conditions contained in the Purchase Agreement, as amended by this Amendment, with respect to
the purchase of such shares.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Remainder of page intentionally left blank</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 3 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left"><B>COMPANY:</B></TD>
    <TD colspan="3" align="left"><B>FLUIDIGM CORPORATION</B><BR>
a California corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Gajus Worthington
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Gajus Worthington,&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">





<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="14%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Cross Creek Capital, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital GP, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wasatch Advisors, Inc. <br>
Its Sole Member</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Karey Barker
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Karey Barker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="14%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Cross Creek Capital Employees&#146; Fund, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital GP, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wasatch Advisors, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole Member</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Karey Barker
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Karey Barker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="18%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>WASATCH FUNDS, INC.</B><BR>
Wasatch Small Cap Growth Fund</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wasatch Advisors, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Investment Adviser</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Dan Thurber
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Dan Thurber
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>SMALLCAP World Fund, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B><FONT style="white-space: nowrap">Capital Research and Management Company,</FONT></B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>its, investment adviser</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Downer
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Downer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>AllianceBernstein Venture Fund I, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>AllianceBernstein ESG Venture Management, L.P.,
its general partner</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>AllianceBernstein Global Derivatives Corporation,
its general partner</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ James D. Kiggen
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">James D. Kiggen</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-variant: SMALL-CAPS"><b>Versant</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-variant: SMALL-CAPS"><b>Affiliates Fund 1-A, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-variant: SMALL-CAPS"><b>Versant</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-variant: SMALL-CAPS"><b>Affiliates Fund 1-B, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-variant: SMALL-CAPS"><b>Versant</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-variant: SMALL-CAPS"><b>Side Fund I, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-variant: SMALL-CAPS"><b>Versant</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-variant: SMALL-CAPS"><b>Venture Capital I, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Versant Ventures I, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Samuel D. Colella
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Samuel D. Colella</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers Healthcare Venture Capital L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lehman Brothers HealthCare Venture Capital Associates L.P.,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LB I Group Inc., its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Odrich
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Odrich</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers P.A. LLC</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Odrich
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Odrich</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers Partnership Account <BR>
2000/2001, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LB I Group Inc., its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Odrich
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Odrich</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers Offshore Partnership Account 2000/2001, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LB I Offshore Partners Group Ltd., its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Odrich
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Odrich</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>EuclidSR Partners, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EuclidSR Associates, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Elaine V. Jones
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elaine V. Jones</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>EuclidSR Biotechnology Partners, L.P</B></FONT><B>.</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EuclidSR Biotechnology Associates, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Elaine V. Jones
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elaine V. Jones</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Iinterwest Partners VII, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">InterWest Management Partners VII, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Sweeney
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Sweeney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As agent for the general partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Interwest Investors VII, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">InterWest Management Partners VII, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Sweeney
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Sweeney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As agent for the general partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lilly Bioventures, Eli Lilly &#038; Company</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Thomas W. Grein
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Thomas W. Grein</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President and Treasurer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Alloy Ventures 2005, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Alloy Ventures 2005, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Tony DiBona
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Toni DiBona</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Member of Alloy Ventures
2005 LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Alloy Ventures 2002, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Alloy Partners 2002, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Alloy Ventures 2002, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Tony DiBona
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tony DiBona</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Member of Alloy
Ventures
2002, LLC, the general partner of Alloy
Partners 2002, L.P. and Alloy Ventures
2002, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>SightLine Healthcare Fund III, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Kenneth E. Higgins
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Kenneth E. Higgins</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Director of Sightline
Partners
LLC, general partner of its general partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ Bruce Burrows
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Bruce Burrows</B></FONT>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>


</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ John M. Harland
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><FONT style="font-variant: SMALL-CAPS"><B>John M. Harland</B></FONT>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASER:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Ferguson/Egan Family Trust dated 6/28/99</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:<BR>
Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Rodney A. Ferguson
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Rodney A. Ferguson
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trustee</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASER:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Health Care Administration Company</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Gary L. Bowers
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gary L. Bowers</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASER:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>The Condon Family Trust</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Thomas J. Condon
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Thomas J. Condon</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trustee</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASER:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>In-Q-Tel, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Scott G. Yancey
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Scott G. Yancey</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Executive Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>In-Q-Tel Employee Fund, LLC</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Scott G. Yancey</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Scott G. Yancey</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EVP of In-Q-Tel, Inc., the manager of the
fund</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASER:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>The V Foundation for Cancer Research</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:<BR>
Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Nicholas Valvano
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Nicholas Valvano
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASER:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Fredrick H. Stern
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
<FONT style="font-variant: SMALL-CAPS"><B>Fredrick H. Stern</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Alfred J. Mandel
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
<FONT style="font-variant: SMALL-CAPS"><B>Alfred J. Mandel</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASER:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Pauline E. van Ysendoorn
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
<FONT style="font-variant: SMALL-CAPS"><B>Pauline E. van Ysendoorn</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASER:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Rhett E. Brown
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-variant: SMALL-CAPS"><B>Rhett E. Brown</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;1 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the 30<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASER:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="44%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>SMALLCAP World Fund, Inc.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Capital Research and Management Company,
its investment adviser</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Timothy D. Amour</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Timothy D. Armour</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;1 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT A<BR>
SCHEDULE OF PURCHASERS<BR>
SERIES E PREFERED STOCK FINANCING<BR>
DECEMBER 22, 2006</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Shares of Series E</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Preferred Stock</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Purchase Price</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>CLIPPERBAY &#038; CO.</B><BR>
SMALLCAP World Fund, Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,875,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,500,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>PACO c/o 80-16-200-1037662</B><BR>
Cross Creek Capital, L.P.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">569,074</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,276,296.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>PACO c/o 80-16-200-1037670</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55,926</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">223,704.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>CLEARMOON &#038; CO.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">625,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,500,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>ALLIANCEBERNSTEIN VENTURE FUND I, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">250,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>ALLOY VENTURES 2005, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">80,625</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">322,500.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>ALLOY VENTURES 2002, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78,505</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">314,020.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>ALLOY PARTNERS 2002, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,120</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">8,480.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>INTERWEST INVESTORS VII, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,285</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">9,140.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>INTERWEST PARTNERS VII, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47,715</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">190,860.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>EUCLIDSR BIOTECHNOLOGY PARTNERS, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">105,875</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">423,500.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>EUCLIDSR PARTNERS, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">105,875</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">423,500.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>VERSANT AFFLIATES FUND 1-A, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">20,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:0px; text-indent:-0px"><B>VERSANT AFFLIATES FUND 1-B, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">42,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT A<BR>
SCHEDULE OF PURCHASERS<BR>
SERIES E PREFERED STOCK FINANCING<BR>
DECEMBER 22, 2006</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Shares of Series E</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Preferred Stock</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Purchase Price</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>VERSANT SIDE FUND I, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">18,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>VERSANT VENTURE CAPITAL I, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">230,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">920,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>LILLY BIO VENTURES, ELI LILLY AND COMPANY</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">89,750</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">359,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>SIGHTLINE HEALTHCARE FUND III, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">120,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>BRUCE BURROWS</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">144,750</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">579,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>LEHMAN BROTHERS HEALTHCARE VENTURE CAPITAL, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39,937</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">159,748.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>LEHMAN BROTHERS OFFSHORE PARTNERSHIP ACCOUNT 2000/2001, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8,932</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">35,728.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>LEHMAN BROTHERS P.A., LLC</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76,440</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">305,760.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>LEHMAN BROTHERS PARTNERSHIP ACCOUNT 2000/2001, L.P.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34,440</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">137,760.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>TOTALS</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,284,749</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">17,138,996.00</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT A<BR>
SCHEDULE OF PURCHASERS<BR>
SERIES E PREFERED STOCK FINANCING<BR>
MARCH 30, 2007</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Shares of Series E</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Preferred Stock</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Purchase Price</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>JOHN M. HARLAND</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">20,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>FERGUSON/EGAN FAMILY TRUST DATED 6/28/99</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">60,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>HEALTH CARE ADMINISTRATION COMPANY</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">100,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>THE CONDON FAMILY TRUST</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">50,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>IN-Q-TEL, INC.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10,125</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">40,500.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>IN-Q-TEL EMPLOYEE FUND, LLC</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,375</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">13,500.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>THE V FOUNDATION FOR CANCER RESEARCH</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,250</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">25,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>FREDRICK H. STERN</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">150,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>ALFRED J. MANDEL</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">4,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>PAULINE E. </B><FONT style="font-variant: SMALL-CAPS"><B>van YSENDOORN</B></FONT> </DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">10,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>RHETT E. BROWN</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">50,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>CLIPPERBAY &#038; CO.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">350,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,400,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>TOTALS</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>480,750</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>$</B></TD>
    <TD align="right"><B>1,923,000.00</B></TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FLUIDIGM CORPORATION</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>AMENDMENT NO. 2 TO<BR>
SERIES E PREFERRED STOCK PURCHASE AGREEMENT</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment No.&nbsp;2 (the &#147;<B>Amendment</B>&#148;) to that certain Series&nbsp;E Preferred Stock Purchase
Agreement, dated as of June&nbsp;13, 2006, as amended December&nbsp;22, 2006, by and among Fluidigm
Corporation, a California corporation (&#147;<B>Fluidigm California</B>&#148;) and the Purchasers named therein (the
&#147;<B>Purchase Agreement</B>&#148;), is made and entered into effective as of October&nbsp;10, 2007 (the &#147;<B>Effective
Date</B>&#148;) by and among Fluidigm Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), and the
Purchasers named herein. Capitalized terms used in this Amendment that are not otherwise defined
herein shall have the respective meanings assigned to them in the Purchase Agreement.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>RECITALS</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, Fluidigm California previously sold and issued an aggregate of 1,250,000 shares of
Series&nbsp;E Preferred Stock (the &#147;<B>Series&nbsp;E Preferred</B>&#148;) pursuant to the terms of the Purchase Agreement
at the Initial Closing held on June&nbsp;13, 2006 and an additional 6,015,499 shares of Series&nbsp;E
Preferred at Subsequent Closings held on December&nbsp;22, 2006 and March&nbsp;30, 2007;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, on July&nbsp;18, 2007, Fluidigm California was merged with and into the Company, with the
Company being the surviving corporation such that the Company succeeded to all of Fluidigm
California&#146;s rights and obligations under the Purchase Agreement and all outstanding shares of
Series&nbsp;E Preferred of Fluidigm California were exchanged on a one for one basis for shares of
Series&nbsp;E Preferred of the Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS, </B>the Company and the Purchasers now desire to amend the terms of the Purchase
Agreement to provide that the Company may sell and issue up to 7,375,000 additional shares of
Series&nbsp;E Preferred (the &#147;<B>Additional Shares</B>&#148;) pursuant to the Purchase Agreement, at one or more
additional Subsequent Closings, provided that any such additional Subsequent Closings shall take
place no later than December&nbsp;31, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, pursuant to Section&nbsp;6.5 of the Purchase Agreement, the terms of the Purchase
Agreement may be amended upon the written consent of the Company and the holder or holders of
greater than fifty percent (50%) of the outstanding Shares or the Conversion Shares;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, the Purchasers who have signed below hold greater than fifty percent (50%) of the
outstanding Shares purchased under the Purchase Agreement as of the Effective Date and consent to
the changes as set forth in this Amendment;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, in connection with the execution of this Amendment, the Company is amending the
Amended and Restated Certificate of Incorporation of the Company to increase the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">number of
authorized shares of capital stock of the Company to facilitate the sale of the Additional Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>NOW, THEREFORE, </B>in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
mutually agree as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>AGREEMENT</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Amendment to Section&nbsp;1.1</U>. Section&nbsp;1.1 (Authorization of the Shares) of the
Purchase Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;1.1 <U>Authorization of the Shares</U>. The Company will on or
before the Closing (as defined below) authorize the sale and issuance
pursuant to this Agreement of up to 17,956,252 shares (the &#147;<B>Shares</B>&#148;) of its
Series&nbsp;E Preferred Stock (the &#147;<B>Series&nbsp;E Preferred</B>&#148;), having the rights,
preferences and privileges as set forth in the Amended and Restated
Certificate of Incorporation, as amended by Amendment No.&nbsp;1 to Amended and
Restated Certificate of Incorporation and Amendment No.&nbsp;2 to Amended and
Restated Certificate of Incorporation, as attached hereto as <U>EXHIBITS
B-1</U> AND <U>B-2</U>, respectively (together for purposes of this
Agreement, the &#147;<B>Restated Certificate</B>&#148;).&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Amendment to Section&nbsp;1.2</U>. Section&nbsp;1.2 (Purchase and Sale of the Shares) of the
Purchase Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;1.2 <U>Purchase and Sale of the Shares</U>. Subject to the terms and
conditions hereof and in reliance upon the representations, warranties and
agreements contained herein, the Company will issue and sell to each
Purchaser, severally and not jointly, and each Purchaser will purchase from
the Company, severally and not jointly, at the applicable Closing, the
number of Shares set forth opposite the Purchaser&#146;s name on the Schedule of
Purchasers, at a purchase price of Four Dollars ($4.00) per Share. The
Company shall be entitled to sell any unpurchased Shares to any Purchaser or
to a person who is not a Purchaser and to amend the Schedule of Purchasers
to include the information relating to such sales, and such purchasers shall
be considered &#147;Purchasers&#148; and parties to this Agreement; provided that (i)
such sales are made pursuant to this Agreement or an agreement identical to
this one except for the Closing Date and exhibits, and (ii)&nbsp;such sales are
completed on or prior to December&nbsp;31, 2007. The Company&#146;s agreement with
each Purchaser is a separate agreement, and the sale of the Shares to each
Purchaser is a separate sale.&#148;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Amendment to Section&nbsp;2</U>. Section&nbsp;2 (Representations and Warranties of the Company)
of the Purchase Agreement is hereby amended to add the following sentence to the end of the
paragraph which reads in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;At each Subsequent Closing, the Company shall provide an updated
Schedule of Exceptions and <U>EXHIBIT C</U> shall be concurrently amended
and restated for purposes of such Subsequent Closing.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Amendment to Section&nbsp;2.4</U>. Solely in connection with the sale of Additional Shares
pursuant to this Amendment, Section&nbsp;2.4 (Capitalization) of the Purchase Agreement is hereby
amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;The authorized capital stock of the Company consists, or immediately
prior to the Closing will consist, of 85,232,144 shares of Common Stock
(&#147;<B>Common Stock</B>&#148;), of which 9,760,848 shares are issued and outstanding
immediately prior to the Closing and 57,961,085 shares of Preferred Stock
(&#147;<B>Preferred Stock</B>&#148;), 2,727,273 of which are designated Series&nbsp;A Preferred
Stock of which 2,727,273 are outstanding immediately prior to the Closing;
6,460,675 of which are designated Series&nbsp;B Preferred Stock of which
6,460,675 are outstanding immediately prior to the Closing; 16,854,624 of
which are designated Series&nbsp;C Preferred Stock, 16,364,832 of which are
issued and outstanding immediately prior to the Closing; and 13,962,261 of
which are designated Series&nbsp;D Preferred Stock, 13,353,333 of which are
issued and outstanding immediately prior to the Closing; and 17,956,252 of
which are designated Series&nbsp;E Preferred Stock, 8,969,836 of which are issued
and outstanding immediately prior to the Closing. All such issued and
outstanding shares have been duly authorized and validly issued in
compliance with applicable laws, and are fully paid and nonassessable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has reserved: (i)&nbsp;17,956,252 shares of Series&nbsp;E Preferred
for issuance hereunder and 17,956,252 shares of Common Stock for issuance
upon conversion of such shares of Series&nbsp;E Preferred; (ii)&nbsp;13,353,333
shares of Common Stock for issuance upon conversion of the outstanding
shares of Series&nbsp;D Preferred; (iii)&nbsp;408,928 shares of Series&nbsp;D Preferred for
issuance upon exercise of outstanding warrants and 408,928 shares of Common
Stock for issuance upon conversion of such Series&nbsp;D Preferred; (iv)
16,364,832 shares of Common Stock for issuance upon conversion of the
outstanding shares of Series&nbsp;C Preferred Stock; (v)&nbsp;289,792shares of Series
C Preferred Stock for issuance upon exercise of outstanding warrants and
289,792 shares of Common Stock for issuance upon conversion of such Series&nbsp;C
Preferred Stock; (vi)&nbsp;6,460,675 shares of Common Stock for issuance upon
conversion of the outstanding Series&nbsp;B Preferred Stock; (vii)&nbsp;2,727,273
shares of Common Stock for issuance upon conversion of the outstanding
Series&nbsp;A Preferred Stock; and (viii)&nbsp;an aggregate of 12,800,000 shares of
Common Stock for issuance to
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">employees and consultants of the Company
pursuant to the Company&#146;s 1999 Stock Option Plan, pursuant to which options
to purchase 7,247,691 shares are granted and outstanding and 1,518,223
shares are available for future grant. As of the date hereof and after
giving effect to the purchase of Shares hereunder, each share of each series
of the Company&#146;s Preferred Stock is convertible into one share of the
Company&#146;s Common Stock. Other than with respect to the shares reserved for
issuance in this paragraph, or as set forth in the Ancillary Agreements (as
defined below), there are no outstanding rights, options, warrants,
conversion rights, preemptive rights, rights of first refusal or similar
rights for the purchase or acquisition from the Company of any securities of
the Company. There are no outstanding obligations of the Company to
repurchase or redeem any of its securities.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Amendment to Section&nbsp;2.16</U>. Solely in connection with the sale of Additional Shares
pursuant to this Amendment, Section&nbsp;2.16 (Financial Statements) of the Purchase Agreement is hereby
amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;The Company has made available to each Purchaser its audited balance
sheet dated as of December&nbsp;31, 2004. The Company has also made available to
each Purchaser unaudited balance sheets dated December&nbsp;31, 2005 and December
31, 2006 and the unaudited statements of operations for the fiscal years
then ended (collectively, the &#147;<B>Financial Statements</B>&#148;). The Financial
Statements are complete and correct in all material respects and have been
prepared in accordance with generally accepted accounting principles applied
on a consistent basis throughout the periods indicated. The Financial
Statements accurately set out and describe the financial condition and
operating results of the Company as of the date, and during the periods,
indicated therein. Except as set forth in the Financial Statements, the
Company has no material liabilities, contingent or otherwise, other than (i)
liabilities incurred in the ordinary course of business subsequent to
December&nbsp;31, 2006 and (ii)&nbsp;obligations under contracts and commitments
incurred in the ordinary course of business and not required under generally
accepted accounting principles to be reflected in the Financial Statements,
which, in both cases, individually or in the aggregate are not material to
the financial condition or operating results of the Company.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Deletion of Sections&nbsp;6.9 and 6.11</U>. Solely in connection with the sale of
Additional Shares pursuant to this Amendment, the Purchase Agreement is hereby amended to delete
Section&nbsp;6.9 (Finder&#146;s Fee) and Section&nbsp;6.11 (Waiver of Conflict), each in its entirety.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>Amendment to Section&nbsp;6.10</U>. Solely in connection with the sale of Additional Shares
pursuant to this Amendment, Section&nbsp;6.10 of the Purchase Agreement is hereby amended and restated
in its entirety to read as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;6.10 <U>Expenses</U>. The Company and each Purchaser shall bear its
own expenses and legal fees incurred on its behalf with respect to this
Agreement and the transactions contemplated hereby, <I>provided, however</I>, that
if a Closing is effected, the Company shall reimburse the reasonable
documented fees of one counsel for the Purchasers, such amount not to exceed
$25,000, by wire transfer at such Closing.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<U>Addition of Section&nbsp;6.17</U>. The Purchase Agreement is hereby amended to add the
following Section&nbsp;6.17 which reads in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;6.17 <U>Reincorporation</U>. Each Purchaser hereunder acknowledges
that the Company completed a reincorporation into the State of Delaware on
July&nbsp;18, 2007 and each Purchaser hereby consents to the assignment of this
Agreement to Fluidigm Corporation, a Delaware corporation effective as of
July&nbsp;18, 2007.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;<U>Restated Certificate</U>. All references in the Purchase Agreement to the term
&#147;Restated Articles&#148; are hereby deleted and replaced with the term &#147;Restated Certificate.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;<U>Governing Law</U>. This Amendment shall be governed in all respects by the laws of
the State of California, without regard to any provisions thereof relating to conflicts of laws
among different jurisdictions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;<U>Purchase Agreement</U>. Wherever necessary, all other terms of the Purchase Agreement
are hereby amended to be consistent with the terms of this Amendment. Except as specifically set
forth herein, the Purchase Agreement shall remain in full force and effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;<U>Counterparts; Facsimile</U>. This Amendment may be executed in any number of
counterparts, each of which shall be an original, and all of which together shall constitute one
instrument. Executed signatures transmitted via facsimile will be accepted and considered duly
executed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;<U>Effect of Execution of Amendment by Certain Purchasers</U>. This Amendment, when
executed and delivered by the Company and a Purchaser purchasing shares of Series&nbsp;E Preferred at a
Subsequent Closing held on or after the date hereof, shall also constitute and shall be deemed a
counterpart signature page to the Purchase Agreement. Consequently, each undersigned Purchaser
purchasing shares of Series&nbsp;E Preferred at a Subsequent Closing held on or after the date hereof
acknowledges and agrees that he, she or it is bound by the terms and conditions contained in the
Purchase Agreement, as amended by this Amendment, with respect to the purchase of such shares.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Remainder of page intentionally left blank</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-5-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment No.&nbsp;2
to Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>COMPANY:</B>

</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>FLUIDIGM CORPORATION</B><BR>
a Delaware corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Gajus Worthington
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Gajus Worthington,&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Fidelity Contrafund: </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Fidelity Advisor New Insights Fund</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Gary Ryan
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gary Ryan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assistant Treasurer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><FONT style="white-space: nowrap"><B>Fidelity Contrafund: Fidelity Contrafund</B></FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Gary Ryan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gary Ryan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assistant Treasurer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Variable Insurance Products Fund II:</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Contrafund Portfolio</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Gary Ryan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gary Ryan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assistant Treasurer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Leerink Swann Holdings, LLC</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Jeffrey A. Leerink
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jeffrey A. Leerink</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Leerink Swann Holdings, LLC </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Co-Investment Fund, LLC</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Donald D. Notman, Jr.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Donald D. Notman, Jr.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><B>PURCHASERS:</B></TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Cross Creek Capital, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital GP, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wasatch Advisors, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole Member</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Karey Barker
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Karey Barker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><FONT style="white-space: nowrap"><B>Cross Creek Capital Employees&#146; Fund, L.P.</B></FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital GP, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wasatch Advisors, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole Member</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Karey Barker
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Karey Barker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"> <B>Wasatch Funds, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wasatch Advisors, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole Member</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Dan Thurber
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dan Thurber</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>SMALLCAP World Fund, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="white-space: nowrap"><B>Capital Research and Management Company,</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>its, investment adviser</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Downer
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Downer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><FONT style="white-space: nowrap"><B>AllianceBernstein Venture Fund I, L.P.</B></FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top"><B>AllianceBernstein ESG Venture <BR>
Management, L.P., its general partner</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top"><B>AllianceBernstein Global
Derivatives <BR>
Corporation, its general partner</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ James D. Kiggen
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">James D. Kiggen</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Versant Affiliates Fund 1-A, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Versant Affiliates Fund1-B, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Versant Side Fund I, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Versant Venture Capital I, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Versant Ventures I, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Samuel D. Colella
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Samuel D. Colella</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>

<TD colspan="3"  nowrap valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman
Brothers Healthcare Venture Capital <br>L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Lehman Brothers HealthCare Venture Capital</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Associates L.P.,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LB I Group Inc., its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:<BR>
Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Steven Berkenfeld
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Steven Berkenfeld
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" nowrap valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers P.A. LLC</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Steven Berkenfeld</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Steven Berkenfeld</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" nowrap valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers Partnership Account 2000/2001,<BR>
L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LB I Group Inc., its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Steven Berkenfeld</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Steven Berkenfeld</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>

<TD colspan="3" nowrap valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman
Brothers Offshore Partnership Account</B><br><b>2000/2001, L.P.</b></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LB I Offshore Partners Group Ltd., its General</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Steven Berkenfeld</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Steven Berkenfeld</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" nowrap><FONT style="font-variant: SMALL-CAPS"><B>EuclidSR Partners, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>EuclidSR Associates, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Elaine V. Jones
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elaine V. Jones</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"> General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" nowrap><FONT style="font-variant: SMALL-CAPS"><B>EuclidSR Biotechnology Partners, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EuclidSR Biotechnology Associates, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Elaine V. Jones</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elaine V. Jones</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"> General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><FONT style="white-space: nowrap"><B>Interwest Partners VII, L.P.</B></FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>InterWest Management Partners VII,
LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Sweeney
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Sweeney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As agent for the general partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" nowrap><FONT style="font-variant: SMALL-CAPS"><B>Interwest Investors VII, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">InterWest Management Partners VII,
LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Sweeney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Sweeney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As agent for the general partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><FONT style="white-space: nowrap"><B>Lilly Bioventures, Eli Lilly &#038; Company</B></FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Darren J. Carroll
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Darren J. Carroll</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Executive Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Bruce Burrows
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
<FONT style="font-variant: SMALL-CAPS"><B>Bruce Burrows</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" nowrap><FONT style="font-variant: SMALL-CAPS"><B>Biomedical Sciences Investment Fund Pte Ltd</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Chu Swee Yeok
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chu Swee Yeok</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" nowrap><FONT style="font-variant: SMALL-CAPS"><B>Singapore Bio-Innovations Pte Ltd</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Sim Sze Kuan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sim Sze Kuan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;2 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>PURCHASERS:</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="49%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Invus, L.P.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Invus Advisors LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General Partner of Invus LP</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Aflalo Guimaraes
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Aflalo Guimaraes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Signature Page to Amendment No.&nbsp;2 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement</I></B><B>&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT A<BR>
SCHEDULE OF PURCHASERS<BR>
SERIES E PREFERED STOCK FINANCING<BR>
OCTOBER 10, 2007</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Shares of Series&nbsp;E</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Preferred Stock</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Purchase Price</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>FIDELITY CONTRAFUND:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>FIDELITY ADVISOR NEW INSIGHTS FUND</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">481,170</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">1,924,679.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>FIDELITY CONTRAFUND: FIDELITY CONTRAFUND</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,389,865</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">17,559,461.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>VARIABLE INSURANCE PRODUCTS FUND II:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>CONTRAFUND PORTFOLIO</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,378,965</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">5,515,860.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>LEERICK SWANN HOLDINGS, LLC</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">250,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>LEERICK SWANN CO-INVESTMENT FUND, LLC</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78,750</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">315,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>TOTALS</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>6,391,250</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left"><B>$</B></TD>
    <TD align="right"><B>25,565,000.00</B></TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FLUIDIGM CORPORATION</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>AMENDMENT NO.&nbsp;3 TO<BR>
SERIES&nbsp;E PREFERRED STOCK PURCHASE AGREEMENT</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment No.&nbsp;3 (the &#147;<B>Amendment</B>&#148;) to that certain Series&nbsp;E Preferred Stock Purchase
Agreement, dated as of June&nbsp;13, 2006, as amended December&nbsp;22, 2006 and further amended October&nbsp;10,
2007, by and among Fluidigm Corporation, a California corporation (&#147;<B>Fluidigm California</B>&#148;) and the
Purchasers named therein (the &#147;<B>Purchase Agreement</B>&#148;), is made and entered into effective as of
October&nbsp;26, 2007 (the &#147;<B>Effective Date</B>&#148;) by and among Fluidigm Corporation, a Delaware corporation
(the &#147;<B>Company</B>&#148;), and the Purchasers named herein. Capitalized terms used in this Amendment that
are not otherwise defined herein shall have the respective meanings assigned to them in the
Purchase Agreement.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>RECITALS</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, Fluidigm California previously sold and issued an aggregate of 1,250,000 shares of
Series&nbsp;E Preferred Stock (the &#147;<B>Series&nbsp;E Preferred</B>&#148;) pursuant to the terms of the Purchase Agreement
at the Initial Closing held on June&nbsp;13, 2006, an additional 4,284,749 shares of Series&nbsp;E Preferred
at a Subsequent Closing held on December&nbsp;22, 2006, an additional 480,750 shares of Series&nbsp;E
Preferred at a Subsequent Closing held on March&nbsp;30, 2007, and an additional 6,391,250 shares of
Series&nbsp;E Preferred at a Subsequent Closing held on October&nbsp;10, 2007;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, on July&nbsp;18, 2007, Fluidigm California was merged with and into the Company, with the
Company being the surviving corporation such that the Company succeeded to all of Fluidigm
California&#146;s rights and obligations under the Purchase Agreement and all outstanding shares of
Series&nbsp;E Preferred of Fluidigm California were exchanged on a one for one basis for shares of
Series&nbsp;E Preferred of the Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS, </B>the Company and the Purchasers now desire to amend the terms of the Purchase
Agreement to provide that the Company may sell and issue up to 2,153,695 additional shares of
Series&nbsp;E Preferred (the &#147;<B>Additional Shares</B>&#148;) pursuant to the Purchase Agreement, at one or more
additional Subsequent Closings, provided that any such additional Subsequent Closings shall take
place no later than December&nbsp;31, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, pursuant to Section&nbsp;6.5 of the Purchase Agreement, the terms of the Purchase
Agreement may be amended upon the written consent of the Company and the holder or holders of
greater than fifty percent (50%) of the outstanding Shares or the Conversion Shares;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, the Purchasers who have signed below hold greater than fifty percent (50%) of the
outstanding Shares purchased under the Purchase Agreement as of the Effective Date and consent to
the changes as set forth in this Amendment;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, in connection with the execution of this Amendment, the Company is amending the
Amended and Restated Certificate of Incorporation of the Company to increase the number of
authorized shares of capital stock of the Company to facilitate the sale of the Additional Shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>NOW, THEREFORE, </B>in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
mutually agree as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>AGREEMENT</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Amendment to Section&nbsp;1.1</U>. Section&nbsp;1.1 (Authorization of the Shares) of the
Purchase Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;1.1 <U>Authorization of the Shares</U>. The Company will on or
before the Closing (as defined below) authorize the sale and issuance
pursuant to this Agreement of up to 18,498,531 shares (the &#147;<B>Shares</B>&#148;) of its
Series&nbsp;E Preferred Stock (the &#147;<B>Series&nbsp;E Preferred</B>&#148;), having the rights,
preferences and privileges as set forth in the Amended and Restated
Certificate of Incorporation, as amended by a Certificate of Amendment to
Amended and Restated Certificate of Incorporation dated October&nbsp;10,&nbsp;2007 and
a Certificate of Amendment to Amended and Restated Certificate of
Incorporation dated October&nbsp;26, 2007, as attached hereto as <U>EXHIBITS
B-1</U> AND <U>B-2</U>, respectively (together for purposes of this
Agreement, the &#147;<B>Restated Certificate</B>&#148;).&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Amendment to Section&nbsp;2.4</U>. Solely in connection with the sale of Additional Shares
pursuant to this Amendment, Section&nbsp;2.4 (Capitalization) of the Purchase Agreement is hereby
amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;The authorized capital stock of the Company consists, or immediately
prior to the Closing will consist, of 87,385,839 shares of Common Stock
(&#147;<B>Common Stock</B>&#148;), of which 9,760,848 shares are issued and outstanding
immediately prior to the Closing and 60,114,780 shares of Preferred Stock
(&#147;<B>Preferred Stock</B>&#148;), 2,727,273 of which are designated Series&nbsp;A Preferred
Stock of which 2,727,273 are outstanding immediately prior to the Closing;
6,460,675 of which are designated Series&nbsp;B Preferred Stock of which
6,460,675 are outstanding immediately prior to the Closing; 16,854,624 of
which are designated Series&nbsp;C Preferred Stock, 16,364,832 of which are
issued and outstanding immediately prior to the Closing; and 13,962,261 of
which are designated Series&nbsp;D Preferred Stock, 13,353,333 of which are
issued and outstanding immediately prior to the Closing; and 20,109,947 of
which are designated Series&nbsp;E Preferred Stock, 15,361,086 of which are
issued and outstanding immediately prior to the Closing. All such issued
and outstanding shares have been duly
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 2 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">authorized and validly issued in compliance with applicable laws, and
are fully paid and nonassessable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has reserved: (i)&nbsp;18,498,531 shares of Series&nbsp;E Preferred
for issuance hereunder and 20,109,947 shares of Common Stock for issuance
upon conversion of all shares of Series&nbsp;E Preferred; (ii)&nbsp; 13,353,333 shares
of Common Stock for issuance upon conversion of the outstanding shares of
Series&nbsp;D Preferred; (iii)&nbsp;408,928 shares of Series&nbsp;D Preferred for issuance
upon exercise of outstanding warrants and 408,928 shares of Common Stock for
issuance upon conversion of such Series&nbsp;D Preferred; (iv)&nbsp;16,364,832 shares
of Common Stock for issuance upon conversion of the outstanding shares of
Series&nbsp;C Preferred Stock; (v)&nbsp;289,792 shares of Series&nbsp;C Preferred Stock for
issuance upon exercise of outstanding warrants and 289,792 shares of Common
Stock for issuance upon conversion of such Series&nbsp;C Preferred Stock;
(vi)&nbsp;6,460,675 shares of Common Stock for issuance upon conversion of the
outstanding Series&nbsp;B Preferred Stock; (vii)&nbsp;2,727,273 shares of Common Stock
for issuance upon conversion of the outstanding Series&nbsp;A Preferred Stock;
and (viii)&nbsp;an aggregate of 12,800,000 shares of Common Stock for issuance to
employees and consultants of the Company pursuant to the Company&#146;s 1999
Stock Option Plan, pursuant to which options to purchase 7,247,691 shares
are granted and outstanding and 1,518,223 shares are available for future
grant. As of the date hereof and after giving effect to the purchase of
Shares hereunder, each share of each series of the Company&#146;s Preferred Stock
is convertible into one share of the Company&#146;s Common Stock. Other than
with respect to the shares reserved for issuance in this paragraph, or as
set forth in the Ancillary Agreements (as defined below), there are no
outstanding rights, options, warrants, conversion rights, preemptive rights,
rights of first refusal or similar rights for the purchase or acquisition
from the Company of any securities of the Company. There are no outstanding
obligations of the Company to repurchase or redeem any of its securities.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Amendment to Section&nbsp;2.16</U>. Solely in connection with the sale of Additional Shares
pursuant to this Amendment, Section&nbsp;2.16 (Financial Statements) of the Purchase Agreement is hereby
amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;The Company has made available to each Purchaser its audited balance
sheet dated as of December&nbsp;31, 2004. The Company has also made available to
each Purchaser unaudited balance sheets dated December&nbsp;31, 2005 and December
31, 2006 and the unaudited statements of operations for the fiscal years
then ended (collectively, the &#147;<B>Financial Statements</B>&#148;). The Financial
Statements are complete and correct in all material respects and have been
prepared in accordance with generally
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 3 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">accepted accounting principles applied on a consistent basis throughout
the periods indicated. The Financial Statements accurately set out and
describe the financial condition and operating results of the Company as of
the date, and during the periods, indicated therein. Except as set forth in
the Financial Statements, the Company has no material liabilities,
contingent or otherwise, other than (i)&nbsp;liabilities incurred in the ordinary
course of business subsequent to December&nbsp;31, 2006 and (ii)&nbsp;obligations
under contracts and commitments incurred in the ordinary course of business
and not required under generally accepted accounting principles to be
reflected in the Financial Statements, which, in both cases, individually or
in the aggregate are not material to the financial condition or operating
results of the Company.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Governing Law</U>. This Amendment shall be governed in all respects by the laws of the
State of California, without regard to any provisions thereof relating to conflicts of laws among
different jurisdictions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Purchase Agreement</U>. Wherever necessary, all other terms of the Purchase Agreement
are hereby amended to be consistent with the terms of this Amendment. Except as specifically set
forth herein, the Purchase Agreement shall remain in full force and effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Counterparts; Facsimile</U>. This Amendment may be executed in any number of
counterparts, each of which shall be an original, and all of which together shall constitute one
instrument. Executed signatures transmitted via facsimile will be accepted and considered duly
executed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>Effect of Execution of Amendment by Certain Purchasers</U>. This Amendment, when
executed and delivered by the Company and a Purchaser purchasing shares of Series&nbsp;E Preferred at a
Subsequent Closing held on or after the date hereof, shall also constitute and shall be deemed a
counterpart signature page to the Purchase Agreement. Consequently, each undersigned Purchaser
purchasing shares of Series&nbsp;E Preferred at a Subsequent Closing held on or after the date hereof
acknowledges and agrees that he, she or it is bound by the terms and conditions contained in the
Purchase Agreement, as amended by this Amendment, with respect to the purchase of such shares.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Remainder of page intentionally left blank</I></B><B>&#093;</B>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->- 4 -<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3
to Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><B>COMPANY:</B></TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>FLUIDIGM CORPORATION</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left">a Delaware corporation</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Gajus Worthington</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gajus Worthington,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Fidelity Contrafund: </B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Fidelity Advisor New Insights Fund</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Peter Lydecker
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Peter Lydecker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assistant Treasurer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Fidelity Contrafund: Fidelity Contrafund</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Peter Lydecker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Peter Lydecker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assistant Treasurer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Variable Insurance Products Fund II:</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Contrafund Portfolio</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Peter Lydecker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Peter Lydecker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assistant Treasurer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Leerink Swann Holdings, LLC</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Jeffrey Leerink</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jeffrey Leerink</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chairman</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Leerink Swann Holdings, LLC </B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Co-Investment Fund, LLC</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Donald D. Notman, Jr.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Donald D. Notman, Jr.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><B>PURCHASERS</B><FONT style="font-variant: SMALL-CAPS"><B>:</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Cross Creek Capital, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital GP, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wasatch Advisors, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole Member</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Karey Barker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Karey Barker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Cross Creek Capital Employees&#146; Fund, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital GP, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cross Creek Capital, LLC<BR>
Its Sole General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wasatch Advisors, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole Member</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Karey Barker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Karey Barker</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>W</B><FONT style="font-variant: SMALL-CAPS"><B>asatch Funds, Inc.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wasatch Advisors, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its Sole Member</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Venice Edwards
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Venice Edwards</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Secretary</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>SMALLCAP World Fund, Inc.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Capital Research and Management Company,</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>its, investment adviser</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Paul Haaga
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Paul Haaga</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>AllianceBernstein Venture Fund I, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>AllianceBernstein ESG Venture</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Management, L.P., its general partner</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>By:</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>AllianceBernstein Global Derivatives</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Corporation, its general partner</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ James D. Kiggen
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">James D. Kiggen</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Versant Affiliates Fund 1-A, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Versant Affiliates Fund1-B, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Versant Side Fund I, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Versant Venture Capital I, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Versant Ventures I, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Samuel D. Colella
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Samuel D. Colella</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers Healthcare Venture Capital</B></font></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>L.P.</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lehman Brothers HealthCare Venture Capital</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Associates L.P.,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LB I Group Inc., its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:<BR>
Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Ashvin Rao
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Ashvin Rao
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers P.A. LLC</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Deborah Nordell</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Deborah Nordell</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers Partnership Account 2000/2001,</B></font></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>L.P.</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LB I Group Inc., its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Ashvin Rao</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ashvin Rao</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lehman Brothers Offshore Partnership Account</B></font></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>2000/2001, L.P.</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LB I Offshore Partners Group Ltd., its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Ashvin Rao</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ashvin Rao</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>EuclidSR Partners, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EuclidSR Associates, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Elaine V. Jones
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elaine V. Jones</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>EuclidSR Biotechnology Partners, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EuclidSR Biotechnology Associates, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Elaine V. Jones</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elaine V. Jones</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Interwest Partners VII, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">InterWest Management Partners VII, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Sweeney
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Sweeney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As agent for the general partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Interwest Investors VII, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">InterWest Management Partners VII, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Michael Sweeney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michael Sweeney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As agent for the general partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Lilly Bioventures, Eli Lilly &#038; Company</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Darren J. Carroll
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Darren J. Carroll</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Executive Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Alloy Ventures 2005, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Alloy Ventures 2005, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Tony DiBona</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Toni DiBona</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Member of Alloy Ventures</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2005 LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Alloy Ventures 2002, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Alloy Partners 2002, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Alloy Ventures 2002, LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">its General Partner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Tony DiBona</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tony DiBona</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Member of Alloy Ventures</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2002, LLC, the general partner of Alloy</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Partners 2002, L.P. and Alloy Ventures</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2002, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Bruce Burrows
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
<FONT style="font-variant: SMALL-CAPS"><B>Bruce Burrows</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>SightLine Healthcare Fund III, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Maureen Harder
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Maureen Harder</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Biomedical Sciences Investment Fund Pte Ltd</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Chu Swee Yeok
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chu Swee Yeok</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Singapore Bio-Innovations Pte Ltd</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Sim Sze Kuan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sim Sze Kuan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3 to
Series&nbsp;E Preferred Stock Purchase Agreement as of the Effective Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASERS:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Invus, L.P.</B></FONT></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Invus Advisors LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General Partner of Invus LP</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Aflalo Guimaraes
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Aflalo Guimaraes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Managing Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT A<BR>
SCHEDULE OF PURCHASERS<BR>
SERIES E PREFERRED STOCK FINANCING &#150; SECOND EXTENDED CLOSING<BR>
OCTOBER 26, 2007</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Shares of Series&nbsp;E</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Preferred Stock</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Purchase Price</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>CLIPPERBAY &#038; CO.</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SMALLCAP World Fund, Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,153,695</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">8,614,780.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>TOTALS</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>2,153,695</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>$</B></TD>
    <TD align="right"><B>8,614,780.00</B></TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3
to Series&nbsp;E Preferred Stock Purchase Agreement as of the 31<SUP style="font-size: 85%; vertical-align: text-top">st</SUP> day of December, 2007.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><B>COMPANY:</B></TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><FONT style="font-variant: SMALL-CAPS"><B>FLUIDIGM CORPORATION</B></FONT></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left">a Delaware corporation</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Gajus Worthington
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Gajus Worthington,
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment&nbsp;No.&nbsp;3
to Series&nbsp;E Preferred Stock Purchase Agreement as of the 31<SUP style="font-size: 85%; vertical-align: text-top">st </SUP>day of December, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>PURCHASER:</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Bruce Burrows
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
<B>Bruce Burrows</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Signature
Page to Amendment No.&nbsp;3 to Fluidigm Corporation Series&nbsp;E Preferred Stock Purchase Agreement&#093;</I></B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT A<BR>
SCHEDULE OF PURCHASER<BR>
SERIES E PREFERRED STOCK FINANCING &#150; THIRD EXTENDED CLOSING<BR>
DECEMBER 31, 2007</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Shares of Series&nbsp;E</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Preferred Stock</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Purchase Price</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>BRUCE BURROWS</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">250,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,000,000.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>TOTALS</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>250,000</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><B>$</B></TD>
    <TD align="right"><B>1,000,000.00</B></TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT
B</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FORM
OF AMENDED AND RESTATED ARTICLES OF INCORPORATION</B>
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">





<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FORM OF AMENDED AND RESTATED</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>ARTICLES OF INCORPORATION OF</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>FLUIDIGM CORPORATION</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gajus V. Worthington and William Smith each certify that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;They are the President and Secretary, respectively, of Fluidigm Corporation, a California
corporation (the &#147;<B>Corporation</B>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;The Amended and Restated Articles of Incorporation of the Corporation are hereby amended
and restated in full to read as set forth in <U>EXHIBIT A</U> attached hereto, which is
incorporated by reference as if fully set forth herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;Said Amended and Restated Articles of Incorporation have been duly approved by the
Corporation&#146;s Board of Directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;Said Amended and Restated Articles of Incorporation have been duly approved by the required
vote of shareholders in accordance with Sections&nbsp;902 and 903 of the Corporations Code. The total
number of outstanding shares of the corporation is 9,274,356 shares of Common Stock, 2,727,273
shares of Series&nbsp;A Preferred Stock, 6,460,675 shares of Series&nbsp;B Preferred Stock, 16,364,832 shares
of Series&nbsp;C Preferred Stock, and 11,714,048 shares of Series&nbsp;D Preferred Stock. The number of
shares voting in favor of the amendment equaled or exceeded the vote required. The percentage vote
required was more than 50% of the outstanding Common Stock, voting as a single class; more than 50%
of the outstanding Series&nbsp;A Preferred Stock, voting as a single class; at least 66<FONT style="font-size: 70%"><SUP>2</SUP></FONT>/<FONT style="font-size: 60%">3</FONT>% of the
outstanding Series&nbsp;B Preferred Stock, voting as a single class; at least 66<FONT style="font-size: 70%"><SUP>2</SUP></FONT>/<FONT style="font-size: 60%">3</FONT>% of the outstanding
Series&nbsp;C Preferred Stock, voting as a single class; at least 60% of the outstanding Series&nbsp;D
Preferred Stock, voting as a single class; more than 66<FONT style="font-size: 70%"><SUP>2</SUP></FONT>/<FONT style="font-size: 60%">3</FONT>% of the outstanding Preferred Stock,
voting as a single class; and more than 50% of the outstanding Common Stock and Preferred Stock,
voting together as a single class.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I further declare under penalty of perjury that the matters set forth in the foregoing
certificate are true and correct of my own knowledge.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executed at Palo Alto, California, this &#95;&#95;&#95; day of June&nbsp;2006.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Gajus V. Worthington&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">William M. Smith&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>Exhibit&nbsp;A</B></U>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>FORM OF AMENDED AND RESTATED</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>ARTICLES OF INCORPORATION OF</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>FLUIDIGM CORPORATION</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">ARTICLE I

</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The name of the corporation is Fluidigm Corporation.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE II
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The purpose of this corporation is to engage in any lawful act or activity for which a
corporation may be organized under the General Corporation Law of California other than the banking
business, the trust company business or the practice of a profession permitted to be incorporated
under the California Corporations Code.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE III
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The total number of shares of stock that the corporation shall have authority to issue is One
Hundred Twenty-Nine Million Five Hundred Forty-Five Thousand Ninety-Two (129,545,092) consisting of
Seventy-Seven Million Eight Hundred Fifty-Seven Thousand One Hundred Forty-Four (77,857,144) shares
of Common Stock, $0.001 par value per share, and Fifty-One Million Six Hundred Eighty-Seven
Thousand Nine Hundred Forty-Eight (51,687,948) shares of Preferred Stock, $0.001 par value per
share. The first series of Preferred Stock shall be designated &#147;Series&nbsp;A Preferred Stock&#148; and
shall consist of Two Million Seven Hundred Twenty&#151;Seven Thousand Two Hundred Seventy&#151;Three
(2,727,273) shares. The second series of Preferred Stock shall be designated &#147;Series&nbsp;B Preferred
Stock&#148; and shall consist of Six Million Four Hundred Sixty Thousand Six Hundred Seventy-Five
(6,460,675) shares. The third series of Preferred Stock shall be designated &#147;Series&nbsp;C Preferred
Stock&#148; and shall consist of Seventeen Million (17,000,000) shares. The fourth series of Preferred
Stock shall be designated &#147;Series&nbsp;D Preferred Stock&#148; and shall consist of Fifteen Million Five
Hundred Thousand (15,500,000) shares. The fifth series of Preferred Stock shall be designated
&#147;Series&nbsp;E Preferred Stock&#148; and shall consist of Ten Million (10,000,000) shares.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE IV
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The terms and provisions of the Common Stock and Preferred Stock are as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Definitions</U>. For purposes of this Article&nbsp;IV, the following definitions shall
apply:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) &#147;<U>Conversion Price</U>&#148; shall mean $1.10 per share for the Series&nbsp;A Preferred Stock,
$1.78 per share for the Series&nbsp;B Preferred Stock, $2.58 per share for the Series&nbsp;C Preferred
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Stock, $2.80 per share for the Series&nbsp;D Preferred Stock, and $4.00 for the Series&nbsp;E Preferred
Stock (each subject to adjustment from time to time as set forth elsewhere herein).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) &#147;<U>Convertible Securities</U>&#148; shall mean any evidences of indebtedness, shares or other
securities (other than shares of Common Stock) convertible into or exchangeable for Common Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) &#147;<U>Corporation</U>&#148; shall mean Fluidigm Corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) &#147;<U>Dividend Rate</U>&#148; shall mean an annual rate of $0.11 per share for the Series&nbsp;A
Preferred Stock, an annual rate of $0.18 for the Series&nbsp;B Preferred Stock, an annual rate of $0.26
per share for the Series&nbsp;C Preferred Stock, an annual rate of $0.30 per share for the Series&nbsp;D
Preferred Stock, and an annual rate of $0.43 per share for the Series&nbsp;E Preferred Stock (each
subject to adjustment from time to time as set forth elsewhere herein).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) &#147;<U>Liquidation Preference</U>&#148; shall mean $1.10 per share for the Series&nbsp;A Preferred
Stock, $1.78 per share for the Series&nbsp;B Preferred Stock, $2.58 per share for the Series&nbsp;C Preferred
Stock, $2.80 per share for the Series&nbsp;D Preferred Stock, and $4.00 per share for the Series&nbsp;E
Preferred Stock (each subject to adjustment from time to time as set forth elsewhere herein).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) &#147;<U>Options</U>&#148; shall mean rights, options or warrants to subscribe for, purchase or
otherwise acquire Common Stock or Convertible Securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) &#147;<U>Original Issue Price</U>&#148; shall mean $1.10 per share for the Series&nbsp;A Preferred
Stock, $1.78 for the Series&nbsp;B Preferred Stock, $2.58 per share for the Series&nbsp;C Preferred Stock,
$2.80 per share for the Series&nbsp;D Preferred Stock, and $4.00 per share for the Series&nbsp;E Preferred
Stock (each subject to adjustment from time to time as set forth elsewhere herein).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) &#147;<U>Preferred Stock</U>&#148; shall mean the Series&nbsp;A Preferred Stock, the Series&nbsp;B Preferred
Stock, the Series&nbsp;C Preferred Stock, the Series&nbsp;D Preferred Stock, and the Series&nbsp;E Preferred
Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Dividends</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Series&nbsp;D and Series&nbsp;E Preferred Stock</U>. The holders of outstanding shares of
Series&nbsp;D Preferred Stock and the holders of outstanding shares of Series&nbsp;E Preferred Stock shall be
entitled to receive dividends, when and as declared by the Board of Directors, out of any assets at
the time legally available therefor, at the Dividend Rates specified for such shares of Preferred
Stock, payable in preference and priority to any declaration or payment of any distribution on
Series&nbsp;A Preferred Stock, Series&nbsp;B Preferred Stock, Series&nbsp;C Preferred Stock or Common Stock
(collectively, the &#147;<B>Junior Stock</B>&#148;) of the Corporation other than a dividend payable solely in
Common Stock. No distributions shall be made with respect to the Junior Stock during any fiscal
year of the Corporation, other than dividends on the Common Stock payable solely in Common Stock,
until all dividends at the applicable Dividend Rate on the Series&nbsp;E Preferred Stock and Series&nbsp;D
Preferred Stock have been declared and paid or set apart for payment to the holders of Series&nbsp;E
Preferred Stock and the holders of Series&nbsp;D Preferred Stock. Payment of any dividends to the
holders of the Series&nbsp;E Preferred Stock and the Series&nbsp;D Preferred Stock shall be on a <U>pro</U>
<U>rata</U>, pari passu basis in proportion to the Dividend Rates for the Series&nbsp;E Preferred Stock
and Series&nbsp;D Preferred Stock, as applicable.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The right to receive dividends on shares of Series&nbsp;E Preferred Stock and Series&nbsp;D Preferred
Stock shall not be cumulative, and no right to such dividends shall accrue to holders of Series&nbsp;E
Preferred Stock and Series&nbsp;D Preferred Stock by reason of the fact that dividends on said shares
are not declared or paid in any year.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Series&nbsp;C Preferred Stock</U>. The holders of outstanding shares of Series&nbsp;C Preferred
Stock shall be entitled to receive dividends, when and as declared by the Board of Directors, out
of any assets at the time legally available therefor, at the Dividend Rate specified for such
shares of Preferred Stock payable in preference and priority to any declaration or payment of any
distribution on Series&nbsp;A Preferred Stock, Series&nbsp;B Preferred Stock or Common Stock of the
Corporation other than a dividend payable solely in Common Stock. No distributions shall be made
with respect to the Series&nbsp;A Preferred Stock, Series&nbsp;B Preferred Stock or Common Stock during any
fiscal year of the Corporation, other than dividends on the Common Stock payable solely in Common
Stock, until all dividends at the applicable Dividend Rate on the Series&nbsp;C Preferred Stock have
been declared and paid or set apart for payment to the holders of Series&nbsp;C Preferred Stock. The
right to receive dividends on shares of Series&nbsp;C Preferred Stock shall not be cumulative, and no
right to such dividends shall accrue to holders of Series&nbsp;C Preferred Stock by reason of the fact
that dividends on said shares are not declared or paid in any year.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock</U>. The holders of outstanding
shares of Series&nbsp;A Preferred Stock and the holders of outstanding shares of Series&nbsp;B Preferred
Stock shall be entitled to receive dividends, when and as declared by the Board of Directors, out
of any assets at the time legally available therefor, at the Dividend Rate specified for such
shares of Preferred Stock payable in preference and priority to any declaration or payment of any
distribution on Common Stock of the Corporation other than a dividend payable solely in Common
Stock. No distributions shall be made with respect to the Common Stock, other than dividends
payable solely in Common Stock, until all dividends at the applicable Dividend Rate on the
Preferred Stock have been declared and paid or set apart for payment to the Preferred Stock
holders. Payment of any dividends to the holders of the Series&nbsp;A Preferred Stock and Series&nbsp;B
Preferred Stock shall be on a <U>pro</U> <U>rata</U>, pari passu basis in proportion to the
Dividend Rates for the Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock, as applicable. The
right to receive dividends on shares of Series&nbsp;A Preferred Stock and Series&nbsp;B Preferred Stock shall
not be cumulative, and no right to such dividends shall accrue to holders of Series&nbsp;A Preferred
Stock or Series&nbsp;B Preferred Stock by reason of the fact that dividends on said shares are not
declared or paid in any year.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Distribution</U>. For purposes of this Section&nbsp;2, unless the context otherwise
requires, a &#147;<B>distribution</B>&#148; shall mean the transfer of cash or other property without consideration
whether by way of dividend or otherwise, payable other than in Common Stock, or the purchase or
redemption of shares of the Corporation other than (i)&nbsp;repurchase of shares of Common Stock issued
to or held by employees, consultants, officers and directors of the Corporation or its subsidiaries
upon termination of their employment or services pursuant to agreements providing for the right of
said repurchase and at the original purchase price paid by such employees, consultants, officers
and directors; and (ii)&nbsp;repurchase of Common Stock issued to or held by employees, officers,
directors or consultants of the Corporation or its subsidiaries pursuant to rights of first refusal
contained in agreements providing for such rights, provided that such repurchase is unanimously
approved by the Board of Directors; and (iii)&nbsp;any other repurchase or redemption of capital stock
of the corporation unanimously approved by the Board of Directors and approved by the holders of
the majority of the
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Common Stock and the holders of more than two-thirds (<FONT style="font-size: 70%"><SUP>2</SUP></FONT>/<FONT style="font-size: 60%">3</FONT>) of the outstanding shares of the
Preferred Stock, voting as separate classes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Common Stock</U>. Dividends may be paid on the Common Stock as and when declared by
the Board of Directors, subject to the prior dividend rights of the Preferred Stock and Section&nbsp;6
below.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Non-Cash Distributions</U>. Whenever a distribution provided for in this Section&nbsp;2
shall be payable in property other than cash, the value of such distribution shall be deemed to be
the fair market value of such property as determined in good faith by the Board of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Consent to Certain Repurchases</U>. As authorized by Section&nbsp;402.5(c) of the
California Corporations Code, Sections&nbsp;502 and 503 of the California Corporations Code shall not
apply with respect to payments made by the Corporation in connection with (i)&nbsp;repurchase of shares
of Common Stock issued to or held by employees, consultants, officers and directors of the
Corporation or its subsidiaries upon termination of their employment or services pursuant to
agreements providing for the right of said repurchase and at the original purchase price paid by
such employees, consultants, officers and directors, and (ii)&nbsp;repurchase of Common Stock issued to
or held by employees, officers, directors or consultants of the Corporation or its subsidiaries
pursuant to rights of first refusal contained in agreements providing for such rights, provided
that such repurchase is unanimously approved by the Board of Directors, and (iii)&nbsp;any other
repurchase or redemption of Common Stock unanimously approved by the Board of Directors and
approved by the holders of more than two-thirds (<FONT style="font-size: 70%"><SUP>2</SUP></FONT>/<FONT style="font-size: 60%">3</FONT>) of the outstanding shares of Preferred Stock
voting together as a single class.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Liquidation Rights</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of any liquidation, dissolution or winding up of the Corporation, either
voluntary or involuntary, distribution of the assets of the Corporation legally available for
distribution to the Corporation&#146;s shareholders shall be made in the following manner:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Series&nbsp;E Liquidation Preference</U>. The holders of the Series&nbsp;E Preferred Stock
shall be entitled to receive, prior and in preference to any distribution of any of the assets of
the Corporation to the holders of the Common Stock, the Series&nbsp;A Preferred Stock, the Series&nbsp;B
Preferred Stock, the Series&nbsp;C Preferred Stock, or the Series&nbsp;D Preferred Stock, by reason of their
ownership of such stock, an amount per share for each share of Series&nbsp;E Preferred Stock held by
them equal to the sum of (i)&nbsp;the Liquidation Preference for such shares and (ii)&nbsp;all declared and
unpaid dividends on such share of Series&nbsp;E Preferred Stock. If the assets of the Corporation
legally available for distribution to the holders of the Series&nbsp;E Preferred Stock are insufficient
to permit the payment to such holders of the full amounts specified in this Section&nbsp;3(a), then the
entire assets of the Corporation legally available for distribution shall be distributed with equal
priority and <U>pro</U> <U>rata</U> among the holders of the Series&nbsp;E Preferred Stock in
proportion to the full amounts they would otherwise be entitled to receive pursuant to this Section
3(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Series&nbsp;D Liquidation Preference</U>. After payment to the holders of Series&nbsp;E
Preferred Stock of the full amounts specified in Section 3(a) above, the holders of the Series&nbsp;D
Preferred Stock shall be entitled to receive, prior and in preference to any distribution of any of
the
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">assets of the Corporation to the holders of the Common Stock, the Series&nbsp;A Preferred Stock,
the Series&nbsp;B Preferred Stock or the Series&nbsp;C Preferred Stock by reason of their ownership of such
stock, an amount per share for each share of Series&nbsp;D Preferred Stock held by them equal to the sum
of (i)&nbsp;the Liquidation Preference for such shares and (ii)&nbsp;all declared and unpaid dividends on
such share of Series&nbsp;D Preferred Stock. If the remaining assets of the Corporation legally
available for distribution to the holders of Series&nbsp;D Preferred Stock are insufficient to permit
the payment to such holders of the full amounts specified in this Section&nbsp;3(b), then the entire
remaining assets of the Corporation legally available for distribution shall be distributed with
equal priority and <U>pro</U> <U>rata</U> among the holders of the Series&nbsp;D Preferred Stock in
proportion to the full amounts they would otherwise be entitled to receive pursuant to this Section
3(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Series&nbsp;C Liquidation Preference</U>. After payment to the holders of Series&nbsp;E
Preferred Stock and to the holders of Series&nbsp;D Preferred Stock of the full amounts specified in
Sections 3(a) and 3(b) above, the holders of the Series&nbsp;C Preferred Stock shall be entitled to
receive, prior and in preference to any distribution of any of the assets of the Corporation to the
holders of the Common Stock, the Series&nbsp;A Preferred Stock or the Series&nbsp;B Preferred Stock by reason
of their ownership of such stock, an amount per share for each share of Series&nbsp;C Preferred Stock
held by them equal to the sum of (i)&nbsp;the Liquidation Preference for such shares and (ii)&nbsp;all
declared and unpaid dividends on such share of Series&nbsp;C Preferred Stock. If the remaining assets
of the Corporation legally available for distribution to the holders of the Series&nbsp;C Preferred
Stock are insufficient to permit the payment to such holders of the full amounts specified in this
Section&nbsp;3(c), then the entire remaining assets of the Corporation legally available for
distribution shall be distributed with equal priority and <U>pro</U> <U>rata</U> among the
holders of the Series&nbsp;C Preferred Stock in proportion to the full amounts they would otherwise be
entitled to receive pursuant to this Section&nbsp;3(c).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Series&nbsp;B Liquidation Preference</U>. After the payment to the holders of Series&nbsp;E
Preferred Stock, the holders of Series&nbsp;D Preferred Stock, and the holders of Series&nbsp;C Preferred
Stock of the full amounts specified in Sections&nbsp;3(a), 3(b), and 3(c) above, the holders of the
Series&nbsp;B Preferred Stock shall be entitled to receive, prior and in preference to any distribution
of any of the remaining assets of the Corporation to the holders of the Common Stock or Series&nbsp;A
Preferred Stock by reason of their ownership of such stock, an amount per share for each share of
Series&nbsp;B Preferred Stock held by them equal to the sum of (i)&nbsp;the Liquidation Preference for such
shares and (ii)&nbsp;all declared and unpaid dividends on such share of Series&nbsp;B Preferred Stock. If
the remaining assets of the Corporation legally available for distribution to the holders of the
Series&nbsp;B Preferred Stock are insufficient to permit the payment to such holders of the full amounts
specified in this Section&nbsp;3(d), then the entire remaining assets of the Corporation legally
available for distribution shall be distributed with equal priority and <U>pro</U> <U>rata</U>
among the holders of the Series&nbsp;B Preferred Stock in proportion to the full amounts they would
otherwise be entitled to receive pursuant to this Section&nbsp;3(d).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Series&nbsp;A Liquidation Preference</U>. After the payment to the holders of Series&nbsp;E
Preferred Stock, the holders of Series&nbsp;D Preferred Stock, the holders of Series&nbsp;C Preferred Stock,
and the holders of Series&nbsp;B Preferred Stock of the full amounts specified in Sections&nbsp;3(a), 3(b),
3(c) and 3(d) above, the holders of the Series&nbsp;A Preferred Stock shall be entitled to receive,
prior and in preference to any distribution of any of the remaining assets of the Corporation to
the holders of the Common Stock by reason of their ownership of such stock, an amount per share for
each share of
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-5-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Series&nbsp;A Preferred Stock held by them equal to the sum of (i)&nbsp;the Liquidation Preference for
such shares and (ii)&nbsp;all declared and unpaid dividends on such share of Series&nbsp;A Preferred Stock.
If the remaining assets of the Corporation legally available for distribution to the holders of the
Series&nbsp;A Preferred Stock are insufficient to permit the payment to such holders of the full amounts
specified in this Section&nbsp;3(e), then the entire remaining assets of the Corporation legally
available for distribution shall be distributed with equal priority and <U>pro</U> <U>rata</U>
among the holders of the Series&nbsp;A Preferred Stock in proportion to the full amounts they would
otherwise be entitled to receive pursuant to this Section&nbsp;3(e).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Remaining Assets</U>. After the payment to the holders of Preferred Stock of the full
amounts specified in Sections&nbsp;3(a), 3(b), 3(c), 3(d) and 3(e) above, the entire remaining assets of
the Corporation legally available for distribution shall be distributed <U>pro</U> <U>rata</U> to
holders of the Common Stock of the Corporation in proportion to the number of shares of Common
Stock held by them.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Shares Not Treated as Both Preferred Stock and Common Stock in Any Distribution</U>.
Shares of Preferred Stock shall not be entitled to be converted into shares of Common Stock in
order to participate in any distribution, or series of distributions, as shares of Common Stock,
without first foregoing participation in the distribution, or series of distributions, as shares of
Preferred Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <U>Reorganization</U>. For purposes of this Section&nbsp;3, a liquidation, dissolution or
winding up of the Corporation shall be deemed to be occasioned by, or to include, (i)&nbsp;the
acquisition of the Corporation by another entity by means of any transaction or series of related
transactions (including, without limitation, any stock acquisition, reorganization, merger or
consolidation but excluding any merger effected exclusively for the purpose of changing the
domicile of the Corporation) other than a transaction or series of transactions in which the
holders of the voting securities of the Corporation outstanding immediately prior to such
transaction or series of transactions continue to retain (either by such voting securities
remaining outstanding or by such voting securities being converted into voting securities of the
surviving entity), as a result of shares in the Corporation held by such holders prior to such
transaction, at least fifty percent (50%) of the total voting power represented by the voting
securities of the Corporation or such surviving entity outstanding immediately after such
transaction or series of transactions; or (ii)&nbsp;a sale, transfer, lease or other conveyance of all
or substantially all of the assets of the Corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <U>Valuation of Non-Cash Consideration</U>. If any assets of the Corporation distributed
to shareholders in connection with any liquidation, dissolution, or winding up of the Corporation
are other than cash, then the value of such assets shall be their fair market value as determined
in good faith by the Board of Directors, <U>except that</U> any securities to be distributed to
shareholders in a liquidation, dissolution, or winding up of the Corporation shall be valued as
follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;If the securities are then traded on a national securities exchange or the Nasdaq Stock
Market System (or a similar national quotation system), then the value of the securities shall be
deemed to be to the average of the closing prices of the securities on such exchange or system over
the ten (10)&nbsp;trading day period ending five (5)&nbsp;trading days prior to the distribution;
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-6-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;if the securities are actively traded over-the-counter, then the value of the securities
shall be deemed to be the average of the closing bid prices of the securities over the ten (10)
trading day period ending five (5)&nbsp;trading days prior to the distribution; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;if there is no active public market for the securities, then the value of the securities
shall be deemed to be the fair market value thereof as determined in good faith by the Board of
Directors which determination shall include consideration of the illiquidity of the securities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of a merger or other acquisition of the Corporation by another entity, the
distribution date shall be deemed to the date such transaction closes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the purposes of this Section&nbsp;3(i), &#147;<B>trading day</B>&#148; shall mean any day on which the exchange
or system on which the securities to be distributed are traded is open, and &#147;closing prices&#148; or
&#147;closing bid prices&#148; shall be deemed to be: (i)&nbsp;for securities traded primarily on the New York
Stock Exchange, the American Stock Exchange or Nasdaq, the last reported trade price or sale price,
as the case may be, at 4:00 p.m., New York time, on that day and (ii)&nbsp;for securities listed or
traded on other exchanges, markets and systems, the market price as of the end of the &#147;regular
hours&#148; trading period that is generally accepted as such for such exchange, market or system. If,
after the date hereof, the benchmark times generally accepted in the securities industry for
determining the market price of a stock as of a given trading day shall change from those set forth
above, the fair market value shall be determined as of such other generally accepted benchmark
times.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Conversion</U>. The holders of the Preferred Stock shall have conversion rights as
follows (the &#147;<B>Conversion Rights</B>&#148;):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Right to Convert</U>. Subject to Section&nbsp;4(c), each share of Preferred Stock shall be
convertible, at the option of the holder thereof, at any time after the date of issuance of such
share at the office of the Corporation or any transfer agent for the Preferred Stock, into that
number of fully-paid, nonassessable shares of Common Stock determined by dividing the Original
Issue Price for the relevant series by the Conversion Price for such series. (The number of shares
of Common Stock into which each share of Preferred Stock of a series may be converted is
hereinafter referred to as the &#147;<B>Conversion Rate</B>&#148; for each such series.) Upon any decrease or
increase in the Conversion Price for any series of Preferred Stock, as described in this Section&nbsp;4,
the Conversion Rate for such series shall be appropriately increased or decreased.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Automatic Conversion</U>. Each share of Preferred Stock shall automatically be
converted into fully-paid, non-assessable shares of Common Stock at the then effective Conversion
Rate for such share (i)&nbsp;immediately prior to the closing of a firm commitment underwritten initial
public offering on Form S-1 (or successor form) filed under the Securities Act of 1933, as amended
(the &#147;<B>Securities Act</B>&#148;), covering the offer and sale of the Corporation&#146;s Common Stock, provided
that the offering price per share is not less than $5.69 (as adjusted for subdivisions and
combinations of the Common Stock and changes in the Common Stock as set forth in Sections 4(e) and
4(g)) and the aggregate gross proceeds to the Corporation are not less than $25,000,000, or (ii)
upon the receipt by the Corporation of a written consent or request for such conversion from the
holders of two-thirds of the shares of Preferred Stock then outstanding, or, if later, the
effective date for
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-7-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">conversion specified in such requests (each of the events referred to in (i)&nbsp;and (ii)&nbsp;being
hereinafter referred to as an &#147;<B>Automatic Conversion Event</B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Mechanics of Conversion</U>. No fractional shares of Common Stock shall be issued
upon conversion of Preferred Stock. In lieu of any fractional shares to which the holder would
otherwise be entitled, the Corporation shall pay cash equal to such fraction multiplied by the then
fair market value of a share of Common Stock as determined by the Board of Directors. For such
purpose, all shares of Preferred Stock held by each holder of Preferred Stock shall be aggregated,
and any resulting fractional share of Common Stock shall be paid in cash. Before any holder of
Preferred Stock shall be entitled to convert the same into full shares of Common Stock, and to
receive certificates therefor, he shall either surrender the certificate or certificates therefor,
duly endorsed, at the office of the Corporation or of any transfer agent for the Preferred Stock,
or notify the Corporation or its transfer agent that such certificate or certificates have been
lost, stolen or destroyed and execute an agreement satisfactory to the Corporation to indemnify the
Corporation from any loss incurred by it in connection with such certificate or certificates, and
shall give written notice to the Corporation at such office that he elects to convert the same;
<U>provided</U>,<U> however</U>, that on the date of an Automatic Conversion Event, the
outstanding shares of Preferred Stock shall be converted automatically without any further action
by the holders of such shares and whether or not the certificates representing such shares are
surrendered to the Corporation or its transfer agent; <U>provided further</U>, however, that the
Corporation shall not be obligated to issue certificates evidencing the shares of Common Stock
issuable upon such Automatic Conversion Event unless either the certificates evidencing such shares
of Preferred Stock are delivered to the Corporation or its transfer agent as provided above, or the
holder notifies the Corporation or its transfer agent that such certificates have been lost, stolen
or destroyed and executes an agreement satisfactory to the Corporation to indemnify the Corporation
from any loss incurred by it in connection with such certificates. On the date of the occurrence
of an Automatic Conversion Event, each holder of record of shares of Preferred Stock shall be
deemed to be the holder of record of the Common Stock issuable upon such conversion,
notwithstanding that the certificates representing such shares of Preferred Stock shall not have
been surrendered at the office of the Corporation, that notice from the Corporation shall not have
been received by any holder of record of shares of Preferred Stock, or that the certificates
evidencing such shares of Common Stock shall not then be actually delivered to such holder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Corporation shall, as soon as practicable after such delivery, or after such agreement and
indemnification, issue and deliver at such office to such holder of Preferred Stock, a certificate
or certificates for the number of shares of Common Stock to which he shall be entitled as aforesaid
and a check payable to the holder in the amount of any cash amounts payable as the result of a
conversion into fractional shares of Common Stock, plus any declared and unpaid dividends on the
converted Preferred Stock. Such conversion shall be deemed to have been made immediately prior to
the close of business on the date of such surrender of the shares of Preferred Stock to be
converted, and the person or persons entitled to receive the shares of Common Stock issuable upon
such conversion shall be treated for all purposes as the record holder or holders of such shares of
Common Stock on such date; <U>provided</U>, <U>however</U>, that if the conversion is in
connection with an underwritten offer of securities registered pursuant to the Securities Act the
conversion may, at the option of any holder tendering Preferred Stock for conversion, be
conditioned upon the closing of the sale of securities pursuant to such offering, in which event
the person(s) entitled to receive the
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-8-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Common Stock issuable upon such conversion of the Preferred Stock shall not be deemed to have
converted such Preferred Stock until immediately prior to the closing of the sale of such
securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Adjustments to Conversion Price for Diluting Issues</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;<U>Special Definition</U>. For purposes of this Section&nbsp;4(d), &#147;<B>Additional Shares of
Common</B>&#148; shall mean all shares of Common Stock issued (or, pursuant to Section&nbsp;4(d)(iii), deemed to
be issued) by the Corporation after the filing of these Articles of Incorporation, other than:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&#091;omitted&#093;;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;shares of Common Stock issued or issuable to officers, directors and employees of, or
consultants and other service providers to, the Corporation pursuant to stock grants, option plans,
purchase plans or other employee stock incentive programs or arrangements approved by the Board of
Directors or upon exercise of options or warrants granted to such parties pursuant to any such
plan, program or arrangement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;shares of Common Stock issued upon the exercise or conversion of Options or Convertible
Securities outstanding as of the date of the filing of these Articles of Incorporation;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;shares of Common Stock issued or issuable as a dividend or distribution on Preferred Stock
or pursuant to any event for which adjustment is made pursuant to Section&nbsp;4(e), 4(f) or 4(g)
hereof;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;shares of Common Stock issued in a registered public offering under the Securities Act
pursuant to which all outstanding shares of Preferred Stock are automatically converted into Common
Stock pursuant to an Automatic Conversion Event;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;shares of Common Stock issued or issuable pursuant to the acquisition of another
corporation by the Corporation by merger, purchase of substantially all of the assets or other
reorganization or to a joint venture agreement, provided, that such issuances are unanimously
approved by the Board of Directors;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)&nbsp;shares of Common Stock issued or issuable to banks, equipment lessors or other financial
institutions pursuant to a commercial leasing or debt financing transaction approved by the Board
of Directors;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)&nbsp;shares of Common Stock issued or issuable in connection with sponsored research,
collaboration, technology license, development, OEM, marketing or other similar agreements, or
strategic partnerships or relationships, if the issuance is approved by the Board of Directors; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9) shares of Common Stock issued or issuable upon conversion of up to $18&nbsp;million in
aggregate principal amount (plus interest) of convertible promissory notes originally issued or
issuable to Biomedical Sciences Investment Fund Pte Ltd. or its affiliates (&#147;BMSIF&#148;) and upon
conversion of up to $3&nbsp;million in aggregate principal amount (plus interest) of convertible
promissory notes originally issued or issuable to Invus, L.P. or its affiliates, <I>provided</I>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-9-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>that </I>with respect to any shares of Common Stock issued or issuable upon conversion of
convertible promissory notes issued or issuable to BMSIF after the filing of these Articles of
Incorporation with an aggregate principal amount in excess of $3.0&nbsp;million, such shares of Common
Stock shall only be excluded from the definition of Additional Shares of Common pursuant to this
section if and to the extent the applicable conversion price for such shares equals or exceeds
$3.60 (as adjusted for stock splits, subdivisions, combinations or stock dividends).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;<U>No Adjustment of Conversion Price</U>. No adjustment in the Conversion Price of a
particular series of Preferred Stock shall be made in respect of the issuance of Additional Shares
of Common unless the consideration per share (as determined pursuant to Section&nbsp;4(d)(vii)) for an
Additional Share of Common issued or deemed to be issued by the Corporation is less than the
Conversion Price in effect on the date of, and immediately prior to such issue, for such series of
Preferred Stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;<U>Deemed Issue of Additional Shares of Common</U>. In the event the Corporation at
any time or from time to time after the date of the filing of these Articles of Incorporation shall
issue any Options or Convertible Securities or shall fix a record date for the determination of
holders of any class of securities entitled to receive any such Options or Convertible Securities,
then the maximum number of shares (as set forth in the instrument relating thereto without regard
to any provisions contained therein for a subsequent adjustment of such number) of Common Stock
issuable upon the exercise of such Options or, in the case of Convertible Securities, the
conversion or exchange of such Convertible Securities or, in the case of Options for Convertible
Securities, the exercise of such Options and the conversion or exchange of the underlying
securities, shall be deemed to have been issued as of the time of such issue or, in case such a
record date shall have been fixed, as of the close of business on such record date, provided that
in any such case in which shares are deemed to be issued:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;no further adjustment in the Conversion Price of the Preferred Stock shall be made upon
the subsequent issue of Convertible Securities or shares of Common Stock in connection with the
exercise of such Options or conversion or exchange of such Convertible Securities pursuant to the
terms of such Options or Convertible Securities;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;if no adjustment in the Conversion Price of the Preferred Stock was made upon the original
issue of (or upon the occurrence of a record date with respect to) such Options or Convertible
Securities and such Options or Convertible Securities are revised to provide, or by their terms
provide, with the passage of time or otherwise, for any increase or decrease in the consideration
payable to the Corporation, or any increase or decrease in the number of shares of Common Stock
issuable, upon the exercise, conversion or exchange thereof, then such Options or Convertible
Securities as so revised (and the Additional Shares of Common subject thereto) shall be deemed to
have been issued effective upon such increase or decrease becoming effective;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) if such Options or Convertible Securities are revised to provide, or by their terms
provide, with the passage of time or otherwise, for any increase or decrease in the consideration
payable to the Corporation, or any increase or decrease in the number of shares of Common Stock
issuable, upon the exercise, conversion or exchange thereof, the Conversion Price of the Preferred
Stock computed upon the original issue thereof (or upon the occurrence of a record date with
respect thereto), and any subsequent adjustments based thereon,
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-10-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shall, upon any such increase or decrease becoming effective, be recomputed to reflect such
increase or decrease insofar as it affects such Options or the rights of conversion or exchange
under such Convertible Securities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;no readjustment pursuant to clause (3)&nbsp;above shall have the effect of increasing the
Conversion Price of the Preferred Stock to an amount which exceeds the lower of (i)&nbsp;the Conversion
Price of the Preferred Stock on the original adjustment date, or (ii)&nbsp;the Conversion Price of the
Preferred Stock that would have resulted from any issuance of Additional Shares of Common between
the original adjustment date and such readjustment date;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)&nbsp;upon the expiration of any such Options or any rights of conversion or exchange under such
Convertible Securities which shall not have been exercised, the Conversion Price computed upon the
original issue thereof (or upon the occurrence of a record date with respect thereto) and any
subsequent adjustments based thereon shall, upon such expiration, be recomputed as if:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;in the case of Convertible Securities or Options for Common Stock, the only Additional
Shares of Common issued were the shares of Common Stock, if any, actually issued upon the exercise
of such Options or the conversion or exchange of such Convertible Securities and the consideration
received therefor was the consideration actually received by the Corporation for the issue of such
exercised Options plus the consideration actually received by the Corporation upon such exercise or
for the issue of all such Convertible Securities which were actually converted or exchanged, plus
the additional consideration, if any, actually received by the Corporation upon such conversion or
exchange, and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;in the case of Options for Convertible Securities, only the Convertible Securities, if
any, actually issued upon the exercise thereof were issued at the time of issue of such Options,
and the consideration received by the Corporation for the Additional Shares of Common deemed to
have been then issued was the consideration actually received by the Corporation for the issue of
such exercised Options, plus the consideration deemed to have been received by the Corporation
(determined pursuant to Section&nbsp;4(d)(vii)) upon the issue of the Convertible Securities with
respect to which such Options were actually exercised; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)&nbsp;if such record date shall have been fixed and such Options or Convertible Securities are
not issued on the date fixed therefor, the adjustment previously made in the Conversion Price which
became effective on such record date shall be canceled as of the close of business on such record
date, and thereafter the Conversion Price shall be adjusted pursuant to this Section&nbsp;4(d)(iii) as
of the actual date of their issuance.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;<U>Adjustment of Conversion Price of Series&nbsp;E Preferred Stock Upon Issuance of
Additional Shares of Common</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) For so long as the Conversion Price of the Series&nbsp;E Preferred Stock is greater than $2.58
(as adjusted for subdivisions and combinations of the Common Stock and changes in the Common Stock
as set forth in Sections 4(e) and 4(g)) (the &#147;<B>Series&nbsp;D/E Ratchet Amount</B>&#148;), in the event this
Corporation shall issue Additional Shares of Common (including Additional Shares of Common deemed
to be issued pursuant to Section&nbsp;4(d)(iii)) for a consideration
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-11-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">per share less than the applicable Conversion Price of the Series&nbsp;E Preferred Stock in effect
on the date of and immediately prior to such issue, but for a consideration per share equal to or
greater than the Series&nbsp;D/E Ratchet Amount, then the Conversion Price of the Series&nbsp;E Preferred
Stock shall be reduced concurrently with such issue to a price (calculated to the nearest cent)
equal to the per share price of the Additional Shares of Common.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;In the event this Corporation shall issue Additional Shares of Common (including
Additional Shares of Common deemed to be issued pursuant to Section&nbsp;4(d)(iii)) without
consideration or for a consideration per share less than the Series&nbsp;D/E Ratchet Amount, then the
Conversion Price of the Series&nbsp;E Preferred Stock immediately prior to such issue shall be deemed to
be equal to the Series&nbsp;D/E Ratchet Amount (the &#147;<B>Series&nbsp;E Adjusted Conversion Price</B>&#148;), and such
Series&nbsp;E Adjusted Conversion Price shall be further reduced, concurrently with such issue, to a
price (calculated to the nearest cent) determined by multiplying such Series&nbsp;E Adjusted Conversion
Price by a fraction, the numerator of which shall be the number of shares of Common Stock
outstanding immediately prior to such issue plus the number of shares of Common Stock which the
aggregate consideration received by the Corporation for the total number of Additional Shares of
Common so issued would purchase at such Adjusted Conversion Price, and the denominator of which
shall be the number of shares of Common Stock outstanding immediately prior to such issue plus the
number of such Additional Shares of Common so issued. For the purposes of this Section
4(d)(iv)(2), all shares of Common Stock issuable upon exercise of outstanding Options or the
conversion of outstanding Convertible Securities and shares of Preferred Stock, and all Additional
Shares of Common deemed issued pursuant to Section&nbsp;4(d)(iii) hereof, shall be deemed to be
outstanding. Section&nbsp;4(d)(iv)(3) shall govern adjustments to the Conversion Price of the Series&nbsp;E
Preferred Stock after the first adjustment to the Conversion Price of the Series&nbsp;E Preferred Stock
pursuant to this Section&nbsp;4(d)(iv)(2).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;After any adjustment to the Conversion Price of the Series&nbsp;E Preferred Stock pursuant to
Section&nbsp;4(d)(iv)(2), in the event this Corporation shall issue Additional Shares of Common
(including Additional Shares of Common deemed to be issued pursuant to Section&nbsp;4(d)(iii)) without
consideration or for a consideration per share less than Conversion Price of the Series&nbsp;E Preferred
Stock in effect on the date of and immediately prior to such issue, then, the Conversion Price of
the Series&nbsp;E Preferred Stock shall be reduced concurrently with such issue, to a price (calculated
to the nearest cent) determined by multiplying such Conversion Price by a fraction, the numerator
of which shall be the number of shares of Common Stock outstanding immediately prior to such issue
plus the number of shares of Common Stock which the aggregate consideration received by the
Corporation for the total number of Additional Shares of Common so issued would purchase at such
Conversion Price, and the denominator of which shall be the number of shares of Common Stock
outstanding immediately prior to such issue plus the number of such Additional Shares of Common so
issued. For the purposes of this Section&nbsp;4(d)(iv)(3), all shares of Common Stock issuable upon
exercise of outstanding Options or the conversion of outstanding Convertible Securities and shares
of Preferred Stock, and all Additional Shares of Common deemed issued pursuant to Section&nbsp;4(d)(iii)
hereof, shall be deemed to be outstanding.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-12-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;<U>Adjustment of Conversion Price of Series&nbsp;D Preferred Stock Upon Issuance of Additional
Shares of Common</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;For so long as the Conversion Price of the Series&nbsp;D Preferred Stock is greater than the
Series&nbsp;D/E Ratchet Amount, in the event this Corporation shall issue Additional Shares of Common
(including Additional Shares of Common deemed to be issued pursuant to Section&nbsp;4(d)(iii)) for a
consideration per share less than the applicable Conversion Price of the Series&nbsp;D Preferred Stock
in effect on the date of and immediately prior to such issue, but for a consideration per share
equal to or greater than the Series&nbsp;D/E Ratchet Amount, then the Conversion Price of the Series&nbsp;D
Preferred Stock shall be reduced concurrently with such issue to a price (calculated to the nearest
cent) equal to the per share price of the Additional Shares of Common.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;In the event this Corporation shall issue Additional Shares of Common (including
Additional Shares of Common deemed to be issued pursuant to Section&nbsp;4(d)(iii)) without
consideration or for a consideration per share less than the Series&nbsp;D/E Ratchet Amount, then the
Conversion Price of the Series&nbsp;D Preferred Stock immediately prior to such issue shall be deemed to
be equal to the Series&nbsp;D/E Ratchet Amount (the &#147;<B>Series&nbsp;D Adjusted Conversion Price</B>&#148;), and such
Series&nbsp;D Adjusted Conversion Price shall be further reduced, concurrently with such issue, to a
price (calculated to the nearest cent) determined by multiplying such Series&nbsp;D Adjusted Conversion
Price by a fraction, the numerator of which shall be the number of shares of Common Stock
outstanding immediately prior to such issue plus the number of shares of Common Stock which the
aggregate consideration received by the Corporation for the total number of Additional Shares of
Common so issued would purchase at such Series&nbsp;D Adjusted Conversion Price, and the denominator of
which shall be the number of shares of Common Stock outstanding immediately prior to such issue
plus the number of such Additional Shares of Common so issued. For the purposes of this Section
4(d)(v)(2), all shares of Common Stock issuable upon exercise of outstanding Options or the
conversion of outstanding Convertible Securities and shares of Preferred Stock, and all Additional
Shares of Common deemed issued pursuant to Section&nbsp;4(d)(iii) hereof, shall be deemed to be
outstanding. Section&nbsp;4(d)(v)(3) shall govern adjustments to the Conversion Price of the Series&nbsp;D
Preferred Stock after the first adjustment to the Conversion Price of the Series&nbsp;D Preferred Stock
pursuant to this Section&nbsp;4(d)(v)(2).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) After any adjustment to the Conversion Price of the Series&nbsp;D Preferred Stock pursuant to
Section&nbsp;4(d)(v)(2), in the event this Corporation shall issue Additional Shares of Common
(including Additional Shares of Common deemed to be issued pursuant to Section&nbsp;4(d)(iii)) without
consideration or for a consideration per share less than Conversion Price of the Series&nbsp;D Preferred
Stock in effect on the date of and immediately prior to such issue, then, the Conversion Price of
the Series&nbsp;D Preferred Stock shall be reduced concurrently with such issue, to a price (calculated
to the nearest cent) determined by multiplying such Conversion Price by a fraction, the numerator
of which shall be the number of shares of Common Stock outstanding immediately prior to such issue
plus the number of shares of Common Stock which the aggregate consideration received by the
Corporation for the total number of Additional Shares of Common so issued would purchase at such
Conversion Price, and the denominator of which shall be the number of shares of Common Stock
outstanding immediately prior to such issue plus the number of such Additional Shares of Common so
issued. For the purposes of this Section&nbsp;4(d)(v)(3), all shares of Common Stock issuable upon
exercise of outstanding Options or the conversion of outstanding Convertible
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-13-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Securities and shares of Preferred Stock, and all Additional Shares of Common deemed issued
pursuant to Section&nbsp;4(d)(iii) hereof, shall be deemed to be outstanding.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;<U>Adjustment of Conversion Price of Series&nbsp;A, B and C Preferred Stock</U>. In the
event this Corporation shall issue Additional Shares of Common (including Additional Shares of
Common deemed to be issued pursuant to Section&nbsp;4(d)(iii)) without consideration or for a
consideration per share less than the applicable Conversion Price of the Series&nbsp;A Preferred Stock,
Series&nbsp;B Preferred Stock or Series&nbsp;C Preferred Stock in effect on the date of and immediately prior
to such issue, then, the Conversion Price of the Series&nbsp;A Preferred Stock, Series&nbsp;B Preferred Stock
or Series&nbsp;C Preferred Stock (if affected) shall be reduced, concurrently with such issue, to a
price (calculated to the nearest cent) determined by multiplying such Conversion Price by a
fraction, the numerator of which shall be the number of shares of Common Stock outstanding
immediately prior to such issue plus the number of shares of Common Stock which the aggregate
consideration received by the Corporation for the total number of Additional Shares of Common so
issued would purchase at such Conversion Price, and the denominator of which shall be the number of
shares of Common Stock outstanding immediately prior to such issue plus the number of such
Additional Shares of Common so issued. For the purposes of this Section&nbsp;4(d)(vi), all shares of
Common Stock issuable upon exercise of outstanding Options or the conversion of outstanding
Convertible Securities and shares of Preferred Stock, and all Additional Shares of Common deemed
issued pursuant to Section&nbsp;4(d)(iii) hereof, shall be deemed to be outstanding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;<U>Determination of Consideration</U>. For purposes of this Section&nbsp;4(d), the
consideration received by the Corporation for the issue (or deemed issue) of any Additional Shares
of Common shall be computed as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;<U>Cash and Property</U>. Such consideration shall:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;insofar as it consists of cash, be computed at the aggregate amount of cash received by
the Corporation before deducting reasonable discounts, commissions or other expenses allowed, paid
or incurred by the Corporation for any underwriting or otherwise in connection with such issue (or
deemed issue);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;insofar as it consists of property other than cash, be computed at the fair market value
thereof at the time of such issue, as determined in good faith by the Board of Directors; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)&nbsp;in the event Additional Shares of Common are issued together with other shares or
securities or other assets of the Corporation for consideration which covers both, be the
proportion of such consideration so received, computed as provided in clauses (A)&nbsp;and (B)&nbsp;above, as
reasonably determined in good faith by the Board of Directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;<U>Options and Convertible Securities</U>. The consideration per share received by the
Corporation for Additional Shares of Common deemed to have been issued pursuant to Section
4(d)(iii) shall be determined by dividing
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(X) the total amount, if any, received or receivable by the Corporation as consideration for
the issue of such Options or Convertible Securities, plus the minimum aggregate amount of
additional consideration (as set forth in the instruments relating
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-14-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">thereto, without regard to any provision contained therein for a subsequent adjustment of such
consideration) payable to the Corporation upon the exercise of such Options or the conversion or
exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the
exercise of such Options for Convertible Securities and the conversion or exchange of such
Convertible Securities by
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Y)&nbsp;the maximum number of shares of Common Stock (as set forth in the instruments relating
thereto, without regard to any provision contained therein for a subsequent adjustment of such
number) issuable upon the exercise of such Options or the conversion or exchange of such
Convertible Securities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Adjustments for Subdivisions or Combinations of Common Stock</U>. In the event the
outstanding shares of Common Stock shall be subdivided (by stock split, by payment of a stock
dividend or otherwise), into a greater number of shares of Common Stock, the Conversion Price of
each series of Preferred Stock in effect immediately prior to such subdivision shall, concurrently
with the effectiveness of such subdivision, be proportionately decreased. In the event the
outstanding shares of Common Stock shall be combined (by reclassification or otherwise) into a
lesser number of shares of Common Stock, the Conversion Prices in effect immediately prior to such
combination shall, concurrently with the effectiveness of such combination, be proportionately
increased.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Adjustments for Subdivisions or Combinations of Preferred Stock</U>. In the event the
outstanding shares of Preferred Stock or a series of Preferred Stock shall be subdivided (by stock
split, by payment of a stock dividend or otherwise), into a greater number of shares of Preferred
Stock, the Dividend Rate, Original Issue Price and Liquidation Preference of the affected series of
Preferred Stock in effect immediately prior to such subdivision shall, concurrently with the
effectiveness of such subdivision, be proportionately decreased. In the event the outstanding
shares of Preferred Stock or a series of Preferred Stock shall be combined (by reclassification or
otherwise) into a lesser number of shares of Preferred Stock, the Dividend Rate, Original Issue
Price and Liquidation Preference of the affected series of Preferred Stock in effect immediately
prior to such combination shall, concurrently with the effectiveness of such combination, be
proportionately increased.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Adjustments for Reclassification, Exchange and Substitution</U>. Subject to Section&nbsp;3
above (&#147;<B>Liquidation Rights</B>&#148;), if the Common Stock issuable upon conversion of the Preferred Stock
shall be changed into the same or a different number of shares of any other class or classes of
stock, whether by capital reorganization, reclassification or otherwise (other than a subdivision
or combination of shares provided for above), then, in any such event, in lieu of the number of
shares of Common Stock which the holders would otherwise have been entitled to receive, each holder
of such Preferred Stock shall have the right thereafter to convert such shares of Preferred Stock
into a number of shares of such other class or classes of stock which a holder of the number of
shares of Common Stock deliverable upon conversion of such series of Preferred Stock immediately
before that change would have been entitled to receive in such reorganization or reclassification,
all subject to further adjustment as provided herein with respect to such other shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <U>No Impairment</U>. The Corporation will not through any reorganization, transfer of
assets, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or
seek
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-15-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to avoid the observance or performance of any of the terms to be observed or performed
hereunder by the Corporation but will at all times in good faith assist in the carrying out of all
the provisions of this Section&nbsp;4 and in the taking of all such action as may be necessary or
appropriate in order to protect the Conversion Rights of the holders of Preferred Stock against
impairment. Notwithstanding the foregoing, nothing in this Section 4(h) shall prohibit the
Corporation from amending its Articles of Incorporation with the requisite consent of its
shareholders and the board of directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <U>Certificate as to Adjustments</U>. Upon the occurrence of each adjustment or
readjustment of the Conversion Price pursuant to this Section&nbsp;4, the Corporation at its expense
shall promptly compute such adjustment or readjustment in accordance with the terms hereof and
furnish to each holder of Preferred Stock a certificate setting forth such adjustment or
readjustment and showing in detail the facts upon which such adjustment or readjustment is based.
The Corporation shall, upon the written request at any time of any holder of Preferred Stock,
furnish or cause to be furnished to such holder a like certificate setting forth (i)&nbsp;such
adjustments and readjustments, (ii)&nbsp;the Conversion Price at the time in effect and (iii)&nbsp;the number
of shares of Common Stock and the amount, if any, of other property which at the time would be
received upon the conversion of Preferred Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <U>Notices of Record Date</U>. In the event that this Corporation shall propose at any
time:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;to declare any dividend or distribution upon its Common Stock, whether in cash, property,
stock or other securities, whether or not a regular cash dividend and whether or not out of
earnings or earned surplus;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;to effect any reclassification or recapitalization of its Common Stock outstanding
involving a change in the Common Stock; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;to voluntarily liquidate or dissolve or to enter into any transaction deemed to be a
liquidation, dissolution or winding up of the corporation pursuant to Section&nbsp;3(f);
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">then, in connection with each such event, this Corporation shall send to the holders of the
Preferred Stock at least 14&nbsp;days&#146; prior written notice of the date on which a record shall be taken
for such dividend or distribution (and specifying the date on which the holders of Common Stock
shall be entitled thereto) or for determining rights to vote in respect of the matters referred to
in (ii)&nbsp;and (iii)&nbsp;above.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each such written notice shall be given by first class mail, postage prepaid, addressed to the
holders of Preferred Stock at the address for each such holder as shown on the books of this
Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The right of the holders of the Preferred Stock to notice hereunder may be waived by the
holders of more than two-thirds (<FONT style="font-size: 70%"><SUP>2</SUP></FONT>/<FONT style="font-size: 60%">3</FONT>) of the outstanding shares of the Preferred Stock voting
together as a single class.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <U>Reservation of Stock Issuable Upon Conversion</U>. The Corporation shall at all times
reserve and keep available out of its authorized but unissued shares of Common Stock solely
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-16-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">for the purpose of effecting the conversion of the shares of the Preferred Stock, such number
of its shares of Common Stock as shall from time to time be sufficient to effect the conversion of
all then outstanding shares of the Preferred Stock; and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the conversion of all then
outstanding shares of the Preferred Stock, the Corporation will take such corporate action as may,
in the opinion of its counsel, be necessary to increase its authorized but unissued shares of
Common Stock to such number of shares as shall be sufficient for such purpose.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) <U>Waiver of Adjustment of Conversion Price</U>. Notwithstanding anything herein to the
contrary, any downward adjustment of the Conversion Price of any series of Preferred Stock may be
waived by the consent or vote of the holders of more than two-thirds (<FONT style="font-size: 70%"><SUP>2</SUP></FONT>/<FONT style="font-size: 60%">3</FONT>) of the outstanding shares
of such series. Any such waiver shall bind all future holders of shares of such series of
Preferred Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Voting</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Restricted Class&nbsp;Voting</U>. Except as otherwise expressly provided herein or as
required by law, the holders of Preferred Stock and the holders of Common Stock shall vote together
and not as separate classes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>No Series&nbsp;Voting</U>. Other than as provided herein or required by law, there shall
be no series voting.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Preferred Stock</U>. Each holder of Preferred Stock shall be entitled to the number
of votes equal to the number of shares of Common Stock into which the shares of Preferred Stock
held by such holder could be converted as of the record date. The holders of shares of the
Preferred Stock shall be entitled to vote on all matters on which the Common Stock shall be
entitled to vote. Holders of Preferred Stock shall be entitled to notice of any shareholders&#146;
meeting in accordance with the Bylaws of the Corporation. Fractional votes shall not, however, be
permitted and any fractional voting rights resulting from the above formula (after aggregating all
shares into which shares of Preferred Stock held by each holder could be converted), shall be
disregarded.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Common Stock</U>. Each holder of shares of Common Stock shall be entitled to one vote
for each share thereof held.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Election of Directors</U>. So long as at least 2,000,000 shares of Series&nbsp;D Preferred
Stock (as adjusted for stock splits, subdivisions, combinations or stock dividends with respect to
such shares) remain outstanding, the holders of the Series&nbsp;D Preferred Stock, voting as a separate
class, shall be entitled to elect two (2)&nbsp;members of the Corporation&#146;s Board of Directors at each
meeting or pursuant to each consent of the Corporation&#146;s shareholders for the election of
directors. So long as at least 2,000,000 shares of Series&nbsp;C Preferred Stock (as adjusted for stock
splits, subdivisions, combinations or stock dividends with respect to such shares) remain
outstanding, the holders of Series&nbsp;C Preferred Stock, voting as a separate class, shall be entitled
to elect three (3)&nbsp;members of the Corporation&#146;s Board of Directors at each meeting or pursuant to
each consent of the Corporation&#146;s shareholders for the election of directors. Any additional
members of the Corporation&#146;s Board of Directors shall be elected by the holders of Common Stock,
Series&nbsp;A
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-17-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Preferred Stock, Series&nbsp;B Preferred Stock, and Series&nbsp;E Preferred Stock, voting together as a
single class.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Amendments and Changes Requiring Approval of Preferred Stock</U>. As long as any of
the Preferred Stock shall be issued and outstanding, the Corporation shall not, without first
obtaining the approval (by vote or written consent as provided by law) of the holders of at least
two-thirds (<FONT style="font-size: 70%"><SUP>2</SUP></FONT>/<FONT style="font-size: 60%">3</FONT>) of the outstanding shares of the Preferred Stock voting together as a single class:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;amend, alter or repeal any provision of the Articles of Incorporation or By-laws of the
Corporation if such action would adversely alter the rights, preferences, privileges or powers of,
or restrictions provided for the benefit of the Preferred Stock or any series thereof;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;enter into any transaction or series of related transactions deemed to be a liquidation,
dissolution or winding up of the Corporation pursuant to Section 3(f) above;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;voluntarily liquidate or dissolve;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;declare or pay any distribution (as defined in Section 2(d) except for distributions upon
a liquidation or dissolution) with respect to the Common Stock of the Corporation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;permit any subsidiary of the Corporation to sell securities to a third party (other than
directors&#146; qualifying shares in the case of subsidiaries outside the United States);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;increase or decrease (other than for decreases resulting from conversion of the Preferred
Stock) the authorized number of shares of Preferred Stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;authorize or create (by reclassification or otherwise) any new class or series of capital
stock having rights, preferences or privileges with respect to dividends, liquidation, redemption,
conversion or other rights senior to or on a parity with any series of Preferred Stock or with
respect to voting senior to any series of Preferred Stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;increase or decrease the authorized number of directors of the Corporation; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;amend this Section&nbsp;6.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>Amendments and Changes Requiring the Approval of the Series&nbsp;E Preferred Stock</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As long as any of the Series&nbsp;E Preferred Stock shall be issued and outstanding, the
Corporation shall not, without first obtaining the approval (by vote or written consent as provided
by law) of the holders of at least 60% of the outstanding shares of the Series&nbsp;E Preferred Stock:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;amend, alter or repeal any provision of the Articles of Incorporation of the Corporation
if such action would adversely alter the rights, preferences, privileges or powers of, or
restrictions provided for the benefit of the Series&nbsp;E Preferred Stock in a manner different from
any other series of Preferred Stock; or
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-18-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;amend this Section&nbsp;7(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As long as any of the Series&nbsp;E Preferred Stock shall be issued and outstanding, the
Corporation shall not, without first obtaining the approval (by vote or written consent as provided
by law) of the holders of at least a majority of the outstanding shares of the Series&nbsp;E Preferred
Stock:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;declare or pay any distribution (as defined in Section 2(d) except for distributions upon
a liquidation or dissolution) with respect to the Common Stock or Preferred Stock of the
Corporation; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;amend this Section&nbsp;7(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As long as any of the Series&nbsp;E Preferred Stock shall be issued and outstanding, the
Corporation shall not, without first obtaining the approval (by vote or written consent as provided
by law) of the holders of at least 66 2/3% of the outstanding shares of the Series&nbsp;D Preferred
Stock and Series&nbsp;E Preferred Stock voting together as a single class on an as converted to Common
Stock basis:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;increase or decrease (other than for decreases resulting from conversion of the Preferred
Stock) the authorized number of shares of Series&nbsp;E Preferred Stock;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;authorize or create (by reclassification or otherwise) any new class or series of capital
stock having rights, preferences or privileges with respect to dividends, payments upon liquidation
or other rights senior to or on a parity with the Series&nbsp;E Preferred Stock or with respect to
voting senior to the Series&nbsp;E Preferred Stock; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;amend this Section&nbsp;7(c).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<U>Amendments and Changes Requiring the Approval of the Series&nbsp;D Preferred Stock</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As long as any of the Series&nbsp;D Preferred Stock shall be issued and outstanding, the
Corporation shall not, without first obtaining the approval (by vote or written consent as provided
by law) of the holders of at least 60% of the outstanding shares of the Series&nbsp;D Preferred Stock:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;amend, alter or repeal any provision of the Articles of Incorporation of the Corporation
if such action would adversely alter the rights, preferences, privileges or powers of, or
restrictions provided for the benefit of the Series&nbsp;D Preferred Stock in a manner different from
any other series of Preferred Stock; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;amend this Section&nbsp;8(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As long as any of the Series&nbsp;D Preferred Stock shall be issued and outstanding, the
Corporation shall not, without first obtaining the approval (by vote or written consent as provided
by law) of the holders of at least a majority of the outstanding shares of the Series&nbsp;D Preferred
Stock:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-19-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;increase or decrease (other than for decreases resulting from conversion of the Preferred
Stock) the authorized number of shares of Series&nbsp;D Preferred Stock;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;authorize or create (by reclassification or otherwise) any new class or series of capital
stock having rights, preferences or privileges with respect to dividends, payments upon liquidation
or other rights senior to or on a parity with the Series&nbsp;D Preferred Stock or with respect to
voting senior to the Series&nbsp;D Preferred Stock;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;declare or pay any distribution (as defined in Section 2(d) except for distributions
upon a liquidation or dissolution) with respect to the Common Stock or Preferred Stock of the
Corporation;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;increase the authorized number of directors of the Corporation above eleven (11); or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;amend this Section&nbsp;8(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;<U>Amendments and Changes Requiring the Approval of the Series&nbsp;C Preferred Stock</U>. As
long as any of the Series&nbsp;C Preferred Stock shall be issued and outstanding, the Corporation shall
not, without first obtaining the approval (by vote or written consent as provided by law) of the
holders of at least two-thirds (<FONT style="font-size: 70%"><SUP>2</SUP></FONT>/<FONT style="font-size: 60%">3</FONT>) of the outstanding shares of the Series&nbsp;C Preferred Stock:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;amend, alter or repeal any provision of the Articles of Incorporation of the Corporation
if such action would adversely alter the rights, preferences, privileges or powers of, or
restrictions provided for the benefit of the Series&nbsp;C Preferred Stock in a manner different from
any other series of Preferred Stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;increase or decrease (other than for decreases resulting from conversion of the Preferred
Stock) the authorized number of shares of Series&nbsp;C Preferred Stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;authorize or create (by reclassification or otherwise) any new class or series of capital
stock having rights, preferences or privileges with respect to dividends, payments upon liquidation
or other rights senior to or on a parity with the Series&nbsp;C Preferred Stock or with respect to
voting senior to the Series&nbsp;C Preferred Stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;declare or pay any distribution (as defined in Section 2(d) except for distributions upon
a liquidation or dissolution) with respect to the Common Stock or Preferred Stock of the
Corporation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;increase the authorized number of directors of the Corporation above eleven (11); or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;amend this Section&nbsp;9.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;<U>Amendments and Changes Requiring the Approval of the Series&nbsp;B Preferred Stock</U>. As
long as any of the Series&nbsp;B Preferred Stock shall be issued and outstanding, the Corporation shall
not, without first obtaining the approval (by vote or written consent as provided by law) of the
holders of at least two-thirds of the outstanding shares of the Series&nbsp;B Preferred Stock:
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-20-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;amend, alter or repeal any provision of the Articles of Incorporation of the Corporation
if such action would adversely alter the rights, preferences, privileges or powers of, or
restrictions provided for the benefit of the Series&nbsp;B Preferred Stock in a manner different from
any other series of Preferred Stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;increase or decrease (other than for decreases resulting from conversion of the Preferred
Stock) the authorized number of shares of Series&nbsp;B Preferred Stock; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;amend this Section&nbsp;10.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;<U>Status of Converted Stock.</U> In the event any shares of Preferred Stock shall be
converted pursuant to Article&nbsp;4 hereof, then the shares so converted shall be cancelled and shall
not be issuable by the Corporation. The Articles of Incorporation shall be appropriately amended
to effect the corresponding reduction in the Corporation&#146;s authorized capital stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;<U>Notices</U>. Any notice required by the provisions of this Article&nbsp;IV to be given to
the holders of Preferred Stock shall be deemed given if deposited in the United States mail,
postage prepaid, and addressed to each holder of record at such holder&#146;s address appearing on the
books of the Corporation.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE V
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Limitation of Directors&#146; Liability</U>. The liability of the directors of this
Corporation for monetary damages shall be eliminated to the fullest extent permissible under
California law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Indemnification of Corporate Agents</U>. This Corporation is authorized to provide
indemnification of agents (as defined in Section&nbsp;317 of the California Corporations Code) through
bylaw provisions, agreements with agents, votes of shareholders or disinterested directors or
otherwise, in excess of the indemnification otherwise permitted by Section&nbsp;317 of the California
Corporations Code, subject only to the applicable limits set forth in Section&nbsp;204 of the California
Corporations Code with respect to actions for breach of duty to this Corporation and its
shareholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Repeal or Modification</U>. Any repeal or modification of the foregoing provisions of
this Article&nbsp;V shall not adversely affect any right of indemnification or limitation of liability
permitted under California law relating to acts or omissions occurring prior to such repeal or
modification.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-21-<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT
C</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE
OF EXCEPTIONS</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FLUIDIGM CORPORATION</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>SERIES E PREFERRED STOCK PURCHASE AGREEMENT</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>UPDATED SCHEDULE OF EXCEPTIONS</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>October&nbsp;26, 2007</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT style="font-variant: SMALL-CAPS"><B>FLUIDIGM CORPORATION</B></FONT>, a Delaware corporation (the &#147;<B>Company</B>&#148;), hereby makes the
following exceptions and additional disclosure to the representations and warranties set forth in
Section&nbsp;2 of the Series&nbsp;E Preferred Stock Purchase Agreement dated as of June&nbsp;13, 2007 between the
Company and the Purchasers thereunder, as amended by that certain Amendment No.1 dated December&nbsp;22,
2006, and further amended by Amendment No.&nbsp;2 dated October&nbsp;10, 2007 and Amendment No.&nbsp;3 dated
October&nbsp;26, 2007 (as amended, the &#147;<B>Agreement</B>&#148;). Except as otherwise defined herein, all
capitalized terms used herein shall have the meanings given them in the Agreement. The section
numbers below correspond to the section numbers of the representations and warranties in the
Agreement; provided that any information disclosed herein under any section number shall be deemed
to be disclosed and incorporated under any other section number under the Agreement where such
disclosure would be appropriate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Schedule of Exceptions is intended to broaden the scope of any representation
or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this
Schedule of Exceptions (1)&nbsp;does not represent a determination that such item is material or
establish a standard of materiality, (2)&nbsp;does not represent a determination that such item did not
arise in the ordinary course of business, (3)&nbsp;does not represent a determination that the
transactions contemplated by the Agreement require the consent of third parties, and (4)&nbsp;shall not
constitute, or be deemed to be, an admission to any third party concerning such item. This
Schedule of Exceptions includes brief descriptions or summaries of certain agreements and
instruments, copies of which are available upon reasonable request. Such descriptions do not
purport to be comprehensive, and are qualified in their entirety by reference to the text of the
documents described.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Schedule of Exceptions reflects exceptions and additional disclosure to the
representations and warranties made by the Company set forth in Section&nbsp;2 of the Agreement as of
October&nbsp;26, 2007, and has not been updated for Subsequent Closings. The Purchaser acknowledges
that there may be changes to such exceptions and additional disclosure since October&nbsp;26, 2007, and
accepts the Schedule of Exceptions as of October&nbsp;26, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.1 Organization, Good Standing and Qualification</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On July&nbsp;18, 2007, Fluidigm Corporation, a California corporation (&#147;Fluidigm California&#148;) was
merged with and into the Company, with the Company being the surviving corporation such that the
Company succeeded to all of Fluidigm California&#146;s rights and obligations, including those under the
Purchase Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.3 Subsidiaries</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has a wholly-owned subsidiary in Singapore, Fluidigm Singapore Pte. Ltd.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has a wholly-owned subsidiary in the Netherlands, Fluidigm Europe, B.V., which has
a wholly-owned subsidiary in France, Fluidigm France, S.A.R.L.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has a wholly-owned subsidiary in Japan, Fluidigm Japan K.K.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.4 Capitalization</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has extended offers of option grants for up to approximately 200,000 shares of
Common Stock to certain of the Company&#146;s employees and consultants in addition to the options that
are currently outstanding. In addition, the Company is currently negotiating or has entered into
agreements with consultants and employees for the issuance of options to purchase shares of the
Company&#146;s Common Stock under the Company&#146;s 1999 Stock Option Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with a Development Collaboration and License Agreement (the &#147;<B>Collaboration
Agreement</B>&#148;) entered into on September&nbsp;22, 2003 between the Company and Glaxo Group Limited
(&#147;<B>Glaxo</B>&#148;) and SmithKline Beecham Corporation (&#147;<B>SKB</B>&#148;), the Company issued warrants to purchase
90,000 shares of Series&nbsp;C Preferred Stock and 90,000 shares of Series&nbsp;C Preferred Stock to Glaxo
and warrants to purchase 110,000 and 110,000 shares of Series&nbsp;C Preferred Stock to SKB. One of the
warrants to purchase 90,000 shares of Series&nbsp;C Preferred Stock issued to Glaxo and one of the
warrants to purchase 110,000 shares of Series&nbsp;C Preferred Stock issued to SKB expired pursuant to
their terms and are not shown as outstanding in the Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company entered into various agreements with Lighthouse Capital Partners V, L.P.
(&#147;Lighthouse&#148;) as described in Section&nbsp;2.14 below. In connection with these transactions, the
Company borrowed $13,000,000 under the loan and security agreement and issued a warrant to
Lighthouse to purchase 371,428 shares of the Company&#146;s Series&nbsp;D Preferred Stock. As of September
30, 2007, the Company owed approximately $9,601,037 under the notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is a party to a License Agreement between the Company and the California Institute
of Technology (&#147;<B>Caltech</B>&#148;) dated May&nbsp;1, 2000, which was amended and restated in June&nbsp;2002 effective
as of May&nbsp;1, 2002, further amended in June&nbsp;2003, with a restatement date of May&nbsp;1, 2004, as further
amended March&nbsp;29, 2007 (collectively, the &#147;<B>Caltech License Agreement</B>&#148;). Pursuant to the Caltech
License Agreement, the Company was obligated on an annual basis to issue to Caltech 50,000 shares
of the Company&#146;s Common Stock on each occasion that the Company determined to add patent rights to
the license.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company and Biomedical Sciences Investment Fund Pte Ltd. (&#147;<B>BMSIF</B>&#148;) are parties to a
Convertible Note Purchase Agreement dated as of December&nbsp;18, 2003, as amended by Amendment No.&nbsp;1 to
Convertible Note Purchase Agreement dated December&nbsp;17, 2004 and as further amended by a letter
agreement dated June&nbsp;30, 2005 (collectively, the &#147;<B>CNPA</B>&#148;). Pursuant to the CNPA, the Company
issued a Convertible Promissory Note, as amended by Amendment to Convertible Promissory Note dated
December&nbsp;17, 2004, and as further amended by Amendment No.&nbsp;2 to Convertible Promissory Note dated
June&nbsp;30, 2005 (collectively, the &#147;<B>Note</B>&#148;) to BMSIF in exchange for $2,000,000. In December&nbsp;2005,
upon the successful completion of certain specified milestones by the Company, the principal amount
of and the accrued interest under the Note were converted into 832,635 shares of Series&nbsp;D Preferred
Stock at a conversion price per share of $2.80.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, as a result of the Company&#146;s achieving of such specified milestones, the Company
has required BMSIF to purchase an additional convertible promissory note (the &#147;<B>Supplemental Note</B>&#148;)
in the aggregate principal amount of $3,000,000 on June&nbsp;20, 2006.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The principal amount of and interest on the Supplemental Note was convertible into shares of
Series&nbsp;D Preferred Stock of the Company at a conversion price of $2.80 per share (subject to
adjustment) upon the earlier of an initial public offering in connection with which the Company&#146;s
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Preferred Stock has converted into Common Stock or the satisfaction of certain specified
milestones. In addition, BMSIF may electively convert the Supplemental Note into shares of Series
D Preferred Stock at any time. The principal amount and interest under the Supplemental Note could
not be prepaid except under limited circumstances. In July, 2007 upon completion of certain
specified milestones by the Company, the principal amount of and the accrued interest under the
Supplemental Note were converted into 1,157,142 shares of Series&nbsp;D Preferred Stock at a conversion
price per share of $2.80.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company and Invus, L.P. are parties to a Convertible Note Agreement dated December&nbsp;18,
2003, as amended by Amendment No.&nbsp;1 to Convertible Note Agreement executed in November&nbsp;2005 (the
&#147;<B>CNA</B>&#148;). The CNA provides that in the event the Company issues to BMSIF Supplemental Notes in the
aggregate principal amount of $3,000,000 upon the happening of certain events, Invus has the right
to purchase a convertible promissory note in the principal amount of $3,000,000 (the &#147;<B>Invus Note</B>&#148;)
from the Company. Recently, Invus, L.P. and the Company decided not to issue the Invus Note.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company and BMSIF entered into a Convertible Note Purchase Agreement, dated as of August
7, 2006, as amended by that certain Letter Agreement dated November&nbsp;15, 2006 and as further amended
by that certain Letter Agreement dated January&nbsp;31, 2007 (as amended, the <B>&#147;2006 CNPA</B>&#148;). The 2006
CNPA permits the Company to borrow up to $15&nbsp;million in three $5&nbsp;million tranches, subject to
availability based on the achievement of specified milestones. The Company has sold and issued to
BMSIF all three convertible promissory notes, each in the principal amount of $5&nbsp;million. The
initial two convertible promissory notes converted into 1,460,730 and 1,493,607 shares of Series&nbsp;E
Preferred Stock on March&nbsp;31, 2007. Upon conversion of the second convertible promissory note,
BMSIF purchased the third (and final) convertible promissory note in the principal amount of $5
million.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In March&nbsp;2003, the Company entered into (i)&nbsp;a Master Closing Agreement (the &#147;<B>Master Closing
Agreement</B>&#148;) with Oculus Pharmaceuticals, Inc. (&#147;<B>Oculus</B>&#148;) and the University of Alabama Research
Foundation (&#147;<B>UABRF</B>&#148;); (ii)&nbsp;a License Agreement with UABRF; and (iii)&nbsp;a Sponsored Research Agreement
with UABRF. The Company is obligated to issue up to $2,100,000 of additional shares of its stock
to UABRF in connection with the satisfaction of certain milestones. If the Company is a private
Company at the time a milestone is achieved, upon achievement of a milestone, the Company is to
issue shares of the series of Preferred Stock that was issued in the Company&#146;s most recent
financing and the shares are to be valued at the price the shares were sold in such financing. If
the Company is a public company at the time a milestone is achieved, upon achievement of a
milestone, the Company is to issue shares of Common stock valued at the average closing price of
the Company&#146;s Common Stock over the five trading days preceding the achievement of the milestone.
In February&nbsp;2005, UABRF sent a letter to the Company requesting issuance of the shares in relation
to the milestones. The Company replied in writing that the milestones had not been satisfied and
that it had no obligation to issue the shares at that time. The Company achieved a milestone in
2006 and as a result issued $600,000 worth of shares of its Series&nbsp;D Preferred Stock to UABRF and
other designated parties. Following the satisfaction of the milestone, the parties have been
negotiating the Company&#146;s continuing obligations, if any, under the agreements identified above,
which may include an obligation on the part of the Company to issue additional shares of its stock
to UABRF.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is party to an offer letter with Richard DeLateur, the Company&#146;s Chief Financial
Officer, which provides that in the event of a Change of Control (as defined in the offer letter)
50% of the shares subject to the option granted to Mr.&nbsp;DeLateur in connection with his acceptance
of
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">employment with the Company that are unvested at the time of such Change of Control shall
become immediately vested.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has approved an issuance of 6,000 shares of the Company&#146;s Common Stock to Stanford
University. Such issuance has not been completed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Section&nbsp;2.10(f) regarding Dr.&nbsp;Stephen R. Quake.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.7 Government Consents</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company makes no representation or warranty with respect to any consent, approval, order
or authorization of, or registration, qualification, designation, declaration or filing with any
foreign governmental entity and has assumed for purposes of the Agreement that none of the
foregoing is required.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.8 Litigation</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Section&nbsp;2.10(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has received a letter from a supplier of certain materials used in the Company&#146;s
Topaz and certain other products requesting that the Company cease and desist using a lid with the
materials or obtain a license from the supplier for using the design of the lid. Upon
investigation, the Company determined that it had developed the lid design independently from the
supplier and also began developing alternates to the materials, which are currently approved for
manufacturing. The Company wrote a letter explaining these opinions to the supplier and the
parties have been in negotiations regarding this matter resulting in the supplier providing a
proposed settlement agreement with a $55,000 buy-out option for the Company and the Company replied
with a revised draft settlement agreement. The Company is currently waiting for the supplier to
comment on the revised draft settlement agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.9 Employees</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;William Smith, the Company&#146;s general counsel, is currently working for the Company and also
remains a partner at Townsend and Townsend and Crew LLP. Mr.&nbsp;Smith serves on the Board of
Directors of two private companies, Theracos Corporation and Arbor Vita Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Richard DeLateur, the Company&#146;s Chief Financial Officer, currently works four days a week and
it is anticipated that Mr.&nbsp;DeLateur&#146;s service will decrease and his employment with the Company
will terminate. Mr.&nbsp;DeLateur and the Company do not have a schedule for the eventual termination
of Mr.&nbsp;DeLateur&#146;s employment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.10 Patents and Other Intangible Assets</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.10(a)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has rights to the patents, trademarks and applications listed on <U>Schedule
2.10</U> attached hereto, although some of the patent rights listed may not currently be being
utilized by the Company in, and may not be necessary for, the Company&#146;s business as now conducted.
The Company&#146;s registered domain names are fluidigm.com, fluidigm.net, fluidigm.biz, fluidigm.info
and mycometrix.com.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company currently is selling two product lines: (i)&nbsp;the Topaz crystallization
microprocessors (also referred to as Integrated Fluidic Circuits or IFCs) and certain associated
apparatuses; and (ii)&nbsp;the BioMark System, including certain IFCs, such as Dynamic Array chips,
Digital Array chips (also referred to as DID chips) and ImmunoMatrix chips, as well as certain
associated apparatuses. The Company has not completed investigations with respect to the
Intellectual Property Rights required for the BioMark System product line or for additional
applications of the Company&#146;s technology. In conjunction with this analysis, the Company has
sought and will continue to seek opinions from counsel with respect to potentially relevant third
party patent rights directed to, e.g., certain RealTime PCR and other PCR reagents and instruments,
such as assigned to Roche Molecular Systems and/or Applied BioSystems, an Applera Corporation
Business. The Company, therefore, may need to acquire additional Intellectual Property Rights to
pursue those lines of business, particularly with respect to microfluidic devices for PCR and other
assays, although the Company has not presently determined that blocking Intellectual Property
Rights of others exist in this regard.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered into a Collaboration Agreement dated January&nbsp;24, 2005 (the &#147;<B>CTI
Collaboration Agreement</B>&#148;) with CTI Molecular Imaging, Inc. (subsequently acquired by Siemens)
(&#147;<B>CTI</B>&#148;), under which the parties are to develop microfluidic chips and associated apparatuses for
use in positron emission tomography (&#147;<B>PET</B>&#148;). Under the CTI Collaboration Agreement, both CTI and
the Company have granted licenses to the other as necessary to conduct the research and development
program contemplated by the CTI Collaboration Agreement. The Company has also granted CTI an
option under certain of the Company&#146;s intellectual property to manufacture chips developed during
the collaboration. The Company also has rights to intellectual property developed under the
Collaboration Agreement, subject to certain restrictions under which CTI and certain other
collaborating entities have specified rights in the defined PET and associated fields. Recently,
Siemens notified the Company that it does not intend to exercise the option or continue the
research and development program. Discussions are underway relating to the early termination of
the Collaboration Agreement, and for the Company to obtain all rights to intellectual property
developed under the CTI Collaboration Agreement, including intellectual property rights arising
from (i)&nbsp;a patent application filed by Siemens and Caltech in which the Company believes that
certain Company scientists should have been named as co-inventors; (ii)&nbsp;additional patent
applications in the PET field allegedly filed by or on behalf of Siemens potentially with Caltech
inventors; and (iii)&nbsp;CTI activities with third parties. The Company and Siemens have agreed
starting in 2007 to not engage in further funded research under the CTI Collaboration Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is licensee under a series of agreements with the President and Fellows of Harvard
College, under which the Company pays royalties to Harvard. The Company renegotiated the terms of
its agreements with Harvard and reduced the number of licenses from five to three, effective in
January&nbsp;2005. The Company and Harvard will be discussing potential royalty obligations of the
Company to Harvard relating to transactions where the Company has received revenue but has not
directly charged for product transfers, such as for certain microfluidic chips.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In January&nbsp;2003, the Company entered into a Patent License Agreement with Gyros pursuant to
which the Company received a non-exclusive license to certain patents from Gyros relating to the
Company&#146;s products. In exchange for the license, the Company has made certain payments to Gyros.
In January&nbsp;2004, the Company exercised an option to add an additional field of use to the scope of
the license agreement in exchange for a cash payment. In January&nbsp;2007, the Company did not elect
or pay for another additional field for, e.g., ImmunoMatrix chips, for which the Company has
conducted and is continuing to conduct research and development activities. The Company and Gyros
have had discussions regarding the extension of the field and Gyros has offered such extension
pursuant to the terms of the Patent License Agreement. In addition, the Company is obligated to
make royalty
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">payments on certain Company products incorporating the technology licensed from Gyros. The
amounts otherwise paid by the Company may be used as a credit with respect to the royalty payments.
The agreement provides for certain indemnity obligations of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect to certain patent filings then-controlled by Oculus Pharmaceuticals with
overlapping claims to the Syrrx patent referred to in the paragraph below, the Company entered into
in March&nbsp;2003 (i)&nbsp;the Master Closing Agreement; (ii)&nbsp;a License Agreement with UABRF (the &#147;<B>UABRF
License Agreement</B>&#148;); and (iii)&nbsp;a Sponsored Research Agreement with UABRF. The license is an
exclusive license, subject to certain exceptions (including rights UABRF may have previously
granted Diversified Scientific, Inc. so that Diversified Scientific could perform research
obligations under grants). UABRF and affiliated entities have the right to internal use of the
intellectual property rights and to fulfill obligations under a National Institutes of Health
grant. Pursuant to the Master Closing Agreement, the Company made an up-front payment to UABRF and
granted UABRF shares of the Company&#146;s Series&nbsp;C Preferred Stock. The Company is obligated to issue
additional shares of its stock to UABRF in the event certain milestones are achieved as described
in Section&nbsp;2.4 hereof. In connection with the satisfaction of a milestone, the Company may become
obligated to enter into a non-transferable site license so that an entity will have the right to
use the technology licensed to the Company for internal drug discovery efforts. Pursuant to the
Sponsored Research Agreement, the Company agreed to support a UABRF research program. The
Sponsored Research Program Agreement contains certain terms relating to the license of intellectual
property rights arising out of the program. The Company has certain indemnification obligations
pursuant to the agreements referred to in this paragraph.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In conjunction with the development of the Company&#146;s protein crystallization microprocessor
prototype, the Company became aware of U.S. Patent no. 6,296,673, issued to the Regents of the
University of California (the &#147;<B>Regents</B>&#148;) and apparently exclusively licensed to Syrrx Corporation
(note: Sam Colella of Versant Ventures, Chairman of the Company&#146;s Board of Directors, used to be
Chairman of Syrrx, which has been acquired by Takeda Pharmaceutical Company Limited). Based on
Syrrx&#146;s contentions of infringement with respect to the patent, related patent applications and the
Company&#146;s products, the Company has sought and obtained a patent opinion from counsel with respect
to the patent and entered into license negotiations with Syrrx for a license/sublicense to the
patent and other patent filings assigned to the Regents and Syrrx. In December&nbsp;2003, the Company
entered into a license agreement with Syrrx (the &#147;<B>Syrrx License Agreement</B>&#148;), pursuant to which, in
exchange for a field restricted and nonexclusive license under intellectual property owned or
controlled by Syrrx, the Company issued Syrrx shares of the Company&#146;s Common Stock, made an
up-front payment and annual minimum payments. In addition, the Company is obligated to pay a
royalty in connection with the sale of certain products of the Company that incorporate the
intellectual property licensed and is obligated to indemnify Syrrx for matters relating to the
practice by the Company of any license or sublicense under the agreement. In January&nbsp;2006, an
interference was declared by the USPTO between a patent application licensed to the Company under
the UABRF License Agreement and the above-identified patent and other related patents. While the
interference was ongoing, the Company, Syrrx, UABRF and Athersys, Inc. (a company that allegedly
acquired certain rights from Oculus) were in negotiations to settle the interference and modify the
parties&#146; obligations under the Syrrx License Agreement, the Master Closing Agreement, and the UABRF
License Agreement. Recently, in an appealable decision, the USPTO invalidated all claims of both
parties in the interference, and Syrrx decided not to appeal. Due to this decision and these
negotiations, the Company may decide not to maintain the Syrrx License Agreement in 2008.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is aware of patents and patent applications controlled by Micronics Corporation
and Diversified Scientific, Inc. that potentially relate to the Company&#146;s protein crystallization
product
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">line. The Company has sought and obtained opinions from patent counsel regarding such patents
and has conducted preliminary discussions with each of these entities regarding the possibility of
obtaining a license to the relevant intellectual property. The necessity of obtaining a license
from each and the outcome of such negotiations remain uncertain although in certain Micronics
patent applications watched by the Company, the claims have been amended to not cover the Company&#146;s
protein crystallization product line. In February&nbsp;2005, Diversified Scientific announced a plan to
auction its recently broadened (by USPTO re-examination) patent and other intellectual property
related to crystal image analysis. The Company indicated interest to Diversified Scientific in
submitting a bid. Diversified Scientific replied that it would respond to the Company and
additional interested bidders after checking with their counsel on certain legal issues relating to
the apparently improper broadening of patents by re-examination. The Company has not received a
further response from Diversified Scientific.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect to the patents and patent filings described in the foregoing paragraph, those
relating to the BioMark System described above and those not subject to the CTI Collaboration
Agreement, there can be no assurance that the Company will be able to obtain licenses on terms
acceptable to the Company. In addition, there can be no assurance that the holders of such patents
or patent filings will not initiate and prevail in litigation against the Company with respect to
the patents or patent filings.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company routinely investigates patents held by third parties to determine whether there
may be any conflict with the Company Intellectual Property Rights. While such investigations are
ongoing, the Company is not currently aware of any conflict except as disclosed herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect to certain microfluidics protein crystallization technology licensed to the
Company from Caltech, a University of California scientist, Dr.&nbsp;James Berger, is a co-inventor of
this technology along with certain Caltech scientists. Therefore, the Regents of the University
of California own certain rights in the invention which the Company understands have been licensed
to Caltech. The Company has sublicensed these rights from Caltech. As the Company is a
sublicensee, if Caltech&#146;s license from the Regents were to be revoked or terminated for any reason,
the Company&#146;s ability to practice and license this technology internationally would be subject to
certain limitations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See also the discussion of the possible new collaboration agreement in Section&nbsp;2.17 below, the
Company&#146;s license agreement with Caltech in Section&nbsp;2.10(b) below and the discussion of the
Company&#146;s letter from a supplier in Section&nbsp;2.8 above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.10(b)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Section&nbsp;2.10(a) above and <U>Schedule&nbsp;2.10</U> attached hereto. In addition, in
connection with sales of the Company&#146;s products, the Company&#146;s standard terms and conditions
include limited licenses to use the Company&#146;s products, including licenses to the Company&#146;s
software. The Company also has entered into (i)&nbsp;several prototype and other evaluation agreements
and material transfer agreements with third parties, which agreements provide for the third party&#146;s
use of the Company&#146;s products for a limited period of time typically in return for grant-back
licenses to the Company of improvements, and (ii)&nbsp;material transfer agreements in which the parties
may assign to each other certain intellectual property rights. The Company has sold BioMark System
prototypes and products and is entering into agreements with respect to additional sales,
evaluations and development agreements relating to the BioMark System. The Company typically
negotiates either standstill, grant-back or other rights to certain inventions made by the Company
or third parties using the prototypes. The Company intends to continue to negotiate collaboration
or other agreements with third parties.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Exclusive Patent License Agreement dated November&nbsp;2, 2000 with the Regents listed in
<U>Schedule&nbsp;2.10</U> requires the Company to make efforts to commercialize products relating to
the technology licensed to the Company. The Regents sent the Company a notice of termination of
the agreement in part due to the alleged failure of the Company to make such efforts. The Regents
rescinded the notice of termination and the Company intended to renegotiate the agreement to modify
the requirement that the Company make efforts to commercialize the technology. The Company has
received a request from the Regents for reports and diligence relating to the agreement. The
Company and Regents agreed to terminate the agreement with no further obligations of either party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with entering into the most recent amendment to the Caltech License Agreement,
and in response to a request from Caltech, the Company terminated its license of certain patent
rights that it deemed not material to the Company&#146;s business as currently conducted in exchange for
a cash payment from Caltech and a reduction in the Company&#146;s potential obligation to issue stock to
Caltech. The Company understands that Caltech has licensed these patent rights to another entity,
Helicos Biosciences Corporation. Dr.&nbsp;Steve Quake, a former director of and former consultant to
the Company, co-founded Helicos, and Versant Ventures, a significant investor in the Company, is
also a significant investor in Helicos. The Company believes that a conflict could exist between
the license Caltech granted to Helicos and Caltech&#146;s license of patent rights to the Company, if
Caltech&#146;s license with Helicos does not specifically exclude the patent rights granted to the
Company. The patent rights licensed from Caltech to Helicos include a cross-reference to, and
disclosure relating to, the patent rights the Company licenses from Caltech. Effective April&nbsp;23,
2007, as amended May&nbsp;11, 2007, the Company executed an Intellectual Property Agreement with Caltech
and Helicos.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.10(c)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See discussions in Sections&nbsp;2.10(a) and (b)&nbsp;above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.10(d)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company utilizes certain inventions developed by Steve Quake (See discussions in Section
2.10(f) below) prior to the formation of the Company and the inventions of certain employees
developed while they were working or studying at Caltech. The Company has rights to these
inventions pursuant to its license agreements with Caltech described in <U>Schedule&nbsp;2.10</U>
attached hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See discussion in Section&nbsp;2.9 relating to William Smith. Townsend and Townsend and Crew LLP
from time to time provides legal services to Caltech and other parties with whom the Company has
business relationships.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.10(e)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See discussion in Section&nbsp;2.10(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Steve Quake and certain employees of the Company who previously worked at or studied at
Caltech have a right, pursuant to their agreements with Caltech, to receive a portion of the
royalties Caltech receives under its license agreements with the Company described in <U>Schedule
2.10</U> attached hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has license agreements with shareholders of the Company. Those license agreements
are listed on <U>Schedule&nbsp;2.10</U> attached hereto.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s employees have executed proprietary information and invention assignment
agreements in favor of the Company. The Company has executed consulting agreements with its
consultants and non-disclosure agreements with third parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From time to time university collaborators may be on the Company&#146;s premises conducting
research with the Company&#146;s chips. The Company typically does not enter into agreements relating
to these arrangements. The Company has entered into an agreement with a collaborator from Regents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.10(f)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See discussion in Sections&nbsp;2.10(a), 2.10(b) and Section&nbsp;2.10(e).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s rights with respects to the research and development efforts of Steve Quake are
limited to those rights it has obtained through its licenses with Caltech described in <U>Schedule
2.10</U> attached hereto and its consulting agreement with Steve Quake. As Dr.&nbsp;Quake has
transferred to Stanford University effective in early 2005, the Company negotiated with Caltech to
modify the Company&#146;s right to receive license rights from the Quake laboratory at Caltech. The
Company also has negotiated a Material Transfer Agreement with Stanford University to obtain, for a
limited term, license rights to certain inventions made by the Quake laboratory at Stanford
University and is in negotiations for additional such agreements. Dr.&nbsp;Quake has been appointed an
investigator by the Howard Hughes Medical Institute (&#147;<B>HHMI</B>&#148;). In connection with such appointment,
Dr.&nbsp;Quake&#146;s affiliation with the Company (including, without limitation, stock ownership and status
as a member of the Board of Directors of the Company) and the Company&#146;s rights to inventions from
the Quake laboratory at Stanford University and Caltech have been eliminated or substantially
curtailed. The Company has negotiated a new consulting agreement with Dr.&nbsp;Quake in accordance with
HHMI guidelines; such consulting agreement provides for certain guaranteed payments over a
multi-year time period. In addition, Dr.&nbsp;Quake has resigned from the Company&#146;s Board of Directors
and on June&nbsp;5, 2006 the Company has repurchased 123,974 shares of Dr.&nbsp;Quake&#146;s Common Stock holding
in the Company to comport with HHMI guidelines.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.10(h)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company notes that it has given the opportunity to the Purchasers to conduct any due
diligence investigation that such Purchasers deemed necessary and has provided each Purchaser with
all of the information that such Purchaser has requested.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.11 Compliance with Other Instruments</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See discussions in Section&nbsp;2.10(a) regarding the Syrrx License Agreement and in Section
2.10(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.12 Permits</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s subsidiary in Singapore has applied for various permits relating to the conduct
of business in Singapore, some of which may not been granted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.13 Environmental and Safety Laws</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has received the following environmental reports pertaining to property that the
Company leases.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>ENVIRONMENTAL DUE DILIGENCE REVIEW OF THE SIERRA POINT ASSOCIATES
TWO PROPERTIES BRISBANE AND SOUTH SAN FRANCISCO, CALIFORNIA, dated February&nbsp;4,
1998, prepared by ENVIRON Corporation, Emeryville, California</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>UPDATE OF ENVIRONMENTAL DUE DILIGENCE REVIEW, PARCEL 10,
SHORELINE COURT, SIERRA POINT, SOUTH SAN FRANCISCO, CALIFORNIA, dated December
14, 1998, prepared by Harding Lawson Associates, Novato, California</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>FIRST AMENDED AND RESTATED DECLARATION OF COVENANTS, CONDITIONS
AND ENVIRONMENTAL RESTRICTIONS RELATING TO ENVIRONMENTAL COMPLIANCE FOR SIERRA
POINT, dated August&nbsp;5, 1999, recorded by Luce, Forward, Hamilton and Scripps,
San Diego, California</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>SUPPLEMENTAL ENVIRONMENTAL DUE DILIGENCE, PARCEL 10, SHORELINE
COURT, SIERRA POINT, SOUTH SAN FRANCISCO, CALIFORNIA, dated August&nbsp;24, 1999,
prepared by Harding Lawson Associates, Novato, California</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the reports has been made available to the Purchasers. The Company has not
investigated any of the matters contained in the reports.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.14 Title to Property and Assets</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company and General Electric Capital Corporation (&#147;<B>GECC</B>&#148;) entered into a Master Security
Agreement (which was amended in February&nbsp;2004), pursuant to which the Company has borrowed an
aggregate principal amount of $6,230,152 (out of an aggregate available under the Master Security
Agreement of $11,000,000) from GECC pursuant to the terms of the Master Security Agreement and
series of promissory notes. The loans relate to purchases of the Company of certain equipment and
software (subject to certain restrictions). The notes bear interest at rates between 8% and 9% per
annum and are repaid in periodic monthly installments over 42&nbsp;months from the date of issuance of
each respective promissory note (except with respect to loans relating to computer equipment and
software, which must be paid over 36&nbsp;months). The Company&#146;s obligations under the notes and Master
Security Agreement are secured by a lien on fixed assets financed with the loans. In addition,
Comerica Bank has issued a letter of credit in the amount of $500,000 for the benefit of GECC as
security for the loans, which is secured by a $500,000 cash account of the Company&#146;s at Comerica
Bank. As of September&nbsp;30, 2007, the Company owed approximately $1,340,433 under the notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In March&nbsp;2005, the Company and Lighthouse entered into a Loan and Security Agreement, a
Management Rights letter agreement, a Negative Pledge Agreement and certain other agreements
(collectively, the &#147;<B>Lighthouse Agreements</B>&#148;). Pursuant to the Lighthouse Agreements, the Company
has borrowed $13,000,000 from Lighthouse, $9,601,037 of which was outstanding as of September&nbsp;30,
2007. The amounts loaned bear interest at the prime rate plus 2.5% and are to be repaid in 48
monthly installments from the execution date of March&nbsp;2005. Pursuant to the Loan and Security
Agreement, the Company granted Lighthouse a lien on and security interest in all of the Company&#146;s
assets (subject to certain limited exceptions and excluding intellectual property rights (but not
proceeds from the sale thereof) as set forth in the Lighthouse Agreements). Pursuant to the
Negative Pledge Agreement, the Company is generally prohibited from transferring or encumbering
intellectual property and certain other assets. The Lighthouse Agreements contain various
affirmative and negative covenants of the
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company. In connection with the Lighthouse Agreements, the Company issued to Lighthouse a
warrant as described in Section&nbsp;2.4 hereof. The Company&#146;s ability to pay amounts that may arise
under convertible promissory notes issued, or that may be issued, to BMSIF and Invus is limited
under the Lighthouse Agreements, and BMSIF and Invus entered into a Subordination Agreement with
Lighthouse (which limits their right to receive payment on the convertible promissory notes).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has issued letters of credit of $250,000 and $137,527 for security deposits under
the subleases for its headquarters facility in South San Francisco, California (see Section
2.15(b)). In addition, the Company has issued a letter of credit for the benefit of GECC in the
amount of $500,000. These letters of credit are secured by cash accounts of the Company in those
amounts.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.15 Agreements; Actions</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.15(a)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has been a party to consulting agreements with Lincoln McBride, the Company&#146;s
former Chief Technology Officer and vice president of engineering, and Paul Wyatt, the Company&#146;s
former vice president of Topaz development and operations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See 2.10(f) regarding Dr.&nbsp;Steve Quake&#146;s consulting agreements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered or intends to enter into indemnification agreements with each of the
Company&#146;s existing officers and directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is a party to offer letters with each of its officers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered into agreements relating to confidentiality and assignment of
inventions with employees and enters into various agreements with employees of its subsidiaries
(including, without limitation, employment agreements) customary in the jurisdiction of
incorporation of the subsidiary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company and/or a subsidiary of the Company have entered into agreements with third parties
relating to their service on the Board of Directors of subsidiaries of the Company (due to
requirements that a citizen of the place of incorporation of the subsidiary be a member of the
subsidiary&#146;s Board of Directors). Among other things, such agreements contain provisions relating
to indemnification.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered into a letter agreement with Marc Unger, an employee, regarding Mr.
Unger&#146;s ownership of shares and options to purchase shares of the Company&#146;s Common Stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with the October&nbsp;2001 Series&nbsp;C Preferred Stock financing, the Company entered
into letter agreements with GE Equity Capital Investments, Inc., containing certain confidentiality
and indemnification provisions and with Piper Jaffray Healthcare Venture Fund III, L. P. providing
for certain matters with regard to the Small Business Investment Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In January&nbsp;2004, the Company lent Gajus V. Worthington, the Company&#146;s Chief Executive Officer,
$250,000 to be used in connection with Mr.&nbsp;Worthington&#146;s purchase of a residence. The loan bears
interest at a rate of 3.52% per annum and the principal and interest are not due and payable for 7
years after the date of the loan (or earlier upon the happening of certain events). The loan is
secured by 833,334 shares of the Company&#146;s Common Stock, which are the only recourse of the Company
in the event of a default under the loan. The number of shares of Common Stock that secure the
loan is
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">subject to reduction at Mr.&nbsp;Worthington&#146;s election in the event that fair market value of the
Company&#146;s Common Stock (as determined by the Company&#146;s Board of Directors) exceeds the outstanding
principal and interest due under the loan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Sections&nbsp;2.4 and 2.15(b) below relating to agreements with BMSIF.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.15(b)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See <U>Schedule&nbsp;2.10</U> attached hereto and discussion in Section&nbsp;2.10. Each of the
agreements described or listed on <U>Schedule&nbsp;2.10</U> or in Section&nbsp;2.10 may involve payments or
obligations in excess of $100,000 and/or the license of proprietary rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Section&nbsp;2.14 regarding the GECC and Lighthouse loans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In March&nbsp;2004, the Company entered into a new sublease agreement with Genome Therapeutics
Corporation (now Oscient Pharmaceuticals) relating to a portion of the Company&#146;s headquarters in
South San Francisco, California. The term of the sublease expires in December&nbsp;2007. The monthly
rental payments were approximately $70,000 per month between March&nbsp;2004 through September&nbsp;2004.
The monthly payments thereafter decreased to approximately $44,000 per month and increased
approximately 3.5% annually beginning January&nbsp;2006. In addition to these amounts, the Company is
obligated to pay its share of common area maintenance and other costs and taxes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to the sublease agreement with Genome Therapeutics, the Company entered into a
second sublease in March&nbsp;2004 with MJ Research, Inc. (subsequently assigned to Are-San Francisco
No.&nbsp;17, LLC) relating to an additional portion of the Company&#146;s headquarters in South San
Francisco, California. The term of the sublease expires in December&nbsp;2007. The monthly rental
payments were approximately $56,000 between April&nbsp;2004 through December&nbsp;2004. The monthly payments
thereafter increased to approximately $58,000 per month and further increase annually by
approximately 3.5% beginning in April&nbsp;2005. In addition to these amounts, the Company is obligated
to pay its share of common area maintenance and other costs and taxes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered into negotiations to extend each of the above leases from January&nbsp;2008
to February&nbsp;2011.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered into leases or subleases relating to its subsidiaries in Osaka, Japan,
Tokyo, Japan, Singapore and Hamburg, Germany, the last of which has terminated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Section&nbsp;2.4, in particular with respect to the Company and BMSIF in conjunction with the
convertible notes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In certain instances, the Company has agreed to indemnify purchasers of the Company&#146;s products
and certain of the Company&#146;s suppliers (such as Eppendorf AG) with respect to infringements of
proprietary rights.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.15(e)</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A limited number of the Company&#146;s employees hold corporate purchasing credit cards. The
Company is liable to the credit card company for the amounts charged.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>2.15(f)</I></B>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has from time to time had discussions regarding mergers, acquisitions and sales of
all or substantially all of the assets of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.16 Financial Statements</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has made available unaudited Financial Statements for the periods ended December
31, 2005 and December&nbsp;31, 2006.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The unaudited Financial Statements do not contain the footnotes required by generally accepted
accounting principles and are subject to year-end audit adjustments.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.17 Changes</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes are reflected since December&nbsp;31, 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Section&nbsp;2.10 and <U>Schedule&nbsp;2.10</U> attached hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has entered into licenses of its intellectual property in the ordinary course of
business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company may enter into a collaboration agreement related to the development of certain
specialized Dynamic Array chips for a third party that may involve revenue and liabilities in
excess of $100,000, such as for indemnification.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.18 Brokers or Finders</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company entered into an engagement letter with Leerink Swann &#038; Company, dated August&nbsp;13,
2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In June&nbsp;2006, Fluidigm was the recipient of a Small Technology Transfer Innovation Research
(STTR)&nbsp;grant from the National Institutes of Health in the amount of $1,000,000 over two years.
Under the grant, the Company will perform research and development activities to design a
diffraction capable Topaz screening chip.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.19 Qualified Small Business Stock</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With respect to the qualification of the Shares as &#147;qualified small business stock&#148; under
Section 1202(c) of the Code, the Company makes the following representations, each as of the date
hereof: (a)&nbsp;the Company is a domestic C corporation, provided that the Company wholly owns non-U.S.
corporate subsidiaries; (b)&nbsp;the Company&#146;s gross assets have not exceeded $50&nbsp;million in value at
any time through the time immediately following the issuance of the Shares within the meaning of
Section&nbsp;1202(d); (c)&nbsp;the Company has not made any purchases of its own stock during the one-year
period preceding the Closing with an aggregate value exceeding 5% of the aggregate value of all its
stock as of the beginning of such period, disregarding de minimus redemptions within the meaning of
Treasury Regulation&nbsp;Section&nbsp;1.1202-2(b)(2); (d)&nbsp;the Company is engaged in a qualified trade or
business as defined in Section&nbsp;1202(e); and (e)&nbsp;80% of the Company&#146;s assets are used in the active
conduct of that qualified trade or business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.20 Employee Benefit Plans</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company offers health, vision and dental benefits, paid time off and sick leave.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s subsidiaries are subject to certain statutory requirements in their jurisdiction
of incorporation relating to employee benefits. Such requirements differ from requirements in the
United States.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.21 Tax Matters</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s subsidiaries in the Netherlands and Singapore have received extensions to file
tax returns in the respective countries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2.24 Disclosure</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company notes that it has given the opportunity to the Purchasers to conduct any due
diligence investigation that such Purchasers deemed necessary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has provided projections to certain Purchasers at their request. For purposes of
these projections, the Company has assumed, among other things, that the Company is granted tax
incentives and research and development grants in Singapore that are acceptable to the Company and
that the workforce to be employed at the Company&#146;s subsidiary in Singapore is capable of delivering
upon the Company&#146;s plans in Singapore. In addition, the Company&#146;s revenues were lower than the
Company&#146;s plan/forecasts. Moreover, actuals provided are currently under audit and subject to
revision. The Company is unable to predict with any certainty its revenue for any future period,
including the present quarter, and its ability to generate revenue is subject to risks and
uncertainties.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left"><FONT size="1">

</FONT></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">License Agreement
<br><br><br>
Amended and
Restated License
Agreement
<br><br><br>
First Amendment to
Amended and
Restated License
Agreement
<br><br><br>
Second Amended and
Restated License
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May&nbsp;1, 2000
<br><br><br>
<BR>Restatement Date of
June&nbsp;1, 2002
<br><br><br>
Effective Date of
June&nbsp;19, 2003
<br><br><br>
<BR>

<BR>

Effective Date May
1, 2004
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">California
Institute of
Technology
(Licensor) and the
Company (Licensee)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exclusive license
of intellectual
property from
Licensor to the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company to pay
Licensor royalties
ranging from [***]% to
[***]% on sales of the
Company products
incorporating the
technology or other
transfers of the
technology.<br><br>
<BR>
Also, the Company can
include, on an annual
basis, certain new
inventions made by
the Licensor by
granting additional
stock to the
Licensor.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The U.S. Government
and Licensor
retained certain
rights, including
the right to
practice the
underlying
inventions. With
respect to the
Licensor, such
rights are limited
to non-commercial
uses.<br><br>
In an invention
licensed pursuant
to this License
Agreement relating
to certain protein
crystallization
technology in
microfluidics, a
University of
California
scientist, Dr.
James Berger, was
added as an
inventor to related
patent
applications.
Therefore, the
Regents of the
University of
California own
certain rights in
the invention,
which rights have
not been licensed
to the Company,
and, therefore, the
Company&#146;s ability
to practice and
license this
technology
internationally is
subject to certain
limitations.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>
<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="16%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exclusive Patent <BR>
License Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">November&nbsp;2, 2000<br><br>
Amended on July&nbsp;12,
2001
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Regents of the
University of
California
(Licensor) and the
Company (Licensee)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exclusive license
of intellectual
property from
Licensor to the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company to pay
Licensor [***]% royalty
on sales of the
Company products
incorporating the
technology.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Licensor and
the U.S. Government
retains certain
rights, including
the right to
practice the
underlying
inventions. With
respect to the
Licensor, such
rights are limited
to non-commercial
uses.<br><br>
In addition, the
Company has agreed
to indemnify
Licensor for claims
arising out of the
agreement.<br><br>
This Agreement has
been terminated.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Co-Exclusive <BR>
License Agreements
(a series totaling
3)
&#091;reduced from 5&#093;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;15, 2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President and
Fellows of Harvard
College (Licensor)
and the Company
(Licensee)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Co-exclusive
license of
intellectual
property from
Licensor to the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company to pay
Licensor royalties
ranging from [***]% to
[***]% on sales of the
Company products
incorporating the
technology or other
transfers of the
technology.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Licensor and
the U.S. Government
retains certain
rights, including
the right to
practice the
underlying
inventions. With
respect to the
Licensor, such
rights are limited
to non-commercial
uses.<br><br>
In addition, the
Company has agreed
to indemnify
Licensor for claims
arising out of the
series of
agreements.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">License Option <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;20, 2001
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Princeton
University and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Grant of option to
Company to
negotiate a
royalty-bearing
license to certain
technologies in
exchange for paying
reasonable
associated patent
costs
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company expects
that the U.S.
Government will
retain certain
rights, including
the right to
practice the
underlying
inventions.<br><br>
The option period
has expired and the
Company has funded
certain
prosecution. The
Company did not
renew the option.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;1, 2002
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Farmal LLC and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Research Agreement&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">See Other Information
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Farmal was to
conduct research at
Caltech within the
Company&#146;s field of
exclusivity under
its license
agreement with
Caltech. The
agreement contains
a license to the
Company of
intellectual
property resulting
from certain
aspects of the
research, but the
Company is
uncertain whether
any intellectual
property was
created. Farmal is
not presently
performing under
the agreement due
to its financial
condition and the
agreement has
terminated.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>
<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Supply Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">December&nbsp;3, 2001<br><br>
Amended June&nbsp;27,
2002
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">GlaxoSmithKline and
the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
supplied equipment
and chips to GSK
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company had<BR>
received payments in<BR>
exchange for chips
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
provided certain
indemnities
(including relating
to the infringement
of proprietary
rights) to GSK
associated with the
product sales.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Development
Collaboration And <BR>
License Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">September&nbsp;22, 2003
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Glaxo Group Limited
and SmithKline
Beecham Corporation
(GSK)&nbsp;and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">A collaboration and
cross-licenses
agreement for the
development of
certain products,
which may be
commercialized by
the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">In addition to an
up-front stock grant,
the Company issued
warrants to GSK
exercisable upon
achievement of
certain milestones.
Also, the Company
agreed to pay
royalties on products
emanating from the
collaboration.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
provides certain
indemnities
(including relating
to the infringement
of proprietary
rights) to GSK
associated with
activities in
accordance with the
Agreement.<br><br>
Discussions between
the Company and GSK
have begun to
ascertain milestone
achievement and
other matters.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Supply Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">September&nbsp;22, 2003
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">GlaxoSmithKline
Research &#038;
Development Limited
(GSK)&nbsp;and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
supplied equipment
and chips to GSK&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">GSK made an up-front
payment to the
Company for future
product orders.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
provides certain
indemnities to GSK
associated with the
product sales, as
well as a [***]
clause with respect
to infringement
indemnity in an
accompanying stock
purchase agreement.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>
<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="13%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">License Agreement<br><br>
Amendment No.&nbsp;1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">January&nbsp;9, 2003<br><br><br>
January&nbsp;9, 2005
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gyros AB and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
licensed<BR>
field-specific
patent rights from
Gyros
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">In addition to annual
minimums and payments
to add licenses in
several fields, the
Company pays a [***]%
royalty on certain
products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
provides certain
indemnities to
Gyros associated
with licensed
product sales. See
the disclosure in
Section&nbsp;2.10(a) of
this Schedule of
Exceptions for a
further description
of the agreement.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Master Closing <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March&nbsp;7, 2003
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UAB Research
Foundation, Oculus
Pharmaceuticals,
Inc. and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Relates to the
License Agreement
and Sponsored
Research Agreement
with UAB Research
Foundation
described below
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company issued
shares of its stock
to the UAB Research
Foundation in
connection with the
transaction and is
obligated to make
milestone payments of
stock and cash to UAB
Research Foundation
upon the happening of
certain events.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">See Section&nbsp;3.10(a)
and 2.4 of this
Schedule of
Exceptions relating
to the Company&#146;s
agreements with UAB
Research Foundation
and Oculus.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>
<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="13%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">License Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March&nbsp;7, 2003
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UAB Research
Foundation
(Licensor) and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company is
licensing certain
patent rights from
Licensor&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">When due, the Company
will make milestone
payments to Licensor
in stock in addition
to cash and stock
payments up-front.&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Licensor, the
U.S. Government and
a third party
retain certain
rights to practice
the underling
inventions with
respect to
Licensor, such
rights are limited
to non-commercial
uses.<br><br>
In addition, the
Company has agreed
to indemnify
(including relating
to infringement of
proprietary rights)
Licensor under
certain conditions.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Sponsored Research <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March&nbsp;7, 2003
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UAB Research
Foundation (UAB)
and the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company funds<BR>
certain research at<BR>
UAB
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company makes
quarterly research
payments.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
rights to license
inventions
developed under the
funding.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>
<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="13%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Research License <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;2, 2002
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vanderbilt
University
(University) and
the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
sub-licensed the
University to
conduct research
under certain
Caltech
intellectual
property
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company received
a license to certain
intellectual property
for research purposes
and was granted a
right of first
refusal on
improvements to the
intellectual property
it licensed to the
University (including
improvements to
chips). In the event
the Company exercises
its right of first
refusal, it will have
to pay certain
royalties and license
fees against a
credit.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company will
consider proposals
from the University
to commercialize
products developed
at the University.
The agreement had a
three-year term and
the parties are
discussing an
extension.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">December&nbsp;12, 2003
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***]</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company is
testing proprietary
materials
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
the material
provider under
certain conditions
and not to file for
patent protection
encompassing the
material in certain
areas.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

 <DIV align="left" style="font-size: 10pt; margin-top: 12pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>
<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">License Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">December&nbsp;19, 2003
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Syrrx, Inc. (Syrrx)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
licensed certain
patent filings
assigned to Syrrx
and sublicensed
patent filings
assigned to the
Regents of
University of
California in a
specific field.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company granted
common stock to Syrrx
and makes annual
payments for three
years (then quarterly
thereafter), which
payments may be
reduced if the
Company&#146;s common
stock is traded on a
securities exchange
or through NASDAQ.
The Company also owes
royalties on the
license and
sublicense.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
provides certain
indemnities to
Syrrx associated
with the license
and sublicense.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Development <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;23, 2004
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">In-Q-Tel and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
provides defined
services and
deliverables in
accordance with a
statement of work;
and the parties (as
well as the U.S.
Government) agreed
to make licenses
available to
certain IP rights
on a limited basis.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company receives
payments based on
completion of the
project.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
In-Q-Tel for
certain claims
arising under the
agreement.<br><br>
Standard U.S.
Government rights
and license clauses
are included.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Development <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">September&nbsp;30, 2005
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">In-Q-Tel and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
provides defined
services and
deliverables in
accordance with a
statement of work;
and the parties (as
well as the U.S.
Government) agreed
to make licenses
available to
certain IP rights
on a limited basis.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company receives
payments based on
completion of the
project.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
In-Q-Tel for
certain claims
arising under the
agreement.<br><br>
Standard U.S.
Government rights
and license clauses
are included.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>
<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Development <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;1, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">In-Q-Tel and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
provides defined
services and
deliverables in
accordance with a
statement of work;
and the parties (as
well as the U.S.
Government) agreed
to make licenses
available to
certain IP rights
on a limited basis.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company receives
payments based on
completion of the
project.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
In-Q-Tel for
certain claims
arising under the
agreement.<br><br>
Standard U.S.
Government rights
and license clauses
are included.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Collaboration <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">January&nbsp;24, 2005
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">CTI Molecular Imaging, Inc. and
the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company
provides defined
services and
deliverables in the
PET field in
accordance with a
Work Plan under
development, as
well as a
manufacturing
option to CTI under
certain Fluidigm
IP. Also, the
parties
cross-licensed each
other on certain
past and future IP.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company received
an upfront payment,
an option payment if
exercised, and
royalties on certain
products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
CTI for certain
claims arising from
the Agreement.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Standard User
Agreement <BR>
Non-Proprietary
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Regents of the
University of
California for LBNL
and the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company is
permitted to use
certain LBNL
facilities to
conduct
experiments.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
LBNL for certain
claims arising
under the
agreement.
Standard U.S.
Government rights
and license clauses
are included.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Work for Others <BR>
Agreement<BR><BR>
<BR>

Amendment
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">January&nbsp;6, 2005<BR>
<BR>
<BR><BR>
<BR>

February&nbsp;4, 2005
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Regents of the
University of
California for LBNL
(&#147;DOE Contractor&#148;) and
the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company is a Sponsor of federal grants,
under which the Contractor is to perform
certain research in accordance with a
Statement of Work.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has agreed to indemnify the
DOE Contractor and the U.S. Government
under certain product liability,
intellectual property and general
liability provisions. Standard U.S.
Government rights and license clauses are
included.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Work for Others <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">November&nbsp;15, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Agreement has been extended to
December&nbsp;31, 2006, and another similar
Agreement extended into, as noted.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Industry-University <BR>
Cooperative Research <BR>
Program UC Discovery <BR>
Grant Research Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">February&nbsp;1, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Regents of the
University of
California (&#147;UC&#148;) and
the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UC and the Company are collaborating on
certain research specified in a joint
proposal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company makes bi-monthly
payments and provides in-kind
contributions of Company
products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has agreed to indemnify UC
under certain circumstances against
liability, loss or expense.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Evaluation Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">November&nbsp;16, 2004
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***]
Pharmaceuticals,
Inc. and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] to evaluate certain
Company products as specified
in a Work Plan.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] to make a
payment for the
evaluation period.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
[***] for
certain claims
arising under the
agreement.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">
</DIV>
<DIV align="left"><FONT size="1">

</FONT></DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
   <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer
and Evaluation
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">September&nbsp;24, 2004
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***], Inc. and
the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company to receive certain
biological materials from
[***] and use the materials
with Company products in
accordance with a research
plan. The parties agreed on
ownership rights for certain
inventions made when conducting
the research, as well as
associated assignment
requirements.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
[***] for certain
claims arising under
this agreement.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;18, 2005
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Board of Trustees
of the Leland
Stanford Junior
University and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company to provide certain
prototype microfluidic chips to
the Quake laboratory at
Stanford University for use in
specified research programs.
The parties agreed on handling
license rights to inventions
generated under the agreement.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company receives
payments for chips
provided to the Quake
lab (under separate
invoice).
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The agreement expires
August&nbsp;31, 2005.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Equipment Loan
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">January&nbsp;11, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Board of Trustees
of the Leland
Stanford Junior
University and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company loaned certain
equipment to the laboratory of
Dr.&nbsp;Steve Quake.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company shall
have no right to
inventions made with
the loaned equipment.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March&nbsp;31, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] and the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] to evaluate assay results
run by Company on certain
prototype-chips.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] to pay the Company
for certain work done
under this Agreement.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] and the Company
agreed not to file
for patent protection
using the other
party&#146;s confidential
information.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

 <DIV align="left" style="font-size: 10pt; margin-top: 6pt">
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer
and Evaluation
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March&nbsp;29, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] to provide proteins for
crystallization in certain
Company prototype chips. The
parties agreed on handling
invention ownership and license
rights arising under the
Agreement.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company and [***]
have agreed to
cross-indemnify each
other for certain
claims arising under
the Agreement.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Distribution <BR>
Agreement (and <BR>
Sublicense)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">April&nbsp;1, 2005
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Eppendorf
Deutschland and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company to distribute
thermalcyclers incorporated in
the BioMark reader.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company makes
minimum product
purchases based on
Company estimates.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company provides
certain indemnities
(including certain
product liability,
intellectual
property, and general
liability) to
Eppendorf associated
with the distribution
and sublicense.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March&nbsp;30, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company and [***] to
explore contract manufacturing
opportunities.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer
Agreement<br><br>
Microfluidic&#146;s
Customer Sample <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March&nbsp;10, 2006<br><br><BR>
<BR>

November&nbsp;8, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] and
the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company to test certain
material from [***].
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
specified
universities for
certain claims
arising under this
Agreement. The
Company assigns to
[***] certain
improvement invention
made under this
Material Transfer
Agreement. Under
the Sample Agreement,
the Company and [***] agree to not
file IP concerning
the sample material.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

 <DIV align="left" style="font-size: 10pt; margin-top: 6pt">
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Bioautomation
Development Program
Terms of Business
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">September&nbsp;23, 2005<br><br>
November&nbsp;10, 2005<br><br>
January&nbsp;24, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***]
and the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] is developing certain
Company instrumentation
products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company makes
regular payments
based on work at
[***].
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company provides
certain indemnities
to [***].</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Letter of Intent
<BR>
<BR>
Amendment No.&nbsp;1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May&nbsp;1, 2006
<BR><BR><BR>
December&nbsp;7, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company to assist [***] in
evaluating certain Company
products for possible
collaboration.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] makes regular
payments to the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to not enter
certain exclusive
agreements with third
parties during the
amended term of the
LOI.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Collaboration <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;1, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Regents of the
University of
California (UCSF)
and the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">A collaboration regarding
certain Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The University and
the Company agreed to
certain
cross-indemnification
provisions. Under
the Agreement, the
Company will be
provided an option to
license certain
developed technology.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Technology
Evaluation and
Services Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;25, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] Inc. and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] is evaluating certain
Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] and the Company
agreed to certain
cross-indemnification
provisions and
division of right to
any new intellectual
property rights
arising under the
Agreement.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

 <DIV align="left" style="font-size: 10pt; margin-top: 6pt">
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;5, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MedImmune, Inc.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MedImmune is evaluating certain
Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agreed to
indemnify, MedImmune
for certain
activities associated
with the evaluation
and the Company
agrees to assign
certain developed
technology.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer
Agreement for
Transfers to
Companies
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">November&nbsp;16, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">University of
Washington and Howard Hughes Medical Institute
and the Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The University is evaluating
certain Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agreed to
indemnify University
for certain
activities relating
to the Agreement.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Materials and
Information
Transfer Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">November&nbsp;22, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***],
Inc. and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] is evaluating certain
Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agreed to
indemnify [***] for
certain activities
relating to the
evaluation and the
parties agreed to
divide rights to any
new intellectual
property arising
under the Agreement</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">December&nbsp;7, 2006
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fred Hutchinson
Cancer Research
Center and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">FHCRC and the Company are
collaborating to evaluate
certain Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agreed to
indemnify FHCRC for
certain activities
associated with the
Collaboration and
FHCRC agrees to give
Company an option to
certain developed
technology.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March&nbsp;15, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***], Inc.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">[***] is evaluating certain
Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agreed to
indemnify, [***]
for certain
activities associated
with the evaluation
and the Company may
assign certain
developed technology.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May&nbsp;9, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Myriad Genetics
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Myriad is evaluating certain
Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agreed to
indemnify, Myriad for
certain activities
associated with the
evaluation and the
Company may assign
certain developed
technology.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May&nbsp;20, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091;***&#093;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091;***&#093; is evaluating certain
Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agreed to
indemnify, &#091;***&#093;
for certain
activities associated
with the evaluation
and the Company may
assign certain
developed technology.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;6, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091;***&#093;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091;***&#093; is evaluating certain
Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agreed to
indemnify, &#091;***&#093; for
certain activities
associated with the
evaluation and the
Company may assign
certain developed
technology.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Transfer <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">September&nbsp;3, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091;***&#093;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091;***&#093; is evaluating certain
Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agreed to
indemnify, &#091;***&#093;
for certain
activities associated
with the evaluation
and the Company may
assign certain
developed technology.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Study Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">January&nbsp;2, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merck &#038; Co., Inc.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merck is providing samples to
the Company for testing Company
products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company agrees to
assign certain
inventions to Merck
related to the
samples.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Evaluation Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">March&nbsp;12, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091;***&#093;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091;***&#093; to evaluate certain
Company products.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

 <DIV align="left" style="font-size: 10pt; margin-top: 6pt">
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SCHEDULE 2.10<BR>
FLUIDIGM CORPORATION<BR>
AGREEMENTS</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;2007

</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Agreement Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Parties</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Purpose of Agreement</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Payments</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Other Information</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exclusive <BR>
Distribution <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May&nbsp;31, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Bioke
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exclusive Distribution Agreement
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Each party
indemnifies the other
party with respect to
certain acts.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exclusive Sales <BR>
Representative
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">June&nbsp;1, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fuentes Bono
Negocios
Tecnologicos S.L.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exclusive Sales Representative
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company to pay
&#091;***&#093; commission of the
&#091;***&#093; for
each Fluidigm Product
that is sold and
shipped to a
Designated End-User
during the term of
Agreement.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Development <BR>
Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;1, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">In-Q-Tel and the
Company
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company provides defined
services and deliverables in
accordance with a statement of
work; and the parties (as well
as the U.S. Government) agreed
to make licenses available to
certain IP rights on a limited
basis.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company receives
payments based on
completion of the
project.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Company has
agreed to indemnify
In-Q-Tel for certain
claims arising under
the agreement.<br><br>
Standard U.S.
Government rights and
license clauses are
included.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Intellectual <BR>
Property Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May&nbsp;11, 2007
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Helicos
BioSciences, Inc.
and California
Institute of
Technology
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The agreement confirms and
clarifies intellectual property
rights licensed to Helicos and
the Company by Caltech.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N/A
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">See Section&nbsp;2.10(b)
of Schedule of
Exceptions.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-1-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left"><FONT size="1">

</FONT></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-5-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-6-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-7-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-8-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-9-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-10-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-11-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-12-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-13-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-14-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-15-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-16-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-17-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-18-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-19-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-20-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-21<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-22-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-23<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-24-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-25-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-26-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-27-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-28-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-29-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-30-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left"><FONT size="1">

</FONT></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-31-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-32-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-33-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-34-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-35-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-36-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-37-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-38-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-39-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-40-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-41-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-42-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-43-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-44-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-45<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-46-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-47-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-48-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-49-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left"><FONT size="1">

</FONT></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-50-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-51-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-52-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Schedule&nbsp;2.10 &#151; Patents</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Case No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Assignee/Licensor</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Client Case #</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="LEFT" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Country</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Inventor Names</B></TD>
    <TD style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Status</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;***&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->-53-<!-- /Folio -->
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT D</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FORM OF EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT</B>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt"><B></B>
</DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FLUIDIGM CORPORATION</B>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>FORM
OF</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>June&nbsp;13, 2006</B>

</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="79%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="5" align="left">SECTION 1 Restrictions on Transferability; Registration Rights</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certain Definitions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Restrictions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Restrictive Legend</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notice of Proposed Transfers</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Requested Registration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Registration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Registration on Form S-3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Expenses of Registration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Registration Procedures</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Indemnification</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.11</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Information by Holder</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.12</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reports Under Securities Exchange Act of 1934</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.13</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Transfer of Registration Rights</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.14</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Standoff Agreement</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.15</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Right to Delay Registration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.16</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination of Rights</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1.17</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Limitations on Subsequent Registration Rights</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">SECTION 2 Affirmative Covenants of the Company</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Delivery of Financial Statements</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Additional Information Rights</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Confidentiality</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Visitation Rights</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Stock Option Vesting</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Insurance</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proprietary Information Agreements</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Invention Assignments</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Key-Man Life Insurance</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Compliance with Laws</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.11</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination of Covenants</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">SECTION 3 Right of First Offer For Company Securities</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Right of First Offer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sale of Securities by Company</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Offer Amount</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Financing</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination of Right of First Offer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">SECTION 4 Right of First Offer with Respect to Founder Shares</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notice of Sales</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-i-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS<BR>(continued)</B>
</DIV>



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="79%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Purchase Right</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sale of Securities by Founder</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination and Transfer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Prohibited Transfer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">SECTION 5 Right of Co-Sale</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notice of Sales</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Participation Right</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sale of Securities by Founder</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination and Transfer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Prohibited Transfers</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">SECTION 6 Miscellaneous</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Governing Law; Jurisdiction</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.2</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Successors and Assigns</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.3</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notices, Etc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.4</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Delays or Omissions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.5</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Third Parties</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.6</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Severability</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.7</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment and Waiver</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.8</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rights of Holders</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.9</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Counterparts</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.10</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Titles and Subtitles</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.11</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment and Restatement of Prior Agreement</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.12</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Waiver of Right of First Offer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.13</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Aggregation of Stock</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.14</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jury Trial</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-ii-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the &#147;<B>Agreement</B>&#148;) is entered into
as of June&nbsp;&nbsp;&nbsp;, 2006 by and among Fluidigm Corporation, a California corporation (the &#147;<B>Company</B>&#148;),
the persons set forth on <U>EXHIBIT A</U> hereto (the &#147;<B>New Investors</B>&#148;), the persons set forth on
the Schedule of Founders attached hereto as <U>EXHIBIT B</U> (the &#147;<B>Founders</B>&#148;), and the persons set
forth on <U>EXHIBIT C</U> hereto (the &#147;<B>Prior Investors</B>&#148;). The Prior Investors and the New
Investors are referred to herein collectively as the &#147;<B>Investors</B>.&#148;
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>RECITALS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Company and the New Investors have entered into a Series&nbsp;E Preferred Stock
Purchase Agreement of even date herewith (the &#147;<B>Purchase Agreement</B>&#148;) pursuant to which the Company
shall sell, and the New Investors shall acquire, shares of the Company&#146;s Series&nbsp;E Preferred Stock;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Company has granted certain registration rights and other rights to the Founders
and the Prior Investors pursuant to that certain Seventh Amended and Restated Investor Rights
Agreement dated August&nbsp;16, 2005 (the &#147;<B>Prior Agreement</B>&#148;); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, as an inducement to the New Investors to purchase shares of the Company&#146;s Series&nbsp;E
Preferred Stock pursuant to the Purchase Agreement, the Company, the Prior Investors and the
Founders desire to amend and restate the Prior Agreement to allow the New Investors to become a
party to this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the mutual promises and covenants hereinafter set forth,
the parties agree as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SECTION 1
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><U>Restrictions on Transferability; Registration Rights</U>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 <U>Certain Definitions</U>. As used in this Agreement, the following terms shall have
the following meanings:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Affiliate</B>&#148; shall have the meaning set forth in Rule&nbsp;405 of the Securities Act;
<U>provided</U> <U>that</U> for AllianceBernstein L.P. and its permitted transferees, the
definition of &#147;Affiliate&#148; shall also include (i)&nbsp;any general partner, officer or director of such
person, (ii)&nbsp;any private equity or venture capital fund now or hereafter existing (a &#147;<B>Fund</B>&#148;) for
which such person or an Affiliate of such person is a general partner or management company, and
(iii)&nbsp;if such person is a Fund, any other Fund that is directly or indirectly controlled by or
under common control with one or more general partners of such person, or that shares the same
management company with such person or an Affiliated management company.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Commission</B>&#148; shall mean the Securities and Exchange Commission or any other federal agency at
the time administering the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Eligible Securities</B>&#148; shall mean (i)&nbsp;the Series&nbsp;A Preferred Stock issued pursuant to the
Series&nbsp;A Preferred Stock Purchase Agreement dated December&nbsp;1, 1999; (ii)&nbsp;the Series&nbsp;B Preferred
Stock issued pursuant to the Series&nbsp;B Preferred Stock Purchase Agreement dated July&nbsp;5, 2000; (iii)
the Series&nbsp;C Preferred Stock issued pursuant to the Series&nbsp;C Preferred Stock Purchase Agreement
dated October&nbsp;23, 2001; (iv)&nbsp;the Series&nbsp;C Preferred Stock issued pursuant to the Series&nbsp;C Preferred
Stock Purchase Agreement dated November&nbsp;1, 2002; (v)&nbsp;the Series&nbsp;C Preferred Stock issued pursuant
to the Series&nbsp;C Preferred Stock and Warrant Purchase Agreement dated September&nbsp;22, 2003; (vi)&nbsp;the
Series&nbsp;D Preferred Stock issued pursuant to the Series&nbsp;D Preferred Stock Purchase Agreement dated
December&nbsp;18, 2003; (vii)&nbsp;the Series&nbsp;D Preferred Stock issued pursuant to the Series&nbsp;D Preferred
Stock Purchase Agreement dated August&nbsp;16, 2005; (viii)&nbsp;the Series&nbsp;D Preferred Stock issued upon
conversion of convertible promissory note(s) issued pursuant to the Convertible Promissory Note
Purchase Agreement (the &#147;<B>CNPA</B>&#148;) dated December&nbsp;18, 2003, as amended by Amendment No.&nbsp;1 to
Convertible Note Purchase Agreement dated December&nbsp;17, 2004, between the Company and Biomedical
Sciences Investment Fund Pte Ltd (the &#147;<B>BMSIF</B>&#148;); (ix)&nbsp;the Series&nbsp;D Preferred Stock issued upon
conversion of convertible promissory note(s) issued in connection with the Convertible Note
Agreement (the &#147;<B>CNA</B>&#148;) dated December&nbsp;18, 2003, between the Company and Invus, L.P. (the &#147;<B>Invus</B>&#148;);
(x)&nbsp;the Series&nbsp;E Preferred Stock issued pursuant to the Purchase Agreement; (xi)&nbsp;all Securities
acquired by any Investor pursuant to the rights of first offer described in Sections&nbsp;3 or 4 of this
Agreement; and (xii)&nbsp;any Securities issued with respect to the foregoing upon any stock split,
stock dividend, recapitalization, or similar event or upon any exercise or conversion, as
applicable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Exchange Act</B>&#148; shall mean the Securities Exchange Act of 1934, as amended, or any similar
federal statute, and the rules and regulations of the Commission thereunder, all as the same shall
be in effect at the time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Founders Shares</B>&#148; shall mean the shares of Common Stock of the Company issued to the Founders
as of the date of this Agreement or at any time in the future.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Holder</B>&#148; shall mean (i)&nbsp;any Investor and any person to whom registration rights under this
Agreement have been transferred in accordance with Section&nbsp;1.13 hereof, (ii)&nbsp;for the purposes of
Section&nbsp;1.6 (and other portions of this Section&nbsp;1, to the extent they relate to rights of
registration under Section&nbsp;1.6), any Founder or holder of Other Shares and (iii)&nbsp;for the purposes
of Sections&nbsp;1.5, 1.6 and 1.7 (and other portions of this Section&nbsp;1, to the extent they relate to
rights of registration under Sections&nbsp;1.5, 1.6 and 1.7), Warrantholders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Initial Public Offering</B>&#148; shall mean the first sale of Securities of the Company pursuant to
an effective registration statement under the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Initiating Holders</B>&#148; shall mean Holders who in the aggregate hold a majority of the
Registrable Securities then held by Holders assuming conversion or exercise, as applicable, of all
Eligible Securities.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Lighthouse Preferred Warrant</B>&#148; shall mean the Preferred Stock Purchase Warrant dated March&nbsp;29,
2005, pursuant to which Lighthouse Capital Partners V, L.P. (&#147;<B>Lighthouse</B>&#148;) may purchase shares of
the Company&#146;s authorized Series&nbsp;D Preferred Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Other Shares</B>&#148; shall mean the shares of Common Stock of the Company issued pursuant to the
Common Stock Purchase Agreements dated July&nbsp;17, 2001 and February&nbsp;2005 by and between the Company
and President and Fellows of Harvard College.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Permitted Transferee</B>&#148; shall mean (i)&nbsp;any general partner or retired general partner of any
Holder which is a partnership; (ii)&nbsp;any family member of a Holder or trust for the benefit of any
individual Holder; (iii)&nbsp;any Investor; (iv)&nbsp;an Affiliate of an Investor; or (v)&nbsp;any transferee who
acquires at least 40,000 shares of Eligible Securities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The terms &#147;<B>register</B>,&#148; &#147;<B>registered</B>&#148; and &#147;<B>registration</B>&#148; refer to a registration effected by
preparing and filing a registration statement in compliance with the Securities Act, and the
declaration or ordering of the effectiveness of such registration statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Registration Expenses</B>&#148; shall mean all expenses incurred by the Company in complying with
Sections&nbsp;1.5, 1.6 and 1.7 hereof, including, without limitation, all registration, qualification,
stock exchange and filing fees, printing expenses, escrow fees, fees and disbursements of counsel
for the Company and accountants and other persons retained by or for the Company (including the
fees of one counsel for the Holders, not to exceed $25,000), blue sky fees and expenses, accounting
fees and the expense of any special audits incident to or required by any such registration (but
excluding the compensation of regular employees of the Company which shall be paid in any event by
the Company).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Registrable Securities</B>&#148; means (i)&nbsp;any shares of Common Stock which are Eligible Securities,
(ii)&nbsp;any shares of Common Stock issuable upon the exercise or conversion, as applicable, of
Eligible Securities, (iii)&nbsp;for the purposes of Section&nbsp;1.6 (and other portions of this Section&nbsp;1,
to the extent they relate to rights of registration under Section&nbsp;1.6) any shares of Common Stock
which are Founder Shares or Other Shares, and (iv)&nbsp;for the purposes of Sections&nbsp;1.5, 1.6 and 1.7
(and other portions of this Section&nbsp;1, to the extent they relate to rights of registration under
Sections&nbsp;1.5, 1.6 and 1.7) any shares of Common Stock which are Warrant Shares; <U>provided</U>,
<U>however</U>, that shares of Common Stock shall be treated as Registrable Securities only if and
so long as they have not been (A)&nbsp;sold to or through a broker or dealer or underwriter in a public
distribution or a public securities transaction, (B)&nbsp;sold in a transaction exempt from the
registration and prospectus delivery requirements of the Securities Act under Section&nbsp;4(1) thereof
so that all transfer restrictions and restrictive legends with respect thereto are removed upon the
consummation of such sale or (C)&nbsp;sold in a transaction in which the rights granted under this
Section&nbsp;1 are not assigned in accordance with this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Restricted Securities</B>&#148; shall mean the securities of the Company required to bear the legends
set forth in Section&nbsp;1.3 hereof.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Securities</B>&#148; shall mean shares of, or securities convertible into or exercisable for any
shares of, any class of capital stock of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Securities Act</B>&#148; shall mean the Securities Act of 1933, as amended, or any similar federal
statute and the rules and regulations of the Commission thereunder, all as the same shall be in
effect at the time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Selling Expenses</B>&#148; shall mean all underwriting discounts and selling commissions and
applicable to the securities registered by the Holders and any fees and disbursements of counsel
for the Holders not included in the definition of Registration Expenses.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Voting Agreement</B>&#148; shall mean the Second Amended and Restated Voting Agreement dated August
16, 2005 among the Company and certain stockholders of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Warrant Shares</B>&#148; shall mean the shares of Common Stock of the Company issued or issuable upon
conversion of the (i)&nbsp;Series&nbsp;C Preferred Stock issued or issuable upon exercise or conversion of
(A)&nbsp;the warrant to purchase up to 17,500 shares of Series&nbsp;C Preferred Stock issued to TBCC Funding
Trust II (&#147;<B>TBCC</B>&#148;) pursuant to the Master Loan and Security Agreement dated March&nbsp;27, 2002 by and
between the Company and Transamerica Technology Finance Corporation; (B)&nbsp;the warrant to purchase
up to 31,008 shares of Series&nbsp;C Preferred Stock issued to General Electric Capital Corporation (&#147;<B>GE
Capital</B>&#148;) in connection with the Master Security Agreement dated as of November&nbsp;8, 2002, as amended
(the &#147;<B>Master Security Agreement</B>&#148;) by and between the Company and GE Capital; (C)&nbsp;the warrants to
purchase an aggregate of up to 90,000 shares of Series&nbsp;C Preferred Stock issued to Glaxo Group
Limited (&#147;<B>GGL</B>&#148;) in connection with the Development Collaboration and License Agreement dated
September&nbsp;22, 2003 (the &#147;<B>License Agreement</B>&#148;); and (D)&nbsp;the warrants to purchase an aggregate of up
to 110,000 shares of Series&nbsp;C Preferred Stock issued to SmithKline Beecham Corporation (&#147;<B>SBC</B>&#148;) in
connection with the License Agreement; and (ii)&nbsp;the Series&nbsp;D Preferred Stock issued or issuable
upon exercise or conversion of (A)&nbsp;the warrant to purchase up to 37,500 shares of Series&nbsp;D
Preferred Stock dated March&nbsp;18, 2004 and issued to GE Capital in connection with extensions of
credit to the Company; (B)&nbsp;the warrant to purchase up to 380,556 shares of Series&nbsp;D Preferred Stock
dated June&nbsp;30, 2004 and issued to In-Q-Tel, Inc. (&#147;<B>In-Q-Tel</B>&#148;); (C)&nbsp;the Lighthouse Preferred
Warrant; and (D)&nbsp;the warrant to purchase up to 126,851 shares of Series&nbsp;D Preferred Stock dated
June&nbsp;30, 2004 and issued to In-Q-Tel Employee Fund, LLC (&#147;<B>Employee Fund</B>&#148;) . GGL, SBC, TBCC, GE
Capital, In-Q-Tel, Employee Fund, and Lighthouse are collectively referred to herein as
&#147;<B>Warrantholders</B>.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Worthington Shares</B>&#148; shall mean the Founder Shares issued to Gajus Worthington.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2 <U>Restrictions</U>. No Restricted Securities shall be sold, assigned, transferred or
pledged except upon the conditions specified in this Agreement. Each Holder will cause any
proposed purchaser, assignee, transferee or pledgee of its Restricted Securities to agree in
writing to
take and hold such securities subject to the provisions and upon the conditions specified in
this Agreement, including, without limitation, Section&nbsp;1.14, except where such Restricted
Securities would cease to be Restricted Securities in connection with such proposed purchase,
assignment, transfer or pledge.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.3 <U>Restrictive Legend</U>. Each certificate representing Registrable Securities shall
(unless otherwise permitted by the provisions of Section&nbsp;1.4 below) be stamped or otherwise
imprinted with a legend in the following form (in addition to any legend required under applicable
state securities laws):
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&#147;THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&#147;SECURITIES ACT&#148;). SUCH SHARES MAY NOT BE SOLD, TRANSFERRED OR PLEDGED IN THE
ABSENCE OF SUCH REGISTRATION OR UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL
(WHICH MAY BE COUNSEL FOR THE COMPANY), OR OTHER EVIDENCE, REASONABLY ACCEPTABLE TO
IT STATING THAT SUCH SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS
DELIVERY REQUIREMENTS OF THE SECURITIES ACT.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&#147;THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE
WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE SHAREHOLDER, A COPY OF
WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&#147;THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A MARKET STAND-OFF
AGREEMENT IN THE EVENT OF A PUBLIC OFFERING, A COPY OF WHICH IS ON FILE WITH THE
SECRETARY OF THE COMPANY.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Holder consents to the Company making a notation on its records and giving instructions
to any transfer agent of the Restricted Securities in order to implement the restrictions on
transfer established in this Section&nbsp;1.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.4 <U>Notice of Proposed Transfers</U>. Each Holder of each certificate representing
Restricted Securities, by acceptance thereof, agrees to comply in all respects with the
restrictions on transfer contained in Sections&nbsp;1.2, 1.3, 1.4 and 1.14 of this Agreement. Solely
for purposes of the foregoing sentence and for the sake of clarification, the term &#147;Holder&#148; shall
also include and the term &#147;Restricted Securities&#148; shall also apply to any Founder, holder of Other
Shares or Warrantholders. Prior to any proposed sale, assignment, transfer or pledge of any
Restricted Securities (other than any transfer not involving a change in beneficial ownership),
unless there is in effect a registration statement under the Securities Act covering the proposed
transfer, the Holder thereof shall give written notice to the Company of such Holder&#146;s intention to
effect such transfer, sale, assignment or
pledge. Each such notice shall describe the manner and circumstances of the proposed
transfer, sale, assignment or pledge in sufficient detail, and shall be accompanied at such
Holder&#146;s expense by either (i)&nbsp;a written opinion of legal counsel who shall, and whose legal
opinion shall be, reasonably satisfactory to the Company, addressed to the Company, to the effect
that the proposed transfer of the Restricted Securities may be effected without registration under
the Securities Act and applicable state securities laws, or (ii)&nbsp;a &#147;no action&#148; letter from the
Commission
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-5-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to the effect that the transfer of such securities without registration will not result
in a recommendation by the staff of the Commission that action be taken with respect thereto, or
(iii)&nbsp;any other evidence reasonably satisfactory to counsel to the Company, whereupon the Holder of
such Restricted Securities shall be entitled to transfer such Restricted Securities in accordance
with the terms of the notice delivered by the Holder to the Company; <U>provided</U>,
<U>however</U>, that no such legal opinion, &#147;no action&#148; letter or other evidence shall be required
with respect to a transfer to an Affiliate. Each certificate evidencing the Restricted Securities
transferred as above provided shall bear, except if such transfer is made pursuant to Rule&nbsp;144, the
appropriate restrictive legend set forth in Section&nbsp;1.3 above, except that such certificate shall
not bear such restrictive legend if, in the opinion of counsel for such Holder and reasonably
acceptable to the Company, such legend is not required in order to establish compliance with any
provisions of the Securities Act or this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.5 <U>Requested Registration</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Request for Registration</U>. In case the Company shall receive from Initiating
Holders a written request that the Company effect any registration with respect to a public
offering of at least 50% of the Registrable Securities, the reasonably anticipated aggregate price
to the public of which, net of underwriting discounts and commissions, would exceed $20,000,000,
the Company will:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;promptly give written notice of the proposed registration to all other Holders; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;use its best efforts to effect as soon as practicable such registration (including,
without limitation, the execution of an undertaking to file post-effective amendments, appropriate
qualification under applicable blue sky or other state securities laws and appropriate compliance
with applicable regulations issued under the Securities Act and any other governmental requirements
or regulations) as may be so requested and as would permit or facilitate the sale and distribution
of all or such portion of such Registrable Securities as are specified in such request, together
with all or such portion of the Registrable Securities of any Holder or Holders joining in such
request as are specified in a written request received by the Company within 15&nbsp;days after receipt
of the written notice from the Company; <U>provided</U>, <U>however</U>, that the Company shall
not be obligated to take any action to effect any such registration pursuant to this Section&nbsp;1.5:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;Prior to six months following the closing of the Company&#146;s Initial Public Offering;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;During the period starting with the date 60&nbsp;days prior to the Company&#146;s estimated date of
filing of, and ending on the date three months immediately following the effective date of, any
registration statement (other than a registration of Securities in a Rule&nbsp;145 transaction or with
respect to an employee benefit plan) pertaining to Securities of the Company (subject to Section
1.6(a) hereof), provided that the Company is actively employing in good faith all reasonable
efforts to cause such registration statement to be filed and become effective and that the Company
provides the Initiating Holders written notice of its intent to file such
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-6-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">registration statement
within 30&nbsp;days of receiving the request for registration from the Initiating Holders and provided
further, however, that the Company may not utilize this right more than once in any 12-month
period.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;After the Company has effected two registrations pursuant to this Section&nbsp;1.5; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)&nbsp;If the Company shall furnish to such Holders a certificate, signed by the President of the
Company, stating that in the good faith judgment of the Board of Directors it would be seriously
detrimental to the Company or its shareholders for a registration statement to be filed in the near
future, in which case the Company&#146;s obligation to use its best efforts to register under this
Section&nbsp;1.5 shall be deferred for a period not to exceed 90&nbsp;days from the date of receipt of
written request from the Initiating Holders; provided, however, that the Company may not utilize
this right more than once in any 12-month period.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Underwriting</U>. If the Initiating Holders intend to distribute the Registrable
Securities covered by their request by means of an underwriting, they shall so advise the Company
as part of their request made under Section&nbsp;1.5(a), and the Company shall so advise the Holders as
part of the notice given pursuant to Section&nbsp;1.5(a)(i). The right of any Holder to registration
pursuant to Section&nbsp;1.5 shall be conditioned upon such Holder&#146;s participation in the underwriting
arrangements required by this Section&nbsp;1.5 and the inclusion of such Holder&#146;s Registrable Securities
in the underwriting, to the extent requested and provided herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall (together with all Holders proposing to distribute their securities through
such underwriting) enter into an underwriting agreement in customary form with the managing
underwriter selected for such underwriting by the Company and a majority of the Holders.
Notwithstanding any other provision of this Section&nbsp;1.5, if the managing underwriter advises the
Company in writing that marketing factors require a limitation of the number of shares to be
underwritten, then the Company shall so advise all Holders of Registrable Securities who indicated
their intent to participate in the registration in a timely manner, and the number of shares of
Registrable Securities that may be included in the registration and underwriting shall be allocated
among such Holders in proportion, as nearly as practicable, to the respective number of Registrable
Securities held by such Holders at the time of filing the registration statement, <U>provided</U>,
<U>however</U>, that the number of shares of Registrable Securities to be included in such
underwriting shall not be reduced unless all Worthington Shares, all Other Shares and all other
Securities that are not Registrable Securities (other than Securities to be sold for the account of
the Company) are first
entirely excluded from the underwriting. No Registrable Securities excluded from the
underwriting by reason of the underwriter&#146;s marketing limitation shall be included in such
registration. To facilitate the allocation of shares in accordance with the above provisions, the
Company or the underwriters may round the number of shares allocated to any Holder to the nearest
100 shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any Holder of Registrable Securities disapproves of the terms of the underwriting, such
person may elect to withdraw therefrom by written notice to the Company, the managing underwriter
and the Initiating Holders. The Registrable Securities so withdrawn shall also be withdrawn from
registration.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-7-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.6 <U>Company Registration</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Notice of Registration</U>. If at any time or from time to time, the Company shall
determine to register any Common Stock, either for its own account or the account of a security
holder or holders other than (i)&nbsp;a registration relating to employee benefit plans, (ii)&nbsp;a
registration relating to the offer and sale of debt securities, (iii)&nbsp;a registration relating to a
Commission Rule&nbsp;145 transaction, or (iv)&nbsp;a registration pursuant to Sections&nbsp;1.5 or 1.7 hereof, the
Company will:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;promptly give to each Holder written notice thereof; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;include in such registration (and any related qualification under blue sky laws or other
compliance), and in any underwriting involved therein, all the Registrable Securities specified in
a written request or requests made within 15&nbsp;days after receipt of such written notice from the
Company by any Holder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Underwriting</U>. If the registration of which the Company gives notice is for a
registered public offering involving an underwriting, the Company shall so advise the Holders in a
written notice given pursuant to this Section&nbsp;1.6. In such event, the right of any Holder to
registration pursuant to this Section&nbsp;1.6 shall be conditioned upon such Holder&#146;s participation in
such underwriting and the inclusion of Registrable Securities in the underwriting to the extent
provided herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All Holders proposing to distribute their securities through such underwriting shall (together
with the Company and the other holders distributing their securities through such underwriting)
enter into an underwriting agreement in customary form with the managing underwriter selected for
such underwriting by the Company. Notwithstanding any other provision of this Section&nbsp;1.6, if the
managing underwriter advises the Company in writing that marketing factors require a limitation of
the number of shares to be underwritten, then the Company shall so advise all Holders of
Registrable Securities and the number of shares of Registrable Securities that may be included in
the registration and underwriting shall be allocated among all Holders thereof in proportion, as
nearly as practicable, to the respective number of Registrable Securities held by such Holders at
the time of filing the registration statement; <U>provided</U>, <U>however</U>, that, no
Registrable Securities shall be excluded until all Worthington Shares, all Other Shares and all
other Securities that are not Registrable Securities
(other than Securities to be sold for the account of the Company) are first excluded, and
<U>provided</U> <U>further</U>, that, except in the case of the Company&#146;s Initial Public Offering
(where Registrable Securities may be excluded entirely), the number of Registrable Securities
included in such underwriting shall not be reduced below 25% of the total number of shares in the
underwriting. No Registrable Securities excluded from the underwriting by reason of the
underwriter&#146;s marketing limitation shall be included in such registration. To facilitate the
allocation of shares in accordance with the above provisions, the Company or the underwriters may
round the number of shares allocated to any Holder to the nearest 100 shares. The Company may
include shares of Common Stock held by shareholders other than Holders in a registration statement
pursuant to this Section&nbsp;1.6 to the extent that the amount of Registrable Securities otherwise
includible in such registration statement would not thereby be diminished.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-8-<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any Holder or other holder disapproves of the terms of any such underwriting, he or she may
elect to withdraw therefrom by written notice to the Company and the managing underwriter. The
Registrable Securities so withdrawn shall also be withdrawn from such registration and, in the case
of the Company&#146;s Initial Public Offering, shall be subject to Section&nbsp;1.14.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Right to Terminate Registration</U>. The Company shall have the right to terminate or
withdraw any registration initiated by it under this Section&nbsp;1.6 prior to the effectiveness of such
registration, whether or not any Holder has elected to include securities in such registration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.7 <U>Registration on Form&nbsp;S-3</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;If any Holder or Holders request that the Company file a registration statement on Form
S-3 (or any successor form to Form S-3) for a public offering of Registrable Securities, the
reasonably anticipated aggregate price to the public of which, net of underwriting discounts and
commissions, would exceed $2,000,000, and the Company is then entitled to use Form S-3 under
applicable Commission rules to register the Registrable Securities for such an offering, the
Company will:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;promptly give written notice of the proposed registration to all other Holders; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;use its best efforts to effect as soon as practicable such registration (including,
without limitation, the execution of an undertaking to file post-effective amendments, appropriate
qualification under applicable blue sky or other state securities laws and appropriate compliance
with applicable regulations issued under the Securities Act and any other governmental requirements
or regulations) as may be so requested and as would permit or facilitate the sale and distribution
of all or such portion of such Registrable Securities as are specified in such request, together
with all or such portion of the Registrable Securities of any Holder or Holders joining in such
request as are specified in a written request received by the Company within 15&nbsp;days after receipt
of the written notice from the Company; <U>provided</U>, <U>however</U>, that the Company shall
not be obligated to take any action to effect any such registration pursuant to this Section&nbsp;1.7:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;if the Company, within ten (10)&nbsp;days of the receipt of the request for registration
pursuant to this Section&nbsp;1.7, gives notice of its bona fide intention to effect the filing of a
registration statement with the Commission within ninety (90)&nbsp;days of receipt of such request
(other than with respect to a registration statement relating to a Rule&nbsp;145 transaction or an
employee benefit plan or any other registration which is not appropriate for the registration of
Registrable Securities);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;during the period starting with the date sixty (60)&nbsp;days prior to the Company&#146;s estimated
date of filing of, and ending on the date three months immediately following, the effective date of
any registration statement pertaining to Securities of the Company (other than with respect to a
registration statement relating to a Rule&nbsp;145 transaction or an employee benefit plan), provided
that the Company is actively employing in good faith all reasonable efforts to cause such
registration statement to be filed and become effective; or
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-9-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;if the Company shall furnish to such Holder or Holders a certificate signed by the
President of the Company stating that in the good faith judgment of the Board of Directors it would
be seriously detrimental to the Company or its shareholders for registration statements to be filed
in the near future, then the Company&#146;s obligation to use its best efforts to file a registration
statement shall be deferred for a period not to exceed 90&nbsp;days from the receipt of the request to
file such registration by such Holder or Holders; <U>provided</U> <U>further</U>, however, that
the Company may not utilize the rights provided for in subsections (1)&nbsp;and (2)&nbsp;above and this
subsection (3)&nbsp;more than once in total in any twelve month period. For the avoidance of doubt, if
the Company utilizes any of the rights provided for in subsections (1), (2)&nbsp;and (3), it shall not
have the right to utilize the same right again; nor shall it have the right to utilize any of the
other rights provided in subsections (1), (2)&nbsp;and (3)&nbsp;for twelve months.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Underwriting</U>. If the Holders requesting registration intend to distribute the
Registrable Securities covered by their request by means of an underwriting, they shall so advise
the Company as part of their request made under Section&nbsp;1.7(a), and the Company shall so advise the
Holders as part of the notice given pursuant to Section&nbsp;1.7(a)(i). The substantive provisions of
Section&nbsp;1.5(b) shall otherwise apply to such registration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.8 <U>Expenses of Registration</U>. All Registration Expenses incurred in connection with
any registration pursuant to Sections&nbsp;1.5, 1.6 and 1.7 shall be borne by the Company. If a
registration proceeding is begun upon the request of Holders pursuant to Section&nbsp;1.5 or 1.7, but
such request is subsequently withdrawn at the request of the Holders, then the Holders of
Registrable Securities to have been registered may either: (i)&nbsp;bear all Registration Expenses of
such proceeding, pro rata on the basis of the number of shares to have been registered, in which
case the Company shall be deemed not to have effected a registration pursuant to Section&nbsp;1.5(a) or
1.7(a) of this Agreement as applicable; <U>provided</U>, <U>however</U>, that the Company, and
not the Holders, shall be required to pay for the Registration Expenses if the Holders learn of a
materially adverse change in the condition, business, or prospects of the Company from that known
to the Holders at the time of their request and have withdrawn the request promptly following
discovery of such material adverse
change; or (ii)&nbsp;if the registration is being effected pursuant to Section&nbsp;1.5, require the
Company to bear all Registration Expenses of such proceeding, in which case the Company shall be
deemed to have effected a registration pursuant to Section&nbsp;1.5(a). Unless otherwise stated, all
other Selling Expenses relating to securities registered on behalf of the Holders shall be borne by
the Holders of the registered securities included in such registration pro rata on the basis of the
number of shares so registered, <U>provided</U> <U>that</U> to the extent a Holder elects to
retain its own counsel (an &#147;<B>Additional Counsel</B>&#148;) separate from the counsel for all the Holders
permitted pursuant to the definition of &#147;Registration Expenses&#148; under Section&nbsp;1.1, then such Holder
shall exclusively bear the costs of such Additional Counsel.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.9 <U>Registration Procedures</U>. In the case of each registration, qualification or
compliance effected by the Company pursuant to this Section&nbsp;1, the Company will keep each Holder
advised in writing as to the initiation of each registration, qualification and compliance and as
to the completion thereof. At its expense the Company will, as expeditiously as reasonably
possible:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-10-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Prepare and file with the Commission a registration statement with respect to such
Registrable Securities and use its best efforts to cause such registration statement to become
effective, and, upon the request of the Holders of a majority of the Registrable Securities
registered thereunder, keep such registration statement effective for a period of up to one hundred
twenty (120)&nbsp;days or until the distribution described in the registration statement has been
completed; <U>provided</U>, <U>however</U>, that such 120-day period shall be extended for a
period of time equal to the period the Holder refrains from selling any securities included in such
registration at the request of an underwriter of Common Stock (or other securities) of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Prepare and file with the Commission, in consultation with the Holders, such amendments
and supplements to such registration statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the provisions of the Securities Act with
respect to the disposition of all securities covered by such registration statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Furnish to the Holders participating in such registration and to the underwriters of the
securities being registered such reasonable number of copies of the registration statement,
preliminary prospectus, final prospectus and such other documents as such underwriters may
reasonably request in order to facilitate the public offering of such securities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Use its best efforts to register and qualify the securities covered by such registration
statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably
requested by the Holders; provided that the Company shall not be required in connection therewith
or as a condition thereto to qualify to do business or to file a general consent to service of
process in any such states or jurisdictions, unless the Company is already subject to service in
such jurisdiction and except as may be required by the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;In the event of any underwritten public offering, enter into and perform its obligations
under an underwriting agreement, in usual and customary form, with the managing
underwriter of such offering. Each Holder participating in such underwriting shall also enter
into and perform its obligations under such an agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Notify each Holder of Registrable Securities covered by such registration statement at any
time when a prospectus relating thereto is required to be delivered under the Securities Act of the
happening of any event as a result of which the prospectus included in such registration statement,
as then in effect, includes an untrue statement of a material fact or omits to state a material
fact required to be stated therein or necessary to make the statements therein not misleading or
incomplete in light of the circumstances then existing, and at the request of any such Holder,
prepare and furnish to such Holder a reasonable number of copies of a supplement to or an amendment
of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such
shares, such prospectus shall not include an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not
misleading or incomplete in the light of the circumstances then existing.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-11-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Cause all such Registrable Securities registered pursuant hereunder to be listed on each
securities exchange, or quoted in a U.S. automated inter-dealer quotation system, as the case may
be, on which similar securities issued by the Company are then listed or quoted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Provide a transfer agent and registrar for all Registrable Securities registered pursuant
hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the
effective date of such registration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;In the event of any underwritten public offering, cooperate with the selling Holders, the
underwriters participating in the offering and their counsel in any due diligence investigation
reasonably requested by the selling Holders or the underwriters in connection therewith, and
participate, to the extent reasonably requested by the managing underwriter for the offering or the
selling Holder, in efforts to sell the Registrable Securities under the offering (including,
without limitation, participating in &#147;roadshow&#148; meetings with prospective investors) that would be
customary for underwritten primary offerings of a comparable amount of equity securities by the
Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.10 <U>Indemnification</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company will indemnify and defend each Holder, each of its officers and directors and
partners, and each person controlling such Holder within the meaning of Section&nbsp;15 of the
Securities Act, with respect to which registration, qualification or compliance is being effected
pursuant to this Section&nbsp;1, and each underwriter, if any, and each person who controls any
underwriter within the meaning of Section&nbsp;15 of the Securities Act, against all expenses, claims,
losses, damages or liabilities (or actions in respect thereof), including any of the foregoing
incurred in settlement of any litigation, commenced or threatened, arising out of or based on any
untrue statement (or alleged untrue statement) of a material fact contained in any registration
statement, prospectus, preliminary prospectus, offering circular or other document, or any
amendment or supplement thereto, incident to any such registration, qualification or compliance, or
based on any
omission (or alleged omission) to state therein a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances in which they were made,
not misleading, or any violation or any alleged violation by the Company of the Securities Act or
the Exchange Act or any state securities law, or any rule or regulation promulgated thereunder,
applicable to the Company in connection with any such registration, qualification or compliance,
and the Company will reimburse each such Holder, each of its officers and directors, and each
person controlling such Holder, each such underwriter and each person who controls any such
underwriter, for any legal and any other expenses reasonably incurred in connection with
investigating, preparing or defending any such claim, loss, damage, liability or action, as such
expenses are incurred, provided that the Company will not be liable in any such case to the extent
that any such claim, loss, damage, liability or expense arises out of or is based on any untrue
statement or omission or alleged untrue statement or omission, made in reliance upon and in
conformity with written information furnished to the Company by an instrument duly executed by such
Holder, controlling person or underwriter and stated to be specifically for use therein.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-12-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each Holder will, if Registrable Securities held by such Holder are included in the
securities as to which such registration, qualification or compliance is being effected, indemnify
the Company, each of its directors and officers, each underwriter, if any, of the Company&#146;s
securities covered by such a registration statement, each person who controls the Company or such
underwriter within the meaning of Section&nbsp;15 of the Securities Act, and each other such Holder,
each of its officers and directors and each person controlling such Holder within the meaning of
Section&nbsp;15 of the Securities Act, against all claims, losses, damages and liabilities (or actions
in respect thereof) arising out of or based on any untrue statement (or alleged untrue statement)
of a material fact contained in any such registration statement, prospectus, offering circular or
other document, or any omission (or alleged omission) to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading, and will reimburse
the Company, such Holders, such directors, officers, persons, underwriters or control persons for
any legal or any other expenses reasonably incurred in connection with investigating or defending
any such claim, loss, damage, liability or action, as such expenses are incurred, in each case to
the extent, but only if and to the extent, that such untrue statement (or alleged untrue statement)
or omission (or alleged omission) is made in such registration statement, prospectus, offering
circular or other document in reliance upon and in conformity with written information furnished to
the Company by an instrument duly executed by such Holder and stated to be specifically for use
therein; <U>provided</U>, <U>however</U>, that the liability of any Holder shall be limited to
the net proceeds received by such Holder from the sale of Securities pursuant to such registration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each party entitled to indemnification under this Section&nbsp;1.10 (the &#147;<B>Indemnified Party</B>&#148;)
shall give notice to the party required to provide indemnification (the &#147;<B>Indemnifying Party</B>&#148;)
promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may
be sought, and shall permit the Indemnifying Party to assume the defense of any such claim or any
litigation resulting therefrom, provided that counsel for the Indemnifying Party, who shall conduct
the defense of such claim or litigation, shall be approved by the Indemnified Party (whose approval
shall not unreasonably be withheld), and the Indemnified Party
may participate in such defense at such party&#146;s expense; <U>provided</U>, <U>however</U>,
that an Indemnified Party (together with all other Indemnified Parties which may be represented
without conflict by one counsel) shall have the right to retain one separate counsel, with the fees
and expenses to be paid by the Indemnifying Party, if representation of such Indemnified Party by
the counsel retained by the Indemnifying Party would be inappropriate due to actual or potential
differing interests between such Indemnified Party and any other party represented by such counsel
in such proceeding. The failure of any Indemnified Party to give notice as provided herein shall
not relieve the Indemnifying Party of its obligations under this Section&nbsp;1 unless, and only to the
extent that, the failure to give such notice is materially prejudicial to an Indemnifying Party&#146;s
ability to defend such action. No Indemnifying Party, in the defense of any such claim or
litigation, shall, except with the consent of each Indemnified Party, consent to entry of any
judgment or enter into any settlement which does not include as an unconditional term thereof the
giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in
respect to such claim or litigation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;If the indemnification provided for in this Section&nbsp;1.10 is held by a court of competent
jurisdiction to be unavailable to an Indemnified Party with respect to any loss,
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-13-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">liability, claim,
damage, or expense referred to therein, then the Indemnifying Party, in lieu of indemnifying such
Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified
Party as a result of such loss, liability, claim, damage, or expense in such proportion as is
appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the
Indemnified Party on the other in connection with the statements or omissions that resulted in such
loss, liability, claim, damage, or expense as well as any other relevant equitable considerations
(except to the extent that contribution is not permitted under Section 11(f) of the Securities
Act); <U>provided</U>, <U>however</U>, that, no Holder will be required to pay any amount under
this subsection 1.10(d) in excess of the net proceeds from the sale of all Registrable Securities
offered and sold by such Holder pursuant to such registration statement. The relative fault of the
Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the omission to state
a material fact relates to information supplied by the Indemnifying Party or by the Indemnified
Party and the parties&#146; relative intent, knowledge, access to information, and opportunity to
correct or prevent such statement or omission.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Notwithstanding the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the
underwritten public offering are in conflict with the foregoing provisions, the provisions in the
underwriting agreement shall control with respect to the rights and obligations of each of the
parties to such underwriting agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The obligations of the Company and Holders under this Section&nbsp;1.10 shall survive the
completion of any offering of Registrable Securities in a registration statement under this Section
1, and otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.11 <U>Information by Holder</U>. The Holder or Holders of Registrable Securities included
in any registration shall furnish to the Company such information regarding such Holder or Holders,
the Securities held by them and the distribution proposed by such Holder or Holders as the Company
may reasonably request in writing and as shall be required in connection with any registration
referred to in this Section&nbsp;1.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.12 <U>Reports Under Securities Exchange Act of 1934</U>. With a view to making available
to the Holders the benefits of Rule&nbsp;144 promulgated under the Securities Act and any other rule or
regulation of the Commission that may at any time permit a Holder to sell securities of the Company
to the public without registration or pursuant to a registration on Form S-3, the Company agrees to
use its best efforts to:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;make and keep public information available, as those terms are understood and defined in
Rule&nbsp;144 under the Securities Act, at all times after the effective date that the Company becomes
subject to the reporting requirements of the Securities Act or the Exchange Act;
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-14-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;file with the Commission in a timely manner all reports and other documents required of
the Company under the Securities Act and the Exchange Act (at any time after it has become subject
to such reporting requirements);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;register its Common Stock under Section&nbsp;12 of the Exchange Act at such time as it is
required to do so pursuant to the Exchange Act; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith
upon request (i)&nbsp;a written statement by the Company as to its compliance with the reporting
requirements of Rule&nbsp;144 (at any time after ninety (90)&nbsp;days after the effective date of the first
registration statement filed by the Company), the Securities Act and the Exchange Act (at any time
after it has become subject to such reporting requirements), or that it qualifies as a registrant
whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii)&nbsp;a
copy of the most recent annual or quarterly report of the Company and such other reports and
documents so filed by the Company, and (iii)&nbsp;such other information in the possession of or
reasonably obtainable by the Company as may be reasonably requested in availing any Holder of any
rule or regulation of the Commission which permits the selling of any such securities without
registration or pursuant to such form.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.13 <U>Transfer of Registration Rights</U>. The rights to cause the Company to register
Registrable Securities granted to the Investors under Sections&nbsp;1.5, 1.6 and 1.7 may be assigned to
a transferee or assignee in connection with any transfer or assignment of Eligible Securities by an
Investor; provided that (a)&nbsp;such transfer may otherwise be effected in accordance with applicable
securities laws, (b)&nbsp;notice of such assignment is given to the Company, (c)&nbsp;such transferee is a
Permitted Transferee and (d)&nbsp;such transferee or assignee agrees to be bound by and subject to the
terms and conditions of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.14 <U>Standoff Agreement</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each Holder agrees in connection with the first sale of the Company&#146;s Common Stock in a
firm commitment underwritten public offering pursuant to an effective registration statement under
the Securities Act, upon notice by the Company or the underwriters managing such public offering,
not to sell, make any short sale of, loan, pledge (or otherwise encumber or hypothecate), grant any
option for the purchase of, or otherwise directly or indirectly dispose of any Securities (other
than those included in the registration) without the prior written consent of the Company and such
managing underwriters for such period of time as the Board of Directors establishes pursuant to its
good faith negotiations with such managing underwriters; provided, however that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;such agreement shall not exceed one hundred eighty (180)&nbsp;days;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;such agreement shall not apply to transfers to an Affiliate, provided that such Affiliate
agrees to be bound by the terms of such agreement, to the same extent as if such transferee were
the original party thereunder;
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-15-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;a Holder shall not be subject to such agreement unless (A)&nbsp;all executive officers and
directors of the Company, (B), all shareholders of the Company holding more than 1% of the
Company&#146;s outstanding capital stock; and (C)&nbsp;all other Holders and holders of other registration
rights, are subject to or obligated to enter into similar agreements; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;if and when any person identified in clause (iii)&nbsp;is released, in whole or in part, from
such agreement (whether or not such release is contemplated at the time of the offering) or if any
such agreement is terminated, the Holder shall be concurrently released on a pro rata basis based
on the number of shares held by such person and the Holder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each Holder agrees that prior to the Initial Public Offering it will not transfer
securities of the Company unless each transferee agrees in writing to be bound by all of the
provisions of this Section&nbsp;1.14; provided that this Section&nbsp;1.14(b) shall not apply to transfers
pursuant to a registration statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each Holder hereby consents to the placement of stop transfer orders with the Company&#146;s
transfer agent in order to enforce the foregoing provision and agrees to execute a market standoff
agreement with said underwriters in customary form consistent with the provisions of this Section
1.14.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.15 <U>No Right to Delay Registration</U>. No holder shall restrain, enjoin, or otherwise
delay any registration hereunder, notwithstanding any controversy that might arise with respect to
the interpretation or implementation of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.16 <U>Termination of Rights</U>. No Holder shall be entitled to exercise any right
provided for in this Section&nbsp;1 after the earlier of (i)&nbsp;five (5)&nbsp;years following the consummation
of the Initial Public Offering, and (ii)&nbsp;that date following the Initial Public Offering upon which
each Holder holds less than 1% of the then issued and outstanding shares of capital stock of the
Company and all such shares may be sold under Section&nbsp;5 of the Securities Act whether pursuant to
Rule&nbsp;144 or another applicable exemption during any 90&nbsp;day period. All other provisions hereof
relating to registration rights shall continue to be effective despite any termination of such
registration rights pursuant to this section.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.17 <U>Limitations on Subsequent Registration Rights</U>. From and after the date of this
Agreement, the Company shall not enter into any agreement granting any holder or prospective holder
of any securities of the Company registration rights with respect to such securities unless (i)
such new registration rights, are subordinate to the registration rights granted Holders hereunder
and include similar market stand-off obligations or (ii)&nbsp;such new registration rights are approved
by the Holders of 50% of the Registrable Securities then held by Holders (assuming exercise or
conversion of all outstanding Eligible Securities); <U>provided</U>, <U>however</U>, that
Warrantholders may enter into this Agreement by executing and delivering a counterpart signature
page to this Agreement.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SECTION 2
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>Affirmative Covenants of the Company</U>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-16-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company hereby covenants and agrees as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 <U>Delivery of Financial Statements</U>. The Company will furnish to each Investor who
holds at least 40,000 shares of Eligible Securities (as adjusted for stock splits and
combinations):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;as soon as reasonably practicable, an income statement for such fiscal year, a balance
sheet of the Company and statement of shareholder&#146;s equity as of the end of such year, and a cash
flow statement for such year, such year-end financial reports to be in reasonable detail, prepared
in accordance with generally accepted accounting principles (&#147;<B>GAAP</B>&#148;), and audited and certified by
independent public accountants of nationally recognized standing selected by the Company; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;as soon as practicable, but in any event within forty-five (45)&nbsp;days after the end of each
of the first three (3)&nbsp;quarters of each fiscal year of the Company, an unaudited income statement,
cash flow statement for such fiscal quarter and an unaudited balance sheet as of the end of such
fiscal quarter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 <U>Additional Information Rights</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Budget and Operating Plan</U>. The Company will furnish to each Investor who holds at
least 750,000 shares of Eligible Securities (as adjusted for stock splits and
combinations) as soon as practicable upon approval or adoption by the Company&#146;s Board of
Directors, and in any event within 15&nbsp;days prior to the start of a fiscal year, the Company&#146;s
budget and operating plan for such fiscal year.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Other Information</U>. The Company will furnish to each Investor who holds at least
750,000 shares of Eligible Securities (as adjusted for stock splits and combinations) such other
information relating to the financial condition, business, prospects or corporate affairs of the
Company as such Investor may from time to time request; <U>provided</U>, <U>however</U>, that the
Company shall not be obligated under this subsection (b)&nbsp;or any other subsection of Section&nbsp;2.2 to
provide information which it deems in good faith to be a trade secret or similar confidential
information.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Inspection</U>. The Company shall permit each Investor who holds at least 750,000
shares of Eligible Securities (as adjusted for stock splits and combinations), at such Investor&#146;s
expense, to visit and inspect the Company&#146;s properties, to examine its books of account and records
and to discuss the Company&#146;s affairs, finances and accounts with its officers, all at such
reasonable times and during normal working hours as may be requested by such Investor;
<U>provided</U>, <U>however</U>, that the Company shall not be obligated under this subsection
(c)&nbsp;or any other subsection of Section&nbsp;2.2 to provide access to information which it deems in good
faith to be a trade secret or similar confidential information.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Monthly Financial Statements</U>. The Company will furnish to each Investor who holds
at least 750,000 shares of Eligible Securities (as adjusted for stock splits and combinations),
upon the request of such Investors, within thirty (30)&nbsp;days of the end of each month,
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-17-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">an unaudited
income statement and cash flow statement and unaudited balance sheet for and as of the end of such
month, in reasonable detail.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 <U>Confidentiality</U>. Each Investor agrees to use commercially reasonable efforts to
maintain the confidentiality of information obtained pursuant to this Section&nbsp;2, provided that such
obligation shall not apply to (i)&nbsp;information previously in possession or independently developed
by Investor, (ii)&nbsp;information publicly available other than as a result of breach of this provision
(iii)&nbsp;information required to be disclosed by statute, regulation or court or administrative order.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4 <U>Visitation Rights</U>. One representative chosen collectively by LB I Group Inc.,
Lehman Brothers P.A. LLC, Lehman Brothers Partnership Account 2000/2001, L.P. and Lehman Brothers
Offshore Partnership Account 2000/2001, L.P. (collectively, &#147;<B>Lehman</B>&#148;), one representative chosen
collectively by EuclidSR Partners, L.P. and EuclidSR Biotechnology Partners, L.P. (collectively,
&#147;<B>EuclidSR</B>&#148;), one representative chosen by Piper Jaffray Healthcare Fund III, L.P. (&#147;<B>Piper
Jaffray</B>&#148;), one representative chosen by GE Capital Equity Investments, Inc. (&#147;<B>GE Capital</B>&#148;), one
representative chosen collectively by Interwest Investors VII, L. P. and Interwest Partners VII,
L.P. (collectively, &#147;<B>Interwest</B>&#148;), one representative chosen by AllianceBernstein L.P. (&#147;<B>Alliance</B>&#148;),
and one representative chosen by BMSIF shall have the right to attend all meetings of the Board of
Directors, including meetings of any committee of the Board and including the right to participate
in any telephonic board meetings, so long as such Investor holds at least 750,000 shares
of Eligible Securities (as adjusted for stock splits and combinations and the like). Said
representative(s) shall be provided with notice of the meetings in the same manner at the same time
as the members of the Board of Directors and shall be provided with any materials distributed to
the Board of Directors in connection with board meetings. The foregoing visitation rights may be
limited by the Board of Directors if (i), upon the advice of counsel, the Board of Directors
determines that exclusion is required by third party confidentiality agreements, (ii)&nbsp;the Board is
discussing engaging Investor or an affiliate of Investor as a financial advisor or underwriter; or
(iii)&nbsp;the Board is discussing a material transaction with an entity in which Investor or a private
equity fund affiliated with Investor is a 5% or greater shareholder, or (iv)&nbsp;the Board determines
in good faith upon advice of counsel that limitations are required to maintain attorney-client
privilege.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5 <U>Stock Option Vesting</U>. Unless otherwise decided by the Board of Directors, all
option grants to employees shall vest over a four-year period with 25% of the shares subject to
each option vesting a year after commencement of employment and the remainder of the shares vesting
in equal amounts on a monthly basis thereafter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.6 <U>Insurance</U>. The Company shall, subject to the approval of the Board of Directors,
maintain such fire, casualty and general liability insurance with coverages and in amounts as shall
be determined by the Board of Directors. The Company agrees to maintain in full force and effect
directors and officers liability insurance with coverage in the aggregate amount of amount of $2
million covering all of its directors. The Company will maintain coverage for the Series&nbsp;C
Directors (as defined in the Voting Agreement) and the Series&nbsp;D Directors (as defined in the Voting
Agreement) under such directors and officers liability insurance at all times commencing upon the
Closing (as defined in the Purchase Agreement).
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-18-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.7 <U>Proprietary Information Agreements</U>. Unless otherwise determined by the Board of
Directors, all future employees and consultants of the Company shall be required to execute and
deliver a proprietary information and invention assignment agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.8 <U>Invention Assignments</U>. The Company agrees to use commercially reasonable efforts
to obtain from each of the individual contributing inventors for each invention that forms any part
of any patent or patent application owned by or licensed to the Company, executed invention
assignments in favor of the Company or the appropriate third party licensor, as the case may be.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.9 <U>Key-Man Life Insurance</U>. The Company shall obtain and maintain key-man life
insurance in such amount as is determined by the Company&#146;s Board of Directors, on Gajus
Worthington. Such policy shall name the Company as loss payee and shall not be cancelable by the
Company without prior unanimous approval of the Board of Directors.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.10 <U>Compliance with Laws</U>. The Company shall use its best efforts to comply with the
requirements of all applicable laws, rules, regulations and orders of any governmental authority,
where noncompliance would have a material adverse effect on the Company&#146;s business and financial
condition.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.11 <U>Termination of Covenants</U>. The covenants set forth in Section&nbsp;2 shall terminate
on, and be of no further force or effect after, the closing of the Company&#146;s Initial Public
Offering. The rights granted pursuant to this Section&nbsp;2 are not transferable other than to
Affiliates of Holders.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SECTION 3
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>Right of First Offer For Company Securities</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 <U>Right of First Offer</U>. Subject to the terms and conditions specified in this
Section&nbsp;3, the Company hereby grants to each Investor a right of first offer with respect to future
sales by the Company of its Securities. An Investor shall be entitled to apportion the right of
first offer hereby granted among itself and its partners and Affiliates in such proportions as it
deems appropriate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each time the Company proposes to offer any Securities in a Financing (as defined below), the
Company shall first make an offering of such Securities to each Investor in accordance with the
following provisions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company shall deliver a notice (&#147;<B>Notice</B>&#148;) to each Investor stating (i)&nbsp;its intention
to offer such Securities for sale, (ii)&nbsp;the number of such Securities to be offered (the &#147;<B>Offered
Securities</B>&#148;), (iii)&nbsp;the price, if any, for which it proposes to offer such Securities, (iv)&nbsp;the
terms of such offer and (v)&nbsp;the Offer Amount (as defined below).
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-19-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Within fifteen (15)&nbsp;calendar days after receipt of the Notice, each Investor may elect to
purchase, at the price and on the terms specified in the Notice, such Securities in an amount up to
the Offer Amount by providing the Company with written notice of its election.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;An election by an Investor pursuant to Section&nbsp;3.1(b) to purchase Offered Securities shall
not be considered a binding commitment on the Investor unless and until the Company receives
binding commitments to purchase on the terms and conditions contained in the Notice substantially
all of the Offered Securities which the Investors have not elected to purchase.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, the Company and each of the Investors acknowledge and agree
that Lighthouse shall have the opportunity to invest not less than $250,000 in connection with the
first Financing completed after the date of this Agreement that involves the sale and issuance by
the Company of shares of the Company&#146;s convertible preferred stock with aggregate gross proceeds to
the Company of at least $3&nbsp;million. In the event that Lighthouse&#146;s right to purchase Offered
Securities as otherwise set forth in this Section&nbsp;3.1 would not permit such $250,000 investment,
then each of the Investors agrees that its respective right to purchase Offered Securities pursuant
to this Section&nbsp;3.1 may be cut-back (proportionately with all other Investors based on the number
of shares of Eligible Securities held by the Investors) in such amounts as may be necessary to
permit the exercise of Lighthouse&#146;s rights as set forth herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 <U>Sale of Securities by Company</U>. Within 60&nbsp;days of the expiration of the period
described in Section&nbsp;3.1(b), any Offered Securities which the Investors have not elected to
purchase may be sold by the Company to any person or persons at a price not less than, and upon
terms no more favorable to the offeree than, those specified in the Notice. If the Company does
not complete the sale of all such Offered Securities within said 60-day period, the rights of the
Investors with respect to any such unsold Offered Securities shall be deemed to be revived.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3 <U>Offer Amount</U>. The &#147;<B>Offer Amount</B>&#148; shall equal that percentage of the Offered
Securities equal to the number of shares of Eligible Securities held by an Investor which are
Registrable Securities divided by the total number of outstanding shares of Common Stock of the
Company. For the purposes of the foregoing calculations, all outstanding options and warrants
shall be deemed to be exercised and all Preferred Stock shall be deemed to have been converted into
Common Stock at the prevailing conversion rate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4 <U>Financing</U>. &#147;<B>Financing</B>&#148; shall mean an offering or series of related offerings of
Securities by the Company for purposes of raising working capital in a minimum amount of $250,000.
Financing shall not include (i)&nbsp;the issuance or sale of shares of Common Stock or options to
purchase Common stock to employees, officers, directors or consultants for the primary purpose of
soliciting or retaining their services in such amount as shall have been approved by the Board of
Directors, (ii)&nbsp;the issuance or sale of Securities to leasing entities or financial institutions in
connection with commercial leasing or borrowing transactions approved by the Board of Directors,
(iii)&nbsp;the issuance or sale of Securities to third party providers of goods or services in
connection with transactions approved by the Board of Directors; (iv)&nbsp;the sale of Securities in a
registered public offering, (v)&nbsp;any issuances of Securities in connection with any stock split,
stock dividend or recapitalization by the Company, (vi)&nbsp;the issuance of Securities at a price (on
an as converted to
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-20-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Common Stock basis) below the original issue price of the Company&#146;s Series&nbsp;E
Preferred Stock (as adjusted for stock splits, recapitalizations and like events) in connection
with sponsored research, collaboration, technology license, development, OEM, marketing or other
similar agreements or any joint venture or strategic alliance, if such issuance is approved
unanimously by the Board of Directors, <U>provided</U> <U>that</U> the issuance of the Company&#146;s
Series&nbsp;E Preferred Stock to BMSIF or any Affiliate thereof or any related entity to the Singapore
Economic Development Board pursuant to Section&nbsp;3.4(xii) below at a price below the original issue
price of the Company&#146;s Series&nbsp;E Preferred Stock (as adjusted for stock splits, recapitalizations
and like events) shall also not be a Financing hereunder, (vii)&nbsp;the issuance of Securities at a
price (on an as converted to Common Stock basis) at or above the original issue price of the
Company&#146;s Series&nbsp;E Preferred Stock (as adjusted for stock splits, recapitalizations and like
events) in connection with sponsored research, collaboration, technology license, development, OEM,
marketing or other similar agreements or any joint venture or strategic alliance, if such issuance
is approved by the Board of Directors, (viii)&nbsp;the issuance of Securities at a price (on an as
converted to Common Stock basis) below the original issue price of the Company&#146;s Series&nbsp;E Preferred
Stock (as adjusted for stock splits, recapitalizations and like events) in connection with the
acquisition of another corporation by the Company by merger, consolidation, or purchase of all or
substantially all of the assets or shares of such corporation unanimously approved by the Board of
Directors, (ix)&nbsp;the issuance of Securities at a price (on an as
converted to Common Stock basis) at or above the original issue price of the Company&#146;s Series
E Preferred Stock (as adjusted for stock splits, recapitalizations and like events) in connection
with the acquisition of another corporation by the Company by merger, consolidation, or purchase of
all or substantially all of the assets or shares of such corporation approved by the Board of
Directors; (x)&nbsp;shares of Series&nbsp;E Preferred Stock issued pursuant to the terms of the Purchase
Agreement; (xi)&nbsp;interest-bearing convertible promissory notes in the aggregate principal amount of
$8&nbsp;million issued or issuable pursuant to the CNPA and/or the CNA and any Securities issued on
conversion thereof; and (xii)&nbsp;additional interest-bearing convertible promissory notes to be issued
after the date hereof in the aggregate principal amount of up to $15&nbsp;million to BMSIF or any
Affiliate thereof or any related entity to the Singapore Economic Development Board, and any
Securities issued on conversion thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5 <U>Termination of Right of First Offer</U>. The right of first offer contained in this
section shall not apply to and shall terminate upon the closing of an Initial Public Offering. The
right of first offer granted under this Section&nbsp;3 is transferable to transferees of at least
750,000 shares of Registrable Securities (as adjusted for stock splits, combinations and the like)
or to Affiliates.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-21-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SECTION 4
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>Right of First Offer with Respect to Founder Shares</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 <U>Notice of Sales</U>. Should a Founder (a &#147;<B>Seller</B>&#148;) propose to accept one or more bona
fide offers (collectively, the &#147;<B>Purchase Offer</B>&#148;) from any persons (&#147;<B>Purchasers</B>&#148;) to purchase
Founders Shares from such Seller (other than as set forth 4.2(d) hereof), then such Seller shall,
promptly after exercise or termination of any rights of first refusal held by the Company, deliver
a notice (the &#147;<B>Notice</B>&#148;) to the Company and all Investors holding more than 750,000 shares of
Eligible Securities (&#147;<B>Eligible Investors</B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 <U>Purchase Right</U>. Each Eligible Investor shall have the right, exercisable upon
written notice to such Seller within ten (10)&nbsp;business days after receipt of the Notice, to
purchase Founders Shares on the terms and conditions specified in the Purchase Offer. To the
extent an Eligible Investor exercises its right to purchase such shares in accordance with the
terms and conditions set forth below, the number of shares of stock which such Seller may sell to
the Purchasers pursuant to the Purchase Offer shall be correspondingly reduced. The purchase right
of each Eligible Investor shall be subject to the following terms and conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Calculation of Shares</U>. Each Eligible Investor may purchase all or any part of
that number of Founder Shares equal to the number obtained by multiplying (i)&nbsp;the aggregate number
of Founders Shares covered by the Purchase Offer by (ii)&nbsp;a fraction, the numerator of which is the
number of shares of Common Stock of the Company at the time owned by such Eligible Investor and the
denominator of which is the number of shares of Common Stock of the Company then outstanding. For
the purposes of the foregoing calculations, all outstanding options and
warrants shall be deemed to be exercised and all Preferred Stock shall be deemed to have been
converted into Common Stock at the prevailing conversion rate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Delivery of Consideration</U>. Each Eligible Investor may effect its purchase right
by promptly delivering to such Seller a written notice and a check or wire transfer equal to the
purchase price specified in the Purchase Offer for the number of shares the Eligible Investor
desires to purchase pursuant to this Section&nbsp;4.2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Certificate</U>. Within ten (10)&nbsp;business days of receipt of Eligible Investor&#146;s
funds pursuant to Section&nbsp;4.2(c), Seller shall deliver to such Eligible Investor a certificate or
certificates representing the shares of Founder Shares purchased by such Eligible Investor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Permitted Transactions</U>. The participation rights in this Section&nbsp;4 shall not
pertain or apply to:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Any transfer to a revocable grantor trust with respect to which the Founder and members of
his family are the sole beneficiaries;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Any repurchase of Founders Shares by the Company;
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-22-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Any exercise by the Company of a right or remedy under the terms of any loan, security
or stock pledge agreement where the Founders Shares serve as security for a loan made by the
Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;Any transfer to any ancestors or descendants or spouse of a Founder or to a trustee for
their benefit or to a custodian for the benefit of a Founders&#146; issue; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;Any bona fide gift;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">provided, however, that such Founder shall inform the Eligible Investors of such transfer or gift
(other than a transfer pursuant to clause (ii)&nbsp;or (iii)) prior to effecting it and the transferee
or donee (if other than the Company) shall furnish the Company and the Eligible Investors with a
written agreement to be bound by and comply with all applicable provisions of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 <U>Sale of Securities by Founder</U>. Within 60&nbsp;days of the expiration of the period
described in the first paragraph of Section&nbsp;4.2, any Founders Shares covered by the Purchase Offer
which the Eligible Investors have not elected to purchase may be sold by the Seller to the
Purchasers on the terms and conditions of the Purchase Offer. If the Seller does not complete the
sale of all Founders Shares covered by the Purchase Offer within such period, the rights of the
Eligible Investors with respect to any such unsold Founders Shares shall be deemed to be revived.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4 <U>Termination and Transfer</U>. The restrictions imposed and rights granted by this
Section&nbsp;4 shall not apply to and shall terminate immediately prior to the closing of the Company&#146;s
Initial Public Offering. Securities received pursuant to any stock dividend, stock split,
recapitalization, or exercise of a conversion right shall be subject to this Section&nbsp;4 to the
same extent as the shares of the Company with respect to which they were issued. The right of
first offer granted under this Section&nbsp;4 is transferable to transferees of at least 750,000 shares
of Registrable Securities (as adjusted for stock splits, combinations and the like) or to
Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.5 <U>Prohibited Transfer</U>. Any attempt by a Founder to transfer Founders Shares in
violation of Section&nbsp;4 hereof shall be void and the Company agrees it will not effect such a
transfer nor will it treat any alleged transferee(s) as the holder of such shares, without the
written consent of two-thirds (2/3) in interest of the Eligible Investors.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SECTION 5
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>Right of Co-Sale</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 <U>Notice of Sales</U>. Should a Founder (a &#147;<B>Seller</B>&#148;) propose to accept one or more bona
fide offers (collectively, the &#147;<B>Purchase Offer</B>&#148;) from any persons (&#147;<B>Purchasers</B>&#148;) to purchase
Founders Shares from such Seller (other than as set forth 5.2(d)), then such Seller shall, promptly
after exercise or termination of any rights of first refusal held by the Company or the Eligible
Investors, deliver a notice (the &#147;<B>Notice</B>&#148;) to the Company and all Eligible Investors describing the
terms and conditions of the Purchase Offer.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-23-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 <U>Participation Right</U>. Each Eligible Investor shall have the right, exercisable
upon written notice to such Seller within fifteen (15)&nbsp;business days after receipt of the Notice,
to participate in such Seller&#146;s sale of stock pursuant to the specified terms and conditions of
such Purchase Offer. To the extent an Eligible Investor exercises such right of participation in
accordance with the terms and conditions set forth below, the number of shares of stock which such
Seller may sell pursuant to such Purchase Offer shall be correspondingly reduced. The right of
participation of each Eligible Investor shall be subject to the following terms and conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Calculation of Shares</U>. Each Eligible Investor may sell all or any part of that
number of shares of Common Stock of the Company equal to the number obtained by multiplying (i)&nbsp;the
aggregate number of Founders Shares covered by the Purchase Offer by (ii)&nbsp;a fraction, the numerator
of which is the number of shares of Common Stock of the Company at the time owned by such Eligible
Investor and the denominator of which is the number of shares of Common Stock of the Company then
outstanding. For the purposes of the foregoing calculations, all outstanding options and warrants
shall be deemed to be exercised and all Preferred Stock shall be deemed to have been converted into
Common Stock at the prevailing conversion rate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Delivery of Certificates</U>. Each Eligible Investor may effect its participation in
the sale by delivering to such Seller for transfer to the Purchaser(s) one or more certificates,
properly endorsed for transfer, which represent at least the number of shares of Common Stock which
such Eligible Investor elects to sell pursuant to this Section&nbsp;5.2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Transfer</U>. The stock certificate or certificates which the Eligible Investor
delivers to such Seller pursuant to Section&nbsp;5.2 shall be delivered by the Seller to the
Purchaser(s) in consummation of the sale of the Securities pursuant to the terms and conditions
specified in the Notice, and such Seller shall promptly thereafter remit to such Eligible Investor
that portion of the sale proceeds to which such Eligible Investor is entitled by reason of its
participation in such sale.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Permitted Transactions</U>. The participation rights in this Section&nbsp;5 shall not
pertain or apply to:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Any transfer to a revocable grantor trust with respect to which the Seller and members of
his family are the sole beneficiaries;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Any repurchase of Founders Shares by the Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;Any exercise by the Company of a right or remedy under the terms of any loan, security
or stock pledge agreement where the Founders Shares serve as security for a loan made by the
Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;Any transfer to any ancestors or descendants or spouse of a Founder or to a trustee for
their benefit or to a custodian for the benefit of a Founders&#146; issue; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) Any bona fide gift;
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-24-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">provided, however, that such Founder shall inform the Eligible Investors of such transfer or gift
(other than a transfer pursuant to clause (ii)&nbsp;or (iii)) prior to effecting it and the transferee
or donee (if other than the Company) shall furnish the Company and the Eligible Investors with a
written agreement to be bound by and comply with all applicable provisions of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 <U>Sale of Securities by Founder</U>. Within 45&nbsp;days of the expiration of the period
described in the first paragraph of Section&nbsp;5.2, any Founders Shares covered by the Purchase Offer
which the Eligible Investors have not elected to purchase may be sold by the Seller to the
Purchasers on the terms and conditions of the Purchase Offer. If the Seller does not complete the
sale of all Founders Shares covered by the Purchase Offer within such period, the rights of the
Eligible Investors with respect to any such unsold Founders Shares shall be deemed to be revived.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4 <U>Termination and Transfer</U>. The restrictions imposed and rights granted by this
Section&nbsp;5 shall not apply to and shall terminate immediately prior to the closing of the Company&#146;s
Initial Public Offering. Securities received pursuant to any stock dividend, stock split,
recapitalization, or exercise of a conversion right shall be subject to this Section&nbsp;5 to the same
extent as the shares of the Company with respect to which they were issued. The co-sale right
granted under this Section&nbsp;5 is transferable to transferees of at least 750,000 shares of
Registrable Securities (as adjusted for stock splits, combinations and the like) or to Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.5 <U>Prohibited Transfers</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;In the event any Founder should sell any Founders Shares in contravention of the co-sale
rights of the Investors under Section&nbsp;5 (a &#147;<B>Prohibited Transfer</B>&#148;), the Investors, in addition to
such other remedies as may be available at law, in equity or hereunder, shall have the put option
provided below, and the Founder shall be bound by the applicable provisions of such option.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In the event of a Prohibited Transfer, each Eligible Investor shall have the right to sell
to the Founder the type and number of shares of Common Stock equal to the number of shares that
such Eligible Investor would have been entitled to transfer to the third-party transferee(s) under
Section&nbsp;5.2 hereof had the Prohibited Transfer been effected pursuant to and in compliance with the
terms thereof. Such sale shall be made on the following terms and conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;The price per share at which the shares are to be sold to the Founder shall be equal to
the price per share paid by the third-party transferee(s) to the Founder in the Prohibited
Transfer. Such price per share shall be paid to the Eligible Investor in cash if the Founder
received cash for his shares. If the Founder did not receive cash but received other property
instead, the price per share to be paid to the Eligible Investor shall be paid (A)&nbsp;in the form of
the property received by the Founder for his shares, or (B)&nbsp;in cash equal to the fair market value
of the property received by such Founder as determined in good faith by the Company&#146;s Board of
Directors, at the option of the Eligible Investor. The Founder shall also reimburse each Eligible
Investor for any and all fees and expense, including legal fees and expenses, incurred pursuant to
the exercise or the attempted exercise of the Eligible Investor&#146;s rights under Section&nbsp;5.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-25-<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Within thirty (30)&nbsp;days after the later of the dates on which the Eligible Investor (A)
received notice of the Prohibited Transfer or (B)&nbsp;otherwise became aware of the Prohibited
Transfer, each Eligible Investor shall, if exercising the option created hereby, deliver to the
Founder the certificate or certificates representing shares to be sold, each certificate to be
properly endorsed for transfer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;The Founder shall, upon receipt of the certificate or certificates for the shares to be
sold by an Eligible Investor pursuant to this Section&nbsp;5, pay the aggregate purchase price therefor
and the amount of reimbursable fees and expenses, as specified in subparagraph 5.5(b)(i), in cash
or by other means acceptable to the Eligible Investor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Notwithstanding the foregoing, any attempt by a Founder to transfer Founders Shares in
violation of Section&nbsp;5 hereof shall be void and the Company agrees it will not effect such a
transfer nor will it treat any alleged transferee(s) as the holder of such shares, without the
written consent of two-thirds (2/3) in interest of the Eligible Investors.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SECTION 6
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>Miscellaneous</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 <U>Governing Law; Jurisdiction</U>. This Agreement shall be construed in accordance
with, and governed in all respects by, the laws of the State of California, as applied to
agreements entered into, and to be performed entirely in such state, between residents of such
state.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto agree to submit to the jurisdiction of the federal and state courts of San
Mateo County, California with respect to the breach or interpretation of this Agreement or the
enforcement of any and all rights, duties, liabilities, obligations, powers, and other relations
between the parties arising under this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 <U>Successors and Assigns</U>. Except as otherwise provided herein, the provisions
hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs,
executors and administrators of the parties hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 <U>Notices, Etc</U>. All notices and other communications required or permitted
hereunder, shall be in writing and shall be sent by facsimile personally delivered, mailed by
registered or certified mail, postage prepaid, return receipt requested, or otherwise delivered by
a nationally-recognized overnight courier, addressed (a)&nbsp;if to an Investor, at Investor&#146;s facsimile
number or address as set forth in the records of the Company or (b)&nbsp;if to any other holder of any
Eligible Securities, at such address as such holder shall have furnished the Company in writing,
or, until any such holder so furnishes an address to the Company, then to and at the address of the
last holder of such Eligible Securities who has so furnished an address or facsimile number to the
Company, or (c)&nbsp;if to a Founder, at such Founder&#146;s facsimile number or address set forth on
<U>EXHIBIT B</U> hereto, or a such other address as such Founder shall have furnished to the
Company in writing, or (d)&nbsp;if to the Company, at its facsimile number or address set forth on the
signature page hereto addressed to the attention of the Corporate Secretary, or at such other
address as the Company
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-26-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shall have furnished to the Investors. Any such notice or communication
shall be deemed to have been received (A)&nbsp;in the case of personal delivery, on the date of such
delivery, (B)&nbsp;in the case of a nationally-recognized overnight courier, on the next business day
after the date when sent, (C)&nbsp;in the case of mailing, on the third business day following that on
which the piece of mail containing such communication is posted and (D)&nbsp;in the case of delivery via
facsimile, one (1)&nbsp;business day after the date of transmission provided that said transmission is
confirmed telephonically on the date of transmission.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 <U>Delays or Omissions</U>. No delay or omission to exercise any right, power or remedy
accruing to any holder of any Eligible Securities upon any breach or default of the Company under
this Agreement shall impair any such right, power or remedy of such holder, nor shall it be
construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any
similar breach or default thereafter occurring; nor shall any waiver of any single breach or
default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any
waiver, permit, consent or approval of any kind or character on the part of any holder of any
breach or default under this Agreement, or any waiver on the part of any holder of any provisions
or conditions of this Agreement, must be in writing and shall be effective only to the extent
specifically set forth in such writing or as provided in this Agreement. All remedies, either under this Agreement or
by law or otherwise afforded to any holder, shall be cumulative and not alternative.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5 <U>Third Parties</U>. Nothing in this Agreement, express or implied, is intended to
confer upon any party, other than the parties hereto, and their respective successors and assigns,
any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as
expressly provided herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6 <U>Severability</U>. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, portions of such provisions, or such provisions in their
entirety, to the extent necessary, shall be severed from this Agreement, and the balance of this
Agreement shall be enforceable in accordance with its terms.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.7 <U>Amendment and Waiver</U>. Any provision of this Agreement may be amended or waived
with the written consent of the Company and the Holders of at least two-thirds of the outstanding
shares of the Registrable Securities then held by Holders (assuming the exercise or conversion of
all outstanding Eligible Securities); <U>provided</U>, <U>however</U>, (i)&nbsp;that in the event such
amendment or waiver adversely affects the rights and/or obligations of the Founders under this
Agreement in a different manner than the other Holders, such amendment or waiver shall also require
written consent of the Founders holding a majority of the then outstanding Founders Shares, (ii)
that in the event such amendment or waiver adversely affects the rights and/or obligations of
Lehman, EuclidSR, Piper Jaffray, GE Capital, Interwest, Alliance, and BMSIF under Section&nbsp;2.4 of
this Agreement, such amendment or waiver shall not be effective as to Lehman, EuclidSR, Piper
Jaffray, GE Capital, Interwest or BMSIF, as the case may be, without the written consent of such
party, and (iii)&nbsp;that in the event such amendment or waiver adversely affects the rights and/or
obligations of Warrantholders under this Agreement in a different manner than the other Holders,
such amendment or waiver shall also require the written consent of Warrantholders holding a
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-27-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">majority of the then outstanding Warrant Shares. Notwithstanding the foregoing, any purchaser of
Series&nbsp;E Preferred Stock pursuant to the Purchase Agreement may become a party to this Agreement by
executing and delivering an additional counterpart signature page to this Agreement and such
purchaser shall be deemed a Holder and an Investor hereunder. The parties agree that <U>Exhibit
A</U> shall be updated automatically without any formal amendment to reflect the addition of any
such additional party. Any amendment or waiver effected in accordance with this paragraph shall be
binding upon each Holder, the Founders, the holder of the Other Shares, Warrantholders and the
Company. In addition, the Company may waive performance of any obligation owing to it, as to some
or all of the Holders, or agree to accept alternatives to such performance, without obtaining the
consent of any other Holder. In the event that an underwriting agreement is entered into between
the Company and any Holder, and such underwriting agreement contains terms differing from this
Agreement, as to any such Holder the terms of such underwriting agreement shall govern.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.8 <U>Rights of Holders</U>. Each Holder shall have the absolute right to exercise or
refrain from exercising any right or rights that such holder may have by reason of this Agreement,
including, without limitation, the right to consent to the waiver or modification of any obligation
under this Agreement, and such holder shall not incur any liability to any other holder of any
Securities as a result of exercising or refraining from exercising any such right or rights.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.9 <U>Counterparts</U>. This Agreement may be executed in any number of counterparts, each
of which shall be enforceable against the parties actually executing such counterparts, and all of
which together shall constitute one instrument.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.10 <U>Titles and Subtitles</U>. The titles of the paragraphs and subparagraphs of this
Agreement are for convenience of reference only and are not to be considered in construing this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.11 <U>Amendment and Restatement of Prior Agreement</U>. The undersigned Prior Investors
who in the aggregate hold at least two-thirds of the outstanding Registrable Securities (as defined
in the Prior Agreement) and the undersigned Founders hereby amend and restate the Prior Agreement
pursuant to Section&nbsp;6.7 thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.12 <U>Waiver of Right of First Offer</U>. The undersigned Prior Investors who in the
aggregate hold at least two-thirds of the outstanding Registrable Securities (as defined in the
Prior Agreement) hereby waive on behalf of all Prior Investors any rights of participation or
notice under Section&nbsp;3 of this Agreement and the Prior Agreement with respect to the securities
sold pursuant to the Purchase Agreement. By its execution below, Lighthouse waives any right of
participation or notice under Section&nbsp;3 of this Agreement and Section&nbsp;3 of the Prior Agreement with
respect to securities sold under the Purchase Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.13 <U>Aggregation of Stock</U>. All shares of Eligible Securities held or acquired by
Affiliated entities or persons shall be aggregated together for the purpose of determining the
availability of any rights under this Agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-28-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.14 <U>Jury Trial</U>. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING (WHETHER
SOUNDING IN CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS AGREEMENT.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>&#091;Remainder
of Page Left Blank Intentionally&#093;</I></B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-29-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FLUIDIGM
CORPORATION<BR>FORM OF<BR>
AMENDMENT NO. 1 TO<BR>
EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS AMENDMENT NO. 1 (this &#147;<B>Amendment</B>&#148;) to that certain Eighth Amended and Restated Investor
Rights Agreement, dated as of June&nbsp;13, 2006 (the &#147;<B>Rights Agreement</B>&#148;), by and among Fluidigm
Corporation, a California corporation (the &#147;<B>Company</B>&#148;), and the Investors and Founders named therein
is entered into this 22nd day of December, 2006 by and among the Company and the undersigned,
collectively the Holders of at least two-thirds of the outstanding shares of the Registrable
Securities then held by Holders (assuming the exercise or conversion of all outstanding Eligible
Securities). Capitalized terms not defined herein have the meanings set forth in the Rights
Agreement.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">RECITALS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.&nbsp;It is contemplated that the Company will sell and issue additional shares of the Company&#146;s
Series&nbsp;E Preferred Stock (&#147;<B>Series&nbsp;E Preferred Stock</B>&#148;) pursuant to that certain Series&nbsp;E Preferred
Stock Purchase Agreement, dated as of June&nbsp;13, 2006 (the &#147;<B>Purchase Agreement</B>&#148;), by and among the
Company and the Purchasers named therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.&nbsp;In connection with the sale of additional shares of Series&nbsp;E Preferred Stock, the Company
and the Investors desire to (i)&nbsp;provide that the standoff agreement in Section&nbsp;1.14 of the Rights
Agreement shall not apply to securities of the Company purchased by certain Holders in the Initial
Public Offering or in the public market for the Company&#146;s securities following the Initial Public
Offering, and (ii)&nbsp;grant visitation rights pursuant to Section&nbsp;2.4 of the Rights Agreement
collectively to Cross Creek Capital, L.P., Cross Creek Capital Employees&#146; Fund, L.P. and Wasatch
Small Cap Growth.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C.&nbsp;The Company and the undersigned Holders of at least two-thirds of the outstanding shares of
the Registrable Securities then held by Holders (assuming the exercise or conversion of all
outstanding Eligible Securities) have agreed to amend the Rights Agreement to provide for the
foregoing changes to the standoff agreement in Section&nbsp;1.14 and the visitation rights in Section
2.4.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AGREEMENT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, all of the parties
hereto mutually agree as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 7 <U>Amendment to Section&nbsp;1.14</U>. Section&nbsp;1.14 (Standoff Agreement) of the Rights
Agreement is hereby amended and restated in its entirety as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;1.14 <U>Standoff Agreement</U>.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Each Holder agrees in connection with the first sale of the Company&#146;s
Common Stock in a firm commitment underwritten public offering pursuant to an
effective registration statement under the Securities Act, upon notice by the
Company or the underwriters managing such public offering, not to sell, make any
short sale of, loan, pledge (or otherwise encumber or hypothecate), grant any option
for the purchase of, or otherwise directly or indirectly dispose of any Securities
(other than those included in the registration) without the prior written consent of
the Company and such managing underwriters for such period of time as the Board of
Directors establishes pursuant to its good faith negotiations with such managing
underwriters; provided, however that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) such agreement shall not exceed one hundred eighty (180)&nbsp;days;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) such agreement shall not apply to transfers to an Affiliate, provided that
such Affiliate agrees to be bound by the terms of such agreement, to the same extent
as if such transferee were the original party thereunder;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) such agreement shall not apply to securities of the Company purchased by
AllianceBernstein Venture Fund I, L.P., SmallCap World Fund, Inc., Cross Creek
Capital, L.P., Cross Creek Capital Employees&#146; Fund, L.P. or Wasatch Small Cap Growth
or their respective Affiliates in the Initial Public Offering or in the public
market for the Company&#146;s securities following the Initial Public Offering;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) a Holder shall not be subject to such agreement unless (A)&nbsp;all executive
officers and directors of the Company, (B), all shareholders of the Company holding
more than 1% of the Company&#146;s outstanding capital stock; and (C)&nbsp;all other Holders
and holders of other registration rights, are subject to or obligated to enter into
similar agreements; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) if and when any person identified in clause (iv)&nbsp;is released, in whole or
in part, from such agreement (whether or not such release is contemplated at the
time of the offering) or if any such agreement is terminated, the Holder shall be
concurrently released on a pro rata basis based on the number of shares held by such
person and the Holder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each Holder agrees that prior to the Initial Public Offering it will not
transfer securities of the Company unless each transferee agrees in writing to be
bound by all of the provisions of this Section&nbsp;1.14; provided that this Section
1.14(b) shall not apply to transfers pursuant to a registration statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Each Holder hereby consents to the placement of stop transfer orders with
the Company&#146;s transfer agent in order to enforce the foregoing provision and agrees
to execute a market standoff agreement with said
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">underwriters in customary form consistent with the provisions of this Section&nbsp;1.14.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8 <U>Amendment to Section&nbsp;2.4</U>. Section&nbsp;2.4 (Visitation Rights) of the Rights
Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;2.4 <U>Visitation Rights</U>. One representative chosen collectively by LB I Group
Inc., Lehman Brothers P.A. LLC, Lehman Brothers Partnership Account 2000/2001, L.P. and
Lehman Brothers Offshore Partnership Account 2000/2001, L.P. (collectively, &#147;<B>Lehman</B>&#148;), one
representative chosen collectively by EuclidSR Partners, L.P. and EuclidSR Biotechnology
Partners, L.P. (collectively, &#147;<B>EuclidSR</B>&#148;), one representative chosen by Piper Jaffray
Healthcare Fund III, L.P. (&#147;<B>Piper Jaffray</B>&#148;), one representative chosen by GE Capital Equity
Investments, Inc. (&#147;<B>GE Capital</B>&#148;), one representative chosen collectively by Interwest
Investors VII, L. P. and Interwest Partners VII, L.P. (collectively, &#147;<B>Interwest</B>&#148;), one
representative chosen by AllianceBernstein Venture Fund I, L.P. (&#147;<B>Alliance</B>&#148;), one
representative chosen collectively by Cross Creek Capital, L.P., Cross Creek Capital
Employees&#146; Fund, L.P. and Wasatch Small Cap Growth (collectively, &#147;<B>Wasatch</B>&#148;), and one
representative chosen by BMSIF shall have the right to attend all meetings of the Board of
Directors, including meetings of any committee of the Board and including the right to
participate in any telephonic board meetings, so long as such Investor holds at least
750,000 shares of Eligible Securities (as adjusted for stock splits and combinations and the
like). Said representative(s) shall be provided with notice of the meetings in the same
manner at the same time as the members of the Board of Directors and shall be provided with
any materials distributed to the Board of Directors in connection with board meetings. The
foregoing visitation rights may be limited by the Board of Directors if (i), upon the advice
of counsel, the Board of Directors determines that exclusion is required by third party
confidentiality agreements, (ii)&nbsp;the Board is discussing engaging Investor or an affiliate
of Investor as a financial advisor or underwriter; or (iii)&nbsp;the Board is discussing a
material transaction with an entity in which Investor or a private equity fund affiliated
with Investor is a 5% or greater shareholder, or (iv)&nbsp;the Board determines in good faith
upon advice of counsel that limitations are required to maintain attorney-client privilege.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9 <U>Amendment to Section&nbsp;6.7</U>. Section&nbsp;6.7 (Amendment and Waiver) of the Rights
Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;6.7 <U>Amendment and Waiver</U>. Any provision of this Agreement may be amended
or waived with the written consent of the Company and the Holders of at least
two-thirds of the outstanding shares of the Registrable Securities then held by
Holders (assuming the exercise or conversion of all outstanding Eligible
Securities); <U>provided</U>, <U>however</U>, (i)&nbsp;that in the event such amendment
or waiver adversely affects the rights and/or obligations of the Founders under this
Agreement in a different manner than the other Holders, such amendment or waiver
shall also require written consent of the Founders holding a majority of the
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">then outstanding Founders Shares, (ii)&nbsp;that in the event such amendment or waiver
adversely affects the rights and/or obligations of Lehman, EuclidSR, Piper Jaffray,
GE Capital, Interwest, Alliance, Wasatch or BMSIF under Section&nbsp;2.4 of this
Agreement, such amendment or waiver shall not be effective as to Lehman, EuclidSR,
Piper Jaffray, GE Capital, Interwest, Alliance, Wasatch or BMSIF, as the case may
be, without the written consent of such party, and (iii)&nbsp;that in the event such
amendment or waiver adversely affects the rights and/or obligations of
Warrantholders under this Agreement in a different manner than the other Holders,
such amendment or waiver shall also require the written consent of Warrantholders
holding a majority of the then outstanding Warrant Shares. Notwithstanding the
foregoing, any purchaser of Series&nbsp;E Preferred Stock pursuant to the Purchase
Agreement may become a party to this Agreement by executing and delivering an
additional counterpart signature page to this Agreement and such purchaser shall be
deemed a Holder and an Investor hereunder. The parties agree that <U>Exhibit&nbsp;A</U>
shall be updated automatically without any formal amendment to reflect the addition
of any such additional party. Any amendment or waiver effected in accordance with
this paragraph shall be binding upon each Holder, the Founders, the holder of the
Other Shares, Warrantholders and the Company. In addition, the Company may waive
performance of any obligation owing to it, as to some or all of the Holders, or
agree to accept alternatives to such performance, without obtaining the consent of
any other Holder. In the event that an underwriting agreement is entered into
between the Company and any Holder, and such underwriting agreement contains terms
differing from this Agreement, as to any such Holder the terms of such underwriting
agreement shall govern.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 10 <U>Governing Law</U>. This Amendment shall be construed in accordance with, and
governed in all respects by, the laws of the State of California, as applied to agreements entered
into, and to be performed entirely in such state, between residents of such state.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 11 <U>Counterparts</U>. This Amendment may be executed in any number of
counterparts, each of which shall be enforceable against the parties actually executing such
counterparts, and all of which together shall constitute one instrument.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Remainder of Page Intentionally Blank</I></B><B>&#093;</B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FLUIDIGM CORPORATION</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AMENDMENT NO. 2 TO<BR>
EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS AMENDMENT NO. 2 (this &#147;<B>Amendment</B>&#148;) to that certain Eighth Amended and Restated Investor
Rights Agreement, dated as of June&nbsp;13, 2006, as amended December&nbsp;22, 2006 (the &#147;<B>Rights Agreement</B>&#148;),
by and among Fluidigm Corporation, a California corporation (&#147;<B>Fluidigm California</B>&#148;), and the
Investors and Founders named therein is entered into effective as of October&nbsp;10, 2007 by and among
Fluidigm Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), the undersigned Investors, and the
undersigned Holders, collectively the Holders of at least two-thirds of the outstanding shares of
the Registrable Securities held by Holders (assuming the exercise or conversion of all outstanding
Eligible Securities). Capitalized terms not defined herein have the meanings set forth in the
Rights Agreement.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>RECITALS</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, on July&nbsp;18, 2007, Fluidigm California was merged with and into the Company, with the
Company being the surviving corporation such that the Company succeeded to all of Fluidigm
California&#146;s rights and obligations under the Rights Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, it is contemplated that the Company will sell and issue additional shares of the
Company&#146;s Series&nbsp;E Preferred Stock (&#147;<B>Series&nbsp;E Preferred Stock</B>&#148;) pursuant to that certain Series&nbsp;E
Preferred Stock Purchase Agreement, dated as of June&nbsp;13, 2006, as amended December&nbsp;22, 2006 and
further amended on the date hereof (the &#147;<B>Purchase Agreement</B>&#148;), by and among the Company and the
Purchasers named therein;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, in connection with the sale of additional shares of Series&nbsp;E Preferred Stock, the
Company and the Holders desire to amend the Rights Agreement to include the additional shares of
Series&nbsp;E Preferred Stock to be issued pursuant to the Purchase Agreement and make certain other
changes as set forth herein; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>WHEREAS</B>, pursuant to Section&nbsp;6.7 of the Rights Agreement, the Rights Agreement may be amended
with the written consent of the Company and Holders of at least two-thirds of the outstanding
shares of the Registrable Securities then held by Holders (assuming the exercise or conversion of
all outstanding Eligible Securities) and the Company and the undersigned Holders have agreed to
amend the Rights Agreement to provide for the foregoing changes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>NOW, THEREFORE</B>, in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, all of the parties
hereto mutually agree as follows:
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>AGREEMENT</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 12 <U>Amendment to Recital</U>. The first Recital of the Rights Agreement is hereby
amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&#147;WHEREAS, the Company and the New Investors have entered into a Series&nbsp;E Preferred Stock
Purchase Agreement of even date herewith, as amended from time to time (such agreement, as
amended from time to time, the &#147;<B>Purchase Agreement</B>&#148;), pursuant to which the Company shall
sell, and the New Investors shall acquire, shares of the Company&#146;s Series&nbsp;E Preferred
Stock;&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 13 <U>Amendment to Section&nbsp;1.14</U>. Subsection (a)(i) of Section&nbsp;1.14 (Standoff
Agreement) of the Rights Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&#147;(i) such agreement shall not exceed one hundred and eighty (180)&nbsp;days (or such greater
period, not to exceed 17&nbsp;days, as may be requested by the Company or an underwriter to
accommodate regulatory restrictions on (i)&nbsp;the publication or other distribution of research
reports and (ii)&nbsp;analyst recommendations and opinions, including, but not limited to, the
restrictions contained in NASD Rule&nbsp;2711(f)(4) or NYSE Rule&nbsp;472(f)(4), or any successor
provisions or amendments thereto);&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 14 <U>Deletion of Section&nbsp;1.15</U>. The Rights Agreement is hereby amended to delete
Section&nbsp;1.15 (No Right to Delay Registration) in its entirety.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 15 <U>Amendment to Section&nbsp;2.4</U>. Section&nbsp;2.4 (Visitation Rights) of the Rights
Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;2.4 <U>Visitation Rights</U>. One representative chosen collectively by LB I Group
Inc., Lehman Brothers P.A. LLC, Lehman Brothers Partnership Account 2000/2001, L.P. and
Lehman Brothers Offshore Partnership Account 2000/2001, L.P. (collectively, &#147;<B>Lehman</B>&#148;), one
representative chosen collectively by EuclidSR Partners, L.P. and EuclidSR Biotechnology
Partners, L.P. (collectively, &#147;<B>EuclidSR</B>&#148;), one representative chosen by Piper Jaffray
Healthcare Fund III, L.P. (&#147;<B>Piper Jaffray</B>&#148;), one representative chosen by GE Capital Equity
Investments, Inc. (&#147;<B>GE Capital</B>&#148;), one representative chosen collectively by Interwest
Investors VII, L. P. and Interwest Partners VII, L.P. (collectively, &#147;<B>Interwest</B>&#148;), one
representative chosen by AllianceBernstein Venture Fund I, L.P. (&#147;<B>Alliance</B>&#148;), one
representative chosen collectively by Cross Creek Capital, L.P., Cross Creek Capital
Employees&#146; Fund, L.P. and Wasatch Small Cap Growth (collectively, &#147;<B>Wasatch</B>&#148;), one
representative chosen by BMSIF, and one representative chosen collectively by the holders of
a majority of the Shares purchased under Amendment No.&nbsp;2 to the Purchase Agreement
(collectively, the &#147;<B>October&nbsp;2007 Representative</B>&#148;) shall have the right to attend all
meetings of the Board of Directors, including meetings of any committee of the Board and
including the right to participate in any telephonic board meetings, so long as such
Investor or the October&nbsp;2007 Representative holds at least
750,000 shares of Eligible Securities (as adjusted for stock
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">splits and combinations and the like). Said representative(s) shall be provided with
notice of the meetings in the same manner at the same time as the members of the Board of
Directors and shall be provided with any materials distributed to the Board of Directors in
connection with board meetings. The foregoing visitation rights may be limited by the Board
of Directors if (i), upon the advice of counsel, the Board of Directors determines that
exclusion is required by third party confidentiality agreements, (ii)&nbsp;the Board is
discussing engaging Investor or an affiliate of Investor as a financial advisor or
underwriter; or (iii)&nbsp;the Board is discussing a material transaction with an entity in which
Investor or a private equity fund affiliated with Investor is a 5% or greater shareholder,
or (iv)&nbsp;the Board determines in good faith upon advice of counsel that limitations are
required to maintain attorney-client privilege.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 16 <U>Amendment to Section&nbsp;6.7</U>. Section&nbsp;6.7 (Amendment and Waiver) of the Rights
Agreement is hereby amended and restated in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;6.7 <U>Amendment and Waiver</U>. Any provision of this Agreement may be amended or
waived with the written consent of the Company and the Holders of at least two-thirds of the
outstanding shares of the Registrable Securities then held by Holders (assuming the exercise
or conversion of all outstanding Eligible Securities); <U>provided</U>, <U>however</U>,
(i)&nbsp;that in the event such amendment or waiver adversely affects the rights and/or
obligations of the Founders under this Agreement in a different manner than the other
Holders, such amendment or waiver shall also require written consent of the Founders holding
a majority of the then outstanding Founders Shares, (ii)&nbsp;that in the event such amendment or
waiver adversely affects the rights and/or obligations of Lehman, EuclidSR, Piper Jaffray,
GE Capital, Interwest, Alliance, Wasatch, BMSIF or the October&nbsp;2007 Representative under
Section&nbsp;2.4 of this Agreement, such amendment or waiver shall not be effective as to Lehman,
EuclidSR, Piper Jaffray, GE Capital, Interwest, Alliance, Wasatch, BMSIF or the October&nbsp;2007
Representative, as the case may be, without the written consent of such party, and (iii)
that in the event such amendment or waiver adversely affects the rights and/or obligations
of Warrantholders under this Agreement in a different manner than the other Holders, such
amendment or waiver shall also require the written consent of Warrantholders holding a
majority of the then outstanding Warrant Shares. Notwithstanding the foregoing, any
purchaser of Series&nbsp;E Preferred Stock pursuant to the Purchase Agreement may become a party
to this Agreement by executing and delivering an additional counterpart signature page to
this Agreement and such purchaser shall be deemed a Holder and an Investor hereunder. The
parties agree that <U>Exhibit&nbsp;A</U> shall be updated automatically without any formal
amendment to reflect the addition of any such additional party. Any amendment or waiver
effected in accordance with this paragraph shall be binding upon each Holder, the Founders,
the holder of the Other Shares, Warrantholders and the Company. In addition, the Company
may waive performance of any obligation owing to it, as to some or all of the Holders, or
agree to accept alternatives to such performance, without obtaining the
consent of any other Holder. In the event that an underwriting agreement is entered
into between the Company and any Holder, and such underwriting agreement contains terms
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">differing from this Agreement, as to any such Holder the terms of such underwriting
agreement shall govern.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 17 <U>Addition of Section&nbsp;6.15</U>. The Rights Agreement is hereby amended to add
the following Section&nbsp;6.15 which reads in its entirety as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;6.15 <U>Reincorporation</U>. Each Investor and Founder acknowledges that the Company
completed a reincorporation into the State of Delaware on July&nbsp;18, 2007 and each Investor
and Founder hereby consents to the assignment of this Agreement to Fluidigm Corporation, a
Delaware corporation, effective as of July&nbsp;18, 2007.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 18 <U>Governing Law</U>. This Amendment shall be construed in accordance with, and
governed in all respects by, the laws of the State of California, as applied to agreements entered
into, and to be performed entirely in such state, between residents of such state.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 19 <U>Rights Agreement</U>. Wherever necessary, all other terms of the Rights
Agreement are hereby amended to be consistent with the terms of this Amendment. Except as
specifically set forth herein, the Rights Agreement shall remain in full force and effect
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 20 <U>Counterparts</U>. This Amendment may be executed in any number of
counterparts, each of which shall be enforceable against the parties actually executing such
counterparts, and all of which together shall constitute one instrument.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 21 <U>Effect of Execution of Amendment by Investor</U>. This Amendment, when
executed and delivered by the Company and an Investor purchasing shares of Series&nbsp;E Preferred
pursuant to the Purchase Agreement as contemplated in the Recitals, shall also constitute and shall
be deemed a counterpart signature page to the Rights Agreement. Consequently, each undersigned
Investor purchasing shares of Series&nbsp;E Preferred acknowledges and agrees that he, she or it is
bound by the terms and conditions contained in the Rights Agreement, as amended by this Amendment.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;</B><B><I>Remainder of Page Intentionally Blank</I></B><B>&#093;</B>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>FOUNDERS</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Gajus V. Worthington
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Stephen R. Quake
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>INVESTORS</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Alejandro Berenstein, M.D.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Alfred J. Mandel
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Allan Johnson
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Allen May, Trustee, Intervivos Trust Dated 5/14/91
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">AllianceBernstein Venture Fund I, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Alloy Partners 2002, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Alloy Ventures 2002, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Alloy Ventures 2005, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Analiza, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Athersys, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Beveren Company
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Biomedical Sciences Investment Fund Pte Ltd
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Bradford S. Goodwin and Cathy W. Goodwin As Trustees of the Goodwin Family Trust U/A/D 7/30/97
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Bradford W. Baer
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Bruce Burrows
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Burr &#038; Forman LLP
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Burwen Family Trust U/D/T Dated 9/30/88
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Charles C. Moore
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Charles R. Engles
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Clark-Boyd Family Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Cross Creek Capital Employees&#146; Fund, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Cross Creek Capital, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">David S. Frampton and Gaja Roberta Frampton, as Trustees of the Frampton Family Trust Dtd 4/25/03
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dwayne Hardy
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Edward R. LeMoure
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Erick Vanderburg
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Erik T. Engelson, Trustee of the Elisabeth North Kuechler Engelson Trust UTA dated January&nbsp;17, 2001
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Erik T. Engelson, Trustee of the Erik T. Engelson Trust UTD dated March&nbsp;29, 2000
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">EuclidSR Biotechnology Partners, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">EuclidSR Partners, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ferguson/Egan Family Trust Dated 6/28/99
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Fidelity Contrafund: Fidelity Advisor New Insights Fund
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Fidelity Contrafund: Fidelity Contrafund
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Finnegan, Henderson, Farabow, Garrett &#038; Dunner, LLP
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Frances H. Arnold
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Fred St. Goar
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Fredrick Stern
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Gary R. Bang
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">GE Capital Equity Investments, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">General Electric Capital Corporation
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">George S. Taylor
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Glaxo Group Limited
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Health Care Administration Company
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Heath Lukatch
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Henry P. Massey, Jr. TTEE Massey Family Trust U/A DTD 7/06/88
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Herbert L. Heyneker
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Howard R. Engelson
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Howard R. Engelson and Mariam T. Engelson, Ttees Engelson Fam Tr UA DTD 5/26/94
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In-Q-Tel Employee Fund, LLC
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In-Q-Tel, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Interwest Investors VII, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Interwest Partners VII, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Invus, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">J.F. Shea Co., Inc. As Nominee 1999-114
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Jacaranda Partners
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">James H. Eberwine
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">James W. Larrick, M.D.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">John E. Strobeck, Ph.D., M.D.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">John East
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">John M. Harland
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Jonathan S. Hoot and Andrea T. Hoot, Trustees of the Hoot Family Revocable Trust DTD 3/16/99
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Joseph M. Jacobson
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Kenneth A. Clark
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Kiley Revocable Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Kristin T. McClanahan Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Leerink Swann Co-Investment Fund, LLC
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Leerink Swann Holdings, LLC
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Lehman Brothers Healthcare Venture Capital L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Lehman Brothers Offshore Partnership Account 2000/2001, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Lehman Brothers P.A. LLC
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Lehman Brothers Partnership Account 2000/2001, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Leo J. Parry, Jr. and Roberta J. Parry TTEES Parry Family Revocable Trust DTD 01/22/97
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Lighthouse Capital Partners V, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Lilly Bio Ventures, Eli Lilly and Company
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Markwell Partners
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Matthew Collier
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Matthew Frank
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Michael H. McKay
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Michael J. Reardon Trust Agreement dated June&nbsp;5, 1996
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Needle &#038; Rosenberg PC
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Newman Family Investment Partnership
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Oculus Pharmaceuticals, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pamela East
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pat and Betsy Collins Revocable Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Patrick Tenney
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Paul Machle
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pauline van Ysendoorn
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Peter B. Dervan
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Peter S. Heinecke
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Rhett E. Brown
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Robert D. McCulloch and Kathleen M. McCulloch, Trustee, or their successor(s)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Robert F. Kornegay, Jr. Revocable Trust u/d/t dated May&nbsp;27, 2004, Robert F. Kornegay, Jr., Trustee
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Security Trust Co., Custodian FBO Frank Ruderman IRA/RO
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">SightLine Healthcare Fund III, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Singapore Bio-Innovations Pte Ltd.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">SMALLCAP World Fund, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">SmithKline Beecham Corporation
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Stanley D. Hayden, and his successor(s), as the Trustee of the Stanley D. Hayden Family Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Stephen J. Weiss
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Stephen J. Weiss and Ursula G. Weiss, Trustees of the Weiss Family 1996 Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Stephen L. Parry
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Technogen Liquidating Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Condon Family Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Heckmann Family Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The UAB Research Foundation
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The V Foundation for Cancer Research
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Thomas J. Parry
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Thomas L. Barton
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Tim L. Traff Trust
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Timothy P. Lynch
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">TTC Fund I, LLC
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Variable Insurance Products Fund II: Contrafund Portfolio
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Versant Affiliates Fund 1-A, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Versant Affiliates Fund 1-B, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Versant Side Fund I, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Versant Venture Capital I, L.P.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Wasatch Funds, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">William L. Caton III, M.D.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">William L. Traff Trust
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">William S. Brown and Barbara G. Brown, or their successors, as Trustees of the Brown FRT DTD
3/10/99
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WS Investment Company 2000B
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WS Investment Company 99B
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WS Investment Company, LLC (2001D)
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT
E</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FORM
OF LEGAL OPINION</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">June&nbsp;&nbsp;&nbsp;, 2006
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">AllianceBernstein L.P.<br>
1345 Avenue of the Americas<br>
New York, New York 10105
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Ladies and Gentlemen:

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reference is made to the Series&nbsp;E Preferred Stock Purchase Agreement dated as of June&nbsp;&nbsp;&nbsp;, 2006
(the &#147;<B>Agreement</B>&#148;) by and among Fluidigm Corporation, a California corporation (the &#147;<B>Company</B>&#148;), and
the persons and entities listed in Exhibit&nbsp;A to the Agreement (the &#147;<B>Investors</B>&#148;), which provides for
the issuance by the Company to the Investors of shares of Series&nbsp;E Preferred Stock of the Company
(the &#147;<B>Shares</B>&#148;). This opinion is rendered to the Investors in the Initial Closing pursuant to
Section&nbsp;4.5 of the Agreement, and all terms used herein have the meanings defined for them in the
Agreement unless otherwise defined herein. Reference in this opinion to the Agreement excludes any
schedule or substantive agreement attached as an exhibit to the Agreement, unless otherwise
indicated herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have acted as counsel for the Company in connection with the negotiation of the Agreement
and the Investor Rights Agreement (collectively, the &#147;<B>Transaction Documents</B>&#148;) and the issuance of
the Shares. As such counsel, we have made such legal and factual examinations and inquiries as we
have deemed advisable or necessary for the purpose of rendering this opinion. In addition, we have
examined originals or copies of such corporate records of the Company, certificates of public
officials and such other documents which we consider necessary or advisable for the purpose of
rendering this opinion. In such examination we have assumed the genuineness of all signatures on
original documents, the authenticity and completeness of all documents submitted to us as
originals, the conformity to original documents of all copies submitted to us and the due execution
and delivery of all documents (except as to due execution and delivery by the Company) where due
execution and delivery are a prerequisite to the effectiveness thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used in this opinion, the expression &#147;to our knowledge,&#148; &#147;known to us&#148; or similar language
with reference to matters of fact refers to the current actual knowledge of attorneys of this firm
who have worked on matters for the Company in connection with the Agreement and the transactions
contemplated thereby. Except to the extent expressly set forth herein or as we otherwise believe
to be necessary to our opinion, we have not undertaken any independent investigation to determine
the existence or absence of any fact, and no inference as to our knowledge of the existence or
absence of any fact should be drawn from our representation of the Company or the rendering of the
opinion set forth below.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">AllianceBernstein L.P.<br>
Dated as of June&nbsp;&nbsp;&nbsp;, 2006<br>
Page 2
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this opinion, we are assuming that each Investor has all requisite power and
authority, and has taken any and all necessary corporate or partnership action, to execute and
deliver the Transaction Documents and to effect any and all transactions related to or contemplated
thereby. In addition, we are assuming that the Investors have purchased the Shares for value, in
good faith and without notice of any adverse claims within the meaning of the California Uniform
Commercial Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are members of the Bar of the State of California and we express no opinion as to any
matter relating to the laws of any jurisdiction other than the federal laws of the United States of
America and the laws of the State of California.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In rendering the opinion in paragraph 6 below, we note that we have not conducted a docket
search in any jurisdiction with respect to litigation that may be pending against the Company or
any of its officers or directors. We further note the disclosure under Section&nbsp;2.10 of the
Schedule of Exceptions to the Agreement. Please be advised that we have not represented the
Company with respect to the matters disclosed in Section&nbsp;2.10 of the Schedule of Exceptions and
express no opinion with respect to any matter discussed therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The opinions hereinafter expressed are subject to the following additional qualifications:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;We express no opinion as to the effect of applicable bankruptcy, insolvency,
reorganization, moratorium or other similar federal or state laws affecting the rights of
creditors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;We express no opinion as to the effect or availability of rules of law governing specific
performance, injunctive relief or other equitable remedies (regardless of whether any such remedy
is considered in a proceeding at law or in equity).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;This opinion is qualified by the limitations imposed by statutes and principles of law and
equity that provide that certain covenants and provisions of agreements are unenforceable where
such covenants or provisions are unconscionable or contrary to public policy or where enforcement
of such covenants or provisions under the circumstances would violate the enforcing party&#146;s implied
covenant of good faith and fair dealing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Our opinion in the first sentence of paragraph 1 below is based solely on the certificates
of public officials and filing officers as to the corporate and tax good standing of the Company in
the State of California.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Our opinions set forth in paragraph 3 below relating to the outstanding capital stock of the
Company and outstanding options, warrants or similar rights to acquire shares of the Company&#146;s
capital stock are based solely on (i)&nbsp;our review of a report from eProsper, Inc., the
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">AllianceBernstein L.P.<br>
Dated as of June&nbsp;&nbsp;&nbsp;, 2006<br>
Page 3
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company&#146;s transfer agent, detailing the holders of securities of the Company and the number
and type of securities held by such holders (the &#147;<B>Transfer Agent Report</B>&#148;) and (ii)&nbsp;a certificate
delivered to us by the Company regarding factual matters underlying the opinions set forth herein.
Our opinion in paragraph 3 below that the issued and outstanding shares of Common Stock and
Preferred Stock of the Company are fully paid and non-assessable is based solely on a certificate
of an officer of the Company that the Company received, in payment for such shares, the full
consideration required by the resolutions of the Board of Directors of the Company authorizing the
issuance of such shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;For purposes of our opinions in paragraph 2 and paragraph 4 below, we have assumed that
the Transfer Agent Report is accurate and complete in all respects.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;We express no opinion as to compliance with the anti-fraud provisions of applicable
securities laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;We express no opinion as to the enforceability of any indemnification or contribution
provision, including, without limitation, the indemnification and contribution provisions of the
Investor Rights Agreement and the indemnification provision in the Agreement, to the extent the
provisions thereof may be subject to limitations of public policy and the effect of applicable
statutes and judicial decisions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;We express no opinion as to the enforceability of choice of law provisions, waivers of
jury trial or provisions relating to venue or jurisdiction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;We have made no inquiry into, and express no opinion with respect to, any federal or state
statute, rule, or regulation relating to any tax, antitrust, land use, safety, environmental,
hazardous material, patent, copyright, trademark or trade name matter, as to the statutes,
regulations, treaties or common laws of any other nation (other than the United States), state or
jurisdiction (other than the State of California), or the effect on the transactions contemplated
in the Transaction Documents of noncompliance under any such statues, regulations, treaties, or
common laws. Without limiting the foregoing, we express no opinion as to the effect of, or
compliance with, the Investment Advisors Act of 1940, as amended, or the Employee Retirement Income
Security Act of 1974, as amended. We further disclaim any opinion as to any statute, rule,
regulation, ordinance, order, or other promulgation of any regional or local governmental body or
as to any related judicial or administrative opinion.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;Our opinions relate solely to the express written provisions of the Transaction Documents,
and we express no opinion as to any other oral or written agreements or understandings between the
Company or any of the Investors.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">AllianceBernstein L.P.<br>
Dated as of June&nbsp;&nbsp;&nbsp;, 2006<br>
Page 4
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based upon and subject to the foregoing, and except as set forth in the Schedule of Exceptions
to the Agreement, we are of the opinion that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;The Company is a corporation duly incorporated and validly existing under, and by virtue
of, the laws of the State of California and is in good standing under such laws. The Company has
requisite corporate power to own and operate its properties and assets, and to carry on its
business as presently conducted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;The Company has all requisite legal and corporate power to execute and deliver the
Transaction Documents, to sell and issue the Shares under the Agreement, to issue the Common Stock
issuable upon conversion of the Shares and to carry out and perform its obligations under the terms
of the Transaction Documents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;The authorized capital stock of the Company consists of 77,857,144 shares of Common Stock,
9,274,356 shares of which are issued and outstanding, and 51,687,948 shares of Preferred Stock,
2,727,273 of which are designated Series&nbsp;A Preferred Stock, 2,727,273 shares of which are issued
and outstanding, 6,460,675 of which are designated Series&nbsp;B Preferred Stock, 6,460,675 shares of
which are issued and outstanding, 17,000,000 of which are designated Series&nbsp;C Preferred Stock,
16,364,832 shares of which are issued and outstanding, 15,500,000 shares of Series&nbsp;D Preferred
Stock, 11,714,048 of which are issued and outstanding, and 10,000,000 shares of Series&nbsp;E Preferred
Stock, none of which has been issued or outstanding immediately prior to the Initial Closing. All
such issued and outstanding shares of Common Stock and Preferred Stock have been duly authorized
and validly issued and are fully paid and nonassessable.<SUP style="font-size: 85%; vertical-align: text-top"> </SUP> The Company has reserved:
(i)&nbsp;5,000,000 shares of Series&nbsp;E Preferred Stock for issuance pursuant to the Agreement and
5,000,000 shares of Common Stock for issuance upon conversion of such shares of Series&nbsp;E Preferred
Stock; (ii)&nbsp;11,714,048 shares of Common Stock for issuance upon conversion of the Series&nbsp;D
Preferred Stock, (iii)&nbsp;916,335 shares of Series&nbsp;D Preferred Stock for issuance upon exercise of
outstanding warrants and 916,335 shares of Common Stock for issuance upon conversion of such Series
D Preferred Stock; (iv)&nbsp;16,364,832 shares of Common Stock for issuance upon conversion of the
Series&nbsp;C Preferred Stock; (v)&nbsp;294,868 shares of Series&nbsp;C Preferred Stock for issuance upon exercise
of outstanding warrants and 294,868 shares of Common Stock for issuance upon conversion of such
Series&nbsp;C Preferred Stock; (vi)&nbsp;6,460,675 shares of Common Stock for issuance upon
conversion of the Series&nbsp;B Preferred Stock; (vii)&nbsp;2,727,273 shares of Common Stock for
issuance upon conversion of the Series&nbsp;A Preferred Stock; and (viii)&nbsp;an aggregate of 10,800,000
shares of Common Stock for issuance to employees and consultants of the Company pursuant to the
Company&#146;s 1999 Stock Option Plan (the &#147;<B>Option Plan)</B>, pursuant to which options to purchase
5,597,763 shares are granted and outstanding and 1,554,643 shares are available for future grant.
The Common Stock issuable upon conversion of the Shares has been duly authorized and duly and
validly reserved, and when issued in accordance with the Company&#146;s Articles of Incorporation, will
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">AllianceBernstein L.P.<br>
Dated as of June&nbsp;&nbsp;&nbsp;, 2006<br>
Page 5
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">be validly issued, fully paid and nonassessable. The Shares issued under the
Agreement are duly authorized, validly issued, fully paid and nonassessable and are free of any
liens, encumbrances and preemptive or similar rights contained in the Articles of Incorporation or
Bylaws of the Company, or, to our knowledge, in any written agreement to which the Company is a
party, except as specifically provided in the Agreement (including its Exhibits) and except for
liens or encumbrances created by or imposed upon the Investors; provided, however, that
the Shares (and the Common Stock issuable upon conversion thereof) are subject to restrictions on
transfer under applicable state and federal securities laws. To our knowledge, except for rights
described above, in the Transaction Documents (including the Schedule of Exceptions to the
Agreement) or in the Articles of Incorporation of the Company, as of the date of the Agreement,
there are no other options, warrants, conversion privileges or other rights in writing presently
outstanding to purchase or otherwise acquire any authorized but unissued shares of capital stock or
other securities of the Company, or any other written agreements of the Company to issue any such
securities or rights; <U>provided</U>, <U>however</U>, we note the Company&#146;s intent to comply
with Section&nbsp;3 of the Investor Rights Agreement following the Initial Closing.<SUP style="font-size: 85%; vertical-align: text-top"> </SUP>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;All corporate action on the part of the Company, its directors and shareholders necessary
for the authorization, execution and delivery of the Transaction Documents by the Company, the
authorization, sale, issuance and delivery of the Shares (and the Common Stock issuable upon
conversion thereof) and the performance by the Company of its obligations under the Transaction
Documents (other than those registration obligations contained in Section&nbsp;1 of the Investor Rights
Agreement) has been taken. The Transaction Documents have been duly and validly executed and
delivered by the Company and constitute a valid and binding obligation of the Company, enforceable
against the Company in accordance with their terms.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;The execution and delivery by the Company of the Transaction Documents, the performance by
the Company of its obligations under the Transaction Documents, and the issuance of the Shares (and
the Common Stock issuable upon conversion thereof) do not violate any provision of the Articles of
Incorporation or Bylaws, or any provision of any applicable federal or state law, rule or
regulation known to us to be customarily applicable to transactions of this nature. The execution
and delivery by the Company of the Transaction Documents, the performance by the Company of its
obligations under the Transaction Documents, and the issuance of the Shares (and the Common Stock
issuable upon conversion thereof) do not violate any judgment or decree known to us that is binding
upon the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;Except as identified in the Agreement (including the Schedule of Exceptions), to our
knowledge, there are no actions, suits, proceedings or investigations pending against the Company
or its properties before any court or governmental agency nor, to our knowledge, has the Company
received any written threat thereof.
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 12pt">AllianceBernstein L.P.<br>
Dated as of June&nbsp;&nbsp;&nbsp;, 2006<br>
Page 6
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;No consent, approval or authorization of or designation, declaration or filing with any
governmental authority on the part of the Company is required in connection with the valid
execution and delivery of the Transaction Documents, or the offer, sale or issuance of the Shares
(and the Common Stock issuable upon conversion thereof) or the consummation by the Company of any
other transaction contemplated by the Transaction Documents, except (a)&nbsp;the filing of the Amended
and Restated Articles of Incorporation in the Office of the Secretary of State of the State of
California, and (b)&nbsp;subject to the accuracy of the representations and warranties of the Investors
in Section&nbsp;3 of the Agreement, (i)&nbsp;the filing after the Closing of a Form&nbsp;D pursuant to Regulation
D, promulgated by the United States Securities and Exchange Commission (the &#147;<B>SEC</B>&#148;) under the
Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), with the SEC, and (ii)&nbsp;the post-Closing
qualification (or the taking of such action post-Closing as may be necessary to secure an exemption
from qualification) under applicable state securities laws of the offer and sale of the Shares (and
the Common Stock issuable upon conversion thereof). The filing referred to in clause (a)&nbsp;above has
been accomplished and is effective. Our opinion herein is otherwise subject to the timely and
proper completion of all filings and other actions contemplated herein where such filings and
actions are to be undertaken on or after the date hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;Subject to the accuracy of the Investors&#146; representations in Section&nbsp;3 of the Agreement,
the offer, sale and issuance of the Shares (and the Common Stock issuable upon
conversion thereof) in conformity with the terms of the Agreement constitute transactions
exempt from the registration requirements of Section&nbsp;5 of the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This opinion is furnished to the Investors solely for their benefit in connection with the
purchase of the Shares, and may not be relied upon by any other person or for any other purpose
without our prior written consent. We assume no obligation to inform you of any facts,
circumstances, events or changes in the law that may arise or be brought to our attention after the
date of this opinion that may alter, affect or modify the opinions expressed herein.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR>
</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.19
<SEQUENCE>3
<FILENAME>f39432xexv10w19.htm
<DESCRIPTION>EXHIBIT 10.19
<TEXT>
<HTML>
<HEAD>
<TITLE>exv10w19</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;10.19</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><b>Oscient</b>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>SUBLEASE</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This SUBLEASE is made as of March&nbsp;25, 2004, by and between Genome Therapeutics Corporation, a
Massachusetts corporation having a place of business at 100 Beaver Street, Waltham, Massachusetts
02453 (&#147;Sublessor&#148;) and Fluidigm Corporation, a California corporation having an address at 7100
Shoreline Court, San Francisco, California 94080 (&#147;Sublessee&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>WITNESSETH:</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, pursuant to that certain Agreement of Lease dated as of November&nbsp;9, 1999, by and
between Mountain Cove Tech Center, L.L.C., as &#147;landlord&#148;, (&#147;Master Lessor&#148;) and MJ Research
Company, Inc., as &#147;tenant&#148;, (&#147;Prime Lessor&#148;) (the &#147;Master Lease&#148;), Master Lessor leases to Prime
Lessor the land and building known as and numbered 7000 Shoreline Court, San Francisco, California
(the &#147;Building&#148;) (all as more particularly described in the Master Lease a true and complete copy
of which is attached hereto as <U><B>Exhibit&nbsp;A-1</B></U>, the &#147;Master Premises&#148;); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, pursuant to that certain Agreement of Lease dated as of October&nbsp;6, 2000 by and
between Prime Lessor, as &#147;landlord&#148; and Sublessor, as &#147;tenant&#148; (as successor in interest to
Genesoft, Inc.), as amended by a First Amendment to Lease dated December&nbsp;5, 2002 and a Second
Amendment to Lease dated March&nbsp;25, 2004 (such lease, as so amended, and all renewals, modifications
and extensions thereof being hereinafter collectively referred to as the &#147;Prime Lease&#148;), a true
and complete copy of which is attached hereto as <U><B>Exhibit&nbsp;A-2</B></U>, Prime Lessor leases to
Sublessor approximately 68,460 rentable square feet of space located on the first, second and third
floors of the Building (all as more particularly described in the Prime Lease, the &#147;Premises&#148;); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Sublessee subleases other space in the Building directly from Prime Lessor pursuant
to that certain Sublease dated December&nbsp;1, 2001 (as amended to date, the &#147;MJ Research Sublease&#148;);
and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Sublessee desires to sublease a portion of the Premises from Sublessor and Sublessor
is willing to sublease the same, all on the terms and conditions hereinafter set forth;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties covenant and agree as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Sublease of Subleased Premises</U>. For the rent and upon the terms and
conditions herein, Sublessor hereby subleases to Sublessee, and Sublessee hereby subleases from
Sublessor approximately 14,503 rentable square feet of office and lab space located on the 1st
floor of the Building as shown on <U><B>Exhibit&nbsp;B</B></U> attached hereto (the &#147;Subleased Premises&#148;).
Sublessee acknowledges that any reference to the square
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">footage of the Subleased Premises is an approximation. Nevertheless, the parties agree that such
approximation shall be final and binding for all purposes hereunder, and that no adjustment shall
be made to the Rent if the actual square footage of the Subleased Premises differs from any
reference to square footage contained herein. During the term hereof, Sublessee shall have access
to the Subleased Premises and the parking lot(s) adjacent to the Building twenty-four (24)&nbsp;hours a
day, 7&nbsp;days a week, subject to the terms of the Prime Lease and this Sublease. Sublessor also
grants Sublessee the right to use, without additional charge during the term of this Sublease,
those items of personal property identified on <U><B>Exhibit&nbsp;C</B></U> attached hereto and made a part
hereof (the &#147;Furniture&#148;), together with the existing network wiring/equipment (including handsets)
and fixtures in the Subleased Premises as of the Commencement Date. Sublessee accepts possession of
the Furniture and said network wiring/equipment and fixtures &#147;as is, where is&#148; and in their current
condition, Sublessor having made no representation or warranty of any kind, express or implied
(including, but not limited to, any warranty of fitness for any particular use or purpose) with
respect to any of the same. Prior to the Commencement Date, Sublessee shall, upon prior notice to
the Sublessor, have the right to enter the Subleased Premises for the purposes of inspecting the
same, taking measurements, installing its furniture, fixtures and equipment, and preparing for the
move into the Subleased Premises. Sublessor shall have the right to have a representative present
any time such early entry right is exercised. If Sublessee enters the Subleased Premises prior to
the Commencement Date, Sublessee shall be responsible for complying with all of the terms of this
Sublease (other than the payment of Rent) and, to the extent incorporated herein by reference, the
Prime Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Term</U>. The Term of this Sublease (the &#147;Initial Term&#148;) shall commence on March
1, 2004 (the &#147;Commencement Date&#148;), and shall expire on December&nbsp;31, 2007 (the &#147;Expiration Date&#148;) or
such earlier date upon which said Initial Term may expire, be canceled or be terminated pursuant to
any of the terms or provisions of the Prime Lease, this Sublease or applicable law. Sublessee shall
have one option to extend the term of this Sublease from January&nbsp;1, 2008 until December&nbsp;31, 2010
(the &#147;Extension Term&#148;) following the Initial Term on the same terms and conditions as herein
specified (other than the payment of Rent), which option shall be exercisable upon Sublessee&#146;s
providing Sublessor with written notice no later than six (6)&nbsp;months prior to the Expiration Date,
time being of the essence. Failure on the part of Sublessee to give timely such notice exercising
the extension option for the Extension Term shall render said extension option void and of no
further force or effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On the conditions (any one or more of which conditions Sublessor may waive, at its election,
by written notice to Sublessee at any time) that at the time of option exercise Sublessee is not in
default of its covenants and obligations under this Sublease beyond all applicable cure periods,
Sublessee may elect to exercise its right to the Extension Term.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Rent for the Extension Term shall be 95% of the then current fair market rental value
(&#147;FMRV&#148;) for comparable space in South San Francisco, California under a three (3)&nbsp;year sublease,
taking into account all relevant factors.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The FMRV shall be proposed by Sublessor within thirty (30)&nbsp;days of the receipt of Sublessee&#146;s
notice that it intends to extend the term of the Sublease (the &#147;<U>Sublessor&#146;s Proposed Market
Rent</U>&#148;). The Sublessor&#146;s Proposed Market Rent shall be deemed to be the FMRV unless
Sublessee notifies Sublessor, within thirty (30)&nbsp;days of Sublessee&#146;s receipt of the Sublessor&#146;s
Proposed Market Rent notice, that the Sublessor&#146;s Proposed Market Rent is not satisfactory to
Sublessee (the &#147;<U>Sublessee&#146;s Rejection Notice</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the FMRV is not otherwise agreed upon by Sublessor and Sublessee within fifteen
(15)&nbsp;days after Sublessor&#146;s receipt of the Sublessee&#146;s Rejection Notice, then:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If the MJ Research Sublease has been extended for a period coterminous
with the Extension Term hereunder and the &#147;fair market rent&#148; for such
extension has been determined in good faith under and pursuant to the
process set forth in Section&nbsp;4 of the MJ Research Sublease, the FMRV
shall be determined by multiplying such fair market rent per rentable
square foot by the rentable square footage of the Subleased Premises.
However, if for any reason such fair market rent has not been so
determined as of the commencement of the Extension Term hereof, the
FMRV shall be determined as set forth in subparagraphs (2)&nbsp;through (8)
below.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sublessor and Sublessee shall notify one another within ten (10)&nbsp;days
after the commencement of the Extension Term of the name and address
of the appraiser designated by each. Such two (2)&nbsp;appraisers shall, within
twenty (20)&nbsp;days after the designation of the second appraiser, make their
determination of the FMRV in writing and give notice thereof to each
other and to Sublessor and Sublessee. Such two (2)&nbsp;appraisers shall have
twenty (20)&nbsp;days after the receipt of notice of each other&#146;s determinations
to confer with each other and to attempt to reach agreement as to the
determination of the FMRV. If such appraisers shall concur in such
determination within said twenty (20)&nbsp;day period, then they shall give
notice thereof to Sublessor and Sublessee and such concurrence shall be
final and binding upon Sublessor and Sublessee. If such appraisers shall
fail to concur as to such determination within said twenty (20)&nbsp;day
period, then they shall give notice thereof to Sublessor and Sublessee and
shall immediately designate a third appraiser. If the two (2)&nbsp;appraisers
shall fail to agree upon the designation of such third appraiser within five
(5)&nbsp;days after said twenty (20)&nbsp;day period, then they or either of them
shall give notice of such failure to agree to Sublessor and Sublessee and,
if Sublessor and Sublessee fail to agree upon the selection of such third
appraiser within five (5)&nbsp;days after the appraiser(s) appointed by the
parties give notice as aforesaid, then either party on behalf of both may
apply to the American Arbitration Association or any successor thereof
to designate a third appraiser, or on such association&#146;s failure, refusal or
inability to act, to a court of competent jurisdiction, for the designation of
such third appraiser.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>All appraisers shall be commercial real estate brokers who shall have had
at least five (5)&nbsp;years&#146; continuous experience as a commercial real estate
broker, including some experience leasing biotech space, in the South
San Francisco, California area.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(4)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The third appraiser shall conduct such investigations as he or she may
deem appropriate and shall, within ten (10)&nbsp;days after the date of his or
her designation, make an independent determination of the FMRV.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(5)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If none of the determinations of the appraisers varies from the mean of
the determinations of the other appraisers by more than ten percent
(10%), the mean of the determinations of the three (3)&nbsp;appraisers shall be
the FMRV for the Subleased Premises. If, on the other hand, the
determination of any single appraiser varies from the mean of the
determinations of the other two (2)&nbsp;appraisers by more than ten percent
(10%), the mean of the determination of the two (2)&nbsp;appraisers whose
determinations are closest shall be the FMRV.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(6)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The determination of the appraisers, as provided above, shall be
conclusive upon the parties and shall have the same force and effect as a
judgment made in a court of competent jurisdiction.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(7)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Each party shall pay fees, costs and expenses of the appraiser selected by
it and its own counsel fees and one-half (1/2) of all other expenses
and fees of the third appraiser.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(8)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Should the arbitration process extend beyond the Initial Term the
monthly Rent will increase by 3.5% of the then monthly Rent until the
new monthly Rent is established by the appraisers as provided herein and
any Rent paid by Sublessee during such period shall be adjusted
accordingly based on the outcome of the arbitration process.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;References herein to the &#147;Term&#148; of this Sublease shall be deemed to mean and include the
Initial Term and the Extension Term (and the Expiration Date shall be deemed extended accordingly)
if and when Sublessee has given timely such notice exercising the same.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Appurtenant Rights</U>. Sublessee shall have, as appurtenant to the Subleased
Premises, rights to use in common with Sublessor and others entitled thereto Sublessor&#146;s rights in
driveways, walkways, hallways, stairways and passenger elevators convenient for access to the
Subleased Premises and the lavatories nearest thereto. In addition, Sublessor grants Sublessee the
right to use not less than 44 parking spaces in the lot(s) adjacent to the Building on a
non-exclusive basis. Sublessor shall not oversubscribe its parking rights under the Prime Lease.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Rent</U>. Sublessee shall pay to Sublessor the following amounts
as rent (the &#147;Rent&#148;) during the Initial Term, which is intended to be full service
gross rent, during the term of this Sublease:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="64%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Lease Period</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Annual Rent</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Monthly Rent</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">P.R.S.F.</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">3/1/04 - 9/30/04</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">N/A</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">69,904.46</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">57.84</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">10/01/04-12/31/04</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">N/A</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">43,509.00</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">36.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">1/1/05 -12/31/05</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">522,108.00</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">43,509.00</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">36.00</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">1/1/06 -12/31/06</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">540,381.78</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">45,031.82</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">37.26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">1/1/07-12/31/07</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">559,235.68</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">46,602.97</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">38.56</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Rent includes the following: (i)&nbsp;all utility charges (including electricity consumed by
Sublessee in the Subleased Premises); (ii)&nbsp;janitorial and all cleaning charges Monday
through Friday (except federal holidays); (iii)&nbsp;non-hazardous waste disposal; (iv)&nbsp;RO/DI
water; (v)&nbsp;vacuum/compressed air; (vi)&nbsp;emergency/back-up generator power, which generator
shall provide at least the same amount of power that is currently available to Sublessee;
(vii)&nbsp;use of common shipping/receiving area; (viii) waste water PH neutralization system;
(ix)&nbsp;common on-site fitness room, lunch room and adjacent patio; (x)&nbsp;access cards; (xi)
Taxes and property insurance; (xii)&nbsp;use of existing telephone and data wiring
infrastructure; (xiii)&nbsp;common loading dock area; and (xiv)&nbsp;all maintenance and repair of
the Subleased Premises excluding, subject to paragraph 7 of this Sublease, damage caused
by the negligence or willful misconduct of Sublessee its employees, agents, contractors
and invitees. Sublessor shall promptly and diligently perform the services required of it
as set forth above. Rent does not include any Sublessee-specific operational items,
including, but not limited to: (a)&nbsp;telecom/high speed data service through local service
providers; (b)&nbsp;liquid nitrogen or any other specialty gas provisions; (c)&nbsp;hazardous waste
disposal; and (d)&nbsp;any Sublessee-specific operating license(s) requirement(s).
Environmental, health and safety and other consulting services are available through
Sublessor at additional cost on a per case or as needed basis. Sublessee shall begin
paying Rent to Sublessor on the Commencement Date. In addition to Rent, Sublessee shall
also pay to Sublessor the sum of $35,000.00 per month as tenant improvement recovery, up
to a total payment of (including the payment owing as of March&nbsp;1, 2004 and all payments
owing through the final scheduled $35,000.00 payment in December&nbsp;1, 2004) $350,000.00. All
monthly payments of Rent are due and payable in advance on the first day of each calendar
month, without demand, deduction, counterclaim or setoff. Rent for any partial month shall
be prorated and paid on the first of such month. Sublessee shall pay as additional rent
(&#147;Additional Rent&#148;) all sums of money or other charges required to be paid by Sublessee
under this Sublease whether or not such sums and other charges are specifically designated
as &#147;Additional Rent.&#148; Sublessor shall have the same remedies for a default in the payment
of Additional Rent as for a default in the payment of Rent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Permitted Uses</U>. Sublessee shall use the Subleased Premises for
research and development, light manufacturing and general office uses and uses accessory
thereto to the extent permitted by applicable law and under the Prime Lease, including
without limitation, Article&nbsp;5 of the Prime Lease as and to the extent hereinafter
incorporated by reference and for no other purpose or purposes.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-5-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Condition of Subleased Premises</U>. On the Commencement Date, the Subleased
Premises shall be delivered to Sublessee in the condition existing on the date hereof, with all
electrical, plumbing, gas, safety, security, sewer, fire suppression, restrooms, and water systems
in good operating condition. Sublessee acknowledges that it has had an opportunity thoroughly to
inspect the condition of the Subleased Premises, and Sublessee agrees that, subject only to the
foregoing, Sublessee is leasing the Subleased Premises on an &#147;AS IS&#148; basis, with all defects,
without any representation or warranty by Sublessor or its agents as to the condition of the
Subleased Premises or their fitness for Sublessee&#146;s use, and subject to all applicable zoning,
municipal, county and state laws, ordinances and regulations governing and regulating the use of
the Subleased Premises, and any easements, covenants or restrictions of record. Sublessee
acknowledges that Sublessor and its agents have not made any representations or warranties that the
Subleased Premises or the Building comply with legal requirements, including, but not limited to,
the ADA, Title 24, any Transportation Management Plans, or any laws relating to hazardous
substances or materials, and as a material inducement to Sublessor, Sublessee assumes
responsibility for causing the Subleased Premises to comply with all legal requirements throughout
the Term to the extent and only to the extent the same become applicable as a result of the
introduction of hazardous substances to the Subleased Premises by Sublessee or any of its agents,
contractors or employees, special circumstances of Sublessee&#146;s employees (and not generally
applicable to the Building under the ADA), Sublessee&#146;s particular use of (or change of use from
that currently obtaining in) the Subleased Premises, or Sublessee&#146;s construction of alterations in
the Subleased Premises. Sublessee acknowledges that it has satisfied itself that the Subleased
Premises are suitable for its intended use. Sublessor shall have no obligation to do any work in
and to the Subleased Premises in order to prepare the Subleased Premises for occupancy or use by
Sublessee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sublessee shall make no alterations, installations, removals, additions or improvements in or
to the Subleased Premises or any other portion of the Building except with the consent of (a)
Sublessor, which shall not be unreasonably withheld or delayed, (b)&nbsp;Prime Lessor in accordance with
and to the extent required by Article&nbsp;10 of the Prime Lease and (c)&nbsp;Master Lessor in accordance
with and to the extent required by Article&nbsp;10 of the Master Lease; provided, however, that, subject
to the last sentence of this paragraph, Sublessor shall be entitled to condition its consent upon
Sublessee&#146;s removal of the proposed alterations upon the expiration or earlier termination of this
Sublease. Any alterations, installations, removals, additions or improvements consented to by
Sublessor, Prime Lessor and Master Lessor shall be performed at Sublessee&#146;s sole cost. At the time
Sublessee submits plans to Sublessor for Sublessor&#146;s approval, Sublessor shall, upon request of
Sublessee, inform Sublessee whether it will require any alteration or improvement to be removed
from the Subleased Premises upon the expiration of the Sublease term, provided, however, that
Sublessor shall not unreasonably require that any alteration or improvement be so removed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All trade fixtures and personal property, including furniture, furnishings, and audio
visual or other similar technical or specialty installations, installed in the Subleased
Premises at Sublessee&#146;s expense (&#147;Tenant&#146;s Property&#148;) shall at all times remain Sublessee&#146;s
property and Sublessee shall be entitled to all depreciation,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-6-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">amortization and other tax benefits with respect thereto. Except for Tenant&#146;s Property, which
cannot be removed without material injury to the Subleased Premises, at any time Sublessee may
remove Tenant&#146;s Property from the Subleased Premises, provided Sublessee repairs all damage caused
by such removal and restores the Subleased Premises to a condition consistent with the then
condition of the balance of the Subleased Premises. Upon request, Sublessor shall execute a lien
waiver in reasonable form acknowledging its lack of any interest or title in Tenant&#146;s Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sublessee shall not misuse the Furniture, fixtures and equipment (other than Tenant&#146;s
Property) and shall keep the same in clean condition, reasonable wear and tear and damage by fire
or other casualty, Master Lessor, Prime Lessor, Sublessor or their respective agents, employees and
contractors, and hazardous substances not introduced to the Subleased Premises by Sublessee or its
agents, employees or contractors excepted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this Sublease, Sublessee shall have no obligation
to perform, construct, repair, maintain, make or reimburse Sublessor for any improvement, (i)
necessitated by the acts or negligence of Sublessor, Master Lessor, Prime Lessor, any other
occupant of the building or the project, or their respective agents, employees, invitees or
contractors, (ii)&nbsp;occasioned by the exercise of the power of eminent domain or any peril that would
be covered by the customary form of so-called &#147;special form, extended coverage&#148; casualty insurance,
(iii)&nbsp;to the structure or common areas of the building or the project or the heating, ventilating,
air conditioning, electrical, water, sewer, and plumbing systems serving the Subleased Premises,
the building, or the project, unless caused by the acts or negligence of Sublessee or its agents,
employees or contractors, (iv)&nbsp;to any portion of the building or the project outside of the
demising walls of the Subleased Premises, unless caused by the acts or negligence of Sublessee or
its agents, employees or contractors, (v)&nbsp;occasioned by the presence of any hazardous substance on
or about the Subleased Premises, other than hazardous substances introduced into the Subleased
Premises by Sublessee or its agents, employees or contractors, or persons under its control, (vi)
which is expressly the obligation of the Prime Lessor under the Prime Lease or the Master Lessor
under the Master Lease, (vii)&nbsp;except to the extent Sublessee&#146;s obligation under the first paragraph
of this Section&nbsp;6, required as a consequence of any law, rule, regulation, ordinance, covenant,
condition or restriction or occasioned by any construction defect or legal violation of the
Subleased Premises, the building or the project, (viii)&nbsp;which would customarily be reimbursable
under any &#147;special form, extended coverage&#148; casualty insurance policy, or (ix)&nbsp;except to the extent
Sublessee&#146;s obligation under the first paragraph of this Section&nbsp;6, which could be treated as a
&#147;capital expenditure&#148; under generally accepted accounting principles.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>Insurance</U>. Sublessee shall maintain throughout the term of this Sublease such
insurance in respect of the Subleased Premises and the conduct and operation of business therein,
with Sublessor, Prime Lessor and Master Lessor (and Master Lessor&#146;s members, property managers and
other parties in interest as Master Lessor may from time to time reasonably designate to Sublessee
in writing), listed as additional insureds on the liability coverage component thereof, as is
required of &#147;Tenant&#148;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-7-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">pursuant to the terms of the Prime Lease (including, without limitation, Article&nbsp;13 as and to the
extent hereinafter incorporated by reference) and the terms of the Master Lease with no penalty to
Sublessor, Prime Lessor or Master Lessor resulting from deductibles or self-insured retentions
effected in Sublessee&#146;s insurance coverage, and with such other endorsements and provisions as
Prime Lessor or Master Lessor may reasonably request under and pursuant to the Prime Lease and
Master Lease, respectively. If Sublessee fails to procure or maintain such insurance and to pay all
premiums and charges therefor within five (5)&nbsp;days after notice from Sublessor, Sublessor may (but
shall not be obligated to) do so, whereupon Sublessee shall reimburse Sublessor upon demand. All
such insurance policies shall, to the extent obtainable, contain endorsements providing that (i)
such policies may not be canceled except upon thirty (30)&nbsp;days&#146; prior notice to Sublessor, and if
they are required hereunder to be named as additional insureds thereunder, Prime Lessor and Master
Lessor, (ii)&nbsp;no act or omission of Sublessee shall affect or limit the obligations of the insurer
with respect to any other named or additional insured and (iii)&nbsp;Sublessee shall be solely
responsible for the payment of all premiums under such policies and Sublessor, notwithstanding that
it is or may be a named insured, shall have no obligation for the payment thereof. Such insurance
shall otherwise be in both form and substance as is customarily carried by landlords of comparable
buildings in the South San Francisco, California area. On or before the Commencement Date,
Sublessee shall deliver to Sublessor, Prime Lessor and Master Lessor either a fully paid-for policy
or certificate, at Sublessee&#146;s option, evidencing the foregoing coverages. Any endorsements to such
policies or certificates shall also be delivered to Sublessor, and if they are required hereunder
to be named as additional insureds thereunder, Prime Lessor and Master Lessor upon issuance
thereof. Sublessee shall procure and pay for renewals of such insurance from time to time before
the expiration thereof, and Sublessee shall deliver to Sublessor, Prime Lessor and Master Lessor
such renewal policies or certificates at least thirty (30)&nbsp;days before the expiration of any
existing policy. In the event Sublessee fails so to deliver any such renewal policy or certificate
at least thirty (30)&nbsp;days before the expiration of any existing policy, Sublessor shall have the
right, but not the obligation, to obtain the same where upon Sublessee shall reimburse Sublessor
upon demand.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sublessee shall include in all such insurance policies any clauses or endorsements in favor of
Prime Lessor and Master Lessor including, but not limited to, waivers of rights of subrogation,
which Sublessor is currently required to provide pursuant to the provisions of the Prime Lease.
Notwithstanding anything to the contrary in this Sublease, Sublessee and Sublessor, for themselves
and their agents, employees, and contractors hereby waive any and all damages, losses, liabilities,
costs, and expenses, (i)&nbsp;to the extent the same would be covered by the standard form in California
of so-called full replacement cost, &#147;special form&#148; extended coverage casualty insurance and (ii)&nbsp;to
the extent the same are actually covered by insurance carried by said party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sublessor shall maintain the insurance required of it under Section&nbsp;13.1(b) of the Prime
Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<U>Indemnification</U>. Except to the extent arising out of the negligence,
willful misconduct or violation of law by Sublessor, Master Lessor, Prime Lessor or
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-8-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">their respective agents, employees or contractors, or the breach of this Sublease, the Prime Lease
or the Master Lease by Sublessor, Master Lessor, or Prime Lessor, Sublessee agrees to protect,
defend (with counsel reasonably approved by Sublessor), indemnify and hold Sublessor, Prime Lessor
and Master Lessor and their respective officers, agents and employees harmless from and against any
and all claims, costs, expenses, losses and liabilities to the extent arising: (i)&nbsp;from the conduct
or management of or from any work or thing whatsoever done in the Subleased Premises during the
term hereof; (ii)&nbsp;from any condition arising, and any injury to or death of persons, damage to
property or other event occurring or resulting from an occurrence in the Subleased Premises during
the Term hereof; and (iii)&nbsp;from any breach or default on the part of Sublessee in the performance
of any covenant or agreement on the part of Sublessee to be performed pursuant to the terms of this
Sublease or from any willful misconduct or negligence on the part of Sublessee or any of its
agents, employees, licensees, invitees or assignees or any person claiming through or under
Sublessee. Sublessee further agrees to indemnify Sublessor, Prime Lessor and Master Lessor and
their respective officers, agents and employees from and against any and all damages, liabilities,
costs and expenses, including reasonable attorneys&#146; fees, incurred in connection with any such
indemnified claim or any action or proceeding brought in connection therewith. Except to the extent
arising out of the negligence, willful misconduct or violation of law by Sublessee, Master Lessor,
Prime Lessor or their respective agents, employees or contractors, or the breach of this Sublease,
the Prime Lease or the Master Lease by Sublessee, Master Lessor, or Prime Lessor, Sublessor agrees
to protect, defend (with counsel reasonably approved by Sublessee), indemnify and hold Sublessee
and its respective officers, agents and employees harmless from and against any and all claims,
costs, expenses, losses and liabilities to the extent arising from any willful misconduct or
negligence on the part of Sublessor or any of its agents, employees or contractors. Sublessor
further agrees to indemnify Sublessee and its officers, agents and employees from and against any
and all damages, liabilities, costs and expenses, including reasonable attorneys&#146; fees, incurred in
connection with any such indemnified claim or any action or proceeding brought in connection
therewith. The provisions of this Paragraph are intended to supplement any other indemnification
provisions contained in this Sublease and in the Prime Lease to the extent incorporated by
reference herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;<U>No Assignment or Subletting</U>. Sublessee shall not assign, sell, mortgage,
pledge or in any manner transfer this Sublease or any interest herein, or the term or estate
granted hereby or the rentals hereunder, or sublet the Subleased Premises or any part thereof, or
grant any concession or license or otherwise permit occupancy of all or any part of the Subleased
Premises by any person, entity or any Competitor (as defined in Section&nbsp;14.2 of the Prime Lease) of
Prime Lessor, without the prior written consent of Sublessor, which shall not be unreasonably
withheld or delayed and, if and to the extent required under the terms of the Master Lease or the
Prime Lease, the consent of Prime Lessor and Master Lessor. Notwithstanding anything to the
contrary in this Sublease, the consent of Sublessor shall not be required for any sublease of the
Subleased Premises or any assignment of this Sublease to any entity controlled by, under common
control with, or which controls Sublessee for so long as such entity is controlled by, under common
control with, or controls Sublessee, or in connection with any merger of
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-9-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Sublessee with any other entity (provided the surviving entity has at least the net worth of
Sublessee immediately prior to the merger) or the sale of substantially all of the assets of
Sublessee located in the Subleased Premise. Neither the consent of Sublessor, Prime Lessor or
Master Lessor to an assignment, subletting, concession, or license, nor the references in this
Sublease to assignees, subtenants, concessionaires or licensees, shall in any way be construed to
relieve Sublessee of the requirement of obtaining the consent of Sublessor, Prime Lessor and Master
Lessor to any further assignment or subletting or to the making of any assignment, subletting,
concession or license for all or any part of the Subleased Premises. Notwithstanding any assignment
or subletting, including, without limitation, any assignment or subletting permitted or consented
to, the original Sublessee named herein and any other person(s) who at any time was or were
Sublessee shall remain fully liable under this Sublease. If this Sublease is assigned, or if the
Subleased Premises or any part thereof is underlet or occupied by any person or entity other than
Sublessee, Sublessor may, after default by Sublessee following the lapse of any cure period,
collect rent from the assignee, undertenant or occupant, and apply the net amount collected to the
rents payable by Sublessee hereunder, but no assignment, underletting, occupancy or collection
shall be deemed a waiver of the provisions hereof, the acceptance of the assignee, undertenant or
occupant as tenant, or a release of Sublessee from the further performance by Sublessee of the
covenants hereunder to be performed on the part of Sublessee (except to the extent such amounts are
so applied). Any attempted assignment or subletting without the prior written consent of Sublessor,
Prime Lessor and Master Lessor, to the extent required, shall be void.
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">10.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Primacy and Incorporation of Prime Lease</U>.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;This Sublease is and shall be subject and subordinate to the Prime Lease and to all
matters to which the Prime Lease is or shall be subject and subordinate, and to all amendments,
modifications, renewals, extensions and replacements of or to the Prime Lease that do not adversely
affect Sublessee, this Sublease or the rights of Sublessee, under this Sublease in the Subleased
Premises or the use thereof by Sublessee, and Sublessor purports hereby to convey, and Sublessee
takes hereby, no greater rights then those accorded to or taken by Sublessor as &#147;Tenant&#148; under the
terms of the Prime Lease. To the extent expressly incorporated herein below, Sublessee covenants
and agrees that it will perform and observe all of the provisions contained in the Prime Lease to
be performed and observed by &#147;Tenant&#148; thereunder as applicable to the Subleased Premises, except
that &#147;Rent&#148; shall be defined for purposes of this Sublease as set forth in Paragraph&nbsp;4 hereof.
Notwithstanding the foregoing, Sublessee shall have no obligation to (i)&nbsp;cure any default of
Sublessor under the Prime Lease, (ii)&nbsp;perform any obligation of Sublessor under the Prime Lease
which arose prior to the Commencement Date and Sublessor failed to perform, (iii)&nbsp;repair any damage
to the Subleased Premises caused by Sublessor, (iv)&nbsp;remove any alterations or additions installed
within the Subleased Premises by Sublessor, (v)&nbsp;indemnify Sublessor or Prime Lessor with respect to
any negligence or willful misconduct of Sublessor, its agents employees or contractors, or (vi)
discharge any liens on the Subleased Premises or the Building which arise out of any work
performed, or claimed to be performed, by or at the direction of Sublessor. Except to the extent
inconsistent with the context hereof,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-10-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">capitalized terms used and not otherwise defined herein shall have the meanings ascribed to them in
the Prime Lease. Further, except as set forth below, the terms, covenants and conditions of the
following specified provisions of the Prime Lease are incorporated herein by reference as if such
terms, covenants and conditions were stated herein to be the terms, covenants and conditions of
this Sublease, so that except to the extent that they are inconsistent with or modified by the
provisions of this Sublease, for the purpose of incorporation by reference each and every
referenced term, covenant and condition of the Prime Lease binding upon or inuring to the benefit
of the &#147;Landlord&#148; thereunder shall, in respect of this Sublease and the Subleased Premises, be
binding upon or inure to the benefit of Sublessor, and each and every referenced term, covenant and
condition of the Prime Lease binding upon or inuring to the benefit of the &#147;Tenant&#148; thereunder
shall, in respect of this Sublease, be binding upon or inure to the benefit of Sublessee, with the
same force and effect as if such terms, covenants and conditions were completely set forth in this
Sublease: Articles/Sections: 2.3, 5.2, 5.3(a), 5.3(b), 5.3(c) (excluding the fourth, fifth, sixth
and seventh sentences), 5.3(d), 5.3(e), 5.3(f), 5.3(g), 5.3(h) through the word &#147;contractors,&#148; 5.4,
6.5, 6.6, the last two sentences of 7.8, 8, the fourth sentence of 10, 11, 12, 13.1 (excluding
13.1(b) and, subject to the additional qualification that Sublessor shall exercise its rights
thereunder only as and to the extent Prime Lessor exercises the same against Sublessor, 13.1(g),
13.2, 13.3, 13.4, 15 (excluding 15.5 and 15.6), 16 (as amended), 17, 19, 20, 22, 23.3, the first
paragraph of 24, 27.1, 27.2, 27.3, 27.4, 27.12 and 27.13, and Exhibits B, C and D. Notwithstanding
the foregoing, for purposes of this Sublease, as to such incorporated terms, covenants and
conditions:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>references in the Prime Lease to the &#147;Demised Premises&#148; shall be deemed
to refer to the &#147;Subleased Premises&#148; hereunder;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(ii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>references in the Prime Lease to &#147;Landlord&#148; and to &#147;Tenant&#148; shall be
deemed to refer to &#147;Sublessor&#148; and &#147;Sublessee&#148; hereunder, respectively, except that
where the term &#147;Landlord&#148; is used in the context of ownership or management of the
entire Building, such term shall be deemed to mean &#147;Prime Lessor&#148;;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(iii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>references in the Prime Lease to &#147;this Lease&#148; shall be deemed to refer
to &#147;this Sublease&#148; (except when such reference in the Prime Lease is, by its terms
(unless modified by this Sublease), a reference to any other section of the Prime
Lease, in which event such reference shall be deemed to refer to the particular
section of the Prime Lease);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(iv)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>references in the Prime Lease to the &#147;Term Commencement Date&#148; shall be
deemed to refer to the &#147;Commencement Date&#148; hereunder;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(v)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>references in the Prime Lease to the &#147;Yearly Fixed Rent&#148;, &#147;Fixed
Rent&#148;, &#147;Additional Rent&#148; and &#147;rent&#148; shall be deemed to refer to the &#147;Rent&#148; as defined
hereunder;</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->-11-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(vi)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sublessee shall not be required to name Sublessor, Prime Lessor, Master
Lessor or any other party as an additional insured on its worker&#146;s compensation,
business interruption or personal property insurance; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(vii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>reference to &#147;Article&nbsp;14&#148; in Section&nbsp;19.1 shall mean Paragraph&nbsp;9 of
this Sublease.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, the following provisions of the Prime Lease, Exhibits and
Schedules annexed thereto are not incorporated herein by reference and shall not, except as to
definitions set forth therein, have any applicability to this Sublease: Articles/Sections&nbsp;1, 2.1,
2.2, 2.4, 3, 4, 5.1, the fourth, fifth, sixth and seventh sentences of 5.3(c), everything after the
word &#147;contractors&#148; in 5.3(h), 6 (excluding 6.5 and 6.6), 7 (except the last two sentences of 7.8),
9, 10 (except the fourth sentence), 13.1(b), 13.5, 14, 15.5, 15.6, 18, 21, 23.1, 23.2, the second
paragraph of 24, 25, 26, 27.5, 27.6, 27.7, 27.8, 27.9, 27.10, 27.11, 27.14, 28 and 29 and Exhibits
A, A-l, A-2, E, F, G and H.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where reference is made in the following Sections to &#147;Landlord&#148;, the same shall be deemed to
refer to &#147;Master Lessor&#148; and &#147;Prime Lessor&#148;: Sections&nbsp;7 (other than the last sentence of 7.8) 8,
13.5, 15.1 and 16.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where reference is made in the following Section to &#147;Landlord&#148;, the same shall be deemed to
refer to &#147;Prime Lessor&#148;: the fourth sentence of Section&nbsp;15.6.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where reference is made in the following Sections to &#147;Landlord&#148;, the same shall be deemed to
refer to &#147;Master Lessor&#148;, &#147;Prime Lessor&#148; and &#147;Sublessor&#148;: Sections&nbsp;5.3(b), 5.3(d), 5.3(f), 5.3(g),
5.4, the last two sentences of 7.8, 10, 11,13.1, 13.2, 13.3, 13.4, 15.2, 15.3, 15.6 (excluding the
fourth sentence), 15.7 and 17.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Where reference is made in the following Sections to &#147;Landlord&#148;, the same shall be deemed to
refer to &#147;Prime Lessor&#148; and &#147;Sublessor&#148;: Sections&nbsp;5.3(c) and 5.3(e).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;(Intentionally omitted)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Notwithstanding anything to the contrary contained in the Prime Lease,
the time limits (the &#147;Notice Periods&#148;) contained in the Prime Lease for the giving of
notices, making of demands or performing of any act, condition or covenant on the part
of the &#147;Tenant&#148;, thereunder, or for the exercise by the &#147;Tenant&#148;, thereunder of any right,
remedy or option, are changed for the purposes of incorporation herein by reference by
shortening the same in each instance by five (5)&nbsp;days, so that in each instance Sublessee
shall have five (5)&nbsp;fewer days to observe or perform hereunder than Sublessor has as the
&#147;Tenant&#148; under the Prime Lease; <U>provided</U>, <U>however</U>, that if the Prime Lease
allows a Notice Period of six (6)&nbsp;days or less, then Sublessee shall nevertheless be allowed the
number of days equal to one-half of the number of days in each Notice Period to give
any such notices, make any such demands, perform any such acts, conditions or
covenants or exercise any such rights, remedies or options; provided, further, that if one-half of the number of days in the Notice Period is not a whole number, Sublessee shall
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-12-<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">be allowed the number of days equal to one-half of the number of days in the Notice Period rounded
up to the next whole number.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Notwithstanding anything to the contrary contained in this Sublease (including,
without limitation, the provisions of the Prime Lease incorporated herein by reference), Sublessor
makes no representations or warranties whatsoever with respect to the Subleased Premises, this
Sublease, Prime Lease or any other matter, either express or implied, except as set forth in this
Sublease, and except that Sublessor represents and warrants (i)&nbsp;that it is the sole holder of the
interest of the &#147;Tenant&#148; under the Prime Lease, (ii)&nbsp;that the Prime Lease is in full force and
effect and that there are no modifications of the Prime Lease which will affect Sublessee&#146;s rights
or obligations hereunder, (iii)&nbsp;that no notices of default have been served on Sublessor under the
Prime Lease which have not been cured and to the best of Sublessor&#146;s knowledge Sublessor is not
otherwise in default of its obligations under the Master Lease, and (iv)&nbsp;to the best of Sublessor&#146;s
knowledge, Prime Lessor is not in default under the Prime Lease or the Master Lease and Master
Lessor is not in default under the Master Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;<U>Certain Services and Rights</U>. Except as otherwise expressly set forth herein, the
only services or rights to which the Sublessee is entitled hereunder, are those expressly set forth
herein and those services and rights to which Sublessor is entitled under the Prime Lease,
including without limitation those set forth in Sections&nbsp;7.3, 7.4, 7.6 and 7.7(a) of the Prime
Lease. Notwithstanding anything to the contrary contained herein, in no event shall Sublessor be
deemed to be in default under this Sublease or liable to Sublessee for any failure of the Prime
Lessor to perform its obligations under the Prime Lease. With respect to all work, services,
utilities, repairs, restoration, maintenance, compliance with law, insurance, indemnification or
other obligations or services to be performed or provided by Prime Lessor under the Prime Lease,
Sublessor&#146;s sole obligation shall be, without expense to itself, to exercise commercially
reasonable efforts to require Prime Lessor to comply with the obligations of Prime Lessor under the
Prime Lease, provided that in no event shall Sublessor be required to file suit against Prime
Lessor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;<U>Compliance with Prime Lease</U>. Sublessee shall neither do nor permit its agents,
employees or contractors to do anything which violates the Prime Lease and which would cause the
Prime Lease to be terminated or forfeited by reason of any right of termination or forfeiture
reserved or vested in Prime Lessor under the Prime Lease, and Sublessee shall defend, indemnify and
hold Sublessor harmless from and against any and all claims, liabilities, losses, damages and
expenses (including reasonable attorneys&#146; fees) of any kind whatsoever if the Prime Lease is
terminated or forfeited in whole or in part as a result of a breach or default on the part of
Sublessee. Sublessee covenants and agrees that Sublessee will not do anything which would
constitute a default under the provisions of the Prime Lease or omit to do anything which Sublessee
is obligated to do under the terms of this Sublease, which would constitute a default under the
Prime Lease. Except if the same results in whole or in part from a breach on the part of Sublessee
or any of its agents, employees or contractors of the obligations of Sublessee hereunder, Sublessor
shall not cause or permit the Prime Lease to be terminated or forfeited by reason of any default on
the part of Sublessor thereunder and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-13-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Sublessor shall indemnify, defend and hold harmless Sublessee from any such termination
or forfeiture.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;<U>Default</U>. In the event that Sublessee shall default in any of its obligations
hereunder beyond applicable cure periods, including any default of the nature described in the
herein incorporated provisions of the Prime Lease beyond applicable cure periods as modified by
Paragraph 10(c) hereof, Sublessor shall have available to it all of the rights and remedies
available to Prime Lessor under the Prime Lease, including without limitation Article&nbsp;19 thereof as
incorporated herein by reference, as though Sublessor were the &#147;Landlord&#148; thereunder and Sublessee
the &#147;Tenant&#148; thereunder. Sublessee further agrees to reimburse Sublessor for all costs and expenses
incurred by Sublessor in asserting its rights hereunder against Sublessee or any other party. The
non-prevailing party shall also pay the attorneys&#146; fees and costs incurred by the prevailing party
in any post-judgment proceedings to collect and enforce the judgment. The covenant in the preceding
sentence is separate and several and shall survive the merger of this provision into any judgment
on this Sublease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.&nbsp;<U>Brokerage</U>. Sublessee and Sublessor represent that they have not dealt with any
broker in connection with this Sublease other than CRESA Partners (the &#147;Broker&#148;). Each party agrees
to indemnify and hold harmless the other from and against any and all liabilities, claims, suits,
demands, judgments, costs, interests and expenses (including, without being limited to, reasonable
attorneys&#146; fees and expenses) which the indemnified party may be subject to or suffer by reason of
any claim made by any person, firm or corporation other than the Broker for any commission, expense
or other compensation as a result of the execution and delivery of this Sublease, which is based on
alleged conversations or negotiations by said person, firm or corporation with the indemnifying
party. Sublessee shall pay the Broker the brokerage fees/commissions due under a separate agreement
between and among Sublessee and Broker. Each party shall indemnify and hold the other harmless from
and against any and all liabilities, claims, suits, demands, judgments, costs, interest and
expenses (including, without being limited, reasonable attorneys&#146; fees and expenses) which said
other party may be subject to or suffer by reason of any claim made by any other Broker for any
brokerage fees/commissions, expense of other compensation as a result of the execution and delivery
of this Sublease in breach of the indemnified parties representation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. <U>Security Deposit</U>. On January&nbsp;1, 2005, the cash security deposit then currently
held by Sublessor for the Subleased Premises shall be released to Sublessee and exchanged for a
letter of credit in accordance with the following: Sublessee at its sole cost and expense shall
deliver to Sublessor, in a form and from a financial institution acceptable to Sublessor, an
irrevocable, unconditional standby letter of credit in the amount of $130,527.00 (the &#147;Letter of
Credit&#148;), as security for the full and faithful performance and observance by Sublessee of
Sublessee&#146;s covenants and obligations under this Sublease (the &#147;Security Deposit&#148;). Sublessee shall
be solely responsible for all costs and expenses of obtaining, amending, renewing or replacing such
Letter of Credit. The Letter of Credit shall have an expiration date not earlier than thirty (30)
days following the expiration of the Term of this Sublease. If Sublessee defaults in the full and
prompt payment and performance of any of Sublessee&#146;s covenants and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-14-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">obligations under this Sublease, including, but not limited to, the payment of Rent specified in
Paragraph&nbsp;4 hereof, Sublessor may, after the giving of any required notices and the lapse of any
cure period, but without giving any other notice to Sublessee, draw upon the Letter of Credit to
the extent required for the payment of any Rent or any other sums as to which Sublessee is in
default or for any sum which Sublessor may expend or may be required to expend by reason of
Sublessee&#146;s default in respect of any of the terms, covenants and conditions of this Sublease,
including, but not limited to, any damages or deficiency in the reletting of all or any portion of
the Subleased Premises, whether such damages or deficiency accrue before or after summary
proceedings or other re-entry by Sublessor. If Sublessor draws upon the Letter of Credit to cure
any default, Sublessee shall cause the Letter of Credit to be restored to its original amount (or
shall make a cash security deposit with Sublessor in said amount) within fifteen (15)&nbsp;days of such
drawing and failure to do so shall be deemed a default hereunder. Sublessee understands that its
potential liability under this Sublease is not limited to the amount of the Security Deposit. Use
of said Security Deposit by Sublessor shall not constitute a waiver, but is in addition to other
remedies to Sublessor under this Sublease and under law (except to the extent of the amount so
applied). In the event of any sale of Sublessor&#146;s interest in the Premises, Sublessor shall either
return the Security Deposit to Sublessee or assign its interest in the Security Deposit to the
transferee or assignee and Sublessor shall thereupon be released by Sublessee from all liability
for the return or payment thereof; and Sublessee shall look solely to the new sublessor for the
return or payment of the same delivered to the new sublessor; and the provisions hereof shall apply
to every transfer or assignment made of the same to a new sublessor. Sublessee shall not assign or
encumber or attempt to assign of encumber the Security Deposit and neither Sublessor nor its
successors or assigns shall be bound by any such assignment, encumbrance, attempted assignment or
attempted encumbrance. Sublessee waives the provisions of California Civil Code Section&nbsp;1950.7, and
all other provisions of law now in force or that become in force after the date of execution of
this Sublease that provide that Sublessor may claim from a security deposit only those sums
reasonably necessary to remedy defaults in the payment of Rent, to repair damage caused by
Sublessee, or to clean the Subleased Premises.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.&nbsp;<U>Notices</U>. All notices, consents, approvals, demands, bills, statements and requests
which are required or desired to be given by either party to the other hereunder shall be in
writing and shall be governed by Article&nbsp;25 of the Prime Lease as incorporated herein by reference,
except that the mailing addresses for Sublessor and Sublessee shall initially be those first set
forth above, except that after the Commencement Date the address for Sublessee shall be the
Subleased Premises or such other address as Sublessee shall designate by written notice to
Sublessor. Communications and payments to the Prime Lessor shall be given in accordance with, and
subject to, Article&nbsp;25 of the Prime Lease. Communications to the Master Lessor shall be given in
accordance with, and subject to, Article&nbsp;25 of the Master Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.&nbsp;<U>Interpretation</U>. This Sublease shall be construed without regard to any presumption
or other rule requiring construction against the party causing this Sublease to be drafted. Each
covenant, agreement, obligation or other provision of this Sublease shall be deemed and construed
as a separate and independent covenant of the party
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-15-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">bound by, undertaking or making the same, which covenant, agreement, obligation or other provision
shall be construed and interpreted in the context of the Sublease as a whole. All terms and words
used in this Sublease, regardless of the number or gender in which they are used, shall be deemed
to include any other number and any other gender as the context may require. The word &#147;person&#148; as
used in this Sublease shall mean a natural person or persons, a partnership, a corporation or any
other form of business or legal association or entity. Terms used herein and not defined shall have
the meaning set forth in the Prime Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.&nbsp;<U>Fire or Casualty; Eminent Domain</U>. In addition to the provisions of Article&nbsp;16 of
the Prime Lease as and to the extent incorporated herein by reference, Sublessor also agrees if the
MJ Research Sublease is terminated by Prime Lessor, Master Lessor or Sublessee because of a fire or
other casualty, then Sublessee may terminate this Sublease. Sublessee may exercise the termination
right described in the previous sentence by giving written notice to Sublessor within thirty (30)
days of Sublessee&#146;s receipt or giving of the termination notice under the MJ Research Sublease and
the effective date of the termination of this Sublease will be the same date as the termination
date of the MJ Research Sublease. Upon execution of this Sublease by Sublessee and Sublessor and
the delivery of the Consent described in Paragraph&nbsp;28 hereof, Sublessor shall deliver to Sublessee
in electronic format and hard copy the plans in Sublessor&#146;s possession as of the date hereof for
the tenant improvements and will assign any rights Sublessor has in such plans for purposes of
using such plans to rebuild any tenant improvements existing in the Subleased Premises as of the
date hereof. In the event of a fire or casualty to the Subleased Premises where Prime Lessor has
decided to restore the Building including the Subleased Premises, Sublessor shall turn over to
Prime Lessor the proceeds of insurance required to be carried by Sublessor under Section&nbsp;13.1(b) of
the Prime Lease for the rebuilding of the tenant improvements by Prime Lessor, unless this Master
Lessor terminates the Master Lease, Prime Lessor terminates the Prime Lease, or Sublessor or
Sublessee terminates this Sublease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. <U>Right to Cure Sublessee&#146;s Defaults</U>. If Sublessee shall at any time fail to make
any payment or perform any other obligation of Sublessee hereunder within fifteen (15)&nbsp;days (except
in the case of an emergency) of receiving Sublessor&#146;s notice of such failure to make payment or to
perform, then Sublessor shall have the right, but not the obligation, after notice to Sublessee in
accordance with Paragraph&nbsp;16 of this Sublease, or without notice to Sublessee in the case of any
emergency, and without waiving or releasing Sublessee from any obligations of Sublessee hereunder,
to make such payment or perform such other obligation of Sublessee in such manner and to such
extent as Sublessor shall deem necessary, and in exercising any such right, to pay any incidental
costs and expenses, employ attorneys, and incur and pay reasonable attorneys&#146; fees. Sublessee shall
pay to Sublessor upon demand all sums so paid by Sublessor and all incidental costs and expenses of
Sublessor in connection therewith, together with interest thereon at an annual rate equal to the
rate four percent (4%) above the base rate or prime rate then announced as such by Citibank, N.A.
or its successor, or the maximum rate permitted by law. Such interest shall be payable with respect
to the period commencing on the date such expenditures are made by Sublessor and ending on the date
such amounts are repaid by Sublessee. If Sublessor shall at any time fail to
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-16-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">perform any obligations on its part to be performed under Paragraph&nbsp;4 of this Sublease which
interfere (or are reasonably likely to imminently interfere with the use of the Subleased Premises
by Sublessee) and Sublessor shall fail to commence to cure such default within fifteen (15)&nbsp;days
(or such longer period of time as is reasonably necessary in the exercise of reasonable diligence
to cure such failure to perform) following written demand for such performance by Sublessee and
thereafter to diligently complete such cure, then, in addition to its other rights and remedies,
Sublessee shall have the right, but not the obligation, without waiving or releasing Sublessor from
any obligations of Sublessor hereunder, to perform such obligation of Sublessor. Notwithstanding
anything to the contrary in this Sublease, the cost reasonably incurred by Sublessee in completing
such cure shall be paid by Sublessor to Sublessee within five (5)&nbsp;days of receiving Sublessee&#146;s
bill for the same. The foregoing, however, shall not apply to any of the services to be provided by
Prime Lessor directly to Sublessor as set forth in Paragraph&nbsp;11 and, in such case, the obligations
of Sublessor subject to this Section shall be limited to the obligations of Sublessor under
Paragraph&nbsp;11. The provisions of this Paragraph shall survive the Expiration Date or the sooner
termination of this Sublease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20.&nbsp;<U>Termination of Prime Lease</U>. Subject to the rights, if any, of Sublessee to
recognition of Sublessee&#146;s rights hereunder by Master Lessor or Prime Lessor, if for any reason the
term of the Prime Lease shall terminate prior to the Expiration Date, this Sublease shall thereupon
automatically terminate as to the premises demised under the Prime Lease and Sublessor shall not be
liable to Sublessee by reason thereof except in the event of a breach by Sublessor of its
obligations under Paragraph&nbsp;12 hereof; <U>provided</U>, <U>however</U>, that Sublessor agrees
that so long as Sublessee is not in default hereunder beyond any applicable cure periods, Sublessor
shall not voluntarily surrender the Prime Lease except in accordance with the Prime Lease in the
event of a taking or casualty. Notwithstanding the foregoing, if the Prime Lease gives Sublessor
any right to terminate the Prime Lease in the event of the partial or total damage, destruction, or
condemnation of the Subleased Premises or the Building, the exercise of such right by Sublessor
shall not constitute a default or breach hereunder.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Upon the expiration or termination of this Sublease, whether by forfeiture, lapse of time or
otherwise, or upon the termination of Sublessee&#146;s right of possession, Sublessee shall at once
surrender and deliver the Subleased Premises and the Furniture in the condition and repair required
by, and in accordance with the provisions of, this Sublease and the Prime Lease, including without
limitation Article&nbsp;20 of the Prime Lease as incorporated herein by reference, including the
Furniture, which shall be in the same condition as at the date possession of the Subleased Premises
was delivered to Sublessee, reasonable wear and tear, alterations made by Sublessee in compliance
herewith that Sublessee is permitted to surrender, acts of God, casualties, condemnations,
hazardous materials not introduced to the Premises by Sublessee, its agents, employees or invitees
and the acts of Sublessor, Prime Lessor, Master Lessor or other occupants if the building (other
than Sublessee, its agents, employees or invitees) and their respective agents, employees and
contractors excepted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.&nbsp;<U>Consents and Approvals</U>. All references in this Sublease to the consent or approval
of Prime Lessor, Master Lessor and/or Sublessor shall be deemed to mean
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-17-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the written consent or approval of Prime Lessor, Master Lessor and/or Sublessor, as the case may
be, and no consent or approval of Prime Lessor, Master Lessor and/or Sublessor, as the case may be,
shall be effective for any purpose unless such consent or approval is set forth in a written
instrument executed by Prime Lessor, Master Lessor and/or Sublessor, as the case may be. In all
provisions requiring the approval or consent of Sublessor (whether pursuant to the express terms of
this Sublease or the terms of the Prime Lease incorporated herein), Sublessee shall be required to
obtain the approval or consent of Sublessor and then to obtain like approval or consent of Prime
Lessor to the extent Prime Lessor&#146;s consent is required under the Prime Lease and Master Lessor to
the extent Master Lessor&#146;s consent is required under the Master Lease. Sublessor agrees its consent
shall not be unreasonably withheld or delayed, except as otherwise provided herein. If Sublessor is
required or has determined to give its consent or approval to a matter as to which consent or
approval has been requested by Sublessee, Sublessor shall cooperate reasonably with Sublessee in
endeavoring to obtain any required Prime Lessor&#146;s or Master Lessor&#146;s consent or approval upon and
subject to the following terms and conditions: (i)&nbsp;Sublessee shall reimburse Sublessor for any
reasonable out-of-pocket costs incurred by Sublessor in connection with seeking such consent or
approval, (ii)&nbsp;Sublessor shall not be required to make any payments to Prime Lessor or Master
Lessor or to enter into any agreements or to modify the Prime Lease, or this Sublease in any manner
which will prejudice Sublessor in order to obtain any such consent or approval, (iii)&nbsp;if Sublessee
agrees or is otherwise obligated to make any payments to Sublessor, Master Lessor or Prime Lessor
in connection with such request for such consent or approval, Sublessee shall have made
arrangements satisfactory to Sublessor for such payments and (iv)&nbsp;Sublessee shall indemnify and
hold Sublessor harmless from and against all liabilities, losses, damages or expenses, including,
without being limited to, reasonable attorneys&#146; fees and expenses Sublessor shall suffer or incur
in connection with seeking such consent or approval. Nothing contained in this Article shall be &#147;
deemed to require Sublessor to give any consent or approval merely because Prime Lessor or Master
Lessor has given such consent or approval. Sublessor shall promptly forward to Prime Lessor and
Master Lessor, as the case may be, such requests as Sublessee may submit for approval or consent
from Prime Lessor and Master Lessor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22.&nbsp;<U>No Privity of Estate</U>. Nothing contained in this Sublease shall be construed to
create privity of estate or of contract between Sublessee and Prime Lessor and Master Lessor, and
Prime Lessor and Master Lessor are not obligated to recognize or to provide for the non-disturbance
of the rights of Sublessee hereunder except as expressly set forth in separate agreements, if any,
between said party or parties and Sublessee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.&nbsp;<U>No Waiver</U>. The failure of Sublessor or Sublessee to insist in any one or more
cases upon the strict performance or observance of any obligation of the other hereunder or to
exercise any right or option contained herein shall not be construed as a waiver or relinquishment
for the future of any such obligation, right or option. Sublessor&#146;s receipt and acceptance of Rent
or Sublessor&#146;s or Sublessee&#146;s acceptance of performance of any other obligation by the other party,
with knowledge of a breach of any provision of this Sublease, shall not be deemed a waiver of such
breach. No waiver by Sublessor or Sublessee of any term, covenant or condition of this Sublease
shall be
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-18-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">deemed to have been made unless expressed in writing and signed by the party to be charged. .
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24.&nbsp;<U>Complete Agreement</U>. This Sublease constitutes the entire agreement between the
parties and there are no representations, agreements, arrangements or understandings, oral or
written, between the parties relating to the subject matter of this Sublease which are not fully
expressed in this Sublease. This Sublease cannot be changed or terminated orally or in any manner
other than by a written agreement executed by both parties. This Sublease shall not be binding upon
either party unless and until it is signed and delivered by and to both parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25.&nbsp;<U>Successors and Assigns</U>. The provisions of this Sublease, except as herein
otherwise specifically provided, shall extend to bind and inure to the benefit of the parties
hereto and their respective personal representatives, heirs, successors and permitted assigns.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26.&nbsp;<U>Waiver of Jury Trial and Right to Counterclaim</U>. To the extent permitted by law,
the parties hereto hereby waive any rights which they may have to trial by jury in any summary
action or other action, proceeding or counterclaim arising out of or in any way connected with this
Sublease, the relationship of Sublessor and Sublessee, the Subleased Premises and the use and
occupancy thereof, and any claim for injury or damages. Sublessee also hereby waives all right to
assert or interpose a counterclaim (other than mandatory counterclaims) in any summary proceeding
or other action or proceeding to recover or obtain possession of the Subleased Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.&nbsp;<U>Estoppel Certificates</U>. Sublessee and Sublessor shall each, within fifteen (15)
days after each and every request by the other party, execute, acknowledge and deliver to the other
party or any party reasonably designated by the other party, without cost or expense to the other
party, a statement in writing (a)&nbsp;certifying that this Sublease is unmodified and, to its
knowledge, is in full force and effect (or if there have been modifications, that the same is in
full force and effect as modified, and stating such modifications); (b)&nbsp;specifying the dates to
which Rent has been paid; (c)&nbsp;stating whether or not, to its knowledge, the other party is in
default in the performance or observance of such other party&#146;s obligations under this Sublease and,
if so, specifying each such default; (d)&nbsp;stating whether or not, to its knowledge, any event has
occurred which, with the giving of notice or passage of time, or both, would constitute a default
by the other party under this Sublease, and, if so, specifying each such default; (e)&nbsp;stating
whether or not, to its knowledge, any event has occurred which, with the giving of notice or
passage of time, or both, would constitute a default by the other party under this Sublease, and,
if so, specifying each such event; (f)&nbsp;stating whether or not, to its knowledge, any event has
occurred which, with the giving of notice or passage of time, or both, would constitute a default
by Prime Lessor under the Prime Lease with respect to the Subleased Premises, and, if so,
specifying such event; (g)&nbsp;describing all notices of default submitted by it to the other party and
Prime Lessor with respect to this Sublease, or the Prime Lease from and after the date hereof; and
(h)&nbsp;containing such other information with respect to the Subleased Premises or this Sublease as
the other party shall reasonably request. Each party hereby acknowledges and agrees that any such
statement delivered pursuant to this Paragraph may be relied upon by any prospective
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-19-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">assignee, transferee or mortgagee of the leasehold or subleasehold estate of the other party
or any prospective lender or investor to the requesting party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28.&nbsp;<U>Consent of Prime Lessor</U>. This Sublease is subject to the concurrent approval and
consent of Prime Lessor, which Sublessor agrees to use all reasonable efforts to obtain. This
Sublease shall not become effective unless and until a written approval and consent (the &#147;Consent&#148;)
is executed and delivered by the Prime Lessor, which Consent shall consent to this Sublease. After
the Sublessor receives the Consent
from the Prime Lessor, Sublessor agrees to promptly deliver a fully-executed original of the
Consent to Sublessee. The effect and commencement of this Sublease is subject to and
conditional upon the receipt by Sublessor and Sublessee of the Consent. To the extent that
Sublessor has not already done so, upon execution of this Sublease by Sublessee, Sublessor
will promptly apply to the Prime Lessor for the Consent and Sublessor will promptly inform
Sublessee as to receipt of the Consent (if and when it is received) and deliver to Sublessee a
copy of the same. If the Consent is not received by May&nbsp;1, 2004 (the &#147;Sunset Date&#148;), then from
the Sunset Date this Sublease will cease to have any further effect and the parties hereto
will have no further obligations to each other with respect to this Sublease and any funds
paid hereunder by Sublessee shall be promptly refunded by Sublessor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29.&nbsp;<U>Holding Over</U>. If Sublessee shall fail to surrender and deliver the Subleased
Premises as and when required hereunder, the Sublessee shall become a tenant at sufferance only,
subject to all of the terms, covenants and conditions herein specified. Sublessee agrees to
protect, defend (with counsel reasonably approved by Sublessor), indemnify and hold Sublessor and
its officers, agents and employees harmless from and against any and all claims, costs, losses,
damages, liabilities and expenses (including, without being limited to, reasonable attorneys&#146; fees)
that Sublessor may suffer by reason of any holdover by Sublessee hereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30.&nbsp;<U>Limitation of Liability</U>. No director, officer, shareholder, employee, adviser or
agent of Sublessor shall be personally liable in any manner for the obligations of the Sublessor
under this Sublease. Except as set forth in Paragraph&nbsp;29 hereof, in no event shall Sublessor or
Sublessee or any of their directors, officers, shareholders, employees, advisers or agents be
responsible for any indirect, special or consequential damages or interruption or loss of business,
income or profits, nor shall Sublessor be liable for loss of or damage to artwork, securities or
other property not in the nature of ordinary fixtures, furnishings and equipment used in general
administrative and executive office activities. No director, officer, shareholder, employee,
adviser or agent of Sublessee shall be personally liable in any manner for the obligations of the
Sublessee under this Sublease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31.&nbsp;<U>Conflict</U>. In the event of any conflict between the obligations of Sublessee set
forth in this Sublease and the obligations of Sublessee under the Prime Lease as and to the extent
incorporated herein by reference, the more restrictive provision shall control.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32.&nbsp;<U>Security</U>. Sublessee expressly assumes all responsibility for security, in the
Subleased Premises, and, except to the extent arising out of the negligence, willful
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-20-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">misconduct, violation or law or breach of this Sublease or the Master Lease or Prime Lease by
Sublessor or its agents, employees or contractors, Sublessor shall not be liable for any damage to
goods, wares, merchandise or other property located in the Subleased Premises, or injury or death
to Sublessee&#146;s employees, invitees, customers or any other person in or about the Subleased
Premises. The foregoing waiver includes criminal acts of third parties.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33.&nbsp;<U>Recording</U>. Sublessor and Sublessee agree that neither party may record this
Sublease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34.&nbsp;<U>Attorney&#146;s Fees</U>. If either Sublessor or Sublessee shall bring any action or legal
proceeding for an alleged breach of any provision of this Sublease, to recover rent, to terminate
this Sublease or otherwise to enforce, protect or establish any term or covenant of this Sublease,
the prevailing party shall be entitled to recover as a part of such action or proceeding, or in a
separate action brought for that purpose, reasonable attorneys&#146; fees, court costs, and expert fees
as may be fixed by the court. &#147;Prevailing party&#148; as used in this Paragraph includes a party who
dismisses an action for recovery hereunder in exchange for sums allegedly due, performance of
covenants allegedly breached or considerations substantially equal to the relief sought in the
action.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35.&nbsp;<U>Existing Sublease</U>. The existing Sub-Sublease Agreement dated as of May&nbsp;31, 2001 by
and between Sublessor and Sublessee (the &#147;Existing Sub-Sublease Agreement&#148;) is hereby terminated.
Sublessee agrees to deliver to Sublessor on or before the Commencement Date, the second and third
floor space that was the subject of said Existing Sub-Sublease Agreement (i)&nbsp;in broom clean
condition, (ii)&nbsp;with all of Sublessee&#146;s machinery, furniture, fixtures, and equipment, and
hazardous materials removed from such space, and (iii)&nbsp;such space cleaned by Pass Janitorial
Service. When so surrendered, the surrender obligations of Sublessee for such space as set forth in
the existing sublease shall be deemed to have been performed in all required respects.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-21-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Sublessor and Sublessee have executed this Sublease as a sealed instrument
as of the date first written above.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Genome Therapeutics Corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Stephen Rauscher
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Stephen Rauscher&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Sr VP&#043;CEO&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Fluidigm Corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Gajus Worthington
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Gajus Worthington&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">CEO&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left"><FONT size="1">

</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT A-1
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;See below for Agreement of Lease dated as of November&nbsp;9, 1999, by and between Mountain Cove Tech<BR>
Center, L.L.C. and MJ Research Company, Inc. (the &#147;Master Lease&#148;)&#093;
</DIV>

<DIV align="left"><FONT size="1">

</FONT></DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT A-2
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;See below for Agreement of Lease dated as of October&nbsp;6, 2000 by and between Prime Lessor, as<BR>
&#147;landlord&#148; and Sublessor, as &#147;tenant&#148; as amended by a First Amendment to Lease dated December&nbsp;5,<BR>
2002 and a Second Amendment to Lease dated March&nbsp;25, 2004&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT B
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;Diagram depicting 14,503 rentable square feet of office and lab space located on the first floor<BR>
of the Building&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT C
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">None.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">FIRST AMENDMENT TO SUBLEASE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This First Amendment to Sublease is made as of the December&nbsp;7, 2007 by and between Oscient
Pharmaceuticals Corporation (formerly known as Genome Therapeutics Corporation), a Massachusetts
corporation with a place of business at 1000 Winter Street, Suite&nbsp;2200, Waltham, Massachusetts
02451 (&#147;Sublessor&#148;), and Fluidigm Corporation, a Delaware corporation, with a place of business at
7000 Shoreline Court, South San Francisco, California 94080 (&#147;Sublessee&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">WITNESSETH THAT:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, pursuant to that certain Agreement of Lease dated as of October&nbsp;6, 2000 by and
between ARE-San Francisco No.&nbsp;17, LLC (&#147;Prime Lessor&#148;) (as successor in interest to Mountain Cove
Tech Center, L.L.C. by acquisition of the fee interest in the property, and MJ Research Company,
Inc., by an Assignment and assumption of Subleases dated as of October&nbsp;6, 2000 to Mountain Cove
Tech Center, L.L.C.), as &#147;landlord&#148; and Sublessor, as &#147;tenant&#148; (as successor in interest to
Genesoft, Inc.), as amended by a First Amendment to Lease dated December&nbsp;5, 2002 and a Second
Amendment to Lease dated March&nbsp;25, 2004 (such lease, as so amended, and all renewals, modifications
and extensions thereof being hereinafter collectively referred to as the &#147;Prime Lease&#148;), a true and
complete copy of which is attached hereto as <U><B>Exhibit&nbsp;A</B></U><B>, </B>Prime Lessor leases to Sublessor
approximately 68,460 rentable square feet of space located on the first, second and third floors of
the Building (all as more particularly described in the Prime Lease, the &#147;Premises&#148;); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, pursuant to that certain Sublease Agreement dated as of March&nbsp;25, 2004, by and
between Sublessor, as &#147;sublessor&#148; and Sublessee, as &#147;sublessee&#148; (the &#147;Sublease&#148;), a true and
complete copy of which is attached hereto as <U><B>Exhibit&nbsp;B</B></U><B>, </B>Sublessor subleases to Sublessee
approximately 14,503 rentable square feet of office and lab space located on the first floor of the
Building (all as more particularly described in the Sublease, the &#147;Subleased Premises&#148;); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the term of the Sublease ends on December&nbsp;31, 2007; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Sublessor and Sublessee desire to amend the Sublease to, among other things,
extend said term all subject to the provisions hereof;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties covenant and agree as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>Term</U>. Notwithstanding anything to the contrary in the Sublease, the term of
the Sublease is hereby extended for a period commencing on January&nbsp;1, 2008 (the &#147;Extension
Effective Date&#148;) and expiring on February&nbsp;28, 2011 (the &#147;Expiration Date&#148;) or such earlier date
upon which said term may expire, be cancelled or be terminated pursuant to any of the terms of
provisions of the Prime Lease, the Sublease, this First Amendment to Sublease or applicable law
(the &#147;Additional Term&#148;). Said extension shall be subject to all terms, covenants and conditions
contained in the Sublease except as otherwise set forth herein. References herein and in the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Sublease to the Term shall be deemed to mean and include the Initial Term and Additional Term
(and the Expiration Date shall be deemed extended accordingly). Sublessee acknowledges and agrees
that it has no further right to extend the term of the Sublease and that any such right set forth
in Section&nbsp;2 of the Sublease is null and void.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Termination For Convenience.</U> Sublessee is granted a one-time right to terminate
(&#147;Termination Right&#148;) the Sublease on July&nbsp;1, 2009, Sublessee shall provide Sublessor written
notification of its intent to terminate no later than October&nbsp;1, 2008. If Sublessee exercises
this Termination Right, Sublessee shall pay Sublessor an amount equal to $332,500.00 on or before
July&nbsp;1, 2009.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Rent</U>. Notwithstanding anything to the contrary contained in Section&nbsp;4 of the
Sublease, commencing on January&nbsp;1, 2008, the Rent due under the Sublease shall be equal to the
following amounts during the periods set forth below:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Term Period</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Monthly Rent</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">P.R.S.F. Per Year</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">1/1/08 &#151; 12/31/08
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">$</TD>
    <TD align="right" valign="top">57,172.24</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">$</TD>
    <TD align="right" valign="top">47.305</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">1/1/09 &#151; 12/31/09
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">$</TD>
    <TD align="right" valign="top">58,477.51</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">$</TD>
    <TD align="right" valign="top">48.385</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">1/1/10 &#151; 12/31/10
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">$</TD>
    <TD align="right" valign="top">59,637.75</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">$</TD>
    <TD align="right" valign="top">49.345</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">1/1/11 &#151; 2/28/11
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">$</TD>
    <TD align="right" valign="top">60,943.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">$</TD>
    <TD align="right" valign="top">50.425</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Rent specified above is inclusive of all services previously provided by Sublessor
pursuant to Section&nbsp;4 of the Sublease as well as all other provisions contained in Sections&nbsp;4 and
11 of the Sublease. Section&nbsp;4 (ii)&nbsp;is hereby deleted. The parties agree that the Sublessee shall
be responsible for the janitorial and cleaning services. The fifth sentence from the bottom of
Section&nbsp;4 is hereby deleted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Assignment and Subletting</U>. The references in the first two sentences of Section&nbsp;9
of the Sublease to &#147;Competitors&#148; and to net worth shall be deleted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Financial Statements</U>. Section&nbsp;27.13 of the Prime Lease, as incorporated into the
Sublease, shall be revised such that (a)&nbsp;Section&nbsp;27.13 shall not apply if Sublessee is a publicly
traded company, (b)&nbsp;if Sublessee is not a publicly traded company, Sublessee shall only be required
to provide Sublessor with audited financial statements once they have been completed, provided
Sublessee uses commercially reasonable efforts to complete such statements with a reasonable time
frame and (c)&nbsp;Sublessor shall hold all of Sublessee&#146;s financial statements confidential.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Proper Authority</U>. Each party represents to the other that (i)&nbsp;it has not assigned,
encumbered or hypothecated any of its right, title or interest in the Sublease or any portion
thereof or interest therein, (ii)&nbsp;it is duly authorized to enter into and perform its obligations
under
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">this First Amendment to Sublease and to modify its rights under the Sublease as set forth in this
First Amendment to Sublease, and (iii)&nbsp;the parties executing this First Amendment to Sublease on
behalf of each party are duly authorized to bind the party they purport to represent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>Brokerage</U>. Sublessee and Sublessor represent that they have not dealt with any
broker in connection with this First Amendment to Sublease other than CRESA Partners on behalf of
Sublessee. The Sublessor shall not be responsible for a commission or other fee, if any, is due to
CRESA Partners. Each party agrees to indemnify and hold harmless the other from and against any and
all liability, claims, suits, demands, judgments, costs, interest and expense (including, without
being limited to, reasonable attorneys&#146; fees and expenses) which the indemnified party may be
subject to or suffer by reason of any claim made by any person, firm or corporation for any
commission, expense or other compensation as a result of the execution and delivery of this First
Amendment to Sublease, which is based on alleged conversations or negotiations by said person, firm
or corporation with the indemnifying party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<U>Condition</U>. This First Amendment to Sublease is subject to (a)&nbsp;approval and consent
of Prime Lessor in accordance with this Section&nbsp;6 and (b)&nbsp;the full execution of the Third Amendment
to Lease currently being negotiated between Sublessee and Prime Lessor to extend the term of the MJ
Research Sublease (the &#147;MJ Research Amendment&#148;). This First Amendment to Sublease shall not become
effective unless and until a written approval and consent to this First Amendment to Sublease is
executed and delivered by Prime Lessor to Sublessor and the MJ Research Amendment is fully
executed. If the above conditions are not satisfied within ten (10)&nbsp;business days of Sublessee&#146;s
execution of this First Amendment to Sublease, either party may terminate this First Amendment to
Sublease by delivering written notice to the other.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;<U>Security Deposit</U>. Sublessee shall maintain in effect throughout the Additional Term
a Letter of Credit as required under Section&nbsp;15 of the Sublease. Within ten (10)&nbsp;days of the
Extension Effective Date, Sublessee at its sole cost and expense shall deliver to Sublessor, an
extension of the existing Letter of Credit or a replacement of the existing Letter of Credit in a
form and from a financial institution reasonably acceptable to Sublessor. Sublessee may at any time
substitute a cash security deposit for the Letter of Credit, and upon such substitution, Sublessor
shall return the Letter of Credit to Sublessee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;<U>Miscellaneous</U>. Unless the context requires otherwise, the terms used herein shall
be construed in conformity with the definitions set forth in the Sublease. References in the
Sublease to the MJ Research Sublease shall mean the MJ Research Sublease as amended, including by
the MJ Research Amendment. As hereby modified, the Sublease is ratified and confirmed and remains
in full force and effect.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Sublessor and Sublessee have caused this instrument to be executed under
seal as of the day and year first above written.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">OSCIENT PHARMACEUTICALS CORPORATION<br>a Massachusetts corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Ph. M. MAITRE
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Ph. M. MAITRE&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">SVP &#038; CFO.&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">FLUIDIGM CORPORATION,<br>a Delaware corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Sublessor and Sublessee have caused this instrument to be executed under
seal as of the day and year first above written.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">OSCIENT PHARMACEUTICALS CORPORATION<br>a Massachusetts corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">FLUIDIGM CORPORATION,<br>a Delaware corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Gajus Worthington
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Gajus Worthington&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">CEO&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT A
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;See below for Agreement of Lease dated as of October&nbsp;6, 2000 by and between Prime Lessor, as<BR>
&#147;landlord&#148; and Sublessor, as &#147;tenant&#148; as amended by a First Amendment to Lease dated December&nbsp;5,<BR>
2002 and a Second Amendment to Lease dated March&nbsp;25, 2004&#093;
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT B
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;See above for Sublease Agreement dated as of March&nbsp;25, 2004.&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AGREEMENT OF LEASE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT
OF LEASE made as of the 1st day of December, 2001, by and
between MJ Research Company, Inc. (hereinafter referred to as &#147;Landlord&#148;) and Fluidigm Corporation
(hereinafter referred to as &#147;Tenant&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">WITNESSETH:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord hereby leases to Tenant and Tenant hereby hires from Landlord a portion of the
building (the &#147;Building&#148;) in South San Francisco, as described in Section&nbsp;1.1(4) below and shown on
the plan attached hereto as Exhibit&nbsp;A and made a part hereof (hereinafter referred to as the
&#147;Premises&#148; or the &#147;Demised Premises&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">1. REFERENCE DATA
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 <U>Definitions</U>. Each reference in this Lease to any of the terms and
titles contained in this Article shall be deemed and construed to incorporate the data stated
following that term or title in this Article.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="80%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">1)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Additional Rent:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sums or other charges payable by Tenant to
Landlord under this Lease, other than
Monthly Fixed Rent, all of which shall be
payable as additional rent under this Lease.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">2)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Broker:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">None.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Business Day:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">All days except Saturdays, Sundays, days
defined as &#147;legal holidays&#148; for the entire
state under the laws of the State of California, and such other days as Tenant
presently or in the future recognizes as
holidays for Tenant&#146;s general staff.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Demised Premises:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Space on the first floor of the Building at
7000 Shoreline Court, South San Francisco,
California 94080 (the &#147;Building&#148;), which
space is shown on the plans attached as
Exhibit&nbsp;A.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Environmental Laws:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;5.3 (a) (1).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">6)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Event of Default:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The occurrence of an event listed in Section
19.1.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">7)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Hazardous Materials:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;5.3 (a) (2).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="80%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">8)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Interest Rate:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">18% per annum, or the maximum
interest rate Landlord is
permitted to charge Tenant under
applicable law, whichever is
less.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">9)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Land:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The parcel of land on which the
Building is situated.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">10)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Landlord&#146;s Address:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7000 Shoreline Court, So. San
Francisco, CA 94080, Attn: Edward
Breakell</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">11)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Landlord&#146;s Architect:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Any licensed architect from time
to time designated by Landlord.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">12)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lease Year:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">A twelve (12)&nbsp;month period
beginning on the Term
Commencement Date and each
succeeding twelve (12)&nbsp;month
period during the Term of this
Lease, except that if the Term
Commencement Date shall be other
than the first day of a
calendar month, the first Lease
Year shall include the partial
calendar month in which the Term
Commencement Date occurs as well
as the succeeding twelve (12)
full calendar months.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">13)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mortgage:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">A mortgage, deed of trust, trust
indenture, or other security
instrument of record creating an
interest in or affecting title to
the Land or Building or any part
thereof, and any and all
renewals, modifications,
consolidations or extensions of
any such instrument.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">14)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mortgagee:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The holder of any Mortgage.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">15)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Permitted Use:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Office and light engineering,
subject to the provisions
contained herein involving the
use of hazardous materials.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">16)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Prime Landlord:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mountain Cove Tech Center LLC, a
California limited liability
company.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">17)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Prime Lease:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The lease dated November&nbsp;9, 1999
between Prime Landlord and
Landlord.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">18)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Property:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Land and Building.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
2
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="80%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">19)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rent:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Monthly Fixed Rent and Additional Rent.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">20)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rentable Area of
the Demised Premises:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;<BR>Agreed to be 12,501 rentable square feet
plus the loading space shown on Exhibit&nbsp;A.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">21)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Security Deposit:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$90,000.00</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">22)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tenant&#146;s Address:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7100 Shoreline Court, South San Francisco,<BR>
California 94080</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Term<BR>Commencement<BR>
Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><BR><BR>December&nbsp;8, 2001</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Term of this Lease:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Approximately 37&nbsp;months</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">25)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">January <I>7, </I>2005</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">26)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Monthly Fixed Rent:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$48,700.00 per month ($584,400.00 per year)
for the first lease year, which amount
shall be increased annually by four
(4.0%) compounded annually.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2 <U>Exhibits</U>. The following exhibits are attached hereto and made a part
hereof:
</DIV>
<DIV align="left" style="font-size: 10pt; margin-left: 6%; margin-top: 6pt">A &#151; Plan of Demised Premises<BR>
B &#151; Cleaning Specifications<BR>
C &#151; Rules and Regulations<BR>
D &#151; List of Environmental Reports Given to Tenant<BR>
E &#151; Form of Prime Landlord Consent
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">2. DESCRIPTION OF DEMISED PREMISES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 <U>Demised Premises</U>. The Demised Premises are that portion of the
Building as described above (as the same may from time to time be constituted after
changes therein, additions thereto and eliminations therefrom pursuant to rights of
Landlord hereinafter reserved).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 <U>Appurtenant Rights</U>. Tenant shall have, as appurtenant to the
Demised Premises, rights to use in common, subject to reasonable rules from time
to time made by Landlord of which Tenant is given notice, those common roadways,
walkways, elevators, hallways and stairways necessary for access to that portion of
the Building occupied by the Demised Premises. There is also appurtenant to the
Demised Premises at no additional charge the nonexclusive use, in common with
Landlord and other entitled thereto, of the parking lot appurtenant to the Building,
which lot is designed to have three (3)&nbsp;parking spaces per 1,000 rentable-square feet
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
3
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in the Building. Landlord agrees that such parking lot shall be on a non-exclusive basis for
Tenant and others&#146; entitled thereto. Tenant may not store cars in the parking lot, i.e., leave
cars parked for more than seven (7)&nbsp;days.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 <U>Reservations</U>. All the perimeter walls of the Demised Premises except
the inner surfaces thereof, any balconies, terraces or roofs adjacent to the Demised
Premises, and any space in or adjacent to the Demised Premises used for serving
other portions of the Building exclusively or in common with the Demised Premises,
including without limitation (where applicable) shafts, stacks, pipes, conduits, wires
and appurtenant fixtures, fan rooms, ducts, electric or other utilities, sinks or other
Building facilities, and the use thereof, as well as the right of access through the
Demised Premises for the purpose of operation, maintenance, decoration and repair,
are expressly reserved to Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4 <U>Certain Amenities</U>. The named Tenant, Fludigm Corporation shall
have access to on a nonexclusive basis, the following facilities:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The exercise room. Landlord may charge a reasonable fee for towel service (if provided) and janitorial service.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The lunchroom and adjacent patio.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event the named Tenant Fluidigm Corporation occupies less than all of the
Premises, Landlord may eliminate said amenities or assign them exclusively to Landlord or
other occupants of the Building. Such amenities shall not be available to assignees or
subtenants of Tenant unless permitted in writing by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5 <U>Conference Room</U>. Tenant may have the use of the executive
conference room for up to an additional four (4)&nbsp;days per month at the rate of
$700.00 for a full day or $400.00 for a half day. Use of the executive conference
room must be booked through the Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">3. TERM OF LEASE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 <U>Term</U>. The Term of this Lease is approximately 37&nbsp;months and (or until
such Term shall sooner cease or expire) commencing on the Term Commencement Date and ending
on January&nbsp;7, 2005 (the &#147;Termination Date&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">4. PREPARATION OF PREMISES; TENANTS ACCESS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>As Is</U>.&#148; The Premises are leased &#147;as is.&#148;
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
4
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">5. USE OF PREMISES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 <U>Permitted Use</U>. Tenant shall occupy and use the Demised Premises for
the Permitted Use set forth in Article&nbsp;1 and for no other purpose. Service and
utility areas (whether or not a part of the Demised Premises) shall be used only for
the particular purpose for which they are designated. Tenant shall have access to
the Demised Premises 24 hours per day, 7&nbsp;days per week.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 <U>Prohibited Uses</U>. Tenant shall not use, or suffer or permit the use of,
or suffer or permit anything to be done in or anything to be brought into or kept in,
the Demised Premises or any part thereof (i)&nbsp;which would violate any of the
covenants, agreements, terms, provisions and conditions of this Lease, (ii)&nbsp;for any
unlawful purposes or in any unlawful manner, or (iii)&nbsp;which, in the reasonable
judgment of Landlord shall in any way (a)&nbsp;impair or tend to impair the appearance
or reputation of the Building, (b)&nbsp;impair or interfere with or tend to impair or
interfere with any of the Building services or the proper and economic heating,
cleaning, air conditioning or other servicing of the Building or with the use of any of
the other areas of the Building, or (c)&nbsp;occasion discomfort, inconvenience or
annoyance to any of the other tenants, or occupants of the Building, whether
through the transmission of noise or odors or vibrations or dust or otherwise.
Without limiting the generality of the foregoing, no food shall be prepared or served
for consumption by the general public on or about the Demised Premises; no
intoxicating liquors or alcoholic beverages shall be sold or otherwise served for
consumption by the general public on or about the Demised Premises; no lottery
tickets (even where the sale of such tickets is not illegal) shall be sold and no
gambling, betting or wagering shall otherwise be permitted on or about the
Demised Premises; no loitering shall be permitted on or about the Demised
Premises; and no loading or unloading of supplies or other material to or from the
Demised Premises shall be permitted on the Land except at times (excluding
Business Days from 7:00 to 9:30 a.m. and from 4:00 to 6:00 p.m.) and in locations to
be reasonably designated by Landlord, except for the freight elevator described in
Section&nbsp;7.4, which Tenant may use at any time. The Demised Premises shall be
maintained in a sanitary condition. Tenant shall suitably store all trash and
rubbish in the Demised Premises or other locations designated by Landlord from
time to time. All Hazardous Materials must be disposed of in compliance with
Section&nbsp;5.3. Tenant specifically agrees that its indemnification obligations pursuant
to Section&nbsp;13.2 shall extend to any claim arising from the consumption of
intoxicating liquors or alcoholic beverages on or about the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 Hazardous Materials,
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Definitions.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
5
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Environmental Law means any governmental statute,
code ordinance, regulation, rule or order and any amendment thereto
governing or regulating materials that are toxic, explosive, corrosive,
flammable, radioactive, carcinogenic, dangerous or otherwise
hazardous. Environmental Laws include, without limitation, the Comprehensive
Environmental Response Compensation and Liability Act, 42 U.S.C. &#167;9601 <I>et seq., </I>the
Resource Conservation and Recovery Act, 42 U.S.C. &#167;6901 <I>et seq., </I>the California Hazardous
Substances Act at California Health and Safety Code Section&nbsp;108100 <I>et seq., </I>the
provisions regarding hazardous waste control at California Health and Safety Code
Sections&nbsp;25100 through 25250.25 and the California Medical Waste Management Act at
California Health and Safety Code &#167;117600 <I>et seq</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Hazardous Materials shall mean any substance: (A)&nbsp;that
now or in the future is regulated or governed by, requires investigation
or remediation under, or is defined as a hazardous waste, medical
waste, hazardous substance, pollutant or contaminant under any
Environmental Law or (B)&nbsp;that is toxic, explosive, corrosive, flammable, radioactive, carcinogenic, dangerous or otherwise
hazardous, including gasoline, diesel fuel, petroleum hydrocarbons,
polychlorinated biphenyls (PCBs), asbestos, radon and urea
formaldehyde foam insulation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Tenant&#146;s Covenants</U>. No Hazardous Materials shall be stored, placed, handled,
used or released by Tenant or its employees, contractors, sublessees, guests or visitors at or
about the Demised Premises or Property without Landlord&#146;s prior written consent. Notwithstanding
the foregoing, storage and use of routine office and janitorial supplies in usual and customary
quantities and the Permitted Materials as defined in subsection (c)&nbsp;below are permitted without
Landlord&#146;s prior written consent, provided that Tenant&#146;s activities at or about the Demised
Premises and Property shall comply at all times with all Environmental Laws. Tenant shall keep
Landlord fully and promptly informed of all storage, placement, handling, use or release by Tenant
or its employees, contractors , sublessees, guests or visitors of all Hazardous Materials. At the
expiration or termination of the Lease, Tenant shall remove from the Demised Premises all Hazardous
Materials brought or released in or on the Building as a result of the activities of Tenant or its
employees, agents, servants, invitees, visitors, customers, contractors, sublessees, and those
other persons for whom Tenant is legally responsible (collectively &#147;Tenant Parties&#148;). Landlord
shall have the right to perform an environmental assessment of the Demised Premises after such
removal, which assessment shall be conducted at Landlord&#146;s expense, unless it reveals that Tenant
has not complied with the requirements set
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
6
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">forth in this Section&nbsp;5.3, in which case Tenant shall reimburse Landlord for the reasonable cost
thereof within ten days after Landlord&#146;s request therefor. Nothing in this Section&nbsp;5.3 shall
require Tenant to indemnify Landlord for any matters arising out of or caused by the actions or
omissions of Landlord, its employees, agents, contractors, licensees, or invitees.. Tenant shall
be responsible and liable for the compliance with all of the provisions of this Section by all of
Tenant Parties and all of Tenant&#146;s obligations under this Section (including its indemnification
obligations under subsection (e)&nbsp;below) shall survive the expiration or termination of this Lease.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Tenant may request permission to use the loading dock to accept
deliveries of Hazardous Materials for use in Tenant&#146;s subleased space in the
Building. Landlord shall grant such permission in its sole and absolute
discretion. Tenant will operate under all applicable Federal, State and Local
laws governing the use, storage and management of hazardous materials for
building Occupancy Groups A3, B and H Divisions 2, 3 and 7, as allowable,
including Title 22 of the CFR as defined under the Uniform Building Code
and Uniform Fire Code developed by the International Fire Code Institute
(the &#147;Allowable Class&nbsp;Facilities&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Compliance</U>. Tenant shall at Tenant&#146;s expense promptly take all
actions required by any governmental agency or entity in connection with or
as a result of the storage, placement, handling, use or release by Tenant
Parties of Hazardous Materials at or about the Demised Premises or
Property, including inspection and testing, performing all cleanup, removal and remediation work required with respect to those Hazardous Materials,
complying with all closure Laws and postclosure monitoring, and filing all
required reports or plans. Tenant shall never use any of the Landlord&#146;s trash
receptacles for disposing of any hazardous waste. All of the foregoing work
shall be performed in a good, safe and workmanlike manner by consultants
qualified and licensed to undertake such work and in a manner that will not
interfere with any other tenant&#146;s quiet enjoyment of the Property or
Landlord&#146;s use, operation, leasing and sale of the Property. Tenant shall
deliver to Landlord prior to delivery to any governmental agency, or promptly
after receipt from any such agency, copies of all permits, manifests, closure or
remedial action plans, notices, and all other documents relating to the
storage, placement, handling, use or release by Tenant Parties of Hazardous
Materials at or about the Demised Premises or Property. Upon prior written
notice from Landlord, Tenant shall make available to Landlord for Landlord&#146;s
inspection and copying all of Tenant&#146;s documents, materials, data,
inventories and other documentation (including, without limitation, Material
Safety Data Sheets relating to Hazardous Materials as may be present or
suspected to be present in, on or about the Demised Premises. If any lien
attaches to the Demised Premises or the Property in connection with or as a
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
7
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">result of the storage, placement, handling, use or release by Tenant Parties of Hazardous
Materials, and Tenant does not cause the same to be released, by payment, bonding or otherwise,
within ten (10)&nbsp;days after the attachment thereof, Landlord shall have the right but not the
obligation to cause the same to be released and any sums expended by Landlord in connection
therewith shall be payable by Tenant on demand. Notwithstanding anything in the foregoing to the
contrary, Tenant shall not be responsible for Hazardous Materials not introduced to the Premises,
the Building or the Land by Tenant Parties.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Tenant shall give Landlord immediate telephone notice and
prompt written notice (which means as soon as practicable and, in no event,
more than one (1)&nbsp;day following Tenant&#146;s knowledge of the applicable event)
of any (i)&nbsp;spill, discharge, dumping, or other release of any Hazardous
Materials (including, without limitation, the Permitted Materials) on, in,
under or from the Demised Premises, the Building, or any portion of the
Project, or the groundwater thereof, (ii)&nbsp;any oral or written notice from any
governmental agency received by Tenant of any such spill, discharge,
dumping, or other release of any Hazardous Materials, and (iii)&nbsp;any oral or
written notice of any violation, warning, deficiency, non-compliance, or other
alleged or actual failure by Tenant to comply strictly with any Environmental
Law and/or any requirement, provision, or stipulation of any governmental
permit, license, registrations, or approval.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Landlord&#146;s Eights</U> .Subject to the provisions of Section&nbsp;15.2,
Landlord shall have the right, but not the obligation, to enter the Demised
Premises at any reasonable time upon 24 hours notice except in case of
emergency (i)&nbsp;to confirm Tenant&#146;s compliance with the provisions of this
Section, and (ii)&nbsp;to perform Tenant&#146;s obligations under this Section if Tenant
has failed to do so after reasonable notice to Tenant. Landlord shall also
have the right to engage qualified Hazardous Materials consultants to
inspect the Demised Premises and review the storage, placement, handling,
use or release by Tenant or its employees, contractors, sublessees, guests or
visitors of Hazardous Materials, including review of all permits, reports,
plans, and other documents regarding same. Tenant shall pay to Landlord
on demand the reasonable costs of Landlord&#146;s consultant&#146;s fees if Tenant is
found to have violated the terms of this Section&nbsp;5.3 any and all reasonable
costs incurred by Landlord in performing Tenant&#146;s obligations under this
section. Landlord shall use reasonable efforts to minimize any interference with Tenant&#146;s
business caused by Landlord&#146;s entry into the Demised Premises, but Landlord shall not be
responsible for any interference caused thereby, unless such interference arises out of or is
caused by the gross negligence or willful misconduct of Landlord, its employees, agents,
contractors, licensees, or invitees.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
8
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Tenant&#146;s Indemnification</U>. Tenant agrees to indemnify, defend and hold
harmless Landlord and its members, managers, directors, officers, agents and employees and
their partners, members, managers, directors, officers, shareholders, employees and agents
from all shall mean all costs and expenses of any kind, damages, including foreseeable and
unforeseeable consequential damages, fines and penalties incurred in connection with any
violation of and compliance with the Environmental Laws by Tenant Parties and all losses of
any kind attributable to the diminution of value, loss of use or adverse effects on
marketability or use of any portion of the Demised Premises or Property by Tenant Parties
and all other claims, actions, losses, damages, liabilities, costs and expenses of every
kind, including reasonable attorneys&#146;, experts&#146; and consultants&#146; fees and costs, incurred
at any time and arising from or connection with the storage, placement, handling, use or
release by Tenant or its employees, contractors, sublessees, guests or visitors of
Hazardous Materials at or about the Property or Tenant&#146;s failure to comply in full with all
Environmental Laws with respect to the Demised Premises and the Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4 <U>Licenses and Permits</U>. If any governmental license or permit shall be required
for the property and lawful conduct of Tenant&#146;s business, and if the failure to secure such license
or permit would in any way affect Landlord, Tenant, at Tenant&#146;s expense, shall duly procure and
thereafter maintain such license or permit and submit the same to inspection by Landlord. Tenant,
at Tenant&#146;s expense, shall at all times comply with the terms and conditions of each such license
or permit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">6. RENT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 <U>Monthly Fixed Rent</U>. Tenant shall pay to Landlord, without any set-off
or deduction, at Landlord&#146;s office, or to such other person or at such other place as
Landlord may designate by notice to Tenant, the Monthly Fixed Rent set forth in
Article&nbsp;1, subject to annual adjustment as set forth in said Article&nbsp;1. The Monthly
Fixed Rent shall be paid in equal monthly installments in advance on or before the
first Business Day of each calendar month during the Term of this Lease and shall
be apportioned for any fraction of a month in which the Term Commencement Date
or the last day of the Term of this Lease may fall.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 <U>Taxes</U>. Tenant shall timely file business property statements with
respect to Tenant&#146;s personal property and trade fixtures and pay when due all taxes
imposed on such personal property and trade fixtures. Tenant shall also pay all
real estate taxes attributable to Alterations made by Tenant to the Demised
Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 <U>Obligations Survive Termination</U>. All obligations and liabilities of
Tenant relating to any period prior to the termination of the Term of this Lease,
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
9
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">including without limitation the obligation to pay any Additional Rent due pursuant to the
provisions of this Article, shall survive such termination.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 <U>Payment to Mortgagee</U>. Landlord reserves the right to provide in any
Mortgage given by it or by Prime Landlord of the Property that some or all rents,
issues, and profits and all other amounts of every kind payable to the Landlord
under this Lease shall be paid directly to the Mortgagee for Landlord&#146;s account and
Tenant covenants and agrees that it will, after receipt by it of notice from Landlord
or Mortgagee designating such Mortgagee to whom payments are to be made by
Tenant, pay such amounts thereafter becoming due directly to such Mortgagee until
excused therefrom by notice from such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5 <U>Additional Rent</U>. Tenant shall also pay as additional rent without
notice, except as required under this Lease, and without any abatement, deduction
or setoff except as provided herein, all sums, impositions, costs, expenses and other
payments which Tenant in any of the provisions of this Lease assumes or agrees to
pay, and, in case of any nonpayment thereof, Landlord shall have in addition to any
other rights and remedies, all of the rights and remedies provided by law or&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provided for in the Lease for the nonpayment of Monthly Fixed Rent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6 <U>Place of Payment of Rent</U>. All payments of Rent shall be made by
Tenant to Landlord without notice or demand at such place as Landlord may from
time to time designate in writing. The initial place for payment of rent shall be
7000 Shoreline Court, So. San Francisco, CA 94080. Any extension of time for the
payment of any installment of rent, or the acceptance of rent after the time at which
it is due and payable shall not be a waiver of the rights of Landlord to insist on
having all other payments made in the manner and at the times herein specified.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.7 <U>Cleaning</U>. Tenant shall arrange for cleaning of the Tenant space in
accordance with the cleaning schedule attached hereto as Exhibit&nbsp;B with a cleaning
contractor subject to Landlord&#146;s approval, which approval shall not be unreasonably
withheld. Tenant shall pay all such costs of cleaning. In addition, Landlord may
provide such cleaning services to the Premises at a cost plus a ten percent (10%)
administrative fee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">7. UTILITIES AND LANDLORD&#146;S SERVICES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1 <U>Electricity</U>. Landlord shall furnish, at Landlord&#146;s cost, all electrical energy
that Tenant requires for operation of the lighting fixtures, appliances and equipment servicing the
Demised Premises. Landlord shall not be liable in any way to Tenant for any failure or defect in
the supply or character of electrical energy furnished to the Demised Premises by reason of any
requirement, act or omission of the public utility serving the Building. Tenant&#146;s use of electrical
energy in the Demised Premises shall not at any time exceed the capacity of any of the electrical
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
10
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">conductors and equipment in or otherwise serving the Demised Premises. In order to insure that
such capacity is not exceeded and to avert possible adverse effect upon the Building electrical
services Tenant shall give notice to Landlord and obtain Landlord&#146;s prior written consent
whenever Tenant shall connect to the Building electrical distribution system any fixtures,
appliances or equipment other than lamps, typewriters, personal computers and similar small
machines. Landlord shall install and replace all light fixtures, bulbs, tubes, lamps, lenses,
globes, ballasts and switches used in the Demised Premises.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2 <U>Water</U>. Landlord shall furnish cold water for ordinary cleaning, toilet and drinking purposes and hot and cold water for lavatory purposes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3 <U>Heat and Air Conditioning</U>. Landlord shall furnish to and distribute in
the Premises and common areas of the Building heat and air conditioning as normal
seasonal changes may require on Business Days from 8:00 a.m. to 6:00 p.m. and on
Saturdays from 9:00 a.m. to 1:00 p.m., provided Landlord may run common area
HVAC on an economy mode on Saturdays. Without limiting the generality of the
foregoing, all windows in the Demised Premises must remain closed at all times
notwithstanding the fact that such windows may be operable. The air conditioning
system servicing the Building is designed to provide cooling based upon an
occupancy of not more than one person per one hundred (100)&nbsp;square feet of floor
area, and upon a combined lighting and standard electrical load not to exceed 3.0
watts per square foot. In the event Tenant exceeds such condition or introduces
into the Demised Premises equipment which overloads such system, or in any other
way causes such system not to adequately perform its proper functions,
supplementary systems may at Landlord&#146;s option be provided by Landlord at
Tenant&#146;s, expense.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4 <U>Elevator Service</U>. Landlord shall provide non exclusive passenger
elevator service consisting of two (2)&nbsp;elevators to the Demised Premises on Business Days from 8:00 a.m. to 6.00 p.m. and on a reduced basis at all other times.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.5 <U>Cleaning</U>. Landlord shall furnish cleaning services to the common
areas of the Building substantially in accordance with the specifications attached
hereto as Exhibit&nbsp;B and made a part hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.6 <U>Repairs and Other Services</U>. Except as otherwise provided in Articles 8
and 16, and subject to Tenant&#146;s obligations in Article&nbsp;12 and elsewhere in this
Lease, Landlord shall at Landlord&#146;s expense (a)&nbsp;keep and maintain the roof, exterior
walls, structural floor slabs and columns of the Building in as good condition and
repair as they are in on the Term Commencement Date, reasonable use and wear
excepted, (b)&nbsp;keep and maintain in workable condition the Building&#146;s sanitary,
electrical, heating, air conditioning and other systems, (c)&nbsp;keep all walkways on the
Property clean and remove all snow and ice therefrom, (d)&nbsp;provide grounds
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
11
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">maintenance to all landscaped areas and (e)&nbsp;keep and maintain the parking lot adjacent to
the Building in good condition and repair.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.7 <U>Landlord&#146;s Further Responsibilities</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Landlord shall allow Tenant to have full access to and use of the
largest conference room on the third floor of the Building up to two (2)&nbsp;times
per month, as reasonably agreed to in advance by Landlord and Tenant.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Landlord shall be responsible at its sole cost and expense for the
removal of all trash and garbage (excluding Hazardous Materials, laboratory,
biological and animal waste) from the designated containers outside of the
Building. Landlord will control the keys to the dumpster locks.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Landlord shall comply with all obligations imposed on it in the CCR&#146;s (defined in Section&nbsp;27.10) and shall pay its share of any future costs of
providing BART shuttle service.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.8 <U>Interruption or Curtailment of Services</U>. Landlord reserves the right to
interrupt, curtail, stop or suspend the furnishing of services and the operation of
any Building system, when necessary by reason of accident or emergency, or of
repairs, alterations, replacements or improvements in the reasonable judgment of
Landlord desirable or necessary to be made, or of difficulty or inability in securing
supplies or labor, or of strikes, or of any other cause beyond the reasonable control
of Landlord, whether such other cause be similar or dissimilar to those hereinabove
specifically mentioned, until said cause has been removed. Landlord shall use
reasonable efforts to minimize interruption to Tenant by any such interruption or
curtailment of services. Landlord shall have no responsibility or liability for any
such interruption, curtailment, stoppage, or suspension of services or systems,
except that Landlord shall exercise reasonable diligence to eliminate the cause of
same. Notwithstanding the foregoing, if utilities or Building services are
interrupted due to the fault of Landlord (Tenant acknowledging that Landlord shall
have no responsibility for failure of municipal or public utility suppliers to supply
utilities to the Building), and such disruption continues for more than fifteen (15)
days, rent shall abate if the Demised Premises are unusable and Tenant in fact
vacates the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">8. CHANGES OR ALTERATIONS BY LANDLORD
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord reserves the right, exercisable by itself or its nominee, including without
limitation Prime Landlord, at any time and from time to time without the same constituting an
actual or constructive eviction and without incurring any liability to Tenant therefor or otherwise
affecting Tenant&#146;s obligations under this Lease, to make such changes, alterations, additions,
improvements, repairs or
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
12
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">replacements in or to the Building and the fixtures and equipment thereof, as well as in or to the
street entrances, halls, passages, elevators, and stairways thereof, as it may deem necessary or
desirable, and to change the arrangement and/or location of entrances or passageways, doors and
doorways, and corridors, elevators, stairs, toilets, or other public parts of the Building,
provided, however, that there be no unreasonable obstruction of the right of access to, or
unreasonable interference with the use and enjoyment of, the Demised Premises by Tenant, except
that Landlord shall not be obligated to employ labor at so-called &#147;over-time&#148; or other premium pay
rates. Nothing contained in this Article shall be deemed to relieve Tenant of any duty, obligation
or liability of Tenant with respect to making or causing to be made any repair, replacement or
improvement or complying with any law, order or requirement of any governmental or other authority.
Neither this Lease nor any use by Tenant shall give Tenant any right or easement or the use of any
door or any passage or any concourse connecting with any other building or to any public
convenience, and the use of such doors, passages and concourses and of such conveniences may be
regulated or discontinued at any time and from time to time by Landlord without notice to Tenant
and without affecting the obligations of Tenant hereunder or incurring any liability to Tenant
therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">9. FIXTURES, EQUIPMENT AND IMPROVEMENTS &#151; REMOVAL BY TENANT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All fixtures, equipment, leasehold improvements and appurtenances attached to or built into
the Demised Premises prior to or during the Term, whether by Landlord at its expense or at the
expense of Tenant (either or both) or by Tenant, except for personal property, equipment or trade
fixtures paid for by Tenant regardless of whether or not they are affixed to the Premises, shall be
and remain part of the Demised Premises and shall not be removed by Tenant at the end of the Term
unless otherwise expressly provided by notice from Landlord to Tenant. Upon the request of
Landlord, Tenant will remove such fixtures, equipment, leasehold improvements and appurtenances
added by Tenant after the Term Commencement Date as are directed by Landlord and shall restore any
damage caused by such removal.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">10. ALTERATIONS AND IMPROVEMENTS BY TENANT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall make no alterations, decorations, installations, removals, additions or
improvements in or to the Demised Premises without Landlord&#146;s prior written consent and then only
by contractors or mechanics approved by Landlord. No such installations or other work shall be
undertaken or begun by Tenant until Landlord has approved written plans and specifications
therefor; and no amendments or additions to such plans and specifications shall be made without
prior written consent of Landlord. Any such approved alterations, decorations, installations,
removals, additions and improvements shall be done at the sole
</DIV>


<P align="center" style="font-size: 10pt">
<!-- Folio -->
13
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">expense of Tenant and at such times and in such manner as Landlord may from time to time reasonably
designate. Subject to the terms of Section&nbsp;9 herein, if Tenant shall make any alterations,
decorations, installations, removals, additions or improvements, then Landlord may elect to require
Tenant at the expiration of this Lease to restore the Demised Premises to substantially the same
condition as existed at the Term Commencement Date, such election to be made and advised to Tenant
at the same time as Landlord grants consent to the making of such Alterations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">11. TENANTS CONTRACTORS - MECHANICS&#146; - AND OTHER LIENS - STANDARD OF TENANT&#146;S PERFORMANCE -
COMPLIANCE WITH LAWS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever Tenant shall make any alterations, decorations, installations, removals, additions or
improvements or do any other work in or to the Demised Premises, Tenant will strictly observe the
following covenants and agreements:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In no event shall any material or equipment be incorporated in
or added to the Demised Premises in connection with any such alteration,
decoration, installation, addition or improvement which is subject to any lien,
charge, mortgage or other encumbrance of any kind whatsoever or is subject
to any security interest or any form of title retention agreement. Any
mechanic&#146;s lien filed against the Demised Premises or the Building for work
claimed to have been done for, or materials claimed to have been furnished to
Tenant shall be discharged by Tenant within twenty (20)&nbsp;days thereafter, at
the expense of Tenant, by filing the bond required by law or otherwise. If
Tenant fails so to discharge any lien, Landlord may do so at Tenant&#146;s expense
and Tenant shall reimburse Landlord for any expense or cost incurred by
Landlord in so doing within fifteen (15)&nbsp;days after rendition of a bill therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) All installations or work done by Tenant under this or any other
Article of this Lease shall be at its own expense (unless expressly otherwise
provided) and shall at all times comply with (i)&nbsp;laws, rules, orders and
regulations of governmental authorities having jurisdiction thereof and (ii)
plans and specifications prepared by and at the expense of Tenant theretofore
submitted to Landlord for its prior written approval.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Tenant shall procure all necessary permits before undertaking
any work in the Demised Premises; do all such work in a good and
workmanlike manner, employing materials of good quality and complying
with all governmental requirements, and defend, save harmless, exonerate
and indemnify Landlord from all injury, loss or damage to any person or
property occasioned by or growing out of such work.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Tenant shall notify Landlord no later than ten (10)&nbsp;days prior to
starting work on any alterations so that Landlord shall have the opportunity
to post a &#147;Notice of nonresponsibility&#148; at the Demised Premises and record
said notice in the county in which the Property is located pursuant to
California Civil Code Section&nbsp;3094.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) all contractors and subcontractors shall be approved by
Landlord, which approval shall not be unreasonably withheld, and all work
by Tenant shall be performed by such contractors and subcontractors and in
such manner as to maintain harmonious labor relations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">12. REPAIRS BY TENANT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant, at its expense, shall keep or cause to be kept, all and singular, the
Demised Premises in good repair, order and condition, reasonable use and wear thereof and damage by
fire or by unavoidable casualty excepted. Without limiting the generality of the foregoing, Tenant
shall keep all interior windows and other glass whole, and shall replace the same whenever broken
with glass of the same quality and shall repair or replace all exterior windows if damaged by
neglect or wrongdoing of Tenant. Tenant hereby waives the benefits of California Civil Code Section
1932(1). Notwithstanding any contrary implication, Tenant shall have no obligation to make any
repairs, replacements or improvements of a capital nature (as determined pursuant to generally
accepted accounting practices) to the Premises unless required as a result of tenant&#146;s or its
agent&#146;s negligence or willful misconduct.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">13. INSURANCE, INDEMNIFICATION, EXONERATION AND EXCULPATION
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.1 Tenant&#146;s Insurance
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Liability Insurance</U>. Tenant shall maintain in full force throughout
the Term commercial general liability and property damage insurance providing coverage on an
occurrence form basis with limits of not less than Five Million Dollars ($5,000,000.00) each
occurrence for bodily injury and property damage combined, Five Million Dollars
($5,000,000.00) annual general aggregate, and Five Million Dollars ($5,000,000.00) products
and completed operations (if applicable) annual aggregate. Tenant&#146;s liability insurance
policy or policies shall: (i)&nbsp;include premises and operations liability coverage,
automobile, products and completed operations liability coverage (if applicable), broad form
property damage coverage including completed operations (if applicable), blanket contractual
liability coverage with, to the maximum extent possible, coverage for the indemnification
obligations of Tenant under this Lease, and personal and advertising injury coverage; (ii)
provide that the insurance company has the duty to defend all insureds
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
15
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">under the policy; (iii)&nbsp;provide that defense costs are paid in addition to and do not deplete any
of the policy limits; (iv)&nbsp;cover liabilities arising out of or incurred in connection with
Tenant&#146;s use or occupancy of the Premises or the Property; and (v)&nbsp;extend coverage to cover
liability for the actions of Tenant&#146;s employees, contractors, sublessees, guests and visitors.
Tenant&#146;s required insurance may be maintained by a combination of underlying and &#147;umbrella&#148;
coverage.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Personal Property Insurance.</U> Tenant shall at all times
maintain in effect with respect to Tenant&#146;s fixtures, equipment and personal
property located at or within the Demised Premises, commercial property
insurance providing coverage, at a minimum, for &#147;broad form&#148; perils, to the
extent of 100% of the full replacement cost of covered property. Tenant may
carry such insurance under a blanket policy, provided that such policy
provides equivalent coverage to a separate policy. During the Term, the
proceeds from any such policies of insurance shall be used for the repair or
replacement of such fixtures, equipment and personal property so insured.
Landlord shall be provided coverage under such insurance to the extent of its
insurable interest and, if requested by Landlord, both Landlord and Tenant
shall sign all documents reasonably necessary or proper in connection with
the settlement of any claim or loss under such insurance. Landlord shall have
no obligation to carry insurance on any such Tenant&#146;s leasehold
improvements or on Tenant&#146;s fixtures, equipment or personal property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Workmen&#146;s Compensation Insurance.</U> Tenant shall maintain
worker&#146;s compensation insurance as required by law and employer&#146;s liability
insurance in an amount not less than Five Hundred Thousand Dollars
($500,000).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Business Interruption/Extra Expense Insurance.</U> Tenant shall
maintain loss of income, business interruption and extra expense insurance
in such amounts as will reimburse Tenant for direct or indirect loss of
earnings and incurred costs attributable to the perils commonly covered by
Tenant&#146;s property insurance described above but in no event less than Five
Hundred Thousand Dollars ($500,000.00). Such insurance shall be carried
with the same insurer that issues the insurance for the personal property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Other Coverage.</U> Tenant, at its cost, shall maintain such other
insurance as Landlord may reasonably require from time to time, but in no
event may Landlord require any other insurance which is (i)&nbsp;not then being
required of comparable tenants leasing comparable amounts of space in
comparable buildings in the vicinity of the Building or (ii)&nbsp;not then available
at commercially reasonable rates.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
16
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Insurance Criteria.</U> Each policy of insurance required under this
Section shall: (i)&nbsp;be in a form, and written by an insurer, reasonably
acceptable to Landlord, (ii)&nbsp;be maintained at Tenant&#146;s sole cost and expense,
and (iii)&nbsp;require at least thirty (30)&nbsp;days&#146; written notice (or twenty (20)&nbsp;days
in case of nonpayment of premium) to Landlord prior to any cancellation,
nonrenewal or modification of insurance coverage. Insurance companies
issuing such policies shall have rating classifications of &#147;A&#148; or better and
financial size category ratings of &#147;XIII&#148; or better according to the latest
edition of the A.M. Best Key Rating Guide. All insurance companies issuing
such policies shall be licensed to do business in the State of California. Any
deductible amount under such insurance shall not exceed maximum
deductible amounts currently required under similar leases for buildings in
the vicinity of the Building, with Tenant having the burden of proof. Tenant
shall provide to Landlord, upon request, evidence that the insurance required
to be carried by Tenant pursuant to this Section, including any endorsement
affecting the additional insured status, is in full force and effect and that
premiums therefore have been paid.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Increase in Amount of Insurance.</U> Tenant shall increase the
amounts of insurance as required by any Mortgagee, and, not more
frequently than once every three (3)&nbsp;years, as recommended by Landlord&#146;s
insurance broker, if, in the reasonable opinion of either of them, the amount
of insurance then required under this Lease is not adequate. Any limits set
forth in this Lease on the amount or type of coverage required by Tenant&#146;s
insurance shall not limit the liability of Tenant under this Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <U>Insurance Provisions</U>. Each policy of liability insurance required by this
Section shall: (i)&nbsp;contain a cross liability endorsement or separation of insureds clause; (ii)
provide that it is primary to and not contributing with, any policy of insurance carried by
Landlord or Prime Landlord covering the same loss; (iii)&nbsp;provide that any failure to comply with
the reporting provisions shall not affect coverage provided to Landlord, Prime Landlord, their
officers, directors, shareholders, members, property managers and mortgagees; and (iv)&nbsp;name Prime
Landlord, Mortgagees, Landlord, their officers, directors, employees, shareholders, members,
property managers and such other parties in interest as Landlord may from time to time reasonably
designate to Tenant in writing, as additional insureds. Such additional insureds shall be provided
the same extent of coverage as provided to Tenant under such policies. All endorsements affecting
such additional insured status shall be acceptable to Landlord and shall be at least as broad as
additional insured endorsement form number CG 20 11 11 85 promulgated by the Insurance Services
Office.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
17
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <U>Evidence of Coverage.</U> Prior to occupancy of the Premises by Tenant,
and not less than thirty (30)&nbsp;days prior to the expiration of any policy thereafter, Tenant
shall furnish to Landlord a certificate of insurance reflecting that the insurance required
by this Section is in force accompanied by an endorsement showing the required additional
insureds satisfactory to Landlord in substance and form. Notwithstanding the requirements
of this paragraph, Tenant shall, at Landlord&#146;s request, provide to Landlord within a
commercially reasonable time a certified copy of each insurance policy required to be in
force at any time pursuant to the requirements of this Lease or its Exhibits. Tenant&#146;s
failure to furnish Landlord with such certificates of insurance within a reasonable time
(not to exceed ten (10)&nbsp;days) after Landlord&#146;s request shall be deemed a material default
under this Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.2 <U>General</U>. Tenant will save Landlord harmless, and will exonerate and indemnify
Landlord and Prime Landlord, from and against any and all claims, liabilities, penalties, damages
or expenses (including without limitation reasonable attorneys&#146; fees) asserted against or incurred
by Landlord or Prime Landlord:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) on account of or based upon any injury to person, or loss of or
damage to property sustained or occurring on the Demised Premises on
account of or based upon the act, omission, fault, negligence or misconduct of
any person whomsoever (other than Landlord, Prime Landlord or their
agents, contractors or employees);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) on account of or based upon any injury to person or loss of or
damage to property, sustained or occurring elsewhere (other than on the
Demised Premises) in or about the Building (and, in particular, without
limiting the generality of the foregoing on or about the elevators, stairways,
public corridors, sidewalks, roof, or other appurtenances and facilities used in
connection with the Building or Demised Premises) arising out of the use or
occupancy of the Building or Demised Premises by Tenant, or any person
claiming by, through or under Tenant (other than those caused by or
attributable to the negligence or willful misconduct of Landlord, Prime
Landlord or their agents, contractors or employees);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) on account of or based upon (including moneys due on account
of) any work or thing whatsoever done (other than by Landlord, Prime
Landlord or their contractors, or agents or employees of any such party) in
the Demised Premises during the Term of this Lease and during the period of
time, if any, prior to the Term Commencement Date that Tenant may have
been given access to the Demised Premises; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) on account of or resulting from the failure of Tenant to perform
and discharge any of its covenants and obligations under this Lease;
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
18
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">and, in case any action or proceeding be brought against Landlord or Prime Landlord by reason of
any of the foregoing, Tenant upon notice from Landlord shall at Tenant&#146;s expense resist or defend
such action or proceeding and employ counsel therefor reasonably satisfactory to Landlord, it
being agreed that such counsel as may act for insurance underwriters of Tenant engaged in such
defense shall be deemed satisfactory.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.3 <U>Property of Tenant</U>. In addition to and not in limitation of the
foregoing, and subject only to provisions of applicable law, Tenant covenants and
agrees that all merchandise, furniture, fixtures and property of every kind, nature
and description which may be in or upon the Demised Premises or elsewhere on the
Property during the Term of this Lease, shall be at the sole risk and hazard of
Tenant, and that if the whole or any part thereof shall be damaged, destroyed,
stolen or removed from any cause or reason whatsoever other than the negligence or
misconduct of Landlord or Prime Landlord or their contractors, or agents or
employees of any such party, no part of said damage or loss shall be charged to, or
borne by Landlord or Prime Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.4 <U>Bursting of Pipes, etc.</U> Landlord shall not be liable for any injury or
damage to persons or property resulting from fire, explosion, seismic events,
earthquakes, falling plaster or tiles, steam, gas, electricity, electrical disturbance,
water, rain or snow or leaks from any part of the Building or from the pipes,
appliances or plumbing works or from the roof, street or sub-surface or from any
other place or caused by any other cause of whatever nature, unless caused by or
due to the negligence of Landlord, its agents, servants or employees; nor shall
Landlord or its agents be liable for any such damage caused by other tenants or
persons in the Building or caused by operations in construction of any private,
public or quasi-public work; nor shall Landlord be liable for any latent defect in the
Demised Premises or elsewhere in the Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.5 <U>Landlord&#146;s Insurance</U>. Landlord shall, at its sole expense, carry so-called &#147;all risk&#148; full replacement cost casualty insurance on the Building (exclusive
of Tenant&#146;s leasehold improvements, fixtures and equipment).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">14. ASSIGNMENT, MORTGAGING, SUBLETTING, ETC.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.1 <U>Generally</U>. Tenant shall not voluntarily, involuntarily or by operation of law
assign, transfer, mortgage or otherwise encumber this Lease or any interest of Tenant therein, in
the whole or in part of the Premises or permit the Premises or any part thereof to be used or
occupied by others, without the prior written consent of Landlord and Landlord&#146;s mortgagee. Except
in connection with a public stock offering, a transfer of any of Tenant&#146;s stock or a transfer or
change of control of Tenant (if Tenant is a corporation), or a change in the composition of persons
or entities owning any interest in Tenant (if Tenant is not a corporation), or any
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
19
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">transfer
of Tenant&#146;s interest in the Lease by operation of law or by merger or consolidation of
Tenant with or into any other entity, firm or corporation, shall be deemed an assignment for
purposes of this Article&nbsp;14. Notwithstanding anything to the contrary in this Lease, except with
respect to Corporate Transfers (hereinafter defined) to a Competitor (as defined in Section&nbsp;14.2),
Tenant shall not be required to obtain Landlord&#146;s consent, and the terms of Sections&nbsp;14.2 and 14.3
of this Lease shall not apply, to any transfer of Tenant&#146;s stock or a transfer or change of
control of Tenant or other transfer to an entity which controls, is controlled by or is under
common control with Tenant or any successor to Tenant or which succeeds to substantially all of
Tenant&#146;s assets and business by merger, consolidation, reorganization or purchase or in connection
with an initial public offering (collectively referred to as &#147;Corporate Transfers&#148;). Tenant shall
give Landlord written notice at least thirty (30)&nbsp;days prior to the effective date of such
Corporate Transfer. As used herein, the terms &#147;controlled&#148; or &#147;controls&#148; or &#147;control&#148; shall mean
ownership of at least fifty-one percent (51%) of voting control of the relevant entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.2 <U>Landlord&#146;s Options</U>. In connection with any request by Tenant for Landlord&#146;s
consent to assignment or subletting, Tenant shall submit to Landlord in writing (&#147;Tenant&#146;s Sublease
Notice&#148;) (i)&nbsp;the name of the proposed assignee or subtenant, (ii)&nbsp;such information as to its
financial responsibility and standing as Landlord may reasonably require, and (iii)&nbsp;all of the
terms and provisions upon which the proposed assignment or subletting is to be made. Within ten
(10)&nbsp;business days after receipt from Tenant of Tenant&#146;s Sublease Notice and receipt of the
information required hereunder, Landlord shall have the following options: (a)&nbsp;reasonably
withholding its consent; (b)&nbsp;withholding consent in its absolute discretion if the proposed
assignee or sublessee is a &#147;Competitor&#148; (as that term is hereinafter defined); (c)&nbsp;if the request
is to sublet a portion of the Premises, to take back such portion of the Premises for the proposed
term of such sublease and to abate the Monthly Fixed Rent and Additional Rent accordingly; or
(d)&nbsp;if the request is to assign this Lease or sublet all of the Premises, to take back the Premises
for the proposed term of such assignment or sublease and to abate the Monthly Fixed Rent and
Additional Rent accordingly; in each case under clauses (c)&nbsp;and (d)&nbsp;above, effective as of the
date set forth in Tenant&#146;s Sublease Notice for commencement of the sublease term or for the
assignment. The term &#147;Competitor,&#148; as used herein shall mean any person or entity engaged in the
manufacture or sale of instruments for DNA sequencing or amplification, including, without
limitation, the following businesses and any affiliates, subsidiaries, parents or successors
thereto: PE Corp., Applera Corporation, PE Biosystems, Inc., Applied Biosystems, Inc., Celera
Genomics, Inc., Celera Genomics Group, F. Hoffmann-LaRoche Ltd., Hoffmann-LaRoche, Inc., Roche
Diagnostics Corporation, Roche Molecular Systems, Inc., Amersham Pharmacia Biotech, Ltd.,
Molecular Dynamics, Inc., Perkin Elmer Corporation, Strategene, Hybade Ltd., Ericomp, Techne
Corporation, MWG Biotech
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
20
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">AG,
Whatman Biometra, Labreco, Inc., Bio-Rad Laboratories, Inc., and Cepheid. In the event Landlord
shall exercise either option (c)&nbsp;or (d)&nbsp;above, Tenant shall sublease the Demised Premises, or
relevant portion thereof or assign this Lease to Tenant upon the terms and conditions set forth in
said Tenant&#146;s Sublease Notice. In the event Landlord shall exercise such option under clauses (c)
and (d), Tenant shall surrender possession of the entire Premises, or the portion which is the
subject of the option, as the case may be, on the date set forth in such notice in accordance with
the provisions of this Lease relating to surrender of the Premises at the expiration of the Term.
If the foregoing abatement of Monthly Fixed Rent relates only to a portion of the Premises or to a
portion of the Term, the abatement shall relate to the particular space and period of time in
question taking into account the rent paid per square foot for such space.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.3 <U>Conditions</U>. Any subletting or assignment pursuant to this Article shall
be subject to and conditioned upon the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) at the time of any proposed subletting or assignment, Tenant
shall not be in default under any of the terms, covenants, or conditions of this
Lease beyond applicable grace periods;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the sublessee or assignee shall conduct its business in
accordance with the Permitted Use;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) prior to occupancy, Tenant and its assignee or sublessee shall
execute, acknowledge and deliver to Landlord a fully executed counterpart of
a written assignment of lease or a written sublease, as the case may be, by
the terms of which:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) in case of an assignment of this Lease in its entirety,
Tenant shall assign to such assignee Tenant&#146;s entire interest in this
Lease, together with all prepaid rents hereunder, and the assignee
shall accept said assignment and assume and agree to perform directly
for the benefit of Landlord, all of the terms, covenants and conditions
of this Lease on Tenant&#146;s part to be performed; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) in case of a subletting, the sublessee thereunder shall
agree to be bound by and to perform all of the terms, covenants and
conditions of this Lease on the Tenant&#146;s part to be performed during
the term of the sublease to the extent of the premises sublet, except the
payments of rents, charges and other sums reserved hereunder, which
Tenant shall continue to be obligated to pay and shall pay to Landlord;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Tenant shall pay to Landlord monthly fifty percent (50%) of the excess of the
rents and other charges received by Tenant pursuant to the
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
21
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">assignment or sublease over the rents and other charges reserved to Landlord under this
Lease attributable to the space assigned or sublet, less the reasonable costs and expenses
of subleasing and less the unamortized cost of Tenant&#146;s leasehold improvements (but not
trade fixtures or equipment) paid for by Tenant, which cost shall be amortized over a ten
year basis commencing on the Term Commencement Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Tenant and any guarantor of Tenant&#146;s obligations hereunder (hereinafter
&#147;Guarantor&#148;) shall acknowledge that, notwithstanding such assignment or sublease and
consent of Landlord thereto, Tenant and Guarantor shall not be released or discharged from
any liability whatsoever under this Lease and will continue to be liable with the same
force and effect as though no assignment or sublease had been made; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Tenant shall pay Landlord&#146;s reasonable costs including but not limited to
attorney&#146;s fees and Landlord&#146;s administrative and overhead costs, incurred in connection
with each such assignment or subletting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.4 <U>No Waiver</U>. The consent by Landlord to an assignment or subletting shall not in
any way be construed to relieve Tenant from obtaining the express consent of Landlord to any
further assignment or subletting for the use of all or any part of the Premises, nor shall the
collection of rent by Landlord from any assignee, sublessee or other occupant after default by
Tenant be deemed a waiver of this covenant or the acceptance of such assignee, sublessee or
occupant as tenant or a release of Tenant from the further performance by Tenant of the
obligations in this Lease on Tenant&#146;s part to be performed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">15. MISCELLANEOUS COVENANTS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.1 <U>Rules and Regulations</U>. Tenant and Tenant&#146;s servants, employees, agents,
visitors and licensees will faithfully observe such Rules and Regulations as are attached hereto as
Exhibit&nbsp;C and made a part hereof or as Landlord hereafter at any time or from time to time may make
and may communicate in writing to Tenant and which in the reasonable judgment of Landlord shall be
necessary for the reputation, safety, care or appearance of the Property, or the preservation of
good order therein, or the operation or maintenance of the Property, or the equipment thereof, or
the comfort of tenants or others in the Building, provided, however, that in the case of any
conflict between the provisions of this Lease and any such Rules and Regulations, the provisions of
this Lease shall control, and provided further that nothing contained in this Lease shall be
construed to impose upon Landlord any duty or obligation to enforce such Rules and Regulations or
the terms, covenants or conditions in any other lease as against any other tenant and Landlord
shall not be liable to Tenant for violation of the same by any other tenant, its servants,
employees, agents, visitors, invitees or licensees.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
22
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.2 <U>Access to Premises</U>. Tenant shall: (i)&nbsp;permit Landlord to erect, use and
maintain pipes, ducts and conduits in and through the Demised Premises, provided the same do not
materially reduce the floor area or materially adversely affect the use or appearance thereof; (ii)
permit the Landlord and any Mortgagee to have free and unrestricted access to and to enter upon the
Demised Premises at all reasonable hours (upon 24 hours prior notice except in case of emergency)
for the purposes of inspection or of making repairs, replacements or improvements in or to the
Demised Premises or the Building or equipment (including, without limitation, sanitary, electrical,
heating, air conditioning or other systems) or of complying with all laws, orders and requirements
of governmental or other authority or of exercising any right reserved to Landlord by this Lease
(including the right during the progress of any such repairs, replacements or improvements or while
performing work and furnishing materials in connection with compliance with any such laws, orders
or requirements to take upon or through, or to keep and store within, the Demised Premises all
necessary materials, tools and equipment); and (iii)&nbsp;permit Landlord, at reasonable times and upon
24 hours prior notice, to show the Demised Premises during ordinary business hours to any
Mortgagee, prospective purchaser of any interest of Landlord in the Property, prospective
Mortgagee, or prospective assignee of any Mortgage, and during the period of twelve months next
preceding the Termination Date to any person contemplating the leasing of the Demised Premises or
any part thereof. If Tenant shall not be personally present to open and permit any entry into the
Demised Premises at any time when for any reason an entry therein shall be necessary or permissible
pursuant to the terms of this Lease or by law, Landlord or Landlord&#146;s agents must nevertheless be
able to gain such entry by contacting a responsible representative of Tenant, whose name, address
and telephone number shall be furnished by Tenant. Provided that Landlord shall not be obligated to
employ labor at so-called &#147;over-time&#148; or other premium pay rates, Landlord shall exercise its
rights of access to the Demised Premises permitted under any of the terms and provisions of this
Lease in such manner as to minimize to the extent practicable interference with Tenant&#146;s use and
occupation of the Demised Premises. Notwithstanding the foregoing, any entry (other than in case of
emergency) by Landlord, any Mortgagee or any of their agents or representatives shall be subject to
Tenant&#146;s reasonable health, safety and security requirements, including but not limited to the
requirement that a representative of Tenant accompany such parties when in certain parts of the
Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.3 <U>Accidents to Sanitary and other Systems</U>. Tenant shall give to Landlord prompt
notice of any fire or accident in the Demised Premises or in the Building and of any damage to, or
defective condition in, any part or appurtenance of the Building&#146;s sanitary, electrical, heating
and air conditioning or other systems located in, or passing through, the Demised Premises.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
23
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.4 <U>Signs, Blinds and Drapes</U>. Tenant shall not place any signs on the
exterior of the Building or on or in any window, public corridor or door visible from
the exterior of the Demised Premises. No drapes or blinds may be put on or in any
exterior window.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.5 <U>Estoppel Certificate</U>. Tenant shall at any time and from time to time
upon not less than ten business (10)&nbsp;days&#146; prior notice by Landlord, Prime Landlord
or by a Mortgagee to Tenant, execute, acknowledge and deliver to the party making
such request a statement in writing certifying that this Lease is unmodified and in
full force and effect (or if there have been modifications, that the same is in full
force and effect as modified and stating the modifications), and the dates to which
Rent has been paid in advance, if any, and stating whether or not to the actual
knowledge and belief of the signer of such certificate Landlord is in default in
performance of any covenant, agreement, term, provisions or condition contained in
this Lease and, if so, specifying each such default of which the signer may have
knowledge, it being intended that any such statement delivered pursuant hereto
may be relied upon by any prospective purchaser of any interest in the Property,
any Mortgagee or prospective Mortgagee, any lessee or prospective lessee thereof,
any prospective assignee of any Mortgage, or any other party designated by
Landlord. The form of any such estoppel certificate requested by a Mortgagee shall
be reasonably satisfactory to such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.6 <U>Requirements of Law &#151; Fines and Penalties</U>. Tenant at its sole expense
shall comply with all laws, rules, orders and regulations of Federal, State, County
and Municipal Authorities and with any direction of any public officer or officers,
pursuant to law, which shall impose any duty upon Landlord or Tenant with respect
to and arising out of Tenant&#146;s use or occupancy of the Demised Premises. If Tenant
receives notice of any violation of law, ordinance, order or regulation applicable to
the Demised Premises, it shall give prompt notice thereof to Landlord. Without
limiting the generality of the foregoing, Tenant shall be responsible for compliance
with requirements imposed by the Americans with Disabilities Act relative to the
Demised Premises, including without limitation all such requirements applicable to
removing barriers, furnishing auxiliary aids and ensuring that, whenever
alterations are made, the affected portions of the Demised Premises are readily
accessible to and usable by individuals with disabilities. Notwithstanding anything
in the foregoing to the contrary, if the requirement of additional work in the
Demised Premises is caused by governmental action solely as result of work being
done by Landlord in parts of the Building other than the Demised Premises or as a
result of the general use or occupancy of the building itself, then Landlord shall be
responsible for the cost of such ADA work. Conversely, if additional ADA work in
the Building is caused by governmental action solely as a result of work in the
Demised Premises by Tenant or as a result of Tenant&#146;s particular use of the
Premises, then Tenant shall be responsible for the cost of such ADA work.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.7 <U>Tenant&#146;s Acts &#151; Effect on Insurance</U>. Tenant shall not do or permit to be done
any act or thing upon the Demised Premises or elsewhere in the Building which will invalidate or be
in conflict with any insurance policies covering the Building and the fixtures and property therein
and shall not do, or permit to be done, any act or thing upon the Demised Premises which shall
subject Landlord to any liability or responsibility for injury to any person or persons or to
property by reason of any business or operation being conducted on the Demised Premises or for any
other reason. Subject to the terms of this Lease and except as otherwise specifically set forth to
the contrary herein, Tenant at its own expense shall comply with all applicable provisions of the
California Health and Safety Code and all regulations promulgated thereunder and with all rules,
orders, regulations or requirements of the underwriter(s) of the fire and other hazard insurance for
the Property and the Demised Premises and shall not do, or permit anything to be done, in or upon
the Demised Premises, or bring or keep anything therein, that is not permitted by the City of South
San Francisco Fire Department, or other authority having jurisdiction, and then only in such
quantity and manner of storage as will not increase the rate for any insurance applicable to the
Building. If by reason of failure of Tenant to comply with the provisions hereof the insurance rate
applicable to any policy of insurance shall at any time thereafter be higher than it otherwise
would be, then Tenant shall reimburse Landlord for that part of any insurance premiums thereafter
paid by Landlord, which shall have been charged because of such failure by Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.8 <U>Miscellaneous</U>. Tenant shall not suffer or permit the Demised Premises or any
fixtures, equipment or utilities therein or serving the same, to be overloaded, damaged or defaced.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">16. DAMAGE BY FIRE, ETC.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of loss of, or damage to, the Demised Premises or the Building by fire or other
casualty, the rights and obligations of the parties hereto shall be as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If the Demised Premises, or any part thereof, shall be damaged by fire or
other casualty, Tenant shall give prompt notice thereof to Landlord, and Landlord, upon
receiving such notice and the insurance proceeds for such casualty, shall proceed in a
commercially reasonable manner, subject to unavoidable delays, to repair, or cause to be
repaired, such damage to the extent hereinafter provided. If the Demised Premises or any
part thereof shall be rendered untenantable by reason of such damage, whether to the Demised
Premises or to the Building, Yearly Fixed Rent shall proportionately abate for the period
from the date of such damage to the date when such damage shall have been repaired by
Landlord.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
25
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) If, as a result of fire or other casualty, the whole or a substantial portion
of the Building is rendered untenantable and the nature and extent of the damage is such
that in Landlord&#146;s opinion, taking into account a reasonable time for adjusting loss and
obtaining plans and permits for restoration, the Demised Premises cannot be made tenantable
within 180&nbsp;days after such event, Landlord, within ninety (90)&nbsp;days from the date of such
fire or casualty, may terminate this Lease by notice to Tenant, specifying a date not less
than thirty (30)&nbsp;nor more than sixty (60)&nbsp;days after the giving of such notice on which the
Term of this Lease shall terminate. If Landlord does not so elect to terminate this Lease,
then Landlord shall (to the extent that proceeds of insurance required to be carried by
Landlord, net of any portion thereof retained by a Mortgagee, are made available for such
purpose) proceed with diligence to repair the damage to the Demised Premises and all
facilities serving the same, if any, which shall have occurred, and the Yearly Fixed Rent
shall meanwhile proportionately abate, all as provided in Paragraph (a)&nbsp;of this Section.
However, if such damage is not repaired and the Demised Premises restored to substantially
the same condition as they were prior to such damage within one (1)&nbsp;year from the date of
such damage, Tenant within thirty (30)&nbsp;days from the expiration of such one (1)&nbsp;year period
or from the expiration of any extension thereof by reason of unavoidable delays as
hereinafter provided, may terminate this Lease by notice to Landlord, specifying a date not
more than sixty (60)&nbsp;days after the giving of such notice on which the Term of this Lease
shall terminate. The period within which the required repairs may be accomplished shall be
extended by the number of days, lost as a result of unavoidable delays, which
term shall be defined to include all delays referred to in Article&nbsp;24.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) If the Demised Premises shall be rendered untenantable by fire
or other casualty during the last year of the Term of this Lease, Landlord may terminate this Lease effective as of the date of such fire or other casualty
upon notice to Tenant given within ninety (90)&nbsp;days after such fire or other
casualty. Notwithstanding the foregoing to the contrary, in the event
Landlord exercises the foregoing termination right, if Tenant has available to
it the option to extend and validly exercises said option, Tenant may defeat
said termination notice by the valid exercise of said option term so as to add
an additional five years on to the Term of this Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Landlord shall not be required to repair or replace any of
Tenant&#146;s leasehold improvements, fixtures, business machinery, equipment,
cabinet work, furniture, personal property or other installations (all of which
shall, however, be restored by Tenant within a reasonable time after
Landlord shall have completed any repair or restoration required under the
terms of this Article), and no damages, compensation or claim shall be
payable by Landlord for inconvenience, loss of business or annoyance arising
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
26
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">from any repair or restoration of any portion of the Demised Premises or of
the Building.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The provisions of this Article shall be considered an express
agreement governing any instance of damage or destruction of the Building
or the Demised Premises by fire or other casualty, and any law now or
hereafter in force providing for such a contingency in the absence of express
agreement shall have no application.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) In the event of any termination of this Lease pursuant to this
Article, the Term of this Lease shall expire as of the effective termination
date as fully and completely as if such date were the date originally fixed
herein for the end of the Term of this Lease. Tenant shall have access to the
Demised Premises for a period of fifteen (15)&nbsp;days after the date of
termination in order to remove Tenant&#146;s personal property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Landlord&#146;s Architect&#146;s certificate, given in good faith, shall be
deemed conclusive of the statements therein contained and binding upon
Tenant with respect to the performance and completion of any repair or
restoration work undertaken by Landlord pursuant to this Article or Article
18.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">17. WAIVER OF SUBROGATION
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In any case in which Tenant shall be obligated under any provision of this Lease to pay to
Landlord or Prime Landlord any loss, cost, damage, liability, or expense suffered or incurred by
Landlord or Prime Landlord, Landlord shall allow to Tenant as an offset against the amount thereof
(i)&nbsp;the net proceeds of any insurance collected by Landlord for or on account of such loss, cost,
damage, liability, or expense, provided that the allowance of such offset does not invalidate the
policy or policies under which such proceeds were payable and (ii)&nbsp;if such loss, cost, damage,
liability or expense shall have been caused by a peril against which Landlord has agreed to procure
insurance coverage under the terms of this Lease, the amount of such insurance coverage, if not
actually procured by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In any case in which Landlord or Prime Landlord shall be obligated under any provision of this
Lease to pay to Tenant any loss, cost, damage, liability or expense suffered or incurred by Tenant,
Tenant shall allow to Landlord as an offset against the amount thereof (i)&nbsp;the net proceeds of any
insurance collected by Tenant for or on account of such loss, cost, damage, liability, or expense,
provided that the allowance of such offset does not invalidate the policy or policies under which
such proceeds were payable and (ii)&nbsp;if such loss, cost, damage, liability or expense shall have
been caused by a peril against which Tenant has agreed to procure insurance
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
27
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">coverage under the terms of this Lease, the amount of such insurance coverage, if not actually
procured by Tenant.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto shall each endeavor to procure an appropriate clause in, or endorsement on,
any fire or extended coverage insurance policy covering the Demised Premises and the Building and
personal property, fixtures and equipment located thereon or therein, pursuant to which the
insurance companies waive subrogation or consent to a waiver of right of recovery, and having
obtained such clauses and/or endorsements of waiver of subrogation or consent to a waiver of right
of recovery each party hereby agrees that it will not make any claim against or seek to recover
from the other for any loss or damage to its property or the property of others resulting from fire
or other perils covered by such fire and extended coverage insurance; provided, however, that the
release, discharge, exoneration and covenant not to sue herein contained shall be limited by the
terms and provisions of the waiver of subrogation clauses and/or endorsements or clauses and/or
endorsements consenting to a waiver of right of recovery and shall be co-extensive therewith. If
either party may obtain such clause or endorsement only upon payment of an additional premium, such
party shall promptly so advise the other party and shall be under no obligation to obtain such
clause or endorsement unless such other party pays the premium.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">18. CONDEMNATION - EMINENT DOMAIN
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that the whole or more than 40% of the Building shall be taken or appropriated by
eminent domain or shall be condemned for any public or quasi-public use, or (by virtue of any such
taking, appropriation or condemnation) shall suffer any damage (direct, indirect or consequential)
for which Landlord or Tenant shall be entitled to compensation then (and in any such event) this
Lease and the Term hereof may be terminated at the election of Landlord by a notice in writing of
its election so to terminate which shall be given by Landlord to Tenant within sixty (60)&nbsp;days
following the date on which Landlord shall have received notice of such taking, appropriation or
condemnation. In the event that more than fifty percent (50%) of the floor area of the Demised
Premises or a substantial part of the means of access thereto within the perimeter of the Property
so as to substantially interfere with the use of the Demised Premises shall be so taken,
appropriated or condemned, then (and in any such event) this Lease and the Term hereof may be
terminated at the election of Tenant by a notice in writing of its election so to terminate which
shall be given by Tenant to Landlord within sixty (60)&nbsp;days following the date on which Tenant
shall have received notice of such taking, appropriation or condemnation. Tenant hereby waives the
benefits of California Code of Civil Procedure Section&nbsp;12165.130.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the giving of any such notice of termination (either by Landlord or Tenant) this Lease
and the Term hereof shall terminate on or retroactively as of the
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
28
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">date on which Tenant shall be required to vacate any part of the Demised Premises or shall be
deprived of a substantial part of the means of access thereto, provided, however, that Landlord may
in Landlord&#146;s notice elect to terminate this Lease and the Term hereof retroactively as of the date
on which such taking, appropriation or condemnation became legally effective. In the event of any
such termination, this Lease and the Term hereof shall expire as of the effective termination date
as fully and completely as if such date were the date originally fixed herein for the end of the
Term of this Lease. If neither party (having the right so to do) elects to terminate Landlord will,
with reasonable diligence and at Landlord&#146;s expense, restore the remainder of the Demised Premises,
or the remainder of the means of access thereto, as nearly as practicably may be to the same
condition as obtained prior to such taking, appropriation or condemnation in which event (i)&nbsp;a just
proportion of the Yearly Fixed Rent, according to the nature and extent of the taking,
appropriation or condemnation and the resulting permanent injury to the Demised Premises and the
means of access thereto, shall be permanently abated, and (ii)&nbsp;a just proportion of the remainder
of the Yearly Fixed Rent, according to the nature and extent of the taking, appropriation or
condemnation and the resultant injury sustained by the Demised Premises and the means of access
thereto, shall be abated until what remains of the Demised Premises and the means of access thereto
shall have been restored as fully as may be possible for permanent use and occupation by Tenant
hereunder. Except for any award specifically reimbursing Tenant for moving or relocation expenses
and Tenant&#146;s moveable personal property (but not leasehold improvements), there are expressly
reserved to Landlord all rights to compensation and damages created, accrued or accruing by reason
of any such taking, appropriation or condemnation, in implementation and in confirmation of which
Tenant does hereby acknowledge that Landlord shall be entitled to receive and retain all such
compensation and damages, grants to Landlord all and whatever rights (if any) Tenant may have to
such compensation and damages, and agrees to execute and deliver all and whatever further
instruments of assignment as Landlord may from time to time request. In the event of any taking of
the Demised Premises or any part thereof for temporary use, (i)&nbsp;this Lease shall be and remain
unaffected thereby, and (ii)&nbsp;Tenant shall be entitled to receive for itself any award made for such
use, provided, that if any taking is for a period extending beyond the Term of this Lease, such
award shall be apportioned between Landlord and Tenant as of the Termination Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">19. DEFAULT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.1 <U>Events of Default</U>. Occurrence of any of the following events shall constitute
an Event of Default under this Lease: (a)&nbsp;Tenant shall neglect or fail to perform or observe any of
the Tenant&#146;s covenants herein, including (without limitation) the covenants with regard to the
payment when due of Rent, which default continues, in the case of payment of Rent, for five (5)
days after notice of default or, in the case of defaults other then payment of Rent, for thirty
(30)&nbsp;days
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
29
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">after such notice of default (provided that if more time, but not more than 30 additional days) is
required lo complete such performance, Tenant shall not be in default if Tenant commences such
performance within the thirty (30)&nbsp;day period and thereafter diligently pursues its completion); or
(b)&nbsp;Tenant shall default in payment of Rent under Subparagraph (a)&nbsp;above more than two (2)&nbsp;times in
any consecutive twelve (12)&nbsp;month period, in which case no prior notice shall be required; or (c)
Tenant shall be involved in financial difficulties as evidenced by an admission in writing by
Tenant of Tenant&#146;s inability to pay its debts generally as they become due, or by the making or
offering to make a composition of its debts with its creditors; or (d)&nbsp;Tenant shall make an
assignment or trust mortgage, or other conveyance or transfer of like nature, of all or a
substantial part of its property for the benefit of its creditors; or (e)&nbsp;the leasehold hereby
created shall be taken on execution or by other process of law and shall not be revested in Tenant
within sixty (60)&nbsp;days thereafter; or (f)&nbsp;a receiver, sequester, trustee or similar officer shall
be appointed by a court of competent jurisdiction to take charge of all or a substantial part of
Tenant&#146;s property and such appointment shall not be vacated within sixty (60)&nbsp;days; or (g)&nbsp;any
proceeding shall be instituted by or against Tenant pursuant to any of the provisions of any Act of
Congress or State law relating to bankruptcy, reorganization, arrangements, compositions or other
relief from creditors, and, in the case of any such proceeding instituted against it, if Tenant
shall fail to have such proceeding dismissed within thirty (30)&nbsp;days or if Tenant is adjudged
bankrupt or insolvent as a result of any such proceeding; or (h)&nbsp;any event shall occur or any
contingency shall arise whereby this Lease, or the term and estate thereby created, would (by
operation of law or otherwise) devolve upon or pass to any person, firm or corporation other than
Tenant, except as expressly permitted under Article&nbsp;14 hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.2 <U>Remedies Available upon Default</U>. Upon the occurrence of an Event of Default,
Landlord shall have the following remedies to the extent available under applicable law, which
shall not be exclusive but shall be cumulative and shall be in addition to any other remedies now
or hereafter allowed by law:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Landlord may terminate Tenant&#146;s right to possession of the Premises at any
time by written notice to Tenant. Tenant expressly acknowledges that in the absence of such
written notice from Landlord, no other act of Landlord, including re-entry into the
Premises, efforts to relet the Premises, reletting of the Premises for Tenant&#146;s account,
storage of Tenant&#146;s personal property and trade fixtures, acceptance of keys to the Premises
from Tenant or exercise of any other rights and remedies under this Section, shall
constitute an acceptance of Tenant&#146;s surrender of the Premises or constitute a termination
of this Lease or of Tenants right to possession of the Premises. Upon such termination in
writing of Tenant&#146;s right to possession of the Premises, as herein provided, this Lease
shall terminate and Landlord shall be entitled to recover damages from Tenant as provided in
California Civil
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
30
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Code Section&nbsp;1951.2 and any other applicable existing or future Law providing for
recovery of damages for such breach, including the worth at the time of award of the amount
by which the rent which would be payable by Tenant here under for the remainder of the Term
after the date of the award of damages, including Additional Rent as reasonably estimated
by Landlord, exceeds the amount of such rental loss as Tenant proves could have been
reasonably avoided, discounted at the discount rate published by the Federal Reserve Bank
of San Francisco for member banks at the time of the award plus one percent (1%).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Landlord shall have the remedy described in California Civil
Code Section&nbsp;1951.4 (Landlord may continue this Lease in effect after
Tenant&#146;s breach and abandonment and recover rent as it becomes due, if
Tenant has the right to sublet or assign, subject only to reasonable
limitations).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Landlord may immediately, or at any time thereafter, without
notice, cure said Event of Default for the account of Tenant. If Landlord at
any time is compelled to pay of elects to pay any sum of money, or do any act
which will require the payment of any sum of money, by reason of the failure
of Tenant to comply with any provision hereof, or if Landlord is compelled to
or does incur any expense, including without limitation reasonable attorneys&#146;
fees, in instituting, prosecuting and/or defending any action or proceeding
arising by reason of any default of Tenant hereunder, Tenant shall on
demand pay to Landlord by way of reimbursement the sum or sums so paid
by Landlord with all interest, costs and damages together with interest at the
Interest Rate for the period such sums remain outstanding.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Landlord may remove all of Tenant&#146;s property from the
Premises, and such property may be stored by Landlord in a public
warehouse or elsewhere at the sole cost and for the account of Tenant. If
Landlord does not elect to store any or all of Tenant&#146;s property left in the
Premises, Landlord may consider such property to be abandoned by Tenant,
and Landlord may thereupon dispose of such property in the manner and as
prescribed by California Civil Code Section&nbsp;1980 et seq. Any proceeds realized
by Landlord on the disposal of any such property may be applied to offset all
expenses of storage and sale and as permitted under California Civil Code
Section&nbsp;1980 et seq.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The damages recoverable by Landlord pursuant to this Section
shall in all events include reimbursement of any concessions made by
Landlord in connection with the leasing of the Demised Premises to Tenant,
including without limitation (a)&nbsp;abated Rent, (b)&nbsp;allowances or improvements
in excess of any Building standard work, (c)&nbsp;sums paid to any former landlord
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
31
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">of Tenant under a so-called &#147;take-over&#148;, lease assumption or similar agreement and (d)
signing bonuses and other incentive payments. Any allowances, abated rent, signing bonuses,
incentive payments or takeover payments shall be deemed commercially reasonable if
recommended to Landlord by a reputable commercial real estate broker as being appropriate
and necessary for the leasing of said Premises to a creditworthy tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.3 <U>Grace Period</U>. Notwithstanding anything to the contrary in this Article
contained, Landlord agrees not to take any action to terminate this Lease (a)&nbsp;for default by Tenant
in the payment when due of Rent, if Tenant shall cure such default within five (5)&nbsp;days after
written notice thereof given by Landlord to Tenant, unless there has been two (2)&nbsp;or more defaults
in any 12-month period as set forth in Section&nbsp;19.1(b), or (b)&nbsp;for default by Tenant in the
performance of any other covenant, if Tenant shall cure such default within a period of thirty (30)
days after written notice thereof given by Landlord to Tenant (except where the nature of the
default is such that remedial action should appropriately take place sooner, as indicated in such
written notice), or with respect to covenants other than to pay a sum of money within such
additional period as may reasonably be required to cure such default if (because of governmental
restrictions or any other cause beyond the reasonable control of Tenant) the default is of such a
nature that it cannot be cured within such thirty (30)-day period, provided, however, (1)&nbsp;that
there shall be no extension of time beyond such thirty (30)-day period for the curing of any such
default unless, not more than ten (10)&nbsp;days after the receipt of the notice of default, Tenant in
writing (i)&nbsp;shall specify the cause on account of which the default cannot be cured during such
period and shall advise Landlord of its intention duly to institute all steps necessary to cure the
default and (ii)&nbsp;shall as soon as may be reasonable duly institute and thereafter diligently
prosecute to completion all steps necessary to cure such default and, (2)&nbsp;that no notice of the
opportunity to cure a default need be given, and no grace period whatsoever shall be allowed to
Tenant, if the default is incurable or if the subject of the breach which gave rise to the default
had, by reason of regular repetitive breaches on prior occasions (i.e., showing a pattern of
intentional conduct or indifferent regard to performance of the Lease), been the subject of prior
notices hereunder to cure such defaults.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">20. END
OF TERM &#151; ABANDONED PROPERTY
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the expiration or other termination of the Term of this Lease, Tenant shall peaceably
quit and surrender to Landlord the Demised Premises and all alterations and additions thereto which
Tenant is not entitled or required to remove under the provisions of this Lease, broom clean in
good order, repair and condition excepting only reasonable use and wear and damage by fire or other
casualty for which, under other provisions of this Lease, Tenant has no responsibility of repair or
restoration. Tenant&#146;s obligation to observe or perform this covenant shall survive the expiration
or other termination of the Term of this Lease. If the last day of the
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Term of this Lease or any renewal thereof falls on a day other than a Business Day, this Lease
shall expire on the Business Day immediately following. Tenant shall pay two (2)&nbsp;times the amount
of Rent applicable to each month (or fraction thereof) during which Tenant remains in possession
of any part of the Demised Premises in violation of the foregoing covenants, without prejudice to
eviction and any other remedy available to Landlord on account thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any personal property in which Tenant has an interest which shall remain in the Building or on
the Demised Premises after the expiration or termination of the Term of this Lease shall to the
extent in accordance with California Civil Code Section&nbsp;1980 et seq., be conclusively deemed to
have been abandoned, and may be disposed of in such manner as Landlord may see fit; provided,
however, notwithstanding the foregoing, that Tenant will, upon request of Landlord made not later
than ten (10)&nbsp;days after the expiration or termination of the Term hereof, promptly remove from the
Building any such personal property or, if any part thereof shall be sold, that Landlord may
receive and retain the proceeds of such sale and apply the same, at its option, against the
expenses of the sale, the cost of moving and storage, any arrears of Rent payable hereunder by
Tenant to Landlord and any damages to which Landlord may be entitled under Article&nbsp;19 hereof or
pursuant to law, with the balance if any, to be paid to Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">21. RIGHTS OF MORTGAGEES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.1 <U>Entry and Possession</U>. Upon entry and taking possession of the
Property by a Mortgagee, for the purpose of foreclosure or otherwise, such
Mortgagee shall have all the rights of Landlord, and shall be liable to perform all
the obligations of Landlord arising and accruing during the period of such
possession by such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.2 <u>Right to Cure</u>. No act or failure to act on the part of Landlord which
would entitle Tenant under the terms of this Lease, or by law, to be relieved of
Tenant&#146;s obligations hereunder or to terminate this Lease, shall result in a release
or termination of such obligations or a termination of this Lease unless (i)&nbsp;Tenant
shall have first given written notice of Landlord&#146;s act or failure to act to first
Mortgagees of record, if any, and to any other Mortgagees of whom Tenant has been
given written notice, specifying the act or failure to act on the part of Landlord
which could or would give basis to Tenant&#146;s rights; and (ii)&nbsp;such Mortgagees, after
receipt of such notice, have failed or refused to correct or cure the condition
complained of within a reasonable time thereafter, but nothing contained in this
paragraph shall be deemed to impose any obligation on any such Mortgagees to
correct or cure any such condition.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reasonable time&#148; as used above means and includes a reasonable time to obtain possession of
the land and Building if any such mortgagee elects to do so and
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
33
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">a reasonable time to correct or cure the condition if such condition is determined to exist.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.3 <U>Prepaid Rent</U>. No Rent shall be paid more than thirty (30)&nbsp;days prior
to the due dates thereof and, as to a first Mortgagee of record and any other
Mortgagees of whom Tenant has been given written notice, payments made in
violation of this provision shall (except to the extent that such Rent is actually
received by such Mortgagee) be a nullity as against such Mortgagee and Tenant
shall be liable for the amount of such payments to such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.4 <u>Continuing Offer</u>. The covenants and agreements contained in this
Lease with respect to the rights, powers and benefits of a Mortgagee (particularly,
without limitation thereby, the covenants and agreements contained in this Article)
constitute a continuing offer to any person, corporation or other entity, which by
accepting or requiring an assignment of this Lease or by entry or foreclosure
assumes the obligations herein set forth with respect to such Mortgagee; every such
Mortgagee is hereby constituted a party to this Lease as an obligee hereunder to the
same extent as though its name was written hereon as such; and such Mortgagee
shall be entitled to enforce such provisions in its own name.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.5 <u>Subordination</u>. This lease shall be subordinate to all mortgages
encumbering the Land and/or Building, but Tenant shall nevertheless have the
benefit of the non-disturbance provisions hereinafter set forth, and Tenant agrees,
at the request of Landlord or any Mortgagee, to execute and deliver promptly any
certificate or other instrument which Landlord or such Mortgagee may reasonably
request subordinating this Lease and all rights of Tenant hereunder to any
Mortgage, and to all advances made under such Mortgage and/or agreeing to attorn
to such Mortgagee in the event that it succeeds to Landlord&#146;s interest in the
Property. Landlord shall use reasonable efforts to request that (i)&nbsp;the holder of each
such Mortgage shall execute and deliver to Tenant said Lender&#146;s customary
non-disturbance agreement to the effect that, in the event of any foreclosure of such
Mortgage, such holder will not name Tenant as a party defendant to such
foreclosure nor disturb its possession under the Lease. In addition if the Prime
Lease shall be terminated due to foreclosure of the mortgage made by Prime
Landlord in favor of its mortgagee or due to such mortgagee&#146;s acceptance of a deed
in lieu of foreclosure, Tenant shall attorn to mortgagee as landlord hereunder and
this lease shall continue in full force and effect for its remaining term as a direct
lease between Tenant and such mortgagee without the necessity of any additional
act or agreement; provided, however, if requested by such Mortgagee, Tenant shall
execute and deliver a new lease with such mortgagee on the same terms and
conditions as set forth herein except that the term of such new lease shall be equal
to the then remaining term hereunder. Landlord represents and warrants that as
of the date of this Lease, Bank of America is the sole mortgagee of the Land and
Building. Landlord shall use reasonable efforts to obtain from Bank of America for
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
34
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the benefit of Tenant a Subordination, Non-Disturbance and Attornment Agreement in a commercially
reasonable standard form, which Tenant will also execute for the benefit of Bank of America,
providing for the subordination of the Lease, the attornment of Tenant to Bank of America, and the
non-disturbance of Tenant under this Lease and the other subleases of space within the Building as
long Tenant is not in default hereunder or thereunder. Tenant will reimburse Landlord for all
costs and expenses in connection with obtaining said agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.6 <U>Limitations on Liability</U>. Nothing contained in the foregoing Section
21.6 or in any such non-disturbance agreement or non-disturbance provision shall however, affect
the prior rights of the holder of any Mortgage with respect to the proceeds of any award in
condemnation or of any fire insurance policies affecting the Building, or impose upon any such
holder any liability (i)&nbsp;for the erection or completion of the Building, or (ii)&nbsp;in the event of
damage or destruction to the Building or the Demised Premises by fire or other casualty, for any
repairs, replacements, rebuilding or restoration except such repairs, replacements, rebuilding or
restoration as can reasonably be accomplished from the net proceeds of insurance actually received
by, or made available to, such holder, or (iii)&nbsp;for any default by Landlord under the Lease
occurring prior to any date upon which such holder shall become Tenant&#146;s landlord, or (iv)&nbsp;for any
credits, offsets or claims against the Rent as a result of any acts or omissions of Landlord
committed or omitted prior to such date, or (v)&nbsp;for return of any security deposit or other funds
unless the same shall have been received by such holder, and any such agreement or provision may so
state.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><I>22. </I>QUIET ENJOYMENT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord covenants that if, and so long as, Tenant keeps and performs each and every covenant,
agreement, term, provision and condition herein contained on the part and on behalf of Tenant to be
kept and performed, Tenant shall quietly enjoy the Demised Premises from and against the claims of
all persons claiming by, through or under Landlord subject, nevertheless, to the covenants,
agreements, terms, provisions and conditions of this Lease and to all Mortgages to which this Lease
is subject and subordinate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without incurring any liability to Tenant, Landlord may permit access to the Demised Premises
and open the same, whether or not Tenant shall be present, upon any demand of any receiver,
trustee, assignee for the benefit of creditors, sheriff, marshall or court officer entitled to, or
reasonably purporting to be entitled to, such access for the purpose of taking possession of, or
removing Tenant&#146;s property or for any other lawful purpose (but this provision and any action by
Landlord hereunder shall not be deemed a recognition by Landlord that the person or official making
such demand has any right or interest in or to this Lease, or in or to the Demised
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
35
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Premises), or upon demand of any representative of the fire, police, building, sanitation or other
department of the city, county, state or federal governments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">23. ENTIRE AGREEMENT &#151; WAIVER &#151; SURRENDER
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.1 <U>Entire Agreement</U>. This Lease and the Exhibits made a part hereof
contain the entire and only agreement between the parties relating to the lease of
the Premises and any and all statements and representations, written and oral,
including previous correspondence and agreements between the parties hereto, are
merged herein. Tenant acknowledges that all representations and statements upon
which it relied in executing this Lease are contained herein and that Tenant in no
way relied upon any other statements or representations, written or oral. Any
executory agreement hereafter made shall be ineffective to change, modify,
discharge or effect an abandonment of this Lease in whole or in part unless such
executory agreement is in writing and signed by the party against whom
enforcement of the change, modification, discharge or abandonment is sought.
Nothing herein shall prevent the parties from agreeing to amend this Lease and the
Exhibits made a part hereof as long as such amendment shall be in writing and
shall be duly signed by both parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.2 <u>Waiver by Landlord</u>. The failure of Landlord to seek redress for
violation, or to insist upon the strict performance, of any covenant or condition of
this Lease, or any of the Rules and Regulations promulgated hereunder, shall not
prevent a subsequent act, which would have originally constituted a violation, from
having all the force and effect of an original violation. The receipt by Landlord of
Rent with knowledge of the breach of any covenant of this Lease shall not be
deemed a waiver of such breach. The failure of Landlord to enforce any of such
Rules and Regulations against Tenant and/or any other tenant or subtenant in the
Building shall not be deemed a waiver of any such Rules and Regulations. No
provisions of this Lease shall be deemed to have been waived by Landlord unless
such waiver be in writing signed by Landlord. No payment by Tenant or receipt by
Landlord of a lesser amount than the monthly rent herein stipulated shall be
deemed to be other than on account of the stipulated rent, nor shall any
endorsement or statement on any check or any letter accompanying any check or
payment as rent be deemed an accord and satisfaction, and Landlord may accept
such check or payment without prejudice to Landlord&#146;s right to recover the balance
of such rent or pursue any other remedy in this Lease provided.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.3 <u>Surrender</u>. No act or thing done by Landlord during the term hereby
demised shall be deemed an acceptance of a surrender of the Demised Premises,
and no agreement to accept such surrender shall be valid, unless in writing signed
by Landlord. No employee of Landlord or of Landlord&#146;s agents shall have any power
to accept the keys of the Demised Premises prior to the termination of this Lease.
The delivery of keys to any employee of Landlord or of Landlord&#146;s agents shall not
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
36
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">operate as a termination of the Lease or a surrender of the Demised Premises. In the event that
Tenant at any time desires to have Landlord underlet the Demised Premises for Tenant&#146;s account,
Landlord or Landlord&#146;s agents are authorized to receive the keys for such purposes without
releasing Tenant from any of the obligations under this Lease, and Tenant hereby relieves Landlord
of any liability for loss of or damage to any of Tenant&#146;s effects in connection with such
underletting.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">24. INABILITY TO PERFORM &#151; EXCULPATORY CLAUSE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise expressly provided in this Lease, this Lease and the obligations of Tenant
to pay Rent hereunder and perform all other covenants, agreements, terms, provisions and conditions
hereunder on the part of Tenant to be performed shall in no way be affected, impaired or excused
because Landlord is unable to fulfill any of its obligations under this Lease or is unable to
supply or is delayed in supplying any service expressly or impliedly to be supplied or is unable to
make or is delayed in making any repairs, replacements, additions, alterations, improvements or
decorations or is unable to supply or is delayed in supplying any equipment or fixtures if Landlord
is prevented or delayed from doing so by reason of any cause whatsoever beyond Landlord&#146;s
reasonable control, including but not limited to governmental preemption in connection with a
national emergency or by reason of any rule, order or regulation of any department or subdivision
thereof of any governmental agency or by reason of strikes, labor troubles, shortages of labor or
materials or conditions of supply and demand which have been or are affected by war, hostilities or
other similar or dissimilar emergency. In each such instance of inability of Landlord to perform,
Landlord shall exercise reasonable diligence to eliminate the cause of such inability to perform.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall neither assert nor seek to enforce any claim for breach of this Lease against any
of Landlord&#146;s assets other than Landlord&#146;s or Prime Landlord&#146;s interest in the Building of which
the Demised Premises are a part and in the rents, issues and profits thereof, and Tenant agrees to
look solely to such interest for the satisfaction of any liability of Landlord under this Lease, it
being specifically agreed that in no event shall Landlord (which term shall include, without
limitation any of the officers, trustees, directors, partners, beneficiaries, joint venturers,
managers, members, stockholders or other principals or representatives, disclosed or undisclosed,
of Landlord or any managing agent) ever be personally liable for any such liability. This paragraph
shall not limit any right that Tenant might otherwise have to obtain injunctive relief against
Landlord or to take any other action which shall not involve the personal liability of Landlord to
respond in monetary damages from Landlord&#146;s assets other than the Landlord&#146;s interest in said real
estate, as aforesaid. In no event shall Landlord ever be liable for consequential damages arising
from a breach of this Lease.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
37
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">25. BILLS AND NOTICES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any notices required under this Lease shall be in writing and delivered by hand or mailed by
registered or certified mail or by nationally recognized overnight delivery service (such as
Federal Express) for next business day delivery to Landlord or Tenant at the addresses set forth in
Article&nbsp;1. Either party may at any time change the Address for such notices, consents, requests,
bills, demands or statements by delivering or mailing, as aforesaid, to the other party a notice
stating the change and setting forth the changed Address, provided such changed Address is within
the United States. Notices shall be deemed delivered upon the earlier of receipt or refusal of
receipt.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All bills and statements for reimbursement or other payments or charges due from Tenant to
Landlord hereunder shall be due and payable in full fifteen (15)&nbsp;days, unless herein otherwise
provided, after submission thereof by Landlord to Tenant. Tenant&#146;s failure to make timely payment
of any amounts indicated by such bills and statements within applicable notice and grace periods,
whether for work done by Landlord at Tenant&#146;s request, reimbursement provided for by this Lease or
for any other sums properly owing by Tenant to Landlord, shall be treated as a default in the
payment of Rent, in which event Landlord shall have all rights and remedies provided in this Lease
for the nonpayment of Rent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">26. SUCCESSORS AND ASSIGNS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The covenants, agreements, terms, provisions and conditions of this Lease shall bind and
benefit the successors and assigns of the parties hereto with the same effect as if mentioned in
each instance where a party hereto is named or referred to, except that no violation of the
provisions of Article&nbsp;14 hereof shall operate to vest any rights in any successor or assignee of
Tenant and that the provisions of this Article shall not be construed as modifying the conditions
of limitation contained in Article&nbsp;19 hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If in connection with or as a consequence of the sale, transfer or other disposition of the
real estate (Land and/or Building, either or both, as the case may be) of which the Demised
Premises are a part Landlord ceases to be the owner of the reversionary interest in the Demised
Premises, Landlord shall be entirely freed and relieved from the performance and observance
thereafter of all covenants and obligations hereunder accruing thereafter on the part of Landlord
to be performed and observed, it being understood and agreed in such event (and it shall be deemed
and construed as a covenant running with the land) that the person succeeding to Landlord&#146;s
ownership of said reversionary interest shall thereupon and thereafter assume, and perform and
observe, any and ail of such covenants and obligations of Landlord.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
38
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">27. MISCELLANEOUS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.1 <U>Separability</U>. If any provision of this Lease or portion of such provision
or the application thereof to any person or circumstance is for any reason held
invalid or unenforceable, the remainder of the Lease (or the remainder of such
provision) and the application thereof to other persons or circumstances shall not be
affected thereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.2 <u>Captions</u>. The captions are inserted only as a matter of convenience
and for reference, and in no way define, limit or describe the scope of this Lease nor
the intent of any provisions thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.3 <u>Broker</u>. Each party represents and warrants that it has not directly or
indirectly dealt, with respect to the leasing of space in the Building, with any broker
or had its attention called to the Demised Premises or other space to let in the
Building, by any broker. Each party agrees to exonerate and save harmless and
indemnify the other against any claims for a commission by any other broker,
person or firm, with whom such party has dealt in connection with the execution
and delivery of this Lease or out of negotiations between Landlord and Tenant with
respect to the leasing of other space in the Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.4 <u>Governing Law</u>. This Lease is made pursuant to, and shall be
governed by, and construed in accordance with, the laws of the State of California.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.5 <U>Assignment of Lease and/or Rents</U>. With reference to any assignment
by Landlord or Prime Landlord of its interest in this Lease and/or the Rent payable
hereunder, conditional in nature or otherwise, which assignment is made to or held
by a bank, trust company, insurance company or other institutional lender holding
a Mortgage on the Building, Landlord and Tenant agree:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) that the execution thereof by Landlord and acceptance thereof
by such Mortgagee shall never be deemed an assumption by such Mortgagee
of any of the obligations of the Landlord hereunder, unless such Mortgagee
shall, by written notice sent to the Tenant, specifically otherwise elect; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) that, except as aforesaid, such Mortgagee shall be treated as
having assumed the Landlord&#146;s obligations hereunder only upon foreclosure
of such Mortgagee&#146;s Mortgage and the taking of possession of the Demised
Premises after having given notice of its intention to succeed to the interest of
the Landlord under this Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.6
<u>Memorandum of Lease</u>. Neither party shall record this Lease;
provided, however, that either party shall at the request of the other, execute and
deliver a recordable memorandum of this Lease setting forth the parties to this
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
39
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Lease, a description of the Demised Premises and the term of this Lease for recordation in
the Official records of the County of San Mateo.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.7 <U>Sublease</U>. Notwithstanding anything to the contrary herein, Landlord
and Tenant acknowledge that this is a sublease and that Landlord derives its estate
to the Demised Premises through the Prime Lease. Landlord represents and
warrants that, as of the date hereof, Prime Landlord and Landlord are under
common control. At such time as Landlord and Prime Landlord are no longer under
common control, the responsibility for furnishing services, repairs, restoration and
other similar functions of Landlord shall be performed by Prime Landlord, and
Landlord shall be required to use reasonable efforts to enforce the provisions of the
Prime Lease relating thereto, but without obligation to provide such services,
repairs, restoration, and the like, and Prime Landlord, by its consent hereto, agrees
that Tenant may enforce the provisions of the this Lease to provide such services
directly against Prime Landlord. Landlord shall have the right, but not the
obligation, to assign this Lease to Prime Landlord, and after such assignment this
Lease shall no longer be a sublease, but rather a direct lease between Tenant and
Prime Landlord. The effectiveness of this Lease is conditioned upon obtaining the
consent of Prime Landlord to this Lease in the form attached hereto and made a
part hereof as Exhibit&nbsp;E on or before December
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2001.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.8 <U>Holdover</U>. If for any reason Tenant retains possession of the Premises
or any part thereof after the termination of the Term or any extension thereof, such
holding over shall constitute a tenancy from month to month, terminable by either
party upon thirty (30)&nbsp;days prior written notice to the other party, and Tenant shall
pay Landlord monthly rental during the month to month tenancy computed at 200%
of the rent (including Yearly Fixed Rent and all additional rent) payable hereunder
for the final month of the last year of the Term prior to such holding over. The
month to month tenancy shall otherwise be on the same terms and conditions aa set
forth in this Lease, as far as applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.9 <u>Lease Amendments</u>. Tenant acknowledges that amendments to this
Lease may be required in connection with the financing of the Land or Building and
Tenant hereby agrees that it will enter into any reasonable modifications requested
by a mortgagee in connection with such financing, provided the same do not
(a)&nbsp;increase the Monthly Fixed Rent or additional rents payable by Tenant or increase Tenant&#146;s
financial obligations hereunder; (b)&nbsp;reduce or extend the Term hereof; (c)&nbsp;change the Permitted
Use; or (d)&nbsp;otherwise materially impair Tenant&#146;s rights hereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.10 <U>Sierra Point CCRs</U>. This Lease shall be subject to the Amended and
Restated Declaration of Covenants, Conditions and Restrictions for Sierra Point
recorded in the Official Records of San Mateo on October&nbsp;23, 1998, as Document No.
98-172218, as amended by that certain First Amendment to Amended and Restated
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
40
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Declaration of Covenants, Conditions and Restrictions for Sierra Point recorded in the Official
Records of San Mateo on August&nbsp;6, 1999, as Document No.&nbsp;1999-134787 (as amended, the &#147;CCRs&#148;).
Tenant shall comply with the CCRs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.11 <U>Financial Statements</U>. Tenant shall furnish Landlord with complete audited
financial statements within one hundred twenty (120)&nbsp;days after the close of each fiscal year of
Tenant prepared by a certified public accountant (but not necessarily certified statements) and
shall, upon written request from Landlord, provide copies of Tenant&#146;s quarterly unaudited
financial statements within fifteen (15)&nbsp;days after Landlord&#146;s request.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">28. SECURITY DEPOSIT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28.1 <U>Security Deposit</U>. Tenant has deposited with Landlord the Security Deposit
described in Article&nbsp;1 hereof as security for the faithful performance and observance by Tenant of
the terms, provisions, covenants and conditions of this Lease, and it is agreed that if an Event of
Default by Tenant exists in respect of any of the terms, provisions, covenants and conditions of
this Lease, including, but not limited to, the payment of Rent, Landlord may use, apply or retain
the whole or any part of the security so deposited to the extent required for the payment of any
Rent or any other sum as to which there exists an Event of Default by Tenant or for any sum which
Landlord may expend or may he required to expend by reason of Tenant&#146;s Event of Default in respect
of any of the terms, provisions, covenants and conditions of this Lease, including, but not limited
to, any damages or deficiency accrued before or after summary proceedings or other re-entry by
Landlord. Upon the expiration or earlier termination of this Lease, and providing there exists no
default or Event of Default hereunder, any remaining balance of the Security Deposit (including,
without limitation, any and all interest accrued thereon) shall be returned by Landlord to Tenant
after the date fixed as the end of the Term and not later than thirty (30)&nbsp;days after delivery of
entire possession of the Premises to Landlord as provided hereunder. In the event of a sale of the
Land and Building or leasing of the Building, of which the Premises form a part, Landlord shall
have the right to transfer the security to the vendee or lessee and Landlord shall thereupon be
released by Tenant from all liability for the return of such security, and Tenant agrees to look
solely to the new Landlord for the return of said security, and it is agreed that the provisions
hereof shall apply to every transfer or assignment made of the security to a new Landlord. Tenant
further covenants that it will not assign or encumber or attempt to assign or encumber the monies
deposited herein as security and that neither Landlord nor its successors or assigns shall be bound
by any such assignment, encumbrance, attempted assignment or attempted encumbrance. In the event
Landlord applies pr retains any portion or all of the security deposited pursuant to the terms of
this Section&nbsp;28.1, Tenant shall forthwith restore the amount so
applied or retained so
that at all times the amount deposited shall be the full amount of the security deposit required at
the relevant time.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
41
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Landlord shall not be responsible for the payment of any interest on the Security
Deposit.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">29. FURNITURE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Premises includes nineteen (19)&nbsp;new modular offices and twenty nine (29)&nbsp;new workstations,
which are the property of Landlord and must be returned to Landlord upon the termination of this
Lease for any reason in good and first class condition, reasonable wear and tear and acts of God
excepted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Landlord and Tenant have caused this instrument to be executed under seal,
all as of the day and year first above written.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">MJ RESEARCH COMPANY, INC.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">FLUIDIGM CORPORATION</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Illegible
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Illegible</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Its
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">VP MFG</TD>
</TR>


<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>


<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">title (duly-authorized)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">title (duly-authorized)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943247.gif" alt="(MAP OF FACILITY)">
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943248.gif" alt="(1ST FLOOR LEASING PLAN)">
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT B</u>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><u>CLEANING SCHEDULE</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">I. <U>Premises</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Daily on Business Days</U>:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Empty all waste receptacles and ash trays and remove waste materials
from the Premises.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep and dust mop all uncarpefced areas using a dust-treated mop.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Vacuum all rugs and carpeted areas.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Hand dust and wipe clean with treated cloths all horizontal cleared
surfaces including desk tops, office equipment, window sills, door<BR>
ledges, chair rails and counter tops, within normal reach.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">e.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash clean all water fountains.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">f.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Upon completion of cleaning, all lights will be turned off and doors
locked, leaving the Premises in an orderly condition.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Quarterly</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Render high dusting not reached in daily cleaning to include:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dusting all pictures, frames, charts, graphs and similar wall hangings.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dusting all vertical surfaces, such as walls, partitions, doors and ducts.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dusting of all pipes, ducts and high moldings.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">II. <U>Lavatories</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Daily on Business Days</U>:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep and damp mop floors.<BR></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Clean all mirrors, powder shelves, dispensers and receptacles, bright
work, flushometers, pipes and toilet seats.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash both sides of all toilet seats.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash all basins, bowls and urinals.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">e.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dust and clean all powder room fixtures.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">f.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Empty and clean paper towel and sanitary disposal receptacles.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">g.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Remove waste paper and refuse.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">h.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Refill tissue holders, soap dispensers, towel dispensers, vending
sanitary dispensers; materials to be furnished by Landlord,</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">i.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A sanitizing solution will be used in all lavatory cleaning.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Monthly</U>:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Machine scrub lavatory floors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash all partitions and tile walls in lavatories.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">III. <U>Main Lobby, Elevators, Building Exterior and Corridors</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Daily on Business Days</U>:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep and wash or spray buff all marble floors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep all entrance mats.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Clean elevators, wash or vacuum floors, wipe down walls and doors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Spot clean any metal work surrounding building entrance doors.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Monthly</u>:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All resilient tile floors in public areas to be treated equivalent to spray
buffing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">IV. <u>Window Cleaning</u>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">The outside of exterior wall windows will be washed once every three months, weather
permitting, and the inside of exterior wall windows will be washed every six months.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">V. Tenants requiring services in excess of those described above shall request
same through Landlord, at Tenant&#146;s expense.
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
2
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT C<BR>RULES AND
REGULATIONS</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;The sidewalks, entrances, passages, courts, elevators, vestibules,
stairways, corridors or halls of the Building shall not be obstructed or encumbered
or used for any purpose other than ingress and egress to and from the premises
demised to any tenant or occupant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;No awnings or other projections shall be attached to the outside walls
or windows of the Building without the prior consent of Landlord. No curtains,
blinds, shades, or screens shall be attached or hung in, or used in connection with,
any window or door of the premises demised to any tenant or occupant, without the
prior consent of Landlord. Such awnings, projections, curtains, blinds, shades,
screens, or other fixtures must be of a quality type, design and color, and attached
in a manner, approved by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;No sign, advertisement, object, notice or other lettering shall be
exhibited, inscribed, painted or affixed on any part of the outside or inside of the
premises demised to any tenant or occupant or of the Building without the prior
consent of Landlord. Interior signs on doors and directory tables, if any, shall be of
a size, color and style approved by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;The sashes, sash doors, skylights, windows, and doors that reflect or
admit light and air into the halls, passageways or other public places in the
Building shall not be covered or obstructed, nor shall any bottles, parcels, or other
articles be placed on any window sills.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;No show cases or other articles shall be put in front of or affixed to any
part of the exterior of the Building, nor placed in the halls, corridors, vestibules or
other parts of the Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;The water and wash closets and other plumbing fixtures shall not be
used for any purposes other than those for which they were constructed, and no
sweepings, rubbish, rags, or other substances shall be thrown therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;No tenant or occupant shall mark, paint, drill into, or in any way
deface any part of the Building or the premises demised to such tenant or occupant,
except to the extent required for the mounting of pictures and other normal office
fixtures. No boring, cutting or stringing of wires shall be permitted, except with the
prior consent of the Landlord, and as Landlord may direct. No tenant or occupant
shall install any resilient tile or similar floor covering in the premises demised to
such tenant or occupant except in a manner reasonably approved by Landlord.
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;No bicycles, vehicles or animals of any kind (other than, animals
allowed under the Permitted Uses) shall be brought into or kept in or about the
premises demised to any tenant. Bicycles may be stored in racks, if any, furnished
for such purpose by Landlord in a common area of the Property. No cooking shall
be done or permitted in the Building (other than microwave use and coffee
machines) by any tenant without the approval of Landlord. No tenant shall cause
or permit any unusual or objectionable odors to emanate from the Premises demised
to such tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;Without the prior consent of Landlord, no space in the Building shall
be used for manufacturing, or for the sale of merchandise, goods or property of any
kind at auction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;No tenant shall make, or permit to be made, any unseemly or
disturbing noises or disturb or interfere with other tenants or occupants of the
Building or neighboring buildings or premises whether by the use of any musical
instrument, radio, television set or other audio device, unmusical noise, whistling,
signing, or in any other way. Nothing shall be thrown out of any doors or windows.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;Each tenant must, upon the termination of its tenancy, restore to Landlord all keys of stores, storage areas, offices and toilet rooms, either furnished
to, or otherwise procured by, such tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;All removals from the Building, or the carrying in or out of the
Building or the premises demised to any tenant, of any sales, freight, furniture, or
bulky matter of any description must take place at such time and in such manner as
Landlord or its agents may determine, from time to time. Landlord reserves the
right to inspect all freight to be brought into the Building and to exclude from the
Building all freight which violates any of the Building Rules or the provisions of
such tenant&#146;s lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;No tenant shall use or occupy, or permit any portion of the premises
demised to such tenant to be used or occupied, as an office for a public stenographer,
messenger service or typist, or as a barber or manicure shop, or as an employment
bureau. No tenant or occupant shall engage or pay any employees in the Building,
except those actually working for such tenant or occupant in the Building, nor
advertise for laborers giving an address at the Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.&nbsp;No tenant or occupant shall purchase spring water, ice, food, beverage,
lighting maintenance, cleaning towels or other like service, from any company or
person not approved by Landlord, such approval not unreasonably to be withheld.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.&nbsp;Landlord shall have the right to prohibit any advertising by any tenant or occupant which, in Landlord&#146;s opinion, tends to impair the reputation of the
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
2
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Building or its desirability as a building for offices, and upon notice from Landlord, such
tenant or occupant shall refrain from or discontinue such advertising.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.&nbsp;Landlord reserves the right to exclude from the Building, between the
hours of 6:00 p.m. and 8:00 a.m. on Business Days and otherwise at all hours, all
persons who do not present adequate identification or a pass to the building signed
by the Landlord. Landlord will furnish passes to persons for whom any tenant
requests such passes. Each tenant shall be responsible for all persons for whom it
requests such passes and shall be liable to Landlord for all wrongful acts of such
persons.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.&nbsp;Each tenant, before closing and leaving the premises demised to such tenant at any time, shall see that all entrance doors are locked and windows closed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.&nbsp;Each tenant shall, at its expense, provide artificial light in the
premises demised to such tenant for Landlord&#146;s agency, contractors, and employees
while performing janitorial or other cleaning services and making repairs or
alterations in said premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.&nbsp;No
premises shall be used, or permitted to be used, for lodging or sleeping, or for any immoral or illegal purpose.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20.&nbsp;There shall not be used in the Building, either by any tenant or
occupant or by their agents or contractors, in the delivery or receipt of merchandise,
freight or other matter, any hand trucks or other means of conveyance except those
equipped with rubber tires, rubber side guards and such other safeguards as
Landlord may require.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.&nbsp;Canvassing, soliciting and peddling in the Building are prohibited and each tenant and occupant shall co-operate in seeking their prevention.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22.&nbsp;If the premises demised to any tenant become infested with vermin,
such tenant, at its sole cost and expense, shall cause its premises to be
exterminated from time to time, to the satisfaction of Landlord, and shall employ
such exterminators therefor as shall be approved by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.&nbsp;No premises shall be used, or permitted to be used, at any time,
without the prior approval of Landlord, as a store for the sale or display of goods,
wares or merchandise of any kind, or as a restaurant, shop, booth, bootblack or
other stand, or for the conduct of any business or occupation which predominantly
involves direct patronage of the general public in the premises demised to such
tenant, or for manufacturing or for other similar purpose.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24.&nbsp;No tenant shall move, or permit to be moved, into or out of the
Building or the premises demised to such tenant, any heavy or bulky matter,
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
3
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">without the specific approval of Landlord. If any such matter requires special handling, only a
person holding a Master Rigger&#146;s license shall be employed to perform such special handling. No
tenant shall place, or permit to be placed, on any part of the floor or floors of the premises
demised to such tenant, a load exceeding the floor load per square foot which such floor was
designed to carry and which is allowed by law. Landlord reserves the right to prescribe the weight
and position of safes and other heavy matter, which must be placed so as to distribute the weight.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25.&nbsp;The requirements of tenants will be attended to only upon application at the office
of the Building. Building employees shall not be required to perform, and shall not be requested by
any tenant or occupant to perform, any work outside of their regular duties, unless under specific
instructions from the office of the managing agent of the Building.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT D</U>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><U>LIST OF ENVIRONMENTAL REPORTS GIVEN TO TENANT</U>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>ENVIRONMENTAL DUE DILLIGENCE REVIEW OF THE SIERRA POINT ASSOCIATES TWO PROPERTIES
BRISBANE AND SOUTH SAN FRANCISCO, CALIFORNIA</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared for</I><BR>
Jon K. Wactor of Luce Forward, Hamilton and Scripps as attorney for potential purchaser
Opus West Corporation, Plessanton, California
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared By</I><BR>
ENVIRON Corporation, Emeryville, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Dated</I><BR>
February&nbsp;4, 1998<BR>
Project No.&nbsp;03-6248A

</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>UPDATE OF ENVIRONMENTAL DUE DILLIGENCE REVIEW, PARCEL 10, SHORELINE COURT, SIERRA
POINT, SOUTH SAN FRANCISCO, CALIFORNIA</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared For</I><BR>
MJ Sierra Point, LLC, South San Francisco, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared By</I><BR>
Harding Lawson Associates, Novato, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Dated</I><BR>
December&nbsp;14,1998<BR>
HLA Project No.&nbsp;43142 001

</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>FIRST AMENDED AND RESTATED DECLARATION OF COVENANTS, CONDITIONS AND ENVIRONMENTAL
RESTRICTIONS RELATING TO
ENVIRONMENTAL COMPLIANCE FOR SIERRA POINT</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Recorded By</I><BR>
Luce, Forward, Hamilton and Scripps, San Diego, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Dated</I><BR>
August&nbsp;5, 1999

</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>SUPPLEMENTAL ENVIRONMENTAL DUE DILLIGENCE, PARCEL 10,
SHORELINE COURT, SIERRA POINT, SOUTH SAN FRANCISCO, CALIFORNIA</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared by</I><BR>
Harding Lawson Associates, Novato, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Dated</I><BR>
August&nbsp;24, 1999
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT E</U>
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><U>FORM OF PRIME LANDLORD CONSENT</U>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>FORM OF<BR>CONSENT OF<BR>MASTER LANDLORD</B></U></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mountain Cove Tech Center LLC (&#147;Master Landlord&#148;),
the lessor, under that certain Lease, dated as of November&nbsp;&nbsp;&nbsp;&nbsp;, 1999 (herein the &#147;Master Lease&#148;) with MJ Research, Incorporated.,
(&#147;Landlord&#148;) as lessee, affecting that certain 141,677 square foot premises commonly known as the
Mountain Cove Tech Center, South San Francisco, California (&#147;Master Lease Premises&#148;), hereby
consents to the above First Amendment to Lease, relating to that certain Lease, dated as of
December&nbsp;1, 2001, by and between Landlord, as lessor, and Fluidigm Corporation, a California
corporation (&#147;Tenant&#148;), as lessee (as so amended, the &#147;Lease&#148;) subject to and in consideration of
the covenants, representations and agreements set forth below in this Consent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;In consideration of such consent the Master Landlord, Landlord, and Tenant hereby agree and acknowledge that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">A. All capitalized terms not defined in this Consent shall have the meanings given to such terms in the First Amendment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">B. A true correct and complete copy of the Master Lease is attached as Exhibit&nbsp;F to the First Amendment;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">C. As of the date hereof, the Master Lease is in full force and
effect and, to the actual knowledge of Master Landlord there is no
default (nor any circumstance which with the giving of notice or the
passage of time would result in a default) by Landlord or Master
Landlord under the Master Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;This Consent shall not be deemed to release the lessee under the
Master Lease or be a consent to any other or future amendment of the Lease, nor a
waiver of the restriction on assignment and subletting contained in the Master
Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;So long as the Lease has not been terminated and notwithstanding anything to the contrary in the Master Lease or the Lease:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">A. Master Landlord agrees to perform the obligations of
Landlord under Sections 16(a) and 16(b) of the Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">B. (Intentionally Omitted)
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">C. The consent of Master Landlord for subleasing and
assignment shall not be withheld if the consent of Landlord may not
be withheld under Section&nbsp;14 of the Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">D. The insurance required of Tenant under the Lease will
satisfy any insurance requirement that may become applicable to
Tenant as a consequence of the Master Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">E. Tenant shall not be liable for, have any duty to reimburse
Master Landlord, Landlord, or any other party for, nor to perform
any order, requirement, liability, claim, action, judgment, loss, cost
or expense arising out of any hazardous substances located on or
about the Premises (other than those hazardous substances placed
on or about the Premises by Tenant or its agents, employees,
contractors, invitees, successors or assigns.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;The Lease is and remains subject and subordinate to the Master Lease and, except as
herein provided, a termination of the Master Lease may, at the election of Landlord, result in a
termination of the Lease. Notwithstanding the foregoing, if the Master Lease should terminate for
any reason, other than because of a breach of Tenant&#146;s obligation under the Lease, a taking by
eminent domain or subject to Section&nbsp;16 of the Lease above, the election of Master Landlord not to
restore the Building following a casualty, then this Lease shall become a direct lease between
Landlord and Tenant on the terms and conditions of the Lease and this Consent (except that the
Tenant shall look solely to the Landlord for return of the Security Deposit held by Landlord).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;SIGNATURES APPEAR ON NEXT PAGES&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Landlord has caused this instrument to be executed effective as of the day and year first above written.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">MOUNTAIN COVE TECH CENTER LLC<BR>a California limited liability company<BR>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left" style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left" style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;SIGNATURES CONTINUE ON FOLLOWING PAGES&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Landlord has caused this instrument to be executed effective as of the day and year first above written.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">MJ RESEARCH, INCORPORATED,<BR>a Massachusetts corporation<BR>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left" style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left" style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>&#091;SIGNATURES CONTINUE ON FOLLOWING PAGES&#093;</B>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">AGREED AND ACCEPTED:
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">FLUIDIGM CORPORATION;<BR>a California corporation<BR>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left" style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left" style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left" style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left" style="border-bottom: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B><I>First Amendment to Sublease</I></B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This First Amendment made as of this 25<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March, 2004 between MJ Research,
Incorporated (&#147;Landlord&#148;) and Fluidigm Corporation (&#147;Tenant&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">RECITALS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord
and Tenant are parties to a certain Sublease dated December 1st, 2001 (the
&#147;Lease&#148;) with respect to space on the first floor at 7000 Shoreline Court, South San Francisco,
California (the &#147;Building&#148;). The parties agree that the Lease was dated as of December&nbsp;1, 2001.
The parties wish to amend the Lease by (i)&nbsp;amending the rent and term, (ii)&nbsp;adding on April&nbsp;1,
2004 an additional 6,323 rentable square feet to the first floor space, bringing the total of
first floor space to 18,824 rentable square feet, and (iii)&nbsp;adding 10,720 rentable square feet on
the second floor (the &#147;Second Floor Space&#148;). All of the existing space currently leased by Tenant
and the new space to be added on the first and second floors are located on the east wing of the
Building. This First Amendment to Sublease is sometimes hereinafter called the &#147;Amendment&#148;.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In consideration of the mutual promises and covenants herein made, the parties hereby agree
to amend the Lease as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;<U>First Floor Space</U>. Effective April&nbsp;1, 2004, the additional space on the
first floor comprising 6,323 rentable square feet shown as on the attached Exhibit&nbsp;A
is added to the Premises, and the total first floor space leased by Tenant will be
18,824 rentable square feet. The new first floor space is leased in an as-is condition,
provided that on or before April&nbsp;1, 2004, Landlord will, at its expense, install up to
two fume hood exhaust connections and ducting into the dry lab area in locations
designated by Tenant. Additionally, Landlord and Tenant agree to share the cost of
an air compressor and air dryer installation on or before June&nbsp;1, 2004 pursuant to
specifications mutually approved by Landlord and Tenant, which approval shall not
be unreasonably withheld or delayed, to be located on the first floor (up to a total
maximum cost of $20,000.00) (i.e., $10,000 each), the use of which compressor and
dryer system shall be equally shared between Landlord and Tenant. The location of
the exhaust connection, air compressor and air dryer system are set forth on Exhibit
A attached hereto. Said air compressor and dryer system shall remain the property
of the Landlord at the expiration of this Lease. Landlord hereby consents to Tenant
making the installations set forth on Exhibit&nbsp;B-l at Tenant&#146;s sole cost and expense.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;<U>Term</U>. The term of the Lease is extended so as to end on December&nbsp;31, 2007.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 1 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;<U>Second Floor Space</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 Effective on the Second Floor Term Commencement Date (as that term
is hereinafter defined) the Premises shall also include the 10,720 rentable square
feet on the second floor shown on Exhibit&nbsp;B-l attached hereto being the Second
Floor Space. The Second Floor Space shall be built out (&#147;Landlord&#146;s Work&#148;) on or
before the Second Floor Term Commencement Date by Landlord in accordance with
the outline specifications attached as Exhibit&nbsp;B-2 (the &#147;Outline Specifications&#148;) and
the architectural floor plan attached as Exhibit&nbsp;B-l and the &#147;Final Second Floor
Plans&#148; as described below. Attached to this Amendment as Exhibit&nbsp;B-l is the
preliminary architectural layout of the Second Floor (the &#147;Second Floor Plans&#148;)
approved by Landlord and Tenant. Landlord shall develop a final architectural
floor plan (the &#147;Final Second Floor Plans&#148;) for Tenant&#146;s review and approval, which
approval shall not be unreasonably withheld or delayed and which shall be
exercised in accordance with this Section&nbsp;3.1. Said plan shall be consistent with
and a logical extension of Exhibit&nbsp;B-l, the Outline Specifications and build-out of
the East wing. Tenant may require modifications to Exhibit&nbsp;B-l with respect to
open work areas and perimeter offices (but not lab locations) provided such
modifications (a)&nbsp;as to perimeter offices, have walls aligned with window mullions,
and (b)&nbsp;otherwise are consistent with the Outline Specifications. Finishes and
colors shall be as selected by Landlord and shall be generally consistent with those
in the East wing of the Building. Tenant shall within ten (10)&nbsp;days after
presentation by Landlord of the proposed final architectural Second Floor Plan,
respond with any comments or requested changes. Tenant shall also cooperate with
Landlord in an informal review process and shall meet with Landlord or its
architect from time to time as reasonably requested by Landlord. When the Second
Floor Plans have been so approved by the Tenant as provided herein, they shall be
deemed the Final Second Floor Plans and any clarifications or changes to the Final
Second Floor Plans shall require the written approval of Landlord and Tenant,
which approvals shall not be unreasonably withheld provided the same does not
materially delay completion of Landlord&#146;s Work (or the requesting party bears the
rental expense for such delay) or increase the cost thereof (or the party requesting
the change pays the additional cost thereof) or interfere with the intended use of the
Second Floor Space by Tenant. The completed working or construction drawings
and plans shall be logical evolutions of the Final Second Floor Plans; however,
Tenant agrees that its sole approval rights hereunder shall be with respect to the
architectural floor plan, not complete working or construction drawings and plans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 Landlord agrees to use diligent efforts to substantially complete
Landlord&#146;s Work on or before January&nbsp;1, 2005, the Anticipated Second Floor Term
Commencement Date, but except as hereinafter set forth, shall have no liability to
Tenant if the actual Second Floor Term Commencement Date occurs later than
January&nbsp;1, 2005. If for reasons other than those beyond the control of Landlord, the
Second Floor Space is not ready for occupancy by June&nbsp;1, 2005, Tenant shall receive
a credit against the Rent payable for the remainder of the Premises equal to one (1)
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 2 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">day of free rent for the Second Floor Space for each day of such delay in addition until the Second
Floor space is deemed ready for occupancy as provided herein, provided, however, that the June&nbsp;1,
2005 date shall be extended one day for each day that completion of the Second Floor Space is
actually delayed because of (a)&nbsp;delays caused by change orders requested by Tenant after the Final
Second Floor Plans have been approved by Tenant as hereinbefore provided, (b)&nbsp;the failure of Tenant
to respond in a timely manner to the proposed Final Second Floor Plans as required above, or (c)
other acts of omissions of Tenant which are not corrected by Tenant within 48 hours after notice to
Tenant that the same is delaying the work. Landlord shall have access, as needed, to Tenant&#146;s space
on the first floor for purposes of performing Landlord&#146;s work, provided such access shall not
unreasonably interfere with the conduct of Tenant&#146;s business. Landlord shall use reasonable efforts
to minimize disruption to Tenant in connection with said construction, but shall not be deemed in
violation of the covenant of quiet enjoyment or other provision of the Lease by virtue of said
construction activities, provided such construction does not unreasonably interfere with the
conduct of Tenant&#146;s business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3 The Second Floor Term Commencement Date shall occur on the date
on which (a)&nbsp;Landlord&#146;s Work shall have been substantially completed in accordance
with the Final Second Floor Plans as the same may be modified in accordance with
Section&nbsp;3.1 (with the exception of minor items (and adjustment of equipment and
fixtures) which do not create and can be completed without material interference to
Tenant&#146;s use of the Premises), all as certified by Landlord, (b)&nbsp;a temporary or final
certificate of occupancy shall have been issued by the City of South San Francisco
for the Second Floor Space permitting Tenant to occupy such space for the conduct
of its business; and (c)&nbsp;all utilities are hooked up and all services to be provided by
Landlord are available to the Second Floor Space. Notwithstanding the foregoing,
the Second Floor Term Commencement Date shall be deemed to occur if all of the
conditions to the Second Floor Commencement Date have been fulfilled, except that
(i)&nbsp;Landlord has not been able to complete items of Landlord&#146;s Work as describe in
subpart (a)&nbsp;of the preceding sentence, solely because of work or improvements
performed by Tenant or to be performed by Tenant are not completed, and/or (ii)&nbsp;a
Certificate of Occupancy cannot be obtained due solely because work or alterations
performed by Tenant, or which should have been performed by Tenant, have not
been completed or properly completed. If such substantial completion has occurred
and the Second Floor Term Commencement Date is a date prior to January&nbsp;1, 2005,
Tenant may by written notice to Landlord, defer occupancy of the Second Floor
Space and the Second Floor Term Commencement Date to January&nbsp;1, 2005 or may
elect to occupy the Second Floor Space, in which case rent shall commence upon
such occupancy of the Second Floor Space for the conduct of its business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4 If the Landlord is unable to give possession of the Second Floor Space
on the originally stated Anticipated Second Floor Term Commencement Date to the
extent of delays caused by, or chargeable to, Tenant or anyone employed by Tenant,
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 3 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">including without limitation, change orders requested by Tenant or any other actions or inactions
by Tenant or anyone employed by Tenant in violation of this Lease, Tenant&#146;s failure to complete
work or improvements to be performed by Tenant in the Premises which prevents or delays Landlord in
performing or completing any construction or work to be performed by Landlord or its contractors,
including without limitation Landlord&#146;s Work, Tenant shall pay to Landlord for each day of such
delay actually delays the Second Floor Commencement Date beyond January&nbsp;1, 2004, an amount equal to
one day&#146;s Annual Fixed Rent, provided, however that such additional rent for change orders shall
not exceed the maximum amount of delay set forth in any change order approved by Tenant. Any
payments due Landlord under this clause shall be paid within five (5)&nbsp;days of the invoice from
Landlord stating the charge.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5 Landlord shall complete all incomplete punch-list items and other defective or incomplete
Landlord&#146;s Work with due diligence and will use good faith efforts to complete all such incomplete
items as soon as reasonably practicable, but within sixty (60)&nbsp;days after the Second Floor Term
Commencement Date. Tenant shall permit Landlord access to the Premises for purposes of performing
such work, which work may, at Landlord&#146;s option, be completed during business hours on business
days, provided such work does not unreasonably interfere with the conduct of Tenant&#146;s business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;<U>Option to Extend</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 Provided Tenant gives at least 270&nbsp;days prior written notice of its
election to extend, time being of the essence, Tenant is not in default under the
Lease after any applicable notice and grace period, and Tenant has caused the final
expiration date of the letter of credit referred to in Section&nbsp;6 to be extended to
March&nbsp;31, 2011, Tenant is hereby granted the option to extend the Term for an
additional three (3)&nbsp;years commencing January&nbsp;1, 2008 at a fixed rent which is the
greater of (a)&nbsp;103.5% of the fixed rent rate in effect (without abatement) during
December, 2007, and (b)&nbsp;ninety five percent (95%) of fair market rent for the
Premises as of the commencement of the extension period. The fixed rent for said
option term shall increase by three and one-half percent (3.5%) (compounded)&nbsp;on
January&nbsp;1, 2009 and on January&nbsp;1, 2010.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 If the parties are unable to agree upon a fair market rent prior to four
(4)&nbsp;months before the commencement of the option term, the matter shall be
referred to appraisal as set forth in the following sections.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 Whenever the issue of fair market rent shall be referred to appraisal,
such appraisal shall be by three disinterested appraisers, one to be appointed by the
Landlord, one to be appointed by the Tenant and the third to be appointed by the
two appraisers so named. Within thirty (30)&nbsp;days after the selection of the third
appraiser, the three appraisals shall be added together and their total divided by
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 4 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">three; the resulting quotient shall be the fair market rent for the Premises. If, however, the low
appraisal and/or the high appraisal are more than ten (10%) percent lower and/or higher than the
middle appraisal, the low appraisal and/or high appraisal shall be disregarded, as applicable. If
only one appraisal is disregarded, the remaining two appraisals shall be added together and their
total divided by two; the resulting quotient shall be the fair market rent for the Premises. If
both the low appraisal and the high appraisal are disregarded as stated in this paragraph, the
middle appraisal shall be the fair market rent of the Premises. Each party shall pay the costs of
the appraiser selected by such party, and the parties shall share equally the cost of the third
appraiser. Each individual appraiser shall have at least ten years of experience in appraising fair
market rents of comparable properties and shall hold one or more of the following designations: MAI
of the American Institute of Real Estate Appraisers, SREA from the Society of Real Estate
Appraisers or ASA from the American Society of Appraisers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4 If the fair market rental value per year is not determined prior to the commencement of
the option term, the Tenant shall pay Fixed Rent as though the Fixed Rent was that Fixed Rent in
effect (without abatement) during the last year of said preceding lease year period until such
determination has been made. Following such determination, the Tenant shall promptly pay the
Landlord the difference, if any, between the aggregate rent which would have been paid during said
period and the aggregate rent actually paid. Thereafter, all rent shall be computed and paid in
accordance with Section&nbsp;4.2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;<U>Rent</U>. The annual fixed rent for the Premises, shall, commencing April
1, 2004, be $3.00 per rentable square foot per month. Rent shall increase by three
and one half percent (3.5%) compounded on the first day of each April commencing
April&nbsp;1, 2005. Rent for the Second Floor Space shall commence, on a prorated basis,
as of Second Floor Term Commencement Date. Rent for the option term shall be as
set forth in Section&nbsp;4. The above rent is inclusive of (and Landlord shall provide to
Tenant) utilities, maintenance, janitorial services, window washing, access cards,
real estate (but not personal property) taxes, telephone and data wiring
infrastructure currently in the Building or as set forth on Exhibit&nbsp;B or constructed
by Landlord pursuant to Section&nbsp;3, and other services to be provided by Landlord
as set forth in the Lease as amended hereby. The cleaning specifications attached
to the Lease as Exhibit&nbsp;B are amended to provide that cleaning of the Premises
shall be done every other business day and window washing every six (6)&nbsp;months.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;<U>Security Deposit</U>. The security deposit is hereby increased to
$250,000.00 and shall take the form of a Letter of Credit. Section&nbsp;28 of the Lease is
hereby amended and replaced with the following new Section&nbsp;28:
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 5 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28.&nbsp;<U>Security Deposit</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(a)&nbsp;Amount.</B> Simultaneously with the execution of this
Lease, Tenant shall deposit with Landlord the sum of Two Hundred Fifty
Thousand and No/100 Dollars ($250,000.00) as a security deposit.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(b) Security. </B>Such security deposit shall be considered as
security for the payment and performance by Tenant of all of Tenant&#146;s
obligations, covenants, conditions and agreements under this Lease except as
hereinafter provided.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(c)&nbsp;Form. </B>The security deposit shall, as of the date hereof,
be a cash deposit given to Landlord. Tenant shall use best efforts to deliver
to Landlord by April&nbsp;30, 2004, an irrevocable letter of credit (the &#147;Letter of
Credit&#148;), in the amount of Two Hundred Fifty Thousand and No/100 Dollars
($250,000.00). Thereafter, Tenant shall maintain the Letter of Credit in full
force and effect throughout the entire term of this Lease and until ninety (90)
days after the end of the calendar year in which the Expiration Date occurs,
and shall cause the Letter of Credit to be renewed or replaced not less than
thirty (30)&nbsp;days prior to its expiry date, subject to the terms and conditions of
Section 28(g) of this Lease. Upon delivery of said letter of credit, the initial
cash deposit shall be refunded by Landlord. The Letter of Credit shall (i)&nbsp;be
unconditional, irrevocable, transferable, payable to Landlord on sight at a
financial institution located in San Francisco, California, in partial or full
draws, (ii)&nbsp;be substantially in the form attached hereto and incorporated
herein as <U>Exhibit&nbsp;C</U>, and otherwise be in form and content acceptable to
Landlord and Tenant, (iii)&nbsp;shall be issued by Silicon Valley Bank or another
financial institution reasonably acceptable to Landlord which meets the asset
and credit rating tests set forth in Section&nbsp;28(d)(2)(i)), and (iv)&nbsp;contain an
&#147;evergreen&#148; provision which provides that it is automatically renewed on an
annual basis unless the issuer delivers sixty (60)&nbsp;days&#146; prior written notice of
cancellation to Landlord and Tenant. Any and all fees or costs charged by the
issuer in connection with the Letter of Credit shall be paid by Tenant.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(d)&nbsp;Right to Draw.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(1)&nbsp;</B>In the event of any default (after the expiration of any applicable cure period expressly
set forth in this Lease, except in the event a bankruptcy has been filed by or with respect to
Tenant; in which case, no such notice and cure period shall be required) by Tenant hereunder,
Landlord shall have the right, but shall not be obligated, to draw upon the Letter of Credit in
whole or in part and apply the proceeds thereof as may be necessary to compensate Landlord for any
default under this Lease on the part of Tenant, and Tenant, within fifteen (15)&nbsp;days after
Landlord delivers written demand therefore to Tenant, shall forthwith either restore the Letter
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 6 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">of Credit to (or, if Tenant is unable to obtain a letter of credit, delivery to Landlord a cash
security deposit in) the amount required to be maintained under this Lease; provided, however,
neither the application of the security deposit as set forth above nor the restoration by Tenant of
such security deposit shall operate to cure such default or to estop Landlord from pursuing any
remedy to which Landlord would otherwise be entitled. Should Landlord elect to draw the full amount
of the Letter of Credit as permitted by this Lease upon a default by Tenant, Tenant expressly
waives any right it might otherwise have to prevent Landlord from drawing on the Letter of Credit
and agrees that an action for damages and not injunctive or other equitable relief shall be
Tenant&#146;s sole remedy in the event Tenant disputes Landlord&#146;s claim to any such amounts. At the
expiration of the Term, Landlord shall use reasonable efforts to assess any damage to the Premises
and notify Tenant of the same within sixty (60)&nbsp;days after said expiration.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(2)</B>&nbsp;In addition to Landlord&#146;s rights set forth in Section&nbsp;28(d)(l) above, Landlord shall have
the right to draw upon the Letter of Credit in any of the following circumstances: (i)&nbsp;if the
total assets of the issuer of the Letter of Credit are at anytime less than Three Billion Dollars
($3,000,000,000.00), or such issuer has a Standard &#038; Poor&#146;s commercial paper rating of less than
A-l (provided if at anytime the current Standard &#038; Poor&#146;s commercial paper rating system is no
longer in existence, a comparable rating of a comparable commercial paper rating system from a
comparable company shall be selected by Landlord, in its reasonable discretion, for purposes of
this Section&nbsp;28) and Tenant fails to deliver to Landlord a replacement Letter of Credit complying
with the terms of this Lease within thirty (30)&nbsp;days of request therefore from Landlord, (ii)&nbsp;the
issuer of the Letter of Credit shall enter into any supervisory agreement with any governmental
authority, or the issuer of the Letter of Credit shall fail to meet any capital requirements
imposed by applicable law, and Tenant fails to deliver to Landlord a replacement Letter of Credit
complying with the terms of this Lease within thirty (30)&nbsp;days of request therefore from Landlord,
or (iii)&nbsp;if Tenant fails to provide Landlord with any renewal or replacement Letter of Credit
complying with the terms of this Lease at least thirty (30)&nbsp;days prior to expiration of the
then-current Letter of Credit. In the event the Letter of Credit is drawn upon due solely to the
circumstances described in the foregoing clauses (i), (ii)&nbsp;or (iii)&nbsp;or in an amount exceeding the
damages owing by Tenant to Landlord on account of a default, the amount drawn shall be held by
Landlord (with interest payable thereon at the prevailing money market rate of the financial
institution in which such funds are deposited) as a security deposit to be otherwise retained,
expended or disbursed by Landlord for any amounts or sums due under this Lease to which the
proceeds of the Letter of Credit could have been applied pursuant to this Lease, and Tenant shall
be liable to Landlord for restoration, in cash or
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 7 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Letter of Credit complying with the terms of this Lease, of any amount so expended to the same
extent as set forth in this Section&nbsp;28.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(e)&nbsp;Right to Assign. </B>Landlord shall have the right,
with Tenant&#146;s written consent, to assign its interest in the security deposit
and proceeds thereof to any assignee of Landlord&#146;s interest in the Lease
Premises and/or the Prime Lease, provided that such consent by Tenant shall
not be unreasonably withheld, conditioned or delayed and Tenant shall
respond in writing to Landlord&#146;s request for such consent within ten (10)&nbsp;days
after Landlord delivers to Tenant a written request for such consent, and
provided further that no such consent shall be required for assignment to a
corporation or other entity controlling, controlled by or under common control
with Landlord. In the event of any such assignment, Landlord shall have
the right to transfer the security deposit to such assignee, in which event
Tenant shall look solely to the new Landlord for the return of the security
deposit and Landlord shall thereupon be released from all liability to Tenant
for the return of such security deposit, provided that the Landlord has
transferred such security deposit to such assignee and such assignee has
actually received such security deposit. If the security deposit is in the form
of a Letter of Credit and if requested by any such assignee, Tenant shall
cooperate with Landlord at no material cost to Tenant to obtain an
amendment to the Letter of Credit which names such assignee as the
beneficiary thereof in lieu of Landlord. This security deposit shall not be
transferable by Tenant to any subtenant, but shall be held and returned
directly to Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(f)&nbsp;Reservation of Rights. </B>No right or remedy
available to Landlord as provided in this Section&nbsp;28 shall preclude or
extinguish any other right to which Landlord may be entitled. In furtherance
of the foregoing, it is understood that in the event Tenant fails to perform its
obligations hereunder, any amounts recovered from the security deposit shall
not be deemed liquidated damages. Landlord may apply such sums to reduce
Landlord&#146;s damages and such application of funds shall not in any way limit
or impair Landlord&#146;s right to seek or enforce any and all other remedies
available to Landlord to the extent allowed hereunder, at law or in equity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(g)&nbsp;Return of Security Deposit. </B>Unless already
returned to Tenant pursuant to Section (f)&nbsp;above, then upon the expiration of
the term hereof, Landlord shall (provided that Tenant is not in default under
the terms hereof) return and pay back any security deposit to Tenant not
previously returned to Tenant, less such portion thereof as Landlord shall
have retained to make good any default by Tenant with respect to any of
Tenant&#146;s aforesaid obligations, covenants, conditions or agreements.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 8 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;<U>Definitions</U>. Consistent with the foregoing, certain defined terms as
set forth in the reference data comprising Article&nbsp;1.1 are hereby amended.
Specifically, the Premises shall be, until April&nbsp;1, 2004, the space shown on
Exhibit&nbsp;A to the Lease. From and after April&nbsp;1, 2004, the Premises shall be the
space on the first floor set forth on Exhibit&nbsp;A attached hereto, and from and after
the Second Floor Term Commencement Date, the Premises shall also include the
Second Floor Space. The rentable area of the Premises shall be 12,501 square feet
up until April&nbsp;1, 2004; 18,824 square feet from April&nbsp;1, 2004 until the Second Floor
Term Commencement Date, and 29,544 rentable square feet from and after the
Second Floor Term Commencement Date. The Termination Date shall be December
31, 2007, and the term of this Lease shall be adjusted accordingly; provided,
however, that the Termination Date and Term may be extended in accordance with
this Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;<U>Conference Room</U>. The fee for use of the conference room, as set forth
in Section&nbsp;2.5 of the Lease, is reduced to $500.00 for a full day and $300.00 for a
half day.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;<U>Maintenance, Repairs and Liability</U>. Notwithstanding anything to the
contrary in the Lease, Tenant shall have no obligation to indemnify, defend, or
reimburse Landlord or Master Landlord, with respect to, nor any obligation to
perform, construct, repair, maintain or make any improvement, (i)&nbsp;to the extent
necessitated by the acts or omissions of Landlord, Master Landlord, any other
occupant of the building or the project, or their respective agents, employees or
contractors, (ii)&nbsp;occasioned by the exercise of the power of eminent domain or any
peril that would be covered by the customary form of so-called &#147;special form,
extended coverage&#148; casualty insurance, (iii)&nbsp;required as a consequence of any Law
(other than those only applicable to the Premises because of Tenant&#146;s peculiar use of
the Premises or alterations to the Premises by Tenant), (iv)&nbsp;occasioned by any legal
violation of the Premises or the Project as of the date Tenant took (or takes)
possession of the affected portion of the Premises, (iv)&nbsp;for which Landlord or Master
Landlord has a right of reimbursement from any insurer or other third party, (vi)&nbsp;to
the structure or common areas of the building or the project or the heating,
ventilating, air conditioning, electrical, water, sewer, and plumbing systems serving
the Premises, the building, or the project not due to the fault or neglect of Tenant,
(vii)&nbsp;to any portion of the Building or the Project outside of the demising walls of the
then existing Premises not due to the fault or neglect of Tenant, (viii)&nbsp;occasioned by
the presence of any Hazardous Material on or about the Premises, other than
Hazardous Materials introduced to the Premises by Tenant or its invitees,
employees, agents or contractors or those for whom Tenant is legally responsible,
(ix)&nbsp;which is a repair or modification to the Premises or the Project not caused by
the fault or neglect of Tenant and which must be capitalized under generally
accepted accounting rules, or (x)&nbsp;which is expressly the obligation of the Master
Landlord under the Prime Lease or of the Landlord under this Lease.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 9 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;<U>Signage</U>. At no additional cost, Tenant shall have permission for one
(1)&nbsp;lobby sign of the size and style set forth on Exhibit&nbsp;E, plus signage on any
building directory comparable to signs for other tenants. Tenant may, upon
payment of a monthly fee in amount mutually approved by Tenant and Landlord
not exceeding $2,500 per month, maintain an exterior sign in accordance with plans
approved by Landlord. At the expiration of the term, said signs shall, at Tenant&#146;s
expense, be removed by Landlord, who shall restore the surfaces of the building
(interior or exterior) to their condition prior to the installation of said signage, and
Tenant shall promptly reimburse Landlord for the reasonable cost therefor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;<U>Permitted Uses</U>. The Permitted Uses are amended to include research
and development, light manufacturing, office, and related ancillary uses as
permitted by applicable law and the Master Lease, provided the same are permitted
by the Allowable Class&nbsp;Facilities set forth in Section&nbsp;5.3(c) of the Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;<U>Access &#038; Egress</U>. Notwithstanding anything to the contrary in this
Lease, with respect to access and egress to, through and from the Premises the
parties agree as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(A)&nbsp;A common data room is located within the Premises on the first floor of
the Building. Only limited representatives of Landlord reasonably approved
by Tenant shall have 24 hour access to the data room through the Premises.
Other representatives of Landlord shall have access to the data room during
normal business hours, provide reasonable email or telephonic notice is
provided to Tenant and a representative of Tenant is allowed to be present
during such entry. All representatives of Landlord accessing the data room
through the Premises shall comply with Tenant&#146;s reasonable security
requirements and shall minimize, to the extent reasonably possible, any
interference with Tenant&#146;s use of the Premises as a consequence of such
access.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(B)&nbsp;Tenant will have card key access to the data room on the first floor.
Said access shall be in common others entitled thereto as described above.
Any servers or other equipment installed by Tenant must be approved by
Landlord, which approval shall not be unreasonably withheld.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(C)&nbsp;Landlord shall arrange for reasonable access to the second floor freight
elevator upon reasonable telephonic or email notice. Such access shall
require escort by building management.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(D)&nbsp;Tenant may also use the other elevator serving the second for delivery
of its operating materials and other freight deliveries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;<U>Energy Conservation</U>. Tenant understands and recognizes that the
Building is designed and operated as an energy efficient building. Energy efficiency
includes, without limitation, the use of electric conservation methods such as
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 10 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">motion detectors and timers to avoid unnecessary use of electric lights and other equipment after
business hours. Tenant agrees that it will not alter, remove or render inoperative any such energy
saving devices without the prior written consent of Landlord.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.&nbsp;<U>Subleasing Profit</U>. Section&nbsp;14.3(d) of the Lease is amended to delete
fifty (50%) percent and substitute therefor sixty two and one half (62.5%) percent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.&nbsp;<U>Landlord Access</U>. Section&nbsp;15.2 of the Lease is modified to permit
Landlord twenty-four (24)&nbsp;hour card access to the Premises for purposes of
maintenance, cleaning, repairs and the provision of other services required to be
provided by Landlord; provided, however that access to the data room is allowed
solely pursuant to Section&nbsp;12.A. Any such entry by Landlord shall comply with
Tenant&#146;s security regulations and shall minimize to the extent reasonably possible
any interference with Tenant&#146;s use of the Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.&nbsp;<U>Furniture</U>. Landlord will provide the modular offices and work
stations for the Second Floor Space as set forth in Exhibit&nbsp;B-2. The provision of
said offices and work stations shall be subject to the provisions of Section&nbsp;29 of the
Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.&nbsp;<U>Damage and Destruction</U>. Notwithstanding anything to the contrary
in the Lease, in the event the Premises or any space in the building being subleased
by Tenant from Genome Therapeutics Corporation (&#147;Genome&#148;) or its successor (or
access thereto or systems serving the same) are the subject of a fire or other
casualty that interferes with the use and enjoyment by Sublessee of a material
portion of such space, and such interference is not reasonably likely to be (or has not
been) remedied and tenantable occupancy restored (in the case of said space
subleased from Genome, to either a cold shell or cold shell plus TI, all as set forth in
Sections 16(a) and 16(b) of the lease between Landlord and Genome) after one (1)
year (or such longer period as has been agreed to in writing between Landlord
and/or Master Landlord and Tenant or is attributable to unavoidable delays) from
the date such interference was first experienced, Tenant may, by notice to Landlord
terminate this Lease by notice given within 30&nbsp;days after the expiration of said one
year (or mutually agreed longer) period. Sections 16(a) and 16(b) of the Lease are
modified to provide that the parties understand that Master Landlord, not
Landlord, is the party responsible for restoration after a casualty, that Master
Landlord shall be the party to make the determination as to the estimated time to
restore after a casualty. Sections&nbsp;16(a) &#151; (c)&nbsp;of the Lease are deleted and replaces
with the following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;If the Demised Premises, or any part thereof, shall be damaged by fire or other casualty,
Tenant shall give prompt notice thereof to Landlord, and Landlord, upon receiving such notice and
the insurance proceeds for such casualty, shall proceed in a commercially reasonable manner,
subject to unavoidable delays,
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 11 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to repair, or cause to be repaired, such damage to the extent hereinafter provided. If the Demised
Premises or any part thereof shall be rendered untenantable by reason of such damage, whether to
the Demised Premises or to the Building, Yearly Fixed Rent shall proportionately abate for the
period from the date of such damage to the date when the Demised Premises shall have been restored
by Landlord.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If, as a result of fire or other casualty, the whole or a substantial portion of the
Building is rendered untenantable, within ninety (90)&nbsp;days from the date of such fire or casualty,
Landlord shall notify Tenant of its opinion of the time required to restore the Demised Premises,
taking into account a reasonable time for adjusting loss and obtaining plans and permits for
restoration. If in Landlord&#146;s opinion the Demised Premises cannot be made tenantable within one (1)
year after such event, Landlord, within ninety (90)&nbsp;days from the date of such fire or casualty,
may terminate this Lease by notice to Tenant, specifying a date not less than thirty (30)&nbsp;nor more
than sixty (60)&nbsp;days after the giving of such notice on which the Term of this Lease shall
terminate. In addition, if in Landlord&#146;s opinion said estimated time for restoration exceeds one
(1)&nbsp;year and Landlord does not elect to terminate this lease, Tenant shall, by notice given to
Landlord within fifteen (15)&nbsp;days of Landlord&#146;s notice as aforesaid, elect (a)&nbsp;to terminate this
Lease, or (b)&nbsp;accept Landlord&#146;s estimated restoration period ( the &#147;Longer Restoration Period&#148;). If
Tenant accepts a Longer Restoration Period, Tenant&#146;s right to terminate as hereinafter provided
shall be effective only if actual restoration takes more than 60&nbsp;days beyond such estimated Longer
Restoration Period, such termination to be elected within 30&nbsp;days after the expiration of said
Longer Restoration Period plus 60&nbsp;days. If neither Landlord or Tenant elects to terminate this
Lease as provided above, then Landlord shall (to the extent that proceeds of insurance required to
be carried by Landlord, net of any portion thereof retained by a Mortgagee, plus any sums
contributed by Tenant or any subtenant of Tenant, are made available for such purpose) proceed with
diligence to repair the damage to the Demised Premises and all facilities serving the same, if any,
which shall have occurred, and the Yearly Fixed Rent shall meanwhile proportionately abate, all as
provided in Paragraph (a)&nbsp;of this Section. However, if such damage is not repaired and the Demised
Premises restored to substantially the same condition as they were prior to such damage within one
(1)&nbsp;year ( or, if elected, the Longer Restoration Period plus 60&nbsp;days) from the date of such
damage, Tenant, within thirty (30)&nbsp;days from the expiration of such one (1)&nbsp;year period (or, if
elected, the Longer Restoration Period plus 60&nbsp;days) or from the expiration of any extension
thereof by reason of the delays set forth in the following sentence, may terminate this Lease by
notice to Landlord, specifying a date not more than sixty (60)&nbsp;days after the giving of such notice
on which the Term of this Lease shall terminate. The period within which the required repairs may
be accomplished shall be extended by the number of days, lost as a result of unavoidable delays,
which term shall be defined to mean all delays referred to in Article&nbsp;24.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 12 -<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If the Demised Premises shall be rendered untenantable by fire or other casualty and less
than two (2)&nbsp;years would remain left in the Term after Landlord&#146;s estimated date of completion of
restoration, Landlord may terminate this Lease effective as of the date of such fire and other
casualty upon notice to Tenant given within ninety (90)&nbsp;days after such fire and other casualty.
Notwithstanding the foregoing to the contrary, in the event Landlord exercises the foregoing
termination right, if Tenant has available to it the option to extend and validly exercises said
option, Tenant may defeat said termination notice by the valid exercise of said option term so as
to add an additional five years on to the Term of this Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.&nbsp;<U>Alterations and Additions</U>. Section&nbsp;10 of the Lease is amended to add, after the second sentence thereof, the following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Notwithstanding the foregoing, Landlord&#146;s consent shall not be required for any alteration,
addition or improvement that either (a)&nbsp;costs less than Ten Thousand Dollars ($10,000.00) or (b)
satisfies all of the following criteria: (i)&nbsp;is of a cosmetic nature such as painting,
wallpapering, hanging pictures and installing carpeting, (ii)&nbsp;is not visible from the exterior of
the Premises or Building, and (iii)&nbsp;will not affect the systems or structure of the Building,
provided, however, in any such instance Tenant provides plans and specifications for such work not
less than ten (10)&nbsp;days before commencing such work.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, Landlord agrees to advise Tenant, upon request, which alterations and additions
to be made by Tenant Landlord will require to be so removed at the end of the Term.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.&nbsp;<U>Ratification</U>. Except as modified herein, the Lease is hereby ratified
and confirmed in full force and effect. To the best of their knowledge, neither
Landlord nor Tenant are aware of any default by the other party in the terms and
conditions of this Lease. Any defined term used herein and not specifically defined
herein shall have the meaning ascribed to it in the Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20.&nbsp;<U>Exhibits</U>. Attached hereto and made a part hereof are:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="79%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#151;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">First Floor Plan</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;B-l
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#151;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Second Floor Plan</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" nowrap><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;B-2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#151;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Outline Specifications for Second Floor</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;C
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#151;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Letter of Credit</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;D
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#151;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Permitted Signage</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;E
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#151;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Master Lease</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">
<!-- Folio -->
- 13 -
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executed under seal as of this 25<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of March&nbsp;2004.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">MJ RESEARCH, INCORPORATED,<BR>a Massachusetts corporation</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Illegible</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name: Illegible</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: VP Finance</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Fluidigm Corporation</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Gajus Worthington</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">
<!-- Folio -->
- 14 -
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT A<BR>
FIRST FLOOR PLAN
</DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 18pt">[Diagram depicting the first floor layout.]
</DIV>



<P align="center" style="font-size: 10pt">
<!-- Folio -->
- 15 -
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT B-l<BR><BR>
SECOND FLOOR PLAN
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">[Diagram depicting the second floor layout.]
</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
- 16 -
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT B-2<BR><BR>
OUTLINE SPECIFICATIONS
</DIV>



<P align="center" style="font-size: 10pt">
<!-- Folio -->
- 17 -
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><U>EXHIBIT B-2</U></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>2</B><SUP style="font-size: 85%; vertical-align: text-top"><B>nd</B></SUP> <B>Floor Improvement Outline Specification &#151; Landlords Work</B></U><BR>
Based on Exhibit&nbsp;B -1 (2<SUP style="font-size: 85%; vertical-align: text-top">nd</SUP> Floor Plan)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>1. Building Type and Use: </B>3 Story, Group B, Type III, 1 Hour Rated, fully
sprinklered office building. All design and construction in conformance with the
1998 (CBC)&nbsp;Building Standards Administrative Code of the California Building
Standards Commission (CBSC)&nbsp;and the City of South San Francisco amendments, all applicable codes
and regulations. All building improvements
shall be furnished fully ADA compliant, where required and meet the energy and
access requirements set forth in the California Title 24 Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>2. Tenants Program (General Description of Areas): </B>Based on the attached
Exhibit&nbsp;B &#151; 1 (2<SUP style="font-size: 85%; vertical-align: text-top">nd</SUP> Floor Plan), the tenant&#146;s space will consist of the following
programmatic components.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>a. Offices: </B>General open office areas to house up to (20)&nbsp;modular workstations,
(12)&nbsp;offices with modular glass panels parallel to the building perimeter and (2)
conference rooms with modular glass panels parallel to the building perimeter. All
office finished will be consistent with tenants 1<SUP style="font-size: 85%; vertical-align: text-top">st</SUP> Floor, East Wing office space
with the exception of the open lofted ceiling. Due to the excess laboratory
mechanicals an acoustical suspended ceiling with recessed lighting is necessary
to conceal all HVAC equipment and wiring. To maintain the buildings tall and airy
affect all ceilings throughout will be mounted at a height of 11&#146;-0&#148; above the
finished floor. Landlord reserves the right to add architectural treatments and
lighting to enhance the interior environment of the space including wall facets,
columns and metal ceiling accents. All door frames and trim will be brushed
chrome or anodized aluminum and all door leafs and other laminates will be light
maple to match the existing. Flooring will consist of stained concrete, VCT and
carpet where appropriate. Tenant may elect to substitute other office type
improvements as approved by landlord that do not adversely affect the buildings
design integrity or construction cost. These changes will be addressed on the
final floor plans, prior to submission to the building department.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>b. Laboratories: </B>(1)&nbsp;Open Plan Biology Laboratory and (1)&nbsp;Open Plan
Chemistry Laboratory will be provided, each not to exceed 1,500 square feet of
floor area. Each laboratory will be equipped with (1)&nbsp;fume hood exhaust
connection and ducting. Copper vacuum and compressed air piping will be
connected to each hood. Each laboratory will also be provided with (1)&nbsp;working
laboratory type sink complete with hot, cold and de-ionized pure water sources.
</DIV>



<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Any ultra-pure Dl water connections and equipment are the tenant&#146;s sole responsibility. Locations
of hoods and sinks where reasonably feasible and as designated by tenant. Up to (4)&nbsp;Stainless steel
ceiling mounted lab utility distribution panels will be provided in each laboratory room. Each
panel can accommodate electric, data, vacuum and compressed air as specified by tenant and similar
to those used by tenant in West Wing of building. Laboratory finishes to consist of vinyl coated
acoustical ceiling panels, recessed lighting, tile or sheet vinyl resilient flooring and painted
gypsum board walls. Landlord reserves the right to add architectural treatments as appropriate that
will not interfere with tenants use.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>c. Ancillary Rooms: </B>Ancillary rooms, such as storage, equipment, utility, kitchen, conference or
others can be substituted for the improvements described herein and depicted on Exhibit&nbsp;B -1 (2nd
Floor Plan) provided that they are approved by the landlord and do not adversely affect the
buildings design integrity, use group classification or construction cost.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>3. Utilities:</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>a. Gas: </B>Gas utilities to be provided for general heating of air and to heat water to
common building heating devices and domestic water supplies only. No specific
gas connections to tenant&#146;s laboratories or capital equipment will be provided.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>b. Electric: </B>Electric utilities including distribution panels, cabling and receptacles
will be provided to tenants space at a ratio common to office use and not less
than the minimum set forth in the National Electric Code. Additional high voltage
power for laboratories containing tenant specific equipment will be provided in a
flexible manner via ceiling mounted panels or wall mounted metal wireways at
locations as specified by tenant. Up to (4)&nbsp;ceiling panels or wireways will be
provided in each laboratory to house the lab specific utilities. Each panel or
wireway will contain up to (4)&nbsp;standard 115V receptacles in metal gang boxes,
suspended but cords, (1)&nbsp;UPS or Emergency Back-up receptacle and (1)&nbsp;high
voltage receptacle with plug configuration as specified by tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>c. Telephone and Data Connections: </B>Each office and workstation will receive
(2)&nbsp;Category 5e communications jacks for use with either telephone or computer
networking equipment. Each cable will be pulled to common Tele/Data
distribution room as shown on 2<SUP style="font-size: 85%; vertical-align: text-top">nd</SUP> Floor Plan. Cable terminations, phone and
networking equipment and distribution panels will not be provided and are the
sole responsibility of the tenant. Tenant may make use of landlord pre-existing
racks for purposes of mounting their equipment. Conference and laboratory
rooms shall receive up to (4)&nbsp;phone or data connections each.
</DIV>



<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>d. Specialty Laboratory and House Utilities: </B>Vacuum and compressed air copper feeds and connections
will be provided to each laboratory hood or ceiling panel locations as designated by tenant.
Connections not to exceed (4)&nbsp;per laboratory. Vacuum connections will be made to pre-existing house
vacuum system. Compressed air connections will be made to new air compressor and dryer subject to
joint specification and installation by tenant and landlord. De-ionized water to be provided to
each sink location and connected to pre-existing house system. Each laboratory sink location will
be provided with chemical and Dl resistant waste lines. Tenant is responsible to monitor at point
of use and downstream, the lab waste lines to ensure that no chemicals are being released into the
laboratory waste system or public sewer utility.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>4. Design: </B>For the improvements described herein and on Exhibit&nbsp;B-1 (2<SUP style="font-size: 85%; vertical-align: text-top">nd</SUP> Floor
Plan), all design, architecture, engineering, color schemes and finish selections
will be provided by landlord at landlord&#146;s expense and discretion. All final
construction and permit documents will be provided by landlords licensed
consultants as required.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>5. Construction: </B>All construction procedures, materials and methods will be
provided in a workmanlike and professional manner under the supervision of the
landlord and will be built in accordance with all applicable codes and industry
standards. All consultants, vendors, contractors and subcontractors performing
the work as described herein and in Exhibit&nbsp;B &#151; 1 (2nd Floor Plan) will be under
the direct contract and supervision of the landlord only. Access for construction
equipment, building materials and furniture will be provided through an exterior
window unit that will serve as a temporary freight passage. This passage will be
available to tenant only until landlords work prohibits the handling of materials in
that area wherein the window will be re-installed and sealed. Once sealed, the
window will not be subject to further removal by landlord. It is understood that the
2<SUP style="font-size: 85%; vertical-align: text-top">nd</SUP> floor improvements will be ongoing with tenants occupancy of the below
1<SUP style="font-size: 85%; vertical-align: text-top">st</SUP>
floor space. Access, particularly in the ceiling plenum, to the 1<SUP style="font-size: 85%; vertical-align: text-top">st</SUP> floor space may
be required for the duration of the project for purposes of facilitating the
construction above. Inherently, some noise, vibration and disruption may
occasionally be experienced in the space below and in the adjacent areas.
Reasonable accommodations will be made by landlord to minimize such
disruptions during regular working hours.
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT C<BR>
FORM OF LETTER OF CREDIT
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 18 -<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943241.gif" alt="(LETTERHEAD)">
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>IRREVOCABLE STANDBY LETTER OF CREDIT NO. SVBSF002780</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">DATE: APRIL 01, 2004
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">BENEFICIARY:<BR>
MJ RESEARCH, INC.<BR>
7000 SHORELINE COURT<BR>
SOUTH SAN FRANCISCO, CA 94080

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">APPLICANT:<BR>
FLUIDIGM CORPORATION<BR>
7100 SHORELINE COURT<BR>
SOUTH SAN FRANCISCO, CA 94080

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">AMOUNT:
US$250,000.00 (U.S. DOLLARS TWO HUNDRED FIFTY THOUSAND EXACTLY)
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">EXPIRATION DATE: MARCH 31, 2008
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">LOCATION: SANTA CLARA, CALIFORNIA
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">DEAR SIR/MADAM:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WE HEREBY ESTABLISH OUR IRREVOCABLE STANDBY LETTER OF CREDIT NO. SVBSF002780 IN YOUR FAVOR
AVAILABLE BY YOUR DRAFTS DRAWN ON US AT SIGHT IN THE FORM OF &#147;EXHIBIT B&#148; ATTACHED AND ACCOMPANIED
BY THE FOLLOWING DOCUMENTS:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">1. THE ORIGINAL OF THIS LETTER OF CREDIT AND ALL AMENDMENT(S), IF ANY.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">2. SIGHT DRAFTS DRAWN ON US.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">3. A DATED
STATEMENT FROM THE BENEFICIARY SIGNED BY AN OFFICER OR AN AUTHORIZED REPRESENTATIVE OF THE BENEFICIARY, FOLLOWED BY HIS/HER
DESIGNATED TITLE, STATING THE FOLLOWING:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">
&#147;THE UNDERSIGNED STATES BENEFICIARY IS ENTITLED TO DRAW UPON THIS
LETTER OF CREDIT PURSUANT TO THE TERMS OF THAT LEASE DATED AS OF
DECEMBER 1, 2001 BETWEEN BENEFICIARY AND FLUIDIGM CORPORATION, AS SAID
LEASE IS AMENDED FROM TIME TO TIME, FOR THE AMOUNT DRAWN HEREUNDER.
THE UNDERSIGNED BENEFICIARY HEREBY MAKES DEMAND FOR THE PAYMENT OF
US $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (DRAW AMOUNT) UNDER THIS LETTER OF CREDIT.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THE LEASE MENTIONED ABOVE IS FOR IDENTIFICATION PURPOSES ONLY AND IT IS NOT INTENDED THAT SAID
LEASE BE INCORPORATED HEREIN OR FORM PART OF THIS LETTER OF CREDIT.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">PARTIAL DRAWS ARE ALLOWED. THIS ORIGINAL LETTER OF CREDIT MUST ACCOMPANY ANY DRAWINGS HEREUNDER FOR
ENDORSEMENT OF THE DRAWING AMOUNT AND WILL BE RETURNED TO THE BENEFICIARY UNLESS IT IS FULLY
UTILIZED.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THIS LETTER OF CREDIT MAY ONLY BE TRANSFERRED IN ITS ENTIRETY BY THE ISSUING BANK, ASSUMING SUCH
TRANSFER TO SUCH TRANSFEREE WOULD BE IN COMPLIANCE WITH THEN APPLICABLE LAW AND REGULATIONS,
INCLUDING BUT NOT LIMITED TO THE REGULATIONS OF THE U.S. DEPARTMENT OF TREASURY AND U.S. DEPARTMENT
OF COMMERCE, UPON OUR RECEIPT OF THE ATTACHED &#147;EXHIBIT A&#148; DULY COMPLETED AND EXECUTED BY THE
BENEFICIARY AND ACCOMPANIED BY THE ORIGINAL LETTER OF CREDIT AND ALL AMENDMENT(S), IF ANY, TOGETHER
WITH THE PAYMENT OF OUR TRANSFER FEE 1/4 OF 1% OF THE TRANSFER AMOUNT (MINIMUM USD250.00) .
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">DRAFT(S) AND DOCUMENTS MUST INDICATE THE NUMBER AND DATE OF THIS LETTER OF CREDIT.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><FONT style="font-variant: small-caps">3003 Tasman Drive &#124; Santa Clara, CA  95054 &#124; 408.654.7400 &#124; svb.com<BR>
Swift Address: SVBKUS6S &#124; Telex No. 6732567 &#124; Answerback: SVB TF</font></div>

<P align="RIGHT" style="font-size: 10pt">
<!-- Folio -->
PAGE -1-<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943241.gif" alt="(LETTERHEAD)">
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>IRREVOCABLE
STANDBY LETTER OF CREDIT NO. SVBSF002780</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">DOCUMENTS MUST BE FORWARDED TO US BY OVERNIGHT DELIVERY SERVICE TO: SILICON VALLEY BANK, 3003
TASMAN DRIVE, SANTA CLARA, CA 95054, ATTN: INTERNATIONAL DIVISION.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WE HEREBY AGREE WITH THE DRAWERS, ENDORSERS AND BONAFIDE HOLDERS THAT THE DRAFTS DRAWN UNDER AND IN
ACCORDANCE WITH THE TERMS AND CONDITIONS OF THIS LETTER OF CREDIT SHALL BE DULY HONORED UPON
PRESENTATION TO THE DRAWEE, IF NEGOTIATED ON OR BEFORE THE EXPIRATION DATE OF THIS CREDIT.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THIS LETTER OF CREDIT IS SUBJECT TO THE UNIFORM CUSTOMS AND PRACTICE FOR DOCUMENTARY CREDITS
(1993 REVISION), INTERNATIONAL CHAMBER OF COMMERCE, PUBLICATION NO. 500.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="28%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">SILICON VALLEY BANK,</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ John M. Dossantos
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Edward D. Machado</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top" style="border-top: 1px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">AUTHORIZED SIGNATURE
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">AUTHORIZED SIGNATURE</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">John M. Dossantos
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Edward D. Machado</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943242.gif" alt="(LETTERHEAD)">
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
PAGE -2-
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT &#147;B&#148;</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943252.gif" alt="(SIGHT DRAFT)">
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>GUIDELINES TO PREPARE THE DRAFT</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">1. DATE: ISSUANCE DATE OF DRAFT.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">2. REF. NO.: BENEFICIARY&#146;S REFERENCE NUMBER, IF ANY.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">3. PAY TO
THE ORDER OF: NAME OF BENEFICIARY AS INDICATED IN THE L/C (MAKE
SURE BENEFICIARY ENDORSES IT ON THE REVERSE SIDE).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">4. US$: AMOUNT OF DRAWING IN FIGURES.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">5. USDOLLARS: AMOUNT OF DRAWING IN WORDS.<BR>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">6. LETTER OF CREDIT NUMBER: SILICON VALLEY BANK&#146;S STANDBY L/C NUMBER THAT
PERTAINS TO THE DRAWING.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">7. DATED: ISSUANCE DATE OF THE STANDBY L/C.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">8. BENEFICIARY&#146;S NAME: NAME OF BENEFICIARY AS INDICATED IN THE L/C.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">9. AUTHORIZED SIGNATURE: SIGNED BY AN AUTHORIZED SIGNER OF BENEFICIARY.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">IF YOU NEED FURTHER ASSISTANCE IN COMPLETING THIS DRAFT, PLEASE CALL OUR L/C PAYMENT SECTION AND
ASK FOR:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ALICE DA LUZ: 408-654-7120<BR>
EFRAIN TUVILLA: 408-654-6349

</DIV>
<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">
</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT &#147;A&#148;</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="42%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="42%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<TR valign="bottom">
    <TD valign="top">DATE:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">TO:</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">SILICON VALLEY BANK</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">3003 TASMAN DRIVE</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">RE:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">STANDBY LETTER OF CREDIT</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">SANTA CLARA, CA 95054</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">NO. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ISSUED BY</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ATTN:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">INTERNATIONAL DIVISION.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SILICON VALLEY BANK, SANTA CLARA</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">STANDBY LETTERS OF CREDIT
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">L/C AMOUNT:</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">GENTLEMEN:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">FOR VALUE RECEIVED, THE UNDERSIGNED BENEFICIARY HEREBY IRREVOCABLY TRANSFERS TO:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(NAME OF TRANSFEREE)<BR>
(ADDRESS)</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ALL RIGHTS OF THE UNDERSIGNED BENEFICIARY TO DRAW UNDER THE ABOVE LETTER OF CREDIT UP TO ITS
AVAILABLE AMOUNT AS SHOWN ABOVE AS OF THE DATE OF THIS TRANSFER.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">BY THIS TRANSFER, ALL RIGHTS OF THE UNDERSIGNED BENEFICIARY IN SUCH LETTER OF CREDIT ARE
TRANSFERRED TO THE TRANSFEREE. TRANSFEREE SHALL HAVE THE SOLE RIGHTS AS BENEFICIARY THEREOF,
INCLUDING SOLE RIGHTS RELATING TO ANY AMENDMENTS, WHETHER INCREASES OR EXTENSIONS OR OTHER
AMENDMENTS, AND WHETHER NOW EXISTING OR HEREAFTER MADE. ALL AMENDMENTS ARE TO BE ADVISED DIRECT TO
THE TRANSFEREE WITHOUT NECESSITY OF ANY CONSENT OF OR NOTICE TO THE UNDERSIGNED BENEFICIARY.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THE ORIGINAL OF SUCH LETTER OF CREDIT IS RETURNED HEREWITH, AND WE ASK YOU TO ENDORSE THE TRANSFER
ON THE REVERSE THEREOF, AND FORWARD IT DIRECTLY TO THE TRANSFEREE WITH YOUR CUSTOMARY NOTICE OF
TRANSFER.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">SINCERELY,
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="1" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">(BENEFICIARY&#146;S NAME)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="1" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">SIGNATURE OF BENEFICIARY</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">SIGNATURE AUTHENTICATED</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="1" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">(NAME OF BANK)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="1" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AUTHORIZED SIGNATURE **&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By affixing his/her signature, he or she is certifying that the Bank
on whose behalf he or she is signing is regulated either by the FED, the OCC, or the FDIC, and that
the Bank has implemented AML (Anti-Money Laundering) procedures in accordance with the Bank Secrecy
Act, and that the Transferor named above has been approved under his/her Bank&#146;s own CIP (Customer
Information Program). VERIFICATION OF TRANSFEROR&#146;S SIGNATURE(S) BY A NOTARY PUBLIC IS
UNACCEPTABLE.</DIV>


<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left"><FONT size="1">
</FONT></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT D<BR>
PERMITTED LOBBY SIGNAGE
</DIV>



<P align="center" style="font-size: 10pt">
<!-- Folio -->
-19-
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>Exhibit&nbsp;D</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943253.gif" alt="()">
</DIV>

<P align="center" style="font-size: 10pt">
<!-- Folio -->
&nbsp;
<!-- /Folio -->
</DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>Exhibit&nbsp;E</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">[SEE ABOVE FOR
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SUBLEASE
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">BETWEEN
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">MJ RESEARCH COMPANY, INC.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AND
FLUIDIGM CORPORATION]
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AGREEMENT OF LEASE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT OF LEASE made as of the 6<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of October, 2000, by
and between MJ Research Company, Inc. (hereinafter referred to as &#147;Landlord&#148;)
and Genesoft, Inc. (hereinafter referred to as &#147;Tenant&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">WITNESSETH:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord hereby leases to Tenant and Tenant hereby hires from Landlord a portion
of the building (the &#147;Building&#148;) in South San Francisco, as described in Section
1.1(4) below and shown on the plan attached hereto as Exhibit&nbsp;A and made a part
hereof (hereinafter referred to as the &#147;Premises&#148; or the &#147;Demised Premises&#148;).
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>REFERENCE DATA</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 <U>Definitions</U>. Each reference in this Lease to any of the terms
and titles contained in this Article shall be deemed and construed to incorporate the
data stated following that term or title in this Article.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="20%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">1) Additional Rent:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sums or other charges payable by Tenant to Landlord
under this Lease, other than Yearly Fixed Rent, all of
which shall be payable as additional rent under this
Lease.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">2) Broker:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">None.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3) Business Day:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">All days except Saturdays, Sundays, days defined as
&#147;legal holidays&#148; for the entire state under the laws of
the State of California, and such other days as Tenant
presently or in the future recognizes as holidays for
Tenant&#146;s general staff.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4) Demised Premises:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Space on the first, second and third floors of the
Building at 7000 Shoreline Court, South San Francisco,
California 94080 (the &#147;Building&#148;), which space is shown
on the plans attached as Exhibit&nbsp;A.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5) Environmental Laws:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;5.3 (a) (1).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">6) Event of Default:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The occurrence of an event listed in Section&nbsp;19.1.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">7) Hazardous Materials:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;5.3 (a) (2).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="20%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">pigs and relocate such
animals off-site or,
within a reasonable period
of time (not to exceed two
(2)&nbsp;business days) make
such arrangements as are
necessary to eliminate
such picketing, signage or
other disruption.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">16) Prime Landlord:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mountain Cove Tech Center
LLC, a California limited
liability company.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">17) Prime Lease:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The lease dated November
9, 1999 between Prime
Landlord and Landlord.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">18) Property:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Land and Building.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">19) Rent:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yearly Fixed Rent and
Additional Rent.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:19px; text-indent:-19px">20) Rentable Area of the Demised Premises:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom"><br>Approximately 68,460
rentable square feet. The
rentable square footage of
the Demised Premises upon
completion of Landlord&#146;s
Work shall be measured by
Landlord according to the
most recent BOMA
standards, but in any
event shall include for
computation purposes 50%
of all common areas of the
Building, including,
without limitation,
elevators, lobbies,
hallways, exercise room,
security desk, and lunch
room. If Tenant disagrees
with Landlord&#146;s
computation of the
rentable square footage of
the Premises, Tenant may,
at its expense, by notice
given no later than ten
(10)&nbsp;days after written
notice by Landlord of the
rentable square feet of
the Demised Premises,
submit the matter of the
square footage as to
arbitration as set forth
in Section&nbsp;27.7 herein.
The inclusion of
elevators, hallways, the
exercise room,
security
desk and lunchroom in the
computations of rentable
square footage shall not
be deemed to make Tenant
liable for such facilities
as if it were the
exclusive lessee thereof.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">21) Security Deposit:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">One Year&#146;s Yearly Fixed
Rent, subject to decrease
as provided in Section
28.3.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="20%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="75%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">22) Tenant&#146;s Address:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Until the Term Commencement
Date, Two Corporate Drive
South, San Francisco,
California 94080, and
thereafter, the Demised
Premises.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap valign="top"><DIV style="margin-left:19px; text-indent:-19px">23) Term Commencement Date:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">As defined in Section&nbsp;3.2.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24) Term of this Lease:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;3.1.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">25) Termination Date:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;3.1.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">26) Yearly Fixed Rent:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">$4.50 per rentable square
foot per month for the
first lease year, which
amount shall be increased
annually commencing with
the third lease year by
three and one half percent
(3.5%) compounded annually.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2 <U>Exhibits</U>. The following exhibits are attached hereto and made a part
hereof:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A &#151; Plan of Demised Premises
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A-l &#151; Plans and Specifications for Landlord&#146;s Work<BR>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A-2 &#151; Landlord&#146;s Work Necessary for Tenant Improvement Work
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B &#151; Cleaning Specifications
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C &#151; Rules and Regulations
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D &#151; Sign Criteria
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E &#151; Form of Letter of Credit<BR>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;F &#151; List of Environmental Reports Given to Tenant
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;G &#151; List of Permitted Hazardous Materials<BR>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;H &#151; List of Fixtures and Equipment to be Removed
</DIV>


<DIV style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>DESCRIPTION OF DEMISED PREMISES</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 <U>Demised Premises</U>. The Demised Premises are that portion of the
Building as described above (as the same may from time to time be constituted after
changes therein, additions thereto and eliminations therefrom pursuant to rights of
Landlord hereinafter reserved).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 <U>Appurtenant Rights</U>. Tenant shall have, as appurtenant to the
Demised Premises, rights to use in common, subject to reasonable rules from time
to time made by Landlord of which Tenant is given notice, those common roadways,
walkways, elevators, hallways and stairways necessary for access to that portion of
the Building occupied by the Demised Premises. There is also appurtenant to the
Demised Premises at no additional charge the nonexclusive use, in common with
Landlord and other entitled thereto, of the parking lot appurtenant to the Building,
which lot is designed to have three (3)&nbsp;parking spaces per 1,000 rentable square feet
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in the Building. Landlord agrees that such parking lot shall be on a non-exclusive basis for Tenant
and others entitled thereto and shall not exclusively assign portions of the parking area without
providing equivalent and comparable exclusive assignments to Tenant, provided that, subject to
casualty and eminent domain, in no event shall Tenant have the use (non-exclusive or otherwise) of
not less than nor more than, three (3)&nbsp;spaces per 1,000 rentable square feet of the Demised
Premises during the Term, provided that there shall be deducted from the parking available to
Tenant any parking spaces lost due to Tenant&#146;s outside storage facility referred to in Section
5.3(c). Tenant may not store cars in the parking lot, i.e., leave cars parked for more than seven
(7)&nbsp;days.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 <U>Reservations</U>. All the perimeter walls of the Demised Premises except the inner
surfaces thereof, any balconies, terraces or roofs adjacent to the Demised Premises, and any space
in or adjacent to the Demised Premises used for serving other portions of the Building exclusively
or in common with the Demised Premises, including without limitation (where applicable) shafts,
stacks, pipes, conduits, wires and appurtenant fixtures, fan rooms, ducts, electric or other
utilities, sinks or other Building facilities, and the use thereof, as well as the right of access
through the Demised Premises for the purpose of operation, maintenance, decoration and repair, are
expressly reserved to Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4 <U>Certain Amenities</U>. The named Tenant, Genesoft, Inc. shall have access to on
a nonexclusive basis, the following facilities:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The exercise room. Landlord may charge a reasonable fee for towel service and
janitorial service.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) A security desk in the main lobby of the Building to be staffed from 9:00 a.m.
through 5:00 p.m. on all Business Days.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The lunchroom and adjacent patio.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event the named Tenant Genesoft occupies less than 50% of the Building,
Landlord may eliminate said amenities (other than the security desk) or assign them
exclusively to Landlord or other occupants of the Building. Such amenities shall not be
available to assignees or subtenants of Tenant unless permitted in writing by Landlord.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>TERM OF LEASE</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 <U>Term</U>. The Term of this Lease is ten (10)&nbsp;years (or until such Term shall
sooner cease or expire) commencing on the Term Commencement Date and ending on the day
immediately prior to the tenth (10<SUP style="font-size: 85%; vertical-align: text-top">th)</SUP> anniversary thereof, except that if the Term
Commencement Date shall be other than the first day of a calendar month, the Term of this Lease
shall end on the last day of the calendar month in which said 10<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> anniversary of the
Term Commencement Date shall fall (which date
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">on which the Term of this Lease is scheduled to expire is hereinafter referred to as the
&#147;Termination Date&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 <U>Term Commencement Date</U>. The Term Commencement Date shall be the earlier of (a)&nbsp;the
date on which, pursuant to permission therefor duly given by Landlord, Tenant undertakes Use of
the Demised Premises for the purposes set forth in Article&nbsp;1, (b)&nbsp;the date on which the Demised
Premises are ready for Tenant&#146;s occupancy in accordance with the provisions of Section&nbsp;4.2, or (c)
March&nbsp;1, 2001, but in no event prior to the date on which Landlord&#146;s Work (as defined herein) is
substantially completed, unless and only to the extent that the lack of such substantial completion
is due to the fault, delay, or inaction by Tenant or to the roof work necessitated by Tenant&#146;s
mechanical and other equipment to be placed on the roof. Notwithstanding the foregoing to the
contrary, if the work set forth on Schedule&nbsp;A-2 is not substantially complete by January&nbsp;1, 2000
and the lack of such substantial completion is not due to fault, delay or inaction of Tenant or to
roof work necessitated by Tenant&#146;s mechanical and other equipment to be placed on the roof, then
for each day beyond January&nbsp;1, 2001 for which the work on Schedule&nbsp;A-2 is not substantially
complete, the March&nbsp;1, 2001 date shall be extended for one day. Further notwithstanding anything in
the foregoing to the contrary, for purposes of determining when the Premises are ready for
occupancy for purposes of determining the Term Commencement Date, the Premises shall not be deemed
ready for occupancy until Tenant has completed its Tenant improvement work and obtained a
certificate of occupancy therefor. Tenant further acknowledges that if Landlord has completed its
work on Schedule&nbsp;A-2 on or before January&nbsp;1, 2000 and made the Premises available to Tenant, Tenant
assumes the risk of delay for Tenant improvement work and acknowledges that (subject to Landlord&#146;s
obligations as to substantial completion of Landlord&#146;s Work) the Term will commence on March&nbsp;1,
2001 whether or not Tenant has completed its work and obtained such a certificate of occupancy.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3 <U>Option to Extend</U>. Provided Tenant is not in default of the terms and covenants of
this Lease beyond applicable notice and grace periods, and provided Tenant has not assigned this
lease or subleased all or any portion of the Premises, it shall have the option to extend the Term
for five (5)&nbsp;years, exercisable by written notice given to Landlord no later than twelve (12)
months before the expiration of the original Term. All of the terms, conditions and covenants of
this Lease shall apply to the option term, except that there shall be no further extension beyond
that permitted above and that yearly Fixed Rent for the option term shall be computed as set forth
in Section&nbsp;6 herein.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>PREPARATION OF PREMISES; TENANT&#146;S ACCESS</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 <U>Plans and Specifications</U>. Landlord shall construct the Demised Premises in
accordance with the plans and specifications (the &#147;Plans&#148;) referenced in Exhibit&nbsp;A-l attached
hereto and made a part hereof (&#147;Landlord&#146;s Work&#148;). Tenant
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">acknowledges that Landlord&#146;s Work will produce a so-called &#147;cold shell&#148; that will not be ready for
Tenant&#146;s occupancy.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 <U>When Landlord&#146;s Work is Done</U>. Landlord&#146;s Work shall be conclusively deemed
finished after Landlord gives notice to Tenant that Landlord&#146;s Work has been substantially
completed by Landlord. Notwithstanding anything to the contrary in this Lease, the Landlord&#146;s Work
shall not be deemed &#147;substantially completed&#148; prior to the date on which: (a)&nbsp;construction and
installation of the improvements listed on <U>Exhibit&nbsp;A-1</U>, attached hereto, have been
substantially completed; (b)&nbsp;Tenant has direct access from the street to the elevator lobby on the
first floor; and (c)&nbsp;utility services are ready to be furnished to the Premises consistent with the
work set forth on Exhibit&nbsp;A-l. Such work shall not be deemed incomplete if only minor or
insubstantial details of construction or mechanical adjustments remain to be done, or if a delay is
caused in whole or in part by Tenant. Landlord&#146;s Architect&#146;s certificate of substantial completion,
as hereinabove stated, given in good faith, or of any other facts pertinent to such work, shall be
deemed conclusive of the statements therein contained and binding upon Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 <U>Conclusiveness of Landlord&#146;s Performance</U>. Tenant shall be conclusively deemed to
have agreed that Landlord has performed all of its obligations under this Article&nbsp;4 unless not
later than the end of the second calendar month next beginning after the Landlord&#146;s notice of
substantial completion under Section&nbsp;4.2 unless Tenant shall give Landlord written notice
specifying the respects in which Landlord has not performed such obligations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4 <U>Entry by Tenant; Interference With Construction; Applicability of Lease Terms</U>.
The Demised Premises shall be made available by Landlord to Tenant on or before January&nbsp;1, 2001
(the &#147;Estimated Tenant Improvement Commencement Date&#148;) to undertake such work as is to be
performed by Tenant pursuant and subject to this Lease in order to prepare the Demised Premises
for Tenant&#146;s occupancy. Such entry shall be deemed to be pursuant to a license from Landlord to
Tenant and shall be at the risk of Tenant. In no event shall Tenant interfere with any
construction being performed by or on behalf of Landlord in or around the Building or with the use
of the Building by Landlord or any other occupants; without limiting the generality of the
foregoing, Tenant shall comply with all instructions issued by Landlord&#146;s contractors relative to
the moving of Tenant&#146;s equipment and other property into the Demised Premises and shall pay any
fees or costs imposed in connection therewith. Once Tenant makes such entry, Tenant will be bound
by all terms and conditions of this Lease as if the Term had commenced, excepting payment of Rent.
Landlord agrees to use its good faith and reasonable efforts to coordinate with Tenant the
build-out of the Building shell and the tenant improvements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.5 <U>Tenant Plans</U>. Tenant shall perform no construction work in the Building
unless and until Landlord has approved all plans, specifications and the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">identity of contractors and major subcontractors therefor and such plans have been consented to by
Landlord&#146;s mortgagee. Landlord agrees that unless it has disapproved any Tenant plans within ten
(10)&nbsp;business days after receipt thereof, the plans shall be deemed approved. Tenant shall, upon
Landlord&#146;s request, provide payment performance and lien bonds in commercially reasonable amounts
and terms. All of the provisions of Articles 9, 10 and 11 shall apply to Tenant&#146;s work hereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.6 <U>Tenant Improvement Allowance</U>. Provided Tenant is not in default hereunder,
Landlord will provide Tenant with a Tenant Improvement Allowance of $25.00 per rentable square
foot. There shall be deducted from said Tenant Improvement Allowance the following: (i)&nbsp;50% of the
cost of purchase and installation of the emergency generator for the Building, (ii)&nbsp;50% of all
costs of upgrading the power capacity of the Building from 3500 amps to 4000 amps, including,
without limitation, any delay costs (not to exceed $5,000.00) imposed upon Landlord under its
construction contract with Opus attributable to said power capacity upgrades, (iii)&nbsp;all costs to
Landlord associated with using the roofer under contract with Opus, Tenant acknowledging and
understanding that use of said roofer in connection with the installation of Tenant&#146;s rooftop
equipment and screens is required in order to maintain the roof warranty on the Building, and (iv)
the cost of supporting, extending and connecting all screens on the roof, including, without
limitation, all new screens, vertical steel beams, secondary structural support and all related
costs. Landlord shall fund the Tenant Improvement Allowance on a pro rata basis as Tenant pays its
contractor for Tenant&#146;s work. Landlord&#146;s contribution shall be funded based on the fraction of each
construction draw, the numerator of which is $25.00 per rentable square foot and the denominator of
which is the total cost of all work by Tenant to prepare the Demised Premises for Tenant&#146;s
occupancy. Landlord shall have the right to reasonably approve Tenant&#146;s schedule of estimated
construction disbursements. Landlord shall require Tenant to provide appropriate lien waivers and
other evidence of payment contractors, subcontractors and material suppliers prior to funding any
of the Tenant Improvement Allowance.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.7 <U>Inspections and Scheduling</U>. Tenant may inspect the Building and the Premises
during the construction of the Landlord&#146;s Work as it progresses. Landlord agrees to be available to
Tenant from time to time, on reasonable prior notice, as necessary or desirable to review the
Landlord&#146;s Work.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.8 <U>Permits and Approvals</U>. Landlord, at its sole cost and expense, shall obtain all
approvals, permits and other consents required to commence, perform and complete the Landlord&#146;s
Work. Landlord agrees that the Landlord&#146;s Work will comply with all applicable laws and other
governmental regulations as of the date of substantial completion including, but not limited to,
the Americans With Disabilities Act of 1990 (42 U.S.C. &#167;12101 et seq.) and the City of South San
Francisco and State of California Building and fire codes, as the same may be amended from time to
time.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.9 <U>Construction Guaranty</U>. Landlord guaranties the Landlord&#146;s Work against defective
workmanship and/or materials for a period of 11&nbsp;months from the date of substantial completion of
the Landlord&#146;s Work, and Landlord agrees, at its sole cost and expense, to repair or replace any
defective item occasioned by poor workmanship and/or materials during said 11&nbsp;month period. Nothing
in this Section&nbsp;4.9 shall limit Landlord&#146;s other repair obligations under this Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.10 <U>Walkthrough and Punch List</U>. Tenant shall be entitled to a walkthrough and punch
list with Landlord&#146;s architect with respect to Landlord&#146;s Work. The determination of the punch list
shall be at the sole and exclusive approval of Landlord&#146;s architect. Landlord shall remedy all
punch list items within a commercially reasonable time.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">5.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>USE OF PREMISES</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 <U>Permitted Use</U>. Tenant shall occupy and use the Demised Premises for the Permitted
Use set forth in Article&nbsp;1 and for no other purpose. Service and utility areas (whether or not a
part of the Demised Premises) shall be used only for the particular purpose for which they are
designated. Tenant shall have access to the Demised Premises 24 hours per day, 7&nbsp;days per week.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 <U>Prohibited Uses</U>. Tenant shall not use, or suffer or permit the use of, or suffer
or permit anything to be done in or anything to be brought into or kept in, the Demised Premises or
any part thereof (i)&nbsp;which would violate any of the covenants, agreements, terms, provisions and
conditions of this Lease, (ii)&nbsp;for any unlawful purposes or in any unlawful manner, or (iii)&nbsp;which,
in the reasonable judgment of Landlord shall in any way (a)&nbsp;impair or tend to impair the appearance
or reputation of the Building, (b)&nbsp;impair or interfere with or tend to impair or interfere with any
of the Building services or the proper and economic heating, cleaning, air conditioning or other
servicing of the Building or with the use of any of the other areas of the Building, or (c)
occasion discomfort, inconvenience or annoyance to any of the other tenants or occupants of the
Building, whether through the transmission of noise or odors or vibrations or dust or otherwise.
Without limiting the generality of the foregoing, no food shall be prepared or served for
consumption by the general public on or about the Demised Premises; no intoxicating liquors or
alcoholic beverages shall be sold or otherwise served for consumption by the general public on or
about the Demised Premises; no lottery tickets (even where the sale of such tickets is not illegal)
shall be sold and no gambling, betting or wagering shall otherwise be permitted on or about the
Demised Premises; no loitering shall be permitted on or about the Demised Premises; and no loading
or unloading of supplies or other material to or from the Demised Premises shall be permitted on
the Land except at times (excluding Business Days from 7:00 to 9:30 a.m. and from 4:00 to 6:00
p.m.) and in locations to be reasonably designated by Landlord, except for the freight elevator
described in Section&nbsp;7.4, which Tenant may use at any time. The Demised Premises shall be
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">maintained in a sanitary condition. Tenant shall suitably store all trash and rubbish in the
Demised Premises or other locations designated by Landlord from time to time. All laboratory waste,
Hazardous Materials and medical waste must be disposed of in compliance with Section&nbsp;5.3. Tenant
specifically agrees that its indemnification obligations pursuant to Section&nbsp;13.2 shall extend to
any claim arising from the consumption of intoxicating liquors or alcoholic beverages on or about
the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 Hazardous Materials.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Definitions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Environmental Law means any governmental statute, code ordinance,
regulation, rule or order and any amendment thereto governing or regulating
materials that are toxic, explosive, corrosive, flammable, radioactive,
carcinogenic, dangerous or otherwise hazardous. Environmental Laws include, without
limitation, the Comprehensive Environmental Response Compensation and Liability Act,
42 U.S.C. &#167;9601 <I>et seq., </I>the Resource Conservation and Recovery Act, 42 U.S.C. &#167;6901
<I>et seq., </I>the California Hazardous Substances Act at California Health and Safety
Code Section l08100 <I>et seq., </I>the provisions regarding hazardous waste control at
California Health and Safety Code Sections&nbsp;25100 through 25250.25 and the California
Medical Waste Management Act at California Health and Safety Code &#167;117600 <I>et seq.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Hazardous Materials shall mean any substance: (A)&nbsp;that now or in the future
is regulated or governed by, requires investigation or remediation under, or is
defined as a hazardous waste, medical waste, hazardous substance, pollutant or
contaminant under any Environmental Law or (B)&nbsp;that is toxic, explosive, corrosive,
flammable, radioactive, carcinogenic, dangerous or otherwise hazardous, including
gasoline, diesel fuel, petroleum hydrocarbons, polychlorinated biphenyls (PCBs),
asbestos, radon and urea formaldehyde foam insulation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Tenant&#146;s Covenants</U>. No Hazardous Materials shall be stored, placed,
handled, used or released by Tenant or its employees, contractors, sublessees, guests or
visitors at or about the Demised Premises or Property without Landlord&#146;s prior written
consent, which consent shall not be withheld provided the Hazardous Materials comply with
the criteria set forth in 5.3(c) for Permitted Materials. Landlord shall, within five (5)
business days after receipt of the proposed HMIS, either approve the same or provide Tenant
written notice of the reasons for its disapproval. Tenant shall submit to Landlord for
prior approval as above any HMIS (defined in Section&nbsp;5.3(c))
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">prior to submission to applicable governmental authority. Notwithstanding the foregoing, storage
and use of routine office and janitorial supplies in usual and customary quantities and the
Permitted Materials as defined in subsection (c)&nbsp;below are permitted without Landlord&#146;s prior
written consent, provided that Tenant&#146;s activities at or about the Demised Premises and Property
shall comply at all times with the laws all Environmental Laws. Tenant shall keep Landlord fully
and promptly informed of all storage, placement, handling, use or release by Tenant or its
employees, contractors , sublessees, guests or visitors of all Hazardous Materials. At the
expiration or termination of the Lease, Tenant shall remove from the Demised Premises all Hazardous
Materials brought or released in or on the Building as a result of the activities of Tenant or its
employees, agents, servants, invitees, visitors, customers, contractors, sublessees, and those
other persons for whom Tenant is legally responsible (collectively &#147;Tenant Parties&#148;). Landlord
shall have the right to perform an environmental assessment of the Demised Premises after such
removal, which assessment shall be conducted at Landlord&#146;s expense, unless it reveals that Tenant
has not complied with the requirements set forth in this Section&nbsp;5.3, in which case Tenant shall
reimburse Landlord for the reasonable cost thereof within ten days after Landlord&#146;s request
therefor. Nothing in this Section&nbsp;5.3 shall require Tenant to indemnify Landlord for any matters
arising out of or caused by the actions or omissions of Landlord, its employees, agents,
contractors, licensees, or invitees.. Tenant shall be responsible and liable for the compliance
with all of the provisions of this Section by all of Tenant Parties and all of Tenant&#146;s obligations
under this Section (including its indemnification obligations under subsection (e)&nbsp;below) shall
survive the expiration or termination of this Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Landlord hereby authorizes Tenant to use and store, in connection with its Permitted
Use, those materials and medical supplies listed on the Hazardous Material Inventory Statement
(&#147;HMIS&#148;) to be provided to the City of South San Francisco by Tenant with regard to the Demised
Premises (the &#147;Permitted Materials&#148;), provided the classes and quantities of Permitted Materials
comply with all applicable laws and do not alter the legal classification of the laboratories and
storage room, and storage tanks, under the Allowable Class&nbsp;Facilities (defined below). Tenant will
operate under all applicable Federal, State and Local laws governing the use, storage and
management of hazardous materials for building Occupancy Groups A3, B and H Divisions 2, 3 and 7,
as allowable, including Title 22 of the CFR as defined under the Uniform Building Code and Uniform
Fire Code developed by the International Fire Code Institute (the &#147;Allowable Class&nbsp;Facilities&#148;).
Landlord shall have the right to approve in writing Tenant&#146;s construction and operation of said
storage facilities, including, without limitation, fire suppression, seismic restraint, enclosure
and landscaping features. In addition, Tenant may construct an outside storage facility for
storage of up to a total of 2,000 gallons of waste materials, provided no single
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">tank shall exceed 1,000 gallons, such outside storage is in compliance with all applicable laws and
regulations and does not cover a footprint of greater than 250 square feet. Landlord shall have the
right to approve all fire, safety, and seismic restraints, as well as all other plans and
specifications for said outside storage. Additional rent for said outside storage area shall be
$5,000.00 per year. Any consent or approval by Landlord of Tenant&#146;s proposed use, handling and
storage of the Permitted Materials and/or the installation and operation or maintenance of said
tank shall not constitute an assumption of risk by Landlord respecting the same nor warranty or
certification by Landlord that Tenant&#146;s proposed use, handling and storage of the Permitted
Materials and/or the installation, operation or maintenance of the tanks is safe, reasonable or in
compliance with Environmental Laws. All references to Hazardous Materials in this Lease shall
include the Permitted Materials.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Compliance</U>. Tenant shall at Tenant&#146;s expense promptly take all actions
required by any governmental agency or entity in connection with or as a result of the storage,
placement, handling, use or release by Tenant Parties of Hazardous Materials at or about the
Demised Premises or Property, including inspection and testing, performing all cleanup, removal and
remediation work required with respect to those Hazardous Materials, complying with all closure
Laws and postclosure monitoring, and filing all required reports or plans. All medical waste
regulated by any Environmental Laws that is brought to the Demised Premises shall be stored in
leak-proof, closeable containers, which containers shall be stored in a specified &#147;dirty storage
area&#148; of the Demised Premises that shall be protected from leaks or any other type of contamination
of the Demised Premises. Tenant shall never use any of the Landlord&#146;s trash receptacles for
disposing of any medical waste. All of the foregoing work shall be performed in a good, safe and
workmanlike manner by consultants qualified and licensed to undertake such work and in a manner
that will not interfere with any other tenant&#146;s quiet enjoyment of the Property or Landlord&#146;s use,
operation, leasing and sale of the Property. Tenant shall deliver to Landlord prior to delivery to
any governmental agency, or promptly after receipt from any such agency, copies of all permits,
manifests, closure or remedial action plans, notices, and all other documents relating to the
storage, placement, handling, use or release by Tenant Parties of Hazardous Materials at or about
the Demised Premises or Property. Upon prior written notice from Landlord, Tenant shall make
available to Landlord for Landlord&#146;s inspection and copying all of Tenant&#146;s documents, materials,
data, inventories and other documentation (including, without limitation, Material Safety Data
Sheets relating to Hazardous Materials as may be present or suspected to be present in, on or about
the Demised Premises. If any lien attaches to the Demised Premises or the Property in connection
with or as a result of the storage, placement, handling, use or release by Tenant Parties of
Hazardous Materials; and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Tenant does not cause the same to be released, by payment, bonding or otherwise, within ten (10)
days after the attachment thereof, Landlord shall have the right but not the obligation to cause
the same to be released and any sums expended by Landlord in connection therewith shall be payable
by Tenant on demand. Notwithstanding anything in the foregoing to the contrary, Tenant shall not be
responsible for Hazardous Materials not introduced to the Premises, the Building or the Land by
Tenant Parties.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Tenant shall give Landlord immediate telephone notice and prompt written notice
(which means as soon as practicable and, in no event, more than one (1)&nbsp;day following the
applicable event) of any (i)&nbsp;spill, discharge, dumping, or other release of any Hazardous Materials
(including, without limitation, the Permitted Materials) on, in, under or from the Demised
Premises, the Building, or any portion of the Project, or the groundwater thereof, (ii)&nbsp;any oral or
written notice from any governmental agency received by Tenant of any such spill, discharge,
dumping, or other release of any Hazardous Materials, and (iii)&nbsp;any oral or written notice of any
violation, warning, deficiency, non-compliance, or other alleged or actual failure by Tenant to
comply strictly with any Environmental Law and/or any requirement, provision, or stipulation of any
governmental permit, license, registrations, or approval.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Landlord&#146;s Rights</U>. Subject to the provisions of Section&nbsp;15.2, Landlord
shall have the right, but not the obligation, to enter the Demised Premises at any reasonable time
upon 24 hours notice except in case of emergency (i)&nbsp;to confirm Tenant&#146;s compliance with the
provisions of this Section, and (ii)&nbsp;to perform Tenant&#146;s obligations under this Section if Tenant
has failed to do so after reasonable notice to Tenant. Landlord shall also have the right to
engage qualified Hazardous Materials consultants to inspect the Demised Premises and review the
storage, placement, handling, use or release by Tenant or its employees, contractors, sublessees,
guests or visitors of Hazardous Materials, including review of all permits, reports, plans, and
other documents regarding same. Tenant shall pay to Landlord on demand the reasonable costs of
Landlord&#146;s consultant&#146;s fees if Tenant is found to have violated the terms of this Section&nbsp;5.3 any
and all reasonable costs incurred by Landlord in performing Tenant&#146;s obligations under this
section. Landlord shall use reasonable efforts to minimize any interference with Tenant&#146;s business
caused by Landlord&#146;s entry into the Demised Premises, but Landlord shall not be responsible for
any interference caused thereby, unless such interference arises out of or is caused by the gross
negligence or willful misconduct of Landlord, its employees, agents, contractors, licensees, or
invitees.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Tenant&#146;s Indemnification</U>. Tenant agrees to indemnify, defend and hold
harmless Landlord and its members, managers, directors, officers,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">agents and employees and their partners, members, managers, directors, officers,
shareholders, employees and agents from all shall mean all costs and expenses of any kind,
damages, including foreseeable and unforeseeable consequential damages, fines and penalties
incurred in connection with any violation of and compliance with the Environmental Laws by
Tenant Parties and all losses of any kind attributable to the diminution of value, loss of
use or adverse effects on marketability or use of any portion of the Demised Premises or
Property by Tenant Parties and all other claims, actions, losses, damages, liabilities,
costs and expenses of every kind, including reasonable attorneys&#146;, experts&#146; and consultants&#146;
fees and costs, incurred at any time and arising from or connection with the storage,
placement, handling, use or release by Tenant or its employees, contractors, sublessees,
guests or visitors of Hazardous Materials at or about the Property or Tenant&#146;s failure to
comply in full with all Environmental Laws with respect to the Demised Premises and the
Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Landlord shall be responsible (at Landlord&#146;s cost and expense) for any
remediation (to the extent required by law) of any Hazardous Materials placed on the
Premises by Landlord or Landlord&#146;s agents or contractors and existing contamination
disclosed in the environmental assessments set forth on Exhibit&nbsp;F attached hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4 <U>Licenses and Permits</U>. If any governmental license or permit shall be required
for the property and lawful conduct of Tenant&#146;s business, and if the failure to secure such license
or permit would in any way affect Landlord, Tenant, at Tenant&#146;s expense, shall duly procure and
thereafter maintain such license or permit and submit the same to inspection by Landlord. Tenant,
at Tenant&#146;s expense, shall at all times comply with the terms and conditions of each such license
or permit.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">6.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>RENT</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1
<U>Yearly Fixed Rent</U>. Tenant shall pay to Landlord, without any set-off or deduction,
at Landlord&#146;s office, or to such other person or at such other place as Landlord may designate by
notice to Tenant, the Yearly Fixed Rent set forth in Article&nbsp;1. The Yearly Fixed Rent shall be paid
in equal monthly installments in advance on or before the first Business Day of each calendar month
during the Term of this Lease and shall be apportioned for any fraction of a month in which the
Term Commencement Date or the last day of the Term of this Lease may fall.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 <U>Rent During Option Term</U>. Yearly Fixed Rent for the five (5)&nbsp;year option term shall
be an amount equal to the greater of (i)&nbsp;95% of the fair-market rent for the first year of the
option term, or (ii)&nbsp;103.5% of the Yearly Fixed Rent payable (without abatement) for the last year
of the original term. If the parties are unable to agree upon a fair market rent prior to ten (10)
months before the commencement of the applicable option term, the matter shall be referred to
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">appraisal as set forth in the following sections. Yearly Fixed Rent during the option term shall
increase annually commencing with the second year of the option term by three and one-half percent
(3.5%) compounded annually. The term fair market rent, for purposes of this Section&nbsp;6.2, shall be
deemed to be the fair market rent for the Demised Premises finished to a level of completion for
ready to occupy first class office space.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 <U>Appraisal</U>. Whenever the issue of fair market rent shall be referred to
appraisal, such appraisal shall be by three disinterested appraisers, one to be appointed by the
Landlord, one to be appointed by the Tenant and the third to be appointed by the two appraisers so
named. Within thirty (30)&nbsp;days after the selection of the third appraiser, the three appraisals
shall be added together and their total divided by three; the resulting quotient shall be the fair
market rent for the Premises. If, however, the low appraisal and/or the high appraisal are more
than ten (10%) percent lower and/or higher than the middle appraisal, the low appraisal and/or high
appraisal shall be disregarded, as applicable. If only one appraisal is disregarded, the remaining
two appraisals shall be added together and their total divided by two; the resulting quotient shall
be the fair market rent for the Premises. If both the low appraisal and the high appraisal are
disregarded as stated in this paragraph, the middle appraisal shall be the fair market rent of the
Premises. Each party shall pay the costs of the appraiser selected by such party, and the parties
shall share equally the cost of the third appraiser. Each individual appraiser shall have at least
ten years of experience in appraising fair market rents of comparable properties and shall hold one
or more of the following designations: MAI of the American Institute of Real Estate Appraisers,
SREA from the Society of Real Estate Appraisers or ASA from the American Society of Appraisers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 <U>Interim Rent</U>. If the fair market rental value per year is not determined
prior to the commencement of the five year option term, the Tenant shall pay Fixed Rent as though
the Fixed Rent was that Fixed Rent in effect (without abatement) during the last year of said
preceding lease year period until such determination has been made. Following such determination,
the Tenant shall promptly pay the Landlord the difference, if any, between the aggregate rent
which would have been paid during said period and the aggregate rent actually paid. Thereafter,
all rent shall be computed and paid in accordance with Section&nbsp;6.2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5 <U>Taxes</U>. Tenant shall timely file business property statements with respect to
Tenant&#146;s personal property and trade fixtures and pay when due all taxes imposed on such personal
property and trade fixtures. Tenant shall also pay all real estate taxes attributable to the
Demised Premises being improved to a standard in excess of first class office space.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6 <U>Obligations Survive Termination</U>. All obligations and liabilities of Tenant
relating to any period prior to the termination of the Term of this Lease,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">including without limitation the obligation to pay any Additional Rent due pursuant to the
provisions of this Article, shall survive such termination.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.7 <U>Payment to Mortgagee</U>. Landlord reserves the right to provide in any Mortgage given
by it or by Prime Landlord of the Property that some or all rents, issues, and profits and all
other amounts of every kind payable to the Landlord under this Lease shall be paid directly to the
Mortgagee for Landlord&#146;s account and Tenant covenants and agrees that it will, after receipt by it
of notice from Landlord or Mortgagee designating such Mortgagee to whom payments are to be made by
Tenant, pay such amounts thereafter becoming due directly to such Mortgagee until excused therefrom
by notice from such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.8 <U>Additional Rent</U>. Tenant shall also pay as additional rent without notice, except
as required under this Lease, and without any abatement, deduction or setoff except as provided
herein, all sums, impositions, costs, expenses and other payments which Tenant in any of the
provisions of this Lease assumes or agrees to pay, and, in case of any nonpayment thereof, Landlord
shall have in addition to any other rights and remedies, all of the rights and remedies provided by
law or provided for in the Lease for the nonpayment of Yearly Fixed Rent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.9 <U>Place of Payment of Rent</U>. All payments of Rent shall be made by Tenant to Landlord
without notice or demand at such place as Landlord may from time to time designate in writing. The
initial place for payment of rent shall be 384 Oyster Point Blvd, So. San Francisco, CA 94080. Any
extension of time for the payment of any installment of rent, or the acceptance of rent after the
time at which it is due and payable shall not be a waiver of the rights of Landlord to insist on
having all other payments made in the manner and at the times herein specified.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.10 <U>Cleaning and Utilities</U>. Tenant shall pay for all utilities used or consumed in
the Demised Premises, including without limitation water, gas, electricity, sewer, telephone, and
all electricity used in heating, ventilating and air conditioning the Demised Premises. In the
event such utilities are not separately billed by the applicable utility supplier, Tenant shall pay
its share of the amount of such bill for the entire Building as measured by submeters or check
meters measuring consumption of such utilities in the Demised Premises. In addition, Tenant shall
arrange for cleaning of the Tenant space in accordance with the cleaning schedule attached hereto
as Exhibit&nbsp;B with a cleaning contractor subject to Landlord&#146;s approval, which approval shall not be
unreasonably withheld. Tenant shall pay all such costs of cleaning.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">7.&nbsp;UTILITIES AND LANDLORD&#146;S SERVICES</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1 <U>Electricity</U>. Tenant shall purchase directly from the public utility serving the
Building all electrical energy that Tenant requires for operation of the lighting fixtures,
appliances and equipment servicing the Demised Premises. The
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">costs of initially installing any required meter, submeter or check meter and related installation
equipment shall be paid by Landlord. Landlord shall not be liable in any way to Tenant for any
failure or defect in the supply or character of electrical energy furnished to the Demised Premises
by reason of any requirement, act or omission of the public utility serving the Building.
Notwithstanding the foregoing, the design electrical capacity for the Building is 4000 amperes of
electricity, and Tenant shall be entitled to the use of half of the electricity available for
Tenant spaces, i.e., a minimum and a maximum of 2000 amperes. Tenant&#146;s use of electrical energy in
the Demised Premises shall not at any time exceed the capacity of any of the electrical conductors
and equipment in or otherwise serving the Demised Premises. In order to insure that such capacity
is not exceeded and to avert possible adverse effect upon the Building electrical services Tenant
shall give notice to Landlord and obtain Landlord&#146;s prior written consent whenever Tenant shall
connect to the Building electrical distribution system any fixtures, appliances or equipment other
than lamps, typewriters, personal computers and similar small machines. Landlord&#146;s consent to the
plans for Tenant&#146;s initial improvements shall, to the extent that Tenant&#146;s electrical system and
loads are shown on said plans, suffice as consent for the purposes of this Section&nbsp;7.1. Any feeders
or risers to supply Tenant&#146;s electrical requirements, shall be installed by Landlord upon Tenant&#146;s
request, at the sole cost and expense of Tenant, provided that such feeders and risers are
permissible under applicable laws and insurance regulations and the installation of such feeders or
risers will not cause permanent damage or injury to the Building or cause or create a dangerous
condition or unreasonably interfere with other tenants of the Building. Tenant agrees that it will
not make any alteration or addition to the electrical equipment in the Demised Premises without the
prior written consent of Landlord in each instance first obtained, which consent will not be
unreasonably withheld. Landlord, at Tenant&#146;s expense, shall purchase, install and replace all light
fixtures, bulbs, tubes, lamps, lenses, globes, ballasts and switches used in the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2 <U>Water Charges</U>. Landlord shall furnish cold water for ordinary cleaning, toilet,
drinking purposes in accordance with Exhibit&nbsp;A-l and hot and cold water for lavatory purposes.
Tenant shall pay for its share of water and related sewer charges in accordance with Section&nbsp;6.10.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3 <U>Heat and Air Conditioning</U>. Landlord shall furnish to and distribute in the common
areas of the Building heat and air conditioning as normal seasonal changes may require on Business
Days from 8:00 a.m. to 6:00 p.m. and on Saturdays from 9:00 a.m. to 1:00 p.m., provided Landlord
may run common area HVAC on an economy mode on Saturdays. Tenant agrees to lower and close the
blinds or drapes when necessary because of the sun&#146;s position whenever the air conditioning system
is in operation, and to cooperate fully with Landlord with regard to, and to abide by all the
regulations and requirements which Landlord may prescribe for the proper functioning and
protection of, the heating and air conditioning system. Without limiting the generality of the
foregoing, all windows
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in the Demised Premises must remain closed at all times notwithstanding the fact that such windows
may be operable. The air conditioning system servicing the Building is designed to provide cooling
based upon an occupancy of not more than one person per one hundred (100)&nbsp;square feet of floor
area, and upon a combined lighting and standard electrical load not to exceed 3.0 watts per square
foot or 2,000 amperes for the entire Demised Premises. In the event Tenant exceeds such condition
or introduces into the Demised Premises equipment which overloads such system, or in any other way
causes such system not to adequately perform its proper functions, supplementary systems may at
Landlord&#146;s option be provided by Landlord at Tenant&#146;s expense. Tenant shall be responsible for
furnishing heat and air conditioning to the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4 <U>Elevator Service</U>. Landlord shall provide non exclusive passenger elevator service
consisting of two (2)&nbsp;elevators to the Demised Premises on Business Days from 8:00 a.m. to 6:00
p.m. and on a reduced basis at all other times. Freight elevator service shall be available in
common with other tenants on Business Days from 9:30 a.m. to 4:00 p.m. and at other times at
reasonable charge. Tenant shall be responsible for constructing a freight elevator exclusively to
serve the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.5 <U>Cleaning</U>. Landlord shall furnish cleaning services to the common areas of the Building
substantially in accordance with the specifications attached hereto as Exhibit&nbsp;B and made a part
hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.6 <U>Repairs and Other Services</U>. Except as otherwise provided in Articles 8 and 16, and
subject to Tenant&#146;s obligations in Article&nbsp;12 and elsewhere in this Lease, Landlord shall at
Landlord&#146;s expense (a)&nbsp;keep and maintain the roof, exterior walls, structural floor slabs and
columns of the Building in as good condition and repair as they are in on the Term Commencement
Date, reasonable use and wear excepted, (b)&nbsp;keep and maintain in workable condition the Building&#146;s
sanitary, electrical, heating, air conditioning and other systems, (c)&nbsp;keep all walkways on the
Property clean and remove all snow and ice therefrom, (d)&nbsp;provide grounds maintenance to all
landscaped areas, (e)&nbsp;arrange for the extermination of rodents and vermin in the Building (other
than rodents arising out of Tenant&#146;s small animal facility), and (f)&nbsp;keep and maintain the parking
lot adjacent to the Building in good condition and repair.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.7 Landlord&#146;s Further Responsibilities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Landlord shall be responsible at its sole cost and expense for the removal of
all trash and garbage (excluding Hazardous Materials, laboratory, biological and animal
waste) from the designated containers outside of the Building.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Landlord shall allow Tenant to have full access to and use of the largest
conference room on the third floor of the Building up to eight (8)&nbsp;days per year, as
reasonably agreed to in advance by Landlord and Tenant and upon payment of a reasonable fee
for each such use.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Landlord shall comply with all obligations imposed on it in the CCR&#146;s (defined in
Section&nbsp;27.12) and shall pay its share of any future costs of providing BART shuttle
service.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.8 <U>Interruption or Curtailment of Services</U>. Landlord reserves the right to
interrupt, curtail, stop or suspend the furnishing of services and the operation of any Building
system, when necessary by reason of accident or emergency, or of repairs, alterations, replacements
or improvements in the reasonable judgment of Landlord desirable or necessary to be made, or of
difficulty or inability in securing supplies or labor, or of strikes, or of any other cause beyond
the reasonable control of Landlord, whether such other cause be similar or dissimilar to those
hereinabove specifically mentioned, until said cause has been removed. Landlord shall use
reasonable efforts to minimize interruption to Tenant by any such interruption or curtailment of
services. Landlord shall have no responsibility or liability for any such interruption,
curtailment, stoppage, or suspension of services or systems, except that Landlord shall exercise
reasonable diligence to eliminate the cause of same. Notwithstanding the foregoing, if utilities or
Building services are interrupted due to the fault of Landlord (Tenant acknowledging that Landlord
shall have no responsibility for failure of municipal or public utility suppliers to supply
utilities to the Building), and such disruption continues for more than seven (7)&nbsp;days, rent shall
abate if the Demised Premises are unusable and Tenant in fact vacates the Demised Premises.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">8.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>CHANGES OR ALTERATIONS BY LANDLORD</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord reserves the right, exercisable by itself or its nominee, including without
limitation Prime Landlord, at any time and from time to time without the same constituting an
actual or constructive eviction and without incurring any liability to Tenant therefor or
otherwise affecting Tenant&#146;s obligations under this Lease, to make such changes, alterations,
additions, improvements, repairs or replacements in or to the Building and the fixtures and
equipment thereof, as well as in or to the street entrances, halls, passages, elevators, and
stairways thereof, as it may deem necessary or desirable, and to change the arrangement and/or
location of entrances or passageways, doors and doorways, and corridors, elevators, stairs,
toilets, or other public parts of the Building, provided, however, that there be no unreasonable
obstruction of the right of access to, or unreasonable interference with the use and enjoyment of,
the Demised Premises by Tenant, except that Landlord shall not be obligated to employ labor at
so-called &#147;over-time&#148; or other premium pay rates. Nothing contained in this Article shall be
deemed to relieve Tenant of any duty, obligation or liability of Tenant with respect to making or
causing to be made
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any repair, replacement or improvement or complying with any law, order or requirement of any
governmental or other authority. Landlord reserves the right to prior to the Commencement Date
create two (2)&nbsp;addresses for the Building. Neither this Lease nor any use by Tenant shall give
Tenant any right or easement or the use of any door or any passage or any concourse connecting with
any other building or to any public convenience, and the use of such doors, passages and concourses
and of such conveniences may be regulated or discontinued at any time and from time to time by
Landlord without notice to Tenant and without affecting the obligations of Tenant hereunder or
incurring any liability to Tenant therefor.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">9.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>FIXTURES, EQUIPMENT AND IMPROVEMENTS &#151; REMOVAL BY TENANT</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All fixtures, equipment, leasehold improvements and appurtenances attached to or built into the
Demised Premises prior to or during the Term, whether by Landlord at its expense or at the expense
of Tenant (either or both) or by Tenant shall be and remain part of the Demised Premises and shall
not be removed by Tenant at the end of the Term unless otherwise expressly provided by notice from
Landlord to Tenant. Upon the request of Landlord, Tenant will remove such fixtures, equipment,
leasehold improvements and appurtenances as are directed by Landlord and shall restore any damage
caused by such removal. Notwithstanding the foregoing to the contrary, Tenant may, in
connection with the initial Tenant improvements or any other fixtures, alterations or additions to
the Demised Premises, upon presentation of detailed plans and specifications therefor, request in
writing that Landlord advise Tenant which of said improvements, alterations or additions Landlord
will require Tenant to remove at the end of the Term. Landlord shall advise Tenant in writing
within thirty (30)&nbsp;days after receipt of such written request and the accompanying plans and
specifications. If Landlord shall, in said written notice, require Tenant to remove an item at the
end of the Term, Landlord shall have the right to rescind that decision and require Tenant to leave
said item in place at the end of the Term by subsequent written
notice to Tenant. Tenant shall
remove the fixtures and equipment on Exhibit&nbsp;H and shall remediate all environmental contamination
and Hazardous Materials associated with said items. All such removal shall be done in a good and
workmanlike manner, and Tenant shall repair and restore any damage to the Building caused by such
removal. In addition, any duct work, controls and rooftop exhaust equipment associated with the
exhaust hoods must also be removed. Tenant shall structurally in-fill patch, flash and cap the roof
to a weather-tight condition consistent with the four-ply built-up construction so as not to void
the roof warranty. The in-wall and above ceiling copper and plastic piping associated with the
vacuum compressed air or DI system and any specialty gas piping must be removed and remediated if
any of the same is shown to be contaminated as provided in the environmental inspection of the
Demised Premises made pursuant to Section&nbsp;5.3(b). Any contaminated rooftop HVAC units and
associated duct work shall also require removal at the Landlord&#146;s discretion. Also, office
workstations must be removed and remediated.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">10.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>ALTERATIONS AND IMPROVEMENTS BY TENANT</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall make no alterations, decorations, installations, removals, additions or
improvements in or to the Demised Premises without Landlord&#146;s prior written consent and then only
by contractors or mechanics approved by Landlord. No such installations or other work shall be
undertaken or begun by Tenant until Landlord has approved written plans and specifications
therefor; and no amendments or additions to such plans and specifications shall be made without
prior written consent of Landlord. Such approval shall not be unreasonably withheld provided such
installations or work are non-structural, do not affect the exterior of the Building, and do not
interfere with or impair utilities and systems in the Building. Notwithstanding the foregoing,
Landlord&#146;s consent shall not be required for any alteration, addition or improvement that either
(a)&nbsp;costs leas than Twenty-Five Thousand Dollars ($25,000.00) or (b)&nbsp;satisfies all of the following
criteria: (i)&nbsp;is of a cosmetic nature such as painting, wallpapering, hanging pictures and
installing carpeting, (ii)&nbsp;is not visible from the exterior of the Premises or Building, and (iii)
will not affect the systems or structure of the Building, provided, however, in any such instance
Tenant provides plans and specifications for such work not less than ten (10)&nbsp;days before
commencing such work. Any such alterations, decorations, installations, removals, additions and
improvements shall be done at the sole expense of Tenant and at such times and in such manner as
Landlord may from time to time reasonably designate. Subject to the terms of Section&nbsp;9 herein, if
Tenant shall make any alterations, decorations, installations, removals, additions or improvements,
then Landlord may elect to require Tenant at the expiration of this Lease to restore the Demised
Premises to substantially the same condition as existed at the Term Commencement Date.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">11.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>TENANT&#146;S CONTRACTORS &#151; MECHANICS&#146; AND OTHER
LIENS &#151; STANDARD OF TENANT&#146;S
PERFORMANCE &#151; COMPLIANCE WITH LAWS</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever Tenant shall make any alterations, decorations, installations, removals, additions
or improvements or do any other work in or to the Demised Premises, Tenant will strictly observe
the following covenants and agreements:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In no event shall any material or equipment be incorporated in or added to
the Demised Premises in connection with any such alteration, decoration, installation,
addition or improvement which is subject to any lien, charge, mortgage or other
encumbrance of any kind whatsoever or is subject to any security interest or any form of
title retention agreement. Any mechanic&#146;s lien filed against the Demised Premises or the
Building for work claimed to have been done for, or materials claimed to have been
furnished to Tenant shall be discharged by Tenant within twenty (20)&nbsp;days thereafter, at
the expense of Tenant, by filing the bond required by law or otherwise. If
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Tenant fails so to discharge any lien, Landlord may do so at Tenant&#146;s expense and Tenant
shall reimburse Landlord for any expense or cost incurred by Landlord in so doing within
fifteen (15)&nbsp;days after rendition of a bill therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) All installations or work done by Tenant under this or any other Article of this
Lease shall be at its own expense (unless expressly otherwise provided) and shall at all
times comply with (i)&nbsp;laws, rules, orders and regulations of governmental authorities having
jurisdiction thereof and (ii)&nbsp;plans and specifications prepared by and at the expense of
Tenant theretofore submitted to Landlord for its prior written approval.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Tenant shall procure all necessary permits before undertaking any work in the
Demised Premises; do all such work in a good and workmanlike manner, employing materials of
good quality and complying with all governmental requirements, and defend, save harmless,
exonerate and indemnify Landlord from all injury, loss or damage to any person or property
occasioned by or growing out of such work.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Tenant shall notify Landlord no later than ten (10)&nbsp;days prior to starting work on
any alterations so that Landlord shall have the opportunity to post a &#147;Notice of
nonresponsibility&#148; at the Demised Premises and record said notice in the county in which,
the Property is located pursuant to California Civil Code Section&nbsp;3094.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) all contractors and subcontractors shall be approved by Landlord, which approval
shall not be unreasonably withheld, and all work by Tenant shall be performed by such
contractors and subcontractors and in such manner as to maintain harmonious labor relations.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">12.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>REPAIRS BY TENANT</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant, at its expense, shall keep or cause to be kept, all and singular, the Demised Premises
in good repair, order and condition, reasonable use and wear thereof and damage by fire or by
unavoidable casualty excepted. Without limiting the generality of the foregoing, Tenant shall keep
all interior windows and other glass whole, and shall replace the same whenever broken with glass
of the same quality and shall repair or replace all exterior windows if damaged by neglect or
wrongdoing of Tenant. Tenant hereby waives the benefits of California Civil Code Section&nbsp;1932(1).
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">13.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>INSURANCE, INDEMNIFICATION, EXONERATION AND EXCULPATION</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.1 Tenant&#146;s Insurance
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Liability Insurance</U>. Tenant shall maintain in full force
throughout the Term commercial general liability and property damage
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">insurance providing coverage on an occurrence form basis with limits of not less than Five Million
Dollars ($5,000,000.00) each occurrence for bodily injury and property damage combined, Five
Million Dollars ($5,000,000.00) annual general aggregate, and Five Million Dollars ($5,000,000.00)
products and completed operations (if applicable) annual aggregate. Tenant&#146;s liability insurance
policy or policies shall: (i)&nbsp;include premises and operations liability coverage, automobile,
products and completed operations liability coverage (if applicable), broad form property damage
coverage including completed operations (if applicable), blanket contractual liability coverage
with, to the maximum extent possible, coverage for the indemnification obligations of Tenant under
this Lease, and personal and advertising injury coverage; (ii)&nbsp;provide that the insurance company
has the duty to defend all insureds under the policy; (iii)&nbsp;provide that defense costs are paid in
addition to and do not deplete any of the policy limits; (iv)&nbsp;cover liabilities arising out of or
incurred in connection with Tenant&#146;s use or occupancy of the Premises or the Property; and (v)
extend coverage to cover liability for the actions of Tenant&#146;s employees, contractors, sublessees,
guests and visitors. Tenant&#146;s required insurance may be maintained by a combination of underlying
and &#147;umbrella&#148; coverage.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Leasehold Improvements Personal Property Insurance.</U> Tenant shall at all
times maintain in effect with respect to Tenant&#146;s leasehold improvements and fixtures, equipment
and personal property located at or within the Demised Premises, builder&#146;s risk and commercial
property insurance providing coverage, at a minimum, for &#147;broad form&#148; perils, to the extent of
100% of the full replacement cost of covered property. Tenant may carry such insurance under a
blanket policy, provided that such policy provides equivalent coverage to a separate policy.
During the Term, the proceeds from any such policies of insurance shall be used for the repair or
replacement of such leasehold improvements, fixtures, equipment and personal property so insured.
Landlord shall be provided coverage under such insurance to the extent of its insurable interest
and, if requested by Landlord, both Landlord and Tenant shall sign all documents reasonably
necessary or proper in connection with the settlement of any claim or loss under such insurance.
Landlord shall have no obligation to carry insurance on any such Tenant&#146;s leasehold improvements
or on Tenant&#146;s fixtures, equipment or personal property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Workmen&#146;s Compensation Insurance.</U> Tenant shall maintain worker&#146;s compensation
insurance as required by law and employer&#146;s liability insurance in an amount not less than Five
Hundred Thousand Dollars ($500,000).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Business Interruption/Extra Expense Insurance.</U> Tenant shall maintain loss of
income, business interruption and extra expense insurance
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">in such amounts as will reimburse Tenant for direct or indirect loss of earnings and incurred costs
attributable to the perils commonly covered by Tenant&#146;s property insurance described above but in
no event less than One Million Five Hundred Thousand Dollars ($1,500,000.00). Such insurance shall
be carried with the same insurer that issues the insurance for the personal property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Other Coverage.</U> Tenant, at its cost, shall maintain such other insurance as
Landlord may reasonably require from time to time, but in no event may Landlord require any other
insurance which is (i)&nbsp;not then being required of comparable tenants leasing comparable amounts of
space in comparable buildings in the vicinity of the Building or (ii)&nbsp;not then available at
commercially reasonable rates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Insurance Criteria.</U> Each policy of insurance required under this Section shall:
(i)&nbsp;be in a form, and written by an insurer, reasonably acceptable to Landlord, (ii)&nbsp;be maintained
at Tenant&#146;s sole cost and expense, and (iii)&nbsp;require at least thirty (30)&nbsp;days&#146; written notice to
Landlord prior to any cancellation, nonrenewal or modification of insurance coverage. Insurance
companies issuing such policies shall have rating classifications of &#147;A&#148; or better and financial
size category ratings of &#147;XIII&#148; or better according to the latest edition of the A.M. Best Key
Rating Guide. All insurance companies issuing such policies shall be licensed to do business in the
State of California. Any deductible amount under such insurance shall not exceed maximum deductible
amounts currently required under similar leases for buildings in the vicinity of the Building, with
Tenant having the burden of proof. Tenant shall provide to Landlord, upon request, evidence that
the insurance required to be carried by Tenant pursuant to this Section, including any endorsement
affecting the additional insured status, is in full force and effect and that premiums therefore
have been paid.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Increase in Amount of Insurance.</U> Tenant shall increase the amounts of insurance as
required by any Mortgagee, and, not more frequently than once every three (3)&nbsp;years, as recommended
by Landlord&#146;s insurance broker, if, in the reasonable opinion of either of them, the amount of
insurance then required under this Lease is not adequate. Any limits set forth in this Lease on the
amount or type of coverage required by Tenant&#146;s insurance shall not limit the liability of Tenant
under this Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <U>Insurance Provisions</U>. Each policy of liability insurance required by this
Section shall: (i)&nbsp;contain a cross liability endorsement or separation of insureds clause; (ii)
provide that it is primary to and not contributing with, any policy of insurance carried by
Landlord or Prime Landlord covering the same loss; (iii)&nbsp;provide that any failure to comply with
the reporting provisions shall not affect coverage provided to Landlord, Prime Landlord,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">their officers, directors, shareholders, members, property managers and mortgagees; and (iv)
name Prime Landlord, Mortgagees, Landlord, their officers, directors, employees,
shareholders, members, property managers and such other parties in interest as Landlord may
from time to time reasonably designate to Tenant in writing, as additional insureds. Such
additional insureds shall be provided the same extent of coverage as provided to Tenant under
such policies. All endorsements affecting such additional insured status shall be acceptable
to Landlord and shall be at least as broad as additional insured endorsement form number CG
20 11 11 85 promulgated by the Insurance Services Office.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <U>Evidence of Coverage.</U> Prior to occupancy of the Premises by Tenant,
and not less than thirty (30)&nbsp;days prior to the expiration of any policy thereafter, Tenant
shall furnish to Landlord a certificate of insurance reflecting that the insurance required
by this Section is in force accompanied by an endorsement showing the required additional
insureds satisfactory to Landlord in substance and form. Notwithstanding the requirements of
this paragraph, Tenant shall, at Landlord&#146;s request, provide to Landlord within a
commercially reasonable time a certified copy of each insurance policy required to be in
force at any time pursuant to the requirements of this Lease or its Exhibits. Tenant&#146;s
failure to furnish Landlord with such certificates of insurance within a reasonable time (not
to exceed ten (10)&nbsp;days) after Landlord&#146;s request shall be deemed a material default under
this Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.2 <U>General</U>. Tenant will save Landlord harmless, and will exonerate and indemnify
Landlord and Prime Landlord, from and against any and all claims, liabilities, penalties, damages
or expenses (including without limitation reasonable attorneys&#146; fees) asserted against or incurred
by Landlord or Prime Landlord:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) on account of or based upon any injury to person, or loss of or damage to property
sustained or occurring on the Demised Premises on account of or based upon the act,
omission, fault, negligence or misconduct of any person whomsoever (other than Landlord,
Prime Landlord or their agents, contractors or employees);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) on account of or based upon any injury to person or loss of or damage to property,
sustained or occurring elsewhere (other than on the Demised Premises) in or about the
Building (and, in particular, without limiting the generality of the foregoing on or about
the elevators, stairways, public corridors, sidewalks, roof, or other appurtenances and
facilities used in connection with the Building or Demised Premises) arising out of the use
or occupancy of the Building or Demised Premises by Tenant, or any person claiming by,
through or under Tenant;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) on account of or based upon (including moneys due on account of) any work or thing
whatsoever done (other than by Landlord, Prime Landlord or their contractors, or agents or
employees of any such party) in the Demised Premises during the Term of this Lease and
during the period of time, if any, prior to the Term Commencement Date that Tenant may have
been given access to the Demised Premises; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) on account of or resulting from the failure of Tenant to perform and discharge any
of its covenants and obligations under this Lease;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and, in case any action or proceeding be brought against Landlord or Prime Landlord by reason of
any of the foregoing, Tenant upon notice from Landlord shall at Tenant&#146;s expense resist or defend
such action or proceeding and employ counsel therefor reasonably satisfactory to Landlord, it being
agreed that such counsel as may act for insurance underwriters of Tenant engaged in such defense
shall be deemed satisfactory.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.3 <U>Property of Tenant</U>. In addition to and not in limitation of the foregoing, and
subject only to provisions of applicable law, Tenant covenants and agrees that all merchandise,
furniture, fixtures and property of every kind, nature and description which may be in or upon the
Demised Premises or elsewhere on the Property during the Term of this Lease, shall be at the sole
risk and hazard of Tenant, and that if the whole or any part thereof shall be damaged, destroyed,
stolen or removed from any cause or reason whatsoever other than the negligence or misconduct of
Landlord or Prime Landlord or their contractors, or agents or employees of any such party, no part
of said damage or loss shall be charged to, or borne by Landlord or Prime Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.4 <U>Bursting of Pipes, etc.</U> Landlord shall not be liable for any injury or damage to
persons or property resulting from fire, explosion, seismic events, earthquakes, falling plaster or
tiles, steam, gas, electricity, electrical disturbance, water, rain or snow or leaks from any part
of the Building or from the pipes, appliances or plumbing works or from the roof, street or
sub-surface or from any other place or caused by any other cause of whatever nature, unless caused
by or due to the negligence of Landlord, its agents, servants or employees; nor shall Landlord or
its agents be liable for any such damage caused by other tenants or persons in the Building or
caused by operations in construction of any private, public or quasi-public work; nor shall
Landlord be liable for any latent defect in the Demised Premises or elsewhere in the Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.5
<U>Landlord&#146;s Insurance</U>. Landlord shall, at its sole expense, carry so-called &#147;all
risk&#148; full replacement cost casualty insurance on the Building (exclusive of Tenant&#146;s leasehold
improvements, fixtures and equipment).
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">14.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>ASSIGNMENT, MORTGAGING, SUBLETTING, ETC.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.1 <U>Generally</U>. Tenant shall not voluntarily, involuntarily or by operation of law
assign, transfer, mortgage or otherwise encumber this Lease or any interest of Tenant therein, in
the whole or in part of the Premises or permit the Premises or any part thereof to be used or
occupied by others, without the prior written consent of Landlord and Landlord&#146;s mortgagee. Except
in connection with a public stock offering, a transfer of any of Tenant&#146;s stock or a transfer or
change of control of Tenant (if Tenant is a corporation), or a change in the composition of persons
or entities owning any interest in Tenant (if Tenant is not a corporation), or any transfer of
Tenant&#146;s interest in the Lease by operation of law or by merger or consolidation of Tenant with or
into any other entity, firm or corporation, shall be deemed an assignment for purposes of this
Article&nbsp;14. Notwithstanding anything to the contrary in this Lease, except with respect to
Corporate Transfers (hereinafter defined) to a Competitor (as defined in Section&nbsp;14.2), Tenant
shall not be required to obtain Landlord&#146;s consent, and the terms of Sections&nbsp;14.2 and 14.3 of this
Lease shall not apply, to any transfer of Tenant&#146;s stock or a transfer or change of control of
Tenant or other transfer to an entity which controls, is controlled by or is under common control
with Tenant or any successor to Tenant or which succeeds to substantially all of Tenant&#146;s assets
and business by merger, consolidation, reorganization or purchase or in connection with an initial
public offering (collectively referred to as &#147;Corporate Transfers&#148;). Tenant shall give Landlord
written notice at least thirty (30)&nbsp;days prior to the effective date of such Corporate Transfer. As
used herein, the terms &#147;controlled&#148; or &#147;controls&#148; or &#147;control&#148; shall mean ownership of at least
fifty-one percent (51%) of voting control of the relevant entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.2 <U>Landlord&#146;s Options</U>. In connection with any request by Tenant for Landlord&#146;s
consent to assignment or subletting, Tenant shall submit to Landlord in writing (&#147;Tenant&#146;s
Sublease Notice&#148;) (i)&nbsp;the name of the proposed assignee or subtenant, (ii)&nbsp;such information as to
its financial responsibility and standing as Landlord may reasonably require, and (iii)&nbsp;all of
the terms and provisions upon which the proposed assignment or subletting is to be made. Within
ten (10)&nbsp;business days after receipt from Tenant of Tenant&#146;s Sublease Notice and receipt of the
information required hereunder, Landlord shall have the following options: (a)&nbsp;reasonably
withholding its consent if the proposed sublease is at least 10,000 rentable square feet, or if
the proposed sublease is less than 10,000 rentable square feet, withholding consent in its sole
and absolute discretion; (b)&nbsp;withholding consent if the proposed assignee or sublessee is a
&#147;Competitor&#148; (as that term is hereinafter defined); (c)&nbsp;if the request is made after the third
(3rd) anniversary of the commencement of the Term and is to sublet a portion of the Premises, to
elect to match said offer and sublease the Demised Premises or relevant portion thereof on the
same terms and conditions as set forth in Tenant&#146;s Sublease Notice; (d)&nbsp;if the request is made
after the third (3rd) anniversary of the commencement of the Term and is to assign this Lease or
sublet all of the Premises, elect to match said offer
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and accept an assignment of this Lease on the same terms and conditions set forth in Tenant&#146;s
Sublease Notice, or (e)&nbsp;consenting to the proposed assignment or such leasing. The term
&#147;Competitor,&#148; as used herein shall mean any person or entity engaged in the manufacture or sale of
instruments for DNA sequencing or amplification, including, without limitation, the following
businesses and any affiliates, subsidiaries, parents or successors thereto: PE Corp., Applera
Corporation, PE Biosystems, Inc., Applied Biosystems, Inc., Celera Genomics, Inc., Celera Genomics
Group, F. Hoffmann-LaRoche Ltd., Hoffmann-LaRoche, Inc., Roche Diagnostics Corporation, Roche
Molecular Systems, Inc., Amersham Pharmacia Biotech, Ltd., Molecular Dynamics, Inc., Perkin Elmer
Corporation, Strategene, Hybade Ltd., Ericomp, Techne Corporation, MWG Biotech AG, Whatman
Biometra, Labreco, Inc., Bio-Rad Laboratories, Inc., and Cepheid. In the event Landlord shall
exercise either option (c)&nbsp;or (d)&nbsp;above, Tenant shall sublease the Demised Premises or relevant
portion thereof or assign this Lease to Tenant upon the terms and conditions set forth in said
Tenant&#146;s Sublease Notice. In the event Landlord elects to match this offer in Tenant&#146;s Sublease
Notice as set forth in clause (d)&nbsp;above, Tenant shall remain responsible for removal of leasehold
improvements and equipment as required in Sections&nbsp;9 and 10 at the end of the Term or earlier
termination of this Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.3 <U>Conditions</U>. Any subletting or assignment pursuant to this Article shall be
subject to and conditioned upon the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) at the time of any proposed subletting or assignment, Tenant shall not be in
default under any of the terms, covenants, or conditions of this Lease beyond applicable
grace periods;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the sublessee or assignee shall conduct its business in accordance
with the Permitted Use;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) prior to occupancy, Tenant and its assignee or sublessee shall execute,
acknowledge and deliver to Landlord a fully executed counterpart of a written assignment of
lease or a written sublease, as the case may be, by the terms of which:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) in case of an assignment of this Lease in its entirety, Tenant shall assign
to such assignee Tenant&#146;s entire interest in this Lease, together with all prepaid
rents hereunder, and the assignee shall accept said assignment and assume and agree
to perform directly for the benefit of Landlord, all of the terms, covenants and
conditions of this Lease on Tenant&#146;s part to be performed; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) in case of a subletting, the sublessee thereunder shall agree to be bound
by and to perform all of the terms, covenants and conditions of this Lease on the
Tenant&#146;s part to be performed, except
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">the payments of rents, charges and other sums reserved hereunder, which Tenant
shall continue to be obligated to pay and shall pay to Landlord;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Tenant shall pay to Landlord monthly one-half of the excess of the rents and other
charges received by Tenant pursuant to the assignment or sublease over the rents and other
charges reserved to Landlord under this Lease attributable to the space assigned or sublet,
less the reasonable costs and expenses of subleasing and less the unamortized cost of
Tenant&#146;s leasehold improvements (but not trade fixtures or equipment) paid for by Tenant,
which cost shall be amortized over a ten year basis commencing on the Term Commencement Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Tenant and any guarantor of Tenant&#146;s obligations hereunder (hereinafter &#147;Guarantor&#148;)
shall acknowledge that, notwithstanding such assignment or sublease and consent of Landlord
thereto, Tenant and Guarantor shall not be released or discharged from any liability
whatsoever under this Lease and will continue to be liable with the same force and effect as
though no assignment or sublease had been made; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Tenant shall pay Landlord&#146;s reasonable costs including but not limited to
attorney&#146;s fees and Landlord&#146;s administrative and overhead costs, incurred in connection
with each such assignment or subletting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.4 <U>Landlord&#146;s Consent</U>. Landlord shall not unreasonably withhold its consent to a
sublease of at least 10,000 rentable square feet or assignment pursuant to the preceding Section
14.1, subject to Landlord&#146;s options in subclauses (c)&nbsp;and (d)&nbsp;of Section&nbsp;14.2. If Landlord elects
to pursue its option under Section&nbsp;14.2 to match the terms of Tenant&#146;s Sublease Notice, this
Section&nbsp;14.4 is not relevant. Landlord&#146;s failure to consent shall be deemed unreasonable if the
conditions set forth in Subsections 14.3(a)-(f) are met, Landlord&#146;s Mortgagee has consented thereto
and if:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The proposed assignment or subletting is made to a party other than a Competitor;
or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The proposed assignee or subtenant has a good credit rating, which shall be at
least equal to that of Tenant as of the Term Commencement Date, and demonstrable ability to
comply with the terms and conditions of this Lease, a good reputation in the community, and
the proposed use by such subtenant or assignee (even though Permitted Use) could not in
Landlord&#146;s reasonable opinion be expected to detract from the character of the Building at
the time of the proposed assignment or sublease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.5 <U>No Waiver</U>. The consent by Landlord to an assignment or subletting shall not in
any way be construed to relieve Tenant from obtaining the express consent of Landlord to any
further assignment or subletting for the use of all or any
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">part of the Premises, nor shall the collection of rent by Landlord from any assignee, sublessee or
other occupant after default by Tenant be deemed a waiver of this covenant or the acceptance of
such assignee, sublessee or occupant as tenant or a release of Tenant from the further performance
by Tenant of the obligations in this Lease on Tenant&#146;s part to be performed.
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">15.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>MISCELLANEOUS COVENANTS</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.1 <U>Rules and Regulations</U>. Tenant and Tenant&#146;s servants, employees,
agents, visitors and licensees will faithfully observe such Rules and Regulations as
are attached hereto as Exhibit&nbsp;C and made a part hereof or as Landlord hereafter at
any time or from time to time may make and may communicate in writing to
Tenant and which in the reasonable judgment of Landlord shall be necessary for the
reputation, safety, care or appearance of the Property, or the preservation of good
order therein, or the operation or maintenance of the Property, or the equipment
thereof, or the comfort of tenants or others in the Building, provided, however, that
in the case of any conflict between the provisions of this Lease and any such Rules
and Regulations, the provisions of this Lease shall control, and provided further
that nothing contained in this Lease shall be construed to impose upon Landlord
any duty or obligation to enforce such Rules and Regulations or the terms,
covenants or conditions in any other lease as against any other tenant and Landlord
shall not be liable to Tenant for violation of the same by any other tenant, its servants, employees, agents, visitors, invitees or licensees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.2 <u>Access to Premises</u>. Tenant shall: (i)&nbsp;permit Landlord to erect, use and maintain pipes, ducts and conduits in and through the Demised Premises,
provided the same do not materially reduce the floor area or materially adversely
affect the appearance thereof; (ii)&nbsp;permit the Landlord and any Mortgagee to have
free and unrestricted access to and to enter upon the Demised Premises at all
reasonable hours (upon 24 hours prior notice except in case of emergency) for the
purposes of inspection or of making repairs, replacements or improvements in or to
the Demised Premises or the Building or equipment (including, without limitation,
sanitary, electrical, heating, air conditioning or other systems) or of complying with
all laws, orders and requirements of governmental or other authority or of
exercising any right reserved to Landlord by this Lease (including the right during
the progress of any such repairs, replacements or improvements or while
performing work and furnishing materials in connection with compliance with any
such laws, orders or requirements to take upon or through, or to keep and store
within, the Demised Premises all necessary materials, tools and equipment); and
(iii)&nbsp;permit Landlord, at reasonable times and upon 24 hours prior notice, to show
the Demised Premises during ordinary business hours to any Mortgagee,
prospective purchaser of any interest of Landlord in the Property, prospective
Mortgagee, or prospective assignee of any Mortgage, and during the period of twelve
months next preceding the Termination Date to any person contemplating the
leasing of the Demised Premises or any part thereof. If Tenant shall not be
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">personally present to open and permit any entry into the Demised Premises at any time when for any
reason an entry therein shall be necessary or permissible pursuant to the terms of this Lease or by
law, Landlord or Landlord&#146;s agents must nevertheless be able to gain such entry by contacting a
responsible representative of Tenant, whose name, address and telephone number shall be furnished
by Tenant. Provided that Landlord shall not be obligated to employ labor at so-called &#147;over-time&#148;
or other premium pay rates, Landlord shall exercise its rights of access to the Demised Premises
permitted under any of the terms and provisions of this Lease in such manner as to minimize to the
extent practicable interference with Tenant&#146;s use and occupation of the Demised Premises.
Notwithstanding the foregoing, any entry (other than in case of emergency) by Landlord, any
Mortgagee or any of their agents or representatives shall be subject to Tenant&#146;s reasonable
security requirements, including but not limited to the requirement that a representative of Tenant
accompany such parties when in certain parts of the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.3 <U>Accidents to Sanitary and other Systems</U>. Tenant shall give to
Landlord prompt notice of any fire or accident in the Demised Premises or in the
Building and of any damage to, or defective condition in, any part or appurtenance
of the Building&#146;s sanitary, electrical, heating and air conditioning or other systems located in, or passing through, the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.4 <u>Signs, Blinds and Drapes</u>. Tenant shall not place any signs on the exterior of the Building (except as provided in Section&nbsp;27.11) or on or in any
window, public corridor or door visible from the exterior of the Demised Premises.
No drapes or blinds may be put on or in any exterior window nor may any Building drapes or blinds be removed by Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.5 <u>Estoppel Certificate</u>. Tenant shall at any time and from time to time upon not less than ten business (10)&nbsp;days&#146; prior notice by Landlord, Prime Landlord
or by a Mortgagee to Tenant, execute, acknowledge and deliver to the party making
such request a statement in writing certifying that this Lease is unmodified and in
full force and effect (or if there have been modifications, that the same is in full
force and effect as modified and stating the modifications), and the dates to which
Rent has been paid in advance, if any, and stating whether or not to the actual
knowledge and belief of the signer of such certificate Landlord is in default in
performance of any covenant, agreement, term, provisions or condition contained in
this Lease and, if so, specifying each such default of which the signer may have
knowledge, it being intended that any such statement delivered pursuant hereto
may be relied upon by any prospective purchaser of any interest in the Property,
any Mortgagee or prospective Mortgagee, any lessee or prospective lessee thereof,
any prospective assignee of any Mortgage, or any other party designated by
Landlord. The form of any such estoppel certificate requested by a Mortgagee shall
be reasonably satisfactory to such Mortgagee.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.6 <u>Requirements of Law &#151; Fines and Penalties</u>. Tenant at its sole expense
shall comply with all laws, rules, orders and regulations of Federal, State, County
and Municipal Authorities and with any direction of any public officer or officers,
pursuant to law, which shall impose any duty upon Landlord or Tenant with respect
to and arising out of Tenant&#146;s use or occupancy of the Demised Premises. If Tenant
receives notice of any violation of law, ordinance, order or regulation applicable to
the Demised Premises, it shall give prompt notice thereof to Landlord. Without
limiting the generality of the foregoing, Tenant shall be responsible for compliance
with requirements imposed by the Americans with Disabilities Act relative to the
Demised Premises, including without limitation all such requirements applicable to
removing barriers, furnishing auxiliary aids and ensuring that, whenever
alterations are made, the affected portions of the Demised Premises are readily
accessible to and usable by individuals with disabilities. Notwithstanding anything
in the foregoing to the contrary, if the requirement of additional work in the
Demised Premises is caused by governmental action solely as result of work being
done by Landlord in parts of the Building other than the Demised Premises, then
Landlord shall be responsible for the cost of such ADA work. Conversely, if
additional ADA work in the Building is caused by governmental action solely as a
result of work in the Demised Premises by Tenant, then Tenant shall be responsible for the cost of such ADA work.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.7 <u>Tenant&#146;s Acts &#151; Effect on Insurance</u>. Tenant shall not do or permit to be done any act or thing upon the Demised Premises or elsewhere in the Building
which will invalidate or be in conflict with any insurance policies covering the
Building and the fixtures and property therein and shall not do, or permit to be
done, any act or thing upon the Demised Premises which shall subject Landlord to
any liability or responsibility for injury to any person or persons or to property by
reason of any business or operation being conducted on the Demised Premises or for
any other reason. Subject to the terms of this Lease and except as otherwise
specifically set forth to the contrary herein, Tenant at its own expense shall comply
with all applicable provisions of the California Health and Safety Code and all
regulations promulgated thereunder and with all rules, orders, regulations or
requirements of the underwriter(s) of the fire and other hazard insurance for the
Property and the Demised Premises and shall not do, or permit anything to be done,
in or upon the Demised Premises, or bring or keep anything therein, that is not
permitted by the City of South San Francisco Fire Department, or other authority
having jurisdiction, and then only in such quantity and manner of storage as will not increase the rate for any insurance applicable to the Building. If by reason of failure of
Tenant to comply with the provisions hereof the insurance rate applicable to any policy of
insurance shall at any time thereafter be higher than it otherwise would be, then Tenant shall
reimburse Landlord for that part of any insurance premiums thereafter paid by Landlord, which shall
have been charged because of such failure by Tenant.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.8 <U>Miscellaneous</U>. Tenant shall not suffer or permit the Demised Premises or any
fixtures, equipment or utilities therein or serving the same, to be overloaded, damaged or defaced.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">16.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>DAMAGE BY FIRE, ETC.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of loss of, or damage to, the Demised Premises or the Building by fire or other
casualty, the rights and obligations of the parties hereto shall be as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If the Demised Premises, or any part thereof, shall be damaged by fire or other
casualty, Tenant shall give prompt notice thereof to Landlord, and Landlord, upon receiving
such notice and the insurance proceeds for such casualty, shall proceed in a commercially
reasonable manner, subject to unavoidable delays, to repair, or cause to be repaired, such
damage to the extent hereinafter provided. Landlord shall be responsible to restore only to
the &#147;cold shell&#148; condition as set forth on Exhibit&nbsp;A-l, and Tenant shall be responsible for
restoration of all leasehold improvements beyond such cold shell. If the Demised Premises
or any part thereof shall be rendered untenantable by reason of such damage, whether to the
Demised Premises or to the Building, Yearly Fixed Rent shall proportionately abate for the
period from the date of such damage to the date when such damage shall have been repaired
by Landlord to the condition set forth on Exhibit&nbsp;A-l.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) If, as a result of fire or other casualty, the whole or a substantial
portion of the Building is rendered untenantable and the nature and extent of the damage
is such that in Landlord&#146;s opinion, taking into account a reasonable time for adjusting
loss and obtaining plans and permits for restoration, the Demised Premises cannot be made
tenantable within 180&nbsp;days after such event, Landlord, within ninety (90)&nbsp;days from the
date of such fire or casualty, may terminate this Lease by notice to Tenant, specifying a
date not less than thirty (30)&nbsp;nor more than sixty (60)&nbsp;days after the giving of such
notice on which the Term of this Lease shall terminate. If Landlord does not so elect to
terminate this Lease, then Landlord shall (to the extent that proceeds of insurance
required to be carried by Landlord, net of any portion thereof retained by a Mortgagee,
are made available for such purpose) proceed with diligence to repair the damage to the
Demised Premises and all facilities serving the same, if any, which shall have occurred,
and the Yearly Fixed Rent shall meanwhile proportionately abate, all as provided in
Paragraph (a)&nbsp;of this Section. However, if such damage is not repaired and the Demised
Premises restored to substantially the same condition as they were prior to such damage
within one (1)&nbsp;year from the date of such damage, Tenant within thirty (30)&nbsp;days from the
expiration of such one (1)&nbsp;year period or from the expiration of any extension thereof by
reason of unavoidable delays as hereinafter provided, may terminate this Lease by
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->33<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">notice to Landlord, specifying a date not more than sixty (60)&nbsp;days after the giving of such notice
on which the Term of this Lease shall terminate. The period within which the required repairs may
be accomplished shall be extended by the number of days, lost as a result of unavoidable delays,
which term shall be defined to include all delays referred to in Article&nbsp;24.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) If the Demised Premises shall be rendered untenantable by fire
or other casualty during the last two (2)&nbsp;years of the Term of this Lease,
Landlord may terminate this Lease effective as of the date of such fire or
other casualty upon notice to Tenant given within ninety (90)&nbsp;days after such
fire or other casualty. Notwithstanding the foregoing to the contrary, in the
event Landlord exercises the foregoing termination right, if Tenant has
available to it the option to extend and validly exercises said option, Tenant
may defeat said termination notice by the valid exercise of said option term
so as to add an additional five years on to the Term of this Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Landlord shall not be required to repair or replace any of
Tenant&#146;s leasehold improvements, fixtures, business machinery, equipment,
cabinet work, furniture, personal property or other installations (all of which
shall, however, be restored by Tenant within a reasonable time after
Landlord shall have completed any repair or restoration required under the
terms of this Article), and no damages, compensation or claim shall be
payable by Landlord for inconvenience, loss of business or annoyance arising
from any repair or restoration of any portion of the Demised Premises or of
the Building.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The provisions of this Article shall be considered an express
agreement governing any instance of damage or destruction of the Building
or the Demised Premises by fire or other casualty, and any law now or
hereafter in force providing for such a contingency in the absence of express
agreement shall have no application.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) In the event of any termination of this Lease pursuant to this
Article, the Term of this Lease shall expire as of the effective termination
date as fully and completely as if such date were the date originally fixed
herein for the end of the Term of this Lease. Tenant shall have access to the
Demised Premises for a period of fifteen (15)&nbsp;days after the date of
termination in order to remove Tenant&#146;s personal property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Landlord&#146;s Architect&#146;s certificate, given in good faith, shall be
deemed conclusive of the statements therein contained and binding upon
Tenant with respect to the performance and completion of any repair or
restoration work undertaken by Landlord pursuant to this Article or Article
18.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->34<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">17.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>WAIVER OF SUBROGATION</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In any case in which Tenant shall be obligated under any provision of this Lease to pay to
Landlord or Prime Landlord any loss, cost, damage, liability, or expense suffered or incurred by
Landlord or Prime Landlord, Landlord shall allow to Tenant as an offset against the amount thereof
(i)&nbsp;the net proceeds of any insurance collected by Landlord for or on account of such loss, cost,
damage, liability, or expense, provided that the allowance of such offset does not invalidate the
policy or policies under which such proceeds were payable and (ii)&nbsp;if such loss, cost, damage,
liability or expense shall have been caused by a peril against which Landlord has agreed to procure
insurance coverage under the terms of this Lease, the amount of such insurance coverage, if not
actually procured by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In any case in which Landlord or Prime Landlord shall be obligated under any provision of this
Lease to pay to Tenant any loss, cost, damage, liability or expense suffered or incurred by Tenant,
Tenant shall allow to Landlord as an offset against the amount thereof (i)&nbsp;the net proceeds of any
insurance collected by Tenant for or on account of such loss, cost, damage, liability, or expense,
provided that the allowance of such offset does not invalidate the policy or policies under which
such proceeds were payable and (ii)&nbsp;if such loss, cost, damage, liability or expense shall have
been caused by a peril against which Tenant has agreed to procure insurance coverage under the
terms of this Lease, the amount of such insurance coverage, if not actually procured by Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto shall each endeavor to procure an appropriate clause in, or endorsement
on, any fire or extended coverage insurance policy covering the Demised Premises and the Building
and personal property, fixtures and equipment located thereon or therein, pursuant to which the
insurance companies waive subrogation or consent to a waiver of right of recovery, and having
obtained such clauses and/or endorsements of waiver of subrogation or consent to a waiver of right
of recovery each party hereby agrees that it will not make any claim against or seek to recover
from the other for any loss or damage to its property or the property of others resulting from
fire or other perils covered by such fire and extended coverage insurance; provided, however, that
the release, discharge, exoneration and covenant not to sue herein contained shall be limited by
the terms and provisions of the waiver of subrogation clauses and/or endorsements or clauses
and/or endorsements consenting to a waiver of right of recovery and shall be co-extensive
therewith. If either party may obtain such clause or endorsement only upon payment of an
additional premium, such party shall promptly so advise the other party and shall be under no
obligation to obtain such clause or endorsement unless such other party pays the premium.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">18.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>CONDEMNATION &#151; EMINENT DOMAIN</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that the whole or more than 40% of the Building shall be taken or appropriated by
eminent domain or shall be condemned for any public or quasi-public use, or (by virtue of any such
taking, appropriation or condemnation) shall suffer any damage (direct, indirect or consequential)
for which Landlord or Tenant shall be entitled to compensation then (and in any such event) this
Lease and the Term hereof may be terminated at the election of Landlord by a notice in writing of
its election so to terminate which shall be given by Landlord to Tenant within sixty (60)&nbsp;days
following the date on which Landlord shall have received notice of such taking, appropriation or
condemnation. In the event that more than fifty percent (50%) of the floor area of the Demised
Premises or a substantial part of the means of access thereto within the perimeter of the Property
so as to substantially interfere with the use of the Demised Premises shall be so taken,
appropriated or condemned, then (and in any such event) this Lease and the Term hereof may be
terminated at the election of Tenant by a notice in writing of its election so to terminate which
shall be given by Tenant to Landlord within sixty (60)&nbsp;days following the date on which Tenant
shall have received notice of such taking, appropriation or condemnation. Tenant hereby waives the
benefits of California Code of Civil Procedure Section&nbsp;12165.130.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the giving of any such notice of termination (either by Landlord or Tenant) this Lease
and the Term hereof shall terminate on or retroactively as of the date on which Tenant shall be
required to vacate any part of the Demised Premises or shall be deprived of a substantial part of
the means of access thereto, provided, however, that Landlord may in Landlord&#146;s notice elect to
terminate this Lease and the Term hereof retroactively as of the date on which such taking,
appropriation or condemnation became legally effective. In the event of any such termination, this
Lease and the Term hereof shall expire as of the effective termination date as fully and completely
as if such date were the date originally fixed herein for the end of the Term of this Lease. If
neither party (having the right so to do) elects to terminate Landlord will, with reasonable
diligence and at Landlord&#146;s expense, restore the remainder of the Demised Premises, or the
remainder of the means of access thereto, as nearly as practicably may be to the same condition as
obtained prior to such taking, appropriation or condemnation in which event (i)&nbsp;a just proportion
of the Yearly Fixed Rent, according to the nature and extent of the taking, appropriation or
condemnation and the resulting permanent injury to the Demised Premises and the means of access
thereto, shall be permanently abated, and (ii)&nbsp;a just proportion of the remainder of the Yearly
Fixed Rent, according to the nature and extent of the taking, appropriation or condemnation and the
resultant injury sustained by the Demised Premises and the means of access thereto, shall be abated
until what remains of the Demised Premises and the means of access thereto shall have been restored
as fully as may be possible for permanent use and occupation by Tenant hereunder. Except for any
award specifically reimbursing Tenant for moving or relocation expenses and Tenant&#146;s moveable
personal property
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(but not leasehold improvements), there are expressly reserved to Landlord all rights to
compensation and damages created, accrued or accruing by reason of any such taking, appropriation
or condemnation, in implementation and in confirmation of which Tenant does hereby acknowledge that
Landlord shall be entitled to receive and retain all such compensation and damages, grants to
Landlord all and whatever rights (if any) Tenant may have to such compensation and damages, and
agrees to execute and deliver all and whatever further instruments of assignment as Landlord may
from time to time request. In the event of any taking of the Demised Premises or any part thereof
for temporary use, (i)&nbsp;this Lease shall be and remain unaffected thereby, and (ii)&nbsp;Tenant shall be
entitled to receive for itself any award made for such use, provided, that if any taking is for a
period extending beyond the Term of this Lease, such award shall be apportioned between Landlord
and Tenant as of the Termination Date.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">19.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>DEFAULT</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.1 <U>Events of Default</U>. Occurrence of any of the following events shall constitute
an Event of Default under this Lease: (a)&nbsp;Tenant shall neglect or fail to perform or observe any of
the Tenant&#146;s covenants herein, including (without limitation) the covenants with regard to the
payment when due of Rent, which default continues, in the case of payment of Rent, for thirty (30)
days after notice of default or, in the case of defaults other then payment of Rent, for twenty
(20)&nbsp;days after such notice of default (provided that if more time, but not more than 30 additional
days) is required to complete such performance, Tenant shall not be in default if Tenant commences
such performance within the thirty (30)&nbsp;day period and thereafter diligently pursues its
completion); or (b)&nbsp;Tenant shall default in payment of Rent more than two (2)&nbsp;times in any
consecutive twelve (12)&nbsp;month period; or (c)&nbsp;Tenant shall be involved in financial difficulties as
evidenced by an admission in writing by Tenant of Tenant&#146;s inability to pay its debts generally as
they become due, or by the making or offering to make a composition of its debts with its
creditors; or (d)&nbsp;Tenant shall make an assignment or trust mortgage, or other conveyance or
transfer of like nature, of all or a substantial part of its property for the benefit of its
creditors; or (e)&nbsp;the leasehold hereby created shall be taken on execution or by other process of
law and shall not be revested in Tenant within sixty (60)&nbsp;days thereafter; or (f)&nbsp;a receiver,
sequester, trustee or similar officer shall be appointed by a court of competent jurisdiction to
take charge of all or a substantial part of Tenant&#146;s property and such appointment shall not be
vacated within sixty (60)&nbsp;days; or (g)&nbsp;any proceeding shall be instituted by or against Tenant
pursuant to any of the provisions of any Act of Congress or State law relating to bankruptcy,
reorganization, arrangements, compositions or other relief from creditors, and, in the case of any
such proceeding instituted against it, if Tenant shall fail to have such proceeding dismissed
within thirty (30)&nbsp;days or if Tenant is adjudged bankrupt or insolvent as a result of any such
proceeding; or (h)&nbsp;any event shall occur or any contingency shall arise whereby this Lease, or the
term and estate thereby created, would (by operation of law or otherwise) devolve upon or
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">pass to any person, firm or corporation other than Tenant, except as expressly permitted
under Article&nbsp;14 hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.2 <U>Remedies Available upon Default</U>. Upon the occurrence of an Event of Default,
Landlord shall have the following remedies, which shall not be exclusive but shall be cumulative
and shall be in addition to any other remedies now or hereafter allowed by law:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Landlord may terminate Tenant&#146;s right to possession of the
Premises at any time by written notice to Tenant. Tenant expressly
acknowledges that in the absence of such written notice from Landlord, no
other act of Landlord, including re-entry into the Premises, efforts to relet the
Premises, reletting of the Premises for Tenant&#146;s account, storage of Tenant&#146;s
personal property and trade fixtures, acceptance of keys to the Premises from
Tenant or exercise of any other rights and remedies under this Section, shall
constitute an acceptance of Tenant&#146;s surrender of the Premises or constitute a
termination of this Lease or of Tenant&#146;s right to possession of the Premises.
Upon such termination in writing of Tenant&#146;s right to possession of the
Premises, as herein provided, this Lease shall terminate and Landlord shall
be entitled to recover damages from Tenant as provided in California Civil
Code Section&nbsp;1951.2 and any other applicable existing or future Law
providing for recovery of damages for such breach, including the worth at the
time of award of the amount by which the rent which would be payable by
Tenant hereunder for the remainder of the Term after the date of the award
of damages, including Additional Rent as reasonably estimated by Landlord,
exceeds the amount of such rental loss as Tenant proves could have been
reasonably avoided, discounted at the discount rate published by the Federal
Reserve Bank of San Francisco for member banks at the time of the award
plus one percent (1%).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Landlord shall have the remedy described in California Civil
Code Section&nbsp;1951.4 (Landlord may continue this Lease in effect after
Tenant&#146;s breach and abandonment and recover rent as it becomes due, if
Tenant has the right to sublet or assign, subject only to reasonable
limitations).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Landlord may immediately, or at any time thereafter, without
notice, cure said Event of Default for the account of Tenant. If Landlord at
any time is compelled to pay or elects to pay any sum of money, or do any act
which will require the payment of any sum of money, by reason of the failure
of Tenant to comply with any provision hereof, or if Landlord is compelled to
or does incur any expense, including without limitation reasonable attorneys&#146;
fees, in instituting, prosecuting and/or defending any action or proceeding
arising by reason of any default of Tenant hereunder, Tenant shall on
demand pay to Landlord by way of reimbursement the sum or sums so paid
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->38<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">by Landlord with all interest, costs and damages together with interest at the Interest Rate
for the period such sums remain outstanding.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Landlord may remove all of Tenant&#146;s property from the Premises, and such
property may be stored by Landlord in a public warehouse or elsewhere at the sole cost and
for the account of Tenant. If Landlord does not elect to store any or all of Tenant&#146;s
property left in the Premises, Landlord may consider such property to be abandoned by Tenant,
and Landlord may thereupon dispose of such property in the manner and as prescribed by
California Civil Code Section&nbsp;1980 et seq. Any proceeds realized by Landlord on the disposal
of any such property shall be applied first to offset all expenses of storage and sale, then
credited against Tenant&#146;s outstanding obligations to Landlord under this Lease, and any
balance remaining after satisfaction of all obligations of Tenant under this Lease shall be
delivered to Tenant.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The damages recoverable by Landlord pursuant to this Section shall in all
events include reimbursement of any concessions made by Landlord in connection with the
leasing of the Demised Premises to Tenant, including without limitation (a)&nbsp;abated Rent, (b)
allowances or improvements in excess of any Building standard work, (c)&nbsp;sums paid to any
former landlord of Tenant under a so-called &#147;take-over&#148;, lease assumption or similar
agreement and (d)&nbsp;signing bonuses and other incentive payments. Any allowances, abated rent,
signing bonuses, incentive payments or takeover payments shall be deemed commercially
reasonable if recommended to Landlord by a reputable commercial real estate broker as being
appropriate and necessary for the leasing of said Premises to a creditworthy tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.3 <U>Grace Period</U>. Notwithstanding anything to the contrary in this Article
contained, Landlord agrees not to take any action to terminate this Lease (a)&nbsp;for default by Tenant
in the payment when due of Rent, if Tenant shall cure such default within five (5)&nbsp;days after
written notice thereof given by Landlord to Tenant, unless there has been two (2)&nbsp;or more defaults
in any 12-month period as set forth in Section&nbsp;19.1(b), or (b)&nbsp;for default by Tenant in the
performance of any other covenant, if Tenant shall cure such default within a period of thirty (30)
days after written notice thereof given by Landlord to Tenant (except where the nature of the
default is such that remedial action should appropriately take place sooner, as indicated in such
written notice), or with respect to covenants other than to pay a sum of money within such
additional period as may reasonably be required to cure such default if (because of governmental
restrictions or any other cause beyond the reasonable control of Tenant) the default is of such a
nature that it cannot be cured within such thirty (30)-day period, provided, however, (1)&nbsp;that
there shall be no extension of time beyond such thirty (30)-day period for the curing of any such
default unless, not more than ten (10)&nbsp;days after the receipt of the notice of default, Tenant in
writing (i)&nbsp;shall specify the cause on account of which the default cannot
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->39<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">be cured during such period and shall advise Landlord of its intention duly to institute all steps
necessary to cure the default and (ii)&nbsp;shall as soon as may be reasonable duly institute and
thereafter diligently prosecute to completion all steps necessary to cure such default and, (2)
that no notice of the opportunity to cure a default need be given, and no grace period whatsoever
shall be allowed to Tenant, if the default is incurable or if the covenant or condition the breach
of which gave rise to the default had, by reason of a breach on a prior occasion, been the subject
of a notice hereunder to cure such default.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">20.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>END OF TERM &#151; ABANDONED PROPERTY</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the expiration or other termination of the Term of this Lease, Tenant shall peaceably
quit and surrender to Landlord the Demised Premises and all alterations and additions thereto which
Tenant is not entitled or required to remove under the provisions of this Lease, broom clean in
good order, repair and condition excepting only reasonable use and wear and damage by fire or other
casualty for which, under other provisions of this Lease, Tenant has no responsibility of repair or
restoration. Tenant&#146;s obligation to observe or perform this covenant shall survive the expiration
or other termination of the Term of this Lease. If the last day of the Term of this Lease or any
renewal thereof falls on a day other than a Business Day, this Lease shall expire on the Business
Day immediately following. Tenant shall pay twice the amount of Rent applicable to each month (or
fraction thereof) during which Tenant remains in possession of any part of the Demised Premises in
violation of the foregoing covenants, without prejudice to eviction and any other remedy available
to Landlord on account thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any personal property in which Tenant has an interest which shall remain in the Building or on
the Demised Premises after the expiration or termination of the Term of this Lease shall be
conclusively deemed to have been abandoned, and may be disposed of in such manner as Landlord may
see fit; provided, however, notwithstanding the foregoing, that Tenant will, upon request of
Landlord made not later than ten (10)&nbsp;days after the expiration or termination of the Term hereof,
promptly remove from the Building any such personal property or, if any part thereof shall be sold,
that Landlord may receive and retain the proceeds of such sale and apply the same, at its option,
against the expenses of the sale, the cost of moving and storage, any arrears of Rent payable
hereunder by Tenant to Landlord and any damages to which Landlord may be entitled under Article&nbsp;19
hereof or pursuant to law, with the balance if any, to be paid to Tenant.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">21.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>RIGHTS OF MORTGAGEES</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.1 <U>Entry and Possession</U>. Upon entry and taking possession of the Property by a
Mortgagee, for the purpose of foreclosure or otherwise, such Mortgagee shall have all the rights of
Landlord, and shall be liable to perform all
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->40<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the obligations of Landlord arising and accruing during the period of such possession by
such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.2 <U>Right to Cure</U>. No act or failure to act on the part of Landlord which would
entitle Tenant under the terms of this Lease, or by law, to be relieved of Tenant&#146;s obligations
hereunder or to terminate this Lease, shall result in a release or termination of such obligations
or a termination of this Lease unless (i)&nbsp;Tenant shall have first given written notice of
Landlord&#146;s act or failure to act to first Mortgagees of record, if any, and to any other Mortgagees
of whom Tenant has been given written notice, specifying the act or failure to act on the part of
Landlord which could or would give basis to Tenant&#146;s rights; and (ii)&nbsp;such Mortgagees, after
receipt of such notice, have failed or refused to correct or cure the condition complained of
within 30&nbsp;days thereafter for a monetary default and 60&nbsp;days for a non-monetary default, but
nothing contained in this paragraph shall be deemed to impose any obligation on any such Mortgagees
to correct or cure any such condition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.3 <U>Prepaid Rent</U>. No Rent shall be paid more than thirty (30)&nbsp;days prior
to the due dates thereof and, as to a first Mortgagee of record and any other
Mortgagees of whom Tenant has been given written notice, payments made in
violation of this provision shall (except to the extent that such Rent is actually
received by such Mortgagee) be a nullity as against such Mortgagee and Tenant shall be liable for the amount of such payments to such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.4 <u>Continuing Offer</u>. The covenants and agreements contained in this Lease with respect to the rights, powers and benefits of a Mortgagee (particularly,
without limitation thereby, the covenants and agreements contained in this Article)
constitute a continuing offer to any person, corporation or other entity, which by
accepting or requiring an assignment of this Lease or by entry or foreclosure
assumes the obligations herein set forth with respect to such Mortgagee; every such
Mortgagee is hereby constituted a party to this Lease as an obligee hereunder to the
same extent as though its name was written hereon as such; and such Mortgagee shall be entitled to enforce such provisions in its own name.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.5 <u>Subordination</u>. This lease shall be subordinate to all mortgages encumbering the Land and/or Building, but Tenant shall nevertheless have the
benefit of the non-disturbance provisions hereinafter set forth, and Tenant agrees,
at the request of Landlord or any Mortgagee, to execute and deliver promptly any
certificate or other instrument which Landlord or such Mortgagee may reasonably
request subordinating this Lease and all rights of Tenant hereunder to any
Mortgage, and to all advances made under such Mortgage and/or agreeing to attorn
to such Mortgagee in the event that it succeeds to Landlord&#146;s interest in the
Property. Landlord shall provide that (i)&nbsp;the holder of each such Mortgage shall
execute and deliver to Tenant a non-disturbance agreement to the effect that, in the
event of any foreclosure of such Mortgage, such holder will not name Tenant as a
party defendant to such foreclosure nor disturb its possession under the Lease, or
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->41<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(ii)&nbsp;each such Mortgage shall contain provisions substantially to the same effect as those
contained in such a non-disturbance agreement. The form of the non-disturbance agreement shall be a
commercially reasonable form reflecting then current commercial lending practices for loans of the
size and type as that related to the Building. Tenant agrees that a subordination, non-disturbance
and attornment agreement substantially in form as that attached hereto shall be deemed commercially
reasonable. In addition if the Prime Lease shall be terminated due to foreclosure of the mortgage
made by Prime Landlord in favor of its mortgagee or due to such mortgagee&#146;s acceptance of a deed in
lieu of foreclosure, Tenant shall attorn to mortgagee as landlord hereunder and this lease shall
continue in full force and effect for its remaining term as a direct lease between Tenant and such
mortgagee without the necessity of any additional act or agreement; provided, however, if requested
by such Mortgagee, Tenant shall execute and deliver a new lease with such mortgagee on the same
terms and conditions as set forth herein except that the term of such new lease shall be equal to
the then remaining term hereunder. Landlord represents and warrants that as of the date of this
Lease, Bank of America is the sole mortgagee of the Land and Building.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.6 <U>Limitations on Liability</U>. Nothing contained in the foregoing Section&nbsp;21.6 or
in any such non-disturbance agreement or non-disturbance provision shall however, affect the prior
rights of the holder of any Mortgage with respect to the proceeds of any award in condemnation or
of any fire insurance policies affecting the Building, or impose upon any such holder any liability
(i)&nbsp;for the erection or completion of the Building, or (ii)&nbsp;in the event of damage or destruction
to the Building or the Demised Premises by fire or other casualty, for any repairs, replacements,
rebuilding or restoration except such repairs, replacements, rebuilding or restoration as can
reasonably be accomplished from the net proceeds of insurance actually received by, or made
available to, such holder, or (iii)&nbsp;for any default by Landlord under the Lease occurring prior to
any date upon which such holder shall become Tenant&#146;s landlord (unless and to the extent said
default continues after such date upon which the holder becomes Tenant&#146;s landlord, in which event
such mortgagee shall be responsible for correcting such default continuing after such date), or
(iv)&nbsp;for any credits, offsets or claims against the Rent as a result of any acts or omissions of
Landlord committed or omitted prior to such date, or (v)&nbsp;for return of any security deposit or
other funds unless the same shall have been received by such holder, and any such agreement or
provision may so state.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">22.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>QUIET ENJOYMENT</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord covenants that if, and so long as, Tenant keeps and performs each and every covenant,
agreement, term, provision and condition herein contained on the part and on behalf of Tenant to be
kept and performed, Tenant shall quietly enjoy the Demised Premises from and against the claims of
all persons claiming by, through or under Landlord subject, nevertheless, to the covenants,
agreements,
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">terms, provisions and conditions of this Lease and to all Mortgages to which this Lease is subject
and subordinate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without incurring any liability to Tenant, Landlord may permit access to the Demised Premises
and open the same, whether or not Tenant shall be present, upon any demand of any receiver,
trustee, assignee for the benefit of creditors, sheriff, marshall or court officer entitled to, or
reasonably purporting to be entitled to, such access for the purpose of taking possession of, or
removing Tenant&#146;s property or for any other lawful purpose (but this provision and any action by
Landlord hereunder shall not be deemed a recognition by Landlord that the person or official making
such demand has any right or interest in or to this Lease, or in or to the Demised Premises), or
upon demand of any representative of the fire, police, building, sanitation or other department of
the city, county, state or federal governments.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">23.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>ENTIRE AGREEMENT&#151;WAIVER&#151;SURRENDER</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.1 <U>Entire Agreement</U>. This Lease and the Exhibits made a part hereof contain the
entire and only agreement between the parties and any and all statements and representations,
written and oral, including previous correspondence and agreements between the parties hereto, are
merged herein. Tenant acknowledges that all representations and statements upon which it relied in
executing this Lease are contained herein and that Tenant in no way relied upon any other
statements or representations, written or oral. Any executory agreement hereafter made shall be
ineffective to change, modify, discharge or effect an abandonment of this Lease in whole or in part
unless such executory agreement is in writing and signed by the party against whom enforcement of
the change, modification, discharge or abandonment is sought. Nothing herein shall prevent the
parties from agreeing to amend this Lease and the Exhibits made a part hereof as long as such
amendment shall be in writing and shall be duly signed by both parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.2 <U>Waiver by Landlord</U>. The failure of Landlord to seek redress for violation, or
to insist upon the strict performance, of any covenant or condition of this Lease, or any of the
Rules and Regulations promulgated hereunder, shall not prevent a subsequent act, which would have
originally constituted a violation, from having all the force and effect of an original violation.
The receipt by Landlord of Rent with knowledge of the breach of any covenant of this Lease shall
not be deemed a waiver of such breach. The failure of Landlord to enforce any of such Rules and
Regulations against Tenant and/or any other tenant or subtenant in the Building shall not be
deemed a waiver of any such Rules and Regulations. No provisions of this Lease shall be deemed to
have been waived by Landlord unless such waiver be in writing signed by Landlord. No payment by
Tenant or receipt by Landlord of a lesser amount than the monthly rent herein stipulated shall be
deemed to be other than on account of the stipulated rent, nor shall any endorsement or statement
on any check or any letter accompanying any check or
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->43<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">payment as rent be deemed an accord and satisfaction, and Landlord may accept such check or payment
without prejudice to Landlord&#146;s right to recover the balance of such rent or pursue any other
remedy in this Lease provided.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.3 <U>Surrender</U>. No act or thing done by Landlord during the term hereby demised
shall be deemed an acceptance of a surrender of the Demised Premises, and no agreement to accept
such surrender shall be valid, unless in writing signed by Landlord. No employee of Landlord or of
Landlord&#146;s agents shall have any power to accept the keys of the Demised Premises prior to the
termination of this Lease. The delivery of keys to any employee of Landlord or of Landlord&#146;s agents
shall not operate as a termination of the Lease or a surrender of the Demised Premises. In the
event that Tenant at any time desires to have Landlord underlet the Demised Premises for Tenant&#146;s
account, Landlord or Landlord&#146;s agents are authorized to receive the keys for such purposes without
releasing Tenant from any of the obligations under this Lease, and Tenant hereby relieves Landlord
of any liability for loss of or damage to any of Tenant&#146;s effects in connection with such
underletting.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">24.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>INABILITY TO PERFORM &#151; EXCULPATORY CLAUSE</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise expressly provided in this Lease, this Lease and the obligations of Tenant
to pay Rent hereunder and perform all other covenants, agreements, terms, provisions and conditions
hereunder on the part of Tenant to be performed shall in no way be affected, impaired or excused
because Landlord is unable to fulfill any of its obligations under this Lease or is unable to
supply or is delayed in supplying any service expressly or impliedly to be supplied or is unable to
make or is delayed in making any repairs, replacements, additions, alterations, improvements or
decorations or is unable to supply or is delayed in supplying any equipment or fixtures if Landlord
is prevented or delayed from doing so by reason of any cause whatsoever beyond Landlord&#146;s
reasonable control, including but not limited to governmental preemption in connection with a
national emergency or by reason of any rule, order or regulation of any department or subdivision
thereof of any governmental agency or by reason of strikes, labor troubles, shortages of labor or
materials or conditions of supply and demand which have been or are affected by war, hostilities or
other similar or dissimilar emergency. In each such instance of inability of Landlord to perform,
Landlord shall exercise reasonable diligence to eliminate the cause of such inability to perform.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall neither assert nor seek to enforce any claim for breach of this Lease against any
of Landlord&#146;s assets other than Landlord&#146;s or Prime Landlord&#146;s interest in the Building of which
the Demised Premises are a part and in the rents, issues and profits thereof, and Tenant agrees to
look solely to such interest for the satisfaction of any liability of Landlord under this Lease, it
being specifically agreed that in no event shall Landlord (which term shall include, without
limitation any of the officers, trustees, directors, partners, beneficiaries, joint venturers,
managers, members, stockholders or other principals or representatives, disclosed or
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->44<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">undisclosed, of Landlord or any managing agent) ever be personally liable for any such liability.
This paragraph shall not limit any right that Tenant might otherwise have to obtain injunctive
relief against Landlord or to take any other action which shall not involve the personal liability
of Landlord to respond in monetary damages from Landlord&#146;s assets other than the Landlord&#146;s
interest in said real estate, as aforesaid. In no event shall Landlord ever be liable for
consequential damages.
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">25.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>BILLS AND NOTICES</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any notices required under this Lease shall be in writing and delivered by hand or mailed by
registered or certified mail or by nationally recognized overnight delivery service (such as
Federal Express) for next business day delivery to Landlord or Tenant at the addresses set forth in
Article&nbsp;1. Either party may at any time change the Address for such notices, consents, requests,
bills, demands or statements by delivering or mailing, as aforesaid, to the other party a notice
stating the change and setting forth the changed Address, provided such changed Address is within
the United States.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All bills and statements for reimbursement or other payments or charges due from Tenant to
Landlord hereunder shall be due and payable in full fifteen (15)&nbsp;days, unless herein otherwise
provided, after submission thereof by Landlord to Tenant. Tenant&#146;s failure to make timely payment
of any amounts indicated by such bills and statements within applicable notice and grace periods,
whether for work done by Landlord at Tenant&#146;s request, reimbursement provided for by this Lease or
for any other sums properly owing by Tenant to Landlord, shall be treated as a default in the
payment of Rent, in which event Landlord shall have all rights and remedies provided in this Lease
for the nonpayment of Rent.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">26.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>SUCCESSORS AND ASSIGNS</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The covenants, agreements, terms, provisions and conditions of this Lease shall bind and
benefit the successors and assigns of the parties hereto with the same effect as if mentioned in
each instance where a party hereto is named or referred to, except that no violation of the
provisions of Article&nbsp;14 hereof shall operate to vest any rights in any successor or assignee of
Tenant and that the provisions of this Article shall not be construed as modifying the conditions
of limitation contained in Article&nbsp;19 hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If in connection with or as a consequence of the sale, transfer or other disposition of the
real estate (Land and/or Building, either or both, as the case may be) of which the Demised
Premises are a part Landlord ceases to be the owner of the reversionary interest in the Demised
Premises, Landlord shall be entirely freed and relieved from the performance and observance
thereafter of all covenants and obligations hereunder accruing thereafter on the part of Landlord
to be performed
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->45<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and observed, it being understood and agreed in such event (and it shall be deemed and construed as
a covenant running with the land) that the person succeeding to Landlord&#146;s ownership of said
reversionary interest shall thereupon and thereafter assume, and perform and observe, any and all
of such covenants and obligations of Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">27. MISCELLANEOUS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.1 <U>Separability</U>. If any provision of this Lease or portion of such provision
or the application thereof to any person or circumstance is for any reason held
invalid or unenforceable, the remainder of the Lease (or the remainder of such
provision) and the application thereof to other persons or circumstances shall not be
affected thereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.2 <u> Captions</u>. The captions are inserted only as a matter of convenience
and for reference, and in no way define, limit or describe the scope of this Lease nor
the intent of any provisions thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.3 <u>Broker</u>. Each party represents and warrants that it has not directly or
indirectly dealt, with respect to the leasing of space in the Building, with any broker
or had its attention called to the Demised Premises or other space to let in the
Building, by any broker other than the Broker (if any) listed in Article&nbsp;1 whose
commission shall be the responsibility of Landlord. Each party agrees to exonerate
and save harmless and indemnify the other against any claims for a commission by
any other broker, person or firm, with whom such party has dealt in connection
with the execution and delivery of this Lease or out of negotiations between
Landlord and Tenant with respect to the leasing of other space in the
Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.4 <u>Governing Law</u>. This Lease is made pursuant to, and shall be
governed by, and construed in accordance with, the laws of the State of California.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.5 <U>Assignment of Lease and/or Rents</U>. With reference to any assignment
by Landlord or Prime Landlord of its interest in this Lease and/or the Rent payable
hereunder, conditional in nature or otherwise, which assignment is made to or held
by a bank, trust company, insurance company or other institutional lender holding
a Mortgage on the Building, Landlord and Tenant agree:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) that the execution thereof by Landlord and acceptance thereof
by such Mortgagee shall never be deemed an assumption by such Mortgagee
of any of the obligations of the Landlord hereunder, unless such Mortgagee
shall, by written notice sent to the Tenant, specifically otherwise elect; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) that, except as aforesaid, such Mortgagee shall be treated as
having assumed the Landlord&#146;s obligations hereunder only upon foreclosure
of such Mortgagee&#146;s Mortgage and the taking of possession of the Demised
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->46<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Premises after having given notice of its intention to succeed to the interest of the
Landlord under this Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.6 <U>Memorandum of Lease</U>. Neither party shall record this Lease;
provided, however, that either party shall at the request of the other, execute and
deliver a recordable memorandum of this Lease setting forth the parties to this
Lease, a description of the Demised Premises and the term of this Lease for
recordation in the Official records of the County of San Mateo.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.7 <u> Arbitration of Certain Matters</u>. At the election of either party, if any
dispute as to the rentable square footage of the Demised Premises, the allocation of
real estate taxes or operating expenses under Sections&nbsp;6.5 and 6.6, the abatement of
Yearly Fixed Rent pursuant to Article&nbsp;16 or the abatement of Yearly Fixed Rent
pursuant to Article&nbsp;18 remains unresolved 30&nbsp;days after written complaint by
Tenant has been delivered to Landlord as to an allocation, reduction, apportionment
or abatement made or proposed by Landlord, the matter may be submitted to
binding arbitration pursuant to California Code of Civil Procedure Section&nbsp;1280 et
seq.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.8 <u>Sublease</u>. Notwithstanding anything to the contrary herein, Landlord
and Tenant acknowledge that this is a sublease and that Landlord derives its estate
to the Demised Premises through the Prime Lease. Landlord represents and
warrants that, as of the date hereof, Prime Landlord and Landlord are under
common control. At such time as Landlord and Prime Landlord are no longer under
common control, the responsibility for furnishing services, repairs, restoration and
other similar functions of Landlord shall be performed by Prime Landlord, and
Landlord shall be required to use reasonable efforts to enforce the provisions of the
Prime Lease relating thereto, but without obligation to provide such services,
repairs, restoration, and the like. Landlord shall have the right, but not the
obligation, to assign this Lease to Prime Landlord, and after such assignment this
Lease shall no longer be a sublease, but rather a direct lease between Tenant and
Prime Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.9 <U>Holdover</U>. If for any reason Tenant retains possession of the Premises
or any part thereof after the termination of the Term or any extension thereof, such
holding over shall constitute a tenancy from month to month, terminable by either
party upon thirty (30)&nbsp;days prior written notice to the other party, and Tenant shall
pay Landlord monthly rental during the month to month tenancy computed as the
rent (including Yearly Fixed Rent and all additional rent) payable hereunder for the
final month of the last year of the Term prior to such holding over plus fifty (50%)
percent of said rent. The month to month tenancy shall otherwise be on the same
terms and conditions as set forth in this Lease, as far as applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.10 <u>Lease Amendments</u>. Tenant acknowledges that amendments to this
Lease may be required in connection with the financing of the Land or Building and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->47<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Tenant hereby agrees that it will enter into any reasonable modifications requested
by a mortgagee in connection with such financing, provided the same do not
(a)&nbsp;increase the Yearly Fixed Rent or additional rents payable by Tenant or increase
Tenant&#146;s financial obligations hereunder; (b)&nbsp;reduce or extend the Term hereof;
(c)&nbsp;change the Permitted Use; or (d)&nbsp;otherwise materially impair Tenant&#146;s rights
hereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.11 <u>Signage</u>. Tenant shall be entitled to maintain exterior Building
signage in accordance with the sign criteria attached hereto as Exhibit&nbsp;D. Landlord
shall use commercially reasonable efforts to ensure that, subject to any contrary
requirements of law or the OCR&#146;s, Tenant has proportional directional and
monument signage within the project.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant may maintain a sign on the northern elevation of the Building of equal size to the sign
on the western elevation to be maintained by Landlord, which signs shall be the exclusive company
signs on the facades of the Building. If additional signage rights are obtained for the roof or
facade, the signage shall be shared on a pro rata basis based on square footage leased. Nothing
herein shall be deemed to grant Tenant permission to install signs other than in accordance with
the attached sign criteria and all applicable laws, regulations and private restrictions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant may maintain a sign on the right hand wall of the Building lobby of comparable size and
design to Landlord&#146;s lobby wall sign.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.12 <U>Sierra Point CCRs</U>. This Lease shall be subject to the Amended and
Restated Declaration of Covenants, Conditions and Restrictions for Sierra Point
recorded in the Official Records of San Mateo on October&nbsp;23, 1998, as Document No.
98-172218, as amended by that certain First Amendment to Amended and Restated
Declaration of Covenants, Conditions and Restrictions for Sierra Point recorded in
the Official Records of San Mateo on August&nbsp;6, 1999, as Document No.&nbsp;1999-134787
(as amended, the &#147;CCRs&#148;). Tenant shall comply with the CCRs.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.13 <u>Financial Statements</u>. Tenant shall furnish Landlord with complete
audited financial statements within ninety (90)&nbsp;days after the close of each fiscal
year of Tenant prepared by a certified public accountant (but not necessarily
certified statements) and shall, upon written request from Landlord, provide copies
of Tenant&#146;s quarterly unaudited financial statements within fifteen (15)&nbsp;days after
Landlord&#146;s request.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.14 <u>Communications Dish</u>. Tenant shall have the right to install,
maintain and operate, at Tenant&#146;s sole cost and expense (without rental charge
from Landlord), communications dishes or antennae, which receive and/or send
signals (hereinafter called the <I>&#147;Communications Dishes&#148; on </I>the roof of the Building
and fully contained (both vertically and horizontally) within the screens over the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->48<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">portion of the third floor leased to the Tenant, and to run lines and conduits and cables necessary
for the operations of the Communications Dishes from the roof of the Building into the Premises,
provided that (and in the event Tenant makes such installation, Tenant hereby covenants and agrees
that): (a)&nbsp;such installation is performed in accordance with all laws and requirements of public
authorities and does not cause structural damage to the Building, (b)&nbsp;Tenant indemnifies and holds
Landlord harmless from (i)&nbsp;any liability, cost or expense incurred by Landlord in connection with
the erection, installation, maintenance and operations of the Communications Dishes and any related
equipment installed by Tenant pursuant to the provisions of this Section&nbsp;27.14 and (ii)&nbsp;any and all
claims, costs, damages and expenses (including reasonable attorneys&#146; fees) arising out of
accidents, damage, injury or loss to any and all persons and property resulting from or arising in
connection with the erection, installation, maintenance and operations of the Communications Dishes
(including without limitation claims or damages due to interference with other signals or its own
signal clarity and other claims or damages), (c)&nbsp;Tenant promptly reimburses Landlord for repairs
made necessary by any damage caused to the roof or other portions of the Building by reason of such
installation, including, without limitation, any repairs, restorations, maintenance, renewals or
replacement of the roof necessitated by or in any way caused by or relating to such installations,
(d)&nbsp;Tenant removes such installations and lines and repairs any resulting damage to the Building
and restores the affected portion of the roof and the Building to a condition that is in all
material respects the same as the condition which existed prior to any such installation, ordinary
wear and tear and damage by casualty excepted, all at or prior to the expiration of the Term of
this Lease, (e)&nbsp;Tenant shall not install the Communications Dishes without Landlord&#146;s prior
approval of the manner of such installation and detailed plans and specifications for such
installation, which approval shall not be unreasonably withheld, delayed or conditioned, (f)&nbsp;said
Communication Dishes may not be used by anyone other than the Tenant and any Corporate Transferees
lawfully occupying the Demised Premises and specifically may not be used by anyone in the business
of broadcasting or providing wireless communications, (g)&nbsp;the electric current necessary to operate
the Communications Dishes shall be obtained by Tenant from the public utility furnishing electric
to the Premises and Landlord shall have no obligation to furnish any electric current in connection
therewith, and (h)&nbsp;the installation of the Communications Dishes or their operation not interfere
with Building operations or the use by other tenants or occupants of antennae or communication
dishes installed by such tenants or occupants prior. Tenant shall have access to the roof as
reasonably required in connection with the operation, installation and maintenance of the
Communications Dishes; provided, however, Tenant shall always be accompanied on the roof by a
representative of Landlord. Tenant agrees that Landlord shall have the right, at Landlord&#146;s sole
cost and expense, to relocate the Communications Dishes, provided that such relocation does not
affect the functioning of the Communications Dishes. Landlord makes no representation whether or
not the roof of the Building is suitable for or conductive
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->49<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to the operation of a Communications Dish and Tenant hereby agrees that Landlord shall have no
liability to Tenant in the event that the Communications Dishes shall not operate in a manner
satisfactory to Tenant.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">28.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>SECURITY DEPOSIT</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28.1 <U>Security Deposit</U>. Subject to Section&nbsp;28.2 below, Tenant has deposited
with Landlord the Security Deposit described in Article&nbsp;1 hereof as security for the
faithful performance and observance by Tenant of the terms, provisions, covenants
and conditions of this Lease, and it is agreed that if an Event of Default by Tenant
exists in respect of any of the terms, provisions, covenants and conditions of this
Lease, including, but not limited to, the payment of Rent, Landlord may use, apply
or retain the whole or any part of the security so deposited to the extent required for
the payment of any Rent or any other sum as to which there exists an Event of
Default by Tenant or for any sum which Landlord may expend or may be required
to expend by reason of Tenant&#146;s Event of Default in respect of any of the terms,
provisions, covenants and conditions of this Lease, including, but not limited to, any
damages or deficiency accrued before or after summary proceedings or other re-
entry by Landlord. Upon the expiration or earlier termination of this Lease, and
providing there exists no default or Event of Default hereunder, any remaining
balance of the Security Deposit (including, without limitation, any and all interest
accrued thereon) and the Letter of Credit (as defined below) shall be returned by
Landlord to Tenant after the date fixed as the end of the Term and not later than
thirty (30)&nbsp;days after delivery of entire possession of the Premises to Landlord as
provided hereunder. In the event of a sale of the Land and Building or leasing of the
Building, of which the Premises form a part, Landlord shall have the right to
transfer the security to the vendee or lessee and Landlord shall thereupon be
released by Tenant from all liability for the return of such security, and Tenant
agrees to look solely to the new Landlord for the return of said security, and it is
agreed that the provisions hereof shall apply to every transfer or assignment made
of the security to a new Landlord. Tenant further covenants that it will not assign
or encumber or attempt to assign or encumber the monies deposited herein as
security and that neither Landlord nor its successors or assigns shall be bound by
any such assignment, encumbrance, attempted assignment or attempted
encumbrance. In the event Landlord applies or retains any portion or all of the
security deposited pursuant to the terms of this Section&nbsp;28.1, Tenant shall forthwith
restore the amount so applied or retained so that at all times the amount deposited
shall be the full amount of the security deposit required at the relevant time.
Landlord shall not be responsible for the payment of any interest on the Security
Deposit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28.2 <u>Letter of Credit</u>. In satisfaction of the Security Deposit obligation
contained in Section&nbsp;28.1 above, Tenant shall deliver to Landlord, and shall
maintain in effect at all times during the Initial Term following delivery thereof, a
clean, unconditional and irrevocable letter of credit, in substantially the form
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->50<!-- /Folio -->
</DIV>





<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">annexed hereto as Exhibit&nbsp;E (the &#147;Letter of Credit&#148;) in the amount of the Security Deposit
described in Article&nbsp;1 hereof issued by Imperial Bank or another banking corporation (&#147;Bank&#148;)
reasonably satisfactory to Landlord. Such letter of credit shall have an expiration date no earlier
than the first anniversary of the date of issuance thereof and it shall be automatically renewed
from year-to-year unless terminated by the Bank by notice to Landlord given not less than
forty-five (45)&nbsp;days prior to the then expiration date therefor. It is agreed that in the event
there exists an Event of Default in respect of any of the terms, covenants or provisions of this
Lease, including, but not limited to, the payment of Rent, or if any letter of credit is terminated
by the Bank and is not replaced within thirty (30)&nbsp;days prior to its termination or expiration that
(A)&nbsp;Landlord shall have the right to require the Bank to make payment to Landlord of so much of the
entire proceeds of the letter of credit as shall be reasonably necessary to cure the Event of
Default (or the entire proceeds if notice of termination is given as aforesaid and the letter of
credit is not replaced as aforesaid), and (B)&nbsp;Landlord may apply said sum so paid to it by the Bank
to the extent required for the payment of Rent or any other sum as to which an Event of Default by
Tenant exists or for any sum which Landlord may expend or may be required to expend by reason of an
Event of Default by Tenant in respect of any of the terms, covenants and conditions of this Lease,
including, but not limited to, any damages or deficiency in the reletting of the Premises, whether
such damages or deficiency accrue before or after summary proceedings or other re-entry by
Landlord, without thereby waiving any other rights or remedies of Landlord with respect to such
Event of Default. If Landlord applies any part of the proceeds of a letter of credit, Tenant, upon
demand, shall deposit with Landlord promptly the amount so applied or retained (or increase the
amount of the letter of credit) so that the Landlord shall have the full deposit on hand at all
times during the Term. If, subsequent to a letter of credit being drawn upon, a new letter of
credit meeting all the requirements set forth in this Section&nbsp;28.2 is delivered to Landlord, any
proceeds of the former letter of credit then held by Landlord shall be promptly returned to Tenant.
If Tenant shall fully and faithfully comply with all of the terms, covenants and provisions of this
Lease, any letter of credit, or any remaining portion of any sum collected by Landlord hereunder
from the Bank, together with any other portion or sum held by Landlord as security, shall be
returned to Tenant within thirty (30)&nbsp;days after the last day of the Initial Term of this Lease. In
the event of an assignment by Landlord of its interest under this Lease, Landlord shall have the
right to transfer the security to the assignee, and Tenant agrees to look to the new Landlord
solely for the return of said security and it is agreed that the provisions hereof shall apply to
every transfer or assignment made of the security to a new Landlord.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28.3 <U>Reduction of Security Deposit</U>. Provided Tenant is not then in default and there
has never been an Event of Default under this Lease, the Security Deposit will be reduced to an
amount equal to six (6)&nbsp;months Yearly Fixed Rent upon the later of (a)&nbsp;the commencement of the
twenty-fifth month of the Lease Term or (b)&nbsp;the date on which Tenant has sustained for a period
of six months a tangible
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->51<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">net worth in a total amount including cash and cash balances equal to or exceeding
$30,000,000, as set forth in audited financial statements provided by Tenant, which
financial statements shall be computed in accordance with generally accepted
accounting principles. The date upon which Tenant is entitled to such a reduction in
the Letter of Credit is hereinafter deemed the Reduction Date. Provided Tenant has met
the conditions of this Section&nbsp;28.3, upon the written request of Tenant made on or
after the Reduction Date, Landlord shall exchange the Letter of Credit for a
replacement letter of credit provided by Tenant in the amount equal to six (6)&nbsp;months
Yearly Fixed Rent upon the same terms and conditions as the Letter of Credit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">29. SALE OF BUILDING
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29.1 Except as otherwise provided, provided Tenant is not in default hereunder
beyond any applicable notice and cure period, and the named Tenant Genesoft, Inc. is
occupying not less than 50% of the Demised Premises, Landlord shall, prior to
marketing the Building for sale to an unaffiliated third party, provide a pre-sale
notice to Tenant advising Tenant of Landlord&#146;s intention to market the Building.
Landlord will refrain from marketing the Building for a period of thirty (30)&nbsp;days,
during which time Tenant may submit an offer to purchase to Landlord for Landlord&#146;s
consideration without any obligation. Nothing herein shall require Landlord to accept
any such offer submitted by Tenant. Notwithstanding the foregoing, said pre-sale
notice shall not apply to (a)&nbsp;an unsolicited offer to purchase submitted to Landlord
without marketing efforts by Landlord, (b)&nbsp;a deed of trust or mortgage and to the
foreclosure of the same or the granting of a deed in lieu of foreclosure, or (c)&nbsp;a
sale of the Building to an affiliate of Landlord or to anyone owning an equity
interest in Landlord, or to the sale or transfer of equity interests in Landlord. The
provisions of this Section&nbsp;29 are (a)&nbsp;personal to Genesoft, Inc. and its Corporate
Transferrees (but not to any assignee thereof) and shall apply only to the first sale
of the Building to which this Section&nbsp;29 applies, but not to any subsequent sale.
Tenant agrees that a foreclosure or deed in lieu of foreclosure of a mortgage or deed
of trust shall extinguish this Section&nbsp;29.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Landlord and Tenant have caused this instrument to be
executed under seal, all as of the day and year first above written.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">MJ RESEARCH COMPANY, INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">GENESOFT, INC.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Illegible
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ David B. Singer</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its PRESIDENT<BR>
title (duly-authorized)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Its President &#038; CEO<BR>
title (duly-authorized)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->52<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943236.gif" alt="(CHART)">
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943237.gif" alt="(CHART)">
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943238.gif" alt="(CHART)">
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><u>EXHIBIT A-1</u>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><u>LANDLORD&#146;S WORK</u>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Building Type:</b> 3 Story, Group B, Type III, 1 Hour
Rated, fully sprinklered office
building. All design and construction in conformance with the 1998 (CBC)&nbsp;Building
Standards Administrative Code of the California Building Standards
Commission (CBSC)&nbsp;and
the City of South San Francisco amendments, applicable codes and regulations. The building
exit&#146;s, lavatories and common space will be furnished fully-ADA compliant throughout.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Site Development:</b> Bituminous paved parking lots with concrete curbing. Parking
allocation as per lease Section&nbsp;2.2. Walks are concrete and masonry pavers. All parking
areas and walkways are illuminated to required minimum code
specifications. BCDC path is
paved in bituminous with benches, drinking fountain and open pavilion area. Loading door
into tenant space with shared trash enclosure and fencing around utility yard. Entire site
fully landscaped including palm tree lined roadway, burms, waterfront lawn area, extensive
shrubbery and automatic irrigation system.</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Tenant&#146;s proposed future chemical containment facility subject to all approvals, rules and
regulations of Sierra Point Owners Association, Sierra Point Environmental Management Association
and all pertaining governmental agencies. Although owner will use reasonable efforts to accommodate
the proposed facility, it is at tenant&#146;s sole risk and responsibility to obtain approvals and
permits. The unit will be required to contain an approved automatic fire suppression system. The
facility and finish will be screened, constructed and landscaped with materials and methods
consistent with the integrity of the project and site. Any parking allocation eliminated by the
siting of the facility will be deducted from tenant&#146;s non-exclusive allocation. Public access to
BCDC path will be in no way hindered by facility. Upon termination of the lease, it will be
required that the unit be removed and remediated and the site is returned to its originally
landscaped condition.</I>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Telephone, Gas and Electric Utilities:</b> Gas and electric will be provided to
separately metered services within the building. A 4000 amp electric service will be
divided equally between the 2 tenants and plumbed to individual sub panel distribution
rooms. Tenant is responsible for 50% of any upgrade costs incurred by landlord to increase
from 3500 amp service to 4000 amp&#146;s as proposed by tenant.
Emergency generator will be provided for back up power for tenant&#146;s use, emergency
lighting, life safety systems and laboratory support equipment. Tenant is responsible for
50% of all cost&#146;s associated with the purchase and installation of generator to be
specified by owner. Generator size will not exceed twice
tenant&#146;s load requirement. Two telephone service entrance conduits (4&#148;) are provided into
buildings common electrical
room and are to be shared by all building tenants. Tenant&#146;s telephone service requirements
are tenant&#146;s sole responsibility and will need to be further
accessed by Pac Bell or other
service provider.</TD>
</TR>

</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Water Service:</b> Domestic hot and cold water to core bathrooms and showers will be
provided. House meter in landlord&#146;s space will be affixed to tenant&#146;s water feed to
calculate consumption of water to areas other than common space. Base building fire
sprinkler system will be provided with only upturned heads throughout.
Modifications to base system to accommodate tenant improvements are the sole
responsibility of tenant.<BR></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">5.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Sanitary and Laboratory Sewer:</b> Additional provisions
have been made below the
1<SUP style="font-size: 85%; vertical-align: text-top">st</SUP> floor
slab for both normal and laboratory waste systems. Both systems are oversized with
6&#148; piping. The lab system is of chemical and DI resistant plastic
piping. Stub ups for waste connections on the 1<SUP style="font-size: 85%; vertical-align: text-top">st</SUP> floor
have been provided intermittently,
along the central column lines. Tenant is responsible to monitor, downstream, the DI resistant
waste line to insure that no chemicals are released into the laboratory waste system.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">6.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Foundation / Superstructure:</b> The structure is founded on cathodically protected steel
pilings, concrete footings, structural slab and skirt wall supporting a rigid structural
steel frame. Joists are I-beam shaped and protected with sprayed on monokote fireproofing.
The main floor is a concrete topping slab structural concrete main slab. The floor to
floor dimension is 16&#146;-6&#148; on the first floor and 17&#146; on the
2<SUP style="font-size: 85%; vertical-align: text-top">nd </SUP>and
3<SUP style="font-size: 85%; vertical-align: text-top">rd </SUP>floors.
The floor live loading is 140 lbs. per square foot. The upper 2 floors are
poured concrete on metal decking. The roof load is designed with 24 lb. per square foot
loading. A continual central band of 50 lb. per square foot loading is provided for
rooftop mechanical equipment. Rooftop screen areas are oversized to house intensive
rooftop equipment. Any alterations required to support, distribute, screen or house the
tenant&#146;s rooftop mechanical equipment is at the sole responsibility and cost of the
tenant. Any alterations to the roof that require the penetration, removal, flashing, or
capping shall be constructed in a fashion as not to void the landlord&#146;s warranty of the
roof.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">7.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Envelope: </b>Exterior wall system is Glass Fiber Reinforced Concrete (GFRC)&nbsp;with a glass curtain
wall system and aluminum frames. Window heights are (floor to head) 10&#146; on 1<SUP style="font-size: 85%; vertical-align: text-top">st </SUP>floor
and 11&#146; on 2<SUP style="font-size: 85%; vertical-align: text-top">nd </SUP>and 3<SUP style="font-size: 85%; vertical-align: text-top">rd </SUP>floors
with spandrel glass above. Windows are 1/4&#148; monolithic vision glass, tinted &#145;Blue Sapphire&#146; and manufactured by Interpane.
GFRC system is white with brown base and darker stone aggregate. Rooftop mechanical
screens are &#043;- 9&#146;-6&#148; tall at EIFS and &#043;- 12&#146; tall at the spandrel glass curtain wall, built on
galvanized steel frames. Roofing system is a 4-ply built up membrane over rigid insulation. Any
alterations to the roof that require penetration, removal, flashing or capping shall be the
sole responsibility of the tenant and be constructed by a manufacturers certified installer as
not to void the landlords warranty on the roof. Landlord does not warranty to tenant any
roofing areas that are affected by tenant&#146;s alterations.</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">8.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Tenant Area Improvements:</b> Bathroom cores, all floors, complete and functional with
fixtures, accessories, lighting and finishes consistent with core improvements.
The general finish concept is to create a high-tech industrial but
warm feeling. Stained and colorized concrete floors, granite tile walls, brushed stainless steel accents,
partitions, hardboard paneling and laminates and accent lighting will be used. Galvanized
spiral ductwork and exposed ceilings may be used in bathrooms and core for accents. Open
areas will be furnished with perimeter wall and column furring throughout. Horizontal
window blinds will be provided at all windows. Rated stair shafts and doors along with
electrical distribution rooms will be constructed on all floors. Automatic fire sprinkler
system with up-turned heads and basic fire alarm panel will be provided. Exit signs at all
major exits. Stairwells will be provided with colorized concrete stair pans or rubber
studded tile treads. Painted steel railings with horizontal balustrade will be provided at
tenant stairwell. Future elevator pit and shaft provisions have been provided for tenant&#146;s
use. Elevator improvements other than the 2 core elevators are not included. If tenant
elects to provide additional elevator it is at their sole cost.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">9.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Common Area Improvements:</b> Lobby complete with architectural security desk, oversized
wood doors, lighted soffits, semi-exposed ceilings, spiral ductwork, colorized concrete
floors, accent lighting, hardboard paneling and etc. Elevator finishes to be brushed
stainless steel with light wood hardboard paneling. Feature stair to be provided with
architectural stainless steel railing &#038; balustrade, flooring consistent with core
improvements. Finishes and other common areas such as fitness and lunch room to match the
integrity and concept of the described core improvements. Lunchroom to be fully equipped
with sinks, casework, counters, interior and exterior seating.</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT A-2</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>LANDLORDS WORK NECESSARY FOR TENANT IMPROVEMENTS</u>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Building Type:</b> 3 Story, Group B, Type III, I Hour Rated, Sprinklered Office Building.
All design and construction progress in conformance with the 1998 (CBC) Building Standards
Administrative Code of the California Building Standards Commission
(CBSC)&nbsp;and the City of
South San Francisco amendments, applicable codes and regulations. ADA compliance may not
be completed prior to tenant&#146;s construction commencement.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Site Development:</b> Walks, paving and parking lots will be substantially complete.
Striping may not be complete. Loading areas and paths of travel will be provided to allow
for the interior and exterior construction of improvements.
Substantial sitework and
landscaping will be in place and must be adequately protected by tenant&#146;s construction
team. Any damage to these areas will need to be adequately repaired or replaced by tenant.
A tenant construction trailer, storage container and debris container will be allowed on
site subject to approval and siting by landlord&#146;s representative. Any damage to these
designated areas will need to be adequately restored to original condition by tenant.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Telephone Gas and Electric Utilities:</b> 2000 amps of permanent electric will be
provided to the tenant&#146;s pull section in common electrical room and can be used for
construction power subject to delays in tenant&#146;s request for upgrade. Upgrade from 3500
amp to 4000 amp main service and switchgear, subject to additional tenant cost. Gas meter
and service will be provided subject to tenant&#146;s mechanical loads and installation
schedule. Telephone entrance conduits only are provided to common electrical room.
Temporary jobsite telephone is tenant&#146;s sole responsibility.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Water Service:</b> Water service to building and main meter in vault outside
building. Tie in subject to tenants requirements and schedule.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">5.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Sanitary and Laboratory Sewer:</b> Below slab plumbing to be provided. Tie in and
activation subject to tenant&#146;s loads and installation schedule.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">6.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Foundation / Superstructure:</b> To be provided as per Section&nbsp;6 in Lease Exhibit&nbsp;A-1,
Landlord&#146;s Work.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">7.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Envelope:</b> Building to be substantially &#145;dried in&#146; complete with GFRC exterior wall
system, glass curtain wall system, exterior doors and roofing. A section of window and
frame will be left void, on each upper floor, to allow for the delivery and handling of
construction materials. It is the tenant&#146;s sole responsibility to protect the opening from
weather as well as protect the GFRC and surrounding area from damage.
When reasonably requested by tenant, landlord will then install window unit in coordination
with tenants contractor. Roofing system will be substantially complete in areas not
affected by tenants extensive rooftop alterations.</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">8.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Tenant Area Improvements:</b> Work in central core areas will be progressing
simultaneously with tenant&#146;s work. Efforts will be made to leave areas free of obstruction
and debris. If deemed necessary, temporary dust barriers will be constructed to segregate
the simultaneous build outs. Vertical circulation will be provided via the tenant
stairwell. Stairwell shafts will be enclosed and operational but will remain unfinished
until appropriate time in coordination with tenant&#146;s build out.
Perimeter and column furring will be provided throughout. Automatic fire sprinkler with
upturned heads only will be provided throughout. Provisions have been
made to zone off
the sprinkler mains per each floor. Any shut downs to accommodate tenant&#146;s sprinkler
installation will need to be coordinated with landlord&#146;s
contractor. Freight elevator pit will be constructed be and left void with temporary railing surround.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">9.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><b>Common Area Improvements:</b> Work in central core and common areas will be accessible
but work will be progressing simultaneously with tenant&#146;s work. Common Electrical room
will be constructed. Completion of electrical room is subject to schedule and coordination
of power upgrade, generator installation, and telephone equipment installation. Central
stair will be under finish construction and restricted for access by tenant&#146;s contractors
except for cases of material handling hardships. The intention is to preserve and maintain
the architectural finishes of the central stair, until actual building occupancy.</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT B</u>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>CLEANING SCHEDULE</u>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">I.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Premises</u></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Daily on Business Days</u>:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Empty all waste receptacles and ash trays and remove waste materials from the
Premises.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep and dust mop all uncarpeted areas using a dust-treated mop.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Vacuum all rugs and carpeted areas.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Hand dust and wipe clean with treated cloths all horizontal cleared surfaces
including desk tops, office equipment, window sills, door ledges, chair rails and counter
tops, within normal reach.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">e.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash clean all water fountains.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">f.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Upon completion of cleaning, all lights will be turned off and doors locked, leaving
the Premises in an orderly condition.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Quarterly</u></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Render high dusting not reached in daily cleaning to include:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dusting all pictures, frames, charts, graphs and similar wall hangings.<BR></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dusting all vertical surfaces, such as walls, partitions, doors and ducts.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dusting of all pipes, ducts and high moldings.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>II.</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Lavatories</u></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Daily on Business Days</u>:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep and damp mop floors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Clean all mirrors, powder shelves, dispensers and receptacles, bright
work, flushometers, pipes and toilet seats.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash both sides of all toilet seats.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash all basins, bowls and urinals.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">e.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dust and clean all powder room fixtures.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">f.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Empty and clean paper towel and sanitary disposal receptacles.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">g.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Remove waste paper and refuse.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">h.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Refill tissue holders, soap dispensers, towel dispensers, vending
sanitary dispensers; materials to be furnished by Landlord.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">i.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A sanitizing solution will be used in all lavatory cleaning.</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Monthly</u>:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Machine scrub lavatory floors.<BR></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash all partitions and tile walls in lavatories.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">III.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Main Lobby, Elevators, Building Exterior and Corridors</u></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Daily on Business Days</u>:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep and wash or spray buff all marble floors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep all entrance mats.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Clean elevators, wash or vacuum floors, wipe down walls and doors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Spot clean any metal work surrounding building entrance doors.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Monthly</u>:</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>All resilient tile floors in public areas to be treated equivalent to spray buffing.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">IV.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Window Cleaning</u></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The outside of exterior wall windows will be washed once every three months, weather
permitting, and the inside of exterior wall windows will be &#183;washed every six months.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">V.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Tenants requiring services in excess of those described above shall request same
through Landlord, at Tenant&#146;s expense.</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT C</u>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><u>RULES AND REGULATIONS</u>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;The sidewalks, entrances, passages, courts, elevators, vestibules, stairways, corridors or
halls of the Building shall not be obstructed or encumbered or used for any purpose other than
ingress and egress to and from the premises demised to any tenant or occupant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;No awnings or other projections shall be attached to the outside walls or windows of the
Building without the prior consent of Landlord. No curtains, blinds, shades, or screens shall be
attached or hung in, or used in connection with, any window or door of the premises demised to any
tenant or occupant, without the prior consent of Landlord. Such awnings, projections, curtains,
blinds, shades, screens, or other fixtures must be of a quality type, design and color, and
attached in a manner, approved by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;No sign, advertisement, object, notice or other lettering shall be exhibited, inscribed,
painted or affixed on any part of the outside or inside of the premises demised to any tenant or
occupant or of the Building without the prior consent of Landlord. Interior signs on doors and
directory tables, if any, shall be of a size, color and style approved by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;The sashes, sash doors, skylights, windows, and doors that reflect or admit light and air
into the halls, passageways or other public places in the Building shall not be covered or
obstructed, nor shall any bottles, parcels, or other articles be placed on any window sills.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;No show cases or other articles shall be put in front of or affixed to any part of the
exterior of the Building, nor placed in the halls, corridors, vestibules or other parts of the
Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;The water and wash closets and other plumbing fixtures shall not be used for any purposes
other than those for which they were constructed, and no sweepings, rubbish, rags, or other
substances shall be thrown therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;No tenant or occupant shall mark, paint, drill into, or in any way deface any part of the
Building or the premises demised to such tenant or occupant, except to the extent required for the
mounting of pictures and other normal office fixtures. No boring, cutting or stringing of wires
shall be permitted, except with the prior consent of the, Landlord, and as Landlord may direct. No
tenant or occupant shall install any resilient tile or similar floor covering in the premises
demised to such tenant or occupant except in a manner reasonably approved by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;No bicycles, vehicles or animals of any kind (other than animals allowed under the
Permitted Uses) shall be brought into or kept in or about the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">premises demised to any tenant. Bicycles may be stored in racks, if any, furnished for such
purpose by Landlord in a common area of the Property. No cooking
shall be done or permitted in the
Building (other than microwave use and coffee machines) by any tenant without the approval of
Landlord. No tenant shall cause or permit any unusual or objectionable odors to emanate from the
Premises demised to such tenant.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;Without the prior consent of Landlord, no space in the Building shall be used for
manufacturing, or for the sale of merchandise, goods or property of any kind at auction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;No tenant shall make, or permit to be made, any unseemly or disturbing noises or disturb
or interfere with other tenants or occupants of the Building or neighboring buildings or premises
whether by the use of any musical instrument, radio, television set or other audio device, unmusical noise, whistling,
signing, or in any other way. Nothing shall be thrown out of any doors or windows.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;Each tenant must, upon the termination of its tenancy, restore to
Landlord all keys of stores, storage areas, offices and toilet rooms, either
furnished to, or otherwise procured by, such tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;All removals from the Building, or the carrying in or out of the
Building or the premises demised to any tenant, of any sales, freight, furniture, or bulky
matter of any description must take place at such time and in such manner as Landlord or
its agents may determine, from time to time. Landlord reserves the right to inspect all
freight to be brought into the Building and to exclude from the Building all freight which
violates any of the Building Rules or the provisions of such tenant&#146;s lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;No tenant shall use or occupy, or permit any portion of the premises
demised to such tenant to be used or occupied, as an office for a public stenographer,
messenger service or typist, or as a barber or manicure shop, or as an employment bureau.
No tenant or occupant shall engage or pay any employees in the Building, except those
actually working for such tenant or occupant in the Building, nor advertise for laborers
giving an address at the Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.&nbsp;No
tenant or occupant shall purchase spring water, ice, food,
beverage, lighting maintenance, cleaning towels or other like service, from any company or person not
approved by Landlord, such approval not unreasonably to be withheld.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.&nbsp;Landlord shall have the right to prohibit any advertising by any
tenant or occupant which, in Landlord&#146;s opinion, tends to impair the reputation of the Building or
its desirability as a building for offices, and upon notice from Landlord, such tenant or
occupant shall refrain from or discontinue such advertising.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.&nbsp;Landlord reserves the right to exclude from the Building, between the hours of 6:00 p.m.
and 8:00 a.m. on Business Days and otherwise at all hours, all persons who do not present adequate
identification or a pass to the building signed by the Landlord. Landlord will furnish passes to
persons for whom any tenant requests such passes. Each tenant shall be responsible for all persons
for whom it requests such passes and shall be liable to Landlord for all wrongful acts of such
persons.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.&nbsp;Each
tenant, before closing and leaving the premises demised to such tenant at any time,
shall see that all entrance doors are locked and windows closed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.&nbsp;Each
tenant shall, at its expense, provide artificial light in the premises demised to
such tenant for Landlord&#146;s agency, contractors, and employees while performing janitorial or other
cleaning services and making repairs or alterations in said premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.&nbsp;No premises shall be used, or permitted to be used, for lodging or sleeping, or for any
immoral or illegal purpose.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20.&nbsp;There shall not be used in the Building, either by any tenant or occupant or by their
agents or contractors, in the delivery or receipt of merchandise, freight or other matter, any hand
trucks or other means of conveyance except those equipped with rubber tires, rubber side guards and
such other safeguards as Landlord may require.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.&nbsp;Canvassing, soliciting and peddling in the Building are prohibited and each tenant and
occupant shall co-operate in seeking their prevention.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22.&nbsp;Subject to Section&nbsp;7.6, if the premises demised to any tenant become infested with vermin,
such tenant, at its sole cost and expense, shall cause its premises to be exterminated from time to
time, to the satisfaction of Landlord, and shall employ such exterminators therefor as shall be
approved by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.&nbsp;No premises shall be used, or permitted to be used, at any time, without the prior
approval of Landlord, as a store for the sale or display of goods, wares or merchandise of any
kind, or as a restaurant, shop, booth, bootblack or other stand, or for the conduct of any
business or occupation which predominantly involves direct patronage of the general public in the
premises demised to such tenant, or for manufacturing or for other similar purpose.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24.&nbsp;No tenant shall move, or permit to be moved, into or out of the Building or the premises
demised to such tenant, any heavy or bulky matter, without the specific approval of Landlord. If
any such matter requires special handling, only a person holding a Master Rigger&#146;s license shall be
employed to perform such special handling. No tenant shall place, or permit to be placed, on any
part of the floor or floors of the premises demised to such tenant, a load exceeding
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the floor load per square foot which such floor was designed to carry and which is allowed by law.
Landlord reserves the right to prescribe the weight and position of safes and other heavy matter,
which must be placed so as to distribute the weight.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25.&nbsp;
The requirements of tenants will be attended to only upon application at the office of
the Building. Building employees shall not be required to perform, and shall not be requested by
any tenant or occupant to perform, any work outside of their regular duties, unless under specific
instructions from the office of the managing agent of the Building.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT D</u>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>SIGN CRITERIA</u>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Notes:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Total tenant signage area not to exceed 100 square feet and shall be consistent
with Landlord and Sierra Point format as approved by The City of South San Francisco
Building Department and Planning Commission.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Tenant shall use Landlords sign contractor. Signage shall not be permitted in
areas beyond those shown on elevations below.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><IMG src="f39432xe3943239.gif" alt="(BUILDING PLANS)">
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This Letter of Credit is subject to the Uniform Customs and Practice for Documentary Credit (1993 Revision) International Chamber of Commerce Publication No.
500 and any subsequent revisions thereof approved by a Congress of the International Chamber of Commerce and adhered to by Bank.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">IMPERIAL BANK INTERNATIONAL 3,696,840 <U>00</u> <U>CTS</u>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="23%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><IMG src="f39432xe3943240.gif" alt="(IMPERIAL BANK LOGO)"></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="center">International Division<BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>IMPERIAL BANK</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>&#091;x&#093;</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2015 Manhattan Beach Blvd.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091; &#093;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">456 Montgomery St.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SWIFT IMPBUS66</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>California&#146;s Business Bank</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Redondo Beach, CA 90278
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4th Floor, Suite&nbsp;420
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Telex: 3730628</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Member FDIC</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">San Francisco, CA 94104
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Answer Back: Imperial INW</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">DATE: 11/07/00</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">FROM:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">IMPERIAL BANK<BR>INTERNATIONAL DIVISION</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">2015 MANHATTAN BEACH BLVD</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">REDONDO BEACH, CA 90278</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">U.S.A.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">TELEX: 3730628 (IMPERIAL INW)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">SWIFT: IMPBUS66</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">APPLICANT:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">GENESOFT, INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">TWO CORPORATE DRIVE</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">SOUTH SAN FRANCISCO, CA 94080</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">IN FAVOR OF:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">MJ RESEARCH COMPANY, INC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">384 OLYMPIC POINT BLVD.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">SOUTH SAN FRANCISCO, CA 94080</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WE HEREBY ESTABLISH OUR IRREVOCABLE TRANSFERABLE STANDBY LETTER OF CREDIT
NO. OSF00001477 EXPIRING 11/07/01 AT OUR S.F. INTL. DIV. COUNTERS FOR AMOUNT:
USD3,696,840.00 (THREE MILLION SIX HUNDRED NINETY SIX THOUSAND EIGHT HUNDRED
FORTY EXACTLY).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">CREDIT IS AVAILABLE WITH IMPERIAL BANK
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">INTERNATIONAL DIVISION<BR>
275 BATTERY STREET SUITE 1100<BR>
SAN FRANCISCO, CA 94111 U.S.A.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">BY PAYMENT OF DRAFTS AT SIGHT.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">DRAFTS DRAWN ON:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">IMPERIAL BANK<BR>
INTERNATIONAL DIVISION<BR>
275 BATTERY STREET SUITE 1100<BR>
SAN FRANCISCO, CA 94111 U.S.A.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">REQUIRED DOCUMENTS:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">1. THE ORIGINAL OF THIS LETTER OF CREDIT AND AMENDMENT(S) IF ANY.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">2. BENEFICIARY&#146;S STATEMENT DATED AND PURPORTEDLY SIGNED BY AN AUTHORIZED
OFFICER CERTIFYING THAT THE &#147;TENANT&#148; (AS DEFINED IN THE LEASE) IS IN DEFAULT OR THAT AN EVENT OF
DEFAULT HAS OCCURRED UNDER ONE OR MORE OF THE TERMS OF THAT CERTAIN LEASE AGREEMENT DATED OCT. 6,
2000 THAT EXISTS BETWEEN GENESOFT, INC. AND MJ RESEARCH COMPANY, INC. (THE &#147;LEASE&#148;) AND THAT ANY
APPLICABLE CURE PERIOD HAS LAPSED WITHOUT REMEDY.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">ADDITIONAL CONDITIONS:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ALL INFORMATION REQUIRED UNDER DOCUMENT REQUIREMENT NO. 2 WHETHER INDICATED BY BLANKS, BRACKETS OR
OTHERWISE, MUST BE COMPLETED AT THE TIME OF DRAWING.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ALL SIGNATURES MUST BE MANUALLY EXECUTED IN ORIGINALS.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">PAGE 1 OF 3 TO IRREVOCABLE STANDBY LETTER OF CREDIT NO. OSF00001477
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This Letter of Credit is subject to the Uniform Customs and Practice for Documentary Credit (1993 Revision) International Chamber of Commerce Publication No.
500 and any subsequent revisions thereof approved by a Congress of the International Chamber of Commerce and adhered to by Bank.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="23%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><IMG src="f39432xe3943240.gif" alt="(IMPERIAL BANK LOGO)"></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="center">International Division<BR></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>IMPERIAL BANK</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>&#091;X&#093;</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2015 Manhattan Beach Blvd.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091; &#093;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">456 Montgomery St.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SWIFT IMPBUS66</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>California&#146;s Business Bank</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Redondo Beach, CA 90278
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4th Floor, Suite&nbsp;420
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Telex: 3730628</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Member FDIC</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">San Francisco, CA 94104
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Answer Back: Imperial INW</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">PAGE 2 OF 3 TO IRREVOCABLE STANDBY LETTER OF CREDIT NO. OSF00001477
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">PARTIAL DRAWINGS MAY BE MADE UNDER THIS LETTER OF CREDIT, PROVIDED, HOWEVER, THAT EACH SUCH
DEMAND THAT IS PAID BY US SHALL REDUCE THE AMOUNT AVAILABLE UNDER THIS LETTER OF CREDIT.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">IT IS A CONDITION OF THIS LETTER OF CREDIT THAT IT SHALL BE DEEMED
AUTOMATICALLY EXTENDED WITHOUT AMENDMENT FOR ONE YEAR PERIODS FROM THE PRESENT
EXPIRATION DATE HEREOF, UNLESS FORTY FIVE (45)&nbsp;DAYS PRIOR TO ANY SUCH DATE, WE
SHALL NOTIFY YOU IN WRITING BY CERTIFIED MAIL OR COURIER SERVICE AT THE ABOVE
LISTED ADDRESS THAT WE ELECT NOT TO CONSIDER THIS IRREVOCABLE LETTER OF CREDIT
RENEWED FOR ANY SUCH ADDITIONAL PERIOD. UPON RECEIPT BY YOU OF SUCH NOTICE, YOU
MAY DRAW HEREUNDER BY MEANS OF YOUR DRAFT(S) ON US AT SIGHT ACCOMPANIED BY YOUR
ORIGINAL SIGNED STATEMENT WORDED AS FOLLOWS: MJ RESEARCH COMPANY, INC. OR THE &#147;LANDLORD&#148; UNDER THE &#147;LEASE &#148; HAS RECEIVED A NOTICE FROM IMPERIAL BANK THAT
THE EXPIRATION DATE OF LETTER OF CREDIT NO.&nbsp;OSF00001477 WILL NOT BE EXTENDED FOR
AN ADDITIONAL PERIOD. AS OF THE DATE OF THIS DRAWING, MJ RESEARCH COMPANY, INC.
OR SUCH &#147;LANDLORD&#148; HAS NOT RECEIVED A SUBSTITUTE LETTER OF CREDIT OR OTHER INSTRUMENT
ACCEPTABLE TO MJ RESEARCH COMPANY, INC., OR SUCH &#147;LANDLORD&#148; IN ITS SOLE DISCRETION, AS SUBSTITUTE FOR IMPERIAL BANK LETTER
OF CREDIT NO. OSF00001477.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">NOTWITHSTANDING THE ABOVE, THE FINAL EXPIRATION DATE SHALL BE APRIL 1, 2011.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THIS LETTER OF CREDIT IS TRANSFERABLE IN WHOLE ONLY. YOU MAY TRANSFER THIS LETTER OF CREDIT TO YOUR TRANSFEREE OR SUCCESSOR
UPON SATISFACTORY DELIVERY AND PRESENTATION TO THE ISSUING BANK OF (1)&nbsp;THE ORIGINAL L/C AND AMENDMENTS,
IF ANY, FOR PROPER ENDORSEMENT (2)&nbsp;A REQUEST FOR TRANSFER ON THE ISSUER&#146;S USUAL TRANSFER FORM (3)&nbsp;VERIFICATION OF SIGNATURE
AND AUTHORITY ON SUCH TRANSFER FORM SIGNING FOR THE BENEFICIARY (4)&nbsp;PAYMENT OF A TRANSFER FEE OF USD 1,000 AND (5) ANY OTHER REQUIREMENTS RELATIVE TO
THE UCP 500 AND U.S. GOVERNMENT REGULATIONS.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">IMPERIAL BANK, UPON RECEIPT OF BENEFICIARY&#146;S REQUEST IN A MANNER AS STATED HEREIN, TO TRANSFER THIS LETTER OF CREDIT,
WILL REQUIRE THAT THE ORIGINAL OF THIS LETTER OF CREDIT AND ALL AMENDMENTS THERETO, IF ANY, BE RETURNED TO US FOR CANCELLATION.
UPON OUR RECEIPT OF SAME, A NEW LETTER OF CREDIT SHALL BE ISSUED TO THE TRANSFEREE, AS BENEFICIARY.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ALL DRAFTS AND DOCUMENTS REQUIRED UNDER THIS LETTER OF CREDIT MUST
BE MARKED: &#147;DRAWN UNDER IMPERIAL BANK LETTER OF CREDIT NO. OSF00001477.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ALL DOCUMENTS ARE TO BE DISPATCHED IN ONE LOT BY COURIER SERVICE TO
IMPERIAL BANK INTERNATIONAL DIVISION, 275 BATTERY STREET, SUITE 1100, SAN
FRANCISCO, CA 94111.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">THIS LETTER OF CREDIT SETS FORTH IN FULL THE TERMS OF OUR
UNDERTAKING AND SUCH UNDERTAKING SHALL NOT BE IN ANY WAY MODIFIED, AMENDED OR
AMPLIFIED BY REFERENCE TO ANY DOCUMENT, INSTRUMENT OR AGREEMENT REFERRED TO
HEREIN OR IN WHICH THIS LETTER OF CREDIT IS REFERRED TO OR TO WHICH THIS LETTER
OF CREDIT RELATES, AND ANY SUCH REFERENCE SHALL NOT BE DEEMED TO INCORPORATE
HEREIN BY REFERENCE ANY DOCUMENT, INSTRUMENT OR AGREEMENT.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><IMG src="f39432xe3943240.gif" alt="(IMPERIAL BANK LOGO)">
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>IMPERIAL BANK</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">FROM:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">IMPERIAL BANK</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">INTERNATIONAL BANKING DIVISION</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2015 MANHATTAN BEACH BLVD., 2ND FLOOR</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">REDONDO BEACH, CA 90278</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TEL: 310 725-4488 FAX: 310 649-3407</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">DATE:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11/07/00</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TO:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MJ RESEARCH COMPANY, INC</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">384 OLYMPIC POINT BLVD.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SOUTH SAN FRANCISCO, CA 94080</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ATTN:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">REAL ESTATE OR LETTER OF CREDIT DEPARTMENT</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">AT THE REQUEST OF THE ACCOUNT PARTY, WE ENCLOSE HEREWITH ORIGINAL OF OUR STANDBY LETTER
OF CREDIT NO.&nbsp;OSF00001477.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">SINCERELY,
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(ILLEGIBLE SIGNATURE)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">AUTHORIZED SIGNATURE
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT
F</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>LIST OF ENVIRONMENTAL REPORTS GIVEN TO TENANT</u>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>ENVIRONMENTAL DUE DILLIGENCE REVIEW OF THE SIERRA POINT ASSOCIATES TWO PROPERTIES
BRISBANE AND SOUTH SAN FRANCISCO, CALIFORNIA</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared for</I><BR>
Jon K. Wactor of Luce Forward, Hamilton and Scripps as attorney for potential purchaser
Opus West Corporation, Plessanton, California
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared By</I><BR>
ENVIRON Corporation, Emeryville, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Dated</I><BR>
February&nbsp;4, 1998<BR>
Project No.&nbsp;03-6248A

</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>UPDATE OF ENVIRONMENTAL DUE DILLIGENCE REVIEW, PARCEL 10, SHORELINE COURT, SIERRA
POINT, SOUTH SAN FRANCISCO, CALIFORNIA</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared For</I><BR>
MJ Sierra Point, LLC, South San Francisco, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared By</I><BR>
Harding Lawson Associates, Novato, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Dated</I><BR>
December&nbsp;14,1998<BR>
HLA Project No.&nbsp;43142 001

</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>FIRST AMENDED AND RESTATED DECLARATION OF COVENANTS, CONDITIONS AND ENVIRONMENTAL
RESTRICTIONS RELATING TO
ENVIRONMENTAL COMPLIANCE FOR SIERRA POINT</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Recorded By</I><BR>
Luce, Forward, Hamilton and Scripps, San Diego, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Dated</I><BR>
August&nbsp;5, 1999

</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>SUPPLEMENTAL ENVIRONMENTAL DUE DILLIGENCE, PARCEL 10,
SHORELINE COURT, SIERRA POINT, SOUTH SAN FRANCISCO, CALIFORNIA</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Prepared by</I><BR>
Harding Lawson Associates, Novato, California

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Dated</I><BR>
August&nbsp;24, 1999
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="Center" style="font-size: 14pt; margin-top: 6pt">EXHIBIT G<BR>
<U>PERMITTED HAZARDOUS MATERIALS</U><BR>
<B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="26%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-METHYLPIPERAZINE<BR>
1-Methylpiperazine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" nowrap>.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" >0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-NAPHTHALENESULFONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center">Corr</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-NAPHTHOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">99</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-NAPHTHOYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Carr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-NAPHTHYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Carc
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-OCTANOL<BR>
Octanol
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
lrr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.13 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-OCTYNE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-PHENYL-2-PROPANOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-PIPERAZlNECARBOXALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
lrr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(&#043;/-)-10-CAMPHORSULFONIC ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,1<SUP style="font-size: 85%; vertical-align: text-top">1</SUP>-CARBONYLDIIMIDAZOLE<BR>
1,1<SUP style="font-size: 85%; vertical-align: text-top">1</SUP>-Carbonyldiimidazole
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">WR-1<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,1-DICHLOROPROPENE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1B<BR>
lrr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">OHH</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,10-PHENANTHROLINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,2-DIBROMOETHANE<BR>
1,2-Dibromoethane
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tox<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,2-Dichloroethane<BR>
1,2-Dichloroethane
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Carc
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">2.1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,2-DIMETHOXYETHANE<BR>
Ethylene glycol dimethyl ether
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1B
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,3-CYCLOHEXANEBIS(METHYLAMINE)
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="26%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,3-DIBROMOPROPANE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,3-DIMETHYL-3,4,5,6-TETRAHYD<BR>
RO-2(1H)PYRIMIDINONE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
CL-II
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.06 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.06 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,4-DIAMINOBUTANE<BR>
putrescine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">99</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">15-CROWN-5
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
CL-II
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.06 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,5-DIAMINOPENTANE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">18-CROWN-6<BR>
18-Crown-6 ether
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
CL-IIIB
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,8-DIAZABICYCLO&#091;5.4.0&#093;UNDEC-
7-ENE
1,8-Diazabicyclo(5.4.0)Undec
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Corr-Base
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.13 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(1S,2R-)-(-)-CIS-1-AMINO-2-INDANOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(1S,2R)-(&#043;)-NOREPHEDRINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-(2-AMINOETHYL)-1-METHYLPY<BR>
RROLIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-(4-METHOXYPHENYL)ETHYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-(4-PYRIDYL)ETHANESULFONIC<BR>
ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-(BROMOMETHYL)NAPHTHALENE<BR>
2-(Bromomethyl) naphthalene
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-(METHYLAMINO)PYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-(TRIBUTYLSTANNYL)FURAN
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-(TRIMETHYLSILYL)ETHOXYMETHYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-II<BR>
Corr<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="26%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-ACETAMIDO-4-METHYL-5-THIA<BR>
ZOLESULFONYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2
MedChem.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-AMINO-5-CHLOROBENZOXAZOLE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-AMINO-5-DIETHYLAMINOPENTANE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-AMINO-5-NITROPHENOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tox<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-AMINO-6-METHYLPYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-AMINOBIPHENYL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
OHH<BR>
FS
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-AMINOFLUORENE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-AMINOPYRIDINE<BR>
2 - Aminopyridine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055&nbsp;Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-benzylalniline
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.11 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-BIPHENYLYL ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
OHH<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.00026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-BROMOBENZYL BROMIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Irr<BR>
Corr<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-BROMOETHANOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">95</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(2-BROMOETHYL)BENZENE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-BROMOETHYL METHYL ETHER
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1C<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-BROMOMETHYL-1,3-DIOXOLANE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
WR-1<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-BROMOPHENYL ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
OHH<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-BROMOTEREPHTHALIC ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLORO-1-METHYLPYRIDINIUM<BR>
IODIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.00022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLORO-3-NITROPYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Fs<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLORO-4-METHYL-3-NITROPY<BR>
RIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLOROBENZALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLOROBENZOYL CHLORIDE<BR>
Chlorobenzoyl chloride
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLOROBENZYL ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLOROETHANESULFONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Tox<BR>
Corr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLOROETHYL PHENYL<BR>
SULFIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Tox<BR>
Irr<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLOROETHYL PHENYL<BR>
SULFONE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Sens<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CHLOROPYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-CYCLOHEXEN-1-ONE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tax<BR>
CL-II
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-DECALONE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="26%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-DIMETHYLAMINOETHYL<BR>
CHLORIDE HYDROCHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-ETHOXYBENZYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-FLUOROBENZALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-FLUOROBENZYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.00026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-FLUOROPYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">98</TD>
    <TD nowrap valign="bottom">%</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">fl2<BR>
irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-FUROYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Corr<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-IODOBENZOIC ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Sens<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-IODOPROPANE<BR>
Iso-Propyl Iodide
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">1.43 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-MESITYLENESULFONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FS<BR>
Corr<BR>
Tax<BR>
WR-1
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-METHOXYBENZYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-METHOXYETHYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1B<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-METHOXYPROPENE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1A
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-NAPHTHOYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FS<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-NITROIMIDAZOLE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tax<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0088 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-NITROPHENYLACETIC ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">OHH<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-PHENYL-1-PROPANOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-PYRIDINECARBOXALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="top">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-THIENYLLITHIUM
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1b<BR>
Corr<BR>
Irr<BR>
WR-2
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.052 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-THIOPHENECARBOXALDEHYDE<BR>
100
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
N/R
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-THIOPHENESULFONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,2<SUP style="font-size: 85%; vertical-align: text-top">1</sup>-AZOBIS(ISOBUTYRONITRILE)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FS<BR>UR-3<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,2-DIMETHYL-1,3-DIOXOLANE-4-<BR>
METHANAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">O.Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,2-DIPHENYLETHYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,2,6,6-TETRAMETHYLPIPERIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1C<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,3-DIBROMOPROPENE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-II<BR>
OHH<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,3-DICHLORO-5,6-DICYANO-1,4-<BR>
BENZOQUINONE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Tox<BR>
WR-1
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,3-DIHYOROFURAN
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,4-DI-TERT-BUTYLPHENOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,4-DIBROMOPHENOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIA<BR>
Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,4-DICHLOROBENZYL<BR>
ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">CL-IIIB<BR>
OHH<BR>
Irr<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,4-DIMETHOXYBENZOYL
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,4-DIMETHOXYPHENYL<BR>
ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Carr<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,4-DINITROFLUOROBENZENE<BR>
2,4-dinitro-1-f1uorobenzene
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">99</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065&nbsp;Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,4,5-TRIBROMOIMIDAZOLE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,4,6-COLIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,4,6-TRIISOPROPYLBENZENESU<BR>
LFONYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,5-DIMETHYL-3-PYRROllNE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0039&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
</TR>



















<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,6-DIAMINOPYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,6-DICHLOROPYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.55 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,6-HEPTADIENOIC ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2,6-LUTIDINE<br>
2.6-Lutidine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(2R,8AS)-(&#043;)-(CAMPHORYLSULFO<BR>
NYL)OXAZlRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0022&nbsp;Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-(TRIFLUOROMETHYL)BENZALD<BR>
EHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-(TRIFLUOROMETHYL)BENZEN<BR>
ESULFONYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-(TRIFLUOROMETHYL)BENZOYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-ACETYL-1-PROPANOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-AMINO-1-PHENYLBUTANE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-AMINO-1-PROPANOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr<BR>
CL-II
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-AMINO-1,2-PROPANEDIOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-AMINOPYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.&#183;
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-BROMOPYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-BUTEN-1-0L
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-BUTENYLMAGNESIUM<BR>
BROMIDE<BR>
BUTENYLMAGNESIUM<BR>
Tetrahydrofuran
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">.5M</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
WR-2<BR>
UR-3<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-BUTYN-1-OL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-CHlOROBENZALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-CHlOROBENZOYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1<BR>
Corr<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-CHlOROPEROXYBENZOIC<BR>
ACID<BR>
M-Chloroperoxybenzoic Acid
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-CHlOROPROPANESULFONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-CYANOPHENYL ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
OHH<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-CYANOPHENYLBORONIC ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0022&nbsp;Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-CYCLOPENTYLPROPIONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0026&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-FLUORO-P-ANISALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-FLUOROANllINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-FLUOROBENZALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-METHOXYBENZVLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
IIT
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-METHYLACETOPHENONE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-METHYLBENZYLISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr<BR>
Sens<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-METHYLNORCAMPHANE-2-METHANOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-NITROBENZOYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-4<BR>
WR-1<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-NITROPHENYLACETONITRILE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-PENTENOIC ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0065&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-PHENOXYPROPYL BROMIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-PHENYL-1-PROPYNE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-PHENYLPROPYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0026&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-PYRIDINECARBOXALOEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">99</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens<BR>
CL-II
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-PYRIDYLCARBINOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.0013&nbsp;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-PYRROLINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Tox<BR>
Corr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.00104 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.00026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,3-DIMETHYLBUTYRALDEHYOE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,4-DICHLOROANILINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Sens<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,4-DIHYORO-2H-PYRAN<BR>
3,4 Dihydro-2H-pyran
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,4-DIMETHOXYBENZENESULFO<BR>
NYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,4,5-TRIMETHOXYPHENYL<BR>
ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr<BR>
OHH<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.00026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,5-BIS(TRIFLUOROMETHYL)BEN<BR>
ZALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,5-BIS(TRIFLUOROMETHYL)BRO<BR>
MOBENZENE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,5-DICHLORO-2-HYDROXYBENZ<BR>
ENESULFONYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Care<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,5-DICHLOROANILINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Irr<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,5-DICHLOROBENZALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,5-DIFLUOROBENZVLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3,5-0IMETHYLPIPERIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-(AMINOMETHYL)PIPERIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Cl-lIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top" nowrap>.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-(DIMETHYLAMINO)PYRIDINE<BR>
Dimethylaminopyridine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CORR
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed&nbsp;Occupancy&nbsp;Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-(TRIFLUOROMETHOXY)BENZE<BR>
NESULFONYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-(TRIFLUOROMETHYL)-2-PYRIMI<BR>
DINETHIOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-(TRIFLUOROMETHYL)BENZALD<BR>
EHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-(TRIFLUOROMETHYL)BENZYLA<BR>
MINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4"-CHLOROACETOPHENONE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-AMINO-1-BUTANOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-AMINOBENZOTRIFLUORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Irr<BR>
CL-II
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-AMINOBIPHENYL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-AMINOPYRIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.<BR>Irr<BR>OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-BENZYLPIPERIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-BIPHENYLSULFONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-BROMO-2-METHYL-2-BUTENE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Corr<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 &#183;Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-BROMOBENZALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-BROMOBUTYRONITRILE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-CHLOROBENZALDEHYDE<BR>
4-Chlorobenzaldehyde
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.55 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed&nbsp;Occupancy&nbsp;Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-CHLOROBENZENESULFONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Corr<BR>
WR-1
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-CHLOROBENZOYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Corr<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.00022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-CHLOROPHENYL<BR>
ISOTHIOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-CYANOBENZOYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr<BR>
WR-1
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-CYANOPHENYL&nbsp;ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
Sens<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0044 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-DIMETHYLAMINO-2,2,6,6-TETR<BR>
AMETHYLPIPERIDINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-DIMETHYLAMINOAZOBENZENE<BR>
-4<SUP style="font-size: 85%; vertical-align: text-top">1</sup>-SULFONYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-ETHYLPHENYL&nbsp;ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr<BR>
OHH<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-FLUOROBENZALDEHYDE<BR>
4-Fluorobenzaldehyde
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-FLUOROBENZENESULFONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-FLUOROBENZYL ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr<BR>
OHH<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-FLUORONITROBENZENE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-METHOXY-1-NAPHTHALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-METHOXYBENZYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed&nbsp;Occupancy&nbsp;Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5-CHLOROVALERYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Corr<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5,6-DIMETHYLBENZIMIDAZOLE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6-AMINOCAPROIC ACID<BR>
6-Aminohexanoic Acid
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6-PHENYL-1-HEXANOL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>Irr</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">7-OXOOCTANOIC ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8-QUINOLINESULFONYL<BR>
CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">A,A,A-TRIFLUORO-P-TOLYL
ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ACETALDEHYDE<BR>
Acetaldehyde
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ACETIC ANHYDRIDE<BR>
Acetic Anhydride
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
WR-2<BR>
Corr-Acid
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.26418 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.26418 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acetone
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>Irr</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">2.1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acetone
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">3 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ACETONE CYANOHYDRIN
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.<BR>CL-IIIA<BR>Irr<BR>OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>




<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ACETYL&nbsp;CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr<BR>FL-1B
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>


<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ACETYLACETONE<BR>Acetylacetone
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">%</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>Irr<BR>OHH<BR>Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>













<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ALLYL ALCOHOL<BR>
Allyl Alcohol
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Corr<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed&nbsp;Occupancy&nbsp;Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ALLYL BROMIDE<BR>
Allyl Bromide
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ALUMINUM CHLORIDE<BR>
ALUMINUM CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">1.76 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">AMMONIA<BR>
Ammonia, Anhydrous
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr<BR>
FG<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Cu.Ft.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Cu.Ft.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">6.3 Cu.Ft.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">AMMONIUM SULFAMATE<BR>
ammonium sulfamate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">%</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1<BR>
UR-1<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">2.2 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ANILINE<BR>
Aniline
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
Tox<BR>
CL-IIIA
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ANISOLE<BR>
Anisole
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
CL-II
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChern
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ANTHRANILIC ACID<BR>
anthranilic acid
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">99</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">1.1 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">B-BROMOCATECHOLBORANE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.11 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BARIUM HYDROXIDE<BR>
OCTAHYDRATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.<BR>Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BDCS SILYLATION REAGENT<BR>
Tert-Butyl Dimethylsilyl
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
CORR
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr<BR>
OHH<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZENESUlFONYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1<BR>
Corr<BR>
CL-IIIB
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZIMIDAZOLE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZO&#091;B&#093;FURAN-2-CARBOXALD<BR>
EHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZOPHENONE IMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed&nbsp;Occupancy&nbsp;Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZOYL CHLORIDE<BR>
Benzoyl Chloride
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-1<BR>
WR-1
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZOYL PEROXIDE<BR>
Benzoyl peroxide 77-95%
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">77-95</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Perox-II<BR>
Oxy-3
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZYL<BR>
1-PIPERAZINECARBOXYLATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZYL ALCOHOL<BR>
Benzyl Alcohol
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Tox<BR>
Irr<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZYL BROMIDE<BR>
BENZYL BROMIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZYL CHLOROFORMATE<BR>
Benzyl Chloroformate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>Corr<BR>WR-1
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZYL ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Irr<BR>
Sens<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZYLAMINE<BR>
Benzylamine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZYLTRIETHYLAMMONIUM<BR>
CHLORIDE<BR>
benzyltriethylammonium
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CF (Comb.<BR>Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZYLTRIMETHYLAMMONIUM<BR>
HYDROXIDE<BR>
benzyltrimethylammonium
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">40</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr<BR>
Tox<BR>&#151;<br>
&#151;
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BETA-METHYLPHENETHYLAMIN
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BIS(1,5-CYCLOOCTADIENE)NICKEL(O)
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Tox<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0044 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BIS(CYCLOPENTADIENYL)TITANIUM
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.11 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BIS(TRI-N-BUTYLTIN) OXIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
CL-IIIB
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.13 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>

<TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BOC-4-PIPERIDONE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
UR-2<BR>
WR &#183;2<BR>
Carc
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BORANE TETRAHYDROFURAN<BR>
COMPLEX<BR>
Borane-tetrahydrofuran
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1A<BR>
WR-2<BR>
UR-2
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BORANE &#183;METHYL SULFIDE<BR>
COMPLEX
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BORON TRIBROMIDE<BR>
Boron Tribromide
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
WR-2<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BORON TRIFLUORIDE<BR>
Boron trifluoride etherate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
WR-2<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BROMINE<BR>
Bromine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Corr<BR>
Oxy-3
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BROMOACETALDEHYDE<BR>
DIMETHYL ACETAL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BROMOACETIC ACID<BR>
Bromo Acetic Acid
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BROMOACETONITRILE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BROMOACETYL BROMIDE<BR>
Bromoacetyl bromide
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr<BR>
WR-2
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BROMOACETYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr<BR>
WR &#183;2
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BROMOETHANE<BR>
bromoethane
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BUTYL CHLOROFORMATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BUTYLLITHIUM
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1A<BR>
Tox<BR>
Corr<BR>
WR-3
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIETHYL<BR>
ACETYLENEDICARBOXYLATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Corr<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIETHYL AZODICARBOXYLATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
CL-II<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIETHYL CHLOROPHOSPHATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
WR-1<BR>
Corr<BR>
H.T.<BR>
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIETHYL GLUTACONATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIETHYL KETOMALONATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIETHYL OXALATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA
Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIETHYL PHOSPHITE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIISOBUTYLALUMINUM HYDRIDE<BR>
Diisobutylaluminum Hydride
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Pyro<BR>
UR-2<BR>
WR-3<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIISOPROPYLAMINE<BR>
Diisopropylamine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
FL-1B<BR>
Corr-Base
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIMETHYL<BR>
CYANODITHIOIMINOCARBONATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Tox<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.11 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dimethyl formamide (DMF)
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Carc<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">2.1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIMETHYL ITACONATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">1.1 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIMETHYL SULFATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
WR-1<BR>
Carc<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity </TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>

<TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIMETHYL SULFIDE<BR>
Methyl Sulfide
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
FL-1B
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dimethyl Sulfoxide (DMSO)<BR>
Dimethylsulfoxide (DMSO)
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
CL-IIIB<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">2.1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIMETHYLAMINE<BR>
Dimethylamine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIMETHYLCARBAMYL CHLORIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Irr<BR>
Carc<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dioxane<BR>
1,4-Dioxane
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr<BR>
Carc<BR>
FL-1B
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIPHENYLACETALDEHYDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIPHENYLPHOSPHORYL AZIDE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DL-ADRENALINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.055 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EATON&#146;S REAGENT<br>
Phosphorous Pentoxide<br>
Methanesulfonic Acid
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<br>
H.T.<br>
WR-2
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.13 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EPICHLOROHYDRIN
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
UR-1<BR>
Carc<BR>
Tox
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ethanol<BR>
Ethyl Alcohol
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">2.1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHANOLAMINE<BR>
Ethanolamine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.&#183;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHER ANHYDROUS
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1A
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">2.1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL 1-METHYLNIPECOTATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL 3-AMINOBENZOATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
&#060;/R&#062;

<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL 3-BROMOPROPIONATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS<BR>
Irr<BR>
Sens<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL 5-OXOHEXANOATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ethyl acetate<BR>
ethyl acetate-1-13C
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">%</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">6.3 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ethyl acetate<BR>
ethyl acetate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">%</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">3 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL ACETOACETATE<BR>
Ethyl Acetoacetate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL CHLOROFORMATE<BR>
Ethyl Chloroformate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1<BR>
FL-1B
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ethyl ether
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1A<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">4.2 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL HYDROGEN MALONATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL LEVULINATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.13 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL NIPECOTATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL<BR>
(R)-(-)-2-HYDROXY-4-PHENYLBUT
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL TRIFLUOROACETATE<BR>
Ethyl trifluoroacetate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYL VINYL ETHER
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1A<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYLENE GLYCOL<BR>
1,2 Ethanediol
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYLENEDIAMINE<BR>
Ethylenediamine
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.00026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
&#060;/R&#062;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="Center" style="font-size: 14pt; margin-top: 6pt"><B>Inventory for Building Occupancy Classification</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ETHYLENEIMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
UR-3D<BR>
Carc<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.104 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EXO-2-AMINONORBORNANE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">FENOPROFEN
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.022 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">FORMALDEHYDE<br>
Formaldehyde Sol&#146;n
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">37</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Carc<BR>
Tox<BR>
Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">FURFURYLAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C<BR>
Tox<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">GLYOXYLIC ACID
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">50</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.22 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HEXAMETHYLPHOSPHORAMIDE<BR>
Hexamethylphosphoramide
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Hexane<BR>
Hexane
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">3 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">1 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">hexanes, ACS HPLC grade;<br>
hexanes, anhydrous<br>
hexanes, mixed isomers
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
    <TD valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B<BR>
Irr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">6.3 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HEXYL ISOCYANATE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II<BR>
Irr
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0013 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HISTAMINE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Irr<BR>
Sens
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.011 Lbs.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HYDRAZINE HYDRATE<BR>
Hydrazine, monohydrate
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox<BR>
Corr<BR>
CL-IIIA<BR>
Carc
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Hydrochloric Acid &#062;30%<BR>
Hydrogen Chloride
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">2<BR>
MedChem
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HYDROCINNAMOYL CHLORIOE
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">100</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB<BR>
Corr<BR>
OHH
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">.0065 Gal.
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="17" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity </TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ISOPROPYLSULFONYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ISOVALERYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">KARL FISCHER REAGENT</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-METHOXYETHANOL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">L-PROLINE METHYL ESTER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.011 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.011 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HYDROCHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LITHIUM ALUMINUM HYDRIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lithium Aluminum Hydride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LITHIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BIS(TRIMETHYLSILYL)AMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LITHIUM BOROHYDRIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.11 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lithium Borohydride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LITHIUM CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lithium Chloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LITHIUM DIISOPROPYLAMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.208 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lithium Diisopropylamide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LITHIUM TETRAFLUOROBORATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">M-TOLUOYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MAGNESIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">magnesium</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MAGNESIUM PERCHLORATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-3</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HEXAHYDRATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHANESULFONIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">98</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHANESULFONYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Methanesulfonyl Chloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">





<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity </TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Methanol</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Methyl Alcohol, Anhydrous</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Methanol</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Methyl Alcohol, Anhydrous</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHOXYAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HYDROCHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Methoxylamine Hydrochloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">1-CYCLOPENTENE-1-CARBOXYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.00026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2-(BROMOMETHYL)ACRYLATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL 2-BROMOBENZOATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.02 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL 3-BROMOPROPIONATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">METHYL 4-BROMOCROTONATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.052 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-METHOXYACETOACETATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL BROMOACETATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Methyl Bromoacetate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL CHLOROFORMATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Methyl Chloroformate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL CROTONATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1b</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">98</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">METHYL CYCLOHEXYLACETATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL ISOCYANATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.007 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Methyl Isocyanate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL OXALYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL PROPIOLATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL PYRUVATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL TRANS-3-PENTENOATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0078 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYLUTHIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Pyro</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MOLYBDENUM HEXACARBONYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MORPHOLINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Morpholine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-(2-AMINOETHYL)CARBAMIC</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ACID TERT-BUTYL ESTER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N-(3&#146;-AMINOPROPYL)-2-PYRROLI</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DINONE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N-(BENZYLOXYCARBONYLOXY)S</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UCCINIMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N,N,N&#146;,N&#146;-TETRAMETHYLETHYLE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">NEDIAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CORR</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tetramethylethylenediamine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N,N,N&#148;-TRIMETHYL-1,3-PROPANE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N,N&#146;-DICYCLOHEXYLCARBODIIMI</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.25 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N,N-Dicyclohexylcarbodiimide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">95</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N,N&#146;-DIETHYL-1,3-PROPANEDIAM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">INE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N,N&#146;-DIISOPROPYLCARBODIIMID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">E</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1,3-Diisopropylcarbodiimide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">99</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N,N-diisopropylethylamine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N,N-diisopropylethylamine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">99</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N,N-DIMETHYLANILINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N,N-DIMETHYLETHYLENEDIAMIN</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">E</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N,N-DIMETHYLFORMAMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DI-TERT-BUTYL ACETAL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N,N-DIMETHYLFORMAMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.&#183;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DIMETHYL ACETAL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N,N-Dimethylformamide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N,N-DIMETHYLNEOPENTANEDIA</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N-(TERT-BUTOXYCARBONYL)-D-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.00026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PROLINAL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-ACETYLSULFANILYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 lbs</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-BROMOSUCCINIMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-Bromosuccinimide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-BUTYLAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N-CARBOBENZYLOXY-L-SERINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">METHYL ESTER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-CHLOROSUCCINIMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">CHLOROSUCCINIMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-ETHYLMETHYLAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-HEXYLMETHYLAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-Methyl Pyrrolidone (NMP)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">26 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">6 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-Methyl Pyrrolidone (NMP)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N-METHYL-N&#146;-NITRO-N-NITROSO</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">GUANIDINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N-METHYL-N-PROPARGYLBENZY</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">LAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-METHYLANILINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-methylaniline</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-METHYLSENZYLAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">N-METHYLHOMOVERATRYLAMIN</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">E</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-methylmorpholine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">4.2 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-methylmorpholine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-METHYLPHENETHYLAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-PROPYL ISOCYANATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-TRIMETHYLSILYLIMIDAZOLE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">NICKEL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nickel (Raney Activated)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">NICOTINOYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HYDROCHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nitric Acid 41-86%</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nitric Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">41-86</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">NITROMETHANE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nitromethane</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">NITROSONIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CORR</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TETRAFLUOROBORATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nitrosonium Tetrafluoroborate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">O-ANISALDEHYDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">O-ANISIDINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">o-Anisidine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH,sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">O-PHENYLENEDIAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22  Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Phenylenediamine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">O-PHTHALALDEHYDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">O-XYLENE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.26418 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">OSMIUM TETROXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Osmium(VlII) Oxide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">OXALIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.065 GaL</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Oxalic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">OXALYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Oxalyl chloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">P-ANISALDEHYDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">P-ANISIDINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">P-ANISOYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">P-Anisoyl chloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(&#043;)-P-MENTH-1-EN-9-OL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">P-TOLUALDEHYDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">P-TOLUENESULFONIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CF (Comb.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22  Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MONOHYDRATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">p-toluenesulfonic acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">P-TOLUENESULFONYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.26418 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Toluenesulfonyl Chloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">P-TOLUOYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">p-Toluoyl chloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">P-TOLYL ISOTHIOCYANATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PALLADIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Palladium on activated</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PARAFORMALDEHYDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PARAFORMALDEHYDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PERFLUORO-1-BUTANESULFON</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">YL FLUORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PERIODIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.66 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Periodic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CORR</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Petroleum Ether</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1A</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">2.1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Petroleum Ether</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHENETHYL ISOCYANATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHENETHYLAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.208 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHENOTHIAZINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">phenothiazine</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">&#043;98</TD>
    <TD nowrap>%</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHENYL CHLOROFORMATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Phenyl chloroformate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHENYL ISOTHIOCYANATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHENYLACETALDEHYDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHENYLACETYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHENYLACETYLENE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">98</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHENYLLITHIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Pyro</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">cyclohexane ethher</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.8M</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHOSGENE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.052 Cu.Ft.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Cu.Ft.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">2.6 Cu.Ft.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Phosgene</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHOSPHOMOLYBDIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HYDRATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CORR</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Phosphomolybdic Acid,</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHOSPHORIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem &#183;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Phosphorous Trichloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.055 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Phosphorous Trichloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHOSPHORUS OXYCHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.022 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.006 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POCL3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHOSPHORUS PENTACHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Phosphorus Pentachloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHOSPHORUS PENTOXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CORR</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Phosphorous Pentoxide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHOSPHORUS (V) TRIBROMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.052 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">OXIDE, 98%</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHTHALOYL DICHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PIPERIDINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Piperidine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PIPERONAL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POLYPHOSPHORIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.26 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.11 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">potassium</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BIS(TRIMETHYLSILYL)AMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Potassium bis (trimethyl silyl)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0.1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Toluene</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">99.9</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM BOROHYDRIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.011  Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM CARBONATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.065  Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM CYANIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Potassium Cyanide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM FLUORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13   Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Potassium Fluoride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM HYDROGEN</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SULFATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Potassium Bisulfate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM NITRATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">potassium nitrate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">NITROSODISULFONATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM TERT-BUTOXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Potassium tert-Butoxide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">POTASSIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.165 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYLSILANOLATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PROCAINAMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HYDROCHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PROPARGYLALCOHOL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">&#183;.026Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Propargyl Alcohol</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PROPARGYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BENZENESULFONATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PROPIOLIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CI-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">98</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PROPIONALDEHYDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="13%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Pyridine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Fl-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Pyridine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PYRIDINE-3-SULFONIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CORR</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.055 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-Pyridine Sulfonic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PYRIDINE-4-METHANOL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Cl-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PYRIDINIUM CHLOROCHROMATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Pyridinium Chlorochromate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PYRIDINIUM DICHROMATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Pyridinium Dichromate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PYRROLIDINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Pyrrolidine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(R)-(&#043;)-1-PHENYL-1-BUTANOL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">R(-)-1-PHENYL-2-PROPANOL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.00026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(R)-(&#043;)-2-METHYL-1-PHENYL-1-PR</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">OPANOL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(R)-(&#043;)-2-PHENYL-1-PROPANOL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.00026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.00026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(R)-(-)-EPICHLOROHYDRIN</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(S)-(&#043;)-EPICHLOROHYDRIN</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SAMARIUM(II) IODIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Iodine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">.1m</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tetrahydrofuran</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SELENIUM DIOXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right" nowrap>1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Selenium(lV) Oxide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SILVER (II) OXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-3</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SILVER NITRATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Silver Nitrate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="15%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">sodium</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM AZIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-3</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sodium Azide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.208 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BIS(TRIMETHYLSILYL)AMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM BOROHYDRIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sodium Borohydride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM CYANOBOROHYDRIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.11 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sodium Cyanoborohydride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM DITHIONITE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM ETHOXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM HYDRIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM HYPOCHLORITE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.26418 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM HYPOCHLORITE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">12-15</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM METAPERIODATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-3</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sodium Metaperiodate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM METHOXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CF/D (loose)</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM NITRATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sodium Nitrate</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM NITRITE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sodium Nitrite</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM TERT-BUTOXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SODIUM THIOMETHOXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.011 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SOLKETAL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TBTU</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.011 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TERT-BUTYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-PIPERAZINECARBOXYLATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TERT-BUTYL ALCOHOL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.26418 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tert Butyl Alcohol</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TERT-BUTYL BROMOACETATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TERT-BUTYL HYDROPEROXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">90</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Perox-I</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-4</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TERT-BUTYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TERT-BUTYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-(3-AMINOPROPYL)CARBAMAT</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>

<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TERT-BUTYL NITRITE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">90</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-l</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TERT-BUTYLACETYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.26418 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TETRA-N-BUTYLAMMONIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIBROMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-l</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>

<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TETRABUTYLAMMONIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">FLUORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tetrabutylammonium fluoride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TETRAETHYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tetrahydrofuran</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1&nbsp;Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tetrahydrofuran</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tetrahydrofuran</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tetrahydrofuran</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">







<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TETRAHYDROFURFURYLAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TETRAMETHYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ORTHOCARBONATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TETRAPROPYLAMMONIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-3</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PERRUTHENATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">THIONYL BROMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">THIONYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.26418 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Thionyl chloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">THIOPHENE &#183;2-CARBONYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>

<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">THIOPHOSGENE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Thiophosgene</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">THIOUREA</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Thiourea</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TIN(IV) CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tin (IV) chloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TITANIUM(IV) CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2 &#183;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.44 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Titanium Tetrachloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CORR</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Toluene</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">2.1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Toluene</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Toluene</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Toluene</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRANS-1,4-DIAMINOCYCLOHEXA</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">NE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRANS-DICHLOROBIS(TRIPHENY</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0242 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">L-PHOSPHINE)PALLADIUM (II)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRI-N-BUTYLTIN CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRI-N-BUTYLTIN HYDRIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tributyltin Hydride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIBUTYL BORATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0234 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRICHLOROMETHYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">CHLOROFORMATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIETHYL ORTHOACETATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Triethylamine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Triethylamine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIETHYLAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HYDROCHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>

<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIETHYLSILANE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Triethylsilane</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIFLUOROACETIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIFLUOROACETIC ANHYDRIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trifluoroacetic anhydride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIFLUOROMETHANESULFONIC</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trifluoromethanesulfonic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIFLUOROMETHANESULFONIC</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">. 0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ANHYDRIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trifluoromethanesulfonic</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIISOPROPYL BORATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0208 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4-BROMOORTHOBUTYRATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>

<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYL ORTHOACETATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYL ORTHOFORMATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYL ORTHOVALERATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PHOSPHONOACETATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYLAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FG</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Cu.Ft.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Cu.Ft.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">5.5 Cu.Ft.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trimethylamine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYLOXONIUM</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.044 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TETRAFLUOROBORATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYLSILYL</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">BROMOACETATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYLSILYL CYANIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trimethylsilylcyanide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYLSILYLDIAZOMETHAN</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">E</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIMETHYLTIN CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">H.T.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIPHOSGENE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.22 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Triphosgene</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRYPTAMINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.11 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UREA HYDROGEN PEROXIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Oxy-3</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">VALERYL CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">VINYLMAGNESIUM BROMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tetrahydrofuran</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1M</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-3</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Xylene</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">2.1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mixed Xylenes</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ZINC</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CF/D (loose)</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">2.2 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ZINC         METAL DUST</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ZINC         CHLORIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.55 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Zinc Chloride</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ZINC         CYANIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.011 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ZINC         IODIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.11 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">zinc iodide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right"></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt">Inventory for Building Occupancy Classification
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">3</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acetic Acid,       Glacial</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.5 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.5 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Biology</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acetic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dichloromethane</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3  Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Peptide</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ethanol</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">2  Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Biology</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ethyl Alcohol</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-Methyl Pyrrolidone (NMP)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3  Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Peptide</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-Methyl Pyrrolidone (NMP)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Piperidine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.75Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.25 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Peptide</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Piperidine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIFLUOROACETIC ACID (TFA)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.75Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.25 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Peptide</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRIFLUOROACETIC ACID</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Waste</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">4 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Peptide</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV style="margin-top: 3pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Total Quantity. Includes aggregate quantity in use and storage
per UBC.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Open Use &#151; Use of a solid or liquid hazardous material in a vessel or system that is continuously
open to the atmosphere during normal operations and where
vapors are liberated, or the product is exposed to the atmosphere during normal operations.
Examples of open systems for liquids include dispensing from or into
open beakers or containers; dip tank operations: plating operations: etc.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left"><SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Closed Use &#151;  Use of a solid or liquid hazardous
material in a closed vessel or system that remains
closed during normal operations where vapors emitted by the
product are not liberated outside of the vessel or system and the product is not exposed to the
atmosphere during normal use: and all uses of compressed gases.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Examples of closed systems for solids and liquids include product conveyed through a piping system
into a closed vessel, system, or piece of equipment; reaction
process operations;</TD>
</TR>

</TABLE>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><SUP style="font-size: 85%; vertical-align: text-top">&#169;</SUP> 1998 Integrated Engineering Services. All rights reserved.
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>Inventory for Building Occupancy Classification</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">H3
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">H3</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">H3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acetonitrile</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">330 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">330 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Store</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cyanomethane/Methyl</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">H3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dichloromethane</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">160 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Store</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">H3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dimethyl formamide (DMF)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">32 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Store</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dimethyl formamide (DMF)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">H3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Flammable Solvent Waste</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1000 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Store</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cyanomethane/Methyl</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#060;20</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">H3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-Methyl Pyrrolidone (NMP)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">160 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Store</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-Methyl Pyrrolidone (NMP)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">H3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Piperidine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-18</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">32 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Store</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Piperidine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">H3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trifluoroacetic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">32 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">Store</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trifluoroacetic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left" style="font-size: 8pt; margin-top: 12pt"><SUP style="font-size: 85%; vertical-align: text-top">1</SUP>&nbsp;Total Quantity. Includes aggregate quantity in use and
storage per UBC.</DIV>

<DIV align="left" style="font-size: 8pt"><SUP style="font-size: 85%; vertical-align: text-top">2</SUP>&nbsp;Open Use &#151; Use of a solid or liquid hazardous material in a vessel or system that is continuously
open to the atmosphere during normal operations and where
vapors are liberated, or the product is exposed to the atmosphere during normal operations.
Examples of open systems for liquids include dispensing from or into
open beakers or containers; dip tank operations; plating operations;
etc.</DIV>

<DIV align="left" style="font-size: 8pt"><SUP style="font-size: 85%; vertical-align: text-top">3</SUP>&nbsp;Closed Use &#151; Use of a solid or liquid hazardous material in a closed vessel or system that
remains dosed during normal operations where vapors emitted by the
product are not liberated outside of the vessel or system and the product is not exposed to the
atmosphere during normal use; and all uses of compressed gases.
Examples of closed systems for solids and liquids include product conveyed through a piping system
into a closed vessel, system, or piece of equipment; reaction process
operations;</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><SUP style="font-size: 85%; vertical-align: text-top">&#169;</SUP> 1998 Integrated Engineering Services. All rights reserved.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>Inventory for Building Occupancy Classification</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-(2-AMINOETHYL)PIPERIDINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-(3-AMINOPROPYL)IMIDAZOLE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-(3-DIMETHYLAMINOPROPYL)-</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3-ETHYLCARBODIIMIDE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-ADAMANTYL ISOCYANATE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.011 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-AMINO-4-METHYLPIPERAZINE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-CHLORO-2,4-DINITROBENZENE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1.1 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Sens</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-CHLORO-3-IODOPROPANE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.026 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-CHLORO-4-ETHYNYLBENZENE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FS</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.0022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="right">.0022 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Lbs.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-CHLORO-4-PHENYLBUTANE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIB</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-ETHYNYLCYCLOHEXENE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1C</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0013 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-HEPTYNE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.0065 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-IODOBUTANE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.13 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1-METHYLIMIDAZOLE</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-IIIA</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">0 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">MedChem</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N-Methyl imidazole</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left" style="font-size: 8pt; margin-top: 12pt"><SUP style="font-size: 85%; vertical-align: text-top">1</SUP>&nbsp;Total
Quantity. Includes aggregate quantity in use and storage per UBC.</DIV>

<DIV align="left" style="font-size: 8pt"><SUP style="font-size: 85%; vertical-align: text-top">2</SUP>&nbsp;Open Use &#151; Use of a solid or liquid hazardous material in a vessel or system that is continuously
open to the atmosphere during normal operations and where
vapors are liberated, or the product is exposed to the atmosphere during normal operations.
Examples of open systems for liquids include dispensing from or into
open beakers or containers; dip tank operations; plating
operations; etc.</DIV>


<DIV align="left" style="font-size: 8pt"><SUP style="font-size: 85%; vertical-align: text-top">3</SUP>&nbsp;Closed Use &#151; Use of a solid or
liquid hazardous material in a closed vessel or system that remains
closed during normal operations where vapors emitted by the
product are not liberated outside of the vessel or system and the product is not exposed to the
atmosphere during normal use; and all uses of compressed gases. Examples of closed systems for solids and liquids include product conveyed through a piping system
into a closed vessel, system, or piece of equipment; reaction
process operations;</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><SUP style="font-size: 85%; vertical-align: text-top">&#169;</SUP> 1998 Integrated Engineering Services. All rights reserved.
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>Inventory for Building Occupancy Classification</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Plan Check No.:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">Proposed Occupancy Classification:
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">B
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">Control Area No.:</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Is this area protected by a fire sprinkler system?</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Yes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="16%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Signature of Preparer:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">9/18/2000
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">3.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">5.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">6.</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">1.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">2.</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">UBC Class(es)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">4.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Stored in</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">Room</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Chemical Name &#038;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Physical &#038; Health</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Quantity</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 1px solid #000000">in Use</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Approved</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center">No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Concentration</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Hazards</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stored<SUP style="font-size: 85%; vertical-align: text-top">1</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Open<SUP style="font-size: 85%; vertical-align: text-top">2</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Closed<SUP style="font-size: 85%; vertical-align: text-top">3</SUP></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Cabinet?</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acetic Acid, Glacial</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">CL-II</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">6 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">2 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">HPLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acetic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr-Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acetonitrile</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">60 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">HPLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cyanomethane/Methyl</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Buffer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">55 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">HPLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Acetic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chloroform</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Carc</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">HPLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chloroform</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">OHH</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HPLC Waste</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">4 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">HPLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cyanomethane/Methyl</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N,N-Dimethylformamide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">HPLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Irr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:30px; text-indent:-15px"></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">N,N-Dimethylformamide</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">UR-1</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Piperidine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">FL-1B</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.75 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">.25 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Yes</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">HPLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Piperidine</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trifluoroacetic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">WR-1</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">3  Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">1 Gal.</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="right">Gal.</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">HPLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trifluoroacetic Acid</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">100</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Tox</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">Corr</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="bottom">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD colspan="23" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left" style="font-size: 8pt; margin-top: 12pt"><SUP style="font-size: 85%; vertical-align: text-top">1</SUP>&nbsp;Total
Quantity. Includes aggregate quantity in use and storage per UBC.</DIV>


<DIV align="left" style="font-size: 8pt"><SUP style="font-size: 85%; vertical-align: text-top">2</SUP>&nbsp;Open Use &#151; Use of a solid or liquid hazardous material in a vessel or system that is continuously
open to the atmosphere during normal operations and where
vapors are liberated, or the product is exposed to the atmosphere during normal operations.
Examples of open systems for liquids include dispensing from or into
open beakers or containers; dip tank operations; plating operations;
etc.</DIV>

<DIV align="left" style="font-size: 8pt"><SUP style="font-size: 85%; vertical-align: text-top">3</SUP>&nbsp;Closed Use &#151;  Use of a solid or liquid hazardous material in a closed vessel or system that
remains closed during normal operations where vapors emitted by the
product are not liberated outside of the vessel or system and the product is not exposed to the
atmosphere during normal use; and all uses of compressed gases.
Examples of closed systems for solids and liquids include product conveyed through a piping system
into a closed vessel, system, or piece of equipment; reaction
process operations;</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><SUP style="font-size: 85%; vertical-align: text-top">&#169;</SUP> 1998 Integrated Engineering Services. All rights reserved.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT H</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Casework and Hoods (including benches)<BR>
Cagewasher<BR>
Glasswasher<BR>
Autoclave<BR>
Vac Unit<BR>
CDA Unit<BR>
DI Water System<BR>
Hazardous Materials Storage Structures and Tank<BR>
Any Plumbing Carrying Hazardous Materials and/or Animal Shower and
Cleaning Facilities.

</DIV>












<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">FIRST AMENDMENT TO LEASE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement made as of this 5<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of December, 2002, between MJ
Research, Incorporated (&#147;Landlord&#148;) and Genesoft, Inc. (&#147;Tenant&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whereas, Landlord and Tenant are parties to a certain lease dated as of October&nbsp;6, 2000 with
respect to premises at 7000 Shoreline Court, South San Francisco, California (the &#147;Lease&#148;) and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whereas, Tenant has requested that Landlord partially defer certain payments of Fixed
Rent as more particularly set forth herein, and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whereas, Landlord is willing to do so upon the terms and conditions set forth herein,
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Now, therefore, the parties agree as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;Yearly Fixed Rent, as defined in the Lease, shall continue to accrue and be owed at the
rates set forth in the Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;Provided Tenant is not otherwise in default under the Lease, Landlord agrees to defer
temporarily (with respect to the Rent Deferred Space as hereinafter defined) receipt of Fixed Rent
in excess of $3.00 per rentable square foot per month for the months of December, 2002 and January
through June, 2003 (the &#147;Deferral Period&#148;), but only with respect to 38,229 s.f. of the Premises
(the &#147;Rent Deferred Space&#148;). Said deferred rent shall be hereinafter referred to as the &#147;Deferred
Rent.&#148; All Deferred Rent shall continue to accrue and be fully earned by Landlord, who, as a
convenience to Tenant, has agreed to defer receipt of payment of the same, subject to the
conditions of this Agreement. Tenant shall continue to pay when due during the Deferral Period
Fixed Rent at the rate of $3.00/s.f./month and any additional rent or charges due under the Lease
with respect to the Rent Deferred Space. Tenant shall also pay in full all Fixed Rent and other
charges, without deferral of any kind, on the portion of the Premises other than the Rent Deferred
Space.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;The parties agree that the total amount of Fixed Rent deferred under this Agreement is
$425,488.77. Tenant may defer payment of the entire December payment of Fixed Rent with respect to
the Rent Deferred Space ($172,030.50), and the balance of the Deferred Rent shall be deferred on a
monthly basis of $38,190.77 per month for January and February, 2003, and $44,211.84 per month for
March through June, 2003. All Deferred Rent shall be due and payable in full on July&nbsp;1, 2003.
Notwithstanding the foregoing, if after the date hereof there shall occur an Event of Default, all
Deferred Rent theretofore accrued but unpaid shall be immediately due and payable, and Fixed Rent
shall no longer be deferred.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;Article&nbsp;28 is hereby modified to provide as follows:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) In case of an Event of Default, Landlord may draw upon the letter of credit to the
extent of any Deferred Rent in addition to any other damages or costs for which Landlord has
the right to so draw; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Section&nbsp;28.3 is hereby deleted from the Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;Section&nbsp;2.4 of the Lease is modified to delete subsection (b)&nbsp;thereof and also to delete
the words &#147;(other than the security desk)&#148; from the last paragraph of Section&nbsp;2.4.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;Capitalized terms not otherwise defined herein shall have the meaning set forth in the
Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;Tenant hereby confirms that the Lease is in full force and effect, that it has no claims
against Landlord or right to offset against rent or other charges, and the Landlord is not in
default of its obligations under the Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;This Agreement shall be null and void unless the Tenant pays all December rent (not
deferred by this Agreement) on or before December&nbsp;6, 2002.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executed under seal as of the date first set forth above.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="3" align="left">MJ Research, Incorporated<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top" align="left">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Illegible
&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR>
<TR>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Duly Authorized&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="3" align="left">Genesoft, Inc.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top" align="left">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ David B. Singer
&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR>
<TR>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Duly Authorized&nbsp;<br><br></TD>
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">David B. Singer<BR>
Chairman and CEO<BR>
Genesoft, Inc.&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>SECOND AMENDMENT TO LEASE</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement made as of this 25th day of March, 2004 between MJ Research, Incorporated
(&#147;Landlord&#148;) and Genome Therapeutics Corporation (&#147;Tenant&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Landlord and Genesoft, Inc. executed a certain Agreement of Lease dated as of October
6, 2000, as amended by a First Amendment to Lease dated December&nbsp;5, 2002 (the &#147;Lease&#148;), and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Genome Therapeutics Corporation is the successor by merger to Genesoft, Inc., and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the parties desire to further amend the Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, for consideration paid, the receipt and sufficiency of which is hereby
acknowledged, the parties agree to amend the Lease as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;Section&nbsp;16(a) and 16(b) of the Lease are deleted and replaced with the following Section
16(a) and 16(b):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;(a)&nbsp;If the Demised Premises, or any part thereof, shall be damaged by fire or other
casualty, Tenant shall give prompt notice thereof to Landlord, and Landlord, upon receiving
such notice and the insurance proceeds for such casualty, shall proceed in a commercially
reasonable manner, subject to unavoidable delays, to repair, or cause to be repaired, such
damage to the extent hereinafter provided. Landlord shall be responsible to restore only to
the &#147;cold shell&#148; condition as set forth on Exhibit&nbsp;A-1, and Tenant shall be responsible for
restoration of all leasehold improvements beyond such cold shell (the &#147;TI&#148;).
Notwithstanding the preceding sentence to the contrary, solely with respect to the portion
of the Demised Premises subleased pursuant to that certain Sublease ( the &#147; Fluidigm
Sublease&#148;) dated as of April&nbsp;1, 2004 between Tenant and Fluidigm Corporation ( the
&#147;Fluidigm Space&#148;), provided that if within thirty (30)&nbsp;days of the date of the casualty,
Landlord is furnished with (a)&nbsp;a full set of the approved working construction plans, in
electronic form, used by Tenant in Tenant&#146;s construction of the TI (the &#147;TI Plans&#148;),
together with a full release or assignment of rights to use said plans, and (b)&nbsp;the
proceeds of insurance required to be carried by Tenant under Section&nbsp;13.1(b) with respect
to the TI, which proceeds, together with any other sums contributed by Tenant or any
subtenant thereof, shall be sufficient to pay for the full cost of reconstructing the TI in
the Fluidigm Space, Landlord shall also reconstruct the TI in the Fluidigm Space. Tenant
agrees to maintain separate insurance required under Section&nbsp;13.1(b) of the Lease for the
TI in the Fluidigm Space, and, if Landlord has agreed to reconstruct said TI, to make the
proceeds thereof available to Landlord. Tenant shall cooperate, at no expense to Tenant, in
making available such TI
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Plans as may be in the possession or control of Tenant. Landlord shall be under no obligation to
furnish the TI Plans. If the foresaid conditions are met with respect to reconstructing the TI in
the Fluidigm Space, for purposes of Sections 16(a) and 16(b), the term Demised Premises shall be
deemed to be the &#147;cold shell&#148; as to the space leased by Tenant exclusive of the Fluidigm Space and
both cold shell and TI with respect to the Fluidigm Space; if said conditions are not met, all
restoration shall be to a cold shell. If the Demised Premises or any part thereof shall be rendered
untenantable by reason of such damage, whether to the Demised Premises or to the Building, Yearly
Fixed Rent shall proportionately abate for the period from the date of such damage to the date when
the Demised Premises shall have been restored by Landlord.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) If, as a result of fire or other casualty, the whole or a substantial portion of the
Building is rendered untenantable, within ninety (90)&nbsp;days from the date of such fire or
casualty, Landlord shall notify Tenant and the lessee under the Fluidigm Sublease of its
opinion of the time required to restore the Demised Premises, taking into account a reasonable
time for adjusting loss and obtaining plans and permits for restoration. If in Landlord&#146;s
opinion the Demised Premises cannot be made tenantable within one (1)&nbsp;year after such event,
Landlord, within ninety (90)&nbsp;days from the date of such fire or casualty, may terminate this
Lease by notice to Tenant, specifying a date not less than thirty (30)&nbsp;nor more than sixty
(60)&nbsp;days after the giving of such notice on which the Term of this Lease shall terminate. In
addition, if in Landlord&#146;s opinion said estimated time for restoration exceeds one (1)&nbsp;year
and Landlord does not elect to terminate this Lease, Tenant shall, by notice given to Landlord
within fifteen (15)&nbsp;days of Landlord&#146;s notice as aforesaid, elect (a)&nbsp;to terminate this Lease
or (b)&nbsp;accept Landlord&#146;s estimated restoration period (the &#147;Longer Restoration Period&#148;). If
Tenant accepts a Longer Restoration Period, Tenant&#146;s right to terminate as hereinafter
provided shall be effective only if actual restoration takes more than 60&nbsp;days beyond such
estimated Longer Restoration Period, such termination to be elected within 30&nbsp;days after the
expiration of said estimated Longer Restoration Period plus 60&nbsp;days. If neither Landlord or
Tenant elects to terminate this Lease as provided above, then Landlord shall (to the extent
that proceeds of insurance required to be carried by Landlord, net of any portion thereof
retained by a Mortgagee, plus any sums contributed by Tenant or any subtenant of Tenant, are
made available for such purpose) proceed with diligence to repair the damage to the Demised
Premises and all facilities serving the same, if any, which shall have occurred, and the
Yearly Fixed Rent shall meanwhile proportionately abate, all as provided in Paragraph (a)&nbsp;of
this Section. However, if such damage is not repaired and the Demised Premises restored to
substantially the same condition as they were prior to such damage within one (1)&nbsp;year (or, if
elected, the Longer Restoration Period plus 60&nbsp;days) from the date of such damage,
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Tenant, within thirty (30)&nbsp;days from the expiration of the later of such one (1)&nbsp;year period (or,
if elected, the Longer Restoration Period plus 60&nbsp;days), or from the expiration of any extension
thereof by reason of the delays set forth in the following sentence, may terminate this Lease by
notice to Landlord, specifying a date not more than sixty (60)&nbsp;days after the giving of such notice
on which the Term of this Lease shall terminate. The period within which the required repairs may
be accomplished shall be extended by the number of days, lost as a result of unavoidable delays,
which term shall be defined to mean all delays referred to in Article&nbsp;24. &#148;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as modified hereby, the Lease is ratified and confirmed in full force and effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executed under the date first set forth above.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">MJ RESEARCH INCORPORATED<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ [ILLEGIBLE]
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">VP, Finance, Duly authorized&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">GENOME THERAPEUTICS
CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ [ILLEGIBLE]</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="right">, Duly authorized&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>




<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AGREEMENT OF LEASE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT OF LEASE made as of the ____ day of November, 1999, by and
between Mountain Cove Tech Center, L.L.C., a Delaware limited liability company (hereinafter
referred to as &#147;Landlord&#148;) and MJ Research Company, Inc. (hereinafter referred to as &#147;Tenant&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">W I T N E S S E T H:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord hereby leases to Tenant and Tenant hereby hires from Landlord the entire land and
building (the &#147;Building&#148;) in South San Francisco a portion, as shown on the plan attached hereto as
Exhibit&nbsp;A and made a part hereof (hereinafter referred to as the &#147;Premises&#148; or the &#147;Demised
Premises&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">1. REFERENCE DATA
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 <U>Definitions</U>. Each reference in this Lease to any of the terms and titles
contained in this Article shall be deemed and construed to incorporate the data stated following
that term or title in this Article.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="70%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">1)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Additional Rent:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sums or other charges payable by Tenant to Landlord under
this Lease, other than Yearly Fixed Rent, all of which
shall be payable as additional rent under this Lease.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">2)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Broker:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Business Day:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">All days except Saturdays, Sundays, days defined as
&#147;legal holidays&#148; for the entire state under the laws of
the State of California, and such other days as Tenant
presently or in the future recognizes as holidays for
Tenant&#146;s general staff.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Environmental Laws
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;5.3 (a) (1).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Event of Default:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The occurrence of an event listed in Section&nbsp;19.1.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">6)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Hazardous Materials
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;5.3 (a) (1).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">7)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Interest Rate
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2 <SUP style="font-size: 85%; vertical-align: text-top">1</SUP>/<SUB style="font-size: 85%; vertical-align: text-bottom">2</SUB>% per month or the maximum
interest rate Landlord is permitted to charge Tenant
under applicable law, whichever is less.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">8)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Land:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The parcel of land on which the Building is situated.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">9)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Landlord&#146;s Address:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">10)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Landlord&#146;s Architect:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Any licensed architect from time to time designated by
Landlord.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="70%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">11)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lease Year:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">A twelve (12)&nbsp;month period beginning
on the Term Commencement Date and
each succeeding twelve (12)&nbsp;month
period during the Term of this Lease,
except that if the Term Commencement
Date shall be other than the first
day of a calendar month, the first
Lease Year shall include the partial
calendar month in which the Term
Commencement Date occurs as well as
the succeeding twelve (12)&nbsp;full
calendar months.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">12)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mortgage:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">A mortgage, deed of trust, trust
indenture, or other security
instrument of record creating an
interest in or affecting title to the
Land or Building or any part thereof,
and any and all renewals,
modifications, consolidations or
extensions of any such instrument.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">13)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mortgagee:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The holder of any Mortgage.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">14)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Operating Expense Base:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">15)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Property:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Land and Building.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">16)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rent:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yearly Fixed Rent and Additional Rent.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">17)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rentable Area of the
Demised Premises:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">141,677 square feet.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">18)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Base:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">19)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tenant&#146;s Address:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Until the Term Commencement Date, _______,
and thereafter, the Demised Premises.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">20)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tenant&#146;s Operating
Expense Share:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">100%&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">21)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tenant&#146;s Tax Share:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">100%&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">22)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Term Commencement Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;3.2.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Term of this Lease:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;3.1.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination Date:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">As defined in Section&nbsp;3.1.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">25)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Use of Demised Premises:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">26)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yearly Fixed Rent:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 5%">1.2 Exhibits. The following exhibits are attached hereto and made a part hereof:
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 2 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-left: 6%; margin-top: 6pt">A - Plan of Demised Premises<BR>
A-l - Plans and Specifications for Landlord&#146;s Work<BR>
B - Cleaning Specifications<BR>
C - Rules and Regulations
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">2. DESCRIPTION OF DEMISED PREMISES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 <U>Demised Premises</U>. The Demised Premises are that portion of the Building as
described above (as the same may from time to time be constituted after changes therein,
additions thereto and eliminations therefrom pursuant to rights of Landlord hereinafter
reserved).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 <U>Appurtenant Rights</U>. Tenant shall have, as appurtenant to the Demised Premises,
rights to use in common, subject to reasonable rules from time to time made by Landlord of
which Tenant is given notice, those common roadways, walkways, elevators, hallways and
stairways necessary for access to that portion of the Building occupied by the Demised
Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 <U>Reservations</U>. All the perimeter walls of the Demised Premises except the inner
surfaces thereof, any balconies, terraces or roofs adjacent to the Demised Premises, and any
space in or adjacent to the Demised Premises used for serving other portions of the Building
exclusively or in common with the Demised Premises, including without limitation (where
applicable) shafts, stacks, pipes, conduits, wires and appurtenant fixtures, fan rooms, ducts,
electric or other utilities, sinks or other Building facilities, and the use thereof, as well
as the
right of access through the Demised Premises for the purpose of operation, maintenance,
decoration and repair, are expressly reserved to Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">3. TERM OF LEASE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 <U>Term</U>. The Term of this Lease is ten (10)&nbsp;years (or until such Term shall sooner
cease or expire) commencing on the Term Commencement Date and ending on the day
immediately prior to the 10<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> anniversary thereof, except that if the Term
Commencement Date
shall be other than the first day of a calendar month, the Term of this Lease shall end on the
last
day of the calendar month in which said 10<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> anniversary of the Term Commencement
Date shall
fall (which date on which the Term of this Lease is scheduled to expire is hereinafter
referred to
as the &#147;Termination Date&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 <U>Term Commencement Date</U>. The Term Commencement Date shall be the earlier
of (a)&nbsp;the date on which, pursuant to permission therefor duly given by Landlord, Tenant
undertakes Use of the Demised Premises for the purposes set forth in Article&nbsp;1, or (b)&nbsp;the
date on
which the Demised Premises are ready for Tenant&#146;s occupancy in accordance with the provisions
of Section&nbsp;4.2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">4. PREPARATION OF PREMISES; TENANT&#146;S ACCESS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 <U>Plans and Specifications</U>. Landlord shall lay out the Demised Premises for
Tenant&#146;s occupancy in accordance with the plans and specifications (the &#147;Plans&#148;) referenced in
Exhibit&nbsp;A-l attached hereto and made a part hereof.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 3 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 <U>When Premises Deemed Ready</U>. The Demised Premises shall be conclusively
deemed ready for Tenant&#146;s occupancy after Landlord gives notice to Tenant that the
installations
to be done by Landlord in the Demised Premises (as set forth in Section&nbsp;4.1) have been
substantially completed by Landlord. Such work shall not be deemed incomplete if only minor
or insubstantial details of construction or mechanical adjustments remain to be done, or if a
delay
is caused in whole or in part by Tenant. Landlord&#146;s Architect&#146;s certificate of substantial
completion, as hereinabove stated, given in good faith, or of any other facts pertinent to
such
work, shall be deemed conclusive of the statements therein contained and binding upon Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 <U>Conclusiveness of Landlord&#146;s Performance</U>. Tenant shall be conclusively deemed
to have agreed that Landlord has performed all of its obligations under this Article&nbsp;4 unless
not
later than the end of the second calendar month next beginning after the Landlord&#146;s notice of
substantial completion under Section&nbsp;4.2 Tenant shall give Landlord written notice specifying
the respects in which Landlord has not performed such obligations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4 <U>Entry by Tenant; Interference With Construction</U>. Tenant may enter the Demised
Premises prior to the Term Commencement Date to undertake such work as is to be performed
by Tenant pursuant and subject to this Lease in order to prepare the Demised Premises for
Tenant&#146;s occupancy. Such entry shall be deemed to be pursuant to a license from Landlord to
Tenant and shall be at the risk of Tenant. In no event shall Tenant interfere with any
construction being performed by or on behalf of Landlord in or around the Building; without
limiting the generality of the foregoing, Tenant shall comply with all instructions issued by
Landlord&#146;s contractors relative to the moving of Tenant&#146;s equipment and other property into
the Demised Premises and shall pay any fees or costs imposed in connection therewith.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">5. USE OF PREMISES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 <U>Permitted Use</U>. Tenant shall continuously during the Term of this Lease occupy
and use the Demised Premises for the permitted Use set forth in Article&nbsp;1 and for no other
purpose. Service and utility areas (whether or not a part of the Demised Premises) shall be
used
only for the particular purpose for which they are designated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 <U>Prohibited Uses</U>. Tenant shall not use, or suffer or permit the use of, or suffer
or
permit anything to be done in or anything to be brought into or kept in, the Demised Premises
or
any part thereof (i)&nbsp;which would violate any of the covenants, agreements, terms, provisions
and
conditions of this Lease, (ii)&nbsp;for any unlawful purposes or in any unlawful manner, or (iii)
which,
in the reasonable judgment of Landlord shall in any way (a)&nbsp;impair or tend to impair the
appearance or reputation of the Building, (b)&nbsp;impair or interfere with or tend to impair or
interfere with any of the Building services or the proper and economic heating, cleaning, air
conditioning or other servicing of the Building or with the use of any of the other areas of
the
Building, or (c)&nbsp;occasion discomfort, inconvenience or annoyance to any of the other tenants
or
occupants of the Building, whether through the transmission of noise or odors or vibrations or
dust or otherwise. Without limiting the generality of the foregoing, no food shall be prepared
or
served for consumption by the general public on or about the Demised Premises; no intoxicating
liquors or alcoholic beverages shall be sold or otherwise served for consumption by the
general
public on or about the Demised Premises; no lottery tickets (even where the sale of such
tickets
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 4 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">is not illegal) shall be sold and no gambling, betting or wagering shall otherwise be permitted on
or about the Demised Premises; no loitering shall be permitted on or about the Demised Premises;
and no loading or unloading of supplies or other material to or from the Demised Premises shall be
permitted on the Land except at times (excluding Business Days from 7:00 to 9:30 a.m. and from 4:00
to 6:00 p.m.) and in locations to be designated by Landlord. The Demised Premises shall be
maintained in a sanitary condition. Tenant shall suitably store all trash and rubbish in the
Demised Premises or other locations designated by Landlord from time to time. Tenant specifically
agrees that its indemnification obligations pursuant to Section&nbsp;13.3 shall extend to any claim
arising from the consumption of intoxicating liquors or alcoholic beverages on or about the Demised
Premises.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 <U>Hazardous Materials</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Definitions</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;Environmental Law means any governmental statute, code, ordinance,
regulation, rule or order and any amendment thereto governing or regulating materials that are
toxic,
explosive, corrosive, flammable, radioactive, carcinogenic, dangerous or otherwise hazardous.
Environmental Laws include, without limitation, the Comprehensive Environmental Response
Compensation and Liability Act, 42 U.S.C. 9601 <I>et seq., </I>the Resource Conservation and
Recovery Act, 42 U.S.C. 6901 <I>et seq., </I>the California Hazardous Substances Act at California
Health and Safety Code Section&nbsp;108100 <I>et seq., </I>the provisions regarding hazardous waste
control at
California Health and Safety Code Sections&nbsp;25100 through 25250.25 and the California Medical
Waste Management Act at California Health and Safety Code 117600 <I>et seq.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;Hazardous Materials shall mean any substance: (A)&nbsp;that now or in the future
is regulated or governed by, requires investigation or remediation under, or is defined as a
hazardous waste, hazardous substance, pollutant or contaminant under any Environmental Law or
(B)&nbsp;that is toxic, explosive, corrosive, flammable, radioactive, carcinogenic, dangerous or
otherwise
hazardous, including gasoline, diesel fuel, petroleum hydrocarbons, polychlorinated biphenyls
(PCBs), asbestos, radon and urea formaldehyde foam insulation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Tenant&#146;s Covenants</U>. No Hazardous Materials shall be stored, placed, handled, used
or released by Tenant or its employees, contractors, sublessees, guests or visitors at or
about the
Demised Premises or Property without Landlord&#146;s prior written consent, which consent may be
granted, denied, or conditioned upon compliance with Landlord&#146;s requirements, all in
Landlord&#146;s
absolute discretion. Notwithstanding the foregoing, normal quantities and use of those
Hazardous
Materials customarily used in the conduct of general office activities, such as copier fluids
and
cleaning supplies may be used and stored at the Demised Premises without Landlord&#146;s prior
written
consent, provided that Tenant&#146;s activities at or about the Demised Premises and Property shall
comply at all times with the laws all Environmental Laws. Tenant shall keep Landlord fully and
promptly informed of all storage, placement, handling, use or release by Tenant or its
employees,
contractors, sublessees, guests or visitors of Hazardous Materials, other than Hazardous
Materials
permitted by the preceding sentence. At the expiration or termination of the Lease, Tenant
shall promptly remove all Hazardous Materials from the Demised Premises. Tenant shall be responsible
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 5 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and liable for the compliance with all of the provisions of this Section by all of Tenant&#146;s
employees, contractors, sublessees, guests and visitors and all of Tenant&#146;s obligations under this
Section (including its indemnification obligations under subsection (e)&nbsp;below) shall survive the
expiration or termination of this Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Compliance</U>. Tenant shall at Tenant&#146;s expense promptly take all actions required by
any governmental agency or entity in connection with or as a result of the storage, placement,
handling, use or release by Tenant or its employees, contractors, sublessees, guests or
visitors of
Hazardous Materials at or about the Demised Premises or Property, including inspection and
testing, performing all cleanup, removal and remediation work required with respect to those
Hazardous Materials, complying with all closure Laws and postclosure monitoring, and filing
all
required reports or plans. &#091;Insert if applicable: &#145;All medical waste regulated by any
Environmental
Laws that is brought to the Demised Premises shall be stored in leak-proof, closeable
containers,
which containers shall be stored in a specified &#147;dirty storage area&#148; of the Demised Premises
that
shall be protected from leaks or any other type of contamination of the Demised Premises.
Tenant
shall never use any of the Landlord&#146;s trash receptacles for disposing of any medical waste.&#146;&#093;
All of
the foregoing work shall be performed in a good, safe and workmanlike manner by consultants
qualified and licensed to undertake such work and in a manner that will not interfere with any
other
tenant&#146;s quiet enjoyment of the Property or Landlord&#146;s use, operation, leasing and sale of the
Property. Tenant shall deliver to Landlord prior to delivery to any governmental agency, or
promptly after receipt from any such agency, copies of all permits, manifests, closure or
remedial
action plans, notices, and all other documents relating to the storage, placement, handling,
use or
release by Tenant or its employees, contractors, sublessees, guests or visitors of Hazardous
Materials at or about the Demised Premises or Property. If any lien attaches to the Demised
Premises or the Property in connection with or as a result of the storage, placement,
handling, use or
release by Tenant or its employees, contractors, sublessees, guests or visitors of Hazardous
Materials, and Tenant does not cause the same to be released, by payment, bonding or
otherwise,
within ten (10)&nbsp;days after the attachment thereof, Landlord shall have the right but not the
obligation
to cause the same to be released and any sums expended by Landlord in connection therewith
shall
be payable by Tenant on demand.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Landlord&#146;s Rights</U>. Landlord shall have the right, but not the obligation, to enter
the
Demised Premises at any reasonable time (i)&nbsp;to confirm Tenant&#146;s compliance with the provisions
of
this Section, and (ii)&nbsp;to perform Tenant&#146;s obligations under this Section if Tenant has failed
to do so
after reasonable notice to Tenant. Landlord shall also have the right to engage qualified
Hazardous
Materials consultants to inspect the Demised Premises and review the storage, placement,
handling,
use or release by Tenant or its employees, contractors, sublessees, guests or visitors of
Hazardous
Materials, including review of all permits, reports, plans, and other documents regarding
same.
Tenant shall pay to Landlord on demand the costs of Landlord&#146;s consultants&#146; fees and all costs
incurred by Landlord in performing Tenant&#146;s obligations under this section. Landlord shall
use
reasonable efforts to minimize any interference with Tenant&#146;s business caused by Landlord&#146;s
entry
into the Demised Premises, but Landlord shall not be responsible for any interference caused
thereby.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 6 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<U>Tenant&#146;s Indemnification</U>. Tenant agrees to indemnify, defend and hold harmless
Landlord and its members, managers, directors, officers, agents and employees and their partners,
members, managers, directors, officers, shareholders, employees and agents from all shall mean all
costs and expenses of any kind, damages, including foreseeable and unforeseeable consequential
damages, fines and penalties incurred in connection with any violation of and compliance with the
Environmental Laws and all losses of any kind attributable to the diminution of value, loss of use
or adverse effects on marketability or use of any portion of the Demised Premises or Property and
all other claims, actions, losses, damages, liabilities, costs and expenses of every kind,
including reasonable attorneys&#146;, experts&#146; and consultants&#146; fees and costs, incurred at any time and
arising from or connection with the storage, placement, handling, use or release by Tenant or its
employees, contractors, sublessees, guests or visitors of Hazardous Materials at or about the
Property or Tenant&#146;s failure to comply in full with all Environmental Laws with respect to the
Demised Premises and the Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4 Licenses and Permits. If any governmental license or permit shall be required for the
proper and lawful conduct of Tenant&#146;s business, and if the failure to secure such license or permit
would in any way affect Landlord, Tenant, at Tenant&#146;s expense, shall duly procure and thereafter
maintain such license or permit and submit the same to inspection by Landlord. Tenant, at Tenant&#146;s
expense, shall at all times comply with the terms and conditions of each such license or permit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">6. RENT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 <U>Yearly Fixed Rent</U>. Tenant shall pay to Landlord, without any set-off or
deduction, at Landlord&#146;s office, or to such other person or at such other place as Landlord
may
designate by notice to Tenant, the Yearly Fixed Rent set forth in Article&nbsp;1. The Yearly Fixed
Rent shall be paid in equal monthly installments in advance on or before the first Business
Day
of each calendar month during the Term of this Lease and shall be apportioned for any fraction
of a month in which the Term Commencement Date or the last day of the Term of this Lease
may fall.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 <U>Taxes</U>. Tenant shall pay to Landlord as Additional Rent Tenant&#146;s Tax Share of all
real estate taxes imposed against the Property during any calendar year (including without
limitation all so-called linkage and impact fees, betterment assessments, fire and police
service
availability fees and similar charges for customary governmental services and charges in lieu
of
such taxes, assessment district assessments, governmental charges, fees or assessments for
traffic
or transit mitigation, personal property taxes assessed on personal property of Landlord used
in
the operation of the Property, increases in the foregoing due to changes in values, tax rate,
alterations made by Tenant or other factors and the reasonable cost of contesting by
appropriate
proceedings the amount or validity of any of the foregoing) in excess of the Tax Base,
prorated
with respect to any portion of a calendar year in which the Term of this Lease begins or ends.
As
soon as Tenant&#146;s share of real estate taxes with respect to any calendar year can be
determined,
the same will be certified by Landlord to Tenant (which certification shall be accompanied by
copies of the relevant tax bills) and will become payable to Landlord within ten (10)&nbsp;days
thereafter. If Landlord shall receive any refund of real estate taxes of which Tenant has paid
a
portion pursuant to this Section, then, out of any balance remaining after deducting
Landlord&#146;s
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 7 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">expenses incurred in obtaining such refund, Landlord shall pay to Tenant the same proportionate
share of said balance, prorated as set forth above. Tenant shall, if as and when demanded by
Landlord and with each monthly installment of Fixed Rent, make tax fund payments to Landlord. &#147;Tax
fund payments&#148; refer to such payments as Landlord shall determine to be sufficient to provide in
the aggregate a fund adequate to pay, when they become due and payable, all payments required from
Tenant under this Section. In the event that tax fund payments are so demanded, and if the
aggregate of said tax fund payments is not adequate to pay Tenant&#146;s share of such taxes, Tenant
shall pay to Landlord the amount by which such aggregate is less than the amount of said share,
such payment to be due and payable at the time set forth above. Any surplus tax fund payments shall
be accounted for to Tenant after payment by Landlord of the taxes on account of which they were
made, and may be credited by Landlord against future tax fund payments or refunded to Tenant at
Landlord&#146;s option.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, Tenant shall timely file business property statements with respect to Tenant&#146;s
personal property and trade fixtures and pay when due all taxes imposed on such personal property
and trade fixtures.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 <U>Operating Expenses</U>. Tenant shall pay to Landlord as Additional Rent Tenant&#146;s
Operating Expense Share of all costs and expenses incurred by Landlord during any calendar year in
the operation and maintenance of the Building and the Land in accordance with generally accepted
operational and maintenance procedures in excess of the Operating Expense Base, including, without
limiting the generality of the foregoing, all such costs and expenses in connection with (1)
insurance, license fees, janitorial service, landscaping and snow removal, (2)&nbsp;wages, salaries,
management fees, employee benefits, payroll taxes, on-site office expenses, administrative and
auditing expenses, and equipment and materials for the operation, management and maintenance of the
Property, (3)&nbsp;any capital expenditure (amortized, with interest, on such reasonable basis as
Landlord shall determine) made by Landlord for the purpose of reducing other operating expenses or
complying with any governmental requirement, (4)&nbsp;the furnishing of heat, air conditioning,
electricity and other utilities, and any other service to the extent to which Landlord is not
reimbursed by tenants, and (5)&nbsp;the furnishing of the repairs and services referred to in Article&nbsp;7
(the foregoing being hereinafter referred to as &#147;operating expenses&#148;). If, during any portion of a
calendar year for which operating expenses are being computed pursuant to this Section, less than
the entire rentable area of the Building is occupied or Landlord is not supplying all occupants
with the same services being supplied hereunder, such costs and expenses shall be reasonably
extrapolated in order to take into account the costs and expenses which would have been incurred
had the entire rentable area of the Building been occupied and had such services been supplied to
all occupants. As soon as Tenant&#146;s share of operating expenses with respect to any calendar year
can be determined, the same will be certified by Landlord to Tenant and will become payable to
Landlord within ten (10)&nbsp;days following such certification, subject to proration with respect to
any portion of a calendar year in which the Term of this Lease begins or ends. Tenant shall, if as
and when demanded by Landlord and with each monthly installment of Yearly Fixed Rent, make
operating fund payments to Landlord. &#147;Operating fund payments&#148; refer to such payments as Landlord
shall determine to be sufficient to provide in the aggregate a fund adequate to pay, when they
become due and payable, all payments required from Tenant under this Section. In the event that
operating fund payments are so demanded, and if the aggregate of said operating fund payments
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 8 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">is not adequate to pay Tenant&#146;s share of operating expenses, Tenant shall pay to Landlord the
amount by which such aggregate is less than the amount of said share, such payment to be due and
payable at the time set forth above. Any surplus operating fund payments shall be accounted for to
Tenant after such surplus has been determined, and may be credited by Landlord against future
operating fund payments or refunded to Tenant at Landlord&#146;s option.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4
<U>Obligations Survive Termination</U>. All obligations and liabilities of Tenant
relating to any period prior to the termination of the Term of this Lease, including
without
limitation the obligation to pay any Additional Rent due pursuant to the provisions of
this
Article, shall survive such termination.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5 <U>Payment to Mortgagee</U>. Landlord reserves the right to provide in any Mortgage
given by it of the Property that some or all rents, issues, and profits and all other amounts
of
every kind payable to the Landlord under this Lease shall be paid directly to the Mortgagee
for
Landlord&#146;s account and Tenant covenants and agrees that it will, after receipt by it of notice
from
Landlord or Mortgage designating such Mortgagee to whom payments are to be made by Tenant,
pay such amounts thereafter becoming due directly to such Mortgagee until excused therefrom
by notice from such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">7. UTILITIES AND LANDLORD&#146;S SERVICES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1 <U>Electricity</U>. Tenant shall purchase directly from the public utility serving
the Building all electrical energy that Tenant requires for operation of the lighting fixtures,
appliances and equipment servicing the Demised Premises. The costs of initially installing any
required meter and related installation equipment shall be paid by Landlord. Landlord shall not be
liable in any way to Tenant for any failure or defect in the supply or character of electrical
energy furnished to the Demised Premises by reason of any requirement, act or omission of the
public utility serving the Building. Tenant&#146;s use of electrical energy in the Demised Premises
shall not at any time exceed the capacity of any of the electrical conductors and equipment in or
otherwise serving the Demised Premises. In order to insure that such capacity is not exceeded and
to avert possible adverse effect upon the Building electrical services Tenant shall give notice to
Landlord and obtain Landlord&#146;s prior written consent whenever Tenant shall connect to the Building
electrical distribution system any fixtures, appliances or equipment other than lamps, typewriters,
personal computers and similar small machines. Any additional feeders or risers to supply Tenant&#146;s
electrical requirements in addition to those originally installed and all other equipment proper
and necessary in connection with such feeders or risers, shall be installed by Landlord upon
Tenant&#146;s request, at the sole cost and expense of Tenant, provided that such additional feeders and
risers are permissible under applicable laws and insurance regulations and the installation of such
feeders or risers will not cause permanent damage or injury to the Building or cause or create a
dangerous condition or unreasonably interfere with other tenants of the Building. Tenant agrees
that it will not make any alteration or addition to the electrical equipment in the Demised
Premises without the prior written consent of Landlord in each instance first obtained, which
consent will not be unreasonably withheld. Landlord, at Tenant&#146;s expense, shall purchase, install
and replace all light fixtures, bulbs, tubes, lamps, lenses, globes, ballasts and switches used in
the Demised Premises.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 9 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2 <U>Water Charges</U>. Landlord shall furnish hot and cold water for ordinary cleaning,
toilet, lavatory and drinking purposes. If Tenant requires, uses or consumes water for any
purpose other than for such purposes, Landlord may (i)&nbsp;assess a reasonable charge for the
additional water so used or consumed by Tenant or (ii)&nbsp;install a water meter and thereby
measure
Tenant&#146;s water consumption for all purposes. In the latter event, Landlord shall pay the cost
of
the meter and the cost of installing any equipment required in connection therewith, and
Tenant
shall keep said meter and installation equipment in good working order and repair, and shall
pay
for water consumed, as shown on said meter, together with the sewer charge based on said meter
charges, as and when bills are rendered. On default in making such payment Landlord may pay
such charges and collect the same from Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3 <u>Heat and Air Conditioning</u>. Landlord shall furnish to and distribute in the
Demised Premises heat and air conditioning as normal seasonal changes may require on
Business Days from 8:00 a.m. to 6:00 p.m. when reasonably required for the comfortable
occupancy of the Demised Premises by Tenant. Tenant agrees to lower and close the blinds or
drapes when necessary because of the sun&#146;s position whenever the air conditioning system is in
operation, and to cooperate fully with Landlord with regard to, and to abide by all the
regulations
and requirements which Landlord may prescribe for the proper functioning and protection of,
the
heating and air conditioning system. Without limiting the generality of the foregoing, all
windows in the Demised Premises must remain closed at all times notwithstanding the fact that
such windows may be operable. The air conditioning system servicing the Building is designed
to provide cooling based upon an occupancy of not more than one person per one hundred (100)
square feet of floor area, and upon a combined lighting and standard electrical load not to
exceed
3.0 watts per square foot. In the event Tenant exceeds such condition or introduces into the
Demised Premises equipment which overloads such system, or in any other way causes such
system not to adequately perform its proper functions, supplementary systems may at Landlord&#146;s
option be provided by Landlord at Tenant&#146;s expense.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4 <U>Additional Heat and Air Conditioning Services</U>.
Landlord shall, upon reasonable
advance written notice from Tenant of its requirements in that regard, received before 3:00
p.m.
on the preceding Business Day, furnish additional heat or air conditioning services to the
Demised Premises on days and at times other than as provided in this Article. Tenant will pay
to
Landlord a reasonable charge for any such additional heat or air conditioning service required
by Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.5 <u>Elevator Service</u>. Landlord shall provide passenger elevator service to the
Demised Premises on Business Days from 8:00 a.m. to 6:00 p.m. and on a reduced basis at all
other times. Freight elevator service shall be available in common with other tenants on
Business Days from 9:30 a.m. to 4:00 p.m. and at other times at reasonable charge.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.6 <U>Cleaning</U>. Landlord shall furnish cleaning services to the Building substantially
in
accordance with the specifications attached hereto as Exhibit&nbsp;B and made a part hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.7 <U>Repairs and Other Services</U>.
Except as otherwise provided in Articles 16 and 18,
and subject to Tenant&#146;s obligations in Article&nbsp;12 and elsewhere in this Lease, Landlord shall
(a)
keep and maintain the roof, exterior walls, structural floor slabs and columns of the Building in
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 10 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">as good condition and repair as they are in on the Term Commencement Date, reasonable use and wear
excepted, (b)&nbsp;keep and maintain in workable condition the Building&#146;s sanitary, electrical, heating,
air conditioning and other systems, (c)&nbsp;keep all walkways on the Property clean and remove all snow
and ice therefrom, (d)&nbsp;provide grounds maintenance to all landscaped areas and (e)&nbsp;arrange for the
extermination of rodents and vermin in the Building.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.8 <U>Interruption or Curtailment of Services</U>.
Landlord reserves the right to
interrupt, curtail, stop or suspend the furnishing of services and the operation of any Building
system, when necessary by reason of accident or emergency, or of repairs, alterations, replacements
or improvements in the reasonable judgment of Landlord desirable or necessary to be made, or of
difficulty or inability in securing supplies or labor, or of strikes, or of any other cause beyond
the reasonable control of Landlord, whether such other cause be similar or dissimilar to those
hereinabove specifically mentioned, until said cause has been removed. Landlord shall have no
responsibility or liability for any such interruption, curtailment, stoppage, or suspension of
services or systems, except that Landlord shall exercise reasonable diligence to eliminate the
cause of same.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">8. CHANGES OR ALTERATIONS BY LANDLORD
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord reserves the right, exercisable by itself or its nominee, at any time and from time
to time without the same constituting an actual or constructive eviction and without incurring any
liability to Tenant therefor or otherwise affecting Tenant&#146;s obligations under this Lease, to make
such changes, alterations, additions, improvements, repairs or replacements in or to the Building
and the fixtures and equipment thereof, as well as in or to the street entrances, halls, passages,
elevators, and stairways thereof, as it may deem necessary or desirable, and to change the
arrangement and/or location of entrances or passageways, doors and doorways, and corridors,
elevators, stairs, toilets, or other public parts of the Building, provided, however, that there be
no unreasonable obstruction of the right of access to, or unreasonable interference with the use
and enjoyment of, the Demised Premises by Tenant, except that Landlord shall not be obligated to
employ labor at so-called &#147;over-time&#148; or other premium pay rates. Nothing contained in this Article
shall be deemed to relieve Tenant of any duty, obligation or liability of Tenant with respect to
making or causing to be made any repair, replacement or improvement or complying with any law,
order or requirement of any governmental or other authority. Landlord reserves the right to from
time to time change the address of the Building. Neither this Lease nor any use by Tenant shall
give Tenant any right or easement or the use of any door or any passage or any concourse connecting
with any other building or to any public convenience, and the use of such doors, passages and
concourses and of such conveniences may be regulated or discontinued at any time and from time to
time by Landlord without notice to Tenant and without affecting the obligations of Tenant hereunder
or incurring any liability to Tenant therefor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">9. FIXTURES, EQUIPMENT AND IMPROVEMENTS &#151; REMOVAL BY TENANT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All fixtures, equipment, improvements and appurtenances attached to or built into the Demised
Premises prior to or during the Term, whether by Landlord at its expense or at the expense of
Tenant (either or both) or by Tenant shall be and remain part of the Demised Premises and shall not
be removed by Tenant at the end of the Term unless otherwise expressly
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 11 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">provided in this Lease. Where not built into the Demised Premises, and if furnished and installed
by and at the sole expense of Tenant, all removable electric fixtures, air conditioning, carpets,
drinking or tap water facilities, furniture, or trade fixtures or business equipment shall not be
deemed to be included in such fixtures, equipment, improvements and appurtenances and may be, and
upon the request of Landlord will be, removed by Tenant upon the condition that such removal shall
not materially damage the Demised Premises or the Building and that the cost of repairing any
damage to the Demised Premises or the Building arising from such removal shall be paid by Tenant,
provided, however, that any of such items toward which Landlord shall have granted any allowance or
credit to Tenant shall be deemed not to have been furnished and installed in the Demised Premises
by or at the sole expense of Tenant.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">10. ALTERATIONS AND IMPROVEMENTS BY TENANT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall make no alterations, decorations, installations, removals, additions or
improvements in or to the Demised Premises without Landlord&#146;s prior written consent and then only
by contractors or mechanics approved by Landlord. No such installations or other work shall be
undertaken or begun by Tenant until Landlord has approved written plans and specifications
therefor; and no amendments or additions to such plans and specifications shall be made without
prior written consent of Landlord. Any such alterations, decorations, installations, removals,
additions and improvements shall be done at the sole expense of Tenant and at such times and in
such manner as Landlord may from time to time designate. If Tenant shall make any alterations,
decorations, installations, removals, additions or improvements, then Landlord may elect to require
Tenant at the expiration of this Lease to restore the Demised Premises to substantially the same
condition as existed at the Term Commencement Date.
</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">11.</TD>
    <TD>&nbsp;</TD>
    <TD>TENANT&#146;S CONTRACTORS &#151; MECHANICS&#146; AND OTHER LIENS &#151; STANDARD
OF TENANT&#146;S PERFORMANCE &#151; COMPLIANCE WITH LAWS</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever Tenant shall make any alterations, decorations, installations, removals,
additions or improvements or do any other work in or to the Demised Premises, Tenant will
strictly observe the following covenants and agreements:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;In no event shall any material or equipment be incorporated in or added to the
Demised Premises in connection with any such alteration, decoration, installation, addition or
improvement which is subject to any lien, charge, mortgage or other encumbrance of any kind
whatsoever or is subject to any security interest or any form of title retention agreement.
Any
mechanic&#146;s lien filed against the Demised Premises or the Building for work claimed to have
been done for, or materials claimed to have been furnished to Tenant shall be discharged by
Tenant within ten (10)&nbsp;days thereafter, at the expense of Tenant, by filing the bond required
by
law or otherwise. If Tenant fails so to discharge any lien, Landlord may do so at Tenant&#146;s
expense and Tenant shall reimburse Landlord for any expense or cost incurred by Landlord in so
doing within fifteen (15)&nbsp;days after rendition of a bill therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;All installations or work done by Tenant under this or any other Article of this
Lease shall be at its own expense (unless expressly otherwise provided) and shall at all times
comply with (i)&nbsp;laws, rules, orders and regulations of governmental authorities having</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 12 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">jurisdiction thereof and (ii)&nbsp;plans and specifications prepared by and at the expense of Tenant
theretofore submitted to Landlord for its prior written approval.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Tenant shall procure all necessary permits before undertaking any work in the
Demised Premises; do all such work in a good and workmanlike manner, employing materials of
good quality and complying with all governmental requirements, and defend, save harmless,
exonerate and indemnify Landlord from all injury, loss or damage to any person or property
occasioned by or growing out of such work.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;No work shall be commenced prior to the time Landlord has posted a &#147;Notice
of nonresponsibility&#148; at the Demised Premises and recorded said notice in the county in which
the Property is located pursuant to California Civil Code Section&nbsp;3094.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">12. REPAIRS BY TENANT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant, at its expense, shall keep or cause to be kept all and singular the Demised Premises
in such repair, order and condition as the same are in on the Term Commencement Date or may be put
in during the Term hereof, reasonable use and wear thereof and damage by fire or by unavoidable
casualty excepted. Without limiting the generality of the foregoing, Tenant shall keep all windows
and other glass whole, and shall replace the same whenever broken with glass of the same quality.
Tenant hereby waives the benefits of California Civil Code Section&nbsp;1932(1).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">13. INSURANCE, INDEMNIFICATION, EXONERATION AND EXCULPATION
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.1 <U>Tenant&#146;s Insurance</U></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Liability Insurance</U>.
Tenant shall maintain in full force throughout the Term
commercial general liability and property damage insurance providing coverage on an occurrence
form basis with limits of not less than Two Million Dollars ($2,000,000.00) each occurrence
for
bodily injury and property damage combined, Two Million Dollars ($2,000,000.00) annual general
aggregate, and Two Million Dollars ($2,000,000.00) products and completed operations annual
aggregate. Tenant&#146;s liability insurance policy or policies shall: (i)&nbsp;include premises and
operations
liability coverage, automobile, products and completed operations liability coverage, broad
form
property damage coverage including completed operations, blanket contractual liability
coverage
with, to the maximum extent possible, coverage for the indemnification obligations of Tenant
under
this Lease, and personal and advertising injury coverage; (ii)&nbsp;provide that the insurance
company
has the duty to defend all insureds under the policy; (iii)&nbsp;provide that defense costs are
paid in
addition to and do not deplete any of the policy limits; (iv)&nbsp;cover liabilities arising out of
or incurred
in connection with Tenant&#146;s use or occupancy of the Premises or the Property; and (v)&nbsp;extend
coverage to cover liability for the actions of Tenant&#146;s employees, contractors, sublessees,
guests and
visitors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Personal Property Insurance</U>.
Tenant shall at all times maintain in effect with
respect
to tenant improvements and Tenant&#146;s trade fixtures and personal property located at or within
the
Demised Premises, commercial property insurance providing coverage, at a minimum, for &#147;broad</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 13 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">form&#148; perils, to the extent of 100% of the full replacement cost of covered property. Tenant may
carry such insurance under a blanket policy, provided that such policy provides equivalent
coverage to a separate policy. During the Term, the proceeds from any such policies of insurance
shall be used for the repair or replacement of such tenant improvements, trade fixtures and
personal property so insured. Landlord shall be provided coverage under such insurance to the
extent of its insurable interest and, if requested by Landlord, both Landlord and Tenant shall
sign all documents reasonably necessary or proper in connection with the settlement of any claim
or loss under such insurance. Landlord shall have no obligation to carry insurance on any such
tenant improvements or on Tenant&#146;s trade fixtures or personal property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Workmen&#146;s Compensation Insurance</U>.
Tenant shall maintain worker&#146;s compensation
insurance as required by law and employer&#146;s liability insurance in an amount not less than
Five
Hundred Thousand Dollars ($500,000).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Business Interruption/Extra Expense Insurance</U>.
Tenant shall maintain loss of
income, business interruption and extra expense insurance in such amounts as will reimburse
Tenant
for direct or indirect loss of earnings and incurred costs attributable to the perils commonly
covered
by Tenant&#146;s property insurance described above but in no event less than One Million Dollars
($1,000,000). Such insurance shall be carried with the same insurer that issues the insurance
for the
personal property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<U>Other Coverage</U>.
Tenant, at its cost, shall maintain such other insurance as
Landlord
may reasonably require from time to time, but in no event may Landlord require any other
insurance
which is (i)&nbsp;not then being required of comparable tenants leasing comparable amounts of space
in
comparable buildings in the vicinity of the Building or (ii)&nbsp;not then available at
commercially
reasonable rates.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;<U>Insurance Criteria</U>.
Each policy of insurance required under this Section shall:
(i)&nbsp;be
in a form, and written by an insurer, reasonably acceptable to Landlord, (ii)&nbsp;be maintained at
Tenant&#146;s sole cost and expense, and (iii)&nbsp;require at least thirty (30)&nbsp;days&#146; written notice to
Landlord
prior to any cancellation, nonrenewal or modification of insurance coverage. Insurance
companies
issuing such policies shall have rating classifications of &#147;A&#148; or better and financial size
category
ratings of &#147;XIII&#148; or better according to the latest edition of the A.M. Best Key Rating Guide.
All
insurance companies issuing such policies shall be licensed to do business in the State of
California.
Any deductible amount under such insurance shall not exceed $5,000. Tenant shall provide to
Landlord, upon request, evidence that the insurance required to be carried by Tenant pursuant
to this
Section, including any endorsement affecting the additional insured status, is in full force
and effect
and that premiums therefore have been paid.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;<U>Increase in Amount of Insurance</U>.
Tenant shall increase the amounts of insurance as
required by any Mortgagee, and, not more frequently than once every three (3)&nbsp;years, as
recommended by Landlord&#146;s insurance broker, if, in the opinion of either of them, the amount
of
insurance then required under this Lease is not adequate. Any limits set forth in this Lease
on the
amount or type of coverage required by Tenant&#146;s insurance shall not limit the liability of
Tenant
under this Lease.</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 14 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;<U>Insurance Provisions</U>.
Each policy of liability insurance required by this Section
shall: (i)&nbsp;contain a cross liability endorsement or separation of insureds clause; (ii)&nbsp;provide
that it is primary to and not contributing with, any policy of insurance carried by Landlord
covering the same loss; (iii)&nbsp;provide that any failure to comply with the reporting provisions
shall not affect coverage provided to Landlord, its members, property managers and mortgagees; and
(iv)&nbsp;name Landlord, its members, property managers and such other parties in interest as Landlord
may from time to time reasonably designate to Tenant in writing, as additional insureds. Such
additional insureds shall be provided the same extent of coverage as provided to Tenant under such
policies. All endorsements affecting such additional insured status shall be acceptable to Landlord
and shall be at least as broad as additional insured endorsement form number CG 20 11 11 85
promulgated by the Insurance Services Office.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;<U>Evidence of Coverage</U>.
Prior to occupancy of the Premises by Tenant, and not less
than thirty (30)&nbsp;days prior to the expiration of any policy thereafter, Tenant shall furnish to
Landlord a certificate of insurance reflecting that the insurance required by this Section is in
force accompanied by an endorsement showing the required additional insureds satisfactory to
Landlord in substance and form. Notwithstanding the requirements of this paragraph, Tenant shall,
at Landlord&#146;s request, provide to Landlord a certified copy of each insurance policy required to
be in force at any time pursuant to the requirements of this Lease or its Exhibits. Tenant&#146;s
failure to furnish Landlord with such certificates of insurance shall be deemed a material default
under this Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.2 <U>General</U>.
Tenant will save Landlord harmless, and will exonerate and indemnify
Landlord, from and against any and all claims, liabilities, penalties, damages or expenses
(including without limitation reasonable attorneys&#146; fees) asserted against or incurred by Landlord:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;on account of or based upon any injury to person, or loss of or damage to
property sustained or occurring on the Demised Premises on account of or based upon the act,
omission, fault, negligence or misconduct of any person whomsoever (other than Landlord or its
agents, contractors or employees);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;on account of or based upon any injury to person or loss of or damage to
property, sustained or occurring elsewhere (other than on the Demised Premises) in or about
the
Building (and, in particular, without limiting the generality of the foregoing on or about the
elevators, stairways, public corridors, sidewalks, roof, or other appurtenances and facilities
used
in connection with the Building or Demised Premises) arising out of the use or occupancy of
the
Building or Demised Premises by Tenant, or any person claiming by, through or under Tenant;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;on account of or based upon (including moneys due on account of) any
work or thing whatsoever done (other than by Landlord or its contractors, or agents or
employees
of either) in the Demised Premises during the Term of this Lease and during the period of
time,
if any, prior to the Term Commencement Date that Tenant may have been given access to the
Demised Premises; and</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 15 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;on account of or resulting from the failure of Tenant to perform and discharge any of its covenants and obligations under this Lease;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and, in case any action or proceeding be brought against Landlord by reason of any of the
foregoing, Tenant upon notice from Landlord shall at Tenant&#146;s expense resist or defend such action
or proceeding and employ counsel therefor reasonably satisfactory to Landlord, it being agreed that
such counsel as may act for insurance underwriters of Tenant engaged in such defense shall be
deemed satisfactory.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.3 <U>Property of Tenant</U>.
In addition to and not in limitation of the foregoing, and
subject only to provisions of applicable law, Tenant covenants and agrees that all
merchandise,
furniture, fixtures and property of every kind, nature and description which may be in or upon
the Demised Premises or elsewhere on the Property during the Term of this Lease, shall be at
the
sole risk and hazard of Tenant, and that if the whole or any part thereof shall be damaged,
destroyed, stolen or removed from any cause or reason whatsoever other than the negligence or
misconduct of Landlord, no part of said damage or loss shall be charged to, or borne by
Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.4 <U>Bursting of Pipes, etc</U>.
Landlord shall not be liable for any injury or damage to
persons or property resulting from fire, explosion, falling plaster or tiles, steam, gas,
electricity,
electrical disturbance, water, rain or snow or leaks from any part of the Building or from the
pipes, appliances or plumbing works or from the roof, street or sub-surface or from any other
place or caused by any other cause of whatever nature, unless caused by or due to the
negligence
of Landlord, its agents, servants or employees; nor shall Landlord or its agents be liable for
any
such damage caused by other tenants or persons in the Building or caused by operations in
construction of any private, public or quasi-public work; nor shall Landlord be liable for any
latent defect in the Demised Premises or elsewhere in the Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">14. ASSIGNMENT, MORTGAGING, SUBLETTING, ETC.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant covenants and agrees that neither this Lease nor the term and estate hereby granted nor
any interest herein or therein, will be assigned, mortgaged, pledged, encumbered or otherwise
transferred (whether voluntarily or by operation of law), and that neither the Demised Premises,
nor any part thereof, will be encumbered in any manner by reason of any act or omission on the part
of Tenant, without the prior written consent of Landlord in every case.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with any request by Tenant for such consent, Tenant shall submit to Landlord, in
writing, a statement containing the name of the proposed assignee, such information as to its
financial responsibility and standing as Landlord may require, and all of the terms and provisions
upon which the proposed transaction is to take place. Tenant shall reimburse Landlord promptly, as
Additional Rent, for reasonable legal and other expense incurred by Landlord in connection with any
request by Tenant for any consent required under the provisions of this Article.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The listing of any name other than that of Tenant, whether on the doors of the Demised
Premises or on the Building directory, or otherwise, shall not operate to vest any right or
interest</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 16 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in this Lease or in the Demised Premises or be deemed to be the written consent of Landlord
mentioned in this Article, it being expressly understood that any such listing is a privilege
extended by Landlord revocable at will by written notice to Tenant.</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If this Lease be assigned, Landlord may at any time and from time to time, collect rent and
other charges from the assignee, and apply the net amount collected to the Rent and other charges
herein reserved, but no such collection shall be deemed a waiver of this covenant, or the
acceptance of the assignee as a tenant, or a release of Tenant from the further performance by
Tenant of covenants on the part of Tenant herein contained. The consent by Landlord to an
assignment shall not in any way be construed to relieve Tenant from obtaining the express consent
in writing of Landlord to any further assignment. Tenant shall remain fully and primarily liable
for all its obligations hereunder notwithstanding any assignment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything herein to the contrary, Tenant may assign this lease to an Affiliate,
meaning, for purposes hereof, a corporation or other entity controlling, controlled by or under
common control with Tenant. In addition, Tenant may, without Landlord&#146;s consent, sublease any or
all of the Demised Premises, and any so-called &#147;subleasing profits&#148; or subrents in excess of the
rent reserved herein shall belong to Tenant. Landlord shall, upon request of Tenant, not
unreasonably withhold its consent to a nondisturbance agreement for the benefit of any such
subtenants.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">15. MISCELLANEOUS COVENANTS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.1 <U>Rules and Regulations</U>.
Tenant and Tenant&#146;s servants, employees, agents, visitors
and licensees will faithfully observe such Rules and Regulations as are attached hereto as
Exhibit
C and made a part hereof or as Landlord hereafter at any time or from time to time may make
and may communicate in writing to Tenant and which in the reasonable judgment of Landlord
shall be necessary for the reputation, safety, care or appearance of the Property, or the
preservation of good order therein, or the operation or maintenance of the Property, or the
equipment thereof, or the comfort of tenants or others in the Building, provided, however,
that in
the case of any conflict between the provisions of this Lease and any such Rules and
Regulations, the provisions of this Lease shall control, and provided further that nothing
contained in this Lease shall be construed to impose upon Landlord any duty or obligation to
enforce such Rules and Regulations or the terms, covenants or conditions in any other lease as
against any other tenant and Landlord shall not be liable to Tenant for violation of the same
by
any other tenant, its servants, employees, agents, visitors, invitees or licensees.
Notwithstanding
Paragraph&nbsp;22 of Exhibit&nbsp;C, Landlord shall be required to arrange for extermination of vermin
within the Building pursuant to Section&nbsp;7.7.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.2 <U>Access to Premises</U>.
Tenant shall: (i)&nbsp;permit Landlord to erect, use and maintain
pipes, ducts and conduits in and through the Demised Premises, provided the same do not
materially reduce the floor area or materially adversely affect the appearance thereof; (ii)
permit
the Landlord and any Mortgagee to have free and unrestricted access to and to enter upon the
Demised Premises at all reasonable hours for the purposes of inspection or of making repairs,
replacements or improvements in or to the Demised Premises or the Building or equipment
(including, without limitation, sanitary, electrical, heating, air conditioning or other
systems) or</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 17 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">of complying with all laws, orders and requirements of governmental or other authority or of
exercising any right reserved to Landlord by this Lease (including the right during the progress of
any such repairs, replacements or improvements or while performing work and furnishing materials in
connection with compliance with any such laws, orders or requirements to take upon or through, or
to keep and store within, the Demised Premises all necessary materials, tools and equipment); and
(iii)&nbsp;permit Landlord, at reasonable times, to show the Demised Premises during ordinary business
hours to any Mortgagee, prospective purchaser of any interest of Landlord in the Property,
prospective Mortgagee, or prospective assignee of any Mortgage, and during the period of twelve
months next preceding the Termination Date to any person contemplating the leasing of the Demised
Premises or any part thereof. If during the last three (3)&nbsp;months of the Term, Tenant shall have
removed all of Tenant&#146;s property therefrom, Landlord may immediately enter and alter, renovate and
redecorate the Demised Premises, without elimination or abatement of rent, or incurring liability
to Tenant for any compensation, and such acts shall have no effect upon this Lease. If Tenant shall
not be personally present to open and permit any entry into the Demised Premises at any time when
for any reason an entry therein shall be necessary or permissible, Landlord or Landlord&#146;s agents
must nevertheless be able to gain such entry by contacting a responsible representative of Tenant,
whose name, address and telephone number shall be furnished by Tenant. Provided that Landlord shall
not be obligated to employ labor at so-called &#147;over-time&#148; or other premium pay rates, Landlord
shall exercise its rights of access to the Demised Premises permitted under any of the terms and
provisions of this Lease in such manner as to minimize to the extent practicable interference with
Tenant&#146;s use and occupation of the Demised Premises. If an excavation shall be made upon land
adjacent to the Demised Premises or shall be authorized to be made, Tenant shall afford, to the
person causing or authorized to cause such excavation (subject to the same provisions applicable
hereunder in the case of work to be performed by Landlord), license to enter upon the Demised
Premises for the purpose of doing such work as said person shall deem necessary to preserve the
Building from injury or damage and to support the same by proper foundations without any claim for
damage or indemnity against Landlord, or diminution or abatement of Rent.</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.3 <U>Accidents to Sanitary and other Systems</U>.
Tenant shall give to Landlord prompt
notice of any fire or accident in the Demised Premises or in the Building and of any damage
to,
or defective condition in, any part or appurtenance of the Building&#146;s sanitary, electrical,
heating
and air conditioning or other systems located in, or passing through, the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.4 <U>Signs, Blinds and Drapes</U>.
Tenant shall not place any signs on the exterior of the
Building or on or in any window, public corridor or door visible from the exterior of the
Demised Premises. No drapes or blinds may be put on or in any window nor may any Building
drapes or blinds be removed by Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.5 <U>Estoppel
Certificate</U>. Tenant shall at any time and from time to time upon not
less
than ten (10)&nbsp;days&#146; prior notice by Landlord or by a Mortgagee to Tenant, execute, acknowledge
and deliver to the party making such request a statement in writing certifying that this Lease
is
unmodified and in full force and effect (or if there have been modifications, that the same is
in
full force and effect as modified and stating the modifications), and the dates to which Rent
has
been paid in advance, if any, and stating whether or not to the best knowledge of the signer
of
such certificate Landlord is in default in performance of any covenant, agreement, term,</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 18 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">provisions or condition contained in this Lease and, if so, specifying each such default of which
the signer may have knowledge, it being intended that any such statement delivered pursuant hereto
may be relied upon by any prospective purchaser of any interest in the Property, any Mortgagee or
prospective Mortgagee, any lessee or prospective lessee thereof, any prospective assignee of any
Mortgage, or any other party designated by Landlord. The form of any such estoppel certificate
requested by a Mortgagee shall be satisfactory to such Mortgagee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.6 <U>Requirements of Law &#151; Fines and Penalties</U>.
Tenant at its sole expense shall
comply with all laws, rules, orders and regulations of Federal, State, County and Municipal
Authorities and with any direction of any public officer or officers, pursuant to law, which
shall
impose any duty upon Landlord or Tenant with respect to and arising out of Tenant&#146;s use or
occupancy of the Demised Premises. If Tenant receives notice of any violation of law,
ordinance, order or regulation applicable to the Demised Premises, it shall give prompt notice
thereof to Landlord. Without limiting the generality of the foregoing, Tenant shall be
responsible for compliance with requirements imposed by the Americans with Disabilities Act
relative to the Demised Premises, including without limitation all such requirements
applicable
to removing barriers, furnishing auxiliary aids and ensuring that, whenever alterations are
made,
the affected portions of the Demised Premises are readily accessible to and usable by
individuals
with disabilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.7 <U>Tenant&#146;s Acts &#151; Effect on Insurance</U>.
Tenant shall not do or permit to be done any
act or thing upon the Demised Premises or elsewhere in the Building which will invalidate or
be
in conflict with any insurance policies covering the Building and the fixtures and property
therein and shall not do, or permit to be done, any act or thing upon the Demised Premises
which
shall subject Landlord to any liability or responsibility for injury to any person or persons
or to
property by reason of any business or operation being conducted on the Demised Premises or for
any other reason. Tenant at its own expense shall comply with all applicable provisions of the
California Health and Safety Code and all regulations promulgated thereunder and with all
rules,
orders, regulations or requirements of the underwriter(s) of the fire and other hazard
insurance
for the Property and the Demised Premises and shall not (i)&nbsp;do, or permit anything to be done,
in
or upon the Demised Premises, or bring or keep anything therein, except as now or hereafter
permitted by the City of South San Francisco Fire Department, or other authority having
jurisdiction, and then only in such quantity and manner of storage as will not increase the
rate for
any insurance applicable to the Building, or (ii)&nbsp;use the Demised Premises in a manner which
shall increase such insurance rates on the Building or on property located therein, over that
applicable when Tenant first took occupancy of the Demised Premises hereunder. If by reason
of failure of Tenant to comply with the provisions hereof the insurance rate applicable to any
policy of insurance shall at any time thereafter be higher than it otherwise would be, then
Tenant
shall reimburse Landlord for that part of any insurance premiums thereafter paid by Landlord,
which shall have been charged because of such failure by Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.8 <U>Miscellaneous</U>.
Tenant shall not suffer or permit the Demised Premises or any
fixtures, equipment or utilities therein or serving the same, to be overloaded, damaged or
defaced.</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 19 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">16. DAMAGE BY FIRE, ETC.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of loss of, or damage to, the Demised Premises or the Building by fire or other
casualty, the rights and obligations of the parties hereto shall be as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;If the Demised Premises, or any part thereof, shall be damaged by fire or
other casualty, Tenant shall give prompt notice thereof to Landlord, and Landlord, upon
receiving such notice, shall proceed promptly and with due diligence, subject to unavoidable
delays, to repair, or cause to be repaired, such damage. If the Demised Premises or any part
thereof shall be rendered untenantable by reason of such damage, whether to the Demised
Premises or to the Building, Yearly Fixed Rent shall proportionately abate for the period from
the date of such damage to the date when such damage shall have been repaired.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If, as a result of fire or other casualty, the whole or a substantial portion of
the Building is rendered untenantable, Landlord, within ninety (90)&nbsp;days from the date of such
fire or casualty, may terminate this Lease by notice to Tenant, specifying a date not less
than
thirty (30)&nbsp;nor more than sixty (60)&nbsp;days after the giving of such notice on which the Term of
this
Lease shall terminate. If Landlord does not so elect to terminate this Lease, then Landlord
shall
(to the extent that insurance proceeds, net of any portion thereof retained by a Mortgagee,
are
made available for such purpose) proceed with diligence to repair the damage to the Demised
Premises and all facilities serving the same, if any, which shall have occurred, and the
Yearly
Fixed Rent shall meanwhile proportionately abate, all as provided in Paragraph (a)&nbsp;of this
Section. However, if such damage is not repaired and the Demised Premises restored to
substantially the same condition as they were prior to such damage within nine (9)&nbsp;months from
the date of such damage, Tenant within thirty (30)&nbsp;days from the expiration of such nine (9)
month period or from the expiration of any extension thereof by reason of unavoidable delays
as
hereinafter provided, may terminate this Lease by notice to Landlord, specifying a date not
more
than sixty (60)&nbsp;days after the giving of such notice on which the Term of this Lease shall
terminate. The period within which the required repairs may be accomplished shall be extended
by the number of days, not to exceed one hundred eighty (180)&nbsp;days, lost as a result of
unavoidable delays, which term shall be defined to include all delays referred to in Article&nbsp;24.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If the Demised Premises shall be rendered untenantable by fire or other
casualty during the last two (2)&nbsp;years of the Term of this Lease, Landlord may terminate this
Lease effective as of the date of such fire or other casualty upon notice to Tenant given
within
ninety (90)&nbsp;days after such fire or other casualty.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Landlord shall not be required to repair or replace any of Tenant&#146;s
business machinery, equipment, cabinet work, furniture, personal property or other
installations
(all of which shall, however, be restored by Tenant within thirty (30)&nbsp;days after Landlord
shall
have completed any repair or restoration required under the terms of this Article), and no
damages, compensation or claim shall be payable by Landlord for inconvenience, loss of
business or annoyance arising from any repair or restoration of any portion of the Demised
Premises or of the Building.</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 20 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The provisions of this Article shall be considered an express agreement
governing any instance of damage or destruction of the Building or the Demised Premises by
fire
or other casualty, and any law now or hereafter in force providing for such a contingency in
the
absence of express agreement shall have no application.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;In the event of any termination of this Lease pursuant to this Article, the
Term of this Lease shall expire as of the effective termination date as fully and completely
as if
such date were the date originally fixed herein for the end of the Term of this Lease. Tenant
shall have access to the Demised Premises for a period of fifteen (15)&nbsp;days after the date of
termination in order to remove Tenant&#146;s personal property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Landlord&#146;s Architect&#146;s certificate, given in good faith, shall be deemed
conclusive of the statements therein contained and binding upon Tenant with respect to the
performance and completion of any repair or restoration work undertaken by Landlord pursuant
to this Article or Article&nbsp;18.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">17. WAIVER OF SUBROGATION
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In any case in which Tenant shall be obligated under any provision of this Lease to pay to
Landlord any loss, cost, damage, liability, or expense suffered or incurred by Landlord, Landlord
shall allow to Tenant as an offset against the amount thereof the net proceeds of any insurance
collected by Landlord for or on account of such loss, cost, damage, liability or expense, provided
that the allowance of such offset does not invalidate or prejudice the policy or policies under
which such proceeds were payable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In any case in which Landlord shall be obligated under any provision of this Lease to pay to
Tenant any loss, cost, damage, liability or expense suffered or incurred by Tenant, Tenant shall
allow to Landlord as an offset against the amount thereof (i)&nbsp;the net proceeds of any insurance
collected by Tenant for or on account of such loss, cost, damage, liability, or expense, provided
that the allowance of such offset does not invalidate the policy or policies under which such
proceeds were payable and (ii)&nbsp;if such loss, cost, damage, liability or expense shall have been
caused by a peril against which Tenant has agreed to procure insurance coverage under the terms of
this Lease, the amount of such insurance coverage, if not actually procured by Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto shall each endeavor to procure an appropriate clause in, or endorsement on,
any fire or extended coverage insurance policy covering the Demised Premises and the Building and
personal property, fixtures and equipment located thereon or therein, pursuant to which the
insurance companies waive subrogation or consent to a waiver of right of recovery, and having
obtained such clauses and/or endorsements of waiver of subrogation or consent to a waiver of right
of recovery each party hereby agrees that it will not make any claim against or seek to recover
from the other for any loss or damage to its property or the property of others resulting from fire
or other perils covered by such fire and extended coverage insurance; provided, however, that the
release, discharge, exoneration and covenant not to sue herein contained shall be limited by the
terms and provisions of the waiver of subrogation clauses and/or endorsements or clauses and/or
endorsements consenting to a waiver of right of recovery and shall be co-extensive therewith. If
either party may obtain such clause or endorsement only
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 21 -<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">upon payment of an additional premium, such party shall promptly so advise the other party and
shall be under no obligation to obtain such clause or endorsement unless such other party pays the
premium.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">18. CONDEMNATION &#151; EMINENT DOMAIN
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that the whole or any part of the Building shall be taken or appropriated by
eminent domain or shall be condemned for any public or quasi-public use, or (by virtue of any such
taking, appropriation or condemnation) shall suffer any damage (direct, indirect or consequential)
for which Landlord or Tenant shall be entitled to compensation then (and in any such event) this
Lease and the Term hereof may be terminated at the election of Landlord by a notice in writing of
its election so to terminate which shall be given by Landlord to Tenant within sixty (60)&nbsp;days
following the date on which Landlord shall have received notice of such taking, appropriation or
condemnation. In the event that more than fifty percent (50%) of the floor area of the Demised
Premises or a substantial part of the means of access thereto within the perimeter of the Property
so as to substantially interfere with the use of the Demised Premises shall be so taken,
appropriated or condemned, then (and in any such event) this Lease and the Term hereof may be
terminated at the election of Tenant by a notice in writing of its election so to terminate which
shall be given by Tenant to Landlord within sixty (60)&nbsp;days following the date on which Tenant
shall have received notice of such taking, appropriation or condemnation. Tenant hereby waives the
benefits of California Code of Civil Procedure Section&nbsp;12165.130.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the giving of any such notice of termination (either by Landlord or Tenant) this Lease
and the Term hereof shall terminate on or retroactively as of the date on which Tenant shall be
required to vacate any part of the Demised Premises or shall be deprived of a substantial part of
the means of access thereto, provided, however, that Landlord may in Landlord&#146;s notice elect to
terminate this Lease and the Term hereof retroactively as of the date on which such taking,
appropriation or condemnation became legally effective. In the event of any such termination, this
Lease and the Term hereof shall expire as of the effective termination date as fully and completely
as if such date were the date originally fixed herein for the end of the Term of this Lease. If
neither party (having the right so to do) elects to terminate Landlord will, with reasonable
diligence and at Landlord&#146;s expense, restore the remainder of the Demised Premises, or the
remainder of the means of access thereto, as nearly as practicably may be to the same condition as
obtained prior to such taking, appropriation or condemnation in which event (i)&nbsp;a just proportion
of the Yearly Fixed Rent, according to the nature and extent of the taking, appropriation or
condemnation and the resulting permanent injury to the Demised Premises and the means of access
thereto, shall be permanently abated, and (ii)&nbsp;a just proportion of the remainder of the Yearly
Fixed Rent, according to the nature and extent of the taking, appropriation or condemnation and the
resultant injury sustained by the Demised Premises and the means of access thereto, shall be abated
until what remains of the Demised Premises and the means of access thereto shall have been restored
as fully as may be for permanent use and occupation by Tenant hereunder. Except for any award
specifically reimbursing Tenant for moving or relocation expenses, there are expressly reserved to
Landlord all rights to compensation and damages created, accrued or accruing by reason of any such
taking, appropriation or condemnation, in implementation and in confirmation of which Tenant does
hereby acknowledge that Landlord shall be entitled to receive and retain all such compensation
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio --> - 22 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and damages, grants to Landlord all and whatever rights (if any) Tenant may have to such
compensation and damages, and agrees to execute and deliver all and whatever further instruments of
assignment as Landlord may from time to time request. In the event of any taking of the Demised
Premises or any part thereof for temporary use, (i)&nbsp;this Lease shall be and remain unaffected
thereby, and (ii)&nbsp;Tenant shall be entitled to receive for itself any award made for such use,
provided, that if any taking is for a period extending beyond the Term of this Lease, such award
shall be apportioned between Landlord and Tenant as of the Termination Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">19. DEFAULT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.1 <U>Events of Default</U>. Occurrence of any of the following events shall constitute an
Event of Default under this Lease: (a)&nbsp;Tenant shall neglect or fail to perform or observe any of
the Tenant&#146;s covenants herein, including (without limitation) the covenants with regard to the
payment when due of Rent; or (b)&nbsp;Tenant shall be involved in financial difficulties as evidenced by
an admission in writing by Tenant of Tenant&#146;s inability to pay its debts generally as they become
due, or by the making or offering to make a composition of its debts with its creditors; or (c)
Tenant shall make an assignment or trust mortgage, or other conveyance or transfer of like nature,
of all or a substantial part of its property for the benefit of its creditors; or (d)&nbsp;the leasehold
hereby created shall be taken on execution or by other process of law and shall not be revested in
Tenant within sixty (60)&nbsp;days thereafter; or (e)&nbsp;a receiver, sequester, trustee or similar officer
shall be appointed by a court of competent jurisdiction to take charge of all or a substantial part
of Tenant&#146;s property and such appointment shall not be vacated within sixty (60)
days; or (f)&nbsp;any proceeding shall be instituted by or against Tenant pursuant to any of the
provisions of any Act of Congress or State law relating to bankruptcy, reorganization,
arrangements, compositions or other relief from creditors, and, in the case of any such proceeding
instituted against it, if Tenant shall fail to have such proceeding dismissed within thirty (30)
days or if Tenant is adjudged bankrupt or insolvent as a result of any such proceeding; or (g)&nbsp;any
event shall occur or any contingency shall arise whereby this Lease, or the term and estate thereby
created, would (by operation of law or otherwise) devolve upon or pass to any person, firm or
corporation other than Tenant, except as expressly permitted under Article&nbsp;14 hereof; or (h)&nbsp;Tenant
shall vacate all or substantially all of the Demised Premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.2 <U>Remedies Available upon Default</U>. Upon the occurrence of an Event of Default,
Landlord shall have the following remedies, which shall not be exclusive but shall be cumulative
and shall be in addition to any other remedies now or hereafter allowed by law:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Landlord may terminate Tenant&#146;s right to possession of the Premises at any time by written
notice to Tenant. Tenant expressly acknowledges that in the absence of such written notice from
Landlord, no other act of Landlord, including re-entry into the Premises, efforts to relet the
Premises, reletting of the Premises for Tenant&#146;s account, storage of Tenant&#146;s personal property and
trade fixtures, acceptance of keys to the Premises from Tenant or exercise of any other rights and
remedies under this Section, shall constitute an acceptance of Tenant&#146;s surrender of the Premises
or constitute a termination of this Lease or of Tenant&#146;s right to possession of the Premises. Upon
such termination in writing of Tenant&#146;s right to possession of the Premises, as herein provided,
this Lease shall terminate and Landlord shall be entitled to recover damages from Tenant as
provided in California Civil Code Section&nbsp;1951.2 and any other applicable existing or future Law
providing for
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio --> - 23 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">recovery of damages for such breach, including the worth at the time of award of the amount by
which the rent which would be payable by Tenant hereunder for the remainder of the Term after the
date of the award of damages, including Additional Rent as reasonably estimated by Landlord,
exceeds the amount of such rental loss as Tenant proves could have been reasonably avoided,
discounted at the discount rate published by the Federal Reserve Bank of San Francisco for member
banks at the time of the award plus one percent (1%).
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Landlord shall have the remedy described in California Civil Code Section&nbsp;1951.4 (Landlord
may continue this Lease in effect after Tenant&#146;s breach and abandonment and recover rent as it
becomes due, if Tenant has the right to sublet or assign, subject only to reasonable limitations).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Landlord may immediately, or at any time thereafter, without notice, cure said Event of
Default for the account of Tenant. If Landlord at any time is compelled to pay or elects to pay any
sum of money, or do any act which will require the payment of any sum of money, by reason of the
failure of Tenant to comply with any provision hereof, or if Landlord is compelled to or does incur
any expense, including without limitation reasonable attorneys&#146; fees, in instituting, prosecuting
and/or defending any action or proceeding arising by reason of any default of Tenant hereunder,
Tenant shall on demand pay to Landlord by way of reimbursement the sum or sums so paid by Landlord
with all interest, costs and damages together with interest at the Interest Rate for the period
such sums remain outstanding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Landlord may remove all of Tenant&#146;s property from the Premises, and such property may be
stored by Landlord in a public warehouse or elsewhere at the sole cost and for the account of
Tenant. If Landlord does not elect to store any or all of Tenant&#146;s property left in the Premises,
Landlord may consider such property to be abandoned by Tenant, and Landlord may thereupon dispose
of such property in the manner and as prescribed by California Civil Code Section&nbsp;1980 <I>et seq.</I>
Any proceeds realized by Landlord on the disposal of any such property shall be applied first to
offset all expenses of storage and sale, then credited against Tenant&#146;s outstanding obligations to
Landlord under this Lease, and any balance remaining after satisfaction of all obligations of
Tenant under this Lease shall be delivered to Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The damages recoverable by Landlord pursuant to this Section shall in all events include
reimbursement of any concessions made by Landlord in connection with the leasing of the Demised
Premises to Tenant, including without limitation (a)&nbsp;abated Rent, (b)&nbsp;allowances or improvements in
excess of any Building standard work, (c)&nbsp;sums paid to any former landlord of Tenant under a
so-called &#147;take-over&#148;, lease assumption or similar agreement and (d)&nbsp;signing bonuses and other
incentive payments.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.3 <U>Grace Period</U>. Notwithstanding anything to the contrary in this Article
contained, Landlord agrees not to take any action to terminate this Lease (a)&nbsp;for default by Tenant
in the payment when due of Rent, if Tenant shall cure such default within five (5)&nbsp;days after
written notice thereof given by Landlord to Tenant, or (b)&nbsp;for default by Tenant in the performance
of any other covenant, if Tenant shall cure such default within a period of thirty (30)&nbsp;days after
written notice thereof given by Landlord to Tenant (except where the nature of the default is such
that remedial action should appropriately take place sooner, as indicated in such written notice),
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio --> - 24 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or with respect to covenants other than to pay a sum of money within such additional period as may
reasonably be required to cure such default if (because of governmental restrictions or any other
cause beyond the reasonable control of Tenant) the default is of such a nature that it cannot be
cured within such thirty (30)-day period, provided, however, (1)&nbsp;that there shall be no extension
of time beyond such thirty (30)-day period for the curing of any such default unless, not more than
ten (10)&nbsp;days after the receipt of the notice of default, Tenant in writing (i)&nbsp;shall specify the
cause on account of which the default cannot be cured during such period and shall advise Landlord
of its intention duly to institute all steps necessary to cure the default and (ii)&nbsp;shall as soon
as may be reasonable duly institute and thereafter diligently prosecute to completion all steps
necessary to cure such default and, (2)&nbsp;that no notice of the opportunity to cure a default need be
given, and no grace period whatsoever shall be allowed to Tenant, if the default is incurable or if
the covenant or condition the breach of which gave rise to the default had, by reason of a breach
on a prior occasion, been the subject of a notice hereunder to cure such default.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">20. END OF TERM &#151; ABANDONED PROPERTY
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the expiration or other termination of the Term of this Lease, Tenant shall peaceably
quit and surrender to Landlord the Demised Premises and all alterations and additions thereto which
Tenant is not entitled or required to remove under the provisions of this Lease, broom clean in
good order, repair and condition excepting only reasonable use and wear and damage by fire or other
casualty for which, under other provisions of this Lease, Tenant has no responsibility of repair or
restoration. Tenant&#146;s obligation to observe or perform this covenant shall survive the expiration
or other termination of the Term of this Lease. If the last day of the Term of this Lease or any
renewal thereof falls on a day other than a Business Day, this Lease shall expire on the Business
Day immediately preceding. Tenant shall pay twice the amount of Rent applicable to each month (or
fraction thereof) during which Tenant remains in possession of any part of the Demised Premises in
violation of the foregoing covenants, without prejudice to eviction and any other remedy available
to Landlord on account thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any personal property in which Tenant has an interest which shall remain in the Building or on
the Demised Premises after the expiration or termination of the Term of this Lease shall be
conclusively deemed to have been abandoned, and may be disposed of in such manner as Landlord may
see fit; provided, however, notwithstanding the foregoing, that Tenant will, upon request of
Landlord made not later than ten (10)&nbsp;days after the expiration or termination of the Term hereof,
promptly remove from the Building any such personal property or, if any part thereof shall be sold,
that Landlord may receive and retain the proceeds of such sale and apply the same, at its option,
against the expenses of the sale, the cost of moving and storage, any arrears of Rent payable
hereunder by Tenant to Landlord and any damages to which Landlord may be entitled under Article&nbsp;19
hereof or pursuant to law, with the balance if any, to be paid to Tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">21. RIGHTS OF MORTGAGEES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.1 (Intentionally omitted)
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio --> - 25 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.2 <U>Entry and Possession</U>. Upon entry and taking possession of the Property by a
Mortgagee, for the purpose of foreclosure or otherwise, such Mortgagee shall have all the rights of
Landlord, and shall be liable to perform all the obligations of Landlord arising and accruing
during the period of such possession by such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.3 <U>Right to Cure</U>. No act or failure to act on the part of Landlord which would
entitle Tenant under the terms of this Lease, or by law, to be relieved of Tenant&#146;s obligations
hereunder or to terminate this Lease, shall result in a release or termination of such obligations
or a termination of this Lease unless (i)&nbsp;Tenant shall have first given written notice of
Landlord&#146;s act or failure to act to first Mortgagees of record, if any, and to any other Mortgagees
of whom Tenant has been given written notice, specifying the act or failure to act on the part of
Landlord which could or would give basis to Tenant&#146;s rights; and (ii)&nbsp;such Mortgagees, after
receipt of such notice, have failed or refused to correct or cure the condition complained of
within a reasonable time thereafter, but nothing contained in this paragraph shall be deemed to
impose any obligation on any such Mortgagees to correct or cure any such condition. &#147;Reasonable
time&#148; as used above means and includes a reasonable time to obtain possession of the Land and
Building if any such Mortgagee elects to do so and a reasonable time to correct or cure the
condition if such condition is determined to exist.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.4 <U>Prepaid Rent</U>. No Rent shall be paid more than thirty (30)&nbsp;days prior to the due
dates thereof and, as to a first Mortgagee of record and any other Mortgagees of whom Tenant has
been given written notice, payments made in violation of this provision shall (except to the extent
that such Rent is actually received by such Mortgagee) be a nullity as against such Mortgagee and
Tenant shall be liable for the amount of such payments to such Mortgagee.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.5 <U>Continuing Offer</U>. The covenants and agreements contained in this Lease with
respect to the rights, powers and benefits of a Mortgagee (particularly, without limitation
thereby, the covenants and agreements contained in this Article) constitute a continuing offer to
any person, corporation or other entity, which by accepting or requiring an assignment of this
Lease or by entry or foreclosure assumes the obligations herein set forth with respect to such
Mortgagee; every such Mortgagee is hereby constituted a party to this
Lease as an obligee hereunder
to the same extent as though its name was written hereon as such; and such Mortgagee shall be
entitled to enforce such provisions in its own name.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.6 <U>Subordination</U>. Notwithstanding the foregoing provisions of this Article, Tenant
agrees, at the request of Landlord or any Mortgagee, to execute and deliver promptly any
certificate or other instrument which Landlord or such Mortgagee may request subordinating this
Lease and all rights of Tenant hereunder to any Mortgage, and to all advances made under such
Mortgage and/or agreeing to attorn to such Mortgagee in the event that it succeeds to Landlord&#146;s
interest in the Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.7 <u>Limitations on Liability</u>. Nothing contained in the foregoing Section&nbsp;21.6 or in any such
non-disturbance agreement or non-disturbance provision shall however, affect the prior rights of
the holder of any Mortgage with respect to the proceeds of any award in condemnation or of any fire
insurance policies affecting the Building, or impose upon any such holder any liability (i)&nbsp;for the
erection or completion of the Building, or (ii)&nbsp;in the event of damage or
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio --> - 26 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">destruction to the Building or the Demised Premises by fire or other casualty, for any repairs,
replacements, rebuilding or restoration except such repairs, replacements, rebuilding or
restoration as can reasonably be accomplished from the net proceeds of insurance actually received
by, or made available to, such holder, or (iii)&nbsp;for any default by Landlord under the Lease
occurring prior to any date upon which such holder shall become Tenant&#146;s landlord, or (iv)&nbsp;for any
credits, offsets or claims against the Rent as a result of any acts or omissions of Landlord
committed or omitted prior to such date, or (v)&nbsp;for return of any security deposit or other funds
unless the same shall have been received by such holder, and any such agreement or provision may so
state.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">22. QUIET ENJOYMENT
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord covenants that if, and so long as, Tenant keeps and performs each and every covenant,
agreement, term, provision and condition herein contained on the part and on behalf of Tenant to be
kept and performed, Tenant shall quietly enjoy the Demised Premises from and against the claims of
all persons claiming by, through or under Landlord subject, nevertheless, to the covenants,
agreements, terms, provisions and conditions of this Lease and to all Mortgages to which this Lease
is subject and subordinate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without incurring any liability to Tenant, Landlord may permit access to the Demised Premises
and open the same, whether or not Tenant shall be present, upon any demand of any receiver,
trustee, assignee for the benefit of creditors, sheriff, marshall or court officer entitled to, or
reasonably purporting to be entitled to, such access for the purpose of taking possession of, or
removing Tenant&#146;s property or for any other lawful purpose (but this provision and any action by
Landlord hereunder shall not be deemed a recognition by Landlord that the person or official making
such demand has any right or interest in or to this Lease, or in or to the Demised Premises), or
upon demand of any representative of the fire, police, building, sanitation or other department of
the city, county, state or federal governments.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">23. ENTIRE AGREEMENT &#151; WAIVER &#151; SURRENDER
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.1 <U>Entire Agreement</U>. This Lease and the Exhibits made a part hereof contain the
entire and only agreement between the parties and any and all statements and representations,
written and oral, including previous correspondence and agreements between the parties hereto, are
merged herein. Tenant acknowledges that all representations and statements upon which it relied in
executing this Lease are contained herein and that Tenant in no way relied upon any other
statements or representations, written or oral. Any executory agreement hereafter made shall be
ineffective to change, modify, discharge or effect an abandonment of this Lease in whole or in part
unless such executory agreement is in writing and signed by the party against whom enforcement of
the change, modification, discharge or abandonment is sought. Nothing herein shall prevent the
parties from agreeing to amend this Lease and the Exhibits made a part hereof as long as such
amendment shall be in writing and shall be duly signed by both parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.2 <U>Waiver by Landlord</U>. The failure of Landlord to seek redress for violation, or to
insist upon the strict performance, of any covenant or condition of this Lease, or any of the Rules
and Regulations promulgated hereunder, shall not prevent a subsequent act, which would have
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio --> - 27 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">originally constituted a violation, from having all the force and effect of an original violation.
The receipt by Landlord of Rent with knowledge of the breach of any covenant of this Lease shall
not be deemed a waiver of such breach. The failure of Landlord to enforce any of such Rules and
Regulations against Tenant and/or any other tenant or subtenant in the Building shall not be deemed
a waiver of any such Rules and Regulations. No provisions of this Lease shall be deemed to have
been waived by Landlord unless such waiver be in writing signed by Landlord. No payment by Tenant
or receipt by Landlord of a lesser amount than the monthly rent herein stipulated shall be deemed
to be other than on account of the stipulated rent, nor shall any endorsement or statement on any
check or any letter accompanying any check or payment as rent be deemed an accord and satisfaction,
and Landlord may accept such check or payment without prejudice to Landlord&#146;s right to recover the
balance of such rent or pursue any other remedy in this Lease provided.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.3 <U>Surrender</U>. No act or thing done by Landlord during the term hereby demised
shall be deemed an acceptance of a surrender of the Demised Premises, and no agreement to accept
such surrender shall be valid, unless in writing signed by Landlord. No employee of Landlord or of
Landlord&#146;s agents shall have any power to accept the keys of the Demised Premises prior to the
termination of this Lease. The delivery of keys to any employee of Landlord or of Landlord&#146;s agents
shall not operate as a termination of the Lease or a surrender of the Demised Premises. In the
event that Tenant at any time desires to have Landlord underlet the Demised Premises for Tenant&#146;s
account, Landlord or Landlord&#146;s agents are authorized to receive the keys for such purposes without
releasing Tenant from any of the obligations under this Lease, and Tenant hereby relieves Landlord
of any liability for loss of or damage to any of Tenant&#146;s effects in connection with such
underletting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">24. INABILITY TO PERFORM &#151; EXCULPATORY CLAUSE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise expressly provided in this Lease, this Lease and the obligations of Tenant
to pay Rent hereunder and perform all other covenants, agreements, terms, provisions and conditions
hereunder on the part of Tenant to be performed shall in no way be affected, impaired or excused
because Landlord is unable to fulfill any of its obligations under this Lease or is unable to
supply or is delayed in supplying any service expressly or impliedly to be supplied or is unable to
make or is delayed in making any repairs, replacements, additions, alterations, improvements or
decorations or is unable to supply or is delayed in supplying any equipment or fixtures if Landlord
is prevented or delayed from doing so by reason of any cause whatsoever beyond Landlord&#146;s
reasonable control, including but not limited to governmental preemption in connection with a
national emergency or by reason of any rule, order or regulation of any department or subdivision
thereof of any governmental agency or by reason of strikes, labor troubles, shortages of labor or
materials or conditions of supply and demand which have been or are affected by war, hostilities or
other similar or dissimilar emergency. In each such instance of inability of Landlord to perform,
Landlord shall exercise reasonable diligence to eliminate the cause of such inability to perform.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall neither assert nor seek to enforce any claim for breach of this Lease against any
of Landlord&#146;s assets other than Landlord&#146;s interest in the Building of which the Demised Premises
are a part and in the rents, issues and profits thereof, and Tenant agrees to look solely to
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio --> - 28 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">





<DIV align="left" style="font-size: 10pt; margin-top: 6pt">such interest for the satisfaction of any liability of Landlord under this Lease, it being
specifically agreed that in no event shall Landlord (which term shall include, without limitation
any of the officers, trustees, directors, partners, beneficiaries, joint venturers, members,
stockholders or other principals or representatives, disclosed or undisclosed, of Landlord or any
managing agent) ever be personally liable for any such liability. This paragraph shall not limit
any right that Tenant might otherwise have to obtain injunctive relief against Landlord or to take
any other action which shall not involve the personal liability of Landlord to respond in monetary
damages from Landlord&#146;s assets other than the Landlord&#146;s interest in said real estate, as
aforesaid. In no event shall Landlord ever be liable for consequential damages.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">25. BILLS AND NOTICES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any notice, consent, request, bill, demand or statement hereunder by either party to the other
party shall be in writing and, if received at Landlord&#146;s or Tenant&#146;s Address, shall be deemed to
have been duly given when either delivered or served personally or mailed in a postpaid envelope,
deposited in the United States mails addressed to the respective party at its Address as stated in
Article&nbsp;1 or if any Address for notices shall have been duly changed as hereinafter provided, if
mailed as aforesaid to the party at such changed Address. Either party may at any time change the
Address for such notices, consents, requests, bills, demands or statements by delivering or
mailing, as aforesaid, to the other party a notice stating the change and setting forth the changed
Address, provided such changed Address is within the United States.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All bills and statements for reimbursement or other payments or charges due from Tenant to
Landlord hereunder shall be due and payable in full thirty (30)&nbsp;days, unless herein otherwise
provided, after submission thereof by Landlord to Tenant. Tenant&#146;s failure to make timely payment
of any amounts indicated by such bills and statements, whether for work done by Landlord at
Tenant&#146;s request, reimbursement provided for by this Lease or for any other sums properly owing by
Tenant to Landlord, shall be treated as a default in the payment of Rent, in which event Landlord
shall have all rights and remedies provided in this Lease for the nonpayment of Rent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">26. SUCCESSORS AND ASSIGNS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The covenants, agreements, terms, provisions and conditions of this Lease shall bind and
benefit the successors and assigns of the parties hereto with the same effect as if mentioned in
each instance where a party hereto is named or referred to, except that no violation of the
provisions of Article&nbsp;14 hereof shall operate to vest any rights in any successor or assignee of
Tenant and that the provisions of this Article shall not be construed as modifying the conditions
of limitation contained in Article&nbsp;19 hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If in connection with or as a consequence of the sale, transfer or other disposition of the
real estate (Land and/or Building, either or both, as the case may be) of which the Demised
Premises are a part Landlord ceases to be the owner of the reversionary interest in the Demised
Premises, Landlord shall be entirely freed and relieved from the performance and observance
thereafter of all covenants and obligations hereunder accruing thereafter on the part of Landlord
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio --> - 29 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to be performed and observed, it being understood and agreed in such event (and it shall be deemed
and construed as a covenant running with the land) that the person succeeding to Landlord&#146;s
ownership of said reversionary interest shall thereupon and thereafter assume, and perform and
observe, any and all of such covenants and obligations of Landlord.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">27. MISCELLANEOUS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.1 <U>Separability</U>. If any provision of this Lease or portion of such provision or the
application thereof to any person or circumstance is for any reason held invalid or unenforceable,
the remainder of the Lease (or the remainder of such provision) and the application thereof to
other persons or circumstances shall not be affected thereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.2 <U>Captions</U>. The captions are inserted only as a matter of convenience and for
reference, and in no way define, limit or describe the scope of this Lease nor the intent of any
provisions thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.3 <U>Broker</U>. Each party represents and warrants that it has not directly or indirectly
dealt, with respect to the leasing of space in the Building, with any broker or had its attention
called to the Demised Premises or other space to let in the Building, by any broker other than the
Broker (if any) listed in Article&nbsp;1 whose commission shall be the responsibility of Landlord. Each
party agrees to exonerate and save harmless and indemnify the other against any claims for a
commission by any other broker, person or firm, with whom such party has dealt in connection with
the execution and delivery of this Lease or out of negotiations between Landlord and Tenant with
respect to the leasing of other space in the Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.4 <U>Governing Law</U>. This Lease is made pursuant to, and shall be governed by, and
construed in accordance with, the laws of the State of California.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.5 <U>Assignment of Lease and/or Rents</U>. With reference to any assignment by Landlord of
its interest in this Lease and/or the Rent payable hereunder, conditional in nature or otherwise,
which assignment is made to or held by a bank, trust company, insurance company or other
institutional lender holding a Mortgage on the Building, Landlord and Tenant agree:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;that the execution thereof by Landlord and acceptance thereof by such Mortgagee shall
never be deemed an assumption by such Mortgagee of any of the obligations of the Landlord
hereunder, unless such Mortgagee shall, by written notice sent to the Tenant, specifically
otherwise elect; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;that, except as aforesaid, such Mortgagee shall be treated as having assumed the
Landlord&#146;s obligations hereunder only upon foreclosure of such Mortgagee&#146;s Mortgage and the taking
of possession of the Demised Premises after having given notice of its intention to succeed to the
interest of the Landlord under this Lease.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.6 <U>Memorandum of Lease</U>. Neither party shall record this Lease; provided, however,
that either party shall at the request of the other, execute and deliver a recordable memorandum of
this Lease setting forth the parties to this Lease, a description of the Demised Premises and the
term of this Lease for recordation in the Official records of the County of San Mateo.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio --> - 30 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.7 (omitted)
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.8 (omitted)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.9 <U>Arbitration of Certain Matters</U>. At the election of either party, if any dispute
as to the allocation of real estate taxes or operating expenses under Section&nbsp;6.2, the abatement of
Yearly Fixed Rent pursuant to Article&nbsp;16 or the abatement of Yearly Fixed Rent pursuant to Article
18 remains unresolved 30&nbsp;days after written complaint by Tenant has been delivered to Landlord as
to an allocation, reduction, apportionment or abatement made or proposed by Landlord, the matter
may be submitted to binding arbitration pursuant to California Code of Civil Procedure Section&nbsp;1280
<I>et seq.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, Landlord and Tenant have caused this instrument to be executed under
seal, all as of the day and year first above written.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="13%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">MOUNTAIN COVE TECH CENTER, L.L.C.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">MJ RESEARCH COMPANY, INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; John Finney
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;John Finney
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Its President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Mike Finney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mike Finney</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="3" valign="top" align="left">Its Managers</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio --> - 31 - <!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT A
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">PLAN OF DEMISED PREMISES
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;Diagram depicting the entire land and building in South San Francisco.&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT A-1
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">PLANS AND SPECIFICATIONS FOR LANDLORD&#146;S WORK
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">None.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT
B<br></U>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><U>CLEANING
SCHEDULE</U>

</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">I.</TD>
    <TD>&nbsp;</TD>
    <TD><U>Premises</U></TD>
</TR>
</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Daily on Business Days</U>:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Empty all waste receptacles and ash trays and remove waste materials from the
Premises.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep and dust mop all uncarpeted areas using a dust-treated mop.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Vacuum all rugs and carpeted areas.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Hand dust and wipe clean with treated cloths all horizontal cleared surfaces
including desk tops, office equipment, window sills, door ledges, chair rails and
counter tops, within normal reach.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">e.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash clean all water fountains.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">f.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Upon completion of cleaning, all lights will be turned off and
doors locked, leaving the Premises in an orderly condition.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Quarterly</U></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Render high dusting not reached in daily cleaning to include:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dusting all pictures, frames, charts, graphs and similar wall hangings.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dusting all vertical surfaces, such as walls, partitions, doors and ducts.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dusting of all pipes, ducts and high moldings.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">II.</TD>
    <TD>&nbsp;</TD>
    <TD><U>Lavatories</U></TD>
</TR>
</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Daily on Business Days</U>:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep and damp mop floors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Clean all mirrors, powder shelves, dispensers and receptacles, bright
work, flushometers, pipes and toilet seats.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash both sides of all toilet seats.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash all basins, bowls and urinals.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">e.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dust and clean all powder room fixtures.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">f.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Empty and clean paper towel and sanitary disposal receptacles.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">g.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Remove waste paper and refuse.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">h.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Refill tissue holders, soap dispensers, towel dispensers, vending sanitary
dispensers; materials to be furnished by Landlord.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">i.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>A sanitizing solution will be used in all lavatory
cleaning.</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Monthly</U>:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Machine scrub lavatory floors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Wash all partitions and tile walls in lavatories.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">III.</TD>
    <TD>&nbsp;</TD>
    <TD><U>Main Lobby, Elevators, Building Exterior and Corridors</U></TD>
</TR>
</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Daily on Business Days</U>:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">a.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep and wash or spray buff all marble floors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">b.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sweep all entrance mats.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">c.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Clean elevators, wash or vacuum floors, wipe down walls and doors.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">d.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Spot clean any metal work surrounding building entrance doors.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Monthly:</u></TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>All resilient tile floors in public areas to be treated equivalent to spray buffing.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">IV.</TD>
    <TD>&nbsp;</TD>
    <TD><u>Window Cleaning</u></TD>
</TR>
</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The outside of exterior wall windows will be washed once every three months, weather
permitting, and the inside of exterior wall windows will be washed every six months.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">V.</TD>
    <TD>&nbsp;</TD>
    <TD>Tenants requiring services in excess of those described above shall request same through
Landlord, at Tenant&#146;s expense.</TD>
</TR>
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>EXHIBIT C</U>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><U>RULES AND REGULATIONS</U>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;The sidewalks, entrances, passages, courts, elevators, vestibules, stairways,
corridors or halls of the Building shall not be obstructed or encumbered or used for any
purpose
other than ingress and egress to and from the premises demised to any tenant or occupant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;No awnings or other projections shall be attached to the outside walls or windows
of the Building without the prior consent of Landlord. No curtains, blinds, shades, or screens
shall be attached or hung in, or used in connection with, any window or door of the premises
demised to any tenant or occupant, without the prior consent of Landlord. Such awnings,
projections, curtains, blinds, shades, screens, or other fixtures must be of a quality type,
design
and color, and attached in a manner, approved by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;No sign, advertisement, object, notice or other lettering shall be exhibited,
inscribed, painted or affixed on any part of the outside or inside of the premises demised to
any
tenant or occupant or of the Building without the prior consent of Landlord. Interior signs on
doors and directory tables, if any, shall be of a size, color and style approved by Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;The sashes, sash doors, skylights, windows, and doors that reflect or admit light
and air into the halls, passageways or other public places in the Building shall not be
covered or
obstructed, nor shall any bottles, parcels, or other articles be placed on any window sills.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;No show cases or other articles shall be put in front of or affixed to any part of the
exterior of the Building, nor placed in the halls, corridors, vestibules or other parts of the
Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;The water and wash closets and other plumbing fixtures shall not be used for any
purposes other than those for which they were constructed, and no sweepings, rubbish, rags, or
other substances shall be thrown therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;No tenant or occupant shall mark, paint, drill into, or in any way deface any part
of the Building or the premises demised to such tenant or occupant. No boring, cutting or
stringing of wires shall be permitted, except with the prior consent of the Landlord, and as
Landlord may direct. No tenant or occupant shall install any resilient tile or similar floor
covering in the premises demised to such tenant or occupant except in a manner approved by
Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;No bicycles, vehicles or animals of any kind shall be brought into or kept in or
about the premises demised to any tenant. Bicycles may be stored in racks, if any, furnished
for
such purpose by Landlord in a common area of the Property. No cooking shall be done or
permitted in the Building by any tenant without the approval of Landlord. No tenant shall
cause
or permit any unusual or objectionable odors to emanate from the Premises demised to such
tenant.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;Without the prior consent of Landlord, no space in the Building shall be used for
manufacturing, or for the sale of merchandise, goods or property of any kind at auction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;No tenant shall make, or permit to be made, any unseemly or disturbing noises or
disturb or interfere with other tenants or occupants of the Building or neighboring buildings
or
premises whether by the use of any musical instrument, radio, television set or other audio
device, unmusical noise, whistling, signing, or in any other way. Nothing shall be thrown out
of
any doors or windows.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;Each tenant must, upon the termination of its tenancy, restore to Landlord all keys
of stores, storage areas, offices and toilet rooms, either furnished to, or otherwise procured
by,
such tenant.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;All removals from the Building, or the carrying in or out of the Building or the
premises demised to any tenant, of any sales, freight, furniture, or bulky matter of any
description must take place at such time and in such manner as Landlord or its agents may
determine, from time to time. Landlord reserves the right to inspect all freight to be brought
into
the Building and to exclude from the Building all freight which violates any of the Building
Rules or the provisions of such tenant&#146;s lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;No tenant shall use or occupy, or permit any portion of the premises demised to
such tenant to be used or occupied, as an office for a public stenographer, messenger service
or
typist, or as a barber or manicure shop, or as an employment bureau. No tenant or occupant
shall
engage or pay any employees in the Building, except those actually working for such tenant or
occupant in the Building, nor advertise for laborers giving an address at the Building.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.&nbsp;No tenant or occupant shall purchase spring water, ice, food, beverage, lighting
maintenance, cleaning towels or other like service, from any company or person not approved by
Landlord, such approval not unreasonably to be withheld.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.&nbsp;Landlord shall have the right to prohibit any advertising by any tenant or occupant
which, in Landlord&#146;s opinion, tends to impair the reputation of the Building or its
desirability as
a building for offices, and upon notice from Landlord, such tenant or occupant shall refrain
from
or discontinue such advertising.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.&nbsp;Landlord reserves the right to exclude from the Building, between the hours of
6:00 p.m. and 8:00 a.m. on Business Days and otherwise at all hours, all persons who do not
present a pass to the building signed by the Landlord. Landlord will furnish passes to persons
for
whom any tenant requests such passes. Each tenant shall be responsible for all persons for
whom it requests such passes and shall be liable to Landlord for all wrongful acts of such
persons.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.&nbsp;Each tenant, before closing and leaving the premises demised to such tenant at
any time, shall see that all entrance doors are locked and windows closed.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.&nbsp;Each tenant shall, at its expense, provide artificial light in the premises demised to
such tenant for Landlord&#146;s agency, contractors, and employees while performing janitorial or
other cleaning services and making repairs or alterations in said premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.&nbsp;No premises shall be used, or permitted to be used, for lodging or sleeping, or for
any immoral or illegal purpose.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20.&nbsp;There shall not be used in the Building, either by any tenant or occupant or by
their agents or contractors, in the delivery or receipt of merchandise, freight or other
matter, any
hand trucks or other means of conveyance except those equipped with rubber tires, rubber side
guards and such other safeguards as Landlord may require.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.&nbsp;Canvassing, soliciting and peddling in the Building are prohibited and each tenant
and occupant shall co-operate in seeking their prevention.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22.&nbsp;If the premises demised to any tenant become infested with vermin, such tenant,
at its sole cost and expense, shall cause its premises to be exterminated from time to time,
to the
satisfaction of Landlord, and shall employ such exterminators therefor as shall be approved by
Landlord.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.&nbsp;No premises shall be used, or permitted to be used, at any time, without the prior
approval of Landlord, as a store for the sale or display of goods, wares or merchandise of any
kind, or as a restaurant, shop, booth, bootblack or other stand, or for the conduct of any
business
or occupation which predominantly involves direct patronage of the general public in the
premises demised to such tenant, or for manufacturing or for other similar purpose.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24.&nbsp;No tenant shall move, or permit to be moved, into or out of the Building or the
premises demised to such tenant, any heavy or bulky matter, without the specific approval of
Landlord. If any such matter requires special handling, only a person holding a Master
Rigger&#146;s
license shall be employed to perform such special handling. No tenant shall place, or permit
to be placed, on any part of the floor or floors of the premises demised to such tenant, a load
exceeding the floor load per square foot which such floor was designed to carry and which is
allowed by law. Landlord reserves the right to prescribe the weight and position of safes and
other heavy matter, which must be placed so as to distribute the weight.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25.&nbsp;The requirements of tenants will be attended to only upon application at the office
of the Building. Building employees shall not be required to perform, and shall not be
requested
by any tenant or occupant to perform, any work outside of their regular duties, unless under
specific instructions from the office of the managing agent of the Building.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>f39432xe3943247.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943247.gif
M1TE&.#EAR`*V`_<```````@("!`0$!@8&"$A(2DI*3$Q,3DY.4)"0DI*2E)2
M4EI:6F-C8VMK:W-S<WM[>X2$A(R,C)24E)R<G*6EI:VMK;6UM;V]O<;&QL[.
MSM;6UM[>WN?GY^_O[_?W]_______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````R`*V`P`(_@`_"!Q(L*#!@P@3*ER(\$$&
M@1X82IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JEQ9$@,'@1LZL)Q)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3*EW*M*E3GQ4P2'SY-"B'#AXZ:.VP@4/7
MKU[#?HTJ@<.%"!+04DC+5@*%"!,F2-"0`4-7EV#SBMV;MP.'K!ZR5AU,N+#A
MPX@-6DA\T`-5CX\Y+(C0H,*"`Q(D0$@`P8'GSZ!#BQY-NC3I!000@&9`H'7K
M`P82&$"0`,&"!+`/P%9M@$$$"!%^"Z^PH;B&XH\9*U_.O+GS@1N>2R<946"'
M#-BS8\>`74*&"P_"_C]PH*"`>?.Q#:B?#:&]^_<7-%RH$%^#_?OX[<N,^2'P
M0:\R0<>!!E=MH,$'!A*8WW$#XI?@@L8M*.&$%%9HX7'39:CAAAQV.),'&G1`
MEP850/"`B2B>^(`""QA0@(LPOC@``#36",``!0B`8P$$G.>C`#KZ&(```.A(
M9(XT!F`CC0(H66,`3BZ9I)145FGEE5@FZ:./!SS@H@/BA2E!>-YI9Z9,6/D4
MH(=L)G55FW`ZQ=5Q=&Y@`5T6S&=!!17LZ6>??%KP)Z`54$!!!7%5`!>AA^[Y
M7:"0`KHGH1=,^NB>$QRJYP01("K!!(5.T)ZB;J45G&;`H?H;<.T)UUX#_@I`
MP$`#".1F@*VY%9`EC0,0,$"OKO5X`&T)%-L`:!-@H"P&&'+DUP<6/*32FW%6
M:^VUV&8[D6/%=5O<6\%%<&(""M2F6ZT'$````5%:"66O\!+06P,68'`!!@TH
M9.!_#52G$05K#I1!<MIJ*U7!"&LD;<+2.>87!QP,7$%F$=36[JX)$<S?!Q1$
M1+!$!WZ@@;\%:<70QPQY<`%+"S/L\LLL20!SM5MI94%<.,<E[@,3,(`0=R13
M^X%7)%87'70!5R"3M!B03)!_!1TM$`<'%Q1RR2\Y?=`%*&/4,D4>?%TU1A\+
M-I5`*RLF=4=K']1!VC/'?;;<=!O$0--U$Q0P_M@/$(0!`B]U]4$'^7)`P0)4
M21!1!1Q$,/@!"Y2\L&4*["U0!1HL8/E`,O?GN=F#7ZU0UP-Y,';>J*>N^@40
M>*[Z30&BO#E'%VP0`08,=([0RL?Y"W5%_EJ@M4W#OV[\\3-MD.D$"K2-/)L3
M<$`?!0/9JY`&=T(4`0<&!!C8R#IUW%'QSY=??@5U19#!`W"97QCI)44KM054
M#Q1Q!2HO`%ST!^6;D,D>D!K!?F>_B%0J9;PSR,;<Q\#GV:=>W-&`[AJX%`]0
M@`"B2PP%'N*!"MB/(!*@CT(ZESV"9(!Z'W!``!US,`RDB2!_Z<#I-C([G(0(
M:13,(49$9!873L`"_A+PF0Y5Y\&G',UT(>/.UR8@'P_DB2`9%`@#G%>0Q52/
M=-9;2``1\B;0+81`0PSC1!C'@`=H```6V$`1Q2BW_2",BJ,CWP;@EI`-*.!G
MT7G+0.B8`152X#$CZQM!#H@0K/R%C<<CT*'ZQ`'_(3)N-7RD1@(&(J=M;D!U
M%!'Y7":XBD0R;A9X0`4.D($);%*2J$RE4;;W'YC\4)!4V2)CHEB1#)Q2.AT0
ME`4:T`$%-("6J@RF,)L"M3\.;H8?0`!"%JA`.C93;R<1Y$6$!R=#70`K###+
M`APYS&YZDS'%VZ0L$4)`8%9/B`IQ'`P_H#B+2$\ASA280"3PR:1H``/1_MM`
M`THYSF_Z\Y\`W4CQN#:XAW1@C5,[&4CN9;^O2<0N8YI/!1K0.I$@,Z`:Z21&
M-\K1AK1-F1`YB/,@()\'8*!Y+AF)YCK*TI:ZE",W_(]4RB*1#&"S`P=XJ4YW
MRM.FY-(OR;(`.GL*,],1]:@%Z\!<9*(!,,$/J81YZK;@"-6J<H@!&=@`5BG0
M/*N"\Z)>#2O,(G8!\!0@)A``JUC7RM:V#F1.<TF+LJCJUKK:%:D<R":M]&FZ
M6][UKX#EJ!.O@H"4!O:PB-4IAO`I$(<N!'.)C:QD=5@!:<+$(BZ<K&8WB[P.
M.&!-'D@`9T=+6E1.L+2H3:WQ-O"[>LJ-KJJ-_FU=588!"APH@-Q\'8B`LEO9
M^K:!O!1B!AJ@3N4XL5I2_:URY6:ZEV!59"A4SMN6ZU4/3("Z.`&1SR"07.R2
MI+NE]8`Z,P!&[^($MN8-2>32*[`%Y.Z/X&5O1^*;E`V<-B6NE6_J3,>``P@O
MO_JUR+.>9\4`4S`K6B4`>@VLD`[*$$$$9;"$9_(7[CW`KQ,>B`4ZD`"CT5=#
MUYP(WC(\1`QXT%YUP;!5!\R2@T$@0&I]2F4]HF("D/B1*FL>`Q!:U_K-Y$!K
MVX!C"1-CCJ[WQB*69D14O%$>PX[#`![?30CXTB$CF2$.8,`"`L/D?[[X:3L1
M)`06G!$?SP0##SAR_H<&=F4.2<\`!*AH2YULPBZ;I#@F$1I++N"8C&P``7)>
M"`4*[!/6MME#5(L(!.3"YT.WJ7$3B.<R/^SH,'*@5PG(9H"+S*%14KK2_XR.
M!X!#F0A[U\[2.22H&Q-E;W8@`CP"XHW[O.IJ72"W.KT*H6N=$R%;U="\#K9"
M`NT4KUC5ML+.2#_9^QA)*X4#$$!ULL/*`0?0$`*":G55#^KDK#*%H=/>K+3?
M&LH[0H!/@96EMG_"@'&'.[41:2H!K*W%^]+DTP6C,TK</<AW^_NH'-CUT&CR
M0HZ,FM_@!.F_08UPXUU86Q08:MY,MO"#G.@Z%,EL8@1><8'$M./F(V\&_@[@
MFX$U/)66!;G*B:*!",0&`1(@\S_-N?*:^R1L$%```Z+U\8YRW.9`!XI6)J9E
M]W):E31/&)79*E[F'!W@$2]``FYW\H4_X.=YLW).1AWTB80H8@]`P`"(FW2$
M.*#L,Y.@7?+&N.?)_,SX!GK`Q8Z`WF[+>$@,X+J[SO>?``9@$+C`H:K>(6/K
M2P+4_,#3>](^;;V][XATC`3*0P!]%W5TB@<A4QXO$J/>=<:0%TEE-0`Y6Q*>
M38(ZU!U%5MR924#-;5VZ9F7/'"<Z8`$X"K'JY&.`X0K$`5A'&'F#0L_G-0ZU
M&XCNAIQ(@<H<Z\MTZV$&VJF^H]R.)QU0>.BO_DR9`6@=818L,.A'0NOYGEZY
MB]\^0-58$N5U1$333KGZ7[IH>@\E`UN>?W;/K_^D?$?B/X$[_3>`)=$SW.5X
M#Q!W^Z:`!+AVPZ0!UX4Z'4`!"7!6$8!V&<(!]H9]EH<MP4=4\4&`_^$!GC%P
MU2)MHL,5>Y<0@_8RV.$4$<AW7.$^)50MAJ40'2@X*UA%.?4R%)!^/.$!`&AS
M&B!_2+9!'[&#;_5<(HA(&A42_%=I&U@1!S@4M'<1/]B$)<%D#(@0[29),UAP
MSF%!;0=#G"=0T484^->%S;(ARJ=:TS59?N$!"*``#J![M0<>WX<2AA.%WQ0R
M#W"&M08PP[0!#P`>_F[AAU8H0$J8$!J0`(TH$EV(79.X'&&S$@@@B`RT/@6P
M(A&@B4CQ8/;Q-(H8%'M(8O:7/*6881X@`6(7`6)X&`=E'9?T5FMB2R'Q@2B!
M;$UA8G%3B4U15O/G%[BC/QL$C.<E<&NS)@6G:A7Q3D%A2G\5B5KH%#AG``)P
M`,AH$D?7%818,N.#`&_8$T98C>98$`$T%PYP?0M%C7/#$*!8/0BA`*=XCMUT
M`3'84VAV``/@'?%($IF1$.WT6.A8CP3A`%U3.:#&8J.%`;K84@.R``@@CJ,8
MA!W1@=N2BM-V`09@CP7#91BP`!B($I9'4IG78*>SC=EE%>.H6Q[I<QI0_@`7
M]2;TE4N'T2E!`80N@X<W45N1%V[@,VKY6!`3)#B>9Q!]-I0*T0%?>!`6H)$T
M`3X%41<Y89`PDP'$9A*.85,&82AL%!?))A.-=BRX9C\R\3'88Q`/9A'FY&VP
M(Q1>%"<8D``Z"1$CJ1%G@0`Z`@`PYXX4U`%R\2G.V%(3F!F9,6(SL6%9`6TN
MT9(#,68O5D/+-A'L-Q0.\(\C$9#7P@'L0Q1Y50!W*!`80!X#X)?EXT0,('5V
M:``#8`"))U@0\"NSX@!B!XDT40&^P5T&J8W5@4SKIBC_8YH6H31!498<I0"M
M1Q"*LHIQ$V)":`!5.!`3,`!*^4\<0'(C=0#"_CE",;=HUI&1IF-Z\]1'5KDM
MDE:7`I:</8&9-?&:&3AUPV:;W31%DC&0!L$]CME-7&5E%J``*LE%+G0=^$,O
M%-%(,K$8!Z(!%<6>'L><A727*W&)3"%!':(`^+,0$@"5J705"N!L;W4`#%H^
M&7I*>;6=(L4`"2!4T;$`^5E(GV@6`A%M;`82]ED3<Q04O+@4-[HAU_DS5]-(
M;4(!U6D3N32%4%2>YI-&!J$!&"01G:D2]B5DW5&1SXB5O7D1$$H31_D3QFD4
MQ;<A:0$=_?(!$````2`M&E":;-)'/#$!&W``0>,O5:,!0\A&<]DV$#!!7-D!
M#U`9]@-[)G%"$"%>_HAR$8&Q@GQ:%)?VGQJA`1W9%$/J'`0@IP3P$@.P``"`
M0G3*J#/C`0*P&071`"B4``'P&("*8TXCGP*A`#+3,PMP9$*X$G*Q&!>``+[1
MHB31`8BCJ%W::TVA&1UB8P31`%13=PY`/8)WF1IRA3=!`0X``;GUB8TE``2A
M:?ZD`"03%1!!'`2AD"GAD'!Z%<QB$XAIA<_CH$`AK`,!B7_S`0]`/3]46-T4
MIB#D/05`$)GH3X]810>S`09`,KA*HY0A$]L3L".AK)[950RF9G3H%P+``)F:
M>0>`GL@3$;M4$-#7`=0Z$*<J3`(0,/4B$$AXD"QQH<\Z`0*0I0-Q@181_G%&
MH3(F>E@X.37:^0$1(``%\!?T4P`Q>Y61`Z0@9$47,`"ET['!Y)H@]!`7('5-
MZ0&]&A+)EP!,]*Q/5&:8U8.C8[`F$0%&6S>QF('_VF`7P*K>Y`&D!$/><S6_
M`5!_XR\!\C;X6!V^IQ+]>0$2,+'KZ*$C@6T,$8<WP83',QELL@#8ZH@6(%K6
M4GXW<;BGY`$&0+$4Q+42D0`J>Q$84``(($'<%0$(H)XE\;4CF%TABE$8^1$<
MT(DL&`!&RB$]*Q%FFY4%(2X;Y0"1.CBRJQ(3&&VP>!W,=!(,H+>/&3"<:A`8
MH*X]MA+7R0"6DWV0RT"2$0$#E;,<90"?U1@(_E".*/&)0C:Z"7$OJ-:\%>%^
MR-,`W,L4T%:'#2`>Y;&ZJL29UWN(4Y-F"5"^Y=,!$$"]ATA>$9<`6CL2RH(@
M+(&P"S&8[5FY!6-,R!4!N:$_:KI1+7<``8``OE(`-<I1U>8D`@"=P'L2&D`]
M'%!W/[$`[&L2KQ9LX#M$?A$<P)9K+4>_P&-%Y47"1+LMZ*J66.L3*E0^GEL3
ML"M),9P0M:M?"W#"2YD4BHM]!-"Z).'"&S&\&.K$<J,`NOBH$W:AI3@Q2D'$
M4.A3,PP4#6P3"'F2PJ0!`5!/VL=3T-H3N)@2E9DR6HRE`6#`)8'`$RH4;VP1
M%KMZP@2C#+'#+I66_CL!;B@QMA312[T&Q191P5:%R!6;8=BAQ'@LQQVQ<T#Q
M9S5,8QL\7PPFO@S1M2PEE3>150\@0YF+/Y)L&!XP`*=L48P\$?6$4PSCQXCD
MLA+AR1UUK#AA`0"3@-@Z2J^WPDO9RF>6DTR,$66GRQ>A`'<L%-B+2"DZ$;;,
M41=Z$_<4:5ZA/!8PD0!@`.AU`0$@DF&D5<6F;19PP\RQ%MVTQEJDQSU%OCBQ
M-(&15@LP`0T``)A:`+^4$$*8)"OU$1N6$T,,%"6B(1@``*5+&%3:4H0,<)=\
MGPE5+Z37&P'@(EW3`-^\`$IB`)DL$8V&$_WL$PVPS+LHRQD3`'6Z<!N-_E$,
ML,H;$7-J^2D*O$]-"1T#($32`\'?J!&MF!,1,TG+4HE<UQ0OB!$-$,1`&<T;
MI0`L31*W=FL"4+@$42P?W(F!H2X"D-)PB:1SU`!$PB0#@`"-"&U.@=55A-3"
M9B=XU=`$:3^TJ0#(&3:!$T(5(+6O2@&58M$)\*5,0<<FA!`:4"XB'#U7P0%R
MH0#BN((1T+\_H=CH^+3AMCXC`;H,1)P_00"GXP%A9QX8#27<I6#:@SB$;0``
MH*H4(0`';1+HI$\0K"01S$K]D9HQQ@'%HC"0;%%RK-;*Q0'L#!*XS2'__!-P
M5,X672."XC0AN0`>%`$`4``3$&6]_0&^%P$*_K#<B%=;D]<:(HPC&.@06D0U
MA3*G3J'7YZC;2/7;/F&D$X`:4-(:"#%*M(M[`5"S2)%\"D``O]O>$.S8)D0`
M7R-!Y5(>4`(E-`(Y(HT23?J29/U/HQP4-R,^)ZHRYN2X!J`X$Z`D"X"D-?$`
MF/&YAST!*W(`ZP@J8R,HKHBY#E#@(]&?IHCB=[4!/5P5S)H8!K#4'P$B":`C
M_$O`%2"3#0:]#'!'GB7:SPV/9W42':`K`:```>L!=S0!^2W,&4%(/P$<!N:5
M1]5A/R'60U,I-WXK_#,U^A,PZV@0Y"43#@``0ZXO<9829X&!@#D0&J"7WDH4
M6/Z2Z'Q4^?H3!D`P_F;Q`#FB/RYD744N$`40`%K#,Q\@`),Z0AC^$9A:S!XQ
M<HBKAFFNEJ@50A8A:T>EWR9Q3P)CL?"T(@@`G:,4@1)0`))V=MZ,D=%)$[L$
MRD5AOY0[%$HJ=,V\$H(Z3!-0GL)X5+5-3F[+9':"`-L<`6?.W?UQ`-AZ4A]P
MXY&$`23=Z050ZTEA`94G%/F',(*2SEB8X-_DM(-1(!DPW37B7QUP(PK:.A*Y
M$#M:$Z(*)D#1<\3KV5E.XXPQO]WT8=P!<.;,%'09HP!P`#MNIC,2.0=P'`)P
MQ@;1/2E1`0K`FI?:`!`K9+\^$0ZPNLT'%'H$%"JN$Q+:4_;^2$P)%(+G_LI0
M70#:V!_EC``\,I%.!`#`*]GC(U2O<0`]XW+R4O$BD;Z5'E)!X;<U?A$9\)!#
MM"<7(<`]U?/5DU]G]U8D`P%;MI4<4P"X'><RF2:^$^,]>8I.:]0,U&H=P/!$
MI?03%_(=<:_P2`!#&P!**0`'HZ2":Q/*'>U"T8)30>\=!>DP8\B)1=Y`461.
MBU4AQ$</'[P?0``<I\L$#!*P=MI!D>T2H7,,<]\ZT<'=9`$O/FS>[FJ-?A+L
M>[<I]`"GGAR(-Q#;%0`"ESD23,$:]Q$KHO.\3?0P4:D>[YY!.,)L#N7E<X,\
MI3).L4UBV?0(L@"6Y5D>T".2>6L0+,*GG`$*_K\4-V,1#.#U*-'Y)\'B$V%&
M]4L3OA%NW*/*!<&JHG,!#I`!`'#KT%%JSH(`LL_,%X&RNF\4&L#I^V8^U`\2
M9N]=$V``^7CPR@<0#2XL`+#APT&$"14N9-A0X8,%#B5.I%C1XD$!%Q%R",!!
MXT>0(452I'!AY$F4*56N9-E2I`4-+F7.I%G3IDP)!BU6.+`@YH<("QX@[)#@
M@X$`.E=JX.#!80<"/V_6S)`A)`.31#EHX,JAPU2P(*6&K?C`(UFT:=$VJ*#6
M[=N;'9S"97CV8H<(!!1(L'M0`X.C!UPR&%#@`86Q!RM,H*O2@%60$XQN@+!@
M`($"!0`(&(`@PM?&_F0W1`RM$,/<TJE5/T6]VO7K@Q>RPM:XX0&``F,%4@@`
M028%"!$8&$C@H,+/`QTN]*7MD()(#P0(""`0W*`'#1D@0)C^O'E+KJ\5,/]>
MGBP"I>;5KX?-@0$![QXL>(@0@+%##@I.8H^@``&!`P"@@``+:..@+8<N*%"D
M!@ZHH#6%.GA@`-_8&ZD`!"W4<$.1&("00Q!#M$F#!1K@8(*($`!,(@H,2,F#
M#3:X@`````@@)]`L?&#%$0_`0$2+)/@02")!=&#((I-4\B(/%-`@`0^B&THB
M#!+3B`,'#A`@@``&D""##DXD[``'TD/(`PB0A"M*L#B";$GUWH1SSH32_J3S
M3H4DJ-"U"N0$"0'>,KAM2H?,O&B#!@1P@(('Y5I(O@8*T,NXLSRX0$VW.#"T
MI@>,PK,Y$S^ELP!,1042`D)5XP"!``[@RZ$(R/L`@P,N0.`#@OQ4B`/O/MJ@
ML!\O.A&!&@V0H+U-:?(@@0;P+-54:,D2X-EH-XP@V-<\D$`!`1108`)'*1*2
M@_DDG8B"8S_RH(`%1<)R`;T$"K<Q:EOJH(!*+65T@@WFU3`#TJH56"T'!EX2
M@G2;ZV`##")(@#@))K`2H0PX^!$#`%)E2(%>+=*@`%U#ZD`"#83+;`$+9"6+
M@AS#HH"!"0Z83D4&:L;L,VMG,WCGFPA`TH*6_GG^K@&-S>.I2P3F,XV![&85
MH-V59L06I;\2*OF``!;X,NBI*I@Z+`\.&$"@#S-@=0&NOV-*Z-2:2M+GAC!(
MENW5(BC:/`LFP`""S!Z(0&D))%A@`0YLG/L#?RLB((*0,`#78PJP'N`!I<%*
M8.*I5$X(`P8:J+>T@FG[',C'BPR8;@XAT'E##RAH@(`!#F"`5`,@L`"`6R5J
M(&2'*C!`<XEN`Q`""OJE2`/78V\`)K=GV@"!M%/SH,3H7=L@8;@JP/X@#Q``
M'O5L[P9?O9PTG(`\#Q;6X`#L/,!`@/OP^RB!PR5B((#,:NPR`0@P3PA&UTW'
M,$!SB8+*HZW?F6<#_KQ;2_P2<JGQK6=Z$=P0!!A(FP-`;2'\.@@'7-22"XBO
M(C7SRP4@X``#V(@``JG?!RP%`048H%DMJ8`(5_.`T%&0(1W00/5T:!,?>FQ/
M/S1/!"[X%O_%2"(3F``"&H`!S2R`.!&@U/<DXH#5:>1;36S`M>1"@0>DT$9=
M]-^NA!8JA5EQ*@[0#Q'1`K"4;*"-;BP/`HZH%D$YA`!?4XA`;*49`4@@`H&#
MP`$*P)D8'J`!BUSD8=3D(7<1X%=""=``L"@7#4A`C%TZ`,["4A7VY.T@/%K-
M!&SH,CZZ\(YT!(D'U$B1(+(R-`@HHULB@*2U2<0"-=L1U@Y9@`4<``&2_JD1
M`+2$129.0`+:4\`"$E"S`RB`,`R@G`52YI#M28!I!`"-Q2C@@(<IP`$5NT`"
M$`!()Z92(NM348;.-<3RK(I[LJQ+<NAY3WS2TC591`@#@H@!!20@H`F(P`04
M8*,:*2```&@```8P@,T$H)D,Z)5\)E"!Q5"`B3!,`)<"D(`%,$`"P8)0<#K7
MD`Y40(H$6$!;TA<!S3CTE0=QG#D'L``[.81-PEK`*FFR@-&]\739<B`^C?I#
M#@Q@IHW10%#_%Z4,4$"C"FC`MQ*`.P0$"*&X:<`"3+B!"LPF2ABX0`7`Z)^>
M-),"'JF``)"R/8:H-(8+"!8%!`!4D6B@B2L\_HY*LK25#3@U)=MBHV5L)%"<
M"G8E(SVJJ%K86-;E3CW>`PL&.-"4"C``:Q,0@%93:(`">$L!1N154S`@5070
M"``&,,``8HF0#60I`1Z!61P9(`!XAL1AB+-1`"@WGK!P1*++S,`%NKH`SD`0
MCXJE(61G@H&A.I=(.4Q-8'?HE@Z\S)`"P$T&K&G-S-9L`0HMIK<88)P!,)<"
MT`6`3\%R`7M:P`$6.]\!:FDOB0C*`!T#RY.8NQ1U2G<D:$1)!F8HX#4%^"T1
M<.=!)%``M4A@M26)"08"YX`O?0AY#4A`80YPT?:.A'&M?6Q8SGN0"2QNA@[(
M+5THD!N#60S!V2KQ_HQITH`:@T4"12L)6C"```,H-R&\<D"KC%@]IOSJM0QI
M$E1.R9(''&"M]OO*LJ@(&@<<&"$5B$`$[CL3#DBY(3E6T@:6*F`SKV27-GY+
M!Z*KELN"!@-0>B!<;?)@EDUD`Q1(+4MS,J07CP11$N9O3:YG2`,@P+(+@20'
MADHXA80-=@)(LTHNNQ-2L21QKFG=.OG)9H5,H-`B40ZHX4R`QG1@.X3+0'TZ
MMA69="!M@G/O0:*ZX\$))4<G_,`&#-"3!]@NEH.$W9(UK='_&.`!N33E!S(@
M`/YYI"A!XX`D>5CM?DFLAR*YP*@;4@$%_-="'IB`N-D,II4LT-1I4?*:_C@@
M@7(BK`,,:!>9+T+6A;@.)1PP80,&0,T*$*!@CLY?C5C:`)(U1`$8T[):-B!?
MT#+`P@!P"F4.\P$<+J0"-H),2X&<`.H\H-8B*\"GY]14B71@Y.L6"08:SG*;
M5-ME7,-.20S`0Q?.!2H3D<]*UF7O0K6(1N@Y$R!Q<X`4LO0T9V+`!@#`N-)L
M@$2:$2FV:`6A9<EM+AX0P)3X9JR6R,H"GB**R4-4%`4C#N93,?;:3R)/L$`@
M>A4K74*H.)$,)*#M#M'`RU6R@58E^CE%.9'G7)A)PE#())FE``#2KA970I<Z
M#G!``0SE@9LGQ`*218"Y%^))A<SQ(`\/._2@_K/WAG#`[S:A@`4N[G;8MXF4
M;KE`FCL0[C/=,BQN/O-%8N(![<DQ`"IM?0,05KP.3,`!YPW`-P/PY39;.`*N
MJASW(/!K",3,,K\/P$PJD+;^V>2T(\G/B\HG$0.RY`(:L,"F4#[C#$`_]J1>
M/4W(<X$.-(`I4$O:RNP,DI0"KQV;/N#0B6_R@`%8*$4A@```$"%QH8B0HHNX
M@,>KB76Q$6!Z%57"`,?I`!;[@`L0O:FP@/I3B2MK@*\H$R9Y,E@B.HFXM+`(
M,AM#GOFK"9DCBP=,"#-+GYCH.V>#,-$`"8PR*P[SJ&("`+W@KF)*-`"P`.A:
ME9<Q``&X``=@%8FJ_@`(&(`*=+8:@0"@2XD03"F8<KR_8;(/,`ZTT```,">/
MRAK;>9$I>Y`/:#_8D!BR\#S4@;4:=!Y4HPN=FZ$MM)<,B)*=BILCY!("0(#!
MN2@*:(T0A*@CK)$/.S"5*X"%XIN]>3Z+R``"J("K:L2*J+V5@(#.ZR#]8*W`
MN90AP8`/BHO*6("+<H#Q"I#9>CNH,P]9VT-=-`^X>PL+B(@,4("LR)*5:XCT
MZ0#'V:@).*&02@!+;!4!$(`+`B^OT(@+Z#(I7*@"<``-LC7A$)ND>*T%"!T^
M8\$I4PF0BI]Q9(#\<*8:440F`HT.Z$9VBP`$:#"-@+?0\*==[$<$:QT%_G@X
MU(#!_3@G_1F`:$1(`^@<"Z``NDJ+57$T>AP]-=2?@)0(P+O%#\`2BBA&AAB-
MT%N1A?N`!)@`X2",*3P?/$0)S,-'?W0CXWE)2V/!FP"3[W&E!9(`=.DR;T,Q
M>)N`"UI)BCB07F,?`E"9TVJ\![B`)BJJ7:F^#IH($ER)"?@HD^@[`/`-#$"U
M#1`,J\F[5H'*M\@`&.,0G*.(Y9#)DX@8M4R)K2P-<ALR"N@RNT$Z_9$.,D'#
ME'``^4.)"["*E\F[WN&)C+"(RM@A_\F`_P.)$[FJUBJ`"#"`)FD6EVN(3*H=
MF$&]ELB``?C"QJ#`BK"NM@P)G1S-DYA'V*B`_N5S@`=HS=:L$DW#`+-2@(ET
MB>CPB$[D'X=@@`RPD5>B`-Z1,898S)'(C@<P"$4CD`\(CHG@`!AB``2PLV5Y
MDPKP3&RB+O:P0_`QL-XS3>_4-)6S`(4L@`'H29<XB_0"@$_K@/T"`!'4*4M<
ME(4HOX7(@$`<B;C$N)FJ1H;`"J(02H3P*@WI`-?RSFO\3EEZ@/O\B/]`POGJ
MH.X$"7V;'@OHOH9PO=LPSSH)`%F4E,51"E=:"/;;D$V;B5:[DM#0%@353`2M
MEJ6#L@J!B@8`1>R:E<PZC(GA1F^9P/A034O4BZ5L18103I5PGP>8@+14EI\(
MCYJXE\\QN[!@K!:=_M(?NA[;_`H-<!*Z");U\Q&Q/`CVH9#].!"(R)NQN!?/
ME("'J8J!0`#_X(PCB35(2[&%K(`(G8@"6%`_+!XJ[=,:%$^:K(D%:8"%&B9^
MXD8!>*4,:+J)&#^$T+>/2#C$D0L/8`!WDK7[X$]+BY_TL0!NJ1D(T%.'.%+V
M<)_O7#0_I2!-D8GNT5"PT`F(RCZ(*@!+[::8BL['6X``&#FGDH``T,A03`!7
MM0B&80B]>K""4+,6HPU17;L'3=4(R@#K;`A1;!ON*AY1BR$,K$(/22U_$]82
M79<W(];6*Q58K$V=>IV^/(EF98@)*$_740"S`%"6V)U3A5:A:0VG\`"/_GP*
MO4LU'/L`8D'"[4DIF8DF[OHU_YBKI<0`T*`,='U4AK`5T.+&P$(-5](F>HTG
MI$,ZUHK&GN(TXNS'=L57('F3ACP(PZO70&4[[@J`#]D`@G(*[V*`@J*`<T(`
MV7@`!J2?K+*(`P">O]B2`I"`,&$5[GH:(J%"E0R)#8`I13O#:379CZA6JA6:
M=`%6EC2`J77+']D`[FHP-!$`?'0/)%PAMJ@."Y``A/1*BC"]XTF>&GD`]K21
M8:4)C$J)#!`C!?@^D8D``1BD.[W:CP!*PA68A*G6<F,)GBB-"2@0K6J9OU``
M70E!9ED^S%"`[%,`2SQ.BR"PBN#,JFHM`?B/_HU-"]F\G])MO[U[G[MUC<&E
MHZK!6Q;U3MDLC;_HVH5@SM!8$*00@&X*([F+D`=(FJ#)`.U+Q/,QT4`Z$]4D
M`'CC"M23C]AE"8;IJLS0U-!DF@VA6YA;&$ZI7K6T)E$)557A+D^Q@`)`08TC
M@+MQS@2`#`W(*F&T%P-XSS.LD6BL#G2S"`L0@-D+S=JUB.58@'/RI_HAJT35
M$"CU4SD\W(3PFA3-$2E="<_U0Z+C1`#("<VPDOPS`'J4@$1D#OG`C!52F1I+
MK;0!C@T^$0.0#NW4*0>`'\>[D@#@HRZ3B7=;/NJ`184#&"%5CP/0W0A**7Q:
M5R(IQ-38-I:0N,8H_IP?(53<"5PS23X9(H_\D,%'*:<NXQ8RD9/H8*UQF@A[
MJHMED@H>XMGUI='_(44`T`#0^AP/>("RB5B4>-H`&4<"@JWTT:?L'&`BDB-\
M`F0B*=&:(,7YD@K<6XD$:."IL"X4&H#E@!`.*(`$X*/DTTF:BQEV="$JPAU&
MB@#C6D-)I*B_A!!T81%!`E;ET*QH6B^:"BU@^H#U,3<D=A?C(L\%$.4<L0"M
MW;V2-34VAF"W$,T[=*%=4XF&9("G2XT74\]'Z2I#>3>6DI68*9TL-0BR[8W`
MX;">"(!N^370&@#VBPG`\R%+J9'5DS4+X(Y#4A24'5=W;0@?`5S)LHGT_MD;
M*501O0EBLLBL[QS9E'!)8FZ,/:,A0!*H?G4)?TO6!U(DKI$C*?N0S2.`V>B`
M6G&V`,"_A8`B+WG7;3Q.*8H<X*6(D`HQB1`F`)!%CC&(V)I`8T0<P1R)&<D:
MOZT(%NLP&\FE\L@_F"/BN"EHV-`)X6RE"W"K1CS=D3@`+<F1.<Y3AL``2VH(
M/&N-4-46F1FU?H&NK"J)CJ*J&E$C#BB.N<F/I_.-[+H?11P`BY"0FYB`0Q16
M/JT(X%-`QE!JN61,MP4UX+@)H/;'&"YFJ:*,;FJ<S+#CM)"-#VB1`8`Z<BL.
MAC";H*U/RU#!,WD`LPHMO1*]Y'/3-TE=A(L4_MRH%PV@CMQZN`.`@*2H3]]Y
M9:M=B.RZB?I@(@-.P(3JD^^1C4I%``08F]-0ZD5J'):3UILH1:%.TK=HDA#2
M$\1Q*IF]Y4<V"/DJ.<0I6B9+`$F:3S82R_PC`+([B#FB@,9.OI:1$&%=6^IH
M'HJ@O(W6P2T)*08"-^UAP/_CRXE0.=INJ;:S#');WL940F,RVK3!``WZBP+H
M"4,6:K=8Y(+^$C_L(`WX$5D<'59$[-!(+2!#FX[FGP_Y,9]8B`W0C`$81*+H
MO-L[`,C(J0^H@&U$C>7[M\`9YHX>8XI9O@"NSS?17HMX-VYQ*\[X78%&"`,H
MJ!?NK#+Y"NU`+OU=_KC6,+"&0-[,0("EQ&L%KW+S\(`#XP"KT(!E33T0?@JZ
MR$6$Z+"'V@Q%^C,(N!R&$$]^<C1C2JD"\,(+8`!GE(Z?()<.RD)W6A5+>2BQ
M,8SX/@"S<$XQ<LJ.;ME(>X``Z"*.W@@((&@0QZWZ50XU]A&/(#?",#@?,0A>
M:<Y=<BL($%\K'_5Q4TV#X(M5O0@.BQY;H0N(T+Q]M3`'@,3,B!&,=;GXQ3I:
M$>]T@2_XX(`C==B-F(\?>]:BRZJ?H(]%H:;^80Y?ZZHFK)5G44R*"*R%B4E$
ML:_4\V.22%1(2@@/A)U=MBY!.21)#*9K4>^/W*4NMP@EEHCT(41W]XHP_JGW
M,/$*>M\I69,+>\=W6=/4**FR(>MW?O]WG9.U8PSX0D3X,R%X>G]XAR=$A]]W
MQ,GW>K<+*G>7B;_X?^]W?^=XD(\1?)<ZDM>`&"GYD_<*DX\1DU]YP.HA35EY
MIL#WD=<431'YAT?YEI<Z?U_Y&.EX0KX)`N\)1"&S>ZD>8X:\=O>+!&A-K$%"
M[RDG)VF=OG`S1>N`U3X(EH8H[*1"`_CP2/,:=1\]UHRRPB`9]KLMA\*KMK[G
MAI`8#VPMG"K+AE#0B_`6+4<2E>-JXDB9K6A-B/(6`G@,*I_L_(*`V9&.`OAZ
MT%K(&"*.,`JM_[B,Q2=/SFA;L:'\Q8<=Z7@H_L___(=J?`_-#-$'_8>2%,^O
M_,M8?<47`$EI?,YGK<PP?=JG?<P@3X2D_=;R?-CQ?&=\8=EO?)PBJ^T(M@@@
M'MG,CG+6#B3MD^-'E>U8?-%_&.FO_.#'_=KW_,N_C-[NK-T_IP%@+=[N[43[
M\],OC,RH_/27_O(G_?0?_`//#`#1$@;$'P"9#LI/-'$&+:2+':P!B``%`@`8
M4*#```$'$#`\:`"A`(0#"#PT4+&`1080(#S8V)$CA`D:,ECX:-(C2I`21FI@
MR>$#S)@R,WB0\%(FSIPR*530&3/"!I]"AQ+U:6%HAPX79&[`P*`@@`8Z.V1`
M<"##APP$8DX8\&`"_@$("W`V.*!!9P8%`PYXP-FA@8$),350@%```%Z\`^06
MC7E!`5$,$F)ZJ+``X0$,0BU@[?LA00,%#_H6=F#`X-(/#0;`U'`@@`/'HG.>
M);H@+^H`!%&SQEL@PP8.'3:TK.W!0^W<NG=/N)!AX\8*&BY<F+#Q@@7CP(5K
M`.[<>8;A+2487TG!P@4(V2%$D(`!P_.-M2M`8$Z!`?(+&'Z+'/X\`H8+%#1$
M`&Y!@P7[#5:W[N\_+T4)0&"1`0I(4)\%Y(ED000CU0?!2KM)R`%N&GC`@09!
M89@43+BU]4$'&)[5P6@X?1A3![?)EN$'+]&F`0<WY=2!A1]L$!1M)((H_J-,
M(6;H`&L"_#<D7@$8P,`"$,!E``0))*#``01:)("0>$5T$`$+//!`8S!A(",$
M.O:5@)@Y>9!`B6D2]5M,&QP@I@0#1.!3!1%D)A,'"=PE0%`?5-#3!Q08L%0'
MDXWU@0>"(G!B3!PP4(`%%`Q0)@8%-,!H3!+@94!!73JF`6!#2>`I32T:=H`#
M?;990&E%91#`!`8<-=H&$1CPD@*>@N5IB1LXX,"L:GXP``"I9DC;C3=F>.RR
M&`PPF+#12CLMM=-Z0``"%TB`;'859%!?!.!>`"ZX$"A``(_5JKLNN^Q6`,`$
MR&*H+++(,ALN=_4=66*,]1Y;)W>MYI3N4!L<_BH4P>WB20%.!@!J:DP4*%`!
MIA]8D*1.%R#P``4`Y-K9!AZ`55I)'RS@P`0)(%#`G3!QL-D$)'HV%UP4NN6`
M`@$,0-,"!@A@0`(3\.H3!7P)M6V/.''@P,,=)@!M41($H%7"12UP00><X>19
ML"5ZP.`!:\W7ZZ`M-M"``VB?K?;9::?ZF,`*RSTWW3BAVV)\Q.4]KM[$J><W
M!B$N6C?AA=.=-:(5L,VV`W9JVX`%><=WE@-#USV;8PY`;7B:#*@*@6(2%`"!
M3A-()H!B,H'ZP`4>;)`=`5D^(`$"(L5$W@<7`,!`!1PLH*J?LGKZ)J@&4$#P
M!0D`4``#/,:X@`(*_EBU0-PS$>5F3!EL/A0%J/;%00"S2Z7FG`P@H),%`U3M
MF`<85%#2`@@X4*90.0.6``7QQ5?!=7]3(,&X#K`!`+2,<P8\H&,(H(`+>(4!
M$G@@=1XX`0DD8$M/BV`#T#0I!'*P@T6I`&<4H!WL3*`"?^/?!$H800A*X$U>
M.6!V'*.`U/GD`!Z$R0:@U@$'>.8J.=D`!!+C)D8):C(FTD!>`@`Y'6%``[$Z
M&%D44#T''$``#JC86X0D`$PQ@`($8`NB)L"``R@@9CE!`.\LD#`.M*QB/GE@
M:2QWN]TY@'1J>L``H2B3".A16H7Y75$\P*G)``\I#>@``8QVPT4>D`,"_HA`
M!A@@+/@`0(Z,O"3A%B"`#R"@::.1RPP/F`&&C:EK.9G3#3'7F0((P`(5\Z($
MDG(`4GX``]BB(9Y<YX$.F$LU"%B/1C1PM][`A`+,PZ("!&`Y#B!@/PRH'@0*
M0K!W$<1X.DJ2`@P0``30$B8,^%`$MM*7">#E)@,I@"(;-0"G+,^,HAEEQ^QH
M)A\BT)$`4`HJB\*!`SC2E)C\I\(<Z<D2+0`#`/`G0!/:+@8$X`(!D*2:PB2`
M[0'T>$*)S2(O%9-F#LT##H`43!Z`2@]$(``#111#<5G+#B@/+ZUC4@<,$)L%
M[$4GW5/(5`S@`/20Y@`;&0RC!+FM"J3,8PK`_DOLGGF:!#S3`UWJG6-&ATOP
M($`@L[MF`#QP`?(D(``5I!BF'-DJ"ZQF?#8-E>':@AL`G&^D0=4)]0!0/872
M-5H;"``'+`#1-,WP?'7]Z[H>(`!FRLB-)HH)!*YE1,X95B<-**#JZ(?`*\*D
M`Q0ST8`>IJ7;B&X!DF7FLS!%`>@EH"55J>HA8R>`!U2L`@?`(P;\&A,+?`8`
M!X@`HRS0S)MT)`$5H-%%#X(1!LQ.>GFURP`\ET/VL4@GN*D``PP0/P`LX%H-
MP,!M2,(`*L$414K30"R'@B;.80!H!TC`2PK0E@.,);L%>!-.?@<`W.(G`MC!
M&A`G$+BD\+<W_#7A_GXYQ%_9I*BR_#TP@A.L8!"E",&[1'!T?HNH`Y](P4G9
MY6TF_.`'<\C`*>+P@`=0G/'*Y`&2Y$!/+M"`='DVGQ@F#'\S3)@/W0;$"=Y`
MS#0PX!3RN,<3C$"/BZ.!#$)R`_RE3:!\K.0FA41;#'!2`C#0/_]F0,D^;H!Q
MF)K!CCSS/OM+H9)2B+6J=N4F$B#`27]"@-*$YK6'`U'J]CE7G0`+L$SI9E8(
MT#R_2"5/"^CHF2G@1@@,0-`F4HJ<)-N!;-(0`2.-4W3PO,/2]H@`+0V`3SP`
M%YA80`)/IH!EG>0`Y`!M?62!K$]XN;L'-B!V"@!U9YH$@`2@&E$%H`!L_HBF
M4L+94F<K:\O&/A"!_`E@`$$MK<>>_.0C)>!(##"?D'R6$.DE1`!Z3@`!BBV`
M!&B[V`&P=`(&,`"=O1=;$$F(M+6=D'53:64,R#9;JWBVRP`MNDYB@&6RG1`$
M0!EZ!$@(`ZJ-@)\5P$D1V;>T!R"]*NY[X.P6``)L>]Y3VM")'SC`07&"`.UM
MP$G$PA9#Q$TE<4L/`5`:P`)Z%B5UBWO?SW[RSRYCO@4P()O/;D!T&8!SG+^\
MYS>/>"L_8.*S26#G-!?IRWFN\V<K@'D:N7D7%;=TI?-<Z3KGMA+Q770&09VA
M5KI)`^`UE+#WJ;H6<8#*GA0_AC1`@@^<W017_G@!`IN(89954PE3;4E&=H`"
MM4.1798VNHIA@+US[<`$!(!J#D0@E&X1703*U`$$;*`"$0?`W5`TQGS*!`,$
M<0#!$&\!R-ULFPW82'[F*UFBV<0QMO3BN+N(7$>_)&MX>8`:RP3DBTFRM8M-
M:P-:LA^K>$Q'9PH-3BHPP"9I[@$+Z`X+[6N`!SCZ0"RL^0.A;_WL^W1E\WV6
M]J$?`>K79_L2T-R!E)>`"!0@9Q>$8'>ZTR0)F*OZ#G@^DPS0@.Z(](%HIS]W
M&,!"0(CUH=T#8)P`$&!];`R09<"75,#D_!!:P43KD,5G0!=3'4`#U$7T=$<R
M!4`$V%;;)0#T^-_)_C"`!RJ`DSA:X_';Q2A`RJ4<DBC`_<%@#*8<3TQ0RD4/
M"48<MK"7],1@-M5@#,8=DJ0<?&P`OSF`53"$R6W@`IP?0^Q4`Y@<0YQ7_JR%
M%3X)OD$`RMB(WGR([E!4CQ@;3$P``J"<1MQ:;#@`3VS$!&@2`!2(SJ',V83;
M0]B@JM0%+<F&JS2``)@53J3-(CE/3)27`JC*!2R$;JV93E2`\3B7:PG$(Q+`
M[V4/1:Q>JUW>`BB2!A3(7&G/`Q!03MA2=7T33@C*KS`A`<"%#8D&QI$AG<U/
M8DE97'0'D@C`<!1$E6`>*7D``'B+!+1%VQG9(>Z5X1`:B1A(+=W%6M0<_ENI
MCEW<A9[@!;;E!?[\SVIP2E3@1<X,G`)$1O2$XV$L``74A<>$A2I2P+!1QSE2
M`)`\`+&P5?0\GXJ5161(P#L^BJ#,TO\<!.9]Q0*4Q6D`0"\"`,><H_((P`0@
MQ#E6U0$0@&TQS04\14&<!G<4S4)4P(%80`Y=0+(DRP2$C\0T'F[A4$@^@`CY
M8P,DB5-$G`+8"1^](P5\14C`([$02Y1!5_0HD`*@()"%Y)F=!D^02_Q%`'%Q
MAP:VU*:$(Q,^WP-4$)0H4#@Y@)&(5+BPTEU8"D4L3UALDUX0BT`H',[P&Y+D
MQ?0AA)58"67AA`48I`@]'PKNW[`!28BD(K[]_LK)H!VVH!RWQ<X!D)'\-`ZY
M4(`Q^@EW0)0',,"N$8;&[)^$T=6UB`DI8<=-T(63F)CQ$`SM/("B28"6Q)0B
MY15D6`CR=<@#$`#6_!"^#8!=H%5A/`G!.-48@>2S=-[$9,!;;(ZYA,ELJ<<H
M2I=AKLE1%5*JH1EXX<DH3<`#!,!5&`#B*1"W\<5/]HQM2<\#-$`!5,X':``R
M%DZ4?$U6>9-7%H!$$D`&Y(D#;`E[;LEZMN=[UL<Y2@!\LB<:W1\3'L1.689Y
M-L#LM.>6W"%VNF<!;$Q[,H\!&*A[UB=[ON>"9F>`;DF=/"B#6M"O5"A]`JB#
MMB>^-:B!2N1$`,!J_IA<%9DG\U"HB2'`85QH=FH)BGZ4@K;GL)TCA-`D&CD)
M3=:H/LYG0HX?!8R+=V1`!FS5.48*3;YC;V0`_[SC3\G'=4#?.:90N!SID3*G
M/NJC;TA9N`#9`T'`.1)73G2,:Q@$09@GO(4/>T%/RCT03^[E_9%@@@H(VFWG
MDXRC9,1A`F`%22G%?71G8W9(@NX=)GE`8E76E4`*!>C)SW`)_H1>E"1,K"1&
MBZC7(?Y,G^!&FZBH<2[F`/0$L>BFRV!`:56,!]`4#:6/\E66*WW`!,#7I"I`
MNJA1Y=U'51@$!,P9;JSJ!P&`![",4/CG@5S`K;C,A_`)B'0/CC6=Z6!%_B2I
MB\UPCY%8#-3@&V&,6U7=TYRQBRQ*BV>BHIV-!JZ=X0-02+RL#(D@V25!0`:(
MU+?*#:&&*0#<*HC8R%FHR+N52(&A2&U$!WUZ*00\'?V(S(3Y!`=82F/]E4$)
MH+AI1.X%"J1Z!<%D`+?Y9NX84<%VZF=]%&N9B,$<$DQDP/AHP$?)$TX4'NBE
MXF>0K`<@@(Z<GW'"Q)EYBF4Y@+7=ED[`QS`21:MIFF'QT@=`P`:H!8/=1`=T
M35[-4E=$1U9,H+0@P+9ZB<<H8>I<RYQ<`%UL4Z%`!0)X9+O*Q*7L6==^3TRX
M866Q*HG]D[JR:]BN"TGEQ"BF$TZ(SL'2#9Z9_@@*SBTF446/W(2<P>PZZ82C
M;&!.@.SH\(AV>$!J<JU,^,9V`9+2'(#G,`H\;5.I*(T*8E?&:)332!(&G`Q"
M(>5=HL]F1.3'N,Q5((`"::Y;--TB"D718(!G2EE6%!YD&,"NO0YHMMK^V:JI
M]85%#060,$`&T!,PDLY/W@5@"%)3P(4`,`!C=.V;E-':6HU<7(L-.<4'"$G(
M1!XF6<`.<=[T2DNMY,1IP*U,W`6C^&S=<,`&7,?+EFI;%D6A>M"W(,Q.;<S0
M@)=O8<H&/`K%RH152%=C!IS08$H&?)0[S82ES95AH`<6F9A:K%]W?E7[S57*
MZ.(;%<!,907(QL\"_B0`Y&JGEI37QM!0/TFP3[R:E313_B`*!W3%OR4)NB(*
M!OC*`V!$!>2I4OPIM6B`M0V-S=3&:OJ.ZA0'VHS:W-55P7J``-1MW0CJM(0+
MHFS5P)+$;=@N)E4.`YAO^*9)G9A)$@O%<.!$\A".=TQ`!&QM(2G)VD;`:9(&
MD!!`Q924`DB69Z!73@GN#]TPJI%5'<_(`JP9J3J`5[RL!#S2;3S9`%R&PC6Q
M3@3M`42F3'P-(/;):08MN`G`GRD)9F2MI+[+HN$J6V`<:R1`6Y11T8H1P'5-
M!P2<TY;6Y#&M8T@RP3)D^S@&!S!MT0;%D(T;!"`4(Z&+(W-.3&4KM;1=_E&<
MY"5UT?-U,;5T`/A&R_@5CHY<`.L,HC-/16(LY@0NYA7QKUH`,P7`"N">&:7F
M!%R$(O[,E6=X5L8P(:\4QL`M0,)<``'8A-XRQ5$A9*9<B,:TY6TT9$QF9P#\
M3$T2Q,Z\\=:@5U20$X#LD%SUR&@)@'-R;Z!(3?#Y3GR`X&@@@#'_[*QQ@`%<
MR)^(U`2TY$!.0$T&<H]$7$-U2/*<"_X`U)LPP.K-C<36C9<6!0\C$.@T3C9+
MBW<*16JBU\-```'4[33S&DRDJDQ01U`_->I4UJVA5+&\DD$DC`5\$2DF7^R,
M5DY8@,$.;I3PRJ(UW=\"<@)*5B<*!0.!%(BT_HJ;:$0PRH1(>`?!K@9!)%(V
MS6'$D2P9>QKI)`K_D'(T3D5-(@24).]6'P`ZO=M:@-[<:H`[#T4T18<&WT5K
M\(=T">(#L91-?%&?-(<F'<`$R)B:]&Y?+,HYIY5J2XL8G>-+8,AMU/`H#3,C
M;:#:1G6:C(M/'&`.9R?,:DY8E*P3LVV+<)HB%?,B78BP[.F`\%#G;8S\#$W_
MFF.ZU$0X4@Q>+:[.*0;N1$QI#FY47M8D:T7MK%X&-'-._*M%3W)VZ.,DX]#I
M,49!D84@XHF23"U'#D;W.)IGUD\XU>VX_+*KD(?)Y:S5.LIZ8IQS$@7N$44'
MO!?BA4L?%87GQ(1I_H]?J6)-BOTKSLP.%"O,HF`P8Q&.Q*J&BJ]X0=-<FB'0
M=7$,;Z?V)6Y46T12:'#```2%!2AT=QQ.8EPFYRE.4(?=[B@:QD&61UF1F9Q9
M)[7%S'B)5=P)<GSL&#4F!#AGQ+[7G4!S@&M`,Y6)6D'`QOE$XGWG!Z`'/X*(
MJYI-2=1XWS&YF3R`3GW@K)VVB70BK\[KM,261T>,=(F;@"2%T#SB31\B/T<>
MK77.AT`(3`1`!T1%HN9R!5$%]6V;?AF0"^&MNK3NC*_++U_-IWN-0G/%;1F`
M!J3._*$33BRUW%P`SGP3!RBI3)AC4`O``F6,I>SYXD*N<5YW!<+$1M32_KOE
M[.T(N_Q4C,90SXR(#JP11@X7*+%T$J>MS$?A\6CL4Y:\1`4@1"U!R//M4C?3
M5JZ%]3$=XF9@'AK5B+9(C5850+60U+"Z3'8DJ/E$0&1(&F#K1#3-G5D(@&0Y
MM4]0$0*0^6"L*SDQU>SHC.+-A1@%XLLJC`*4*J<']2[]%<?L]JA31G[+Q.A%
MWEXE!TBV>D];2QA%1L>=R!]G\UPYRMT$#6&X"4+1^<;*A!1!`,3]>O*<[-8D
MTTEI1:[/2&1<%P4T`*!L0'XPX\`,12[SO`5DTV2`1T3>B+!V"%@40&.^3%P`
M+JQK$UNEL5B$Q@2M"VT5T)D,G"3Y]FJ*!K\%_@\3WBPPXU""ME`B;JTF$400
M,4S":,"64#-T;M'&/W(T_]-CQ63@LP^:3]*^J\OK.-7I^<XY>\`K.C,'J)2O
M.%H<D0ZLLPK@2L;J1<0UE^)K*7G1#V?)_F0H/H`#8*Z)-%Z<+6Y'N)%WFN>'
MT&>:J^B*;6UT81Q1?7#65Z'Y-L5IX@<[LE)$.YZZ6("LD(8$_&1<>&G$ZX2S
M#(8(%<"+"P6-]`D0W3-9M3++L-7J%2S(`<MKJTD&C+09'G[8&D!5/*WZNXP4
MP4B'<6Q1A*O<F!;_3`9=:%Y0.T^K`<2%#P,)*G@@(`$&@@0[("!0X8.'#!@\
M$)P`8<-"@AP:/-0X_A`#@@(</FY0(.#!QP\<+!1@4%&CAPH'&L#\L&!@AXXI
M/W:0,$""!PD#*S#XT$$``X$4C'+P@.$```(45':`0(!!AX\>+@P0J#("``%:
M(Z@T>_8CA@(V-698$`!```49'6#0>M9@Q`,:")!$JY*!@``9-':8\,$"!`@&
MV"[,8/0#A@0"!"!0N#'C7\T>%'PXT%AS:-&C2:N$,+1T:M4?#&0@D'EU;-FS
M!UH0``#```(##!0HT/MW`0#!"R3PW=NX@@(\:6_U$,'FY8$>"C2WGAH!S`L%
M&A#^N$"!](43#`@X0!3W2Z@`S!X\</AC`P460,^D`)N@!PH&$H!>B2`!_@LT
MPJFE!310J2L%#DSL@PD<L&J`!(@:*:<%!AC@+HTN0``!_`C:(`$#OM*H`@<(
M```^R*X;R`'XS-J`@@&D0H`!D2;PSP,"`M`@I`PD5.D!JLQ"X`(%&O@@@0.$
MS$DH\32*P+N!.*```@$*0."!#2000`$*_%(M@_/&6I',YG@LL[D.!LC`@"71
M?+,Y#C300`+%[+1SS@SN5.P!`QJX4T`T.SAP(?KR@P#.1*<C2((*ZE-@`)4V
M.(@"&O6Z@((`"K@-`#<_R``!!2W`::&0LDJK3T(UVF^`0#^Z(($(OI02@@8*
M\'"@#2*PC"`'*L@`H04<H("P#@CP#L0)-HA4_J,-)B!2)0\F(."!#!E2`(((
M=+2V3`WZ^XLC!!8@8($&%C``HYB*NXD!"%S4"($H->+`@`<(D.^`!`*HB((*
MM/(`I@?6RB^!68_"8`,-(IBL-P;*(\!5TJ#Z0`#_%+T88]HX$,!'7#/^&&0R
M?3ISH`ML\L"`T?P-^:\+*H!()8X6@*"SA0P[P`&G=OR@`@4JT,``#L"3:H,&
M')!``@8D^/=+#!Q@X%TI)3`(5PXR:"`";FL+-6(IF8)`588<4,`!MG*N%($#
M#)#@*Y+T.X`!DAH840,'%F#`R946=D#>@32`X&4-+"!@X$0/T#IF"2R\%8,'
MXFYZ;@\2V&`!@S>R_A@"!`"8>P"*!@!1`?XVD.YOF^C]B((_]<M@2@@<Q@V!
M"AYH(.^S-)@K`,19AO,!1'?_JX-;;_V=^.)3$]`F"JPE-;0"PB:^1AGC2G<A
M"1+PSO>M&[@KQP--G*!GUF3T&3?<UO*@Z($R<*"`K@>:@#NM.8`?YE<'^*RG
M2B7P&(,!:E[(`Q:(P%YJ$R(!@,UI#FA``(Z$@<YHJ0!1FXX$","KCTB`.Q7)
M`.Q6TK<5S6TTTCI`!!YP``GTCP%Q(X`!.I"!"&P`?Z4A4FNPM9(`A&HEL:K.
M!TRFD0D<224M`@!&!JB\"S"```)8@+)&TP&%5,QXBL*`!Z-XE->\IHI9_GQ5
M%2?GMW<I130`BZ*:<I.`$,4E``G!P`3L0A#?<:8`(QI(`@8`EP4$+P(7,`!N
M1@>`/48@`"$Q@`8X`$@%6,XS"I`C0<+$@.>ISP"M`8T'.$1%#2Q@`1O0&@8(
MT$4`!@\N`[A/!V""DQ*Z[U,+.``JA;9*1N'&`1_H'9PN@)HF*@``^9K*!>*"
M&YKU3D4A+$L#8K26!L@H(QPH0`2JLX$`&(P!GB**77:D@`2T*#\=$)C$Q&0Q
M+7YS11L0``8"X#%P$N^1NY,):MB2@?^=TRPG8HY5$E`^`(!Q(&4Y(@2LE1&`
M_>PM">B``D`%@`CH!@"Q?(!4%A`7+'XD`Q$T_HL#.M>>`/`S9@2P)0!Y6*VM
M9`YQS_EA`BA0@`#4JR)*BHA*MK31A3P@`F4IU`#&\I1$N5,U)O&3OJ0W+'T!
MH$.+-(O3%O"5BM`+EZ-2'P...5``S,H#![`<)C\EH9,D0(+!E-27-H``BGD3
MGJG)`%B)MP$"?&!X88UB]G[7`0Y@``,7Z,#8_&8WYJFU>KB)F'YZ5RO!^*E/
MD8P:!7`#%\#9I`(!"``#'/`9`R@D`P/00#0K8#D--"!V6[$`V=)9`0M1T0+X
MA&BH)MDG!C#G0P]8P%`.X)T.5``")@5`[9@Y%Y;2"%<+/0\GR2H;6,6&`Q+H
MR(D"X(`+W'$`#A`8_KE,9C%RJ?*&#W#*IS)"`8,HZ42X`2)!+K!8"%#D`QM@
MP``J4BL.&&F<A?'J680V``34)21?Q2MMI`O/#53GH?/]'5NK"#8/Q'8"B,2K
M!(#JF"[-"WX`4*1*QJ4L"S@``0B)0`4VI!"H)`"+!Q%`V5C:IJV45`&@Z<!F
M%:02#3P``5KS`"E78F(%3"`#VM0()^/VJ;-N!&8>I-PA5>+`;WV$`S*2J:)^
M.QO"W.H!`XC`8A;"E`#@S&";+55C@2H!OV3``AS8&*<,%@&CX1(A%H`?<FLI
MH$<J53.Z4H".$MO;V7#X=]VQ+P%R9$[]8HR_UW%S3K12V4/25)IG<6(6_C4'
M&6T20*A2NH#EI(4`@VGI`#1%D=LN<"!Z-<!C%J@DD-.FO)X8P"/1!*"](,#H
MR4BPH\LD2OV.F&6"4&`H7$F`!%!9M*2(F"]9LJA!/^"`=%['1]9QF`4:,('9
M`=D"!RA`E[3\`0H$&@,14$``%B`=#_#HN*@C%`9ZQB48;R0"^_&0:$/#20O<
ML-1[3DVB/Z8!=2OJ`:HR*P8`8.<[)\H#VQ79:/AV%P@XH&"DZ8"]02:<H;AF
MP6F)I:3J^<[(+"TG8[LA!0!V@0<D6IOMZS$!A@S`@XZ(`JJ2C(%4XJ,&,+H#
M^?K2"8^BK8Y_@'8R,9+6!HX`VDF*XV8I$@?@_A(`1U%Q11?0]VQ*"H#M!-IO
M=)01!7*F$0NX2@,]4^4#8KPH`$JS`])^LI5E28`0`_`\I*F`5P?0@`6Z1,"Q
MH<Z[R<3U*A+R0WNI][U9)A/C]5DA&Q!S:0*817+>4Y6/G)("$/#(J[5+`!%3
M4_N<5=3P8H`!:DNH!JQE&'*!YG86=+JX7.6LB(2V7EN)-@)<&A$8O1"`%+&`
M&3V(-0-(%<@5H)*D>+3BJKC.`AO`#4ZPK"@)H#HVE^2D[MK"`66/T-TWH0H'
M('``DVF`2H2/E06L52*S6*U$=P,<!F:U@91)K&`_XI%\%`"UG]&F*,5+P*^-
M9U9G$ISN99(Q\3B@_A4YA[OTX!I3%*.2R]IY8`%D124JH``NX\?"ZP!N+`$@
M(`#H;`(8H``J8`,>HP`(QZT@H.P>*>NHI<<48`'JIS9\3942C25(+UKT!5?"
MA#]JAY-(SC2N)YY@!VPTHOE00YP`8"@@+E$Z!'C2KB3^Y/M$XX6>13<(3R&4
MY@$FYS8T#OI`+5X&X@-+3@`H[/42!@)/2M>"I#3&3C*V(@-FPDJ@A/C^@GI^
MIR_@B0->0P#@+_Y6A`.T*F3^K0$JH'$D@`+83=!`L*QD!`+\HZ10[9(J1WUD
MJ@/``P(DA`/J(C=X[@!<B2`XJ0',(]$H@%H8S40"K4HVQP\+8.%BPE$D_M#$
M:$=K)L4`4"GC$&G$&&!F[$4LBN,!7L;3:D,X#H3M4B.JR&J-1J,!5N_EYL5Y
M:F/(!J4"W.L@FC"\(NI=^N<R(":>.B`!9@8V-B"V%BL`4`DM9N("Z(R]-D0`
M"$"E2$.\C*<FX(DS-H@-V_`Z]#!DW*H`%N`!%$`Y:I'0<$,=BZ0`/"@1`^`!
M$`LB4H[B+@!1]&2AI*(/OVTA'"!;5*Q*;N0C*L",$$EH0BY:3`2T:DA2U$;G
M.$[C9BP!,`U!ND1$IJ/QX$(J,$!5%DH;+X8"@&\U<F0"!L`'M0DFS"XF'N0!
M-*4;"0/-%D*@$-`_.H`Q+D0=GT(!8F@TFJ\K_GJ+`RZ@L4`-2D)#`X#N8QQM
MSL3)!]'1#>_J=_R%).8'*X\B0`9I(>AD%T?1YKJF`@0@DGC"`@BC:)(HR2KB
MG9QFO3R1;/*&*7VF)TI$`'IQ)0X1HV:,`10@*%!%7+021AJ``5BG\,8R"?,F
M@,:&,!SO0VIIR18``?PG`EY2P3"&+]A/T48#5!R(-#;$3_)(RPX#ABJ`6B!%
M+L(-)BY+2O"&I5(BN![D0_S"($DC`A8`6-XMV@`N<WQ%P!+">*`E8]0-1#B@
M+K\R480FB[3"`O!POJ*--?Q"<@B@#R%J`6RO,#`):3:E3;0"*#VB8BK@^XKD
M)H<N,FPN;[H*.=LB_@$80,P>"7X@8*PT@DXXL"<@<!]!\1$]T#LHX$?"JT96
M)B;6+'MNCB"6K#!8,2YJITS>$"7L++A&`WQ(BN\R0`(0(`#,`_72LBR\)0,J
MI0"2BP.H+I^$(RFHCR`&B3#H)9W*<#0PP$`<KC2L(L+:9Y&RX^X^Y@&L45+N
M,0B=$TZ@TW@>0#H"#"OIL,CH91][(A)120)";SI\PD,%`]$&@@($(P+XXEB"
M1UY@Z%B`I+A`PT=,Z"@*P%I6CTU5(E/N*']0`B8"[B@VK5<@`D:TTS\"PU$6
MXE<^`)#R[P.FQE_&L$Q,PN?,(OE$(Y,V4C5\8C+DXCYJ`S:>@D`53"'6_B)%
M)]7Y/N!`:&:%S`+I_J*$BFPV.H!`ZZ@G0?7N#E!1WLWX7$,>C70TSJMX)&=*
M$,``YN,JPRI+$D`@Q`O5X"<^":8`0<-!8.TVN@1]/$"9+D,"PNY]]+%/&=2'
M&$@[7(0ST,4_Q,5B)D``$.DGX/`\+"!"$*G8%JTD'((`:F?LH&,A].YCS$H=
M/X#<T((Y@;(Y`HA`3ZK:;F\!?LI5)&(!3M17\BV3S$(K1<,!\JA`^_6(/G36
MHNA/S\FL@,96;ZHYZ\Y1+FY2*@TKA;6"R*7'WO&1GD-<M&8F(.._./1<O+%5
M[D+V6HXFJD+3&%(P?70CM$(:6XM13V4K(H"%_@I#[VS4?3Q@`*ZDUJ0%Z-BD
M=OXF`ALD2J(.9+K*2290-(.$/6DC`Y:+;`+5V6#F$.^50\THW')O*T#S+.P&
M5<G$`M[Q&?-HX&IU-0K1;A,E8XMT8\E$(HH'^AHD(UR&.L.*.L2B4MNB..Y5
M`@+`+[N*K2Q`2#K@*T8%(0+#N@B@Z6*"F>150PR``5*0`B(-U>8*Z+C"!4D$
M`%JU,,I/YZ;-D@@//+;BF%QD>WH%41/5(PA"147#2^(H4:*MGCKI<P8B)3=/
M.FOI`"ICPF""9V7H3R(63D9%.""@5,M$/_(63B"/3?KV3=[PF[@/*X$%1;:B
M$/-/`_#49C*G:QY@_@(HC[_TK@'$`@$,A2-YL"TPJW:"!R5H;NQP,R9.-5J:
MCXJRSD/[9L5*JKYBHJOJBUDFR.OP`S_`*V3TZ"Y2CFT7HG)V)B;\U@*FE0"T
M@B_,(FEZ+0"^8E).HATA``#D\6DVY$VD$:),(G>M@]Y^=7<LS@+XUGNM@R.*
M9]#$-X"T-S6F2S8<(#<:(Z*D=X+*3FM<(V@^8B"G`C28\B=?<COU<SD0)Z((
M%2C5]".\I0'2Z7;69B\M@T%\""OX!UV^I,0"R!L-)@-@@\5V!X0>;S1@2!6!
M3$)71'!T[E<NY``00%E@PFE`=S4>]A"_UR_7\0S/*0(DH'M[F$Q^^'>$_F(M
M:JP#7B*,B!@QSM$L**DS-^)<8C$_W"D\8D)'*6Y>-BLQ",`;#>"%$@;N>H)-
M/"D_'&A+&5B5\L\G^'->!,9S%X+Y#F`H*<<`I)$>3YE)MZ)1/&4"%"0!GE"*
M725UUW'A]DXT8*M^?X>)5&*,>0:3QJ:"E,4ILB:1(YF)K0.`4Z..FT-(C2<"
M?(V'*3E548ME-H`M2&G/+*Z*.``WC.I@AYD@-"`!4[8H/6K&-,I:L*]\'L)#
MU()&<P+#>J@M0#<#%*8PU*:9`:A&O*0D"L"84XJ852D_)Z"P#"!4+@!79*U:
M0$/W.,:R($55./EW&I.@_V)[]H]E`@-=\&.@_D[F0THT;00@@R<J:1IY-CC@
M7D,#CB9Z-1X9G(A68^WY.F#MFWZOAH]BJQ5E@V9+/SH2<4J*E?7S/22%5]-I
MD\&F9^)"3:VBQEZ%XU3,1`(E`Z+$`]A'`%$G?CY*DK_D^_*Z`&V&`"9`@(3C
MR:#$)I@)XU8O+0U&)Y*(>6"D>![`N/#Y+PX'#C,&*`]11M#E0"XI?9D/7C?;
M8;T,1YLC<]3.1J-+!XM8JK_)R_;#JJ]#`C"[>#;`B.D.ES['0K(X/T;73N<U
MMBAX(3!0$#^"L?,C*BEJ-XPNC),DG4H*?S_%.W9X/EQL*GH,*D!P4)Q-I)]G
MLC#@L0;E,0S@?AQ`_KGRL\<";NP<@R94-4J0IGB8$@.Z=J@08&&Z>D4<,B?^
MQF&\SDLP*+89A24UXV$;8)UG(Z^/^B\V@"^3BU#_HF&S*)+)N[9M&+?;C2U.
MJPU3+BY$VG+69XGX^`"NV6^(%A^CK36V0AJOJ3<($V$FL%%&',5T=EXG`*NJ
M@D`#DY@IT8,NJ5+N=5I0_"AN4D820K<7PJ)Y5T\/44A@<"`2;BL[T7=)$BA`
MV3H4H!<#*/(Z4FP_(HH%;<F#*`.B&7LG@+^!1U>HDC2,SY/+)`*F<\,SO#0"
MEW@N(&*$9LV-AY<,2HP<@YAJ9SOD]#O?%30.2E;JXUZP$UIGXD-Y;5YZ_J;)
M-R)6W,YFR"-T@0RS[-=F,`OI&E=W=+S^@BMT%NL"+@#V8J(!T%MG<74Z8)5E
MG$:LD"8"!*#LXCF<*MQFXC:2B"E#K.(O=!PA//(@*<BTO=>%PBH",$`Q[)PV
M-$#+,::/PPJ)R>LCIF73/P(#9[2X/`B*:Z=H%K8D%F`Z]46)]!2#S$E@?@U^
MU@]!EN,G?4/$H*1#58+8&C67^R^7@J+90%6'N$I5P#<T1JS:5\.L^IPAM@2H
M`!1.*F#"(^.-"%0PE,19(IXA=+R39K#78`7C;=62(5EIJ!7:5V,"E!ICW&K&
MVC`JX)#PTBDDGE=LIC8F]`7.-$1S$2<2ZT<F_I#8`!3+8SAT'(&,CNYUH"JJ
M)Q8'LW]"JA1</VM$YR@.8.X;C6;YY%;"W&/#1F\#V\FDQ65C2NI)R>)<)0I<
M(V@2@#C40P&@J4/Y`9/D7+SLP%4CJJ;=.@YV@;F4V>NDGDM^-&J9>(B%(;J3
M[CP`-Y;DOPH@_]RI31I#(K""6_3#':D(`#L%3K'B^LBYRMP&,8QRU*@<@%H"
MQ\>#$Y\"/V2"/@=B%_,CR:P\/VRE:V3BUAN0F)Y-.-JDK.TNE(6N-R"@2'A=
M-KH*V-YBE_T6^$MFPJ^M5L6L`A%"(,A^I>K.NDIH`:B$Y+^I+H[-[U=#9',[
M(V#,?:%?BL2"N_0;_E?JQC(</[8,G<FY0]QIQ&78XBD,X'U9RJ8?+W,C*6L`
MIE$+,4``PL.'@00[.#!`(0-!@AX>++"P8>`%#A(K:+A`4`,"@10H6,!`<>&'
M"PT6*!0Y$,,$"@,6+&"@((`!!P$`'!A@($,'!2(W4&A@0,"""1H(*HB(,JE2
MI0T<+'WZE,.#``,:A(2*E2`&`1,L"$RJH.A2"%F?.MB0@`""`0@B8"P+-ZY<
MJ!LP5&@0X``$KW/[PG4+(8+?P80+]Y5@P;#B#QMV`KBZU,/7Q8,I`"CP08,"
M!$A%4B`0H0-*C0(HH/1@X<!)D1X@#*CPH0-FAC]AH^2PX("$R0P;,&`P_F``
M@.`'-&!(\$#T[04.Q(K,,-.YYH$4`@A>B`&!A@<"$B>%0&""TN,U<R[L$`$X
M@`0<>'_@0"$F@@>K%Q*`K-B#`>^4!V9@@$!XG176`01!&<#`!+SIIUQ2&SSP
ME'M)+;#!`>)U8,$#!1S00`4-RA4!?_T-%H$$#`A@@`8?C@AB!@_PQ&*,,D(E
M@6DSPL5!!APH<(&$*!W@XXU*&0"`=0,PL&)L#BB0Y`<9$-"`<P7%)&5&!!B`
MP4`>2)!1`01(V,$%,TF8`5D+74!!`@"L&4"6WP'`95(2#!!G1A=L@$`!^'U`
M@0`!L)=4@0KL&5L'&:`H8FP4*!?!`%0ER,$%_@@(($`#)WF`@909),"B;`..
MZ,$"`03@`*&5-3```0],Q)A32[GUE`1-+L09`N(MY.("!2"@0`5!*O5`E4+2
MI2!U"?P9Y:_#?M``!A!`N&RT(TKPEK10=66M800,1Q]*'6CH(4H;*!#6:1(4
M4.YY&C"@ZF0=>-#!!@SL5]]`&AQ0@)L,P6<`C")U0(``P0VU07L#=8"<O@QE
M8,%U*%6@5U(>*&"!L.]!4$`"GW[@P00&0*!``@M68`"@&1TG```"1/"I`WZ2
MA<&6MO7WV;#D$<#`HOU=D(#`!SRPP:\.)#J7=@/<>AL&[!YP0*FS3IDM70IG
MAH$#:AUP00=:9\L`_@8.10VV7Q:%/19D&T#@*T$95$OV0$02[<%!%B3)`0,:
M)T5!`:6B9($!^Z$4&`$'8)`D6@4(VT$#X>WI<0$+O-M!U0D44(#?#C2Y@=\;
M=]RKL*WMFA0'XTZP\0?IJ:3J0ENBVV"&"\&G)VL"7``=!`'D73IA%2(]8\P:
M1%`3`J8.Q@%\[.*<-6N<%D:`!0-8S%H&#E3>JZD5^-LV03DJY4&.#1Q```$0
M0!]C`BZ:F7WZ2CT==D<->B```UXN`(&RV7(7P(H<I%5ZHTB>EINT>>9P$D,`
M`I*'D@F(CTQZ*5T&,/"?F6D/`FD1P`,FT*!O,:!T:#F*@YKV``:,YF/`_L(2
M8PI@HY04H`$I'(@%B):F%56,,5?2P`"&UQ<.D-!:/PD.`]A&F0ZDB0`#2`"K
M/C`!]`V&,T>+RP8@=H"9)$HRZCM/5C0P@1.ML(4R4LT#N%C%*D:@7MG2`/U6
M$QJ&B+`#"+`:T<BV```T0'5BVN!H)$`Q]W`@.Q20D.0(M0$''(!0_]E;`@D@
MP-<ICB(!J%+5#D8!OQWI@1D(%VLBL$()>2`""-C-`R3(+`3$[#9X=),"YDB0
M!Q@`B`-A4E(8L)N"8`<C4S.,!GJ6R&@E+F40R)UAPL0N`20`+[SS"P$VT,2Y
M8$J0N[((!]CW`0A"L`)?S(`$/GE-!SS@`0Z@_ATTH9*FN'`@BU=:%0X)`P%G
M*3&,5>01V5"#`9Z)ID!7X<"&-C!'"+`2C@=8@%86@``R/H@`.A.)!@30O*2X
MK#E)>0"4B-:!$Z7Q.7:K9<?$AY0!+*0"%%C`GBY0@#4-X`&C5%L"TB62U"Q`
M+`EPSO5DE90*+$`!7]&``[Z2G0;XR"Y*V4`!(O`5QV%@J`+A@#`=0(%SQ@4!
M?_+EC#(0@9<YE4`7@``"3$:8^W"E,!B(0$P$@("G=:!(1#(`T\Z*5J8)!P"@
ME(L#UED6#'FU<@X@8V&Z]@"XLC-[&K"?D#Q0%(I,3$H.``D&@F.^*E[`HS<E
M"0)R.9`)+""IMU&`_DF2Q$D);$Q>"D@G?C80@010]CD*4(VYVG(5",Q1*LA)
M$J9BLX$-6,"J9EU`22@D(0TT@'09,0"\,$84;\E4`E?I@`$H,H%5O3$#"A#*
M4G"SD=@\8$T`8))H+2`!!#"M`4VI)8YBZS$P+HL#$CA`_*:J/MEPX#6&Z2,'
M(&`BVTJ`C&OKGOV$:(!O/B6V!-(`!:S:%@021CN%W:N!V?E`A@A@(`Z`&!LI
M]0`+[#-:%EC)K@)03((@=$\>H,#0DM2!FWAW3I?[0`40L!#G/>XT#J"3A#C`
MJT^M%`,!N`^P!NDM!U#7`!@4R0(&4*\)%,!`)7ZE:3?:RPE8*"F:*<#<_I3E
M@09$UW27>:;(]B79E`FS`N@526<'HL,)+XL\%O2K7"Q`J5YU>2D(^\``]!LK
M@KRE`Q/0[@(04Q`4APXE+66G!S+0`$HMP+MPH=`"Q'S@1,]H8A@1S44F(Y;'
M#:`Q'JBJF@0``;L*R5(5&$"111+58OW+``_P400,`%240`>K5.38B?8Y,9V"
M)0!V16@!@I:4#/`J2`GY\XD"(,JL:2`#$IIN`MY8H`68F@/<E5@$PN,!9"K5
M)5K20$1NR;T*S*E(%B+T:29#8Z7>"`.B(FA_)-``"R3``'D9=%]"##\X1T9+
M8.SJ`!QVYZ386"NN,G#W)""``YPTU7$QB0(<_J;HA"\KVA&@0`24?1K388``
M[Z,``XJ4@`GT:%D,Z/`^A=QQ;SDTP]%,0$!O(S_Q>N!8_^M)`]@CH0OTDV,+
M45%J*.#=#.2F3BE.P`$^!%@UK6FRGS)(DSIPE_GFNH@><L_*:<J0LCC`GS4G
MN>K@\^,B=8CF94F3F6]D3P`05-Q8V9'V/"PX+CM1`,B4-U08QCU<%4!_!#A/
M<=@LX3]S5.T94,AKM4*!"AAL:QRH`"VCR1`A&EYB_V[N`2+@;9$,3@'B5;CE
M*;,!OQ>L`SB,-D'Z_9X,2#:*E$?T794\-=PDP*)U%OQH'%!8]SS(B'O")PHE
MA,^?[2D[75-H`6Z7_A1UISMT"F"`7<.T@6%7@`$RZ1!40<<:C$G`NQ<@0(VR
MCI/=>@!)4D(;7#RFKS[C2"4+"-@!%$"?R8Q-)&]5GP8DH+($^.KK!910!-B$
MKH<HJ\T#>&-?0%(6H242TX=DSW4EZW8``,``@@<<P9$!=/(!.0$`"'!HG00!
M/P16```\'1``'B4`FP(3OH45&E`!-*%I!5$`.D<^E\>"_1$T9N9_T00@,I%.
M;I<5%P<`4B)D;15-.($X$@`:$F(!!(!59U)\9+1)E(.$#L6#.[);DR82'/!L
M^Y0X+G8:%-!)JK96;'(5DI$`XF=0\@<9&J!NU#4`63,9$$!V+F1N%1)W_EB!
M`1;G*`60("7U+T!21=:4@`!P4X/1`)UQ-B?%`!<T`>E1.2:Q/ISR/(L!+5FA
M']4R6,IA$$_1`:4A$2(4&YB!%LZ#$1V7/P-17MN45TYB3Q%XA@.``:C$(AQ0
M=RO5@J^8'\_T'!<@0AJP@ED1)@\P*2QD@TNQ+0"0$0Z0`$T26K+X+R<%1JAQ
M=[>1-V^T?;?F(`QP:`VU0GNABBEA`(BH:C_3)!S0-*XE<Q(61P#@'1/CBG@S
M9(1R8KZQ5A8B&FM($!4@`+_3B")QC5D!:,$!``@"55BE`"<(-INT)EA"?PL1
M7`7R)[3F)`85/SV%8@50D$NQ'7%Q'/$H4@C`_@!-`16+Q1X38$%\@HE[`84-
MP(%0&!,`$!_ZXA0](W80D$X2P(.%X4_G"(LUV1<Z5R=GPR<HED4P]CV]-!@;
M(&0#H!<1B1+W!P!UH0`$@(2&0I(L5@`9AAH(`B:HP@![@AYC<ALN@W`$D29'
M\1&/]4]G&#H@)5Y5@T*AHS=J,TD?\$EJ&"@O!TC.<B9`P6V5]W9>4H^J,Q@7
MH`".LB:8.!)ZU38=TP`A=0!\X41710`8-A(8HE$&F8-*`1T?0'&*D0%XJ11P
MB41I,7DJ`P$]MA1W<I@*,7$#L1?1E4Z()!H)0HX$T&@?0!9'`3X:L0'E9Y1+
M434?F"(VZ9MSL2)=_A-P'W!^!B(^=65%<R%;TL@\:Z)=$B`L&/`QQ8,2+R*:
MN,(K8%0@J$8H?HES$H(QF99`MI48?^8!;R9$O&(QF_1X3*8`!F!)%F`;.G<`
M;;5)/T1("H!4>V(!#7`!5$AY#W!O1HDGD5<8%D`5(K*7[$2+`E``#["&'O!X
M7765H"B8<3,JII(!@X2'AM&568$!4*<Z:(,!$I``>D5N=A-:>@$;O]$ST,%"
M5TE0$9$S&)8WJ"*@\+,77^(X!Z!GBR%$S<,K8]2+O]F"4T,!:#&,`^`G)-@Q
MO%%1$"$7CT08\@,`WC4Q*9@4?GE<I\$N]<,:+;9B*"$IG!%\""!K%&5$_FH3
M4!\3/G;U3-H5.@OU(;+5$/WG(*=4.E%&(5L:`23H(.,C$.>)DOY&;*"F<!L`
M</$#D%JRE(,*`0(@$`A@([=Y<1_*IMCV2W4W%\<F$A,`>CWU8T<120+`$_MS
M)9EA``6`$9-C`&?3`1J`7)^T?1\P7QW3*H9$&=[X`<.D(1\#`45JI#-B`973
M<<6:C<8740.":\E)$(%D7`T``0L@`+!W6"LB?RH#(7!6`5875Y.BI2)1`:V5
M%*$%4ST!4!NS+KV">R\2`5C)'7\H+B=J4!6``?LX-TEQ6$A2.*16+Q&E2K'#
M&FD22ZQQ+GV($D!X`*4#</+*)VMRBV"#<R@1_G(*5S<"`Y1*@1OEU4>J!0!:
M`P`3,3UF-%E+D41F9QC?TQ<R-1DKMV8?8C!:`H]@4XJ]"5CA-:R4X7F5L8!Z
MLB04<`#2B!<?PC)8T2,S=0%#V"&1"AGD]EZ;TFD$$*JO%+%/<0%K$A,UYP#^
MR60FER2`MF^@9AU*47U/R3=Z@Y5?R$K&@1RELRZ)23<0\T:W>6\K@BGK5CH8
M$$4$=QY;2RB2(T%E%4:%B)JL9*#LA$\!4*U-T@`\X3$P=GYNR8<>DQ@&P'.J
M-D8_BD[""H8-(Q>'ZAG\$2\#\6PD1US64HI@F+,C`C"$D1"RJ7-G(3(QT949
M^ZQ(HQ%7)K,F"IN`_N-5C9MQC8L5.#88&1`\2+&N&]<3(R&5!F(!>X*%9[&E
M\U$Z)%.T/2%(EJ0ZTO@8K[<`VJM&1O2U+590-==&H*NUA_9BV@%(PJB88+8M
M,1@UT)F)&[.@A`$O0@(?`@,T"_$3`J$!LT%S3Z1;HI$!$&FUO80]@U&QR@F-
MZ[5F\2@!Y4<!;Y$`<:*HG-(!WZNY]N*8TJ)#$5BUJYM#A%&T%>`BB&)B8!1<
MJ:0PW=-'_Z)-DW$GQ$E$)C%W\#&\N2EG:\(I4L$K'"8!!D"V)TJ,J,AD!U$Z
M;'1,6XH@K@6$=O,E"_$@BZ>O;>0C"&H5MW&8^W0O$.<M+S$KKM&L-:<R_C-[
M(U^1-PH%*LN"=(IK0ILR&62D;E_A&S22:51'&*,[&%_3%L4KH!GH)I;A6P<L
MH",A86Z2EB`\1\M8%H?%(SQ,PEE!+6XY+MR4&!SU,`OR+U_G4"G#``X`>9R2
M'5"!LGVY)H@D.&^T32W\.@8"IBE%:HBS`$]<KFB#>^`A:F<R``:B(4I4-\(3
M*$P%6>]QHOLDC\'R':3B(R1#,1OC/,2+$@JPCUF1.0L08<N2<1/RFZ!5$RD#
M>A4@(A(0`$AA&?+[`0VCJ83!`2/,/2\W`)*L)8:"`!@3,DW::3JF:]2%$91J
M+2?V`:SZN776$A,UR2F&3J-"<5%I`2B6S9Y!_A%HXAF+DEA9T1%)JD-BK)]0
M0:6$D3)B5\P?D)%-:'V!4F=("!XD)80CU203$`"G.\WN-C==&DUJP77BF@#7
M^SH/<``QK$\9\2+[))VJ"]2K-Q)L\R`(H;$3,)!9$5I_623&MV@AJVKW^XJ_
MHX$?<H':LTI&\7,TDKF&(8*$<;41C!73]V<]0P`*T%4?X$\O^!4)8BW,19SN
MS!H6P`!1%'AF?7EZW!?^15E($1$^`E)4H6EKTQ<7<"X%<#0`>4V%(2GR0S</
MAZFW20">$TD,$)U'4A3@FRL\"#'=DK"Z<3`3,4<=M76W855#<QJZ&,LF=C!2
M-@&[)V7+I8OBM5@%_L"#K?$S:W6Y2E%D%5`!TXHS#N#*06DF`5RNF%J346E0
M1#P28-@G2E4FFV(88#Q@\FR/C@,4F:):Y"(`>[*FTD+7O4D@)E(Y%]1JOZD?
MB@'8$R`!\7W1\[TH.?(K`'C75S0W#O#;"[%;A0&$\8$2Q^'(M&'4K`%=2;(N
M^05FZ%,@`FM0"A"N!E7+Q;5'4&*)I]%!S7RBFJ2W^<H:)*-R[(*IJ$$QW9EQ
M%+&'IO<>]RAGG-2!I".LXNF6<+5RPGIY@U(!P,<Q?>+7)HLE'3P7[V<8ITP9
M=H4:41<VO+K`AL$P,;'6??6;+)X5O"*-5W[E+Y$;1Z+EZ!R%R[,8'E48_AIW
M/:]C-:"=`+J:9Q"($D"QQ6"6)4A'A%@9:$UH7ET9`5E$*J6S/V/K+2>2IMA1
M.=Z%`1N2<^MF,38TU@9U(F+!@6N"7K`7.B<!'PD@'*L4LV6A`+="U2(A)MJ=
M<!@#`.CC`3M^N.D\.$(N%\I;&$WN%]:47/S]`!(`W[1NZX*D%B:'D04[++PJ
MS"QB3=3Z4_C]BH(Y&+(1<:>!QN_!UU#1<H,!DWUS,!/GL-N[5:HFM2#V(BAQ
M%BPQX:]3R]6K-[GU;$@.M*['&C*'I9@$O@<C2-ZUX%@Z/>(E1)AV%26:D5BA
M'W#S,^]1(J+!,RF#(+(*HE\1``T5DR1,8[QN_JL_OA02D$ZJ'A?G6A@27S1!
MVQ)2MD+<Q?%-T9\<?Q,:&"TP]@%A)21/A`!R1.P'S6;&SB=4IUMQGH":F;\%
M@2D)WQ>$&1<.=Z^&XJ,D9P$*0/%:$0%+QAH>(Z+^;58&_:S9%>AJXQMY.R]"
M/DX&8"FY!E#"0E[GU])#YB"!UX0\K>8F-?:"D85YZ2,!Q6P3L,W3WE%K`4M2
MKA2WDAH/P^`G3S:NHSHGEQ4/T"P6#Z)>7A8.WQ?GZ2TA@44"T55L$V4E(\IV
MR"+R$M!V31@D."]W1A2@OFC]+1?KQ1M,_8ZD?0$30+A+@=AJ0_E.;1@;4"DV
M(=`HD=FN)9U,[Q\&_O#K*:9-Z,L0+>9=ELJ#%M<F:>X9;7MC>?MX3:*WPW@:
MG>;B`U$!44E(YP=1(F/>3Q$!A"D\V\2\L7'@8(;7I$*9<1(EJE8YFI]H__@O
MK@XL;F'592%ZBE&1AN$!'<S\F=%/0!4@!R`29)$C!D(R`/%`PP>"!0T>1)B0
MH`8&'Q1X4!A1XL2#&R`0*(``PP:*'3U^_&`!I$(.#0\&@/AA`D>"$R1(Q(#P
M`H61$S.\K(F0`````Q%V4'!`Y$$/%Q[01+A!@8$*'0YV@'!@P5"#'B(48.#3
M(`<)`QQP0&CA@8,+##P(+9CA08$*"35,N+#!Z4$."PH@/5C!@(`(<PMZ_J!P
M`$&&A!D6'"",4,."`192'K3@P$*!C@G\;FWPX0"$#Q$F:`9`U2"$!PHOQ/RP
M0*$'"`]SOH:=D\,`L`8[$$!-\<$"#`AB_S9H00'P#V?I0HB@<D+)#PT&X"SH
M@"B&!P@RKB3^X8)T!+6SC_2``4(#`@@J9+C\7?U(#I0/&B@X(;$'!=X]1E5O
MX3-P!SP?%^Q*@O2*0X"`_0["(`$(6-HJ@06LLN\##11(H*V$'E!`*X,F("`Y
M#P1,@""@#O@ON`(,P,N@"PJ0+J$.$H@@PN(8&"#%@K@RP"R$ZO)*M/@<"$"X
MS"A"X((2/\B`)@,N:(ZZG7(;S<*G#IBK187&_AIP/2T[RH"`$BG@R8#E)GK@
M@0RLW/(CX8CS0#4$7T+1`[,8&VXT'PO:(`(%!BC@`0RR_"BP#W1,$R0.,""/
M3PT+9?3&$`\:("4)<(+@3H0@B/#(V!Q@,#8+>/*N@YL:N'.#"A1H"J$*%EA@
M40D9*&`"#SQXX+$,(D``@B//1.#.#BQ`@`'4.+A@NPXB,*`OA#R88('N=IQ`
M`0H&]*`")MW2X`)E#])`@@(:Z'2A#RJ`($N7(MB@@"<IPJ"``0900`(*:HOK
M@P0\L(``!@)(@(`L#=#T`PX@LL"DU1AH`-!&&74@N8,R0&X!`@B`H`(9"7H@
M@@07[F@QXC3P[:`+_EYJ>(/&%,@@@$X?D)(D"AA00($&)*@@W(Z_2ICCC\*+
M(&"=U>.@3H,<UDZDH!U(#*$A._"9N*_8#`"`Q((V($L,RK.Y.103HH"`!^;J
M`*\*"I!`TPP4Z#DI!HHT2`,-(CC```$3\@"!!+).%P%7/]@@QZPM"*`TA1)@
M(,L*`H`RN`80<(H^``"F2+(..)@``0.^I<"GL06(J0,#!MM1Z(@8@"ZB`G_6
M^2Z).N`0``%*+^@H;5&/Z`+18=-@2(,H2&X#C!H8NX$##H(@\8DV("\`W3TZ
MLX.0:8<^^AL#0(#//6%>X(+Q(ICI`@N*I3;UK&O*@*<'-E@@``J.W`"!_@4V
M.'*"NX[4P`#+##J_`P<$<&!O#!1`P)&LXC6B&$D!#X`=038`I`-MI0*]2DA)
M`M#`&T$``D92S`8&=J4!M*P@OZI82B[`$Z)))`$:PI>W`B`M#W3`+VZ2B8T2
M(H!K2<0#!MB;](!SM8L5\```*("/'C`!ZN@P.+=[C0<>M16?=,`G;XD0_&K2
M0H4I1`)?&9X1M<@Q#O!E`E_\H@0B`($%)`!&%#*C`2R5$`W:,&D=Z4`!>LB>
MJ`$@`-P[D@0Z%,$$'&!O>LS`ERH@F#=^4`$%2!NW"/"@G]B1``H!$KK<TJ&_
M$2!S";D`OXZD/P+D\$6%6Q:R0%<0,`E@CA^D_A+=.B"!0]ZE9L51"+@FPH%'
M<FEY6_P-!`Q&$:L,``"(B=T&1H;+-0%GA`=X0`-8M4QF-I.9!0B2SN3%@2SB
MTII:XL#R-NB=:LW%`N/[P+,*T@#CJ8B"$T'4=Z)F@')>P(PVXPH"&K"KUM2P
M(%=+%MTR4`#.)$4"!G!`>CS`D`9@Y2F($E9A>B-#?-'(G@6QP`((M14*#"`"
MKBI*KC3%@0BTBBX-`$`M;7)+!3ZMA=U*@`$6$($*:*!$M9I(LSQRPU->LR,S
MJPG<`)"`"V1`;^*!I1$MT,_?5(N,"ECIRRI&@05,(`)B;``#*D`!#"U`AM^1
MRV,D8`$./,^F7_V-_CL-TH#/<("JGML3!A8`@1SN:(G98=5W"@``-!&D`C"S
MV4U>QT<#%/(#'7A`:.A&`<2YR`$$\"O?#'``FFCD+Q20ED(\ISX7'4!8+A59
M`>ZV+`R\#J,8H$"JPM*8O6V`)R1-2`.NJ@$!_"JD@A/8JG9R``D,)`-OC:"7
M/O*`AX+5(QT80%N/YP!?#@<#.X57`M#&`.4VET+/;6X#$B"O"5!@`FZK;G:M
MN]VV6N"JOH4-!+KF@`9HZZ+P`6]ZV;,\AA"$<)3[P!`'T%>).(8@'$AL;!@`
MSIHLP(Z/X2C;=C2`_8;R=>D!+(%[BR\#T)<H$!!`5I+2``%4``.%RZ('_M`G
M8`0=UE(<@,``]I/(ORH`L<LR#%LBB(#`N8@!6UM6!RK`D[K2#8<1G"<_]6>5
MZ=[3`>D[0`"(2I(A4\0"N%6O1/KV&];&!%\6L$`$$`9E*GNW`F-DP`0BXX`'
M[(0G7^8)5A@P9C(7`(D0/6>27Y,!KC"``$*NIIKE7!C8AD17#```XPYP``$,
MY($28222/,@?_HY$`CQI"XB_=:3_:9AK+#)>'"VZ25A=0$8;B-O%*N`5L&C`
M`O\KC@0"X`!-/4``NDI(!`10@/G,1P)H65;URMF!!=!01G)2'MTL<(`$?+F<
M!Z&`>Q#"VY+,2J($L,``DE(!4TJ$FKNDR&SF_CP1SP`G?>1<"0>TO6UN:]L#
MW>;`-R6P``/L2;4FQJS`P$+&B'QQVMF1P/D"^&YZ2^@R%UC.`Q*`N*+D!H8)
MR4T&A#O%`]04)!.8+V,1$-FG/`"9A8E``DI5`4O:-6D:6,N8*@(!?K(O*O;]
M`%N=BBL&R*@#VV'XP]!VF0PL)T&\61:P%D`M""2@O#^Y@$0QBKX%$$8`0.P(
M2RN+;\Y@P``#8!)N$'*VB1C`=>=KVE_B7&^"U&W@'?F0LS!"@`%PW>OS]7J_
M,-+UKMMM;4A-@/O4Y:"E()W="HG`=ZGN$3]A?.[3K@":M%QU75V9`;>2:?0P
M4./8L#9E#A@T:V(5_D'&B#8X`LA005YID5/?FL)EVU&()2"C_=4'X`1@+!\%
M<">C"P#F82G``BZ6`0.@]D,8N=BND5V0G90P(@D8``+F1DK?."`F#3"`X)#\
M`0>D>:Q@)D`#8K2ZJ5/=9-;T683("@'"$R3N6_HV>!-PW2(GI8IW_UE7W>8V
ML%Q&VP3AG<'3A)SU!&"?QF-(`A+;KIDK9L^+ND`'&'!JC`Z2K:GN$QF9@`>@
M#39ZL0D0E:>```0PDY\@(TL1#\=:ND-:'W]")AGA*`-YC!$"@%]3$1%+E,'@
M"!>2$,_PFN2@M1TA@$+S@`QP08BIG@$X`$E*B'_+B>_C&`D8/MJA#P,H_AZ!
M$S@)H#X:,@@&&"H;W!"YBXT,(!'?VBH-V$$1*9`#:*FH`[_"R"]#`3,[4I<3
M2:8'((TP_!J**+2<^#_U@(^5$AFOH)]^.:?P(``%L)F*FKV?H)`*.)*N*H"]
M@1L!:#[]$8"<D0D"@+&J"+9[699_PI2?<+-MJ8H)"(")NI&U4+V#\*_F2X@K
MJKH*`#X#B$,)X(@?@S*]08!SRH`!P,&?0)8"$``":!C[@+::0!HM(I4MVC4R
MZL0&:[#-Z)0*F("W2XCJPKYY<D(*V(`Z4X@\^:%21(\K](@)B,6:T`#<T`!R
MN2ZWL:!LA(`DL2"#:T+U:("K&XD&:#D8XH`'_EB2GPB,W=L*<B,UA#`ZQWLL
MK]DD!UBTI%B`@!(R;B$<*2**,NHMOHD`,+PTE[BU!)F6GU@,Q&"TM,-#HHB:
MZB,>X]$P-\.(N&":!2RX2SDS";'"%ER+=Z'"#,"`MFBAUS!&(_*``DC%1L$`
M<2P(HD-"`%%"V,@3*XR>RT)&)1NDRSD?9XRI[JL)33P(=+$*C?D`IFK)^%J/
M=,%)D%`B!&@M3$,`?_R+":`M>.HCV\.8O<@2"G`?C+J*@"J1]JF1:D&)@@"9
M`\`;X+D8*)RT>#&(#7#(POB<-*N?$Z(?Y_@UJ^A`BO`<&SJYFBL/N-"4$Z*;
MDML949$`ZQ``E1H`_@'(0HE@Q^C1`&7;HHL2'I^X@`:PDI.K%\\0KW:KR212
MO^C1&`T0RHEH(5-QE_(ZS7>+,N`@RJ&)"P+@`';J%:[\F739DA\"@,B4E65A
MKH#,@._)PP1P``D0@)^0BH#$.`1,K0F:"PIH$3D)(@$B0,6$1Q]$C<>@2XJY
M&`<X@(#,)A]T$?(80[<P@'VD"+'ZK7^*S"P[B(Z4,=C@L9_;J:<,CMC<$@A(
M(.B9"2[3N`9X`(-QN``H``^8/HF\/J#\"(VP.]CH@`V(%@5@@`?PSXC8`#(;
MLS62L[&`QZDR"W<IFVC4F8C:DO[X)4W;HZ7#LW*B``&XEY<QB`1I#+<@_JX`
M/1O<)(B8\+W.X)>+`<OW`3CKN#B6^*8*1#W".\Y8T90+R)$LZ0!2`2D`X$V$
MF`#4>AC)_"#M&8``,+TO0M&@R@EFD9`OXY<%D(#)W!TMXJDM0J"`_(O2P`"1
MR#)@1(@'A="@`ZV=A`T*(`^K8K.<\"E^D1E6"@`_HKJ&63H*H("70`"I20T=
MH@`W?0W3`H!8+`NIVI%@4P#C*8E4^@`,2(FWB!5JL8#/$=5-Z[D;4:+`Z!7Z
MT3=+^1#&L@_$^Q^V9",%(*)E<0B]698>#-"Z,1!:^SE,C2_C,PB]H%(R^B'>
M=*+8*):_.H#EN)5#$@`$(`NFB0C^W!(."(`-_M62E137^R$(!B":%ARKH<K2
MSBC-/B4(WRNB]>"=((N5T[0*@`H76AD`9?VJHT"(K6I,6D(D#,!$G;G4-$$?
MD2K5!3@S9ND01GO,W/"`YO0`!_!!C(H*[IS+?5G/@EBI`*A$>`2@@%P@<DJU
M/3/.6J/!N23"9=$`!T!1_9M%@3FLU42(,KW104,(!SL(W,,=QGD5KCF,IV/2
MJ@#7]1BS+?H0:CH("8"2RRB<BHD([BG760D8K5W:[#@A76(4B]BW^?&9!M!9
M@0DTCM$`<ATV&<H`CE``&@(9`(C7-`%1X)@`.QJ(U\,\ND"`\OR\06,=4ET6
MF<F2:?R[97$7GP4,_GI,"`LPO5D;([H)L<150$BEFP38JU0C@`H!$)[H2(2X
MF^\+4B6+%)FE4UYJ/>L+T'NB$05-`#-)"0C85*;IVM\H@-3]&>^ZFJIC&A=B
M&DO3B*/H#1![5T<LO)0RHTEU'3,B'&@D(_T,/C3ZF0?A'8X)&W(;`+9*CPOP
M*BOBV?5PM]^(MY7(EN_9H(HPHM`U)I[PHXS`J/U+LP5"S(.`Q%-+3`Z;2R:\
MDV_+4$K-"]AC/';"I.JYF`[@-9O)V/*P&IO+$H'S6(PA+`\TB/()*?G+DKJI
M*?FAFX2]*=U!F8X1U,C$BMX8)":4"@I6CY7$)11\%%&+`)X0@+S]GP!8_J&=
M$-3C56&/N`J$\>&\X\0&\,RH(HOO&<B<"X"?T0BGHAVXW%:RF!4U^J"(N#&.
MP=S?V(``B,QW$0`Q_1R[`2`$$&,QALGOD)-":1.>&("0K3I@20"*A#!0>AAA
MC3D$0$JB`):=;"$:,8OOM0@")HJP`:A-DI\V940,2*Q;D6.Z.(R]*0G/V[@L
MQDDPU!YW"41T"95YDPCJ:TH`=IZ:,"OGF$&F4"/$:\&'+!2/V:)+(Q8,P(!#
M4:#$0!G5NEK=#91S$@XCJ8"RX:C>FLDT&8R!E![*P3UY<@UK?8JY&,!W.SVU
MY(!LB0L-""T,*)8_H1W;813/`8"M$@WY8:L2_AD@#26*P-"7S"LWOV(-OU$,
M9[E4I#*8WEB2`2D+B\)`"&"*R9DH1$&577FJO3&,-Z8?9VG=OK(?CX`<$=&`
MP1,`R&,`(XFZNBE#\-@TPCA0V!@AKW@SWE(*=X&+,=KAFI@`GYTS<ER0J[W=
MG;T3?NH,"XJX_0F7=UV/L^"`4]$B#6.9V`$`!J&XV0.<=[L@A3"`#4@0LIBI
MM5V/".#2[^BU@Y80S17*?1HE%=F3OJ`@)ERI(W%C2TDVF"((_;`S>;$9P-JI
MO;F``9`EOL&@8^D5:E%--KZOZI#'392*6[/0<!R`C^YI-E(+ZXA#1`Z8:8SH
MFM`+#-A>V`"@AHB*_H**&OGHC8GQH]HZ:=%E6VM2+0>0.Q*+C:D("P4IHZB2
MN`ZJSY^Y&YJ64R7]N0.QEHJ^C7=+N8/H%:Q,VHFXS`$@U*7<Y+LECD,#`/G0
M#@,QN0E0(W!>$>GT5@4BCZO*)HH):`&PD3%B3DB&#*G0@`&!B@*`$FI&$C&V
MF@(IIZXJ66Z1"@5FT##5I:0^B*:E"+5PNKXN$2$LE%/LB=>@M:Y@PMHX4`=Q
MLW(Y1AL6$!<$FYH8(?!CRP40Z9"S[=%A7%39"UW:B98Q#NR%#]7$)4XI,9X0
MC;K9#T"6,PD<6/@9C_!E(@?HE^]]C:A.$W=J`#$M`.M61_LQ'DQCBH*0_J1C
M^98'Q@KJYA!01(@P#6&UX:D\+"A$-`B"/4.Z(*YWI(LLL\H;442WF,$HLZ/"
MZH@]I`B+*8X-:,RMX]ZZ`=C7*)@=>A'5TK_:P(``Z%R)80!=6I%?JE"IL.T*
M`-1I\U4"CXAR(0X%\)%O0Q\-(PP.V(!T4Z!?+E??F%`M*FGE3)<(""0)2;DH
M]"V)4PA-I@^0Z"P[KMN)0/)"F8U="VIPEI^S;L>^^H_!V)/*C,F(HV[BDLYA
MH_"PL`Y4>S!D&Q"Z))O!*IX!.1L),,^4,G6!B1O[,B,`($8C2V+67#S;.)2T
M$X!W:90+$(#`9LUP.Y;6<\6F,"N>L&'D6(GT_@'=V&2`2_>MQFAFA.B?.\_S
M5T,7J1B7!)`A\UX/!:C0.*>=70XJ@<M=58,.&YVV-U8(.303A.T(KQ;7F('V
M35Z8.!*5;TP+ZX"27X6`2!P0&VYHA:`1,TT+E7K+'[JJ":`A3?$6E46(KAEV
M8)NTA&"Q1;P4L@EK"AM.)/DY?Z&[LZVZ!76V,FD4/)-WD#@Y^[*`-D48IX!4
M;<.XR-1/ZE%W]>LS\.,I([V2`X^EZ_(>2W,RL)B5GPBWT_B9^I#P+4H7@6*6
M]GR)]BAC7"HP%T$2F(G7HO@`IX/8+H\(_5F8XQH(<4(_`NC;>VH7O0P+9"/D
MUC,<BTK/4Q.L#SQF_@1)`"I/"HUM^0IV@)\.'>0E)<W*F@L0#`V)@,7^")I'
MIV*7"`JPY:)B@,,BCK*V(P+OM!>C$0TIBR]KC&/Y``)@DKME7SE+@+J0B(LB
MCLL'LZA9:#%54`+H_2ZV86S7F<"D*FORU=5`Y*0D\23;'P:0J.C/T`>P@`KH
M^;BK?I!3"%^2&H>%C5-<F*F:5S.I?F<I)XI[63QY@`#8&V#1W_CX''36"PJQ
MQ\?`SC1C#3O6M,_9^B*D*X#X('#@!PX2"$3P0'"@@P0+%@K,\.``!H4#/10(
M`&`#Q(X"`QR0X'&@A`<C!7I@8/$D2Y8=''@@D*'ER`X?.B3(8('#`P4!_A!,
MX/#!PX:5'!Q\2``@@`(%!@!P$`!A0X"1$Q30S*IU*\T$%Q9@&)F0JT<%#B@4
M]9"!0@8/;M^^Y9"AZ`8*6,GB[4!``P61>/^>C#HAL$K`9!W,-/P!`8('/1U$
M:*"`0=/*E@,([>A6`````DQVY$#!+432!"504$SSH8,`&A,04'"A]`2$-A=R
M6)"`0H6%'28,@*"A8P4##,(N]&#!`%J)"B((M#M@-,0-#1*`ADC!@(3A$)`*
MQ-!P,$2#!"#<)LB!@0'DOAM:2(^R`8`""P0<@'#!M$<.%A848(`"$K2UD`*)
MC:3!`:JQ!($%'RB0'5FS:4#`2C=I$,$""#!`_H$%%F40U@0`#"#0!@`N)<``
M1774(8,O_I6`=0\N5(%-"1$E'UD*T"A0!1@T,`$&L1TP00$#D#?02S"Z)``'
M$*3&I&$;(-#`<,D!AZ"4'C6@Y5\,7.G1A1=Y)-(#`'B8&40&:&1``QO<ID&;
M-BJTP&Q;JI?`!P5TUEF2!&%@P`%A7O0``0]*9A0!#/B%&P($Z"B0!@84<.<#
M%!#`P0:M_7D1?7IV1`$"%`V4P6T+`+``1U@6`(&:!$&`T)@W.2``=1!),`":
M'G1@`0,,!$#`!1W,ZF-;$;`G@``,Q!=12U?A>5&F'T0`'F`:@'I1E!]DH("R
M$KQZP;('7=4`GZZ=_L?B0`\4&RV>46FP0&\$G6EA!!U``("$._;X`009."#!
M!`MXH%0$$U@[$'3N$M1!`!H\QS!>]`4W@0830!`LH1+#Z,$!D2I)P*I:Z4J!
M`R,31-0'%D!0@++Z+?``RP8,<$`"`VR\I02J#B"!1@"XMV[/H1UP0&(-W-9!
M!*1"U$$&!>R+4JP+"[1`!P-$0$"7'6UPP`)>#F1DH^$-]<`%02OY0`%C#\1!
M`PB@/!`&";0WD@1]$N``!C8]B0!($7``\D*^#B``=ONQ)#/#&@@@4`1W`<;`
MG0,=T/@'%4S`D08/&)``4($G``$#$6Q0`+Z8/9G13_&)SG%+&TQ.5@<%_GCP
M4(T:7<<G`!`8QB-!&GAP@<RI`:O!W!`AX'I!!OA+M?(T9<!`X<H:8./S4MH^
MTK];=2!``+6_*G<!@)?Z``(`#'@;!Q,$8)P$$+2K&`,;/(`4XP`LB!(%";Q9
M&@0#-,`B'#B`0B(P@`&@+2($&$"_!F*!!##@51W8@`5(%+NV2>``#XB4!RJ`
M@/`)Y`$2`$JQ)K`LS=3*`1R,`)K$%(%'`0`!PEM```00@0HH1#0W"\`#<E::
M"RRM/@^80+L,`#('^)`LE!$(M`PS*`,QX`-#PHY`.,`!#2RG?1-(VH.,1Q#8
M2:\S`@!;5I#&H`W$C2L$S-X7==4GF/2N@3=Y_D`%HE@\#&Q+(!V`G,3TDI0\
M7B^0@B0(&SN2N:V()RQ1[$@$+C"!1S:`?)L3%0(28!8*8`"/:N,06N+'%9QX
M``'#><E21A.O"8#-`Q(PP%0(8@'>,.`!>X-('7O8D?\T@`+A<QN4<O:D!1#Q
MEOR[%4&^`@$<:N<"#A@61`:VS.HX0`$02.`'OO*5SAQ`3;##V`(6T)<-<.`"
M$&!,8\#)$@Q88`().$`D"R2I$I7F`6D<25^*98!5-2!J6@G>(@EIHP%D0)FU
M(X``:&0\SGG2E1H10&,B0$:/=.``\R2+3`R3@-IYQ`('`,"A5*.`G&7H`@=X
M(00.H(!.=>""[M(+_J8`.<B7/J^0VIFH1S3```A(QB,$2$!0/K"Y`EBG.S9Q
M6@,*=Q;@K:\`!&!E$A'9'0(01`&>>:`/+^"Y-&9@@7!<2+P*,"_<C--YGJ)A
M&E]IRV8R1J4WD8``U&K5CWFD2IK93J?DQK2-`D"M!<F`A@(P`+!\8`,2<5F'
M@,<2#8BT/L;!`#N)HT^/#"D`,G780'8#&).I-``[P8H%+I77N"EG*Q"00$D,
ME2JTT$1P9`DF8!X"58@BD4$R#6Q8,+``#GC`+F.ZHO(ZD#S(P#2XS\-(4S\@
MSZUX`*=T[`\$$E"`6")N`D4=`&+X-LX"!*@"H\0`>W:3@>*>Q"O;(8@#_CIC
M)=XM)(/4Y(`"OE::_56D(T\3*THJ<(`"!.I"&5@`0+D&`>:`#`,#**=O8H6>
MCDB@`2`4B`)$V1%\8<TF#.A,PD:R`0RT+#\24,C%V*2UAZYK`A3XKT;TNI4)
MO"];`REI%0>PX*Q0P&7/*5`&],2`Y/7D@`)`&[$,4X&)",`^R!0N2]C[@=D.
M!+Q:X5$&YK(6##0YRE*>\EIH*B4_\H;(6G:7QUBBKBW]Y@"4ZB:UUJ*`(B&H
M@_?)&W(R\%_TQ7>?(G-`PC#B&4P2I%MF3(X#[#,K^U:O(S8U@!P+8C,&-*`"
M;#S?;6])``20L0-J$RSS\KQ3D&$*J-49#C$O_G(!`\36IYWI9U8X`&@"+(!&
M%%P``6+S4'8-!(T>2<"+.R(;R4'$3DRL-&#4@@!='2`U0AG@`HPH$T8M!,^J
MV8`'.0H6*P>W:Q@="0-4NQ6I>L8UKA$SMP5E`/Q0:JF5(S7#UO.!9VXYW4P*
M)0(4H#4',*#5J!9A)C.),()):7T",(`,%<(KZ3)`;S.YH@5>R$XXP:XG'#JP
M2ZQFQ(5D0(R=]%6BI4B``B1`;SNS'L01((%YYL9HL]+`D]72@9+<1#>R7HA@
M`^Y#B#%+*"R36R[C[$H$I#I2ZJRPU!@UN2&1",0L(4H%).,^4V5@`@SPW`+N
M9:(&I!8!";V(`#9@_@`06FYV)OYD78IM'PM0L"C1?")!6/LBN:B34@K@^):-
MC&2!5)M!:$&X%5_5R"JBY#;H["W4(U!H=0,^+Q2T`.$)?X'":W0I([6`T`UC
M'@#<C-9);L"C"802#$3``&QV2^I4M.>.F&TY'1%S>1N)@*^.-'I],L`%/2`H
MEW(KEYW6HT_$2NOBJ%"^`H"Z1PQ(S+G<Q-T^W%3=('*!`2B@6!5`?MS<J.12
M4\!<`CA+40R"``$\!P+H';H[6[*S)4%\D5>I-6"<QE;\Z.<W7T7)VU73P0DS
ME%%3Y]BG/6`YC\1=-;SN2`.Z,Y(,L,U*+<@T!5X!OHLXA8X&6!N#``RV_O5)
M#7U4WC7$VM"(!]@6?C@`V/'*?C%%`Z"-!V#%KP@:4DP8VM".'IE:K;#9RA1)
MNW#(/(G+UU@$"%Y``!0`"37-2>%61S"6`H"0*D$-R*@-K/G&SIB=DJS3$=X$
M9^S?BUB@!"2`#<H3KU2`3PP``_S(29`=35"$!?!<!*2&QY"?:G3`^K":`"R`
M!`3-?DD,%49`%**A!#">?R!>'3*>'>)A'AI)`8"-D;V61YR@:DR+1Q1)K6G`
M]O51%#&'`3(B&2K=`'C%`L((?3Q%?1`+!BC`S6C0!62&![A--T6)!=J%YBU7
M!U"`VOP5Z12$2E1*[^T$`M09U.V,X@S%53`%_@^!#;8<0*%=C'`8WP5`'LA<
M0/\-WXWM8,H<"=.`5:-51P*L7]L\```5RT;A#,-L0.;]Q`/,A-F4%/Z`"T38
MU#YAAC==`*'`T60HABEFA04Z`+#)DG'QGO)PP!OBU<_TR3WB8S[JXSX"@!Q=
M0/)4!;7-7TM\STA44@`\U%KPW0<L8B,ZY">94.AL'9YXRP,PP`0@`!CZ!0;<
MXP$$#$<0'21M"^8Y`#O1D5L4'*MIC;B\6$HD``8$0*-D0/^E"A@V0"RI84!5
M0$GB#RJI4LQ$BDWE1\YL0&>XE"K=5%U=S@&<7K'4SS<.CD,<Y?YX8*@4@)6$
MAE)`(C5MB0=$P`/<_H<-[8<9^L1%?@AM:<7`>$P:$9"A0%M+>,#SX<8$](1K
M!*#R*,397`!OG&4'\8:-?(B_">90#"9I`&$!@-`&",#LA)<DKD9X8<3?[9WK
M=`#4>=-#8N9)Q"4$%!M6"I($8-Q01,29V(SNY"/R08="/)D!6(Q%6,<!)8`$
MR,<%Q`9J,5*?/$B,&4\`3!A31,"^B=D6#81(E=B#12-]S1$:#H!\Y-8&S$]'
M7$!36-A&)>;2K->-O277<,;N7`\<P2(#;)1$*D0%&%"P',A`'E,&","8U$YK
MC&%F.N16+00&`*06ODC^X-^DO%@FR2.M$0#L%>!WP2>OM&,->>8@>0SD_EU.
M>AP3:1V`/>;C`2"$864(J"5?CVD`3S;&67X`!6Q48[#=31!`9W1.GUF@/E;*
M(2Y+F'0`8.'&`;G'2M#F549``2R$`S1AH?"01UC5Z2$D1`3,#UK`@$7*`GK`
M!+A)?0SDY83.E'0`3@SG=8#$A1Q$#0U1CXT$4F00K@1%`$PD?#:BO(0&5EC(
M2"PG@P1D?Q0?#SZCE*C%TE5B`+2I`6I`=A*9V[`)`C2+<!7EBB@,4:`8L6R`
M!!3=^?0)!1C)`+B&,R*(\=@'!92A3T6&BC3&;&"`,DEH;,[+!F";!^H)?>@C
M0\'B^3#&Z+A8REB``!"*TJP,YQC$=2R2KR&G_B=J2#$2P&"D5,.<!&/Q'!,A
MID=$SXA"(@`HI4>,"&<,1SG^Q3R61\_\XV[@EBDV`,V$1`8L&'1X!?+8!+R!
MZ9;QQVK,Z3_NR4FTWU88@`A)0(18$FFQ:[NF8;NB6[ZITU(U0#Y=P`78:;>^
MU&\`"T^])UX()W)Y2YF:B%J`!\IT``9,0.9ID$UPJA@UAGX(!0!^QTT,'!Y!
M0(,M@'!,T(B95!IFU5(@T)[@3P54@".5Q'8^X'.A3WJ8CX`NA#)%DE"<A8-M
M1P387!6-4T[PX`-`26:XAP6,RH)=Q5F,R<E)@`/,*04PRO\<S/@LZ:T:!/T$
MV51<P)#1A+)]T4;<_N1W#("`R!-N=1;-Q`SY<,N_5./O&$`.?5`Z.J:^_A]7
M$D0%^,7:06?RM%^Y:@4`.$#]^"R=-4#`0,`0?<<0+2P$($Q#GMWCY`?CP>U#
M;L#`%(`"4(!<_D7WK>-4I%$%(.*#80JJC1.*]M_(%,>8\`4#",!.6<"5B(<#
M4%YG/``+045UF!`!+-2;J4@$/`Y:1(JI_<G>M`H"%,#L#053%B,K70CO2%K>
MI!&09&MYC`H'<00:I40&5,`8;84&Q&-N:,`(C0@`O$GC"00")%#&NMYM6(#"
MQEOJ(I$G?@6E&`=0@"6N4`UB*`8%`.CCOH@Y'5FXXBVYODCR[*IJ9>&+_DP*
MM.IO(Z:4]"S3OY+ADD8$;J51]-%$!_EL`ZAL/C)%!5AK8)PBGWA%F-2.BG`4
M)%9N>>269VP`)!K$SR0L(OXCN<VC8N9-SJ2$;2;']?9/S"Z'Y/G&<N1?PU">
MT_E&3@F$!01`:Q2&5HC30.`:$$G&B/2$*IE8!]P3\CB2`-^$*UGD`!!`L'&$
M:#A&O/30A2#`MFQ*`@M27$*PF$+$XQP9`*O&I+!$1WD$![](;=RE&I,%!CBP
M5J04;%SE'[^4W^4'1#PG5UP1?^6C]T!L!9#?9@IRA\Q$H`#`7!1.?<1&O"Y&
M`+`0:&Q`O$@4-")$,R4MON%&C2;`\#$E5P9(_NZQ'`(\7#,J8Y[!XFW42F?X
M(%G\5;MY*80([8#U8^IR9VC\SZP@!02Y!!8]*`'(DD5T0+RURG"4SDH4#!]?
M#P4$0+[V+W1B1?OQ$6!40)KB'XC-*5EXY5Y@LVH$[K*B3090JWYDYF@8`-@8
M3?EAK*XL4\$A"V=<H0,XB(XXDE!T0(:\#:LI*'\)A^Z^#4]51*!(EIRF%ZBY
M&2N1T=)=LG88@+S,BFVQYJST2LP(VCAAK=QP9L!>1+HR0&*L!XF6M%9P%Q8Z
M1=;`I&Z(Q-(1KT#$8'4\1$@8BV9&;@.(V7.`W3P6VP=<1\K@YSI+C'9QA3.&
MRO^.A-[21`4``$OX_M\=0[!'B([E,C57U8^#_$7I%`3"V(<\#ZB>DIM`P!,9
M6E6J2,!>H@H^GH<VZM''D5;*M'`#!$#G2NH"V:,^>8"B,MR-MAOCO$J\[')U
MW-<LT5+-T%=EKLBL@.!N@,P`$<J$<10WCT3P$,A$$$3^HL2:.E#Z%N1-+&D9
M/H#W+`KE8<#N*;5B`.!7LP2':H57,9)4>P15O\Y5G\0AW;'X-LA:T[9+L`4"
MM,P>T\0`'5"''".84D5,E@=OKZ/U*04_=@;49`:^9*A'<@0F51#;C-/E=$8`
M4`#0:,8#18I5L9XCM?5+],RLS.,KS5.WR(@RI<P+.0#1HJ%\/8EA18>B_AJE
M84108#'34+#H'];4CR[$2CN`%O_%D]H64%!%T+B>^Q4WD]CM&S_$VQF9:L!D
MXM"44P-&5A$R4^_-02#W`V@$<A:9KWC/GCYN]-D*KL1C5XY8)>ZC:]CU4!P%
M*RH$`+U*NR%U>0/CQL1*6%B=FIP<3UG$^TB*YPBC;E!3;OVG0FC?17B.7P>6
MYMUEUR0&R2'6=@[`E[)$09T;B;3I-?]VCNX)!P#`(B$J`Q)0PRQUAH-X9AP,
M6:A*;I^;',NV;Y=*<IQ$!7!V@WLU4W]*S.Q@`C@Z]_PF*XD''S_%7>(QQUBP
M`W+N5VJVFX`AC>C)7'N&X/(F!_R,<=BH'CT._IC4%_F*TQCK$5)K0!VMC:`E
M[?I=",L@"*TIQ`C=9;7($)<D<N#@RW82(6!$8V_HTAOR]4;[&W@]``AYH08`
M0&\$SXM40`-5)H;C^4)$0*(?V8*]C;^<A-0QB*)Z#_:YAMHYP`*TE[MWD[MM
M-`'(;4L@2[<'1I`81VSHZ8)@H6:RS$%_^U=#0-5U!"H_3P<H6JJ<A17?H_=D
MA`(4)8GDX\GFE4,Y1(#/UO*YR1<M@)Q\FXL'UJM,&"NU#FXH1`7Y<,I0WF.-
M!43,C9^H1C12A.M%4W/Y,4C6^^54U$)XA8;H45AL-7%`1$`IQKTZX5M@*:YT
M:Z]2BTAP^4"$LU9\_AY*/$BN4I!R["1O:$I\:)?)'GJ2/0R^MP0KIE36',#0
ME`:VU)"+%G?-@,QZOM0A?AN$[GA@M7MY6R0`I`1&[.6O%9I7Z@O+T0^:^-#?
M,<OUZ3+B2,H$"`\9E<Y^\V`'0]SJ?H`=&T96Q5L:CNC'9)Q%-$#[<61]0,1B
M.F/!\,FYC@0'9%PF*C=2Z,9%?0"S]!X$.?KM._JO;!&O9`:V",PC`3^*X;Y8
M_8;GW&,`.#KC*PG&&NXC\4;PJQ6O/.G2^\86#8M.!/\CQ4>[\,K<?.UD0.IP
M2@62&#UN1)&$PVV6D_U)X,L'',#2^;'2ED=1V=")=VL%!0`''3M,Z82Y_O`C
M0$SX,/##A@,0*@``(&'``P`&%#CH0)#B!`09*#B@^$&"!0`4-@[L$`'``PD.
M&D"@X`$#`@82/ER8P*```044.$0@H#%D!P<+,(3\H*&!@`H$/<!TP&##!@D5
M*$P4.I5@!PL</G3`&@%"@:Y'"S"8B`'``JH?,@0`H&!C!@(>"'#HH%!A@*`;
M/7"DNW#J!@8?#BCTH"%`7J$<Z`80(&``X\4*&U``^8'"W@!J%0I0NQEK5@0"
MZKIL8&"O68H$]J9.G4!H0KH/IG8`;7GV7@@A.4A0H+KNS0\8&#0X@/E`9,,9
M-")0F.%L<^?/H>--(#5Z=>O7SW;(8)@@!PL6_C9B>-"A0P,$0BDP0!#@@0;L
M[^$?YOX\,-N0,^/'OW#A`X<-N3'80";S!M@K*`DVB$D`"<B"0(,$%`**@_G0
MBL`"]SX`2J0+&""``-PF\#`!!$@<$8$$%!,@P?\&RN"!!`H`H(`*.AO(@PH2
MD(#"_BA(P`'F"+K`J0,ZF&"!"#AXX*[J/$#`PP,LO.H#"#HPJ0*8/O!@`04&
M:&Z#!HZJB"G69*OM``P)HL""VDJ:J@*-2`*@`P58HTJA"%BDJ,@[D:KO`@TT
MV`^##C;((%`@.X!`(04"I`B#"P)KDR`(`8#@@D<O%72_"H#<R(&Z(JR1H@(_
MVF^[3"_XM"Q'U1(@_@%+#ZB@@@L>0`V`!JC[-``&$C!@`0H"U:@!``2@+K]C
MH\,1V669O<"`!!(DZ($"##A@/@8&,(!"#2QH0`$%&I@`36;))=<#T,+<B($E
MRW7.`U$UZ,"#"`C:0#.%(,"@LQ,'(F"B81W80`$!"L#3@WDY&)2@"6[+H(`#
M,F"8H@T<**`!=FU,&("9"*A,``0<P,#@#"I8@(`&(K@`@@4@Z)0B"P:(@,(.
M+@`M@&=%O0ZY+#&00#D&*(AV*&HA:&"SZSB(*P*0/-@-@=T>FF\N`!`@K=*I
M&'#O@@@%X(^J`0(8=Z-A/VQQ4>@XB/%JH3K```.!",)`K1V=VP"U!"K`_HS>
MD"(E"$N*%E`HR`(+$+KL%CT,X.]6"=*`)@0$F@"`+IDUMEV"'$CW\LVIBN``
M!0S(N3\'0,-X(PXN@)&!"2SGW/6"A'9N:P%<EI;NU\\ZF"`&`HB8I@`&N*`#
M`PKXP`("#.T@`*DXH&"WF@"(O;^#"-@`V@?`ZP^"`!"0?J`-*L@7``X"5\@`
M"H@G(%;#.L!1H01$K[*!V@>JC*XS\V.@]@PB^`Q*]S@P@0<\P"D!>(ZQ,*`M
M`O#'`P5B``=(];</1`!L%HC3;4*R`0/4CRY[FXH&`!"`/UWH0A/1@&O^MH'-
M,``"#X!`U0Q@'FK5B`(QNID!6@8HL5&$,`!@_J$+6PB!HAG``'#3$VKL8X$8
MV6<C,1H`>:!8%0X!X``#21H`WD*1.FU$`]RQ800F("L-/(![&2!-%9?%`2:Z
MCDJXPUV"*H"``9XO9Q18P`3HUYT*"(``$/!>=43GQK-@+SI;FTQ($N`UW%!@
M.X(,20//X[<'&`!L*E).A`Q($0H@P`+H,P`"\&2C__5'2Q-QBP%TA)LBP22!
M'[!:9@R0`0$%X``/J,!$.J`!"@3`@UF!F<QZ4A0LNNIVU>E>7U16-9QHTCG#
MHR&5"I,EU#1@2G7I3`;,AQ:%2)`@X>/@VJBR-=X,0&T?R9=(V(1%(JZS0**Z
M$1$Q$QKL68XLO)D<_M@`P!.D3.`R:)*`0HQ(D/(-@*`$(%@!H`>`"$C%?OH<
MB`"<$RE[TJ58:8RDZQ[DR,M="C`<6)<5`T!-Z&B@8@$@@`5:9YT+%$^CS?%`
MT*(S+,UI\78%X-(!'.``"`22<]O+GA6SU)0KV>J,-J)``W!5%0H\`&0-*!!L
M"+)3"03``3O*"0(.J=-ZJL]6Q"*50@9P,@UL8`"=FD`#'C`9#S#'`[0B:@>F
M<ZP-8)"'!G!/!]3$OP<LX`$.F(#I#D.1D$EN;Z0YCY;P]8$*$(X_P^/+4#``
MI`1@*`,%*J85%Y6R"H@+?)=\P(1$\M2F=/%T&S`,!S@0KX%<(`,2@$`$_K9$
M&@($E`*@`=0&QHI;K33%<I*;'`1RZM=A&65LB^I0<!X0`0=8+5WU-(U(#D<1
MT`Z$=RK*[5AIU:/E+&NMN,O``GB*FY9.A3D:6&AE(K"T(L;-.=Z9)`$8(*24
M8B>\XZT*="RP7(=21*1"812AR!(KC3X`C6>!0($L$("CQ+$`.RQ(`I(KG(9$
MBYP/%$H&!`"!^1"`I`180%X(%0&CV=,`#QA`7M2H`.;4""I=A0P&*IH?Y0H%
MJIX3`)JJ%*,$8"L!EQ6H*STH.9XD!6Q0&\!DL/E8J#&(I1\8L8\1`X"?;B1.
M:()+`:#J'-)QCRHO'8[0?.MCBNPQA`<X``+._JQ<F\5N6``0"5X6`+8PP958
M/_7`^%Y6``'42%$0W4B5*!-"!]MWI(I)@`**<P!*%F`!-B4`01DS@%C]T748
M$`Y$&Z1"8A$@`@68$"414(#]#J0"#&`,DN9+Z,U-()7.:<!<_]@\JLQI(AQ`
MHP;.0S,QQ\=IP?F.Z!0%@(0PH$/`#$D</>B!3WZ,-+VLB@(D,%V"5(_#;/-9
M/$T]$Y!,8&E2>0H',B!,A1P@@"++8GX20#\.'&4#9L$A!A2`@+R\JX8&S3)5
M,L`6`61/-E3K3CPE]1O08(D!BRK92+H*985,F2+B_"D'%M/CYR0Y``RGB%L`
ML"15[3HKMAJU7K!(_ITVM_:0]5++<SU0<%ZB>(.-(TT`:C1<"EV`7O\$0![I
MJX!4+\MZ`+<,9@I`HA/9+*ZOPVMD=L.<#@S`+"Z,D<\*D(`#4$`""))NZ@`P
MV9VK>G,KVW76N!FWL%<$/*D:2*W0<N/&?#P_';#W62%T`(:C!@$)B>$?'093
MP<HE<`98BH,(HI-6\Y!866=`!0!+LPDH@`#%TY#N&I?RDFQ`S^WY`-`$G)^D
M">4I'W@`-7&88'E3)*T<0(`BIR)`#?AKM73IE&NB)JUMDCHQA;^?<\K7WXV(
MTXB:GMP"&`!\`B0`18OY"W7IDH`&H'0@K%8;`[BSY0"$A:\,V&OP@Q^4_IR`
M-9!34RA!2$6!4(;G;`0QHT((8$MY6^!-,1(`]*V(&IBW!38D61YW.7XL*.Z?
M/!Z`XGR$R*FV3O\:8,=,"]JR@@$.8`$0X-4@QR_.B8>ZY68:8-#*)4^X[CHN
M0`'>92HD(*"JHI86@#4XJ3^<!"T>X`+@2\K*A2R,;2C>J^XT`,-\B$3HIGDN
M@&YTZJ4VR`,F(`$&('.L[W;Z!_;J(@4[HBUN18TV@I7RAEN<I^@RQ`,R*3\J
M"V\TH$80P#T:D`,,H"D&@%TZ`(WRK>0&0K4^`*N^120D@%<4('8@X%MBI[44
MP,Y4IO$8XW,JT#GB"`&%PB#0#$-ZY&D.`*$0_HJ<#)'1>`@"$L!6+J-5$(J;
M'L<0^0C]#LIB/L`0ZVXJ4JXF!@`KO/`S\NO""`8`4`^O0JWV&B\L1*4#"J`Q
M0H+F/J!BJ(7GV"X#%>LWMHA<K*("DL(G#&4@,.!#0`@!P$;>(&]BX&T`(&<`
M<9%SRN,Y+"`IGFLCWI`J*,"//H`UE"VL+D\#%(`!/.*14BO_U&4O#&!IJJ)D
M4F.'/.!3&F!'7JJ/5*B7[$8!"B``)HL[+,``4(,"OHH"MN;1%*(`6BU20LI&
M;J2<J(9JV"7?,N"B\L,#&/$R,HRCC$?/BN=31$5B"`)*-@+P-,``9`-+>@99
M\.H#/-*1Y-$Y%&8B_BZ+0N;#'!\).Q;+<CJFD6P$.BY`@B0`];HC`GSQ&?.#
MLVXQ/M;BT*9#N[S&+":`<NCFI<A)(H@R`T?B.7"+``#K`YZHR^8#J2@`>0Q`
M;DS*%XUE/6[E/0PK`@*``4TJ`4(I+TZH$6<2`@1``1S,C$R,)J+'J/9-)$S"
M51A1Y\PH`X)/TE12A`JB`IPJZYA+`H;/&%4C`%0L)"2`*^YM64;"`&[&0>8%
M?W)J(R8@H$8RCRQ`?.J+OO;F**NR-9>E+8DO-DN$^$8P-FU3ZH9/-JGH-BD%
MG%RS.@3R`B2262S$`V(%422.03;`XH:"$6\%*'^SI9SB.73L@W8Q)`9&_HZ,
MA5.@)`6I:6L0X"=_(RET+SJNJ%<.R0(D8`$^9@"R9_R:#R+RJ`)`ASEL[L.J
M1-)$QP/T3-(:$?XN#R14XG2B)"P<AS<.8`*8<R`60&!FBEPXH"L8HP$N`"L6
M8*8L3[J2*B0I8`*TI5PBX"[&(SI)E%EVI0&(#46);46)CU>"`_N(3<1BM`(\
M1$55=#;,L$3/0B`CX/CBXY9.1R,88H&JKBNG(G42X/TF`#IU5)#<QET"XT&M
M*+Q<A.:^Q9:$!,44--QX1#TBR:/&SCD*3MB$XAV?Q5?8LC,L@`$!RRDB0BIZ
M2",^R73:*F6L:$T4,+(6*`TI*T'@(AYQQ',R_J-`$F`"+BL#J@C/<.<"[`C-
M4D9H*%(H+*#N,`!0Y`+Z%F!!FZ-].!%_)@CGFA0[?&8!&<09+P?>R,4O,B@!
M<C14:2QBKK,ZP&=*@#+ET(*O*`9R*,0[1B2&)B`U795SQ,\E0V@K$8(J*K,"
MT@L#,J):(B`#F$<H5JH\HR,P/JY)-*Q%DLL#!.8```O<ULM1TO'F4LJ,*A,I
M_$Y&U`)*J(BW\D*%<`6IP(I*?/!5*I0J)&!^W*RE7(3N=@H#]HM_#N`QZH(`
MN&?^KL,'IP+&&"HS@Q4[S@<#&--#',`"(D:C+&"-CL560X):'W9L"L5A75(@
MDL8","!6N<WZD*D!_L("CS[6OM9J*)M#<DYL*D)F*I*F*8#'H"AT!J?%P\1E
M6_Z2OJ8O@^CECP!2`E)*C9PM2QQ@1&[ND3HM'MO"6U=BN1X`:B*D4LM'?3S`
M1[)U80;F[D)B72J@P,8K8A!*`"H04-Z$Z20@7HY$KR;)1YG%(@AB4E_V/?+M
M=+*6,2J`M'`G8\L%!`>"<O:V8R_``D0V)`#%`RZ$K/J#,:R'0C8``=H(*73)
MU+P"6!.76=SI2K1L5::B00&KE2BOQR)&.1X&6):+8`AI(`Z,`*1T=,MS`@1`
M9!/E`/".2W;D0:C(UF:J`OR.;@1O(,;2\^Q)P5SK7!ZF\=(16H?"`FC"_J96
M8B"H"6]P<0R?LC1J1(U,M<L,E2K0*DCL]G.?0W0I`G*S\'4-@%->AS[+99DV
M`G'1=R`")@(:UU$(IFH6HFMJ2Q\%`(^F\8-,1A^EY'X%B6,5*P/HBBH"IW8%
M9@-:-:U$`@'N0@-8IH56`B><1]0D(`-0:U:PXP&(JT6J!CJ3(BQ:!Z]*#+"P
MI:HH(\MRXD)W9"1F1`(@[!/3D*HT`#))A4@5P,3B$#4$('`&H%3[@X@(((88
M`"_WU2H;@'P:5(".K.'@)R0PX(%GEM*:1FC$0X&A0SS'[!7Y(P,BADNP3%]H
M4AHU]EB>-23\3(SAI'$%!F\.PK'P,:3"$@(H_BF$"N?/T&<`5H?2Q'AS9*E>
M',=+0HH(PQ0P8B>2=#)CGM(!\(1#XN(]NE'I.H1)M_$:\:(K,I>+SH<Z4-6C
MPG!':)0`UB-$T,\J,KE(_&_U-$`\)(<ILL([1DQ&)`U^_8]_N(5,,Q`#J&62
M6Z<?+2<9?[0:A_60FT-F;:2J7FAZ$&)U@(,Q.,DP&"D_Y/<L<.NVT`*WW"93
M0G1QSY4BJE"!S6*IIH*`_B,%LX01-8!HJ,G__(,[$B5;_$A>G%FC.O![K*(Y
MMJ<:-R*Y/JAX[$8<.4F%F/4EA,1X%D`"(DZ%+'!F%6)U^JAU'@0!4HIX(U"+
MBXA"7"+J%O1=<@.*_LW'+Z)68;.BK"@C'ZN&4;H#.7H3>!:`.GSP``9``?Z$
MT/Y)4WDH5G*P7#)'DSRYGPN"B[4D1&!C`B"&>XXO82#`H,JNHMUX83LI'Q^Q
M0"YCHJ)V(Z+K?LU"?R_./3\`+P?"M88B+&]I&ELG0AL`OM`0J5MJ2;#GD4EM
M0:C"H*55`"@`*F+$6D($=:3.WP2*YO`J?#V%+O8T)"C@(.B4`0U94>PB),(S
MI1Z$.])*G.I"+<X710;6FF[$=%+K1=1F,0B`0:Q(APE*3=J8USSVXDJ-(&4$
M>YAO(BL[\`RYGS>@:2E/,?WXG\).V3PW?=]X(`;6'UGH`T>SN2V@N27@_J^/
M))G#&GWYPW/\8SH\`GE8=4J<ZB08Q`(CH%!9AZX)[=[`D2IRPK=JUPOGBP-@
MI"RBHOD""@-^*J+3&J]SYY/$42ZMQ488CSDKP&)X2@$)BFH.3"`,,XF%8KG"
MEC^W&%_\;[R)90'XXWDZP.9"*)'^,%K>I<V2E&K2Y:44`'@"QHUL#6<'_#):
M%%K#!T5"***+NS7"NFDWMMJJDGK'90/$0Y]NNC*XJ5N8A7"%`I6Z`OC>9`$6
MH`%^15:<W,D=C*!/AULS.%`JH%!XO&UDQ6O8#_%D91H-Y5(DECLD-@/VP_R>
M_,LU0(@6P`&J[DWD33EH)XD1M8488(.6BSU9_C!NO%RBUU7);4E6F/Q(PH@Q
M947\4L)(E#QS(MK)L['1A#+-9>6U9&5U^.K0(8!AKN2O-]W)BR9\(MV69OQR
M,C6,C6?GS"S&0L*,-M5MF,HF+O0PQ)$@+N(]"",=9UIV#?*M@\/!/$H<B_C$
MO.45960!-V*37G`H)BNQ]*1DN$0ASD-5)L`I#'8`M+?+`H4!Z2+HQC<FTL/,
M0G1A7YLB"L"(\F*3^*@.I7>M=(]32H8SAR]HS%$=S>^X)[)V56WH'N;5<H-U
MH(W)\\)(K-&JJZ-OBYP\+@`J_GKA%QXJ''Z3WK@#I'Q4GD;)%6!++O[BE7P$
M;6H$(6)+0#[>N$?C_C4>Y-,KXRU^2R(`Y;=$)3+B)\)%V>PHN9*C$)?+H&Y#
MF27'IA0TLKC%8A_>X1>WX8D^Z(M>,A3>Z),>Z1O>S1^>X9<>*BR66:'BDY[Q
M+I1Y]\#+W@MBZZQG'1W`0^X(2"3`8N2E9>S7.H+MD((B+#_+<1GO6Q=@ZK3$
M`9IG@U@HZIBN+;O)27:$GZSF?/^LU"1*<U)%,>B$M+Z6T7Q1LS$#;!9@DDN&
MEAX@&9,D/U;O8/(M1M(1FG%V7%XJSM3B:0JX.2)?B[@862"W-3-JW5;\9!(D
M@0:@9#0@\\ZPR9"%R$."AZUC5KEHXD4"^$LT"VE4@\CB78Y"8HVEK?RX_B0B
M8P(ZE.J@?_JC'_J%J/JQ'_I/9:TZU+ZU'R.F7Y<B"W6855P8E?JG__RC7R8D
M=MTFQ/^&0O!;BB+O`F^QQE"&4[IBIZ>?PXY``R`02+@`P4``#!0J(/C`L*'#
MAQ`9'``@H>&%!0,X0/Q0H8"##1LM%(``,L*#"Q<^),B``,""AA0.?/!`H0"%
M#ALQ0.!@00&`"!4\;&S8H0```D,O-&AI(,$%#QLL.!A@@($'H1\R1"@0``"`
M`@D$"O4@%4&!!1,P8!W*]N$"``D$"&```4/;AQI2;LQ`@<$```@20-"`\P,'
MNQD80G!XH8#&NY`ATHQ,N7+;"@8>\F0@X,"$_@Y"'0!^6+!M`[N5*RC8R$&`
MQ@X=)ASNP`%V[0R?:W/0P`!BAI=#-1C0H-LV;8:@&6(5FMQ#;:S&:4O/D.$"
M;.F%L6/7H`!#!PNP/VP`T'4#`0V)-WI0"GA"4P;PXS-X`!_!@`0,,#)(8$"N
M_/]^F95``@<44``!`B`@UX(,RK5``8$I*-\!!R2@@``+P%>`7`<P0``!#/0G
M0``#)F#9B90YT-`&%#PFV7`85#34!!4X9(%>E'5000,?/B!!!A;T)".*']A7
M`$XT#<``:@YU\,``$4A&@0(,4,!0!A!X($$!#<@%@`)8:8#``0\@@("+#7E0
M05P6-&3!`0,4(`$&_F@ZE`!<3:9G44$!$`!!!;1MH($%".Q4V`82\-@5``,(
M]-@&#O!(0`0<U%F9>0V@9.E=E*[%%I8)#!!`H^XQL,$!0D7)$`<)5*`BD6UY
M\"JL;*GI*64\3N"0!XFMYP`!'B647$,,S+K1!H5EH`%D%@#W4`<"6/"D5P$$
M,&*UUUY;;;47@-F0!LY"Q,&BU7I%7H)Q-85`4P0>(`"$?P%@@)FB;JNMO018
MVZ>%`X@Z0+;_6LOA!Q,0(!H&($'4P08-'%#H!1H]0.O$%)\H@042K%;QQ$Q.
M@`"3SUHUV%`>++#LQAYH0,&O_26,H@1>1=`!!A$`H&>:$A`@06%$89``_EI8
M11"`!1I=`*@%`UAP%002;)#`CY*M2<$&$!"`0`3>71D!RQ&`UQ`&U;H\$\^:
M83!!`@8V$,%3&E00P01=-\2!:OEZ9<`#GS&T000%DEF;90]\B;78D3FY*<D:
MF`TG`0=`L/4!-7)P@)4;*[Q8Y;O>G".@9&LPP`885*C!!AFX7<#=&PC5P*VU
MDCV4!+U)E@"K#V"`\`8;<(![[KL+"GH!I#L$+EL<.'`!!N@ECK#NO!]VN_(8
M7$!=!M%G@/OHN%-P`>^Y,X^[LD+Y[,$##^!4*6W%<T1`G+>R&")=)RNG*N;T
M5]Z1684[0#0'4+%.Y-R/X4`#"$<4[/GO`QH@_L`!&3*!-IWH`@[0%:Q\`H`+
M6*`W,MN5QQ(0/[DI``$27)'/!&"`TUR%`@;0B0`F\`#\/,0#&%#``7#$@945
M8`!X2]T'.K`U8%4@=2T!'HHX,`$&<,4`%%@6I(R'`*5]ZP$38922)N"RE7UH
M`1+0P`*)$A=S.4`ME+$@K6"X)0%0ZTU#JI_>U$@K#EQN5P_P`'P<0($W.0"&
M#DA``$ZW$`],8(N5Z<E&.K":*IUH=IJ9'T2BPL8FN6Y5<_N9BB3P,1@VI`&%
MD=@$")(9AA!$`000#`%GTLE&FM(R&OB9`"*3`6J1\"A5X8\!9CE+"S6@(`90
M``1VR<O'!*5&,QFE_MZJ=:2A=,!8&[G8B3*@,5I14$;6^1HA!1`!UF%``&]\
MR-1P$\0(G`P#_0E2`'C&`2AV,$T3*.-7'I`P7D7@0UZ1T\0V4#!Y,8U_4])`
M-=.$)020JRH9&`N6'/"N`@"S+:0KTU]`5(%S^L:!%,N`4;SRN5-:]$05H)Q#
M.&`J`@B*1^[B&:)TF94"`)(R$&@`:S+"`$5"A@/%W!7('F(!C5X49P/(U0<D
M)H$(#$!,"?-0`3"`E`A09P`5D(`!CH),B%SPIE"=40`BD$VV3,`K"B"?5C5D
M`+A)@`):?0`$Q$I6!YPE/0J(GP=<ZI#QD(<")\5<!QR*2FLMX#$.T%.!_EJD
ML`<08*972@`!](0ESA!`E\29B0(<6`$"+(!U'H!``52UFPB@32!9;<!1$)*`
M!D`45BF#@%]("%>&8.!!M5..H-YIKE!:X&0\N5!5V_*=!W0E``9PP$&?A;E3
M#>9P40WN32""MQU]8"MWC"->4`/<$S&@F6TU0`<8$,+(;&``KKN``.CZ`<^2
MAKN5Z\`!&K`LR^;G`Q+8XX@25``+(,\#)IH`!*X:`,\0!C+D"ZY^&5BAIJIG
MLG&UC.Y0(X$$?+:M7B'`4IKZ`)ON=R@6`,`!F,2`976@`1*PU'0+0,5%,@`!
M@-H52!Y0`?E:C0$7X)L##K``,&J33)HS[0#<_N42G[S+/D<)90.4JS?P#O("
M,0FE`BJR@0I<8`(+R"MR$,*W1>5R)SO=+64.(U^C@`A-'`C7Q(HHS`=#U0-7
M+"U#,-G`#Q`T,:M[B`)B3+$&5%=N)C+DI;`K/"H5P*$=>"Q>`ER9"&0Q`=Z)
MDV[!3(&_XD=-)0X2SR:PX@,9@,UL.4"7@UM@`WSH0TVIT(<<%I@2K4LP;8E`
M!!H0.\@,QZ)U.:!FB\F;6]WM,@Y^J8\CXY,`Z`ET!,#1KBJ`14NQ*@!Y>Z&K
M-$H;V'6%`$Y\R`42\``V<Z<`%^".M0[TX0(!@"2)FE>&/Q`B*)W(.=(RP``4
ML+:%00`!H9R`GC@@_H&J>84!K>&S>BH0N`$XH#`>>"2L)"`Q+_N;HU05MY)0
MHP$!*&`!!YB;`3PE.372Y5BHDC-ES/,0SWC@`&RU[$7-JB#&,>P`R/X``=@-
M`64I3"D\4BH&)!Z9":C4WPZ)P)![*CT)V)Q.NZ$`%6VN\PB<ERVP\SEE$#!I
MBWJ`@@M(+99<A``?C^Y$?J585U:IM_5E\(6"C?5QYZ+#%RZ`1[HV+0'^N!$4
M:KT#$"`33@9C-KX()4@)H`!?G2,J`?R5`/JFC',H20`#8&V'$&Q5R=,D0`"8
M,8UW(4O0;]20L`Q-C>8I.LP;B2SE4.#<`DC`9S)ZX88AGM<.USJKN*UU_N)Y
MU"()$$H"SSGDBR(`)PRHP'A-HJIH!\<"2V4`)8MDM@!(_I*`]?)`'O(`#&UI
M`!G8#S(IH.6'&*^SE*FP1>^K'@(8?D`!0,"4"I">L$,D`;_?E;PAHH&N`$=+
M8L:+O2&[%6$2%?PVH^E5-M(8'N.E*O%[20=TK<,(>T9:BV(NS28\\R5OL;$`
M(S)#>E,U"Q`!.B0!2$8MVE<KO%8M`R)#$H8H[;80;.0`;#5Y%V4RDF$!82$8
M%K`!].$Z#_"!%+,`6N<T'V`3EK$!`I`PK0%1'M@D'!:"0K%)&``6,-,?C_0=
M!Y!]#(`3';`0:Q8XX4<H(-@0F[11F+0`!J,:_@)@/`\!>FS1=/1!&:=V2BNW
M*11`'NF1;PC1``/0=P+@?;NR7TH%`!6``0U``:X!$4JE`-[G-&*Q$7Z%`15@
M`1-`9SOD``L``8_D-"OQ2!*%?.C%'"_!`?LD+A?P7'I$4>;"*`;`8E7B&422
M,ACP)`B@6[21.(28:S-$%C*7AHM%%.R$.[=R3.,"3E*&.5GVA%$U70O$`=3Q
M`/V!`*8"'7A7/Q9@<*P19XAW%QL0`"?C([MRA*LR5.-')!+P6"<A'JE'/6HE
MAW#R`%JT*S(Q0[PX90/`AL)WC,5S)A?&`#R")F#5%@KD79%!=/NU,$5Q%'GG
M.0#0;^KQ8&]!+2H"_E@*T`"6HB9CQQJ_TF\@L0$OP2N/QAI^<6"F=4-Z@@`]
MV!L3D%5Y9R,58$:7&``+H$<"@$,G4S+--13TUA48QS\LH5E^,G]S@X9P02#>
MPAIQB"H59$H!8(M0!8ALT1APN"H>@UMKMI$9220;,%%(\1`P*$]S5A@SV1!N
MPQ`.X%^-Q#A)HQX,LTZ0Y@$J=0`9T"4ER1":IY/HY6!RM`$*H(LR0A(.00''
MZ!!XMV,[5"D+U)"GM']*>8+_\I8-,1%=I6^0\T#1N%%=40!+LA%I-Q0<8#6C
MA`$(L%A8H1&0DP'BQH9TR``Q%EE^PC-:PA#:<UQ=`5UWD0&P8WT?XTD._F!$
M<)4R;H(WD'8LT[A''0)6Y20GGH45!,$9]Z%U%X,1E#28E+$`X4>6M'*80\%!
MKJ(92&::]%,!`>@2G@*#2&09[Z08;.4!P&,>15D_Y>2,35)H7P*1+P0F7AF.
MD,%KP-E(+MB,%?$`!]<`"G`V9..6;2&<<",:UX(`W`@17WB7CW1-1P$!PP41
MF3(!9,(Z&;"=$#%A$U,!/S%*TV4`L[@>#0A9%0`EGE(1!Z```\"6$%$P;S83
MO'8`YU1B6I(W*85;-A>6*P([)40G!`,!C.*+>M%9HV)4?Q,99.$E`I$>*V<F
M-'0!5;$1%9::?T&1ZLFBQ`DK'6`B;+$`&7``_GQYE`I:&>D%``[@BPGF(J-G
MG)11:(8QC@S1C0P!.T\#<R,%+%$(&>*%G1E@G@CU4\0)`?SW+U;Q7'(X`%J6
M$&T!)IOT3D@H<P10/@[1GXWD8KO2=^TQ:KHTH#H"$T]3I:>$;I.E;*06HN/#
M;#&F`:0V0))Q`1@'6!V0?)@$$9/H`-M&?`GR%S-F>"XA`;^29$855P31`$UQ
MB10%'WOTG/;F7B7)45F64A22`)W24.("$=>$81PQ'Q3RF,FV,0XP:TM**T4A
M&T/Q&_&G'C*!.5)AB`Y00^3F(C`8<I61`1YE,)=T4&"F9_N58A)!1Z^I'JG'
M?7Z1D2G3=$M*2?&!_F$FH7M;0SX>*%IS=`!4R1`!X$9PHV60V%GI0:(612E.
M!5>-TQ!OBC88![$QEW"T8@'Q&ADA&8SR$YCB`A^Q]AWDJC!+]989(`!L5CQV
M^4)-:B5-ZA4),AH<D(;QXA'2NF1287VX^K,=B4T00#3)U"+-I!4%<C>SFGC2
M8QUV1QP0E*5TD422RA90-JUJ=`$!TT1HDC@0T'Q0^7)J))Z&L1H/H*2>I&`@
M^P%&HQR-]90W136"93R#F6=NZA/"-%UK.*W3.)4/,)7/U0`5$(>V<V1_.Y5F
M5;`?\!)K(W/JL15:E'H6-;AVZ!UO.3,.8%>[)1)V07:6(9P3,X8<Z)FG_C-*
M2F6H#-%8`A!\.T0FV=H0$?!H;%9\")"9&N`P#D0U\O(D$+N8M8$!!$4>!@"E
M?-81&V(@79&:&W*)'$FS[=5!:<D!WC<S#<`5ADDT9),[XF&@LG(`KA-A-P1+
M(T,DI8:UF(.=M/&F-^1W(,$!9O*:#$"V%1._&Z$!%:$`5?L!$79Z;G(R9M4!
M@P55W?(5`PI:+P$F"F!2@V0A:*M?P^<0!:,`+,,BA_402-86)M*XY?L0E'E-
M#?P_L_@23%,K=+$`!E``Y)88T-(2'<O!`I"_!)J/RI%.9+I181%\(+HIH=.A
MUT0V'*!+`VE$`249$701,L(9`+!C?9<[!*)1_H<!`13D6+/8%H^2;$3T)/U(
M+?QA?;$W$R]!(P@5`?X4`,;R*T:T<OI+0"9\%4%2$.]RMED18+-EOA$E9?H$
M2H:9H+4B1&RTGN17$2QK&:TT4]3!:QQ$,!L,>685`/M9,?!5%#]<2C%GF.GY
M*:Q[(FL:<S\,5@J">_,)MGVI$A50+&V!-`5P49;4)%G26<62?L@!3%!14PY`
M)083HHGWP1#1$H!&%W^'%YWUK,C1+*D*1TEV`0!00[;&$1EERPHII:9+%SC!
MQX8W$7M4$10@,_C[0H.R%;"T8RT\,K%&92%27Q969!ZBIFD)&2GC-1OE-NBV
M`+A5+!_!$8W";4G6_KZ`N!]]UU)WX21T3#]HH9A%=FY/ICE'9TJF4K\JM7"6
M$3JWD@&]BF\BR)U0[(N;-)SJ#":#52#,`:O/11*57"N5LS8?RHNT<1:+BR9:
M.!0Y&7N!<1="^F"[T0'75FD,"Q-L!D/4]&`=*A=.D1,#\()5\X%.8P`)DY-?
MRQ`+L!"XX\M$BZS=`1T'11XDQJ'+,BD?D%(4&`$(&$\WPF8=L#/Z>Q<DJ&#'
M4W`(8BY8`S%$,LNXPP%+U5JC+&&&@61I*+AC,5T)UL@0D5'_C#D,RK2VFGV,
M]P$Q8DHMEA-1(@#RMM*&+7.`I1!KL1OD%SUAJ12&*1N091>'(2@;=3PH_A$]
M(`&C,P%OOF<4_<(A\_S7F1(2"R%>+_%Z;:FX`/`F40L9\JA?PN%/9=@7Z781
MPK2R<BI@$64SP.8Y8KM#0SO%IV)_+3HICQ%A:)@I%YH80'$`;8(EQQ,2)(&H
M+@8S8#%12E-,IU(XD#)12:PY&B`Q?&%=O`@70$NS=%IYK'1OCP4!7=$?N%I=
M.G*1PVL=HF(NHS*'9"-]?[TQI]P6ZI@F!#$1',:4;&0`;$@S'X`J@$,`VM,L
M/W%`AZP2U8)!B1W7(FPI1R9NK3(4$-!%`8XM_Q+@N#HJ7X(<9Z*,;CD!Z@;#
M.6(7&K`8N*&.L0<I2T)$,S$Z1W8QI361NA8;_NX+`,R7+^Y!-@LPQ0TQJ-#6
M(::6$:>D88'CI#*U'TG,A@TFOR8)RJE1@Q9>%$C%$1[).A>&<?^9>;IV5=0R
M42EQ;P&@`.,1P!`Q%7#[`7#E,]0B+Q4560UQE7JG&I4H`'`\IM_!E^K1Z%T4
MWR0R97%H`#"52RFC`<%K,T$M&:?5O%^A`7:-H?J;W`?>1N3X+9#5`9<'`)=<
M,:"+K%&BP-$'M!@"'PM`)?EA1`KT`;EU58"N(AX@%C2M:SYE3QG92G5DXS=Q
M'7/E[-=!)V@I(\.^F#L)`$<)/,#&`!*V;)V!0P``%7-!(IB95>5'.>RZ*O:A
M/Q:R-Z`6<Z]^'DX!_G*0D0!3>4KT]A`K1^OU^P`6T``?"3]9<6TH4AT4D\`(
MD&;K09D!()"+]`"%:"F,=AH0X4VBLB9>(1L@-G62O"J4M-I-DH;S\10EA'#E
M,WBINZTG8C8M5"W&PS03C2+.P<D_2^8/81(40!WA/J8E`1B0>#*E<S,4Q"_*
M)!KD(2II=>H44Q>T57K/>$K<I]C'91E74?4((7=8G_5N*7="`9E#Y1[;BF((
M!!>3N-08IJ`J`Q$0,)4"Y"=K;ZH21)))B<H%,%Y"(1-%81C<IR84L!##F#$-
M(1HUXT!>-;@TDE&#6V(E)J`V#A22)>4&2X*$(IJ2@;\I9$IS]1":!1@D_B'Q
MGR4M(8GG&%TYK40>$H0!K42B505#!;E((.(I?`J[=21=@F%6F=<5B/>#X$=_
MI[E3:^0!!N$5ZCIR;?2J$R7;&^,V')GJ#]$J#@-7]%2H`%`L7-[W>R2<8.85
M0L$B!O&<YC)>P*STP8FE_+,1"V#SIS43C<3'^JXBVW53&O-%<.,8I)?5%(7R
ME9&32HE>`#`Z&`<0%CX,)#AAPD`/##@`R$#0X4.($24^)`#@PD`&'SH$T$`A
M(\$(```@L`!`P(8/"PZ(1/E!0@$%"Q;$C#E39H($,6':!/!@XH<#'Q)<.(#@
MYP<.03$X.-KTYP0)#Q4`"%"!@8``"3!T\##P_@"'B!D0+'#ZL$/#LA(U!)`@
M\$/"!F@C0.CZ84."`P<?>KA`0`/$!PTN-/"@H8'#"AD<B.SP@`!8A!`(7(3(
M08(!`R@W_-7PP(.$"`/1$FS@-BW!#0H*+.@P0`"`T*>;<JCP`/)1#`PV"%@@
M@("!O!CL^N[0(2(&"@D"B#P,L8,"`LM%3C^`4\)MV=FU;_\P84&``Q$J<"6X
MX*/$!1(Z&!C-/6*!N@\Q@!40WWU3!1?$"@T00,$'!A*`8(#EA,L.@(@X<*``
MXQ#8@#*'&M"K@P0X$,"X^YQ**((!&AI`(P`PN&``X[ABJ@($,$@`0P8\6(PR
M!B"$2(.6(EK`0/0\_E```P0(.&J#`@8R`,,,*R,`QP\&`*`!##&HH+<"'M@/
M/=UDPP""^Q8#8``.+"@@,X<8H."#!@J``#N$%B`I(@8"$(`""402CKP/+M``
M2Q0)HJ"Z]@C2@(`%-M"+@?\LF,`#"F1TZ`*C9$.4``LR,("#Y0@@LLCL.L``
M@]@X:*#-`2#X4J'')NH-@`,8:(O(NS2XDP$#IA/)30$0&`]37#/<P(*K!!C`
M`0P\Z!,B`CSH\E),7>R@@@DLD&"""SJPX"+X<C55)`?AT^"``1,H@+`'QG3T
M/(>D/!/`"?Y[2$*$%%AH6&M%2^"#`ASP0``0MTH``>46_$"#!"008((*_CY0
M8%<`6B)K(@/(?:@"-"EZP`"B@OH)R($<$#=>#;8BR`.JD!W(V0(*8``"12T(
M`((:RZ+1/0X*0```"RAX(-J'.(`JJAD?<.#0B"10Z-\&#`A`,`$,P)*#VQK"
MH`$'3/O8(P?`RD#<0#TP0(.2-M[K@+_2TD"!!_X20`(4P;,OWJ82<H"`!BK8
MH"L.+N#P`)\;C<B"`19@2`()&DC@`0G4[!-P!J)30%,*>E15@I;9EORG#BB`
MX(`#%(`@@[5%T[O(#G26`((&9GY-UND,F'CRG"\0CB\)'GB@`D7+\B"^S2"*
M?=J8'D`.H@C0ZF"!=UDGJ`.Z,K#M($2-0_19_@[&1/3.!AK@``+C@#8X8I`<
MCA!)B!)([H($F/J)@R$_L(`NMON<`(!Y)XK+@@..C`NL"NHSWB'RW@?`@,X-
M9`,+^,W:/)`_>SFG`D)S"^W24X$&+*`"!5A+5HK#M(YU+@,RJQ$%F.*!0V4@
M*!E0ST0&DQ8*#&P@E-I`W[RV/XG$3$G3(8!X"@.6/7F/-$H*`)$ZL"4%#"!*
M%XA8!1*@.L/(B@`0*"$,G3@0Y"D@``:(P'P<$@'S94A:%4$=50B```>$,8P%
M.)U>M".LMQB(`_8Q%D$X("A^$8`!&>!*!T#3G@W$YB&,JA!(UJ8\!V@J`B)#
M"O&@2*HGOF4#B^04_@4B<(%=66"1>:3`)#60F`U40`/V80#X'((!'TE$`06;
M2``N8(`*#$"'#FFA<8`4P`RMD7]%V4SD!M+'@73&`(`2(BS9)AXRB<0GE3%B
M0S;I$!<9P)-V00`D#4`!XS``8&^#GP,4D($=!8`"!/"5U!!R@0*0$C4HN<"8
M.L"DDMG2C<5J6P/>Y*<)_-``ADPD1%3619'\1IH7("+#L(7,-7$@`V4J@(#0
MI+,'%`"?`WCF,>MI/*X=@(P29-I7M"B961&@``0`EE\BX@$,/.```L">=BX@
M`+`$0"`'$`X#C&,!!$P``D:;3@`V"H$),`!S!+#80/*$$*T`I6AZ"\!O_C!S
M5)4<5:E*59)>K,*!4#KQ`?W9:,DTJM$"V+2J,L-J50&`I?+\I`+JLI$W'X*O
M0`[N1T'"""$SU(`:@;,G%""@ZI!D5J1HP`!D?:('%#J`8?*O9)1Y`)&(LJ*(
M/""H'Z#`1H6F)`$P(%0%2-2-_/.__SUD@_0L%P5VV9`#%(QV1]G141)"@/9`
M0`,=>-/0'OJ0.RD6G],I@#H',K.OPC9^QQM0#54+$=S.%E`W>ZWQ-C`Q`;S&
MET[I`#6S,DJ'4"J`%K!:11`0MM-4```'2>X&4@2443[`)#<3[XX*()>7\.R3
M`!0-`.R%`!?U=(F)T<`$,J`?^F9``\J#P`/Z_DL[,#&VDP-8KK4<`,F)M`Q>
MCG2(NR:2`3-"9&&FVMY0?A15"118-AD0R`$)@@$)!,!`RW(``R(0`0HD1B(=
M@.]#66R`YCCD(`Y%2K2\$X`(K`UY#(BG!L(X@4DF14H84(`&.KFO`1S``A$0
M@&UXNP`](O,!#!#I?@'0D>T>Q8-NC5[#D`7-."$``<0M[EX@4&*%SHJVXHSN
M#!7E@0/4+G0>/(`!-%87"Y18.;)Z#4D7,#@4EWER&\!`A,]'@0DXT@$GCD!%
MYJE>_@4@@`A&`$81P+V?1,#$'^"H2NP[%04HP**W[`JOJA8N#J@).RJJ2P0^
M]0$#)""RQP,,\;!H_H&EN)8T+?'(6FS+MJKEK(ET[0K`#M"G"T#Z9AG`0,V8
MC0$.NX[0A48T!7!]`+<.Y#&9,8"A(8*Q@?`S5R+L,$$>D+2/5L`!!!HELK#X
MVM2@BB`.:$"4/S8`#51Q;@_A&U@_\`"#.,;.UA2@F!=P@0!,H`'"@8"_`>:D
MB&R@`6#[``DKK@`/!""P.1-1@_`*U6-WK@!)J8@#IFP]04/$`P_:49T%X&#`
MY+-SH/G)R@V3@`$(YG42EVCJW/B:>DDIY7UU4@.XB;HT`X`"OMQ(`*'R`:.`
M$@"0=DIU4%L`#,1*5G7;;0>BJCX)B&\@]?ZD>L$#P$MOVH2"43(!#A;G_G5A
M**>M?&*PHWND@42@6NK;+4$N$.$X`0=S@Q^\``A_^`'4SB$%$-AKJ/YMMJH/
MC%"CO`,0L,OJT5OSE'<U^Y#I`>35969\!0S@5'+@EBCYM1`0B5XP,``)8-<A
M&2!P1!KS79!`40$1D(`4$]``[$J=1"F)S9]<"I$,),X!`B@8Q/WK`0E*1+P`
M6(`'+-#W%8YYTM3WS85N"YD+0"`"F.[K7SS`H5J9]4D4\$_$-UYSG36`H8^$
M8N!B-0#Q84`ZM+T9^8>N1?\!`),!',"Y``\0$%/ZB9((H$I*"2BZO&S[-IQ"
ME2U!@%`A@"?!J0+@)Z8AL#R3@##BC0:@``6(_K$/`"6"P0L)R`O>^**?R#HQ
M^8``R`A)BKN!R*D,0*FZBYA.(@BRDH!200SU.D#.D8@,V#<;.1\`&`_ONHV.
M^;:H6@H"G$(JC)TJ)$!8&AKVZY%ID;X/\X[D2@"&>*T&$`G]&A!O^Y<>H8`B
M&H`BXY^#P2FTZ)+K(P""T8W"P)``V``%$0#9(XC[:@N-N"V!>"2)8QAIT;L-
MN++9.P`3?(@4XX@R-`"[6)@?PCF6$C3#F)L(4`!*C`A@R4'N<9'LL#X&^))Z
M,[\)L$"JF"VJ&!QX^;_M6!"@HZ/INB__RP``""`,0`G]J3C&$QM^,8!*ZPKG
M08H,N)[+<R`CBX`$_EB`CI"=O6J9I$"``DB\.K&`HK&["<`7Y`N`E/*1A7N(
MXQ,P(DLDNPN3$>,K$5F7(?P<B(`Q"IN(IR$(?U.D;],;#=N.-JH3"-`IR5B-
M&A2-]TLC[]A':]$ND:BSQ7&.B:L`#QC!Z%*`!#"K=+$S(L&I%3H[!&@`E.D*
M8^D(6TJ*3$2*@[BOB@N-!BC(%<)&#:B^`8D)#]J[B(/&H%A!'"J^_SB_P]B`
M>ZP[!X"`_`&`5;HT$)R(5=(0.\*<00+)ZSF``>`I+NJB*8*`8)%%[<@-D>B;
M/]0.Z0J::&FQBLN*II"6THDI7UHD5UE+5^%#&G$5IN&*M>3#CS$@9%(4_FB#
M@%!+H?#`Q@B1.\*9,!A"N8?PC('`@!%R``V('4B$-,&$"(.8"-+3K-#H`/)I
MBN,RM[AA2[84D0K``+:$C`YXF8B(J5O*K+?X%PCPE6L*%XDHBM?B@*N@F8^2
M+#V*CX10J8C8%F^KR*00B0^RO@;P#P((PNA*@!9QB.BC.9DRF%7R+Z8PS0\X
MDZE@1`I8IB>1I'LQ``N`/K<0KXQ("J_[2<D9GKKP`/BBJ26Q/03H@`/XM<<L
M1:=)B6)IB?.4S?VCBKJ9@%'I2JR4B`U@`&&BDPQ9P(B0FZ\$D?C\&`N`#FDJ
M,`QHQ>4`CXHH*F)<C9C`B@!``)?#J["P-PR(_C[D0(D42TW2@`R/&"MTC!@<
MX8#8B`"9<+=W?`H/=4!Z7+Z1>+QO"RP[<H"9,`F:F(D@C0EO.:+?8(T#=:7E
M^$2S6$7W2I2U63?%^PD*>*$,Z<4/0X`W_+"NZ$:80Z8RU*%:L1SX0`O0`R&9
M<#LVVZ9'!!!$F12#H9$!\%!VTIJP@8"<X!&4``XV6:V&<`"C60EIV@`,7*'J
MX9*/XA@]48BL6I)ETK\@(K\%/0T*,%,[8:P+&"60ZD@`62"_(<H;A)^B4@#M
M^4_($\`IY0X#!9Z*<J.I4[GP4XYR;`H'T-&Z/$_`6*:/(H"<Z-7JX3%$"[6<
M,("7Z]6$&PB/*)SM_DC5GW"`\FFX:DNT1(L`@Y"`:+U6!!C"R(N(9IF(G@H+
M_-O6BYE4T($BL(C(5Y6(OM`T7U&/4@/'[-``_WN(7<%,E!B>)H,(!F``!"`I
M9.&+7]$<R)RZ#,@?BQ+0D:B+/S$?3EDL9+*\&>P*^,@-3`NB!-"`7_2;/[4^
M'3S,@H&J$S(8/JP<;H)*6UP(`5@FOX*BVT'(B7!&/<&U<\L*[J&`Z;`M3[F/
MX/D,+FJ1`^HD`65#LDJ,>5F/+AH`%)O7,O,`=O//^[C,`ZV;&/,;)$$>`X@2
M"W!:B3!.*%H`1\H`Y2`,HW,8!_BUAP#"?4U;M=W7![``MUV?MVTLN5.5_BRB
MTELQMZQ46PNTP+ZIE=]`@`#95YP8*=]HF<ETB$1AF)_`)O0L"Y6)1?<P%G$)
MT`^(@%@YL&1$%M`D"&U4$Z,#`*6]CP50'8C`&8SHB"BQ/9SH)_D878$@FPTH
MD:N!FX^!Q@]P@`!P@/8@"Q*RL\YIC`)XI(9(B//SMKHA(D=2D7`).VRKW$8+
M+/T+"HSE%="LVBJ%E<1[GU5*I;<(#YV2`&8]"OTBB`J`*=;SF8^JSHZ%B"O1
M(BDB5<?`N/(`1^\HS!,,``*9K8#)VM"%(8!)0+;Q$HF`G`X8/WXB5LV8@`7)
MC_XE1V2S1BI3S-!Z#-(3.J<8K16[#OF9V]YC_J[^8IK_9*UIX2<2=IT2/N$2
M/@H"H(`/:0JP90#"L!;%PZW=D[]0N0W?D8@)8*_)B9G78Q+$A0SH>[F(618^
M=8[+$2>P]95]$8!K1`D+")3J6,UO_1=271*1X0!1:][5FL[[>B=R[#[*6B,%
MV%<E^0\(`.`5$H"&:+22T$_3>IW2.-OZJ(`C&0`/RC`;.@VMX0"/D:!\6K*/
M2C/R!*H:12%<0@K\*Y@-.!I8,[0Q2:B*F\HNZCZHB<#]@3.+F)P+V$50Y("U
M0!WPR(L&%J6N9+#9Z0[:BP!X5,PB60NM91!D9:*ZO1@LLM4R>YNH+*JH[&4"
M\&5@=KN:X\XJEH@$_F@('K.6*(.1+3E/'BFHAIO2UT/2R3$BC3B`+`*I%2(=
M=0(21_Q)85F-B-F@JWV-4F$4D>@VK'L([<6K#""`![@+9.66'+.<B'A/C5B*
MI`F`X67ERGV_Y,.(H)P.776.!&`SH1B)W*6]EI"L*4))IP`G.,NP49*Y&)H.
MA'95K4T+=9./=2N<$$F250N-7<(0Y:%DD0B-^K(\E"EE7%D)<BT2^M%AE'B`
M3]V_R"I"[FA/W8'G:^H.]3F`QX2KLN"`"%Q?B&C>[G"66C95V3!;V[FDSS6)
MI@C1PQ1+MHF*UH"?SLFWZ(BIR,E4`0C?^]#(:Z:,Z#G!;.V<`Z(LEV@9_JM=
M.K/@E9;0ORV9H_T*FR\=B`5@R>>8#(UHCND#W?KZ0P[8+1`:`'73*&`Y.*-^
MB_-RB?C)"]83`'N3C:TVP_>).@89FPGP"<$@K<!ZE3@!U>.8%5VUXR))I573
M"#'D"""Y%(-`.`%4ZHISC.G8D;KXU)=CPT0R#^.Y/HF8CQ%1DK+-@`RP7&QQ
M:76$B`HP`!!4`&<=S2A^")8IBU>;B%^T$0Q9@(9K:J>&(9`B(/@9G"7;Z(%`
M&X*@.<E!B0FHB%^C*[T$K"/L4KJ<'/3DB@2(70I""OK!0!K3"!+4W;>@(RA"
MS.1$)OHI6]0`OCMQM`28@"X^3)U*'_X!5(@)_K>P*6T`J`A?Z>_T#BQ8V9K0
M41Z)THK5ZH#D;#@A09_D0N^/F:E!XES>NPH-H"P2-:,N#,:?`#Z"8(`%B0X$
M"YJ%!-!P>N49C-T-"&C6`H!"N4?WS*2$>QJN\+?"\*Q\*K'\-(EZ.4+C$<7@
MWFYSE0SP&)M+2>S_@>J)2$>_^YF7I*(-P(P7NFP38M;:DPB>KEP2;-/PQF_%
M*$[=#?"R;,AV<5G9B*=_F2("AXB16Z%\"Z*K*&9KV8`QL=F!::RQF"--^581
M6@"=)AUD=<.(T8".1!/%5'&*X</PDZBHP2*$@D2.NA19TH`DZS-WX8!X)H@^
M*N#=(A=$V1>9*2$Z_BF8*0II#4F`1D.;@_*ZDY%-];H*;C+;@=(3G5$W)DTL
MJH`70DW#[:@`-\E?WSB5T-`8Q/414/^8B%FYZ]LH5Z2*>MG<>%D`FBP+7):(
MZOZFO6TR"N!S*'J?1L^.`!&C15LTFW&=33GX38&*9H/'G[B`0_8_0H>6H^QS
MR:D`N4ZE3D)"1X$[Q&UJ8=F47UMRIX`PP('*!E`O]Q29L:&^>#V-!PB-EV^3
MVY&_NJ"-%1(U\,&>CE#LK@Z5SE&`RZ/FCQF1?#HE?Y,X,/Z8#)N`&1(`W(6/
M>T$+(_N`YQ8)+/$QS=+JQO(-R+$+5TGGM/`NHMB3@O%ROY,L=3L:-\3`_JL]
M"A;WJ<V0":<GI(V@BI'LP5S)MY>'&+"8`(Z`LTO1M-9H)GZ"H,PCI-M1-PY=
MB4JVP!K"Y--H9(:/%VRJ&\E2)0-T%PM@R7(A2N;VK-,9B:+@4-(O"HDJ@)60
M&:&&_/0V$_%38)NIGNH9#-FO_>'$$`5@:HJ7G,7`.3AU#\3D[KU(,RM=[VN?
M"!5["USOU]"J`#JOW.K+#NI*D(CH(]_F3PN(CI8HPOQ)<,XEV<)RCM'-Z(%0
M`$03&;`]$X#9DH)I:]/])%_!J"W1/_8B$L,0%5"Z6)?PMMNL&Z@$"`T#*C0`
M@,##AX0*%S*,``#``0\".GQ`4('A!XH8#`QH_A`AP0<(#S`R9)!!X84-#!X2
M0)"@`06$"CNPQ,@!`8(/'C20[.GSYX<)`SI8("`S80(,'00`:!G@80$#`"P`
M5<AA@X*G#QMDO'!@``4,5<=N""!A+%J?$P($$-"`P]$''"Y``.JA(,BT"CUT
MZ,"!XD\/".'J39AA0`*<+0\0..`2I^/$CQ$<```8@@4)#@IS[NPY+<RG!$Y^
MKGCA@P4!!0!3H,#00X&'=7M:,/`3PP$.!$XSY##!`8$$$2YP8)C@@(2CI=<&
M6,"`>$8&&"V\A)``888-B7DRM`!`0`+2"SU$.!!!><(.Y7-BS-#@@-B9"#%0
MYKZPPP4#$2@6_(Y@_N@'&$R@D$,(4(2`4A\P<!$'%52@00</6#!!`;Q]H(`$
M!&C`U`!I=3!`!``2$,%*XF$D&&H6>&"``Q%LX!,"+WYP`0$S^H6`!00-<``#
M#FC`@0,/;;90!0/,EL&`I55E`%<)Y*70`A]P\%"4$"R@@6`4HK=7`Q8FY,$%
M#A00U03N/=14ES)VA@$`KBG9DP<9Z&A`!ULVL,$%20960`!J*BGGFPQA8)],
MA?J)$0&`*9#!`UP%^BBD/TT@@`07($#`19Y)<$!"$AA`E4(*^/DAE;UA4($%
M"-C64P88('2=3PML,,$!`2BP0*8'C/0H`UAN`$%E3XW$`0.U'F`A;A$(_H"`
M?0MA((`!\75WP`&`C1=!`1F"NA<#`6S+T`,+$`:N`0<,F0%39Y[W000*/?"0
M`C%5T"T%`$S`%P4)`"#:!0$`A@&P%=0+0`$]3;``!6I:$!,!&PP,0)1I;=`!
M`FZVIX!"#,R6T0!G>OQQ?!P\4("LD2I$P:X+O3M<HN-%6=``WWZYFT\(21!`
M`>V.!V:0'S\40`/2IE4!`&>9K`$$!`3@XP32D?36!4_^M`$`3K_9@8F!2B`T
M0[1NJ1"`%V)0P)`FFQWI`O$)MH``&WO89T(3&%"P5376C<$`$YW\':T`K$H2
M!R[B7.AH,T64$`<4+.`8`G`7IC-#2+]6`01B_M'G8(8'G.3!!`!`SA`%-&-$
ME+<DR9U7`<UNT(!<)%6@@-M6+4"`:\6%M$!3'B25D%@:+.Z@`T\E`,$&=PT0
M`&\->H"``G0'=<$#!^@+@-1[&=`\O%@F=$$'!Y1+>Z004)#!@1W(F,&^/I_9
M,0(/])N`EV:GK!`"4T'P=T**PZ:`4`,8N!>GQG*!/!6``11HE@?FI95T_2P!
M"+,=4#A@`*.]"0,7^`C)I#6!V-&/`PW04V"D=[9'5>PGG\-(`@"3``LPP%$C
M?.%G-,`>9S&@`%S[FD(D<,*2Y1!R#JB6!```00A0+R,$P)].T,,`$)KH=22Y
M`%,HF):L)60#A_I2_A5AI9-/:>``"K@5>CJP`!^=Z`)@:=;V:D@:#1@E/0\(
M@-46LH$%%&!^7[)``)A5D@8"8%<.J(T"($B4!R@`6N)S`->FE+()1``!$N!3
M'DE"`0-@IP)L(P!,K'43#Y9-23"!``(\N`$$>0!7";0`*C,S)@+LZP(-8,``
MK@A#G11@*!!P8?["`P"Q=*`!RP+,API#%U@NL4XHF:16/"8`IE@$APII@!0]
MXX$-!(<!^NG.!/HR@0E,+"'56B):*."X678&`IGJ2<1(LB*9-,`""S@A.>-9
ML[Q9BTAN@>`'J)B>PWW)`[UBR.$Z0(']X-%B^TJ2!-+).XQY(#,7B"9#_LP)
M.`28Y%&:LTD`0V*`!#``=Y/,5`0<(),.2("B)XK0`.*G$Z%`8(@0X$L$`I``
M?%:Q`09`HTZP8@#>8"`O4V()`00P(`]`!*<+L4`#"G"`.\%%)@H`E0<@P``"
M^`8U%EL(-%\#O0488$%_.8EP`M6!W8AK`U2YB0,$L)=ZQND_.:0I.=&G`-AD
M35PW4UC5.)`:)$HL7]"R0%]F8AT!/"6`>#J``")0`6-B1%6?08@&XF6[*]U'
M63]["M!$\@$*@#`P`,#E9ZYB,@JH="$'Z4D',(:45)U3GJXEB0-6`E?#+&``
MR?G`!EJ[$+(!,`'(Z]J`<-<6PJY&)P:1"04R_KH7G2Q``@T`K;.J=[(!&+4G
MNGT-53$2)MS&A`,:&"`%V(HRBD`@`G`M)5]YUU6,8*8!B,$IYPPP`;AV(`$%
M,!$'2+.!COUL`?'*SU6<^24\N9<`3_6``X:D`09$(`(86-A%4>@G#TC`:-/$
M`%>14UW.?$1*.]E`!C3P$$YMB@"-F8T$,/8`IVE`NI$2Z'@Z]H`-^6F.'[@>
M0VBT+PV]R3T)Z&I*`!.G8^$&?M,#P``(\(#B.2L`^JS*KPQ#18'6BF`7R,YW
M)^#+CB3`CCZAR54_4QZ3+<@G5675DU:(H->RN3M<R>Z7(V"`\/8DM\JY"I,;
MXH&@DN\#1--997:5_H"6^>0!Z>V4:C'RG+3(T)F:5?2`FD>1""0L`]9Q9&Y7
M4BUUCJP!]41<4O7)`&AQK8H+T"-&-M*`,,ZJ`5HI8%(@4`"E0:4!&1!P>E)E
M8@+$\@,/F,`%-.``2P)`GZL>3Y=U4JRZD#1X!TA;-SUCKI0HB`,2Z%R;\/BS
MA[CF`2-9$6F*Z]JTA@2TJ'((/`,DR]($CM<'L,!DV56Y^JFO`,P"3(H_31)]
M8V0#FR'/\1)``?Z1)#8<2;<Z^QBH"'A920L@G@:L&/&(;V#B$J\X!7(D9Z?*
ML-1MEN<"3D-5OECE4*,4W7AFZY,%-T4A1"M`<5C9L`H,[B</A5.TU+E"_@&M
M>R&,_(D#.IN1B'`@L1G!V2ZEA#('=*P``@@.!2!X`0HX@(IQ*D`"9/FZ6]L$
MENOJS0,$OB4(#(`!;*(>3H4]:Z@X``)/9D@&$BJ`;B69X:B9X7V@ZV#<=E4`
M>()`2BH`G`!,$-?JW.F"8)/`8%U``0E00$HF<"G89(IY&1%`:5_(`8PM>B&N
MT1=$9]F!"A@`6H14$.(L+16?&;("Z.MD3QR@\KV\5`%-R10X&:*=U51`Z#V9
M$G0[8_=(/7),'Z/U=\[4$@2,B60RB1(",F^VQ7X\(1HH`$*H&KJH&(`ML,<M
MM`PP-Q9U7_Q=+=<!K#3^KCJ)E9Z;"2MSLH&8_J:KC9WI0.H`]QU]!4`#&3!O
M3YA=S?R/[DE'*15`!2!`E&",6:V8B:F(7OT8U%V`#561M/R*`KB*[E6`;W'0
MC.0,?5'(7&$$TCB`7P@;9=4,P##&4Y!,B-D%!%2.3<5+182>!H39!P3-!X1'
M1=Q/]_&&!P#,B'"&0'@0!]R/!F#+OG"$0HV5G"G$AO#$!/G$!F```TC`7P0*
M!IS'`:`1`WA`Q^"@/&F`!112+04;8R%-]ZF/^UTAUU61]NA$55@:[HA*Q@B=
M2"0'!/B>)"G<FT#`]T%*B&D`(>X$(58<(?);0D0)?,B3(LK3`YP%&'+`$<9@
M#+K/0OA?`PR/)3X`_N!%P!Z*A"AB72?&H`40(H0LA'>I"=)$0,1]AF;`B018
MTT,LTW>\6P7XB00\HDJ0Q!XJQ!9>0`(%0$LD0`5<!5PUR*DAA@,01W'\2C,Q
MA'JPB`4,`'J$R3'V6P4$A[XMF#$Z"&&]5!S:16X5THY!FSHI0)T`GK\YP"["
M5C3I#FYA7_?(2(1ES(;Y!`.DC`8,RKN<"0&ZG`/,C^+,2.@%R`"8X`/P6G/=
MEF<,!P=43P)^`#$:'@R9W0\E1G#T64XE8;=XC&.<2;;D!P$L@$5^R000@`9F
MS`GMEZ>H!Q]B!.Z\G5Y@2_55Q:((@,?=Y`@M3W$4W>QUR@!P4TW29#Q%_H#,
MG`@C_9C'(,9`/13>:9?OS10POLX`Y$P&<$""`*-,2)";S)]]%4"7Z,J6=(`!
MF"1JQ-$B7I<1'<L3(<!+/0`'5J,CY5$#$`]:"%0$N-_<E1K#T4>`U`\?IE5'
MN(D_941.6(>4*(!:?D##%,98>4#"?,`!;,#JG<GW58!:C<<77J$Z\=;V(,`/
M"0!B6-!)?@GV_49)2$"1Y&,\;<8(2LD$),``S%D]`8=(D`P1?8Q039&E"0!.
M[2/HK$:U$%Q5Z(;S*`FP\.1/B,MO,2<Y29!"B!M)J,3N%,8"&*76/*)"546<
M,,!_!,``V!Z\9`"\D<0_O<9];6/'9&!^\06&_D34'ZE&J?G3F?!(!1P%!2"@
M0LR7&R7*EOA;`7B@I>Q.!X@%`C"%8CU7XPC`4VGG'97'0R2D,*9'*%&%!#!%
M3")-@T[`9%Y(`NAD+WW?A@3EOO7?G&4`L\2&W[C%%4%`HCU3D80>C#*$HP#)
MI7Q'`4R`:Z9'P7CF;B$86[Y6X`13;UC``6!?`_#$"^J$;OP,`S4%`R1E&?D-
M20@<0]Q*-=973"Y$D%!I9V0E=*+34NSDF$**!6P,G+U&4;Q49^C@+`F8&$J*
M6%A;E+(.C]@$S)$@2YB7M="1RE$&`\C2@O7%Z-7/W''@@V`5[SR;46W`L\U6
M:L0$XH!*8.463YB/_DWAC`&A!5\(X7?,W?P-@+>EBW;ZAJRYA04XS$F\RW4A
M%6=(`$@XP`8T"@?@#@!8APYAA(2DVE.46F2AA^R-Q_RQ$LZTCD]L(1C&3Y1@
M"G-20`7D!^`8TP0H0$L`AF6J#V\6D`6(FK[(T@H!5+M4RR_V1/1<&RN9:%ID
MQIEBQ**L6;N.D(.@A#HUE[K&"H1J'L)]&02=Q_\M&1;I7O#%R=>$!4D@:>6,
MSA()'=9P!$0,&T5$3074T6QUT9(^35?5DP6<1FY]P((EEP`LE:N`R6SZ#ZYX
MJED)Q5,H0`0H0&7$)EHT"`5,E7E$JZX8QR/&BHJDA`!D`/0\A`X10/XI_D32
MZ%.U8D1Y)&-NG$@04D`#'-%&75==4(=R1"*D0B>SY!Y#2(",U$F_'!%;I!3E
M7&;R^8RM:&T.%EOL><F*;``'K$8,^D1_E`JO!-^8FB"\QJO9K,6S945D+`#@
MTB9BW`K@\M!Q)F"^CM"U%4:SF"EPZ04&7-&M4M<'5*!"(*G=4ACB6%(RF06_
M_0H!>.#J["G<A8['Z(Q`T1VE(03GL`WU7"Q:Y%8&C-I#@*EWCMY4S5F>28ER
MI<6_!85M^-9#Y"<L94M6>MULT<=1^%/_]<3P_80&S,M#)`"/(D5%?(X_@<F^
MRE-9[-EL81^-.``%J`IW3%53N,C4.0#9MDD:_IW)2\A-[R[$2RQ$2/E:7:!M
MOPU,5)9&*D(*!.2L7AS$TNJMV52C`-`1DK%H<P`NX=X*O:DD6C3B32(24#0C
M%,9H6MR47FS->$R*&':`Y.6G33@22>"-D$B2D:C37K+EVUY)90!`(%I`N("'
MBR3$O#B=`8@/`&=B94A?6N@5GQ@8-QD:9Y!'1<@P4FI%`-34QRPDOQ6$SB!8
M`FS8GN6K;XQ:'AF```M*3@SP34;``BS%;&D(V1H(0KP3KCS<QFA`TSP%`A"E
M!TC0Q\1O#OD)X/J:47A:!'44RGEG:5@DB@0L``=R>AAJ7YCDIQBR(9.<3BBR
M(7./(QMRJ_2%5D)(_B17P*!$LB9OLB:C2%\P`"4&0'CQA6!0A*'^8V/V1(R0
M$PYU`-!`"`X9['(5Q@;XG5Y`<$:077:^1D,-0!B_1B\)P'7%20/43P%,6`>(
M"7Q=7T5)H[8DQ$?0R2,JX[(D`!9B1XBZ!21/38XF[EBL6((>,&?\GQ@I2&3A
MJMWHQ$(>L-,"P)9D@%+!'%U616P1H044P(3T[D-E0#K?Y#O=$C!#`&$EDT@:
M0&/X<#X35HB>"4'?"WINRU)T&\Q9T@1(0&8T5T4OP.-=FP01@`3X+&=)P'?-
MKK?!3],L0"1"0(7)ZF_@1&)(!DQ3AD;C!'BZQ!6"HJ=0R^.EWZ@YB>,Y_LGC
M/9X"&/07)09;'+5,Y>`RY0U3+Y/3?1%'+)-4L\4RM<51+[549S56-S5I=K57
M4S534_5P-357MT7>5/4R;917@X?3)6@X*\!9#RA'H86MD5/#(0Z)1(5[_@0J
M<883>4A\8`5>8D0%F,<5>4#S1)U-*("G14`T+5@&DD07*0!.);,CG=8'+(!9
M$.-!RM$-LT@V>:RN*95#DR#NA,V9_I%YUE?@6$"0Q"0)YUAN>,`#U.9*!D9Z
M%D:--'.HX`G,?MPHI19WZ!6PR!<E.LQSL>B(!<"]5N$%P%+'(!]4_!H^Y7:1
M&$:4JL^JXHEX:NN$!ML`X>I#4!H%W!(@TL76_F``!53*`+7W=[4W?&-`B%D1
M?=,WQ2$BED5N?>\W?T>08`08%OV%V_XWGKGMEQ@38ZD3X%C142!CM"TX0O3%
M-+%N*X\.:W2I_-HNI.QP/KG7LE"J17FS2(E1V>G;30PI/`^K-(9(DH2K&_'G
MB4S5%Y)@`:AC1&Z/QP3`,9[D!I28`F0C;A78`ZE,Q]`Q3^[BQ&"%GU6A-;(*
M/UG%=<IA6D`/9V#`7`T`/J46N]P)A\MKNR"(I8BGBM^10L`SO#PYT#5&U!UH
M5J@/_F1=#JFI=U-)15?CG,M&@[6LQTCJ:\Q?;M&W?(=%G@\ZH9=7@RE`VU%+
M1S%VRU*+HT<&M7C$_CWFI8P(.(._B/E8T4PP&87?AX%[I^W(1+3MKEY0(E!D
MW!RFRKVZ%M844G"TE)+HQFGF4W+MQXEP56F)C.9L25&`\G2^"(4)W&P9&HBK
MHC4Y],S:\":NQ,]P*X];4LB:DS;5D%(=T,2RTIQ67VI,P$B0LZMDB$^45&]T
MX6?45Y<3R+U4CP9P!7D6@&*W6:-@0`M2[Y8DT`<8C142HS>O8`Y?A0ROW4/H
M"9("8>=I@%:,T8.Y'LIPU9CHRD"VAIA[VT!VB[T]0-N]D1"5L')XQU4*K0%8
M_-.2S`0XB,7'EL5[V\D/I,67EPX)3`:TRLO+-_2D_'I'R2R:'\[GO!9W_HSX
M1<4`_#R?..Q#F)_,C=^8X#PK^8_.ZWS0&[3X-<73<]_23[WX+=./;=3'`XLG
MJK>&%S*JZ6T#EIY88L"J=X>+F=E54L6AJ&C(29*]):.LB7!Z4-)^4K9D_YK'
M41/,1JL-0P2O-85ZQP9*`^Q8-`B,^C+U$<5_V(L';%J[>IMJ[N'U[%D@)H1P
MEOG-ED;0C<[+\YLUTD6.<=..@M+/0U[9OPD'5(8`D)%/C-=I<*UP.2Z<1&]Y
MN+M.7,#B0!#N''`2-L5'[Z9E5!%:3*3NO89#R!(-7N[_0F<IT<1=+LR#(,DI
MAMA\^Y__*3+U6S^2:#_W9W_VYY?U3W^:RO`!_F7`>GL_]Y^_]D^__\D)TKC=
MA(BB)\Z_0#=*Y4OC`'CSQYU*(R&&V0'$A@\#"18TN.""084$+SB8(/"#AP0#
M/4Q@`.&"!X48$D#@H)`#A003,!A\,`!!@H0;&RR(\-%@!@44-!C<L`'#`P0`
M$@A@,*#F!@$+'!``($"!`P@9%BKT@(&"@P0(&CS8P*'!AIX*.C3U^A5LV`\%
M*C2XH($`A`D$&`"HV72!1@X5%DB`*=8KA0%W/U0H````@0<&,3#PP&`EP08-
M$BP@V.'"!)T%7+[%>[EB`P8&"EP``-%K@PP<)'R@@"%`8(V7068HN9##`,"S
M`1=`D!HPA0]S08.%_F#XJV<`?`E62/S!PF""'!PC'YB@:X,(`Q409]W40X,.
M`ZYW]_X=_%<&&BA,#^OA@.7PZR];B!#A-H$(7;]Z4+`Z[-\`]"U,B+C`@-(,
M8N"!J8XC2`,#$/)`MX(HZZT@OQS`CZ##`)A/(08*:$"V`@@0P``!!%(```LB
MPJ`!`69+0((,*/P*@P@.&&``""R8S3KVP(O`@PQP,N""&P$HX$6",I"@@Z)H
M?`VO#BI0"H,+&F)`,+X,4*`"#1(`P#^"*/`/`8,\0&"#`Y@T2+("`CB@@3/#
MX\"!`0A`4@(*8@NKIH\XL$""!88L4L?'%CA`Q=D"*!2P"0H0((``%"!H_BTY
M!U`@,0H`4*XI2S];"`(!![*@P8$V&,"##?SSK#0)!#1`/1T]6*`#`7(,E-9:
M66,`5!/%.H`I6WU=J`($!!!@``8@7(X!O#A(30#Z.N@@NPD7FI&"(C6@,M2"
ML'IT(;3N6TB"!S#(D8(#/NI@@0<J.&H"#[24X`#\.@B)`=P&2,""617JX*4+
MF*7OU^LFJ&"W#R(H3\@P,^TT``B<5*FD5A=Z0("=`#,``0:(HX#;YVI<33L+
M#HA)W&;KR^"!OP9H@`*`6>-@`@,"0.`"^A[H8(*.F^IS`P/Z8L`E`)(-F"!C
M.T"+-MHFN$!5"1+;H.D$$K#,@[]ZY12P'!.X_OJ#";+U($0!IH/@@)%9'B@K
M7V'ECNBVW1YH`3AU#2L!?=]FKX,,`'1T/(.2PVN#U(;^P`$!"&B*`P1@78B"
MAET>J`,($#@``H4T&-1-R*?*%M(#"(#I@M$"0"W9O"7*_(,.*)``MP(NLCLB
MW<I\]FZ\%JC@O0X(B/$!P$KZ;8$$M/M4(PI,C(``C"\0X`+-"%X(`?^>A;8I
M`[J$G``"N#6L3X,:L,`!A<_K@&(`BJVVR092:T`#"F\N@'.%:$KR`P0R8,`!
M`%"WM5[7+<C``7]16ECJY#>D>`4"@#E6Z@QBG(+8QR+3&4D`/O"`E;#*5J_:
M3NTX6"N@*6!N8&F._MN<=*"P5&!ND0/40##PF^PMH%/!>EY8,G"``#A@-Q(8
M29$X\``%+&"$!"G,XA1B@<I`(%L:>$!='O>!#13(4P5IB$<>\!$+!(``",`8
MJ0Q6D@F8!SOD@8!LUB0=B45$,.GJ8%CXY8'07:``&O!+8"RP*-E<[",:>T[7
M`!,``T!``0IH``$R0('C:&``39P6&(DW1AA^P`",Y$`!.L"BZW@@)!'0$`(Z
M%<*!:$"3E$$B#Q^`E@469#"GZ8`!*C`!/\%.1PS(`,X:X!\/9"<!1KF>5Q[`
M2(\I4G>-0MU2"F(!G<GD`X7!@/8`(!('5*`#!XA`!4[Y'5@)8(5K#(L/_B.I
M@=L$8`+0^8!=8A:`!F3S,C]!@">]\JVW1:``Z;G,52H4H?@)L0(*,$H`SKB0
M+0'@``MPU+$XD(`!E`8G!2F,69Q2@0.`$&YOT0`$Y+,0#Z3L9@K9``0:MIO/
M?:`!LU$`C5BXFGB)I504,,!L_HB^@60`,+S2)HP:0)`'&!(#LN&,!2KJK@'<
M;(0+,)4?`:K2@<3K``3S0&D>0`!%*B0#\KGE!9;X@;8`('2;@A0$QO34RV0@
M-8XZ&`4:L"@0HC,"X=*9147%@0Q$8&J6@B5[#J!("WY``/TLR`+B%[@9%F0#
M85KA!?AB@9H^IG*0L9%I)"`YQ>D3`$%<CP;9_C;3ZQR``@YESBW!Q@$/$+(`
M#H@``+QZ&9<PX*]?(1,',1#(!-!DA;TJC488<%BKXC`L&&"G5P18@`B@#@,&
M."?<8,*@D2R$?`.8(4PC8LR^6<X`XA33M>SR2:9@X+$+(("C4N<I!^PV.'1I
M%`#^F)&8`6"MOMJ?5RRP$K"19Z6T^6L$ZC*XWX:3=3D9V0?J"@""-4Y(_A4+
MB9)FP]1`S;;/R=<N*<(:#R!Q-_\<2LL&+($"5.XK*+QEUW@*-0!$,6!UG=AT
M$MF4#2RN``MT`&YM4H#Z4$@"ZBG2AKV"3M:LS;+=X54-.4``71V`)`/0"G5*
M6V,/0*L#.FS`A)"<_DW)!JP##)`,;OJ8E=6L)#$=V(`&-H`?!NM(`ZE)`*`V
M0"7UP*2&",A1!A#P``I90"5:-&%$U.)+R"V@`&?B`+0P(!`,:"2:$U@:02S@
ML^_@S',E$B!X<PR<W8SLJK/A'`=4%"H+5,"M%R!8H9V8``Q$UE(.&0`%($`>
M:#&:`PQ0]47^%Q$$C.E,T=2R`_8\+PEH2`%ZK1!V,0"9S0Q,UPHAI)#!XH`6
MA@D!"O"9`_QH8_88X'&87,`L=Z>!#%A@>K5^5DBX5IS]&@21T"I5.*<B-0(,
MX`#E;N:K4D(`J:5$B[(I]U1^*#6#(N">#K[F7'-,$&+&K0"#J1H!%K7,_JY0
MLCNK')8`7+=J*JDHP0^4;MN6^H!!4OE>"AA:MR.2S#=3R-EA\=.%G-(GEQ:D
M`YJ90!/AI"Z%L$[*"]FH`8P-+`-@2C$0P'-7:E))"#C@;`/A@`$8+9;"$,`#
M*JI;OQ?"%1ZII6<J.I0!7O395QMI*9Z%7"#)HBG`&':URP*E`+IS`5D2";".
M`>N0_"0`-NTDWP.1`&=:LN25I`TO&9@`,L%B@`U08)87L1.N1N<V:#]PI`-@
M%&T:I:)AT6@`8;5.K#*W`0)H`-ME:9X"_AF``I0W7Q7L5&0FT!\IG1[U`M'`
MZ37.'E@%H)I,]QX%1"*!^VCD``!H5`8,@#^D_D.3-:;JBV:`N(!`EL8!3Q:Z
M\MTFQRL!4J_N$M-"C!6>*+?%E]&TL\&NM=LR`QFY]F,KO([E`?CD*)I3&5KE
M%$#VA5B@LI>T\)`VT,=@KY$T-:PD!F`(F!I5+\$X:KLNK,N<Z"-FXE`<8TL"
M(`)"Z@$>`,-8PR$J(`('HO2L2O>N`D,BP@!*S'*VQ-T\8D#NS]]@)N(VXG"P
M!'S(Y#W&(J_:1IZ02P.B!`,PP$<XX,_P0P,HHRG`3R%"RJF6*,P:H@*BQ`*&
M9<\B`N<&XJ8@1UHN"L3*8K+V3?;$HBTZ0R@(KHY(8CHR@$9T8V588P8-QIT&
M8GF@Y92B[&Y0"")J_@*3@$\,86,]^(1#0*,#*&6!*"".FL(S*G`Y).!>WL\`
M9N4"?NB,1$8W&B*9%N!&_+`@%`#$Q"(#$D`!)B``*$"@2"+D.&AU%J!]U$P`
MU`<`&L``9`JPE*L@$*`T0(E0!"/T(F(&L>VGE@@PAB7NO`(Z*M$@N*H"HNNC
M"&,O#"+*1I'CO"3V`*NN*F``_FA6?BZ9D@0M0*HD)HF0B$;$PB.XTHLZ(M$T
M`*,7$2!6'B=.\*-(>H\)2R1U!*.!6`P\8(4=J_`KVD=4;-`Z-L!9KH,#$F("
M_+"@P**2[L:82K$&Z>G0,J)6(F`"$$!A(D>:FNC!4@PVX*,8KV4"TDU,_E*$
M1_:EK#)2&"-@+RS`C32"JBRO&#]E(C"#`D*Q(L(DIXYQIO!MEN!$*P@,?!K@
MI"AB`62E(`C@KT+B`4*$`:IKZQBQ3,HG%$NMR(1N(A#@3#P`AQ2`JR"`,RI0
M(@I"[S8DV)CR/":`1GK.(I81B?AB[XJ0<.",OR!"`H:%&W4D+L!CS_P%YPIP
MG,;,<HXBROSC`%QLKZBNGF:/(O9C("C0(,AJLEJ$^>!1&!_"#%?.B5+'LTA-
M`C9Q(2ZP("1`?+PBM=P&110@`O(%D[SC`!Y``K"M8,`#/2J`11[&`4S(`X(%
MJYR";*")+BP#9<2/)Y?#(F1I7\R.?1@'`1P`_I3LPF$Z`"0EX'M4ZZMT(B,Q
MH`*R`V,>0#+4XL_Z+394YP.0J$U())'TQIQ"IRS0RR#X:=<:!&H>0-5$J\]T
M:`PG\3=R:0">:5PP\P$R(.(FRO+0C&+,XZ(.Z@&WQ`%*TB!HYBN@1I!R@@`6
M@"1NP@*`)B74Y=+Z@IH2`&@ZX.H&`@)Z0LH,TBLV0`%<DB`JU#O@+($`1DM&
M@@)ZIP9]Q-I0)&N@<CO`":<F0$684TH28`-<`T==0B`\(``JH%IRXM)HCSYG
MX@*^I.@TX(LD(`(@<'5$$_8&-"H>P`$@4$H?<$HE0#*FM$JU=$J58C&JM)=$
M4[0@(*V@LSQ$,UQ$_K,`Y*0!/Z^N@,*8(&`H?@@"I-0!"&1*-[`I*@DIK#1E
M!N`"EA1+(0")OF1UY`,"_DXC_H[4N+13PL4A:,]K#)4"/!1R)%.CC,)\&(`Y
MP<.P,,`GJF0A+B!C:`_D),#'')(!DHH@$`Y.$$!/"R)!M+$#^*^*A(X)/V!Y
MDNXR)V;.%,(2.;)K&N`W\H=&J"PIM@\@<\W-J(D1QT1`X(\VD@?G$@3E%)()
MB2(B_BX!UA3M&DSHEM0H0NN>/+&6#&)0>S6GB&(!\><A@E$LIL8K,L`VKJ:Q
M9F1F_A-RC.B&"$*3D$XR%(*B`"-ZXO/E].<RG.K0""!_```_RN,]+I0V_B34
MMP2H3"@1,`B@;!0G-?J$37@E`<JF;`RG+0%`*1ZLSC@O`N@4AJ0I.'KI/2)V
M`?`M`&!'RW"B3LJC/(PCK=R#RV[B[PZFE8PG9G]V`P(52R$V9I?6(U>./*!C
M.V!*FBIV44E":2.`3)^J5!Y,.L@4:PWG:+&6:;$V9C`@,AM$=9;61V["1V\B
M`@+U:OEM-S[B5\]#`U*DCXQ-;FT*(9#BY!Y#V>`0L'IOSG)*6@+3,2[@0/MI
MHK@QFK"D2$HB73C@PQ:BA:3D;L&".0X@A+Q)<0^@%!D%-P[`8FCD`)"$@QP@
M*DP$(0[J,.0%7E"KDKC&(KRG<HXP?SB``Z2)_K!2;0`N+$=ZA`%V8F4NX#6L
MM4T&!("6D(_(B]9DE7F;(@)*4GU\"29J-8`"PRP$0LH,:4SN9YSB!Y.T:#88
M;C$DH,\\;!GE%2RN$1^/R]V\8K1FT`$4X`%,9(RXA``$(O)Z0Y\>[)1<A"(&
MQS5\)7*&#C'!8N($!(0`"J`\8W#PL7(LJ2`T"2RD3YL:*V+6`P+6):8L=:^.
M@ODV@&4N8`'<1#D7XGXHA4(F8#%><U3_!ES^KR!H34M*8@"N+8)W$@%D`ZST
MJL=`U`S5130`+5AN0P`>(/>.PG/<KFYKY7/&0XE7=G)$V`$@Y#!D-0`.A.@^
M@#/YJSDMI0#T9$[T_@DL-$"'5.0`&"`!!H,`CB/E(.EJYJ(``DY#T<3OPJ)(
MH<H`,.B"<2?W1N9S-,"S!`#J$#8O("MIQHLV=G@A/)`UZ)6K/@!?$*B9C`2(
M[NA)3"2R#"*`-NS!@L\"1OE_*-,TT?<D$[@IEBQU#J,K%"`#R*[WFHH$9:XK
M@`Y=>U4C+0M3J^<GJ$SW_HB0;S0L4@0H($>(-$2[QO@Q+-/-0*)`'-%@!,`!
MFBC)5.T003<SDPTPSJ)N<!FZ;@E=A,LT&',Y`N"9O<?VS!9"3,4\3;;+O@0^
M$L`!)`"$N^-1V@6UJNC(:I6^$(`M%LO:K%(GA2B1MH,#PNS(QA%2?,30_L[C
M2W[23IC9WQ)5R"9`*H2K.<'"+Y)W7G6&K*RG2&ST`LAT<FV*4YU*8RIR?PLM
M*?-1`E9LQ5ZX%O45+$SF.EK)`I&NG1"YP1[@4-Y*`B@PM8H"8!2@\1KEH81E
M4K*H^.J-\\ZMZ"31*N)/E6.",@;`/2B1D,C.PGY25/3H,BY`(+2H`L[ZVG1"
M<[]MC<9EO<0B)!@C:6;C0!EQ.0ZD:@!CAPSIQ*J,+_PB`A;H`EZK2'!&B(L#
M8SCNP:1FM]!B7)CB2S[`)18B?X8&5MBBCQ"@)K#TE*;&OS*33+N,A&>F70Q&
M4]'KA&W%H7;PT[8%B)#(O3AF2`S@3-I"FIXG_JV2:3@<P&<>;`"8A#DXJ3O\
M8\6\!P=U[\+N^#PHII2P0SO<I?TF>2&R)Z;,IP"8(IKD"(>FHT/#I"H>XYX[
M((YH+"P.3RS(*L$FZ19[V(022'\V8V5M"```&G.2R0+;A;,J1"/V.U:325E9
M(R>\\*HWU*955R->X\C>HB*N0P.`\RE4]X<>2C<LH)^8P[):+5#N=O$(]DF,
M8FL6FD)@*@#N)P%&%X@PS2HW`W70@B^+*/>>C#G(`C8HYI[*#``JITZ]V#\*
M3R$,H%)=35>18@,J(*J,PI$I`B7ZB"_"3*0,*9^FPF0%:#:D230%.#Q.V"(J
M(`#&1(`:Y5`P8K\I_D"S*:(!L,0F9^9V5H.W+_''M54Q'!::`RDS#>8#;K-"
M!,AA/+4GE/6(YSOV=D):A@X"QA@M(@>,8"5,NIB%;G%?[!POW%=;<&4@RL7/
M'^/ST*G-@.5B`F!2`HE0=.\H`HFG[61`<"LJ)$)!7N0P+R.S-NA7WC$\R,,&
M:8_VR(,F*O4&0\*0^'H3Z\_+KT0!]&.\3E#HM''`->JY!T1FWK@K'@PP8)E"
M.B`P`'=6>N:YT"0M"IMLP`?G6A/=%"E!V-<@%#=F$@)(7D57M]QR?MM"GZ=`
M/@(MKD4O(P(_QHA,V<*3FZJ6;@.@6&24?W(V5K5\AV0^P:.N#,DE/."._@"@
M5RB``1BE(S2@P0?"J`&K*(9B`N:B).JE)Z(H<5YDE70O-=X1*\3[62+#H.(H
MV`]F;[TGE6TB>815YGB<A3B$U'R&E5KF51H+/9+2*V)E+9M"815"6$Q65\7:
MWQB^/@;@RV)#-@B50&ZM]"Q@`Y)/U<QCL0KB-Z@#09E2Z87(V"T*4/@OIXZ=
M(7##RX?E4!AEX=;^4-9>:+Q#`\QEG1A(7RR%T:LP<[!"W*TR(=D$2ZG,-C!"
M[Q2OO<))?/FO`:S#`XPI;D!"I:2E&B,"-9M;H^"#G7I$<CXQ=<AB02M(^<:9
M4S^L*S!?),AB3CY%3I0C77`%(PP":^%,+FR/_E!NJ`B+E"A(Q)R.=GCIN5)]
M'D%>33L.P'C+ESA@)F1]ZW)N4J-T@E"BAS1N1QCWUY.EBGR8T4M(@IKC:20X
M5R(`:5$"BLB!'VV.G#4XBB\.0Y9$VM.8DIZ!0G'O61A_BC40#MRHCG0M*@("
M(.A9J'(!XH-`@1X4``"00>`&#P,;-KQ```+#@1@>?)@`($$$!AL0-IR@P*'(
MAPE%7IB`(>3(E2Q;NGSY88.#"Q8V;!#9H:&'B0,=,(`Y$@&'!1A><C`@@4!)
MH$R;.H7)(0/##`H84"`@X*!6K0@:8#4`8>'`#@L2W#19@*-(#PX$+,CYP4,"
MAA8*--`PLH."`136_F8XD&"I0`P1+E;8@*"O0PH0*-C\$$&!`8,"!##@D%6B
MP`H5*!2(2<""@0X&!',H4+C!`H<>+#08<!!!A9T/"#R8P&%@@8,#%EB`Z_*!
M8P0;"'A`8.`@@>!NS[KL<,'!``02<C>4D.#S6*4-*0`8@/>#`P,$"EB8Z.$G
MX[$57G]?<($GRPT%Y#_]4$!EPP@$$@C0@(%&%7QP@`0"?*"``_=MIR!3`MCW
M00:K]2<28@6$UY)_P`W4T0`!6"`0!=:Q=$%R!23PVP<7(/`!!08$8``"&@"`
M(63Z+=BB!!AHAV./0'7F4`4*,,0!`44))*-#$_QTGP`3R/;2!"!BP`"$_CY>
M^9(##8BXTHA'?M!!!18DL)4`1VY@`0("$-!`!!`0(,%('$!0@&(.95``<0U)
MV,$#`A2V%@.VK12!`11`N--%'EP0@',#(9```0,D<`%<'11@&9*KZ:3:!Q9<
M$&`##0X$P0`W76I1A1A(L```!!QP5P72`>;`5KP=<-N((AU`)0,!:@#C0:,Z
MQ,%&==Y7[`&P5A`5`00TRJ%'UV&`0`1^*@#M0!I`\$$#%ZQ5P0&P%;"`!!LZ
M-*:/'0S`K4X(Q-9M6+DM`&D''_;8`0$&-"7`N7$QM(&N'SP00`'??L!!P"-Y
M,$!](F70P)Q.N7F!5QK!*E`&$7AP0'E*`MIC_@058#``EB:O-,'!%`60TP4#
M@.AIMJ0R^=1T!X"\4@<HXH4`S"?#].5]#S!00`$W.TH0!!8$/5`&%D@*0`#M
M*F3!`P4$L*E#&A!`LY('#.@0M0<L4".'"R@@V$`67&8E!TRFMN^=#78P00((
M/)"!`QM<<+`"N6V04P<,*)"3`0,0H$!-#770U4#ANI1!!A(DA_7($SQP@*UE
M&H#BN09L@`$&%F3P@$$'E4V0`@=H]M3:!NP&0&7?1>`H!PK4F`$"'0LKVIVS
M<2U57A7M-9VYYTZ`,[)NB00!F0YX$)I`T"F`@09S^?@BZBPET*4'%83'@00,
M#+#QH['+-=D&$SBP_IO*W3U0[$B(6=E`D+YJ?8'`$'2](`4CE_RS`$8H50WI
MET`H%9?,(6T"=G+*`(;"-)$X8&I4$J`%!S*B.:FF*Q+`D&L$D(#&8$`^&"@2
M`*86DPS<9((ZN0`$."`PA%%@:.[K"8K64A$404@#"D@`V!K"@8HQ($X:<`!F
MAB60+6VF,7DS@+(:`(&@(0`"$^@-0^22`;``P'W%TM4#?-:2#D1@`0LH``$<
M$($,:"`#$%``[``P10<LX`!@L99-:-8`N9`)`'%;2[46%*XY%BV-:O37!R`@
M`.%8:P"P.DBC)(!"3W7`,PS(".OD%X$&O,X`$:!`0CQP24"2)V@6$!<`_C#@
MF0T,2`(K^D`%N.>C!YR2*;`4R60$$`#VZ6L!::-236QC@`<DQU56PLY?Y'<]
MD30@+6Y4P`/(N(`(B*PS9$1``0S0``8(H($+NAS)+G@R#<3)(;7L&2@/\I;N
M<!,H&PA`%EU2'$<1!9PL&=E3.I`VZ55@`:]R0`<7X,D(.*!C#0"1!<@F*?F0
M*20'X(G.$&!(#B!`+2(14A^!"`$#@'$@'GA`!V((IJ[,!CF)00S3.M!0@12@
M5%'#2P<V@$A11<`Z=;.-!W1V@01,X`!W`L`X!5(D[;'$>^P+``$64(&<:"`"
MTUE(3CA``08H"TXQH4#/.BDLEGSS/@4EB`4D_@.G$K*F`@'(2D;<Y"8&<&\!
M2'O>`"0@@88!`&E=BL#N3L2C"1C2)<?1`"Y1@@$'U*T"`^A`\]CX`:FRJ*L^
MP@``;N229#KD``&(W0%P0RR&%+%%JZ&``]X%1RM%H#H1$TF15I*`+6U@C1GX
M&P>2&A<,O-0F'="`5:X$@9'QB)X]$IU(:DD]#RS)`,_[R#IAX@&6L:@E&@T;
M`JQ$SP[4SRD-$,``#!!!A!7K:EMLB`:>*9<(=,!5#JEDY'YZE1\ZI#;)`ZI4
M!;#<AE2W2B/A(60'<H&52L^LEFF`MQJR`9X*Y(S8!:!N'F`U`=P,+R<1[N40
MX`!NQO5<&#C`7EOB_H$-U"9V=GF`!EQT.`A\E`'$P25J+$!%T'9W>Q=N28D*
MX`"PT2T!`W!24<('8\`]IB$52$C6!G*`"SS(`2-D0(O70H$&C`W(?2DH&QD[
MG\]4X(W.TL`$EF.`"4CO``HX%'?0Y93CS!(F>1S)/N$+Q($PP"(>Z*R".#`!
MC!@`I"I"P+N0B+#EC$0!2*-`4:9\@`V023$;:),%VOL4QCR.MSY*F4@>,!$\
M*^FG3I&:GE<RPY$P()*,1EAV6U(T.]<X0?[R@`;B,Y:)N,T#&>`-`;2<@:R`
M\B=Z"0V$ZM*`#D`HOY<Q@'J/8N&5"(K2&)3,4CPPS(,((#D_U-%FX)B3_@,U
M)"QQX<!!`W!9A?"3`@DX5\]&,A,<>>"U#4"``MXR[B?)+@#>`0!@8@>`2L:.
MS@)10'S#K+'L-`"V'VW`=\I*UX;XS78?H\!JBFNN!0$'NT)>%P',S0&ANK)!
M'84C7SC&$8=Y:@(%6.V].?H4#]@%*`84R=/03)`D?8!D$0\)MPU#@-"R!+3$
MCLM&'U6V<_M5+@%0P)MRLJ@9!F"((8O`DCK=(Y!<(`,56'-\-&"!E'UJZB>A
M"4T6P&F2CZ\E`CB8=,]BNP?4G+<)R>=*WG4D[SW`FE:1+4?E$_&,Y<2Q98KY
M``JR9N+N4`((0/6=-J"`;R$[/*"TM9E%Y:\Y_B5``O*I@"-WPWA=#V2>.DLX
M@412%%"R%9\*(`!A)V``ZQ$K`*@39`WOXP$,-$#+8R%9SS4'DH/4LDL&;DH&
MUGRJ?4Y42[R,NE0/0(%*L>8G&W%(HQ(G78$8\4JHN69RPY-?#W22-0I0+]#!
M-`"-"?@#"#WD=+$D@0)\VB'WS5BD[KT3*IE[Y2$1]/@"D,NQB<\^T(/-.CGP
MZ1LV1+!T2FS'BR,?I00!7*8`#5`]T+42.G(!Y8=T0!%KE7$X1I4`!P`I"3"!
MR`$8U_0ZST)`3<$!`<!Q6A5?%7!O%'`>#:@30%$06.,`2T$!K`)_8S-^'_!<
M'I`50V0K<P9"B>(0_F$"6Q5B-,[!`=SS6ITA6B\#(7T")_XB`94E`.3"$%ES
M*;(2<_M&5`(1?ONF%-ET;BFG31+P6#_V`=]U+@*X%_S3%#!%`!$@-0X1`0!0
M4*^5%)J3=>YR9",A3+`!(Q```1!&`0:'`.7"`3NQ@-858]+#+=6W)T-R`!R`
M8"N74CBB%UK!9[&#%PF`%`'0@6`B`&9W$=S3`#_%2X<R`*R'):01;PBH4E:B
M,0.PB=)S%CRH(KNQ*3N1A)GC4P]3AP60-OZ4)H<$AX@1)("R$U6#`#T''S"!
M-EOU$F$B<>`D);9HBV-T*`L`/V#R2?_R`?KW%.QV:2*Q`#SA`$C4<2CH_A3G
MD0$&%W.)T8$8\$K8-AM!X2G?$1<WP0&9HSIP%'PZL2.2-C!9YA`RD46A-Q)_
M<0!FIP%C(U2UHA6;HA\<<Q`3<'OUH2\CY#UJ!0"KL0'SM"T3I"\C@S1K<R[V
MU"*IDDG!IXH*028-D`$HM2$,XU.=*!`?M@"5=1"G!XYAQGWCE@`P8I,.H`$3
M$1D%8(J>X@#]E``E5``;4CKV(AZ-P4EA9@&S,1%;PD\NQ$L"D1Q9L5$8,!K"
MED>!)A`Y!5#Y%4".EQ&JZ(^M&%\>\(=O"9<[,0%9(1QO:0%_*!:D<A!CMQ+(
MIDS5`7P]]W`?]P#?MR<P2`"'TA(B$R`N\559_E%9V/2,`>1HW6%&+A<`WU(W
M(B$E"[)-TL8\67,!&:$K7V6.ML<I6J%3@\@A6`$C+8@>N>$=D(5U)>D3UX4;
M'N`5`><V058A`4`^$"(3VU1J:M)>X=@!#!DUY8<!B=D6G$,!8?(N*"0Q6C(0
M(H,=T3D`[M,:^>1O">$BN=&3\%=[%8(M>),QE_$0Z)21`@$_$H$KGDA^]"82
M'Y9<KN)1,_D:995:03EXDB,E.2$A54)6\8@DK.8J7'&'/0AO"(!90$4@@99Z
MEY66;NB/#),_W[=Z[N0?`D0P`%!<*R&&/;$`*'=(\`="QV@T9**'"?!,!B``
M/<0UB-,0PU1S&%"4_@W1=XO!8`PP(`;'-&SE$AS@%>6":?AGF%H#HW?Q+1?`
M`(8SF2?S`#6D0J9)`0>2+YS6`*\($V-"&G)2<A_0A!FQ7HAVFL\A.!8PE9*A
M8(+ECC;7=#V4``[@0^,F7@"62(?T)2LR*7`2E!SEC@K`>*:U)?["=(`109/T
M1:@#2A9H5NSR0*[T+:J4E&/!;0/@3PP0/`.Q4T/2$]X!%HXH'ZU6<PP`,\T3
M:.`1(=#B=W&Q5`>@GFHC$<`!A@9`8G$B<M3",;C2C`2PH+7E&L[BB=NR`,DQ
M'=AV31WC%HZA:QX@`8#19<_JEGWAI/3E%!(P(.I#+PFR=..&.21(.P%`_FPB
M)U09P#*>-1`2<!4<4X?J`@'?,1.04BUPX8\%,AT#03@X8:X5&D1((R$Z>A#K
MI`%)2BI?)"47,#*@HK`8<`$4L"02,`$5<&5%\5(+>P$`PK#N"`'EP@!;@@&Y
MY4*ALY8&@),MXC>=9H`CT57(1@%O>((-(1SW\540X$[41VR"<RZVDY)G*A"_
M,3Y<:@%EQ4=`>$L0EC:RU!<`8!W.VHAC2`$'0"ZM16(!)R'6!2$&HE[3=D;:
M<Q0)P`$=8%;%ZC`:(!,/!UV+0F/*LGP8\">*P18-<Q5]B"Z%)1*NF%0NYR$.
M(QN-F6&:-&8ZH25Y@Z_Q%@%'$E@N)'(/$'#$_A*)?3FPSR(!&;"`,`$!)^%?
MI@@=[A%,4@$=#_!6W$>?RDA7A`&UU2$?$V`?]\@2%%`R1C>3"S`X'Q``])1D
ML+$5/Y$!LP>S&S`IDZ<38P(;`Q@`@TB!=$L1Z@5:H>L0R.%?_O4`^N8M?!A\
M?-.P?#,9`_,=`Z"]VIM:_C6!$#!!D,1'9E6Y!*LBP]L2S1FE5_(`$5013?,Z
M\">&B2.S%G%1(<*E*R&Q//L2#9.9!;DE'-`6`$8[K?<:U1*/'6"1`K:1FAHV
M)',0"E#`WD4=!1@V@&%(1204\L-/LS27CZH8^:%R+Q%85T,I!A$WQ<(1G*&(
M#4$8]=5#&7!Q7S00_F)7`!6P(I;1*O<G?CH!&X1U%N4B=D.3G_#DC]#Q)HRT
M?`(QHB/!ER[\)MA6$R-"LP?0@@OR<3!U%H&E+SZT5Q-@ONY9/PA0$AI`@E("
MFN!TGUH1`-7#@`_`5""3*A=@5^C$>(R2>C)"(PWA&C4:L$S!,3<'5!2XN(<6
M$P(0NL!!)3<5(/T!)WD))D09)=]X04"I-0=)(*43)];R:(+\$A:@(/>[C1)@
M$V+U4O5H$ZF,&`MZFLZ$.C(Q9QGCME?J`(D'.^22(HT1/@*0=4,8&H'5>;YA
M:C!T$VC#41&@$8D7?DN,4:\&+`R1.'X5-7&21?Z(89)C-/&6&Q-0*AI`_C8-
MX"CV\F->2443$2Z14L3OZBH"8$1L$8ZF54/MYC'U=AH34%GE22BO*$[KV)*_
M%4`?UGF6H0%X8<;205PI`A07L(G?"2:-,88"I2R^L2$B,R=\^%,%0;8EYV>(
MK%.,AB=:$2.2FZ,U?`"\#"8+:``O$C5&8XK[(@$1HZK:DC4BMY=-81Z8]DK^
M>)=)M(DPY="<`AQZY3*==T92`45C,4X:<"YFP5N.H217XXZV>A.R.!#<V!11
M]P&B3#S:NVQ?@0#E41YK8D8SR+\+PQD3S!8SB1P(^0`08,9MK61/VC$(U(//
MJE=0#+5P%#!R01`8,$>((C9T=5.E`R)1M1,'_L(HP&D;^-A:RKL25I,GCGR5
M2[F>@H',J.HM&C"(N6L`AST`5F$=.X*&GE(`(Q+(`M`I240?K49>S]%M!+$!
M405?$""?HAQ.1\E($Z#9^"<9Y-)!1^8;`=E0N>,G![,3$%,TO)03H@*944-`
M^](`7CL5:Y?5GD00"VJ+CNU*-ADU4:,OD:,PUTDM-S&:9=(7,7M`DT0<IN+"
M-),O-:V"O!@7D1,Y2RLJ`*;9WDQH\JTM7K''G/ICSW-["=,>10,`AP%#,LP3
M,`1#%^$8J\7@`</@K!%Q]&WA#=Z#?S@ZX)W@,#30]'UH%1"Y:I08,HNZDJ9K
M7\M:&!`Y"[ZS96T2_@E@9`\A(G/4JF:3KZQ182)6(:#WLCHA&8<!`86BO9*K
M,7^Z&`\'R011`:_C'/'X<BSYM2]U:MI4&40IG_HK8A_U)MEDJ@[!A_*QP6"R
M+6H%?&0E&;GF2F'Q+03'&AT]$#.T5!<"5$8WY'_L$JN2>E[QV6&1DBQ)3S?E
M0AUS-WH%5;C=,W36N`(QY(E5&-_69B4Q;@97)<!)%.K#93=!%=##S47!``N@
M(*4-,@L:%;G[XF+ZI"#XL<IIZ57A$S3F+(_Z627QTS8(.$:S6ROW4^T$W\CU
ME>^M;$6136(>.Y5E)[T#YF7E.$VK9AF``66U)LZR&_#E+)5UC:?A'VOB_B%E
M!>V5`>V75D3^$9ET-$R58:TJ959L7!GKCFUNPH=#?N?*5K)/`F'.LJT#]838
MM5<=(`'X_A41EJ@,5+*IEP$CW6D,T,:_Y1^0-A*@IY@(#28+$,:,XYLF<3<O
MZ6_>'4&`=P!"9<]T!$)19$";=UPRU'DK;0':/3!J)E4EBC,,D^O/!2;.XGD(
M4]*T:,[>8AD4^#!Z@J]KXT:IEYS[%"`'L;@<50#:RSD14+(CX:0-^%J10@"$
MMP%V]7`&VK,C_3D$DAMWURV('#:Y!0#M2'1U^2#2X[DPU*X7A-X;&=F:HSFD
MQQH\X1RZ'3:C@AF]_A(B5Q(J]E@:T-G[P=T`_M!`"R`P[S*[";11(L/:H_&U
M59\;062[#S04AX05L:/*J8Q_TW=`RWD!CA+;,4?X`O<=#X!&TK1&+J(E1D5L
M$'P0P5:?MT+NRG(XV`)M85.B`)`GGT+[O"$8[QW&8F8<O+6E:N-,,51)68D3
MYL83S-*S=6)(TG%<MB4`@BP!@@I)"N:C"#,!9,.*,=(N%R`^,3<XLTO'?.5"
M,?>$JQ>ZRT?'*(4GM84>US@6[<)&^'<:-39"&#$`;1+:`)%``88/!0T^<&"P
MX`$/'R(PX%"`PX$-!3H(`&!`X<:"&@X8D&"A(4>2&PEP*)E2Y4J#'3(H^*#A
M`LH/'"0H,%#@P04/_A4;4%`H\@.##A<(;#`@`.9&!AHH!*!I\,"!#`$P0'A@
MD`,%`QXF6&`95FQ!K`4O4-APH0*"CPX>#```H,"""AP,-'CPH,'>O0SV3N#K
M@((#O@T*,#`8P0`!`$#'(B8;-P"```("-##H`4%<SA<4:HB@<,%D`@4K)-Q(
MP4*&N)`_=*A0D.N!SAP07(!@8+)KE1OB+B5Y`4'E#E(!8"9)`$,'`QQ&=L3X
M8#,`"27C@OWP_$&&#P_B(E`(@7.%YPT[6&!\.7,!`!!23@``?NQ\A1X:<E`P
M8`+)T]PY<EC``+0RVR\#`A3P;R,,YB)O(P\B$*"!#?A+X#F7)D!``,:P_MN(
M`P<.T``#SZ+B`+`$CK.@N+`\N"""Z0)(8`+/2,(@JPP,B&"!ESX0L*`(`"`H
ML>H^J&`_#W*3(*H+)IA@@0(.8""VDB28T:`+,I@K+0KLH@`!#>)";B,-+%#`
ML@7HXZB!,]%D<R,#UAJ@S`0<8[&!!`Z+``("E((@R.X$&(`"\>+C"+P)>"OH
M+0D`0`H"#K)2`(+0=&RS4@T*,&N_S$:"0(,!$NQ``CL12"`!!!Y(X`$F&7@`
M@@D0(E4")C5(+`,,'$@P+`4HX(Z!`@[D#`(),?"`@;@F,"`N/[-KSB#&`$",
MN5P+DF"#+P$HK:`-'*.@(0DP$DD!`AR`J[W7_E1,*5D`+*"UI`[:+>A$!3SH
M("K9,J`@(TU?2S:`#^`#0(!E"\(@+L>"*LZ!N++]8%%LIU5H`]H`R(PQ]U):
MX(!*Z:.`@0R>:^E4DC1P\F,Q_<(59-D.0&#"#M=ZP-Z".&!@@0$0_8#,",YJ
M``$$&O`L@P4&:JB""S8(8(`)'Q@I`K@"(&`!"'@*:P,,*/A1K@,ZW0@!#QP`
M&P,&/+.O(`6`,]ME"P)FX("!.\`,@PHBJ$""MC;J(%*%+CA``@H&:#@""1)H
M0`+OE#9H@PKR2Q4#4M%MTS8.-Z9O[@`*6`[?!1#8];ZK&[CK*@0(.,"!"C2@
MU0,-&$@`<HD]4""T_HT:B`L"I#^FUX((-*A*9<K#ZD"B#RY`+<T-"!CR]XTB
MR.!&"BJ`OH('HE?S^0I<3N``!1;`2(`(%*9,,`C*_>E$`%1&CR8/O#NS@>(5
M4H"#@N,:H``#X"+```5&OTP"QQ5@R+,H$P`"%I"`@$L<LM@S@`$8P($(,%V5
MC#/``CIP,0-PU(X*L@``#"`V?L.(`B#W@7P!H'02H!OT)&4WRCBF(L=:B7W0
MQ0$"&F`!-]S>`AQP0]JL27DEP<#^FN4@#`@``2/\EP"Z19(''*@DAI%2AT@W
ML)E%`"T)F-Q0!B#!F#``(]!JU_KD1ZA+V<<!#%`79S("`5[YCB0>H(!A_NBW
M*\]H@#'?L@#B,K.EC<#D:LII2`-41)Z&.$X#EG%9ES8R.,@!S#(&@8`%()(L
MF'@@`PT@'5#LXQ<WHFE!,OLA2P87/I-EX`$%B%2#-!!%S1$@``QP#!+/XAL?
M%L0#'`2280RRNO@U8`"=#"5)#K"?AY2D`'9,7C`1Y)7MB4M<VAO:V7"2@()X
M+5X9*8BQ`(`2#.R)(A^@W?D*);L/<'`!%A``*,OY@?EYCP+/NTD$\A,7U'`@
M`A-*CW-RA@$+4.!J<N/(?;XG334B2"%Q*<`[%?K.Q;EM@Z;934,<-:BLN$F-
MDOGBPJ*"-+D`TUUP44HTF[F`!R2+FL'D"`86_A`!WV5`8>0,F0"XJ"U4E<2.
M!G405ZB8G;4X!J<?N%&%2-(!PITR``8@EL84IBF4T)`R%^7,9+#%Q[!<P$Y2
MA<"@:.=+R%%``"XS"`(B$(`#'`@#=C$/7`;@``\<`)-5HD`MAZ(QA:C+,@X(
MURTY@)$Y#>``#T#7!CCG4?HT`&<H54D%,C89!$B@./8<C@+<1Q*;,`8!W0(9
M3Q1`P*AXH`$*Z.`'$@"!LJ%P`9I!&V)3X@#W0""9"DF`IU[[PPCXR3[TNFUV
M.F`?"U`3=@9Q@``T`E3VL!2T`-!4">NXG`EU@"%FXPQ,18.!^<F5:=D!;0`N
M9A#X"&!%K"-*22[P_@#2H,ND):D`!B9``-"]IEQ0I9^]/!"7!$"O2GN5ZDD_
ML($O0@QO99N9*[?+D0IDX+#!=&,'('#4@7G@6^\C$/*F94D$%""+V;&`S\":
M&0LLIET:.&D'&$``ECIH`PN8`+S^Q0$RP;$Q'8!Q=IXR)@4DP#)Q`0D#?"4`
M`3@`QH0M2`<FP.,#ND@O&Z&:+>%FF0`\8`,.4(`%`H``@IRG`0*H"P&$6I`&
M9+%F&\$(`2P@6!Z+.:N2,>%NM87)"_\.`EM6;5A6Z4H`*&`"SMF`!!@@W8UD
M0`*N%,`"-F"?"@6@K:WKP`:BQ$',',`"AN/`%A5P`0#,-,X;@0!X\%*2_@?(
M5K41*("I#C``#4$-:L-A<@"6<C$/)&NX,;FH?@<%E$%ER[4%H;-<1</.N%14
M*X*L%XZ7%S`@.S<NL]W;L<,J`#@_AP//%A5!LM:`"EA@A]2>6#(=AAP`@Y-'
ME$D0^`H`3-:$-LAP&7!J-G?IU_BL`?R43E(H51]D-<"-&8B1U28GV`1LV):"
MA0#$/&"!K362M!`H0%U2>H`$^+=A*9(J_48'@)TTT%4<R`!;$%`!%0U*N`X@
MUHHP+K2G#&P`R)E``1"0HIZ,-]0,F(!J0$:O#JR\(#<"V55`YM0%:-(\>@JS
M_"X`0+8H)\[%:AF[Q5*4"AP`:@0XXM)7Z4"H_J,G9V%^Y0#&2BP&?"T#9&(M
MPH&L6DIO0'!O=)L`D/V[#I0KYAN`.]PS,).>P%U%)]TK-FW)`*DB("K>V69,
MV$/6)(D:H<`\;77[7.$!.&P!*K+`6W[C,V%M3H<2$)6V)D-6"`965!Q4`%AQ
M:0"-LPP!FSL]!!>0`*E:L``%F)!G*9.\"TP&.8FV)0%N6;O,_-F$#5*(D-.S
MW8N8,"4+?G6<_3R<`V%0Q1T1B'\5;8`9==8!!.AZ0,E58KPE@``',TCL6`:Q
M#HQF[1FO]+?@"X`"\X0"=QI;B+Q_`*=!%97W%$N*T_D9`&0`602(HCYS@/GC
MFIM3CBA+%+DBJ8T`_I@[\X`$^!#=&!2M&[3LX*?1<2L-&#OZB`#L4R>E`R(H
M,SI/X@"@F1D)(+6$JP#=(QD,H!58.H`*\`L03`D+.PO*DBFU4ZVUB0M0>K0W
M0@VX*97@*QT(@)P$,):18!&^*Z@&"`#PXX@:"Z<PJ;D#&",UTC($T!\"(``&
MRBBH0J#]PA#.()VI4".+4`@Z6[_HZBW)V`D1P8#6@2@8^@"MX@CO.(`OLB:#
M<)S)4+D((+A1^XW)X0`P*0G?T+LX8R4,`B78Z#F2V``(V)KGL,*86+T`3)SM
M0:*8B+)-+`#]H!$$L)V1Z9D*T(A%:3@7$:`%$!&MD,'#N)ZKV2S.$(`"_LBO
M!H``3,0;M$@W#8":8=I$!2DI`6"`,<N9`="R[+`YA;"PC?`.`R@*"!``8,2B
M+QP7ESD2!]"-K?&WWW&<;Z)!X'F^^9#&V%$1#Z")NJE#5XD-!!BR2!O'<!0M
MU?"UC2B`"]!!Q,H:1N$`UXE''E$)W4D)..N("7"+<=.`U.((/8$Z`IB+K#(`
M3?F:\?(^]HH`>W$.ZK(5#-A(6\$;/T.(!V`9^J,NF=D`H.%(C90;#)``6^G`
M<9D>IE`(#/@>3=$`A-!%E;(AD90+O'J.6QD.,L0+*NJ`'5J[HMRA#U0>EU&I
M!ABFC:B(!0`E.!*`"5`9#'BRA/*=\BL`9(M#_@*P-`,;HN!SFGK4BNMC*1G<
M`+@@EMB#C[_"%I"+"B$CO4A1';$Q%P[R*[E@KSX!)<RC"F=TG`*8FFXL"<#X
MQ#<LEK.2C\P(O>`KESTI`*L$*M+"'(Z$`)NY'(_1P)IX%6*D@,Y4GJ]1.\.4
M1T@*$_H('NG0$!V)"L<2+6QD+4$;M]-,C02(2&/"Q[6C'![<IAB!K70S"#1D
M$Q=\#Y&$PA@ZKD";@'=I,]O4-8.@/HEAR9+0+S8YQQH9M>R+F.8Q&=N<#[6H
MD0EHKI^9F0=`0(Z@@$B)QP@H'</,L"3AB!.C&]]YLLU(MT=)@`A`HJ]!'I<A
M"A'K"@W0B+:J,]4)_I$W.X"#X8`Q88#]V<]JNP`T(H"I>8U^JK#8@DUP^KI@
M7*7<*`"\$HMMP0HG&8#3@\K'S(X,J`!DA!Y[<8";!(`.G)%W$13&T#+3V0`6
M.Q14<H`+^,?YV!8-P1SP;(D"<#B6T!/N2(M#&8!4L0"+^!(5X8`*2("S,$O;
MY(`NW(]WB1B!R4>4*K=MZD>%X`#3O)]?>;VSR1Z'5#F'=%,XQ8A?@1)'@1^"
M7`FAV0X-J%([^2LCW0@\Y:XB83:'HRLVD8G_.)08V4!`92+A"L`CN9J3\YT2
MC*VA`C5U(CB_XP@%(T;Q2@`)\(`!@)R(&,N9G`L5>[P@L\"8D"H">(#E_LB.
M'747?#L`5.(.%NF3)0$JI,`(K8M##4@WXED62^(>I727/`N`:9$)#KB`"_H.
MDI@74LD`_KQ#`V$`![!%6!VT#:C6S2*=(*TJ*D,N1]VA2LG*J,&./',Z`H`-
MU^BG<7L`/K--VB$(DN$_3]/'Z>C&"1#.F8$[FHR`@=V="O`GM9B`:HD[JZE*
MT,B-`)BWL5DZ*%*9KZ%7VU11CE@`"1C`MGDC=VT3,DF)%7Q.1XVA/.E&I#DF
MDHA2[F3`9.G&O-%*CL`2<.P^7!D>M*&`A.M//>$^2(H0D/N,G-@`\SFY)%L)
M#?@S!W*`#1`7`9!&"@",BQ*N7#DNOPI`XD03_@IX+:>SC*:8G\;,C*P`2YO*
M"DI!1WF"FEC-#IM@``;J,C:Q@"QS5`(-QK'P@%OIPHV5H>)H"NYR`/!(.I,E
MEWVIC^;PH$][%E#2(=6BB\P0UJAIM;L-BM,K#C6+.91@#9L%3P_8/Y(8V`>P
M@(@HB65$DX%3"3LJ69,]Q$VTJ@CAB(34VL^@OPPXU"!S&K::SZ&C3#&QF>1A
MDIO3UIUZ"Y<-"@,P%0V)DN*@EYBHERXQH4@RS<^X`.XQFKR=@#*)@'"ZJ*2)
M$MKX1#(475EM$]AIB`V8@!.)T8Z31K$U#81HCV[4C/TH"S.]%1X;B""+//VQ
M@-$="WMK$D`M/UVL_I0.4*FRDMB]>HZA<2SA,=D?0380^X`!0-9*V<=NY%CE
M*<JRFI!7FD_)VRF%,##D:8BV<APM#(!^FC(#2%*E\P"&T5CU(CWW#:M&[;,#
MLQ(Q8]VQ\*<^&Z:S,@!X43!'0R(RH;*&&9A64:<N<;CQX3B%\#N:.2??&1_Y
MI-F_HHD+(1<H`40.H9>K<*4#:<G,<,_]=)GG;9(%^(GTDMHT\IFK04P<D10R
M(4.Q6MV2.!+2B9$`D"")L8!Y@ZVG4!:HS)CB<!QWX:>A@9("4YWT)3VZ".&.
M\)H&$-=+PX`_52T_@XISE0W<W`"195U?C&"B&(`[;A/P$0`D&M@?2H`X_JP.
MB"5C@Z@*:"P)#YGBS"@K`#"5_NL8(AE!VWSA#^S'O,5*RH)A^K`CEK"+?]UA
M!S'+]5HBH%J*G>W=#E&`*(([6\H+FVH@=0HBXRV(:0P`")L9UE$G#C@1PYW5
MG<T>R=!%=%Q/A!KC%57%QU4(Z&4O8M'E^)"@K5B85XF/FGD6Y(GDO<F-Y"V.
M)ON,7*Q-,UW0W]B(%N7C\*L:>:J?[2"8F^!"H>4(M?@`&J;!&[G84(+&.='F
MM>B`(]OA21N9KJ-@U>)>4/J>I02/EX9EDAB4`X@F9!P:6P0`)'**P6!IKJ46
MD`7/?GFJR1@``@*`C+FAS4'>!8@:RMB8L2N6_@K>80^((G2*G_I8@(0T`-+B
M"#P2X=#0ZB?=1&U59UMRSYBA68@US+?07?4,T\\X/0ZI@/&)CSOCCRN+#XRN
MHHPQG9R3`-T(`%"CC*X<L[>%JEQ!%:FZ9M]A$="BY0\P*)61`*=H:"N1FD&V
M)2E;@"HYY/G``-"9S+*I4JDVH6IN`)0X9AK$`*U3.J6M"A6YB.?YZ.0TTK.+
M78U(7'WD#%#BZ-]IG0&@E::NY<V+FJ=V%0D8C6I."0KPM3<S4@,0#*F)'ND1
MG.Q6DYZ+GIVM%%!F"0M(S68.*.Y(Z4^A$8H#Z@C8B3Y;CN@+COU\HPY$-JT^
M`$NCF7ZCD9XS3+M8_E6H+``>VVLU@THOJL5B5!%VA1$'C)CA2"@(X;$O5*/3
MRP`UT^H1^PY"X@!)-*+*V,]^_`@@@6+BP1GH,1\-*(H)6.IT&VTT`8W[@3E]
M8DDYP2L!L("L.LT.^)N"_J$'D!7]FH"MR0"DF=[3G%"2R(!T(H"U5A[&9I1"
ML30V*6Z4&.>!O![\(PF;B6;=@K$?BZN6Z!'H7`G_Q>/H%`OQ7HD.((!*WN'!
M&(#KNF'MZ=1,`ZR.-A5D&[K0+N*S$;CT'8T1@IN$HY'MH:K/4(`0#:@NP0Z:
M3(`&PD7_<@!143E!TA:>08!L%0J":1*=]A\-\-<!WSR^VDPSOQK:$"XZ_MRO
M"S"<%:S%SC*`/*2B._NBRB#&`IQ)-%>)S'0MCGPT-9ET%5=:4;FGR0REA_C1
M?JP72Q(5<0EM&@R]=SL("G";G;7A2^.;D<&4ET8I$9.`3/>=IU0>>SLFW^#-
M>=DOTXWH4H0QW2`U4I,`8:'=:Z><MKI;S2!@6])UEEB<L>@MK';4DKJ>^5X.
M1#%%!U"GC.-KO)%$I%4(-#+,"14T#]ALKYC$@,HT)R\GS"FP#L%-2[MDN(`2
M%6L7^6%Q+E9Q@J'VPS#PUZ@`T"D=FJ``6"T*U;D`JSK1[557XOFL*;,T+]6*
M<H'"O`$\1T%6CZ$/N^@9TBB<INJ84)L)@]AW_OK`@%=Z*B)C#.:DW&`Z'KAY
MEX]).%)]Q&86#M^1X.]#+(EQ"'7JFQ\"BN;H`(I+B67$1Z6\@%\Y&G^;`$QT
M:WEL-8\ZK93P`']I$PA02,&/'?.FK$U\LGWQ-0-3]\\>FG=V3T$+J(>HP`Z1
MZT+JBG+.[^#0,L-L.@DAH<YJT0/HSY\4P<;*?%FF15W>'15A2;ZA&W2!C>L3
MJ^N!&/P`%%(#.72QHP:B"W@I4]>/CY!K"0UG/VU)G9GC]K&HSIC`D*QW*X)P
M5FV<EP#^H1U2M!"AKN_?>L2"@(0X+=8B[V\_'H"G04J#F#(*E+1/IU'D"/Y6
MG@=XBF#CS9.P)<Q3_HFML&Z`Z/!AX,`)#0@.S``!(<.&#A]"_.!AP(:("C)`
M])`@(D<+"C@RK/`1),F2)B-"`*!`X$`&!0E(<.CA00$('AIJ6%#`PD,+#30X
ME%"@`0>"#PY^T)!@`DN$&0PPP-B0PX(&#P1Z:%#Q0P4##C`XW*``P8,,10=N
MH'!@0($%$K9J`#!`@(4+"@H((/!@`D$.$`HPB``A0],,-`U`P*#!`P>?"AQP
M\.!!`\T!@3MT4)!@`````1!`H#`8883.(Q%2D-`9`-@/$2I\L*IA\0<*!6Z>
M3,VPPX3*``Y$T+"!@P$/"_B>C'C@0@0'R9^73*!X)80.#RR`5@M].TC5_LX9
M:C#`08!4[@XY#/"`8"O#!&?-?^#`E^*'`+`?!L#]H<-MCAX8$+#`>Q`\P!`'
M".@''TD>","1`SP]]!]W(IW4P0'O*7@2!`U<@.%`%32@@(@49*#?!82A!L$!
M[DW5'`4)#J14`?<U9-<$,+J&``,>&I`!!@DP`)2!#"C06D@+*!"!?A0<I-8"
M$"+D000(1#!``@880(".H6'4@0860.!``@\L```#$ZRX``4:9$"!F`<P<`%!
M&(AD`(E;^3A!``#@92=74$JD`0833*"```V0R-Q?9C*D```(-$50`Q9T5EQ+
M-P'V0``$1$"`!1Z"%$%,#W4@&@(&;!J`H^7!_H?=!PS0F.%V'0R@%&05=!`G
M>7[*JJ`$6L(8WGB@*HB>`U0VY($!1IK'FP8!5&0?J?DAQ,"H'&7@@`$/W`1!
MK`,I(&>O_C48D07LH4601MQ9L$!RWHY;4@>K#5`D!KBE1,`!!G0V@`$7",F0
MF!O@N$$!!)RU`7)2$E`!L>'MR2<%!%FG`+H)Y84`LP1=8(`%.'XP00%7[98!
M`P64V-`&<!95X$`<-$`O!`%_H!H``F"EV5I%>M#!!0P`X-4$9_D,@0$)&*QM
M5!A$<,`!#[+*$`88(,#GF!B4"D!Y''0F9`4+Q7?!!9V-NO('%P30P7@64'I!
M`9%V)RY('#`=&LC0_C4G8;S0<9"`!P10()UK#53P=]1[GR3!`P`$6]P!=\/'
M+P`$X+C`QMMI$,$&EC(JT^-.N0Q29K]=\,#$$B46&]B()TOM=AX<P)U9R65P
M+>L.5;":[OXVP.]]&UP``6<!J(E;!PA\;J`!"."J+D8PL]A0!4['K+D$<&X@
M5.@,7>\`CAY`(,#I4@-V\4`44&D^S!YO,!Q2'XCE0`0)=!:`X&ZO=A]Q&&2_
M`)61/:`""`B``!90G@[4*4`7T(\&[A*TLACH8`%X0%KZ=0``C"\#D\,-!>XS
M@=)U;2`7V(@"%F(!$EH.`'#C2`7&=[N,$.!$WWDA230`@0T(@`,2`,KT_B[0
M`;_1\"0-2,G&<L*!Y,5K<;]Q2/3@DST.O"TN-&M/@CIPN0A-@`*:$D`$!M*!
M"$P,`NX*XD`\,+D#-*`!"!@``1*0QK4,`(X$&("_YDB`<N$-.2;90!?)B)"J
MZ:XS!Y#`]0"P.B]JH)!00=0&WD>0"@C`)N`Q"&!PI`$'%`!K$1``;CQ@*)2%
MI6DK/-L`'+!"A2F`6"$#8D,R@`"DQ:8L+JF-I_J2O:H-(&*=$<!6+G"`G,#*
M``)0@&4P0P$&.,T@#'```3``LU,QX`%G\4#VZ$<`PA7E`H`,@--V6;4"W.@#
M9?I.![PW$`ED8$^42XC'&O:JF0E@`M=+#@9F_NA'A&R`<GNY9T1>HQG<5-`L
MV^/G0Q20.P0P1#0<.$V\RK3$AHQ1039\5@?,2"@(,*`!&3T*OPZ5408@X)H9
MG2)$=&B^#.B1C/(1#"$)R0!K$?("J5&<2UL**'JFM"208]V\&%`7S&``HQ+`
M@$(><"@(3"!@'@A>[VZVD4<NP*<<B%H#"N``DG9``@N864'&R$<"G.RF&&A`
M`E[9$`LP8%DP4@A90!:!J)JO=-;2CV2&:("?-*0#;.N-[@C`'@P4P``*8(`U
M(?`7!U2@`AD-$S/-)!4/2.!8"XC`I[R(`3()(`$2L(`-U;@:L/C,`0I8`&>D
MHC"").!X!MA):RK@_@!)(H\!`SAB'TV2@=@1E&/.0<!-<SN0J]*%8Z.MV15]
M.Y!)&6``#)D`!/K&.OJI)%D(4"7M%O(12D6@``EP`'>YBU1"@9=0_EO`LN#C
M,^.BMT*][=5P&K*XRW$@`F-9P`57<\T*;*`I/2,101P0)!'2Z)(5=4@&P!JI
M:/Y'`!(HB@4L59`99::V`_E+X:0G``>8[P,9*,!'+B<!.X$,,>O-'`,$HL'5
MW)0JG9R>HW:IE]9D0$0",(":SK(^`<!*J6--P`0KRH$'*$`OL7(``!P@-[0L
M0#T"(.!O&F`DV+UE.3A+#G^H2\/O%%C$.Z6ADP'`G@/LQ`.@3"]#")"!_MPM
M]X9/W5N5!B!A@B"`I-"9Z$8V`(`*-+@D&CC`QJ2T@#^CBBW<_/,"",!-+15@
M@F26788A<F8'$(^T<T$``@H=($,'(-,%\"-D]Y3#B%``27D!&KT:H"2&N$T"
M.++0\GK;`?*"JLA68M6&:N/&@JB$@R4MP"\)+-N/<06?`NCU;M3"4'51(`"K
M"Y)K!WO6QWE`-`$RU*-(30`'4"`UO`%DG'"C@:\5H"8)\@!D$-)@TU"`,ZN)
MY`+/5@`-T+$B/P[I`5YT52]2JL);_F-Q@VA0W*!5`/5:$T'C^P`#$&1E".?/
M*-%;``Z@)U8$ZH`CQY42`+PY7@I3RD`.4#@W_B/$M3;A(T(*<"T.$*!^E1XM
MDOX\6@EH=`(M+%1.%\TZ2GE&`9%F.<L[Z/,6'OEV&P!D9[X5(6T)4Y>"3(`"
MF**!46+`G4$9P$#18DAB]6XG!+FX`!Y`&5!%6P%WFP`"S&D@RT6(`@:0`$(9
MD@$!M'U.G=1,0S`PXTB^AVH3$$!G"+`\RWA1C`+7BHFXQ9`'V),">J5)IA.S
M5`CP.``G>\T&I>89`%ANP!W3EW)+\A3C7B#E![``2P(>@`8,F(Q:Y#!!M+H1
M#!Q[T6_[0!L18M@-L#)>1C/D"VMW1,G@EN,$:7H`F+9I26&%*Q,S944Q,VZ&
M2$8^X%4\9BK:L^IC_C_[/9-,!S+0OJMT0&'@U4!XZ408'WKINZ3//ONKK[#V
M2Z:,&;``S!?3<(EPO_W.US_\X_^08UJ.IT6`E4V%!1S3'`T``DC`)E7;`T0`
M9B2%7:`=3F14T'G1`M@3Q5R`:.W&9&'4\LB/!%``\'C)!&08!2@`ZB&$</P8
M.*V0R13`5JA:&3%)`MS4!F14:\R$<TQ&65E5`%B@07B`!9"=`&02:"1(!2S.
M\K@%P:B,?DD20I#=$+5&8\A79Y28NBC6T!A@!#3``CS`4/F,"_E'`G31`Q+4
M$/;&BBB`&,;72S6``YC@OG''5@V`W,S,C3A`1-G<!\P65R`<03#7JQW`_I^M
MW"M]H8B,Q2N-!=,E@,L1B2)R5QKM4E1EE`-H5)(@W@-P(N*)R#)QEZC$X2AB
M(B;2E^(MP)4`P&S4#(:IS4]PTE,0!@?8QHIP&%0PETHL$S(U8DBE8EF%5``8
M0`0(1@0\0,KU'3+J#O($4@#0D;H%TI9`P/P$4@$$DB%AHE%=XS7"R4LYU.[H
M"Z7IB)1(`(&4%3"B8V`)`(Y]E.3TRS9>&S$R0,1L2L9Q#%CX5,Q4G4E\T3J6
MH[IM"A<Y(#,9(-,QA1>QG05J&*D=CC8MP`847Y2LA$10BC,J7=?AQ`$@P.%,
M@#`=DA1>6%-(@)QH1`&0X0=$W6JPQVL-T%)\_@@&-81_$82/P$\Q10DX^43*
M%0`8+9-D;(]:P(B=K08:.1-7=`:K6,BF?1$"G`X?&8H"WE\K"8`-1640(=`"
M[,E#FAA:Q9&3[0WLA,<&>(\G>8L&]9MQ_:$%$(`4?J2<<`#`:,`":0#=B,U;
MW@M8`$^'<$!<!@R__`N1;6,@U878?&-@_D93E$:_((\RKL9&3(1A!I(>Q0QD
M/A3&4.8!<,H%%*9A,DM<0":T<$!%62-EEH<'*%U@8DV,4.;-S"4'*,QJ"@C$
M:<!H=H8](D1\A0RDP`?=B!9CWLP!#!-AW9#)8,2&#:#*I")S>!E"=,!?&%ZM
ME9'=5`"2*,9D``@R_JX'2WS1`B@D?S#`%7'`L=R4!E#),,H98&+A,:T%WP4=
M!9C9;C#`1R;%VC$$[G61!UP6;8)&2C&3"4[39C0'7JP&!?#=\2'$P3G`B@#(
M!U@`,0H*,Q%`&Q+@A,V2S6W`6!$0=][$$.)%O57E2:`5!KP%@DS*DR1H'R($
MPDA$#&Y=`DXC,<9A!##`9!%CC;YHC<IH8!"C_(`196E*T&C`9%+FC9(:9')*
M-$6`.QKF\C#H:JX&-SG-:=[,.NJ.`3@-9EY>_5PC&Q4B-%*FE3J-;QHF6SAI
M'#F-DAIIF'J&E(+C'37C-F9:RO&=[MB.0^Q%KE2HK&2.,.E.[\B/J;5$_IPE
MBU`T%U?@$8.V18+$S@9`0-5@1P!(6/;$"#']1IQ8P.&($`'(Y_DTS`II0%YT
M)P;4UVIDBEEH2Q2>4R:!!P'4W(;=8`*P2NT<(P"X#'ZBT04=BFL66<)YA!%V
M1MS!V:=.)<J)&0'HQ9S0!&Z!1)*A*%I<#QNYQ4V@5$@9P$'"AW=9P#$^BR>A
MW#Z26?(H`)10QL$10`&0!2:%6[E:A0/0Q,$@T\$<S+YHR1I5FI5B6@'045O`
M*[R6*Z]QHG^-!;NN5K^&U,%LRR9F2;B)B8X82KD.STS@&*6)AFAL(KLB'ML0
M5;:R:P6@4_A-%8%$0`;X"%E,@$_X")M8@!*R_FM3T(W($A51M8G*DHB/B*S%
MLJO-;N(#G`A1$0@8,L]E79;%4H#&_FLG&J,\^4B8(-X$&"-B^47%%FUUH,67
M!%`&V-#+GME;5(0$E$IHG,A.F8PGW>'>>$E.(`#?&9I<7),(8D!E(<1EA:ND
MN,P&-D#*'*B87(=<+$#`R*BXKL<FJ:/IV&U28!2F_DRXJ,P$+%./X$1D>>D`
MP`W07(P$U,INC$SCQ,G;[B2.+)-`:$N2E6`T`0WJL4G;-DU]Y6E2'$0YGHT-
M1FAO(55)2,!_-:L7@4BE"6[WM4M9&=GL/`=O)8`&9)O;9(![L$9Z95%#_&'-
MU"G9@D=%0&!NC>1^_MP0_$3&CJ27!EA+MF5;"W40!,1>[8IO;!!,#`717@;9
M-?*=H$H$H41-K?C2`&#J!RP/4$A`1*Y@@@#9QXI0`E@C6('O5.Z'VY650@K/
M?6@'06COIER0,$4HLC!$=GF(`\33;@Q2*PU`G<+./B8`TC``R*01Y;+IY%@`
M4<VHONBLV*$=9!U`I!B.281>`]"A<4W&P24@.NU'Z>`%.$THQ1C`;"9<!FA4
M`J,H;WP:2J:N<5&<'_''35'3HND5^)(%EB`38MBFS<TOF6&`,R8@/X4?!*2<
M,_;=IFA+QG5`\5&)G'G+'DJ$QZ$%`YSD!^A<$ELGO<BCND!:Q;W,]1Q9_@),
M#/CPW5T0R/7MQP!4G"<!JT0T0.4RIZ;B1`!XB,%L6*3D4T8]Q!JA[0%`GO@X
MZ>0<\=`EB#8E1W@D\?AN@$@\REM(!*/B19%,:)`*L2`JBU(T[Z(-R\MTGBW?
M4Y+J;RF/;WK-Q$,\I/A"@#IE\0OID(H@0`/,::5,"D(XB@SCS@%P2P?@#/+L
M!X*.THR`C'%T"&7P2P!00(<T*-B)#+!)9`;XRX)Y0(Q-$7K4*:4D<K29[]M&
M4D.(C/2D'-STS:-8Q0*]Y3S>C`J>C31U!G"IRNRN$2&M&_,\0.HBUG.4Y*:.
M+RVNT361I`ZU\@A"Q&:!(4$L0%>(V5FB%WU(_@0C9Z^!!I$GE8?=R1E!H10%
MO$>;L,I+^Y'1_?)`8(!@X30_K=1+S87_]IT<`LAZ70#,T0@889X`+<`*>0"(
M0*[*D$FL0!:0X:L##!5XS"BZT**,+AFJ:MB%)0@&3)93:$E4,`087\Q.U]P$
M3*!1^%6-#)!B-K/*B2`"%(IGV"^G"`DM-NJ8-)5*/-D/0X<'**X#?E!.WZ;B
MS"BBG$OM](X"F`XZ#T07`8<7-9)S\"&*WO)`(`9SWDB#$B.AI"PQJEH&4!9S
MR$E0!<=SC(=-[XU=X,878A@P1Y57+M1@]9%Q^&]/HQ?$B2]VU2[X@!G1]0N,
M6,<!1$V+[22FPMXB_B>R6"H;@<VN8=.$7%``6#S`O5`,B/`=8C2G(<_)G'YP
ME/`90@B(E33$(D?-)#>$4&!(!="1T1EVD*7<`+AU%F&E[J33HQ`$$1)32-]$
MJ1P3=)E&18@E?,Q$I9#T0Q"5;\%>+MD@_KE6/5;$3'``M.BTHPA'!O;AL[P'
M332%]N*G06B&9J@)!/"$#8TSO*0%5R6'!4SW/4'0!U"00I(9C)2.AO4P/ZER
M[=)/^))1+$.$\/XHV81$YT1)I1Q=F-6$%I92A(3(-!&&4*S&0CR>E0QD@C#M
M310I[[UM,\U)=@,>0_0.C%0``<"-)SW<.94%!4=;3HE,A!Z`9*M+J;3V_IXD
MLD04[V35VTRN7F<P"46?Q"#6TG-<0,W=$S7USF<,#9]#6H1^A;)R`(C4AF^3
M653'""23&7IP1RU'A)?\R`=X.'J1V_W-L&(3U!KU^-ZTB4G(*%@\H/8&5[+L
MRV9+1)(&(JT(R="EDDQHBAYYDKQ-5@70C[]@7+0]F<*DQ@@?FU(0#!\)P`7D
MDX<3EO2<]W(]W.8L%1P/(X:4QND-A*$]C>+I!P;49A7!S\N@2KD+"6198P!P
MA)"G=6CZLJK?)@IRTP[=1#W1R0!4V)GP!>**+[J_1UQ<\780884$HNH-S8P!
M0+.>97SBN\2W^MZDSG.,\\A8("M7((`M%7U!_@D48<:OE!OT=>1+3='C<=;7
M6&("H-$$\$\%R!>0Q.<ENF,<X7=?!-7-6&,"J+EZA%-?O!*,V,::-ZH;?X!R
M$YF1H,U@7,2<2$"0;=<"78"ZM=$'685QH-80*M;3F*!`3```S*"#@X28N4;"
M5SS%/`#,'X#,+T:A6&F8+$74P39Z;7%3S$O#2\V'GL<Q3T4NTW@`E+KXWD1:
M3$;/K#T-7_Q7%CY(2&U>&8U!_$RO8T!:1<TF`8VBUTR$-IQH-8`SXG"N:Q'1
M]9'/8(02[AE;5$2!'<L%D44%!!;"Z6Q2Z`N,],[%8!3<=`"J"(E2A'=%[-T8
MY0I+S%]1Y`HW95M@_E[;AA[;%PF%6W!&X>\X1^"@LN#XXLM$\&!)`#P=2@H&
MIOA];NVT_AZQVS7^=F"`X-_3>O5A9E#:!(`<=C33[&G__?M*O'3P>YR.82,&
M0'#X,'!@!P,"%&0@N'!#@@,6/'R@((%@!P@'$3B8(/"#!PL&*GRXT(!!`P<#
M#C084"&BAP@6!GJH$&&!@0`%'B@<N,$`A8$38&I(N;!C@@81%RHXT&%A`P@-
M#'"T@$!#@P0;"!!@VN'"``(1/B@`$""!!0T+-A3(<&```+=OW1Z($$$#48(;
M+CAH$"#`1KL-.-I=:($"!P%U!2=6O)AQ8\>,(0@`0(`!S($6%CS6O)DQ_H8#
M1",`P,"9=.<'I5$3Y$`Q=>O'&RH4QB#0PX:!B%WGUKW;KH?`O#=S.`V<:`<'
M'CHT4!#2[H8!%P1W>&```M.=`CLH6$!9IVH$"$:GA3Z0P_<``,!W?%!A00$"
M#D).Q3TP00*?SB-XT$"``M*8VHM+8(&(C&.@(P4:(*@""R2(0(``(M@`@XPX
MH."`"P!8P`&;W**.(`DND.`\MQ1XX`$`J*/+/Z(N*`"``1:`(`.DAF.,`0TD
M,)"X'5V3H((*-KSI`0H$8(U'US!P@"@/#!CMR"=SRP`L**ET#;DJL4RL@PFR
M3,R"\8CC8`$),)A``@<86+$@"KQ24R0#"K"._B`--'B@@`3<?).Y\G3:((/A
M_'Q``01<!$`!VPCRJ(`-D,)``0P(P&Z!`3,HDBBLN"2*@04T@-,Z#Q#H[ZX.
M!#"``0(*8.Z##`@`0"<-+IB.@`0@T("##KCB:RP9#_BS@`$2H(M1%@7`@`(%
M"D"@,@GR7*@#!#XX(%,JF\72`2<_T(""!`I0J\O-/%@@``TZN/*#!Z:MTDU<
M.?-M2;N80HY==CV00(`'JOU6WP\XP';?*NG\-R:JH)2`7.OD[*`"P(8D2@/M
M.%@Q`P,`N/<W@BAX[U,#QG/`6[L@0,`M`BP;:.**!_"I`;"<LRX"!2C(H(`$
MG0UUR0,.H$#.#[*+_HJ@"P)H[^(/-@@`S)@D/"```0J0H(&W6IWL@;HZV$""
M[1`XP%\3*]+6/08FV'FA"B:H@(&A><Q7L(A+$]L#)0536^`/0D.9@`$44`!5
M`A2`$U7W``><OP4:*("!"`+?NUO%#]C;``10_8Y0`I03?/'$$T!@.@5*->``
M0@M`EE#/%Z#`@`8.2/;7K$:<;V[@-J@1.+1?K]TQ?WG#`(,"'/Y@-`HBN"!B
M"12PH`(-CI=]`@(.0-!8-RM`H`)$.T+K`P8<Z(`#UXD^0(`'QSK:.+>*76D@
M"`I`3`-E*;9,6P@XN`ICP@WN+0*:5R/``^74[,`M"JAW&P=HX'X4>XN$_H!7
M@`"@*FP\`](`)$"!T;1H(;32P`8N`JP($>5:$TB7[7BT@2F!\#$2:`M:+K`!
M#G"`)Q&8``4F<H$)S`5X<YF+!"3PP@O4Y@(VG`L&0&3#!OEP+A"PX00\D($9
MFHF(1*Q`!JKFHQGY*0(2R(!9-)"!%=ZJ`BS<@)_.@P"YD5`S[B*COGQR1AY-
MR#$=((``!C"```S@`0+10,@&^#(%L(LA0&S@SR+`@0@LI2`+X<!4X'*`"@A`
M5>K9CF?D)`$#?(H#(2O`!"Z0'9@\@``X7(#V>,8@>$%``1IX&P0Z(H$$X(Y6
M!,#=!R#@`(H8A'P<P4`'&`2!636@CCSK``40_K``O7E@-!TX0`+D9#4?K<P"
M'4#>!RH@-C7JIHI5S&)J7@DE[;E)1]-,#.V<I;852M.;Y2SG&,WY&`?`C3&(
M'$L!(D``L@3-`QZ@P`X%L[X$"*8^S0M@01AP.@K`)7T.($`&%`+*#UA@`*@<
M&V"(,@$!$$!D3!,`H0``DR_Q+`$?[`@#$&!,FGG`3KAADD4N9)>,U#,!;G%H
M;RC0`,@QH*,SXE>R(,B6HRT$B/7ABP46E4YJ7F"5.12JE@1R@5(6I)FC0:@%
MH,H@#H0HJ@OZ$@6@>D4,^.:+C`D8:OX9DZ..-6[@%!@+R;J;`(25(`SP5P=,
M"!?^V"0`#=CI0$14_C)#YBQ/0$6B!VZT`/ML0``;R)@!(L`7@F$@:#[BR`4(
MN1`-I(\`$T"32`(`$PT-A`$`\.@'$A!0FEU&C`/!$'0R]L&W+0`#'6KC+]$7
M``,X(`!01)S2EM.=OTR`<_<[7EK!%=)(`5<Q#]"1/1E5SRU18`+PDX@'/8C5
MLAEK`MH:3ST9LX'/)DJW[R+N=\$;7L=4X#.*6=$%VK-5XLD3+FZ1+00BLDCL
MV@52895.`0SP`">MA7H6N`J;/+N_TPP2+M+C@')<=P&2240"'5@``E)&`-MD
M8``6R*A@)`"`-!*$E$A!@`+P*H"AU0T`HWV,!RXP$0`H,@),$:%8[%.N_H5D
M0$D7.)XNT8/.M`*6;!T1+UX3:U8H6<#$=KG`2W^<9"4O^0,+:&1BJJ)`V0TD
M-A1U``(,^**\L34M;F'`L`IR-5$-)@&!F<``_`0`Z#!@45I)@`%@$T^HB2UV
M'H"9KLX#X@\X;54"^*Q3B%*>HY!M7`,!IIL<X!8CM>L`$%@`'!F@LXY0H"8P
MPFJ]4)F9BASG4DFF-$(;HF0BL74W^>(SM>8VW_DFYF79]*:DF3Q6-YKWC@D@
MRQ_C9H$(?*>]+PI6%R,"@:O$CR\#"%YM-IRH>PK*/U,QSBH%`($)%,`W##@`
M4C:@:P,8H#X=+=<$I)<7XXQ$`!&QV:H.:I<,_@1@RJ`]%)/TO*KJ[M4M3]8,
M,'UL@=@:1<:_Y)Q-6#*`QK#DQQ4VF9#'N@'/+F8F#88R!.ZZOG8OI+F@^N21
M($!J*K56`#R39[(7$IK(`G<#"Q@A;[8%$S+%&C49Z.9=)'`1ZF!`XX*Q&BE+
M];2W#"!TMU0-;"J:@&@R),LHHMX&$F3<B`#Z)PF8CWX&P.O)0`X!B,)`!B"`
M(@R4FR`92$^BQ`6`-#EK`@8RX:?89"1<5F"2I0'5:0RKYZF"FWF/VHEM\M(8
M8B8*X6?T0`$X`.+#*=D#H5V,`>]Z&0"TFP/H64R%F@R`FF^&G,7!4@4JUA&*
M);X#2^/>6#F`/8RY_C4W$UAXK!E0^<;`L"*"_!4#[/T8T@\D`@ZP]5M&E)+9
M).H"4_'*`1QPJZR_!0%O#DQ>*B0]@Q-$)>1:R)E$<K\&M`H!8.+*`V[2KP])
MF%](#P#G-+PS#O#',,FN0*$3%6_.=$4A['FE$J'2:.$)Y^2.:0!""C-62B<'
ML*H'+@4"`)P,J/Z(::J8YBZ\R'`6HX>D1/(((DD&B+O.I,6N0P,,+XFR!@'R
M0]T>0``60">.Y\B0R2YF8C08Q#9JPS(,*P*$;3P:K^.B!0`^+^O8B6?.)`$<
MKOM6`VQ8J$'*)":D!$28(XFT*P<7HS8:A.!XYE;BINL`P`B7A(7$9H4V_L`Z
M+(Q+5F@A5HWD4B/X^&5Y%FB[-,.F6*3V#J"SX`(A%,E9+(`!!N![VDL!"J_M
M!H)_!LH`0,8`#@6OMN3B!B))Q.4!`NE*3(\`\)`@EL<-W>(T%`Q%`B.0%F`"
MUDVW@`9;/,+MLH(I(H`.<^W*X%`,%<-7#+$!?*Z<'$0N/(/)%([4+N"B<JPI
M""HB-*"]>"<Z)`HN;,/!QN)%$"/KV@(`]LD#1L3Q3*\`'$`RD"Q;Y`D!EL8V
M!FIDI"G1CH+Z0$OL),(M#.<\PB/S#$,&!4-DV`E4)N,\].<#3&\L6N4\?M&A
M3&]IW*(N%,Z])N]MX$)'+&"!I@K+]&O;>$8I_MQ"TX@B23ID/%A0,M##&;WQ
M(`X`,1S"_UCNHZ:#Y_S"-6)C,63&/891.RCCZOA%"BF`S7X1`,`B.S9L?Q:@
M/`#/+H@'*=J.?SJB`<J%&?&&`7+(`I?*6:*&`.C&5M8B]7Q'X#C``"0`RWZ#
MIA"%;3A#.@``;A2@!A?#3Z`H-0*E``[`R<HI`VPM`!;MQSA`*Q/CS!C+`6DO
M`*1-,O!PZP+@1UPD&0DB-`*``4[$`4T/SA;`&HM&!KL"`.II4`:`T[(.OB@@
M)X@BPT)BH$*BM5#D\[I2*T?F+GV"2.1PS]3,=S(O!KE'&$6LK1S/ZR9S%C4L
M+);R62;S[T2C/!;O_@,2+4,^CR@&J@&P[D%:XD1"!CTBYD'FQ%#"BDDRI+,&
M("+BPN5.T_280F9*;%5DJUE6(]8P8/JHPP*0,C>8CC&TYP(H1@(L0(7L13O@
M2$Z"LB^0(ES\$)K>Z&Y&[),X`,TZPM&J!EHZPH4T@`&&<<5^XQG/AF>^<U/(
MXS\PX-'TBE6<$R:3LE5\4B1<C4HZ(`-BCX2N$\S2YCL<DC>H,D^P3%M$LB#>
M*-@RI!KUC+'JCR#$HG0\H'&8@C`USV@R[-K,L4(/(IDXYR'^:;(,H"681R1*
MK%I:*BZ?L-[(X^IH[#-G\1`IAGL:3^#(HRT0`*%"`Y5"0\\.#99$8U7<_N+J
M$HUW3@1/&L.-1.."GF9:I@\`@LH#WN@V]:KKVH2DC`9##L/C4$DX8\(`]$<L
MBHPHG"[):BT`(&PK=:-7.`/IW@C"1L90-.!:*D`L!"#97")E?@9^'F#D8J(]
M1D).'.`,<>,L9N+^'.`B%BAX8*E5O@=/KP=U`L,B-L`-X8L@$JU0.0,#3DC'
M'E(S(*]*^`A+5$*:(.`\W#$`F&*@-&W=4(EBIB4CUJ8`!*`!0L)C(B(!>O-\
M/(L&">+[/.!%Z.L`QB+9,B!#!T*!WO,T%<,S,P0NMJ*EV.UI*`+S8%!:N:<#
M%`A1-"`^)0/$JA5N;`^O)A/S=M$M!(Y9K[0M_OAB1-3N:4J&*F\3Y.JP.*\5
MDX`Q)G`B1>5D`MCM16H.`B8.]-HP`*0E8HB5.`@(K#!@U_I4\F3B&-^R+3XH
M`O9I2>P#7J;O-SP``GPRRB`%3VJ17TZ54$Y$2@*P.?J214;C977B'%UMUX:.
M/,1%`!+OG`J42O+N(45D:`)1`K#/&P=J0S.K&L>.H<HK(`44`UHQ,SMK9_DB
M`X!FK<XEP*!U)X(G8EKKY3A`@02B*Z\MZSK4D$9DZQ;Q)P#`N3`O),B59]KB
M\R!LA#K+.54H_T+C$!4@`$;#]+Q6`*Y3"A=J*1U#-QL7-OPCPZRQ(XH/8RK4
M+@9*1WA"$E>,/.Z%_FX`0$Y4]1^E$P'&=*P2BS+&[`,&X$%3-6(;XX+((V1N
M8K9629"DE5`635,OI5LNI@,80`%2*%$.X#3$0O(RC-NTT&.8D2\D\2,%@SJ+
M+#DJ(.NT$BO&8C4MEP#J`@,H)DV)@@RG:?P4Z6B/A%7):@,BTUF\`A$7[N]@
M,-%0R<+TLAH!DBA:)23&KQ9-3TE,;Y\0LPK/8X?*]AH7KG-94\-"SQHSC"TU
M!46(]W\&XD0H`@-.!"P&*@`;;S+M0ER,I"ZGI+-\PA>90F2@0RR@PXT&H"XB
M`%BJL60;XT0RY?Y80P/B:%H'(DQ-9G.+XXT$HBZ?J#(;#\2R3D["Q44\_K5\
M]]><",A['.`"MBH@G5(W&*"[6@.7(.`AD-4V8(,!!`!G/HPZV1+IKC91((=Y
M-"<#'H;F,-@W$L(N&+9BFFL!E*9)[")^D$C7<"8^Y6AD+'(BA'5I)*#OU"B)
M*.`D@JEHB4-]8\TT:^0>N<_"/"<N.L+T/L=>$V-W!N`@W`*,Q4)8M89GL.^-
M!B!!.L`KJ&<"E$8=GZQ>^`(DF(+MU)=D0^(!ZH,CS+15[B0!4BP!=!*HN&^/
MQT(G0H\M7&2XJI0^2K<:6YBVW!&"0M3Q!@(!'B3Q*L5+I;57.L#6EN+\/`M-
MY1=5EZ2SN&7%B&DL?IAW1$;\3&6,KB6=V`Y%_JI#,>88.$A%BW,#*1B@BV^D
M(_!"50W`PN+63'J#ES+@6-"C<39"(2)H.W2K"E<T401%EQ\``@`(8<DQ)X3G
M2.LI+J_8B0WR?<6+F"+53@^Y58DC01G"FIYW/"I`CAH`J^Y"*0;(D5U".V)#
M3H[%*2ND5A+%37@H3_J%*8SG-]!K4A#9HE]$M[Z3OC*#I`@68P#H.U4-J[5P
M/R$B)E:M0E:37XX%03@B`ZJ87[36L#;L3R!@=7FF>*G9T#+%4>[C`90XL>)6
M,(!DFCR"<Z+-(0U#=H-#)Y^D-MC#3C6:*:3U+4I5"SMICT6O(V+#)J9$D,I$
M;`D"^QI*3<X3AUR$_DLBXV[MHJ.N1T?CQEXL.#1H][N\CP`6H*N!8P_3SZ59
M6LE6(R(H!OU6)3:"MEUBM8P66;!K>S$V<2PT;N\(XDA)2#\N(MH<V8I_#)<"
MBGEZS4O/!MN,43`68.QBH@)010%HI5P\QC8J($D@Z"V-K.J()D@FQ3L-*57<
M:S5UDY':TE4>DH`6`%@>`+9;PS`N)I/$2Z@38R1HJMOL>C$LT$J)8T7R.N0@
M^4>$NTJ4R`$FCZQ>%TF,)ZQY9C[^I'9DZ,TZBD$;8VU1=,D^N+HG2EFNLW10
M5L%-)GDQP+\>PG1N*?`RPU$XA2ALN2N^+"\NJJ/\8TO<@CV]I+=+%!1__DP#
M]$T!X-*M-2/"E0Q#$F"*,:.JHP,VB2-CNJFIM;OZ_.X/W>*YR0K%H#PW]*KP
M^#DU?JF-)B`!X"B0DE("HD;,TXI>#05U>FUF&.!4B$QLBG=%M,5)1B*.4,+"
MTBA^"%NRVD-M/T!D*.HH)',R$J-:)BMVA_LV-A$!H/#26P-#MH;K)#M$<..B
M*J**(FA%X,J*M)!!(D`)9<+H'M"*S&HFFFDA.@M?,"8VAE<"$,698.B?M(>%
MLK#KKLZL)F!J,,2^8X*%U(2KFIT)(TI@&2/-SRF+&5S]8/4]MVV>V\6@"HS)
MZ!6SS?H!'FU^J=,M<(U?""`96>5BB,?"J&=M_F.94*1IE7%B`Y<7V_&*VB4B
MVCC]0QS@(P^'OQ_OWP/R2?\C``ADL<<B)*KU$$G7O3:0;@J%+",B?N!"E?VT
M0EWB+00@S9=W,C0`DT3&+2P#M2>C;>>B579H/^!BPUS>XZTCM'EX;=#P+1"#
MP+Q4)V0"#97[3PBLP3=#P\L)V@O"RP$&`G@NXU(C7`0@X-_PXY=L78V;-5V.
M.K*H4%YD4:]+TP=3O1<"`)7=M(SF^2B#4</BC49(6BV]--BBS'_,GDZ%,IP\
MLXG^(;%BE30``UJ*9C+L2,4"#S%$X7GFHI1(,@0B'B_5RVBT`("(G<%<N45&
MOZ1UI#]`["C`18+)_D\J/R(Z2]-=9$I&Y)-6>2DO0&3TC#3U:WD%8J`>(K>U
M6!CO5D1"63+O92\*K1TA1]+CD6(AF:4OX.5N0RN.)$D<0NA*L;];GS!0A'V]
M"5+<HOY,AU&`!W?;BRP>((56R6%<25/0WNMT`@"C:5%UZT8@"R:27?@W(RU6
M>[B):0*4P^G@OE4M#%5`>7ZWM`,8"P_7M61#`R`F?/CP`(`"#Q$`'.CPX0(%
M#!\R2-Q@0<"`@1\T`(#PP0(!`!DH`AC@`2/&B@4H7,C``2,#`"4S#`B@X0.'
M`@0V:`APP`)&APPM!$@P<$(``2UO%BCYL@$'#@<VFAQX02'#!@%`=D``_D#"
MP`4`(GB(JF`@@@!/`PSP.;6MV[=PX\J=2U>NA`5N'PBL6[<#A`0%&$QHR;=N
MA<`='$0HS+BQ8XQ@`4A.4!,C!@)L/W@H4$'"1\F@"1QU6G)@!J(8/1`0\*`M
M!@02-@@@0#@"@LH?(-3$4(!#APL%O+Z5@($A7`<"-CQ>SKPY7`T6<`K&[;RZ
M=;X2`+#EH`"``\V2U0H`8*`A`*(>QE=@R"$KAY=[IV8H(,```+Q4I5X8(%E`
M5@`0I380!E$%H(!Q'[P4$WFE60``!1X$P(!)'CS`0`&3#90``!,.%,$!&O;W
M&4=330!`:P.MUL$&DF&D40$;'$58=A=T,$!9_M?EJ"-<'90VE0>H59>!!`,8
M``%A.GH@00.O[>@D7UP!$(!')&(DTP6F#="2;`!@")H`+PV```3&78#B!QL0
M,!\%;6T@IEKX?2`!CKEAV9$!+84$EP(6.;">6PXN]N2@3G)P000)"'#``Q@@
M2>BCC&$`@)T?4."=60`T$`$%&[14%6H;'M`2!@$0X($#Y'V`@0-.?1`!3U@F
M$&="',D4U@8Z6>!C1*6M*($`<797DD8",.0!?!\8B-%6`4!@04(=6CJ`<AHA
M,!!_`T2@;00!FF1BAQF,!Y%]QEF*@&P!5#"0I1<X2">D\!96$P7"M05!!LUE
M`($!!C2066$>(!@7_@4,E-1;O/!&%D`&P.%K$F\M08`C!Q(<4$$&#IRU@`<4
MX"EF`_@R8"<'UE9`P)D8;7!`;`B.A6(#52ZPU%P=5,`GL!=<L&L!#2#L,W,<
M3`#!``1`0.G/2)O7;4'??=#`@V@B,.&G`['8LVH`"&0B;0EES<%X7K7786Y2
M?;#AJ`D@(/!`#0Q@;`$%8+2A<A^<55,&5FG$9M67HAF`6!9T()G.V5G[07?"
M/3#`WB:Q&(!R3T]*4-8#1>75AH8'0%-"[T+:@:-)8Z3`0Q:[13+H=5&P``$)
M'+EK8ZC_^,`"QB70;>@Y1B9`21?T-%7'&`S0]$`<-*"N!PTL8+M1H,%9_FH#
M':#&P0)[86!`608T.]4&#M`.@>&YW4YS!A0H<,"-$F3@@0$7X>[^7!YL4`$#
M"BA@]/N/=F"?N@,YL%I)Z"I`5M@$EO)HABOTR51).+"A!!9``QZ8@$6R)Z6X
MU4U*WZE`]LX7EK5]8&L'P%#3=@(``NQF-@H8@`!\XB`0#:0#!Q```B@H(0YX
M@'PJQ)`+>1.`!7#E<6W9#'DV)!F(=$Q""="<<H0B@`;8AP`=2(@!<U,`E.T(
M`A;$'P200P$/#H0!5:++!1A0'P9XT4D3F.(''&!%_#$G2I*SR0$$Y2+[B"]-
MK='`[";0`0DD$32`S,H`'#8!_'A`@Z`9&T8B_C"`!L2M1PTX@`)B-Y<-(.H`
M/SR:&S<IGPLEAY,[\H`%''5#C'!'`0F`D&8\X",/2"R5%-(`!?SD(PLD0`$-
MN(`&`A0P##BL`_6#Y5LT<,L$2,!'NNSB"R^D@)%1@#H54H"1)D`!CJA.`0O@
M0$+`A[P$&"";;U%2`@:P`#^EI@&W=`"2,+``_JA2`_?""`420,="4>=]"&G`
M/5-#F[FP$T,,V">A_N(H`H&R.:@:W$\&.96OH8Y%BAP(!`A02$!:U"`%J5=B
M'C`>`ZARD0B(&P:`(QE*\N58DBF``BKPNH.Z46<NC2E<6!+3^-6E0H`4@,,@
MQ4KWD0^4)AV(!7KV_I8,W&P".T78!8AJD@X@1::-B8J4DGH:@7&`/`]-5UL<
M8JF+AN4!9\F*6.0CU0-```,E40`4=8:A`#AG?0RH0/+X8TQ-OF6E4,VK7A]E
M1DC5TTF'K(!@L30!NNV5.0QS2P?V]AMX]6RD<0&2834S`09$P+*!2YH%#J"<
M"D"D`U=)ZF&'Z=$*,-1;"&"<S9PX@=<!AUMM04`#NM<`!M#O/A,8C(.Z!#/&
MD0P"E^4)`X@$QI=PR#D5H-P++2`!!ZC4`1"(35&#.EH=56`PU<VN<R)P1N8$
M3+L/Z^Y;J.L`QA&J)DB5RY`^\!L&$*``1W+?!'R7W`I`X"@:Z!YX`84>_@!M
M-0!>@:%/?B5:5=VH+=ALJ`#\-QZO&E,"1R)`V"YPF)D`DG_,>4``[&H3"C3`
MD008DP;$N]^,2$!7;_W>`!A0G!*[6"X"1>X!"CS:!/Q+NQLH0'S":5D#!`>M
M[ZN(NISJ-@?0CS@S>W%'RJ(:!+2T=QHP48`H(`#Q54H`&$:3``10KX$8P`&@
MC8`#^.-57-IGLA&!HP'0S!C]!0DN'A@C?PBPJ9:Z>'8%0$`$^.B</N99`1'8
M`(F5?-).=8H#@B:THN&"@6U%X`&2W%8DS>NS#31``B;MP`.R1P!*XTX#MU%5
M=QK@@78*@$TZ);0M-42`-;?I`7Q"$#I;R@`G_KMD`;*IIZ128ID)$.`S%P5C
M!9"4T*QQF"]@Z;)</+"JU12@=316+%2)DAW)K#BSSLG`ZA35*>XN>BX2X-<!
M##!N`(Q'``4@6AB_K>CVP->7&"B(!>)-L#@A;=[K1E.C9558!D3[9QI80&6X
M-X!%X;)#%%6U`31P`2<[(`%LOB_X-,,`D&UO`1'`5T*P=`%`$P:&F%PWQWR<
M;LET[[T(<(`##-#@+#X&`L=US`8@P(`#L`X"PQXO(V^\2?U=T*(%?\#]FM.9
M.&>9W6YQ`%(GD$)S^\<`@:LLTK_=`2AV#)MI4SG&,1!1A'$LT*FY0*(88%X-
M'.1]AW$4!Q8N<*@,_D0".R[Q;LVM&?^A+E$WID"23>+$A'2Y`702RM/L/9`*
M1(`#9B?`HBZ@D_^`1MD`Z\Y"G,,!"ZA8`0_X:!_YPYF87D`@&\``%BVZ6<)/
M?5`.P%(!%JZ!IVS`U\QNX^GWRP$"9&1C%"K+JI-6(4YE9*)&XC`;WS=.W?Q$
M77H74]5,#UZLT5TSD21EJ=0V%<#G!0!Z;J4!A',L,H.9O0(!$IB,/`#^;/FB
MPVLSYNP,-`F\A``*&+-D(,!^_'TW96/VD@<T\&_K<``#?\)N#N`5HK<]"_$`
MLC=[VL4!%^$1NQ(AO^%R/],!&#`!2;0`QS80&E``@T8HVG0AK7,!2+(!_I@&
M&1R0?OLE55F$/&<W(`=0:F^F&:TS%=%S(L=D$C*Q4QI`9ASA$?T#&@GP`(C6
M-L`V?VX1`3%6-5Q198,2-`@0)7]U4/<T/6B5`2S%5(.B`>X%+$?W8@Z@'`^`
MA3;Q'1>0;WKU%`IH$FZG`4R8,I,R5'RA=OM7(YV2$3F3%#62,P*U6!60A"8A
M`5W(>QIP604P@!9P3PX004IV%N;6,L!%-V3D``$GB8U3:R6Q6`;@;YCW.J\Q
M5K<G)8\V9-TA&5,T2I\3`0M0*FM3@?[!``^E8>31?SF2'4>1+1;`9LO!/;:E
M&!9B6[[XBPQ@9,"8*!"06Q)0/B=B`887`47C_FB.5G^#N"T3X(RXR&QW00"6
M14T2X(S<J"T0`%S=J"T58`'DR%S.F%M[MHT40`&.%G<--0'710'D>&*VQ"8;
MDHG':!M:\A?A"([AZ&C0961;!(RVE8F^J"BVM0#LLV4)L')R80'ULP"KDP#P
MQP#"(Q<0()$+8#ZK<0`^M&4(4!\QE&<"D``6Z9'T@0`260`+L"@6B6[DA``*
MP)**,VXI9Y+FPW.I<0`6:&XA](0?D3-1N'P0D#P2B4T:B92RY0`*0#^V)70/
MP$:L`GE5$X<+QTF-`FE1D2UVPE*$]A\2:#;E$2/LHV-M0U4)0$^BL1YF=Q]6
M0CRV<XM"91\&HD<6_B5:&&`!'2-:;@(:`U`EKJ0Y!F%#7L<`Z6*!.F19]7=3
M`1,P%D!AC">/%$!-E$F9DSF9#9!;N;6.]3&9U"1-#;DIR0-K"5!_W`%&Q?07
MMV1E/_(;:<D?`T@]L_0`CX:9$J.-QD29KY0`Z"0K?G1+#)"6PCF<P-EU:B@K
MY$:<`?`=7&$`PXENAV-6MR0TD_D`N5E-</>-$A"5W#D!>9DSFVF9-1(PH.4!
M_S<8G4*>/0(P/=68`/,4O=(C/=*8[FDLK%0:EZ@9\ED2]ZF?_0E:Z\DCY<%1
M&W"?$?2&&=A3@X(09@@7L\9)0((EF#@2+8F"^Q4E4U(:&/,!*M40FG$!_OYA
M;@RS?4,C)=GTC1I4('&#`,4!`5SR(/Q9$%[E7U,!$?@I6$1B4<6"BEYB;M3E
M)##'5++D`*6"5[AC+1L@A*ZR=VO$FC[#;/ZS``\@B^[S.K@V.5-A`7E$I6F8
M5\63(!'E`9,R`1;J,V%8&!U0`%P*+S2A1NQU%QA':)$A&8*">%]$>#4SBC-!
M3O/U6!(!$:C"@0:Q@962%>]2:EXE28"VCNL8`?4SHY!Z(*&S`?4#*&`1``C0
M6C_SI:,(&DEE>YQT*#[&`"B65PX`$0C03QB11DY#E5TZ6K67&^MV&1]4IF_U
M$";&*%MU78P!D6ZD1^ZG@!X0):E%`$<W/0%H_AD;HJ5_@R8#,(T:D)D)LEGS
M40`1H*8;0`$#8%<)16X-9E%9L65'L7IS)$$7I7A(J%<8$$D%AX$%"BD9$`"*
MHZ.R@GB=LTD74#%2XUD_FC3#E::^U`$CE@$3$#>7]JHEQH`$H0"::0&Y=0"-
M9JN()34&4`$2"3-M`15K:A(*H),_HS.^,WMS-Y8(<&-IVH(OE#UZH1.BQA7,
MJ"X'X1%NDY83X!26TQ898&NDVCN+TRZ@%A>^AGT.VZ^@A`$$,Y(#N+&.\7G!
M&:*`M(T3%U-1QG(,ZQN<M`"W"'.`A$NM=;`("U[M$4)>90`A*;'+07VOIW*/
MYA8CUAC1BC\B`P!^_JAD).26#3$`4\B24[%P+X$`+($!&,"&KT=A+#$!&C$!
ML)8!!.!++Z%L.\$1!F!GHJ(9`L5TBE8S#?`1!Q!7BUD=&V"1//A)A\4!$'`^
MF=B';;8C8/&MUH8`!Q!"`/:U^R57'_9A*F$FLV5Q.F)`FI9""Q"(P=H8..<^
MW#-/:<B`_;&JF-%0!?`OZI,8LX&NC.0OOV8T"=`!C@2)YK8^VF$26I@!I&)G
M"J`<PE2C;DIHC>9L"Z`G3C)*FK%94M*!!^5*&.)1&3@5_J8CH0>X_-LH@&M?
M)2B[`KP<TR(G->>D[,5\<Z$!DQLZ%*`O9DMH[2$9H%H4!S"%V6=*&K"!_O(8
M`>$F&9G*?R.&>!,P``'6>NPU4912=9]1IJFDD#2&-T2[@&3ZD\`UMZF[+!F`
MPU!U0Q;@0\K3ARW5`18P9@\0B`.<Q,ZQP3GR&@9`47X+I`H,+Q,R8VDX=^WC
M(@6@26Z">P6K0N36)1[Y`!*P'T5"<O1!`,]*>"#:-'AS86UA(A(;KS\JOS+%
M;)D;`%6$74K,%QL`&`3@`#0U$#W:B`OJJGT,7GS\,#S,&&TK7@A,,WB;-&9'
M98U<8MJB`14@`'$<`)2V'R^8F9_#7@SP3:W7$A:``(C&?S:!4E;V*VRBM:"Q
M;N^!LFZA)G.Q+YV[5_N'*.9&JKB8R(!2<QYY_@&D<A1F99PY$H/"O%]*ZD80
MHD_+8;%)HSHSM,LO-CH1D2YK8R(WQL`9X,$F85S(O`'DXQ\6D1J6Y18E+!&.
M)[I?-!-BV!;.F1&1U:`E1A$4"2:%U<SP4X:PZUD\=:_^G%VXZD:?TU?+(7!(
MDP'1,\](1W8V421=%QVODV.QFQH:8``B6#,3\CU241E0`7F)P9)JH3GQL0$.
M,7,0;1(9$SR+B<W-UW%E.6\SW,=Q%E+TU&)/TM(%?5C!"$H!^A@Y>]/5@58Y
MT:6"81-F5(@XFVIJ&!R_,Q-Q1;:%%[44AX%MTD2'I$:EIAQ<)Q<9,W/"S$H6
M$)Q#X2QVK,2L1`%F_O4DBOC3^T49H%1*S*$8/A-EK*K4'CEN[&4`<1=G`1!W
M^[%36P.BUL80&@'18,%F-]%ZZT9,JL+,4Y$Q<HTFDK0A310!@E4!P7S9.A(]
MH*U=#R#3\6+7RY&F2ML<[#@FKVHB(&P:B[M5R_L3YZ,<FR$_&6$_VO$UVDIJ
M;3%;KX,W]"1RG#4_<L$NIEUB\$07"S!2-F14WUK`HQU9S.%SU3U:"LUN\V74
MRS&`GORJ%D!FG#P@8^):%XP1]V*Q!=JQBP$51M(0>90`[HB]&.@C;RP9<1<!
MN33%`P(`:X-H2KQJO/D!+`5I#?:7#KU)RYTT"J!G/`TP^)S=!R4!:\U3_M:Q
M`#ZM(RWA-N(-&FJT%?D&/)4#&^>3RG]Y7S8#&Q-P8@RQ1>]K$A70K.L"2%G\
M0C-&T`]S'_^B04BG2\M699N1`&)'$*^AD$:6DN-+F*'S`!Z+E7=1DM[)%Z)-
MX7LE`.[H/NM8'<?2X(YAUI0]=;)L11P<QP*P&P303BS7:K6;;IS6=.HT`)X]
M>1AA,B12R``0W(4D%T26KVDH77%1Q+\W'CWS`+@R%;*,?13`Y*9TW<^\(QVP
MVGVV)`,@*TC<5,ILY:`D@G7M0][=%GC]*)M2<0@[=VT$`0)@5YL&.J3+2KAB
M'(?!2AA`+27;4AK&)EV3(5,!:UB]/>,!7.R5_L@.FQOQ*CE-V2H#<2HK)WH'
MD!409QQ^`310DR/K60$NA#2?@T4TD^F:[D8D<^&0L@$&T!KW)W,&`.Z,P4=)
M_:JY/@!`]C#NWA820'W>XEQ;1B>P5J,)]R-DU.*S42JH`Z+7_A88L&4^84G)
M3B]P0;I9#H]TP;)>5TTOU"F?`UJJPT!11A)`PG(+L<'!*##F3*0$H"F)MAPW
M]-F,L7^+%2"?/H%$!4P<W>V@9*PNM7^NLA@5@("1S,X%DX40H'=>OE]=%1Y1
M^,<\=ZU(PC%$.J5)?Z9-)5NOPVSBPC&4C3<!(%[FF3.(/E5OP2+G*S@W#A?L
M@^Z/416U(AKE9Q$S_E$J':0^!+(P['%59?,[69-$-S*E^",4IS5:461*9+3S
M,H\PI<U)T9[L>D80BD>;#E"JRY8`DLX7],(J7SMW';M";:$1-^8!#W[Y+/<O
M8R&&B@O1%+`P#5'UED@S-OK>_Y&`7U,L/V(;=#&3U[$B<H$`6@):)=2'.J$!
M.B$I34,R9F(E.?M1N]X^T#%1!N*)DWK)/F.U\I[XC=(0)Q/X;O3X"SHVMK$8
MUZL9!8=]Q-&Y[!3T=-$CYE3JH+$8H%9@(/H``J/Y^98=ZP9#CCO;P0U%NS<5
M97@P5)X1#>9"&0<0'SA`.,```(`-'SI@*'"@`0`"'R1.G*C!08.'!296_KCH
M`,/$#A8<$%"04"`&"PD6?-@@84"``Q`H4M00@$`!!A<`()@ID0,`"Q(?))BX
MX8("!T@[4,3@@,*!`!0P7,B@<$.%`P0&1,"@X8.'KB@Q>.C@P('7G@H]:(C@
MT<,$!Q,X%.WX\635#QHZ9##+8&E:E@W,7O!`D8+@"G\52E!P0,)$#Q(2#'`P
M]^M1`0,:6/[0U,#!`0($-*`P@"A@U*E5KV;=VO5KV+%=$R@LV_9J#@P1`!#P
M0`,``QHX'/#`8<,!``PT7#"9MN3MU!XH="#P&/IU[*\M'`0JL0("O$P+R*3H
MP8"#KQ@6#"@P6K'$#C%KPV>`?F;-T`'>2W20_G)^:P\<V$J``!+J("0!"$!`
M```"\&H!``Y`@`"(`*N@``4_T^@#"AHL(``!YNH@@0`,0*Z`N2`XJ,0-5#0`
M@0``L&NF"@!0X,"?#-@@@PLNP&"I";K[0`$"EM*`P`84.,@"PC)8D(`8`8A`
MQ8B^@L"F`E9<(((&`Q@`@-"@#.""M`QXB0`&16.P@`XFJ"!&J`"HX`.=]/M`
M330!L*XG!1B$4L@-'@H-@`0Z\"`#*`V(D4P/&H`I2YXZ@PC&"'WR4C(;.]"@
M`01>%"X[4$,5=53H""/UMN,FZ(`K#!!P@(&Y.K2.`0D\4`!&!C:PX+^O'CA5
M@P>V:^Y48FU[:,F*_@28<R9;EX5,`08P4`"N!X@D(#SX'"#O60@X^T!%[C:L
MJ$B_8/.`@(@PT',B)8-*`+BU8IPKR"I[.F"`PG[3R(,O)_#@W08^D,#&KP:F
MX`.#$-"@,'4C4&@"P)`+2J$5N0,`8@>Z.[>`VAB<[J`)$MC`H`8\V`X`DRN4
M%``.;'UI@@:^%"""&!/PP*"#>S*HR`<:["H`CK\J`($*&%PI@X.64A*!XBA$
M:Z;=ILL@`(<_"'*!#CH$0`-U+QX2`%\W```]#R!<*N.`N9Y1``4XZ$"!&84V
M0+2S1KW``@N\+79OOET+NF_7.O!6/;068$ZBE30@R@-;`2@@9W;)'/6L_@("
M!OQRU2!$=J,B>^IP6XEL%3=T!?:<:#B(RQN``8JRM'BF!EC?#+8.7EK@70-J
MVTDB#08PX(.,;19:@;1Z_EVB!#3:H,3"?L*70OL^0&"`#]Z57*!W`T`@;I`8
M//ZG!,8R]*^,??W``'$9E.X@,CGP6"`*.4"ZRG=9S^L``03RTB(O#:A`2<O-
M!$('VPYZ,I`@"C!@-Q;3"-(`H+1U#6D`^PD=XR[0``%$*DN^LF!G0E,8LDA$
M;`F`@`0^8Z1W.>0]$-)>]"9B`']-8`&*(L`$GA:;1KV$.S#!%N9\V#<'\.J'
M,[F`_4(R$PX08%D<"%B'[+<`#R"@,2N1"**$_GB=#6R``'H;H@\;T"(A;41D
M/:D``2CPGT8E0`$+4$#I/N`07FD@)LPRP)X&]CJ0Z`AX7.S)<29RQPB!:2EB
MB]3Y-/*0U/V+>CT9V/$^T(`&!H"*TAN`V`"PK6HA#`"0DTA3>,/'SUCN-RZ<
MB+HN\!CTO1`A.@%`^THT$2A9K4*UNZ0(#<`ZL6WH`0$@TD%.,Q.#S*EGZ*D1
MF"!@R0+T;"7+F^`'8I2ZS]QP(A9X20&R=`")0(E72"MD;;IFL>MYX`$,"J`'
M-N``$H&N,6B\``2F!P%3N>9(LV-<9R)`@$EV49_[[%L4YT*B`2Q`5?Q1D.)D
M<H`)?.1<$U"B`&2"_I(//$Y4(YJ`(_F).044Y@#.F@@ZI=D9`<2SHPV*"\0R
M4("/:E&:6K1.C:)4-8FT4R(1X"AN!,D?.0GD2T$)TN^X-("Y;&>1,\$``;XG
MF@UX@$%+>4CN'A#0K]1H)2H*(`;.*!"P?:6>$E$1\3Z`-%)Z1T8K2:7^4,:O
M5@J$07-:'LNV4R5UG28"`E">XY#WP.H=1``J6=A,912@!BU@`:)9"@4"X"L.
M!,`^7S(4A?`2S9[T+J<<V(I$E.2K_^$R1E4IGZ0F)IW"3(`"(EI089T%H^LI
M"#47F`",%C"=*U+$28E)"P<6$-:+YM8UYHRM/A/"Q.)<D`$)(*%>.K,4_@)$
MH&4(D$!4#IB;#':&`,.Z#@0<@`#SZ;8GAAI51CE$@.MM!*%]',!5*1*!`0S@
M`#E#74^&PTF6$,`!'3!`!C@@`=-AP`!_D<#$5&.9C$UR>9W;30$<$*/?2=8!
M3^4-=?W*W,]LS0/(.8`#UGJ_F?4L`!\!X$12*('=R.0!Z#*)!H8FD<^EA4L6
MR,"(%-O:@U3``^RS;'(RH+D)T"MT$NC-E8#S2+M^X$M5,9H&+,``:Q9D3>^"
M"')S]X&G4N5=`^!1TH*4U?-U;B8="D`%&`J<N0P,O`\)T0<HA%"`L00X4_G0
M!3J0I01,`+T!F`MRIK5+`]CE3?9+#0<TP``&_@P``=U*2]D</),'P%>[BT:-
M!_ZF6_I^P`*IHT@[A_:C3D)EE^;Q0`0>X#+[/0"FV-G`F[G':)J.RGXZ$<"N
MB$B;GJA(I"(T2'8Y$)R>8*#,-"&`HQ(2`<AA8``SD@`?M_N56W%4`</V#H5"
MPV<!!0!$;"JT01JD(!$-%CC1X\!N0)2Z:LU(BPR2)(HA^31'%0:#OZ3(]%*G
M:^YD1@(7"(VS>@8:S=![0V2Q0.4HQ+H(G%@#4/+*@ERX@<-\6X+$>W-4!F*Q
M&$&@:!,T[``898#]IN58#0I3<>8&FHEU8($P,0D%&,0;KW(@T'!B;Z!#@U*?
M,,ATK+%``RJ`7PG\_D6<,NG`O"GX%78S6NAIH;1VH<B`HG?`6:TRT1?-R:,/
M+,!)"3C6:6P+JILO[]!##Q4"#J"``D0@:F1\]$0@(`!*=^"<$/'6P,/;20/`
M=^`($9Q=-B#1B8@6-WS&S5C2HH&/]L1'#LY-3SQP@4^E9B&!GXA.6!?"OW\%
M,CZZ@+?T9@$(^/UT$K$`@0Z`7BE%WB>`N<"H*0)(&9V'`[,6"(`P,($'&(@S
MN7'S3"Q0`?^&;O#NQ;3@[6(>`$#1-KH:-`(H,->EJ$L`&>^)<KG^?(KD7K>5
M!RI%,C8LL%QH6G]Q6P3FJFW+Q#X[$6!Q`*$_*B8#Y69;9)8";(:WT^/Z_E\6
M*R3G"2!]#\)W`YU:/L1T[=6)H("9ZX#L`HE]JJF]L8!\<B_S8XKKL#`*";W;
M8(R?X[+'`(]BZ2%B@:C+@(#>>HVF$("<^3-AX9T(0(M)RZT'0,#SBSJAXP"N
M("ILXCPRJ;F\R;$%8`#?^(JJD);:V`#AN8XOVIX6)!5KDY&OX!3\:ZT&.(#W
M"#B(81(?J:@'P)9^T\!YF@DE"1>BZ8DC.S;`Z(H;HHHB/)U$&Q4CPXZ6T8`6
MBXT)4("`^0P]\L*J0)2]V3J[,3U160#+0*\!\*X)*(COT<,?X@`+8+SGDPZA
M.SQ>H8#3&#@*V+\'>#*?B(`&G`D'(,37$*<W_C.V,K2-D4,+#S@[_+,`[YJ)
MN8K"!UA!#(@*VRL`#1P."/@+ZJ`_TJN_U;"V&3FA3_P-).RCV+@U`9BY(1HX
MGJ"`(SL-(/RJ!\`T.?O$U("98ED`KQ@1""@`D\A$"J`B#BA`:+RH"\#%B\J`
MV-N/:/DN.BNJ!7!"BB!`Q3L`#7P-3<D`?/G&[$B_\*(`)>J)H:`@1UF`L%L0
MS#L`Z;O"[7((5>(.`+0]<4P-<&$:B7B(#Q0ZKKDBW%(-7[PA#.B]M!`<U#`R
MCH2/IA@6D%211P.TO:BPT%@^X*&`"S`+%K-'_O#&/9R3"X@[1W*T`)@8D9#)
MW,J`H+LHLGB*"@@/_I&9L`8I#0,@`.Z1@'BD"`BXQ-=0E0B809^\C6,)`%YY
M*EY1N2"L-&Q$L:HPK`U8#[RP@`-P,/HBCWL["*G\*N)P#<HZB!G$G_EX"Z>L
M#>&P#,[`@*?\@`K`B*M:O0N*NW8\#-+XBZFX@`2XI>;QD<NX@.\P``@X10P(
M-`(@B*)K/.1PG*6X&;T"'<AH#\3JE-3Q,=X@CWLY.0%`"ZRP&-HPDPBP%='@
M#M/@B?0["(N"Q@SX2^Q8@#EIE8)H$0XP#H20B'F[RHOZ.7YZ#`VH@-NYI4CL
M)#ADFOXH#^&+C@10-`"I#`/`/^5TC<X["(4ICP28+F:!`.9K-W:4*9#*_CF*
MJ(!*$CR'<K0)***1B,?:8<ZTZ)",Z1P*^0L&(#<0^8@%*#>3,P`."))=:\<%
MF9#NN*,7@0DC^8SI`9,ZHTL*.Q3>4+L5Z12(*(P-H*L$.HB%/)TD:J7"H)`(
M"$>"Z2,,$1BVLQI)N@`*@)%2^Y*+429)Z3*@=!S`XKE_D\P8*;8BO:]/DDF]
M(Y:!:[N$4I0@;)OPU*<$$CH)F!&P@``H`0\0RD$!&)8B8HUMM(U_Z3Q/G-+4
MZ,P5X:3AB,LM6T_DC!!AXS,*4%#;(X"/TC4,^C6V&!W^:$7^;+X)>HB`^1*3
M(!$,X``E<1@M0ID(K``5L4K9&ANU\I6>@37D_AC+X`.ZM/J,Q[N7E,D?]]D)
MQA&-PG@7`R)/P*"E>=G4J$O2GH`1_2(4B3`(*NJ98F,0!M@5!*T4X-D=6:DQ
M\H`J+H'(B((U>RRA8AE%0EP+O>0[-,6<!1VZ'S0?<Y*`K(@]DY&^*F6-!<##
MZ#"+$XU6UNA,!]DE;+$M:.6/!)`F'LN4TT,`O9$`+6M')4D(>%H>3-R`F@C4
MF9@`!WDSVF`L2>.-"F"MY(C3RR1/!AE7&24/)<D`=:$B",$8,*&`_^E4KY&>
ML>F0_#F?K9&(Z>$06"U6P!A1)(209:&.+]4X.7F?.ZF8@_B1+VD99\*F@5F6
M"P@`UAD8#LH2RE@>_HL]#>K8S4_,L;UI%-78`(LCUQ_2@,UDM`>0U*BB@*'9
MU?]H`/!,"_R2#7,B0J=UC9'["@:`TZA+JIGH`$A"HYNA206@20CX2LA0(P4(
M@,<X`%#R5^L+O8'Y$*\!)&E+6*RR&+WBH['+BP"8`*2A`(@AI$;M$FG[".1`
M"^38$=Z0B*7\B_9@G`-`$87X#)H4(0;YB)[Q*I0%3WH\",\=5>"DJ<KX59M%
MEX+-.(#EB8SAN<P8#@9@'B6AL[SX,24]M<EA@-@"PK<,6V+9`.'5+C>!C(#A
M``>0@`V8$BEZ`,6ME]6XN^6-QKM#1.2=B<X<JH"+&PU```300T";"$3)_@T`
M:(#W&,4$Z$L"=%.*T!R0N4Z=V=[0^8MA$@KNJ(J3F<T.`$Y8^I("T-&@]`Z'
MLJP!T`M*A;)+BH_VY9W[U*2<00ZPN%R0]0K*"@")")(;:2XL<R\&P0MY:90F
M`PQPN9[M^-:;,0#?J-D5;!`Z`9D+8)"MR!+649<-`=@&OIT`2``)@)`B@5X%
M\$VIC=I1&<5!*[7QT0#UW-KOG>*.G(A<$:'D\8F%W)0">XT(6,#5:)1[HN+5
M.#F+$CON&2PAJH^O\!\4`YM&--;^>J1:H8A154@!3(L!4&([]J[^98F3^\P8
MR1LNX;/.C)V#($:?<!P!U!Z)\!(+$+:0[5NJ_OB2S3B(846(&A%5!N%@$&F>
M7;(8AY6E#H5@].&-OU21^?2):P):33F(U7N7_"F+*-%-M.I9I/JJ+QF`8CNI
MQC@(Y<T,_66T!D!B4`$LWL@2GIU(,J;B`18AJUQ4H8"8LE&,8)%'6-2.!J"Z
M9D[3@\#>[T(C!(C:6\,:9+UAQ>*5""#>\F@`7`L=US'1;IV)/7:-SN*J+ZF-
MHCFY39J(F!&`D$@O_/O,-]$KM"!<F$+-F]J-JOF0PV,/EDBO91D)G]"B6U'5
MCIRTDN&JS`!;U&A#FC``C&@C-[-1L#"*&<$`C&"2JE@]KR"+ON)7)0%85$XA
M9AZZ)04<'I&`!X``_N_M9J#FP8EX*I[XEP=XFP8M%-C8QINVK`IPXZ!FE@;`
M`*A09]$\CE.+#P8X``.PQ`U#E`8L&W:.OE7^FA6Q43!^)#ZNK9#\JOG(#0AP
M)^H"5X%1WXVT#'W!@!:=B99P`-H2B/"0@)^N7U^"%!9$#;U-C996B(`QE'\9
MR\8[T_)0B$1U"8B`B,'FNIR.ZK"=WA>4(K\.TV^I`*]0G-UPI`O"H048YM"Q
M&A-+[.\M/8$!:&9)`'F5+:@NCVUT@`.>S;P8@)H2:[UIK6I,``LPH8_XL[1@
M@..]#IMMQ]O0@#I2B-B`[="I``I@7+E@C0,1"+U]WZ,&"8=9"\3;U;66_@T_
M.Q3)ACZ!ZDB]\$C.MD?&'+J>XVW'26[=I<PKV35@0^_0922&N4B@OAG$&:CS
M.N#P,K&-1C2'>0]$>;NRR<Z)&*QB@\ARR8!U!9X$/I77N@T,>`"W26M1Z9'8
M0+KIN9X'6%>&@JFU<+7O<6>@VKH!SFS9HO$6E`#N9`@C.^_XYCJ5ACZP.#`%
MB(!2DSB)*`"LX0\;U\*;GLTY[O&\\PH*08!A,93)X.OZVBXSZ@EZE*:;&6N?
M>*H!38A/`TQ"G&\H5XT,$,WM6LC$L*]V])8Y2>^9R``1Y;Q:D6SKKHBF;D$%
MD.(T#_10*:*9RPT'.("-JCR!F`]%;HVH9(T"_F@5UB;CEW@)JJ[7T-GJ]RB:
ME*KGF7`)[A%K7K$`H#DE`?B(`GB[F=IP0?\*?U6YV&ATIOA,I58-"]CSL$T`
M56]U>X1O[2K.]U!4#\!N!H"`K7ZMPZ$`-M\M!`!T@6`Q/^WQ"(P(#DB`L%+4
M(XZ^9L\U>$Q/@F26:N&,D^;G`B#U*PH97A<Z$(</UBBV0#?NL!6G/I]2--<N
M#?SQ$K&<XA@)2;);Z$@B<.T*90WTN003^%`)"FJN&R)U_$,4#:294WN``BA*
MA:B`@N<.JFT\5A<5O\P.=R?7P\/U=/>PPQ[Y(KP`$5\TR42:H"P.FA'Y3V_N
M,_+H-`]?D%@OPY,`_F@M(P?31PW4QX\*$O^Z8^Y8WI0`G`J@Z];0/'*%`&,V
M>9WA<:CG.GYMP5GLC'-,"V.5M%U?#21'#8(X3D'O3(LZ#D4>-%0LZ\9CRN9K
M6=@9ZW.!S:VSHF*!EJF_>^>>=[R_J$-DM-P8EEP)"O7@VJ)+5-GX<+#_YE;G
MYZNG#[GED)@P+RBC^4Y:[?V8Q`S0^=HH&R1DVMLA%#Q<'KV'C?6.]]?=^U$9
M+=0O0^YBM+MK@`E(JA8;1EU/"VK+#JT$#`[0X<77*RAQE@D+(F;IE/]HE3'Z
MU^=V]08XP>YFK7_Y5L41&G!5JM%??>LG%<F_?NVO(`44``8XHPL*W<2"_GFN
M'>6H4W2"CQ(=:0_.$+FM#QUX+X_.W<H@8^P&&"PO60LN1?32*,MZ!(@/`@<.
MY!#``\&$"A<R;.CP(<2($B=2K&CQ(L:,&B$JR+#Q(\B0(D="W-"!I,8#"Q9(
MV&`2PP,%$2)@6$B!`4*0'`[D3(A!`<J@0@5N"```P($/'A9$2&BAPL`-%CQP
M*%#S0P>:'0)(4&J!YH>5`K]&X/!A`H(+&QP\,.MA`H.C1T\Z--!S*-Z\>L^:
MW>OW;\>_@@<3'CB!0F&&&3!4>,`6P8()$PX@*,```H4-`R'T#<FAP5V!C1.3
M5ECT*`(-J@]$:&#@M8``%3I`*`"@@`0&!BQ`_B!P%$(%`Q$6'`WPX$.#!W&/
M*L#0X8$`VP3:"LP@0"Y.A]E+<^].X6KW\!056!!O_CS$#J&Y>V`PMD$$#10L
M8Y6P@("""Q@(=`XI66$#%Z!7F&VW`7"=`0/()9<`"B[HVX+,(1`A`,I1&$`!
M$,I5P`,+&+4@`\HE\`"))3Y@P`+@*38@BRVZ^-$#FKTX(XV$=?6!!!!8<($!
M%T!`T`4G#F``72)Y<%Q""*Q7(TD%?J`!!YIE4.!192D0860.1&C``QH>90`"
M!E`X880(,.#@@P8T``$$$;#9&@0#"+#`0TDQJ5%@$<5X)Y\4T=DGH'AQT-]Y
M'3A@``$!!+@0!@*B_N1`>0-I\&>@(F'PH0,4."`!!O:!B`%Q"SJ`P:4,(G3:
M40(@Y`&5`"A0P8=R3>`!!!0*4`$'SBE4@0,$Y"7CC(16.FQ%K!)[+$@40-5B
M!P<<H%Q3"EE0Y$@7%%"DF\A^1($"M1[0``,*P/=``D@ET$`"#"0P0``((-``
MO*&^*VD"[DY0$`$$N.ONN1,J*("[^?*K@+L*Z(N``@LD?!\`T0X5*4E1:CLQ
M81!02S'&#NUX'JX")2"`!!%T0`!B"76PP)(+9;"L1!/\*-``?1W9P,49,T1S
M!@K<I=RTU0E0G@<U!W`O1!XHJ9`'%FBP8P=J,6`!!QH0Y`'5"3W@D4`>_E3`
M0`/"9I2!`T%Q4+/-98/D`0!8F[VV0!`X*IX&9E[@@=3<VJ70!`E,5/5$S0K8
M;$X'$""`PVPG-`$&#!"PDJ-B$D#7!@"\O!``+#O400-/5M#Q!T@ZL``$$GAP
M@`,;4-#A`ET/=,$!`1C5E`<-Q%I`RA:99/@'I.)NG@<#O+U[QA1`#/<$]PG`
M607`$C0!V986P,%P&FBVM`9J?U0[>A-`J,```PA4X`,U50#`=KG3_($%`*@H
MD)8`#.``0AE`T#X`1WNP@88"7("``U6YZIM[SG*@"!C%>V@30)0$@$`^80]X
M#A1(CQXH0<)H8'+R0U@%,$`H!%@N*$I;``,8_M"4"TRE`\K+2`02D++[-?`O
MM;K-6?CS`2I-@`,2`$``Z.0!+=D&`1%(&U4&$I?%*2AL/T3*`L1$.[21;P,(
M"(":#A"7'VW`-@*J50$VD($0*J4`7,G`"6DT@3!.L(QF/*-?+O`^A+@F``R8
M@`;N!Y2\C&\`&K@`P`2@@2&V<",<8(#7"G.!H_AJ`@W8XE$2\"&C!#`N#,#<
MAC"0.8$X!B$W1,R$`K`6^2"&`P=22/O>J#T`""@#!X@-`A[@/8%0(%1(0B,L
M8RE+,TI@,CWAP+IN0X#)#>4G-QK(?@@PK:D`+P.^`8H&X'.`HVR`.,TAWY-2
M58`&L`L`PM*`!%19_KD;UN\#_=$``"@UD`84IT%R4I$&(J`@I00M=[4J&9,Z
M.,MYTK.>#+&`WA2RL@%8+R@5F(`#5"@0#1BL/%5Y'/`H<)2D;,U-1G%)``00
M%Y:0<P`RPL`Z$R(!URG,50H$``$0@H$(0"4#[D,(!0Z@,PA%:Z1C&TY?:N7$
M`O#D`QL80#Z9%#9[\K2GL.Q`D3:0`*DM!)=Y><L&%)##ZCR`+A[(0"#+QBI7
MX4@F'RK/,K\4EJ-`A4='^5U1^/F!\0'``)$CY0YO0S>C4.`Y[AO?A!2P`8R2
MD@,(RL`#CJ(!Z-R&>P&`IT\#*]C!#J8#@7$B&04"EU\9@`,&P.COS*A0_JH^
MP(</>%U80N4>!MC&`!DHEU&(EC5%ILY!B(G3`+Q8(:5HP(N^(0`&IK2!WKB.
M`+.R:6NBXP`!:$8J)>HG88,K7*R(=K@7X<"/%)"`]1'$`9%%28!F>Y8`%B2Q
M"VD:LK@)%$,F8+()F(``KN2^K(A)+L*I7$(VT#J0@I2H&`@3`D07E02TR2P2
ML!-M($!4@O1E`?LU+H"-N\<#2*:/`1YHKL#V2E`V3R040"[1&J"BE!I8:\@B
M)U7AA8$-1!$M!F#-JS!P@`]+L0/I8XA+(""`!C=D`0M^2&K$^%^)=(!4I,J@
MIA[`&^#T[P,9F,ES%W*!">R)(=!S@.56!@'E_IF.5`YX\I,9X``W,1=]3VF(
M_#*4+P(D`,DGE,!W2!55"LRO`IDY,$5,LH&HHID@$$#``0J@@*O5K#UL_@@N
M.V``HN(S(0W8*?#:EQHS7>3$#+F``EAL9`)85R'^I5$<+=*[5.5K`%NN-,D^
M,$BJ0N2%OU0(.)%"$).N=B"D=I^E,9VHLIX0M/WQ`*C8)8`/1T`"B+J.`."W
M.APFDFQ&6Y`\V\Q3#@!6+T&C@`'F-,:"%"XH%&@`!090I&<1Y#EC:39ZI/>1
M3?,ZIQ0QM,E`:."$L,5/59Z8@B2@GJ!133WKSLEUO-T0;I[;ID:QDT`V#6B!
M7`<`Z_YWT"R0*%XZ_HY:9/WKNKV)E0Y,]@!8TX"EY;+O<4:HWL*>9P2`NQ<Y
MMLXR%6A`<8-2XS<3I"CK,^Q#+Z)HAGC@TQ"9\K9_T[1Q$\301,T*P.ZL&`)H
MO,7#RYB8>-D0#QA%W@SA9K';MH%0X[N+`)AXOQW"S4E^0)W6C(J";*L`!=10
MUP/I``<>X"@/*+![.(PLALMU%(M?O.T@N8`$N`>`I`>%O@FY24XT<!(W.=<B
MH,((VQ-"\X9@6)P64:A21(9LJV!D="^&B`1ZKJU3OB\!"@/AY1<`N:-0W2$O
M)",&J'+O:A\%ZD=YR%$*,!#']>2($$@:!R`6&KT+Q"!SWS21"*+VQ*V=_C2!
M=[M0#K!R]#QU+QQ@M$)X[K'R!,FFYY,('G5N'@S/\2(9$)-*91URBG0`SL,G
M2`5^CC$,.\MUYG?=U97RFXA,ENX#Z2'IGYX0M3_$-Y0J5],59(#T]IM"6#MB
M4[S057B`OGW`<OQ>4!@+\!'&\XD'8XC'!%1?R<W1H9P25.15YV%9MTB?>80(
M`;A<120.`US`!7"@8O#/X(U5L$V,;8#@UQ$$?KB@0@"@0RS3OFU%KOF94318
M!]B&``S$E30=AJW/TEE`!ER`!KQ7V@P49ND9#GE$!5S'`I@%<:Q88IS,`A*&
M"4Z0`02;T;@7!%S%9P0>!G0AH``%`4Q<8;0<_@!DX$1PP`IJBX)LWT(PD0P>
M#N<-'0(,@`1J@%&XG),T1%ZUX4`L4],1'4@UFF,MH3>QU5@8!9(9Q4$(Q`T%
MP(S]A7IEH29BA">)GT!$`'59A`4X''KHQTR$3*V=XDQ<ED%(8&(T0`'$843(
M(K'8%32E1^E%Q*8)0,]-5G'U8,,D1+^M1]+PU;4,A)8TW0>\4`$$&;%!R(V<
M1O4=D:Q0G/J0QO=M8AF!W5YHP`+583-B!`5<8G=HV:41`+Q0QI-%@`<8@-`5
M!@3H3$9L`!UJBQ\"@-'9Q%$,P(@YP`%8'L)``"EBA=41P`@N73H]P'KEGF$<
M17&A2@*H5`3`69RE_DH$`,M4[1]_(1L.488%8``%Y!:OS=U8,$=4:,CS#$2H
M("!*()HV]A38[`6\.$05I:"+<!`2JH9.ZB2P:-Y$/``M9L2:9`2MF,T&D$B0
MZ9.)5!9;&`!;<);UT$J7V(:#I%+&A4;8A<^H=<@#<,A2/D#&$0IM*(!\F4P&
M/!N:W$8"9$`%40?ZD`A@$5LV*8\19MP5!N5+EDU;A0<#L!T#&%Y!D..+?$QT
M>(E<8`B'@,Q$5(!@?H1))>4L"MM)Z)T&W)9Y1(UJ2%Z?=`!>YB7&4("R\"5$
M0)RP6)TGOLB@8,72%6'D68`VU<]J<D<#W"'D>:8F6IAM`D\VYD4'A&)#_E2`
M.!'4`8C8:?+)Q4S`(KF.I74/`3!G]Z0.9.J$&TX$`N3F`A*@=6;G6-'FUQ5`
M>4Q*`DR%$VTAD^@;W$D`>J8G!+`$!:!G?.&%!ZPE1@"F=@88]-0GV^@8=UC%
M!TI$!2B)T82-!'S@`;SCL=B>^RF$!$0G2$@81O@F?@(*>:)$W$2HV<1):1#4
M!)`2C0F'C]4+`BB2@W;.;KK(IB5H0HQ@7H0,1JBAA=Z)BPZ&3;XHC3`HRX5$
M!BF`1OHGOM$*`F#-C+;(AI(D+K(D1K0)1CP>C2XIDR;&W'`F1:A;LHR.9BZ$
M`Q`-UP5-!BR`'5%,^A#I0UB`M*VHDD;$*C4I_IJFZ5\X%S8)DA^2IV$-A`2H
M%I@BR\@<!8H*49Z"A`1,9T3L:'UR3J5`J9H&6&-NG"&IGD6`A3<-F6V)1`8$
MJ4B$RIZ.S(1:A`3$*$0H*G[J%['@9J&B4<)IFLY=#6F<3@$8:$G$C$`8BG-$
M@+/4XT0@%'<@'43PCTQVIJ2<!..%JJ^&Z@94`$FUW`"D4DW\Z$#<3\V8$&F\
M"@`<JD,H9+Y%G@]9@`-4IT8TVE]0ZD-@P#$>E0Q1!!)^``?]JE\`YTIPI[GB
M3@7-QI/\366!5\XTQJS)C]K0BOAE@+H*1;!:`*!6A)Y%"P=,H6+M*XV8UN68
MH5X43T:$Y[I&1(DF_D38O="E/NR=C,T%P`=6-%4'"$`#O`IRV$E1+I=!&228
MJ,BFZ!.V$@9-1(9&6`=*645YT$:5UDAY%:>A0*A0)(#!+D2Y6FQ#:`I(?!C0
M#DL2_M>U6@`#[,L`**0)S9UCH0]4Z$9.W`L"@*8W\=8EE9S7E.A_?,0(/II&
MO)%2+%,`R%T`Y..=3$!+-)KW:00'UD;$;H:N%BTG2JK=_DJ.:)#"C=6]Y80%
M^%#.:`8'W`O-6(!$L4JO2(T_+@M4($#@=L"&ALT![.F3%`O>YEM[X!FV4L4#
M3`!4N6;FD@8<K6<#[$N^2$#<-&W*M-8`@.![;98`^$JW)D#%?J*JYJWN_JY-
M!`@'V^Y&`HQ(>Q!3JS)`6WV<1T0D_-P'`6@`SS8O!GAL4K0CN4)*92B--]VN
M7G#2T3@$J+`96&Y&061`<=*(\"S3`+Q1+8'.D$:5\_XL06!`66D:!)1I=UJN
M0[227VCO[@Z%!/#O2XJ=I)",T#I&0NS5`WRL<S2'0*02`U#&D<`9!<2.9IP$
M5"U<"`+P13#`UOAIL?R)G@''TL+97_0@_K*?TM8IW"E5^B7$N")-!9#@_"[$
M!C2`Y<2'UI0,9U9`[7#F</#PZ0P4O,S8?:G.0&P-DG7&E@8OL'2*;PP`MO5O
M:3S8KQZ*V#9'!F0.!.3C!.SH+V5.>V@>W;@K_D4<H0@E';@<56B.&KG:J$38
M7=4M0('HD6`TD*E*1`4IB`V#9@*SCQ7ZQH]PP!P"(]%X@)<D!3G-D?,N2`%0
M@-HMB-GBZ75YB0(\&8XL2,EP4ZJ4DK>@AFC<A@,81:0<11(=B+9*\5_PK:^^
M%P_G#A_>US+*&YO\RS0UH*2IH`,HE5$@#,@JA)%>1%$H%?^,H_3L*-_489ZV
MULML$>CN".@X1,NU2'E%R,M87ML\JU*(R5"%5@/WR,E0E9;\"!-M%N>5"B\"
MX$Y(#J.D;?(^W0*,3V-90`",Z1^VHW%<<N9P@)9X1*V`1HY,#PY-!9EI,"IO
M&[2^Z+.U$P+H<P#X_DK8.458*LM!8T70^$A,1.0"5,::3("@.H0;:X0"P@2N
M$0#M9$V])0U$F)+5)$"J$C1A+(=EA(AN+`#^V,GX1,H/6<QUW,L$I*]BJ?,/
M`06IU80&:(EF3`A4;"BV:HD,!DW3^`:L7,>-1%KD<.I`Y)4!$)F8`(T26<P1
M)PJTC6Y!;]LI6^A-&86.;`38:<`_!51$'H@"&<`;82]&3#1(+X#U-(HZ<0E4
M92X$J$T%%$`4\XEX`5;+$0>V*M2-E,L$SV'5@6D!Z$WZ`(5"W8T``05Q0(7\
MVLDRN6#LX%"_C6+OE9RB*,0+=4]LB!8&.("<=$;A/E%*AH=+!PH'B/5@_@C/
MNMX1!X+=!J0G>K[U//,AO#C7W/0)1RL&HN10S3[$E/17;V$`D@)*@="=;@@$
M.;W,,O&P8V=``.S4I0!%7`#%6=4$J1V/@D#%#]'N,BDI.>%UYP"`!W#=``3R
MG-F;JBPCZ2PC4B`$YH3>F>5.`#3%5T1*K0QVQ<SMQ)1%H)"4[KJ$%@W'`I#.
M*<D%_ZQ)HV"`76M$W6;$WPF1U"S=0$5`0!%LBQ)-#:N=`/RR;),)=>-C,ZDS
M'JFS;1"-ODC/E>R?E@!%>TC4UAR%,7'5>_O*/;IA.X;3;!''!6A26:WV;9R$
MF.2';^P?!<PNF_@&:"A2&!)'YFC)+KW9T(PU_G<P^%]\M!EU@&I(!IM`0`,H
MC(X*#DES"?L>AGY@.-NT8][94:C\CI@BN$V5M`F!#6S=A/::$I]?A*TFG_O\
M*.<5R(\X]EG$RH'T)J=Y$V<Y"`D!>:TX]'5,)_XPLA<AAX,$@*.(V(80E2FE
M2J)AQ7KAT%7\9W'H+)@+AIAKIQ:I!ILH1X(<9@$40"J1".A&JHO$ATQVQ7ZX
M!P)`0`!`C`4T\D:P2;(.500`C*3>SV!@&#E*1F\.F6[D!Z3@""`-A+^Z8_AY
M4Q(J!8DPP&?IU9O1GIG+B&ZC&&7`D4#8R6PA6;7IY%U4YI*E5RV=D&J4=:SC
MA59JHA:=939E",(;_D4!<$F:LXG2:!N@P-I>2%*2R]\I[6AK+?=#"#+6;$X$
M%$"&F\>=WO?0P;HH]A\`S(J(A41:!/SN>.J!0=5<@>23W1HA.8M,D)2#V_8$
MZ;-(#\!*_%F^T;0&]VFK;AW`9UO1080%>'!%#,K23;!`A!1()`"9N_RP]+(]
M;0`)I>>?.<#I)DAX61ZXS&8$U-":%3J@/$#($Z7>:(##V5$$=HZHH_3U?)?'
MF/R,A)HKUF&X!H7]5H3#8CW;D$<9D1`)[8AR+*T"-<@N/T`M@=G8C(W:)\MY
M%*Y?/))2/'H;[N&&,_W=Q/>PZ'%$0(#>;T3Y:(35$S[;[+O9Q-[F`-1?_IY)
MJ@0O?5&`9&2&4U=^7ER]7F@J2C"J35'-3\SV.,EJ;?L1J_92(D4$T1F_2HZN
MZ;/^VAC^I[J$L$*``4AB`6W=UCT`:/;UL4#W>1"97^AOR2VT4#@6H3S5'M+G
M0K!]U@Q&7*2M1"R`[T]$ZF?$8E%_V0!$@@L?"!8T>!!A0H4+&7[P\)!#A@P4
M*#90H"`!@0`&.!I``"%"A0H>&I8T>1)ERH(<.*AT^1*F2P\*#%8@L"&FR0@'
M#&XPX(`#!@<J.]#,Z?("3I03&AQ=F,`IP0D,HE:U>A5K5JU;N79=Z*%#!PX/
M'#A(D#&`@``%&$1@\(!"!0L=O-:-JD&I79,;_IKJE5!P0@`,=15H($A!P%\/
M#?ZFY$!5+\$(*B],T+JA0-6ID3EW]OP9-&B2#B](D``!0>H!`E838,"@P@4+
MHT/71FG8]L$,D26TY+!@=UT)?340L&#!P8,*#U)2&,K9@DH.?;%*@!J5`N3<
MV[EW]UYPL%6Q&S*$C(#@0('4!P@,2-"@P84+X;_75_C;OET/!XX;CYP@N@\N
M.*N]!"C8@+:&\HI,`0HDB$`!`PXXH($%(@#IP@P5R`PK#Q`8*"H,KJL*@^`.
MXBN_%%4,S:B3.L!+@^/D>M"!]`@@H(`$&"@K.0SH6Q%(@S)@+LBL+#@`@``R
MX(`NNSH0H,D.'&A@_K<%W#/I2<\B`"!)!![X\DL%&GC`@`+,+&`!GK"J8$2G
M.N#0*LN*G)/.SSC80(,))H"`3`,&`&``,Q?XT@*)EJP3T2!QJVN##0C8+8+)
M_(+,@PM(N@`!"P`P"0((/&N`RQ8_0T#.J+*\2@($3$R4U591ZH"!#):38,,"
MU"J`HP0ZO2`##5IR%=@54W4R4TD[>Y(^3QMP`,62,$A0KPFX]!2T#`YH\BX!
M.L3@`>V"_7;.H'R\H"P&V/L3`%P?@$"""C18%%R$%FRU`F.W>]')#B:8ES=J
M/U!@`P4:HY(A#2CXC`$N%Q!M`7Z/:O.J#+"-EV+0&NW5@G8?6+:!`6Z4_O``
MCD"28`.2H:U8H0@F9K6"YSQ#,+0))!A@5<XZ0*`"@BPHX`##,B!``!`3DL!E
MSD`%P"B6#-)@M`P@D*^@=Y,ZR,>3("B:H)I5\J"`#1+(^2J8/;"W@951/ANE
M2BT@MP%S66.-``40<,`T"7QEB<D.1GMH:;3]/H@#>SF#0.O_*!C@U\\P&*!)
MOB<@8`(+$D>H@8.UG)8@7PV:8+<&##C+Y0M>@_<#"WY4J(,'KD6(]*T%4.!0
MK&*]0-2_;2]H@PYD.^XU!@0H((``SEJ@K,CUG.#DE!"X_6^B2Z*@@.1S(CRT
M"#90D\7E">+@+(</BM7.`@`PH"'I8_+P@,*=_F)`:*P"!HIYBCL02:0'%E@@
M@>"3!/YU!AJ(@`)@,9M5"!`_OYEO>PL(4-@24K:Z7.!^M?.,!PP`MK@\Q`,E
M4Q\$O.<5#!```-K3CP8N,L"HD,H@)-$;@EZ$&PS2!H$((L^26-*!#&R``P_1
MFP%%`Q8/:"`#/G(.A!2P@`TA@`!E0H`1%Q`7"B0.@5LYP.1X6$6*42`#!3C=
M9RK`N.T=+5VM^T`%_-69+0'`<E[Q@`4,$``B;04U!BD`!R`0``0$+WC1>0`>
M#;,GAF@$CX$4P`*`%ZJ&=`!_'4S)#TU2J7<I!&8,Z0`%]$3)D6Q%@!RH#/[.
MDI$DI64`!BBB`^12_J+/[/`D$B3(#Z-H15<JQ`,,4&17PD(`$W:F`>'9``2D
MM0`F">X#%-BB7AS`I5)Y!4?"2>-)J'B4#,RE))6J"@<:TQ#1)8!\"1$F0Z;#
M&EP58`"SE*18=">S!B`@`0CX4_`$,,BW6"!R8K2-!00P3(44,"$:8(`]7]G/
M^\1L`R*TS9`.,@`!$:",!&E`,_52`2XMLRL<Z)I7VE+%#E2S/CB\$TLJ\"`$
M""!)`&#-``8`G_A<P%>W!%8V_=E2F#"I6A<X`-9JDP`3L6N/`M!<0<`2FH0!
MX)A>&8Y0)4<=EW)%AV%IU`8H0,0#+*"=`KC1`!3`([F01Z5^8R@/[X1*_F`E
M3X!A"6M8Q'*GI3;*`I%2:Z26I0`<B5,K#L```/B)D`MD]2@:""=!*O`A]CG`
M6S8,#0(>&AD/010KSOD`7H^*$@X8K%,0X`C/)E0FXGU)`A)IE-(:6Y.6@M`]
M"NA4A#I2VM+.+5<=P:9J$_``C'2D`1"(;60=8``&0.``NHIL9,7$IP0<@$^N
MS6W(L(DKTQK@8QPA0&J6BYX)F6FY7TK.NH)8W1)QUC,6V,#"'-O*HP#6(!(M
M0&$,LL#//%4`0?7*!8R:E>ET5B5`M$`""$E9<'I31X2[0`X7"U^4&-2?(/S=
M>(VX+M=^B9<3>5`$#&P!/O&)`0HP\(,G;&`+_E,8`@OX'`.\]#GUV+9"$7[P
M:21B@3P=!X@ISET'\$00N-IG`Q%H;VX\E!<%#*"V`2"`I`C@72EVX``4D*=6
MN$?+&;MT`Q@0)EG(XM8"W$A\!L#M;B&@79CZ]RCM<V4&5(7EEPXY*NXB`$8/
MTE//5.``)/%`PQ80*\E^(`/<!<W"@OR`Z^G%6^Y5)=H$B('Y^)E<4W(``LJ4
MQ`.L%8`W7*J7NY)G*T(`L8QNI):Q`L``=#`"9([,`H1FY^W9+0,^O@Q4!'"P
M#+#4*T<6CT#=9"F+R6=*\'G-`"CT9*FF9HFFP0#><LA82<.QI16(WJ]5D@%*
M6Z6)^.0,ITN2Q=$(_J0@=?2B:`BP@`!8)@,0XPK)N,(!5A_E,:)V28R.<YQN
M?50M7!)I)Q^@)PD$T*O$_DX`6OH:>:=D`JM9P`2.'9,[A<0S&&!L`2QG`8\U
M(`"=&H"XLP)"-'X``W#R2@5\_9*;=4<#&%B._8H82';F-@$*F,"!]%9ROMV;
M3O3.25V#%&&4+U)T`MCJ2S`0O)GG)@.;6F5J``#`!#`<*T<S]1L]V)7%(-4A
M2;_`<B;`Q"(.(``A!0"2*%06BE0@U$E_>;RP!Y,(W!Q(%=CSUO6R+@"G"$+;
MZS%?Q4VPJR`)`#X;.U8F`.:C>(`Y0.?I0Y3<]->:Z4]J,<#]]BV27KT+_NQD
M/YNR7UFY5M'-@!_Y=GT(,!BN1:=J*<D=5A3`)9Q@P-%;2<"+8=(R.9>YY!N8
M0`4H`(%.)D!\7.K?:RA0[K4I'LL)M2)<<*\0O"@$]$(RS002#W%"$ST_%M`>
M%C]0%MM(E$LDR4#HM:+[Q`)5DW63P`,0$&60!B!0;6.,;.1SU]Z?OXIO:=7F
MNW-EUGE+D]PG@`,X>,MW!\"\^>%:^]KM$!;K_2@Z`%UV8_KT8^X"D+V21"U&
MBCV6)0+&I?C0C]@FCX=<CE4@KSM<C2B&Q+D@H'46``,HL#XH(,VBQ@,H@"->
MYS,<[F`XH.NXPBVXHBCP3Z,B20)OT*YHJHH@_N``543(O*,`^LU%4B7_/B`"
MC&A.*(0@+@`D;(H#)D`$NP)=L`W5MN))U"<J)`#\<)`+)4G5#`@Y6B4"[`Y<
MF,H`U"M%Z(DD+(`$?^4!R#`KGH1+6J(\A",*W80"'@`+NQ`'K8^'X*-5$`"8
M:D-E_.\JP"(`A-`D%%$K&.`OSF4^9N9&3H]10`H`+B72#C$`-"TK[(8//]$@
MJ,^`'"`3@\1!O*,"<(+CXJ,J;@;O1"D54^*9.@,SH-`#*H##N,0!=H;EPB;J
M`"!G1,?H$$`!`#`E*@X4MPX__,D!!K%(("T-W2I32$\A^,0AJ.D``D!@X,H`
M&#$.=W$T.,`C#H`Y_O8K,N00`'""Q1K(&TV"`HHQ&>WD!@.FWGHP13`P14ZP
M`8!'`8KP)!2(:E0G`!2H@V+$3@C@5T[0(8PQ)N:*2P8B^!""(0O"6B8R'B^R
MD<`-6!@`#8NDB8J$`QRD3`X-&1%`>D)R`0A@IIII`/RQ+BX/SFPPX))-^I#/
M*C2%&LDNB#!R*RJ`$E\B)[^#`4HQ["QR@ICBJ<8DZQ9"GTRB9>*F&7VC'8E,
MG2H$34(#`\;P$N$,#BF#`0R@%]%/`Y"1)V^#$RL0;!)E`LBR/HX$_!I@+!.B
MRE(B*\WE`.H)-.0#G<`J+.RB7C[`)(/))6$"`ZSM`8SRU^*M+*MB`Z;2_F\0
M@"A7I`&"TCXZP,'\!`$>)'$2H"L18@(BY#TR"S%-0F(V8``H;6>29#"M(BOW
M@R3BXBINS#'1#P(B<#%1H@#]Z0!F\SL*X"Q!(RB<`@(T8M]88MA<(C@7*P(T
MH@"LARV)P@!:8M`2I"@:H`)BJRXLX"("8`U%\26\[3D5[P%L\S87,3)OQT!:
MI3-Y8P$@(!9C(D9DRT^@:9%V\2`TX`(V)D<J@#P=`TY@@Z>"+&MX$RA!ZCI:
M#RM08S0E32;+TYE6DWD6X#=Q[PBY9",@(#P+(L)N1""Z,NT6(BB0JP#JCNY<
M!@-DCB`$D#PS*"<XP$#YZCRWA@#6TT%KE-%X_J\+)<```$`CT@5'F.\E$"`L
M\G-'=44QP\LZ32)P0*4`]+`5)X<'HPUR/H":JNHK,J`C3\(AKP.'LD)/;!1,
M>^^V^%"?$*JI%N`C%@``<DDZ"F!B\J0!,F(,$\(!:#3)<&NFP-$JKB=Q0"\!
M0`H!^$D#_!`EMG0),_0K)C1,%Q7+AK(+Y21PZ&8"ON1_`J6(W+,7EP.6)(`!
MW@,N$B=+E52VT*D!)F#7G(("J&.7(.!U.@`#B&\K')*[*`!1%X(!%I11<_5L
MTI,+\X^:7F,M#_,#8@Q),A,+1Z\D\O.CXH,^\9`!5F-$CV**4N@!.B`"HNXG
M281+;@+.^O,DA%17_L/5RQR5)ZU5PU:%Q10@+11H<M[$-O7E3PS`&6'BAW2T
MG11U(2A`H.YG1T<T';7"(9.$5@@U)U9'7`^VL=BG/+DE(4[P'0%`(%I"1%QB
M`6Z18,_GAQ8*)C*3IQ0@`AQ@-S"`,DO"H=`H`)9E*[HL'C6@0I@-84EVC/RI
M01+%`:`N`+RS.[`N\Q8"`SB5`.+T8A'B`>:5.SY(C#"@\X(6*:).^?*01K\U
M5"6PMESK#E]V`-($`&S2@``(4?;#,B:UY=[L-J"JM?:P(!"I^+2K*S0P(2)`
MXJAT2S;`H<S6)3(@7GN.P;0"`9[VY:@G!%^V(4J07?H)1^ND8@6$;K=#_C9>
ML"1VT0(\)P$DH"\5`G8:J68]MD'=1*J<TVP6("TC3L/TB&\9PB'MR,02UR7`
M-1Z5XPG7#G`5XN<^8.3ZB2.[EBTFH+5,$:%.`B*,BF4]IC=.AD;UE=9,QBK6
MZ%EUC#%,I`-8:J@\ZRK.B$MQE2!P5@(?P!*AY'43PD53HP!T,'[(M4Z8`D?P
M=3N@I_BLE<MT4'30B0&89K%&5G:_\@#ZT3'`;D@TK`0)P@'DY&?"PP.LY9*J
MX@%6@TB^+BN4K%R#R%L9=4`2P#Y?:6:]HX&!9$O2<B%^A@`J0*<8HE(XXEG)
M*R=LR'Q3%'@JJ$DB4`/@I$L_@%6+"4)3`F"B_O1?1I<AY&I[_8UZM\R&$Z)6
M/X-7NR-&$<5M\2H#!O)GJ/3FO`WNT@5\[&)+;@10V"*]3H)3A>0`9$E3$*<J
M9,DB"$)IXVN.<CA73?4J?M@S()-5Q+&"/0-D3Z*8J.H"@`9\-8"P-@)I]H30
M$L!4%]155TEU'H*P-D:DFM1L*2@MSZ(\#.#4P)=B-X`L)`.->0J=R#A7*R!J
M;T=`$^7HBJ34HFD"(L`2N<0`.!'([N<C>/!_V"4;QQ&`3.PHT&S^AA8#(.T`
M%HY3+P"D@G8"CA/(!N\,9S<JW+-_^7=!(:2-+1D'QU0WP](^\&Z'$SCN2B).
M/^"G#$!K^8JE-(#[_BA$LM)"`=*G@).D07JX9)`$I,1GX9J$`0(@\=9,:!*`
M+EP5(QY@/H[B`;B$2##8*4YMDI6Y]YZFI7KF\8HDEZ*H]4C"4135_<XVSO[T
MVOB3`7X6B)ZUG0Z`XEX"+$36(<W$/4/I))KR,(@D8$1Y6[$.)HH)J`@B6^F5
MH`%Z41\@AFT'`>37-C8`18$$N1#(`EQ7ZQC"T[Z"`QP@`&8J`D(9*H."D-;"
M>AQC)=)-W=;T('[3<PMB/G!E80K#`T*01V5:)1Q23EH:*08@C&$Z'AL&C'NX
M53BS54Y.13P@B"521_FY)(BG%P/8.E0R.7A0Y&I/`C1LS.+"5T[RC4[#_@-"
M<CFYQ$"6<B'F*W&LTVT]XHE6"6GEA@%@.5F-J7IK=3ITQ:P9=?56J?&BV2YF
M`T@B[F0>(E6=64@$8'_I\@@'(#,C8/#$)(`IX'YDFWUJQ@**&D-GJOF>!0%N
M]3I70P&&$B_X11A7(N_D)GD@:"UDVGQ*5DX4H(V9:@"R^;/+$ZW]J:PSR@!(
MFS4%0*;)"@,0S@".="$9PDIJ5<E:N:0LP'\^)&,2(%TD3$]R1\EF;8X&HP,`
M8($L,SL$3P',SR`JER`D@`VQ6:6L]:-D6P).1J7!1JR=<J6WFU$!5#?%VRM0
M-S*.S5K]I)U(2@'>4R*/Q'Q4KQ6%#+#<@R.G_L.(?'/D&D``.@(!)A/B#("\
MQ><LZ>A92VHM,X?HT%0=G:\A_*P!HBN2)(!+PF.([V.B,'Q1DQE<X)$+EV2S
MS*I1PK%\'"^N#0)9M@)+F]$B@$8`U&FX2?&H=P2PNJ\]`$"6;HXO]C@">MI$
MWL4"'@"$M)MUF#"W(B#.N"1`K+<A0EG*#QU<;K4+'^#)/*:0N"3-DLP!(B1D
M)(0CX(-"'%&O[+E3'I`@:FY=3`Q&1AU/\$(L8"1W[B0E8L1,*.1"=J13[7E1
M2/!/#B"5$>]7L"4H)J"V#$!SD&-'`2!Q.J5B]P32,DZ[F.979`7NJ(6U8:G"
M$5W:@<3*X8NSNLI:_EU/0CJ2)/@+B"1B8@*86PAG4A]``LI]/+<D4-1C,N#Z
M:AE`/<PD76QEZJ".I,HDZFH\&[^I3/J=W_D]B"@NSQ_@3R7$(KPDMZ3L:HYP
M8[*WQB>ZR@0./`;,0,:&<&@C.S@3`@`OJGGT=RR'R;D$5P;@MBH,PPQL#`^/
MADYM++'%S*8=YO/CI<'%SQ;"AMZE5XR-<#KEMNYHK_81`S3`<24B>:A<(N/2
M(!:G=7"CQ5[$Z3\`UUOH7::>ZJN>/U_>(=ZEEAT@1PJ@<KK%MTIUD-^E4[`I
MZJCJ)^!=<F)D2'8*1*M^ZMU0%YEPE`N`RJCL*R<+5Y@+A-JCP]KCR:`K_O`]
M9[RX+S7LYRVDJ]T&?KH4'TP:GRPHY$NPB<G`9%`4?XG`9&/&I%L&A?-K124Y
M['Z:M/(=O_-W1/,A?^/6I42:"B0,I41@WU"J2_9KWX9J:)6,\9^/<?=O6DAR
MASQ2ZET4>O:IU&[<!8AB'^N2`H@H(JTD8OMD6CZ"*_K)(C-31W(P"Y!-GR(J
MGY!P1.]K=G/_F@3'9+M@;_#P9_,9`$W'*SD(H+7LIUM:/?7K_\``ZRPVIOLX
M_TM2,O`!H@"!!04$%B2@P*!!`@4.)"!@(*)$!A`@3-``08.&#1\Z>OP(,F1(
M#P\\>!")$B0$!B<[1L"0,J;,F3--+E!PP$`!_@,)'$RX\!`!`@@/(%AX8`%#
M!0@1#N0,T)#`@```!"S`H*$ES8\0#`!XT)&!A@@,##BPP#&F28\>-C"(L&%"
MA(P;ZM:]("%#70D1YO;U^^``Q;X,#C3HR]2O8K^)&RMVO/BQ9,B))5N>ZX!I
M104-$$1`X#3!`J<&G)HN3?IT0Z<"I;IV/6``[`$&:*]>S1J"@P@.&O1\:$!!
M:08.(B(@`+JU@H'+$3APP*#![@<1)#QX`-V@3@(06W,_0"#!`X$Z%2#H^?SY
M`M'8TR^0D-Z!\_CTXR/HX(%W?`P4'%`H^MQ+SWF0@0$7.(`!;V7!1(%$!@AP
MP`8)@+=3`;(AL)T!_@@(1.$&&3CT@`2%'0#:`0HH``%.3JF8DU,+D.79`PLT
M<%A?$W0`EP<60$"!1Q5@<$$%%/2%P8Y]48`D4T,FQE`$&53'P4\1<&#!7XA=
MB>5EE$WHV5R@0=#``9F1=AUI*CH@WF*0S47!!$E=L`$''VBU59T=62`2!0I<
M$%MM#-CI`5%R:A#``78>BFA*'72@`5\I;E@``P,P@-4$:":`80,,$*!!!QQ@
M0&5A!00PP)X7P+35`U1=,*<";+EEX0,7R#D3!1DDBFNNNN[*ZTALX;?HHAX$
M2VRQP7(0K`?(;N`I!QS$Z2RRGA+K++0>QKE7!L]N*VVTS2);;;/0/BON_J+6
M7J#!I]P^VV@$LU+YX[,)2F!!!1OP)0&H<9[$@09PDMN6MOU&JT$%<X+;08*S
M=M#1M-,.:ZQ)$<])YYR]7KR5`Q5CS''''G^4%D@.<,```C>""=(%%M"*TG@6
M(```GA_/_-&B##QPG@(0-O!``Q5DT,$#!#"U@`,J;^#!!#C##(`";ZE\*TKF
M!2!!1P6,9`$#`03@JDQNT@QVV&*/37;99I^-=J\';)QVVQZ'_-$"'E3@0,-=
M6PT```2`E9(&"N0-@=L>=U#!!.L1(,#6`"1@P7\,3""!50Q4L,`"!:^7`%4!
M('`SR`8S$'4$BE[`JDP4E"YXZJJOSGKKKK]N_C7;L,\N$LL^+O`!`P#@WL$`
M'RE@T@8$8/`050;8KBP%MM..ZTD2&_`H``$80$#>")P(P04-S'BZ!QATM;55
M!PP000!I5;TK7,ROSW[[[K\?]@51?[0V_/9[E.`'`G3Z@05W?[`3AFT```RH
M"P$H(+O[X6H"@9N3!C*0%,IM#GL\:YQ\=G*`O`T@`QE0%:I\IRL/U$V!)"RA
M"4_H.H>$I`$)1"'K,'``#%#M)#/RR+TLT)(_?<`M[UN+QSR`@.6!I$@4:,!*
M"I"W0DE@*@$0C080P!$/)"!7'%A`:3K50A=J<8LNU``7:]*SD`"OA$%JGX0:
M))L.[`]_(;-``A@&_@'<N6\!/?I8!1I0IPM$:@)4:@`."7```>2-;W7,U0`2
M,(#=52"+7VRD(YD'Q4<JJC^<N17?2`@T][$$?WCTB`2$,B0!&$!N8GJ?`@SV
M,2"B3E$/(-](")`!)$J/5030E1OGI+(-70]NDNRE+U>'`%3]TB,'>,\%6MF!
M`C"2=IIR'\,\,JN/*.L"%(`66!#0)E2N;P++Q-4&.HF2#CA@``YX)D@R$(`*
M4`4`MP)BKCHP/&E^Z@%"'*:O[(E/C$6@FUKLG008E@$!<.!_^73F!_#"OGN%
M;0$30$DL%2!,MLAI@`T0)`!HU5!<O:6@B((`/SD*TH\PP)SVK`!X$"``_A;*
MD807R"@)_Q/-$VX@HA_+@`X_HH$%","E*!F@!*H'`(-)2"0=@$`%O(@2!ZPT
MI/;+P"J9VCJ/@O13:9%;"34@,P4"D2'PV2$&/#6_]GE@`;S\X0&R>M`"G'(F
M`W0`4$MG`)%L0*=4^^I',C"A>M*$`T:K9P=&"M7`VJFL\!L`88?9P`\L5;!F
MXP`]3\*`APB@/Q:J&EY;)\0-2!51_-O*!A!PDIPJ`*FU`L`$$@F`*(Z0J$.Z
M5`6R1D>2'LH#%(@L0BA`V@]PX*.,E:2S4$);$RXVG^`<+OP:\%3X30``Z--C
M!AK`,'>=9$BMV]AG<)6!;F[``0)0@%NMNA4._NQMG:A"WTPB`(!$'D`"O$4)
ME49U0)KV%JH4D*\6K^;(L<CDIJ(K(0,("K\'++(C?/E`'160EOXR#Z)BPVO>
M`!##P<9LG5&+*TTZ@(!T40`!`3A+KX:5`>Y"2'WS1<D$"EGBF(`S=2OF(@=C
MT@%PMMA^/E0@`F062P-XH&H>(`!'L,(^"\AV9AM89][LA`$"]"YO#/->G:IC
MPU8&0,!ZG:UC#P`5!QRVM^T-;)<_%@"F:B6Q*6YP`PRPM5@6``$'%8`'"C-D
MUSE5;!W`5`8P`+K=YM$`$[#HK2PPXY1<P%`@F6D#"I"`!F2W5XRB7`(,X*0O
M/Y)197X?F_$IPYMZ_H2G][NQ"^7$`2$=M`$<&(!]7;<`;=)L;G'>"GJ]DC<&
M&1>X!Z@R!AH0FP38]6)D`>156E+E81:ITL16W:)``EX%4J#5+B1+^X+9/@I`
M^,%>Q,"LI49FE&C@T)O3&,8N4!@-Y4O2**QQL6F7VV%R8&L'X&-'KMV^":B:
MBTEC-NL(Y+X(#,`"5;GH#@.=DHK4:2PZ88`$TJVK#42``%!)=CX[L.5SKZY^
M^)3`K#X9``AL0,<E?,"I:<<!!<?$`?.>G<7SO;\%7$``'X^)M6?+'YPY+9.]
MVD"5)%`Y)]E;XCS'&*=_B8&0V?ROY!8<S5$N@.2")%#N\[C[EFL!6!HV_E$:
ML#"N,("S\$"@Y3!O@%3\&/&>BWWL(ODYV44"::`)C`,-NK&H7>@!`-..WV[=
MP`;[)_*9B(A7'CBFUP4S@;#7*3]%V9#!$7[VQ,]$T^J^#E%"),6BIQ@"#TFD
M``1`&_1QX(TNQ/#[*$"`-WO`U`8F]%8RPK&$>5T`9PDVHC3K=04@1?**+W/H
M\XF!`>Q$(O"D?=I&-CN(8S5.*LD[">5M-@T0P.PS6<X#TLO._F5;)@=`/*\@
M/B2"'`#U%TL8!1(`_@F`2J:NKSV=+YU//7\$X)H4/.QZS'7V>2!"9E-6E_6-
MWKS=B@+P!HEXW;\K'`!N4@$!8<5WVH-F%%%^_K-C*>8G.,/"6)>D0.Q%0AA@
M`#NW/CT&/PY0`-+&9`96<BG1566C(Y"62E%"'22T$0[H-G/%6-,'/P40?^_'
M5_=10K4%/PGA@0+`,`X@@6H!2VCC>XYT*BS8-@/%6.SW;`#H.C9'$@9P<#7Q
M.@I@?,PC-,_W@2&R%8:#@8WT+$989E3R.IU%-DA80HIV0AE`$(M6.ZKB<`^(
M8NU#(AYX:1$0@B&14UV(-B>"0$/H$0$5'%OGA[LRB&"X%1T0AZJ#%F?3?^M3
MA0H44`*0+]TB%^3A9B^$7^_C5A60-X2V5C(!1,RG.ADP`2@%`#G2,<=4,@30
M`!A0B(C"8(:8?'+'_E&-R#P%P(3,LP'4@6L#@'FU$6'P9'UH0Q3P\V8I]6`,
M(V`RD0$(\(.STW<.$`#(@2"2=TE])P$[X1F"@S2RF'RF!U6V2#LR6&Y3,A,A
MQSI!9(R;LEP`P'$-8%XAL5T#`(.ZB`$3P#.O^`$=4(3>B$\<$(],I8092'\G
M%&K+A``&F#;N9#\,4`#Y=VGU-1(2\#<+H)#^B)'N@Q&,Q7C&&$DFE`$#,(SG
M=`!Z2#,:((JT$T@.D#>W%P&)6&H/P(:/U!9ADQ49B4)^\X(F9(,F1!PFB28F
M^3$6@%;N<U))Q#!1&!()H(^M$U`DEXMU8G<$@"!">8@X26>/6%!WZ#X'_F1"
M%;"`(#$!!W"19+-)]F-$[7AI@!42H#-,<8$IHY07J?<]A3$4B]@K#V"56'DH
M"B58S[B!,PB-"Q"6*4,``0D2%F``B=@K3$EC.X%.R-$P*"%PZ;=A$($`%(@Q
MWH,3DU)-?+D^&K!:4%64]@,!A?DZR(==!=!=:(557H$``["7,J&3]V,6&<`4
M`,`P[A82X!92!%**NH<4LYD2`!DF"W`SJ`F:8Z,!C%E0'6``4=DZ9'@_Z1)"
M.\)AHB1(`0!=N2.8=<(S"G0`,LD4GAB"?-*4[A,77A<`!O>=-.$]OF$`2*&<
MRSDS^A58&51+)%1`+U6?*=$XV55C?O.?*3%&_O8#3T;#%)=F.7)%BR!E<T1Q
M'B$RDHB"=8%A1!5`G/;)*QKPGHZT`4AD`!4*C0E0H(*S<B=J)Q2`F+FRD?<3
M4#<C$)?VB?[WH($5)`NP.=F#'QC3.!'Q`,O&H68S9X$5:E^9GA@S;)-9-@R@
M=(E2F0@Z`)^4-_TE`?7T7#Q7`0RP`+'!?1@C(@+@C#@TI&&3`<Y9IKMRI??C
M`0/9,1Q@`!\J$F.5I*E$E;!&<3TEG?25``(`?G/9?;75`!2P=7N:ILPXFH<J
M276**#%V(S-!.,;UHO?3.^8A/0-`(D+AC-51'1#`BGQQ$6+'*)37$!;!+!>S
M;0RU+XKZ82K*JDLG_A/'9C9L.:<;FCX/F1+Y`2%K5'PD!$\6L``$Y%43<&?\
M45_\81;/40!N6F;>,P%:,S2?N15CL29!YR$($6DAL5N>\JIJ8:M\F31S@9R9
MXA01,"'4XQ`.T"(M4AJT(93?*B-ZA2!NLWD&P`"XI1%/`@&(MDBW%A*AJE4&
M(J+/5)I>Y4DD>FXVUTI-<YHS81HDD@`%L1!Y(P!(M'L1L1-0$1NN>G8X4A$?
M6Q'%,4H)`1$&L#VC!'Y'9`!<R9=%-DK7X7%'H:,`0"/<Z17IQ$$YRT$L9"??
M>E"+B8>\VC'F2!/_$;&)4Q#OH16<]Q$LNSX60(\9=):$%0'F)"M@R"A*_E,J
MTCH2CHD2$M"*SE(`#R``A3>?#Z0!7LNAK40<#R"C/4%Y1/%XYJ$`,W(S<GL3
MBKIQ?5.`Y_$!UW%J]6BFUQ-6RC(S&HHHSL(V%0!:;"&GK6,`S[4XXR=0'M(2
M$Z"V"U"P#J@!#KEF!4@G'%``K19B-O<!&O$!FOFWG",TM+J<#2!XYB976LF7
M_.A>\3EH'-``UBD2@ALV'I"V3LL\%Q!/NL6Q;=,[&"!+IO4!`/`!"0``,"$T
M)/4U&#DL5((A`U`ZXC4ZF+*/"F`!!F@N.G68Q\MS]UH3640YBHHC*`%#&4<H
M&R`<58,L*O&`$7`83[H^./@!;GIRL,,![+2\_JSR)S*$D@50E!)@J&37`8^Z
M0^"X="_R3!"@F^[5*!*`IMZH`/59%R"!<XJ*;R!1`0.`0'J&2BTA`//&K!QS
M>7[*`)&5-PW@)@8G`2)RK_)&E$3Y6J15EF.#9UP:$U4$'CX[$XL&042Y0]:G
M1FKX8."+%,&:``<:-X?*O>[%O!TA;:V6``NL>#WYAP@1$\M!4DBBM\,E;2VW
M?""1P8BB,O52EDAR8DAB*PL`,P/P``H0Q7A\(GA<$#K1QX^&.(W;,B(R(W98
M`4*"0+F:`8=\R$$B/XSL@7:(%:3S0'=DKQ@@IHW,R'=4.9U,Q^&#9J22$R.E
M5Q(@$1);(5Y<,P+@_F`/YLK68U2;/&C:$G0@H1'F6V*:E1(#)$S0*3NTFY$;
M;,L`D(DBH6\DA9MZBYB=NP'IHA$6T"G1W(&%YA'<&CP:@<W/7`$1,*YUBP`Z
M:F0T6R=(R`'..'BP&A/V0I'O442NNW04("05`+:54[=4V!050<?2(ST+(&!M
M(F\2P)WQ#,_PS!_Q'$4=T1+`=H=TLDP>$)W+^\IZ0SCPO,@4L",1G5Y<LP`#
M@9R<X=$*H"=Q3".R5TT":!(G_2X=`$'&BC0G[=(O[8HO_=+XX=*(C#1G6E_R
MH]+>,U,IHBD8C#2(+,?U-=1%75_0PD$M+20S!;R+!-/PS(G!00`1@$1-_F8Q
M"#U@%",[_2*[B8=P&)!>-#TL<HPL!"'"$<=//I30SG/25STW.J+6U_O226(=
M?.322-/2*],X0TU;1HTD)F&L_]$?+"H=(/V22/)?3F,K,WT!R3/4+\D?O8$D
MC0W8L(;1#]9A_J$GP8%2-W'9KWQ`2/)31L8T`)"H,1$!I"4!F_5(1U4G,8;+
M(E%@%'S9_X-:GTW,)Z;2N)U$%5$!=\S;&C2NP:TW3:0`X?S9`L"EFT+<`K8;
M.L7;!8"<-$+<R"$4MXW1#7#9,HG'R$&5+%D`."<]X<$SV^,7&91>/?&L<R$=
M/3,!)_;>\&$IFO+>;2+#_ES7\!VR$5#?_7UB_A8`WY`C`?]-.O^-`:3XWT5D
M$>(G+,*"+L)"E/X,-"!V$1`S+!!#34+64LP",4#3HQW!B<&=B29!J"H3X/[,
M83(,WQ2A5-$!?E',<)A2MJJR.)A=$(\V2HE#%20"?1C]S5SZ-[QMLD&*W9]-
M%0H0.<%M`/52.$"%V_,I`140Y+P=`-VE.,'].&T"O5C.HA8E/5NS.4YZE<@V
M`,++.M]D)Z++VBEA@2G5E!B\9+7-%D5^V0.P/72.T87RS9:-V\OWWGC^RM##
MSQI0W1#P3U..VY@2Q1/@Y)?=1->#Z)^-:$-!`1!]V5T2Z9?=@<H#UL3MZ9U8
M+T5#W(?=9\$-TDH!_M#!+<?YQ]N<<Q:9_F"W34XTCMN96&I\CM&R26"`_F#P
MW>B.CE4,U([1;7"E2-R0#@'HC=L#T,F>#KU-1-R/OA.>?AX;0MS:=`&>KE:T
M[<I5WL+?WET1D,-[V@'&=0$2W#X/="B;=U9L0R"5DUT@?2B?5!(S`;7$(SW1
MD3WXF&C5#!V^0;,T(O!W'AL6<B$ZT:6QX8N^^"";HZ,Z#O'ADT1Y\S=7?MD'
M0*@'P.K(#=H(4MIYGC@GHBFA_.6)@]$/&:RN'/$/%AP@K3O!?0&+P@%>7NO7
M,>RX#7@F%=P[!0%E&]R3@IQ6Q.MYHU8,Q>VXW0`Z@^N.KE0;3=QV#@%#_D_,
M;!$!-(_1M_<!L/[*3B,<H^XT$[#TV6TOGR+U-/L<A9%$FA,^H!Q'N(9YXZ/P
MB;/P"P\1`L`=53XA+CX5<C\JW^[MOA@^$,]PF#HJZ85Y%%$]58X5>H%2)BM(
M)NMU4<^*#@'2U'0ZI,/%,['F-7-:Z[4^@%D3HJDA5J*N:C4_.[;"04,I.Q%V
M#8*(Q!Q_")3LA&B\V/(LV(+[VY*S&,#[6/$IO7_@O']G=N@FXL?['EJLP*_\
MRP_\>M',+]'[S;P1<?)`S+_\>G'[OQ_9/GC@83(!!6#HI\+[$\`UO$&ELM<7
M!\)GTF&LG[&R8.(9\F$6@,0=$.$4TG$<LM$;_NL!&L@!?@"A8,$!!P4;%'10
M(,`!`@0./"2`@,"`B0`F#A`0`(#%`@X/#`B0<4'!!!4)!$B`8(`!`PH(*$C@
M0*##AAH=E@0I8,"!`"<%`!#``&-#``$4'/A9H.#/HA^<.@"*\""&"!@P3*#H
MU,,"!@!B-ECP8,*#"`4-'&`0@8*#"`^LOL5`H4*$D@H*6H!;M2K<"@C9QJT`
M5[!@#1@T9#C,8<,&Q1LT'-;0P8,'IUHY<)CL5#+C#A\Z<.A<V>EBQ8TE=UA,
M^3+CU1DR@'9*@8"'!J'7:N#@N3+E#QXP4*;]X4$%T<6-'T>>W/B&WQ]R'Z]@
M(()RZM6M4^>`X3IR_@L-.G8\,)SW;@4(+F!/<"`WAP@*-"CO0"#!@@L3+#B5
MD-S!AP4!MO\',$`!!R2P.@;VV^`X#<;[(`,&/R`N@P@>O*Z#T*ZCL+@$1?,@
M`ZT\\]`S#@[#X#,,$$--,>,<3'"#$)-+$#(,,.L@LLXV\&"##E[[P,4,3MR0
M@PQ"@PH"`39\8``&1'-0M+XHPT""`@"X\+@,"\0R2RVW%(X`#`)X[C\.&OA`
M@?NX_,\#!9Z#X$HTWW3*`N+@M-(!`ARXDH("*"C.@@(:F/&X#`9(@,_KIC.2
M3D47910Y@@I<\@$`"BC@@1>SG"!!"L(*M%%/M>R@``X6$*W*#]Y#[@()_KHR
M]5-77QUP@0$ZF,#-Y#K(KX`Y877*-5[IM,!6.$<]P("P''B@`8<,J(#"#218
MX"P"%B#@+`1^4K6!!RC(X`$')/@1L0P6VR"!#A@PX%=UUT4N5`4*A`#"`PI3
MP(`-(+@`QP(QZTV#"20X`($(%F2WX#@'\"!>`:,D@$J#'U[7@`&$;+4Z#A#P
M`($S>:5-6(BK\YC.SS:(H.2J)*/.PL5FM-`"`'[;P(((+J"*`@@<"!@!!&!J
MP(,)#O@XZ$^-_6""":RB&3>KA"SL1]$VV,\!A2LC6:4#)KBT0-0<V/E."4(6
M&E,`-BA@P`LJZ"ILM1=]@``-!J#HH(-D<H"!_HD:4M8AN`G(((#\?I4`U;4'
M7]3E`QJHX`+%+VA@\8HE0(!PR;$\@#BN!RA@`(L"@/LGC32"N_,#.D!@:@XY
MN`""B1C0CLL*)(#@SP<$GSS+"P"P(``&#J(@V=T;\.YWX`VP6R(*-*\]>0$;
MX%-5"9Y_0`(%&'B^>NLQJ*""W!S(NL`,4H_@:/C`5K[\XQ38*'WUTQ>@?0$*
M<#\`_\RGW\H"$N!M,@LM]&!_T#[K@`4`2)D,;`PY'KC``Q0P`(VA:0,3B!T"
MW%(_`%T@<@^$G03&8C0-4L`"]M'@ORA``>U$(%T41*%H(*"Q8)WH/J$95\PL
M,$,:SG!5`S@/=310_L,9/H`!/V2``MJ7`*\@(`&[6E$*)5<C`5F``A-XX@(D
M8+,&E.P!";A9O4J2@(XHD8+Q`<``HH4`KBS`C&=D`!HA(,6YF%$ZV_%`!<#R
M@(H1*$<4\(X!O6@<"`R`.!TJ3@>RYX%@C<@PGJF`!:0$@#TF)S>,V1#VLJ>]
MT"AFDI>\9&X0F#T.#/(#P7(*ZBI`NQ5I;B,:.:7\/H?*]:U/.A78U!D70$99
MK4\G"E#`$Y\(RCH6)TR5(5@CA0FRW@Q3>1X('U@$DDMH+1.7SB1B*PD`15BN
M12XCK&8V1]C'`L#$`?GJC0<N4\`*;`";Y[QF.JLI@8T02@%0?(\X1Q@!_FUR
M*R[-N0`)T5G/:A(,.!A($'"<<QX=%5.@!S5H0J%R2H8697VL;&CZ&*#.?>)2
MBAJT"P6DMP"+=M29'(5)`LHCD&(5P`#I$<A93`HWEI@T(SH!748<*C^'"F`!
M`C#`SLZX3([NU(P"J0`$!.*`GQZ`HSO[Z#(1`)2>I-(B)RF*1@HPQ1$Z`)T.
M0-L4K4I".5G@`C/\D39AJ3BYG`@T.!+HFWIFS$:2BJUOW<YE"%F9",CRC/)1
M"$MT:M<%+B`!-(VJ_.9SQ@)0BY:TM*L9AQ-+:J'2J`](;$]GB8``%-:-\IN6
M+'NB2LYVEJ:J3*5G12M:RAJ@L@A("]<:D$8I_IJ1`;!DP-FR)P&BSE(!G,5(
M`!";6-8FMK9@B:PLZ5D!R$K@DCGLY".Q1TJX-M>Y:_,`<Y\[W49A("9X(=]U
M&(>66BWJ.<_I3#`M(%WJEO>YV37OVJ277O9Z]V<MB0QZJ7,!`]PO<+UL;W[U
MNZ_]TH^)_04PEE`#K9U%@#%;,N0"[J>67P;8P0^&,/V<%F$*P]$"+NGFN+A4
M&`AX)P$7(&^%1=Q?4(X8<`0P<8KA,P$#"$`!$.B>UC)0$@/@2[XJQG&.C9.9
M[73`='"=P'YT/.319.!:?Z)`@[6F`02P!,9*)G*4I1R@PTP7;5,F\H@F,!`$
MX%=`&4!;2[P<M!MC_MG,[&I`B(4)FS,;#,J#$^>B/E/F7ZVUS06SP)OOC+'I
M&NW.[-+`DO[\*P;0>=!8FMVABY/#M>D90%=6-,>&N2/S+L#0D180OC#]`=@1
M;LS7">:FI7SAA4C1T0'R``,0\*?`%.P!EQ;U=JRR:0(@,84)$[1Q$A?K,T/M
M)!%HTI822"T`*"!POVH3KZ_#@%/?NGX<2(`P-\``/5:&MLH^,R$3(H!F!PA[
M#4-`ZUQE:6PSRL"2"W:Y`V15=6=;S5G:X:>Y5.AVTXD!,29SM\EL:^<^@-'U
M!OC:Z#VYSXSX1)'>P&P"OO!A6D`L^@90!X"](2T-'-U"KC#-&-[(#OQ[_N-W
MIB_\&``!BFO)`P^`WP,TC26+?YQ`$O"XR^D'`4/)?-`:H*\`$E!M+!6&BPNP
M0,D!].I81]?F*2;AT1$^@2#&)#"P=HH&ZJJM",B[W1RHN=(I'`&>:_W.&TA@
M1!`'<>S()'-_ZJ[7U>[@!;Q[[5BN4=L*P`!_#PCK"1!`SJZU$9QB[>U_9V_D
M`+_IZ#*=4+4!D*PF@+)0[LQ??TV`!JT^>,J7KP+XKOR=">E#,D*@6?!9P(20
MX_G1:``"#U@U5MV>>=8/3@)";SVF+Q`1H^BK.,:F#K6/8X$5<HX"%X!Z[(6O
M*`3P>_B1[F1_WLF;0&N%`M)MOG(<GA$%I/OX_M=',^RQ'VDP2P0"$]!5CY#R
MLN.DV3H<@)QNN[Y]]BMJ\NV?,@(OP``!=.;:"6B=!I[W'H?#,8$3@+\`9)0#
M$#<!W+0,$+)D<Y+CF8X,>!<#A,#_>+_JR#H`ZX`U,1]^4;<,4)BOL9#*D`T`
M\!`+B+8(K(P)-#$4]"(`?#!!HI\$6+U!,S*GH#L"()-3T9D"H(P+,\'*(+D_
MZX`;9!<!XA45/#K&*[<-.(`=-):?B18)L(`3L@"W2HX"'#X(L,+K0T)7:;D>
M'+3J\R74P0BW6H`*-`XA/+Y.`3S?6!L#R$(O;+,+RQ"PZPP,Z#+J$+SK:XX[
MJSHYHT*A(0#M@\,S_C,`%DP._*L._,$^!C!""-N`$VHO/AO$0[L8,PRE!?@Q
MY,"\3PJ^6"/"-OL>_9J?23RTK1@`/@&.#;@IXSL.2`0P#:2?Q>/#,V%#\RH`
M021%,Y,`B%H(7#2./Q0^!'(5TVNN7:$5H>&61?'%7#2S`IJA&*R,$KR^3=0Q
MQ]@O5V1&F9/&X_N\,X/"_4J`900\6(R]![P^>VDS!A#'YI+$X;N:XU.`3@RX
MC"$[Y:``>52>@LHOU&BO"UPS?&RW3"S'YPA%*0/(8V+%YUK';/R5F(N]`H!&
M$9.`-S0O-&3(C]O&X;M#,VN`>APF![Q(F=,`<SP^!82[_MH`D@S)A2-!_NRC
MC48$L(3I+PX02-:[`)AD.`XPQ.&K12P[L/W*`&",/8R+O0RP1-831C.;CE?$
M/HJD/`LZR':+RO+*R)6TRG5QRLKK``/PR`?3@(5LKIBYRIRDQL'S1RP#/@"[
MBK%<N`PP@*G$M@YX`#,K&[9$(0X@2JJA/%QQR:YT,'\)L((3P$>DO)X\/K\,
ML+8+,`RP2+O$MI;40G.9LO5+KRUT3&S+#I?$R96$R\NL,`V82\^DKGO\R[\1
M366;O].<+L0T)@RH2=4LQ<X<R_X1F@UH3-C$30*9L-PT)@I82MX$SHN4R2B3
MS>!<2:-TR:P4,0Z(1^-TSKAB39F+HRB#(`BC_LWCB[/A$TLMS#4=:[4'DPLM
M/$K*XT#L(YWG1,]-<R*7=,CT=$\LPY[WE,_YI$]L\P#:XB((B$YC4ISZ],_R
MN<\4@X"<BIX5LBFP/*__5-#:,<P(D\M//$$*0,<%-<[+P#Z:5)Z$')9PA!$8
MI-#@K,[K,[H*0P"W.X"R_-"Q1,X471<>[!&Z0XZY8%'<5)$9_17)_``(@`#U
MB+I/S!@;5<W4!-)702;>>(`#P%'&,1;*4``$'5)2W,^/&U$(^RJGF!D(,,TX
MT<$/&)@G]=)RXS$J-104DX#0C+H'>(XFG<DO95-&>18*8TRG^),:VPWSJ`P%
MV$P4.J(VY=,WX<<(_E,38$*,)NV`/:T,;&PO-NO31<62$:FPG?.E'OF:R@@R
M1K74,]/)S^2;ZD``)V6KM+S4?HQ2%+(]`V0R6YD`E<PO/`G51(U(MLK3M2.N
MY/B96.6O=2G.5E70/\42"*!,"FH`!)"`7Y*-M--54<O2_S0GD\M56(&:EH`)
MW>G&8V7&0Z+6-R&D1'K5:U406RVW*C)/;V5&<>56M;',V,M,]VS.<F77,$5/
M3V57\W&1[2-74AS/>-VC\-3"]L37?O77?TW!4078`LF1@358U=0`#3W8A67(
M'6+8AQW+A(78B0W)*G-/@&I6BK5+P:Q0NCB)`#``5M78*4O6''/8X/29_L*:
M2*=8(2\9V=H!L9=5L0XX@-_4D->26<*ITIP5L8RQV1U;`'CEV:%=.->L#@VX
MUU?YP$513J)U6N@Z@'4DNJ>E6J4SVMLK@!,5#7"IVJZ5.0?0(PUP@"_Y-ZGS
MVK-E.$@MCJL)``892;2%VV?+2^5I@&H;2?([03.-V[V-M9$SCK$0``9)(+Y-
M4;-M6+V-$P7P.+&8KHPE7`A;489T#^M`O.>JT<?%W$_I`')3CBC)W,\]M`J(
MVN3(@%L$W=.],PT0J0:3N'`K+QY!W=C%UMA1N0C040)@1/-:#-GE733!.A^Z
MGU]EJP;MW>(]28";4N-57N)4V.6%V.MTWNC%%+'DE=[JK;!9L][LI3!RU-ZW
%"P@``#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>f39432xe3943248.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943248.gif
M1TE&.#EA>`*V`_<```````@("!`0$!@8&"$A(2DI*3$Q,3DY.4)"0DI*2E)2
M4EI:6F-C8VMK:W-S<WM[>X2$A(R,C)24E)R<G*6EI:VMK;6UM;V]O<;&QL[.
MSM;6UM[>WN?GY^_O[_?W]_______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````>`*V`P`(_@`_"!Q(<&`$`!$**ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'AAY"BAQ),N3'DRA3JES)LJ7%@PE=RIQ)LZ;-
MFSAO4F"P@*?/GD!_(EBP0`%1HD:/)ET`88+3IU"C3L#0H:K5JAZL?LB:LZO7
MKRTI(`1+MJS9LVC3MLQPP4+;MV[CPG5`8(``NW8%%,"KH(``!0D<,$@`@<$$
M"8<3(T9L@0.'#HX[>(@,&?)C#VHS:WXX`8"$S:!#BQY->O2&"ZA3JTY-H8%K
M`P-BQT806V]=V0<2!':=@`%@!1,>1)`@87AQ"8TY;'!,V2KFTM`E.A@;O;KU
MZ]BSU^Q`,.3R[\J__F_8H(%#!@P8+$1PX&`]^P0$%A@X@(#^@?D*#BQXT#Z"
M__\18+`!=]JEM8!G!2:HX((,-EC3!A@\(*$#$_+'0`$$8%A``09TR-0#$(0H
MXH@2:&"BB8]5)1"!#E+$`'4MQBCC1BS.:"-V'&!P`04@2IC`AD`"20``1!(I
M``%U<3A`D`7TZ"0$$D+YY`499*!!E5=F8(&56'9I)8'FE:?!!AF0E\%S,RD`
MXXULMJF0>6[&V6(')U(0H@,>*M#AGK`)4"0``0@0``!'(FD`DG\FJJBB2]9E
M9`"##@H`D@4<H&&&F%Y:``(3G%<E!IY&I&9,7M6H705RIJKJJFA!-MYX_LPM
M)QEW66D@X'ACOJKKJVU9X"L%ZDU`006(#>>?`T;E=X!P#!QP`'O.*GOHHJ*N
MN:`&T<%9D`:?7:0!FJR&*^ZX967EV'+*<5`MJ0Q>D)$'[-)DDD+87D0!N`VI
M2^Z^_/:;TZC^?E`OFQAPQ`&^`7]`9\(,BPMPPQOIFZ#$"BV<007N#M0M8@IU
MZQ&JH9D*\<@WJCD!R2@S5/!"8RJTL@4#%X3P!V<*M,%#%=R<\LX\2_2BQSW'
MZ4$&91$]D`;<;?"<R`(!^X%C%`A4`08SHXDO!Q`,Y,')`ZT\<]!@*TBD!6&+
MBRK&.B\4TLIG&;T<T`,9_0'7`F%&M+H>5'">_L(-A$3V0E--I'39A),%*-.%
MN_F80Q=P\'=$'E"000/Q/M1!VA`];I%D"HTG$`<::%[0P@S56)[CW2U$\=<V
M<9XXJX!2_'KBH&-^4@4-J$=!U!1-$!+O'4E,M\(+19#!`W%[@/Q`RW>-M$`9
M3P1R11?8_M`%K,\>':#9:X_CYJ*E*SM$5'?@,0;C=]=]11X,++=#D-D<D8!-
M3PT1U]UB`$&)YF=_0?.NLPB:TN>]EG"`2.\K8((8P#;(-?!&!X.?[1XH$+<,
M!$(.4!W"5G:P"`YD`13Q@/4@`K+G:&```2C`!1!'D+1E8'@$@9M`,FBSJ'D@
M:RN2@`<5J)+8\?"'_@W!GG8FHS41:K!T2/L600A(.H)TH'$7`1W7++"`P*A+
M11E!G,0\0,&A:4D@.-Q*&#G@K@Y,#X@/$8``T,A&]7DO9A/1P`4B@#<*D(EL
M%Z@7\"A"M;]5X(Q.+`@4!P*9\F2`15S92LX4UJFFK8B`LR/`&MM(R4IZA(40
M>4Z9&!*]%8$K)!=S&^4:4B]]D0>&"EL?R@AER5:*ZS0D`U<'-+<`#Y!M:%09
M74%29+D1^HN5K@QFJCC`@`9`DF83L(`J5X6F,F%@`AJPXQ(_``%(*L>6OAP(
M!^BF'*VQB'X3&5H%#[D98`KSG&[J'@<H$(%E0FR%`6RAW-RI-HGMT(&N_C)1
M`A^RQP\\X#`]G"0Z!TI0-RW'B9VLF^@($H'Q/,`"V?S@0ARP@0<L0$`2N)=`
M*+C1"YQ,9";JW#$C8LZ"FO2D`3/:2"O2@7Z6CJ,-.6A&-E!2E-K4>YB\Z5<J
M4%.=^O2G0+4(3P4:U*(:]:@M["E2E\K4DVH```-HJE2G2M`7,8"J6,UJ)0]T
M5:UZ]:O>XRI8QTK6L(FUK&A-*\3.JM:VNG5<;'TK4&$JUX;%M:XMHJ=,'L``
M""C``0U0@`(DP!T&1&!X&2!`O>8ELX%<`(1X5=5=([L@#E3N*V+I35`6<+,(
M'$``V-KF`Q#P'#51+`,):,`'-A"!(QUV`A%(_LH#5M@UI>F(`BM$CP4F`,E$
M4O8LD_VM`B,0@.Q)``$9,```"L"B%U&,`P10+02(M("#`("W`IG`DK@C%N`P
MX+LO`H`")+G/@20``,T3+EB"JU[M=:"6#T%`D<[(@`#(#K<?:.T`<D2D/4H`
M00=10$$8@`"(O!<`!M!K>U-R(%2"K0/E52\$`I`KB.:Q(`MH`'IW>4AT*6P`
M9`-=`E8[J#UVH``%.R]D![(3$A8)CF;9``W5JB:7ABVGD7W1`)"D1@&$\7,-
M2`"^-H"`(2&I/AO.`((55H$"-/1@&X``\!8P8X%0.7/-`D!7U2)#LCYLP0J4
MP`'PQIP:$1F%(X[A_I@S$*L!N$O)!O@``ARP@!0>*@`#`%D'$*!:K16@RJHK
M@.0.A6,PK^1`-K8)75="1$.WI`$"8-T&G'6!09W1`@?8%@#.MN0%7,``%*C*
ME1``VJ<%H,H=(`"@%=*``-QL`RIT-$X.M&J;:`"0,@&=K%<"H8AZ0`!$HX``
M#)"V"0B8($I6K9*OBC$&=F<_']!PE3T0F(<<9,=^VO*N9W+>A=J$L32YW$D<
M<(!%4S9O!X"`:M"3%0P@(,T?P`">GR,?<&'`Q]04[],*`(!.;D``JGT```"]
M'O@-P`!DC,`""KSM-ZGD``#P]LXP(`%P&WJ."$#`:!-09`YD?`$U<C?R_E(-
M`(I)8``)F6Z<>3IPF'V``O7!C,"KK(%G.82FG1Q`H=NKX(@,2>(IN4"?&62!
M+K<7`PZP0`5\M?2E#^N/2K=``PDD1WQQ+@/^B?<$&M`A0A%``?JB,ZH-4.L5
MU66)`@!ZPT_R<WGU?.VAR8`$!'N``0"@[@!`@`(D97<`*.4H?S\*L?ZX@3].
M;3)4HQ)5*E`OS$4NPJLE3D$H<("WPSTB!XSXY0LX,PQ4X.EVDK)AD4)Z%`(J
M4H.B30J)HMPE&<`H>-?[CXHB6`7L[O84F("4<9_[S:=D4&KW/=@2FFO0(2V/
MN#J1K08?]:8[GXH_%G[$QB9]MT/&+5>R_$:T_M\0R%?$W-5G"`5@G).G]CO\
M,FFR;&IS;*1;&P$-%+/FJLVX!6SJ`>"*%0<8+_%S09B<@81^-5$>9?%4`2"`
M+G$!YZ=-"*`N$<!P##%I``!O<Z,7$N,G7Z,!$?!UE!<`"O`<'C`D/18H!,`0
M:@)5?C(`,Q8!!^<L]>$LJI4W,`4FLF-&_J%VM(*`-V%^*Z6#&'%B_01-'[!W
MK,,!?E)<,10`6R8H$;AC`S-ID.4!E2(^CJ$Z"L!`#U`!$?``!*`S&B8Y&&`K
M6!<U%B!)@.0!^2$0&/(<%?``=B%)I[8B$<`GA_)Z'R`??*(`[=1]3>%1(6(]
MY$&`/B@P@#(NST-0_APP`-%7(A]@=RPD`0_@)YC3:@%`-G1R;`HQ8:(#:3>C
M`000?3%%5!9@`,OC`0>@12?$`.!2)FGF7`+A)\;T-`LP`$1C`48");B800=!
M&""B7$.G$`*7*%WX-`Q@`'Y!)`/P`/JRA1="B@A0*6/R7>/#`83U-)M$2%7R
M>=QG4P8XB"JA`<3F*1'`==Q1`0&@10SP0@``/!A0`!!P'UGA&ZKC+&]"&/YT
M=^2G$-,Q.I5G/@K@2QQP7@`0,R=4@M248/E5B-HT`)EFBP``BE9&-QTP`0+@
M2R&B`"=2`?F1%2DT(FY(0VJ2;@K`'PA@`!5P8@A2$`=!--/!<"UE=\IU_ET#
M$1SLH2$&\#C!D7$/I5/FYWW>B!$5X"=^LEQ<PU-?PX68T1N.10!;"&(>,'<L
M$P`0^8`?(`&0T@#L<64,X2?;,@`F8G</@!Y;`4[Q1B2D$CIWP5TZ\U^;AFPW
M@P%VAVL?]HL?8(<+T0$`\(M$YCCZ1A#M*!!?R$EYAR]/133R=FPA"64.(`"U
MU`&!`H/.<@`G<T.$4B0!<%D#U8T_>1(<X&2/X1AH\E2(<Q_Z06H&L0"HX@`@
M1@!(6!`5H'<*<0$J^#05H&K5U1.E8W>"A&(*HQ[/V"<%L"(.P'&1)A`($`#/
MR!VMQ1T=``&LV0"T%4,04'0>)2'**0#I16TZ_K<0_Z5MQ`1A`[<M:38=B09=
MZ]A"_&8T#)`QED80,'<P`J!M3J1QEP,Z&H:9YZ29F_DQ>1:!!/`UL?5,$I``
M1@,OZ(.&`HDP>0.*:!@U%*``$.@0'K"8"F$`V**:M%(9B'2%;4EDQ))I&V!W
M$F-&1L8`(PIQB>(N:D*!'V".(Z0F\1D!%E!?`K8!^2$WD],MY-D=8`)Q*W8!
M$G`!P+9:`M`M_$:7'Y1H&1``PZ-T$24N8;B#"KF?'A$@#.&)7P-_`]$`D`4!
M6BH0&AA5=YD`_>2)V/(``9!I$6$!=-D!!L`="H@X(0I_'AAM!;`!!%!@'=".
MIF)+#H``O',F#A!J_N7A%.JRI'`C;R-D`7LVE!-((-,%*8RY7'XFJ8&"G$\3
MDP-06@Q0`0M@F!OV`9^6=]%#-!W0+,H1=?72`4=2`=O8)@`X@%-*I1R!F@S!
M`0[P>063-Z!S(&E37]E5I$=SA[?*`)M*$+!YCVH*$3M2$!B09A#'0A!:EX#2
MEALH$$.B+G_40!YPDP(A<"HCDRVTG0I1`5L73;O#(A+0`+@'`:5&,P2P([>G
M>ULA`:0(`#<SH7U'-!J@A!?TCD2YIPHC*9(2JB0Z@>"7G[-*JQH!`>1')S"7
MIJS7&@KP8Q.P`$B#0G*C(YA8/!)B47$X$'\E$7,7`;OSC@*PC*>641MP_GM$
M<SQ790&V\323HC""PAW*%6=:TP"99FP#J39DND0$\*8+(18069>`!B)@!`#E
MA1D4P`$&4$L"5P&?];*"MA4@6`$0\'KU(@`',"R@TC(J.2D.T(.MI)\,"Y2Z
ML;8.`!5MD7LKM$*[)2R\Y1RS<AY7D14@F*%;44$^`4,10'P,80''*2@`%STM
M2VJ0`BE^%V_TH88;Q@$I%&\B*C#R10"'U`$S1S-V%VI881(M.2LR&P!R^0&[
MA:1@%"\2@$,2,(P*$3D?V!D*P'71UI;)]1D;8F)KB*<=FR\.$``L6E!*=H!I
MFQ$:D#M^Y:EJE!<]UKQWX;S,Z[S02YP(9G>1_ID`@K4I'#=8BM&]$C"<&4>F
MH`-V&OJ9E4%&S/D8BR1'+J0O<#*CI#40%K"8R/B!3T.X!8LA<<8`:H1@1E*Z
MHHH`$F>7`P$!D+4DEV&^6Q&)YB$IRJ1<9,-3(,13_TD0`D=&*5D0&Y``\3)I
M*6%Q/(.VQ8L6%"-'J$&=)ZQNRH$:$("]#%`7!A`HQ>0:LYL``[!PJ!<;1%*P
M1E(;M/&,>?IN&4<?"W!<"(`<YN$6S+'$%R!8$8!(GZ(:F*,:F,2F@BNYO4N5
M'_!91,)O.TP>/B0?2*AAIFJ/4(M@C;$!8@9"&-"6G`,J`M%:T7,YR_H19E0V
MNSC"-C(@#F$K(34W_GF$'H*L+X*,'CMBKL/B%(CA%"&"E>S!'HX,R8^<`$B1
M`/-QO2]XO1$`7H8%(IS,R?T!(/[Q7:)\*^.1`;@U%1?P1Y*1'@+Q0B!C`=6T
M%59:01'0&P=```]P,\T)>^^F1C>3`7_:&_"1P1\Q`66',O^U8GH\+AV0JV0!
M(9X"*M1\'O/+']A,(=HL'"\D9DBR8]],*>*<(?U;)#FK7#"\)TPA(JXQ(NXL
M97AS.;EB,P-R,>C30I"8="EAA.FE%N*D&2_"S,T<+AV`NJ5Q3SS:MR#\.:!3
M)0[-)542`5""R@;PFU%[(1RR(<:H)"F$(03+(8/B*$B"BQMMC,8X9L?,_EF@
M@76;\0"D:!84-]!E@]"MHGPVG4<VK;4/D`#09")^.,LR'=1"/=1$7=1&?=1(
MG=1*O=1,W=1._=10'=5'+;A27=6N=))6G=7D\JI:W=4[HS=>'=9B/=9D7=8K
MX9-F[=1<+2Y;@R&3@B14G=9R[2^?9@`0\!W$0@``/-=\'2X3D(YW2;1!!2\,
M(`%+M]9]_563!DD9H(H_A0%SJ!NYO"%[:$D3L',RHT^'F-@GD0#Y.!#0K%,6
MM:MU$Q*>6E08L'=?5T4!8*&<[1$:()]/TQH<U,\FA<P.,:A`U0""1C'F0P"8
MK2HR118C44`6`#R`]30"5XJV35!X.E)?:E-H_FAT`D/=Y+(!#K:#7KK#<0TV
M$Q`]1/'*!8`FL7A2RA-\JQ6\!.4!Q?00$H#6YY0WS<(`P++*/-'=/--(KQP3
M%U``TU.-)Z5P,:0OJ$P0GUI0MU9!1^M$=6Q3F\PT&[``9CLR@;/?Q*.U`R';
M`[4`P)-J^G(!$3H!>QU,##`PBU.5Y2:_P;W/*\XF&I``D"1TKT.6C3V$$Y"L
MQ(I2)DH090M&$=H:-C5TGJA:>.H[1X/>+4&@_I(!`X!?#5'>A!/38"I@&8`A
M*Z.Y-J58[DDK!="QQ(12<D=(#)!!$H"=F)-H-/&DJM)[%>-!>\,1&K`IK.(`
MB%0W+#)**`5R#*4N_A`7`,"SRB@EY1OU&<HA`=HFT`4%X/[T9K&1-@C0X@KA
MD*Q2&!+JV"C%YC.D+MO$`"RB`/C=2D#J1$/71#F.4D-GA*BRA13C`-O8Q@#`
M*J:(F1O<W`,%:PSA6YV)V(73/NX9</5!*FQJ4QOPB\DD9P$@X:"]C1LP*#@Q
MX3*Q`0:@Z*]L`)9N4\@"$5!R4ZX:-Y^1V@D0/;,EW>DU+'(&`07P.`T`Z8)$
M)#B1L#6A/`!73`D0*%3S4X7M$&*F4Q"P/AZGZR03:@[!S,#2`2H(J!^$&=:=
M.>P^+NNTF*#F[][C`1J7/IVIYL+$`$\:[J[4/3T>QZA2Y0#`-JR^6AHA_NES
M/>P!\`"2LU$;"-_"A&FL8U$^]7D082L=(7`1.BX0#T2L%1N6C)SN?DZU>2]6
M\ZRN>U,GEE.?[C/B2BX<0.M%Y3BQ&E387='A&Q]+CTX5D``LA#L>\2*]*R[.
M_MI@X0%SU`!@;52C5>].Y%E<_3/\8CQD']2M"W\#HL9#^]D6\2)HGBI\//<R
M;4:DAD+>>A)\#_@ZJ.[\XL<J<?B(CW[;!%2.?]T[__A#/?GC(@$6;_E9C?F<
M__DWXOF;P=(MX0!!#_J97U#*U?=RT@";C_KC\OKA8O8L(?JLXOJPCS)&_C2R
M+R>LKQ$UQB]`G?L-TV@BU/NS<UZ_[R8$</K$_A\N;#;VL[/ZBU_YSY\@68]&
M0[+\<RW]N^;]!>0GW'_]AK9_%W1.Y^7R;$+G/^4`>L^PQXTFSO\ZRPX`UA\=
M)=[^"!G4[,TVR`\0'P0.)%C0X$&$"14N9-C0X<,-`0!X>%C1XD6,#3M<R-C1
MXT>0(2]*`#!!Y$F4*56N9*DR0TN8,65JD$A1YDV0&!#@Y-E3)@<!#GP.)5K4
MZ%&D22MB`#!1J5(-"Y["O+!AJL4*0J]NY=K5JD(+`U^^[%I6Y(6F-LWV_+H6
MI%JW!S-(C5NWJP2R1]LRZ`#7+LX-)E>B=?H79@<*AA6+3+S8,5$%%906B,`!
M`X;'-S5(8(E6@-_,_B`W8`Y=VO1IU!\I8,B0P`/IU'4)@XZ]5&MMW+EU6YR0
M]Z@$"QX<=,C,\?'LW18[P$Z>D'9SZ(8/<$Y:X,`%!`X>/%Z`H>]BY-$9:H@@
M'B%Q\^GK=C#`02D$"`@V\'V<0<&`VW\I`"CP7/V'#C3X;T`"XQ)0J0@46."!
M`"!XS`,$`&C,,+3Z*["@#!R\<$,.._P@@9<*2.!`Q32(BH'R%$-K``\!;*M%
M&%O*@,08B:I@@PT*:,"_KCK(H(&F`GCQKQ5Y3*\#]VI4,J7O_LM`L*T8<."`
M`8Q\JH,("A@`@`8P8&"`%'UJ,J,*`"#`2O$PH&M)-MMD"+VK),"LS+#*_O+`
M`@@44`"!""BPRH,',#``S91P],@"_@B%3@,&W'3TT;@XB`!+`"3CJ@($!@B@
M@2$)6@V\1#W<P#=(2S4UJ>&`I#&I)Q$@`((-X$1(`P46BR#4#M4\=5=>ATIR
M`0"8.\J"!P`P8%*'.CA`T:>`3*!%#E;M=5IJ44(`LP7UNH""`@30L0)F/WB@
MSK\4`.!9#RE(LEIVV_5H@@LPD,`X,1\@X%P&*`B7(`D.4&Q+=#ML8%UW"S:8
M(0\J,(!4F3I@P```!H#RHPX*(#BN`\YMD8"+#_;XXP\P>&""!2:05B4/*/BR
M``I.]D@"E\LR-V`.Y0/YYH\G>,``B29,R8/-_A@@8(`&+I#U)`Q\9JRE"&G>
M<(&C<9::VADMJ&``#:+N*,`($A"QMTY_;D"E1ED">&JTT_ZY[*TBX,R!`02H
M4^MD51[:``>$C8GMDV(&Z6P/*Z!;;8$RH!<G#/PF7"D/.("@3-(4/RA`"`@@
MX`$*!H<)@8[-@MCI"SE>'"$_?<+@\-&OLD"###8@0(#.%6K\@IT-8$"#?5&2
M(#^W`._0`,UC\B#L`7-/O3D/%@A@X@\\8%@@QQ,@(`$+.#`^)0XLK,MW#H<S
M"K'CPS>K@P<>R'A-@50N2`,+$A!`@0EB/^IVN[C?T&+Q\X^1@PLB>(!XQ'0M
M``:``.[*@H&Q;4]C_AZJE?X<Z"'^/8!A%V!```3```B,R2S:ZQT`T+<AX#VP
M*`R0GPA[\J,#::`!!A@``EIV/:)0@#H=!%V!&A`\$[9$A3#,X?4VX($+W&>`
M&7P,!WA7EBTQ[T(\S.'6F&.!N1V,B1I16D/N=``#"&`"@C--`SNH(0YQH(9-
M'`H&K"(H@Z5L*\N10`->=Z_G<6>*,4FBASH@.C)>*8\?&5X$J(2`>67@-0C`
MX5\F0*ZR9$`B>B-0C@JY1TAVY34)\N#_"-(!"22``R6D4`)APLF%,`4`CXQ.
M!.88R5T),C8<X)8``/D\"CP``:=,B@<&0$J,C,8C$1GES[*V&`V,$97#_IR*
MXS3U`/EQ8(4%D)QA$&`IEG0`EP;)0%.FB3`)7#,I&H`F,;V9%!PQX``'*"#Q
MQ(*!+6K3+!/P9%=HTLL.40"1WZ1G3S0P@0,$H`"P8M9HJAB:#NS$+*)4)VXP
M2"!0UG-#*5/`IB*0`6UJ``#S#(FA1OC/BB0T(P3UD`<*&IH(Z-.<"BT0>090
M``EH5"';40D%4'<3LLCP(PA0HD@XVB$)8!1Y&B3IAMHW@`3T1B!&4X\':IHP
M@5B`;QCQ`"T)<E,.Y;2G:F.D43R0H/<Q(([JH6A!/%"`@5K30P\(TU3-ZI"D
M->"D#=CJNUZ*FGP=,"WIZNKHG'K62_8K``%@_D!=47)7I6!2KI])UT<+IE*\
M(@PQ#3@``1PP`<!.SJ^A,:I<X<DA`\PPL9$,7L+RB0`+M'57'YP*5#?D@)&J
M"+&;-0P)$;(!/_(UM;UR0#=+*]9X&E9ULV4M:ACJRAO=+),K,2RBSM1;Y"*/
M/`U8`-XLP-MJ96^U&OG(!,P4V>1FUR@;H$"F%@`SZ+KK`#5%"EK\I5WTED8#
M#@@`('7+DA\FIP)+54JQ!)I>_/Y%`Q0X@"O).Q5D[>:.S>P)D,#(D`Q4-;\+
MCB:>%)"`!F3S@0RP+:I*\A`(Z-11'`C`9!ELGE%%(&X.F.[4)F"`K0"+I5/K
MP`4_?*'Y-*6OV*U6_D!I?!$&`$"SR<G`$7T2F1?_)V'F"E2)%T?BJYB+OC?S
M7Y"CP[\I$4`!>/&F4*>2@`M[3&L:4+"33X,!N!W``:+-HP8.G!0L_]?+:[:(
M$?/)J:F:^2HJ;M&-V8P:#E3`CP*X7'C%DU+%."S)6>90,.^,$YZZ90-Z1L"#
MOTMFA+[7)PMX:U'2[*$,W/?0,%%771:]@`%,QX#)I=V5";U026]:=FYQ7D@)
ML`!(FY4#LWS*I55]Z*C<:P'@@DE61$B`\&H8).92<WHVL./%'%L@'<"1!R1\
MZX(L)P(+*$`!\F9DWE0Z=0X0-D&PW1!;<R@#'F8U`3BC``/LJ0(-$$"G_APF
M`**QTST1F``#&B`E.Q^O`@L0@)B]D^\\`H7`>YMH>B)0UPR%Q@(.H(@IFR>0
M!905>D$]I`<40($*-`@"`@B`]PAR)ZM5CY['1D``",#%)6E`V[EAP(J/`JQB
MU\8_BPX-!<C2@`(.Q`+MA)[+-X"``E@*`EWU`,0@!H!G`GQ:>69O`C"N],P@
M.SG=54JX-[2!@7=EQ0FPW4`29!`.:&J&%EB`313PUJ(GB5&9ZO+Q/)J54$O<
M3;!2#ZV1@F5RBR=/("6-7RIPY@]P@&\;H!)U(.!R@I!V`[:#>IN<EX``'$!?
MN_KV8ZB,E'NENC3,#DT%)%.Q!""``12).-@-_B`X,YZ>*9))@(,L4Q#2"@0"
MC:\1!Q;@/@$L(.N'3EI2,I_8GS<O`@UHP'`J@,>"3"!3"+B`@X`HH`A8I0&:
M_H#<]4?V"%&:J-!NR'P:DO>._-X@S-X`!Y"$(_2G?P(18#_[87NZ"*"S`A:(
M0%72?W_\HY\#.+*>1]'C_UB1)@&DO6;IF`.HL((8*1_Y."]RE,9IB>&Q@$SA
MMK;COO$[KH60NI,0O^0C@&I+@,8J``9`@`=P`.+SGZS0#@=8$`=0P1)\01=T
M@`?;$\LI`,MQ%6OS0,LQ``.X&Q[TP&HS@`/0D@$P@`+@01Y$`/A80B:$C^9[
M'&[*@)91N7N*`/9Y_IP(@`_B:T(N-!$NK`#6B)?5"0SO&(CS,Q&LTX`TM`HD
M<8\`P;K&838D\2B$`!JLLRB-H+XVP11?BJ5QLCD"3*ZX.@H.-$-WFI'`*!\,
M<,,/P#J(PI,'.+SRV;BFJ$1+O$1,O,236A!)])HC%!%RHC8!X#,CU"<CK#94
M1$63^\37R<0@L4%-D9Y*[!9-T91JB\3R*0`%B$0LJT0!*)_6DP`(&$(C=(#0
M8IT,8*8^81UF3)()D*8,<`\_D[F46"]C:1D+S(D&)(I"7+;<X+=(9,()B`\#
M6``N9,(*&@`_VR2*>$"%2$,3B<<+6!UY-!%A;,(I-)&_DX`LQ"(D1$)S_H0`
M?G0C_H"8`=H2B;`<`.`S5XP8&S03`5C(;M%!$O0\VU&``FBT!_":!6"KMFBJ
MMRB_A=@D53+$R?$1BM"<_8.HC.B`"@B]Q`G$_!(`S+NLYMBGU]`SMP'#R^A)
MG^Q)]V``L$J-#7@`$M&`0?D`@?R`"T"M6!D>\Y,`'-DO?GPN[C*9XF,_"/`?
M(1PG`L"B<<*B!'``!#B`!%``("0`H7PU*5N`&RQ+:VM!N6S!!9!+M!R`N+$<
MO=Q+R^$S;SE"RQD`OM1+AFPL/FNLP?Q!`N#!(4P`*2%+RT%+M91+ZQB:B*G+
MN6Q!!"B^N9P`#)@_N:2`%NS)^8,7UAF5:"R__M&(1I_,&M7</]C4`-C$)8_R
MCZ8R/V:#S3K4S4:TGFB#3?/#LVE$B"KYGE'4O+78)PD0`+?A1S\J2^@\@,WD
MQ]T9`(5!L=3(EW6!@`!P#PC`#/@P"`C!)N=0K!6)3O24SG'BCX5L"K]TSVC<
M)*SSO-=\3?/;)/F$S?K$SUC)3_V<30$4P$U*&C`\MD4\-@#8%'Y<-%:B3K=Y
MT/+[S/C;$^E,``DPGP6`SD8C2^E$``1P'Q[D.%*TH"U)T%&T(!3EN!2%MP'H
MR"^QM^FC$KPT2[QL(1$)/>)K++P,@+@141:M42`54;SD.""MT10MTA8B/B5M
M`+*Z`"=]4B>MO*YH_K*,D%("T$/=Z(`!6(WIX@@CC`T%4(OA@[`/N!9Q`3R=
M0)AN8X@)N*6!8)VJ$!`XL1[<-#^/X@!AM(L[R=!GZXF^B,/^JU/^C)\*D``Y
MP<\V[,6&7-1+A!\.B,_[[`U#G8!YP4]NLIH,8$T)H%0+,!K\_,P\VU0)V!,$
M,$)&3="3&@`&L+=5O3=6C1N@8E59=55:7=4(R(IYS%4+F``*&+I<A8`&D*=Y
MY(!.+59=I:"!"1GT:!*@Z0@>TM+SBHX"V)8U+0@K'$4IG8IR%$(+$``U#``-
MX!.EI*\+$":"D*"/L(`!X(#^BDB)D`@1M2`?;2\&4("^VCNWH*`KG9#]_GN,
M+%P.SPP,>`E0@A78&1E'`D!.B_`_:/1,:4*G":#4<4P`BJ6WB-6939T`BMU8
M`TB`NMQ8D*78"+E$D(4W]Z022Y0(1F7(>+6@!1#*!ZB`B)T_)PVY<9F_D!.0
M<?N(:L)2W5B`7D6\ALB;CHT-&=03SFM$H'$/EBR("XC6A>"A!U#'2FDJJ[U:
M^EL.H-FO;1D`61(`A14)#F`0`H`SU!B`YYJV!5A;MLW0R&NOMFT`,&S$A%VB
MIKH`D!R(JVW'X:$`O_U;0-S;.\$XJTF:Q[J54W5%B7#3C@`*J/TX"YA"[OK;
M/%G5/8&`NNQ8;J/<1M,3S_5<S`%<T1W=X'@-_@S8V^:YVOA*79L@*WH3B"&L
MJ@L(.HB[`"ESB+S-#0[8QI80IPV(O88`EPC`SJE0*AM4`+JKC6MATDZ-EWBI
M@!F9$1.)W@NH``H(4W.IP(,!BFEC#3BM`"?%./&=1_&]50VLB!8Z"`]H``6X
M-R&LRWLY%[]-,#"+'\3`.$IE'PM(&M$]O')D@+7-%P#.E_FC@`B[-WXK@+TB
MT@)82`LZ@`I:@(;BL[-L+Q?[@'R*(P[P((&XT%',6-$,V0:@V`EF`).Y)QFB
M-]'DU7'DU?B3IDTB#O^K30#YTX_S1IG(@&CM@`8(CI60``.X`.!E"'EJ-,;)
M@`<X0HP;SK]8&)/!_@CKB8BP;9-JP@`0Y+JOZ55VLE?'9&')6#F'V(!^0X@&
ML([VA0`0#`I7755QPD((,)8)T,6796,Z7M4)4!`%^5`]"3T%6$$)SF,)8`#'
M-.$(@)OBD^"QC%AYB=AYK%<%^`H_4HC+$8@'&$4`4)`',$<H>H`IHX`((``I
ME-DZ9E([7M4'8&-*',51E!Y5OB`%4.5&8:[0DV`!Z%@$^&-`6K],>@"<D\%I
MN[<(VTA%YE4*.*2,S20OJB8`\+A+^HAAE``"T%M.6A>VRA16X;HNB0XAB4:,
M,"7NW#UV(0GPA2*K8>-!-N%5M1WEJ8`","R@P%),,E3XX%$&Z+>SW-A,_BE"
M";;!#/50D-78L]P3'BSF3`)@3L9+#RU+`PA=O]635XE(,SEDY,T8Z0'!&+;3
M`#D70S54=7G48B$AZ^D+*!(1CC/+`WA9LBP`=6W?%:38VTOH#PV]0%E;M"S4
M>JL<$]XB2MWH"E##68->0XTXK;0`"=BK`%`0O_4\J_G;+.S5!<@G3+P7O%P7
MG:D`Z?0-]NACBC54*=GH:?O0"!A!/JF`3:J<-D4/"?#9H0H`2U$`"5Q7_I%-
M_)SKOFA#N@[0N<[K&&ZJ_V.VM)ZHQD'4VH3A`&W'Y@D>::)AI;#.8%DV'E%L
M4V*O;#45(-$S,+96(`()#L-2T[V`<>Q)](M&_C4D#M^T'BY+G,39/Y^.E<`C
MO]&XC'@Y'=B>D<]T`('DS&+^2=E.$`F^/7N;'G%2@`B`Z$75)^L8)P$HX\4<
MIZX,RZ\$PG&:44U92#Y+2"F[9=L>2^Z$R!9EK$HL51-DWSR^G(6+5RRCDI<U
M-PS($X<>`'LM`%FBDE7E,P@0"M\4"`PHCSMQ.IMP'@?(0A/4$YQKBB-45>4)
MZ%=#`#YKT8$HVH2P+N,HQ8C)/>D<FH8ZJ?NP'&"VMY/:E)BFX.)SI1;D9/;M
M2BUA`-E>Q,HE2ZX#R^4.2[$LRUE>VT;K[0P-RW1KM`/0DZW,DW%B+O8#P:UL
M/R)OOR%WOPV(7$_N_A,,(&H_P1%*(P#C<!7YT8`M%8CZ8R\SVH`+4$/T^S\`
M&9[TLUX<V?+TD\_[2TF95`I$6;@A/@AP(0#P2XAW+A!U,\:FC%FWR;$/2@#B
MX&8`28A%DTK89AW+8(W+>,08].3RB4$5[$$/5)"XO-+(5$'(W,N]$DQ4)0!3
M-``EQ%R@"X`$R$*NX\'ZS@ZR`A8&L#^*/:FS;(`$R1A>_MQ"ELLFESM^,QD(
MF,?HP[H.@`#&70T+>&3^6,Q;%L*OA#R(L4&]U*<&*5464I"UE<ZU'<N_R[$K
M;:'XR%`_CCCX^&_;7L(L%,H`",=37L(%D<J#Z]6MI#"R<SJ5P<L\`5K2_EVX
MF/U<!4$1,6,O&1MQ?_\2"ZI$TH"\$CJ`)'DH!^`/;RE!-_*:6W85(W25&M1+
M&TR`+3FI'61V'<PJ]SY'^$@<9#01C4JTKD"4ZA.2@DB<YMNO"3%*`G"XCJ@F
M<VV.H%*(Y?FX`F!BKV#MT6Y$9"06@62-3.U%M^F?'K2.C3QH`&BL[#!5,T%%
M"3^I'MQCH:FB8FG(^&6>_.XX`AA'\Y'$*<F82\2;]LW*EL/%6,F0HVL*`BI!
M/8E$)CV\^A;&Q_+;<IR`7T2Z47RU7K6V@,Y(R-L=3^:6<C\\B&:93%7+RBS+
M$3S"(4S%"C5++(.86T:WRM?%44?-IN46C_)R_F:D;?SY@`SAY'&2)27$Q:&#
M&Z]9PG`\O'L;2[_-PL/#(/B(Q/7\8UW$11DT2Z"C>&]Y7RSZ1",<?E=/XN'_
M1`^-Q.8BH):9D=J'#V'$17IC'^(@V!FI7MD,D$PE"Z"APP\HD^'S6H(@#$ND
M28%P`*347H5XX_-MC@YHBJJ2J+(*J`T!$K#B,K62E@T.`-^XPY0$B`D<-FC@
M\,%#AX0&$A`X\.$AQ`L``!R`P,#`1``"!$R$`/$@@@@:-$0P4!$"RI01*F#0
M@`%"A@8-4CXPX"`EA`D'`""@(&$"A`H:*CA@T,``4IP0%AA04#&I`8X$4LY4
MP!%``*0&"DS,JG4A_H`"!`H$R#B@`-FQ`P@,4%!S@,8'#QPD*,H`P8"\&1G,
M5<#7@=NY<PT\J`"!@T0"!+!>S=A1;@4)&28L)J#@\N4#314,*&N``@4(H$=3
M:$#@08+2!>8":$O@*,:N)A?03K!P:P(%!M0N7KTS`5P`L14T$&``P00*#P0D
M*!"!0'(%R!ED7"S\:X,%KQT\:'#@`(+ON1VTUKJV`%*T8L.>Y4I`P(`.!B%N
M:)"`H_$!$!M\@/#@(X`!"OB!!`!(,""""2JX((,-(KC`!A]Y4($%'@R8@001
MTL>?@QUZ^"&("#XPD0(!**!!`AI&Q,!D"CA@(40<`$;!?!]=H(!0'U2`_D"`
M%2BP00<0N;0!!QPT`$"0$'5P`(P'-0GB!A@XL(!H&3P98HQ`!CC0!BIZT&6-
M0G;9I09C$D1F2QM8L":;%+*Y9ID99&`!!A>L68&;=ZX)F@421`#!!0E,)(!E
M,WW7P`,*\+02:!%$0,&=CDI@@4[$1>#GI8Y"L-*>%6AZ:9]K2@#:J'Y:M)L!
M#!"0`*L,!7!``@>@%5YXZMEG0``(.%74`4SQQ)1V1N%5P`"Q3037`T#M.H%T
M,AT`%+$)/&#!`Q1$D%P%,T5`FP*Q!D`H`(LY`&27"'(@T`<U'BA!!5@^-.*!
M[LH[;X<&:""O!AS2NV^''MPK;VP/<&#A`A]I_N!B!@]M@``""7=006Y)?C3!
M`@C4B"&`'3"<H$X9)[#O!@\4H$`$8?)[,LKS8D``D5<^U$$!)EN9,H,>#/3E
M0#D3)($&UDH`@0..(F"?HT9%\("D#=`*'M/A5;P`>`X<D!5;`@10ED;PZ<I6
M9P#(U.UK#.3%=5Y71\"`!`_<14``Q1XP@$P.6*!BG0S4><$%&'B@P`5!RPLO
MS8'+B\"_6&I0L.")?Z!!`/-BC0%$##1Y0;SI*D!@`17(FC"`'CPWP9-`=3Y3
M!@,(X`!$%C20P=07?,0!XEAZWMF/BMM^NX!'JAB@!O$!2$'AN#-H<N)!RE<D
M\O+!F)`%%4P@0=K/_O\$O01U3LI!!`[<!+WTS]_%<%>*28<15UQIE-%_[@(N
M//L!)L!`\_$W#_E#Q'M@`42EM7_R!A[)6U;L/L"`#US@61DC``8Z`!<!!.\A
M'K`/\2:0O@"]9`(\^D`&"I``O77@21PP`)8L@``!'(`"$ML?"MV%`/Q!!`,:
M(1Y$(."[CRR@@2GLW`U1"($.7"!7#\G`QSJ8D`ZDS0`1^)N!<LB^#"P@,PG0
ME72N5A8I4A$K5Q,``DZH1!2R)8`+T&"%:A*CB30L`Q0P0.4V\,5V!6@#?$/0
ME-)W@08814!&\A`%FD,`FW!NBWYLD`&>Y"^728B%-/PC(O?G@0'Z:P,'_OH3
M!2<P@7FM+Y&*],!J".`Z"\&(DY9$H04N<+:#:&`"!D@8!\SWD`MDP$62@XA3
M"#(5`6'@`65YI0,_LH$*U*@"#&B@A3"@+P5E0&0`@``AV_A)/S9N7AX0P#*C
M&3@/%&P"#F!C`2@`(.Q5:UX%JIPT;]>!7WXLG$J4DP(6X`$',,=_(5O9.BM@
MQ@Q,1$7D"8`-,1"!`"R``X*B"*LT:)MNM>IHK3HH9^`"P@1Y(`,,"$`"))!,
M`2U`F^;<'Y/H=;F+<M1="K`0`7BD`0!85$D3*)T6/_3-CBJN`PJPP$)9VCX+
M1$!0!AA``B?Y$;!]P(43(0",+'@77"HLI/3C_@";>(4`!OAG4`QX*E2CR@!6
M,8"-`>I`R#92PP\=P*HR59QF"-,`"03M6C^9P%V>2#(%/$^2/['E[KXJUP$5
M[";J?&9)'Z*!Z5$RB7--F;1B^E?;840`KGO(4RU`1-I`H``3$"4%YA@!.A[F
M`PH\HN<64%4!)81^#IS($3_T)0FHRBV&_!#A!BLXGTQ6)C*9BVM1`EOMR80O
MKFW`1%7+TB5]H"(-Z`#C\OJ!#3PGM.KSJV[IA1'!)I=F''$(1';"@`4(@(T8
M&.#+6$>C=#$%<AUP0#8'5`$#Q'6D).U0!RB``%S-!(8>"H!GFRO?^6ZQ`R"T
M0`$0)X#X+HX"O^PK_CCIZR&8&4?`*>-(.1^B*`1<0&(<P"Y,2TH9"%E6LX3L
MP`,&$%?++L:X#-6``_)2$1MB*9`&/C&*;7>!"0Z$/*^!B5[KQ%\053+%#-*8
M&&WL.``$<%A)2LX!'"`!D]`O`\?1D`.R*"`/0"!5*4W71`(<H/LA```):'#*
ME*SC+7,Y1!:HD;$R4DX*5*``V#VN3KN,H`T\B[EJ;E`'`/@!"C"%9S9YB`06
M\(`.1""!YUJ(!+"ZL`80SP(,*$`#3,@[">P$`&D&$`9(JT$()#!P%7TSORQ`
M8DQ_]6<X:<X#))!H,P.8TP+:P`!R;.H&+5`"`WB>-C50@"0YX%\>*.`"_EAX
M`09NN`,,N<"&":BK8D890!N8@%@40(%@HVP!AUTUEBZP:6@O\[2G%F6@Z51J
M:BML`./E]H(6,P`L)^<A"7CL`23*9*0`P+O@%>Y#+$``!SRY/@+0:07@8LB8
M!(``)1.>`-P+;@5-X,D#3V1N.8`!Q.0-3_-:`'*IS0&V:60`$;#*5"R0@*-5
M"-BKI@``K-JS'R;6`ZY.0(4HH.P!:%E"A_9?Y_9);XAXH"R(.K2)]-:^`#S[
MX`V"`+-][L<)#`"JUF+`!$*Y$ZQ-!+KNHHY7D[N!/GI(C:VZ"D8.2A:L!%VF
M9K2(GB-@`4C%KP*0DN`M\V="4;>+`^D\+!&-_C.P`%E``96E(`(>H/,QAN4F
M%,AMXAHP;:$3?K=%:U4#DNR8`N1D`<,,T7L,SFT/4/X@$O+`RB0OTP(YIO.>
MYW$ZA70``KSRH6Q\(`$@Q4``%9`!,'1C:B>FG9\6!KAXPA,&;G][S1?^=C/N
MO30W4!J]`=Y#8BE^X35P9MUF0"26[RGER2Q]5FX@F`[T;Y`DD'.]"N"W#PFQ
MQ#)P[R7O\\P80H_2+)ZMS[/_@L!'(?+?O\4%5*#K6!I+_+D<?Y_(%VGHU:>1
ME84DC07]*!\"(!,-T5MH%,",;0!X.8!!$!$"\!/PW$6-1)I_D9GNW1X%>)O\
M?6#OC9>UT8L'-(3/_B5=@R@`U:D6!:`.@G3`WKU,N$R25:2;A72`!<'<1RB0
M`#">R=P/RFD`Y<2*`D#.7EV9:"T?".*._2UA#NU3U`T$OE"$SXG&\,R:?(%8
M@N#7[AS;@,B;$CH0!\B0`*04[.Q1:R2`X"F,:3Q:A]R1$PJ/A\4A(DV5<$V&
MO)2@T^V+%,Z5%2Y(!KB@?"F`>V4``L3,1\#/5=7$WTW9B+C>`.@@`2T&!3Y)
MF=4?EDQ`U-&AX.0?)^+.!!R3L8U@U;T*RL!%/_V1!MC@@ORA@CS`"NI6MR!(
M!I@,NT@(!!!`*G:.!7S'!5A(!A#`O>`@0S@`\!C;=,6BASQ`$WZBO'"`_I0Y
MXPU!W."%R$CM(;T$0)ZAD3*V#ZH=`%OE%@20HK$=`.\ID0<D2_Q-W.\-B"9"
M1$RLSI98$-\\"08L`*,=`#-N203H8TIAU<M48P<\GC06)(I5F195G[S0$S;.
M"W2-(0)(@,#=CJCI2+=,&Z4IB#_A5CCUSEH0U18&D(+@R)QMCH",5XIDS`-4
M&0#T7`NA!4<&R`6L"LDI2%%L43="&Y\9Y/PUT^MXHH`PY"G6"#41P"8*CS#5
MSP-4!`QQ@.9YP/L`Y?Z(&I\5P`$T(0<@0#L&B-WMQ`X)2*)4`(Q$B359!ULT
M$)\EP-T9FU@@6H-,7#4JCLFUI-"-$T\JD:*<_N.'".7)%``O(H`ZH9#^T,>A
M;1B,P5%&F5-2'D0#,.""4``!3.1^`(#K<=8L'01=]!L".$"_B>4]3DQ(U=MS
M+(`0-<@HW=`J[L11WB5KADB5;266\"6_^*22#`4#7$`$"L]@?D0>H4L,=>.M
M-4`S;I$%"**.D-[@+1*%$5.P\9D!L!*R'<!8$4D_1D`GJ24&,07H7)6K">>5
M<`"\1<0,[4^^2.<'),!JMJ9Z.D@NKF"9R(L"-:2\$("P?8L4,0"?G89DGDQ,
M?,!ZZ93@-4``5&9_*",&+)54IE!%2D@!"0R">``%!`#O;1>`:,`!LE,`_):%
M]$];:)$'C-!5$M(9_D%@DP2B`[EDC-@+"@UDZL'(<JZG[^'/?F(:1O`7A<8F
M%9X,ZO@+:1SC0:@*.:;,!/R67GR4`4R2!MQ9@0:(3J3G,I'5!QB`LV$0V@@H
MBR"(>@6I@&C<7OPB1!#=`Q`25+8;+2D``6@I@F!``:#H[5A`6^R."L*H[7!`
M<"@&_OA))$[@@$9H`#R`\BF?PI&F!?%3@#"1&W)4*$W9O,CFOHCD@+C1?WA2
MYU2>I'(6I+@C;A7`FE39`-B:=`2BEU2`9LE516)$GV(8-(D2="33!9Q%-_Y;
MST"`<8SCDY2.W'RAMW5'S&TF#&W*@U)&>":.OS0FO+VHG`K.`0";E#S$_DJ<
MAJ9.`'J2C-<,``?<6P1HZC%%`#0!2`3PQ/-U5&K0#*/2R\=`*/Y@0'*LX"*M
M2EXTD71<!G"04%;`2K5H(K0VP`1<Q5RH)9UD0*3QAY4@1`;L#I_MQ`)<W'T,
M0/7X*P8,;$(4R<-J0`?X:YDT+`8`">517D(@A/$(40<Y4(+:R']<)098Q0`(
M(@8TQW9.&5W,3:%B`$PU10,V`,PN&302XD-`P+_4AP$0Y$'`U`'\'D)`#9MV
M(L00QI.%X;&FS!D=D:C=ARE1QN@A0+94``!P1I2>Q@&4A&6YC$0(A_MQU`3^
MX*+F*+\X!`;PW`<X0%1LU$%(0#9!3HT4R0>L_LF3:`"U2-4X*LJKL0D=/=5F
M]M1]=)$@K<P!7,13)4!9$,MT;83C.NZ@K,7C<@1&Z(5C&$M9G(X$*$:FI%5:
M(8!:M55;_02E.%ZZ*,@B;6U+/$\&)$2\F01@0(\,7>W'TEVP_JRU0:4#9`>S
MP0X"VM$#"&/[V!<2/LC2WD[!W42^78"]S%O"E!D#`(]^K!=%V`<&"(#;UL\(
MU9-,O52AEJU\N@M]>@`X:JO*<0A4>M^^D&_OXL]N&$_Q+LZJ8-GKY$9NX0TA
MW0W>["__LI(08@_68!&^WI914,"0/M%-Y84"FRE_6,`.74;#;`G9*/"W'*!I
MF(7I*'"X,`P'@T\'_B]`1/F$V*0;]=1BDD[$6%5`[5K6!1".S>0>!_B2L&BC
MA4#L012)S<P=OWB`*>E@Y0$7_1CG\:*,/YW-94!.3QA`F;$0+[U,`7SH!BA&
M8R&57R8BO0V`HYJ3TM)+@4S0OE1QRB)'DIA<`0BQ,V5OA?)'ACE*\`9)*Q%`
M-#H0L^CEO%3`>\PH@D!I&<N%QB!`DT!D+!8$R)'1!,3@#\W1[N[&[BYRXB4>
M1[0-6T3R6C!=O^&'57Z'=81+5WQ>0U"'1LB*1EB'26R<HQS-=YPR*I-,*9<R
MJYQ-&0<(TKBI1B3,=S01>)2R/CT*<96RM>1RK47)F'R)F8S)2MRP4Q*)_A1*
M#+DDD\W4L,GTXZ'2%X9]"U`$B0/<HPC13X74#\M0*V1F94?\CN5F<?`1#QXG
M"`0`P!P^(QH[D.9H9<@B"%IA*?[PL-J\5#HB9\ZZ5V,-I[PXBKQ`*0-(!:ZX
MK>8D`(F=RUA0&N!ACW!RENJTQ)84T^;:C64Q+,/0K,4R;)0TK-C5B>(&;>Y%
M&@90@,7Z!W=L9GX)!G>TM,@HAEB,!0+[Q5HHUD=41#I%*`UNY@/HV6XHAF*L
MA2Z.#`(`M=+$=%#?U$9$\E@H1GB\Q]N@!<L=!ZP4BW%\Q5>P#7KDQ7HU16SH
MAXX5A)/0G"#17/5Q3I)@@"$KC"8:8_<*P`JN_O6'I/,ZN\N-;),I_1O-'`V"
M*("'7MR7?41,GAI(!LZ)R,LUWS!+9,"]A(QTNB=:]>P$*.15T0_F@9=<$U=/
MN,QB<8Z??@0&*/&`..6C,H`9!PX/_9J07'"N&$38XA`='\3QR(?KTASR`,G'
MV@R1('.1:("<^#9CRXEP,_9``'=,#,#M+LBYL%1C%D`&,.\L743FV(:938IU
M-M34`5>Z(--0Z.Q?+42`K&6(C$A=8XDOZ9))Y"2]9,^#2&1$%(#%!`@Y1TYY
MGTSL84D$9TP$#`U1SM%Z,%5N?>;!I!KQ?)=-$%+IQ/=#($"$N)$&D9@;P?&:
MG0;[Y"LX-1)$S/=?_HG2,[(40M,1]&B`S=@=<7C-8[$%/J5M4:>S2P2`!;2-
MZ:!I-$44[\3V@)#WR9B=`XE-(R8.7P\(W+J@JZWF`0S>!NR7XFAX@S`8@."7
M%T.C8K"(YM1,`'!FH`F(*+W(J>E*CUO6Q\SD9*?4`[V:9*ZB7PM/OC$`LRFY
M7%UJEY&,M.1&A+SC0ZRA?RY%"T941=$N``0OD$C&7&%$C2-1?8.(I_2/M,3E
M>I_V0SR6PB795GZ4@DB`I`M.RX5(I0ON5RH<!!1U"27)E3/(6)!B(!9`0L/M
M.F/2:Y"8R;W/<.X-HP>.D2#:AK'Y5S6`C,\7W]:'E7W`M&1X`&B3LXE?_DOZ
MB=56S5*DRSE;TJ703"@6^H=8+439^#][,8!(@-78RT1]Z#G21B<ZM[P@C@4M
MVP5`ZZRV;B)&\X!4GK&!L%Q_`-$I&I.&G'@AVK(?!,JU#P]CD8K4G8#].I=Q
M`,^58:@%$P0"BJ9:R#4KD%]"C-5J#&4>$Z[`IC0A!\W4F#.94#R#2#'?^&:C
MKK6/=H*ES(=N_'E2C)5UAIDIELM(@!]CR4"6<4IM@+3E-^N%!P#D4W<4[>((
MW`4@8OND[-8&DZW+5&%T&090*]Q,C8FD4ED4R%)10.;XYR2=$<0MS@&(WU:X
M64=EZ,6?EV[]^)+!V6LC"(&FS,1YTZ!42RQ*_MO+V/R'V)=68CD6L;N$T%%+
M!-P.<B8$)@C`#\BYI9!Z/:>H"MC9;YF%%$3/7"KF!4EH;!RA/1_EE8OEE:RR
MS94#;]B]@Z6C)9?8!T@=,4@"Z&6&3%/9.\B7R%!$-D@KA<B$&"66RVH[LIEQ
M'8!!6(C5[J*$@&?\[5H.08"<T1>NWY#)X\MH_&+&.@DG);_9_5WQ^U$&F;$_
M(\B1)'='`?1HJ[NQT2>#D(3@9'J#\/!Z(8>B9SC%3]GL7.64-::7%NK0]-SH
M?ZA-!%OJ%G:")%H.A4S(RZ)Z)XZN`L0'@0,)%C1X$"%"#@LJ6*@`80&#!1,C
M4I3X8*+$`0(B)/3X_A%D2)$#,3S04!`#AY$)&0"PL!)F3)D"([Q$*.%"2`\(
M1')(,!.DAP,=1'K8T&"CA)D'5([<,.#`@H,>-"#H>%"#`@,V"1984("!AZD/
M!C00NY*"`J!KV;9U^W'!AK<K,2`0,(#H7+H3#)[M8.'LA@E-!T8XJ1>Q2`L9
M#'8XO/8!@`J)*7^,@"$AA9Q!,>M42YG#@*`4(!0(4`#PS`Z?1V9H0)A@!P0)
M.A?T$($`!-@"/11H(/>@!0()\L+T8*!R<N5S%SQ>+K"#!`(5/#QXGM`"WX$>
M)B#7("``4PT$#G`52*'V]<H6T@O<0*%M9//J$U]VFV%#=@L6(O2G$*&"_@T$
MK.LLQ$+SZ((&"`"@@`DT*%`F#2!PRP,+#H"OKZH,:$\@#B)S;J`.("``PYD8
MH`_%%`U:H+CGNF/@L,E4[%`[@30XX``/,G#@`@`R8$"!%@6:0*D9];*@Q!"!
M@TPR(_6RCRT(!```@"D)N'+!`0H8@$HJ=WN+@P(,>JB!!ARXC#&W-CC`3`@<
M@(`"G#;00(,YZP21MP@4X+$O"Q(PH,B"-`#RPX(XB``!"H2,*0((G7PT,07P
MI.P"!1)P3L89.:A1H$H'LD""WJ[,=$@'('6+O<H4:/)4MJ`$R@,')$B4@\=T
M)*J#DBB8P-&W.B"`H`L,$."!).?:H(!D"Q!@_L$NG>V2`9-"5""N@RY`0%*$
M+LC-,0"<NZ"`!]*<2@,+-,B`3G31/9?=!L9M%5ZV%'BW,BDY%8C4%`\M*(//
M?!((@@TL+0C`>(&RP("K$%O`)8-GHHVM!#.P#E(%-HC`@`((B&#)Y3CX:P$(
M()B@`CHUH*`E5C_PX()>/[B``0YM1(``X#8@H*G2$%CT`PX4\"KE9X7NDF*'
MC5Y)@2_UPJ``!)3.%\4)C,U*(`8:(,I-!$XD2`*%CU9L`9GC:_CKD0X0VZD#
MNH;TN``&>,`"GIW<"0$#'%"@@0_RVI'/HH/K>EP.>,J@@`0HZ)4[`B8X@$H$
MNHX`@@@:B("!`R)__@!R7LO>W*.M@;JWH`D*N$!N8U'4(-\-3FQ@R@'01>"`
MS3Y%FW."%C.(@XYG,H#LVCUJ@/:0%BI)Q=L8F(WU#>2&M(,#$'!VHP&D-X!-
M`]R6'GL$M#]`6H(X$*```UH^J#L'/Z"`2MU]7S\DJ=9R.5;NU>?:R>^EU[X!
M!JR>2`&\R_R_`?AC`.C8]RD!""EW;/'`@N97P`_`B"T^@X#?GH,!"&R$`1+(
M``?R]C4+#(U*`K"``S3`@:`-#0&]0MCX#.(G!91H`P%0F0-IB#L"*``"%Y``
M!>9T`0OX\`(Y21,&@/A#(_IP`CYLP`-:=)0';(DXJW'2"*6F`0E<40(3_G@`
M%J\X`05H;P$3T)X`.EC#@4C``/GB@-)6P@$9-K"`[EM+UQI@.LIL``(*$$`"
MF/BI,CJL`PRPVP`4H,4$)&`!,@1``&2HOT,>DG$`"%E!CA(`Y!AD`PXH@.YZ
M!(!`F1&44WH6(X4V)?`(C7="*X"C%M``!F%``'5BC8H<D)X.`&<_'YC3!S10
MQX(D8#XU%$Y[@A<2#:0/E+P9"EL>T(`T*F<#:`R`51:UPZ\I(%3G^^3*/-#-
M#KB,8>V)@%?&69`.5(``"_B2!V18S&1N[@(#<$`W/?!->MJ3`IK!``8VN*D'
MT;.>'N#`K!#0L08D@$$*&("`9IDB":1'`=;!_M8+`0`LP]%K`L&DX0-J69``
ML>68`(#C^H0RTI!D\9F(J1"0M$8!-GY@;4:K@.<\(,>1K&HS'I``]U12@:*]
M)P$0D%FL`+!,DFPQ1@E<&4Y6EH'#\>8"[GPG8J`V%=F)I`)>.<P&`D0:QIC0
M20\EB!8Y`("8?0`!#@A-`+(UD(!-]0$3XM?R1!)2D]9N)_&A@`'L.!,/5"`!
MTW3I2>7JL`HH+*\KZ0"7E$*!`(AP(!7@B^`"4*T6ZE&1!,'-`@Q@`*,$(`,`
MB``%&E`!`3CV2F*)0`#2.544>2!OV:&,`P:@T9455D6O>IE)"."``'#@`*82
MB-H(`@';%E!*8WII_EV1^<X%N&PE$@!L56%RL<!65JH"D>[1,,":"=@T)*&5
M9`(8L)N'C*A1!SF4Q1Y(I8%DP&D"F9S5/G"`RDXF80885UJ@Z]KD#$5YE9%`
M`"#H4<^EZ%>PN=8%3(6`"RQ`N.<C%5.FZH'LMG%*=^7<<33L$9P4H*_"DP!2
M$/"`"TSJ(TP]FM4P0`'%P42\N<%3!4XS5`P<H`!I<B4`"E,;#$BD90-`:$X2
M$(&-Y(4"`J"7?Y=#@*M2II>;A-"/C;38]"3H9A$`P+74J@"F<2H!2UZ?!;2W
MUTL2I,,>B:%(IPI>F2Q@2B%.2$E^-K(T'T0"QZU,OKIYD'-RE+H>$2^'_CH@
MQB=#!V8D)(AO>2R0!Q1-AWS\0`!@>X'0*(``C,D`S&@C(+K6;@,79HN;*Y,5
M!.BF4P=^+5\M(*"/J00#2>S9!BI4K%O*A9V@1%\`('":_OP:26VQ:YO;@@$)
M#$#.AD*9`!:@Y^@>6CGPO8!U%D,:ED$`>"NC`&?[ZQ%8>K(@%V#3O`R"`?+@
MZ0$8:+3>1B?0!011`!Q@S#>_>P$9N<D!"R"`Q@+MNPY\>BX:('5R+)"LDV#@
MCREZ7I<L>0#J=78!!TB``QY@`$Q3J4P!`.5QNC0`!!3@`%<RP,!7,NQD>J"A
M,FG`1(IIX9`[[LX@B:EZ(I"!"0#`BXI::$5C_O<!ICVZVPE90`8&$*CHB.]\
MMAQ1W/H"'V!%%GQE`1AL,A!T)C]'X/J:P`WUYZ0$7"`#88]`NL,>]NR8/>P3
M?$`"I`?*"#",2\Z>B<E!V;RV(&4Z";D-I@G0/<2H6#U)DP"#`G"X"YGU+'61
MZF"YI@%`=<KC3:&`C/!X@/+ZF0$0Z(#&O4<GJU_=2!;`+7TV16`C"<4@&8@`
M41Y";P@XJ@,1IF$\,^"84C<7E&%JBP,4M&0,O#TBX@+X3,(47_4X;>L,@\\"
M!GQY7A;Y\VZ&@`8*`(&'&&`"Q4EBI!G`=$H^@`%]1]^9)E#^J+:X_.E7?T;S
M2;+R.V2?\=]5_#%#_G\,H.Z'Z9]4J.V_SYC+=/0$HNJ>(P-$;2Y"HT6RHDT,
M@(\<8#9D;V5$PXPD8)64@^[,B`.>;BT:H`!\)$0HX`"83<P28V0D33W2361V
MXD$.H`(D<$<4I$SHRR-XHB!X2X:HPZ.8Y374JP$.@#%`Y0,.*P(L3P&<!T>P
M*0*ZAJ.2,`&,,`%@Y^UP!'88(-\0!>0`@$L.`"H8T.$6Q'FP!PP'@+6X!.2H
M)P010,B&SVA(*SA0S+\0T"!.)@`J8,`"@(@HR`,$`)3RR&,Z\/\<YD#8HFLR
MS>=&I``D0`W;PD-ZI@`2$:3FB2`\X"?2)`/R#`*T1VL^@@4+8OIP:/H,_@)E
MV,@GDH8WFNT#T$4YQ&*-[&EE>$.@H./58O&;.H`#"D2@\.BW:H@T0*\GXLT@
M7L\`-B`T!D`#'J"A\A"4].WS@.(":RBQUJ("J,0`M(0!!I`^DG!(1C`Q/&#T
MQ$6!'`4"CNU+$`ZTIJ*5'*4#I^0T]`?'%$!_EN6QP`,\+&\!M$0`Q@@3P2<>
M,T)_+"!_]"<B@.1XM&:`S@0"]$<B$'(!\%$L#&"YRN8A>%$G*.@43T0!LJ,'
M;6[T;@:4'N``EJ.3_M!@.N`GV$+=`,`!Y(XRMFX@?.(ADV,988Q*G`/A@&?H
M#&4B(N!+((!!\FE7VN\_?)("'D08.8`T)JC\_HI%B[*(2$:+`A[MT=3.*7\R
MGT[F*2GN`:2&*K>2`AQ@`C:`!FG(I]9"J1Z%`U32>R3PO:*BQ?;M`D9$`)YL
M4$!)=-S0+9J1ACK@S&`"X5:%2@)`)".(PMRJ)/WKY@!@K\2B][1K26)E0Q!"
M=0`@Y:ZCGCZF`H22UK@)H%;F,O.).MXCM%[R:';QG6#&.,K#J11%H.P#[*#C
M)#:S.D`I_`+3F*I$-#<'N%;"*$`P`!Z@`GPF`PA112#,G!+@-GU'O'!M5@@C
MSWKF>2#P4R0.XU3$`L"#D1CIXZ[S.M41"TU#.QGI`6+H.$]%,\1B\C[`(6+2
M81I@FT)BX12)2@[)_E(28#XMA0!$Z9#TT(R2K#WUPI42KH;J0B<ZX%J8S?L^
MX+F(0T6HCWPHTDDPP!''A$HB#CHI0/4V1F8X8$1.8DHF<SEJHJ[*Q1J-0@##
MC``B]%$B8V=&3,L\L(8X)B8DI?:0)"5%;S\H`%1P=#]V]!(_THP0*BPI@R=]
M-)FRR".,8J;V*)MB(P&0145,J#/\I$8N!%[J9"UZ)#R^SB#(PG`.`J@8("]6
M!0&T$3H0`T1MHP(FHP,HH,1.D5H.32@D@#9GQ)7`YR\/8$X+2#82PH243._Z
M#5(X`-H&@@*033DBPT,+2*S4"S<``.800C8X,D6H$#J:32TIH##?*1J)_I0@
M)`1G^N+^)N>7/$GV;JDXCN.6*H!G;%%Y.L#F8`\"3#`V<.AEA(HI$N4K'&6!
M#L`NO^;8NJ0_)9(@&@#%*L`=!U5O5"U%?@\[^JWB/`)%#0*A`)2&%C5$NDMC
M;@=:%TI,4&1;SL(G,&``"J2/IJHE*/(!!.!G^F)5@NDI>B<(N22%Y(MRXA,G
M"2!4_H1!N&2&?,Z5ABI3)+&F>"GEK,R,-."Q'%0U\O0Z.J!;IV*1X(A!G<3V
M9J+B^@M91X)A`K!:.T,#](0``@`11<+*-%`]$H!4I`,`:B,#.):&6L)K)-%B
M8L6<C@?:.JDV%BM:TFL#XFWM6C!T(D(`/$"T_M`EN)ZJ)4$L%_LB4U#F`Z["
MS3;`6Y(1+46"66M'7!-"W'PP(3*`Y&JG)5Y*/1'B>12V@"I@`8S1\O9C/,/$
ML7I5+]`60C8`ODZU2]]I5;9F8AQ'+`:V9WQJDN*0M'#O-DKK+![M?`R@XEHD
M`1J2:(GU`^H('(ECH1!"1DQ(+!I7<#!I:E4D[,#N-V>B.83U([XK(2YRB1)B
M@D")`Z'+PMJ"=UQV?30``YX0`JPQ)GYEZ\9V+=AK.P++6(Z#=QV&8?"4[7YC
M6C9E``9H4<ZR0=P&7G6I`#"C9\7B.P(`1!KW`X@#`)`N?#HF`VEM7ON"+V)%
M.Q)``C""<^&6,CZH_DNHM6JPA`#:XR*]I\4`-3/UAO[&\U$R*B&RZK14MVH!
M2<A<AH>2+21B-T"-C`!@)V-#8K$D]3I4KR^4QKC>":$8R5VDE5F"-0.:,"<8
M``3?I19'Z`/4]WP0H+1^"74`@&@WPP`.XS`8`&H30B[(#'PXH`7)C9).=$8\
M@%^I1,PL`#[[50%(1;R@,]RP1Y1""&@*"38Z`(`:P$UR:+3^QY8N0'(`R,18
M*"9&K$R2,*H*9(UB(TU.@H=KB&&4QJ4,T"`4^&SEE>F$*H)HPV2C39XHQ[C(
ME'#XUV`X:`($P&49`GX2`%_/XFH6($DP*SQ=YSQJZ8Z_+1BW3"#8:\"B_HK-
MGM;$?JB(KHH6Q:(X/O<D-F`O4X1*-D(R<2>2NB1?$(!4.DEV!>(D'8>+'!!V
M9*AF0D24G(=FAD:NUC2('=4NNH0`,.4N[L)2V!,I-B(!)F>:M*=9CCE_CGDC
M6D<>`V"`'69+Z$5<Y\F/WQ@`8CE>G(H!0`X1"\1:B:\:'W8Y:I=Z#LDNP(,`
M.FOD>BMC7NQ@8X93W8.T@G0@BE%Q(221DT2@,&/F^FQ1RD4L-H@W>$-1W&0@
M:$9C]HVB"6``R",!DL5Z!*"SM&1+YGDC#I0^I-8E6O3)'(!*@N;)-G$[GO,C
M$!;GY@RE;8IQQA4Z'./?_NTQ!H]!/B8O"JT!_F1(`!J3F#7&J*_DJ&NDGOYM
MX0`@*R$TIW-Z\+2FM"@.(#-(`^2F5DHB(9$2`WIE3AAV(&3UO7KS+]H"H<09
M4A#&;4289^AX+8["Q5+$%F&3GK@IF:@OR5H$!(71GS]@1*C#40::(#*@LX*S
MJ*)I,I2"`01C(NQ(BIO-AS[@$*%#>_L,LP$*LR'TKNGI@[QQ6:GD)1"*DFUD
M022@K+!02%C:M$7KI65(=GUB`,ZL-RY:)/Q288TR);>#2UJF;S-[J4QGQZBD
M`)3&C?[2D"W%'8=PD3;&(%;KE`_@9YREP'C#>@`3,NOQKQ,"Y!8%6\(.K</9
M:#Y6`5BK?#VB6-A"_C;0,%I)-^"ZCTAA*[XVER06(%$=,H`C6H1[R0$(P)FD
M0BT`)7R2I5<H`"S\&R\F@/-\!B&RA?J<FP'<!D\*M;W;0K31LW&(PH0J:F4Z
MD)TKF50<-@"\QL_N@DH8YX868+32%0#"C"!Z>=_Z1\9EO+#`99$48+2"#HBW
M["SZEF!V`P)XYSU.?"H8AR=<9@,81C^A8\>`!T(JA'%.JT!21FR(EL-#HF?W
M69>0C439`HY/Q2@<(+!*[#;362:.^X[=N[C(]"[%)6\\@$T_:4+."=,>`'$P
MPI(0DR""!&``NPFE`@&$0V!LC@#`6JUB9Y7XL&?4TGN*^0,<X+`*("M(_AET
MXJG"H?'".2"5JJX#&T8H&,0@(#"D2!QWK&0B/NXKX/.`"@+.!$`B`LLZF24`
M,E5$%K)+OBA1)@!W([!9V,JBBXH^"RI1O*<#M;?)#^)YE'4[T$<##1L+W1"F
M8[IJA#@AGD?+N1LZ+:1GW+@@OOST-L6^F(]_`:_DFD(O'57-M65X5P)9$D``
M=NHG`JGVDKPZ+T1]_LH=:XI*2*LI!F8NO19E$;2^,$#)J?57/`F(ZZ+1,M!R
M'T0J@`MS(A=TT`<!N!W3R>;3MR2EK9M!5#']*K<EIX34^85*0&>E)C02>4>)
M_>R;A@0@!0#FJ002!Z*!R8L!Z!-(+`4-/[B,_G9BWP=B`=S]2U;E`-Y/47S:
M`E:E-P?"+X-U()1H2=P]EO[-I_^MFUHBS84.`':CH]["V^GCG"3``9R'A-K;
MS$4"M#N@E90]W=6#<0*@EHBB/$Z)C#1G3,`B,V'Z`O)W=).\T#("K6YD"`.M
M4@2@`L3+O7IFX(8R:^O+%,,H#A'STF<"?7J'Z+KDS`X>>WNFB0,V`V1HY=^+
M2CR4&Q>)*SI@2MC>4#9BX`J-2XJF-TH[(2(@IR*CHE)BC5"ZXPM"`KBS2JX'
M/IV#=WP1)M9.:&3HHDT#"T<B?)S#[O1FW0GBZY]CH,A#5O+T[&'")_ZD[8W$
ME3A5`7P^E?WL$CMF_LW>A7MT<EE0\@($P.$<UL"!`P)X5;,P)US<9D'J0LP1
M0C,62V\``@$$"A\$3/B`,*&&`!H2.GP(,:+$B1\:$!B`P>$#```,<$BXX6*`
MC!\R+!``H$`$"A$2<`R0@>('#!P93&S`T4+"#B@3=/@HLP#'!Q([*`"`(*$'
ME!=D4MB`$`)'`0,`4`U`@".`A@ZE(M!P`4,'KAL<!`@``"I"EP`BR(R(8"B&
ML&$Q4'``00#6MP@W!"C00:/-F1[XRC0``(+AQ1,Y4#@0(():QA0=D*3LD,.`
MOY@[>_X,.C3$HTD3.D"`,H""B"U]/KS`L7!"BP0L7#A=X0,'"8$19I"-_N$!
M4(0<-GB0D$%GA[D%(`R0&$&#!P01("C@('#`Y(0<#(A.^#NT!PP89#_4T!MA
M!Z%:"R1H$%.F5``))C+@N"#A!*T#!!@X8,!_"1B@0`(D.8!21PUPE8$$%+!'
M$$(6Y"13`P40B!8`#3B@@`00,(#!`1P=``$$%517U6KG?12!4`<A1,&(YD&$
M78"Y(<3`9MLYY`&"@[WEUP#I?8#`8!W,Z!EBBGW76`80_/<`5TPB],!EGF6`
M4FE3;LEEEWRY^-H%%UBPP%@9:*!!!A,DL,%P"J&%)(UHIHDF!W86MT&>;<YY
MIG0T:KFB;@H4D)L#!$@0T08%N`F:`D-&=.26_@-DD`$&$#!*$0>4[I@9!`\D
M()L&#XSJ0`&FGHIJA+I!8"A:!K`'P``$J/I!!0!<]&JN%Q;PP']@5<41`:<*
M6P`##XC(T0"FW@=`?@_9^0%B`*AZ'%H(A/>0![8"$,"-'A2`DI4\+F"``X9E
M`,`!#M$4WP52>L8!6DMRN<$%QS8`@5A>(H1<:!DT0.Z^`@_<I5!N?;"!!`40
M<``"%\:EE7\&7'29IAL!$*=&`1J`;Z\'-(S`QPTW/,#&!@R`Z+,")#!JRRU;
MD%P&%%#08`,NCRK!I_1EC!D'//=50'QO=7"C0PU8*8"[!'_GP09S6A"=S]E*
M9T&)5E]=H@<:6%V!_GE(4H#6`!]U,-5$;!7P4`8N8<6KS*\2X.J+'WA`0+@2
M><"MBD`*($!Z!6A9]&<;<)0RD\LM$`!U0@\\[V<8G$C4TI(O[8%.C$U0\@85
M""L`4!HLX`"W$K2IW@%-?7`!`0]D!8"X#S&PN&Y2;X#!V&*Y>8'<W`WP\0,*
M+*#``0T$+^Q_!PCP\7_&&U`D6N\2C&EF$T2_TXRU_SQY]H+37M@&$$1P<$09
M5%?X3@X<P/I+`![@P)`>9.@Z0C0A99@&]"<$@.4?1$#]8H,#<+K0=.`!_3$`
M_[#')6>!Q@(*($#XM`?!*2'P605`"]\FX($#]"8D!U@`IAR0F^XT!"<#_L`>
MB!R2.L5(H"H-B-:M'D(>&IEK(I%2#T56^*@(@N=6.9Q(YW0(Q"!&I&EXBMVS
MBL,S#41@0X;IP`!`A1#,F0<"1J3,_YZ'F0LPX``=ZEH$'16:">5/B&0D&&P`
M(`$.]&8"`K`051"0L00$`%&R.<IS*&(`W76``!FQB]HLD`#[!?`#%G#=OX8&
M@1XZQ'X'Z)_VJJ4[F4"QC)2LI.3L]\,/*$!O)5&D_SB"1;Y(8(L&O`"GM+>`
M"<K$`FB)I"5?":^S,(H##)!``S"WHPKDZ`(S<LF/)$*`1SE`:%%R``4\8`#]
M?>!2$)'`("6"KBHZ9`$I465$+&``Y"V``45B_H`"&+!-"%C``C.SP`:2,\[E
M6$`#0*&``!9PHPW8I@,4Z,`X+3"!+7(2EOSL9V<F!!C="&!Q\:/,_$+9&$,M
M8`+EH:0"/V,!`2`@</ZLJ$PPN;@(A.PB#<AD7QRP0HA4Y0`_X\`^/W"`^)RH
M5@2YCD-XT\P9'D::"6'`@#XC`8X4H$##2\"%`I`@K=Q*J!GBUEF(>M0!1(!;
M5DF?NBP*58-2THF#P>9K/&F8*_+%`Q.`S-%@^4O/="T"Y8NJ61,2H[:`Y``D
M:<"#$**M!2"J`][)S`$H4,+&$`!)*=6-`7C)`0),`"8OS:$S^=+7"BA2`1KP
M*&4\\("P*@6N4,G`_D\JT!2"%$8#ZZQ<``9@2@I4@&8=.%-&"I/3%IYUM1,I
M*`3WL]<,'.HA%3@E8]"UE;MY8#Q'48D_&^<9"3@L<JP]ZT`44)X-+'56:G2`
M!0J0P:,"0`%8V@D$_H97BGA``879[6[5X@`YKN8!"VB<!R*0PP<\<")41%<`
MVI<M.!8`H7S9`*U"PP%>+88`Q>UO/]GHEAS-J`-L"HU6L]6`_S`@.L:I*'`[
M<Y<$W->__J3N`Q#`O+`P8,-;?$``7").`&P$01V(`(#:I(`UM;8J`2(``0(T
ML@0@(`$R'M",:SRQ'#*4+PFP+'(@P,722H#&LDK+9RY0UL\$5J9\>2B%_I\<
M1*DT(%[[[(!J07-&+#I@`<^T*'$_H]BO0MG!&7B`9:#B@3O1,@#>D<!%HO24
ME*`L,,&QP%,C$CJ.)$!,1Q*3GR\0S@M`H`'X:H`$&GH>:R+D1CSA2`,N$(%D
MNI8O*YD2Z18CV3%K6G(;@<!^GKE=T8B1OJMU<F<P1]A-\Y,!%7A`T3(07@(L
MP(&GY$!B`E/:?U&@/A+AP`,:<`#;>N8!Q0(?^$+&O@@XP-C'UF@V=1I9BG8F
M`J[,'MI4C>VE2:5%=4V;:+*LZ4Q39@)U$W:V*>*G+NT98,/I`.DB4($&Q&D#
M>JL`<M\8P16Z>$-F-O,""N"`?@><=P$O.(<"_G!EQU5[<@$XM\.]M)$8/9BK
MHCEHN$4S@9/0].$123>7CB6`"@"E`S8MP`(&`#8,_`X""SA``MRLD/3!$8)5
M&IJ=6"(1#!C`W'RAP,(E)VZ."YTR$0@``PK`*9F)!K>D/JNI,<-&`&Q\Z-KF
MB%HVT,%X3:``>,U`5012HM0I10,-0,O3"?;HMTA``%E9KT,.,`#A0/3GW\GU
M8Q00'82`A>I\G[:>$]5ES%A\S$%?#`40,_6^[VL^3B)``B"3%5/%Z(E6(OG<
MM)@GM$QX:7@'T@&J)NV^+$@!`GBP86RSKPJ<1*@O(0"P3ZKXV$=D/ECT`%87
M,VI-,]DS)I:Z[+4W_A^46*![Q>&`L@>`19(_2``$B1<`Z+XO`[UE+B5![Q()
M/8"DW&5N#&0`!\!R@=*.R395Q$`"=O^=S6D%=AAHT_B0%<S?RQ\B&^FV0DYV
M9XB"<LP>X#5H\.I[\Z=M6)$!PS%HYO1K:/,`,7$!!1@2SC4<50%]7H(`@><0
M6%<?5=,!$]`A.:,8%B!3&'`6&:(7P1(R_8&"5#$5/+<8YM<?"P@M$)%F%(`:
M"1!ZYS(F+`=.#<!J$*!H,"1H#,"#0RB$1<B##_"#X^9(,G%[0"05/_(O1Q<L
M2[=_8W9VC.%SC22`56=_]K81X/)6D)$A9R$`$'$?FT<P%2@?L[9,2=87_C;1
M`1#`1QU`AW5(A]W5`>%7AQQ`;H7'&!C`-P_0A+HQ'G%A`/5$&0I05*PW%0BP
M31/0A!M`;HQ(B4*E.C<81!G`:FZ6`!L&3QG`@A"!AO6R2#-R:5%!`!]!2\!R
M*)TH&C$2?V.&?E#758FWA:$!&WN5$!7000'P(`JC&Q2@`1M`:!L&$7(T@5V"
M`)/V+R#X`1*@3!?(9<>#AF\!;]_Q`'PS:0\!<-PG%`?0=!*BB$*E`!3@331&
MB0A`=T7W$M\T`<)X`3-3.3/C("VA%:8G$9"V&:HA`150`?TH<E>B2\A2B=S"
M:@&Y5;KE$/RSD(-T'_(D+1#08.$G&DMU;5!F_GFA<2P!$(JW^!GVXW\SL0`1
M\#M*55?&ETH?D)$.@1C)R"5J.!&!DP$W.#@%T`"#"!T6N!@:$!?@R!AFIA01
M4!5(>#=8PA\1P#.H10$G]Q*)Q",Y=2L/,'R,X6M9$6QW8U\X050%*6%+R'V'
MQWHEPRTF]SN+2([AJ!1-<Q?`(E0&()'SEF`<80"V2'0IH6D=<(689A$>.3#V
M(R0E1D>VIS4\64\IIA8K&6]'`4!)*!H)X'@%D@"0^4T-0&/?M$GN(9F560`:
M%!H1$(V4@26U@1EY`A$6$!>,I106D(WOQ&K;6)J&,EWM)P'CB`!II&0:-5UP
MI0$91WK<XHCPQ!47_N"/'L)R""!=[N$`@^0!,M-1[7A+"-EK'@)L2<4`GJ9(
MX\$66C&"V\D?"W"3$C`!7154"P46NQD6%6F78V9EHG$I^<>77#(?J.$`8%$W
M>M%&JL$HX9F'5N8!9Q2>$%0Y]R2@JJD:`NH`>"&5%I!3`R!.:"D3E296HM,9
M(RD1%0`N8Z.8"T"7-Z2=`C!,4V(6X,0ZB;.`&SHWJL>6J612TG(K'RHXSZ45
MJN,^$)`A!,!-#\!,#F%/^<2B+Z$5QIF.Z'F13[:>H#$="?:>^R(M#J`6UZ)W
M-EE%9`4\"?$[.P=+F/@!$X!Z4Z(`6*I=)H>3$`$Z-/1OJ-$1KKD8VX*/_KC8
M'K55<9&6$EKAEFC:@@BB%4CH`=?%+0M``5X)'A<`,6>S`0(@A.%):`W@I7RQ
M'T-*847Z&=/Q0DG*)>N!86^':Q7@`+87$1*P7JGHDD)4-%HZJ5J(&=/AGI3!
MIS*!;!#@H(:'7%ZR'@S:D8;!`=O":G[:&9((+!:A4ZWZ$"6&32<A$*5''J3#
MF*R1+II&C*)1G?PEJ5NR`0R`EPZ1`2&#&O#$,.7U/=8A`-&H02YJ2;^S`#C*
M``''30&P`-NT3>TG'@1@HGKW8F$:$:GZ<.P4?;/8)7D8.H3ZF8RAJ3XS6EMS
MH&:&-EV*GGEY5LL:&O?AK,_*)&5F4IF1`#Z(_@'FLIN#AA*F8@#/DQ\.@*N3
M<UX.LRPF-ZZ>TC)'$0!7^1G4A1D=1:<300%?YK"5E*?ORA>8HA@'\*D3L53X
MREHE)A[4%)(S"QH1@(0J8D^E-S<(,$/G53NAU)]BTR*U.0&40BETX2D84&:C
MTEYJHK64DC.%A*.CTJ?B5V96.Q<>(@&'5K56Z[9OZ[8`YQZRL0'R>@$!L*82
MH0&@11PVX6LMDS.C\F^F(IJ^D1QI,B1I0BG'2K3\Y';F8CKHZ8=FI0$^NQ@G
M`RB-ZQD3$"7SU0!%UAO;1X-EHK=+"0!J1(SH(Z?KLSPB0TK)`[L`XIV/%R`#
M4!6\P[H`(F,?,VCH_O,P&[4^N>MRA(0^+L9VCOEB"Z,Z$8$!\$&JF1(?1Z%$
MF`J.2U606N%!"($X3"4K+I8^4O<19&(A3'N@#$``"H``PC(<E5(!<^&/=G&@
M!QI`8L$^ZH47(!B_0#$JZ4$['$`>$@!2L\I:C"L1#^:#!O"R$Y%3,NM?JBD>
M#M.PFNL9T>I$O&)*#A2/GYL`"S"5HAB9%]`=Y=*^*OE]Z"$=/A.<[(15FE(>
M&<!+;5*WV5(<*BF8<S,C7L-.6%1\=?L3=5L<FD@C!9`1`/P6CO&,TP(UGY(C
MURM4!6"[F\'$>N:A><;$CR8FWUN)X<,`056)"/``PF45M@LW5L%Z'HHH_B;6
M`"3),836*^\!'WVAI<`C5Q.PMG0,GF!1`1,P)AYK66%1*95"`?VX5?%H6Q1`
M`$X)&AH`G@P<)9S9F0`PN5'5`6[HKVQB?Q(\FE;A&NIQ819D6[PD3FB5++%"
M%7QCGY\%5%5!ABG(RGQC01:4(ZW<'WHQRWR3`+)<RJ=,%8.R8<"6?2=SRP/P
M;U21GTT[41+A-`D!B#^B7-_2+`UT3FJF9K9G)X"4`"AQ*&NKS6M;HPB``!WX
MN67<>E',+2AHEN2,SE`<Q=M$F>0,.A'`+&2<(&A15)&1Q_UA4PE&%0U@IE%I
M&_@4(,`6+`J0?38S$.8$,Y"&6;;1@$J3.G_W_A#.E;F\)V)WF;=;92H(B\F9
M@A+HYP$G`7L=D+X040'99WLS62=J-!9V6(=J$I[AZ7,O_=*6M1PO+18O+9P,
MA0'3,R;O(=,_;1OZZ=*>]M,OS:GA.0"!LP&3A#H&(!M,C4\)(2)%PP#_X6@.
MD'`R8:%9$7H<8`&W%"?G16,6<"2U=21T*(D30)GH84_#&)ZCPH&V>TM%/3T:
MP$U$'9ZM@8Y:82@70L[(PR'H;``#@LZW$C*%C=C:R<1&QY:GRJ01_!E+Q<#]
MU0&6NU6GN=$3/!0/$1(S>5(98$"<`AL3S7'4,4UEQ;0((0`9,R$R]2V6E17&
M`GL2L4+PU&L?ZQ1O_K%;-S0W%$&,QJ&@"W!.O+1;1^*6#&![6D3'5=-3/;5)
MD?EX&/0!>[N(WUP@"B`M>=4CC,B66A$!8F%[Y'Q7,W,!!,G$I]HFD$W1DUU<
ME2U`"K`!&LTD7M,78]==<-7;LM%=6A,G:M3;_SU$2^-\"O0Y'I%FKKT!Q%90
M1S&T0K=L:-7@&V``@>%8"8%A,Z*%0@$!Z6M-"]#@3'**L$2*H@&-'D`!/A@1
MV'%E/T$>QP17^:$ML.,0,S-:HD7C%&`A!D`4FF-2&NOC"W,K4'RJ2_L=DGV7
M65VJQ3+;77*@SZ@N\4(03M01:_=]`7`!`X`36LL0T@(H_3<4`8!!*%,2_@6"
M`7:-&CII.%F1'R%BI<1A+L9'%8'GPHI)V@_W`*>S`:5QUK)12+8R80OQ0'0#
MBD/A8M9DG)E-,`VF/:+RJP<LP-!1T4+4-/C%WHOAS.J]+Q'`7\<RW7A;$8AZ
M`)NC-;Z8%HEC:Q701N:T2",!,U^A2:/C<@B`<M-%(HD^%2*R7OF5C=(G@UV'
M4O?#=^JU%KGQ+6@1.>N1%0R,+MN!3/ZKV'Y:6FGB)>9!D9@AKP">V='8`22U
MR44;Z5#F:P)T%O+]'7=KU^J24Z!2AG#5'$4W.!S@$E,M8DA"8*CY(8`(C?SU
MT9NC1!<M&GL4*^@+$7XQ46%]`1/S(M14YPZ7_L8?8([FP0$"("7E'0&F1FSN
M,U^X!7!#3B-.?0"53A$W24,N]0$>BQD\2:MN$5F,<>W91G;9PE8<3QGW0<FL
MY20"I+.6/26P]1<$QA$8D%>Z422W'"]X$\OQ\KQ*08,<\&_7W(^\-A"Q@@#]
M"JV.ICDP9#-#5+'+Z!"A$P`$S%I"S`%]E1#9>!E>IP$-#I0/,9>V1NO0-7VF
M@QB^6E'NMAB`!E<58+,?&45>J370JBEA)=('+QK(E%MCMM/B0:A(GND5-"($
MX``&D*[BI``L)U"P\3[/J!W(1^].\P"'UQ!=)"0TL1\)_*C.`5RTQ$U)MEU\
M!!$9L)F*5QM']S5-_MN)5"$NY94M3OT_CBDD;Z&A@,I#MZBI_M3R%"%;[@$1
MEQ+),N'V>P]+_PD:%9"^5-\E90X6X!D3&D`><%>.G:,99+(!S_';0*5?"7$!
M0A%R"``5`_$!J_-92]6G2X.7`4!<&]A&^_-+7"58$A$C`!'`PP>"!0T>1)A0
MX4*&#1TF1&!`P(:"'2ADN."`((4%'Q`@&-#!8`$(!ST4L,`!`(`#"0XT]/`@
M`08)!Q``N/!0YTZ>/7W^!!I4J,("+$TBX*!@Z`</!@!D6!IUZ`0)4QD0P"!U
MJ`<.3"E^^/JA:\$-%"!,0*BAJTB#'B!<X-!!@X>!6A5:6-GQPX4$!G)^_I!0
M\D.&!Q\M)-P`80`!!'8=.RY:P2`'IP`D>T`@LD,#FR/1MBV`@4,```8<!!B;
M4$."`1PR:-#`^4#8A!D^$^1`^_%NWKU]WTQPE`,!W3X[#`"@P??R@A*J"J7@
M,BOS#Q4>U#UHP8$#"U#!BL40P4.&#1U$>MC@`<-Z#NLQ;,BP/CU%MG0_=,B0
MFG?$``PP-"C@.8(DP$`#"0@XX*^V#$R@``(X8(`Z"1M*H`&$.M@@/0X:N"T"
M#@J0[`,-`HC`I`)<.R``!!H`0#^#-C@`@`0XL,##!P8PH+@7'S`H`XTF!#)(
M(3^(42F#.F"`@P&P`ZH#`9X:TC$%!`1J@@`"_E!P.0@`B$"YM@Z0H#L!-,C@
MQ`$<4$"!!1*0``'U#L!```2Z#.`!"3HX@($%#GA``"31<H`""P800(#I>%O`
M`P<&4``#MIH38$H=;5O@`@\B*"G"*('$``&H-+@`@PM"O4`#"PA@@%0-)JC1
M@*X<$,!%#Q;`LRD,"C"@M@4$@*"H!1`@P"D#O%PH@Q(W13;9W9QZZ<@$,@AN
M*)6@5':H!PX3*H.5*)!0`0`"*.!1IA0XSP`(,B#`@HX\J&`"!B0`8`(*&L`@
M@;J,K*X##IX%H(,%"OB`@0D0@(`#!PY]#+,/%`C1)`488-(@"02PH*X,+-2K
M6M_@!6``%3_ZJ(`K_@N(:*4K!?!`S8"3,RG)`3X8%L&#,H`W@,,V6&"EE1#0
M\2`R-08ZZ)Z*PI>@#A"H<*EIO1.ZIPD:!NH"B1#NS8,$5CJV(`R,XD``%0^(
M`*V4Y-T```$,,(`"`-Q4:5B/#C!@@JT[J`"`!A*@@("(=U-X3H0V0(YJ@BX0
M8`"$)7@@S:9WTR!<\]J"8,R!/#"O<H(82+PUDV9<DH`*!BB`*POZ9`F"L#R8
M8"7#%V?=MPTR8ZYL`'@\L@(*>N9I-)9;URD!J'^B`(&#J9O@`@9V+VBUKCB`
MP((`#'@@29(;8*""[0!0@`)ST3N`VP\2."T#M?\LBH(`-K@`*=\Z,O=(_@B&
MA?,@).V-V-C8>-?*@EP/PD`!!`0W204*$*N#;"`!F^D``19`FBNMI`!9.Q*.
M<">_!7@/?Q=4B`<L("[>:`!K!X'0`@#8DZ5AD"%6H])/!I:`+/7F`LC95EL(
MX(`*,"\FQ(G4`PW`ID0](%0(H("H/$<!#G1D3>-;0'IP<@"2!$`PO#D@`FX#
M`<\-B%@>N$H+"U(W&9EP*!G8GWH6,(`!_*XA!4A`JI(7H9L`@`$)4,[D'/(C
MA[#+BW<44M>XE+@T*6``$/B?TE;"-#P:Q$Y36<D('T,3#E2`-AXX0*$P`+5&
ME@@^%N`6!V!C``(\``-[JI-&^C>!1#6K>"_L_@\'I40``)3D0%02X6"N9D$0
MVFDE="PD3S9@`#0&0($I?$A?$O"\!+R/C8/TB8L<(I=<-I,W12G``")@`0E4
MX#`.4&4RD>E,@BB`6%6*D2*C%)<.7&`"Y'E<0?9VGPZL,YO,6<`#9'0`K!SD
M`0Y8P`Q'Z``"9("+N.2F0TQE@0U&C4<=L``#%`H5CF'K(?NZ4T46H(`(1*`"
MYL'.-`.ZS'5N=#+(2<"#Y'+.#DA`F=JD%C>?A4@`B%-("R143&.:`)JZ)$T)
MF$`$UD0H3VI,GM]2P-XB<"8=>2`C&\C*!D@#S*A8A`+MY``'Z-+(N6!@`E*5
M*CNU"A8)J*6=7&%2_EWHHL'WB"4NE!O(.YFBK[7:YT4$:&<[7T0:#^FD`PG(
M65ABPX`&$``Y"$#<9FC)G(Z^"*!#"91'&5*9RNCL6RT59$J=R<*I-&!U0$M`
M>DP"EMQL(*J$*8]!6*6QT^#D0HK1(E,BH``'7!$YFK(+!@:P@.HEH%`,B!P!
M)B!/`@B@;MQ2(&":%;P`**``"C6`N)+X`0PX8&($@(`'`E`H!5#L`R!*2`<X
M&:X)^+4!&>"9=C8@)P<A@%@1V)D#3IJ0"7CK-LRM:`00((`&N5&C;<$`+3T`
M&Z.E)JK_52M9X)-:@E#.+H55;,">M!("-"`"#H``!6XGR`!\LYD)<"A0_LX"
MQZ!EK"`0>$Y2XN*``PS@O8`AL)#::.%.,2``@LO`E"SL`>30SBX<.$`#!O(`
M#50@`0^(@$@H6YX!('5M'XA.\C2R`9&Y"`(EHAZ'/_!@B]1K+@-(K0;@-)`%
M1`!>$CB?3#P(`.@*`+8<(Z1#)A`C_6Q-``AR$`&"1>:#7&`EV+&S4C(`NH%,
MX$F%(G-T";+:MHQ19WXA2`8@`.*Z=&`[R5V(4160MM.A9P,:N/1Z=7+I`"OK
M<V]FJB`GLM&5"F4!%@BDQIJB&P-8:,H5+@B'#B*!P6[J>*8U6E\/D^J"+.K$
MN'G28:-B,$`-\,G8:XI!,L,QBP",(!K0U`4\_DP0""B@:P^P['40X%`JLA*`
M(_K?W#S2IP\XX`%[)O,$!B`@]$)V)^HEET$\6+#W>K`Q1WH2=O#"HPRH:"-N
M?,`]GW0LY%2$10UNP$T$`)74K>0YXUW)>JWF6`#H)6^DT1FOF!N1!J&M0?:"
M0&8-\A_2$&`F"W&-BW(SE\UJ96!E20@%$*R3T9R/U"G620/2AW,AY6C6QZ(,
M6_S%P;#Y="7*<4T\QQ)(N?!%Y"9)S`=Y<U4&<`=U#$B/S]MY`'^MI`'!*PC8
M/V`!5QMD2ZQ\P`$6,`$-&.`RY6Y`SIBJ`0$LH#W]NF[7IOP`"EP`7@,XX!97
M\L2'-*!QCVRP!R10_A<-=,"-",DW668G(G\C.5X6(P!J(`F`@N`E=%L<@(74
M=LMG8[RCWEJ[!2('ZS'[\,FD,14"&&#<;QG@C=+%->H*ARN1&:HZ!$!C71S0
MRB/Y=0!,LZJP@S+\$095U)KV8JF#DBA>*^MH$3M+03*64(3<5UDN!D`UHZ>?
MH*J[F&DF"`:ZE[/)ZR2_0<R/>^2_GHPX(`$?F8X$&H6!&\DY=7Z&@.%K``$@
M$+=P-KY`"'I:"08X+@R(CS,Q``0(@(N(EP+QF?^1*BF"@`#H`)MI@(`SG0"(
M%JZ8LD3:"0](%X!2*E^2LU1A.^R!/`'H$;MAB@&XMZT1M`SH`'F*KB=I_@X`
MR#"M2J`G<;;1`X!U\B`"2C]P$9%O28WCR3!X(;RK^8NZ>9#)J9O@D)UX(0B\
M>*^RD9.R8PJ7Z@FG,+P+*9J@T!;-X29(@KY@J@`$X#D@P0P7J:@"BY8/L#N$
MN``SBI(--!MRB1@OHRB%2(IM8XJK",)BZ9@#B"16<JP8<2`$<,1%*2XD8Z+H
MNIL:6H#X&)`,<,0*@P#:V0`SZA)YF8#WX9(/2+CHJ@"Z.#<#2*$*H">]21^_
M6IAO&1T(P`"_XI$',``4W":=:#7.FXPW<\3YZJVM>9F#>+.QD)LC^P`;_#=L
M@0`-0"\&Z$!CW`#@ZPH-Z#M282Z=61+MTIEU_F(1,?2(A:N;_4E$(!0M=R.(
MJ_&.+0$H!QE'DX&*?1LY!IN1`JL`=1R*6R,\QX"7:6NF>Q,*!9`:"TL6+:H8
MW+BW#7"`O2E%C;D)FU$(-5(("2@`F4NTE?@UA:"`>&.G_XHJL2B+@C*:)"NP
MG7C##'K#=\*H`H,*=HFCKU(;33H,%L$UG2`98PP[XFM)W^DB>9NN1BN;>Z-&
MR\LP;4F5E2"(U-$+/W*LLIBGI]`6G0$@.;,P]$I%U2F<!:,->8(@!8`U)6F_
M@J#":<F+#T@=&]-#SV$E`?DQN]B2542(F'P(>%%(9VJ<K0B79M28#E``@B(H
MS+D6P5@GJ:*F_-`8_A9QQQ>Y&@"R`%RAC:T<R9B#H.I8C,T0@`>`$`$`J-2*
M,,30#^^00&=+".-QP*YPE`Q0J*JX`(*B"`XHGBZLG@^```9(B4B+@'["C:(H
MR(8HE1/3%L(SJK)IH=%H%H(HF^#0EGM3FPQ+G:@TQJZQ.<K1%Q&\#QE1FU]Y
MGCO;RP#`LNR(ER2LJ30ZL=\R"&_)"=FQL`XD#P!P`,`)"7X<G-`LMZ-$,K[<
M"9_L3*;(0Z&`%[EL)B4!T`P*#<*LEN-```5(@#2)L/9:@'BZT(GZ%;73`-E:
MQ"B9%1:!&@E@$QS3#PYX@`)P`/23@-K<S.[['='P(PY1"DC*$@U(0[$X_IN`
M9)+`2![4^``!N`";0XB$HX`*T),/*`P'\$TX"8`%L#T::P"T&8[HH0`)`)T)
M`@Q(\Q8`J#6&D#T'M3P;^PK'TZ(M$1!YXA8:H\Z?7)D2,4_MHT&RN$25T)LV
MDB;R1(BK05"0**?2:(@M:1C,0)G[B!&`@A4..-"Q`P`T(DH]=)!_"9:ZB(`Y
MY(DV0E""4+Z>&+Z_;";"V8HD$M-DV9"_>46FN``=E+`6B@F-H9'`Q(T)70MW
M5`^D*:K9`A.=.`!E*J+Q<L3[$%."2@BT-!MQ&:W+@<<SF4#56*X*R`IY*<DV
MF48+"*D&4`KMNLPIRPH@<PC`<:*XX4*:XY5I_L,+5SM5L&C4/E(`'9,G`8@`
M"?,:BE"J-O4D#;J:1`E28PR,CI$K#KB)7%&;E\E+G=/368NX@D@=I1BS"5)3
M99/!J93&@E"`EZ@;VN&8]FL*BH,2#[!/NQ!0A%"8I8`7UG2FD`T*Z0*<H$&H
M/54@)Z&G4IS2B$'(<7JJX%"\92VP&^2DB#2)]`&`#9"U8!I6J("6ER"[@RBZ
M@S"?M;&PPY18JYK&J_'#ZMBV=@F8G'J>JF`EXH@`VF%(Q@B)@,E4I?68;2D;
MAV2(4HP8":@@:AL+\,J\*[D2TY'`C#N6=AP(8G4L-R$(TE"G6VL)2.2\U,F5
MO*S4@CV2&#D`>1DJ_BQIPLE,"'DZE)-XV/N0LZQ*F8H;1]IQDL'##6D*N_[0
M5-A:BHP-UR,1R)\8OIG%(P04BI-(6:`Q,*0=+_6`&>5P@,XTV62Y&,")`)+)
MD@Y`B;X:R?%``![+C*!UB!RM`$'#CT2AK+;8RUCYL8@YTH'`B^=!EZ.9BXC!
M7CM!BP6P5@$)VD]B"GHYFV#4P[$M,#`+@`JX`(;L-RV5-]_)49K+#H4*BPXX
MS<&HCNX(R$>AGH-HKT(!+&%-*(V0S8J,`#DIK+I="=+<3S9,B),@D9$HU(T@
M#?J*8*A`+X6\-1Z9E?#3FK6A"P/HGO:8@*M:R!@"H4WEB>$CW00EV9]H_@J0
M")H-R%3P:48+<#XPXB#G4Y9&^A`6EA\WPH!ULAJ&)`AS(8[>B8O4&)T@PQ2I
M2F*W*K??F17C.P`FB8``L(GW78V\`0D,D$5[XB1K*X`4B4.@"Y<"4SNT\<BN
MX1;^K."<P;JI)!/):@B@M3^&L%0O`I51\=X^#BVM:0!QH<@2BYNZD(`/+(B+
M<3"QN`K:(#%,$H!H<A"I`XIV0S\+H-^'N(D9SB4/J%R@X%@RRN%,_9"24)1'
ML;:/VA0JX0`*@+:$V)#G-`F1^";V`]!V!6-'%.8#(+%AIB='=#&F>@W\X,.#
M09@.2&*Q4"7V`(^D$CI"T@`:2H^J((^]^+9#_L6.QBD*M%6(5:F``&`(<E::
MJ5V.3EL<+]DO49FYAG`*(,V.%^6)G&'?.S+,K;B_4446U_@;JQM@Y@$OVN@:
M=Z8.X2V`&D8R;$O=")"^@KBU+V4O3^*([7B`%88_!UP/U3.W`0PU7<(43'D8
MSY*+J<HTBL`T^#A7H=`C?"T(MT2_A=B`-\I#YD&+"D@S)$%A-MF;5`RUJ&(Y
MA7BD0S8:;*PZTR&A#TTP8FQ4BPSE.5K+DB7EGK`:ULCA6E,HM;B2;6MH]9GI
MJQZ2!#**F;X;B]!EYO(?M.4BA=;#O10)YLF*"#"`-'..H6"R3&[HAC9/Y&AH
M7EIC`_B7OG[?+T++_EB:#)VI:87`@.8A`"_!"[UQUK88/L>*Y8J(X-284EP!
M-'NY#RC-";YPHJ$L4/;3&?-JB`EP`-CIPD6[/]M;+K%XC0Q0/0-1D,1(Q:EN
M&F&I#=YF"%@1-@S1P<EXVPQ`[OW"#02#ZV1*79XPY1++X52)CX!K41[C@%(!
M9==`[NY6-+(6DN-HO_GY#'\M,`I0J)=6IPN01*=&"$]54K3(GAP#+$_UH6$K
MH`(ADP<($2+*CN*$20HHE-02;SX^H?NX`+90B0I35(,XC0J`C7J!0772F:R1
M)["I`"3%G@RA*Z;`..\9C1R9@+NRSU2M@"]^D,7Z%F)QO-)H`&MMU*ZX_C6S
M`;Z(-5UVYAUAW)_92Q.0V.=\KNKT*]O%D+-(RB''VEJ_NC\$D;,FIR<BES,'
MD!L*V(XJ#Q0)V(X'VPX+F#_WJ`"GP/$Z<@#7U9BR&6RX<41>ZJUD3)%(BF"/
M@=Q-,>M=':I_3+3&2`J2(&<,8,"5<.^#.*P+*)C@4!L($%ZD_?.'\!&3`"1]
MB8C(CI,6\CZ?.)[#SBZ,:VS$.`!O$8L:>C.Z,,D/Z)BWTN6M],\1$9#,30GD
M$(S*:):NL1?78$*#\+&BB@L8DLNS'A=X/)X+0&D1>93A6(G[Q:!_)8B;:(`G
M6X"1YHE>&5NDRB\(:`D)\+**JB;/0I\)@`\&_J!$2K2)#U0`.['VBNIVFS#W
M<D=W)H(;QYHNKWO=OPZ:^]E+KCAD$L20\LB-'Z=#2#R;%G(2!JQ(7"86+@)0
M4GYL\*J.>.EG@["HH9`M<<&B6.F`"5"4`CD^>])WF_88=MY&Y.E6M.`\A.I`
MAZ;*@Q@FIHDDO`C;A)=+.\N5HOB+R[8,L1!=1@7O"I8GTEAYF"%=PD&+XRDL
MNBL*=,ZE?]&QE:F+K%J*F\AXV64*E)2+X1M0GMB:40>:#0"F"(@0]AX3++4N
M]RE,5IJ)O1D1.P?93BJ(HF@1G8!O14/!72J,%SJ(!J@AH?@/D(6@'XF`-",,
M&S8YZ#N)87R(@6":_N-PZ!CYG=3Y"Y50"GJ$6`]#00*XKK77PP1`+XHE2A91
M#@K`D2E-<87(&9_$%L^KS0MH`%\2B>.QO=GCJ["`%W/,]-8Y"0-P%-X\PI>,
M"J;W*+D*"AB1B1S^-0TP(AK!)^%/H>$(>_^D]093B%ZY$^QH.+AN>^40?IGK
MKM]I@`5U;(3,@(SAR-R4-P#O8X\A0_9#OT:R%`NX*.B4C,+_S%N>QT>-_[_`
M"S`I"O51*M*UT\GW'KPJ08!0``%`@P\?#`!@\$$#A`D3$`#08'#B1`X"!FQ(
M`."!00X%`"08(`````<&'9!,H#+DA8D-%'S``)(BS9HV;^+,J;.F!P,%_B92
M`"#2P``*.X\F$,#Q*-.F3I]"G;@!0``(4:\>W2"A)H8%'A!\X*!`X06%%#L8
MP*K69@<"&VE6*."@04&:$QQX\%#S`<D.3!,@D%`A@X8.%RH@KH`!,07$#19`
MJ&#`PEH,)N$>,#A!0`:#"RA39/AT@]L$.SL,(-F9I@*2`4@2""";*@`#L2.D
MY*#7(&[3%%L;_;``@((!"D:V#`ISHH22'SX&1P#S*^WES9=/'-C2)E_:?6,"
M`.NA0P,`F3\P`.!WXFX-$EX[&`X@^-KZ3E$O_9`!``0*#1R`MA9$^=E7H(%.
M326`50>NI1577A7@`0<16'4!6!1Q,`"#6+7U_I9!&$!P``8?3.";01XP8$`$
MN]'T`$+K[83``0L8\-IK("D0``$*+*``CSXN,-)6:G554P<3?-!A`!S$Q"1%
M&2S85',$!(@3!R1%Q!,%3.KE00:(3?!8!1IP@!H`$:RGUU0'L-A<A."!!8$&
M!_#W`6Z7?>"!1EM]-&(%!Q``P0,78%F73!A-U(%&45+D06L*4`#!:T95`,!/
M$Q60%HD`L$B33`8X$,%(C&Y8J@<%"*``D^6MAL%V`@(P9*FSSGK!`AG41>MH
M(]*T@5<&3+"`!`R()6M'!.AZGUM+>0`!GF%^&"1]C6;PWG=(5>3DB10HL,%-
M"JR&E01*T=7`!!1,_K"!!AMT(&$'%'1`V)$89*!`E4?E&*Y.=%Y:$P2\VO19
M1Z\)H));3+9V@`10CHJ!6.%-U%H"CIJ'[@1T7O91!)L",%@'=-9I$$(*7.#>
M1R'3U(&.$^'&T97]/B<`D^EU^IN)O27+H(0%Z.A7:JU*M)8'J=V;L]%11<!`
M!A<>O=,&TW9$V09T<8!K`S5GV+1.%EEJ@<(I+X!!`PA0`#!-$#2``0%NP9@N
M3IK>9`$"VM+4`-U1=6#!70^$^@`#?P,>>.`-,!"!V3IYT$``4%L)6\T&5?"J
M5`]0<`!H'02^P-]..B"`YP$,4$%8%FP^409_9X"JYZO7=6K''U@`L4%F_IH5
M%@,"W)CJ`8PG3A!S``BPF.PBOPX18,<G@.0$OG](E>A:JW7!!JD-X%=ZO$I?
MWY4`Z`N]]SD)JL'SW]LT9X\0C+5``Q(LS`$%[,,/__O%D5\3!P9`1"76`!#`
M.&_C<R!=2V(*W&R2@0$$K29IN\GCZD<1B.!I)ZZ#6:^\]1L,O&8Y'>"5!\9'
M$R\ACBD;N,!N2D:1#1S.(!FX0`H;11<8?4`":=.`!38V.PID[P$7&8!(>&@Y
M&>'E1!`H0.T,LH&BZ:0#'-`-##]XMZBX3F8?@`AH)M#`IVRO>PYTH+THD,`M
M:@8!<QFCCQI`@`$0@(AH+``"$K"``1B@`0)@_MH6.8`!#2#@<1Q@`'9HLC0'
MP"B`'QC`$V]20)O\YR8-^")%]`9&/Y*DA3>IW-IP$I=.)0"#<X3<`;PE@11*
M8`,<,)8!']D4#UC02KO131(9Z30'.(`!$A"-8.BS`23A1`*%9`]=;.2G"S`)
M`Y^L3P=&HD530@]<%$CE(PN3$PVXDB(R-.4B->>OXY!2/PI``#,_L($5#>"8
M-J%@HSQ``1MRY8KM0N9)$N(4!70``LAB8`%PJ1F-7(X^ZZ2),YO(SIUH0)+_
MC,HNV8,!"HSDD+.S3P=4,]#O(:`"$_!@J3!`()TLH)NA4<`!_`F47&W1`1M`
M`($JX`"K($!R[HNH_C^_%#N/VL2>-8G``A(@S@4\]"89","M3ME)""B4(A?H
M(P<(Y9<)%32G4=&`_Y2Z(0@DE"WVR:)3FV8O]N4LJ30))4[D]`"0;C6"7/3`
M`VQX@02(R#-!>Q<!T'03#!Q4`##U5P8>8`$R98!)&XS`!3+@U\YL(*\9J2I%
M;C=7ML2IJ1-)P/@28``#=&8"!=`H82O[3]<%-9I0N5(`-&M9`UU5L=^;0$$I
ML``"7%2:2/P>`SK@`+\F@`!VF\@$6G(!-")QCV@EV&$I8@`!N`5XP#LCEHI+
M@)%\3JO()``=CV+.#PAD:P9X(HBN^-GK.I`#KPDJ93?+/^S2RBNU92<$_@KJ
M@<ZALR98?:0$!@`Z`DB@B3SZP`,FX-$,3"`"&Z@4<9H"@0[$2P(1,!P'*B#*
M#1R8`P@N\`7>1-C]R/0O[A6K30!4DPEX%KP:UMI4W/E!"A/TNQMFD+W&B\SR
MXL0#$DA`01MBRN80IY`'`"M-:.HD,X'X)J2JL6=%RTXY]M8F$/%03CJPHM#D
M>,1*SEE0/.S'J5*ENTN&B@(P8&)3DA8G'1A+3E1E2MP$0*,66$``CDDZ5E+$
M+<W%209$ZP#-;MFRF6)*M2:"$B+G)&PG%.>4^[PAW*",/7QVRI7FZ6>UX/3*
MCXR`&Q?@Z$<_(#'_>8RY(B"!1Q=`N4>CJC0)_C"!H&;@`-VJR1G7?!.3YL0"
MDCN+B:I:`!JG^'=X3C&+,B#E0^.Z/DW>L8$*G6NL;-,`J]YB!*33H__`4@$$
M0$@!>M2C`K@12.2L'XS#Q0$9Z478&)H,3MR2S9M,*"<,:&J<";L!`:172B1)
M[4WX"#OG_#K>!0I*1&U"T:M,I<SR?HJE`S!L!P(R)WD!W[^_UYSJ+00!J)W(
M`5KB@;(TO'SQ(LFW;7+09_(9IX25R:!QDAX/J:O(Z9+.ODNNEMBM]MX$!5V0
M3>X9UQ:<?!"P[@=@F1/*&:@#*F=*!61C40)4H%,(L``%#*"TFUP`Z/N!]TXX
M<+4K+I$]C>+U0/>3_FZF#)E7$B``S3$XV<IDV.7@G4J$*S)5-(H=7R2)^?=8
MG!,))/D#$&`[%LO>E.7QKX@308"._.>E,(V(`\MJBJ4&@(##(UX!$GB`!!#/
MQL,W``*FKOJ9HC+D!MB5*4<_9;LZI<2T^SEVXJ3Z:$0,>IPHNP!TAQZQ<L*!
MN%?9E%P[)EIV?FT$4H1.?=2)JRXPZ4F/\5\7@(`$+C`!N#=@YY=MH^5=(P`V
M=<2ZHDE47A!\Q`$S29YH3$#<3Z_AYCA@]5B)G:&]7Y,%Q%/\3>-F3C80=P0(
M%'JXD2*&*,``?]NO1!5HHEN@;_Y)$L"MW<20#1V]5$`$#,`!1$`&6,!)_D%`
M!%A`8#T`\6D`KD2`!H2$`%Q:P%5-!!P``]B=E80=H?W?@<3.3,P*^95@31P`
MG:C?T;B=E<1=`[Q@LDQ)IS38S*F>I\"736@%`AA`R[D<@CW'Y.7$D#E?<0V7
M$C(AEGS.1?`4!`@*`C#``,0?6]2@3OC8"C:%3`"`QI7*?DS;_Y$,`V1ALBQ`
M4G5`ABT0&'W%1X"&W-B70:141YQ5`:S6794(%U($VL1$`,#:$9+$2%#`G6$)
M7G1'$Q87`X@2C!47R)PA'_Z31@0:@S1'JW&A`,B=`"83`\#2V"`;+(GB*)+B
M`03`%1Z-!W14.`F'4K"(`NB%!3#7?VD)0D")_A%Z'XCDR7#XWU%\W&M(`-YA
MR59@D!+^BQ*"RL,4U^)82@A*HF5I`$GPVFH]Q24*39]A0.$$57:=U`',Q:4=
M@(R(8SB2XSB>%,TUC9Y<207\#2,QU@)8CDUX@`:,C05`"EJAH_FAB.%Q(AT^
MHHQ@R0"A1T!*@`&T1G$1T98IX0'L1P!<W3-^%G_Q6L<QA37Z$>&(A`)@Y``4
M``_MD.?T$!H13@,DP$@R@$FB9!Q=0,FLD*I=@*I90']`@`7XDVYTAAVI6LNM
MH0;LQ@8D#D1NR`0P(O=XE*B1$`.-FU[,#5T`9<H@@`#0H$TLT6I8P$A$4EXL
M$0>49($5CL)9"O`P_@`2^L8&G`QLM$9G-25X16,E)HG>785%-DJ\`--=1(!#
MV*5#M.267,`&V24#)`^C^64"^"7AE(A*?,2-,*$!J`3NC`7@)$``(!=B!L!8
MG!3@2&$#&(#?N%=X_(D;E5]:KD683$]+;5T^LDP'D`UH3@2AI(3@/.;*=``1
M*29(=(J>&(>3<`WW?`"WK,L`X)(Y04!JD$P"%$#%J>9#==B.=9!]P&6!:-H'
M(2$3VI`A*B(`6$!>>(!\5&<X5=]!`L]QU@>N;$`0T@0#P)<F-L4#O,9SNMS^
MH0>+>(`]6B43%@3Q64#DX0ZCA!^5+$2)8`E-8<!N;)VW:$!\M$7XY0EX_EK6
MG?':"!Y%<T8-!5#`7?T581R4A&*HA$[`H!"&7P56!79HB)+)>%A``:213Y@H
MJJ21=&RF(H+.N$GHQU5GJO2'!(",I2BH6A03_B0*!I1D6S8*?5V1!:0&>YK<
MFTW1X^C%EY1)@NK%!%!&F+Q6<>)7`A#C9)3E(PY`72#@`RR&M\0.V3P`%6:H
MA"H`!%8`T35&7U4@!BS@8RC`!/@5O?A5!88)Y=B?CT!IAE+HA'[)HT5`F0Q<
MYU4@B+998^B&A`P<*RG8H:X03PY<I'9)U72H3R;HI>:)7I1)YTE0EYAFW`PB
M/#4**AX%7V#B0ES:5PG``B``J_K$`E1`I"V>_G\XF@$<`.[(!NCH"'%NDXGF
M*E5$0))1@#C=3T\FQ@4\@)[IAQ&1C/@H1H&]ATCD*(>0A'B4:`-8$.8($:)(
MI02<C)&6'"UVU%-H``%08O7LU!<VBO'@*@&0&4G41;T`P*MT6'7:*Q.FSKT6
MUWWJ*_"L1W0J(GPAQGQ6)T]!AG;:ZXRPZB`F8*8H@*TN8VQ,9@(H`,5:;,5N
MDVO(1GR-AQ1B0+M40"'"'<;R9)XTF;]2!+TP)PJ2#P5`!`8`"^KMTE`]#FIF
MDP:XY0?0R7E,:U1,"7I@:Z.\F0-XHT=A#J3(![CNVX(@@!`FBG%]!0-T9&V&
MC4)\;`Q9CFZ4J`7H_M!J("Q52"9BZNN-]FN*]&MXR%!JW&ORZ$V6*F+U`-C)
MVFL&Y$6'W.ME]$2_UH4CWBNP0(1BEB4!I)#3WAS+?H^%S*L&&$!\V81IP13A
MN!(>-5%VIB%KF%[/WL=(?"9[S%'$V40$%(`-#00`**V\69#2J@R6I(5>+2Y[
MG!4KJAH=,J(!K-4#+,?)HEL&&`8+<4!`C9OQ?14(1EY=OJ0#X)`,G:1)3FA_
M-,#[1$ZH2.'Q08`GKN2`T84L)>]).MI($HX!T`@<`5<;]=`.V:I(4$5(7D3Z
MDN](9`ID@JW&FJ]L&-[AB6UU%F?CG6UQ4J(2$L#D;B%2&*[WX)W#S1=/_M14
M`R4.`;B2W'23HW@%193'J6*N!"&$!*.2!$N%LGK311"NV%G14[@.2<`B>TP&
MWR!`0P!7<9@'H)#$D4T$`_Q7(GJ1]WD`!G07W6P0"P'3,@74F'C+!D%3`_Y'
M!?P'VLS%?_C'[QTQT<H6&A7'&4$Q&FVI'.$.[O`02*%9?6@$!A\-C&V'!]R%
M/$[`"#=N#++'!#CD!VDD16@$STYP4[QL35R`]^;L8I2/>8!FTX(PV4X7>R#`
M`#S`?B&@YY3$?*+1%ZF,VF))`3CH<3Y7.L[.@3%`@3*+#@V=?9BJ`WDQ1>27
MDBX`NQF$&8F9`$"-H[S*2(#A&V,=`!P.38F2_MYQ0'#RV@9,)F@&HL`I\D4L
M"`?`*OZT*O\$%AXNC!RY!L"@D`,,@'8ZF"IW!!FO!078U%I<&Y;\[T[@3/VD
MAT">"$?I$0*$("]G&E<<`"/-,6B(,#/#\;S.SJ<MA;:>B+?2(D^@,2`/Q@=]
MTP-0SF[8V@?YU6#XU6%U0&`I*3_[51;KRL"!L")?8/^$B,,L#^/-AV:0KD$D
M@.3QSZI%SB`V,CH_A=JR$881&L.0A.;THS4',/0TV:JI6!!]$`AZU'F%LUW,
M#69X"TFX,4<S4&IPQ`:,Q5'FB54X71M15K/P74#R3ZLJ&W/9ZF.MC5L`5U.O
M#0\MVP%(]=K0\7\`_H9M$,`!F"A4[XBC[<@9'8"M-K5!IE&HS(6MR@@$+(`#
MB%%\G!1<610L!6M$R36(0`H*!=9=NPI?WQ$>_>=Y68H=S8@&O-%\@+5/!!UP
MY2T!Z,N?8`DHX_158%"-..%93X`-*UB3GH@=#9F.P)-Q/L5`Y&S3#+!-2*$\
M)NL55<#,79@5\I,&VK36%!70=$0TY7!?7Y?K]$@=-HI@^N85I4V``MK;JFQ8
M?&UQ"<!>!LWH-J&*_`<&$.F]ZEN>!%<3*D5A!'3]*O=*+M,(N2CPE)6E,5H3
MS@:6N.MF#L!KG4BEU&$#Q,L`#$0`Q-%^7<0,R6@`B/9D8U'@24#1'9=R_D/F
M1<@645CEEEKJ@:1':1_-Z((+3W"9_;C1%;4J(G&=753K32?+4UIG!,@&@.#.
ML*E9^N:196W/9/F3!Q#`)`O<;E0`_*S/'S=`L1T>Q?Z6&!$?J[811U$/^9YP
ML:T-X@'AYPB%+PLY`I0E&Q$X5P\9P7XA`]AN8AI7JH0)WS9A`]20JLEH=;HK
MDEM:#WJ3&;W.!\P6YM0&.O$%KBJW7[%0DKAD4["+TV0`7/FTZW:PRZ'2V!PY
MDJ/WX1F'V6RT3HQ+CD%I3?B5D3``J>Y%>"!@BC,E3Q2.3G&&D<3CV<#WYM**
M!L"B_06/7U6%L/3*`_A%**%%28,1:BB%3<A-_BH_"1<'*3]=K98!V*S79FT"
M6&$@]`=U`-Q]+(!U29*TRZSSY89*P']M:K#O.KFHA`S5%NGXI4:"X`,8IFNH
MQ!@%(^E8);,<BZV=B^#YIMSY108@Q+2@B*@#V-*]+_`@YNKPT'$\X>K@Z@?^
MUKNOSGFKNP"HCHW4.[Q3(>",A:!`^>UP]45`J048_,&3S@0B?&9+1-7@,(`A
M/)_EU8E8@$%OR-]1P&Y0"!W=^4UH!(51P(W4SL>X!EYX`&32"8,7K@!D!*MO
M\U"W]5OY]EG(-USPU3:6R@48Q7[PK$D\CJ_HA:5=`/W15G`<]R,U0`8$:TWP
MT=_8C^WB=LRYE@$H_GI3#)JW^`E^-=*MT5!,Q+G982I=\0U/^*1UP=@X]TH`
M.`!NTHF-O`8/X9]O74V>D(05&0:P!&B[,-6YH`2DE,P=S2,>[<BY$#Z\W$\`
M)/IXY$6:JN+N8"6;HI)_C#'&6JGZO,:,X0^ZT)0B/FP!G`SNI+O$YJIL6/$?
MC_[I@ZUED_X`--JC.9HIGCZ/@+7\!@#%RK[KEU6D(888?=%^,\7)6^=>^%5Y
M&$5L6F<&N`5E:(3@EBY*:**>C"M-7!M.),!JD:4_D>6T8!`&:#BM#)\V84?W
M>Y.[;D"(5!Y%G*SF?'(5;F:F/):)]G'.#`I-500\=L:18(@$*,#.)=U#_L8$
M0"2HX.%#08,?)ASH<-"@!P<++#`L6&'!!0X2/V1(0*&@A8@&*6BP<%&B!P@*
M,68PT$`#QHP3/BS`@"#"P0T-,&S`6"$!!`\3*"`X$*#F!PX)*A)@T/`"`P``
M%$RX>('`PI\/-C"H\*$"`@81-#A`0%+B`Y\$&5)(<&&AQ`T)'+1EN,$`1XP>
MBF+$`)'LP0L-/A`47-!#!@P5.`Q&:W*`!*N!(1_&F2&#A@PD-S@X4"%#APV5
M06<XH(`"!LN5-6R@"Y6"!9$8*%^H(,!`!<L6*%1H36&"@`EH._9U.=Q@AZ<8
M)$(HN&'`4@P"!%QL`,"!!P,`[!)W>9-"@((=_A8\P`A!/$8-!'3N3`#<X$FY
M%1PP**^=?OT/&Q9P:/````8*%P#8H((-V./`+N4@6.H@!Y[*2SL/QK)/0I<F
MF"""`2ZCH`,+T.I`N?L6**`!X0H*:H&6)-)H`?:6N^`#V#"B@`#`2I(``>0D
MFNF`]#YH[3L,<G(I`P0J<@G&NR(HP$6("#C`H`L"F(\A"'(C:P(@!8#`,@<(
M(^"C@C`@@$4)&)"``)(X,&""!(T:`":,)+``1X8N4``!N1AR@``4&<(@@AM+
MDI%+C#IHP``\GV1`2_,H`&L[-C'*ZDR7NLI.(@X6L/0@"PI`Z5())ACH`A:'
M1,``B20@<<+OCI-(_JX'`M"`OT$W($`Y`P+(X"`)MJJO`K`":,N#!-X\R`,%
M/I2H`O3N,B`!/MM3D*OKI%S5V@\.&&"`K``(@*<!"!B@`+(V>'-$#7RS]`(.
M)5SQ6FMYA<"!"0S8\Z`,1I)`1!:_>^"`.>DD("Y7"2B6H0X.B/!2`^YT=8(-
M`'Z1I`5HE`BW#=AEZ$KB/)#``9+D*Z`F#2!H0%>&/#BV.H8LT%4#D?LL0">*
M)$@@`O8\(```:3^P0```%D"```DPLN`!`Z#]3@(!'E#U@@/R*PD"`?XMZ0$$
M,F8H@P$60-0@!R`@T21;AX.@@(\#+4`"?@-KH`"V[W,[XH*..N!DE)\S_N#D
MNS/:(,X*%#@XZ7>-ZR]%M!08H`,$`DB`[@``<\K!A^PSF@(!#N)@@`80/8KO
M@Y;ED:$&!F!/MP,>(*B"IQ9X]]T-+DA/`Y)*MF!@PH33(`*>K4W@<]>U:QWJ
M"T;5N-Z&8YS1ZP\ZB.\NTK_,O`.2^>U8R9(XX$`!$E4]J(,+!SWX@4DQXJ`#
M@WNV@($%>JO6H`6(CG$!!1IH0("(!=U>/P(0D&#=#C@0@08$0'0<*,!:!I>!
M!XB(1%`Z@*H\0`'41<H`J=/+!596$@ML8'"!X<Q=+#"!!D2O.`Z@0+*,A8$"
M%*!7*#/3VLKG+PNBC`,'<%">F@2!B/V$`#CB_D"U'.`=X+'*<*-;R`0`L)5:
M%:`#QP)`V!```!?U+0("6%Z*)("!`<S%`9R;"P-(^*0%B&Y7#6#1!A``F-7M
M;(AM=..J$A#&-S+D`0L0P!11%I_E=6P!)RI)!"9@,T29A'V$XH`#XG<PL$6`
MC/?)P`T),X$.%L0R%?(:?L!HO@8@0(D0"-H`H/8`R^SN60P;#04$,R`-8.`!
M#4"?!U3#@*ALH'D#P`P%5/(47>XR`'8+S/S0TH#,"(!/%=B0`Q30-+<8JG@,
MX0`$Z-=(#3!@`"T$G0*BUA$&8,`D!V!`#Z6F@%;=2P%UB50Y-640#31`ATBR
MX=QZ9B=42JT`".B@_@7"HQ/5W.V1%EA4CP80``C$[HB\(]PX#X*`-`)``#KQ
M@%,(4```&"`Q`Y!B06#5K2M*Q)5.D@A2)/(R2!9D`@60XP<4D``2'0`"$'@*
M^N884YFZ4J8ND0``"("1)#443LX24@(8P#8,K$15G$KG?<QVNWLE@(EZ,14$
M-6``%&8.6811`/T4MX``-&D#9QM`_P*@)XG^B0`"_8!+&2J```043QAX2ND.
M`H%#Y:8E$=CE'6>"G<P-@)$=R(`'IG.J@F2`FC`-C`4$$JEOWLQ5<MU@BBZP
M,9M\$P%JTX`"(O8R`#B$`7BZW'I*4H$#6.0N#E`;H1+0DT:^B&'=VX#G_E(B
M`04LY$]\NX``PD?)>A'@9P2X0`*VV,;"S4U69A$=*Q_@F.7\59T)0("$$M"M
M1G8@F2$];8RV5;YZ`<<"GBGK4PQ:4_$"#RCCU1@`X%J<!F!6`4DC9`<9DTUC
M0:!@_#(,2R(E@!'M)$M>.Z0!NENT`KCK4B?YDG46DIH"I`8!#C'*OW(%8**,
M"P,,R`!Z#\";]0Q@BDV)(GI9Y`!0]BJ`3NF6;4R"O(+<%`!O<LIS>S8`9;KE
M`,\J20.4`D^JC,15571?VP(@``1``%$5(%T%`H"S+!8`GAH($3P_X&1/S67(
MJNH``P008%<IX(Z$JF(+W1:`SG[`?B>E&[ZB_AO<(0Y7IA@(@&$QHK,G$@H!
M[GL9E$7+MBN;<3D$61QXS4LI;_K5`QCH0(4G@"A:&F4A%##0`ZPYH0G\N*8;
M>,K=+E#!A6SS(#-A[*6^`D%9AO&']H+3:`D%@3BZ!`&^,X\$(L!<MQA`OH%9
MBE0D4!Y;?K75%)BH`'Q]H864<RP>F\#F[NBA++%X9RCRT-4PFT(Y`Z``_&EP
M8&X3UH*D^9F;89L%E,(O?$9`56_9"$9^:QN7<(`F&8#`Y@S"@9I9X+D8(@Q%
M"N;?D\QP+A$@P*=M,K[YM/!\!#`GNE&G*M$TIB'(R4`!`,R!1GI`55QS(YMC
MZM:18B3-!U!J0[["_B(GS]-B!#Y8II0%Z$`GIP)2Q4YC`D"!"C($F++]0`)4
MV/)(VV>=*R_14[`&.`?,291&>0!0LV80Q%:M).MK9G%*1H'51B`"&!#;!!00
M`:]5N(EZ0>;.)Y*!"LR-`[[9P'\.T))QU1@`!]#738-M2_`<`#"\"0K$Q8*8
MP%SG*4IJP`4T=$@F]PD!OGX*_0P`-IQ8X`(+_L"'"\"`P=$EBX.SP%7A^4-.
M\DM`"OC=!R)0U;-_IW4\@4[JJE*D<MT(EFY1P$F)]Y7I;E("@]L0:0R]3`0,
M72](,:;W="BOA+R>(:)UG$0H$#CA(O2-`#(S0\1IX0%,E3`F#:E27()-_K;1
M!8\34;G/H8_D`6K`.P)D".,ZL+K0.X!+%#@J?3I`Z3:#&`(/FY*[U:0J\U5`
MRVFI(+\TH"<^#XWNAU#J1U48X'I<HG[8A@,TH`.Z[TFN(\@*(`,"8`%.@@-R
M10`8@`*82&8(H`*T10`J(@`N@"8BP+EV!H\Z(``8ZK)VACU4[3LF0#:"[*T(
M1*)<AB,88#VN@UE""I'8I@+&Q4@J(+R.1?F4A0*PHOY:;954S=^$J>NVI:$>
M(#HH!6X*XIL2R7L>8`"V)R5,!9XVP%\X#2/T1+DD0FC\ARV^,&P^`/"RAVV:
MX^*8+][^!]VTT*T^#R.F8RDXP%:\9DB\1@,R_HQ?KBR#Z*B(O(^-P,][2D,`
M=&8#O$,"6B?>[.@"<BT``D`!"J!'*F95NM"\"D<\&ND"_NJ*-D``1C'>&":,
M:JD/#\MK`,M+=F)'-FHX1H)*U&.#.*`"$HUYH,DSM@("-:`ES$A)G,N>0,^;
MGBE*&@9'"H<$[:0J1H=^#F"7+,J8'FJ!$J`M,B`S+`H`0A%,4@IN&.;SE$V.
M-(!(5*4[/F)9[J>*<,H#$,5?&,KSS$/$].P!'L*USJVQM"U&TFBU?L)HEN>'
M%.<Y&$J7(D]FB&/Z[)`1XVVM&F.*\.7F&`KL7J3%[&,!'/&VRA&C<JLA#D".
MAB6H=,K>&C&\5J[V_F8"B;KCAXYOL%P0F^"#*`+GA-[E$E=.`W!J`PZ`!!V`
MQ\Z*(PDC%Z_HF7)Q.#B@_[1FM>A#**4R)I"2.!"#IU"&I.#)`PI@`.XG981&
M+AQB.G;I4`(@3CS`13H@`92P,]`%O1@B+&#H8!I`I=9M<[I'3OB%W<;(6-KB
M&-DF@B:@#R_K`6BQ_GS")9+DB@QQ`0:B),JI*H="CMI2S,JC`S13,UE,_K[C
MC5JP`%'F`%(&6Y"C)RS`;A!`"5%F`*!,(J(OWK#FQBCJ^L"N+.^B9M!BC5QR
MO,`#:!C@3@Q`G("K"[?I+7(JJEI.KB)00DIRO``D`)Z#I=:'?UPP2EH*_B@:
MI:6XLZ6H;@(D($%XI0+(<^S(<P+*A#S'<SG,8NQ<!#/(I/X6HNM^40)X15>(
MISS+I852PR`P0`+8J4K<@@PCX"$60"P4JH\4=`!PY0#`LSOCHRIS!KV$Y6HH
MXR#X3I=<\-**PRM:(O=<JB8':WE(1D/030)D#65P:3CP10O?90)X3R^\R*:J
M8S"U@N1&1S[+QP$TH#0E8G=&)0-:,34@,`%P8CA@="+A*00+@B9RA@+V@RL`
M8-T$0!89(AMSQ21'BGXB)2U1*[M^]-K6R#/%RP,N!H_^0OZ`XR<4H!4/X@&'
MPX]6#HFLB`&X)`-J5(O"2C?69ZT4@`"PZ:KF_H?+AG,!=*83NT67W#)0`W5#
M-311KQ,`5C,!(G67#F#:'/51=VE3GT)G5G,<=6G:`#5#\S$`TH@"9.MGD"E1
M^^[=^JX#F;`!J.ZJLO$IJ,31/.!H`"`"W$_JXB.Z-E4F;(,#5,**2C.Z"H\"
M0@0H=*,U8(DW]$OJ>K57%2`MN4GB8*-7#Q56_\,#*()7<V-:H?4KI*[0",/=
MFD@P@*-YJ"^2CD1(7&(QC"0!JC(HH,P#-(#D.B!^DD27BL4"!@`O[T))K^]D
M](0!3%`!N`3<J+0W\X2A#H9A6&18VA4#N!0C&&!'7`5J0._['O$1[7$X'N`U
MYX@_<DHH*,!.T>("_M*K,X9#)[HG`!UM._B/4O:2/#N-;Q[+*,A3WD+0ZB[B
M(@3$R#*E/(WV5R#M:,D3)-7&62;P`EWP4'D"*1;``+X*I^`'6+N%$Y_"5+%V
M??J(OD*UCP[U.H>R:QV5$PE`0154HM"6$^$V;H.F;+>6$W%%0[FV;N,V;[>J
M;[EV-'Z&4Z%"*#SU+@_`65**RR35+1/@`>P.FJ@F<9$BI2```<#0_8`B<WE#
MG.HG*K+('CG`0C:"2G0#-M8D/AYP5/RJ)BP@B>SJ4M<4XKAI+MS46C#N36=K
M(6J5'&6+NKJFZQBB#NO#*0)`.*AK))GC.:/,`)IS"UWR7T#2$3]V>I$T_@.:
M-Z8H-:>^$N!Z9`(08%08`(*^L`_#Y*AZ;CA44B]JUT6CS.I<(E_C-1?-%,8,
M358.[:QZR'M7A#U*HSB>@J>`A+G\94PD*CN.!3$#K`-6@B#$R02W(TL&IS#<
M8B&>KD3L)<'^*4<B)GMLAP%&R"-`&#>`B@%(N(2[B(1'N(15&,L*0`%6F(0M
MB@.A0P"`BK>@(ZUF.(=U*8=YN%MX>(;),2;T2V@RP">GR8YV=2Z?3T(XX`Z9
MQVH'("@\1H>:AS8T0`(&8'!2JCX"$6+]D,CF`BY2HH_$YD"3AO$20*VP[Q$!
MZ"(HCGW-2X26>(@\8$<,`,M&TI,2YL<\I$QL_H],)`]E+*`!9*(D,,CD&@)*
M!ZK`I@QE9.7S@N(!8.I[TBBN2()D6D+-0.\]Z2T]3`)F`BEBD$B7+A5/4O`!
M*:9:G\(MTX@#?HO?:DA7HDB3)20"./("P-A[.&>!5*4"KI=Y,J)[.&9`XO4"
M-FXB2H-M_@)BA(H`'J""Z08"*@.URL-,R_4[/@9&[41T]`7.5@4H`<!*6V]5
M@M,^_A<=W4>!#4MERD>AV(9(@.ICD2Q*),I+#L#M0.V>/:4M48D#,G9=A,*;
MYT*P2%$`K&-IJ,^$`N,DC<7?M`Z[6'*^7,U5W*8P9VTQ?S1+A@,#1/1>A((,
M6_ASOI&P9.Q%A,@H_B0`/P)*4[X0:GZ'E5;G*WW2('"L=05W0Q\@`S@0+0S#
M-7^&EK6#6.-U2`;O8+YJ1KWG3Z%,BZ#,-8;#R0R@`0^`A7(3,?7,;>`KLHAC
M?-J5*U0M?C@%7,[F4@%'H/!"=**H=D51+BU&+N;IH5"'?>&-/BZK`&AC>=K2
MH!9GG7W)+0:,7R@BGC_V:J`)`VHL\:1S+@W@,*ITH8<"`THJ09&BHW4QIP*M
M!<7B`PH`A3(M5CH"A3:I@Z3LJ%(S?;VGI/C->Y1B$'OP\P((QOY(["B$JB4B
M\:J-+(0(0BJ+HZG/@!1`STHJ.4OZ25)KHD@5`(!*FBEI1B;"GYZ"G0S"_GOG
M`_#4Z0O!3GWXBD3V%0@;NLX$;;'+)TS@B=X.[BYFUU4R[:C:DIVL+&/[4+1R
M62(2`DB(IE;V)N82@EY=P@75>D*<@C4-(GP)0TTR0D2L2#O`L#X:0%E58N,6
MAU]ZHWG)9/ML"3;M>HYCJ@?7I!UY`Z5(2#0((HM?Q*"9<(S>0O)2TSX"<>4Z
MP(H"I]J^(P+L1F`]8(R>R0$,TM\48.+HZS=TJ@!PU"`N='EZG!87""M28CBW
M[VCD*`,`-=*.CS\"@'G7:BWH)@$92CA^B.X:3[<&0B5<\Z&"B@G=]BFZ[SPT
M8\PL(`"^Y.PD&:/`4E=F0Z':XF@D+XVY-[JS_@6V91,!#&L#RLEEDV.%R,YL
M@OS>#*`J1<LRZ06CYV+2D/I>$K!=3:*J[J.^"2`DUFFBYFPX7/`JVX6M&2)]
M+?!.M^FW$7RFAP/`6F>HLN,"S*+JY$-#GL[?=`5VR$*65(4\R*B!J3>"#*XY
M-!&E-$5S#"VQ)Z!URO`20P1<!/I-TVN\#`A"UIP!<#F-%@(!>(0"OJJ0G4E9
M&Z`NXPT]&8",()`)@?=>O!<6]P+G`J4G:#%?'0#L#`1U3K$'^8H\_\,CK+=1
M*N0_E%4`+8#6]@.WX@V9CK0MU6G`B*4MP.--=%J7-'E8V@Z/Z,=;KP9@M.X7
M5<V:J$N+F.;S_&0C_A#+>XAPI#I`+1[Z4AJ`F'.$8E:K*<XP113*31'+VYW)
M`6C-2-!SY3/G"#-X7P]+EG#%E?BD?@UFJH5Y0NPJO##:/I?"U_B'/@K@V0N"
M-"XQ3=Q%W@R@-A)`9R;`LS^``:"X.]I.6$)DM0P%3VZJ>$%6)]:\`A($?A4@
MTB3`HTCS10*G`AX`U6G8I9JR.#XQT`*1`/;DB6"-)#S@I*OV;03L`>3(`WU<
M(H+FT`^KKP_&N<:;@0A%Y\M-KAA)(IZ&JIG0`+P):NSZGN7E`8+S),*%H0Y7
M)CS0'LW&BP#]`B[QT+;&HQH"TBHL4Y4CQ8346[X&L,B114@P6_B/1\4H_J3+
MI\=)JF*B*M%WHE&:MXC5+:3N61V_SDC8APQ[$,HR+;[GBP/]BW3&S'MDPI_+
MQ4%3*`(LPF(]SFU!W3Z<@O</@L_&W@7KKSKR'"`^"!S80,'`@P@_+.B@0(-`
M#@46#'S@X8."#`@*$!"X88&'#A$&,-A@H,)`#PL25$2(4L'*#Q,`!$A(LZ9-
MFQ8&*!!`($*&D@4:!#"`H,-`"`<$!M7@022!"@<B0"!PH$("`Q2,WA288,/6
MKUL]&`#0``,`""P#9!#8@<,""P@Y-$C@D&:#`W418NCY\F"'!P<PT'0PP`%-
MMPC@TJQ@H$'?AQ`26-#J-P(!#(_9(KC`H::%_@T8-E#^T&'``0$).@N4$```
M@@V676H8,$'O``"X"3C`<$&``Z)U$P3PZ@'!@`6J$2(P(,$HA@-H!2Z0D!QA
MA@$)*%MH\$'#`P7-$W*0\$"P>`,.1M)\0(!!Y@\6"CRHR<$!`8,).T`8X)AF
M!@8$C'80!@J\1M,&&>5UD%C078!==6(]D`$!8Q&PP`$.++"`5V!M!0%9-#'`
MP`0B;E#@`PE0<,![!TV0`%@1+$#520B8)T%%D6UP0`$":2#!0!$8(%<$"R[@
MGG@(<">0`C)UZ.16/E[P$6GC,2`!!?T)A(%Y%T3T000(..`!!AEA`$$'/B*P
MUE>!/>FF0`P8<,!8_HH=5$``>5%@&$<,%$`!?1*HE)]]F-$$`6J95;3!GPEE
MX-M['#RPP`4T6;`<APA%($`!F!ZDP0("F-<H!!"P6``$&_3UH4P!U#A0!FI]
ML$$!M^%&UDM,_CA0!PMPQP%N2AYD@0(4T<103]U91T"-?4W0@%`/""A0!`$P
ML%@"!=16J9S2?H"!`0ITJX$#$$BP9J8'/%#=2:`ZL.X''ER`P`$49(9!`WS1
MY"("$AC'E$"4PJL5!QX0?-B;"#$9[$$;./"``VMUD`$&#CB@[4V1@55!;@PC
M\.>1(WZ4W0<<1*<0F`/HNNMW[W)`KT!CS83PS#3#^QZ+;(I:\TT)`*#`_H<*
M<D!!`'62;(`'&<0(0<`(->#`C9G)I2Y->FK005\>4,#`P@=%4``'W4X+P;L8
M,.#`OPAY!W%F&B!%'4T79""W?T:UB9`$M@IPKD`5+(#``F/9*I.1#"!`X@%[
M;T#AJMQAVH"&NF90@00,1-#``!!H<(!PY';7P*GO.E"``U(F%,%VJ2)$`6P/
M=#H0!A)L8$%F'3B`0`7O4;``Q`EYYRS3#,<Y-4(;-/`W\`/)E0"JXD&`0`0,
M`#"=J!P0$(``J!&`/?8!+#"``->OI3/",7$-GP23HU\!!Q540.D&[5>`@?SC
MSP66!P0`P.-!'"0@@0-&40"C#(`YQ96K5PRP_@``QK>D`+P+04:IT,XF2,&9
M[::"-NF9`B(`@#PMP'D).<`%VH,S%O5+5C21@$<RT[#=9$9>$<"932@``0PH
M:"`:0,#R]*6G8O7N`@U`GD`\$`&\=,!`!ZE``X#U(2*QQ8:80Y$"$J"``PA.
M(E\*@*@:$)G6@`A.DR*>!SQ@@0>\#5ZBB9?U?,BP"O#'/QIY5W<"<+&T*6``
M#"3-5`JE%P8(BB8:2("[:D*!`N`NA02H5TW8PRCK?*M4-E,=`@1'27I-0`$[
M48#K9K9$\S$`DPM00`%D`@`!A/*4!"#```*POZ.\Z"MFT9^^($F!G?Q'``#P
M28;^!(&4"$"(.L+B_DD\]X&>S0>#R$PF32*01PPV)9<7Z"#)'H"`,5IK06>K
M20<FH+*$D*F9W>E61YK9/B$.)($VR<`-7X6LPQC`G*1IP)4F<$EF4J!>M;P1
M:398E^IY#S<242`%,L`:(E%`2&D+0`WKX@$&""!&70.6!RH`EY=0#)0)0`VX
MPJ4EWNSM)%"AIA!5U$B:L,@##OBC7]C'@'5^`%8,D*-`+-!-AE61/GYK9@82
M<(!-OM0`Y<E=`1@`JZA0H`)'K4#KX,54#"K,31[8I,D`5@`9/B1_`DC(&!<P
M@8_T10/PQ,``Y,BO71D@`;C3G$S&R-:K>35L%+2J,A/RO[F>Y#:G`X`%_C!0
M`%VA9%<=<8!/258T)TW4)A(H0#/95Q,-F(1F'>B6!VK*D@O<BY*8Q>R>")*_
M/6$@`*MLY+>&Z($)&&X`-\36^(#%JSI^`$62F@#INB.ZE9B1/G\S2@*`U[\L
ML60KT,/)5`_BH,?6)`$?39XHCVFZ":SO,)81TWH&8%R6E)92L,H,!`+`W=94
M(`*#==,#OKB@"D0G4D;IGP%<^X'-`DP`<BT-;AKIE@-0R+YSTM`I"T=%_2I`
M0P(XP`.KPA$.8M8`5+G-];9'@`3TBEB/T]!__XL`3&X0`I5+@!\3H,->)B`!
MCZO*EK:$/GK24P(FIL`$+*#.+55@Q9;=JP4H_G"!%8=FQ#@>L>PN@@&#C=%F
M;!586^2Z*R:Q,L"G.8"(%B"]A\UI1QB:0`1,7)`!W(=$%!CQ!1A`4>?6<HH,
M^$Z.+8L!"R3@.U;Z9)9Y,X&C:@"L]'1`!'ZSNLAN0`.BX<"654S/-<\NLD8!
M-(XM0.C(:A4C9^I`!0JPHP@\P`)2)K2D<W*9T3`&`'O:@'`*2R+`X&8H`$#H
M1!V@HFL.<9*%W95,P\N6#:A'.I1JBP3VFI\[.U&9&4BUDS@@4UYOY0$M70S2
M:M)0]W(@`/`<R'=93,&>F0\D^)F-439FMX,P=XA5!4MKN.O$B74M:&R)@,$.
MX@``C%6K!(8/9@/0_@%,UZY3;'6(U8CW@0LXA`.YOH"^+V"!??M[WY;;&J0=
MT&\)-,!]#FC`UA*@$P8<0.'/VEK$N8AA!2A\.9]4I5-HA9H!%,`X"%B.QRF4
M`.W=1@`A3WG(ISC%OX5\E+9BKP=>R3`O"JZ.),DL;C:3@0U<@`('ML#I:&H!
ML.J;IDY[@,UQ$X%]NU'GN!E`C?E-`5R&&I<!.$"MML9UF+=*Y<81P%P^N1Q<
M#C5,$DC[`QZG@%3B$D/FLJ+T>-T9#""7N+AL3*MJ-8">`Y`T"7R)!`2`.>,]
MR^6T"E/*%3`YW?`K[9/3`*\KT)J/IYSP5FQ-NGP2<K^!C[OR=![:51@!_O11
M,^1F/#T"'B!Y7FN@S/),>]H)*@'.M)[N&:![!RX@.[`AI`.+PK/N>2W9AQ2,
M`QAHBX"FE!]D?X7?%72V287I$EFMW=0#<>\<X4HRK_2,`11XRDN+YI;HH)1#
M$]")7F*$4.(9P"N6`6UOS)T!3&\@ZP?`Y(Y&%X'^JS-VW[4!&R`T0E=Z4\8!
M`XB`%=$6"#B`#BA7S&=76T(I;\8;O/%Z%3&!3;<;$P`!C^8T$X`!678!("8G
M)35$V`<P^4-)$\`K5%0K`/!P"F!S5/%!GH99"<1[_==_W\5,8S0>E%0M"]!_
M<J=SU?(`$:`!.0%U!,!["%@?4(=I`T)`4'=K_J31,U!G`$M#`7VW&@'6)]73
M&92'2\"C`0'6?^46A;9":O>T1&H8@WME67*(`!`P4*!1`0ZP=+^T`1FP*E'X
M<$X#<U'($W+RAC+Q/2<G.$AV`(RX@J24&U%G-CLX+XQV`*!F;JU!%8S(B`6P
MB'3H<&/!:!>"A-`C0D#22CLC?30A3,^31`F1:AP%);BA$G?!`:47%WNB0,%A
M=Y9&,!PF+1K@&-'C&A]@/0CP*UU10[*U5_/C,`X#@Y3D<7-1,9YF=52A/9^V
M@D,A)]SX9-P8<J:QB0[F-$K&B-UH)!I&*E(!`>O8CA#P&5+!&6B$9_0(&_5H
M-5K1+0J`@,26@K("_AH8,#'W\G[\UG8!T``4H!I@M5<00(V[T8S]5D6I9&4'
M@``6X@!*1A36@QX5TY$/\P`%,"Y.TY$5LSLZ)",8TI&I5`!METH3:2L$$!$6
MZ9*JI#W=&!%)MFTU"0"Z`1B^E$J`(SB*%1G8*`!P@3==Y4N=X0%#=3E28BD(
M,(R*&"8DV9%8:(A""5X*4GT(02&"<P`?Q&1JZ#$3\"EOV()(8X@4R!!O6$,V
M]%F&.%"S@97LB)72,Q$($'WDY1?X\0%J\@%NAI#EA%0+@%3V]F:!H0'J]&:*
MN6\5B!L&`1(LN9AO=F<"-$8&X!#7$0$4@`!Y`0%KT5#^^`&U-XP$D`%1_G5G
M`9`:R;8:#_":%9`!W)0!TC)1K_F:#7";#V`2BBF`#F!A__6;F+09@/D`<0.<
M%B:<"F`!2L6.OU$`T!F=C&8<&`*<]E4`@9,;A&=QF'05-HE@V(F=1-$SX-5C
M?(@F;X81ZS([Q#-)I11#&?`P0V4!"S`^A'83<(5O!P!7UT9!$G.?8D0:WL)5
M<M,9""D[>$8:?"A;F"18X]8!&E%*A]0C5929,:$M53=EGR,1[)$24].0CDAP
MWU6'[0,7CL6.SG6;N8EB9D0!P/:<C)8E&L"2??%=;@A4KQEF#P":A/8LNOE@
M%B9QSX*<W:E#/-6=9[8`T@F=#E9ARY%_^@>=_OEG`-BY/!#P.=&)21ZG$5:&
M&R+"`%MJ8;122N9V&]C!)%;&2E4$G:)D=0#P2AF@.WII/O`B*JF3`;E)*CM*
M*I9"*H)TI:AQ%1\FGM@)<7)G2CPE<M@YD0;`2O)A91H1`"3W2P(!F@,A0`0E
M*87C`!MC*XYZ)Y@62'(C-RRFFVOW&`(XJC)E4G;U).P9%XK)F$SA>POR9N:U
M4"H&FAQ@=H2'2V8*DU]Q?[.8*6JA2%]1EAW2`'!%)&C3JJ31%^LB)^NRJ@-1
M<K:"7!CP`%@!$T2Q0!/!*1^@</5!*PEY,6"Z<^J(`5)!&S-S1@?!`!V`3@2A
M9^:F?<Z:3'>FF,8R_D0$TYC]MBX?P7O)MWNV^&8$XU//@6RJ80$9TVQ[21IF
MDF,2"SL/B0'L%5-@8478MZNA.62&4643`!K[:``P0:D><Q(]4Y@44'J2MUTZ
MIUC;>!=R\CSL2$W)D0%^\Z0$5)'_I2%_@V`$\)HN.9(E63%@Z22Y]S"=<0%3
MUB%@A6/M@S.Y]R03(``"*(!E-H#DD1.PU!K,XQ=YF0#@)"S#E4%P91C^0V3.
M2JTV(1:!(TI6]DZ[4FXJT1D@5D.Y5``1T`':4QWN*84(@45LFT)6^`$-^5.4
M$40*=)?WVKB.:Q.*(P#),2:4-3/1PS6N5C%%=!K;F$J,."\5F7\)\6KX_GD;
MV-<!W](IE.(!2E<7$``>6I(=8NL7'R8M*ZBK/B<`UI(Z-`,VHU$13_@1#BAE
M(0L;U#&`2#M1>_M230L6%H!_%U*17D$8U.DWGB=Q?0D3QL,?-71'W=,`J#F!
MWY(!%Q`>-_$KN$%X5D9%ELBZW#<0&]"?VM1^*51,94HA=Z1U5C8`^QN]=V%Q
M"><TC_,L`IR;/V>!`4QJSV(Y#2`5`BB/ZT*^\W.!X(,;G\&2YV%N5DL`+BL3
M1V*+*J5UP)(0`_"^-M$V"`&OJW$Q"E!F`/6X,.RL9Y(IN*$@A:F7["406+(Z
M]V042KA)TL(`8RL00O&F!]&')1>']B:`GW(!_D;A@`KX/P;P43,W7(N;O1Y0
MD8JV%<XB<5SW+">X>T=78XY&8^,#&F.\;\PF'G@F@&#C<X/+/Y4++P1C,*I!
M=[5WQ+R6>U<C(Q73`:O32_VR`/')83*T`3NG<]%C3I;U,]<G`!6JD9M3<E$9
ME?IC9?.B/4JV$W,2-[(G>V`"'A+@//G7+_[SR:@,;&GG-W."8"'7+R%'12I'
MI:7T/>I+>*5$%+%L<R3+5Q7PP'=V`9U*IH(CMBQV9Q:R$DR2OC3F;P+0%J_1
MQDS,NX`D$0U8-GQ89DT(-D(L`;>QCZ)QM=(<QR2CMC'LN!Q4PB!505D,`/#D
M`0WQ<T;1AU<3%_*K_C=?L1`BHCKT1"M^-$4#H$,(<#W<56%@.47XS!)T>!!X
M`P#=='\;$@`*8#;T9"4/L&+,>4\:?26@U`#,)LRZPYT0<RBM2%PF=M)2=B2[
M\DFONQ.M,D6N4P'_A8@(`#X"("><5CA?^DG84UVR\J6GHW`Z2IL'X%RC<0'O
M2&C?=Q..PI-B"V@?XD#N#$A`=C57PE9>!2^K>S5&Y%:`ME59XS`[/=9QHA$[
M,50[35&?\2H(.!FDA:K.06B8X0$:L+**>4\_EU2$%C$;@$L2\6(+T#T`LIK<
MA'^8-@%>U&!4M$%1:1&MT8&X,<D?=C3%>!_(*6`VP;=E,X-O.D4.!BH<_A9J
M<L>25=0SV,)=I[T]-KT]"V;3$OVEV%*VAT'65K(5'2!TM/V.CR9I&$8>:09^
MV^$^DS;<,T9PN2D[:Q)+*U8PF1I7,N%2\$(`^]*"EC*A)\%`?[D5$F$9;#00
M%Y`4P[0D%%$1S5(4"4%Y3#->`'!M87BE]]1F;?8S"F`Q?O0`*O;>]UTX,L&2
MR\-R$\9RGPTY?:,A7*:G#*`A\3,>O21A&Q0_L7G>]X14J8+5"U):-*1BN`.,
M/\=-8!8!,&V_K`):OLIPF&0!3=BVV(DXJL-N>-(A'3#'*;RJ$B&6C4$J]PW?
M]WW?O>39W4HTS\LJK')6W64]W45*V-E=H&8]_IZZ=/IC%#5='4;2'7Q$:V/E
M,I^250B1+F8Q`'M%`*ZCSGRT(%LAT["6$.7Q`4)2?P!P3>3=5E4]1K))`7]&
M8T*SX7I"+&\!%O="0PC)387K30`>Z'^K$?S=G8%.13<=.+<!GJ@Q105@K3+Q
MMY_F1<,Q01Z`&\F&$B+(+QDE'[@XND/,`0:!)^*7$!A9$UQU7/9*FL[GES`)
MB:X18(S'5#\V3&U.ZPDI*ZI!WN%-Q!HPC+<A$2LAK#J7';19$0\`C8*C2C^#
M5+74/3`G')9=(*<D87V".1%^3__%$]BAT4C5J%+7YL'6-<+TBC$G21U`L@L"
M3M#Q%5]C$VC!>"G!_FHW83O+^0$]54NAY*;KAAO%XE:1]&/D323DK4D*4>FO
M$P!_#D!$M5MPDB6RV3\?\A1VIR42818O/HN_CEQN<9H)!R]IF)?%R!LTQS`_
M,E:+2Z?G/%<";UBTOA(W8S/EQBGD;8LG.#.7WN):U1T8FEB<\5$<(/+O.L09
M8!`2P;?2A1#LX4[R2QJGLAY'T]=>Q*GMHP"F-10NG<@2K2&KA.1(;HP[012X
M;-F6?95`+A.&[G5,+A/R=$]`"'43CM4JI',K,N&DH>RV@A;G`A&8M1&7FFH<
M,)KPXJ:-GBKE9I0I6#LL@F%;T=>]5A0#X!7/.\,=,B;@,5FU00!]D>X>_C?$
M;]*9.['>-E-+B*TD!7-'@J,8\'PTU+06/P&9#B7P8Y1MZ2%T6B<I:^<S!A%-
M5^I$,ET`JE]2\#I6G:KR*W_\;[*?"5-30D/.88'IB\$8#-MI$$`4A247H/X5
M0>OE)'/Y"0$!.8Q2NC:C94M$%T8Y*D4D#7`Q(:&%%9"@SK,09A8@DWMG^9IK
MB\F'>#8AH4*;=P80&31<L%`00X8-'CALR)"!8$$+$QY$:`#`XD6,``@0*,!Q
M8T:0!P(0,("``,B+!!`HF-!2`4H"'V12>"#3ILT(%F[:[$"`P0"+`@)@;("@
MP$ZD.STPF)#49H8!'9QN4)"A@`>9'28<@(#5_JE-"@402/TPH8,%`!5N=O#Z
MU>W;!@<N2H!0P,(&F1H$4+!0("C&`!"R&A@@H:T'OP`",$!@P,"!`@LH>/"@
MH$.'``<##.#@04"$IA\H(&C`P29+FPP$W+0`M,,"BPS>SJ9=V_9MW+09D+69
M`,-."[]S)_6@6,-;#1,O2WC05B:'!D@I7)@]%(`$F8@C($5\/"L'\!D$9$C:
M`8%@I;`G1%@@P$,$O-L58)?9P/O1#Q4,1,#`P4!<"H;K8``#AG.J`X(N:("!
M!")3;:@`!!!@``H-@*`!`@+04+&,K`,@`91"!"F!O`(@+RD,9.-.J@P8:$X#
MBA)8$`$!3%-J`@\T_@A-*@_,"]`IJ'C;B0,&,CA@IPP0.,`"YVY::H`(>(N`
M`[06L&F#\QY8J4D#;8(-(P%"L\F_DPRH0`,'`!!`@@!(I,`G`11P4H"+'I"`
M/0@(.`"!Q@#XP`,#+MB@HX0$:,#*[!)P0*9!HY-)`A5[,P`Q"PC8KDM,,]74
MP*AV.N!$FRC;](,.+!*.M@XVX`"#"%J-`%+T6-/I+>LBW2"!"IJLH`#O(J#P
M)``&.'6M`H;-3@$[+0B@`P/(<V`#`FJJ3ZT/'.5@T0\P,!8W#PZH<52W$!+(
MQITVP&`##3`8"(,+*(`O@X,Z@!>#!AQHH($'+I`(`PD:N.`"?B%P0`$;_BM8
M@$LOJ=MI@J[T1%2FKC[88#6D,/.`@@`V>)/(=`E0&*D@IUK`2*0X>$"`W92*
M0($$A/S``0XN`$#:#R``@#2@?AP5K8OHO-3)`@S`JRP`(@`1`&]_FV"\,2\:
M@``!'&`N.(`I:/:#E2U<(`$%#H@`@58;B.``;.L=(+0((LW*L@,JBQ5<N./6
MM+GG%B([@@O(R@#'33<8@.+:.!`X@8T0<,`!`N3<J8)9W:KU)JBHO<F!!`[S
MFST!F$1*`P.VM0"!"198%H'C'MC@`)HQQ*I`B3/_P'1,-1A*3'![M"U'R>5V
M,N*L0KTL@[=GV@UJUF4Z^`,+%$<*`0\>`,`"_@EF/D`M#`@P"^1.DZ**Y*0X
M+V`R4I/TR>6:.TLKJP(*,`WC`LCO,GJ+VO?U5`X8_Y`L#";]`,0%ABYK``MT
M@$@7L9"CD#*TI3!`(8]!%Y\&QA'R:(``'<#``+I"`;7)Y``:.(H"@J<[$(;0
M+72;&$@N58$`Y*Y+I7*/IJZ%%,95)S;E,IQ2*I``TR108:>CG4TN8,&=:*`H
M`4#`!U*VJ`/0IUHGPM8&*B`5"&Q'`^Z;300T!"IP9<"`5;0`>KPCDPI\D%'#
MT4"D*H5##R#@:04(0`\QF$8(*.\#"L`*=)S2,@0`H`$0$`H`O+.!/`4O`Q.<
M2@*X!Z0$,"`L""`7_E)@AA9J/4"!8^H<N.`'`/Q@20.W4H`&FH?)XT#K.'G4
MF4SREP`)7%(`"3C236(&@0<P3`.SG"4&"C)+@:BKEE?[@."XEL$/#"`#\E&A
M"(UYS`\<;U`/<`!0`F"7O%S/A1;Y6)?L")Q2.@4H``"F!Q*0S0](@``8THA8
MCL.!`BC1E4O:B5\\MK_?6`EU-C%)`1P@@`(\@&5VXL``_-*`H.$&;^>26XMN
MLX%+#2L#C=N)&-_B@04\S#$"L!*Z+F``3#9RH6E$`,T^<)7\`),F*-/(9B!0
M%^=PP"@0\,X%2.04#2`@`W+4WC:QB)0I888^$L"63=@Y*IM9Q$0S(9`2_BM@
M$0(P1#$T$@`!3H6F"7"&9VHBS4X(%S3'8#5H#&"``;#J50-8)W@7.`!-/]K4
M!Q2@A\ADJ^Y2=I.E]30_"!.01NAZFQ<"9ZT[>8U<@/DG:#J)`@)`G0,.8("6
M[J4\8PG528J83)DT10$_8Y6_C+8`"#"@K,B#``4ZX"[<7,`##O@9N*B$5_I8
MAC9;7!S"G(<H#5BI`FISZ0%*R:P*+D".`3#-!%AK1`&<%`-:@4`&EF*5AUTL
MCPJP0`*R!T,''!)%T3(:`1JYD]+(#%L2:!M/%#LJYSEM(W32R$:"=A$$?"E^
M4%O``:#V3#5MDZJLY0`5+]"5"C@``1_C0$RY_M0!!>3S1!UPP%1+VU8$PZU]
M.Y&``#RJ2"KB)@,``.=P%`2R"M]D8D-94U(J8%VD7"`"'D"7<R8@M*2,33@3
M1II,KN99KA!';A"XP&3EAM#;>*`!6*';;/XJDRB!K"1-K$D%;]*`#0"X+:4:
MR:%N<KS9EN>ZV>GE34D<EP-T-RD9&)E9LV-8:GF@+@>V"00Z8#/T')7&#LEC
MA'.3Q_CEQ`*;G/"Y5*4!D6!DLJ[ZS$+,%0%F?DD`?&KHL`3W@0L(Q3(4T.-:
M$O<T!?SJ;T(=@`(<T*:+%#/!8YHEP#Q-8D%MCET$1>8"7`8;!FA@7HF\ZVT,
MNBDA(@4#>]T)1@%`_A@Q8@!T2.'C``[P4IOHVG\WR=-O6+S=]9V.S/<\&U\^
M`+Q,04`"-H[;!G[L%$!-V2W7)@YS,_N<!%S@`0$84^7":6Y2620"FTS*A3O`
MF#T=MJFDV1J#&I"`1,:[FU^Y@");Z:0')("ASX%`)1?F`9D)!^&VQJ1A()<@
M@`U[-@T@;P#4F2V!AVH@%C!`-ONMPO=89``(`+;Q:/=N4G&0>LQ;RWPD,)U_
M_2L#X&'7;"60@?!>?-,V\75)^$0:!@TLO<Z=D%@:@\]6;^JSCM1(T%.I[>$L
M=%2'MN%L@!6<``Q<)A<@@'.L,FX*"&LG&.@?=PR;(W5K$(P?^.GD.@"I_L.]
MKG@&8BD#JCGU;;WEA(&[C7D\\.IP!L6']/$F63P#@+Q'5C8<.$!+)E#?RT3D
MB1VH0`92Y?@'S'TV&["3YG>E`(FSQK:+>QWB7=D2##A'+R`A@%S=,MK$R"6;
M&!LX"@GPQ>=\ER=R$0MK"[P6]"`4*Q'(9@=*3IL34WCGLMYQ6S#@@%RU2"T9
M<,!PO=(\U^LN`\=_W0"XC2F%3/WNQGL+BY^7GP7SFG86H$X%R+8M"#PW5//1
M@$40A>+H)!$I"]C(!!!G1,W+#6E#`$W+E`W0NK>`F3_1'0CX#0O8(C%[K"6R
MB0E0'$`!@(=!B@D@$<[;";JY@`68DK#Z-Q>[_@V*2)Z;$*?L$S(!.)4&.(OS
M014*2`BVX`#N6@S:"#"+<``^NJD)X"V;J(`*>(FDVCKC8@`_V@D.JZJ;R!LG
MH8\'(`L'<!D"PXVC*<`$<Z*=,!H-\3X`H`J3V`F7.B8-&(!J>@]GTA`U3+S<
M@#K;8!4%^(^DR,"DF*I92;344PK7>10Y\8#H01C]XI)N0<*+Z`GR.X!M60"Q
MD)B;B9-,X1DR>PNJ4("*$RI+5(S'4``%$)VGX9!;PZBA,(!-U$3=HH`XTBW"
MTJU1I`#HPXH,H`!8C,49[`"0L@!$X0#RD#9&P8_L`!O`*IJO&)!>>IN*(#%[
M&@`-,I85Y+<&Z")3_M(3-U2*/+&1`$%"!+R-#Z,-J$D[Y\G#U'@L;YH`8-&?
MF]`L(0D*)BPSW/-#1+NU9AR`)N&`2'0+.,-"!".[I#B`SF`[SR`,,?0H$)(@
MZX"0BSB`2ML,@E&Z3;F`,%I!D/J*$@*`CTDT^>NE`J`6#J"`PR(Y7MP)Q,&]
M[!@LBY@4A3$+_?.4'S08],(`\!D.#+`(D)P-V1&("U`U@:"E31J(AA#",\%)
MGTR.CC,`Z*L`"8BH!F`8GJR`<8NH!%!#-80,17P,Y=N?6R2,H<(:FJ+%O[._
MF4.1`L&YG:`C,`H0\V"Y7KP-#;"`0>(N!6##KY!'!-@`4V.T8E*I\<N4_@'`
MLY;<``-H)`^H@"+"K&"J`#KYC-V),8D9"0=@``/J(CWQ(`IH">(#-'U:#Z[A
M&KR)@+Z\C7I</N"@0^0)C0<@CZYAK<AL*UHBL0P!2,]T"WE,BHY,BHH8"G7"
M`-VS"0F*Q*[*.Z/YKVV2P)IANVUY/)9D@'ZA"3:)R<!)GVCLGMCDCJ0#&:T3
M%1FCC6_+"_]9*%!),NF80HLH*T**+,7KI0,SH"C,B@$8-A*\":/!-Y+#MP)H
M`/A1*X8A#2UA$-!@F)8(H'_A@);`*`'XK!@,E;B#FPVPC@H0C@UH,!5JK]O[
M``*@B\SZ0A]BQ0.0"@90')XR)0SD*@8H`'Q*_B0$\%`2]5"H$8K?"D;KN$;:
MT!$<B8@%,)TGLKSLN`Q2J8`)4"$.`$TD^Q/!Z#>^3"E:.R8D9,U1<3/<<("[
M!,TMI(L'O8G\N:D/X"!^D<\$X)-^,TOL*@")*Z';5(MY^A/P:,XNJ;\DQ,8`
M:#7IH@V242V9L#NG2%&9,*Z\(!U,Z8`&>$D,C*.;6):R.`I`VHFHN!B"X1?G
M(9?1\K#%N!?&O)<'X(M!B[15NI<%H53&;-0NG)"GB8OV>4D5,ICHE+`%X+JC
M+`M[^9O<X229&(`SF:"N4;T"D),AE(E="R>Y<@ZVF%()@#I3O(TK[!)O"8![
MVPR&`]&(``H"(,S-_G`]AO1(*)FV$;6:]ABV^]HY#K`((]T4,K6-_4J*[XO+
M!\A+7GM!G,H0BR`-"C"-QDL*=,H@J+`():H,S*@MAB.MPW$5?,W7*:D-^-&Y
MM\`,Y0P5%@62(RFE=AF3MIC'UR&+\]24-%DE!G@;(-P*B7&]'#(``AB`!6@`
MU#@R#[NV8<*-6:I#Y!G0/UD`!]BD;;4-`^B`<`V0A."\<"47(FF]#T``[!"N
M`'!34VJ\E:%51WD`AXJ_TJ`0I@$9AW**\`K8'(P9`V`*F7"`"1BN`[B``)B.
M_Q"`T'NV;,J`?JF7>J&2/,6FG2LAUT-2V[A+`TG(Y:D82,DR-2G,PSH`_K$Q
MC:\Q%H2;GC#:H^=0@`KCLM(R/YU)(T"A",<+#@I(I5=)7.*;`%.4`,>MP&Q%
M"@GP)[1E,.#<L@"<"L'`L]-RB@-`H"$5+9F(5098@---7=1=7:Y:S(FH`(0B
M/@C8@(KXD`FH)C_MEUXBB8U<B1%E7>`]74)#"N@I#S]46-QHBJ.2'&MS@/9P
M,*HHB;^,6&S1+SZ96P,X'J3@"`B!V06@%\3)+Y5""&2),0!3%_[#/0*C**E@
MPHDH#R7MU`[0VNYATJ\@1*:5Q.V87Q"UD@18`)UHGZ[K104,(L+BDXA2DO_E
MJAA=3-15`"7Q%GL,H3?AB$9*6MQXHE&QW\`@_HL%9:,"*"YA"<&9<C"1$";1
M>,XI90#P,$@?`B"G,),@W*8M@AD`ZJ%1S0H>D0#I;<()+K.9R0T,^E<VU&"E
M6!)RW+^AL8`,2Q*OD!>#B<\'F&(JKF+&3!\LSF+K8`_:&:K%_!.;W!O898B&
M&*8+<(@(4,K1W%KYK`NP\JKQ&M+D?9D!?0!$2=EJ*8S]2(#LQ8]8/8@,>-JP
MD](YLC4ZT0G3N`RCB:,!@#X,\(L`$-JQD9>..([',QZ-,(F@_:MW^\'C>!.$
ML8!E=(J?.#^7K(D.\!H).`[^6Q0S'&"9F"PNX2"$L!%<3&2U]%JUG(Z&P(!U
M+5MV'95>74@NF;;(_C"/H<`5FS@<H8SEXYBIK+O92"2[D1LV#DC6Z1H:!O";
M(,Z.'5,D@+Q:P*H)S9P``&BDVZT-<X9EVZ``^PU"M14-+,*+`<$`+*P`&['G
M`]$R<$&7.0O!/L4*Z-,=!>@WKCCC"YFEE5TM(P(`4&&DTM6)(D$>ZAV8^O"?
M"=`)H=V<I;&(OBA"]M23E_P>E0H``X@E`>BW2RN0!0@-:%$34YYBIX@`-DHR
M!+C&8:X-N3!9W/":7PNL[UW5$Y.`V8JJ,[ZN"W"],I*8C&V(O\DFR%V^1W*.
M'ZX-JP$J5=$6=0FF20,*U'&.^%,,</L-'0N`FDQIX$B,>F$P+DT*"(C+_ILU
M/@280:Q(Y=R\./E\T^@XG?9R#@F(YX8"`"][BPGX/F^<#3&3"9"6R8!-$A"J
MKV>Y"=;Q%]U1'T4:$W^-MH;V#I1S,;RHBFPY%!Z4E@88@!\!X"D%S0JP&E-!
MDQ9T$E$T9S-+IJ/M+#"Z/>YL:,'.F)E@PRIDCZ]H0-O8T0;P4P/!,X)A`.%`
M[8]*4(PR[3[*(&>$4EEM``JXMP]C+=#8N6XA`%.[B9;,E#>18[>P@#TI@`08
M-*#(W@4`"O(J`$(^%(VXDI8F%7%4E]'#S=4VF.P#P;PS&#Q+)@I`%JDP#[^Q
M[2?[D0G`CB1A`...+,"^">?)7-HX3;D!O6`4_A/P@*DDWI31:A&&Y`VR>E/D
M[9("Z#>=<3:WB"E)XY."#FX(92SDZ2E]3*:::`G24`!'&1FO@(!9@6CP%DG3
M>SL4JX_KCI;,DIT,"1"5:JFSN9*3$(D3P2&G<`"AK)Y*<ZW\';NF0,8NT1:`
MV9;P8Y0"OV7L*J;2F(]K]2.<K;6M/::_G+(,$V)N,A`!ZA%:3"?P":^YN",(
M6:>FZ*<B$@_E-)DIJQ3E].4"<:Z/2>5K/JFPI):HWFC.2,$([PU,NESP'MAG
MV_*D2-=@).3RB!M`X;*Z^)AN>=.JS@U]O&PP*O$I'=/^*LI;B\0I?*Z_]A+3
M*,,!R!C=@@W2("+[_J@6A9&IQ0D+4UEFL:P44L%PY4X+H9#H?WMDLC@J;D+$
MJ#T3F5N+?10@46<IVXB(#P"<T`*6KA:`DCB`]C!:=O^;D6ND--;`,R-J`JF`
M`6"MBF2K^H'U+HF`.L>41Z;?9<Z(>23$F'`E`@PY[(BH(/R)/E(?XGU2X%B3
M`/AN;^XG!,<)A;F3UT'W`(6K2S]9VLV-G+A?H5@,]"8`"EA@U?#0M'(1`IL/
MB!"@@X"(B#"6W-XZAC#0*=4++$*49M0=Z[H3"S"-_C`0G/,R):70.55.//\3
MA6!)AL$WM2CZ^@B>U:Z34/G?-/H1PI0`!'A)D6"C=#5KG'@L/<U0KSBJ_H&4
M$'SJ&L(Z4;>7D$3Z"4\/MJ8@M^$8F,M@"\IS/&V9/`$2(%4S%\1Z,BG=C23Q
MVP^UN';2]+B!,Y`4=3K_OK=P'@4`L5`1W/L5JLVQ.+3H0WLB%7-WW`9QZPZW
MB7[MG?(A`$@_$+SH$0H`R5R?C6LNRMS`EZ^P#OFZB*-!B0@!B0T!_F=2`*=4
M0PZ9<VY1'P6H@,`=X'#3'<X(J@UQ/2:^4YA)T_+@20I(RJ2DC@SP?MBM%H#,
M>C7QRZXJ'D8#Q@:[(.O2IS'QM?:^"&$W/N)+B':)W,CL#,I+E]D'B`X8)BQ8
M($##AX0*%S+,X*`"``X,)U+\$$$"PPH9/FBH_E!!HH4%&!D^0*C0`8:)'A)6
M@+#!`X4+$PNLK&CS)LZ%"``$V,`P9<Z@$0`P"#J10P0"!#1X<""3(04%&RMZ
M*`#@*@$*##E`H``@0D(-"AQ\\.#!0H0&#C8T,.!S(8<'"MXNA&!UY(*R"C@,
MH$!@08$!`90N4%"X(`/#APTKR!JT@P$,"HPN;/#`9H"O#!9<$)#@[@,`2@WP
M-#!@Z-74J@4[4"!AP@,""A0<2!U@=N:K%BCG3,#3`0.)"9$F9/"4=]`!'!@\
M6.D!`UB%'`YH1;YP`]F#"ST02%"80(,%EB$\(`^AP@0("QP\")^X@((!=!-V
MS3UAX@(&+\M^Z-"@_D,'%=24P7\#.-!``0*HMB```A#0P4096-"!!`HT5V%T
M##4P'TX;Y&82<@X@`-<`!W``W@('7```:1-%5A<#["E6T`/L41`!!3=&4-X#
MY04`H75!,N3```,`*>1-7D$05$T)66!5AF191R!6"@!0`4,>#%5=0CW6Y`$#
M`G"@90+"528?25>-E%('"/!5$0<;?!16!4]E4`$&9N9THHC60;!;1;=)L.0'
M&_B$5)-PG36!`AY5(`&$%`@&P`!6!7``6PA,,,!.""3(``,99IFH41``,)E-
M3B%YDW(,<,G!JP9,A61<'PB0Z'04F>1!!A)(!$$"@"J4@7@3.4"!5902_JH0
M`SOQ))L"!110VP"&)3"`;0D\(&`&V+(XX@4+`."FAO+UI-9!"8#([+H=YC8K
M;PZ,I!`"0'V`P9*^`3!120LMD``#+3GJZ`0%#'PP!0$(NZIU$C3((<,+;1D4
MJA]($(`!$C29EW4<6.!P7@H88-9P"#0``)=E(6#B!(XE!&8!>B;40`*)F@K`
MO/TE@`$!$1O5`:8('&F4`@LSA,``$TR@00<=<1#@TP!*S<$$PC4P40>782!0
MS7HE!-8!$CAP`$X/%#!T4*8JG.IQ/BO4*I=L#0<PDC5A4-2MUW%<&0`O(6"`
MM!XNT.X&`!1@;`4$_!;`4S!9X(%'SUW`@00/_AP0;`89J.8`VG$I/D!";0+`
M^78+3-=!!@'D%4&['T#0NDT:Y":S40Z(^@$#LRJ@P08(1$`V0P6LNSM5#01P
M645NN8W<3CW_Y+971E/49ED.C$[JWKQYC.UD'B``V`,)(*`@BZ0R@*T`"!#?
M'P'WS80\?5=5!Q;0$@Q`ZO)9?DX[3D7;9!J#`'"`2040>`@@%60B`"$,7,TB
M*.O`X29#`>#9Q#M^X@F6*J*J_"7$`!UPE4(DD,$%P"](4KE7`SP@@*%MH&(*
M6=%&(-`!""A@`@+,8`@+X+Z%5,`KE.).QB!`FG%9Q0`0D``%,@`@7S&`)PH(
M5W,8LH$P$2``PI&`_H+:IH$!:.!J&3"`5B*P+'91A@.S"Y*\CG8?F.2E`?<A
M`(<6@,,/!,!>4('-X9*'-@[:9"<]X6-"'+;#EVT@3ALX4H`,4(%#%K)0'$C`
M8Z*2@`0<(#"IF8`$6C@``UB/`KZQW-`R,(&P22"3"FDA!$CUR!3&3S23&U$'
M$I`!`4`,D+ACD77\=Y,Z8:`"#P!,6@YTD0=<)`(5B(!/"$`[MGCP;@DYP"@[
M8$4#&$``@[0(<!BP&PH4!3FA`5VJI.<S#](L`N94`%@T("4D68`L&/`.`!(U
M-HH$0"%-60D&_)(HL5'$`AA0T*4$(%#PU"@UU2Q2``+@+0!`0#A@FLM"_C!P
ME?$!Z979`YH%>D8!!!3%`:U;7U#XPA,AV8XA1_2`E5PU0084`%X?$)"_8*>0
M!_"O@_BSY=$HA;9K(JF);7-@@QIT@,LI+C4*$D!M>"+3A&P@`00X#>\P8('<
M*,`WT,2`?!Y`D`"`:9T*:0M//6``GG*@`%+2%\X^<)E'^@6G6:J-`7(I3B$!
MZ*MV+$L'O"<!R?3'00"P```P0$V:,(0VA/G`!*UCP_O91`%W=9MRGHH`!RR`
M`!AA'<,X`,L$(#51#'`>0^H9R$$><"'\9`B`.""``8`'`[PBUP;,.C;"-B"I
M\NN/66!&%X=1"I*AZP^:7C8!#]2,IK+RZK!X_M.!HKJT=OKAW7PT(%69;&!K
M4A1>3&^2O8FLT*T5+$``7+I4Y#31:+S*``<R5X&0N#)S[GWO33:5.U*=C$5H
M(98%#N#!U.4%,O!BJ>*VRQ%%3F0#`I`)6C.IE0D@0`*@]6X'L(5<BJ6,(G.<
MB&M?F*%2-D0`=]GH!QH@E<_0D@`8","$H4)!HZ#T*A5(P)$H0"C]`/(`L;Q/
MTQ30@.E(Y",>2`]7+,`!A+PF,3;.P'E>UK6Z,D0#>0QM(`-0M0D8P*G[+*'K
ME**@"37IEQ-LW"8U\(`->,LW$'A(!UY2F)I`)#4-@``$PN9D`I0'SJ]S*@$J
ML!,!U/DI&HC1`6H(_N?RL)2:!T`/!0HV4H58@'=!L2$!``JXP5*Z`)2>=&;:
M!F.;-)I5>_1N0IQUN^6%IL(4J0JYD--4`5#@TPUH@`#@/``/HRM!`)C*!0@P
M%2H_+0("Z*?!)O*D#Z9&`AG0RMTD\&10DV9$R#$,3D:]D!)B8"K5'6-9!A4!
MLQQJ):C;MJ]:@A-/6D=?%O"@0F2<D`5@VVT>%,!N%E!E`ES`V5Q$``$*L(`(
M(,"3A>,),3L@4&N&^K$*62Y/K]84""#`31<`X;0SE($'<$I681J`O9KBX1[5
M*`%^*8`(QQ<3@MO3`%&D>``9%&OR+#2`TJKB`2#0Q)2OYBJ^98D!!#P]_J9L
MX`)+0[(8\_FG"S0Z/1HXN@8RD"@#+%4I[5;(S4%]M&K*[,)(,D`=<0*FI5@'
M:`CX*:/)`C`.Y+P\"\A-/%_HQ@^T]`(K>8"OA$T`Z>UHH4+6R@<3=U-`^B:N
MSY9V79JKD.QA8'(<D%<#*>+S">`)`XZO-@:DZWCI4L"?3#N2!SX][H3F.L8-
M3$#;)J!YY.1%.QC(3P8VH*(+&&#8;'>R`P1`L_"89'`-Z*;,;5*5`+A1:;['
MY`0B<""E><3GO9P`C2''J=V\3K,,98@%`+89;7[``OZ[`-->.H"%?9$"&R"-
M0&E^E<$H!>TT7^U>)V#^E.LKQ5(W%@1^+W^Y_CS@`HVGP.,Q<("]>[=Y$QDO
M;RQ:DCP?<@`-EA76H!B.0,F%JZ270ND)!)55GGP`!\#:BBF$!L#147B+`!2>
M5FP`"76-U)&&W_&&+@E)*L$%NGG``2I$`1`3`PS5R@S5`0S&`-'@4`6`0"U`
M+1E%!&!+!MB1\"6$`B2*U0F),HE)Z!C'!P"._/A6`;10L4D4XWR``C@(4(Q2
MD@"+`!W`ROA.,9E3#.*@@GCAF-37:D6:$[I80T3&NDP`+47`<?S3&,56^.1)
M7*"3.5W`%"&5\$F`.8D1`00B(=;6`N";I1$`#:X';2``)0E4)6'%^^6$V7RA
M^GBACH5&LA0``R1`_D)A3'=-(KV(QO^YC0#V$0'P7ZH0EDT,P)A5@`;LQ$9P
MP%@4%<DEQ`0Y2`)`P``T@`6<!D7\$\1$(ED<VP<@7[^]W[^YG^Z9&`<!R0Q5
M1`:XT%%`2%[!!0=HEN!5A`9$0`*DQP5XBP0D`%U<1$*`'B`=T+^\&LW0U/YA
M``+DU]L5"B<9B62\Q5C`3P8XVTV`B>D815D)BT31603D2>J9W^V$1M1A5;X-
MDJ3,1PL9P`5<P.E)"03(A"-2!+'@Q#6.7G]`2.H8SC:*X@<LP$A^@-ME8TUT
MP--X@,Y)W4X8299`UJ_U(U$TS`"<Y+WL$)DQ0-9(@`6<S/G\U4),E2,V_MA*
M=(NIE:0R+<1R78616(!6*$",Y(Q;_=L1XH1HY<\BH22[)8!5PIE"0$"D)8A`
ME>"T*5E-74>8%`!8$D#&N!'3!8="X$A9Z%I.>,!:3L_^59D$#)'"Q!56R0Y'
M%2,"],Y+!0M&>L`!F(0&/)U*,$``:`Q.,)A)L$4`L*(]<18`6,[HD(05C:4%
M7(!;_L0!V,N8),M5--!0G%T+6D`++D0W&46>3$`#'*8%=!I)NB#_C1+_@9W4
M>4^^S>9PF.)62B,!EM$W!H53@8[F"-"UW(SW5<K06`!=3L!;M,FH,>:#O)!X
M"%#UR02H)*/4213*%."MZ0K295A%8!^$D$P^_GW&55PD0Z3'VV2`!E!`-Z;@
M5M2D]_1C!=26`RA=<5#`L2"6!_Q'72[)?_)17)@1A&Q`5ZS$H>P&6R@`D!S2
M1A#+4&%5!2*/;5)&."X`J3"2GB$`0FQ`A0"<4T)(%0'``E`(40Z+:`B'1Z%D
M<*6;1`Z9A-S,52!/C.P$93896E($IE`&4Z#'V:G/9U`?22JA36AFECS.;EJ,
MVQ483>+$R0#G34!`*.+$S/650P@-:D3H`!"G@VU?F`P(`3Q=!%0,G$G&B*S7
M,3*8P7$$!VG`?*I:;:R?^*D&UMF&48F'L^"/6#*5@?C$`J2$5*)'[87.!6['
M0Q"HO^2(1`B8TI3%_K(M3UQ<0-1Q1(X@A',04G]\Q+&9A:B^3'%`IDUP2%(%
M``.8!#=A@,-8)0?TD&HP`$R((`5J275TDU?D:+VEAGRJAA)ZZLR<2H'QXZE1
M8_]`#@7D!W]\0`9H2P_:$@_>!'%*T?Y5*>/1CBH&X'$::6CRAF4916CTS*94
M#P1D!OQ<0+GB#N2H"%<I1`4<F$H@0'-HR;88`-GX4YU^G3+N:9!L0&YZA`4X
MRJVN%\).``6TQ$.(4`\]0,"H!V#<%DF,D4/D13+^$F<]!:IT@+,JV5+BS@7X
MCU3`BUVJ$"!-$;*^#'A]8A4EE&$(P"?>[&`XXEC(YIU2QIW4R2DYS_GL_A$M
MCM^BGJ-6-<F)[$8W7<!MRL>YC4X%`$>(=<M5"%1"]!*S?`61WD2M4,;^;0`%
MD,8`)$"5&80..FQZG%F%Q"@?E:Q"U"M%R$V5CN,>`9YUG")%1`MRS))'VM-0
MC(S]6&%J2&DG>EN]():',<3%-!?/!!9Y9-392.4Q-DO/<M"*!`#>XI15+L1&
M'>9$'"I_N&1)`AZ)]D>1*@2^V(1X5-X')`!M+(0#K!$SKDH%DN9*^M9-[4=%
MR!Q/<1!Q[89$=>[+0*53UL8@G1M?H>1]V%``R-!)$(@9024`R,3J#D<U#5('
MU"Z%F*!+BLLWYN:$](>7'L!XYL<5[F605,"X_DX$QE7$!ORNU-4;Q&2E=214
MM#U84#A`[2Z$OD@99W6`PR[`K-F1]_QC!GBA:9RK:2%`<VU1>@2,E&B`1"`?
M`UQN_NP(W.UFZIX2@!@J_'3BM."._%9-?T0J!W`ILR"9QE@(LS+`&G7F!%B7
MVU!-ZKBE^/B6!,B$@7:)(LHJVL"$6X')2#B8[HW?NFC6$U7`>@BP@T#(!632
M`R"5GFC``;0/V@4`0DQC-F;C!UA/!'2Q&'-`Y.%G%S\F;Z10`^B?>66CG$37
MY@I)!<C'&,>)2K()2V9C'HM2E8*@2$B1^E*&WDX$!=0D9:"H4=07Z,294ZX,
M2EZF(@I'Y+U44RZ$_@V9FNHYBQ):P$8@W\Z\7T%&,2`1IQPMA`I[G(Z%[J4$
M6HXT0"`JC05L0`;PH1V'1>I"0.)5!&=X10'DV2!!`%AX`*4(Q@#`5,1033AB
MGY@UT!=1B+.%<=A0H'(0LELIFW/(GNY1U3XI2&3@<J%LVA8!`"2Q%*F41%%1
MG58E5&KHUX(4%52R%@'A$F5L&XDF`'*%\ZGD)%.U%!]MT8N.GPYBQ5"%'T#;
M7)6N"*4LS`7HI""W;T;<8DY$&`!^%7C%4T&@E@!`2HR)<Z*9R+J-#.,:`+C.
MG$SFYC%:"08O3P3L&_$R#'<L!*4^$T?2#AD;TV<I1?FQ%DXKA;?HU^*2_D1.
M,``2_:CNR>0TWD:XAI13P(]_#%Y#54R"E@4O6F->K83]1@QW9&=GZA[Y"("N
M?I57N`D%-)#ERHZ"5H6-F3*#!.$%8$K^.5Z[)A&U/MY"2)X%L"I%I%#(G*=3
MD@=BW8_WR*_;2%[D4?#C!>$#T.I;3^!N=L!5-&9$_2UE5%%.A`22RB1SIH:(
M&+)"P&$GRJI3[4Y,BTB[_`[_8)U,1L!N()\.@3+1X?7539N>=.M-F))1'!+6
MN!=0R@SCY438/&<NXT=$>4=2XP3EO&Q_))[(>B'Y-M$:)N)H,(`1V9ED\X8$
M\./P'C&EG-A7D^\OS=I3W%[.+5L%.D"3['!N_B@(`[%;LU[&!*AP?[1T12Q%
M!V)=*FY'JDGP-%<I?W/D52!7=1N%S>9EQCR&!G2P352K7T6JP'7FD;@$?)!*
M:Z"-S*$-!&6&1(2QQ80'W'*0@3(`;,NQ3NC)R#(5D,0T'WD`I.2$`GC??^M>
MD9Y('.=$ZCW<P9504\"2`"WTF2$5+$H7>:B/`C(T91"7O82&"@MS@QP>`71W
MV(TE8C5(HC!F$<Z,-*F&3`0A512`EP;W5L@W11P0C.G0)#6)`PC+(W%=?Z\Y
M_+ZX)0>R4>!O3F#1M8:.(@;`9/&O`>QT=ZQ'#-:;`,3H`R@,KU0&K*$.A/37
M'S-$!&PKF6R%MY#%_I^4KDF^WW<+-I+0[3/-QTM6;2`%.!KU;W$PWFIRM;`%
M0(?G!`;T7'@]1SME"3E^`%QB%[52A`2$C0=``)'?-K,"5I)?!4B#"5A@0"\_
M50?.#)EY:87Y1Y7_1VXH3I:S*K$_[TUT+V6,S(`>P&A6;^A(I+&%Q5RQ^9K_
MFU7BML\,<D4D@)=/Q`64[P&LM.W8#FWDAQBFQH@0R?>(QE1(=X/0TNM"B`9X
MM9YTRZBY\G98P$Y,QK?+8>*6IX)<M=N0#G*(LBW%74X<$$*7>%DPG;%(*7),
MET!7DV447C82W>^([406GLH+1ZY5AREE%"LAB;AU]HQ&2'VEI\KH9\`4_F0$
MH#KNM,65!S=C+LD:+XA,/$IM)R=%4`YOJ*.344!3P,\0B:KOB+O5.Z6;#TN=
M\X9@Y+;,$/NZ8PUEP&:1J!65I493.LM5I$0J>>E$U43/-\@.H51FC-$0Y04%
M_(H&#,[[V1"W>U=*4X4M98U1D*B><FU&?!7$0"B21%Z]>?$'-1R^Z6##H0^P
MCP_@F"6V+`MF@8?/(TE#-7)60HY'78GJ>G6BZ)\0$>4!A`:6\44&9`6?E5(!
MR$2%5'LO5CN83\3^'1"L$N%;J&@&20!+@?K50QA4;CV2R+GL2HNTP##1616H
M3+^#=(>KY.;CB:_//0!:A$INCJU2:,!4+<AN_H1&:DB%R2P(#X:C:D`*=]B&
M?GJ`APC0/D6?\MO$-?[,'!M_10`(0@`$!PX6+'CX<!!A0H4+&39T^/#@A`D0
M#WI`X,'#```.%EX\^&`#!`P*&VR@Z!`#A@H2&GKHT,'@A@@7.,#\T"'#A`0$
M&$C08/"@!),%.#`8>;)AA`X*(51PZ"&!``-`#VY08$#A!@(`"A@<H`'!@*,(
M+QP@D"!!Q0$7;HYM:$$`!X<<6"+]D,"#``\`CD:`L'"#@0T+G-HU?!AQ8J06
M``"@0/5#!LB*#P((P!#CAL:;.6]^X$$#!@X&.I<64*'#A0H,.OLL;:!`:=D`
M#"A(T-E`@`"=$P18_J`@MF4%`APL`+!5P`(#"Y@O<%!!=07I%2@PJ$[A(`4$
M#%9>Z#`=?(7B#79?V%#0PLBE!VM>R&`RH0<(!'37U]T80?(#`1(T#TM@`0($
MH,\`!R1(0*7G"K"`LH<F6`\B#@*@`(/&%%C@@83J^F"!#!3X*R$,(J`,@Y`F
M0BB#ABI88*$,*)",(:$^(&"T$Q5CH`'P,&!`@`DTB$XZ^#S(@``-%EI@Q/@0
M8.L#O3RH0(`4$^*@@`D\"HS)DR)(DJ$-,K2K`0\6\(!&A!+(\B`$3)+@@`;=
M?!/.A29HK(#"#H(13JX6*DZ!K6;;;(`(&E@`@C\W$X"""AB\8+?-BBH`_H'-
M')#/3_P4&*XS@SP@#;\/,')@,P0\/:@#3O_LD0(*)*AT-E$]-72S`)YCP%18
M-S/@@`/Z5$"VV@ZP]=3;-BL@5>HH,`\A34=5%@-E&QR33`%8@HRC@UA4R*`,
M#IC,+M$N8#!9A^"SRP*Y+F+`QL1`Y:Q1V0[8DBW;;CK6H`X.&$E9!P0HB('U
M)B``7+)(,ZA"MBJL38$(*)A`4`F*;0#A!B)P((()$EW8,`7(U$K*#R9@0$,"
MV!,YSI)-1DR"QNP\^0,`0%9(@0``;&Z_LPH(SK<5<0RK4?ONX\^``01H]S@/
M`IC`@T$G_:`!1AMK@+T![FLL@4OIH_.!02.E_M.!!QR@H`%;!TB5@PIX-=15
M#8"%-@,--(*5@`K"!O;$H('%+@.B3]W*@`3"LE6!"0)'$@((&("@XDL3Z#@#
MR6!"P()"`5!@X:4]Q@@J7!=H@(((!O`3`I<P@HD#T6'RP(*%FUU*-`N6U&"#
M#@K20"#07$H5<]-'+]TF]DPRH`/N-%46*(PJPOSTIR`0X-`,*CC@;:X*\#-*
M#R@`X.TP(V`-@:T&,&F"[QGH\`/6`(B)KYL@8*ZZ`II[/X+)%QB?.:G[6YDB
MC0FX`("`/U!@+&UBCP!95D`#*B0#*CL@`*YEF`XXP``6.!UD+E``"'U@(`F!
MB?,LD(`P+40"+A&6_JLTB(&V6:!QGB*(!1K0$PQ\RP(/8,#X`J"`7VU'`-R!
MU`H?(``?ZF9^$I#8#,'F%^Q\H()"&]H2F1B`H3GQB3Z#HGT04(">6<8R4Z/3
M!,@#+)=Q46_1X\P#)`>L+GKQ91]X@*T"`!\)!&``8BS-`OPV-#8.2`!6M**A
MIMB8`00G5K'2#0+0,KT;[J9O0R.D#6U#@`*@12,:@:.L/J2`!NA$(A-8@`#$
M&$=8?:XS<=2`!IA')[FDS)1O,\#ZXF(7,KFE01>1"@!`=!`+;.L##JCE!Q`0
M@=C!Y"4O<0DP@RG,$YKP6\`<9C&9*<S</1.:QEM(-'-WO.-)4YH)41L`_M!T
M,I<I1B8R*X!@-)2`"RJD`G))"-*R4K[-0(UEH+D@MX*2EI/0KB+`9,_Q-J#.
M#?RS=+"#CT`W,,H-7,`];7O//S>0`0L@=*$/_19"7SC1B4[L`ABXY`,F4#@6
M&FY0`S#`=J#'24X*36A0S*/4`%!*=O4,414QCJT2T,]5V2H"M..`L`RU@)KD
MTE8$R(!`YF0KD+QG77PL$>RN![<2-=2+FUD>N\Q#`:+U*WZ<85!3G\:``_"O
M,0T\249VV:!M;2`EDVE`>LR9D`L(\0`#XLSG!H12!$!LA@P80`M#:@`"^)4`
M*`4L(4]*@+\>P`")+4"N$)LK7$T/`9&5;/=N_F98PX[3L)$U9!7-,E($F&6R
MDN6D`=3),@"DRX$?.,`>=]D!`GS536=K3$$**`&69.@"7%((`^Q)D0(<$+@G
MVX!+$()6#F04N28,S05H!Y0,<`X""#C6"U_(I@8TH%*70BQ//C<`WC;`+/<1
M0'\24(#K.N"\#7B;2"VSDS@&=@`*N*L#6-48`1R@`>A=+*2<"`#H_0I0<?S<
M)!OC`+]!+Z@10%)2O?BW845`1("DY0<P0#3LK/%6"%#`<2.0FP?,!"FOA=-H
M_HF!LGY@`P&`9[(2()#QJ8H"#UC-=8]H/..=$S,."8U<7A(9'&.0NC%,;D&3
M*YD,9'0FU$WNDBV`_E[.C60#$BBM-_UGF`H8+0(9P,`Y,Z`O^/SX(5#16[5.
M9J`/#,!Z!-PM"1^B@<L$%\YQ=B5#U-F!E.!/7*$95TM2TF<CA;G/?09S/P/=
M9\E0)7:AF9@#&$T=E:3$`A)X805,[(`"%(=B!@H+`QC-`,/&\6NH'!"!9_,E
MGF+E`XQIC,P:0P`'$^`Y)\E`3-^T@>G!4<T(0>]"AB.UP!HVL;@2]FH3ZT@#
MW'?8&,(5Q!![E<8*.P$1.`#B'E"US35``0SPR[8QH($,1,"VVT;<N,4M[LZ1
MNRG_E,`$"LK0"T0*S08$`)[MXN8TQFC#4982/:=T2P:*QZ^^+"`$)H+F_E4U
MA`$!X/<Z42UGAS_\)"SJ@)&.#'&+PPD!'4,(02Q-2`J8))T-=:AMZ>B``8"(
M`]W[;$4>4(`!9,@!TD5Q!D)HEVH+M\<+.<"?X],V(UVPH2KI7.-$TCB'&AT#
M#U#Z`R000PEPM'&J8OK2J;Y:!E"=ZC=+0-8.@`"L8WVU"G@`;-QW,[,OUF\N
M/WL"K*,0,"?FM)21D`(@@I,.6V>Q_+;``J8GH@8,C0()@,`\%VX8XYF$N`QA
M`-TIDH`J7QSR#U\<!XQ4@1-''O,/V6G).&"CV(U*@PAY.T5D['"B-$0#$,@)
MU3O`@1)E'L[KD<\'?J)!C;O),0TJ+U(\T$/I_A'@`=V6"77@Z`">DZ9`.3_(
M!>X-YYM3Y,VPESYPC;)WII%Y^ME'2.=*EGI=PU(AE%=,!PJ@V^`.8,IN?39B
M7:Z1+T7F:TA<RC^+Z\]F>0`#,=\S1.3C'$9+P`$RJM!2@M$*,`!'[RD,@#QV
M*?]*!@`V)#$TX_8T;[C`8M7:90'V;&YBHP+VK_!8!KPHH@+>3_M*D&64SP2G
M+P&PSTV\+R(8CV46(`!X#LX.`,<X8/\J`JU<D)?V8P$02XU::`#D)BXD@'D.
MX'JLJ)L>0ENVY*8^J^L.`"URY;,40*0:(%+,SRY8(P`T3@/H33'ZQTW0(OU.
M(C_B*`($(OT2*`(D_JCT,(]'/I`":#`%Z]`.[]#P"``"W>0";*2#:DMF/M!D
ME$-HX`D"=".-/(<$KR5R/J##MB.7)`9[XL?-**`H-$!CRO`A,&!#/$`N/@\'
M#X)62$53$&`/[<(X`L`MLNE-'M!-J(18[$(""D`!&H<!^"TJX`/"@@NU%H*W
M(&(E\%`8AY$8W<X5X\3$-DZLX&0PCF,)@4LL4D*=W&/+V,-':/!:'H!!2@4!
MG.*2XL=/6&-(/,5O#@,#4&M3MLP`7H8"8!`A(."($.-Z`@!-.B`'*4,,6W"-
M#D`3DV4U"N`!9,\A"``&I<R`8`3*^O$/YV)!BM$A'S(%.^`8X40#;,1#_DI&
M)C2B`)X1&A6@`\WD02"B6IKN(&J#)9HF`HB"-%*F`V3P`O;%'$]Q%R4`1"Y@
M3)BB%Y&""^\Q3O+Q3=X-`+9N#D'/`R1`(X`GQ,B,*CP@)RE#)#A@1#RR(>@(
M(JO2*O'0`\JO^^*10^#$>L(1QP313>(+"1%B\;B2(1I`+C!`NGB+OK0CMP:@
M`]8(`P0`'B<D`.1"+`^"$Q=B%[GO(&(M(0B.(NCI-@+@\1PP,16C]Z8&V59M
M2<@%CA`03B8@G;##`193)QR"(Z]2&.ME*5C1,P](`;LO712.,BS`8OR$'E6D
M'^,$_<*%WR!#!@$`VW3#)&00:C"@*SX@=&8M_@`&[SZ:DB'>"H1&A`(@@`-"
M)_X2@@'H,/P$0"T7XC`+HG=,9@`6DS)`PZ$@0!L)HC,;@KXFL(`LT0,XPF(:
M`@$N[SQ)<#2)<><RX"\8S>)$\PXC`"_>1`(6('*HHC<38S0.133BC%LX(#8]
M!0%XT^L$A[D*Q_$H(#1'"2DP`"TQJ/8HD\(FT`),0B5"`CC2KP&@4YL6("P.
M0.-$K0#RB)`N+PRU$_.TXH/@[&LT@$4(I2'`9B$P8*0P]#VUST1=Y/H<KO6R
M$OS^C(YX\N(VP+O>9'GH*Q8_`#4/XTFVPC?<P^&,(BNF`B'6D@$>B0*2BC0X
MZ;DL0RY@9$,]@`$"_B8C6$)*6K*74FX`WN4#,*8X&^#IFDX-\_0F!$("5L)/
M"T!$BRM#W!1""B7>:*\-7Q,Q?%+[**"5XNP!8&<B&H`\/\"V$F(#+"8D>]0A
M3=0F4B>X.(`C]$KA#A0AW$8!MLE%+4X&'Z-!.D!H&@-$#M4PLFHB'2[*IHP#
M'K4A-L`HVD1-QN8`5',I!H`C"*"C;/`=M30`6&(""B#AK`@!)B!%%F``&J(N
MXZBD9,:.QBMH?JV[-")0#T(#WN\!(A.H1$;\,&@O3X)1LR\J%-5DG.(/`:@A
M&B`MEG-YFH]3AW%3*(\MO"VX=H27%N#GJ--15:4:LT])XXX[Y34M+:-?_JRE
M70="KQH#*2%.3.C05.G,.03@`@@@;"H@/VE/`$1EC>0R60#&4P(`*]Z*_/0*
M3V[C&?MR2TT")T1#`FIQFA)@7%'L_7HOOC(@-MHH\;P)8BV.E'B593!`61VQ
M]>C.3M_B`.A(87ZV7^OP@3Q%+J@CN"1@1!!G`8ZBH`3J7$YQ^MBRAH+COC`T
M`ZIM-Z0S`Y;"1W0L]8JC-RQC/6GKXAA@RCJ`:1?"`J#5G(8F`LB$M#AD/G("
M>WCN`33F`U8#``9B0`8/0*1D\2:"#FU6(2R`[L[5$AG"8-NLRF1'<@1@N.SS
M3:)/^_(#_)"B`T*WYSK&`\;%;]4(Q?JU@K2P_D<]P!T9!K@X`$#4:0(X@I2X
M]0$(('AZ*P4U`,`V`PRK8A;I1"4`13D:X`&<9^FNKE:D`AZQ-DD#5R$,3#O.
ME40U"CX08#<V:3^O!5:=PEXB12*48T/_LRXYB2&.!3/X408;4N=^]@+<TRSM
MR[)NA@4;A'6G3T(``'P;(H%6C"\;XW458D#"$R*T@P`JU.+X1WFSEE34K"D.
M@T?9PP%4<2D`\Y^&%/T4`&VU+R,XPT9Z[$MCKI02QB#:$`)RPU82*T23-O("
MH_`FP(D"AQ\!H(=6L#HTH!WI,2-^8E`,@C$@H`$>B=,&(&4XS>0@@'].\0(T
M>%.&*\H.V#=_MEQ%_B]9MB8`#@=Q&,""#2.!I6].(#<Q*B#NXN/U*$+_/IA?
M'<2(1Y@BM,R/$:(N%2"0A?&YXN,PH,0=*8(##/9DUX(A9`@Q*2QZ8:]6@$9`
M0&DSD'#*'HH]Q.-=)F9+1(3=Y(P#*M4N-L`CYF(F,")%2J=S&&"X2`4^+@`C
M=JXJCF@#YK`#V&U[[NIPD6@)50(SW/'R<%E<`M(*Z^JKWH..8_1DWCCS?/>;
M%(-_T-(#O@7%'`;;5@(!Z&@R2D=`LD0#(L<[%,+;KB<Q?P2A),I'LIF=IBE2
MV(ZO),JBVAFA\!E4I"N?&Z=TW`.A'C(Y&\1+_(M'/3$R`IHA8M>6[?`G_FIW
M;+K8MH1HHM<MHQ0/31PJ\TIX5?E/CA'CH!!*BRM@25@(7[_JGBT*E;&5/%MR
MIVQ(@#EDI;WD@1F#5RXD<@7`"J6L)$J&9"!..TMEWDZB#+,YG=P.<2RUU6(C
MLE3,2*!5+J3-43@@;$KI:3E@/[!(C.>&,^Q2,Q@X_$J'-'8#4H)-L8Z#>0;D
M+&S#JTHC;IFG43S+<&Q+OMANM?+(A\:+`@@"`U;(H;8'761(A@B"\YRB67*I
MD.?$ISSX@D6114\B4N.C@0VH)04@(!%C+))&,69Q`/P&+0C);PC%P+9BCT(%
M>U9Z(=QC(,IE(>BB;LOTE,MG]&*L,7V(-M)S_J96+0-+9H\QCP-HPX<Q0RRR
M0CH]ABM&XS281@SCE"T,8IPP@G^F(@-(@T'JL@"J]U;)PHB[.#5L^:OI$"@0
M9'U"TU/^26T>0X:N\R8(,B`%PI:5:8/*QFLX(%4NB0*01%,7)E7`I@%Z6<,B
MJS82(,`!3(JD:$"^^9MO\T(0P$E_93>P,%>ZICB<8W.DF."0Q+8DHZ@"Q8/`
MEGZX0SHD@'Z8`].^6:0H)#PJ8'NV1SKN+#P*0LO8-=6RN9_V*4ZTI4$H)R%0
M.[A8@SCMH@+("3&><^&>9(+@VU,T^"%*N%'*;SVE1J3HPSZPR(F0E&G`)<HP
M1Y`!X)LW%'9*AG<Q_D,OV]5!+F@]>$2,4[EP2(54=KM0\$8IRB>8PP9<G-:>
MK@MJAN2T'BA]/B`V>-?-3L1.W!0E0&^:AGM*8N+J-!8SB,=37`2M/NZ%5&5[
MO,9ABJ584,@F)\!A(D`!OB9ALHWF-(!S?B/FHL)/%D<H\"\Y-<*V_^I2',"&
MZ$BG?X6E.,,L,AC5C\.M5^UJJ)RE6&TWAKVE5HW7_:A/.D/#@F,Y.$>7_.9"
M+N4WHDW!=C:N@G("\N^U+B2_M@?3!^-2&@`"N'WQ-B=5!.<WHCUP%F]0+J0F
M4H57+)O3/WU0%L\Z5B3=`S#;-,E.(6@`>%SQ8"FIBW)[MJSK0@>=PP\B_OHE
M,Q)%)0H"(TJ'>`RB`G[K(0Q@I3]]Q!BBX:1/(F'R<A!#(O<P*YVB4-AB%G^G
MK;9B+,8I*.RK-X[&M>)"+@I%1-TL`6ARW29"207HNA#O-Q;$98MK9P7<B"TU
M>[>/:FS+)"0HZ9C.SI3NRK93(!X.)T@$>^J1S1NB)@JYM3>1+"9"G0I"(/I)
M41YM.BR3$_LT/*Y..CJJ*6@R`LB(.AC&8?JT<-9X.W`$`G0I`BJ@H[S&.0A.
M7PFN<,B()J7X<++&\//>\>'1<`@%`)EG`2Q&.F0L=0PG8?+^NAS?+^3K*\C\
M("AU?$<$=9"(4B<E3>/CL5%OX7)XD8O+XAU"_@)^K`.F^+H/Z*>ECXX#H)(I
M0B*UT.N0:,)L_@-(8R)X)6#,8BD*A3]AO"8$1)T*92QJSU/D2!6_^\P`(#2]
MAXY1+8%L$\.@AE>2I%`*`)7BCE/^2I`V@K$;PBA541B#&REL[>TP5.`$&8(1
MHW0HPWD!XD"'#P0+&C3(X6#!#A8\*'RH\,&&@Q8&$N1```,%`A8B.#28`:+(
M"185<G"0``%$#05$$HSPL`.&"@`(7'"),^>`G#Q[YO0@`,!.GS%K(CB*P`&'
M```^0`#0X`,"`!DT!+VI`("%@@4`3'0``('#K!0^7-#ZP0,!`#`)*ICX`0,`
M!Q8N8+B@X0.'H'D'_@#XR$#H!@`&""ZHF?8`U`\)`$P@:`!`A0]@'5,&4,!A
MT`8='LPE"CJT:*(5`D@8C3JUZH,(HJIFD+=@!06K4V,(('8TA9*B$<"5G3!M
M`@P$+1P(P/L#`]`1DA?T,!L"1`X+<,)&.`%!5@``B-=^6/C[Z@T*`M!.;8'`
M@`,#!A`H(`$SY0"<#02(8#]`V;63/VQ@FL!`BAV050`3645?8P!4I]`%`3QV
M4`<$")#0`01\U-@`@PTPD%_]#1;54V5E@)A_C3W6E70?K$4030Z(!V.,!7DG
M8XTPEE:6:@;$5MQY-O*D0`(?A9:!<T0Q:%`%-WDP`0,;<.!!!QXP$%Q!_DCV
MY("1'T2@008J/:3!E0\]4!(&`B3`@5P`'+"5C0+\2-1O$[05HP<8#,2!!G!5
M%<$&<"7EG0<7/)#E!QU(D``!"D#X@08*%%!`D&TZ%1Q8*AJDU@`)=>60!UD5
M8$%-#D76I@:+R379?RT92A.*W1&$VTN?P2G>!KQM,"2MNL*I`0&7IK:C01V(
MN6MM'G"0IFH*Y-IH0ALL4``!!U"`0`(,,$MG3QY!U(`$%20PG8\0':!G!4>%
M9"AW!$2@``(&'+#M=P$4BY,!S-+K7[8YUJB8:P@QI0%0`C@4`7<%#!9>P2H!
MM1A-IWT065X3<#<!!WZU90"X3LV*[V@2O%C0_@"3=DQR:@RLJMI>Z!:D<<FI
M(0O!3:D=T,`$$-P,@<TY4P`!EQK\_'-5/U>P'%$8W$N0!P^PN=(#+JFU@'GQ
M?D"BP9!"ZK1X*+N\6@15HD;CBC]&,`"C!0UFH`<-+%A`4$+%1\!`\4%UV&)3
M94W!NQ5$YE@'%Q,TP)L?K`TRUSY];)"FAB_>TP8#\)B:WS(7),#*C/?DP0(O
M:NG3!!DO<%3&!C#P[@$.&#``4P$88`"D[XG+DP-7%W!R`0T\\,"CL^\N+4X-
M$$`!LU47O1",X5VN$),..`!YH\VGML&+P;UJ8P?.>>!GTA1$T$#/#PR`0023
M8M!`5P=`4%8$##Q,_A`%"O!-4NLC!B`X6%\B[U($OW*(?_\&04`\U7B@`,TC
MEO\>X@$(+,`"[*-5!_)4)0\@+2<(F(">+G`S_?4L@QR,69\8<`"<1.DA@^$8
M0297F^,9;@'":\!Z`D"`V)P$``%@@`,FP@$)3.``Y)I``_IS@09L"P,/B,`$
M)N`0#+0&?(/ICZ!F\@!T:>2(D,/`7122@0M,A"%'`PWLGO,;A4A`6N&K"7&D
M]!$.P*4#MCH@1"20K<>Y$7\2(-=W)!2V#QAPC@7AP`0:R,>'F`V+9(+(!@)(
ME*H5KD8JY-K7"/(4Z5B@`7GQ@'TND)X%?2!4W%F6F2HG%0#<!",#0(``_@ST
M@:X`0`$:*,W9N,.=TQ0L<$*Q2&FXHR*4^(6&"7#;`/KS$`PPH`$-J$@'"K.!
M"C2``7GD0`4<D,<"`<!)"[F`Y=)R`2T&LB`1"!M)MFDX#P`@:[61T#47<$UP
M%B2=ZG3`!#?92(,\:S0E7*2,XEDR(1TD`ZA#X0<.4#02A?`L`<C`1Q1C`9J$
M\`,T(0X%7M65"SAD`PLUU%JFY8&J_:PK=^H*20XSD<!`14T"V,!4ODB0`M"/
M;PS(P./6$BVV)$T"3*$803+@``)$!@'!,:G;"O"ANM7PG<B30`,/$$9UXLL!
M`2`J:)IX$`H`4ZE4Y1;G.M`RA6B`G*"9FSUC_E31<))P*O1)6@!P4QY192``
M6>W``7*G23U.\UL`D(#?CH>!L%KK(Q,(P%#B@T2_3&1B+UH;`[K)G9L\!:5^
MD\P')D:E\]4D3TR!2<%*JICP*"9@ASE/9!Y`T[`0I#'K"TJVW/@`%"IN-6JL
MP",/DBR%.&`!KXT)O<YR)0]\%30%R&,%IEK5X!;D`;4M"`&*NX&M$65N!(`3
M/B^W@4HZ0``C$HH"%`!:!70@`]+*5?G\`J&U#>!JIXF409J;-`(4+C!ML:0#
MGI(9P^RD,1+UVX4&MTJ(5&`@&BA8`S:@GL5\('<3R<IR-,``Z>Q%<1R@H08D
M)!D[40`NASE-!BCP_CS_06"J&JH-)U%Z4Z8\Y##^?$A7DFHC#R3JD4[-B0%.
M6X%!"C>XA1+)`9`;5J)$(%KWX]<<+VDG14EPFH;:@``H=)9&F@HS'XG/32R@
M`.(4H&P\4\"56%>04+D&L!:8<D(XD"C\2L=4%%).?A_RE#7=3:0]9IDHH\J=
MF@J%(!A80.L4T("/J(TI!L@C:E%H`,X1A9-4@8A:T)LT"6:EQ`I96XMK<YCB
M`NN:%?B54C-@::HJ)2U(8_$ZV^P3Z#Q6TJO)JLLDD.D(,.64&3%,6""P%B&=
M1;EGD>E-Q\F!N_F-?F<50`,-P%6^9("CH21.?&!RF*B0.2&!02D%5A>2_H=&
M0`(,\,M6-K!7N4H'`PEX4<$4P`$+,+`M`V&(8F@C0?]8(#",[A]Q#;+'T)#5
M,L^90`(2H!@`).18:^,;(&>$DFK_A2`=F(#F>(/@!$!@C3*!P(L\8`$(:$>B
M!_D/(LO)D8-46KC'>O0![2<4!C`@`0LX8@3N3?*1&^`H*5&N3Q#\3W9^Y[GX
MPD!M.\`]`TSJD-P90`,2HH';'<0#^($<`VJJ,9KYYY%[V1H$Y%S2+07@`%%[
MU5I@8JK[=@6E$[MQ!AKC@.Y-A;:<=,C$5$*BPL@%9%Z*"@4$<)X.'%EM!E"1
MD3/MOW=;J9P"<("T#?+0UJRE*9<1``AC^1"+_DW=;9TZ#)^#\]!3A@5[]%-7
M!\#"5CZSI@"DIN<`F,6S&1=\QAH(XC)/?_IA#C/U%,#D84?3@>4\P,_B,77)
MBBLEB&01Q3WQX<@@^9`,7--1"&#FC%H'JA[A,`&N&>;OAPM+`4PY``O0P%3B
MS$*S1,8`0:%-!R`@`!Z>LCH5"`H"QKBFQQ(@``^P0+*W9$0W,@`!`#TYWD.#
M*L5;Q)**4Y"A/OL!<[,O!N$946%D`^<9#X!@B\$P>:(8N^$7!"`!"?$4""`3
MW9,D'28C>:,0%7!:2H4],^8RF/8!"B!SM6%[(E@;!^!QM)(!5F01$-`F%"`!
M>!%5M-,0`+<`X--'_A%``&04'+K%';XV*@N08_B3)A]S0[61%=(2%%D3'^=Q
M&RVQ(0.A-`-08I8D`+'Q4%%R9`-!(A0"7PX1*@:P%`!P*7)G1K<B`!_X'>2A
M$!&G@G/8,10@53EX$3$2;W0H&@(@:%Q#;9&#.<*787S8$WXQ`(?'@H^%A@6A
M'6G1'DWV9K`E`*L5'QEU9A)B(/'Q,`UV,+@D3UX"`(9G$9[S(^F!9H:HBC\B
M`4<65K27&GM(+[#8$QPP@/[1@ER1B_0B`?ZRBF[T4(726%NA`0-@+P$H'Y9D
M&1K`%%E88?[A%]BC'@,1*@$0;J/H$(<!`8U5.!20@Q80&<0!8+X((\FE_A_,
M<G&_.!H9)7R[R#@>H`$0@`'")WQK,XK69`'M"",I*%R/5#&A<8P?UV[JN#@>
M,!7[%QGWI1AXX7\E&!874#>W2!"!81.>H6\,!0`39E@$P1^W1!R1<2F-(1&B
M:%?/QGNK,6RPM&E[1Y"J44+C%%Q^4P`&H%,'0).PA)/4\QVRV)(K`6*,8U0]
MV3\-0"!#@FD(D!?D04,]MT6>`T.F\V]I\5"C&"G2=5:K]!%?QQT&4`$.<727
MPA*CR!TL=#K6&",<T`!^M7Y,T6IIP9-"*1+B9!SWQT=8)4%#,C%M&`$1T'JX
M`B-O"9<&L5N7(P$_&9C^<RPOR`&\$25_"'&+_IE1!D$^4Y,6&2`!N6(]F((L
MR*)GG2<:'3"*X<,1`%(0Z7B8(H0<!Q"5@11["E$PJT1,/^2..`&8I_F'@*A@
M`R"1I]F2A:@:L`@=V=$SP'4XDZ$!+[(!__@2)$-T@4112S&8?`1F"O$4;*4`
M>YD[MWDDO*D0;D5]OO=;ZS-;=-DQ-9@TW$DR'1`P+;DD$A0^VJD0-+(!Y`A\
M-9<6@90!?MAWP95KU$D8(#&;+E&;!`EN@Y>3`0".R$,HZ`D:`1HAUH8_,S&0
MBQ,!7,62#"I"`*`!IA-<S7D03S$4!*&<XC&@OXA52Y:3-,1M136AZ$D>US5M
MQ8<!%K`![D.?//$4_A9J.!O!':9)9PTP8:L!'<1QERZA1`\1G4^3;NSY)DDA
M7$@2)0F$&12`+A<`)7^)H1>Q`!V@`")G'P"58,6HH+N9I1A0@RG*'>=7:$1A
M2?'U'(;C%PC`%,0)?8ZE&C2Q'%D!:H!G0*9)/O=V1(B"<BG2D[=AD+0X1YE#
M.2E:.-4'(SX*$04771M@F4;U?,D3)8LI)9L:I6C4*5':8I_Z:">!*:#R$1U`
MIB2#.%D:A_N%IDP6`(@J2#H)<060`!(0&P^D`4:UF&;:14E3<*ZU?Q*TJ]II
MC,>$%A#!270*&J;B=@P@8Y*9@H.Y3%)%`6E)0P.`J\JT3:$G$F!V+4-7_@!N
M):L'U`'^0DP)4%,"0)YWVJ#9!%IAUP`.X(8'X0`'$"VL\RX_J![(=P"APT/X
M^J\\1'\#.[#O,I.C$P&:TS/3MI=P)`$)FF4:&AN.XB<>"$<G*2Q^HD;68X4(
M<9\/A!,1RZI:E1!6=`&SE!*T07A$X1D\DA5!,HHA43!^=59G%1D5!0&T)!@=
MX#I"$:VR57E)6C46`6;_NBP$=Z\%"TQ$]Z_V$17AUBD/I$1(L@'$M0%A<W](
M9)"]E4P90!->`ZF,TV#\6!`/I4_/01L(4*[^@U5BA(WKY*`0T;;5`X\O>"<:
M<"=ILC*6Z0#/]``;9D6#:T45H!'+LSP68F7T_CI;#H``OT*40U(![F&,E?B#
M'"H28S1X/VB,TF*3!Q!^TG)1H$,S`+1!L!8I@2M$/<,S^N.Z&_2ZS8$3'H@7
M$3MMT:5#_9,<',!Y!F&V(G%O0X)O:3$QIW%W<7&/'C!>!)<Z&F`!C;$5D=%W
M'A=[1.82G+1%Y<$>,&EF-1$4J[(!]D&OH`@6D^&#2SDKCN,V/`03F79(QL@`
ME;@0SR9[%W%R"Q!&X;-!"-$S>`A)$)``EPIX,7,ON9<6K9,38&$YEB05JYDT
M;31"/P$:\&D07W08(:H7=>L3S'J8$A`VSRLL%+"8>N$0PJ>QYTF/PG<7650!
MPF<![:?"N"/#,SQ=_@S0>KC3`$F!.]!".S2#73.,`*GZ$@\0+9#R/E>3&V,%
M`:-C``J`,T]\,PJG`51T%T!CQ3]3)7FRG@P571:1`0*Q$$?H8O=S`4&1`!2P
M=@'HA[#R&&JQ90(0-QU`$Y/Q%$&+0)E$+C^C>]R1%QA1&)GS)0O@*U0#`!HC
M%PPR%5MA*<B[2AF0%>+H'C/J%[112`N1.D>V)A!"Q(T1J\O!`8'1%4@YD;W&
M'4!T?;9V&4/(P:$U30Z1)Q>0*.,*25\2=B$!CWJ<%@0P55-"&0+`.@G[R[_L
M5S1IC-H1S/J:`,C7.@:P``G@Q#?CN._3Q.6C*-J!,]BUQ`JGS0XWDPIQ_JN6
M<W(Q`ER>@SX-0<00X`$4@!(.7%4>W"7(\G946A5$<\(]D46IH1;]DRL:!`&!
MV\__'+C^O,SZ.I/1HE/NLLQ(,67K$3K]VFU^03,I!V+6)SNTH\,-4(F`(13<
MUQ[7F5G];!1IR:X[JRY3)@#=\BFW4T0Q9E0S;$V.O$J[Q!WR7!4?48T3B6NV
M6%#(0JD9,#%94QX/\Q\5(6UI0C\!$RK!DQ[2H5NX<1(5@RQLQ)469(P0D$4U
M1!/<<6.!H12&M9APK`%@IDER!SYYI11J%!93W#L/@;88L!9D(E(!1B4>P$,)
M$1_244)M860/,"0<H-=!`]A=$MBE=S.!.P$1_D>E&+!A$Y!-6?0`K),2!N``
M_OP`M_/$IS/9CEO83SPTSW?&$5+/H0%<Q\(![6<!S'.K[.I:ANC!D><VL%1R
M0AQJ%(Q`<8,\<@@C2[H0#\3;UK.8FIJ9,>/;VP5B43*I#^:Q[E(03P$3#T2C
MI/0D9*&>-:2>H?PDSKN8H)L!DVJ+KWNZ$3`5$Q#=!L,Z"S!_%G'3#FD!<](O
M;0-#CIN1'$D`<+$4#0`MA)',H[@`"A`4QL@4D0(M3,$>!Y`2]W84\3MXTE<3
M$7`<?O<>1\9\J'9O@3$`?^L9#-(8VD%_U4)6CQO!"A$8SEQU;5,3]Q84[\$4
M&LX4YMUS/^AXI10M_JG#`+-G11G@3-/F`!,@$3G1)8.+M_/($S*!+E""`;:2
ME`4AV!1`*,N#QABQ`!0P`>K,Y'/;@?LT$4!JU4K[B]XR0&BZ`!MV.99T@@Q*
MC+&Q`!*P,D%'),=%$*U8`-D4&17`C+:=%==VT@2QD0X))9`B+"T,$9X!1#0T
M00U6:,?F'^$G5_HD%^@2'R!3OEM2:&#1%HWA6GZ!+B(R>B#!?;0STR2"=LL1
M)9[Q@1.@2F[#(&BY%E%'9^=[?PV&)`K<&,'12VF"E6Z!A13#L0!6.4]2HVCZ
MVG%&`)J#`.IA0S<#I-CZJK-G%\M^%\V>-^H2.'YAL^M'N:I#0TO+0Q-#_A]?
M;D.@0]LYD501,!D*4`'9-UJ@9(AO)WDR'6?L=SEO6[(?.A_MX4M`-1NAH;P\
M11#%"$O78E\.L19/5E94PQ3M\9_*BTJ-XA=N>A!R00`,D%:K1'LT,2]Q$7[]
M=1^0OAQN/4X#(1<WEDG2L0!1M\C_]&8T<1-8%=\6^B[#,C'QM3:623\#8)G_
MN25O,6"X]D#;+2PL`3+((I4$<*-G$7<S2=<`8!$(K!;$\U"ALC7Y:4\\;513
M[\$2$+@2L-\XS'U(P?6/2_53CP#LGI/C=12.V]^C.!4%T/7KPP"C[1?L7!O%
M54P/X%H24<FJR$9'!-76H_>>N2O'%._R#IIH_NH`A<D3U[0V[#/%1W2JL7$L
M"S$D.'=OE=P!*(2/T^&#@1-%?I&.W](RO/MX!.$90<%6[.J6J5-39L@=(7$8
M19-8:2$!`Q#Q96%I!8!4N_0P%B``<P)+:,P=R$)L<I%G@T/=UC(9;A5"^6F6
M%J.AR5,>`S$QD^$7>`*Z_L&][=,8`\@2`LRFW^ZQP_W]F/G]AM)IZ02]!N&;
MJ%%<H+*A,*1J[P+W@2\C`_3M0LDNJI2B,VF8%W&+&97^`/%!X$""!0T>1%C0
MPT*!#!,6O$"!@@>!'#9DJ$!APP>''SA@S("A@P<-%2ABH(!!8,:-#"04D!@`
M@(4/$3(0U&!`Y@,&_@H,+%`P`$"``!8@2/A@80!1``PH>G@00``!``,V4D``
MP(#0!@(O+#5`]4"'@Q:JZA2@X4,!`!<^4``@X$,#``\(+IA:T`$!#@_]_@4<
M.+`&"@8-`*@@6#'!C0<;/_4P08&""(LM7\8,46UFSGX[R.T<6O3H#A0R4K#`
M0>)J!RI'OX9]&4-CV!$`:)4Y02`%NP4Y((`0@8*"H080"!"@($#A#QTB-*!)
M,,-JVA\D3)Y`4>"&R0LHD$4HV;C*#CTI<F?PH8("W0,K`$A`L(*`KK'M"YX`
MP2"$MO?E%XR`@.C\([`S#+0K\++/$F2P00<?A#"S!B)XX($%'-!.@O8*_K)@
M`0\]E*`"$2N0@('-(I3PML0$TH"J$U&TSZ$.+HA(*`(BZ,N_'`>ZX($-8002
M@@&!1*B#`8A$,DDD+]A1R80.N,D@U)Q,4`,&"A!@QP<&0(I*T1S*0*;;QNQ-
M@_I>JZZA(;U,,`*WV!1H03CGI+/.UZ`\B`+][.233@VZ[*"""R8X`(`&)`#O
M/M>DJZQ/^XZBTTA')Z6T4@.B+*B"]"KE%,8,]KRKOP(3':B#-3O%#+I(04.U
M55=1Y&"`)@?R8(%7;_5/@T8)2D#4"$_%%3`%>H-3TF#OZR"!68]UU`,%$/)@
M4V:GQ:R"-#\0"C@(MLT`P0(QI=8OX>B\X(!P_E_SP*1SF\73H%C7A?<O")@C
M2#D(,A*Q6P8S^#'>@A(`5LD.;/6WX'7-BL\@#U@UV&`)%ATH*P0<H-B!"ZZU
M+X.`_>4K4@0:!OG8#0J(0`!P&V(X9'@S`*Y'"%`:,V8!'$@0@@/Z;5A6.C>0
M5F6?.874`6+K_3E>#P*,&0`"$$A``J<EN.!D^S!X@-Z0%2"U0`XV-FB"78L&
MVT[NM$-`Z@/>##M<#3I@FX,.,E@`[0=I]+F#`K(F\#""_YK@S+3_]A*"#2'P
M6Z`$<`9\V@HL\/9!C7S&0`"\"=P`XH<<X#IQS1GT@(("FB2@.@\&D'OS8SE0
M8$7YNBSP`8S]Q>!C_CJ%-)T@K$0KK?:#,.B8H`>>I;4`W<\="477(2>@<2HM
M'OX##1"WK`/+=??`@-(%`J[>99MOM8%>'U`^P>-5QD"!\)5TD_L/,IA<_<LH
M<%KHAK1K`$$%MG>_4MN6,U[J@C=@'9SDES\"<L8`'`!``?:D`=D]8%$`*V"K
MX"*`Z3%H?"'C0,+F1+$(=E`Q?=M`5?9$@?JP;""I\R"GX+(W!UT@**^+UP9`
M!:<'S#"%-RP(R_I2(0-\X`(!8-T!]M0W'$YJ@BB*%@SAA8&>L0D"U],<!\Y7
M1(-T('0$<<`&)-88NU%D`DVDXIR.:#PEK@L#A?,2\X:WK3#^Q6D4J<#$_@Q@
MJ@048%$6*,P7VV@G#"@-1JF!'!B7]S7336F/1:+90"@0@>A@X$4?.,!'!'E(
M)3V@*@4IXV@>@+]XE:].#4@D)2,H`0=D@$;^*\@$'@8\4:8Q+CELT`5!AH$`
MLLE'K8P@`P10J*$@1P'(`68PFZ(47+HR`.UK72;#A8%0PHEVQ23@0CPPDAEI
M8`/3Q"8UI2D[:"8)`@@H"HKTI3(./-(@6(/1`U#9S3;>CYU(<H#2H*>C#30`
MF?"Z`#=IF+EWWA"=_801<1!000)!0"C*I)8%],DF!4P2H#@<Z$-11!4`6,U!
M$)CB$H=&):@(8#D9E6@!&0#%&X(4115(@#T9_L.Y`_IL<7#R0%;&M(![%JUX
M(0V,`Q_2$?=EATT66&>!G/4S62I)`VQ)@''$@M"&>2"+.`U,!&J)27-"%3,+
ML`E.:CH:%H),BFPZJET6,)L#6,^J*40`URQZ5LQ0(`/@^BJ#$K#5<$&`DTEJ
M#5LA2M**Z)4S1YT90>Q:*I,J2(,ABP!3(Z0NOWHPHHVUSWMF@A."Q"ZHF>EJ
MPW0Z)P^8JWEWU6L"-JH7Q4)V);>1&\0NH+K1>.`"$.BASP9+)T*:KK!6E0`:
M"<)3TP(FA`$`;6PR6%:B3I5*F>TM]R1@P^1R!H&&0E&R?O94VC:7@!)`KG4M
M\]R>&=<^TO49!8(+_B,/"$^[ZLO`D6##N,9ZX#9#(FALM/BSV<+4O.?]K'I;
M.TZ_#F6\L<E`;%7V'3IY@`#XY1[J$)P9LU1E1[?MS'Q]QE[.IFS!43SPA2T3
MPLD.9)ZPR0`KP]6!ZK"MKP4^K(8U)V+RTM6#&Q`*:QUT1GAU`'\/D#$2-Y"U
MSJK8MO\$$DEP*5GF%J@"6\FNOQSP7P))``#-Y$B*??PW($_9+Q.XS8?MPX'E
MEO98&H"P?R`0`!D/U<J)4]:9_T(8_KX3RC`B,4DP@(&^_$;-@).`ER^<DPPX
MM)7>C5`$F-8`!"0/JW?^&XX0G9#I:*"JQ=0MBA3`Q0(XJ[:+#ID$'KUH_AGF
MN)M%/BD!&*#+]#04TV!+P*81_=:']B7)$4()A;PXVE,WS)VUE@]P?@1H*CI`
M`Z^.$`=V91I<H\A,>A;-`I"-X`6@]J&@AA$'#J`=0Q;[01V8@*H+E&:$:!N_
M\40`DXL=.T5ZVMKPJF^Q;0/L&''`;3[C`+11Q#MJ\_K<E_$VD"8@;AA=TX-.
M9C>`GT:Q"46@`A:)EZF\9"IJKU5SLP%<OF&D`1>NM7-4NJSNL!QP`DEOSA0[
M``*`$X'@D%SB[NL``MJE2(??^UP<"``!\)8N#5\@`=[B#XN-^E:>O]7%[CO:
M`QZI)Y=3BR04%]RVXBF`:QU-PQW"^6TR;FTN_C_`>X61P*6+7J>W9>`B/*<:
MH:DB@`(80`$0Z%5BS\T?CA?[`!*@0``@(`!+;QU)/`T)!B+@`.\E0.5E/X`#
MA&@`!P1G-A:PIN\@L&S\+F``"/AYK8]\@$TN(%I:M[M]'(V!"WB/``,8P.<_
MO\N0"\<B&W#W93@0Z47+M.5;3SS+F^>!^*:M;PUH``$$L!29B+QI$["`TU`?
M><!PX+[%;O8`3EYK"QR@`1NIWZ%FCWED$;](%@!J4C@)+F;N/0$,2,!4D'.<
MW2>`/1-`O\^MWYGU+[C9?KZW!@00'`0P```;6("6)3BBC'AMN?<2$;5XGF=Z
M"`U1N_"`@$T:""M9_@`9([EM24`(4(`#^)!YV8\%@+R#^"(%H*BA&(H%:``(
M=(`ZH@`!8``/"8`">`"A<8`)H``79"`Q^1P4\;?,>PL*X*NB0P#@<:$/4`![
M:Q4G2YHA!`!SP3(`8#>ZJ*B$$`H`P)0^`@`;XJ4=Q`Z)>`!>:L!0`0!K$A'3
M("$B!(#N:,(!D`BR$,+;$+!,^;PQF;K88(#VLS('\I:UR;P.>*0!X"=402`*
M2H@<L1L@^HL+N`W6XR5,X8"MV*AFL["&R(#;"`#A<,&@<$2BZ$`!R+9`L1RH
M((HSB9TQ"2=,H@HQ<4(;)!+NL!I%@Z8P@Y"%8I;W8$6$(`YS$ZS;H#6!_C`H
M`$B4S@K#@F@`!@@`X/.:!!#&`QB``A"3`/B^!Q"`V]B5F!H*6<0)!.$)!%#"
M+"F(9KN_V[!&4H21!'@I]^"W".J1.M$O:I&`%,0]W%,`W+,Z8MF`97R]$]*)
M*;(-Y7,WU6"+`V``IO$0;;P2W',:0>F+1@P`:<'&';$_0`00P@E!=L2<@?B\
M)8NGIA"LI9@`#ILC;H01^*&P=\H`ZD,2SSH6C!(((1P`Y^,[YP,];MH`F8A'
M@8@`J1@)#A`4DCL`RNC`H2``BK(8#(@2MH"_`RB`4)K('9&I?LF`SPL]T%O&
M*!R(!2"`9S&P9Q0("Y`)6^&P#-/("&$+`<A!_DKZR`(+@&G9&PD@@"1#D);L
ML.9`O0W8`&O*N@20B9V,.5&SF)0@#@"8`(A+2@$@I`4X`)$\B/EP2H%@"P#8
MD2-LJ8?8@$(!E:5()`VX#:O(@&4$KN:XC>/;2@<Y#)"D)+>J$\1D%MJX`!/\
M"^D9Q`A(@+V(BR8D@`)H@,-T*_]Q/`!`$`[0/8L*OT6,$[8(`$SAI2910FY#
MB`V`BST9'0&(K:.1B:6X#>;H@-MXL\U,D,.`QMB@/3C$E0P(QP89'3,2.8F8
M@`JYPI`S.Z#(RP!81\%QM+<!LX80"N]XL(LHS00BB`;KJD()`)_LN9"8@,,P
M@`"RORTL"`B@BJ@$_J2!,$YPNHT]$<3;H)7#&!,#T([GTCGJ+)##&`L'<9;N
M/!8*(4?MA!`-F#-FXKN=)`"A1%$"D$$#H+R+=+?86Q]/##T4A4T$()8CTT:[
ME,LQ28#JL*0G(X@'!</;(``"4]`QN1X-D,`=1=%E-``)W1,H',N!D#:98+J!
MB!P_PM`&D4PD?*@^JQ/+<Y*MB0B^&T^Q"[UC#$P&B`"2>U,W<<LW]2F_X)DX
M?=.LDRK86J@-B`!>*L*928#KL0@+@)BCT30\E=/IF+F/C(#V\8`-*$^5.P"#
MXPA=612](R0;0SW?N(`\[-+0""$!N$Y*HALZT4S_,"5'NQC.HY$1_*70_C,.
MD1,YH`C(>ZPB#_T+WFH(7!71%'(-"S@>W>#.16/1ET253IV3]Z23-`R,K:D`
M1L(^[-/3X!@U!C`[!=A!811&4!(<])N`D5#%BOA*?+NPSND+LN!5']L`JF`]
M5TF].7'3.N$UFA01#U$.+.U1^%"`!(#$%\P`9IVX"LB:"O`0$X&6;@F1"C@1
M>VU##A$1Q@O5AGDN4+'#;GH`SX202/V`QLP(!5@`I))+40R]JD$-[?"Z<;TH
MZ!H(VUC#_30(M8R9^*#)PP2`7>F`>)+%`(N9B7"2$O5"?`'5B;T/W$2,W8(0
M1BTF:7I!RNB;?IU`1W3$!0#`"G!!:WD5">@5_OBP4O_Z@'BZT-M8@%%[F:^M
M"D$+`%MQ+5X"M>K1B@:(BB54D@'UP`DE6B`Q6M6Y6`:IG`X@C@MMGK;A/$.U
M`'`=06'T"8^BP%$[6%*:UHOH'6IY@*T``&Z"BX1Q,IV+3LFQ&O[HC9BD/>20
M":T+H5"J@-<D"!-CD8R:IIO:+==U(WDJ5.Q[6(,8P>6[VX%H,&=E$`X0@`0X
MFPFH79#Q`'<+/@F@55$L@.,8``-@@%Y<')%8/L#],C#ED2B!BS>SC<JE1K>(
MEE&TCJ/UBILMSLH-'Z=:QI"S&&WUW@E``+5PK<,L@/3P@*-`FNC@@`J!FO`8
M@%>[`*<)U]U:K:SI_I5WS5V$L,H!*-78N(#TN**BL0C5B%:;H50$*("EV#WG
M@UM7/9#7D+]XD4SDFKL`N)9F,X`&.(P`B(C;V)&0&XA&)%V9,`#!J8Z<@XLB
MG`OH<EN5:,2F*)0,"](B/)"YVSVEP1BS,`"IRM,ZG8#=LQ'MN``'6,8".`"U
M&`XLE=B$4X!R+9IR8=A?L0L&0%94B51KPE0+@%/!4XX:71J*J0`(H!C&V;$&
MJ8!R#!>`ZYJX0*XH5E?'O.$348#[>@_,8R;*A8^;R%LKPF';`!Y+2@Q!=(H/
MH(J2S++>',4`N=`O39J.:43/LC^DT`"BT)BL8)VT4Y]?K;&-6&#8Z+RO_JV]
M`G.;>W2T-TXJ`\`2T"N`7,YE"U[-V4#ET:``WIT6MDM=_B@;WU*@'\+%B@B+
M@2@4[[((BI">K(@/^\O`"0B`CXFG1K$_U_`Z#9A(@6BV7>EA#7`W8L2;4(8`
ML"O6#["D]_T(Z.*/`[*Q`'B`XE&.+,;0YIL`M%E7[!Q4JZB3MU*EW]%E+-D*
MLB.`$YX71S/G=Z,4[(H78H;(`LA!!MB0,'$*_F@,+%,=NJBJ0^0?^'P6R=R4
MT;$+000>VU`)#`@_(5I&@>AFW77$`;!,J8%DA$"`,92)K@A2IJP+"]@(XAC>
M`RX?7:$5E;6,"[C@7][5@,T[WG``#EQ1%$V@_K(J/`ALS[><II%L.U2)I[TQ
MBYGA.P:(#M45"OTXJJ.-I_2P.1(^(;T,#_C($0M(#H$HE)MHMJ[(7HXX#)5@
MBPB8)F,4"+I8E`LP@+2P)@?88^NUW<JUINFXB@#`P[?$`%#)BJ+.79?V$.EP
M$!M[#1N;LR@&)>]92@],T=*SB=G@LHM!/:6>%&4M2?B[%;K8&P@H@)S$Z,_K
MDNUET2+LBPH@"N?4)[9HN0XX#`)@[$KVP2>SZ\KU(;*C@*W5C4(9JT)TY[6<
M"VMLR2PMB!5"B$X>W\HPL-CZ"E;*[,0QYP[ZTF:";=B(5+>D$1II@*BA$:LC
MM+**4N,@-*9YFH=Q_C>G?A47%*Q4G19:6A1IND=?CJ?V\`!2$CG!UET&2-%C
M5B0)6">XV8J=-)\X:0`GQN'PK0J10PH+.$P!\+T/@,H``JS=K!_;'0"':@#*
MUB52;8X%*,@&$(I$<MN5"YOLBR`L,QD(P0`+<(!1DP#LP]83!*;A%D8<E0S$
MA;L-N`!L>N^TB=:_23GQW56EMO*8)8D4U`ZVX3$F(14/.)7(F(`$0"5L>HA!
MR8]<+)_'DP`$L3$)T-50#=(5X5BA`C\/,3_S0S\:(3$[C*MCF9$Z$1'`45TD
M0@J-R-GI!(PKQPQ*/V"!L"01L_3`G<$Y,=A+-RU4_)FL^.HPRBHQ6F50_G\G
M.BP:^Z/>5C*S.6F`,5;U6G\-^^--7)*P.<$Q6_=U!G&\2+I'`:\=^<MS`LGR
M7U?V^Z#;,3'P0_(`*:.29%_V:N<JL:68=62G4G^01;?V;^\,BEJ<"Y#18N)V
M!WE!<%=WS&CVH1!,7#IW.I;V=:?W)XE*,YYC:`(O3Z_%>O=W@GC4D!K:"&F`
M5/_W/LE98L<AQ@*HB*@3%#KX"`'"11L`;_GG/7JB.@F`38_X`T:`XGVH_-#X
MCB?Y@6"`T*.58U<?-J*3*BWYCK<_4.'XX<':EO>Q\E#XET\V+G\GHJ,3.T8P
MU\IYG>^,953Y`EJND2?Z@Y<)B3)4I5_ZAVJ`_K*"VOH+3`J<0)_HB>Z@$)(K
MO&L=VQ-DW/K6%9*[`$>*""%Q)*M-"6MRR[=\>[AWR^`C,;=TFZS0Y^N2-R1Y
MQ:B')@IB'ZH!JI[3@/YD'][@B0=PFAZ1`!_!@'X^^__$0`L^Z-<\Z%Q.P<NW
M_(/&Y<.,N<-,W:-O'NRKDUP'G+SW>[PF,>"C&O*L$*$9M0I9W@>(&CQZJR(W
M_+?:B$09B;<Z$1)CG_$RL8MPM',&@$6)UV)*-S9Q>=TQ8+#A@`Z&K+DR8?T&
M#L#4%L*9#-@*@"C5[_W>"A<5_[!@X]`3W165BO[=216D&`Q<WIWT$`)8S76>
M`(HYC"?4[`(JVY8?_OI@F7F`^"!P(,&"!@\B3*AP8<(.%#HPC"AQ(L6*%B]B
M%'B@@X0%%#MP2!B2H(<-)CF8W``R94J4%BY8B/E2@\R8&C)HJ!!A9P0*%`(`
MJ##0`\2,1H\B31H1@@:E3@<J>"IU*M6J5J]BS:K5JH`.#SQNQ8H@Z$`,%L*B
M39L0PEFU$1&XC2MW+MVZ=K,2\+``[-V,'020%:BA:-^D%4;295J88(#%CA]#
MCCQU0H:^!3PXX"N9(0>@0@5ZV(SQ`N&Y#R!`)B!Z->O6FS-@Z-O5@0/7(A<H
MB&V;X07$$SV$MLHV]>[BQH\CMVB@PX+:R3]TT#UPPW.!*BMJ$`!7>-ND_F:=
M-JXN?CS=X%@W^(Y;@+GFXQLH0.^0@31YBS>O[G1Z/ZF'\!<U.-!!4R1Q8-YQ
MI=678$&5996!@7$EX`$$[1GW'@,``"#``.M=Y8%.$UPP`08J%:A@0=(M5H%J
M&6DPP00%7<#`9][YI<`!"BR```(.["3!3@Y,T%-!'A@PX)`6P">03A)0X`$&
M&(2&@8L7/#@1!Q9T@-X&\\%TP7PQ55#!!!+@U(&9(I4X)$H@?5`@4:YIV691
M'&2Y)FCFT<D041RDB5"6):&4)Y_H"51G!CAIB2!"#'`@053/<1#C`Q1PD$%Z
M4W50`&T,)%!`A@(0<(`!!XA::JFC-M#`3JI"_K!3JZU&\.J(%&1``0:NVJI!
M!!IH,&)HEWY0)49&+H9!DB9^`)L'L,'VI+,8]-K=0#@=U($#$@S$P9--!1E:
M!+0]H*A$S4$`:JB9(<``;<TUMRD!!"#0P$$<(!#``A",.FJI0`D@0`($&$"`
M``HD<``&#40*P0,1+#`!812(NG"K#)1ZV@$/,!!;!A,H$(&-"DA[T`0-C+H`
M!Q'H:P"&`)0[``*=%D````040.H!CHHZ@`$IVY@RJ04,D.'.-SKPP,4,'R"S
MTAJ&:JX`"QB@X0(QOUNUJ?G:_!D#!HP5*Y8=XX;`C0JD?)JJL:)--JE8,X`V
MVK!NW3;4'5/@8P49_DA@D@4;0+L!!",2FNT!@*U\`+!6+9N!!7?C+4$%K3X@
MP0.33QZSY9<O\(`##&!<0`$!!$``4#-[3K/H*^\LP,ZK[UP`ZSLS`('LLT/@
M`.L)[$R[[KM#T(`%O&K@)5,W0=NK[!-LH`%*RG?@`0>#`0]\0AX\0,",R$):
M49]#WL2G!8=.?JCXELIW*$@:+.M!!`MC\#=A&CS0P,V4TZ]YD!=\8-*ADD^Z
MD.034``"'K!`!#+P-PE\+SH9N$[S*I,X]-S$4E>"`-X,^+WQC0\#]9M<!#"P
M0/$Y+W$#JHSY#H+!0V%``KP*SH4R)`$>J6]R7CIAK3BH,,?AK8"'0I+D_AB`
M@`+H"(@*4!?EB%B]RUEN0S3;$-5TMKH(\(MF!5"`L-S3%`Q4`'T%X54&*G":
M+T)``@I3V`3&^``#&J!3G4HC`Q2`@#$JC`&N*X#JYF@`.R+@CG>4V<I`M;(!
M]$MG@!%`%`4&@*"M#$.N^Z'G;H0`/@X`>Y*<)"6/DH$`(`!%CR$,89RT*\5I
M`"@,2A!P"G,X@V0I><S30/+XQ*;W/$`#$*``*VO)R@A,0`,=(2($&!`["CP`
M0Y$\RIDJ:<QC(B<`I[1-!F8F+F1"\T016*9$WA3-:V+S,1RJS@4`X)]L:J4#
M10(G.<MISJD$H(J[Z28`SDD5WRQ`G>[$YM[F_FG/A"A3/!8`0`+NZ93K4<B?
M`ATH*I]IH@%0ISH8`,!V@C5*@F(D`0:%*$7=68&`(DL`Q$+.):D(FH=6="(=
MZ&=(2VI2$P4@H<]IYJ-.>I&6NC2F,MU-.L73S;S,U$H'R"E/>QJ9`%P/.=V$
MJ4\1LH&=%C6I2G5+?^3I&@D`@*A+G0X#IFK5JU9EGR$[#@:`A%6":*``7QVK
M2;&UE5""E#Q!3>H&#$!6J1#PK5+9P%JQ5]/J9*``$7BK!Z0JUXR4\J]*L68E
M!>#4UH02`1,MJ@8:*MC'"I8C`7A1=1J0(?R-]0)FA2QGWYJ!H*WH.1"(JEP/
MV]G3]G0#D]4G`)`:_BQJHC:VLO5G9TR[FM$BE*P54.EL>\M3.=I6-!-@V5L5
MYMOCYA1?XPD:9J&ST:1>X`'(G2Y"H"501XG'`Q=J[E</1=WO$F2QX(2`8Y%#
M)`!PM[04)2QX8XNR\5BVKF,5;SF=U-[96L"MXG%`8.[KW_\JJ`*N?<X"`(!1
M`",XP:Z1XWAD)ET%0SC"K"&8>#@`F)8^5\(:WO"0MJ(=\82UM<'9*X=+;.(/
M-$DK4PON9CS@NX$<2ZF8.8#K8GSB&Q?'E_`E%F^3:N'>M`W'0JZ*!RA+E03(
M2SP9(ZL'MF,!U/B7.0IH[9"W4B(':-(IG3&L>!+`71(O-5,@48"-'5.K_G)J
MP'H3&.9_,Z"`*2L`MEC13>">T@$%@`X`24Y.FF<6G"S[5$*#&X!\D=LB@>S9
MOQ?0*P0*T&.U(,8"<J;(^D(CQLIBZ%B3KK(]-9``/OGUNQ=(4GKG<H$$`-HH
M6!:(L:H32N*^%JL68'%L.3``T.GWOQ"8`$H&0&NKO&0J'8F`WZ"<'`N3-M97
M=<"F>\O*!&,`D=ND"T@,4.:C1*!J`T@T<H(&94]C=;.<[FWY^K*!765XL!4&
MS*]C>H!TCSO>%*E`JN=Y`:"4VJH5:+>\^PT=/D%TN.7%*K?]S=DK+88#`[X*
MO&\[L[1:]=T&1^V9S2V!>KMSH09^JT0GCEI^_E=E`T8FJ,8'!!.L&@#B'O<L
MF.\B@69C4P.'S/=46[[R:\)<RX].C,KG&8%#[OSF0C?1?OI2((`/U`)B#/K0
MFSZ>+IJYHMH:$'V=;G69/KM-/2\G!8(D7<Q</>Q+_1X6(4KL[PP41,$24P5P
M5(&8T%SL8>]``S!NS@8`,>[V?).`,J"Y:\L][&J':#!S&_C#]Q0#50=G"Y-D
M]WMN'?%-]\"G(7J`H`&>HDR7?-,Y8.R!6E8`6^4\Z0FO@(:;<Y\!>'SI6Y^<
M0E?$LI^_9P<.8&#4^Y1-KJ^R`Y1'T%?CWJ=\VWV5<Q[-#B`2Y"7=@+CE'7RA
M*U^2&D_Q6)EO<`O@_I2ST:?*`#\I4`\$;?$YU0GQ>;J`YX?E+P@POC&C#8`(
MA"9+6#VW@I&>8&8OAOG7$:C&<1HIK%Z`WE%7GBB8`VR?5"A>50U4!@#&YB55
M!MA<3HG?RCF@6[#2`$P@,FG7`*!?3A%@[I6?75Q`O0@@.+4/Z_G4]X0@CJ$/
M!BB@/[4(E;R5F*S@C7F)!S3?/!W,NX1&!>94JT$:<C7/REV`8@P45#$4JWV5
M]5W=`488^[4?AF3?5_U?@D5>"';`R-V3Q@V<53F`#QZ7I(%3!PX4[)W30J74
M6YU?#9Z8@`%`YI63QKW@5R$`&/J6$UX=!IQ:!I)'Y&E<A)"5`M@A64')_D)P
M@%@I6!9*P")*`*_IGEQ`X7A0TVAE"!X>X2".U?8<Q`8\6(*E40,X``6$2`,\
M0`&0X5.(XNBY4X%MQ%M-$QN>U*.@1."(""32X$`90``4``KR%`1@(BR24R;A
M72,=P`8L`!\J!;UPF4#9WON]%:\!8TD10%<519-Y120>105T$R]"DVH%S2G&
M%#1&8T4Q0`?,X00DP``03`+8"C)BQ!<^P"\:DP><SF>`8TFIT#A6U`)@%X%L
MR?IDB!D:10=PUUE8``-8(GD@6T-A(T09H3X2E*,=F$!4R@`<P!5>A(#`R`%,
M0$*2AV;58K!\U1<F6!9"6`,P1T1XQ7*\$V]%_L?O.4\)^A3RU!^$+<=$%L0&
MT(8[_D9#8H\#9))'^E,\0B1$W22+,0!.DM4(HM=;R6!1#E0"0,!=55,!Y"!2
M5-P'7)Q`T=T%W*-+,0I4#M0!4$"H*80&&,Y48&0Y-1,`F.);X1^"::2"-<`%
M',"O58`!#L0%"&11;0!@$,!:\I1'(1A[`5@#3$`71H3)$,2L)476<:6G3.%7
M*:6A529RQ<PR5@2M$,3)(446?24E(5\2OM4<_A>`0-C-(*)%<(!9&D60$!3X
MD69/>4!34(>7J-2R&(1*^>1258J"90`!Q$A&*(!,5L0%"`!*<N6%T>8CA8X?
M>9/I$(`22:>YT%$"_JBB6$[2!!P``URE1"1`:!H$`#F$4(Z'.`&`/-X3`E``
M2YP$!42`F!0`K-S*K8A(!.37[&EG)1W,I6%$>QH$%.HF1/TEK.64?2V$4]G*
M?D+3J74=1:#(`Z3'2"E5JO1.JF0&A@@``S3`<,245QS$!0A);4)'3%0)U/F6
M<5Z38*9%^SC.D?C(CR0`Y_B2+ZG*CAA$]'5B.=F:`X"B`]1.`R!`<@K3=U(4
M!X360%A`<2[`]S1`D^71CBI)!*(6-VJ@:?;%"#*`D=7>Z+AE`JSC.B9`!`AI
M`%#I49BG<0`A06P`<^U;8+E4:QK$`X3&!#`*D%958QD$O3$HD4$&!C2*_J85
M)P+`Z?1,!7KT927EQ$'0F)OQ2&]&D\(9Q)9*"`0H7"\M"P86Q%;VJ3%-4[!1
MY`48H[.!&7`84-"H#&Y`*C1Q0,%I4.;PB2DN0,&LU2(^%E&8298H7JY"1#6"
M1O.82:'*EDX69[8@3\%UE@:`19-YJ3!Y`*7(%`?@9$HJQ(O*56(2CH;FV2%I
M!T/ED8[DX@``TK;]E?/P6J4LXI@T(KZLC([\4*@0P)M%``.PZ%(MZG2HB`%4
M`)GP5`8@:WAEIT!TT%\%@`,$X,$Z26L^:?!@$7S^3^U0!P5<ID^%DKA:K#JZ
MC!O)3Y"`HITN@/R43`#\JU,*Q0`)T`<X`$GU_A0'.$>V5`!A;`!W-8IO0("*
M]E3+%L3(J"P&$`S-36Q/68!B5L3;G98&P(<$Z,@Q`@Q/CH:"^$U!5,\I/4``
M<->JO16U&H1$]5,&C%21Y1O6DE7D)(4HI@73UD>K`8FGM=4A62E2C,H/'<`,
MF<^6Y(]\`(>`B*=:9`"A)H2*&$@QD=62#LD"X1VA0@0%>([QE`;8CI78(D41
MIL4MEE,%),D")$DP`<"J1D1?)5(BW=K,!("XOIG,!("Z9$[1H.Y78$RH:([C
M`&G73<`#P(0&75P*D491J)2`A(2`6->\/)3(`8`#4*ZQ/("S5(`!^!I!M.U,
MT=60$$!5[9]UJ,3G_O38S_+4M12$!?2/49%*0>`26J"/D4)3F`3+`@1FIF"(
MYC)$!71N^Q8.A[JA^ZX,4/E$8\EO(NE5VT`1M[Y+`'"-N`8`J`12Z$[-`+P+
MCDCF=+[+_2925PP$.C:,'J80?(8B!13-!3P)!H-4<#0+!A<B0X"$V;*&_4'%
M1$G`9.K%7S%)S@*`%H97`:@LHB6J4G1`!;`9.4$=?F8`0O*1^BY$A_JH+[D1
M`KR9V,P,EIW;(7F*_`J`!+01!A08`WL3D%(&'TEQQS!``#/P`$C06$BQ8UF6
M%'M*`"3`Z(3NQ6I(T)1NJI",N*:CRZ0*C4VGSGS%M>`&P"S`Q5HDT"A`_JJ\
MT0V)4>1,3JJT31@QHN.,VL'R)5_2B@<%H"9Y)70L[P=80)8E@/`&H#8&#Y=(
M@`$\B`B'U,L:Q`+P5M$Q1_,I)_BZ<'T,84+$;``"$`?$3W-\`"OV76&8"1:9
MHTI@P`$D0+I,0,I>,IC"L`(00`)(0,'490(4CH;VR\MDJ_L&S0#XD!1C"(,H
M0!IC2!J]S,L`@"=_0`40DA3;B^JTD!0_30+,J!4S<`/DR)8:<+.VKP'X$,'(
ML_R^+)W(LOR**X8TC(LL0+_TBS<-M-.(34##,.=4SY`>0`,`TW7V2Q\/5_L"
M1;,N`.>\'0,T\03$Q)7LQ(8\&0,@21CMA$Q4_LI!^A);Q`1'QP2#>%X$D"6/
M$!!+QT1IP`0%O-TH&>:TR$3>3H4#@%1G!,"-]`OH"#1@&(!,A$;'Q`0I0@#E
M4D`]"01,@$GL-(`"R`Y^7DE-R,2\UFB0<'5,A!$@S:B&Z$A-T+32O4PV@XJ^
M>D"(>)%,,$"\'O7`+(XO)<WS^E("U/40M1'4U'5@]PL=T9%`Y[4B_?(!/">\
M]!'H%$"]JH4\!4>5$`7?`6LIX6IF!RNP<D#7O5W-NDC7V8H``)-0=``9WZVP
MXEUH&&PPU8L7`T`+J?$W4P!L=Z[*Z&(Z'X!M,_!>3(K$(M(?N:\`++$U?_/G
MD'%PWV^Z[`4S2['U_L0$.\LOF0U&!O"7%%>S-8<N``6)=D<5B#"@_((.)G$W
M!3AWYXZW43?`EDZ`P(C.>./(14\-#(.I.H^WP,`,)@$1T/@OC:5W`NQ%JL@W
M<J?WYPR`?`/X7B0EGH%.-H..@B]`,QHWAFSKMKG(FA%.>AL`8M)&:'.W+Q,,
MP9#*6"1`:$]9AGRS@8T%D%P``82V!3BTS*A,BB?2`[A(9Z\,'P%U&$>5L@"K
M<P?`"Q4A5JM$97-$3_`)+<W:WC3/P<C(0X@V`!$%?]$IX&Y`:H\F`"C>8,R4
M!^SB<%R)/+F(0'@$.HKDH80&<*CY9*^YT:;8W;Z'3XBBG/O$OB')0WB(_D]`
MP)O]-IU?><S2FT]<=1]SJ,;BR+P>NHTTHX03-E"`:3/B650I-P,OS#VW+YFU
MR0:<-Q,'RXQ;<\%TS(03`#]NNOR.^EXH0'$S<'SGL36/^OH`I'&'8O48][;9
MB@5H,0,7@)X;-P.((@YZ^G030&:<N/M6-`+@QJQZ4U392\=\+H:\F>3<;T6[
M)>A(N!1?W@-$\_RB-U",A:7GN&+G$5#0$;57M.A$^OP:@/EB4NBL#")_``8\
M.([DXKO3YBXRP"GN2NQ$A`]+A4%Q`+UI2UXVA9F@!$72506HRKV$2<([3DQH
M)8Z0C0&LRUY8?.9P"NYDR/.N>QG'M_!>?(MX_A..@"M#M8K%IPMSK\ZLSFH>
M&;#KC(HOK0[0<(VHG$[&2@Z9[@S`[+PB]?.N^\2MY1FXQVO\-".XHTX!5,"W
M(WV&9(X>3OIP]\3E6;.1C=8X3[><\[:Q/U*J3W@`GXX84[QB=_NR4_@Q*P`@
MB7&$SZAXY_A<_XMVVP[9&#>H5-6USS-J3/(YU2$<)@2E<.A?*9RQ2,?6N5A;
M>$G;J<63_,Y!+(N1\.7B0'RVT,3;+<Y\(!"0_@YU*,[;O9#E6WX#>-'+!<OB
M]`3E7K17IXLO2;[$)F52.L[K^Y(%$\`)(\"W",S'DFEPJ&!P@HQ.!/2HFT7D
M-.+BA(GV)N4#+$Y3_F31XGCLY$B.$\MW=PQ\4K(%Z"]_F^"K5+N2XAA$3FBO
MY(")TAE(3"#0VR$Y08;+="Q.T;R^?$_`XPQ$!RQ.`_00QHLT!3Q-4GY`&$T.
M0#!80"```(,`*'Q8\(%A0X</(4:4.)%B18L7,5[D``"#`0P</'3@X+##AY`0
M%7B8H"%C2Y<O8<:423$#QPD;8%*PL"#!3)\_@09UF:&`AP,>&'I@V;)!0J%/
MH4;U^6!"@P82.3`@$.$"PPE2P8:=N1%#A0$#$!@`<``!6P$'#@PXD(`MVP$<
M&G1UR0&#6+]_*WH(0$$!SI<9,BP``)AQ8Y\;B@:(6:'#@*^.,6?&N`!"_H4*
MFBM&$!V!`X<.IU&;1`HZ)MF'&&"7C0U;@^R^'R;H;=E!-VO?,RL@='!A=4L+
M%Q)(_KT<,U'!Q5M*X$#@*G/KC`L\:``!-?2&'D*69/S`P8,'!PH,('#VK($"
M!0PH@#!_000-&N93F&"A+(0)$#*X[P+3[O.`@_ONVP"\D>X3;Z;*"#!`P@FW
MF\_""QLP8#X#"%CJN@^EVB```-DR``$'(#A@P@3F>V#""0G(@`$(0*PQ*@P.
M^"``O39`\#X,+H2`@@(W.!$`!#+3P`$;&RO`/P(0.`N^%R5\;P`#O`/,0`T"
M#%`#"[ZL#8('+(#`@/8($.`]]]R#;\WT#%KO_B```B`@O0+HM/.]`A!PL0`&
MS",/`04."-30!Q2;<X`Y&6UT3@0N0,Q`Q"BM-(.1(A*I@Y,<9-*W#@(0KX,,
M>NR22R`?@"!2+KG$J39/89V)@J(4V+,@@P2(\#T&`(7ORA,Q0*`ZS&"+52P%
MNBJ)50D@J`V##,!LU=@/3J,6TXDZ$!,"#'RLH%D$-[@@R`,XJW"^".9S0$4#
MUFT`16XKL*"#"C)`]SY$@[PP@@HDI#,!`1RE,X!<"R"`@($*9N^L]>Q4P,4^
M,XSO``(<:&"!!08M3V/R.-YX`:HR`/*"!R2H0%#R%'#W@0B>;3GDEUN6@#P&
M'<K2IP!.Y"^#,1$E_D\"EUO&0`(*,GC`X&F1QB@#+!G2H$<$07K(,)$8R@`!
M&C-3,.FH%`C@8XTER&`""2:(P+P++"#9J:W9QLB##4#*`.T-Z*Z[M'I9CH`"
M"NB^J4<,**C@`@D.4("N!11`-X'1(JB/`@:N+IS0!AI/?+0^$W!//;@(A0LN
M\ZYNR_,"T)N80[E*5[%.TCUOG</UFB*O8M%@N\#=`RJ>`#8'&@683@$&N#7@
M.>O#H.X-,+A@=PLH8#GYV8P/.>CGGR>5;N,W0.QZY:L_WOM2ZW[V-+H-A)M:
MND'J@.Z*UA?I6HG`@VD#`5)VH.**"X;+8/4(.IC#`A)@D`2TC'O*NUYL_NA6
M&PK4CGE^.YZS"EB!^PFN=A@@#P7N5S&#G4@"#N!/!19X`739SUWNTAW@[`<!
M!S!K.Q)4@+H8(,+[,<!P#E``NW"G,@MDL(0DY&$&(]!#%:UG8>H17IT&=A`!
M,*!M372B1<+C$J1,$3SB0<II2I.^TX0D/%D\D`3`&$;1D"QE8(2<_;R81M-@
M46A@1(P:.4`!=Q%D``E`0%ONB`",M:4!$M@C'M.2QSNRY8X&2$`"[!2`@2'@
MD'?D4UL,,+``\$\`DZPD`"K)E@((@),#Z^0`@`=*!%0RE`HS925!B4I3KK*4
M[1F451H@I09$Z2P!P--!Y`*`@N%1`0Q8H004_H``&@X*`@[#6#`%P*&XU$DM
MF)P+(:^6@`8PH`!UXF0C!QD!"3#@4A<3Y`$@0,-M.H!>%9C`?C#F``1HLX,(
M"*/,I"F!/+*ECV#4SSO?"8%WPLT"%2C-!L((@08HX)WU+%D8!S0V=I*L9*8)
M#VK>6!I-9;%:3[3H1363&R:EIB4V>\AJ-L71[WQ'4ZA!C6G6.$64:F`"'-A`
M246"`8,L8&P<L``'R);3#1!M;&/K8$]SVE,+9&]`';CG!!B0``;D-`%`!8D&
M*&,::ITD)INJHE4UY5&3K+%3&/7J5\$:5K$^Q0,]88P&`HB`KHZ5K6UUZUOA
M&M>,:#4J&5C49^2J_J6\[I6O??7KUBYP@`C\-2H7(`!_>+,7P[BU`Y<AK&;H
M^EC)3I:PI7'(^RAKDL5F]B\=&!9G01M:T8Z6M#_Q;&E1FUHH1O:RC=G45UC[
MUPY@3;5".6UM4>M2S$J$;A8PF^<,L+:/5B`":8E`!BBBO@0J+VP16*L'+D`!
MZ/@6N1#Y9[@PX%R89`"O4/%`=6-RFP]\9+0XQ:UM/WO>T"H&217IP/`L$)$)
M-%.)X(5(!`PBO`&D9[<=(```).`0_"H@(A<HR'X+4@#[8K0D!B+MO-0+E-M&
M.+0,`(!C)W(!@Z2*PV&+"`<6-0#.:`632XJ(!`PR`6AEH"1K98B%!>"A_@T`
MH##>J8E:Q\N``!@@(Q+HC8T2.MC1=D"\%*YJ>HVLF0LLA#D/`$!W)^(!``P`
M(QH>P&([`+``[)8A!?GQ1!I@$*9]P`)K>0!F:Q+@ABP@`)M-+E*T]H$%+\<#
M""@`AD';HR3+9,)[U@S5F(-B*,,/DUR^+P"8>-D*%/DABOFR1,(L0*0$A\`0
MJ0EM/\"!$4%D`@FH-$02(![A+H=O,2ZM3?T,DSZGFK`0>/)%$(!)$2_@+*-F
MB%I,G+P+L(3%UOT`GJ0)2P48N@$QQM,#/D#IB&C`:P^!"T0T`$;X;?0!`9"`
MBRD;+E:[9-7;!HQEF>/J1%-$RFMAI&@2H.:'_JAE*;Z39'HYT)7_3MF.H\1S
M0\(<LK-H(,R?=HB(VML0"2#9B2KADJ$GNZG6>AM;/&9X8YAG'0>(&(H&8;1$
M#@"`I6!`7F4&`,$_$&L-%$>K6D$*[TQ$XXC<^"&$>WBL-@!E-[\\*1>GN504
MSAP*O#HP!GGTH>^-@`"`/(!SE@B;XSM>-JL<(B)2MTD20.667&#F-Y?*3:T^
M+9MG_2F"AN*B?OX0"-E7PQ_'.$<P$N;N:GK*64KS=RPL9*Y?9P*VGOO=Y>IJ
M!9RS+"J&R'L!0`"E5JP!38V(`C!I@9!`X%8$KPD`F@I,":#+Q8I!=D,65>C7
MZ)(J9@*`PS^J'YLA_IS.L<5[@8U^>M5+Q<+Y/0B-WH<!3G(RE9PTL=@=H);,
M'P3D!O`=HVSM@6,[1`(!.,!N@S.GH7O((4[F.=((=Y^VQH_/I/<+55>??;!<
M(+K&XS[5/P`!TV.+N"0[SJZQ\H'O<S]D68+N!;HJ_;^'[/S,?PAW!\0VEM@?
MK(B9R?H8`]RT;P`)D&W&C[#DCS'BK``9L`%MI.I"RWP<<`(G`@(I\`+#0@(Q
M<`.M;P,]\"?LXP-%<`1)\"?(JP11,`55,"*&9`5=\`5)4*H:(O4>;JA@\`;Y
M+%ZLPP-,!@*2CJ_XYM_N+@'"#@=ICG`ZI=IN+R)H"#8&32(FP`'P#$_^_DL`
M?O`A'*#(YL4!#O`B/&#>#$+N/&4!?T*ZLN\!BM`(QVKK_@+Q^,\B/L/5Y"[>
M1HHA#D``BDQ$>F(#S@3C)`.D%J4#DX+Z!M$[\(L!0,)BMDKQBJ-H2,,AY,8P
M0B)PNM!M7(T`TC`CQ"_[T$\-Z4P(N^,T,M%3(J#-'`)(PF5,]FX">.(SK$(#
M+`P!Q&LDEFP`\L("JHD!'*3,*DW;!.H#T.HSU"(MANT#[&136"HOJ$4"#FD3
M,<!@$$+.HJX@,&WGMH(!5D,QDD@"BB0`Z((`^F(#NL8@%$`#8NU?!,`"8V(#
M:,@#(L`C@`(!!/'A6M`3?T.0[,SW<`5@0.\#_F9IH"#G`?#1G1P"`@;R(-7-
M`_H(729/FQ)`(,%(%B]"QYBOS,Q)ES(.9P+/`P"FN'0)RC)@Z";`&RU@41S`
M03A@`=B"`2A@)#CD;:SM`P`&J0*`FS`),@#`3+8,`@J@>0)@21H@`"SH*UQ-
M>8SOL@[@5B!%_33N`[1BIT8N..)+,1R`I6BH3F8+`"Y/*,HC*8SF"F,B);)O
MT>QQ)OC-)S)N>,3,(=)2+9<PTM3R2!PBUN(2P"XB`@:@4R8``)@'`*A.Y3#F
M`Q#O(L>-(<*,)19``$"%`"2"^P[)`Q@@+[,,V>B$(8Q&`P)/PP0@`GB'P(PJ
M*+\B6VH%`_S+W.3"_CN49);:3`$$8"0P(``\H'DP!M%"$@#>IP$.0"MR4R@@
M<]028QXG0AZS#UEN$#@K@@YEPF@,QD[LISF=LSAJQ9`F9CD58#DQ#0*6DW^(
M:"XB,^!D"I.6,SP-IB#`4B+PB_DP<T`NS+\60EUTY,GV,@#L"[]P(@(4<Y(Z
MA3"JBP,$(`/29%0`8$DJ\P,H8``TC`""XR?M1P(T@`"VI0`H0VO,!+\00D&Z
M:@&J0_:F`P!PHOAJ0C%KP@`V8%&^0C0T0`"0K0,\#"C*RM\:8B>P#2/.[$5C
ME.$TJBSEJC@`[7P:(E).<-EZS2+L,T"R147A\\EFK``^0"U`Y4@O[-\$_D!8
M:(P_3;$A,+-#H$HQ&:`U\>LJ_BO>#`DS$4*77`H"-H!WJ(XZ]I)%UL,LM+(!
M^.0ARDQ"O/'7`&`!U"(!.$`M%&!1Y',"!,`J,`DO/R]X[@TF/&`![(XA*,``
MC),B7NKN;A1'@4)>P.H-F<)-TB*<"N`"^.4!^'`A&.``.F"3N.\]GD[.:F4!
M3J-@W"RPW&2P^&5BWL-/Z,(`ALH]V#$!W@,!H@V:"J!,5#*&3B.(>ND*-T#%
MS`8#D*+,4.0!2H(#QH1H0A`#[.<!^F)>4H4&.RH"RO,A,@13+8(XLF]2*=4G
MHN:K:C0L=C1^'M)%&\+%WE"J-'`BTM4GC`HB_IQ,7!FCK`J@`[<I)A*@$E/-
M7,^UME(UY\#B0-BPB8AL7?W"'*U"#"?B%U_B6^?.8`\VM1A-;FYP`5(U,%CD
M)0YU[NAE8\]KT)3B!3E`FUXB42O@`)EL]7X494&#7V&%6X$B66W4"F6"`9Z0
M(D*M7$?19L&BL:8E:/T".5EM`@B@9-TF6#&B`\QJ]=#0:+T-`UCS:B#6O8K6
M(29``<16`19`9R'"`AK@46%E`@;`;"VB03$6(AK6ZL`$:P'C`G*C4_#V)K[#
M`LX)+*&*^3P``^H..M[&>!ZB-NROBJ"--`,#Q1*``M@,Q\A-JQPL*;HV.'*S
M:R@6(@Q7;&I&1V&#_F`SRE&C+"(\2@,,0&D?0BQ7+V3M-BIVSB!NKP*44CR<
MCTX\9':CT22*SR#&+5'CI+LHX%8<BP,R1RN_XP$`A@#4<2,^;6?@QHXV<9:(
M*4T>0"7(AJ8F8%--(O<$8`$T@`,$R0SC]4F=,KXZ0""%R3#;(@&LQI$@AU34
M*2T2POD&(&X_)`*JUG-GY>\TQ&8\@#@K8FA7#VIC=V>%1P"2(E$,0LW`4'DS
M37B.@D#G1#%?3/EX37B:TBF52#Q:CW:3*T#O2Z!>+>,0+_``A@)0[%$"$;^V
M!=%F+`!2N,AJ@@'012C]L0""J"DM3%%%)`"^0C$L`,4>0`,V"<0^;UI4_D)/
MX<<!%,D[A*]WH8U40T/[9C:!HR+Y<*4D1&1.D$TPP)@ARNX@XBN`Y@13=@]X
M!9-16%5,#Z(K9FQ.^K'I`*!S*]@`=/$_"2(K$")W`V]];1-@D(+69JPGU&*S
MR@P!_#9&/D!!^.))@](P!@!K=JZ(`6P#,HX#N@8IN`16'*``8A0!Z@Y>^8U0
M4L\"#$!<.6`)3P]>M?@G1LZNE&@I'#@`DBZ%Z<0I;!>72H)W-Y(AZ/(@$L+`
MYN19`-DOJ86^=(DB7I/)8K.#0F5)'55W":(#$$]RZ83QVBQ#OA``D*(!G%?E
M>*?(RNPR9F54&,"0^%(P[X(A"*#2I!+%!$]P_B"S*'CT*=2QHQ[`B5$W"@L9
MVF@D10QM`OZ5MS`-[Q(UEJ$"_C*M:QB`61F"-]@B`U:#`XIF6XH#`\+L`,2K
M`M!#?+^#+@5@`J:H(P+/L7BW@L=KW@8`9TNQ4!#/`/;2889N(XKBORI@A1%/
M,?_+'-L,,_4H`")@Q@@,3Z"LILDD@"#CRO!K2>X04Z"$(8*#`C3,@]:#?,$9
M+$CWHS`T=0-8F%&31@8WBZ5F8%&W:QF:!#M%;3]JY#"B09JN4SS``HJX4QJK
M9B6B`RP@+2BF)-[13D)B4,A7`$`Z`92$QD)T@`WT`X!)0T1B``A,IYO/('Y%
M\2B`8<[$P`*`)2H#_FN<]B1=Q$1,>F=@!7D7P*.,8A.!T92'I8,FHBIVRUJW
M+5O6.LEXL*,^:JWRTZ,)5"\4EB1&PK?PFFZZZFVB]9$7ZUZ#.VD&SJ.RX@HS
MP)2W\@/H8B**RW/5FF-A][9%ZVUJ!F<G4-.VKB,H5FLA0H)JQET$&%&ZVKM!
M*]HH;&5K)@71=N;"=N:0`R+FXZ,FK\`.ZZVSSP,26@5!%[[]Z@(0`#H(`RL*
MO$P.+T=(`@'F;$=/K\X0W"<\H&TI+`@I[`+&K`(67"(LP)0+W"36R2$:P.C,
M9L`#+L-5K34IS**3S'XV(`((`.%*_&Q/W"0(RB3&9*^WF^%@&<8SHA@=_H)<
MF;AS_X)ODPP7$9LB=B*]J_NC.@V`L"T"$)ANC1Q1R9>B2L.=4`JEH"5]['6*
M7F+(':(P&:,E_4P&)\("^I>,>[PABB7*WCO)BKP$"5$SBA=75JD@.$E@,&D8
MZP*/V$*7[.S0&1W1$3WJ;HH#_(F%M5QL,'KRP"CF+L`!="O/,X(,;V['Y;3.
M,<);M<^M'=!3?Z,C]!HWQ)<O?H3(,&"=H2<V<*>`G),"R"6[:KVO<49=G--^
MUL,Y"8!<EK,`]EDH6FKNY!S:OA8K4'W/*@#DNCPP%`!C59G+8O-0W;'*OX.`
M/7<!#&U]9\Z5`0-4K\.\YG9KIKSE6!<C)N#=_F].)VXP>Y?#`0A``MPO`EC:
MJTM6"GEK@"0B`SA]K^&W=9/$TX6"X!G`I`<%H]J](,4[-+S=9)F\VH\S-QK;
M<_O$9F;E#2O`>26B0;=.H+`M`_R96JB=KR)D;YZ=2=*&OR>>(B#@XK-.23">
MVY;$'(U.^'Y.DXU.`I24MV@:=8,HPP;@-EHV:T!$`GPKVD$$;67>)_I[]3B@
MXG/>7M5,'!_-L[CPPP[^OGQUKU]((BJ`S2'QH%/RTQW:)UZ^9I0'*BRZX+UJ
MQ2%B[&<"2+(O<+(^(ZX^7@^@YPO`K!N"#^W.L`RMSGK<MS*L)[+B(C9@Z0+U
MO>6]8GV'<G]B).HZ_MF1AB4A8I7=GO,?;K9N4/%^`WD=`A:U?9H&'A,CHI@P
M%9MAN<X:`-NJ0NH#HV"4!T_V/"PP<P)X(TH5'CRPWHD:'B(88.8GPH!5X^XZ
M`.U3T-Y]`_4=P@(042*J$GY<M^4D/%.PW@/.`^F[F_BJE`?UP@$6X.O]B&P1
M1U'5;V@:X.PY`R=:^6*0BZ7.WLU?M'?M6LY`""`B5.#PX<,%"A4J:"CXP4(%
M"A@^>.@`00&%"Q`8:MS(L:/'CR!#BOSP@`)'`PM'?C1@@2$'#RICRIQ)LZ9-
MD1PBW-S)LZ?/GS<?P`1:D\,#CA4>$.3H`4'&CALB;.@H8<'0C@\J>*30_F`I
MQPP*1%HXT)%`@@D$)'0@,`!"`0$/$@#`X`!``0,`!#``($%#@`(?'`384`$`
M@@4`&&RL>!C"PKT)*A+@@`$NA04$.FA($#E!@0P"!$1`W#4ET=,R&5PX:=KF
M58FO4<N>3;NV[=NX<]/NT,`J1PD"6C/<0.!H1PL$IB)%$)MAAP,7FG^(4,"K
M1J,B)0#>:`$`000&-A@.C.!#80L3`%P$``$#@`7==78`<"$"``T<!$CP>($!
MV;TP>4!`!@5Y4$$!WJ47$4,-##`!9!8XH-MM#)BDT7,=\+3`A!QVJ)('%GHH
MXH@DRM:``=)5<`"!''&PP'['%2!<01(DD&%'_A@8H%-'$0C%$08-B)0!?3!M
MP!D!]WV`P``?&)!`DP5X8)^+`#0`06*((7!!8A\,B8%]&G0P`(P%:>"`A1H,
MP,$`Y4E$P`0=1)!671Q(D"1#"0@`P006;."!<B7^Q(!P'$RF(:"!)GI;?8HV
MZNBC&[EHG486*-:1!PF$N!$&""#*4`0(W,B1!LEY!&IL&3P%D@<*`$#``0(`
M$,&6`U1&`)0?*$"`!P<`\(%<#?2:U7C"'G`K!8/EI\!5Q+5%70`<]!H!!\A*
M!8`#1MUW00`4;""!8P0$4!\""IPX(Z0J,="<C3PA<"ZZ\-*D@5;QUDOBI![F
MEQ9_"GA:$&@M=42!_@+G5I!`P%\U\.X$76DTP8XA@?B``[/"=,$#"SCVP03[
M?>O!Q!L[<,$$9V;@P'X=8##!!`1>@*U1ZFJ4000../``@?8)0``":GD`@0,_
M`^V!!0:$%D$'%]<<`07%B6JO2`S@&]9./N/[]-4?86`IUES;5H%T$^:$`0$+
M_K:LP`,T()T$S'5T@0!E;U1!U)<&6W8&9.KF-$\/J#=2!QWX^\&-[Q;$@997
M%_#`!1=H,,'%ANZT0.%=<VU@Y9AG/A('BF5`P&H=96#<J&==>MG>!1&7MT81
M'"!X8`4L:,'JN-%^DUL(V_12!PMLD++@<%Z=@0$%%&_\`5;+1`'8FC^=_D'<
MS4>O.0=3>XYZ0159W=2[%1A@M09P>X3!AOR1SW&'UX\X]@,&*/!`\2RV"+WT
M]-</DN/VYX_U!JIFD,#\@^,*`#>@`-!Q)`(0$)R1?,01"SQ@81MJ@.UL(QP,
M3!`W'K@`!J;VD@_,J`,4R)W^1,*J](VP4160T`E7^*BH7`AY'M'`=IB2@`E>
M`"67`MKUQ@;`#V#@`!+L$/D:I1FF=$0#%['7<]HBD24-@'*;8V&\*+`U*39O
M6O#"SG78U9$*!`DJ"J`74A@@N`X88`+B*]5QG((^U&0`C3>)0`\WT@$/,$]1
M#GR```97@/1`T8J:T\`<`4G(VG2``4-D2(W2_N>`+W)D+?'CS@&DPX$"B)`A
M6DL?PSAT2-3\J9`J>9P'&-"`#O3K5J#,GP4BF<I6SN9@771=#M5T'`*\*P)G
M&Q79/#(!+FXD`V+4S1T]5$42/FU0$JE9`S8P0]U5QY6!&B8TG[:90-'E7)7Z
MR`.*.9S(<80!N=Q(ZUC)$`ADAB.+JTT%!JDH$UXJ>8U239\^`,X+--,F%W#G
M-&VCL7U.CYVXV8``VL81QH$M`I<L2`42N9&J2.<"H?*(!,)9$`8`E)`=S)^Z
M=+6!"2CNGC5Y@#[].9L'7)2D*/V1!":0,08@(`,<F-U*-6"!`=208Q*(GP?:
MYZ>)`*Z.+`6;!4IY_L0+4F!Y&F%H2NVGK@448%D78"9/<K+4"2FDJE@-R0/(
M98!7Q2H`11O`77:&`+:PZ54(.``"`@``NPR``,4;J``&8`!RU4BM:I7+`!X`
M@04@P*X1&`#%)""!"!26L!`(@%I/UCT)A'`"?\QJO1C0`:4<P"0;(,M.-&!`
MR7KVLQS"`($Z(`'%P/,#E,&`:E4[@75R8`.4J:,'2ELSD:U6M10H@`14FX'G
MJ=8!@J68TFQ;`0(TT@$[<P`#+(H;"R141">MW$916P#-@'0F$8`C:&6#@9%N
MEZ08\,II9;.!UWF7GM']B<N^ZQ,&0&"/YG'I=642)O:BA@+GM:\K$Q*]_O]!
M$U`>&&_F.,"9`E%'NS:90'KUR^`&:T0#K\-:`B([0J]P5L!+M:.#?9(!"F^8
MD"F+'@(P;$4.>)BD4?TP3P2BXI1J6',?BW"+I7C5&==$FC;.L6T:IV-08J!_
M/0ZRD(=<H@X@&)`OE@B1Q;?D)CN9)SA^,B$C0$XI6_G*^S0LEK?,9:YUH,I=
MMLD&3MSC*(?YS+G1`,30?!,.D%C("V:SG$]#F#G?9")A!K.=]\QG1P&NSX`.
M=$]2+.B13$!5A4ZTHC]"Z)$DV<Z/7O2>WRSID&R@LY7.M*910Q<]GX8#%]@M
M!BP@Q]M21BH?V``&3.HH59.9DQO(@)DW36L=_F\)`,&LS9#:RNM>YZ6M0>H.
M`%#4J/0$8-83\D`!`G#.#D$``@V(MK05`,X&:`I[#9@`LE/YVEKKV#VX[HF;
M21@K7YL;`&3A`%N)K:@,L'7;N<E/6RD-%`2<V]=/TDBK`)!?5T;:VPXV4Z_"
M?9,*!&`P(Y'+`@"7VMMV."57TFP[8P5O#*ZVXGP#0``,>S*'7&"H;7UF0>K"
M;X";/%X/8&NO+S@283_W0FU5JD?D(O%$::"MN<9J>I@4P[8:D.3]/KG0<1,!
M!AC`KSC?+%MS/BI@JX3FCKKUM74.`)Y[).(,&7C0A\[UYGKG(R"$0':1RA"?
MVD<!$Y#Q3M&=+K9O_L0#;V0I?L&6,I(II3DO!E':&=W6J7_$`XZ;0$8O)=LZ
MPH8I*E-`!E!GQPS)>G"&A_NA%^^1QJ,G0XT7R<Y!LOF"V'L`>_.I':4Y>HQW
M_?05!0`E%?#5`<0J;1$AE;D-L*JVJE`DO9JD1GX8J]"T=0#7YD`#REUN2^Z>
M``*(T`#Z_G>V`M1`QNIU`2`0&TXM?Z[#/HMP"-CK`#P`P,9J]@?:6E>\\'KC
M=&P`\GFM'P,$(-^<KSI(*#"``0Q%,"4W,(*838"=K5FA)[,!"#!0=64!IH=Z
M0H<D"548`=`PHQ0K#C`1#D!J")(`0002"3``ZF)X;Z<1",)N!D%^+=$!_O:6
M%Z^Q;XIG'@-G&AQ@?N27@AZQ:W[W2[R6*;WA=`P!/AJG@4[U>Y$D)G9A`2[3
M5E6T%Z#'$$O25G\!`0^P?%]73DH(-,/':Z@4?U9W'!JG'(B1?R2AA/7G>FWU
M?P/':TYX+0AXAD_G*Z.R=!O1-P2'6LMW47+A*OUW``>@``I@A['#$!]X%7M!
M'S+3*O'C%U4B*J#Q'F67<FV%:/S!?"'1'0&@*LK65J)R`<N7.QBP?*,C)>,!
MA7/!(%4G*OM6*\[1*T/4`;'2%YC$?IHG?Q[Q'(D!:H%!B07R>O%#6K'265?2
M5KOE`1B`(`#@:6AXAFORA+O75IYB00^4@_;&_G1OAR3WQFL(@R`25QENIV_H
M%B#[5D&NF&HH*$U2%Q*%PB5;!``!,XD"X"E[`5^IYHAE<HD,07)>46Z8EAY/
M4D=[484,00%MQ8X?86QA]"T6P%G0AB0"T`$<D"%`5Q#V425O-W`:87``$$X7
M@!@O-XQHB"27(A<%0%0?(5!O"!+4N$X8<%0/@1`4X!74Z(E3YX8$<AF(N!'B
M`8B#TP#OAV&H:(XAD1XZN1&(,37FD42;4@"G*!<4]657,7!>T2L"$!M,<X_J
M-I%?\7NM&(V\=GL;0XL-00']Y!(38``UQP#%@R@;L!='AI%HN7PQY(0-H&<;
MP(81LWQ8"1*((7%U_NDVL6(2<WB6K$*.;\D>,1$K4&0GXK>*QP82&Y`ER61D
M;$4`"A`!:S-O#.)Z'%&!!<&3M.,S>2$2NV@ES^8`D1%M$!`=E!**(9$!"^!]
M&K$7C/@K?(&6L,D0:AE#H-)6"+!.:QB2*Q&3(M$`UX@8W)1J>&$2=O*);^>;
M,!*59QE#;"6,)1A<Q^4``_<:,U,S%Y``*D=[&G&=O-8`X;48>>$5ONF/(P<`
M^=:0HZ,1=:&/'L$!X1D3N^@TOA@A#E``T'B-'X`8<_F7+!>;7-<!".)I'E"?
M5&@=&[!\S@ASKJ(2=YEZ,@=N.M&0``2!AC,``4!AX4B75ME60S%;*L=^_FU5
M<P:6A';16?QXA`7!E$AAG@4QA_]7$-T1G!MQ<PBG$FXH*A]C;L"HCW)13`/Z
MFOZ)D5?B37^7$['B31:P)".U4Z+A:/8F<?:&3)&")'K95O/C`6T5,/(F8Z5I
MC![QI!H4IOC18>>XA0D0IKYC'VW2$::T?.A7$'TC`.*YF1M1%_G&?6NJ$4C"
MGEUDFBI1%U%2$&/C*@W``!;@9A^S5QHA%]JI$6S5GT%Z<H6AAFS*%*RI2)T8
M$K=V43<GE2E*IP\6*PD`$[LVEQ]@)X?9CB@J$EL"?Q^1,Q^1$A$0*ZUI)R+*
M%.3'$/F84;V2IP7!>OFV=GRZ:S('GE<H$@A"_E!(<J&_X9@:X9NN6A!X`:F1
M"G!1R1',%`"V<R4&M"5`"1*6:)PAT:D2MXM'1HB6X@'+5T5NAAA#9!^-RIDL
M*HYXP4IB\G[8\YX;86\[X@&]8:K"@B?9R!"YNA'+!G_O!0#IJ21MM;`=P7JW
M"A)(`B.3VIJ'F$AXP8C\2)/5BH#7RA%(XAL/AB#:19A<&H+B6B`=$942UY`C
M=AU[81I]XST:T11OR(^%R7GO)TW=L3K@]A3C.2F[1B\YN:H%L0`&L#57$AH2
M`!-$R!'+!W]FI'&K84>32H[Q-U]LNGQ'.)/<)`'#J1%7PHCV$0#"V+'>MFL"
MPU;`5WBM(BX,P9-._G%:/`D]9/=@(>H2P-@O'9!"2%)%`C)L@N<MRQJ1=A$3
M$IDVT58S"\``G*$<[M&`W94R"#(@J8,D"H!YOFA^$(!Y).<`%2!;%6"A1-LK
M!D`!"&`!X!:M\N:J&J`K=@&-*B>C98<7\2H22+*F>,$M`7(!-@EL-[)VC&@!
M"()I:#MTQ2D^'\H6(1I)ZJ9R,WBT1C,2&RNB$G"?O-8I&W$!V-M6:B2]S#H2
M"U!NYW=PY>85$NEKA7EKYIF$'VJ<:\5^3GA[DT@`J-L`;GA/J_NP`E``%B61
MM%N+W3@22,)NDV@7$[!OY`L`4S&3&NMSQXMZG&6\.<B]7R@`CO1@G!4!_L(1
M:7A&0HQS267YA2'4GLA1?PM`P1YD9J#&.(P3)KYC4##[A0,@LF7G%F58*X*A
M,Z:16Q;:CRDI$1!0)P]!2HTS@<6$-#SF01+04:AC)QE\*8R37@F05E<Q2O6W
M@Y#),#6<(0`Z`/_7A*08P1&\=0C)8!XP`12@;662/AHP,P2A'$V+D`1QO1TF
M8%2"GQ+!`.$[(;U%QH",>@FY`5_T,1E``1DP9CEU:2/Q0QKG/DR(&0%PD8%<
MR98<14NC;0LQGW7D.X[F1;XV`"=[R:1<RMN)`0^QCS7*.#%!$<_V;*-LRK),
MQH-G'KVE``M`&2%RR+-LRG_6RS;Q>,-1`1O@.P"9*Q18!,RF;&+*7!/E-140
LX%QOW!UGZAFOULS8#,Q%(A'<2Q`=&L#9',[9/*!OPR?TECF<%<LB$A```#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>f39432xe3943241.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943241.gif
M1TE&.#EA,P%'`/<``````!@8&"DI*3DY.4)"0E)24G-S<X2$A(R,C*VMK<;&
MQM;6UN?GY___________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````,P%'```(_@`;"!Q(L*#!@P@;,$AP(*'#
MAQ`C2IQ(L:+%BQ@S:MS(L>-#!`H4!@"PH($"``-">ES)LJ7+ES!CRM28`$`!
M@0<`-&P@`("`F4"#"AU*M.C*F@(8-*@90"`"``!4#E!JM*K5JUBS8LS9="E4
MI4Q+,NBI4JO9LVC3SLQ)LL$"J`W?ZA38<Z?:NWCSZG7(`.K-!@-\"@S<M28`
MI0;L[EW,N''5D3]YHA1H0+#7`"5/`G#,N;/GE@0LLRTI-Z3<G60_JU[-&N+3
MJ"(!&!!80';L`4X!(&C-NS=KP[L!SQUK6W@!L)-]*U_.N"<!@:$CCVX07:#<
MDLRS:S];N>O3`,@!_B3P"KO!R-G;TZLORE6IYMT+1HYG,#)X[;_K\^M_*7>\
MY.<-P$7;7-19MM^!"&I$GTT#XM9`;>"9E-QK925HX840U994`]TI1>%2([D'
M57`8EF@B06Q9)Z`"J9U&%P``GB@CAH;--U)#Q/U%F$(]X3?CCP?VQ>"#Q07F
M8&6P=0CDDOOUM%D#.4D'5690F38EDUBJ!V%)-;H%U7PC#B9>EF1F]Z$"YRD$
M%7HC.5@;B67&V9J+4,+XHI1MG1090?YMM,`!@&(WT'@+""KGH1E!AA,`WGWI
M)6;D]2F08519Q`!;4&7ZI&&,"J3I@&N>E<"HDB*T`*FE'J2``@FHE(!2_H8B
M:M%3#E(J85N&A20D>@/U9Q*<$:&IZ;"39NK@IT0Z:I:F%1ZDJ8,.?2JDLC(%
MIFD`(Z%4`*\P*5#`MSX"U1-I`DJ&VI#.%41G3Q4Y.6RFUA5`P+>>PIOLF&;5
M5BY"G.(;+;S]INK2NP2'VU*_1.DF9F3WY;8AA`:-5-B0$LGE5Z4+%-#L0,CB
MA23%!UD+%406-]7OQ@,3_*[`'GW<55`'.-C3D<EQ5>QA!2&)7%=H1H3IDQ$A
MG->T0!NDV94/_4S>R$!INA"I"&3+]$OZ@KQ62=/YVB6=`VEF);YU0:0T0IC>
M-+8`3AIZ0-4V*6;2QP(`6A"@:ZM4-LONLEPU_GYT`RIIV4L7'5/'@VH:ZTI[
M%_6>0#?&]I>&!2TN'&[$0>M0?)E66E#5NV':E=,"+4APUVQKZJ/A_69J\+W`
MAL[L`5(/>X!2@`NMT,=0!2`5N`=EG-C&MA=N[U()X!Z`QKTB0.JD!@0@0`&2
M)MXKJB\M>*Y]/BE5F^6,#UG9ACLJY!JS!U4]'N`!VIOZL"&M/^S+IJMLH/"=
M&O0Q;O)#A1O@;.,4NZ9),9]!0!<YPN7&+S=3V8;NIC+_2*\!K]&?YCS2HT4]
M*4H6C%5."(`UIAD&.P(XG$'<51Z""!!P1]N,Q:B5@`$D8(4A-,G/`$2PM;WK
M<`:LUY>0(C=0?4ED_C?I7[\*8$/5<:I4G(H1GPRX`'>II&IT$]F8,(4V!?KP
M+RM4(DL8):(Q84Y7H2)(7R96'&R!T%\)(9K""**I\ZG.2_"*8`D)`C?-X6Y5
MP[+<SU*%*;=148;.RM00[W43J=D%<U]ZHPF'5Y"`C0H!!9`:M+[5K`C>A(1^
M*8`4Q]1&,>5.A!V!'AP;(KG`N,T\L!'2X_`%,8E(\72"3!\"E28U@4WK98M<
MTR`+(K)4K9`@*71("ONU&RARBEL0%&35"I*MU05.9:TS"*<N^2Q!(5)AFBIF
MIB($$T*5JR<QK$Y!Q.FD147F@Q0A88PZ:;HZP2N'"5P=`QDY$`&.,%."_H)B
M[WZ6R%A"T9[8*=O1RL(I4/*S8`]AT1M#@\_-Q=)T/P,E2UKY&@]5R:$XVQ)Y
MOL:R-,8N..33U&P`!\]D(M`@\ZP?,S.%LH^1B'R#VJ33.@E%F2)4D<G"94$B
M>#QPL0U2P(S9NV[23HQR,E-1^R10;(5.R0WD-;O1F9H4!AS:4(0XN=/ADSK9
M1UD*KIY(/4A*5U?2H_WE8[R2H[$^Q<Y,';2!]U)1F!`206024B#>RA]18VG4
M\8@4IS,1`$=?I$6%QN6;=I*,=)R9D+$ABZMN]2K9`#L0ANIDFH&<V@#MY:Z`
M#DN47EWA>-RUQX<4M$!(*Q]?"?++]6D,LYWL_JM7$^"NHK2),BIUW9`:)IE&
M;>@M=DW:8^W52=*B,K5+U)]!B)8`2V;VJP,1F0(LAA^I%<!0;'VH(&&:D*.]
M*K()L6=!LOFL/AUQM@8QWQZ/MJ&@:(9V7'1HHU:)LY/P["OAW59RLRJTMCJJ
M:H)];JF`>*_@EG1I4JR4L3;;3_Q^BG,0:68$'R)>^MF$LD=,X03C^C/M92JX
MW6P?<MU))5PA]HR,O9=/WM40I?6K))HZ;*;BYA;:-H1MUX42"4.B3P9#EV,L
M9N-)A=S@K0)LQF*#2A6MEM[56H>$F$*B(']YSY&-33(C!LI(PH4Y,-D&<PPK
MCKY0!E;YX6ED`?/J_D[>RC2%Y@\]%4[@GD+VKI6.:`&L\FON^FNOCT*M-@1]
M%YG+K"V?QJZY3KY7J^#YJ2M'D'M`854!UWA;5>(V0OJ2*%X%\#]&E053N$DS
MX1+0:<N5;L:5BC,<F4S'80'+?3J$'NB0I<8Z$UFY#\E?.XDV`-Z9+WA`MC+A
M1#;GJH`S@\DB5UO8<DIA^HUD?E.)`@S`$)3JBXA(/`!ILQTHHR7F`(->=9;Y
M^1<C#E>SIZ8GVYI=$$S6<"`'O3$^@:U5KQ9MA>P.2J[<.1[-$*IQ0H+TDC1=
MO`.T*G0,$`NIL$.J9GG+I]^*5?]<`W&(M\X`D;0)\A+`NX?3*[W?P@VG_ADE
M.*YHEBC7B51L2KS*%,MJ*+U\>4+HI.1%G4M*Q9:Y42R6<YV+J5$X:X])_SU'
MGQ=%9""6N52Y4I+7C`>=Q(FFT6-2DV])3:=&+PUY9'R3=<UOZD%Y-]C=DB94
MZBA[PB%C1\>>LABS/4<#^DM/NO(]^+:%[4)AE<%?A?=,NQ/96N<:W@=/%'^K
M7$C8"X[$-DSXQL.DRU-%CRE?1%_&._[R*_$Z@,0Y':]A_O-4JQ]3#@A&VQ@>
M]*CWR(=LM3C,X:CLJ8^]1BZJ^7I)28NRSSU%,/[S!@TH0O;5M.Z'[Q"IZBL\
MI@D1\9=?$9]\;2>T'S+SI_^0`>QF09'I"9SC*TO][F=(S,G1I/"]3_X"1";E
<2R&_^B<"R7RO__WPC[_\YT__^MO__@\)"```.S\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>f39432xe3943242.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943242.gif
M1TE&.#EA_0$\`/<```````@("!`0$!@8&#$Q,4)"0DI*2G-S<Y24E)R<G+6U
MM<[.SO______________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````_0$\```(_@`9"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*M:O7
MKV##BAU+MNH``&C1QCQ00$%*MV7CRI6;8,"!!3(!$"`0@,!)OPL/!!A@%^6"
M`XCG*I:[@`!AO`,7$#90\,```G`%'B!P%V&!`P05#(`L4#3A!`,3IR;-0`%H
M@@@@+V`]$,#``:A+#F`H(/+)`@$2'#!`NZ1D`81?,S``0+E.W"PS+T9YP*T"
MV[?=%B@PL$#OZW`!_BA04&#WP<\$RW,O+9X!`N5GNS<G&*#][?6J"V)G8%D^
MVO4,8%>80.7QE]9^")F74'\'70<@`^@)A(!;"&RWG7)L(72=AB8-@,!!`13(
MTWP;U0>`@@T"\.%/$5;5&X&4";1?`*D!1A""Z2FW```+T*@9C@(-(,!K>BF7
M0',Q"B1`>_G=&)F"!?BUH8P"&9`D`*@1QD!Q!J%XT([.I58?0?')")IK>D$G
M4'U<&O#@0`:$R<!9K`&P9`!),G"DC0J]:!"-?BIT6&>P%8<8EQ61F-$`,1J0
MFT&6(9I3BU/U6!M\FJ$())`$*N?FG++9&2>9@AF8'V<!$B0``C0V69N3_@2:
MMQ]V"?C(X`!O)N3E074!D">H`<`W9H#P.9>`F[\&F2L#J!*T(P%YDHC@D#XJ
MQ&!EE!'P*$*"N<GCCX2-5AJ>!6!Y6[@%[2CII0PEP.><2PI`&HG-%J1`M00Y
MYFAEVQ*$V+^507K`BO[*>9[!H5FIG'3.YK1D9D/>5AJ*"K)EGT$MJ@BA<^2=
M^*IX'F9(Y9P$`WKA0?N)UEV(``"X'ZYSWI86P9XM:]"]%$.HH%T"<'?Q@`2Z
MM>N<RP*M&7?XVI?R;D8?)')!;?%G<VUP;4=@KA&WIB"^Z=&<D**Z2B>RRA+:
MAL#0#&0=FH?\%<1U>A9J/+';V[4\D(/E,HPQ_L(_;L<V>*\:B!;:$*)5+0*&
MTVQW:Y1.9$#%2?I9K0(V'B;BW@+M2!AR-[\\IV/\F7<D88.]>J^K:Z8&Y6":
MP@GHN:AW.76Z]@&'V,O5!0#F;<[Y&.A]!]6[IEL(VDF8C58NERRV(+9V+4+[
M,?BI?O,.]+O$A'[-][AM!ZG<M/6]F[F=C@'X?(T,G4W0ONAO66T`58L/]?9:
MNOV:I?S%J':^[]8ZFP&ZJXVM`/`VB<!,27$"FF,0(ZZ"J&E^`JD7=A8`EU)M
M:3?7V0V#"`"9(P7N`&`+7-H>59X>/6H_.Q*`C0[($,*A+#SA(E%A'F<N[\EG
M`/61$P`/8C3-G>5*_H]SC@"0,\2%N`ME,=3;C2!SJ\$D:4>P(E;V\A>SA820
M=H?QG,0Z9:!^&0@RP=*,_+#TM.;=K57L"A(8H^B9[8&0@_XR3[,V$R0EOFT`
MF;E,IH(SIRE9A&VIB1K4;(9';A$(;OPQD0#@0IXZ!FED2GI-M:X8H+H]*$*S
M2@^"A&2AA;C0>7,S4"!MR(#ZY/%[KSF?C')EM`A=:S[V09Q[KN,U@W!*.59+
M2('*]::SA"<SU1I8N>CS2"MNSVH@S,X6DYDI2.U'1"`D8&:LELN#J0HT"E)4
M8<@&R38RI%QRJV+TTH*VMR$(FFSQ6:HLHLJ(6+`BZ\J<A$(#&8(E@$O__F*8
M:P1RSRHE+(Z.>2`/%](8(<&16<I1'[.86$.$\K-X#>I+E"!#@!,5YH&S.I-Y
M&`6G]?0E>&&<D#,7\KAR%2>,.A.C[)I9185PZD9N829_``/%+46O<N.[38P@
M8P`_"<AF-=6,CW:F')^J:B&-TY6".$-'S31J64!:9'?,@QC1-"9M%#$``0JP
M/(=$"72*D=]/6$.:S,2F-:QY3?UNEAPE%J"6D)(?2@W$48,\+D@",)%81>BT
M$^755];;'&G*@Y@`BC)3QS(L,?44+,&H2::8@>D%[_:MJT9P/7I42%(1`E8]
MT2DUJ43A0!1[V32.ZC)X^=9T7/))JFQ6(WX,_LU+053+ULZV,M>K6<#N]EH?
MD6<[`<C:/HO9G26AQ4_1]!(XX0I!7;4,.'3SUW,7M\[6M*R1UL6FGPH#W3ZN
MEK7;HTIX*X*`GDKG/3T=[V'NVB6&W-9?!>Q(4TGEM*ZVE"'QY*)"7#/%63KK
M7S3C$UN`1KG+9(8X6VJ4%[][DOPRN$MR&E1#&O-:^_)5(74)2:T^"F$>2JJU
M$6G:@T=,XIOD5B[[*[&*5\SBE`RLQ3".L8QG3.,:V_C&.,ZQCG?,XQ[[^,=`
M#K*0ATSD(AO9)98!VK8X)L^!O.=0@T+,68],Y2JG1$0'A-(S,7LC"U7G1':"
M7^=`/).324B?07NQ_K_6W)`*;61V5HZS17*;Y:P5\KZ<BN]RAL636L4)K%RE
M+PC#)2\1#I.X'DR-7W=%.=(LH#S)&:@#P[76CY"&N4<9KIQ5TM!1$BM&6NSF
MA8\JO)[B:EOA"M-6M>6OO32P,8,AS>-$O-+V/I2ERON@8BN&0CWCBC5;]8VM
M(:S$C<SWQ`\1S7@Q\NB]0JVK5MTT2$`H2/985V7<;-V?-*1!BH$&<9G!3MYJ
M,R$[L:>3JVQ-U7P$9Z))FC\ODNG3:!3;ELH;;=4DMR<3E%`OWPUCU0Y,J+OS
M$"$5FR.BP33F#K*D92\%G(M[:]>NMAVX6@C=%W=X2=@RF'`?9C>V&0Y?_BV*
MHA.+O+IS2J6-2)2\D5E0IJ.F-6E_Q.I\2;*"V(G4QVC#Z\A0EXT#X<NZT`8T
MX/SYPH.N*[1L&E>UIF<P'+:6EZ)\J$P90#K"4;-FJDH?VE0'-,79+.*.>#<,
M^4MAI:FG;#('L)DHM'OL'5ZG;I>LVS'5I@Q<\$MVV"E4,>U1)4=9@N($PCQ&
ML8:2N91E0LOU*IW(2"="\&T0U5-%93BH2<?AO&#N6443I%>%)E":#DJ@^A"2
MWU.U967$!S(O8A.2<1<HRBCHZ*\S!R]QRF)NW'4[AE[F>[^JR^;>=KGUJ5,^
MN7G99Q)0`+Q@V3RVLLOC(!-##)VH=/GZG62$_I0;\R1>(<(;GVRJU2*T*2JH
M.-E/A<SC-S*Y?]CZL5"9[IM-P\NHX8K.M]2H2Y[Z*!QJ%],JYN,GW&0;1G,M
MG"=ZW;$>]=8:2_)N#H1+YE09NP)"!00:$K<SYN-"B&,G!`1P!I%BQ'(T]M(<
M:"$GJ*-_Q01(A2,KHZ90'UA*N/9!T0-];N,E0`)]T]17#)=*`!(AQ7<CSO%>
M>X<BP74TF_1^#O0EE5-#%;-R[9,JH_(C"[(K(0(1B@(_I/<\V>0^TM%S/6@F
MUH,0?+2$/(1+%G5"E9&&/C<T8,<C.Q-'FE4MJ^(L!=1I3%<E;P)"CG(=V](C
M8;<\&_6#D?8R>+(M_B%'`-\!&.\TAH<5.DI2,/D1:/J1<HIF,!5E-&330`'"
M5)RH'T/8=C&!'*2C'][G,8Y(7$J8+]N")T%">(IE+H)1/=[U106Q(BWW*&JS
M/([64)81*#+U?5AEB[`77WX2)5L$?\D8@>>B>JW6):+A>IFR,YDQ7^>Q,WQ2
MAJ.%BOE"&CA45X]HC357&2A(0&G1'0=P)`GP.XJH6G;QCG416I,A0!VG:#@4
M*-^R-7+".KN%$+U"&KY#)G9A&5UE>6E"9C^A1`83)N]1&A8B'99DAE-R'6DA
M28;C'S^79]-%,PXB77$#3/(Q6CU3+@0C,L4G9M@%(2OR=JM(7['BC*!E_B_<
MP4VI,5I0LEWA52UWYA[+`CCLX5;Q%CT`PI*(Y$`0\QI6TX%AR!_)=#NJHWIB
M%I,;(WIU8SW[Z),/05V?D6\M$E^*TH`_UI#_Y35ZAQCLXR]D]2]:USV:$1GE
M,8Y;$E"DYQZXPB>/0XI<@C;CF'F007*HD7DR0GUAXBDH]'O=Q2R<PBBNX2?J
MXADTU1RH41R5)4.`AS#(6(FI-Y4!PBD1@@`/>"3!M"NV(8Q,J5(IQT#XL2L8
MI&=DF"3#\8E`8WY#*&U:@9`8<7"\4AW.PER/8Y=3<YG"%VF8&4&/!R>$TS@*
M\"M415,[,Q@]TV7I]E"LDWP_PE"_N"(*DFC,F#*0V%DE,:*.D(*+7!.#H_4:
M]P(]LTF;6&&;0*%G6*E9R!8DF/9:,U%&K9$>_K(=%41P#M@@WO%SFN$U$'<Q
MH`ATZCD5%F84UY-D.^F/FV%;FJ5Q*L8P$GJ@%FH1PJ%W$+&6%]JA'OJA(!JB
M(CJB)%JB)GJB*)JB*KJB+-JB+OJB,!JC,CJC-%JC-GJC.)JC.KJC/*J>`0$`
"`#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>f39432xe3943252.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943252.gif
M1TE&.#EAIP+2`?<``````!@8&"DI*3DY.4)"0E)24G-S<X2$A(R,C*VMK<;&
MQM;6UN?GY___________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````IP+2`0`(_@`;"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIPI$0'-
MFSASZMS)LZ?/GT!G)@A*M*C1HTB3*EW*M*G3IU"CRK0IM:K5JUBS:MW*M:O7
MKV##BAU+MJS9LVC3-ARJ=N8!D0L6M-7*H"W5B'61YIU[4,%5MGQ7^AVY-[#A
MPX@3&P6L&"3CBP@*2#90@++DRY@S:]Y\&0&"!*!#BQY-FO3GTJA3JQ[]^73H
MSY4-R#:0P++DR)YK@Y8,.G)FVY=K<_X]_+=MX)1;\PZ]6?9P`P<N`Y\\O3AF
MVM01T$Z06[3KT=M#_H?W+CM!`=+)3]..'-[S^=7PO\.?3U]W;^T'1%O6[GM[
M^<K<519;`=J=5T!TGKE'H'[@F=::=KI!Z-UDGQV@G0'=44:><Y1Q>)UU(%XV
MP&4!`$#BB`4$$$"(+`Z'0'0`@I9?@#)^1AN&PH47'(#N<??B=C9.5EM[O&5D
M'@!()JGDDDPVZ>234$8IY9145FGEE5AFJ>667';IY9=@ABGFF&26:>:9:*:Y
M90$:%:#FFW#&*>><=-9IYYUXYHEGBDRZB62)>MYYUT5^RA770`G()1%C@\FX
MP`&01BKII)1&&E>EF&:*:0*:YI<IIS).V@"G^36P`*<"'3#808\JNI"B_H"Y
M.JI#J"+*D%RK3B0K08<*]&A!!YSZ**2)%A37`@K(2"JD<E4Z[%O,2@HKLZ.6
MZNNID9(:JJ0-9,NI`M!U*NZXDP[[Z+)O);IK00JL^]!CIAK4ZT!R/88K=(YV
M*^ROB3J:[+`)@$OLJ=VR5:Q![7[DKJZYQ@LOHF\1;.Q;\4IL;+.`95SLK]>"
MV@"2#T_DIT!L,1"P7PHH8#)H*R=[<@,)"\1`82J%W-'""R<TLT#M)K!S`PS(
M-;-?+3<\\\ZG!LPNT`;1K)#3$T$-L\P#2>V3U579S#31"W'-4:X''Y17S@RL
MFFS0IJ:<K,HPA^:RR_6!:EK`JJU,M\]NUZ5R_MFA+8`U17\_C1#(;2*9<IZ`
M/IFXDBH"*AD``Y2X8@$#+*FBY94'JOGF5R[.>9B>#Q`Y``&,N.**E4\.N>F0
M(UDYZY_'+OOLH$MIP,<`:`W1R`G0[OOOP`<O_/#$%V^\F#81GM'("B#Y'FK=
ML7;:]-!U&"*&+6:O_?;<6_:?;\IAEE]N.(:'X0$<<N@;9@]&YR.$"^(8'88%
M.E?@;3J*9U][H)6'FW2@Z@R%)J,9[!"(>]:!$6>J@\`&2@9%(A(`]]:W&0J^
M)S?=D8R%7/,_^B&(.^:I38*PUZ$+62A`D4$?]EJ$/O=8$$3T.Y!Y8M.A^<@'
M/N]A`(Y84QKE],]`_@0\$'!F^$+I7&>&`.04<-!70/8(R'M^&HKR,)(YF$VQ
M,5C,HA:W^!3"7=$BO/LB%\=(QC*:$29>S%WA`&!%-9[Q*8%[HQSG&)0TZNXA
M870C'??(QS[ZT2!V7..HQ/A'Q`RJD(@L9""7AZ1!ZC&1D(RD)-NR2(SD\8Z3
MS*0F-PF52A*JD;U[)"='2<I2(L635)/()4W)RIGDK)5'B>-/4%D3@:P2EKC,
MI2Y70DN*W'*7P`RF,#722Y&!DI##3&914J9,LX",`<A4Y3%%V<QJ6G.8"RBF
M--D82DQ>\YO@W*0V(_++<)KSG)P<Y^ZFZ4UTNO.=9U0G'MD)SWK:<X_R_G1(
M%;MYSW[ZDXO-4V,TR4G/?QKTH(?)9T/*B="&.G0L`07-0-?)S8D^U(^RO&@9
MN\E/1E:4FAKE)#-#:D9HYLZD[5P(0TG*TI8N):*X2ZE"5NK2FMKT)_RTJ#X+
M>M.>^E0G.07I1`#E2)G^]*A(=8Q"&4)3GF0TJ5"M9D1AZM&B%N6I4<VJ,&&J
MTX7R5*M@#:N10-91C`C@JV)-JUK?1=:N,A6M:XVK7`L2RF0A":L):>I<]YK6
MNM95(T0M*U\'J]:(AG(C@74K81<[DX9%DJ.*G2E<&4O9HQK6<!HYZT>-6MG.
M-C24IVHD,2?KV9[@M;2*@2P`'`N15>61M:B-_FU#8'M-U6XD258%"6UEVT\V
M]?2R`#CM09`D`$<*-R'\2PC;!@*NT(P*;Z39+6_+>#;G,K<T;7,;RPX"&KIN
M5V8@-.4K$>)7S&8$MX?MB)\DB"1WG8<@3CI`DWP[W3UJ5DF#N:^2$J#?)%&L
M($ERE7]-)=\D"6"\N@0M:$?[4>E.!`%JC`PU301?O[A)(`&0(GT3$(#Z]M%-
M`TA6B093N;J8+,,-J!P"^"895KVN:JL52.5\R^$!U+:M,3[O-(^;D-ZMR@`Y
M%@B$V3@0WUY8`9_Y&'T;<,B;\GB2%![D[1IP8>;6Q4V`,1E"_#3EC_$LRE_^
MKS*!R]F#Y/')W-4C_C2[W(`,`Z#)51X(F#L\JO?V$<U0C3*$J1)G)-O2C0I8
M<D'.HR*VQ+AR@!2`@V&IVC(;)+'!]0B$<P7FZ*28S@2)LT!(]T`B0YC-'C8C
MY+@#``'D!<2203&5(9=J06?:9RJ2BT")3)`2.5J3JL7SJC^JZTP_<D4R4R.0
M'Z/ICPV@-[2^=:@I>3D;%SEWW!G`E-V$G1'E=2BAA.:F:?UL94]2M8MNB&8=
M^1'Y,B;*?DJ2H(L-9E<O.YX%R&9QGXTHMF#95^ZV)5OD>]9M&^2L"&;T-&\[
M<(]HNGE4"8"J`E9LR@%XR65[]QPIW#OZ%OMV]V8J8`K\9UE!<][-M.UH_HN;
M7O7F6+YT1H"S259J7S^<("$.M+<E3I9L^A;(?.9V`FR<<9@WC$"U)C)*!V)K
MH`V@UW\4N8X_ZI'$9<X`=8&PP@>2.6?[Z;T!+;62I$SS,?H)V`PXZ^-8G3GM
M_&E0%6=NB@+096CF)>PF6GNCA(K+;)<<(^@5[==FUEV"K,Q5*?,9ST*3%^BZ
MC62%@5O<%L_XQCN^/@%'[6A\I9KG?A=1A3F\E0F"Y"031/#7?;S^>CCZ\7AG
M1I%A#GS6=K>[N<QNH$$6Z'F6W=:/!O;:K<O)8@\TM;5KM^7E]D7R+OREI/MX
M<)IYUU%R_"Y=;DFC2Y+HI)^ZL:?:>9GC$_*9_H3I-`<WVPPF-Q\COWQ(AOLE
MY(\):+-9_(H07_GEO^;YD1I\Q)(V_O@'9D!-9EY+WC__`"AP#29(@A6`!EAW
MAG-WP]=R?W6`#BB`$D5W$7%6Z:)W#WB!I*1:Z:<0^W17&/B!G`1NX0=^(%B"
MDJ1T%I$RD#9_)MB"8U1_!!A9+CB#6(2"G_11&TB#.H@8"F:!%P%I.QB$;V1W
M/F@1Q(=T0IB$5_$SB-)(0-9^%'&$2CB%65170T9P3$>%6I@8AS4R(UB$6]A,
M2'A0AW6%7RB!O)6#8<A%AZ6`1KAC:QB':M&&8!B%<"B'>%@61`B%$T%\+)B'
M@/@4,)@1D`9_@7B(_CAU5V[H?G>(B.(U6'M($6*V;3CHB):(%3W(APOA-'YX
MB9XH%72HB1'Q?I]8BDX1BECH2']HBJPX$_R7A4LG?JW83V/82JAXAFHXB[K8
M$K<8BPVXB\#($[V(=_\7C,;H$L.X@)MUC,Q($\GXAKS6C-(($\_(B+`XC=C8
M$0Y6C798B=GXC2?!C7TX3:L(CN88$9%XAN4X1NN($[5XCF$ACA)!?/!8CQ\A
MCQ$!:>\X9O:8@07GB_U'4DW6CR?82&8(D*)(D`K)$/@($?0H$NTH$R.UD(S5
MD`\AA2$!;!09C&58A^-XC1ZQ?UFTCQM92H?UA*FXB!OQA(PQ9$SR<UMW_E]T
MM@#I%CFJHB3(PCA-`G(#<0"`$@"#X3D>V$9,XI(%8%)-4A=/6#I+=GR2,1A,
M`FHDLW(IUB1"*8,EV18=F9`/,6XJF1'L!V:K!BDM9VX$8995QF]#46`1XR81
MTUZ^TG(4Z);\)7QB)Q=NXA>A)"EN5''R=1[]]I<\(W:.5"]J))@$08%UJ49[
M&1TM!RQ!UBT`0``D<U8"\!;]UCN&F)5@<5@<=X8AP6%_LA>4L6E&QAC]!C0!
MD!=OAF&/="`81I44!IO-,Q00QGFEMA<E<F5$EBBTP7*F:46#E#%N)%IQUF*?
MEV,<MIH?@VDEYG<ELF2]\U\*<&PR1F=HR)F'_G&2'CF/_VAP1Z)FBA)E3-@`
M9\46!J"7C`D`DU@KR!F<>]&7+I><-M%G#Q-EV*9'FNEOJ\86@497009-R6-Q
MC[1SN]F$%*-E]&8J)*F=F.B$W3F*!@F&RV6$CD25<I9O['=T36@3MUDUHD%E
MJREX8ODQ#U,Z!0%-/)<[+_*>\"6=;[8RP\:?`24`4CE(E,8FD,-RW==F2`8`
M759QGF%M5,>5#KJ=C>2%""DV&&$`&?:$D?9R",$`F>.?LPD`KD*E2'([?Z(D
M@@92):IDJX8B;#=<,,HDAD9KU>D\-+.?&=IF7IIXV!FEH=1J07>D&Y6D$>J0
MW\D13%D`F@4O85H0_@B@(KH'I`T`9+LB6D0:G/!UHCV:=G$6&69*GTUH:)%:
M(J#FIIMV.XA&;04!9".")%0QG3S3E$:*IWS1A7MZD7VJ$;T#7V$ZJ)!RJ<%I
MJK)J2TM6HB!5;*9:;)5JJRR7IK9$+S[8.ZZ234,A`/,&EP-Q8*2"G^RY9:FJ
MJEJII]6Z$,0EBQQ1FD4:I6]J$`8`<CYF1;X5`*:6JVVVJU_Z,,VS9,\)K(`$
MH\1)K,T3GX+FIC09::+5.\PY*E0)9.HYB7*6K=:*%JQJL`GQD!P!8>]E,F6W
M*KUCG>SR9KMQ.PO@I$<Y2!FV,@PX:B2S(B53<5#CL+L1`/7RG,JUHS+S_FEU
ML0`J9E4J8B.J)C/4)F'6.62JDJBD`VO_"K,]6R**9A"AM&('6X5WI:3$")++
M<QDP\QNG^D!FEB*2<663XVPTF2(C,A2!%AQ=^Y1/.QD(`;0C<FJI9C.1XW!U
MMB(V(0"F@QDA1ADC0K&(DAF`P3X",1WT4D'B>AD->K10D;`IV:J`>XZLBJ'0
MR*VQ5+@!R)V(:XV%N12;R;AS);@CMVN32[F?:+DZ5EQ*J[D$R;G$2'*$ZU`#
M";J(@9*?F[A#%I'U]+>H&Q57B)+AM[JQ:[@3JK"#,YF[=KNABZVI>)#-Y+J^
M>T:BJXQ,5KK%RY'`&W["N[S@>+RL.Y30&[W-_OL0.8,DE/F5U<N,TMLU"PNA
MNMN]FWN]HZNX<P6[Y(N,>MJC;\@FS[N^(46\6<&J[LN(Q16_\GN,5^@F^3:.
M;,*]^ZN+]CNXXSO`#3$O.LAQ_DMP^:N\"'R)!3Q:`5R'IQO!%@$UZIM53G.X
M!/<6^GM4GJ=1]-M9_3NH=O@6M#L2F8O!L77"CYO"Z+L1&^S"E:6Z*#R.E/F9
M'$$L^&+#)9&+2,7`.>R=;&2[%K%SW'>C0'R`(]/`#!9H$,PT*K6ENQ;#4&$Q
M"",1QS614\,S)5R*?K-)3US$$LJT&3%D5(%;M588F4-D`85I#/"3KI-C"'!?
M&^MK3/+&;Y9U3^)8_H6:)#;AQR;"%B[I.E#'LWU28$EB`.ZRIL25R$X2QC/(
M`")B9%)KR94C&WISQRM2PV=1QO]KQ#/<I,K#QE\V*%H*&":R%[6Y<\<&84/A
MEGRC(@!V(WUL;9M\J*TY8\E2J(^!<WXCRZHHFH/Q:<GB)LPYL>+!)BH*+M3K
M*RHR&"@G8UC*,W3[B0%5`(V"KD-1.J!1.=^,KBHRRA^FI^;,IVB,$1V%RJO&
MDZ;RF+%:$/.&G.\AEKBZ:<-:9Y+)RD0F7_]E9W&Y9,S*G[B:=JE"<7I'DXYZ
MG@#V2&BI<T),A0Y=9&_)RE+$*0:2242<SJZZSI!!JHO)9M-',\0\`$UF_K8\
MPP#$#%\\.1BU27N<VJ_3VC:$6J`Q1M-3)J`PUV'O2G3A*LZX67Q7>EVS*-06
MO6D<FJ@K%G=0U\*&<<(>[1#;*L`4L90EDLW1H:*/=CHSA:J`%)E?QAB]$QXT
M?1Z%NFZ1V3O)PT9K.G>,(;#^:AFT!J0_FJX#`6&(2SIC61LU:XI7!)MPVK'/
MUIJ:A,-8K!"LM:TA?!$%&&RS#*Y?)MD&X:+`BM3)2=:DL]DT+4'1.6C"EW:,
M4Z\$,6S;3#F8YJ5$&Z:1LVHD`M4M6'1);<VDXUJCF4EEK+!0P]A3W!!#=J*M
M8\4`1K"#AJH-`X:<.IP%RW**HAVANM:S!DW__JK<],;51I>A0":5_CJOJU9O
ML]AS5"9FH02N!7:_A23*#ES*-P@O"I!A*4.E[ANA&IG*N$G<R=T[\=F;-0TT
M;,;6)).\=7%,*^??P69CS4.528:H)3*)<)=YK2FO80'*NP3>`Z#"J[)G2H,@
M!\Q%Z#U:%;CAU$I-EKW?_+FP@E;0SPJ%]ZU'H@7034C//"E!_$F!+$=?#MT[
M,=XN%,9^C]$\,7[-$&Z*;EEA5+9AN0.;[@/B6M3A.O862%P1-/F3:`<YBJ*E
MAJU#T21ULS?'$D0Y('4`KV,P63TS?C*WI789)=K>9!II0W8[VZS$JJ-&5H[F
M6)HZ%O9%$RL9#OV$_@(`VS,84`B0,JW-LZ?A)I;\9JB=V.=\Q&:LSLFKY+RR
M'LE!$+Z1H)AALY<!6YB1*PP`(^FY9=*AJ[QAR=;A6.`R&42#&;K'&1E30.WR
M1$`S0TUC&4J3J)9!R4F8L8Z3%^W]=3:A0\I\P7_$Y,3HY+U-BRR"([XA0KG!
M&[.!/MXA>M(^[=1>[=9^[=B>[:AA$>@C9.4\JJXC`$ZG=9C3?-P'*-/':ISF
M0,\A0TO4[@+R1.=C/JC7&Y4A68P^U0V!)"!\[/<4Q\']?-LW\`0//#.'1-N#
M'`ODZ>L3(/'.[A#//6*7:B@B69[;Z*[:[Y`.B&C#Q3Y3GC0S-`%C8KGB_C?O
MS3>*URX*>C;OK30FHS++Y3*U9WDG\S==G*)+4YY`XS0FUGNMEQ(2?A7$OH#0
MXN]-O(9N0IE0W.2]>_2Z./1OJ/%.__3H3'#P6X1!/_7+U\!+3XP57'Q9K_4T
M!_6,6/0;+_8Z2/9VR"9/CO:!J/8`W/1N[XEP[YW&?O9SWX)U+Z%W;Q3"GO=@
MM?=\VO>`;XF"G_%R7_B'>/A4/:UMK_AAR/C[?J5X3X5A_XU<C_&-3_B0__8M
MU_4+R/9&3U*7W_F^U$B?3<&)#Q6E;_JMY"87K^__O;N<[_IR..2@7Q$F5?LN
MA>NV#Q-#[CP:85*B7_F"^/O#9#69+_O::KY`_M'SA('\X33DJ<_TCR\160NV
MGIZWM\'V#V^TG"<=9JLAI1T<4]IVG?&;X5\9X+^&K5\6OB\5(S-C'[SZ'G5@
MDOGYDYE'2[(J80D0!0``6-!`(``!!1LL/)APX<.'!P`\7##0(D**%P$D@-C1
MXT>0(46.)%G2Y$F4*56N9-G2Y4N8,67.I%G3YDV<#`$0,`B@P,R!!WI.M#F`
MZ$($`1;Z7)B`:,6?#9)N7!A@P$,&5I<"4.#1J$BC'!\*U!G5```&#10$0)#3
M[5NX<>7.I5O7[EV\>5,*%"HP:LR@0V\&.-H@P4\%`*XR%,MT(0,``1@@X`J1
M<ENR'C-_/$#8`,3,_DZ)&NTJ];->U*E5KV;=VO5KV"H%"NCY]R5D`'T'KDPK
M<O?#PPN-`F@+$<#IA1(3?.W(=&!OT(6;(Q`(/?/LA8ES/X[=W?MWNJ7!CR<?
M%_K,@PT&VGXYD';ZHH6#-V!P4')3XA`E(F!N_.KOCC;KZ"RUCAO+)\\4,FR@
M`,0J[T$((QQ)/`DKM%`O[`ACKR7<?H*O)@`-LVT!@>ZKJ+CD-A)PJ9]"/!`D
M#05:K#;'(&)`(K0NU'%''GOT\<>2,JSQ)=%TDTZF$(-SL">.$K-MH,.DJT@H
M%W7ZJ"*-Q")+`(*`BX@J(,,4<TPRR\1P.RXW9$D[(V_J3RH/D7.JL;^<_KH*
M,A2ERM%%`>HK+*L&!D`1LM/(@BR`@IP";D@S&W7T44@C_<BO!C0$:KL/:7(R
M@00ZXT@@!#Z]3T9.S^ISH;,26$`!RC[3+E1.OX*2T^4*2&S)``)08+D<*:/*
MIU(KD_`\28LU]EA)*5U/IB(;..M(F0P@#*'B*)NVP9ZN+2!/J:85M"J-(CLH
M7.V.&O>BM`XR8+B!D$/V77CCE3>OKK!;-B8V!9MW)`4A&J``@`,6..``!A[X
M7Y_^+<"HA<7U]N"!!2@88(4+L`I@`0">F&*#._;XXX`-*$#DD`\#>61.!3XL
MY8`1,`#6;1-XN8`$0D7@9EI#)1E@6&FMV6<#_GP^P.688;VY9Y^3_EEIIIMV
M^FFHHY:ZYJ"G9EIDI$VN>62;H\[::K!I/2!L`[#FU.64C08XZ)@[I9EI!J).
M*X%=Z::[-`9*V[6K7=52J*NX#>.;0JQ>JI>IL#PBUJ1\,]WW)&DA7MC@A$^N
M&&3W-`;Y8H\1MG@`T"^?&'2-$3H9X\L#-JKB7#=>>(!I!1ANVG`9O+9VBVO7
M?7>-:.?]=^"#%WYXXHLW_GCDDU<^^(*7=_[YXM5\R"C=N&T)RS8?UWY[[LOL
MMT(%55W@@+$-$ZJ!!0I*/R)^%5*54_<74/6`KCHEOX'RR:=_)+YJNU0HT71/
M@!UAP.(&>$`$PJM__I9"$J:JE$`(PHMP$:1@LK9S+YC@)GL5Y&`'/?C!\2S0
M0#'1H+Y`>$(4IE"%<.D?J&120L>M4(8SI&$-02)"Z:D$>R:T80]]^,,/]B]-
M+PQ,B8!X1"0FL7O]PZ#ABOA`)491BE,D$Q,9Q:$G0HN*6^1B%R&$0R(Z4(M>
M)&,9S9@:Z@7JBBS980S/^$8XQM$M5CP?3!H'13GF48][1(D5K<<2&.+Q71-$
M(B'Y>$C4&#(E:6Q7&#>(2#,9$)(^5&29EB1"=[6'*FXD8=@\23?YU<TP\J-;
MWAPTMXZ`4BP%)%:3#*,T4])*`06T&Z?BEA92SK)^"IAEW%;UM%?N*F]Q_H-:
M`7^)M^RDA9?TZ0T#"J+,WLQRDM/<'F&HE!\29A$GSX)>-[WY37"&4YSC#"?M
M_H6PBQ"&7<!3&,-`9Q'?148QI)M8ZV0'.M^ILP!<RA4^[1-/=2HFG?8!'F$T
M-)!U6N4B]XSGN6QW$8#U3C&Y\TGMWADN=<(.H11-9Z[6(S&#CDNC\-1=/!'Z
ML,BD[G0K96E+3[8S@<'H@F""2;,XZ9;O7>F5(.&(_?"GO[%Q"JCD&]_^[#>_
MH0Y550HH:OGJ1LJ?)G5L4B5?+8'Z2J5VRG[Z2U]3.R6_JE9UJV"5ZE:3:E:J
MIE6M:=5J6*F*UK6FM0#Z^U=<Y:H_GPS,)P>8_@U?$8([+EE$`(%UCT5P1%B)
MC`NO&AFL1O;)V+D&=J[D0XC^!$#7R_*5LACC*P$22[YQ7=8GGM7?9!\;6/(-
M%F"DY1+Y&);:`PP`M%P2;?`(R]C=>7:PI9WL`3(+6LN:UK26)2?PSG5;Y8&D
MM>JAZ6VT24WH1M>'!DR`)*W)W$RZY+G23:$DN?O=&\YT22X)Y!C!"\'QGE>]
MFA$OL[:[7OC&]X1^E,D=S2M?_.:7>]>%DGO%J%\`![A[@>EO3&PJ2`MY][N5
M%'"#1<+?YKKDP/>M4&_2ZV`,9YB1$6Z)?3/\81";B<`<9LF$0WQBU"@8Q2@9
M\8578N(5QUC&#VJQ_G\?.6,<J_>/%JIQ-O^;8R`'634]MN,39W1$N@E9R=PC
M,DS>"T0&+UG*DFJR)F^LWBA/6<MY&?&.57+@'&*X?%LFLUNJC,4?EUG-:S[)
MF0'Y9#;'6<X/<?-*[GCD.8LDIWF6<9U54EX^!YK-?DX)C%]HR[W9J#=[?@CA
MJIM,^C"N(\BD3Y85"9VZG6<!"N:46AI-P/.()V_TH96G(ZV61V>'D`6T$7<>
M8T`5"WK&A$;)@6DS$RPMM#0.)7&7\%,[3H6KCA<1BVCZRVN%$&!W`BAV[1J[
M4.42F]<%7I!%>AHNL2B`L%$1S:V'4AC$+B2P2TJ`M[]=&&C3N78+"#=S_FF*
M(_?4L2,.60B6_H*C`B@[*!(9(D_W2K..'$!!4W(0B=1*.'E_)$IO,RM(UA>1
MH88DS`%?3[D#+F_+4LBWI:4K:!>5&P>=%>("'WE2(2*_DBR`>D3=*U\SVZ_+
MZH>H8^FM6Y>D@*I]KU/X*\U4LSP76I_DP$JAB<J!-97/,.`L-$L*G@N4)X$8
M8%6>H0^H%%`B]UF%W.T"'.PX177T@8I7@LI=5*R%,M(8A6TCA,A90B40NATD
M5L<YCZ^JFY4!T"IQ3F%+S1QC]\=8[.9J;[1/SD.@1OME2=+R"842H,^(RBQ!
MPJ%[XB=:H@G25.D%?GR#.J,8NB'4Q4XIW7@+_M;HX?3&5\/A-404!1(&K*YA
M%:462$06'<7P<W&)B77G`^:B?V'E(`!_R%3RNM&#I"NOEKHZ0BT2E8,L)BOK
MR=WIBT]TD60E8QI:_7JH#1ES#S_P&UUG9+2DD0$HY%D!$,I:J#WD]N(+SC4%
MDY_:,B>D1'AUS3$[-COSZU,QB`T)$>K0"6%)#/Q`#J.XM1I1@*MPBM)X$RL1
MCOMSC!5A$>'`/OIH$-P0#Z<X'XNPL`UQ$JP0EL=X/_P+$`X3$`/@F\B8'NM)
M0<I@CZ5303`IP`6I'[;[B.#;P#SAN^9X0?Q0CT39I,)@F/!R$+(XBX0KP1R9
M'J*`#*<S"B_+CLB`_@[(@`CM.`\)Q(^H>),&21S\N+7JH#RQ\)6_^#ML>HCK
M$@FG4(B)(0KKJQ%?.0^Y>Y&MR`X7TI-K>T+*F!%IB;6Z"#J3,+292,&E>,`;
M;*ZU6!&+P0^BPR;2L\`!+`P<7)A<<4'\6)+^JI'%0#PU8J_B6";2TXG%80H\
MZ8BW8Y3G4(^S(+KYZ(C^6)<!B1S76T%<C`CQH(P^X0^%`Q.GR*2*ZI>&@45N
MXXH/'`G"4`@<!!<35`_"N#5%*0[\N[K":\5)6\.E6)`F1)6!@+JC((Q4DB?^
M><*Q4$+"`,=?C`HA5`M>8A0J[(G>@#M(!!.^VD3+F):1H(SS68M.4X_%_D"Y
M#!R2TIG'HU`,?ZF,%*2V_N&]UR#$DA@ZFT!$>72[FLF5`4&`Q#`W?G26@=B5
MHW!`_]D6CP@1@&&(;4'(UPO&Z"B`0\$8HH`[F=G!QXA&%"E%>2S)GZ!(*/R>
M>$0+7HP;-<%);,$*I:`,!^%)-4HOF43*Z(`=ZCJ.KS-'TP`_T.@4II@/IW#*
MD1"-%IPT7=E!%5%)#53*LCF+[*)'+?3(;LR*Q-#`T&`4E'G&DCP25E,+I<!(
M/!S'J,@58LH[)E1%ILB,!2`,U4.+*\2?8\25F:Q"W!B`S!O!`3@4ZZ"?Q-R,
M(=G*!>$(\#N/="Q*UX!(DK`UFU".Z`@VP?H>_J(8B'[9"?7@B]A:%'$CB+FJ
M2_V`/J%HK94DR`NZ+0-LHI,SK%^;0/[;S$DY$B;:BK&1GMUX/>#82=?$1Q5D
M2HWHEQWZQ70[QP;@$B7D".[42HM@-!OT-8;0#>-(GZ!P3N-L#O0T-YW8LV3T
M"(L3"`7AB^%0S8)8(SISSX#SD,*XP`6)"N2*DH1+K-HXB#HB"WY33.E$']IP
M"OX<1]8LSHO#G^THS^W$",PT-ZBPT(M`./>(#='LRB>:N!=K+K+82HG`LQE4
MEY;\C\BHH]W,E?'"#="`/LYL%Z+`29W@",>H")TP`"[QLAOY2&XD3N.`S@M3
M2RCTT5\[R8^XC-OS_I>"&8[24$HF/9"T@(SQRM);/$.V2XQ_`3N#R-$&.4:C
M0)2(-"CH"("@(0TZZPHL:<;U+#Q.X4X5)*3X#!#`9+L2P<:'2)7',Z]VY,&@
M,96]O,6^W(BOBY+QFL&>&(X?E$/B@%)$7!?4)`FC>\8K<E/J0$@,G;[#\+;,
M-)"M7!>$(!8N^3F[&%&1N"/LNTLBH:D.Q;]6\1>C`53`>\5;_+A*!(U"H4:+
MR+]!,=(:N:54*4RZ%,G\^PR<7)&V<`R:S#_;L%'UR`C]?$M=T<(&D1DDK%.U
M\),EV;3-V#2-(S$^A,*QJ!@C#91F<PRGV#RZU$('<3N&V)@:>4+1.#*>_B2=
M`>"23.+*<;PPA6(0A5#0(:F(=M+/4`0),<4G,%D1'63'&:FNQ$@X%Q((G$O,
M_*O)>^%*W(@,@)6XXBM41GD\@A&6VC2,:1DVV[#5H[A5_:`P+HN_(G.@OW"F
MF.#*.EQ/,:2,F2W6'=5&]:04633!;34(Y,`1;SR-Z0-!V]`5>GQ+`A(6_(-0
M)%V.US1#K"B;2J&IQ$F,7618HX5!)YR;YKH*C2V\YK,,VS#-7UPE<:0/<]3,
M,CV08SR<^Q`<+9R1Q$@ZFL),RRA4BH0,Z]A;*V2/K@#:KC6(&>G(GNC1L=!`
MHX@FP>269?H6_%B,-P$4G"Q4<,%"PCB<%)E,_N(4C<5$"MN`'55K#N@`'8C0
M"M`HUL6XT&IS6:R`R@59%/:0B.YPU9``,TU)IXICV1B5U[PCC%4*+!2!TDI)
M2G6*W1&D/KU\Q7KE"N.K/LX</G895-GR2,1EKC%5BD$]#L:#'<EBO5F*$=U3
M"RX9T_R8/L0%T`9E@#2Q,`:)DHW)%5]QTXCB"L^`20=!P\69/H7Y1IT0#QQY
M&<50D-.+$L#]1C%M#MF*DEEBTMEHS.@0OAUD05`-5,,+EM@#N:^CF0_VE?4%
MDW34DYQ=G<E@E'2D%6E1@/VXQJ"9%6^5C!(IH/<KD&Z=BB99X6SA)3'TR)_P
MDR-VTX1LD>:BT1>^_DE=74/M,`#P&]M^;."I!-/Z$>(#8=5!M%DGP]F:2!H*
MJ1OX(36?:299H@@'D28]?!D;N;`%H`Z21$GB0Y6X@9E0P8J<J1I669LSO&.I
MT)JYP1D9?AE:R6,#.``1!)CQNCJ:46-;L@R1H&*L.(`I-1^B69N0N;I241DZ
M%IA!X>3THF.2T<BF<&0]-)A3:HM[RCL[69B&#50A-;\"<8R0O0CDB#TH_%AJ
MLXA,*M_&F[9RZ0V3VHY]M0B]L8B\NR)N4@P>;L=C)K9I'J\%8#QH=L:()1>:
M4R-F;E=C8SQY6Y?`VF5XBD!I5IA<&9D-]A5=+HUPR;OST&78`%Z'>Z((_I4U
M,O&M`7)>'A'/>_9B"+)G[-0-I]-GP^D.T-PO@082.ETA@I;/^4-H#J%H]8KH
MNC1HB][H',/H(#020>1HD>:19=(>C[Y&(PE?&:M"/0OID0:PDZZW+"+/6>4J
MF5.JJ!JJIM)IJMKI^Q$)FU:+1=9I^>0JJBHY_1$JH"*WI0:J?!LS\Y'1FDMJ
M]$FJG(*KF6N*L@HECA#(C@"KDQLEBLCJEYZFF%;.;,DN#HF^-C:I!M&=\F.]
M\OO(V$$H`WK%.RQ?@V*49QFID7H^;7X^=Y:G]*.\PB+>&A&_:FN>]:A`A^%8
M*\PKY#J5:?M?>AX0#+H6;RSG!EL+<T*`N[ZD_N<SJ-G1B+&!IX+YRD,Z:^:Z
M,I@HXA/,V8VX#Z<<`'O-C%\YBBP$R/QSNJ`TQ0+YBXR)#N2@1U14RW9\/+J=
MB+CY5J=DBYSL09D&1C`IU5];DF_=6O]9$!0I0#MI5J_X9<ZE;A,]+^W8E=RI
MT1`!O=5!6?N5RJ][4/.C#N5=;3`FK\#(;O28UV.M+C!5->@C"D:.W-;E[3SL
M"-FE,W:,BK@96SPS$,<P4`-WQP-?;HYP2I<D\,F8V59<2/88V@;$('@50D0D
MQ7S=$+[;VY-,C#RAC(:&+@"9OL-K5_50OI[Z"8G`-#HY34EA,)<&NOO6KC3;
M[\BLF[R[Q<59$3A]_KS>`-7OUD)M)'#'^-X#L>:N0,4AW0I:.<C"D`AG;2Y0
MI#@27,@'WUQAL>T3%^H1[ZFU\$(W5\%#P<`5@8SR!J\0H7.C_%OV6A*)N-(T
MM(T)WJ.@P`T7^[.)=@DO=3=K:[MY79%X@N>$40Q'BS`K`NPJ!XG'MF1%!Q`7
MR4H4U2+?%;OJ+LNA9<F*P/.M^-!?L_1#B1+354$CWMH+9%CXZG3LNSW89I*9
MA1V+^?,@Y*.S-D292'3'N)4O9:]?'Q]?&PA]B]MYRXT.S5`>_PB$6"YU2Y'I
MAG(EG5F0\%WF0F[Y&%KF:@`"H(U\?5#L.%*L!$`HRHS6NL=9IUD[EPX`_@&X
M/=4)C*.]-#<.>><B8T77E3CTEB#V.JF[1J=W<[GVLBV\3/H*$C0?1E?KUR1T
M.@/$$_S/_$@51C<@;W?GQ@CW(?S#7_'UV=1!)73S7&>(6YL^ICB+4*/U]>KT
MQ=`.=K'#'>QSU57P7Q?T('^S[1@.FV!2$M%NI!C@7$Q(UVL1I9B^[$IPNEUP
MAP7=5=E::VERVPB:<;?"^Z#(,.=V`Q2+N6T*6)P(]X-Z#)1<BNPT5!Q=CP!%
MU"V0)7'Q!DN2$1(9&>[@YL)YBKARVY!9/6)M@?^S07V;I9-"GTE:-;*>(M:.
M3GN\ZA)"W,#<5-W`'`ETSC`\M8BZ0)<(R6CU_K-!QH^45[&(Q_%++S]I4S`Q
ME5EZO-.@C+1`/"F4:<E@%2&\C*9X/)`DND/Q27.LP4#96R#<3L27+P#Q;%SB
M5'/<PQ3QP%\!1!K/(\`?<I@8;(BJ':(K%VWLWFK#-F*K-L4E+,CT4#P2YB.'
M)\/6'>KW"85@%P:\B*.-<9IZY@"'$E[.96<['(P:[*YXEN)F$/$`B`(%&C1@
M$```0@`#"0H`D(`@Q(@2)U*L:/$BQHP:-W+LZ/&C1`8#$`XH,'(`@P8)$!J`
M6`!A@)0O`01H:1`F280*1M+D:2`ER*!"AQ(M:I0@P@,-$#X\FK3!S*-2IV),
ML`#D`:54I2J8N$!K_L6K0K^*'1OQ:].+6L4V79`V8]NK"\J^58FQ[-:\5?52
M_)KU;UF_8!,`;O#W0-/#?PLH$/R7+^3(DH<^92KU:=3)FC=S[NQ9Z,R$HD>3
M+FWZ-.K4JE>3#N":=>F#K44'X`G[=MW/%@_*IGG[M^G>L`\.J"WP./+DR$LJ
M;^[\N`'D!A(80"`P`?;H!A!'+V`@.M"*E1T6Y)@V/%(`2C/K;N_^/?RI"11@
MQTY?`?WZ^O?S[^__/X`![H?`?P3JAU@!"%2'P`$%4(<`@_5%%V$""7KGG((5
M(H>==QPZ6)^!`V(78GWHQ1>1@L@IF.*%QS'8W'??&0BA?M/%.)V`$H)(_EUW
MU_7X'',F)1>D<D0"N9P`!02PG$`G,7;1>+D%M9)Z4"%T(I99:KDEEUUZ^268
M8?(5Y655OA2`F&FJN2:;;;KY)IQ:6F:94V9>&2>>>>JY)Y]]^AG?G.35N=Z=
M?QIZ***)*KHHG'?2:11FA3(Z*:656GHI9";&2>:@5@*`*:BABCHJJ7XRQ8!.
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MPL,R713464O<,M=E5^QUJD:%/:_9;>?EM-N6#FLSW$2_'#?>>5-[I;Y@1RJ`
MWH$+KJRCYQ)U]^")*SZJT(93YNWBD4N.Z;-#"P6QT9-KOGFBMAZUMF9D<SXZ
MM3]3.K?E4R*>E^BDNZX17J.G.K?:J[]^.^Y;!EJW4*#G_CNS#)BN;N&M8Z1S
MYL`KOWQ[Q:MJ._.O_L8>L_!M.X\UV]%KO_U6?*<.DN_<BS\^NJW2[C?DY*N_
M/D>>&X5YU$;EQ\!\"0S//O[6`W#5]Q_!+W;Y@I._`>;M>D5!7OS050#Z)40E
M2XJ(`AC`NZ&8:&9-J>#]W'._E-3-?AG9(`%#6!#W:00![TK?9;I"I599AR`+
M,$!"!C`]B<`P(0;(U9)D\Y(!H`@`#4%)`Q00FN)X+`&R&8#'7(-$@IB+6Z%I
M"D^<IH"8N"0A@&-B;UI"D!HF9$G8\8T)&\"3,*ID-`FBR!(A0I,%$F0E(SG.
M`)"H(25E4(2<@U?Y=G:4*ZZPC0/9EE(.\)2*K"20"FG`MJXBR"M&1)#[_D-D
M4@C3D(<L,BL-Z<H"&L+(ERP$(@T9S"$A(LBT9#*4HD1(`?#B2.Q\L@&:K&(G
M">+(K`Q-6F\!Y"FUTDJ;"6"&=L0='BD(O9$UD(D-.`@9S36SE[AD(7=:22S5
MV"K7A,<@\Z$)4`PB`)F@DB"HJENN.FE$B8Q$BVUTW$MR0Q.7*,4@5%S``R=R
MR`4@P)0$J2>:(C*3M`B*F64$RR^7%S+'"668=I.4,O4)@)9\AX8`"",#M/A,
M>ZH13;DRYQ:C\U"%MD1)!VG)2G(S$K%X!X*NH>(Y<Y/.B1R$B61T(U10*I%0
MHBJ:`!@)W$Q")P!XC)GU--YFZAA0>T6R?P5#_B%5^EA%M@ER(%F[B0#(:+-S
M1G.$/`PI140&4X$H<R6\J^=`OJE/!6TTI1-9J40.@IUX;M$W$US*`+"#TZ>A
MI*P$<5`-4\+3NSX4`-4;*O,&"E0HH?"MJI-4/=D&397PC@$SX6%ZJ)I5'J)U
MIN=:"9H$8AB:Y$I*!U$``B"K1ORLTZP2J2PLNPF1F_C29J&1:ES%Z%>74/*F
M2^EI0@8+V'&U%E#D,:I'#-J[8IY3L0L]RVI=^!*)MFJQ\D035B<RDK?4D[(+
MJ2Y!P3H`J28V(0N)KD)5FD_JG#9[$3'E7,MH&S*6U$K3Y>L4";K;URT-N"Y#
MJGR("TFFRI>14_VO_G/;R+]/2:NJFP7H2];3R8:8=[^/;&96,@->NVC5E8Q<
M0&.J"*5.HM6'?_%A,Z7Y8&9NR[`?Z^U\J5)?^1X+OU)1*D1@*$[;-J`Z,^6G
M,YMK2FO^-[U;M!\VO7D0F<RXP:ZDL0MG2Y"1F!"\J+)96BH$5XAT5L/"ZN1<
MP8M6S3(1(4!Y24JHA-$4N^YB]FV?BXV"@-XXJ)%+$H@//8;D)2M$I_:;R71&
M\F8E^76,PG--@P1"12,&`$*NN0JAT_+3L-@U`9/T)D]T&B37U)`Y;W3D<8;<
M5H7DQK&HU.E`XLM>A!@Z`$[SJ@,7RH`%1%JH9`[<BG4KGC0?L#Z(`>=Q_MZ"
M'XED1R`FC&AR?N0@T!ZG*\`6R$]6VQUS]B@BR:[(LU5R'3\^IT7*F>.&FNGK
MB0@Q.1=$MC>;\Q;&.#;7V);JJS<7ZXPEKUKH3C>\Q80V%A]5C_&^-ZQO9E3C
M";=:KL8WP/6RXG\3UM[B(GC`$UZG+]+[8?U6N-0BFFZF?"V/[>Z3K"&N\391
M_,P;>;@&L8.>_$2$?O8+C\BYW9^0:.H^Y<%.1>B#GKI8!8+V6>U^2JX?])A<
MY/8I"^]NOG'MK1M[8=H6[1Q9)88@I)=T'IIIWA(=B2A]6+FUK"FE!19',E(T
M30G-U3TE&JV`?33%/<W0HU?4AM^74*(UII:B_N-H\M24.GLU0`#6RD,8?H>B
M"Z42@;AU$PAR>NX2)'4/SR7CU<[$8_&%6PW7NE!BR;A"J?+TW6\J%I'DG65R
M57+:@3=OT9DX/0:/.U#(4\_4+["LJR?0DJ.93R_76-%I*V-;?EM:@AS$IH^B
M4M[Y&I)"<1+W?&T*9B'2TM$N.9\%86/H1;^_BE^D]#8CE/.W@O"+P).;58SN
MA$U=$4VG=?%=WBMC9?O@-=O3B&^$"#1I[$\J2^JST7VT>B%23ZVL6?F=-'+T
MD8Z9L1V:G9[\<`5//,3R60GYK806L=^825/='`":^%BEI46"T%[>V5/>F0O\
M.43QS5]QA1<TA5:0_I61\ZU*2FR7-`D:``;@'9D/`7X<K64)`UC'.NW>2RQ:
M&7T7G\T:S]V4`O`=!$7:DED>`DS1?P610\Q=&*T$G6F41'C@]V&6:IU3]O%=
MKH0'4QC`2,"@]!&+QVD$0A#`Q8&)("T%(TV2H!32TSR81#0$U9'&6:'.%PF`
M`"A%H51=**V$7(@&KTG*)!722YCA!\Z+M`B`E'G2KKQ@>Z`8&(())'*)3E#?
MXQ@@EZQ$1.V*:RQ%4_!@E\T*[2F?(G((>01?>CR$0ZS*7A5*H=7'2(39KG17
M(.Z*!X;43119>9V+I"R`@;W'7T7&)$;BPN@;^L7+&6X)S(E16&U4/9E0_FT4
M1&U(T)/@W:Q%V;PH$U>-T&\]!$Q-60/4TQN"%.A%#95@40`@&MTUQ'=EC;1D
MWQ(ZVB^JS/8!(S%:3!/>'E'\CR/"1V\`43CZ4)`9D6\\!$\0$47T1E,TW5+5
M1$X<DFPH8!+*1I(@'N\])"H.'OP)!V<%$6^8$#S=U!"AQ]2U$8/1A&R\VSV&
MA."8BQC.(!G6X(F87.P($0)4TP'<$/PM(T5$4,H%$7VLE@I)T!`B@%B`E@?M
MI,@1B!3Q1S6]Q0TR%MST7#:)",\])8[HQTIB1#WVS*F,848T4`)MI:_P(6N4
M'7"D!@&<Y&F@)5NF)5PVG6C@(2HI!(/1Y6CD_B$>"@`!""0[*H0/,5@!'`!=
MLJ5;AH9`,!@!#*9B-*9C/F9C$L9C-`]/66)!R219PHIU+$D<(<=K!$"25)MH
MPM%H)J:1F,2>>>9RU!EIEJ:2!(E"E,0/\9D/E01OL&;9Z9EHG(1M^$87E41J
M<*8//59QD(0.T69<)J=_=4;1H0\FBHGU969F9A-\&)#%C:6:1*=T;F=URF#&
MR1-F<J=XXLNG],UU`M`^CJ=ZBDISGF<_=H1V>H32<9DHQ9(FE845F<9I$8S2
M_65"`-1Y*11>`J@:P<Y)BJ"T6032$1YQ+1)>)*9BS:/9U!S\R85@V(57!!'5
M(=(43@]>$,8P*JA0_L0GMK3GX83GY82%S%R4Y;T=JL@4^XD6#`V`C/&9G:V6
M785$[S'(&]70`<Q*KDC1F13`#TU$/96>.QU'UL#0K*Q$14(6`YPD9'$2-=U3
M#)&3A":-0717%X51;^96`BI?:G#1:/2&^+$?3C31<=&?T^0F&ZEIDR7$FCT$
M%RU@&:$73*#(V\T$NE&)3K6&$$6@GGB@>9[H0&"G!I5'C>V*->J?/N(9;2VB
M/RU=0+Y=1+P71)3$4LPC#$F5<V&JF`IJ1%2I::6'2GYA&74%DWK39CT$JH11
M!TJ00F7IT1A$,RX4?:372OQ:A=B/GK&%IJ+*5=$'%=F66QA1`M33-BWJ_DT&
M$3,5ZC,2GAP57ZJ)5G'PSS7]FIW>Z07%45JQS4E\JY<V87TXQ!0MJZF4)UB>
MT',F:AF%T4[H4[BZ1'&2G:L*GX:J$:CB:#0)T:8*"_F-D!:A%J$!X*Z2D]/$
M:%8U8DOPADXNH9)4:K2I1&<F"OU,2J-"F94B'[<DH=A]G3-UT@LA12==K!NB
MRI@%WRA*$SS25*'@C"8B1;*6E4'434)\62P!GK/=7F)]'=LDVZOZR2VNK'M^
M203)E@",&3S)5INVWG'%EI71U:I,Q,%FU2\J2*Z04=`Z$GILUY%:!"@FY!`>
MHS2IT4!H5)!=C)50+$QD4TS0)]<4FC2YZDL4_I&@-,A=:93X<9G++B26>6.5
M3%@0<5-.;1?9]J&D8%;5AJ/PH%*8R5/R046HW=6:91_[=5)M]-.\R)0@=>66
M#"U,AN4A)9:88!Y`_JL#AAC+M%G4NH0)+5<@JN2_HI$J.I^:RE09(04\[NR]
MGA4/">M$5!Y8]9`)$=^\U),6R:VFE@UXD4:1>===#80@O>U"CD;U>MT_6<FM
MR*&C1M"<T81&*>(N&AA!KNE,+>HVT:=!+*HY4<=*K5F5><IKS$MT>>Y,FN@E
M)B-1S$5>$.;2K1!#1J\L">2X90\=OB&!DFQ/6N\YT64T]:5H^-(H"8M`GD^2
M8>]Y.16'L8UF0:'D_IK-!*>'@_BO5A325RQO'O)5:")%'C:(H/B07Y"'&[Z$
M+_5E1'"OI)C=PBHH!!-HJ[`C?78PB$7O.0YF=*535MCP>7VG,E;BNA+60)PC
MF*3@G1#I=6!J$(L,@DX(A!!M38E'+%4/IYE@.SJM%#V4^YKO%*KQSO9(CD($
ML13'63G5KGBK/@T$1[ZQU(2PQH[0>`D*/1VAD.T4A[%>C*E0E83M#2L9*]J0
MV=Y$`B,HW`4DZ"'%V9D31Y(4'8-9UN+K7;U%Z(;).5IF4#"D%'^)7:T3JN"%
M_)6L6BE46F'CF*T44$#(["Y9%SO-M?8@)*$BD8YJ/MD8,%?3=!P30'4B_D5$
MJZSR7DL(DIRUA"Z#5'W41E)J3?-RRT2]!0]!K32^<"P-X2U_8#M15/5P;XV]
MG1U_\=7`LCPY#0S5Q:YLR\":F@1)L68E5ISZ;$@LA"U1A>QN!OY>IE+44)AP
MDD[=Y$B`16)5I%WQV*8]VPZ&&TN47(\>=`UEFD-,=#<G"6\`;J$E5A$=A`"8
M"]Q,44T(&F-P$E`0Y$BO%@(TQ,#Z4&BAE))42$R\XV;6S?+22C`>W9JN"H[`
M;J76CTG8ZAO^VDWIQY(`KT0,KY4TZPWFG0J.4`%[='&A6\"Z!!4)427'K)4V
M(T9UDTEPXSEID8\E@!T[<U)I4$"#!#^*LONV_EFY09^PM5<;N?-Q`(5VA!NX
M\1IT1)!VJ(B&P&MSA)&P(9^+H%K)X5U)_%IW(/:TW5-)G!ITT)!`Z'5Q0!^*
M_/.HV+*:>"$3EFD8H:5"](:SP5EI<&E9Z&:KX%T7`9EWP<11FD978-K9L3&9
M7E9"-"TK)E%K&,:AKD93",#NXB.&/3$%MZO)>'#`24N(>@9A3(4JN06']J2@
MHH5$!$8C=818>"BE[HD4(_>L!?=[<@Q/!MQ8\XQ(H"N?C+)X+ZQRKV>[/"S-
MP&U[MW6+13%ZRG>*\C>E@"Z)LJO^^C>!_PJ5N,5[@R=Y%SB#?T0U4XI[AS)A
MF2&B-OA:6SB;1/A4_H`<AG?XI$0X$Y_7(56XA]M+@+,/?A\5X)"XVYQXB5MS
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M'K`7.KACN[@_CI&;^[DCRJ&O3[I?YJRW.[U3A(8?;?EP^Z1\N?CPNZ/'.['[
ME;4/N[\C.L#G=Z;7.[@??+TEO,*/SE=\"\/+N+X_/(:B3,%_D,0S>YU\RL!;
M/*^+>SU^.KN#?-OTM+I,?)P[O,GGS:JY"TR=<K=X?+"W_(6__,6J1%-X3,X?
MK<P5!%#P_*FEQ#(O<X;U_.8Y'M'S?-!3&?QYTTH_?1LQ4=`3_05=D-"[T$I'
M?;X.+MP!*1.QA=173\XO\WQ<BLJC&<V7O,T/_H4@'4`BO7W#:-V1P?TAL:,:
MAG;=[SW#-,1<7,DD`5(F`4Y?*L4D>6""'=E#?-+@?P4`&#G#.3[@Y`K@O/W>
MMQ+:5'Z5)'0B;I;F\X_F&_[T78G<!SZ(8?[^+-*!.6LJ&0;<8W=6(!)BJ`3<
MT[XL*059R!*BE7"(>T3:T^#:MSUGP$0-F6!&QR93?)I.P`2>-Q`J81K)7'3D
M,84.-7_R/]0JD83-Q-7:E:^YX"`(+K^7=1/S-UWD1>1N*__Q?PI+[!-O8-H^
MP41BH783^:G[YR!+U)`7DAHJY=7-`@0```@,"$P0`$"`!@4`#&@@4``#@0H:
M5+1X$6-&C1LO)A#8_L`C`(XC-TK\R%`D294K6;9T^1)F3)DS:=:T>1-G3ITD
M#R9@4""BQP(,`@A0X-$`@P%&B1IH4-!G`8<'G1HHD.#I``0_"RSX&<`G@`)9
M&1R\RK7!`;!$`S!8$&`L`@!8#6A]VE5I6[D"G@8X*F"`@H(.U5:=V]?I`+`*
M`O@MJ!`!W)]S#RKT.("!7`5OVQ8<.X"R9(8^$29@/!;AV-$)!.@5FW9BR`1R
M,2,TX%$APMH`!$]DZ+"@4X0'%$S<R?.CW)0X!8I$J9'!<>G3J5>W?AU[=NW;
MN7<?R2!Z@P4L*58,WZ#\^?(DU[<\[]9\]*,5%40O:[^\SP9E*=[?GQZK_NU"
M`NFCG)I;J$#O%%R0P08=?!#"""6<D,()<2-PN9L.?*["#CW\$,0011R1Q!*Y
M&W!``P$X`,$,37P1QAAE?##`&6V\D;H!#TA0P]<X+$FG\W#,3L@AC3SRHO:0
M7)+)D094+B>35.-Q/^J*;!++++7<DLLND1,I1>9.HM++,LT\T[P.$5!R):N<
M@DF!`A"`R:H"6,3H*SG'^FE.-!6\,,P>G2/3ST(-/32[UU8JKB+=8OH-)N5<
MQ`V!YPI*Z4KQ6$K@S4P1M>A)0F<2B(`6/ST5U51K$HHE`?B";2R8=HSU)8'N
MM,B@BG:$M:(:DVPU5A<7&.]4%$65"2)35<W2_M-EG8WITO<2,.THTQ!<S+.R
M:M16/VTW\RG..:N=ML9IU0MK18P$>O,AD.0T;]KRJE7@J//(K6B!W\BE=EKT
MXJVW5_V\#-5%FDP:M.!G%5X8480&LJBXABX=("2!"D#)8:<F`ZVMB)M3["/0
MFIN+J(04PK"Y5RT2H+FM*'(8Y8]'3HB!B$&;<F:Q4$H`I>:N8IGF@3\*U*8-
MCV48Z:2U/&"`QRYB:"R+$8R5H;9$1M`IEA-+:-9+'RI+:H800&H!@TRZM5>'
M<QWPP'5#"D`YGC_*]68,#8@89<]28[7+`;U6$6&E!1^<V8:46P_JAWQ4-/'G
M<MU1H<0KH@V]!A`Z_EF@QFPMT-:,E&I.(:]A-BBD.4D70,Y<I99-<?2DIC?S
MJR5D,R=6B:[)Z(0)WYWW%^7JF=;$PV9\<9$>'Y/6WRN*MB*W3=LQ):E!?96!
M2Z?]:&*:63>;Y9VGQG"KCR*.=?Q[^WX-2A5+_;'W]MT7T4Y=$Q1^\5<;_XAE
MK';D2W("^2K;1]"[TP$N-9[.@0H`Q%)<;_YGJP.,9WMS<=QA5J<Z,$E/<;'R
ME982=[N91(Q_1WO?"$GX)T4I)P#C><REVH*2WR2D`2++3$-,,B='32YDZY++
M`5PX@*B)13D106!;]I.<CR!$``@8&]@`D!2!2,J%,309QD1VO:!)<2`%_C@9
MEVPG0I=X3%DE%.,8NW,P`T@*(35+#6"NHH";56P`''.*I)S"F*L=3"R72XA7
M4((9]'"L,>_JU<S`8CF+J4T@<<Q9`":FFP5<"C692T@!+M40\VB1AD*;BA?=
MDSLR?I)"S0*E=,"#$:RPB3_DNE(@+Y;&!"R`(OT1#U9J!C%?G=(B"L0([;)T
M&0SI)%GL&^4PC\/+B]22F"62"%@XQ<A1^O)O8@J<A$293&M>LSL':0Z[/LDJ
M8>)N3+K#YCC)64ZAC<6#,JE8&#]43?>Y<T+P-&=-^C1/$GFF`93#24A"*$Y[
M_A.@`1T1/@=3NV!R4J`)Y4XI%9I05A5TGP?U_F=#*4HD759TGOC4YTW6^4V,
M?A2D(>5H_7("1H^*%*4I5>E&"&K)B!9OI3&5J4SQ>=*8A(1%-IWI3GD*T/O1
MRB8X96=/B5I4<]YOBT$=WD2-VE2G[BY32#4H`-:'T*=>%:M*^^E4<VK5K'X5
MK*F2ZDN[RM2PGM5,QLQJ2X&Z*HFB%:YQ397R^F<3D_13KGG5*YJV2M:A[A6P
M@452XI3G5YT*%K&))5'B9L75OU:GK3M1JV(I--DS5=.R&_'515U23QAE-D1T
M5=1(T]6SG)T6M:D-@")]>#'7OA:VL97M;&E;6]O>%K>YE6V==-M;VE:J4KZ-
M;9T(8H`ZW69L!+G*_KZ8NQ_F/A>ZT64NO?J52G+1:S_A`4]XVJ-=\VPF/`(K
M(6B;FIZ,>'.T2@UG:MG;7O>^%[[QE>]\Z5M?^]X7O_G5[W[YVU__IM:U_Q5P
M>S4'7]W([&,.:TT?Q2))1*)VM9E#9($OATG7QE$J2%0,7(3K6Y[!]@"5XNUP
M"<@I2BYW6A>[#;E6+-WHWL^LFY):<#MLX==&N"$X;DU[4<>QAK3FP2,+\H")
M7&0C'QG)25;RDIG<9"<_&<I+GI)#<'*V:\HSN_0YYI6VFZ:;7*D^^*+==4'B
M7;?4#+N@0J9%P'-*T_A$ND<9FXO)-6<ZU_G.T6WQ;8RK8A7SC"`$/'&?_D4L
M)T#7&-&)5O2B&2T5D66N9X#1G`]!9UJU%662$&E,'#&,247F>-(7+O`BHVSD
M*45V)A5#\JP.T&I7OQK6L9;UK&G=Z@0<X-:W=O4"'LAK6;^YUKI^M;!S#<MA
M'5O8OM845N(U+0/(^C8$;/6SA3WK:D,;U[!^-G$,P.M^"89%K>9UMQ^8RUS"
MDK)$'4]Y?#V><HN'.""YR`-C/:Q:PWI8O'IIJ?G=;W__V\"2%/+`Y3MDT.6Q
M(5+YS6I?*_`I=EKA6FSMA1N-:!I7'./"O;AL9R.G$<_639S:^*)YZR8E\E"Y
M@[:*LW&=9Y?'&>;D6L";R3P??W%V)G6MB<<`\=YSG_\<Z$$7^M")7G2C#YC*
M48)8D+@['U6.RUS[JAET[_/*EU\=NM3-,]3S3,GGMGPV=KZ*$I]K%;!#U\Y8
M9^Z<*9EV7"?7N"&>\]CTQ*DSAGCM'3?NAU]+P(_/EM.Z8>VE?=C:RREFP573
MXN'U")=')X3`@#RXPPQ^=,M?'O-*3FJZ.4\2+"OH\Z#/I4^F_DI_V2>ZU-7Z
M=?]5>G#-QS[.U0^UM.YZUJO=Y97:E]=G(W<\WP;%9S3QL\\H8N0.]V*=5_[R
MF=]\YS\?^M&7_O2I7WWK7[^HY,7^]KE/QC5W'_SA%__XR5]^\Y\?_0T("```
!.S\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>f39432xe3943253.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943253.gif
M1TE&.#EA<`(:`_<``````!@8&"DI*3DY.4)"0E)24G-S<X2$A(R,C*VMK<;&
MQM;6UN?GY___________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````<`(:`P`(_@`;"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*5>""
MKF##BAU+MJS9LVC3JEW+MJW;MW#CRIU+MV[:KW;SZMW+MZ_?OX`#"QY,N+#A
MPX@3*U[,N+'CQY`C2YY,N;+ERY@S:][,N;/GSZ!#BQY-NK3ITZA3JU[-NK7K
MU[!CRYY-N[;MV[@)*LCMD0$#R@EX3]TMO+CQHK\/)C_.O/E,!<N=5_U-'>%R
MZ%^)-UB0//K!W=45_GJ73KYV<`4*!C`8D*!``00,WB<X8"`!@P3X%R!(8*`!
M@@4&*%!`>PH<$!]_#12@GP+U#0@@`P(.,`"`"2!0@`+\C5<>5'AM2-4!"QR@
M8'[!+>`>?@E@:,"`!AR`H8GS'3!?`R*F..*`!^288P$R8IC``C_2N````BRP
M`(:K_08>A-OY9M]NP2'0`''G->!;=E/>U\!YZ*4(W6Y2&L``?/NYF&**]U7H
M86(-)MA`?P7X=Y\"\-&)X9@"OJFGF`@@V1]\4;X9WY[HV7EAG`;TV5X`JN5W
MH8\$8CA``P!@*""=4[+7IP'ZU4=G>Q6J"&`#`P@8'P)P6@@DJ@BTBI]V_FL6
MMF)P]B'`7J;\):#IF)L&5Y]][>TGY7[\'1!`A07<EZ@!+3*0Z'NSMKI?`0&F
M-D!]$/:IZ+0,DKH>I0ST*":."3KK)H/H,2!`N>KUIUZ<\!HZIGX!:!CK7\]^
M"Z><\!G(GZ4VN@E?@`$CZA^I-'8+[Y%W!GB`?Z@R<*1J`P[DY6X^0GAA??L5
MN&6X:?ZH;7O.XKE@@_]E>*B,@E+KGWWW%M8E@B#!&I'&)C;*8WLR]LQ?D>L*
MD$#0"0``XLX%`-#>D$43,!^*`,"H8)Q15]T``3BVN&Y[,1>FH-4W"9#CNJE5
MFRYW1BIII97=-3GEVKH9M!N6&!<T]Y4O(]SU_E8V?\0?@%(.=*26O@D$Z$#]
M$3QE<%-2.>=_!$,X**#F"H1>BW&FYBI^.3$ZZ-Z"U0<``XP*-.FQI5X(*GOU
M"4#Z>@I46JIZC#):ZNB5`M!`[?HA$("`+0Z4;,ZI7:BW0!+[5CAW7UKY5:!U
M0[FE?4?^ISQU7XGIY)&,,YLKZ((M79]`C+LTOI4!_)<Y:A*23'Z9!5RK8+U*
M'WL`JK.ZYZR`NLYG(:JCFU"]:K<[!1Q+`.A!7IQH!CY\*0"!NK/2I`C2GX14
MBR&5L]SZ["80,1&L@NSS%?D89R^#A,=P!3%>0<9T$"FIZ4WUF53?&IB7]P"(
M.&)R">E(6!_BH69H_GG:SODJTB&O7(1L&Q3)#&G8%*$I+8)#HHG11-0H=R$/
M9B_9#_D&=*TE=N0K)9Q,&/^"JC<1)XDKB=H(`^##TZ@I15-2H0X)(D,T9B9,
MWEN?>TRUN+=MYCVNBV#L7@*K9`D@<*AQ4.#2$Q,D34]78W0,<>(#+>EIASC:
M(18B,6,N^`@D63I<'[(FAAIE+6""6_+B2<IW,$Q5!D#,P@CA7&49AR6@=+M[
M271^YQ[5)&I4GXPD28)(K/1-ADJ<XPB$DCD9794KF"X)XO2BMDG3L(QL6RHB
M2XQDL4]*II<CT<[#(L,C]I`MBC-9E]-4XRH]JM(D"=R2@F+YF/;(D23A_@J0
M-A7#("!U[YTDF90+8VG'T6@Q<QF,9N`J=";')`<Z*1G3BAY3IE89KIH118#0
M6J4Z$)X&53Y4#TP@:J4!W1,Q*)()2;N2G#B)-"0?K"`S9=*?)Y4/H)<I%:E8
MA-&5Y'!Q^.FI1B`JS*I<2*@K":I'AY-*[Z&*/G@*";7NQSA'SF16G2K6I?I3
M-\W\:(';H5%-%A"T?6J$K#M;ZE8>QLJ8P*@J1A(:_]:G.VR"9$`8.N<X9U(`
MK'U%05,*D8S:`X`!!0=$CZG;L&QELZ*.Y(*)HD](LA4L&`YLK\WL#P*CTIY?
M'80_)^U(#SF%0IK<AV6^2PB:&#11Q7`'=N]A_I&/D,K7-Q4T(VA*(G16I-:F
M^(:V,:F83IDBI5*5$(BXO.O0/N?,YQA``'&RU86$MB7(*`H_>*W2D;A:+)N\
MIX/8?6RHON,?[SVE8SOID^J4LAM0-L1%[KUK>UOJ6)-,*KK)@I>N+*2N5A7N
M,#5EDD&XHQ[^`+<ERXGN@3&"RH0XBY1*,4"#<>*;>2:4**Q=<!QS.=G(-E>:
M,<$/=>LEM\4=R#T31DQ-*T35H[:6)HDR''Z8A5.*;&S!-M*P3JZC)<N%53MJ
M`Q/RLO0;6@G.-^GJF+;2]*M<N0Y1X:U7:`<B9(FU%28&C@A]+JC<9WI9I2:=
M5JX$K!R))89']`$5_JU"1%:QCI4@#VNC1XP4I(?<UB5X*=%"`'LB$24M:5B#
M;@&@6]@=M0=K/(*NV!0-:),*X-$-$)I[]MBB7+E(:`]34.Q@Y**$Q&E=41M0
M77VTD!\!*41N,FM$[IP0]F#V(]#%$!1??1*S%BEJ)H*1TH!67<:L!W:H]>/+
MZ!2\FF!Q/Z>LKT2P>V7Q]!8CS6-(KEH5(/;<DI$%%1&8,!6G(`M[R$55MD'.
M]"+HZ"I$2X2.E%YK)6:K>B"\<I:%=E<AT@'.P.%"49QDE)SP'JRH@XSO1ZY%
MH?>QM;K]@="7%``D3(5)3_V24ZT$-:Q(LW"&%9,;BA(E`&8QRZ*R^C9!_L*T
M7_6XKB9]LARGN@62`XD;7>53WI"[-*9?%XA`L2T@G\98Y,+]5]H'VXFR#F#.
MAZ:LQAAAI2<-AZ&.*7P_X2(6IWX7@`$45G;OD5*RU`0=ES9[(ZK2(L3VFZ@N
M:1*T!E:O@9<5*N\1B#\!@ARH##(`'1<JAHAQ$D/U.SI&V8>-99;YV[R-L269
M^V/0*=R7E&=D(Y/TEJM2HK.:?3U:K0AV%NI2?42$JD<M0,J68IZX+X(GN^:$
M02.C[I2(!<>=J%LYU053/K=;=[PZRSW41E-&D"WVUF?DJ*R=VJ=B&ZRE^F9"
MFKDO_[@FI<8^<#PS,Q6BUM-P'V'H0M>".YTV_F:BFA]*89]*^9;^,V^//`FD
MU('6?.*G;4V9:O,,&KU*4/3NF1CX7\^G<M:M>I-$Z?@[A_(DU9,M!]96?:-(
M%31$&/$>LS4T<%<A__$N;44@]?<8OL%5#G$LW@&!Z)$R$#<YCF)6RX$]0P8W
M:V,?_:8^SR81&H,A]-$Q['%*0L9J%C,`)+9C*=):%R83/"(ER_0?!L$L"G<3
M0/)S%,$YPS41+(9B^!$?Z6)8Y^-[&2%AU"(?'V<KOW(K!0$?$<0:ZY1"2U,T
MD48I8S@T(0)8&T%:";(`!,!-%R$@,K(UVT%G;FAC,E*!+_$CKP(D)H6'*J$[
M('(`<G40DT:#*O$\_H;H$'5(1'/8(S,&:=C$,D9T'D`25BEB))5X<`51AS5"
M:Y^%:J-A+XE3$+FB*W$R0()2*0%X+!O!0I8#.,A39!#X)TAG$(<B?P3!-116
M(!ZW3%G''3*!(#9B)P@15%+82$4(;<G"*%V($<#X6JW2*1=5+AM3('22>R(#
M/%S$2`-11G'$40`%/*U!:G8S,$'2+O'Q(`QRC!?A7H#4=*TR*:M59Q5Q(:RX
M@+5X$K[Q.U8B(V77(#VF4/=Q2@GB1>$'A#.A41IA9AP3$C&(2AFG-M%E*,_E
M7^66(N+W91#X4@JA+:UQB@U!.L<C$,G%15SC=]/V+_U#=;82::W723.E_DQ<
M-%2ZF$X-.26'Y'9:)W8LP5"_T2=):!W^1Q,,E'3+Z(0?L7PTLX,KA!ZK$G\=
MQW8(D&8B52!C(G`(82M?5QK]U1`#8V\JMT)9PAU29R(PAR3PX21OPCCPD7%2
M=2D:85@)J52"(V;(LAXQ>1)V<A^NDV()42:XR!%39A%/IB<?(6^"TD&XB#&M
M8I75IBJQ15*BB$6KH2,-059%4T2Z`T?K(B*@)B(A\F**N#6):&/TB!&:Z%9I
M1FL[<X9LMI4A`23^F"+-*&W[%F)^^!#.M"ZE&1&"=7WDLX(/T8SY821U)8A4
MI#L*TB$@4INI<7->:2D+%%2I$R`Y)W(.<3YU_G=(_R<1HA:8I`AU,2$L6/E)
M86=@'E-KB3)CHND0\R:<):&`9W4@'-D1.O52O:E:Y;-).+=W>6)2Y5(I-96/
MFB%9L?A:"G=#;%=);IF?"`%DB=.=$1%W'9$?A(0?]U-"-@0H]I1P^*0?*%)W
MN4E!(\D2]+01SY=?4A54@7.B%9%<WE@TZ;&"]W%B#S0M*P(P)^09,C(L<S4K
MT:(K(+9)_$<1D/5<E_>6@UD13>@2*'*:A/@HA>(B/#E9U`)W5RH1#V1`.@2?
M%(%`&!D26O13?KELVK%!#T*#2,DV[?8;8G(_BG1,5H(D4#(F.>)_F-(W3GA/
M\>6@"]$M>:E,)BB8_N!I$<[B(IW&$+92+P52*O+9$8P$/"[JF^HAH6?%CM!F
M)H_5(MY8I=_Q3B)%(0-CC?&S,<.F&S.Y$$4VHH7AIA;B'C&V5=*V/^L33]-X
M$>=C2%SV$=_7&UXJ$MCW;D2*77C%+%L'$F:C7IFD;-]"H+(D-(5J0LOHK`]A
M4:A4IA,:'.OBJ+QW*JG3/QM$(*\1B-)F)(@55G9UKA91A_OFIW8VAKS:$K+I
MB0N1(Y#B'HG*$:>VAJI7C_"JA*Q*$*'Y$:=4DP0['RY(/O0*$60S5Z"B-";%
M-0!*$*'V&B:21,]2+-K"*M`"=164D4Q*)<(2K9Z6'M3ZI[_J$>A2G@S1_D\M
M,BL6VHJO4H7N6A#MHA+6Z#<$1K((L:')P8^XJJWKJ#K&@C]]XCIMHICUN1I!
M18KR<7.J0R?^8EB9\ZAF:CG!L:09D2TM9ZE)5W:C1TD?UR"!2A&7,R%6:YJP
M^1%IJXS8J4Q/57Z>.A&E$T4+NHZ.^C(7<A_8Q[.O!$["$[6#Q5#UP3'JQ708
ML73K&3$PQ5!W9:(O9*2L$A^<M[;9*749JA'V4;-F>[(8)#1+6Z'JDQRA*Q$7
MA'/7HFW4LA^RLXZ2PJ6P46]O`TN7LE'K:"$8R2"3$E47T7K]5+9Q::L>D;(R
MF:06(2#4PG";XKG;-7P&THJ30KQ;R[FE=B1`_IN4$G8_'VNY#(%++)(K'F0A
MU>)_'\1'L,%16)J#1[MQ56BLV(*XN(I#`Y"E4@4[+?>V(<$_GIN+U1(LKZ>E
M\'6-7BL>C7D2;MD;P5&Z:=A>9U2H8L<`SGD<>(%61>(B*R)H>84C".0>15)G
M,]*[`V&O16E^<J:OV`H2(6*PZVJ6MYDC)XP0G?DCT!6P#4$N)E'")MQ-!"N(
M##=.BVAC@<N]MN%)ZO9@R4(P#)<XYB(FNP5"]WB\#\4I++L1[\)P*#S`$@&B
M6"PWZH(@$_(?*]6RSQ4JF+I[(#L26UQJ`U(O+VP1\=,[[X,1/R6$Y'$@Q\M`
MWF@1<PPJ^[L08A*S_DGIMPIA'UK8$60B*#*BM?#V1@$`N,.[JR(1N2`1'&,B
MQ$J(*"U:J.Y%Q^6A'WI,$-=;$8\G4-3[I^8+$FV\$;E2R@CQ+NF((@680ZA2
MQKLG829AA![QG@8DR,A#)PM24I;L:4;7Q^4A*=T8S`BQQRH*4W."QB7!/](K
M$?>E+IL7D,HAH#TRQ;(D86KX6,3L8,_SS0`(+\GQ4VY\1@K,1*!</C=XO/"F
M:<@<$2D5R6FLB-0F$NHQ(=[*E%M4+._!RQ3T-\\,T!;S9+#KJ[ZR4&F,2UJI
MS@K!AXQ3B4>$%Z`&I1TQ($4R$O$\$07[PQ[A4CY3'P3PB0*1:2;!RN]E_A*#
M%1*2I4<9(8EMYM`.)D?F+,KPIG7BK!QA_+CXY"WXU(,#,SP>RG2[(28X7*'/
M4A+U/,C<0:4ULR)`(E/1+#<0J<T.?3G"4Z@@!"<;#1''DESW2Q*9E].#G"\K
M8B#NV"WPH8$G;1)+G1!W(D.->SQ6G9U4`M8H0<.=@9>(4ZC7P2FTG!&[D<K'
MB]<0@<M9F2`H[1#LH1YI,C$*,E`O4A('8GJ'.=41P7"P)59D\F#$YI&)PS4;
M7)`K%B!_\D^DQ]!MZ]"."TT7@4@!2-#!9-@5BG1AY!U08FXUK;+"HT"`>B</
M5&_O"T\,ARCI<2#J96]K%SO^YVC?HCM?C'ID_KU"U/(;R>*(E^)/*FE2E:R\
M-=H?^F&/VP%U=*+)Q`%R,OU9->G1$A&)\R'1KW@0;J@=9H59*4P2=15I!9(C
M*9PGRLF&,?(P%HQ=J*8T?B9/\&0Q)KEH1+<==X@2(#(I13(U8A4G>;9%TP-8
M9H*)/])>;G(4@SL`8C,V>IU"PI/1Z7T0'$G8#X$DT74J]\,Z,80NK2)IC6EM
MUR8FH^-!B^U@Z(6TU<,C)0-WS_,J#^-"930L*];51ODO;.P?Z)(2M1=T)NC`
M7`M/+/X0#V91/1;8#7'<G^3E3%0AN`2\=G9+$*Q1"!(G2Y)-(CBH(I<L66X1
M^[':>NQ,D/S,?:*<_E!^2(J,P!73?`=3)75:*'5Z)O<AZ%)R/P]GP#^R(K'%
M(C$D8B9;+^1G3^E#+?GL':P,D9C=-0TVYQ9T<6_B7[)$$,GB2B1!N$V2>%>B
M)562/)+#,-(#+)*3*+)=C/<\*9.B.]*241IEHQ$+JS%TI>PQHYIN8+C7(!VH
MCXP"?!Z42L*2M11W+C5Z=,(+7@LH/&<<&]/]62T9Q^WX67)R7R:U(L)R+.ZB
M*SFZK7CI4I3RUATY>?.KZ2TR`&F6*`'`6_MEBNN![N]Q+=9Y/]\.URA#[?72
METGU-$A29`E4-\KS/!@T)::-$M\N)K]#52BS7<@M@]IB*=A()A6".9\>_HJ4
M72G(,SJG+K!U%SFIKG"<`\OVX2])CLA=_.$!U8$07QUZYA6"9V8E:#'I6-<<
MX259=I0]GMFB\SJS^S;2PR1J:6Y6EB55PNKP1,Y\\B;:_8#1NQ[!+F6V$MZ.
MRJ#74E[$=RB9IS3H'EF\Q8#48N=,9"+8A(9NO$]T]M%D6!)/L[!'E"`$8-GY
M2[7Z36=5P^07(9L*4E91(S2\EF:WYH`\DC1DA9D"?B*U)E>+1E9C$_EDM1NZ
MD]\]DS-.$X>!Q68-YY+D>EC5!2(_(L+:G2,JG.+!*7Z.K7=K0QV2`U%%_!LK
M_2>I%.5/@B>Y"W5L92EU$W?Y)N8:H>ZVS';,_F(LJ'?=?\Q1C/YQ?AX_K5-W
M)H$B+PC82K9:*;&.LK-QX!M_#"@LB$R,?V(N1TQFMSQXO88=:N/TMP^,/L]P
ML-)8$$'?'1,PL@\0#00*9(#``((#!1(@4*@@@8$"`PX>>%A`H<4!&"T>.%C`
M($,##T.&Y!@2@8`$"D)F3&"18<0"$&,:&'!@`((``W7NY-G3YTX&!AH(+1"4
MP0$%#!8D2-!`00,`3H\V2*"T0%(%"(8.9$"UZ4^P87LB;&F@8(&A*A$T9:I5
M[%NX`ELNB%O7[EV\>?7>99!2(<V]@04/)ES8\.&W*D->#=F@ZU?'2L4^?=J5
MYU."B#5O%FM@@0',_IR'MD2@%L':!J<E'J#*X*KHG2H5H(5=VS;L@DROTK[=
MV_=OX'%=;U4PP')PY,G!NJY:>_9"!8J/EU9@<T%,R+8/TE7>W3O!Q0NS?R=?
MWGQ8AZ6OES[?WG;+F+45'NC;\KA`HJ=/1QR_F4%6[MP34+.@/+J.MP$35/`W
M`:!J8`'6%I10L-D0U"RJ!CE*(,*=&@1@J:4:&"!`S@Y(*+0)4ZQKJ00$J"DJ
M%6.44:^4!F@`*=1FU-&GH`#S3RBA./+(I^=&:HFB_@P[:K8=F^S),P66LM!)
M*G?LB\F'JJ22`912V@P!!FQ,X+KF?%J@M,6J2TLTAU#4<L8P=2KJ33IO_KMO
MK[;:`JU.'9$J\S`P!U"IQ21Y*BB`!'**+BHW":O0+3YE-(N@*2.U]#P;!X+T
MT@FOB@ZQHD)**@`2Q6(@@*.$>J@@Q`9((%-.)RQ.)T%CM?4[I@:"L-2]0KP5
ML0,$N.XPI`PX@*X";-H)P0;E:@I"B*BZ$<+#-N3PUP01K!1;;F%CTJM)NQ7P
M*O8*(XVQE'@U-26#HO-LV[Q`@U?<[KX5:$YZ\]TLUX%&U!?3HN[<J[036^+7
MKB+7NF@APOX#\]_S`G;J3X@KQI.W4P6V.+BU&!ZLXY0&+10NT$CS3-[!!FUT
M8^""DJ@EXUB6V2ZFG@U3XYE[,\A+"A7J<L_`_F8[K26AA0ILZ)R3<VUHE7!.
M^FFJ'.J19ZA]^\OIN!8*2:25\9IZH3"EU@NKJH$;*;V'RU9[@0]9\U7MV^8S
M>B^*"MAU7KPXFNW8N?:R2%VX]V7*H3$#3Q'K+UVS"FC#1?O/HY'?LG&W!O#&
M*[J_P#R5*<1[6JC<QCGKRZ*_0G\Z;(4.-IW`M4"WZ[J;1]_L*4%#O='8NI1*
M;W7.%#:V7=XGE`PVLU("H.G@-</)(+P*-\Y8RP6KO26G%-H4+-UB3A[4A6;:
M?D'J<4,4+>:_Q_ZNG2/W?"U!'9J;^()2#?M]'DE3WWR$!S^`(?P'=*@VK;A*
M`#'I6O_X@IKK+><Z_@GQ2P(Y8Q:[/>0S1P++`D;$.`/NI2`.68H#,Q@<P(F&
M-5&)W@??TB`"*"0N)E)`ABCBFP;59$,-0.'(CI40$P9F835Y80Z[T[G"0,15
MQ?+A7C+BI[?4YT2R^8U*%I`5AKAF`?$;3VE46$2]""4G5P$B%JG4IHQ\RHM\
M:=%I.E<RPH$-..YKFG$H<B9IR24Z]QMC3]Q%*%35D5,I80H`#$`_/:ZK3>B1
MS=;P%1S=7$5128$<N((22+L(*B>-@:2=?",;K<2IDG$Q2]IZ\D2/S-&3R6F*
M6?2V-<>DIG(%W*1.V&.9$FHFA*WL5;!,M(!FT3(L;,/E3ZHSI@&V4""S_D1,
M?UCSK-1%A(;6TN4N>3/#9E:I>XH;931C8Y1J;H5=-.%-4GK3J*YXYC0'6=+G
MNKC)1U+*FE^$E+W6R1.S&,="H&%AEMR3D+XXIF;A>N=.[.D40/:&F/WL3&@T
M2="=@$8H*"$(\W3#RA_JA(\#;68Z'1-+A.;EG'69E4`ZFE$Y#6=NQA%`F.A(
M'J90M)G_1!Y(4^2Q>[ET6;^LC`)(-::3>B=\,@4/5P)Z&Y7R="#/Q&@SHW+,
M!['-8!+:J5"9(BP`X%"H"\J10&`E5+1EI7+7^>EY5#)55\[F,QZT35"%*E*J
M=#6C9R)<2`2@5K`*J#1@N@A$XZH<D_3ECW>]_NA'$&#6Y,QFH]:,WU^OR%?W
MF(4H<`7I;H:7(`MZ\Z[ZH:%-!XO8][SJ=F25:7&*`UC@(.2#&LN.70=2IGQJ
M2HH'(25F/;=5M+R-K[T\EFOIABRTV-)G"0$E2A)2@*BBY4-H$0`#26@PNP$@
M`3"R+7EFX]:L6$:Z=DRE=%&4%`9,MXBZR:9R"L):$P9%*^,ESD">0I^N8)<N
ME7&*M-+K7G).T;2;*6IG'X*0@X0D*+#KR#[3)ZJ&E#0F:,F)013JFOF:;G`H
M'7""0P<?CA@E63O+"FD4,X`!"$`V44$4AU\5V0!PMKG*H1YMJH+3)^HN2O]I
MTXHY-\?_Y#.]E(G._A2]F-/942R'`.@*>2FCRG2E)KLZ8:]`VLF5\H!VI:1U
M"UJ*\Y#/7N4FB#J(H&XB``1(Q,`H"?'Q2,B0)VL8BU)T,&%R$L@R[T6,)!XQ
MD:WJ4:F\MRF5R2=FO)F4!:QWR$^IRH^3)N*?<':L5OOH&`%=F,NV&39?R66O
MX+(A)6]/6(O&,?YJJVA]754O75P5)(L#D43[<J^T'#6FZ55?-4=Z>]GUE1GO
MHM6TQK&5:[Z5JEUZYMM$*YI@0I21=^91T"A%)M"!\ZXK[:1K89JQAG$52.?Z
M%:W212MI'J.F38TM5-.(VM?^8+:YW21O\P77WZ:E,,G]JW!'<MOGQM]C_FUE
MZXRZTUOK9O?WY%WO2%F;,^G&=[_]G1=^DRS4_^9=S0@>J8"_174'#\YL``"`
M*6WHV.U9[L,GSO`!)3PL%A50?9+T1[=4IZJ]L<C(*I3F"I%.Y0$X'GF&\Y-7
M/5SF`-C4PS6>'`/(_.88]^[.B41O[3Q<W\`U\<,/?1B;P]SB=ZGXS)U^\<,8
M@.4_8<#,"\#RAW,HZ4["^L-YKB6?/VE!,^<5T>5B=.!LW7-+1YC*'QX`E0.=
M,`/PND]R_J'3RCPT.I91Q>FN7%]2;,&&JMEX"#?PKX=EV4%;D`*LSA.S4^7A
MBS?,Y)4.^+VH'3$<#`O%PN1UC0&7N59%^\3&_B.3IT#$SM&"V6'E<G6(TT<G
MKA%Z5H"KD[L#H-=A`:ZK-%\YB-^=-@B8>0!01/RG#Y7MB3],V&-S].30/2/+
MOQ?$STYSB<J$<17B2LDU99%A"I$E.K'Y9R+"SXI#)BA8?XU8Z%XIA]O\.%4_
M'O)UGQVISUQ[Z1<]VYT^^H&X.RS#&9;#F*[S([:KN-Q;OOZ3N3QR#*<+`*Q3
MON2C.LL3@(>[CP;T(\D#@(Q@N0?T.X9X.PJ\'\0[GVNC%MB8M`3)NHI+MLA+
MOX$X@/_C#K9AKHKC#>!J%@+X/ZT#``R<.0Z108&@P9EKM)_XO0?YOT9[N""4
MN5QJNL?K0"84B/];_CNK*SOKJSX@#!:9^XJF,Q'1HPW'`\(\"\*O$+TN><)A
M>C@".$,@Q)ZE,\+L4,-;HJ$MQ$/:Z$'FXL,9A+B!<KYO^RK1."0!J;BG($$Y
MV4(B+$.(ZS_N8#OD@Q7+NSM7R3W+F+F#T+OK`T.CVQ#+"XOWXXF_:YU0A`JT
MHSW,H[L\6@`0O#[LH[^62Q2+*Y0-U#T4&46G$+H2O#[>F,`'`;7K<PNLDRZ9
MPP_=,Z^'*R#@PC5>I,#0*$/(R+EQ"PW1NXMA8;ZZ$,3*.4';8$4N1)$89+N_
M,\8,%!$.!+ZZ*T,^`S]DQ+RWXXXR++I5],"\X[&P^+TRY)"[&XAGW$7,_NN+
MX[C&#L0UT4O#NO,EV#M"R]!%Y%._!&3`A)2H@[3"/%1'@6`Y5QF<TC,4M1.]
M@9Q(Y-N:ECA'CV*(KL-&;_RWET.,_]@?!;E!MU#`1:3'IJ`_;5DZXLN4KDN]
M9`0*6H3'=*R^,R/"Y:,_]?F]BGLBIKB[2,0^CZ*^T>D_7^Q%C%2XF"N]R+N[
M^XA(?.1"KL@RI].*%UQ$&/D_G;.[MR,=F9L;@N1"M$1(H0M";?06Z+,+AH`W
MVSC('CM&Y:-'5<DZB4HZ^EM"B>!`NIN;SSA`H:S#NI-!6?P_N"K`A$)+P43%
M]V&[SW-"8,S!`&2[M^0)SEF6K8N\T$3*ZS/+_F%BO[58NK*D0(L,@-_ZB$+Y
M.[0TR(F\NZI8BL<0B"#$#".L2]%HJL+(QIBT3(FTR0Z\%L]$15"D".MC.R/L
M0C2T2,>$$1FL.`$(P@+`P&3C":5T0Q,93Z2P3O+#/-&+D(JK2BZ42Y]HSGND
MC<@SP@`APJ6$S1MY..XP2@`@`)V@2SV$BS(L+O(,0NX(32),*[=1._H4SGTC
M$+FS#?M#2U@91\!+T`XT&JGK3N6BO^`D/<Q[2(O,2>Q<.M2T"\H<3,SK">KS
M/ZA,C<=4.]T$2Y\`01)!/OEDQ(Z<T0X,R;-,2!%M`*SSQ+ISRJA<4;-T$YJ\
M2H+8NL_+"?K+%$?\_@H>=="C@3H>>0X)*<7""TI8TE&H=$):\<IE5$=['%&K
M5$3'2%$BU$CS@CN(TL>/3,CEDT;S?)#.5+L@!<F5R;VMR3V$_,7)RTK,6T_\
M#$+0L+_AD[D!.,`FG3R<^,G8\,N=B$<F-;*U_$+?M$RYQ%(K!;;#"`I/O8TR
M'#=,A4H+I0U+9(J_PYB9.]47E;FU`%2+M+G\*U1)%#JF>,5\/%.SA+M6?51(
M.5'VLTU\A,^*-%,`I$`?5#Y8L:F9"U)$Q$]7U$0US;WQ24@IU+W04T)TM+[0
ME(NN,SZS!#Q=%+T(S0N]1*B;@Z()*<7+4,3(&TF",-93!%%Z_,JA<+J__LN4
MR7O"H4S0!>16L?A'W',Z!#G%,C2:H(PJ.T76,EU3-15-BQ"Z48*(]_&XKM!,
MBSB."O.IF'B,A>.7<*T95GJBP;"Q3PV.E@R,DQE5DK.(/NW8U!@2JO"^TY*)
M]I.HT70,5,H^C\@N@_.*'L-9@NC9DTR6DQH\GF`1JG&6^Y"LH^6[K(%92J$D
M"$32S(/3@0#&E>46%AD,$ZF<KUV0&\0[/%Q6O0A"`N7.LNV6A6N>_WG;!;%7
M;\V+;>7$![NVC@F,IJ1;"5D_1N6GE,$(N/LKP/V5N5(SJTU<QW6M,+E+\T**
M='U<RT4LK(6+^F"HRW6I_^C<:LFI!6)8T&TL_K4M7;R]GPWY*K=8UVY)K<*0
M6O.J7`WB)-IMG/)Y7,K+FI\XB"SA1N^@NP)BE0K"&^)#NC0T&G?<"5>,V;AH
MMC;[7-%$$1N;6X(06LRHCV@,#=ZT+>5=&D7Q%%MQO!#[B>7U"1I4/'T=#,"K
M.FC3F/2]C8OLN\+)C*B9VE+Q.")1BM%TB)V]6=<[$Y>8#I?83\CXEJ*P"86Y
M%Y5HU+D)"IO3+'B"PB;+/PFT#)NX.@G$C"P;Q>6:/J,A/LP0@`?$+*'X#[9(
M%;]R7<V0NY([W<K1M*<%+H-BVMN[C(FQC$'RJ/G["L#+N=>@-8\"KC))#_7K
M,W("VO+$#P#&C+M+_B"7J0G+`!K:$Y3&>(B8$[-WQ$4*##%<R[V2Z@G1`\''
MP##0"X#ITQX@CH@2'JH"I#N<X%!BA+NK6]2;B&/\0!1:[(KE7:X1]0B<L$B3
MB*I[,;ZCF$A,Q>"6(^)[R10:5-ZB!+PH2<?E^@H,V]?&W:3OE(L\VY`ALA3`
MT]I:A9'^F[3^:XKIU%'1A#B9@\[+7-X;5BXIK)PI.>7\A,*S>\)<,L+JA`JB
MT\];_L[M3(@XA`I&(]`R33\:;!8:?);M+,(+K;MF7D(D7$)HBV:D>F;?7%`.
M*2[(:SD\/%"T\.,VI`MMA1%OEKRFZ..SY`VI*F8\M&;EXXFQ]<=U?B;`_HO?
M)>0SYM+G>%Y"&AXQR^F+CUA)\Z#!KK@)S\$PMH@J5G4R(LXN/Y*V651;7"R.
M^X.9>]'!LVSH)JN4&ZXZ,L2^Y<JC2H9`2)$(*\R44S&:^=W%+[6JAK8,XJ.+
MY0).?(R/LX-`WJ`[JYH;<B8R!.FUY3+&T`ADQ1DJ0%*F1@Y`M#A?[+/>XQ41
M1-%`?+9"MSRS/+R]HM:4TVT+1H9JK9`J*SPFYO)5X/-JX!VC!/N:-SG31/$)
M=PR`N7&\KHA?=R)JB_;$F21ECK;"AD[#2HG?J2YDR8,40FZ-?J&-%77'EW:\
M_ZV<IA@@KB#DH#9FG9"2J#CIG?9EK9GFRWB)_FC.NXS`"'R<2EV4$QTDJF^=
M0IMX5:?`.MG<Z+P#[*'RU[^^[,LF"!!,%L!S/0Z$ZF.BQ)QTUC;;W=,:9R=9
MKM3A[&5Q,B3E0'WNBX2@NX9F44_T1-JN/MOF;/!+N;$F9;149W^,D`))2\S>
M[I>FPBM2H8NT[*NZT'[UZ9NN[0]6N<@^%8A;B_(-:N+KTJHX%;A;B5I>[:$B
ML*L(<&^"X^L.R\2DY=I.;PCWY7F^[)R#O(2]9_)#Y?AFC:MSXS&-2N:>JDP.
M/UC3$5;4O11][EW,#NF&$0&'G&:[<*#X2LXF9UCN:,E3WG$FG?!N9``G[[)>
MTXV<\,9F;'C)"@RD_IVF>.]C&C?`@SO[7M&I1E(=^_"N#4QEC$8M7VP,/W`P
M9^J,U(K$AE&K"@UPA14:;VQ_=<MV7LUEA4K:6^<'!"X^QCRIX^XV9-CVU>OA
MDUP],FB@T(JU]H\RA]&R8^R:0V52CN]26E;'RSOMGO"TQFS'$^R>(.S1XQ_G
MMNS1RPC;5N^(@_*F:#8[QU2SWG`)O[VJRR/]MBJ6#F@YB77KNVPT[@H+$A-P
M)KX"!W/\@&Y#PL<`Z!+DLZH0*TFRI+F2U''#IG`]OV\27M8UACOLT^"(P#P:
M!-;=NV%QU3VHO&1HUG">*W1@B7/_9/'*V66\B]_NE'3)*Q5>.KM)O^$;_NSN
M+3S?/[3IQ&:;<5Y13^<./UQUQD9;74ELNC-G1@LNP;SL4(XJ+X21>?1+MBDN
M,?4G(&3;?L]LIWM***QFRM[N&V%F(81FF5.J!WG"T`A"`HA?SDUW*_SK81K;
MW89FNZ$*W%J`%`J0]*WG8>H/%22WE8S;!9'RG:"[.P%BR1N@<4SP1]1@(`'G
MO,.,&R_1--;Q*!612KG!1Q^@6Q=RJ&"-)PT^9I]P(W03,/Z*W9N-C*@ZU@CD
MKN4SNGNKV;`SF0WJE"L4^&`+H2!$G](O\S(8H;V,[>6*&NX/GKF3E:$WHPA`
M?9/KP89AAK/:'>Z41B$:H-"UHS#:FGV,`?:2_NJXD\6_*.F"%*Y)K3(YDSGK
M&K$QO2,^COHEVF++#NF-C)_S'(,B>.'863$WG5/92-!^"WRW2#TJ<<.P7L%X
M(D#_5$:>#5/5W(S^[^2!UN"KB],08W+G*:'?M-Q%W?[3'FP<8^)'W:<9N<&(
MG_9"7=@5_[AR/<+(?O5_?YYRG5=;&?F'_V^S)PP2T(`3=-XA?W,!"`4-!A(L
M:/`@PH0*%S)LZ/`AQ(@2)U)<R*`BQHD7)18XF``!P0`+$C)(D#$B`H$G5PX\
M`&`@`),2$[P\R6`CRYPZ=_(\6`!GSP0=>Q)E8,`@`P0(<"HX*A&!3(,%5.9<
MD,```JPF%0PMR*!K_D$%`:(B3!#@)$VB.@N0=5A@@,$%`+HB``"4X("V:AO$
MW,NQYMV':4]2]6OX\.$$>G5R=8HX8X&S!!7,+0#@P,#!$0>`)=AW;>6W6P/<
MI1FX0=Z%EFW6?#SQ\T/*A2G/)<@``,B#`W(?AMU`P>*"BH$"-T!6H.+@#8P:
M4.!RH`&<"`HT)QC=P&Z"FKD"`&!@Y&VJE%V3+T]4L>'.YMW6)B@`<P.7(_GJ
M]+VRO52$K6>J?[U>N'*7S=?``@?`A]!J!;U7`%@'"'"02P)T91D``Q:P`(4'
M-D!A>S0E($!W\'57FUPC+N:2B2V-","##7P(XH@(E0AC39\)\!Z((\DE_B&*
M(PU&V7LHPG2@@_\9>61$Z.TE5&%(>@1``%$6!(!*MX&D`%P&S6;;5CA991)L
M)25PFE4X)3"@9XY-UE],0E4WT(4#)<562<C!-5UT!T%%D%($%;"4708PR!L#
M!PPPUT97F756H0%`V22<79D%IZ#=Q1G6B!TQ`.(`49X6@(8(P,5@07+=95D`
M3@V05Z<J6;;;H;E%!E5=R'4'58(T51>```EP)9E7EP$7V6^(NM@735-]A9MN
M/S5@0'<#C16?73!U1-E0-($TF$L;U642=GZJZ22YY8Y+U'3E(C2=45T]YYFF
M=]WF[6<%/$CJLP"LZJA,-'5Z&4(!9(F`2`;I_BHH;PIUQ]FA*@'<0)0,1FD2
M3?I&!JQU6:(&6$RWI7H5LZ@)`)4!I%&;ZE$#""!078'A>RR<?3'@J'XR';H1
ML0?M-^^&G=G'EU,Y]PPGL.U-&^FQCGW6%V7PE710R;;]Y!Q.3%,I)WX#R445
MB#"9Y-)2P58-EV8;+;O5U7PU>9JZ;1N6TF%-N>V1N_L)@+%!J6WHW9!#4R;3
MMS#E1MFYMXUY=$%U>7<Q0_@%,!3`!$^&;(58M_5C=RS;93A>'4V*UU$NR429
MA>HE"/.&&@=ND-51A6?P?GJ_+&W"M,.4EV+04@IO6!\]?FQ42\ODZ`!O2M6?
MBQ)3/F5G[ZKH=<SZ_H8]'D'/:2;JPI]-*_3<W9.7YV&USRU4]1HWT'5"X4+\
M5K&[O\QY70J:KYW`_0EE-J\+I3TT7Y@57U!J-,,7O2"+04?!UWY(5;*K4$=@
MU-).:"*S'Z1EIB8OPY;.*#9!^V@&6LE956%^9Y!IT<91C-M05/`%K<K\SD.>
MD<EG2E(R*/E$/91YG*^6Q[N"..^!`^2298YR&QZ^9#!W\Q7P!B(JSGFOB8]1
MDF'F-SY@]9![6GK)UEXB*O>IJ2\K7-$$\1+&](W1,P5!(&9\PY8&Q.^%S=J0
M4N`BLP1V)#(,NF/H6N,A`PB*CSXYT.<NF#7H"?"'PFG-H<!8K8%P1C=7_AHD
M(QUS@&O!YD])A-X/GS:0OTG%?%,YW0\%.$@7#@1]:Z2.GXJ8MMMX3I5=\2#6
M+,,V)])2)P=`TUX*Y,0/56\_!$">UR9Y/J'(A%2SZXM\2I60[BB'B/I+(>0P
MTZLSMG)*>DE+FV)2$[E0DW\&<9X`<0DG`D"0@L?2$"'W)Y?+E7%VWO23B%KD
MPY?]$G6E;&7P8*A!JG`P;33!4.6HI4'F'>1&%:S)-)-YOA:UQR68&4RTCE7)
MA]6RHCT!)D\8H(!9.HE\6ELD7S"Z&V919Y'&-)\.M;:8.YILA/+<F/ZZV;_4
M%61:HES,7&K4R.70\5@#:J3S.,E(O.UM(X>*_AG.0.J9W/`*9T2E7@U9IY>W
MV&HI9AE*JJI'2:@(I3:D-*3`0,(KXW1*7H[BX^_JPK`H'464ZO%79-#WF4-=
M3""W.524X#,8LRRL+HY9G44#FY.I/$:C3?2HM)Q2JX4H3G/`0N4_*V@25E90
MBJ99']3XQD:*ZH<J:"Q62KH*$MVY43?ML4QN!(@O7N$*F0GT#LCTHM:WT"Q?
MCSO48DKFN;O1=C&@0A!83*4G?67&4=[92%9+F:49"L`XUR(LG%3BIN5,DCJG
M*<F@M$.=,2G`K@F#8N_&9)5-FFDX6/O-F,+"I<5L4;#N78EQGBA.=<TN68="
MYT%H4\$)#>55_^I7_O8$4)J0-0U"QOU9L*#9-Q>9T"S@PACB$C<RZ`!++`7Q
M(W4/I3?$9N:.D.KPGXP2J:\X*R%(W.2>R(B0F\COO4Z"JD1N$@#QN;C&#HDO
M8K[21,-ZQ;P-*<QQO(3$TBB'H[UCR4:M:6,_8;0B5F+(5Y=<'AA'Y%52OG)#
M2HR8<V&YRU!K:<NN[,Z<F(6C`\"OEPW33(M\.,U8;K*;X^R7$HT(S>\=<TYN
MN1`[R[G/?G82G'?2W3^[>4[0)?1_VHSH13-Z)7![C`)HW.A)4[K2EK[TEHTL
M:$DC6M&8_O1#-&TD!DC1>`,0-40\?4A5@]IMX'M,BBG-ZE:S1),Z::Z:_L-8
MR+VLL<KC`FQ[RQ-E6COQU8A1P'R)766BK@=:7!XLGY_$$TCR9-=)>0R"%4)E
MVI`EPD_,MK+;!EZ*)#LA!YAUN,U=QO*`Z*73CC;LIAWHC.R:)^5>IW`.H!QA
M*DAT/$1>`B;)S@?I&4,%(8!,%D`C`*\YW4A2TEDZ`I>\8,4`!U!*2M:8EZG8
M)293.0M<*L['K#B<(CU,M#;+?1+.EB39:0$.I'Q<%L7P\R?3F4T?HW*=-2;E
M8V$!$5;"B*7H4J@_AH(@Q2H%I<!DBD`<DF(DA7,6WWQ.*H^SHYPLHSRT$71F
MJ3H`+(==<G6A9VIB4J(FK^VK0E'L-RR[2)(/_G#MHUA\?.!MUW'8V.OI1&5;
MU$&34!BT$:XDK\2QCD_M^%UX+1>^.;RY:J^A8T!1ATMEU@3Z<A)YZNH9U]M\
MB='>NA.`F.NKZ3%;%8+MJ'68F+!AT/%.5C2[,%P+#&39NLQ'(GK(F+&E+O@%
M9U^"2*!.U:R4+<U?!B<')K*\#E/X&VW(`N?68N&DD6(?^Y%8_)&/&&?T$V?2
MF2_.%MR-)3JGIM*I!T"ZK&`E\N6:;4,M]KCYZ`OUMT7M[7;#+\D[EW+UNQD;
M`<N3_1O1M)9,N`19M0>TM)93U)Y0,-M!9-5BP03N'4YT8(AD0,M01(W.P$?)
M.-63I!;ES(=L(,5G_K17=Q@55DF23O$)L&P-Q&@,:>T>3<4,A.A1\%78SU@-
M;P#6\\C)T=B'?43&F?A*(UF>Y=A32`$(P>`3]KF&IW77143'58C:13"`R@76
M;>@5E1!.+,&$4^@*=&0)<?$4HXQ>YQR+QDQ+\X49`0K5AIR%%TH+Y/"&+!G2
M5Q@996P$KH%AQDP)<H#%&#U,R/`4.P%0'8%%<MF&OJ279SP66(B)7-DA[B@&
ML\#&K@W&RX#2#R;1,8D/Y41%LGQ3:Q!A#AF/(:42&,'%;[G1$/&.45@*UEW?
M$YK'-#E=4S1<G(73WEA(C>13!6&2#QF$A%P2"E'0>]R@$GK(5PE39+D1_HO`
MVQG)D_-44I`8"&<%'/JPCHB013]UDR)!$HJP"/WQE];02$1-%!AUA&_HF@5-
M2!@!GTD<DWJ$(@0U3VN$XWX,(9N0DQMQ$^_X&]+08BV2ATR0&LF@6IJQCU3L
M1^#L(X`)HPL-2]$EC9_DAN20CC*VD>7,8/(H(5]LBW%E!T,<V(CD!FQTRAUE
MEP+`"&<,(F8TG^`8#%BP3R,FQXEI25>9#'X(BK2,Q9B\"^+@&6Q0&>IL8CSB
M(+@((BAJT.,58B?BI*X4QA!B3)_<H2'"Q.#5QNRT$+@5)*2MG6(LP*--VIB!
MD@N!U&=`E#>:Q*K0'*EHRT5B35-`W7-XI.%`_@M5I$LA027(>-JWX.2J"*,(
M;9*T[`],SF02TB`C)6+BM`7A)2%^D`H<)@AL<*#M+")'EI,W<2*U)!6X+)(;
M*MFFM!0`E@J""6&38-!F'06VW(1E#,]4\%5'+*!BF)`Q@N5Z7,E7*$;84!IF
MH@8?@11IJ65$AF0J*:'U%2(JC:'G[<VQ[*4J.<9.,2>57)8P(L1.\<G57.8B
M/1E^;*9GP,=@(A7LB*"M<&'ML*9>+B'2L-*PI*/KS$6DW<U%^%[NN:,Y>2;$
M/$Z4!)\L(IB&#1^40,E\S5CQT4]9')AC)$`BP9)$C44Q;LQ<<%]TZF;V8:%B
M_`FZI=EM"%AT4M9F_FF*<08C7Z"A7[F=20!4*TT(;^@7@M1$I_AFR+@$PR@@
M;H!,ED1):TUA/Q&0')&%2I[0JUS,SR32<D0,B%Q3@6*>$JT(EU4,E,#0A&0)
M7^$&#/H&EH0(4P!=9(9%MCP>FN%=25P$@T1:3B)%3B:'0@2;:LQ;@F*H8-W$
M`GP%LFU>I775E&I-(B$H]7F&=$F&=^#5@1#,7)!5L5#%_Z2)N3G&#%G2FGP2
M77!&Y+4+=:@$5S0)AVG7LV@J@Y#%1^Q)DJFI*(Z;;2"'(QY9H^&93:"A12B5
M1'REG';/@-S2EUI:P!V$+L6J+CZ$K"K$`A2&O<SJF\%I1"B>N;D;KQ+K_IP6
MAOJE*J<E!'`@Q+0RVJ\^A'@F27O,3+22BT)BJ/ID5),QWD2D*K/6TK5E!IZ>
M:VEE!+=EA$L(C&:Q*[W6:Y^A:>)\*_:9*T:DJ9/1G+T&K,!VV9@`!00.+,(F
MK,+J)H_Q28<N+,3Z!:L]K)$,19\LQ.?X)'FP:L3ZQ9GPD#36:Q9VK%H@&'PH
ME!-5#L>:Z,J>1Z^2;$Y4JX[AF+T:946,ZGJT+$6(&-T(UL^DR['HZWH$7Y/5
MFT4)+<RBW=$)K-&^QLM>E+$^A,8>C\].U>W91!1NA%4DC/8=9%9XHYDB3\[5
MQ$?`R;,('HE%7N!%7DH0S"(N2X5*GBKZ*<1@_L_2*1&,/&?2&@1O",H"/!NS
M-NVR]NMI^.MRY*1/EHFTWH3,908488C>3,9;:@=6*%I30&JGKHF<"$IS4I>'
M7=A9#<B6_HE]K)"@&BKBB(7H+8;JFM!%+"(G^0MN59"CG(5+,$A9:>4[:0V/
M(BG_L`A;1,G'`"!^KH[6W6:+O&57"02^1(;FD"?39)6(6M'>Z@E>%$JW^EFA
M<(92"`2&X`2D_HKT:)>^D):B>!6%^"F6."B4B$AW"!&%1&Z;9@I.?%'D?I&S
M1$8B4=M<=-[H@,C%F.G"\&W$$`V#<!8$H97%7LT"2._$N*VTC,P#.M6&7LW,
ML$57M06IZ<V4_LHF_H4,M`2&"#5P1TB.$L&%4%V6&)9$(2Y-V!:4:;ZCM7PP
M;_0%W9HP0T(G<F;&"\M%WW:G8\3EPS1L]2*$@?C(@R@KHP$PBGP-;+1'-'+'
M1Q%`@404B@@3`"#<WJQHB#B(/6Z(`(R$06$L`X^Q0Y52B[C0CNS-R0YB0$%Q
M0(TQGN'+,\9F!WX4?!0CBY@H\`A0,:*L5[4&OE$M)G'+2TTH!-5JC;@'9LQ.
M,C:CDOW0F.&')D;31^637!B(@23(RV@B.793#Z6E*$*.I3QMQSJBI%I:"G_Q
M$F+G#X4K)Z]E0/T090P.%%/I)C59>?(4\]*%C&J,,)W.`!(4A17+@+31_M3*
M5+C>QKBX,A(F2[V8SSQB3"/%9G)$2PZGHG5TQ7=:T&X81Q,:#,9<5G:\CNH=
M<#4)A]+IT^ZR)H,ID25?J-=(Z8K,HZ142RPNS`N'L@WWW5`42OP6L;:IA-^2
MZZ*%*VHX<?!TAE7T15'6Q,EEAO0A)N04$VQIVDU:XHO>9HV(3S+O8(.>A7@6
M$'"9DWOVDB*ETH&<I2)-73B^D^=-K5H:\$K6CH,&BT"$"PY7(L!N!V\9(4K:
M\WDJZ._"1PEZS1XN!R'K\&0@X-#P\_*YX.%R)\4N[&\JA<[*V>STVA-OX(C,
M;CMV8KY8"AM2M#!BQ_LVSM7=T8H23Z5D)SQ'_O*4]&!M;A#%],=J=='\/$>=
M0)%QX8SI],?=(`A*6:T9'?;L#!ICHLYM+`!)9G-\054(EQ;1ZHSJR/!,Z2[T
M%.)BO4P(#W,U=X0/BY%`P`9?!M11"[3!3`9(&#2B;34[SS#!1,6T0"5$M\8"
MA<0^[5`,S8?OZ8^:;-1=<294_L0Q$1`\^A0$W2=>]Y?&B&@O487&?N!I"6!,
M0,M/M5*5=(T;PJ&?9`D,PL23FLV\+E5(:(SO%HMZVA,L+4M%[RZU-`=?41!%
M/?&#L84&[F>U1$;[70V^U`7NOG$*U03Q8)UJ0XW#3EBEU<6`)%<,<>5S]\4N
MM]'IO(_55,U[[[![_N:6QFB+7"9I37P@4GTT`?UPDH+H5RS7NGZW0-3R;U@&
MI$Q,[CU47Y!PDF)P6<V,!-MQ'$*%HS#5C$D0DT[%(`N5UJ%*8,BNODA'UBA.
M6ML3W"X.Y/3RNN`5T`(MXJPK=`E*6/')XQG>Y[I(5%SN;[H(4Y2JJ1ZXBQ"$
M5>B;I97(2)PQ7SR(PM6&OWFQ$U,QG`^C0P4<,PDC%$^39=P2B-B*7I0(-C+4
M97CQ-D4CB#2R("(W9XYC=\Q'Q3R)!:T(FM%9H/>2CXQ(&&L-`:2(*JX,FUL&
MPH7Z#0;K+)^;5B%PJ6@RA(C3$0L'A+"YFA,;>I_9BC>:E.*?1.%&,<[,_DG^
MM^BUT0%0\['[9&I/J%HM1_Q6R7/N)/@`U&Y\Q7S$XMXEC$'3K-SP"8<"2)*/
M>>-Z1*IR5+`>!(OE.KL?R>@HQ56`VD7(+]*6A_RV.[[O[(%OH-P`KEEF;]M@
M2;WG.\$?.'>=$:V19,$O/,-+6:A2+JU5=<-//,63B[M$;<5GO,#J65R8<KMC
M'`!I/,RN^XLII(Z)N4<`/$*T9XS!FV7"J1@NM<AG':<Z'-M@H;2NV$2TF<0[
M!!'_!E8D3L9]F)&MT:VNRZ$Q4L\S6<Y;O+_'&WQG=5GL#T3PYQG5B+%"TL]K
MO(,:UFBE6\5T1I0_GDMN1(6NF\(PZ=(KQ`4G_LY<'$K0D*Y>Z"WO".ZQ^(S'
M\ZW*5^S3T^!98OQ)6'URGK28RPL2:3VFHA>_%OR82!Q`IULV?_=%T(1=G5:V
M_`3:FUB27VM$J*YCN/AG?N0.KED@0]F?MVMB0`K,=;Q=`46YAY=GI00?@2J>
M2!=F4U/@E?G?GBFU@BC)+`RF]ND\IHBA/OG+\VF!BJ+PTE54S4RR!S#%7T@=
M;8B6@-J8/>/Y8$:1F.@D*5Q]Y+U"1`AL`"3T&`CV?["&-`7'MW+F0[-<5PR?
MA3W3$\BHXQ[DU'D6L_F*R!.=2<A0`,0"`0`(+FAP$&&#!00)'CA8@"'!!`</
M$"0@L4$"``\+)'S8_A"B0X4`!!R`.-&CQHD0!2PX(*!C`P$"#@ZL"<#@0I$5
M#4(\"*#C0IH->/X4.3!FP@(T%^+\F=1C5*E3J5:U>A5K5JU;N7IDH,```@,*
M#B#P:+!K6K5KI3)(4`"N@@8*"@0(4$`NP@0!I,)-"&#E5Y0(Q1).ZA?P000$
M`QA(/'<`P0(,HFHTVV#Q8(0`###P*U6C7+D,T")4P+CC7J"140+-N+&J8P:N
M?Z)T;*`N5(0&`B!`$&``QX,!`"!X2QM`[^,&A@>0N]@L@P`"%-"E79=RW=((
M!\0\V0"B:`#!&W!&>/>U<(_A%0.@')DR>+XI$T.,[_CG9;K982L@7QL\_O<:
M"&"BS,XS2Z/X3M,-O(Y.$ZE!MB2<D,(*+4S(,__$6N"_"SW\\"/C'$O`K0$&
MT`PSO"(C4+WA+ILJP8/@:V"VB1+3Z("OB)MH@;L8\&P^CW[[L;BJ"GB1L,@8
ME"HQZ9+Z[:GT8ML(.@`70FDV!M&;R[O4G!HN)O.BS!`AOQ9+J+N1!MORK_]0
M^DPFV$CDSLL6R^PP,:`2V-.QO/02$$Z-A@,*`3]],BV!`U@+4"[7(((++D?Q
M9-`OE<I<$L1,-=TT*P48$/$MYC@=-2V-2C/1SH\"(&U$\)"$<ZK'DD,0ML0&
M$/4UN>I":#8(E2H`52,IA6B`^*IZ;,Z#\"NO_LZJS@R0LL0J4@HV-#G3S"]8
M<0,PRH,40"#2CF#UJZ*[(JWVS^0Z:W%:+HF33$I8[40O(H90M#10V!C`#=X`
M#Y)NO"/KJU5<SB`],L+-AI4R55(=?EC3L0IXBT.(+38RR'@I%5!&<:&2-RIR
M!P`7/%'SU`R`1H&"2\FV"+H*Y(-ZQ/0O+,\E+DI!I^0NN/H^1G>WR*[S.*&W
MN&5V4+@22'/<CBK:$VH4_WUKQX2)VFBV$WMJ%F18\_05M)2MUGDP`P_EK69_
MD;;/-+F6I9&V7QFV^N*Z[58+K`2,$T#JNR&&56>0WVX`;:^1E$H!OHH[;;:\
M3OXKVA.CWHY7@HR=_NI67OW$#&@F)Y).<BE=TYDJTD\S&]U#$\KK4P`<\@OM
MW<(<S+7%C$W3@`[3?%KVD%EWW>II26\@S<`I_>\TN::+;['-7ULI*4%/_W?@
M%K]CV[4%J6=N-E$?#=G+P6+VF_SRE2(J4;K,OWBIHF$#>?CVO>X[H2N_KO;K
MM$E*Z`#G:YII*%2!4[L^<I4;?4ETS2I=ZC!2E)\0("J/*<_KO.0GY-".)J1;
MB)=$LL&?#&4A$/0(;71BM9?AB"*C>]_&CC*4BA1@`1H)X)^@]Z>;'.`E3GF4
M2X!R@(L,S$8Q^>%``EB1B%`J@\!KV/J8:#?<)``L!T@`KIHX*E/=J6$U_CJ/
ME]!BNZL(34;CV<Q*@M0JWKV&00G2H@"3<AJ4+(2*L6*.I>:",Z21;F)1>1;U
M'F.7'T&$<L0CT'&V]A&677`S&SE-=R`"G(]TQRXQT4AWDA-(C=Q%C"9\'T,:
MLQ'CA6P`[W(.0HPXGLL=)#16.\V_'#,>U@'+++@I0(Z,DY')$&XP=!G9Y::(
M(/]5!Y6K\U\5B>DP3T'1`(F*8S$S!9%DMHINNUE9*./S*&A:93$Q<<R+FD0<
MN%0M0,`2D_LN@\*IL(EPJXF;D9(3(,8T[X[X8]#@,L(B&M7%E&WA#5#RXAN]
M&*`S?EG`+2DB*KK,\BLOBF$-69G'J2@`:J8Q_E8,]9(`M+#N7Z?\UT:9V5&/
M?O0J8$FFWG`(T@I)S21Q(<SA]`(7!/!2I5C9%UKV9:RQ3"V9&3&6W@H%&LWL
MB2K`7-V>`EFZO$`T+V_4J$9)I;XR+1,K2ZL<2TU:5:M>U6YZ^TI8](;5M=#/
MJV&MXFGX-D6Q=86L`+6+6-G:5K=*"(IB2:9#WVH5!LRPKGG-*D3XN18&I/2E
M>A7L8/.:*.X4E;!S2>QB&=M8QSX68IY9#V3!"EG+7A:SF;7LQ'`E`*H*]BN:
M%>UEF0HB<.54<Z-5K8?V<S['#G.U@X6B7Y^(%V?1##.?C6K&I+*8E>%V0AI1
MYZH*&%OC2NA3".&;_F,K6U755`92@TG35CQ#$OVX;GA6*0!40>30=7(ED@:B
M"CW7`]RJ$/"<D_&,>=FRO']M*;3'E6]:4*NLQC;7I%E"T8(2U9OB9B5+$/6O
M=/K7.38Z3&Q96HL$)30^K*"722*!56F%BJ'9PDB)BB$/1!&R`+%XZJA<6E=+
MX7(Y14T,J*B,S(CGVU:C482]5$%LBX-KX/:E$)4&I@H!7U(3N>!56`CFT>BD
M9E@,'\`@2%9(DDLJ,P@EJB27@K*OK$/7UP`&PO6+R%N2,I""=-C+CS&)EX]%
M@*(>JBD$@<E3&!+`1^40)4@Q8DQ>^!(@T_BJSF&.`0;*EM(R\<]ZF>CF_A80
M'[>D>&K)JNA^$8VX/<5G`=MT7I&H)Y<3;05.C&-`<&H9%;#`)4<<X3(5!PH<
M_1#4EJ@DC@"@:B]F"2TIU24(BW/,&$LMC3C>+*Y&PO602"YJ+@&+3%+'@P`P
M3L4M)"&17^XZ2.W0"#A[$@!Q>=U5`:I+T6IS+Z]_,DI+S>9%F7M0CF/2&.K%
M&,_%)-%+R\(6V*XOT'=EB'?..J-+ZOHUE(R)=&!"3;C=Q2[^:S8^)[*T8H\0
M9?AE$A49'+9D(D``Y"&6WFA3[2J5AYL.*M)>&+1&@M!*)":B3(]:7?`#HB25
MAZ(T[[#3G@]BD7C[?MFQ)-P1>`XGB<8R=W9W_LS7?-;S-:7YS#B!YY;;B4MW
M%>2.CM/]T0$D#C,5&XM<%DHCTM!H-*0YM''<PBL2%5HT"O=0?,\I`,I(1U2A
M3"=:Q&09<&\OG=S9,\?0&<9JSH?G2//6=[/"X(9')7>D?%^0DC>@`"[&(+&S
ME+GWKE%9)24R1\O[R3F7-I7;\U(V?!!2S^1&P5M%B=EB(-UVE?>J@*6=_AK<
MMLI#.Y$<=-ZD=UJ]9M[TJX(%+."9R*T.YANQ3`PN`(74D`#*Y>V"RZ7;1;7#
M*GM%Q<S'2?:,$2J3K11.NVYSCED^AC*LQ;Q#9T_$X2[H$RY3O0TD.U"YE@1[
M!3==#25@AY3:X\N4_D034?*L:<,7NA*S+-40JD4$1;CJ94_0)<M&J.;`8X9.
M`G#X8B^N8HH\PO,$98\2)FZ*KMB6C6@R[P!M[ZI<PB2@3"T$@JT&D"1JC]MR
MK#)H;R,$0LW>J,W`9FY:;P;+Q"*N!,,8@G+\KKE<,"(>`F4F!FB4:+F4B"1F
M`H>6"^&Z!3P@"$=P"`H]YWF(0OTF`KV.PV=L*._HZ&I`+P%5)T`&ZF.2"&;P
MJH2$)_^&#D*`)W[$98;6[(S4Q@.KBK/>PMJZ8M,"S:.R"3>0[T_<I'/J(FI2
MS"W$"5>F"-]L2/^8[D>.1@(/)H*JT"I"J:=H$&$VHS/\3B3`994<,5;B_B-N
M?&+Z%*)O*(]DQLA?/`/2S"-?@JV-)N;M_BM6$K!/SH,FO`A,,J)#'FJ=`"D5
M]\<5F1!X9(/<@LWLTJG<R$.&YM"JP,(XN`QOF,YONLXJAH<:T8[QAH>KT"4"
M$>U,#`!"Z*G]]DXNON]%1G$K`D\%R<\&5P)YQ(9-Q"MK<"58@LU_Z*^XV&17
M(LCD3,[RL*;B6#%Z8",R7FHOYD,0OZ7V9E$XFFU/0@DMH@WBB`M*8,XC',-<
M@,W_),-$PB0IBBZ2IDWM,L++@&7?WF6<F!&DBB]17JPK4JF*KLZN@.+L1A)5
MOFU+*N*E*@X]>,,@@"1`+F,DJ24Z]C'O^L0M_A@/#\UC+\;O/)P-(YPI_"1)
M3[+)6OPD<4[D>Z+"+D@D%.4DDI)#:B;0-6('0`Y%-<2O8Q3QKQBB6%A),CJP
M3&SC,B(ME%CL4T`M/B*0,+C+PX+/6+ZE:!CJPC*"IB*JZTX)<+)-)3\*H'S/
MP:K1ML1*N'*-,M!/638.)24))=]RTSAI-,)LE**BE-ZR!L-HUMC"X/BN+2(C
M<_+(-[Z)U*+K$;U"ENB'+I8-*R$D+QE3+P0-Z[P"-#:G$2V+"Y5R*_;BHO*O
M,;UJ3W[C+791*W)'[![&-T\/T:X3E<;2-RL,."]$#YM3/).F+H@K+8@CE%AS
M/"]FQF#D=1*E/=E)_@;)9S[7TSY'*X?J4RN@L#KO<WW$Y5/>(CRE`J"<LF[>
MS3\35$$7M*/\8XKH(K"X8KWZDU,0E$$O%$,S]&)XBLL*4RO>0C#7QT`UE$0;
MTU-*U&+`PNB.9$"%Y"Y&%$5C=$*,SD-\4SL)U$*[HKZZ(C(3(G:V2T8=QI\(
M(T?UJ%!@%$,I]$2I,25B4IO>I$5W3!JK(KD^].\DY.^N-%8HU(#T$V9B+,5Z
M-$A/RE<6(#[[PB2:S&_.5"HXI"'N+&VF0BXO1$NW5`X_KXET!I'88D[/:TKI
MPTO3XN_8%!7I-%"#C"O$M'0(-4@[35F*M&ARC3GK)DHOLMC,,E;>K4\K_J1.
MI1`,9>9/+88:+XT&G4@ZJX(+/2VH/"U:BDQ!YJ+1:@:B?@HS2*3"F#147.^@
M-./3:`WY_%"/.O(RC$TX2%5&;..=-L.W(#5(H>)$I],M0XE+P5,M/G4M-I5"
M)I4=K74A."HM..PL/+308+6TJ-&>$N-64>XKMHLRZ.*F%$*;\O(248E8AM6;
M\J*56,P_U.7O/E/-0-&W,NG*QB-+3<[G3G4\((ECDD,B6E$^OFD^<DV<+D._
M(@,MZL(X6L9%]T0GXRY"@,4TQ"8Y*(..Q%*WQE0"$Z(2`8Q7\`(!&/5#*K5,
MO.E([^E;ND-\\L(D]"2%C.WG:,0U48VO1@8T_MZ%H(#"RW!EH&+O+#MG@QCB
M'%&2JH`%):6+8.VI/!EB/@.G-1A*='X-*.YBV+IP0*+M-D*$XLS".DAD-@B$
M+N9C09+M[P(.;L)DE*9GW`)D_DQ.5'!PA*`O]4)Q((,-)9S*<M82//YC`&BB
M<=[K>(A48W)%6:Y/?&9G/?6064-F:<AB2-$*W:I(-0I%3_4$FOJO.,Q*+LHE
M_,@#[2!JVAY"<MAC=8J$0^9#+%M';9-#-*:C:1WO+5L%[;P%\]JQN)Y-/BCC
MC,:6/A["9'1E<,L#<!?6+-JE'G\40CZ#6--)YV(I2"[.1RLW/S)/'3V1!D<Q
M)<,WA8@$?%50.@)`_HK^HEJ&CK/V":)29YZP;2]7:#A$Q;^(!5+LJ%/3C:+:
M%(H^-US!0_?6PH`]Q$P56$YJ)8!LPA*K9;D<B&QF*$\.@W(T2"0R3*`\N%96
MPL`D"``@"+VZIEHL)<-HL,=RK,C>IX,+:1TO4(20IEVB;!V+9LU(\B.@\(7&
M1DM=8BLE*%LD<0F'!X?CE'#;4!%-L#7B-TQHKP"+9DERZ,L^B2B80H=<QX<[
M>%HSJT6_`F:Y<C]HXE2S8H$MI$JK]8&94.5$>#)Q;!V!!6H6PBP>!3?'PZ*4
M&%8@ZC="F%$BR%A\(C?^-Q`'LCH8;'<&$GHJY7TN(PMG^".O=_:`4!&M_@,U
MUM$U&=:_IHMP]0@U(NYH$.-C]G9N0$:"5-A0GA>5<D=DW<QRES?S'NH@(Y=P
MU5%V@[-445:F)B8XXIA'[T9F0Z:-]4YMFD11)`-Y4UB',`DP,F=?O,PTJ9@A
M3&9]\>E6(F^"F81:'O9@EBE?DDTS=B=(\`52XL6:@5@8*9EL_8M]E4T]=$:;
M>06([T6"VH6(D4Z)49&)E_`C6G66X\X__J(C])$\V$0V"@]Q$T(I15%_963:
MKBLI'&F7>=DJ"&0R^.:,0RJ-_[.8O](16X<Y".B*8L;0K!)#DJH6\SF=Q`>0
MK;4\;F<CQA=6P8>&UN@GF"-?7O@A(-EKG^4"_J_7"F&#30007:;K;,XJ>(F1
M<U"D(@QMYE@:\5R8'^>F[LKC+5-0@D9$P``2Q5;:S?#N=!=#P@9)^P#O6BIB
MCAZ:<S*F(KI#6LG7HJ<"+SIBHZ]"LL0*+0G&!@$$&".$I/LO2.`(XP):68*D
M<5F:;>#FI4?XNAS"\X9#.AW61-"B%DV"AE90."S%)^N)KXUBB]IY<&>CK%:$
MW#PEHG_#/.U"+#[N+"*))02$I0/$+L!I$1F:00A6F>%F,/P5)L#2UIC0+%7#
M6`EG<<."JI#/H?BR<UW%*US*6"*T.8N3*BZ'.)VG$2&J6/`B93H:@?7ZHP\#
MD!WC1*HDL'_2U`Q@_MHH0_O`I>&R!F)'V4O,A6&;-BJ:0C:E"6(U*IRA;3S`
M"4[$:W9ST?/\M9/66>[(EFA5S5L&HC?R.G'[";IY!5P,<JDJG&0SO&TZ#*BH
M6Z*"B5?^+'/GFCZY6``(X`!P`R988B"$@@"60D]>2-F(""Z(*$V!@@2M+%'9
M:J_=&)")AVD#.R]\T,QL$"/NNR39KC0P>RZ(R$R5#(8R8CZ1+`[I%<5A9#!<
M@G]PJ#3`52'J4R2R?*A(G,SK9C%"<F08Z5$,^;^!Q43"EC&2`STYJ2#!18J\
MV[O]:E-N%$/*W,__'&)F=1"?<]")RNCV1-"_XM"JX]#;M3/`$9BI*\_3_F*8
M`=W2+]T#?8.DIJC2O_MA.AW30UW48^LM-#W2M^*N1UW55]VXGE5SH`C1O^);
M@`K6OZXZZEC0]Z(L-%UOCF_!6!W82=3+%92OBETRPFPF8ES-&.+%5[R$<2(B
M?DB9^B>!!15BQCC8_=STM&O2FRE451+Y<N=@(*7?QGW<94GYS!W=[7IU3K:Z
MOYU"0!VSBM/5T6K$$XOUM#56NAU$MAU1JPBFLUUE;^?>9>33F\C=^U0]V>(S
MD#-1E\2S+@MD*_J\W#VKX!W>8.1.!=XK.H0O=;3@7S)/IU3A4STM&M[B#XP^
MOCBLA@XW_TR,VX(Q%UU(^"PCO$[',23XM%%I_E064OKI17CC2$C&0?D*5_;)
MX:4IN`?D9OQ$:.P"XU5]98<].4->0D?>*A2>9FBT,HJ,H21HH3:GX`;CT>1E
M7SC#3UKRSWK]PKH.PUEI7^9UUK$W^"YV<VSKK_!X*EKIYUR^,KSL7+6)8$UD
M(M3;Y\1;G$[R+B(.7:>#:I?*NHZM;,W*-@9IO1-&$+$PV`:I8VUG`4YCF6I1
M/G["-9SDL-MU(3G>(]RL/-2"Y;<"VQ^,)%LBG+:#)0H7*7)BB-!"Z^F:V=DN
M`;PL@!9@B';X,=*,A(W(3(M?-TSP)M2LJ$H)&'FMS7(,@$H8E<+L:F;IRW9X
M)`Q"SF[,(RH"R8*__DO(%_ME`OZ"(O0.R(5@8R%XWRD(:"`FPON]O_Z4"S8<
MZ(8_\NL!(D&#@0``-%@`X,#`!@(*-"@@8.$!@0L'-ER8P&"#@A(U)EQ80&/%
MD21+FCR),J7*E2Q;NGSI$@%%!088*(#9P(`!G"\9\$P)0$"``@$`%!A`-(!/
M!@`")`@I<$'1F@J")D@P0.,!D2:-EC000"8"KQL!&$@P=F>#HC)#.MPHD*F`
M!`Q"^MSH="?4G&0K9D0P$.Q-!@,"D*P*N`%3@1F5-LAX,^/;O7\?,U5;U2$"
MPP,W-ZBZ8&$`M14'#%B(X'1.U0`H8FP]\"E!S9P5P\XX$W;=UP*'\H:+_AK`
M7=&)'WM\:UQA`*<C"SC<6C&D[9L#G3=(2S?E@J<>168DZ-H`UY_DRYL_C_ZG
M@IL%%#B&F8!T>I+#YQ=<"D#UXH?".W/^GE-M^T&'4E^E%2?=1J19EU%H`_G6
MP``"$571:`0E5I5K$%:4X84+547=0@QD]R!C`!0WP$X9W<640P`:%YU!3%$W
M`&#2K:>`:2AQ5QUKK@W$E%$(#.>5=0M):)QKL"D67TBP+0E>8\YE!4"(X'W8
M74%:*I1`44$E9IT`7$G'U'!&BE<0DB-AE696!'EG$$*NO3A?G7;>B:=*"B"@
MP(0(%.=2?'E^EN='`]6XT),%7!7?;>.-.)9`_@2>9.!(?1H@YI75.71410:\
M!5N*T8%*'9U&^@4;B!5!*>)31#EJIHM<-05C8%P1*&J9_&E94&TB4AE`88&!
M^N-`"KQ*5I'(/62BDG$M5P`"X@G$:FNX,7H525`R-5N?=#'@X&,(B*G7<V,:
M5%6L?G7IZX,#4,=M6:]IRM>@]MZ+KWDTK;4O3ZKA*5^=AD;H;%F\5EEK75KN
M-6E7R[[6%$0>N6;=J3F]Q9Q9HVIJZL/&`;;BJ@%7A=0!.9JX,9VTOIC@0%OY
MU.5UJG6:$E(4Q?P0L2/9%-Q-1?X+'&Z)3EA;I&N1AMM^QGH<5G`$_7NL0.^"
MQ*FL%`69)-4Y.SW2_HD+B><S<@`&*]IX^9Z-=MI4%\"`4NVV!+2=]0FL$+U/
MUKVF1D2%"UO#)55J&VD$0EGQF&\ABM3&P-6Z*4E",U6<TE]SA:30ASH4KVTN
MU@;90IG.QMQU`(3[J;84<Y8@JWPYN)]78Y4*F]%7TMPV;-,>5)34`X36]MMC
M\5Y4;%ZYQUEAZVUEXV2CI<91YXUG=-9F`:\UV@%4^L21\,;F=U1!Q:H-?OAW
M)A#:`0O@_=+YX<ZWP/IV#@PE;`(0L)"<M9YJO]_:>MQ@HA-K[3R&O&4N_*F?
MH69%O]DXSE`"B(C+S-8RH4EF(/9#2-VV@K)$O64KR-F*2!`RNN1HRX%._M+>
MX@Q(@(DT4($,20B5)!4_$PG`@TL24T'$%)6#N<\B6OI<`V@8PH/P:C+(L2&/
M^M>X706E)`NPH4,(.#^,./`Q8C+?[L2'Q2RFAP$&6(`!9)(`*[&$`28;W]SH
M)IJ"B6<GO8-9:^H2@-"XIV\B\1A>L$6^C;"-3?_KT8.LY98'8<XJW'%C>(S"
M)CM&[#.(3,MAN)<4%?4JD(P,5E;J1J>,-"4HP\D(T!)@0\`9IU>=2]WW0)DF
MB@A`+5QTSGX0T!Z04.=3!=!+8D9$OAD!Z0"U/*-$%O48#D6K/B,ZBXA8%".5
MC"@EOM2B,Y\Y*)I$"XQB9$F?[+0G>\&O8#_T_M)[UO)&;Z9F)P2BD_\.9J*"
M(``A]"J=8CRHD\.QTDELHV`],9(51C'12%QL2#6-]:FX-"L^<S+(58:SS(K@
M\HS?^PR)2M),\F1K:#CYT[S`ASP@#0R:'.VH1Q4CH>C5A"?3,\](!Q71N3$@
MHA]M*:J^ESF7MF0L(+,+3L0CDP-8*'PA08K&9`K4H.9+)GT"(T_L2)Z$"G6I
M';4<JO[)U)&@*3\-90DLG5-2M%V%3U'MJE?)(Q,#T$0F_D*?>>[YU;2F[5C5
MK`M+U0K7N,IUKBA9`$T.@->JJ@0K\S%K7>D*V,`*=K"$+2PS7];%N+4$E.D9
M4DO>:MC(2G:RY`F1_D\&HQC*:M92)FM/>Z"JD@-`=B4+`-1F3_O5,)K$KA@)
MYF6ARL7U0-,F3SF-9W-4%X*F*"$Z$>L7!?`NNPP%+`:04"VC5:/=884H3"EM
M?&"I5]02%C`W.2E,@&D>T4KWF0K8(5Q7JA*DKDFEL#Q`<;)9%^N6Y"G&?&88
M^307GF66,802B`)&1-N5#@9<ER44S`@5S/LJ1HX`WBYE$68LT[;$B^91,%T9
MD!ASFL>I$#U`5D7C5[7NJ;\F4>])`!6?]J(FC-L)XX5C$SUGFM@]WH6H@5^,
M3:ZT>"49?DF-Y6HD"9>'P@N,[D9N[%7SQ>8D@@JO@ZY"P)$LX#F,]?$/_HN<
MQ>UL9R,PKK+:!/R@GYQX)0,8[5<M5B<>Y\W'&X6KB%'RMI/49"Y=IL]I;.M@
MD[!-`%[.4VZ1(EXKZUE@(5*`=F$B5O)LV4[DHTF@KQJBTM;RO,61S77VA%6?
M;&8HZYG,59`BG]1$:\DE.=9PEU07HL2R*DT!#!>]=$]#=:D@:(UJFBO"8*ON
M!LL*99MQ00O1`E@8BUY\2DZ7>9-@?X9G"[`)S[J[GI72)8S&#K9-^G19_"[;
M,G3!]9XU_!9<6MLD$[UIG=$3E*$41M.%N:Q0G$,66()$;\%*P%949)IE=V>:
M7C/.64JXLZ&@Q7N*:?=3E,)%H]RD,(76T8\9_AD5874U6BEICY,_(RV4L.V+
M#R_)KK'X*6DM*D7']?-3V-O%6GZQ1M'2R56&XAQI(<!D-3F+3F`)\T7MR>45
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M7))%3?$E`G'@C.UEUWOCM?7D1\\7<725;7=:_<T)W^V1`\S![\2=]T.:X6O5
MEYBERX#2=_R$D*H;]89_9L4=[*=%7/10W-90$,95[;=>L$1WQD(8?@9=X*,`
M<Q%6]%=^&P@?B_(GM51S#M@2@U8H>,-PU=$;4[0?Q;5NU6%_2<1T8@,J"V(V
MXG$71E-U1^(0B$%T+:A'`8(E(8A%JL5,!;!#5]%J'^)@IH<3*V40B[(3LI4V
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M0*$Q05DH`-_G,N3314!&$@2(/@*9$B:S9+KV_D/JJ%6>!1%"Z(_EMQOMT8!F
M!UE2R'J:=$,1:&#D*'?18H1">$6[)$8C:1+@$BT'=2S;6"?NP0`"D!J[\9%!
M&1U<=!WQ`88?XF,0MH$+I8D:2&0TV1)^!A)GM"<S1E36<Q58*3Y#XBVJ(I1?
M23`",%8$*6=]=Y1@25FA2!(?:``3\1+DJ(K9UU"?LE)TMAYJ`CZA!A$JAY9?
MF4U[-(\F06N'$9A]N5D01H1JEA/[F&QCI!&)^&=^(49801.G81.+0I3@LU42
M\B<Z:9@VIWUWP8O7I68J^9F$)2CA^'F?$35E=Q(Y5BK>-9*UU">JD1JR=9;G
M`6&?XF?%59BG67?C_N&10[9>$`F<FN6,#<=MGO5]HX.1X>5N[G8^"TD0!S&$
M$W(^PWF<5I:<H\E]WN69VTE8HJ),.](ES+9#V]$O*B%6`V!%U"66N3D?"`AA
MUD.6XKEGS?4K#,EM?H6/^"E=VKE>[5E:];$H7/>6E<9:6704J0%*0`F@6!B7
M%*22ZG6!$6I@B7D2<+<2K=B>HL$3&8*7#.I6B66:&(I:K@%AQ883V&<LAL6?
M`*J640<N.%%47AFBT'12?R*`*+J!>-4^Z?<3X>)H/KI9[$1:Y:$0]QE4W1:C
M1EIE4?->1L43QA:>4`I7`CJ06@I->B<BJX>,*B4B6*I%-?&!7O2D%3$1_J;!
M@F1*6>LT5$P*5-T64W6R3C2!6SMS%L<RDG3Q1:'CIGGI@;B$$PUA7-\4J(4E
MGS@1DW'5DRJZJ/_8DSG!F\*4DZY)&`^1F8F:-F&5=U"I3+PT&B#(J7WYFT"%
M79T1J:0'-6$T15]D:G\2(IY8JFCC5H"Q2J?:BUE15+4Z6";Y5^7!<]_5F]7F
MG?,1,$CH$SKA*S3!(HKEJ_G21`]!K4RZ'>[Y$#.4IM$J5+.GB=/979CBK792
MC;`6(M2)$<@Q.L;)K7:*+5&S6!?X)\NQGNVJ60LJ=Y2U8>$W@7CB5C7)E6MR
M,\=JK]J4J>_RFUQD/=*BD06+A5P*3?'A1>T!_JWH0;`<$C!D1!V>A9@.:R^$
M`2DMQWUF"+$>BT6#261<&EMRY:!B%1\GRIX5>XMG1([.VF4R:[+H`1@WFU0Y
MFX4P^TQ[NDX-^J)V\D5+T59Q$XS#DED^FR>`D8=\]1,EZ[0Y*W-[.5)*>2>.
M!5[-P3]O`8M5BR?L1!:IFCYBB[;IHT+NQDMR"A-+5BQ$.'Y^T4';E[:N1Z=7
M2IQWR[<F$5)=Z;8X@1;A,B(.4J"M0AJ)T[>N5T;&(J"4N+AI0UL:FB?0]A.1
M%WEZ^S6Z2A)B-4UB`;0K(7K/%G@8@9@V\8C]%KE;!&5]LJVKZTR$811%,:/I
M\11W$7TH$22,8H<"_BI*+L&`?.*>JUFYT9-Z/R)R6/&3((&SL.L2O,0A^,I]
MJ^J\+Y$?@[%&9R-FI)<]0"(FIOF[(Q@UMJ6YI(ES:ZF/'A:XU;M>UU>O9\N^
M][(5>`-"KH%7?G4^<WL00M:0+I._[:,0QQ(4YJ._/W2LFC02&'0D!6%63K)]
M9$$`X6L2;@E*O)1`\5N.I]$GD5=9&#PH"HP1%'-\;>:*P9(?PJ,DLI(F?6(M
M6>$;67%+)ZPMXX$0A],41?$O,$Q)/S@6B+I7WAI&R>G!AG5?9KI5BPJY0WP>
M".'#U9$J,KP14Y,55J-!C/1&69.061Q])+,_HE,WM_.#T7@Y94AW%'DL_LTK
MN;%!E5&HQ"]!C=Y"JX'2QH2F)4YQ-5!L-&+2:`@9/SL(Q2&3D*1V$\MQ1EC3
M-9PR*Y/1HV_2O2[1EL](O0-937\"2FTZ8K`$J'/,GE$3D(_[NAP5NMQ8Q-W3
M'U2%A$^"H+^A0`G9@ZS,056158V,.PXQQ9%'%@I3(U:W24+(DH\6RCU!O"#5
MBIQR,T4UK)JLA1[H13IQHE2K-DF\G2RJIF8AB)@;2[*,PE6<&:_A1LOB%@@V
MPPGL-;G#*,`Z1W%4'0%0%6+Y6.KV6K\,:-54I(>"&I$<O]WWOVYY5/;<QJQ<
MQ:)4$$?8QP2!-TAD(!YDMZLR'A$\(>"LSP^=_CT7L14)?1((^4/M0]'X8H1)
M1D%V:R01C,P#&2&@][[`&]+""G0=L1.69QPWP4';(WRZ(2:#Y'^,M(P%D56D
MAD]D(1F1\5,RC,#4HQABHGX;S%9!K)FYE8A'TC48P;DA+2'EW&TGG3:>A+U-
M45U-85[=2[N:)$=^B&J:\QNU`\Z%:"D'TQ0_0B54LK'<XX</XD!808(0MB?/
MM=1HLV0\J5!*X6PGA7?WQ<_5"X[2DHM4_<P'$YFK)G`BTL.IJI?KT[5ZTG1#
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MP?74R#S/T@*S[4U7*][AGRC:;9.Z:K.R7OL9Y`DD;[$`&PZ%,Q["Z\.E%BE8
M#2[D+/$46R'>4;9#!;TF1"H12?XA(0*%0#O@5!Y8MWL=&I?E6@X^,D?=_L$\
MWV#N*2RU4NN[,U^.'A`:&S)NYAY53-WE6?])DG$^W!#KYBVU'C_BFO>2;,X6
MQ'X&8=(&&$-2$YIQB%U4UV(%YYJ,%IH-A21<I<4AWPA.EFK.(0=N32/+(;U\
M+VQ32VOW*5]D/80A&_'$)[1\=P$95D9IYA;5%C<>HJ+IS.S;O+U:'J".+W4V
M(L`*2VP.VL)NYM&Y*!/!KA6Y-$E.D$@:678UKM:2-N@:YRCUXY6I3SMFP)P.
MN\--O1/:47U^,F#TZ`-)=Y$==[G$[6V\&Y2<32MN;(T"Q1A.D&TS67BT9!EM
M+_E-9-54U^/2Q'%>$^]U@6'K$J]"/FBASB^1_DU#O.>".6&:?B^$+:L!"3YD
M7M$IMNFB5]C5[M2MV26KW:&%@56*J^24>\]OE2.ZR><YM85+O>Y$YF7K%$:M
MMH7Q2.S5.W/I1['`VLZZ!A;\;BG0[+QN!=B$0EU,<DW"%AED%&"$<A,@8U<2
M;V?,C!9?)!\YGQ-1>2*F41]#0J1$3^4*,4/K;83\VZ*\U$#Z#FML7[T22\#K
MG97+5_;(SDO3:H2ZAE<2,A>M$=4>A83QP4M7@>39M:V<YCBP9H0>O^:)>8A#
M"BS*1.EMS"=PS#/D,V4!6VC#YFR`S5_"5F#0=*.4W$M8--R6$C?S'(N,OS-3
M4\])58:XMK2L_U4(_K@>ZZ036<3K#9>L\I%>M.\I\.BX.\9OG;;PP(\G]#WX
M&^>(653HP,O=QB)&FXK\,C$<8I7L&VH61WCZR-^B].V!*M=%,>\2(D]V:P(T
M;.7]O<@SCAYK4QL`C=M[HHSRCE/_4/J<D$*1&'>4T2\N`,&@P4`&#!`,1)A0
MX4*&#1T^A!A1XD2*%2U>Q)@QH8($"QHL.)"`HT:$!P`<*(F2Y$J6%1,<4-FR
M````$6D6:)E3YTZ>#&,.[(BS)\8#'BL*,(JPP`&A#0X82#I4ZE2J5:T^-&"0
M@0$%!A(D6,F@``*P"II>1>N09LV<,P$(?'@S[5RZ&A.<9?"UKL.#%@?`_DTX
M0`%0!'_W'D:<^&H!!0@:BTS0EV0"`PW.*KZZ5J=;L'$!7,8<&NU(A'FYBFZ`
M`/!$QPL9"$:P8"QJVK5M,\SJ]0`"LI(S%F!\F^K:U23=%E\H5_CREF9;(Q1,
MNW+%UPP9R/[:F?EV[G,-((#JE;3&`@&Z\R1.,;OVA,>_/AVLD&8`!0(`!`C`
M/J](A901_#PO-)&^,T"H`FOC+T`%%V0.J9->\HHD`*)B,"/-)%K`OK4*H-"M
MM39D3\,/;TKJ0J5HJA`S!198H*,$`.`(J=H$2+%&&Q,;8`&R./*-.@%ZO)&B
M`&B*#ZLA/QM@+=\\_.RN^0#S<*R[AC1O(`-H_IJN`0:.#+(N!F`BJX`$!D@M
M2]0BLPP[KG@#X*X&!OBO0*XH$Z"KK5Y;X#L$"HBP2S\K/$A,KK@*R:+J_K2(
M,XA>!,"P@=(;R$/`&&TJ20#,O/(SH&@B<R`%E$/4*K(&-.NK(FU3S2/5.EN@
M(+#`8D"!6`UJH#+5*CN@L0820"Y47X4[*+L]4SL5HM=Z_94A13T#P#<$:-+.
MK4ZA0S%2FGHTT5*$,F4O69[($N`NWA28UEMSSPWPJ5'OZJI;AQQ%MZ%E&_J4
MR(TX/;%9A=Q2B4N%+.TL4QK?K#;>G#@""SPQ"T#68(<?/LRK]Q#B-:+O(%YH
M7F5!S3??;AD=V-^$_I[5]U&:\L(78[NJ$V#+R-Q5.6:9IRIJX$@Y?`BFF:UM
M,V>.>?:XOPO=6HA2A#0,Z>>=%[6L`1IQP@GFI:>FVE"R%`(/V;L:[HYKBC0N
M6FFBK816H7K9&CLAHWD>P%*OJVZ@JUI?)+<!^B@J%FZ]9]9KHP%@'I-JL(76
M=-^"2>Z6@:$+1HCD+!G]<&^'Q"(7ST[SECSSS&5-*%99#P#LM:($+]NA3`,H
MCDJ*KS7\))Z+A=3D#37O+TNO&-:R9]IWWWN\K<A]MC.Q@)QY</E*1PA4R/\M
MV*VSEA\Y<M[C9D^!4S&?/GN5$XS;L:\$O0Y[F8U/R*3[$LI4,LC53]FR_K7X
M,PMY3]>J<G>1HH+];>WW]U;G@5J430,(`$#)N65@+(()3+2S%I4<0$-J^Y``
MF+*6I##I)+-;B/D`)#D64:AO0.%?"'?VES6AY&_B&]^(5,@6+5GJ0]%970`L
MB#N*C85),%0(`S0DM:K%RDT#49BS]"="(@;I:IZRWF.ZLJ<A.@QAZUD/YSH'
M'."@<#_<8XA'"F*Z^>QN/U*R'J]B-;(BEM%<6P1B`NB3@#H])CAFG`MEE$2[
M)W($=`;(T0=KU40X]I$[IP&*0/CTE)=1AH9^'`Y-?J2YE_!F3P8(3U_0U#A$
M5O)/3QD(3+Q2DYH0`#0*XN&O*+2WCA3E52\9_@#.,JDV2[:207W*8;@XPA4Q
M3;)"?'0E;0:#$]ZL20&%*DU[<CE,[J!Q2V:J52HEHQIB^@J%A^&ET\@UIB,B
M1&[6Q&4SM2FJ4/8&:\_<YE548SW0J<95"QC,7QRS`#*ASBO!VQ-8<%(9P;0I
M/X+A$&/^DB.=Y*E4'*)E-3MGS?K)#)SA]!,::Y4WX!3MH!.1Y_<BP\X[_6TL
MOCS`7Q@&-4@^4H?5\4J..#(6)D+R;E1K%U0<LU(FWFIB63E(KCQGO:CM*B^I
M&>.K=A6W^N3D)8T1B[C`0[QK@A"A1T4,+!V"NHU\!9F3$4D8?VF9K3A%)'F)
M%>@ZHII@E<4@.JK5_DX3MJM97D>@,Q-+:!K*DCG)LU0%PMY-"?)4I-9U+@O0
M70:3`A*H$*`E-L/,A*JF1\2P4".R0:=2&M`F'O[0KH^ERW/BIK4"7=$LP"1)
M-J="V)DI]3##(DECD$FN`#Z$/72%;&IU(D5B34X`>O*>*5=2+L5XMGC/S-M@
M!M.J@O2V+'$#KE=U6II/4L0QR+$H1(I*-<VJECFP!.>.R'([K317/[O54G89
M-LZ\>&278A5>1RKSVQQ>=4<H55B!]$C-/0W```<(0#S;=%&+JO$NXLI5?,/D
MV*5H)*4*8>I%<.A<`K/D5(=L2/B\5R=>">:A^^H<))^BW@$P98G?49>4_L0%
MR8[:<$S+K54T`SPU6<D*G;ZITZPX-QB!L/@ZH8L(9A=[D<'LQBN0=,J;A@B>
M`O>8)X#,KD0H,R9VFD4!J-M@1*Y'/)VLQGH$:3&)#4(9@@0K-;)Y\N=4PS"P
M2`QA8-4H&_=(PJ8-A)\5X5&+1L6;TF9DQ#Z&LTO:,\J&"(!#`WQ)=J!BD9^T
M2*=@04E'.N@1%KD()``LBLYT6E.PT`@D3FN16!]&Q?K`)$/_6\I2)%@`"7Y&
M`)Z<[TPX;>=PI3(D"ZMTN$Z"V<"I!Z^+5>![#(NA),?9UA-AK6257)_O`!5"
M3YZ(F$HS)F*'9S>II*(`VM;>.`E&O>6A(I\N_EI9+0VJ*^B$$W`"@)('=X=7
M%J[E=;IG%H'HQ7/!E:)ND5.0%HWD5CO-2JW45VN&1&9<)VXD;24RGK#NK+FW
MQ@SW*C:1O,`G*W_;ZL"5/,46<Z2[!9%JI($+EU4Y]4[C;)%`TDHYU%Z'BEA<
MD(ZJ6AG6HD\L&F>81K$,)V$9>2$(XW)C_M,8C@S&E@8`[$/`,R@V[NFB&-&5
M-0$^=-,"AC?4$<G?N%(D[TE$V)YB9E:@EB=(=N5V0.*5D7.5'81-)\LKQ:WG
M0,X<6KTEE(VK>6K*4DN:^V=`5,[A+R4JL>](R2E9,DM$\M*5QT!%M,75NQ#]
M3?0%21;(%!&D9SG2_BJ(^,:I(G%,+47"F*^<.&,U?PF?(/]>[S9T2W8C^"]=
MOAW*@'A1E=,2E_%$>3ZMR)%`ZBZWQ?0?WD2F[GC/^<O?VQO1[B8__F6/P@D_
M?!8IY>PYR[$P55GG4YD*)Q-""51"$A+3.V7Z=7JO4]I-HZ?MRB,R#O;R=?D2
M>ILV.VEZ+X<FU*9P]??Y+P()3.Q\$AI-B#'Y?`D[8_)HAXC)*+'.*,";"(DS
MJN$SP+_1B511BH]ZHXC0LZ;!)[ARKU1ZC6GB*(5QJ^1BC/QX(\90*+PI,=J@
ME3W#B"TCB)0#BGD:LHQ:K&L3E/6@I6E""?,@D_#8%A[*"\D8%!YC"5JA_B0#
M!,+`^+>!,(^8(Q-G6ZK.T0MUJBJP4XW=F!5Y,HAV<9/QFIN:"A::`CZ&&<*#
MR8J.\*\DHBJI>Y&KRHDMTZ$BP;F%\"?"PB>?.JT@'+[?*T"2*"<=JY,C3(U%
M&3+%";J<"*JQ@)-(F:7)`([CDXJO:+J5X(H`@YIR:[*:J`R`@HXLBJ=_@;N6
M&"/%DD.B4R@Z7`G'^`L:?!.J:L!2'+;OV:/^((G*N)VF(8N3:PE;2@N).AB$
M43OZ\(HZ$;I@4@\M.0@R.20=FJNM^![<R0MIZQRX0$3=&[9.)+J3VL.+6*;2
MJ!PQT<-\PIY189C\Z!;4^AK_<!3*0R%@,Y:T_DJ+V&"RWSBR*JN.+]&.+)$K
MB`*]FJBPQ\&)D[N=R/B+K7B+8A$WX+J(>:PJ:#3`O&J)2ZL)J%FL^XH4A6"1
MO"L_C&`,^PL@-YFUE1BNJN`LEIB^5\F0#'F1B4P4A8R*'%$_IRB5^ZH,.M/(
MYWD8ES1(8"F2DFL.RM"3K=B-<4E&:\))/#HKCS1&&K*VG0@)9IJ*0^&)6&&J
M0C(QW=(2C2,(%U.QX#HWR_@4TI*,'!%&`Z`/!E/$7Z*5@[`Y6;FJ2!NK).JM
MC#/+T#$/J(2X+[DI7OFSD;"3D8B,68D\7ADO=.*//O2AVKLB83DY[]&*B5DI
ML3C*/;$C,^G"F92*_E-YLYS(D])3.KHD$/:0DNT:HX9[RNS"KLG:1!=[Q#7I
MGCOAB?MZ3'H!PYYPC'A3.G^RLUXS"QTA(;DC-N`XM2/#HS>Q+\%HF=*`D?L;
M"2G9QS:Q)\5A%[(8@)9)N:Q$'6>#/)_K%HV*IX-CIS?YE+EAR3WB"L$`'?.H
M"74TE15AC$$QQ5GAD(XP2X\XI?V0C>Z*&JQ:/%?Q(7"$3-%`L*G@$;43BM]I
MBJU``!IA3N<0$PXD*?O21MB`"D$I,:BY1+5[B:'H2`/3MR8#K:X#E[>#$SL3
MQ\KDDSU1$S<Z.8:YL6TA*V%TR)UPLB`3C=7$B#S)3^9@+?QLCL@3GSNY_@L"
M4:D]49C7<B34>8OSC`Q].I:0HHRJ8A<!;$4<VPF'FXK;,4\[R0KG]"K&L[F/
M8#'0=%&=:C%DW,4<K,&C6J29E,H$@T2"$+HMTJ(MRE+M:)6:]"[1!"X@XQR!
M8#R!C$J%@I7L^BV;NRGK>46U^0X?FD^I;,O=RKHQRM/PB4KPL+CK.(V3F\<?
M6R>=$#[7/+(6"SZ<I!BNRCN($!,:<93PJ`YA3*5N\R-:A%'-&27Q\[[O^PA%
M^PCMRQ7$"B"_8@J/R+1$(S_QBL@\,:6,4J`&M:/LV#H7"8D"\;^2>*\EO:^B
MF!`VHJ*0D*@5-"688XJ,<BSW')VGD[36%-7U_H1(`OR(J)%6J[C0WZB*4<VD
MG[B=F/BG"1U7!\*D7<F1[\,K,9,90D,("EF1&-TIEZPPA-*S%U&<&9/$=F&8
M.N&]V+`3;?S",-FCE0HK7,'*\C25Q(RFW""KJ)K5Q>,5SB0CR-.+D;V.RBNQ
MHG#%L#H(C[VCG>+"$[POZ^%!ZKDQ<6V(`=G$2!$,!`2*@"E4JFA0MB))MB*W
MUDH>^_*4R+!9</H<>;,2&YLN*#S/DS.5\YO$/80,I\5*QGC9/6*8W9"YR$")
M^Q.+!<B/@XB\IN$R>YN]994;G$"=A5%.&[(,QH01E7([0V+6`B"3>-I1DL)`
MJ$DE:EV-7$$H5>TC_G*B.1_=EB_)E7@KNO@"LBA4F[(XN%;=69NT"%V;BO.T
M$LF@G+Z94K.P47D##J"%*Q_]I=[H#="I'-G82=%21X>3FS_#*9UJ%<=H3['J
M+A;#2['2K1`4-#6ERNZ:++@4.BT"+JH<*'&[GH`,IC]TFG6<T8S@7-3PGL9H
MBA++#IGT%&,<Q*:M36OJ"XEIQE;\P(H`W:G`4<O0CH]R%!U:#^P%(O&8C=1H
M/>\]VEMZN:ET".V`RBW%'(V3%5>QRH`]"(T+E^?-7LT1"R[;EG8Y(8B`J:&R
M)G.TDO$2$]"YBH)RB?5E"7TB#'6;O+Z07(:-",?XD9,=T%GZF\DME:Y:_H\\
M:4+*B;PIFT*IHRJ72J*HVAI\>A&[8<R6E3HU,]D\R1I#*KU&))8`\$J\*@P$
MB*\?B:_9&S)(TDTX2=5:"M$"L6+`+8S5=39!<21P=2484U,\78T^M8Y>7,;>
MVJDMA96XC%/,;5FP\,LH;)5%[3*NM<I4&9>LFRS((+GEE<LL#;2P\BJHI$N;
MK8R]8SND-)TC&Y5>G*I'1*)3I`HFK3<.K@J+72A>\E%'41.*;;ST8\Q!XF+*
MF#!9$3::VHH,J3T<FUR]')`U8I?#[(B"V"B;RCK1.S=(+C@M^6,OY2FC$*,M
M]9PY->0"WJDHT[@M<N-@JN8B"9VB0%1BHMU"_N$D2)NON[@T[G,3:UV*56N1
M#ZX/D2R0"4&*I+D[39LE:^6^&:L_2U.U%4$*#JF_D`0+^[,T]DL3`"``EB5G
M`N"D,K0_^$,)I*B_4JF)?QYGD\@_E`@)&7D(!,JS?WV5P]T5E.@@-:Z*W-OH
M-EL,?G7;=DLT:_K@[%N45XL)0/N*>-ZF_SL+ID`H[[&RJ-*56_$UJ8J5.`TR
ML9NX5J%<$\VN-HT;QE/A8:[)[%+@WX(+=9M3;8;@!&$QHPB?FKP>GO(JUS`-
MI9";/'V(,'J)T!D,B$V-H\N[=8U,4"X-4+P*5<0I%`R)`#.5?7J;QEC6Z8CA
M'>VII-PW=$$6A(Q@_MI1&&L,1'=YX\(8J<;YTB1](XW:WH?8.XABW)40W=3;
MPYJ[V=+#VS5:(G^J07)[HX,E%[E&I$P\U\2>GC"Z02NCI;QPMKK1Z=GP#9+#
M85IJ:W:9BX?:W[G@)8$@Q7I2(Y\$'JY@/%MYE5CQW=(3GC6I*F1D5"ZMZC%2
MMQ)[L2>+,JA$)XA#9@B.ZJ&&L+A,7C?54R@SJL,49N"5E:Y22[K$JHGB%8O=
M#;YT$C2Y;]@^C,N6"/V!;KP;C$4:%V?.2R'N3R!*X`UT2%WQ7->0:A=E;P?<
M0^2`R_`.0=[*,C^=+-$TWCJ.ROFVGFR3NTD<J6`&BH"B)R,CBR(CXCH)_K`P
M@=0<84XQ1F.%N:B[.$1I^S"GI4Y!K#W@\-$"P8[A^0\?9VY63%FS[7'$,HL!
M`PRC"#,9!X]2^1MGLU_@^$X=V3(V0NT]H5K(X%;'F$P?<\G1Z:!3^B`*03@H
M9Q$.B4CMZ[Z%:9H5H=V[\*NS4\4[(S]K/=KWJS\QJS_Y;;_,0ZSN<Y#,NZ_G
M<YH\(S*<@.B="F=J_0SQW15.8XKO`8!/L[/1,3\:B9'V*P`"N`NFF`ER1K7U
MVU;Z<Z!._PP'HM:,WO3Y2B!E6QCRZRGU*T.;R3]_;L@$@I#\$VA-2A[L"`DR
MT2F,/C1FKM55*C0MW2EHWRF1'C3=G?/_P9!R_L4('BJ^G@#:;3*+A=&\[SB[
MNC-0G!R3H,(P"'FD'Y$V2(+;OM,3Z]&1TNO>JWLGEIJNX\N-*9NN/%D*KP&?
M?K\HOMNZUX#ER//A&V,S'G&J-V$,WI0IP*81U&$J/A'0MX$BAQN5",>:X"JG
M<?K3['OD:1]8S,8E=0K:=H%''BRX+=X5\6@K=BF0EJD?5^2[,PLG'R0,R-I2
MLD.4J_QAF=V2^J`\EMLNN<$[GN,J)76,C!P-9"G(ND#/6@%1(VL*H>J-'^&P
MKI@P2-T1)YTYGOM?/^I9K/3OW:D[BC&(ISGB%NDH\`@@BY(,+KP3G&!=K-J+
M<-\(_*6*MI6WVFND_J2]7ML#Y0(!'1J:+AZ3>J$O)K,!KFK*;*A<^[WQ^6`.
M2@DO5-)=*6OER[BYO__^I$PE[D/A,CRJ#^!I6K'7GPK+%:YBH]_ABI:1%>>6
M?<<@I"]<4MJG8=V@.1.]=]X+'(OCRZ!21[O9XI^D/6C5I\K*\B.[+P[$R0FK
MH@)Q+Y_+-![G#3[)\DS+_MO!\<+(0S5RTG!B7O+B4D^I5?4>WZ%6-SP-KN=5
ML3CE[L\6Y#_+X\S^+=TU2X!HH(#!0`4-$!`4R$#AP`0,'"9HP.`A`X0-&3:`
MF)&!`04&)"I`H$"!``8!%C9(J7)E@00(7GY,.6!A`@`-9A9`6:!!@)4^_G\"
M#2KT9P*#/A$.3:I4J0$$,44F".!P0=.($@\@:/DRJ8("!@XH&."28X("61D,
MN!DUP4P##+0V,%!4;L<"5#VZ5("UHH($"W(B2`!19$C!!S@N0!BX0$B"?<<Z
M=%OPH<"1!!DLF(S0H<&($1$(S"BZ\VB,%ST3+(K9H..4626F/.`VM-&EMF_C
MSJU[-^Z_"Q8D.!#Q0$;9HH$7M=O2<`/@P`\(6'#@+UO/!PHP#DZ\P`'A@NT"
M$.R7NW#LW05<KPG]P`#LZ`L((%"6_(#TP0'HQ0Z`^W[XUP7L)P!W\`T`P`$&
M"F!`>`*BMY^!^\D68'`%]"<<<='9%IQ@*OW5_D!WTWWDF7*\D>@3<3[M5***
M(V;T7'3"8=B<6,(!M]0"`TBW@$K$_2:C4#JJ&*200Q*YH4IB$9FDDDN2:-%C
M!T'YD91Q4>D6:)XID)B'%3VDI6`Z&O719BTV]%!#"TP4$6FDI6109BL99=!`
M.GI&6V@H38223WJFM!"?>ZHD9Y]&QJ4=3W_^)-(`3M4V&W4B=2113D4QN51?
MH:444Z5++9;13,0AU!)C;0JV&&A#]85=5SH)8!19F\(:*ZP)]=GJ2HC*FJNN
MEC+6D5_BC8154P8TE9Y<(@E0EDL&)!827M_1E1915MV&`)"VA91;BMB65"US
M*14EGD-<=;6<2L1Z_K32AJIMN^M*(MU:F[M'7II1;5T1:Q5F+35U*JJ!.9MI
MMQ(A<.*\!R,<E%PK"7=KP@_/6VJXZ3(&6D=BOO567!4!-U)1AXD$6F>3(;JJ
M4'C2AI*@0LV%LKP__>6OGT)Y;-6]0`';:'(,&"P48V)1ZEJXUR[\5KT/4TLE
MQ#F%F%.@K6+7)E@U)R585V'I!-:1UT+<M;M'<_2RUV/GNEI(@2$@P$MGOYSJ
M8V:YQ!;`/B$GL6$MF0QGEL]"59B_YWHE'$%->87=GW(7C$!['ED+KT\&+)KE
M2X)5I6F@CXD'Z:5.*?66Q"JM^ZYG<K5[L,;-69XPOZ[)"]QLX&;EU=]!_CF5
MK+]63Q12SV3SSJ1+*O&<=._#+TF96YS=A5#J$OE%6%\ER=77RP0U&W?'X?Z)
M5F)Q!P:6141-!'D!8CT4&5!G,NH6LV7]))G5(T&50.KA_FIM15-E-'M0#RE.
MK=/M#L`H.9$6TEREOWF)15JCDAH"3O(30<WL)WGB6@-V8I:U49!X&BS10(`W
ML`V"<$@6K"!;%A`=NPC/+^O[506;HRR@3,>"->G+;^SB$[^DIR6RZ4JRA)<1
M&UK(:J(B"G$,]!\3TLF'Y:$0=+Y3'77)I2S3\6&0?G.=E=1H`0#H4->`9).N
MD2<E/<)B`TYX(N\0ISO,$A"-X&.U9`E(5>5A_F,(Z[B;J!V)BG;<8U(R=A(K
M5=!HI1L(:`+#OAY2AEIRLMA!NE+!PH2D1A'QW+*&M3W`>.@@97E(Q9Q%E\F%
MZ&J@P<_%.%(HC8P%++^JV:7*I)7+!`9="-F7QAQB'.5EI2E]R0IP`.:X-GTD
MD5T+2T;TZ*ZT*%!/)%'`2=(B%?DYI2P>\22_H)DJOG1$.&\S)A^[V2<X9=";
MXA1(W#XBE@`P4P'XF8E-VMD`FW0D/(;<"0#.(A:S\&TG/0$`6AZIE<1,+C#^
MC$H9-S;"73Z&/2UL24_<DI-D5<PD?\G8`.020!PQ1@"'$HM-3L*8G8"F)SGI
MY*("D)A>J;.%(2V5_E,JTLB/3.IX(MF)4:0BD)D$+6$::Q@87Z/)J"#F=4JZ
MSMH$.LZC@DM3Y4,J4_6D3*:*TZ5,FJE`3"61NG2-2U\$HRG]V3^U<?,VM+HJ
M2[\"U7%B)E"[.RM;B:2U)3D2JEMA4LWZ.1-P]7.8?;G,TN8JDEJR94AI[5/=
MB!7.MFYP82IQ&F(;ZU@-EJY('5H.^X;HM=]L%6)%3$ET;)*L[D0V2,'YBW(R
M^U@5'19G0=$1:\5(G.&DA4[-.2UM:ZLKQ5:*)`L]5PLAYKG4[FHUI_+5/W&K
MI)>T!U>-5:58XBD_DQ1,?LPTI5B<LBBP$,XL%VQN5K)2T>!TEU_7Z5=V_A;5
MJ[#:-KWJW<T!A41<POR.6'/U;6@1-I/8JH\C;W&@DH*#%\4!ES?2<XARA6(_
MJ)"H2Q!!DV@V0R,L1>0C!;F30M2T$3F-52()V5L'1U:9B:PWQ"+FS2")Y">F
M]=:ERSO82,;F.=#\921TX:+O%D9`(AG`+#`E%%/T`I$.DC@FC(O(3CK2*NZ^
M#*8#."<3`Q/`]I5%O@5B5GL6]9,!\'?$6M[R4/YV8P["K5GPB\M+ZNLN'C_,
M:#`&VMJD"5>FY=BLFS))B<QL&Y3$<J-="6R.?YG4#8'F4]=,E+7@%BZPT/2&
MI>(RHQN=*96U6+`"\5YO;U)IB(D-8>6#\5]%_D652F5&,$_N[]^`O)11@ZM$
M.T37JHJ,`/QLYFBNZ9)6NM)+I/BDHE@I3.6DNZ>X.CK86E83C:MX'>GLY#<Z
M0N%:#^:7L3E'HQY"HH5LV-_RR,]6ZIIM1(#K0R`!J73>YE`%P=VC:[763;.E
MDW+8Y]F%3A9F(X2H%GU#0>1DR=,[22-0:B3L?Z\7<RM.L$$`5A?6F,]K!48@
ME&X4P)!$+U1NTN^38>(5U*'%*R3A"'9TV)6U%6YR&B)<"2&'EJYH,W9I(U:O
M#(=<[#BE7]TEK^1>`A/;Z;AP9<E*E,O\%:^X9%(>*Y^<Q`,;UE`F3X'ZW4+0
M5!`.%\5C"A$-\UR'_EZ`8QVIA:$4S(,N78'V2RX`'8E'.BD9O(4ERAX9N+LX
MIW";2UCBUG*(\CQ$0TJ):2-#2Q6:=$F]%D^$P9RAG(61GAD0@Z8B3>G[+DLE
M*,XPAGH,"6I1D-(QV'`F-&K*$T%`1KGF,#0J-T)+T+'=DG.NG9XG'^E$22><
M12GJ`,U4W`_[E^FLXQZJ6Y_U0F#:0NP*IDNFS+MCZ%X]4\8O]\2LE$N_WA?A
M6,F0P"O+IW?LK%B^B:IX&UK?Y#XNUE6>A-&,V[TL:$J0.LM(X@%+PT3F=)/3
M<"%S.OI5XR*HVF`FK4;Y$FL<EOO_.Y9E@$ZNI,O_F<6F\!JK4<Y(!%!+_M`$
M^T1=7DP,I+0*L1!0=I3/LD3=]F`1HT@?1&P@G!P$7_S82#T;2$0-5CQ.`2K%
M-"V04EC7[0'@#"+6[_3)EU6*#>9>5]'56<221]R%U5S'0PQA535&=3F>J;@*
M]$B3+G6$4T3>#9T<5$23;&0/T^R95JR-IB`=L*4$8"P<\#A%>YU/CH4A#:(A
M4NV.G26)M.5>2\`*D,"1>9"6%(&(M9F0`,01='"'@!1%C+2)'OY'N?@&=_P$
M=$A'66B4<CB'B:Q'LNP'`3@'''[A$$W'2@"`&RI%&-G&<S1;&H(B4WDAVR5)
M4P"@5"6)RM@,9V2)8QB$-G4$39`=V46@943>_B0UQ]-A!F=4!)*TC?!!'6&@
M2>X`1Y?(26;\59D\1JCH28Y=7:;((%"8(FZ082A:8]?T!$N(59T!X.KXW,<X
M&4%!U'Q<D5G4TWY4%%W<T(!TQ9)%17OH6#U=%';<R-I=EZA$T_A$6>@U10"I
MC79)$<N5B^S)7#@JBZBP18X-88YEE/SP"P,DBTIL41_U"5^)QLSTGIU0Q$#0
M1(,%DHS!QC6*9._,1++('%NL2EJ,HY,=QD<QDUI@QV#,AV"@TPPBQ&M51OY<
M"?+Q199`B498!$>(#$J88M1)Q+7<GYT,HZL4'OTIG9\HG9Q8AO!`):;$"_!$
M&LQLVO$$&/-TW,\U_E``P.-8*J3BC`]$YIA49,61-1!;8,>B5,5(RJ77],2S
M-8::7$R@Y`Z(K<RM1%!(7B-A")@$#:5,!(K73%)74N3Y`)\N?1#-)%Y'`B9L
M*!TNJEM5@HD$?=-<<N;#T).&=*8=\=1B#1NX..0[*:8FNLLGAF9K+@F_=`PI
MNF9688E!L.%I`=T8%HRE/$PUSN9OEHC5A(<7`B?9S%/PR69MV1P-12.XW&9N
M%6=T#@FD!-]S2J>N*-BSX2`($5U83,W:'$8#:LSIK8K:Q))@E$2HP,<NR==>
M)$QS7F=\&AA,#8Y\>LUF`(MUCDW.F,F5_$HQ@D:BB0@TY5B60`3U8$]1_@"'
M?J9B<MKG@\H$#0T0A*;9^ER*@Y)-;:*-R/%3D7D..BT*.\F/LFA(13&&;"3D
M:SQC\2@FA<KGE_`(:[HHK(#(@EY:'2UH`@@(`:#'A*A3O8&';YS0GH%6<N3A
M3KR(=J2*ZLQHD^J-7IS-&3IID?@8W7U'<X50\TBI4`"?*EV=O\V+K$TIA88,
M_8RIKGQ);LI/J#'HP3SABD[+/1$+1)ZA#D;,F<YHW.`-AN)I<&H32BY&3/Y(
MFKF0U/GE;.F)(H%.N^C%4H`8PK3IE,)G&D:1_"A-GV[*FD:=T2`'3`E(>\R'
M><;.@(Q/N8Q/[$`.46G%Z<490Q9``'0<]#$._MHLAT+JHP[)(^3D4@#0GCKQ
M"0^B"I_V%Z9"J)[F);'FH'0=(!RZA&!"2>Z$1GLYE9U$8Z91T%\"RFQ=B9T$
M37B\BXSR%L*P(+)>YXN(!KB2*XFH4H]$AR2B1W=P")VTQX.H!X,@&P%<AX.P
M1TP*"`^Y!X7`!X`<"(\>B(ZR!W3H(8#P*(/@AZ@`"!.QB*Q)QU($1\*T:+K*
MY5C@1[9@;"GRW"9A&8I""M<H2UKLA#]JC)@@HX85T@A:2T$06&F$B+T0TN%!
MJXY4I?SMR$MTU0D2EJ->;)*,:\?^IDVT;#82K9"D+->-%GGMB5],:N_PCZC]
MT"3QA;8-!65H6M):_DI_@LYE(.=2O`XM3DQN0.FR=(U`]9!O<JUM&%<[4@7[
M?!D-H=H>02E6\<S@@.`9BJFN#&W;^L1(#-'WZ9-WH-D!^8OTL%R&*05X74W4
M5DI#/=)V`BYNH.)$G.A+E0Z(62H?I0M4T-1TY*.O<06<)DFD$BM.@MZ-2B)0
M(*E/;!68$IFV&,4404R.;!&:5:ZVD.QU5.F-0N`[[1'[?*$)95(%Q5`#R(=2
M%)N[H"ZFDFX&O@N#/9!1@0X7)@W'6HK/_NTQD85#W-7N\L;LS,2RE1G+7.H&
M:>^RL$:R-%=(F-;)O*?XMD\T&HTT$N>HY=076JZF?,>6,DGT,(;VTB]N_D3*
M2N08<@3:45"+1FR0?K&$I9Z*].S$]W79\ZH(*A:P[QI3>_D>GQ#*T<SN;C`@
MQ."4EB!M`=]&M@B*5-!4800NG_R5!J'%6#D$8[GO?ZEF4.QO<*DPAZS-[>4-
MAXQ%"K^3*O*EFV7K9!Z%$3M;2`PPV_ZPNA">>MZ%,SV.\"3;\,38R_1$6GS%
M0#A4_C$%``NML&*LQ]C:XV103<C?[)S*0Q0HW@!/6BR&4+[@D9AQY!:*0TWQ
M"C.+8(J%COA*ZI@:,%'=V&Q<Z="=2AS9-(E=&3/I'Y/F[B@4&5F%U>R(NEC1
MFRS6:*D1?-RHC8*1%34'NE)RH5*'=`"?T5'Q_B'61^]<T4]X5H?4$/OX9-5@
M\(JD\KEHR:(&+F,]T1<:$,)-3]X5'!/W+<)<##ZAL0K/5+.2Q:@@Q)<=X+20
M3<8A"EVT[ZSJ#J>\YS,G;1[CD2]7S(B>BZM$&B5:;E%0[KPHAG2),_V*"\_*
M!=00SJ_QL`7KE'$`A=&<A)-Y()W"X#P'R2[CZ9_\LM0X%=@-%#22"DK@B!2#
MDT$K2<7(AO7V\C[+%TP4TA@*SS(G5=`NB9TR\+@L8+/:CU&FVJ'"SV%TF`^)
M=%*0K$6?J3]+I+S$\N5D\5/$\:CUA;#^KU5Z9KFAV$;3C!Q;S3U+8.H,UC[O
M,9$(8%`P$_LX&:AV_L\.+9!05=#QK*GLR%C2?(G_*46"``]"C^E<<(X!J`V<
MC*8&2TIGV-1!X%J;0&X^9L?%)4PS/PE2*\R(*DOPQ+,A5^LU1\PA)TJA2`0_
M549+'%[0!,QB#0[UMICUYHZU'";U<D@$Q0Y*F#0]ZZB&O`QZO#(MBT8#:_%M
M_$9:A,<L)PP<[99?]]N^&>].$,"T&2(6`5<G.UN`_8IUH%M-9-`E<LARD(>H
MB(J/M1O0F`=)P(=OJ)..FE!-:,@)I7+3E4A4'Y5;M,IGR_8CX8=T4=](61H"
M2[%&R\IHG@Q(D1-+,(O8Z/6LR8V9D%U%`,9C=.2V5F2+:01F8(4[/^IW_BM?
M0XV>$W^W(_GQME2S\$BQ?9LNB3`+I[S*.U&+XAQ&X-;UN82HL.AFC#F@<WO%
MC$@%K!X:Y(0%=NA23U"T@&^91T`D7K#X2N`$HS@X)LV/@P;'`<,*577.ZL`A
M2O`J/Q.,_A!$_!@2X"G/J!09E>SE2-P(E$P.0C'Q%*\)98*$8^QBA>G=N8+M
MT(6+0%E8;>[56WD-ED:&=HOO6\18@#+`.DD3L'3N^2293;=@#PO%P66$[9"3
M5)P.J?QST&&M<^;%BA]%@A`OH1/M>8:<=L6<_'Q%#NT<Z?#<Q4!3I8\A/B*D
MS3DZ6A>)_D'N%"-$2>`CVCB2"DV3GW%%%-(5_E!ABUO`4\]0X>S\;9SM$HH0
MQCMW3F)`3D;0>9_J+DDSB6O?KEU4(+S&N,_LR&BA%BKOQG-<+(O46W0,*3:K
M%E6_UH,SC',@1R\#:VYD)O[Q"<YJI@AR2*\+202BS;%3=>+.10;;N0B9,5ZH
M>-0]X1"KQ'R!3C52<)TQBL9Q>]O0ADM^!F6@$,297]QD8"=%V$'B"\=Z-\+$
M3PFKNP11R[!@.]W,-(DPUFU4ZF(SCI3(M)`+!"E^7N"*E01G)25W>S1_G"7A
MA:'!X9K\G=-I6)$Y7G-89&"-S9OV]<2KB\$,G]*^.X1'=9$3&]L<8(`SSV$T
M'4WHK-@L*9SDA:-&_J2C;S1B0X7!!-W3HK%&'XV_;#P8>81-$*_/G_6]QPV.
M:7:"/>],.-!X+O7VJ`8YJ4]^5&WC$5K@NKBCC@H!4[)ZGVMSQKEJYQ287@O@
M>Z9TL(G9<XC!<(?NEDA[!,D.WX:XK%N'V$1W$)YI@D=!$?N--&_SQH9J;Q6G
M8RJBY`X;<D=4RPM7G\O%+TF(E`3B3[P.\EJ2#'WEHSF5I,BKF81)H#/C>Z86
M<TS=/@Z4D`C9D69L[/YQW82.H+K/\R#\?+K8AKT![[+EHU!>9)/P(PU1R'T%
MNXH'*71"/!7%B[5GF_Y!/X1-5)3W;T2@A(R2N/@>DT7U'W\VZBA/O-,:_LL*
M0"!HL(!!`X,'$294N)!A0X</(4:4.)%B18L2$RA(:*!@`XX(%!10:"#!`H0,
M,B)`8`"!R(P)&2@`B9"CP0,)+N9\6(!!@00H->H4.I1H4:-',8HT6$!!`IQ(
M&_1$T%&BS`%4+SIUVJ`DQP`,0#Z%BC`DRP4#&@3E*G#D6+=OX<9UR):L6H-3
MQ1I48)(F5P8&9#;@J?`OW;L'$QR0.S%`@P$'"B#(NYAR9<M0%:A5.7-L1JP0
M0Q(5B3:M`,&"&028#!4LR@2FF>K=FK#Q9=NW<2/TF5"Q0M,)"]R\J,"`<(2_
M&P#(O;#`@HS.5R^7/OVRT@:*>[L5L"#[0\C1_BLZ=7Y=`6SP;JTOY0N9]W6^
MU.''SZG@LV3"L_4BI]@R@0&'^*4#JP$$3+M*O@,1/*HF@_IK"2X#WG,(NJ)*
M>LD`DEH2B:2X6D-()9SV&L"N!%1+T,03$^+L((XF6XTDNR*B[X`%$2(MN?@8
M`"L!Y;A"<2P5$5H-1JX.""HFF&@T$;^KAD3JM?/T6J#)BP";:4.-L(P0O?0$
MTT@JSA0HDDL?R:2.OH02B$RQGT:+$('N)F*+OBD3,$PZI@;`2<0RCVI*(0#3
M&M-/!C,C*\D$`4.,)?\L8@"MS"Y\R2.UZC0(,`$B:TJ\V#R$LK_/.*HI-+W^
M6JPFE`8\4U-&!YR4_L]7IYLJQ0$3R%-$%ZDD,,T+@U+`1AZIZVE`D52"E:A1
MR;)3)OW2*M+2_MZ;TT=A+?4H)YP@"ZE2O>QB-*,"F.))L@5D571*@P08=$69
M-"KN(/KL=$O;X'BR+K+(9"O5V'TO^RPMLNKT%U"(0)*LSLS\'0C*RP1BRT!^
M=1+P74";TO)-Q,1#[$P4![-4)58IHI8YD`7;["#7&#3L@')'2G-CQ#H$UU"Y
M9,K(`)[$TI8XKO0\%^*?C3I`RS$M^XV[^!)+DP`B@;;(IP7>$WJR&0'(RSKG
M7E2J)"T1Q`^GA1O2DR&BA<X./YD9K+JAFYHBN;FG:DTHW<7$FBPDJ*\3_@GM
MIOD^2E+$EA.K8^I&$[OOB0IB>><@!UR`2P$ZVADY($W<<*F:KVT(69HB9UED
MIVQL*['/,MLJWH21TM&@L^@JK"=(L3Y<]J$T=0HH_P3H3]LW<9Y76Q&+7,F`
M/%<>(%+>OTV3H$P'F#O8J9J/*M[9__2)4;`4J.T@M)PW:(#W;M;(7K"E>WDT
MU!^R?*'I;_9/=8#O8I8A`!U7@$<$`$!U*F#?0EFP;:,BG(P4RC[4,^!^0J,I
M=GW*/X#YB>-0]1/Z%$0Q6.K1G!B@&"DA+$<E*1BJX..HU/SD*P=LB&L@Y!%]
M'<0ZH1/9A6[4P.D=2$6`41=%^N,7.ZUD(1>*_@S)5!@HT`!@2"#9$+'8M10.
M)>8@!C/(7W""IX+D,"TS-.$5%>(SN?PM/B$A#DX2A<6-8*Z*$K.6?P@BEN^M
MB%$\\0\7$]0Q1Z4)?0[)#%.`U"'"!*=8:!((&244QNTM#G\]>1T0G42NO)2$
M03/BF4;(%93!B9&2[<'-`N07'^Z(CVMBO,F.&K"=QUTG.>\Y"V*0HYS=^&@\
M"('31'9$@.UHZ6@*40P`.LD5QQ%-(01@Y'%X%DI=^N27<6'B03"Y.@#T9I7'
M/&8EH7F8W!3J0,(B#2*QF,&:&5)=!O-F1X+S1-L1*C-:G,XB79:5-1+&>#UL
M"N6JZ!1S<@6(5QF,_@'2Q1_'D$\H.^P(2DQ"S;A%DZ#OLN)B0M=%E8234]#4
MW5X*14W)8$@K;$GA7=(#Q3J:22P.G,^4&""E/0IDG&BB(T3^<B3=O,XCBJQ3
MK?A94)G>YJ`SM18NB;-1ZF$O3;8K%UC^R""XY<PP-<ME?`S#%"J&)Z$GZZ.A
M.@+/*AHF1T.:$5;.HJ^W?:@`%[7I5Z>CTMLL[D`DT8ICYBD[M)U44F1E4!N?
M`A:0L=1'8!I@3HBWD)).[*DWQ%Y",V,GE+#L+B$IR(N:HI&F2B2@[^I10:@2
M$U5=<"!^LF!:<I0CL)HP-9O=HV,4HSUH@G!E0F607AED'6J>K$Q6(TY:_F'2
M,!)A;RD?<QE(P`4Y$0DR*@W5B_J>N#<6.DH]'YH*+R'B.`2(*`!EB<QQSW*S
MGJZD)7?[V*(:E)%U>I9ZR)5+*P_DDJ>L$IIX4\A1#5A,TZ#7(2+!CN,0\\ET
MO48P\&V.<ICU3`;!]T]_XJ_-#G`3_E9$I#T"T7B^IC"HO<0D#48,U!IL7NX:
MT(RVJ3".V-35F$ZX;V8,ETX9LD(8Q:0G((/1W8Z"EII`2#4SJ2E#PL1A&2/N
M8;:Y(8;3PB80S[AI&7W?6P1P4!G!-I"+>XRP`H``T>)PPSS>[(TM<V'XX,4G
M%;LB-@WJ5FL)I#&"2RE)0&@MX""(4Z6:)%0N_O:0ANUX)V*.XNO$9Y$PL?E0
MXOP+I0K"+C8[^41UIHQ8Y2.3FRUOS\;2,D(B>=*)A8:8J?5(I#;T$:K<L9J=
M*F&C!N+8/$MV-S])\-=(S!,,AA15".-*H4#D&8VDB8>"69E(&N-="=&Y29+Q
MR0#8PLB5G)G/Q@JSA66-&X3M94"%AA4<FVA0=RUEBI?K+62?"+FH^"<]BY5.
M6Z-8D>6"*P"W9LD`P$6?YY*()<M]4F1L!2[`D$0U>O/5DVQ;M6\_!2U*(=;!
M>F01^L8(S**C)ZLLJ]E>_ZPY,R[)`;Z72=D-C)1!XHY8X%0W+=4-.4VFC'Y\
M8IR(,'%KF<9)0*&C_A13)L3!7"DXUPH\/W3]MSMIF@][E]+3,=OK.!H?^,]>
MW#\L+X?*][YB$A.2F?<`E"\W#@J`I**Q@/IVRD\)S(;))^A"UVGG)]3@5&I3
MS&#*6=H/6<"%$$DCVM+SYGPC,E2"C1L-W?6*!=Q(GH`3%"!)"E]!R@L"I,1T
M,XV1O"BMNO>PLF,2RYDM("%-P4]V]B<*#9:3:6Z0%%]V%.7\+9&7RQMWTW?J
MY;1E?V)48D^]RDA&Q2D"F"M3@(M4I^>(L`_1HD"LU\Z2Y;PI_L([2$7R]<`T
MCBQIS^(!=@P2VY_DJ4Z5_+Y\[Q:++R8P?Z0\Q/P<+]"G:J)`_Z1,)-.]_M4Q
M/*R&24E,#\W"\E2J7*LE&("<HG>,/E)KDWD^FM+JOV371;"6/_YR7EF9`<O'
M)2+-'18S:?\.(CNV0S'H)3^N(VF@#/$0A/$&`N9LR3L80I1@B56:@RF.JH*>
M!EW@)/^2:[N\SJL:"4W.2^ON;UK^#B[>SS*@1S%6T%@0B3BX),U.HR]*HZA6
M0ZE,9'!PB\V62B'@;B'L9\].27I<CB%8HEJ>`N].33WTS0.%\,S,#X`0P^U.
M<%I>T"A62#Y(@BD@Y](.R%<6HJDD(]?FBE7`,$1(;ODH0XXD8T\DPL^LA6A&
MJ")>+2IZ0O-.YHU(@E'RQ#4^YB(`2B+&[HEX_@OHO`?9KM!$=@\WV%`NID(R
MH&QVD.O7+$<,:^2)^*=9/D,'$V1C9&+PJH)]6HTAEBQ&%B?U/,2BA*54OH4^
M4C"+N@XB`@8F!N<'8^(1%[%?LK`H`"T^,"0!PR*D+JMO&$YG/&8CR,)&Z((^
MBG``=3$NX/"0Z&PU#(9$"N#Q5K%)/(W$2@>,CB1,P$-8@L</OX_J!!$"\V6,
MG&YO7*,DC&T7+V,2*8/[KHWJ;@O2`"-<\!!B4L/,'(.%ND0EU$(J_$-$2.,U
M&("(\.B5@BP:WZ)C0D(EV*SX>D1#K`D(QW"Y;F)XIB*%\K!9PB8H5*RWBBTL
MD@]^,`+X%")<A*<C_J2D8%I/'LDL-]31-D).:$R"\?`&6ZIF.U;'6`X`OQ(0
M.7Q):/H.OE1);DC)`8,N%G$R/;"%(FR.::XC429.X4P#E\IFWP9".1ZN(=P+
M,O@B.!+#<:IR(IS2Z]9R==*%2\(D=P2,)D]$$>O1_N"BG%)H']$'+'R""?TQ
MQ!:BV0C#T,01'XE%LFYF(0?`VIXH0JHL&?6J%TD/?\02DJZB-M`B3R@R)9L(
M"K,(I#J)(&*"(.CR1/!2**0L6)SB]G(Q(F(",BCS5>(Q0>3*.0Q0,H#ON/("
M$YE#+"2QB<"#)VKS?Z!06%Q&*1KCB](O)]3/*`KR-)4D-76B$0--)L!%_G=X
M;7[P33HI@SZ"+"8X8C3<*.C.A5-6HC?!`S"*,R9FT3Q/"RW`XNML)N7VHTC*
M:5S&T\P&BR,^R=9VI&;R)`"^[H=4T3NGPS'E0N`.)+$DT1/WXT,0!"7"L?DD
MZSEJ3U;`$20J*!1A;\L@ZLLFDD*I+8@LPV9HY1I7IB2T,;@:HH!N;!AQRZ)V
MI@L+S8G^A?C6XB5Z0KMZE#(OI&`&4D=(JO:VYB?\8]5LQ]-^`B@0]$!^(C?L
M,7"X"C4\4S8DHSA98Y-J9;<@9SPS`_BR,Z1(A#A8`ER.RR/JA8[*8R5"PWW<
MM,I8Q#;<2Q+S1&^,"#C0ITE+<47R9%$<1##0_C1IH/(N=(\Y"B*K&D-80&)G
MKO1)P0J\;N-1%^,"3<X$86D!U`8^)#73XH,!ZY$]GN8[D#*4\D(`[0Y4`:=4
M->YK1*I0!T)H,BG`W,.\=!!<:!52CX\ZA0)6*8.B?D(Y3C$\>+4H?/5$+>P5
M&P,O/.*L.D5SPL\R9"_H\B:!T**ZPD)7=[58+T)!<^/+H&;Z>I5!I\GBAH2`
M0E$(]XQ;1Q'V1H.D.K,^PN8JJ@JSJ@I5ZC5'O>1K2N>)I"4Q,A04CQ!$[./K
M\+4DP.U3*%5;"RI:%Z-/@1$E+F0A`Y(H&C5!+>)0[H@X+#+'WN\Y=<YJZN0L
M`@O^&"*2,B1AF6M'_DA$R;;-``+@9I1L*)6,1$*)70!#-5ZK##'%FT@6];ID
M*XB#-&,B4!EVX.QR,<@51VYM>:1J.)9V'IM,%04D$O7*80E#2X?#2*(BL5KS
MSF;E3U8&LJ(61*+62Z(B;2/ON/P%C[@"!'_M:/EL-H5B2G/CC[9"1!9V)(@M
M-[PU1;I3430G7*#R+VZ20M@B47%-(&XE2CU$(4!B$\OG3]'$>M("N$!6;C5W
MXR!R+*3&)8+C<"'"61QQPP0@5^VNOEK$/9JL<R>BEI"I2W*G4_/-E3+W-C2U
M4T7"-`8F:3>7AGY1&J=):]V")&:$(*["=65C.0HU<6#$8+PH.N!0(DK$_C+\
M*C+DB<NPHOC^(@@/)*O4PG&H"'.5]W?S\OM,@GC_0WVS@F[1(R:^9X[V]FJ%
M;05K+^C0HFI:XC-`)V22M2!;<P&2;'-<)<M.!&Q7!S`>9<38U7SSDB.P1B#8
M%SYQ8PL_E?2D9'$[HWP)\6__!$9,#)&\-VO'Z#(2XVU*HJLR*-(V(B\L&$'(
MZA4-0C4R"XH<>%J\L6M+)DF10@X?EH.+@B>,1Y&,%BGH\8$K`FO]->BLD.1@
MQ&Y9XTR+K6K<[0A/)F>.U3:H2%&#J<I*]H9/Q#D*`%-,M4+^94V*`E4W2SQ,
MHR-%E[%`TRTD;")4U;^TY'0IHH[CHCG61">W_A*3DFG,T.78KN,[!@(V?$(N
MP1A%PC?/BJU"_M)3KV6"PP.(+798<.(KLMCU")AFAM6.?#?'`B^4J;5??,)M
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M?UJB#!GJM2!$Q5:"7`#ZS>Y*:@"*7[U6GDIB+UAD@T#DIF662'5YI^'"/G-B
M)P'@:2*$=BTCCM4N:4Y#CX]B`9:F'M^X:!);)S[I1M`XFB77ZS"B1R#,P:1F
M`#V.2Q<L7/V$K7ODO8ZF?IRBHP';KCMLH=ZF"7%C)@D'GGWEA:%"F"NOKN%B
MG^$"8-VH/XC)FUK3B)!YJ[L*`%PV9I/34=[-1KMMN6"V`)H'3VJVJ_0V_AN+
MA[G!I:OJ!9_NU%?4#=?2XGM^Z-U,.YIJIP^GR7W'@IB4(Q*CNK\@$4(:M5)N
MHF!>:J)Z:MUHNJ-]J#G>[91E<[G24WC^&X;F44;R!/O^(AL=I27.E+::=#;N
M2E-R1$HZ*-/ZU5[_*1?)UH((@F@M"";Q,+(N"._JQ$W'.;SE`R6^![O66\U*
M/)?[(TGO]&$?^C3DR:USB">"IU2NKYRTHH9%*L%(TTM2ZI<'@J2T^$)N`OB:
M"WDHJ502MJM-O))X^VF9+ZB+@B"7TTV5EK87$;<F!?M^AY("(ZO[-\J7([/2
MUL+)%D2(#2>,/$M?DV`O,*5R(YR#14,<9J!H_L:\3W`SG$-\FFW%F59\K<?^
M)DTOTGQ6-JB&R>*Q,HO+;TZ,(2-/3A>73"-W,#UWQY@K!^`G,>DQ`BQW3I@[
M(/TB:-ES#R[3"!OMMGF19$J_K-(.0TD`"K``9.DUQMBP(2/`6);6JQL`,`78
MP04`A#W)?_?3P@P>G3'"U6+5^M'9S3E-1.2(MTC0\>I_+,6VH:+4CP^X6!N+
M!#A%LM"P1LULT=REA5RSBA&2_L7:'7BPY,F'%Y3;C0+U-(1C*P.A-=>MB(N@
M.O;L_GFC;29(&]60PJ4L,H0E3.^'JMM69,[,!=&',H*4WP)3J>,CO>0K3CTB
MUOE)FWCC7X6`AQJ6_J9B9;J00U]'GE1((/XY%`-#(R0X@R:EQ8?"RGG:K"96
M2NF]*!*+6'2:,B!V<P'$.BO)Z%;P=B$>:7*'*P^T'D'^*`JN-V*G#1<Y;U>G
MM*D'CZ&1(OPZ+A8[Z0/#HWG.W2TB>94B$+^3YF7L8/+G(&$X+J@ISV3;(>@\
MZ<ODX/-4V&3-YM/'N/^'XGE^YY&V4I1*[>5#>2*CN40%(_C<[F5<Q?@>I0P_
MCW4DMP5?KR8?K#0EJTXY>[(()@X=;1FGP!++)-S<2&NF]GZY4$)%0/`HL1HH
MI6):1YHSUA+G#=-3P!]BL!S?1Q8H+!I?SA(DNUYJ>DW%?`W2<.EU?],%_B''
MF+K^DHCRN[H7RGA>+52*PWI:`C(`]4W*C5?$Y<Y2?"U0'KM2(K!"PVK=35SD
M3J>4N?<;%/9$YC8^>3KPJ#B\B.Q'VGROIS\@!R`2-`C`H('!@PT6(%S(L*'#
MAQ`C2FR(0,$!`P,&)-AHL,!$!0,FBAQ)LJ3)DRA3JEP9<4&"!01<+O#(LJ9-
MFPL4WB0I8*?/GT!%SFQ08.B!!@*#*EVY\4""`Q>?&NPY,>G2JUBS_D3`0(&"
M!0HJ>E600(&!!`80G$V@%@';MVT/($`PP$"!LP;"*M#*T"W?ORJM`F8Z>*77
M!G@7J#5;N'$#!@;`#@@`4B!DD0@<:]Y\U6T`_K1$W:Y%K,!CV9=[4S=(75#A
M7@8;74(N6'@OY]L(&>,>F7GWQ+2KO99UV]OW4K(]-U;\'%8D3>/0HSL.^[1L
MWL8AI3LN8%N[]Y%DYX)T>3;S7@.P5Z_NNI'LWHT%&,17P"!S=:Y<OR:874"Y
M`;P7M<56?P8TH%9_!2"0H%UW)5C`@P_^!V$!`RBHX$`)<%>@@R)UQQ=MWX7H
M&&0OG>;A7\V)R!=9*K9(45CUM1=<@@!LA-%3:LFGEEP$(I5`A92A]U]:82$@
M0&SQ)9C?1JC!5A]23PJT``-4<E5@0?0QX-IAW0G$G4L5ZE52=BZ6::9$U#U%
M7X&%[7?F4L^]669Y_C-UQ=5!)\KYT&4#@,2`1B45I^>@9F9(U*&-Q4EH32\M
MZJ)+3D6FJ*,/>>34D2661!6EG$K'EH+*Y<F78)V>=%VIVKE5E$?<H?K0CT3]
MR```HC[$XFX@NKHH;`@L$-*D?+6JJTD<#6L<DVF516:(KBWTVD%4%D3E8P>A
MQV-_AU%+;:Y(J1>`L>`.AA8"<IW66'KA.L=MNHX-D&M\*F:8X(#RV467?`$H
M&,"#M`8P0(+?%IB71@Y.:%9I)%+F)KL,*V4GE,!JA5[#$,&F$\6-%6N06BHR
M<-23W;T'+4(7&Z@?M2EV]=B47:E<UF/P8BPS2SE5AU;)@)%:$\XM.C5S_L8+
MZ:S=S0`<4(``"S@%55%&"R```/UI]%+14!TIP`%%FW7`U=PE</61!1!P)%0\
M_VQV5;%)ZMBW9Q\4<=M*5820?/$F25]%`BR6UVG#*2@?9&1E"-D"Z/7'UEG<
M)=E5G?T-MB[<-SUK4+14@I7:850*1-]1!7(EVUMD]2EW8X*:O2SD5RE*GXKN
MO3U1@@N-+I+'J.]Z%L%U16;7`6;]J2IW5EI$7%B$P]A?G:?_11G<&M=^G(<'
M"U2Z<>0^F9+U!OE)$EO.+RHYR@G1!N+C#L%V`.$QGCL]QFQVGSI98/G(Y&72
M@=J^J5YFJ&"MY2?O/NIND0O]"N,_BE')=?]C_DE>=%>?N12H@+@A"[HF,BV$
MS,4E<Y%52>Z70,C5S"Q)*UM61$@Q!'90)0HY"M+.EY.]%"6%2)%)64+8%!`*
MY"A**Q%WH)*A!=1(:48SFKQF(C:L/>@I!0CBT<1V-*P1``!/@V+8H.BEI!WM
M:(WBR0EKYQ5R521FXB(4"4=RJBWZQ%VW(]%:V%(:"`T)+3>RBX3^E"'JR"4M
M:OG13`+7%+9H*2]CZ=5L!*88N>U'(=)+"+14QH#EA>4`&G$704HB-#/.C$6=
M(Q]6^,>NA5ER)R])HD#@@Q0E":9EC1I.>KAB(Z2X)W,;$T^29!62N=C2``'"
MBY%N21<*^1)QOLS0_D;Z%"NG<(<^G&1(`@#PR;:!!$$(:PP'*5:12C83)5P9
MP$RJ$Q\`N$MVCSG-D0SPF6J6ABYH$29:$K3-VX'E3WI!"Q]+`Q*BI`=XB%FE
M>O;C%2I91$SLK!#4)CD2E5WS9UTI2D@@B)67-8PV+CSH35AIG;?XZ&`+J8ME
M%C)&SN0QG8@1Y5E@1!*Z251F="J+">/VLWJ>M"9"FHEIW/6@^G!+(]&,5U@$
M\*?)/=!/R^--X/K#%58AI2UI(=RG7B(D6_*N2$6]"QZM^=*_<,0CFQI,46:6
MQ:JJ9%5.@4].&H"TK9+,)5]ID2@OTCA++>!J3"H),WM2E+D^18BL.E]__IP2
MDI[4#"E'6=5!`NO5S?Q'-"9M4S)=I:7U%98D%2'7MY)$5A(I*B\!%!%[OM@`
M=QFH0)1QE]0HIR7UJ.8UJ]N/:M,SEJY\!9FL;5E%G`)5-6$V6X\UB4Y2^QC8
MOL=E_,P2N4+"ML),[*%=S>U)R")*K]B%**(]45*X%Z(_L:FBG86-7?J4SD@^
MQ5<@0<!GV**1@2;@,]ZE$$;2@D4'&4``"J#,9_Z33N*<]V_35&Y'Q/LO!P5`
M0A3Z5P;+HR![$;7`>4R+T3J[G<66"ISZ#513"%)4LIZ3@\)*D7>(N1IFTD0M
MR&L-M0CG%BQ-KEES<TM:'U/!QQT7(MTQ:(3Q_J2>[&EK<M):Y.0B\K(^K30H
MGDP7;F=<DL0E:$T%\F.0A[P137I4,-PAIFK/*TR-W,XLAL(3K1)'-]`.9%VX
ME$\Z`3"K[/8E,P0AR(^)S*BDE2:NC>EHIYK'YI'L50$]B4H(C;F0QAT$--$)
M7&Z&T@"?G86%89O)6V&",_B-DG??/1]#%#*`JR&R6QZI4=!@1=<Z:T5KV=5F
M8XJ;KOQZ.B)@?,R]>OCBU=P)6G3F#&P<>A#X>O8R5&)09.92H5Z5KCV'_4\7
M_\,0K_AJG6X19D6X96R":>_42ED3:#CL.,=VZ@#8@[9(3A>>.N:QS]RJEV](
MM!#Y],Y`O>G::@YW_C?$!$T]>2F*?0S4D*_`!IDF6MV._0D60.I;VS^9]:&L
MC152NVH_=P$X9*%WH29S&UCDODU8ICDK[1G.;Q#:CP/OHW$$W:XI#R+8'_52
MS0<Y59Y2)2IS[6MR)RL<)<Y%'T.OXF`]U<>L+W_=0@J'Y].43E@,\;-F2+0N
M!L!7;@F*E"P%)R1[5K..`KN,P/(Y);$07;5.-ZUK6B;H4;H\YR6Y-ZQFOA2#
M=RJR7P>[06A]U)`LN-6WPO;<YJ69\#Z$S*T2>I!WXL^T%[MDR9VQQF*-<X0<
MA<<N24A.Y!R4I)7J?#Y3^TB0MF[`'F4`3G'\0612J6YES)H^7#2B2DG5_LV#
M12&7/A'J=9*4FB7>($?1W.)C&'N7Q%KR)WG*AOZ&G9J+:"]6_C?N*^9C]#D(
MS]\4E`0A(G3`\/3P#3%Z3TNY=E/'SBOSJM!9CN3C/\E%+79A;AV_Y>QU`I.Y
M>(Q/Z8<O$?8(D.Q*6;^(1GE>]H_)+'D7#Y)*%U2'M'$P9&%]!D%FM#)Z!O)U
M')-OPC$6EK$E8[%NT>)*8Q$X_61LZ^$YGN8FK,4B[\$B6(<>PP$6PR,OY:%-
M?0)_0>%[TC%KR^9W]J=J(/13*L5*N:)A>V)V6.$7,,9,V>%92(&#?=%E=%07
M\(59YV4T$9(@`A`U&8$8Y`1'#P(2(%%I&`%-_G46.L(4'P01;\F2%IVS0,1#
M66OA'A5!..Z6*"XX'>&A&/52(?(W-R_8$8.#'CYF$7U21C8F$1!&<^LW*R9U
M/SX(8_253LC4+2*S'R:F.=N2A^H!(K:1AG'H$!IG*&OV$RC(&>%1(Y,55Y#X
M@NS!)'K1-6)Q2J]6,;"3%;H1$1*4'0GG:J^S.%U4&)T8B3)5:&3E&)'G(DF!
M-%##$8P7B45!?TEC-*6A:#7V5B/QBRRA:1,!`,8(?3XB$?)R>%D6B=\16?36
M:G^!AV_B)6)AC:C&%A>Q-S(12`8``#=RB75T%=3&8UIH$!6R,?)7(![",>#H
M'6Z!/@)X%16T*.-B_H;WJ$P@1!SMDQFEB!)G$3>^YS%L.'H#!!$*4G@WHX(J
M09'6J"209(!_H1@6R2SC$I`005`^DI!,T9%H8H]5@6W9@1$^]1N)A1"T,HL@
M&7_Z\9`;F6J<0ATSV1#%8H:!F!(8(9/E@RTNZ#45=X:/`7]SD423%A)OJ!)"
M:7^)<Q$:N8TFR3K4M9/PZ(B@4A.M>!.YB!E@01/,N(<-$1^FQH):N1EU=4.-
M`17@<D/0"))"QS0X`9>,LDS*:!"^0A0Z\9=SZ1`YP3N"&8QK*4V@LE!7N1)1
MV2+ZTYC0%B<$LI@(@5DPM6(D41H#`8^O@9(041:8J4QH<8F'>1.0L4N:_MDF
ME:@GMD>9I\9AL+*:J$8N*^$WRQ5E!I&0]`%_&K)W0>,QKEEN-S9CTR)B^P8^
M(B,ME>-NF0%I$A0P5?DAP2DB(CB=1%:*4?.4[1<9@=%\F:EQ\(@G\A<?Y-)1
MO:*=%'1JI<%>2Q@A^)<1!/(@^T)?_X(17\0[#**$N)DH#P691`8;',:&I"F)
M"R$7*7$K!T%PY<93V1%4+L5CBX,9Z/F">UD2+H%5L?*6&!.8<2@8D%>A$[%@
M)H&7*.%#B/(<4B$13.-[85F:<2..30<T%(.@UNB#:-6.LR,<^70E+X$^"`$:
M_=$3/[5VO4&2Q38<%I$K*M8;@((4O&F3$I$7_O[IHK9R03%:&#A9:D`7AR^F
M(9`H'`(5?@;!-L_F2@VRF;EI=+V1FCP9?AY1.CV1'1ZR4J)3H<=$I4&A*ADI
MFS:1E0U#@34*(HH3=HZ54.$4,P5`:K3!%0%P,6GQ.$>2;O"5&[S3H(^HE%!:
M%86FH.F)IW@2.)G!IR5%/@?)+HTE?,/G6M5"4MLCDGVV6S=#%+5B*0GJ6(#&
MEX%H=&BZ+"O%7,O%1V@2)67A3YX:.PF6BD&1J0QV20.JGB!B=6&'H]F3FE2"
M>?21I?U17#KB$''B-4%S1[EI&T8*$?1(2>9V8.%4=#82&SBBC9YZ0X=V%:_G
M/&,5AS@7I!4ZKPQ1_H";9Q99]:.9YC:,AZ$P::**Y#8ANHXBP4P,^V;G`RL,
M459>@Q:'5Z_%:D]1$YT[@7W2):J4XB2>&(@\1TE]TH^3PY30@I;E^F<.<GBL
M"F,]]Z,J!8_3M8]RJ)W6DQ1=D2RBLJ6U>K$^Q5S("A2SMBX>RRD3RF9-ZBLO
M.3OM(6JP1BI[9'*6P2N`A4PKE2Q!PU/?TC+9`W^QR!ODXYVY64D0>[%)TI<V
M6YLUI4QMPXV2QZOT%'8'=DK$YBQG`4N$PR:&4TC2"#^QXQ29T4ANXV`"L;8(
M`2Q8!BP^>Q!-RF;*66/#R6(Y]BS8YB1)UAQ851&(>STTNG9)6RI_`J(S_B8L
M'-&L`L<0\E$VAU4MO'I$TIB6/4&FT+*V)\BA#@%!=F%N@EHK-CAC9K%Q%D*'
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M(X%YJV=CH,,75,!F$M6Z3`%B'P*&7>BV((+K+%/,$;B4%AI%L7]6J4EI&V>[
M)S,K5+DK&($#''L"M,3!8)T+<T8WQ:AS>P`W09OYDQ_115U6+>Z&EE^K'$=6
M%:^&GR0E&&O!)CXXM/66*>`1,4;RPX1;;X-\CW13(^1+M"A+,BNL*Y^;<P%J
MM5DQ%[3!.ZQ4;D)I)-8S.JL<?48U$M/KN,""'U-ZD4,1S$I15SQ3O:A">9*7
MHAWA0S%L$YDGLP7,%&PU%2P[$66U/<G1EQX!*9"'*(LV2L7(EZ0;A_&UK4=+
M0>-*I+5SROI5)Z"K_LB:&KGN,6+Z9CXJIC+QU('KL3+T=F_QLR2CE)MKC"$=
ML5*23$;I%,;>UT6?$AJW15N]]<(O]Z:'XA'^FR73<A2J,26L@5H`'3][D1ED
MIF^OI=%R,A>X9X/QYH(!,AD@(0#D1$>-JA%I)E,8$8\$`21&AUD(PCL%<TX(
MEB$WLAI&W1%X8D*`4WBJN!XBK;,M9%I831VH1;8N*CCE,E3C$A8[E"1T832@
M,B]KT37DN;B'$EI$\<X/=LP'9;K5!!X;Y61:8B>3ZA`ZZ"QP6#&9$1D<2";#
MK+J)@R+F6R0G[!'D=X#H+':%YEIE\52!Y(08]%NUA&=RS5@N;4;A.Z;8_CMY
MG9MKI>>N)=$<=40376*SYO;**6%[IDVEEX%M&H)_D'%83=%31`4:?B$:[:%^
M;(3(M6.6`$?7ZRO&NT<@C21]$='708,XY!K81SP0C[A8]7'<Y784@?TDMH1E
MXM$Y]J1F8C9QG5W<ML@TBP9">V4`,3%7'WP^8,-#V\0[/5$C_6'""235"A<G
MYX/?$0$U#?&A/8$T5A.:>QQT2/-6"RQI6AS.")'-#'$4&2P1!"-,DUI7!6!7
M1=U#JX)G,R&B%TL<&I)'VI1'J\.TT-T>/R(P,+)3+8,>O;)%A5W<K3<<!96E
M&Z,;&&5T\C>]>-$50$A]!!9.27$AJCAO:**!_B,V,CL6?;360)O]<NL4R8>"
MB,,A%>2I(YBE(/!U%PY[:/KCS`S3N-HV&WR9Y2/AQ;]IQWX6XR)!*BR);A8L
MJZO!M:X(R1'Q)SF,)CC>Y.6F$'8R/4-6K%-7$#.4U[V5&[U1=!"H2&(NBZPU
MN5=!Q65NH]JU/8]S7J\1DY.3-Y@Q.M5H(+C+,6%VON)J0F2(-M&G*G91+(.S
M62<<=GY<;PKJFV7RVW[3?U@!UR>5BN`UV@"P/EX*M0IMU]R+2]Q:$.1B*%F)
MW="R4$H,<;=C)`^2/8=&Z</GYM!;>H_;$+I^)F@7JAJ;Q8]^4@-D.9P*+;BK
MVZ4%+?Q:/K!&E;D1_JNFW%EBNMS6?I(F^Q#<J;IX""+MP4E1;G^H]YFHMB@#
MOAJSIQ5<#6W(F#W.J-]W5S8O\<T/[A"$U99[)6DRVWF`Y:W2['FH]O`\YC^V
MUQ![M(_KO)-BQGP1(:US`IJ]0EE9H:S0-D'%D^Z30V:2&'%X0ICE%EG-\71Y
M$3^5]RH/I%2/05#?SI/GH:E\O3[TU7ZQ'GU3XO)8KR<'8SCJ5O.,G,CM4R>E
MBL<]:YL[5TDFYH@=(7?]1*ZO43CA!"W6'3!]..&Y@8?.]:!5'W:*`6.2OJJ#
M$F^,L2%:`=.2AZ+*LCT27$`*\.XDL4U<W*88,CI^UO`_*NXJZG_Y8<=9_D+L
M&X-C)K;WE,I)B42@@R+97J,J6O&\8+]YDE105)QD9UG-S2W<3BWJ939D6=OX
M"\N37K[)^:Y,&12%HD\R!+#`H=X0SC@H^'I7?W$DDD=HJV$:)!$3$6Z+@_FC
M+`*BM>>.MVA6T%]H<M8H`ULI1G$_(3]8'+[R,RDX$$E5?:Y6;,38OPP4L9R!
MS0'C!F*4$^<QH0(0#00.'"@@`4$&!PPH,(``08*#"`0:$&!@88(!#`AN1%@@
M@<>'"@I(Y.BP`40&!DX:T-A``4F.'14,.!BS8TP%$!L4<#F0H4V@084.)5K4
MZ%&D294NM9D`)L<$*H/R9%K5ZD:+'A4L@/CT_BK0CU_%CB5;UF74!`)$(AC0
M($#8A0:X-O1*4$!+@3HQ#AA98(`"@3D7%LA9UV;?N`BH0E7Y]J?(EAZ'*F#`
M`/#0`0ML#D`0`._`MF9%CR9=FFR"`T$99`Z*X++ITB(AMET8&K9AV+EU)V7`
M$\&"`KV=,JCX<B-EH`?P$M:M$ZCDW@BD)F@9=6C"G40-I"ZY\W/@Q;O%CR?_
M]0#N!@S0NUQ8GJR"EX2=.C=-T_U]_`T0I"2>?F0#N6C[S#J;`+C,-H$T>HTC
MO%ZS++V--%I`(P868`DH^':R\"`"3UK0)I%.(NJW"%-K2Z()7T--Q/7R<_%%
ML^BS2:KG:H)1*8BZ_MK)*=@6<.U&($E+J;.H4K(NN.$(,L#&$FE*0"2/1G)(
M,0#\PLB`*J.R2"ZV&BI@R0+")$P!A?B:Z:.'O/11L8,,Z"N]UQZZCB<:@Z*(
MH)PP<DN_J$@2"3@&`I@I2$(+K>H`)C?23*CP#!T*N`-XRDQ&T@!P]-)#@5L`
M@(_2RHXG`!;-JTZ"-FW`(*Z8$T!$#ED]B:L%8A4QM8,RH]7#6"$]X`"N1-RJ
MUP8.V*HF2_/BCM'L'EW00L!X,HB`%04ZH*U5.6T44VPOA4A4CA0(`-ELI_KL
MVVO+4F#5<-/5+B4+>U,O`4XI;;'/[W*#Z-B8Y'HR/=OL$RJG!A"TR4B?_H)3
M]V"$8THHT:-Z2WBC'_W+T[2M'K88P)0H*FRP!3(2%$]2[3+)/>:`6E*A!'UJ
M,3V)!)Z1NX7J51BA@2B\^.;<'I(YP9`W^OAB&GD*KERRML,9X3R7W&\_B`!@
M8%\E,>PXOR5-!@XPC%KRMS7`/CQ,6,5<<W/*EP20#KXP=V+((K[DD_-HN,EZ
M&CWUP`7:LOT\HK2LM^,.U[6H#"+L3:&/ZYDR@_.+."8I3X*)1Z%22O9?`4::
M.R(`,W\RI\I\U.]SY21BV&_2DX(,*(>#@MIB00EK.?/1)"\]W!.!PY@ZM2#W
M268V8=S/ZP3:]6^@"__M>BBG/)]]^?P6J-BF_@7PY0C6FP\0/%BNI#^M`&Z9
M)U0SX`CH-<=@)Q=(UHVBO7%7J'CE"7V!B-[(HV*3V]5K[_//K3?\$QR=H/^I
M2R5+FY9Q1).2_NG/1=19"**T!"GX>*4A$?I/D!`@/:%A;3$_4]V#6H.1!"I0
MA'PKV6%4([]TL06!(`F@51RR,['`<(1@R1%J(NB4D;SD,U6KF0&!]))(`7!P
M9ZD9"D&3NI@\I(0S9*)9A&,GU?3L8#IS"'"D(QKJ-/&'#-&24UP#$H9\IF^6
M::%XOB.2XF5'3C^9"%$@PL-N]4V+<Q2+1!((,-1)45WJR6&D]F,68-'113G)
MB8\8XI`"**1#"7H-_AM?Q+LL`@A1/$$.SZYCJ9X11H^"Y*11SB7#3;KK9H.9
M3T/*F!2);+*3.3.20:(2G)`X4B!_;(#P+N60#$F$*B$2"`?!0AF&J7*5!SLE
M('D%%-NI#F<"B-6*>*4]JT!SF.)!R^"B%ZMIO6I^TMJ:MA!UJEWQA#Y[FYY!
MT%60:<9-)]TSC5I0)\.>W`R77U1/"%%ISW26IE%/4HFDS*<?L3DO7-:9%-9@
M8L3`V%%)^,QG0R?20EX"96786A)-?J.W&%*'H0XMBXP"%<95U068W$M7A=3#
ME8.HISI$,0Y5(+)1CN;3(*AK89*`YI#!R$8L$8SI>!*7T-8!ZEL$&<GJ_O)3
M&9H%IH?;DDR'X(@A0O*SF#U-IQRA8L2?/NPO#[E@XZRRF@Q1=3=RS-B3@A,R
MB(1)6`R\8ER>1B:Z[.0AUF')>8:6D_,T9`!N`A`NT1)!G$;*BQ>M9D@D\K2!
MD--P#Q&L>^`I5LC>AT.I"15"W7BJR.JF4=R[WJK.F1>/",M-T4-4:IQEO5J&
M*7C.BQ)F>8(H@Q0R>+RR5.%2$ZOWE>^U+H$5:IR'/ALM$GK<6RM:#&(?]NWV
MLYEE;OX>^ZAX-C<V=IR07'''D,M0IS*=TPQ@)"0B!=52(QRJ264::5(1P>E!
M&JVAJ"@S(8T.:ULY^LM*!I)5F_AI54/DGMA>_M*IALA2N@,F<(&5LK2T$')H
MS))26D$8)C8II@``8)-'!J"0D01`,0'SRZ!H,@`0]V9P?E'M6S3,J;C,Y%PB
MX2*:+")AXU2H9BL+BU+`:F`<:RO'D<7+>"%DL\1&-V4PC8F!$K08RPH30Y;=
M<9/%0^2O.KG`[-P-E*7LJ.<V-,M7KLKBN/SE[TU9-%0&<YG-?&:<H%G-:V9S
MF]T\PBV_6<YS%M+!XFRQ\*K+RG3F<Y_];.`[_UG0@R;T4NH5Z$(/FLR)9G2C
M'?UH2$=:TI.F=*4M?6E,9UK3F^9TISW]:5"'6M2C)G6I37UJ5*=:U:MF=:M=
M_6I8QUK6LZ9UK6U]_FM<YUK7N^9UKWW]:V!+.4^*#7:Q2R<F9"-[JK=)VVY$
M7,R/`$#:TO[2=R8\5&-GVV+3YG:WI>E3:5-3VM\^WP"FG<@)3YM;Z=9VNQ,V
M[0_-9-PNDG!BI<VD`'!*+/`"`+D!1.WTY1O;^FFVNPV>K6D?YMY!XC>3I#U1
M-\X;0].N%Y:,?'",JROA.-FXW+RVZ/0M?"#25G+$^ZTZ@$-%Y$1!:N1>NK-A
M$SL]Y*-ICO:<<51WG",ZCS:U$_6TS4T8145*-P#><A)NIW$E/$E(NHO:\[<P
M*0'YEO;1NU7T+TF\*2F/T$L'HIB0=6;:<:F3:J<U[0"0JC=4GW9%&,26_G.S
MI83JZ38`VH/S6^M\(QVON[KMW>W7]OW>?2=JN/G-[0(0H.[G$WS]XM=X<A\>
MY/<-]T`V=>YN_YW;`I@VOHJ^*\ZO_/'2OORT;51TYQW`[WBOM;D=7W@`A,;I
MWK4XM@]_;XVHONJ(0SR_5L[NIUE<*USQ>4U<7UZ+TXC?T/F\4*B>D:&PF_)V
MAR_;-5\EP%C<G2ZA.DQ<CZ#+VT;W^D9Z[/%$<M;76N\L,WWY+YX>JF<7[009
MOXVHOICE3__O#K>[3Z2-H$"IO("1M@5)-W\C#K2C.8Z0/I>H.KPX/,T+C_9S
M/P#2N=![B@F<-J]PO?2C-;:+/:/C-MM``&E;_JYT(XG#8Q+=*SL"]+\JT;^\
M$+V'^SK1VXEY8P"]LSA_(Q[7FS::^`P&),$7]`FJ^SN!F<"G$98*%,##6Y#C
M:\`65)(:[,!6\\'G(S$F2;?N@<#R$QC=8Q)S0Q`%F,'1VS^"6#F*BY"$XS>O
MX+<=O"JJ\PP8M$&GF1\FY#J!F,`(40SKFP@\+#\.^3^5&T(J?+4B'(K[^Q(Q
MZ<$8)$1I$3T&++^@N4/RR\-*=+UD"Y,UK$$W-#2+.R@!C,0R;,1&@3>?F!80
M6[S1VZ>%NSW!8[)"%+7U8YS&V[C\HS](=,2&F\-='+E*#+U:!,20.SFP$*B8
M6(#0FT-1I,._*T61_BN]$MR5CC/`80Q$:HL4`A"`RN&\-XQ%613`H#B^&JHA
M^7/$8,G%@1M#0F3`7K1$&S&]<:PA85Q"<DM#6JP?!DR^C>!`4MP[D1/"2N1"
M"B2()^0WE_%&69O%!9S"86R4+X2]\UM'`51'_K._*-RZ_HM(<J.Z_V%`=A1$
MS6M&?R0_#5S"@=/#!F@_'+S(!)DKA*Q"<`2+/[S%6QR(AQR(?'-&)*-$_GL<
M,G3!8JDZK-"ZF*A)A#A$9DP0UUN.CC/*E!0YE"RZ4OF_K@%&8JE!BUNVE^PT
MA3P.4P0-,G3*F^PE<%3'G:P?HT2_P!`XA'`][G`])R3*;OE*@A#"270\_H!4
MB,SKQS,4N?L#RM>S.!#DMIH(O\MX&K;<RE7KRJ&,/?KB.J=,-S`TOYKA.@9<
MR2J1BN>#&9][&DQTP0#PC1X\P+';G,-#D&44S"IIRC^<P-,L@`_$0[ISS"?T
M0VJ#S?]#-,7$M&0LBO'C-@)8PD91O$H\%5W4ND@</Y?BMO/YS7-+'V`L06Z<
MC,9C)H@4BMXL/^D)/1N)SGE+I&]*#M$#CLT[IMWT-3>!,-T4#V23(CX*$ZF`
M*2A!ML<"N@4)P-<SBH\PI9V)E*R*/ZC@D/4\3P*-&_R\#(;X2='0/3D4B3\L
M4`BMJJH+D^<;4*(H.A&TT`C=T-F)BO\K*@UE."EDZT8.+5$3/5$435$\4U$6
IG;.;:U$8C5$9G5$:K5$;O5$<S5$=W5$>[5$?_5$@#5(A'5(7"0@``#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>f39432xe3943236.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943236.gif
M1TE&.#EAT`*P`_<```````@("!`0$!@8&"$A(2DI*3$Q,3DY.4)"0DI*2E)2
M4EI:6F-C8VMK:W-S<WM[>X2$A(R,C)24E)R<G*6EI:VMK;6UM;V]O<;&QL[.
MSM;6UM[>WN?GY^_O[_?W]_______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````T`*P`P`(_@`_"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQHT,,"BA@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LB5"#QY<RIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*M:O7
MKV##BAU+MJS9LVC3JEW+MJW;MW#CRIU+MZ[=NWCSZMW+MZ_?OX`#"QY,N+#A
MPX@3*U[,N+'CQY`C2YY,N;+ERY@S:][,N;/GSZ!##]4@NG3:#AQ,JU[-.JV'
M"1<ZM(:H(,+LV[AE<@#`6W9NA1@&"(SYN[AQD`UX-SA^\`*``:F92Y^>,$.&
M@Q!X!Z!.,`(``=S#_G,G;G`W[PWB/R``D+Y]>]X`;(O/`&""^\T;R"/L4.&^
M0@&\'=#2`XXYYYM_I7F`'H+8\09>>PD`<""#%+8&7W3B=8"`!14RMR!U`,;7
MG@;L=6A<!QB$%R$`!KAW`04<FM@2!]?)2%<'\-VWWH<VHN0!ACW&-<!Y]RU0
M8I!(8C8D`!3<-V2-248I60;9`;"<>PX`0`!I4G8)68[W/0!`C`)E<(&7:!YF
M)`!`IF<``!YDH`!\!:1IIV!9CHE@`=`!4`"`"7!YYZ!%>:!`BSAM$.">`;S9
M*`/?$2KI4!+TAE.EO.D7G@4!@,=;`7G6%Z6FDQ*%(Y,U52#`DKQ!R1T$_@$\
M)UL'37[`FWQ("EKJ47,F0%-V$'R``7P7B5?`=@=ML$"*/-I(ZJY"T7=D2Y5B
M6("#Z7D``($(;0M`?]"&>Q-O,@T+KD!5`N`JB-,6=`!O!(@K+TW7GKN2E051
M`!^NW%D`0(H'<;#FL_,67%)V$K1$XH0"A5BL>!$@:U`%`"!@\,4J^2NQ2@I8
M;-"UD>+6;+<;#^3O`+&V&=&Z&+=<4*8FK2M`L!_#!W!KKS6D[[D7%+`F``G8
M.Y'*+A=]+9D.03!R0K%R*Q`!-Q/T)F\TIU<`N!&&BC1#!!?M=4%9^OK0;E43
M5$"M!,4JW$`%+/TN;PGWU/5=%3RPG78`;"#`_ID0+?WUWP)-\%Q$`S!P4``>
M$Y2E@!]PX)SAY1$`0-P\Z7J7!P>@YX`$<TI``,@)\`WXZ!I)&Y'@!\UY.-#)
MP;?UW,41=VH!Z8I*^NT:'1W1OP8-._+/\.E)H02L`DC``BSCKOQ#E3KMD`'Q
M&A2``P9)^YP#"*#MGP>L,A#``,DO+WY#PT;_4'+8(?HRN15F?^R0;VH__OP/
M#0E[0;N-3.)!2U;XIK^2XTW4Z$=`ALSI(K1RR+8.`@#+?0!2MG./!AHP-0,,
M*0'R*Z`&$T(Q\`RI;`E)P(.$A8`4&>!*!-&6G^X#P0C%"@"BVZ`,%<*^`"B@
M(103R)R.Y@")<>``_J0!4WI"-(`E!2!\,TRB0*YU)@:(;2':(DT`@I4`ZDGH
M`\ZYP(HL-1"B664"!`C`_99"(@)T0``"H.`3E<C&@ES+8O11(/4*4"<&&*Z!
M'RCB!P1'+((@<2K.$>!4#!7&X+&HC8@\"*8^H"TH,4QQ=1*<Y#@D..L9LDXF
MH8#?:#(U-D7%DL%S7B)'*:W4P/`#F.*=0?PUD#F=J76&#-Y(.J`!#(#LD34Y
M%0`>QA0-!6]8"<C`)D?)QB'9)P&^`@`#=F,?!M9H/;&,YBD[@H$-/`""P;OA
M3O0%LZ5X`&3P\17WB$E.@D"J3L.RU7(PB)!W=5*:L63<1L`IS9Y`D)='_AE6
M\,PH$`Y\#Y?EG!]`_<4>'&'``R$B"*TJL(`0P?.A'`$E`!S`@51ZD28JG*91
M-@!++<7P`Y(;8T!)=U'>G"D`,?+.`SJP@50^5)IG>MM%#1*!`0XD5@%X``8P
M-#7*Z22`[0I*!L0$'P)L;2#R'&DBKT4]!=1JBR^-9@,\H($#4.D#TLK@0;S#
M&VT6!%('H=@A=Y+171+%I<)#2``D(%*97.!,'.#`!C:0`0Q88*9*_4V6MM.`
MZ455FO89`+<((#F*\F:-"'%IX@BB@&861)<Z\4"HA/@3";QP40M9SV)Y0D]#
M'C6OQ]'G!XCZ5]=9!`%GVD#TZH-062Z$1/#9_JQ`&.#3+L)':#-15#0=VQ.@
M*@>'O,%K33Q0`6@>%K3IB54&.OK0">R&2R"+"7N<TS`"A.@!''B``QC@P`_,
MB;(#&4!M;WK<FN@M>`RX0`#-EY,,.*"OP7-`6]\T3)V<*@#I12YW*L4`/L82
MC0:HYH(*<!T,!(`#"A!.?'0[.*X:$H0"87`$!Z*NQ/)&?3)Q,&\@IYX+FP2@
M%C;D`'CK$`1X%2@=N&<"QJO?XN!(`+J$3\D8>\-*89$]!Q!G`[BE3T-2SR`Q
MWBQU$P+>E52`5163V:U&$D@.+T2L\`$B11#@`,3JA`,4_&6+PQ.K#U3)`6?$
MY$'VMQL$=%E?#+SP_EROA1`D%V0`6AU(`/\XR[?Q9@%$XV90.2*X"60)MP7!
M@'$!$`";0H2//F%N\`"]Y=S8#U@"P2P#2<,!8WZ`1+HZ`#BKE@!1"@1X!%E/
M9JFVD@U`=4LT[&H'(@`Z3T.$/G'+4D(Z`-4)8R1"PG5)E2NP@;AVP`,4*&&C
MI9,="M`'K@,85E()LD"#&`!#`U#`%N6Y&]Q:$CWG90@$UR:1#!C``%9."/`F
MQY".IK$"$W`810RP6`!`^(&&'"%'(L"!M@[[:X>,E`6"-:QG'8#;>Q2`!`[`
MK0`4*U0$V<UXP;F`Y"C@?E"F")1!/!`H+[DA@1S`1S_`*3SV394"05_"_F/)
M8HS0"N3VK36_;K+R>^-%<K9J8""#>Q#!^<9?TA(.?<@#GPEI*P":%`ALM:.`
M[G:+-XQ>B$458@'?5O@A%T#A5O>LD/VE$`!>K9U90S(DH],D0@C(@`8V0`$C
MR;LF$FBYRY-B[X\\Z5KVJ?("WOT!'-4(7Q\(0``4Q2]HRN^;AK1SG)EVYZ'!
M9_"#WCI(L@,1""Q;6(1./`1R/1%ME7PFL&58E@:_DK:O_2=B=XF8+D!0AQ1@
M.6@6B%@Q_($\R78X%Y``:5KG:H6T[NP/>>&)!Z)GWKR>(ZUEV08NL("&3P!@
M#OAQ06H=;I"D<R<T5YRM/S\;^B23Z@:Q<5H__O`NR_6X(;H%>$.L1_F"$/3L
M&7#H]#M25:0'6IHM:H#4;>MAE"@*GS9Q3@`:``'MNI#BU&<:`!)S&Q<PG](0
ML"5^1&92N\,;)/80%R(0P1$\O\=GP44`)-9E!>%MO]4<:[420\(3P](ISP%N
MY1>`G_$N%B`FE^=&<.(00[)["3$U8E9BDA81`00JWW5G7J<1'?`_0/58'E<0
M&Q"".`$`CX>"@,-5^I*$!W$`N*<0;<5-K,<0,T<1X\8;XC42'.`='M,!"K`!
M&,`P$E"%_71%.,%>D84`#]"#2J@:NA5S#@%6(@%9$#%T%-%C1$<2UE.`!K%^
M'U`!)V@27(03(#,`_@YE:&^H&ID"*8KX?H-8/T3"2``8:;S!>:FV82:14>93
M5F"#?3I1*4G7$N_2`!@B5J"A((N8$.NQ`(*C=@P$BQL!05<25PWQ-FKX$-]E
MAB'18XZ547]8>SMQ>CFA@:$&BJOX$W[H%8(3`(+#BP8!*6%T-94($0<($>:!
MC`E!4#,V$K`T(4/R48KB>2T11T?H2<RFC<FX$Q,@BUVA0E7R$.X5`>F"B0VA
M(/"A4_5%$&\SBM4!'_O8$?#A9#&'`!.B>#\Q+-#($E6R``K0``X`('2WCCZQ
M?6,Q)`]@))&(57A'$1S@=/E(9P*!``3@``%Y$"!CCQKQ+@+020G7`/93_B8@
MXXXX(0"?-1,.8``@$P!G4HT4B1$<<"`7$(9]$2$'X"\/Z!!1V!!\HGY1AD5O
M(HP9(%D^DQ&MTWP;X0%^=R8ADB(:`$VHYDN']Q,>P`!#HI(^LA<>X),4,BP_
MADT3.1>BI243P0!QB1"]%TUB1A\8(@$[A@$2I7P1\3,A00&2(W!=I&<%0``;
MT`%K@TT71U;TIB7>HTSD&!)^9I<#(2:/B!94A29#DB+OX@!$U1<`<BIN6!%/
MMQ`;H`$54&L.F!K92!#Z\EZ&M!Y#,@`@XY'PD9J[<P&GV`#!P2K%D@"=A7\Z
MD1PTDQW@8Q-:=P`XY9L_.1'7\FON)A!&N!?K_F%+0$,X,@@V"[`B&#A9H@1-
M`M!I#P"2+,([OD(`0S814T.0&3$!1W8@8E4!>8D`=@8O)SD3`X`KES@N):*%
M$'"9T]D02&>,QJ@7CU-Z#_$`"B@0_)$<"#`!M3D0_E5;:!5-W.(`!W`!*4(!
M#$``"*"*$?%=$1H17PD?KL0J!4`:&#!9AK2,.B%"2%4Q&_D1YF&)!VH2L+0V
M1C)_>9%OZC@0"1`C%O$=#S`UZQ$]0(>A?31RTC1Y&-(Z!2`!T'0`,!<1#J81
M1A),&_!L#;!O!1!@ZV-(:(D3!B`HK=6?(E%6O$%1!"",/9H1&L``=*H7`,)-
M(CD<^,4`3ODM%)8:_A$2$Q$R`!N">^I70FH'07R4'1V`(@%`DT0('S2:$((6
M?0S!G<'3@CWQ@P5P0QNP@BG*$ED(-W4:,Q&0``:*%ED"D72I$+^6>(:$8:CF
M78B8`#?T`/[R2!K@:Q.#50S@7@K``;SV`040'>E&.(4G$5GB4\9::!/FF/^5
M%*UC9TLY(V,7E+]F`6R9JA$A`2!3@WHQ+%?*/BD4J1<0J-IQ61ZG*!_R.+7Z
M$)(#0>!A`(XE`"5*$:VSD`?Q`,&"CBNJ3##$)!L`F;'4F3^1CQ>P`8O9JN!*
M%!,P`9#YK6]Q*OKD&VN9E[=9`,0!0;%"1\&5`9)S6=]SEJR91@)P+0KP_@`%
M`*B?(Z&3^`'(F1!7Z!!#=TUY`Q\"8!L%8`$2%CQ-`C(W!+$9D*,4L5WD42FY
M&+%2@60D^X)78:(G05]&XE3OE$T*8)-I-@$/P(85$RMK`@$+\+%35!X<<'QA
M4U1=1%I1RI$?AZX*<0%#<A'[TT#UBE0<LH/P,A`9I;!#\6).>Q46P`#0&3P6
M>Q14:Q+>,:S2]++(DQ`Q(0`,$`'QD@!6>@#XIR@.T$QQ<JH&H!\:X!T&T(:`
M"2050*X,`3)_-'/GPB'/H@`24#M;>(P5\Q3.`;B#VQ06T$E""A5NNA&[L:L3
M)8%RFQ`#<`"HD6Y:*``<\*NA1@"P>F'1)`#)_C,L#7``.HD0"."/!K$F="H!
M\D,@V%40&N``G<5BUJ.[0N$`I;J[4?%K6TH5$!L1IS(<!#&`'-28`+(D$#`!
MRZ4?WO9`KN@<`O`NDJ-3R;,!E^4`A20`GM97$D%0>X8B%.`!E&,!`+*JAD.E
MZ_I@(':S3$$BWPF_3#$!0BHF@"$Y#A2:8`,!,AH@!H!+WC%_&`0U.V40YYN/
M'2`X,/PML2JA((-N`@!F"L0;2(,I0T(Q&Y`N-,,>`J"'RE&)-?P4^FG"4:%;
MZX*^@'$M$#9)HX5&L41EC;D0Y&:^T^,;HUJX+Y1L'P(>!&"76IA"#+`@%V"X
ME-L0*Q(C%Q`K$1`3_CU3*1!@`,X[$!+U'-(Y%6,U7*B1'UAL>+SS(P+A'8`A
M.(@5`9!R`.N1)^*E`8G\`0WP>I)C&]*B=P[@0!%I*]8E)GDJ$+'BAFLB`!4`
M*;M'`$<V,F[K>V,1(<$;40]UDX\\:^SS)B$GM5_A9Y^\$/<K5Q3PLKMT`)K&
M``W0I]VR+K`E;>QQ4=I"250SK'T:(9UI231"$!A@&^R!CJBTG[M4OTQ1N]3"
M`,GG?B^2S&&A-%UR*A+`1RL6,E]Q>_O1=KIT+7V%`9!B&_6[F@.1R6*K$"HL
M@0H`J!!!,3T8(CYE8`)$91`@B(H6=F>1?#5!S':1N/?120-@77[2RE4!_F7/
M`A,1X0$1(JX:\,`HEQ$(+1!5UK]#4G*".A`>R@#>2Q`:,#=$=4,)P`$T2#V5
M)A"U5G1I,;,N823!#!+LK!39^-,(.B3N!+(PUA$(@'O6XRO9L=5^U"X>@%]8
MB1`5\(@4_`%%2-"ZXBMY2:E?$<4BK1$2,+M#'9X,,-5.:T=`[80GP=<0P0!T
MY%`HW1"+DR,$(`%&DJ8+82`&0515`RD^)2(%P=CORS\E7'<VLQM/B&0>RQ8)
MP$\K(<6&A+3PFXUCH@'?)1-GC!(04$BQU+0481M&;44T>YT<02*NHG"#0\Y;
MIR^/]#;L.UOR21!+0B#V8MHSK19O(MA1?2_L_B%AW"43.942?(LW\,'.<51"
M!)(`".`=C-D1#%"BX6EF68(``R"8=7>:FC9UU(R_"[$F'D,]&5!KQ;W+J"*Y
M(R$!=1W=D?8@[W*7)P&1*7%M;.-^&U$ISC@FL?3??WB)8P@\$/9E",%1R1P;
M"8%P'Q`!"Q!`*P(N$*X5V:'-^>T08M5,WR77`&Z)%7!&5J(!#^"I)($Z*L$R
M^L3>$A$39F>NW_$N`7#6E:?#NUD>W5D116XR+5C30&VIEE@?A!83/UB\;[%C
M.T[3$10G^MOB#/%0],P1J3<3UL,1G1H??XP2+W(H*V00`60`S>+25.-<V)2M
MR,@JOJ4WL@%!+GOB_EYA)&W7RP.!(U8F:EQ./E\^$CE$$]E8W(RF','!YQ(A
M,&U.F.97(A&"I#>U(@*`4E5",/ZJ:.RU'G&CKV^Q'E8-?&L^$+H%W;O;`0WP
M<"XQ+*C-$5.3E'Z[EDO2M(:I$I628XX%'ZQ'`+C20;YQ*A8P)^1ACA,12`90
MAC2C`2N&+(+SHF_A'9<*$H$T,Q400*=>Z&Q=`14T$^B<8;J<?1/06?Q,FT6Z
M$8IB.49MZ@1!,0RSG1]@F)7"9F83;A9PJ>8AF-B4/0$:%QJ`?^6<`/Z*$6#D
M(*KK<JP.10X0`4C6\/0*Z1^A0MRFKNR*.$QN*YL-$@U7$!X`\=U)'%1>_A#9
M89+QXBB\]-LC1ZEO<R8$%7>H.A<4H)L.8`$4`&4VYNW)<O`@H7[90=L1/<,4
MT5@VX3KG%4T/O0"R,0!F:)8IP0#?R>!<XMD(T;O(0@`UO]-R>'5RS4>$7+QG
M@I!R`:'!XUP#X?,0X0$-P`#%AP$)X'B$3/%8O&J#]M-S(P!"OQ!67A,O94</
M:-D$0;<7<-@9\2X'L46R@0#''>\$X$]&$C6*XE@[BG&N1<RS_A7D01KZP2G.
M!T\#T.U<+J+P,0``B+U>I$P/0546D"6/7Q.PN0!V=%'ZTBPX(ALFZ$>.W>4.
M--K@K"T@%J/?I<&"1&%K@R,$(%*6%"&-SQ<]_E,240;HA:X!&0!&>,5@SY(<
MMEX0&A:!,Z%+"#!5#I$E((28M@0!W2]D"_"R$N%GU1,`UV(=0551T+3>&%`K
M:Y*_MD$Q:C];,@80#C1\(%C0X$&$"14N9-C0X4.($1-NV"#18@,`&2QNY-C1
MXT>0(46.)%G2Y,F$#P"L5`C`PL(.*E?.G'D`I<4`*U]*S+!R0(8-&@`D.'C!
MPX<#*XE2*+#R0`(`$BRJ3$@3``:"'2XH2`I`08.=!CNLY%`P08">#R1RH*G@
MYENX)X^B=##3@@<.&BK&Y=O7[U^^&3H`)EQ2P<H+"1DX*.BA@H7#5@$(2'`@
M;&&$`U9"X%BAZ\H&_@N]3I!08/''"P`2"I`P<P+&E90I,'R``,#<#P\X<S0P
M,P!FX(0=$#C94_),C<&5+V<.5P/NYM$5"CA0`'K!`0TP1#@^<[=T@A!B>[R>
M<&R!!0>2%WR]4?4'#P,Q5%@9@,+,!UC-.Z[`@*9-@C"22J'R"MJ`ILO`4]"B
MU`8SR0,+'*B@@PX\Z("!!1)<<$,.._2PN:X82"@UR0H8(``$$/!PIIOPL@T"
M`0"HX""A9I,(``>XRPD`"C:`BB$+(,C`@*9F,@`!`@`HP*`#(-!@O:(F4$BS
ME6;\\$J$$+`22RZ[]/++#XT#(`*$H(H--@D6P-&`%5>R420.*(J,IKT._C*`
M3(ERO$!*#/3+"4^"+N#@R")7LHW%#R`P@+B"%J"2T8-:4\@!!,0K$,SH+CA0
M2I1*DV""""!XP($'RKH44U13514\`@B`X,T.,`#@`0M6$A&`)!EH#=`-(^,T
M)%F/R\F"">HDR-6//'@O1@`,X$`\`%#,B8`!)ICL`S4I&*RU!@"URD&#E-W2
M(`78O&I5Z9353(.O3HI@1\D&\O)4=.NUE[!:%RB6`#5QG'4F`@(H8#`H.1P+
M`!5%\F^FKQQ(H``!Q$OPOH)Q:C8!!A@XL0(*'E[``ZA"N^N#`1;XX#TSYY*@
MHI7T.^A:A!X0X&1>[V4.`P(2<`LEZ``8P$MC_FT6>FB^[CLN.X'`)4B`7SOT
M:20Q0ROH/*D/"J!FB));H`#;+JB@`0,.L"V"T*X3[P.AP@-`WH)J71LAH313
M^@.VV%J2Z.8\R("`N4^*]N:(Z,6;N:#K[9NC`P$0,21F-Z,()@`*7W"FPSFR
MRR`QORM(`+8APL"_A1'&J"N(`]"\(%EG&XL@!2J=.R>U#F*`S23?7#J"'P=O
M[H'*1ZKKY^6,TGU5P3$M2Z1@`P@-@P<&M$B#`#QHFJ'>CN_03*P[.G1<!03@
MRGKL8F_H\Z]\HBG)*AWR"KNRW.8U<>#;YI$@:P$X@($)Q"/`-I>'#PZ!BG$D
M=%910._\=T`$+D=9_E:965P80)0/'>QN(9&)\^#S`2TEAB`8Z!=C%'*!!FB@
M2,Q*P`5"1IS6G(LA"8`@01B0L%KQ2EV_,<B8#H(!VP1@`!"8@%!VED#,2,"`
M$.'``9ZB@`4PH`&G`V(3G0@8#W#'*B:+RP`DUQ$'`.@D5"K>0X(%J6/1Y`&:
MX>'<7G*B:"G%*S&2EP`R1!P`<*!^'D1(K6ZXK*$<!#9U4A-$!A"_)_IE`"T\
M28P">4A$GF1AA/0+=\!''@5TD2/]>F1'@O6>1JU$>LTR%H4T8`"!Q6@`0HE*
M!BAP&`T>)B\3P("\C+8`\,GJ=,HB")4TM[!4R@@BMI%D(C>R@0HT10/B_MLB
M)GUY3&1&Q'Y#?,OLKD0?`%`Q)#/I'%L&P)@<$60N`JB+`%Z$H(&Q924#$0HH
M_V40"N0$`<?+8V:TB0`#`+(".B1`!6QCNX:DQH+)](C#`#"!&(T+)4WI)3_K
MQ4&#=HD!&MI0XB8(DB(Q$@&QZ\#/.+##:#$-?6M;(MO\\P$!+$DF2K+A02H*
M@`901R'H41L83T8GBS0KH1QA'L-0PH%/Q4D#&JA5`V=ZP$K^="$,:`IEB$2`
MJKWE/LQL#K,*NA"9N+19T83`!1!0+<D<P`!,E)5&"L`9^A`49$'M0&^B4LF>
M$,0V@%26B@+H$,T(52)JNJ)(ZG<<E\I5KT\T_JM9=:A)OF"$J<N)C$`[(B;N
M'8=9K])@2ZIF);;0,(G3R0")F(A)!`0`C`)@4T>@TMB]+L0#HX4+!S9:GP#\
M,+2K32!+/F``*B;EJ1SIB6$7-,>1%&EQ!$F<QA[P@`(T!;0KU>+)!D(BM4@J
M2PG[P!QQ@U*"M.:A=?$(6Y+*6H0L%;O;Y:Y#Q'DL`0PF2;/="'?PR:&GB81$
M+NW``A;0DU89H'6V+4AKE!;/YJ[$+1M`0.?R>Y`-."`G#D@,?8XRGAIVEB,$
M\&EW"^(S!T=8PO#I#EGXTI2Z@@=1(1$30KA#@*9D`"OULRU;B/F!#'"*.P^6
M)D%FI1`,Q(@S[Y%)_M-ZXY&F,'2[Y-U(!Q#`XPD'>4,BULL&.%`ATO*32N>E
M[88+8E8E3F"W,CG=`!X:W=M\@`$!`%!F#9*`!B?DDNPTY@<JD->(B$>U$3X`
M(%%R&"''F6A`WD@&).!?#BULMR"9"3[I<QAH14HI9?DH0I25F,C,9@(T-',<
M&1(!#'@@,5(;Y\OV>2-&<]<#%1'*]$Z"$3F'.E7UDP`$<B(`)I_D/DS<D-NN
M[)%#,;<@&DB2!J!RZ2`=($DZ%H`&V_R;U&0E(PP9R_$*P`&L=(4"/AR61W(2
MYP$,MB/*%76UN<2=SP@@1K)^RP30C-Z59&\CXLPT01(P3S+9L26;20A+_C]P
M-1IF0"VX<HAMMDP3-)[Z`CG!<T0.--SNUN7$)J&*M0WN(;8T$&8FZ@L&#$#G
MN,0)Q7.*%@(BP(!1'2#5#&&60*%)0Q4>!`$FNT",KGNR&2U,V`R?B`:TG5&?
M(:`N#%8-9>[6DWX_1%E[=G"M^G>2LR5P`Q`_.+H.!$%ZYR;+?!GV0N@+%YP%
M`%X5MLH`###PA41FX`O#2LCEA\YP6^]J+L81VF8R`-46,8W^$=@?!^FS6C&@
M+%'YP+XWKCX%1W@#$0@J259<=,"#1YP&,%,!S/KTDMSG5(KS2V8;1W7(HZ@!
M258(M(H;*$8C0$/_C)G)CS(`_=Q'@P7`2D4P_A(`_T"`.Q6034TRPACN/`!]
MB?9(`KZ]735YFD$+:0W1`_][D53']I]:P-5AV1</..!P]7MU28()^1CMKUD.
M&`Z(CT1U#05E`Y_)3$ZDQ,*#&!+&28K1DCI@^SU/8-7^FL!A;,>!!#P+.M-J
M`&P`P&J(J$G:/SW0Y$%R*FOQ/>`;P%3)@`+YI`$(,Y'P``@P$P:*$;6H$)W#
M@`T@$:LH``V(DPTP&JLHC_'HB3HY``$0'`^@@*V1BKHX%V9Q(^^0"%FAB@)`
MGQ9["&#2,R'+`#<S">TB0![$#)#1O;BH%?P#NC3JCL6!N`N@$JIKG.M:()19
M'/$PH"+1"`5@E%II_IZ5""[7V(BDP`B:R[!PR0`'Z*N/D;.20@GZ`,,>7$.2
M,!')^+FW6`"!60@(H*./Z("I\PFF&2T!-`C6.XX(.*Z5<"D/@!C5N``(V!G.
M@QP.>`EF40L%N(_(&`!JT:6-,!J`:XA^L1_>$359L4.34#<V',6;2))*H0`+
MD(#1\8OZ6PBC40LZ<QM<60DU'`FUHXDW,2N`ZXW04("?V1^&*,%F28H"4``,
MR`#_J`M%L;(9R;F'Z("W$BV$`3R,J$6."#92S$:3@)D:*C?GT+&>F("K`PEQ
MRL2&V\0`H*)^,2QF(8@=&8CK&+H*,`"WR0`%:)T/:(I#`0`*"0[Z:*()_D`\
ME#@`<0N))-1&A!R)E;`@H_D+3=FI"["`"OB5&7/&B$@`;BN,2^(DW3H(MD``
MGXH`"W@`#6``F]BIUHB1!0BIWDB2(BF7!1A"P'`4_QDM#:"2>QF2A,22(Y.K
M%"H9C%P)K).+SZ")Y2F+II`("40(.62.LCJ.O".(!X"2'TH*)?2)`,`*\FL=
MF0R.5KD7#8C(#;@KR5@`!2BA?DP(TI*X/HE(##"*"[B`#`C+"8A(CB$-"=`,
M.!0M^."`OANM"G&`YMM)PHR(?8P6@:2@`0"9V)``"8B_`:``D*P/(W(0\<@)
MVVJG@["6Z(`FJP`X:LN938R)>$J`O?P0`?!&_L*(@&B,B(V,O#R$/-F<S21I
ME01\O-GL#M4L3-ZTB`!["VA)DIP`GX.AL'E3DL-D,O_HF[%H3<!X2IJPH&%*
MGX]+D@0`0B^QC0KH0Q]LI46C.ALI0030F21J@-^*@%&A@,>X``I`Q:"(@`A`
MQ0ZP@`LXQB*CD*,0``;`(:FC1,,3&R1:@`8@%=63@/9<SPK(@`HX1@RP@/DX
MS=Z,4(=(RIN@CYR0`+Y#B'_+2P>4C.Q1"32S.O`HRJL1E<C8-P7`08>#)R7)
M04S91#0ZN7DIB*]Y`.[@.;[0&^Z4T$/:4599.I08"DI$B&!Q0`:0HID@"@=0
MP-SPQ1SL(_`8*<G@_H"V\AE*9!8#N#LPN8\=\M%`NC\@ZCL>!0ESK)?Q>@L2
M\<;4`TDN2Q2=L!!M>IN#(("RD$,HZ0DQ!8Z\I,0-T(BMT(!W2:.MB@"O$9K[
M2$SLJHL9')[]&U,@FH`3B<U&M8AX*K,/.!#Q`*Z*8RBZ\T/,T@D+")).!0\,
MN,>H0"F$`1F3&QSQ0%36L@#_6%1'G=7$\YFP00`%V!%&,HG(8E*:<(`,Z#6%
M:(`KLQ^#X`"*$P`(Q8S#:(`_\1=>2I3=-!P`*-/MFLB9\`]KI%5N)<=)W8B%
MB<H/F).*J)6@"KIC<=$.D14"P`"K6P`)<!@/\"DOC8ZGN"`)\P!S>H#4_AC,
M;OW7+Q$G#9%%M:B5-2,(MI`7J0.3""B`#4B2#`@5HG`6%[-659D?(5,*NHF*
M":A7@/U8OK@J)BV2WW`XT4@`"\B);4V7R2B``UB`@)F)A%F`C*R7?X2V^-D>
MD-U9+\F)`0`X64Q")2F0A:E9+'&;!;!0E$J1VV@-"HA,0YU6[DH;A'4MGKW:
M#VF`),&Z2)T,6IR(!EA9!2DG34J`,9**`:@5,7'.+SFE8[6`(N$;[*(`+0(;
MSL):O.T0-;F,79&`JVJ6^[!(59&B`,#(JQL3!CNSIAB`/&58`BA!!S2`"U"3
M@[V2HX@`CY7&&>F`?_S6O/U<N,B))3$O@*%%_LQE`+9%E0.H0I)Z*<D@`!U+
M%5*:C`90F@`05YY4$E<M":O`+]`%V`YHW.#!$0S@,LI)6G:B4[R)C!VQ%BE3
M$L,;G*7,#'_U$`M`*LPHU>\(FX+\7;R%@&4]"?39D;,L'/H0WE3QF0YM&43B
M#K%M#@ZPV+_X6N^MWT\$#*Y@H09HW($AF@G0JJ%8(F2Z#^P,K=RI7^]-#5"4
MCG))73#!PXF2541Z,0F3*03^W?O=D+6)77OA1WZBEGP=B\R]X!X4BNX%CKEH
MI>$A*GYJ#0?^*5D981+FP5%5$"?#&PH^IM8H8+T*%L^=X=YD/.G@7-@X-O])
MC?!-(*&X/.PZ$'4%_F*`W93FV``+<$#YM1G_$-S@.#)"%<<?AHC4K.#MA&*\
M79_E,))E>R+Q\#^U!([#D`#\.8SF@0O_0-^?N@HM)N,Q'8L%+HRF0R0*<,D&
M38SXT-*;R)"T!;!H.HA-&XG[N#366F0]YMFQ8.+"B"1DVIOC*(Q26R$Y?1`+
M-@G+$`M#!A,1.^%)'M-!+&4>9`L#Z-C"Z$ILL52%I&6YX&!4(2493F6#PP#;
MJPG'Q&64>))DLA99]@@*P("`3`@'M@V44(DK_JGAY&6>I>(&4,*7A>2;\$LJ
M]26,&$HRU8ZAF!4Y`I<&V-6ALF.)H`\972V5I68LR6-$F@!Z5D(!W64!_D%8
M?4X@:TGB\?&SE0!%$GD)95%GALA`CTBZ[G(CHX5G1,*`+UZ.#$BI+#P`!\C<
MT+F:]/(?H8AFAA!#W*@5;?Z`6IF0ADX(#4#%WTH`<#'6BV!IJ^4N279H[]T`
M!2@4^WG?B%B/"8`*5EX5_?2(![`)5K(`J6&+/C:(U$``'%6,J;(*EX%2B.#`
M"'`_!W,`!0!GFL[;"*C4E1`,G5:F%TZ58NNG&>.1A!$`K2Z(U)!@I@@NU#M,
MD'RHHX.(NI`*%I[&A<[AK29AK>C0QU`U(=:=^UAG@S`1/(D3U1"PB+BF=6.6
MT`$]:!$?MD!EI9.7M`FN60OK)\+4OIYD!_V,_J_@X8@X5/]Y``G.K@L@``>`
MI04B"E7<`,X@@)]^G-40@(WZ``QX$Y60M0#@E,^I`#Q+PQHJM6K-BHAN(B7Z
M;%[VRTTD@#L)"34Q:$S)4HA@`):9D=:(R<G8+>$)B:3HK[<Z-\SY*ZMHFM02
M.0'0C,4,N':&Y^3^6(?#-X_6(^C2':]#B#C!#5GZ@`2`@*/HG`UX;XN`1H8P
M3S#E+6I"6&A)#D<SB,0)-\S8P!1%E;AB;KK992[Q`'\&RW..$7I:68P@<*.C
M9;R(@$-Y*+W8B`0]B0AO#,HY")4(BN93PA_Z[H+H9L&>:2^!'EO&\$32\`6A
M`.`:7P?`4'I)P:D3_I)[H25T@I:F6!AA+@@8R8K$Z!?2W@CT,0A2`C@IFD$&
MI(G?,(!MTP`/VK8+,`!YGNJ5R'(.P60@CW,-D++&68`20@B=V`!E?@Q`+8#K
M[."YA``UB9$$.)%"N;2A-H^9@18(ZHVQ?H@=D9VR0XC:TB9'Z8X9&;H-B!&@
MJ``C(Y7ZUL0V1Y76WMTXY^4*M+\CD1=^68AB[)A5\0_.H@DDF8E=08B#"8!^
MDXD/.)B9,'4P=@F#,,7I,`W<O,#&B!5/#]Z@@+\U=XA^&>FLQ=A3KW:#&".G
M6(G!*(^$C:*?WA!9*0`.[`I^"]Z$*&P,.!T*05(E<="WL`TP0A0*L8"B_CR:
MKJXP@)*,*0_V,P23!'AT:P>\^+Z)RZP/'`$?8LWQ4(_2(NG7=O)@TQHX!;B`
M3L8+#BB4`O`:@-\(!:@+MEE0'C$KJB-(3O%U8!6QB"V]HZ@([DQ!R\X?F<D8
M^8HT*M4`B":,#C`RO!`QNQ0,O\Q`G@_5B:R`"#"R)]&`^03V@$\FZ@8,V)7*
MZQO$)_GDNDN5`_&>*LSX0,$DO5;+#G4`^@0,&1$`@NX`"8A-R>"F\Z(2.*P0
M;GZ2MY1("B"-4'F`^C/&AIB+J-J@!JV4[80*G-9-,2=(B]<+B`G5N<=047&`
M!F"`>S1<(H&GIB``*/&`:[[*W%R)L+&*F(6P_J7/6PG(Q$9L'&Z"972!EC+#
M6`AXM0T('92U@(&W"`KD``ZDN@'`W%-10K3/?)HX*FIY.9H(?-X??N*7S1@!
M?GB1.N\8`%P=DZ$0&)50D]-;"71<1*&*_<]_"Z@P?860.M(/`";EDMGE:YQ+
M%)-A@`MP`"5$_PZ'"^&W"HPSLH<H?OJO_[2OS2*T?_T/-S&*%JD#"`,`"`!`
MD`!``0`*`QAHH+"``00*+WRH:/$BQHP:-W+LZ/$CR)`5.8@L:?(DRI0J5[)L
MZ?)E20\``B@$0#$C!@`6-3BH*:```IA"/RK4L"#H10\>/E!`0%-A1`E#62:L
M:17A`9,<!%SMZO6K_M<``@9PK;H0@8"T`PA`/(!`@8(##1P\($!`PM(/>?52
M*##`K<298`<3[EHAP8<&`B(`2/#4+`*!"B<H?)"T(@8#`C1,[>Q9I87/HD>3
M+FWZ]$7.&B0L`-#@0P>+&P!LT*B!JU4*L&4C11UR@H$/`C!<1'!APVJK>WU[
M/-AU0(&4&"9(F$#!0H,%#1H\@%#WP8,)=`O0I-"!0X0)%49>\)#A,O,.U2M4
MN'`A`X,&$")$D&#!0GWW9;"!!1#<1X$&&G"PP08+QK91!DMUT$%>&Q!7$0`7
M8@3!``.\QQR(0I$4(HDEFGAB2Q%8=I%D!RS%`0#+710!<1$L8!8!%>2D_I``
M,IYXP5,`,/`!!X'5M``&#_A8&@$?76!5`1CHAB*557)D`6(:2<"5AE9Z^268
M88J)V@1=5K0:36OIM%$!'U9T00042'95`C>A^*1"$`"@`4(TF?AAAAMQP($#
M'5@%P0<29#4FH[Y15EM&"AVP0*.56GII20]BZEN.'%6@T(@:&6`G1AR8914!
M"81:XDP+"`!;C`,,A)J,#S80`$8;G%?3;#41!V-HFPK[D@*O990!``,$.RRS
MS8JYJK.?5;`D9@H(H,"0&A&P;$9Z@M4`!IJ"&-T'!4@@$(,*K3<:!QTH`$!P
MLEUE(08.Z;0700H1)Q.TT?K;T;ND6A3``/\:_GPPP@EK)%.#!R@40:3]7J2`
M0`P9\.Y5*,[YGL,%3]7!!)PE^@`%#G#K@048,/@4HA@]$&1!&$Z@,,T?N,;1
MNU/6O#///3.GP<P^&N`QD?8B(#*,*$V`+0,MEPAC310M,``%;KHDP9$++PS`
MBF<2U`%=C-54T;OB^MRL8N)F(`%;!TEU-MQQR\T2!0#T^Z33(P$'``0<$&#F
ML*<J\($"$'@'TZ<-:`"I2`Q0.L$!`W`P0-<V+V31GG,SRYBQ'T">K[J:BSXZ
MZ1A9;=&G'%V`&^/,[EA3D[U"K%)D$K'$IWP%D)I!`LC6]&"/I5]*&0`*))20
MK`HU*3SSS?O<;P%9_G+D`*71BFV591+E;5*@&*RK$K+9?H!!`,3'AC'?%0T@
MO?-A,@"`!084H*=;&=0'@`/MZ[^_OX%:U-KL.`*`[S7K5`H9'`!%$A@"PD0@
M`G@*@PRPK)K@BG``,!O_3D09LXD/1H#+(`A#^*6ZL:AR&H'7OW`SO@-^X`$`
M$,#I3A@>!"Q`9$/1P-\T@,&*;$PO:Q*AB0R5MPHT8"\R82`0DQB2\RA1*(R!
ME`+>II$-`.5?/0'`[-[E,8+$,",['(H+/7*]MP%`9TWT#0HO$C_&60``4CPC
M'.,X&A?&:8`;P=._VJ@0U('J`T_Z($88$*^A;,`Y922*0I!"$&K)<2IZ_M)(
M`I;'E!\VLI*6?`EN)@`II7A``Q+I3;3R)3Y[S<Q5@U1=!5V2@0LLH&-^$]A&
MDG?!%@)@9I?TS).X51$]D2IFM_PE,"\20W%Q``-&LDH"&-F9#2AS);Y+%@<T
M,*=[P6M[&OEB23+0@7P5H`#+:Z9%#+F4-MHRF"\Q%+DRPH&NS<:&YGQG(V,(
M2`]@0`.^0QCHOL*9AWR&`Q:X8B(?%)TGA>1ZP6HE/%W"F(UT@&@5"0`2$RI1
MB1K.8``%RWO&]I(,#.H!"LA7`!#5``*VS(17J@E2NCE1E0#KI!;)Y4IC*M&Z
MM8Y9AKI*X2#0@=8`@%(5&$`Y.<*!4R8%4@Y!_A_7+J*K#RR@92,"9T5`1Y*%
M-@J6!],`!20@LIYRQ`,<T-F3H"K3L3;1=OXR$@W=>=-9#L"=&\E)1C;POD-R
M@"*9P0`]8:4I#!2L`05S0#H]@KX/"<",81(KIMP#@2N29)%"M8#X^"0QLE(6
MCA)(9;-<J)`N6FY/?!+21P(0V`\0A#[+V0`"`OB!T&P`LQ:AP.!`@B?_+;:R
M%^G`!1P`@;SDQ*H6(=3W7#A9VQ)7A![`2[/T6#R.Y`M1:QGN1?`76XX4L@'1
M$4#^+&*`VB`()3P%;;E,:EL;!F!PC'R7^'(2U.*R-X0[@BZC9-D1G@8'60[E
MR'0^X@%FUH:J)(GB_OC.9YD*O/&V%7#858RE)VQ6-JP?T4!P,]?>"8<P`>S;
M%/I\^Z:Q32X`\"T)25H'US!Z@"(;D$H"Q/>F8W8E6#E1+7MG(UZ,1$#%P@$D
MA7,\.G=M8+J8@EJ>$)F^FB"V(Q;(2BT_`#0/!&=R*^Q7!_I2&/_9;,:5)<"K
M0-*![R&K2QW`L8[#3#,/V*O(59))3:RID:=02E;9;0E"&9`_K&F$`;&IIP<F
MP.*P(*">%VD-A1<,$C[UAC)J%C.B>S89FX+.RAC!&E>'YE:5-("H.LE`:"X@
MQ0T@F#`$F71%9,+98%Z@`A8P[`>055/\#J`W?()QHF,]9E\.B\DUT65'_GJE
MDT\58%$L059%+%";O_T6`1QP3&$@`*G1JI&2$J6.@3`B1)-D^0.ZE36V=^;-
M9KWND(CE56==8H$*FLR/K]%`!#H-%@GX^;?.QDCZBCNTDB#`UQ61`*JSK6]G
M16#5EC(D`$;-$9:UD`*;:<D188,!#E`&X%`BP,PL!.H,N!8CDB5N3O+=D0N4
M\UT%WC?(A67P6JM;PT:&RO@08!!5"HDP!S!/2!AP86F_>ZSQ5N`L*X*L#X>\
MYV!:>6*])2DS1U<A2TD(44MB%$$.!BBP]HA,-(XYXD[M)`.RT\AE"FJ?*SJB
M'IC02P[S]),`62%O3DE-UL,87`N500Q@@`%1_@6``U2`P2?O",AH/=8GV5TC
M#G#HQ;DN^$:%J@,`@D"^JJV2AFIT)?92"-5:$IC!,6``25>GH@JC``I,@.B1
MZIQ%`&1PA3@&S.8TE+U%(A,;(FOK'V'[X&,_%0Q$`&82V*8`^MX1&&4E)_X&
MB0>0NER7`'F2BYEB(0L#\0D(G-HUQTU3(V"H]4XT,BIIC$4>*?OM>PEC%L@`
M1RWR+I;,"D,?]X@%)'#1GGI>@`H)#8S>"#F8><7R$67)DYAMD0&TS@$^GBA<
MI80++8<=<9\!G@@''%H'#(A*B,5>+,#,<<0$"%U-C,I4U,20U$T"J,@!X,97
M0)S4K40GZ4GU;`0!_I3@!\B*S9V?ZEU$&!T@#(;)07"6`]A>LXE8S27%!(8%
M[*6(\I1=TTD`SZ$$A-V:1V"?1;C0_053`*2>23R)SM!9#$ZAE2"+;\V$!5S`
M="A$MB!A=$W:!B#>8)B<2TP95+#@2ZQ?#D:7F12`C;U3!52<22"+S@1@$K4?
M%6I.!"@>1E0:1K114-A-1@Q'Z-F(I^&A2$Q35QQ`!`P`(G9$!LA25\`797P(
M!W@``DA20MD$_L&/15"&$GE`".;A_KQA1;13J0S`^&6$9DR@)'X%&DZ%(M:$
M+5&`)JJ2`^335U!?1KP+!#R%ATQ4U;&$>%P$C#QBW"`C*>X,^$$:9WEB_J2L
MB5)<@!@6Q@8NH6<(W0)XP%Q9!`&,W4G4S6",R!6!XTN]RP'PHCGQ'?&)CQ3J
MFS(NHVAH@-`9CPG^'V8DP`;,XF`<P.^1QF<)(M1@SC\.FKJ!Q71]UGU-F$R8
MHT@LP`-HB$SHWH05I#R&2&QDU4!T`'DHQ`Y-P"VFVO5,&0&086D\Q91P!=F$
M)$A@@,/0GU_4A`$5'6V,%39^P&RP)-HMRT'$XTKYY$6NQ`2\'0'8"TULB4'D
M7*GHQ`9,P%!Z8&$<@#Y2"8)EB4!HP+L4607P(^FI#P$L14#ZSVPY)##!UQZ]
M!)\P#M:X7E"V94A@S2QVVI0T@!-BB!D^1`),_LN70-J:\%0`4.1(+,17U(9,
MN*!5R,]AZAB^"84CAEY-NN6),%.B"48B.65%:):"E5,81H`:UE\#X!M@@HBN
M<09C7-Y'R,H#/-XA(13#:%?3D:),O)D=0B9M)F)/X2/49-D%,``&2``%@H4`
M3``370HMXN1,H$1/!("N:8@=719UO")4&$D/REY"M$ZGU"9V@H1U;41-X%MG
M=D7A6,"##&&5(-CRT`1;;@2:W<998@A%B*,!0,#:8(T":$J^1*`!SH]K`F5V
M&B`%R(J:0:=7S,^@A&:8*%=M2`0*BH2L$$IE=%)"E$4$P)<XRB$5'N/<I&=_
M[EC4#.)7B$6O'9JS_M0$9PB$_GW$NTSH53!`C9GDF1!9'@KB+C4?S5CDAHY.
M9F!11D@$39`,!F2`AD9+P+U059RH1WR*BSQ,W:'$4TPG,%&(:3"&IDA``?#G
MC<J>`3R`?BYE!\H-=O%-#;412N#)9ZT$F\D4E)8&UC".G@1IHR@%>QDHHC'&
MI_3+5O+A[+EI:;11W@B`DV($)G;%2E0%GF**B\I-?%J$PY#GF.@0>YG>V;3+
ML-C%8V;$`!RJ7OC+M56$H8QBJHT%5`HFHV*$.*ZAI5AIL[Q;I5XIP@D/V`G+
M!@@`*&&$8XB5GHI)`52.`ECH3HG%5V3+J&;$4V!JI4CFZ$B?160&JRYK_D6D
M&U=URR'%C;4D!0%Y0"/27VXL"$SP%.@9(*!E7\`QZ[+61,D,`,2(84+(#0F5
MROL(J$(T@`4(@&FN!*3-:^RYD:*:JKA"IM\\14_(B@$L14C%#4BN)`2$ZE7H
MQE[HED^"9./!H([L1*'N*Z(9:V=T@`!\ET"HF)$JC$P4@`"\W&`.RD8(1+?&
MA%Y\BF9T*`R>RT6L*\5NZ&=AV>+<!8LL:,\<1'#01``0``5HZT=L`&JFA$S`
MD'%RX13JCD7D8LQ>:82XFR:VT9\>#)IY`%?(Z0=\"J2*"BC)9`RF'@=8:-/V
MIS6!8MP`$&.H(U%X:D;`+`_]CD1I`*IR!-TI_NK$CFU_'L#VI%C<($L1E1^(
MS9U':)J91&L2DJM$R6AIO$^7Z"O>?H;:$I=,0(!A%:#/R`2N])%(M%%=*M7#
MSN:+5D9"D0<:?<^N/NZFV&@<)8!#_*'C'LP>243D)@5-W*22@5M%+(`<6@4\
M]81OU(T-927J7LK<DD[K942NPHW#4$#=S*H`X2Q'2(;X,(#S"D=Q!A.R3.U0
M4-($5.GPLJIY6)/B\LR3)$"9@D0"Q.*&7$Y%,,#YR5+'QE'Q@`UJ(,OWD.7W
MNB7;9(28/L\><87J4M6C'4`,-5YW:(1FW=PM81FGHD;_5L1_YB_XNDJDX"/-
MP,S4$E1&.$<!Z(RN_E&(!R1`]7Z`1#@:'$EIB%!2>V9$\2):"\-@46#$D]"H
MOQS$6`@N2$!C4KB1V!"':EK%UF%M!L4?B3A;#GJ56][JC4:21K31"Y](3@B`
MMX2$<Q``XTA$D_DEPL:(3!&`*9X&E74N=C[Q`0+N10S`%R,,3>@1#=<-![Q+
M`4Q(`/CN;\'*0FS'9%V`$._/;)#Q1M2-A@"6!"^KK(`AE=5,0D1`0IP=1Q@*
M271`I\$(!N'&*`8K".%P$>^%K&SM(,LC05C5.]:,GBA`&RTD=W9-!LR%S6AF
M;`0&_OZ2"IJ(4M9;)U^I!PPC\NJDP?!)`*"9ZBJ`*0]`=AT`3:`%Y,F-_A_+
ML(2%R"TK;D\D<RW'VJ1PIQ)O"DU8[:IRA-N&WJN04+>%*]RH[@6^LF@8"N,T
M1#1?*8Q8E0#3C*Q8P-#J5[@&*FCIA!2^2E5P<B5I!HJLL!.G\X8"+'?JL[#H
M"0'HR=W"&\2X2@>$T<%A3'!\2I)-%&7$8]6`#Q?GKE("-+.T!QQE@`%HW,OL
MS$T-)$@L0)-@%X9\0`*LR*<@BK?H\B\I\.W0\$8D@+W=!D='RR7*T768H$Q'
M"TUXBPD'FTXXA,SI!`5D"]8(0#X)HQB#2*6^ST[WYV==(3EOBD1PQ\U\0.WA
MS]80!V7<"$X&`#WJ4T+5S1X/!<H(P/<$P`B'_IG%5O5+P(AB0,A&'XP+Y=YQ
M\AJZ:,0`M`P\8Y&[UL3)SG11G\;D7@0$Q&_(I2E=@P1ZF')%'$2-'N=Q!N`R
MSTB,R,==!K4<^867_+,/.3;()4AD)R)EFQ_-<$6@Q@;/OAOG"=]=,HLEDT8H
M4\EQ[84$K'9J+V/80N+K"DMK4$#&/51J!IL$;,E=RJ157`@X0;-'5#-IP(CM
MGDB'_'9M>H"LB#$$*LR3%,P+G6*R7,">F2&Y&(GXJ.T;Z^@EI[%OJ%]644`$
MJ%PKCX5V7R2^083\S-6HX:NE."K4O=]!!,5OFN$!&(`^'H2>>?$Q>T0"VVOI
MT#&*T/95@'9^<]V)_K&-8';%%WV*="^>1D"/D)1J<S_%:QP;9H#'0ZWP1BC7
M<,]-U#4R-+^+F\".I&3X`4[``W0:342$4SP$30<2?EH*!E&&(][E4$-P&C4F
MK2H/]=3;83\>L<(-&D,B-&.RM4E$\>GXX$&`<;PB`1A%!0#%!F0`?2O($=IT
M@._1=WU+*[<,`KR=3@0`K)DX2DV18>^/!E.)W^KYP9D&T'JY)4DTWW"%GNG6
M>E#.`83F!(@ML[QK`B<8!FCA:V79FARU\P+AHFE$I^F/!UG);)AUOQ0/V];U
M;<NC.,L4!K0&`1C/8<#))\;X&4NX5D.35ZAGIN-%&1G*"4$>@#QK1CQ>_JHG
M#)]`KXE(QH(Z1T(3ND6$^"7#J$48BD-D];-[H;_DQ`#<5%ZX>'3I!D#51D8;
M9E>3%B-?9G<Z3[*`R<-6!&40@*T[NY@I)`+/1&)KQ-(<S#T970NYA4[R[6HE
MP(,LP,?-E?0D7*[41%3'36X#'YNG!(Q$H'?DA[P[RUHGEK<7A_K"S4U10`(1
MHN5>1,,K&9[.UD7DA`F57?,8;DE<]TJTUD;,E<M7/)BL>K:GD:=;^\Y4.WV2
M5D:9HDR4$YJE:S1N-K+H3JA8A?;NS`.%R4U-@"X9.LV'W%Z?4([0.L_H27#L
MD=!]T;5X8WR^GZ6:74:`#@0`7)'#C1Z?A("/_H8X=FOQ8/C4YYBT1U>B;/SE
M^M"K<`6B1(`!C-H+_F)%.(R/0)K^(<<#_`1:-8^9P2EI3$1<!9S.SWUEW92=
M8$"].$0".#7SM,PU.\3"&S6&B`S6H%JI?IA$QWM[R03;2;2(HJZD"@\%0'MG
M2(0`4$0'7`]T##GIM(:RC7<.:_U%B)8ZI;M'K!7MWV%0#<I0*<0"G#OE(QIE
ME,\&U,W2:T[Y6@[/M:L7:41@(#M&Y,O,$]<#?P#<>>`)1G^V<460TP1!S\T]
MR<KL&K7V?OI'\)0%AUE.&(#\D(5@`$0$``8Z?#!X$&%"A0L9-G3X$&)$B1,I
M5K1X$6-&C1LY6FS`_J%CR(<<`!```(""R0<B6;;4>)*#!``K(7I`.7'`R8@R
M`01P^1-H4)$/'#!@@&%"SI45"`@0^A1J5*E3J5:U2C4#A`$4..0$(.%JV(L-
M9FXH*3%`A(D>+A2,>!*`!;%SZ6+,X/8#@`IU^?;U^Q=P8)<<'%`0_)<!@`%Y
M`8"$>*``4),`'!RV?/6"@H0)$ESV_!ET:-$A,608;36#S@6-(VH`<*$"!0T>
M1*X&<.!T[I`,?!Y4@$!W<(88-@@W?CSH`K#(G\)T0%FB`;@G!USH>`&N8^8M
M:?=-C9"`VNW!.>`=?QX]1)GI728`@(`D@(L63(:$NY?]]>YT,73V;2"__@`%
M'%"T"0CD*+X/`F#-(@'PXT@@`!K8B##I@#O0*@CD,\BFR##\$,00H[K`0!$M
M<F^!!1^<B((-KSL)P(LFF$Z`!8LS\2G<$*(@1AQ]_!%(B`::RK3@5C/@.<TJ
M*F`YAQ00[R&S3C)O(@MNL\X@!A8+TB69;LQK0B[%'-/'N*2R"8/@,#C)+*<H
M^NXA#6^"2("35J2HMX,*`&`_,C>2H,>\W)SH2S\-/10TDJ@,J@$"&)+KLO@Z
MJ%.[MR"`2,X\G3R)@8M(*M$@./OBH$_A+M#Q@P[>0Y355IG+H+*I"*`IMSHG
MHQ4B!SQ\R+63-,`4KE(E0H!!@P"XE"^!*A6._@%'#[K3(0Y`=97::L6J8$NI
M2((6M,3@RI;.11F""\MHX8+4HF,1VE-8JRI0ESD->NP@@`LC$I?`#-*TEE_+
M7"M2JAEU>Q>`Q`9]2&"$)8BPX+=."K,B#0^"P-NZ;%(2N0X(V)6D0`_=8-E^
M1>[+`'2CZJ``C$53M3%?'9+S)&01\B"!"&">#MR%(%CP)&<K4E4`KPAP(&2K
M#CCX.%5QG0#ID9U^.B%2?W+/L#.M^RJWU23("5H.I)L.QH,T6!@`VQB@+36X
M$L*@@PL6.(#G@EVVR((#9O5KS4*9R[:#`XJ&&G"1&6A2I!:AI.K=W`1"X#FU
M-+C``02(!7LZ!`SP_@J`7[%#*&Y(Y05[``O<<N]PX6R2F;D-"%B1@`5<[>#O
MP&4'*F&K!,`5M-1\HAQL`Q"@#?.9#$+`*2L/6I-WN!Z(H%R#9,HY.`-0'8^W
M@VR"WD\+]IV=^Z`@$`""=J%2%>#0[*R3]]*M/$EE`(K+20#T*1^`^>818ADY
MLV(WKE.#2'*]51X07_<(N!$*%*!J5UG-:5;#/+#I[5EP@1A)BL2[!F"``_LS
M"/*.8Y-8H:=\'V!`TPI80A,>1";3LPJ\0B.3E2BF)M.9@`;2)H$'3.8D#Z``
MMQ9"@1;IQ#@$\$]Z'J`R`83PA$DLX`82:!7:&,\A'L!76`#@%"`^)'E@_EN8
M_1;B`1_:IB<&:&)N'N"B]`0`=0L8HA+96$"/6<5R49SB510@GSKQ$"%?HUP&
M!!@1"AP``3P+0`$*`#'AN,:0Z%G00<QBLC8^$G`<\-E<W">:U5"`++A#R`4L
MX)[I+$"*$<$``A(0-P(0()''656`&G80!*0R*MN#Y"R1,Y`!2F5-HDG,`$BB
M29Y,IP$=$"9$1FDYN&RL`'VZI6@B0,+S/.<@JB+<5/"R3%I>\S`+K,L(6UC%
MO`0`)!SPUG0@0`$(*J0#:L0A``@Y1O0`0);L:0"N`O#!J_P*FRPQSP;PF<^0
M)(XO9K(F7;I2@`,D#P(<V,`<#7*!/^*,`.';_@C;/$.`-Z9G`4:TES]/<P$"
M%(<#Q`H`3:##T9`@,2P`]8P>Q_F1A4(D`PU```X7`(%I3G2@8H$F@1*S'Q::
M-#0S,A/85C(TH'+$`3<52R`_`X`)4/0#H:O)T>(V``@\()X'LHDFT^.:23X`
MED<]S$DJP[(,""0RA11K1CQ0I[^8Z3(1,%D$-)40!QA`CQ%]@"-#5`#LL:=%
M8A/>6CWS+O$(9#E[^L`!`$C8BO0JIR<SHV!(TD^;H(L#$$B``N2G``B@SD?O
MTN!X)$"X`#C3L7TA2Y'6XSSY%`"/J6W(01E:%0)T*K)5,<LT,V"!MX'M``R8
M%I`J^R$*H,X"HY5M_E@$TC_%&DL^!.#K<AU22<#HQ3*J0LASIA.`!#`@K$`J
MZ8&DM!^C4A<P-G%J'?NGH<X,(+;H10@@`[.FVHH%``K(J/P6L+Q622=$$;`7
M2=8H7[Y,[B01\"0`3!,`=QHX(6;A:ET0\%>^_+(`%P`9M=:DW//\QGJKA'!?
M_HC&#Y!E3DX=<4-(DE6^<"``]PT+!AKPX`^$DDS_"]&:IA4`I:[88OU4T(_9
M$]_@,/8P'%"A:/I(IH.*R`,8$'+F@/P9`91.0![NJ)"OB^4J'P2*(8*`QV[S
MY;FH,50WFI1UK&IFN];U+[5SLT%<8YA;P@X]UPLQE^<L%0!T1IH;%%X]_OO\
M@>>`%C`,N&B511PB#3R@3ULI=%6@$^@/[#8O?)ZQTZ*LZ;=.>,0SRNUY8E*^
MGTX:*@VSB7C,8B`&]T7&?GK7D@'C&B,O]U,^N@`#*O5J5/L9@/!259K@66BW
M@>;89D[`KDQD`97EA8N_!DI^C46KUT`[RR@]3P=L+.VY["G6^<D)(Z_M[>9H
MAB202HU<X#IGB9G;+RT:KHA(0CCLPALH\9'?=/9R[SX_X`'AQG=0)#!J]BQ@
MD@#P\L`YHM[D&69.<]XIP\5*`'`-EN(LX0`&-0"R#O0I`-$&<BXS?E0%#%%5
MW2[Y3P3@Z16W5>0KAV0!^I<JK,D\)`G#P``V_K:<8KE95?;$.2T%8!Z%#YTC
M<KHQV*P3`)>/6%6+7IF6D=Z7`7PP,8BN.HMB]@'L("`I$LITH6<D\*T'C@#E
M:T!XS^Z0/>%'0_OR)I4+7>RV/_(`/;+2=._N$+(<Y`%YJF->M+UB*U&][T'J
M@(NC&'&;%#CQ#I'.C89DK-TQ_N4'H+6!.2!D/E*73YR;=^0?5;`-7-(@901+
MN?L<43,WF4,&?V2Z$0(`L[>=97#A-EQ,\W/`R;XC=B=]";%3KC4]>_C#@4MG
MX'*AT,MN`S%_RKB3'QKI`T8!J!((W[7JM(\;)`*XLNZ<>_7TZH]L`A$P^N@Q
M=$ZHV03QLIV;<"P`_OSS_V0#7U)5_.]_$-^;6>R.(W[ZKRX48`#,0P`:BP`1
M0E\N@),H8`(N(`+$X_^^;&&8X^@6,"P\(`.:9$U`[?S6)WE^A>[FC`,N0**.
MX^]FZ0(@SU`BH`$&A>0T4+""YI3P"I#`R2S,S\`FKI:T[H3.PE460.@(C08E
MPB;L;ZW^;#M<P_T*:/#8@RU8`KYJ#_.@0@%_S?8*30-JSB!NCR]H0Z642/A:
MQ0*0A@"N+R/&##(*``(<H"@RZ@-<H\JDI;0^RP$:@`'4J"`FR\W>93_X[R\"
MP`M-",FLA0*&:$W4$"."AW(NS0_E"WF21\,B\<L@X`IUP]?^X@E/([#X_H4"
M5"8`;NTB/*`\.-`"-&!/=((DE/":I(0ZB(,H5J(5)ZT`!-$R*@`X7)$[XJ7=
MJN5.RE`HO$5)2*+*/*`"],@(_>?Y^JQLTL/?"*C,^"4U4.6@NH,7&X(G!$#_
M+-'`-D#`X$(`#$-5P)"PGA&$O!%J!$)D6J2?ZHU#<+$A&*;@$&)-LI&C<(A4
MU''%*@\]0*Q[4FYD/$!FK*2:-&YRLM`@Y.S+)J".3L)-^''$N#$_HC%PKD@L
M:.@T.H!P"(#(-F+!4$D/3\YUQG#%.*`!XN8`0$4B(4P`/M(X-F=V9D0>3ZH3
M/Z.M@)`C'!%L/B#,1@S&X$*,UJ8E#8SZV..[_F;GU/CEM@X".VY2(S(H`S+@
M`DI#`S3`,&1RQ6X&D!``;FQO!LT1J$X"'P/CL@(G^Z`F`PIE$ZMB!D>,NY*'
MGS8$S]Q,`%QP/%(2<,PB$UN%.,1FDJ+"`R(@,D0%*!L``B)``B9@ARR`1.:0
M+OO,`&JRJ82N7\:K6CK@Y$3J-@;@`0:@3BSS)SQ``E91/AZ`V5#-+-Q,BMIF
M319N/(IK9-S#,KCOS.`B#\'&)*!2(Y!QG1!`+AP@,`UL;!9%`X##&+],(!8D
M;BC3,\9L9$RR6A:`V;SEH&B,-R]BG&X#AIP2M98K,4"B[`RB/NC%S$9H0>0G
M.XU#`)SS0U*#$?U$_M$0XE>*(\/&KR5XYD(*P)Z:J<HTA#96\,3D8P+@#,(6
M8``JS#'S8CV%@R%=Q1_[I0$N2DJ<Y3A;0AP38$9PI;56+#$*XMT&]`,>%,)<
MPZV&YP`L8(8$1*VFLR@-)4010B9*"2;9RFW`I@+P:0+PDKK"\P/8T2#@Y@,^
M\3_5)DB!24!^D54R<&1B%,Q>XT4U0@,>\F$^``$44K[<HR!DHCO843I/`\<^
MA+L\YE<F0"P_@TA9I0$LC%K>9;H&X.VF(AEU`@&03[Z(13Q=9(%^4C<V3D0@
M8#B'IT:/PP#L=$Q:#6I4!8+B$@1_@ML^`"!7C"P*X&OT<'(^X"U7C&7>_L@U
M!E65&C1$F-`]1:1%%J5%%D0TH^)MJFP['Q$##-3`1)!**(A`.M1/"@!6^46T
MT(F0;J<J-DN$I`[7)*`Q+Z`#'>"S,#4U1VP"BV(A`@!+SZA1381$148@(.@"
M>"Y0FP-`Y-#;,F!;Y:M%RJ@L<\,)R4152-$O2S":>H)=HT(`<.,`8!.]-J`T
M$&(##&0#V)2Z*(!8QJ@+F71`RHA,:%,ILZH"'&"1JF(`.H4!IC6U8,8!.$MM
M(H!?EPL[J,T@J%0`V(\]%"!&-J!<<R,U>-`E4M4X7$,[U&)">B)5JL+$?!7(
MRJB**"<ROF=,8.\R*&`!&B##BB,`100_ST-G_AM/Y?J%)+YDG/;D8C/BN`!.
M7RS``MZEJ%"V(>H2FZ0C3>1D`C;L`R0@5T6D`TRV+A8@`0D@``8@)T:5@8:V
M"65,F[B'2BGQ)R;1@CZ@15>,6)AQFJI5OA+CH*;C1]SP1[!#)YTF`Q1``8Y"
M=1*@MTZB\#2B;S9K`1A@8I%)+0YQQ0QV6Q(B35<L<?]L`18`.\ZTSTAB\[B'
M`M!%`]CN*4BIRJ)05>PG$0F$`,@V>MAV.T;6,IP4"MTV*-KF`MHE`0Y7ME;C
M5_[E`S*H(.B#0*0F0.[&3QR`=P5#(Y5H+0^"+$!U(FCV)/C*`-15K%JU)Q=@
MHR"B/&2K3JKW"#%D_GB=\EU#0KT<("?>*.(:HN/6RGOGQR>%=<46Q'3;%T=H
M[DD#6"$:R2``+"$$=L1`QA2+=CX+[70$V&DP0`$`!FQIY]X03B'`Q]QT9=):
MC((#I`(,."%F!%W,(G*==@M%J&FN[,LJ8$$.`%IN*"ATEU5.=#P^#R-P&,+8
MUR`FSE99HF0W]GRCRE/7ZI?(,B%P%O_"E8!2PU"%X_LPPH2I!8C]8HCC]T6J
M"'WRK@`<Y`/$&,BDPS#JR)'HZN5FRX>/$'=5J;&4Y2<R-GE:]HV/BJF6MRU'
M-$I-2F07@B2<;H0O\W"TTB6L,O^DQ8<J`&C[TK&$5(_'Z'/G[`':>)#E_DDA
M`L!CF\.1*0*J3,AE;6Y9^-3-4N*2^<4#-(^1PK8YXG,ME.AH/@X[NE9??F5"
M)\TU(/:4N:0T$R+MJ$A\\3B+%H,S4&T"EG67$84![$4@[E@D[A?"%NPD`N"T
M`D`S5I7LCCB9#T4ZC*Z37:*%@4R8Q">"^ZP#;'.;Q80D:BXUN-<^LAB;&`"9
M001Z(RPT..!H@P2<DMDL"K*/62*<D\B9,\(`H)A`BC8W",-5@/24R:*QS"*8
M*6(#*B"$\*D"9T<5@78J]`O5FL55!H!'/0.?@4H#'J2,(EHBA"J_)"!HZ@1H
M+1E'-(!A]'@JWA"7+WI,%%43M9F6?LXC?^*'_N2202_BN%9WD\4L>'!#NZ0B
M`@K1S3`242PV-Y;MJ-+V(%;CBJ]Z"^,#`J;2,?88(G*/``[*SG!D`R#`-%T6
M&YLQ(5Q9(BJW(CS`G94H`%983&XN-`S3GS84A7!:(P14`(Y8&"$B,4JS6_TZ
M/[HCJ"5`G.HJH&>FAZ\J%?,H6JLL4Q$E->S:+]!Q+,LG`:IWXI9RL+%(+:0Z
M71WM(!@F34J)`1&[(O2H2H=GBC45-JRE>KKEGTV(+!)HDD,B1#'36.+ZU?S3
M+/)9.&Y2%^&".6>&K3<"?0S`?$\"@!*`IT<NM\MD)>#9@,`ZNP(D`^@'\+@8
M0E@C-9RZN2'"`%HN_HPOH$8$)*>26[D-@Y0S(B<,R0.D`RP6%]78B5]6TS/N
MDLFR.C#R)#$TVR+(MT:F)`DK(BBG`Z9SHP("5SXN&R-LXHU4Y5(6P+CE*S4,
MVD_B5C`$0L"?1@$*@"W=>B)2LBE*`FSV4?82]P#F^GDE1J]?8LELXHQGNX$C
MM%J"%C#>9<2?QBQVI8R"?"'&%B1LPLC%I,8K'*]#[%(0P'C;R!53X\'3P\H%
M`^/$JILY9WPFP)'@CXWHL"-L0IL;QH--2@-J$I5&A@)8F8Y2EZ,Z`%3\MB-8
M>CH2`"^`=R$>P"O;T.)JI+JY)#7PD3IJ)&[417H+S0!<%U%&6RRL9*"5_DB<
M:D[)@0*,$MW_)L*33NL&<T+'@434[".+U.*\^DQ_G&9G_F(`'!V;?-`L1IQK
M'0,#3,)#SKN`_#,D-L`Q$;D\\(D_]WO##06\M1LBHC"UWF50R&+$07,A]I;,
ME2B#I<(`OIFZ5`6=684OZR+6EXM2-XG/->+K=&8FHCTC])M5>ALCFO(#*-H@
MMATX44U`1T;$Z8+''<M/-]TE9D2I2`("S%TB;B:'?B2#'.)++\(UE"0`%U%!
MLIWS(-U:CF8NYCVU(B!\:T_`W^6B!,),_[DDB*6IE314PW:^+\(L_",`$=@B
M7P_%#V7EI6+=ZM6,WL7:)P*J@]0I:K%*-N0`_D^L:5EIMBW@Y]%WE="Q<Z'9
MS$I:=KZ;B@;]J)XC6X98).3$`7Z%-&W=YL*M=#^@T=O=M0,D`.3\54-"58*M
M:@12Q0J-H0%'DZVBY`G+2;F[(Q`,AY3$OR>"9=XE`/;UNK?#)-+6`*@;KYJR
M`>2<(G#<6,I%Q=*^T-I&=J3^*9[2)7G-($#\D$VS9HX'SA5"0QX`%H>=/=8)
M;)Q"UQLNOR::,NSPZ&"8"\5;9!)T*LP<PNI=T+3[?>VQ[YWGRCW#K]J&*B7`
M`G8H36R8U)/'U:8<PMH\/79_@>F5)0K:0UU$.K3[CW%?=J:1(;1")`8@;7F.
M4GV'-4Q,)&0\48%[_CN6O/1LW_7QO1`?FR4L0#A/(@'*Q9`G`O@QE0%`GSVP
M?R%*/]4`0L.'@00+&CR(T(,'A`P;.GP(,:+$B10K'@0@T*+&C1P[=D3@P&/$
M`!%$FCR),J5*`!8(7@#`027!!@!JV@00\@,&`!81`%CP84'-F#*+&DT`M&$$
M`BHQ$.3P8`-!`$Z-6KV*U6J`C%F[>G6X`4"'JS2_FCUK]L(`@@)@%E50DT&&
M#Q08U)3P(0-/BCLG$-3P$ZU@C@X4H.0P`,#"!#9S4AT,.;)1#FXE6T[Y8&]1
MRF,O>_[<T&]!`%)5>@`0X&!8GA0T2SS@.FALT)<I&#X9`/6'TP`,U)0*_N`"
M[>'$#PXX4#PY1`+(37\PP$"Y],$`\`YT(%JE!0`($-+,H&$M10EB"9XV,!VK
M!@\<-FC(@`%#!:<0NIO,O"`F!`!^*P"`\`%+Z0TX6`4%$(@@`!3(]!*"#A;E
M05L+#>1?:2DQQE5!.UD`F$4U#;``;)4]:!)E-YVX%@+VB00;03Y-U9V`),YH
MU&,T%M>:3``T<..#+8D4@68$S&:2`P"4=)!0'D`@@$8+#`F`7#UZY$$!!@Q`
M0``!""#```.$I,"*'A60VD`M#A1`C!E.R:9%>HG7YF<!+(@28W'>^=`!'!#U
MP03H%05`<P8)D)H$96JT'IY&,?"G2(R5%)9X_CMU%X!UBE[*T$Y-8AJ97GQZ
M9.1<G&(:I*69K7E230>(ZL$%;1TX`9%M:M#951,6Y($%HG[`@*`>K0:7@A_L
MAU&`/XZ*[`<*))#L8'"9I)=PMS;+I@81/$#0!)O*Q%M-/GD[4*P567A!!,(5
MIU!7'"RP0`(1^%<3G0WP>%)B-GU@KW@C4JLH9?P*=J5(`##[;YRYU1K6M"K%
M>A.2'_@WD8D#T5034P4;E-N)!=0DW`-BBJ0!`PTL!!<#$^Y[<9L$.)QR5M5U
ME&/+;,)&5,!8R5?K0!1L"U%N"YZ&P`8T?7HQ:AQL5YY>`!J`K5>DR=SF=DU#
M?15Y1!_D00?M90"?_@46M%;555=3C1(!E@[$LUD>2T2>J&4--##4_)FI&0#8
M$I!35\62W6,%N_(-*&J"GT@XX6D;]3?@)V4@P+D?.'"H5VD^[JM#!6RK@*`&
M'"CSR\/NU8'='PA`KTD;;+!01NG"G;CB!/H7MNLI!3"`N0(0@`$$$4B`00<4
M_%Z!!1S`IP$'!!PNNW3D'6NG68'RVNA#+Z*Y(@"<IZP7O1)L&M9<!T1G$F"%
MUP1W[,FGAT$!X)]O4N@5P)T=00FT/M!^[`^8`9QYR6H53A\T<+V';&=!L:)3
MVV0&F`(\H`&)@8`%8#,7!-Q&)*L9WUQD=+\!&4!A&=3(RXR4E*?\AR'-_NM@
M<B)TJ^V<Y64/L!A$3)2QO`2+@_P2W_@`A(#2A2\#'=!:!Z8%@/>94#D4<.$0
M-W*DS]UF;U%B"`"'@[HC`B9G_#,*`0#$`/U!A`$+8,#[AF0`"[6L,`YX@`,@
MH#L%%$`X"#B6R^)WQ#C>*8E!8A9YA!.ZLQ5D`5J4HV<$L"()%<5KOY-`!-!H
M)`!!H(\1HU_R%`#'CE2``A.80`0H8,9Y[>9I?J3-`SOIH0.1YT0BFII!W@9*
MSR3@5F$9Y/AJ$I((K"^5$6&`'CF"M/&-)0`Y2\GP:,F7R@&S(=S930,2H``&
M!"`!#8!``5!UG2H.TVEAB^1).%"``5CI``A`_B:C_/*`6:;R=Q,PY`,DX``,
M."`F9CM):V["3`8PH#NA&]LTS1(6:]YS*CJD2&;V.9@.N2AZ9HG`!,?YRA$*
M@&4=V<`!,@:``<3N-/;,H!LM$SKS`70JX.M`6V)B(K_0<'H;Q:>P)F:CE&P`
M=PY!YC0/8*5N(D5D!7#*`$QI$@L8`*('<,IIQ'A$C4J&``<M*=H,([ZI$:LA
M!#"B4;N"@0DJ<#-!_,`&`J#1!!#LJ00A@#XI:*^][(VK7<F`4Y\:-__TTU@,
M,0#RR*J2J_*,/#3TB'_>]Q+'$21$<!T(`:`ID@XT`*(?`(PC^ZJ2K?0U;D'J
M9VOH=)`#O!6Q*`D`_H#@5AZ54&9!>M$H%X>IE[9P)TP'@(U`"B#$DVP@`KZI
M6`0R@C+*JB1TO31J`)##&P5\C0+?:@@"(B=;E'@@-Y=]G#0WLIV6Z.6B'SC`
M5QWB`04,H`&U+9A>7NF4`Q272F']R9HX&5QN%1.N!OA3!QAC$P%`X+")":],
MJ%N0!C&H/#MI'4DLTMK&4.T"&-!`9AAP`0E4<BP&8.Y&=F*3`C3@`1-08V$5
MX]ZB3+>OVC0(!BZY'$9&F",:0`"?)/"QCG"@,[#[P$MJ6[N*9`8"PL&`7>IJ
MW=AB\%<)O6!%-[R1R0*T`&=U46`0<CP<ER@W87N63')9.+\$`*<0\=Q4_O(&
MM?I>)+4B<4`9(2`!"?S.`B$)G9!30@#(<G5+!ND`!%K;`*%^(#=?-HD!5C0Y
MF>PD`$,2;<8`A+>*^&\T8I99]R[29ZM0!L9MGLAVA%G2'W=@*0`@5%4;8J5"
M=V0`%*@5!PB*E0YDQ`!K?4AK!,"[(.FX6>WA0)!*X@$,_*A2**$`!S<`H--4
M5](3Z<#&%AL2),OSI`SQ$JTWTLL*]+@K!!!G1(1RDUE3ZYWC4S)#.5*A#VRG
M-*T92VQ_/1$$*'N?HI-V!42DJH'0<$C8CLBTUE,>\@30>4R6B`8@L&UJ(7A+
MMPNK3:G<D>T()$@_\D],P%ONB7@``8?E=B1;_FB39P^$3%@+^!Y[,SX##-ME
M^-[G#PDR`+P`EB(O$4BL)@07:V_<X0/)0`(*``&A0-0F6:IX*D^C5X/H19]&
M4@W)T58=#6P@=-6!>+N[(@"7@R5Q#B"TS#BPD)6=Q#]SJ?9`5!B@>#N<8@!H
MJH*\!H$'U"<!HY:CDR]``34?A*0W-XB1!W*!!SS```GX+74"W9`,P.:V31U`
M6Z`V@1[K92X"&#G''[,=HOQS)X"S@-0_DP$(++.IVR5(XX%YFJ9EIB;/)<B9
MRFYA(@4`+L#]RMPD\JV:B!8`12T830@P+:25SYU/.S&%>*(7P$5Q0$$J0(@+
M8ME]GF9!K4%.9FX\_A"R8WX@9W\XN:\R`0?&G-</F1`!A-XR>`5F`ZT%7TH]
MDID$5*`M#7#`8'G22M<9_3.,@3)!,$`!\L`]E2P<88"`BI`2#O_I/]XC!"Y?
MD0@`GV$W@:P`*G\0&`!\*3-*K;4J4Q%S'$$LX_,!_J(<"7@5LR<=#+-5&J)X
MUY9*`P`@08(>C($7&U!10C%_!0$O^/9;SZ,1AN<00=)HR&031#%6P\1L!!4<
M)V%F`E8!%7`!%Y`!F-2`Q^5P$J!&(600&Y`8`QA'(V0DS<80=C&"YH$1>N0;
M=S=?(^(!U[40`$=+"&83%0AA%#%^#.%E3_@7&U``!M8J@P90HG,!ZS4!_A10
M`1J``5S3$$Y(AK&"*MIE/6\16ZTA$#$(2K8&2\8543\R8Q#A=V9V/'3F,&-(
MAGU2$P9&$-"QAN;W%(1&A4\H%`90.0/P/D2($JA4$'IA;04W1$L8-AN`7G!S
M>!)A(J0T$`[XB/CR:`;Q`-\#A$E(+WGU`1U@+Z775;F(;35!9:=!'JU8$:+X
M%V(E=D=$$[45)#^462*16P"R`4L8$C'SB'`Q`-:D-92WAM$1.DQA(A80<@QQ
M:V1XC,9Q+S(A@@<A7X>X43"(A!&1&:7'9E#WB';Q>65F$\#(?D"Q'27A$YU1
M@PCA&X^8?`@1)0(@B1X!&W:W>6_66U&'6%I(_AA$XH3R]8@4HW"+MF;U.$2D
M)VUVTQJ7Y1L0^`''-X*R1A"=80$+T$P`Z1'(QH`!8A%$DVI0LUH(L0&&Z'<3
M88<&X82$-XM&8@"/5Q`"L'Z@-%XW$1.JQQ!D)A/(V$GD$R[=N`#Y910[.(<Z
MMR<]](-A.!":MB,74`%OF(XM\X[/.!#O"`"F.!$U=Q`U%WNSR#`/H`%I=A`9
M!5"WA7;<9!T9L``J&2"@>$UD]2$9<`'(!E%=5Q2T-1&CAR)00Y<^41IO<WT=
MD1FWDB[/(E"/F!E0,A3O$1\7$"N0.43&B$05.'\@-GI"L3(*,HW"=9J[)0$7
MP`$"44\4`1@3T$,__D26G/)/RJ(9-?=3)T$Q*U<3!Q*:9,@!/G$`6,*<";>&
MMR01$46&K/26AV(`--D1X%8XFV25_Q.4_Q(D"_&.'U"<P@@15#>>03*+"/$`
M<W$K>[)1[N<AB/:$>>82_.D1$_!0!0!3"#!Z<#.<[`,7"S&4+326*/$>IS-B
MZ3(7%M!Y\SD!"=I)I_&0#Q$W\TD0YC@5B!F9HN47H0-_[B:7S9*.Q?D!V_.@
M71$!JEEVD0)7+Y&B$2$`F$:&IY-:#H`>Y0F&_%@`$Q)^%;&`>R8SY'%.;7$!
M7C.=/RBD&R$N($H0>G&A`+43T/<0=F>EHU.D!,$`!S*ET$5_=V$0[CD0_I/G
M@OV8,OQ8.$TBF5U!'E\ZB>`Y3931C`Z1)5^Z`0]P+F&Q;BC!<VXZ$$<Z$<PW
ME"FCBLG4?2%27H9!45[AHE\*B"4%&(;Y$$UE0AE*'*=Q4!*@81[!@L6B-1'Z
M8!6Q'3D3%F7J2^B"@4>FIB2'E5P5%LIU``EJ,R"*`04V%:,Z:0EE56IZ&MG1
M`9)U&:Z:%4TI$_9CIT:H<`!%&9]H/2!(*QTP'PV!K%^J5U=5%,J$)58B``F0
M&$VBAA3!CPZ`7IKJ7HOJ7AK:$(ZHF`L"GR<"D`_UI>YSJ+UQ%F/!`31:$!(`
M)0:PIR7%)"]Y$,H87!O`K@+WA5P5.GYA)`B0_F5OJ(-/2D*SBFTTD1ULAA8<
MD*4W1X6[2A"5"J*G86R)AA=!<IX$47RS"))7&JVDVE3>QT51X1(:^V72-1`)
M:8L31X85P*/Y.;,/L9ZS&)W;<AH%ZT&OI#/"B`&&I"L<$A\,H*Q^9(=T61`S
M:J?$=Y$`P@$VRRX+$":-TX0Z*VG8JAFG`:`PHX/RM&#(=B#Z^!"O6#C,6E)N
MM::SH4PT<K5WP@$`.$RBPR0Q=2)"I[#[*$1`\Q4>D)!T6[=:%H?L(2(-"U!N
M]S^'XZP/DC6*$Y>X-G8U`0$YRIYH6VC^$3_NBA4OP0&)*Q'H!:_`Q!@9$"&D
MT0&))Q`[T[6TN%C]_F0D>/L!PJ>0X(615Z$70@.L#0$OEHA8P<*`$-.US(=6
MZ],!R#86'A`!LU:KL_@2`;2YQ,83#C"H#R$TUB.2&[4?6$(`!`HE3&$!+M0[
M('H`P#NXAO$2XT.B:P:T&Q&[J80!^M.G1]9]\I0`%+``N8$<#K"_,E<31=MF
M?+4;EIJR^4DP%Z`!$X`E$%!Y5*E2P46W"L"\`O-*"_$`R5L04*)72(=C%;`[
M.0/!7^H!;<MMMT<0T/>AVUD:/DLWW^JH#I!%"W!QPT*C"?5S`)4!GR(!&\-R
MI>$G/8*?5/.W)C1>!=$!"HRF#)F_\X>]I(.`@C$!(7L0]Z<`"M!%WH<E_J3[
M5"*R3-^R*0VPP,.G%_V;A+YB`4F*G7`SP?-'>+52IU:A`9GC`&)TP!(AQR4E
MFWH%%[[WQL-W.7#%FM+''8DQ<CH\G[[!%0$PM"(Q2C<1`$3A`%E,JT1";HO4
MM='9H=/D'PMR`9<3%P7I$"0)HN-8*Q5`P]@G>L*37S%1`:Z)>93!H_NQ`=K2
MM3L)5X`A9G)H$P>@`-$ZQ2"*<N*&@BD1.@&`;_<8%)GL<-NAE`UBH%W[IWT%
M&-"D`8;"KP@!F"!:`0/```Y3?RA!'@I'/F%"AJ'#HRVB`-@\@CNAE%H:@_&K
MH_A<=JUB=HM,$8Q!0_+9*X_(&'VF;L$[OK/(_FIDI1<E00%*;#?#TP`*<,?K
M^Z4`Q"JPG!(;XW)ET0``76[W&R4<P"21&+R\/(O#!<X"8B0"$$XGHI($8,(W
MYP$-0&79)!/^H91[^"1(6SA"I%6[FP!@/$UAD8!#THV6H]3#ET3[X](BK`!$
MT0&B^C(!$,*8UP$8P!BH=2L+4,M/&!9X.DS32H($8``#J+<@JM(&85`UHBKH
MM6<:F*\'D=!V:F9]%3ITT@'\2"\6`'V8.Y\+@98C:A0;$'J!8BD$4,004<AD
ME0`FC7E1U5?%^F#C$ZW"2X8T41IA`<K0<DL*QA$2^&L'0-`ZS3N._#*^$P'7
MXF(,\#,,\;*/2`'1_F/`@O$]NUL0SE0PDUT<2@=74YVB#&!/F?C2VR="5U&8
M!F$!V876CWA%!8/&,W(:7_L_F[FT",%S5MJ&AQ(ZTVT1N51L.-T6S)(`=VRE
M_LDF*QK!>%+.BHDM/B%2"1`380%8VPNSC[8=90UL->%6A#,7`7#*L\AI<7*^
M\GW=T^0_I?)@`.(?T,0;5AH6D8,`J\TVQ3)<^@DW]$N&!S#:\R>+BAD=WV+7
MK>6-5?>E56IBAFH2=$5\@RJ]\]=#[;$!7)/C,2%!I0RP[!<=&;!V;W;/W#$G
M";&'(,HX^H,`7+H1KJ<L^,C>)$>9]OH!1VVG)<Y5(*UG(UYVYWKEEEL1_JWA
M?*6W4`K-R:/7'62\NP$@N+1TUG0Q``G:;7!-`'P"XR(!U&C)'6&G`3EQ4S![
M*_S7$@H`XOR[X.SWT/M$&<R2&:M"V)24O<34U<,'&+$39-J14$HFYB3'CR&T
M`%-.C2T+>08.5^31'4AV(FK61%:ZJB6WF:834>O+B=TTQC%1`/`=<!J@Q&)4
M``X,75$\32\AW!G4>R\^/BK9SONH1P=Y%C7UDL6.6-%5$Z773!S1N9(6J_?4
M&GCQZ!3!Y8\8.MME`$[>$0O1`>[Q=*M7EM(.5W`:/Q."UW8*O60UD+MQU>!>
MU2.8&T01*^:>8SQ".$[A[".87UL"3RM9Z2.H_M\W&NL)T4.G\Q[-+.Z69"$U
M;A(;(_"4^8.=3FL0Q9SH$72[^[EDA6`2QR4)53AE+>Q<E0$*(`"WDN<>01X$
M<$'8DIIPX_&[+A4J/#J=)A&H+612)M%5UU3E9>M=M&`/L#L6:P$\Z-E/L8_[
MW!&UVNI&XA?;OIULE,>^O4\,L/!=VHSN_E3_#NO`[B$A=,//\[!6:F9Q,P`[
M[W`H:N]M;Q'U_HB``64>WC[1_-R]2)*U*5LMWV'_R%9=6P!>GDK?*1)FB[29
M&!:1+1&)H]R.5U5:_U2)?A`">Q,+4!64UK4F)^JTY)(><0%1?7-N9-H>80'3
M<GJ[X@&C!#<-7FY<_M>%.W+";UYVBD=6!;#H>G;HV-9@!8$416&`%6"3UG&I
M`6T3UB=F,T^&1HE6M!\1+GZ'>],:7=\1-ED3"7`NO4F&Z74`Y'$V$3V"&I"`
M%K#OP_2<`B/WDN:0707@'I$^KHFH+9G;-Q'W&!?\-S<!`*'APT""!0T>1)A0
MX4*&#1T^A(CP@(&(#2$`J)A1XT:.'3UZ+(!AX(0&'CYFQ`"@PTF6+5V^?.FA
M`@$`-0%(^!``)TR>/7W^1&A!)5"B13-V`'#A)0`%1IT^A3J0`8`)!#D`L!#U
M@U*M!4UV!?N2`X8"`!I\()`A[%JV&K\:S`!`9%NZ+"5@?!GW;5V^?3UH_@#P
M=0*`!%K5LMW05_'#"VI#+H9,EP/"FY&)>MC;$D`$G@&:6@8--0.'#2L'$J`8
MNF=FU98-<.7)NC5HUBEASVZIP;3+E#T!XP8.\^(`JP!2!T>>O.$`!Q^2^N0@
M6WGDN!`B=SB,VP`#GP+F3@</4<,`O!\`2P^?7G7<JEC5O]?8(0!MX%=WPVQP
M'/[^@1009/_`@)WX(W"Q#=P#H(("%TS(/0:A2@`!H`2P[L'W#C`M+H$LY+"K
MJQ0$@((.&;P+O=#N:\N#S8"Z:\3I+DA`08(0(,!%&XM2442J;N2O`@$^,-&R
MR?@:;,B?5N2QJPN"1`@I`KX"C+,DI]Q(`PPN_M@@@PTLL"""'06X#:8+C*02
MJ*O*?$F`SX"Z",W0A'KN@[B^<[-.A%2T*<^:.!M`1)]0M/,EI`H+E*.4`.UI
MQT+[PB"K@A+D\`$R%VWH*@$&$*`F`A"H2<?$*`7.@?E`K2B!'XVZ"]&%/*"3
MU)8&*T[&!YET]2#,#@I@PUI!2TG771DB($R@!M#O(5I_=<B##LA4E,=6?U6V
M05^170P``*D]Z,R&,GAV(Z&PC:J#"$[]H()F;[RVU@[*(@Q0N<`UT%IX$9K*
MH0FD/.G<>7\Z4-8/$*AP7Q=ILDE"@]X5F"X/$E@S80`"=DJH:1.&B0(`XZ38
MPJL.^`"I41]U-..U_ARHBN(2M0+@`9%[:D`#@Q-`>.4%KW*4TX,`^%1FK50\
MUM4#N-,*,%5U;N@!``@0(%,]V06@.:()1$I&!(@[..2.K'XZH:PP4(``F"/P
M.H!N=\49+`+.RAJBJPAS`($))(C`Z)KZK"QM^%24,0&.#0I@:+M/\G)N30DH
MX("FX6V`7*V\_/LAYA#B0`(,YH.`4,4F;IPA%1FH@`(#'I:@@042$V#2S%G*
M8+`\'U7\UZN$A>KPTQ62':&4:O)W]N3TU),S`$S7O2,,.`4`@=SU!M?F;#G0
M0(-T8>JM(@ZP'*AG4!-`NTF;L`X>N`$*,.``!!)88(&IE/J]>Y88H*G!_NR1
M;<#R@>#,4W'K#<*NP04@DEO/EDPK#4$V<#_<#"H`2"J(ZBA`0/5!YEIE:Z!'
M*%`3X`V@8?L:P`(4X(`'+,`!Y9&3WQ1R.WP59(+'FHJ(,*`!<V%.(Y_R@)&B
MPR"F@9`@!KA(SB+XGN?M,"(3A-1!-F"P@;BP5D-Y%.!J`K2;[>\A`M#5@1AH
M)P@@@`,'@!A!E.8T'W81310P54(00$2!Q>P#L/H($)EH$*$<RP!TDM>^)LA%
MA)!'7U[$8UTXT$.77`!WE"'BK>!5`*L9CB'+8AZW&M6YMTU@`NQR(B`=`ICO
M(`5VU"K`DTIV$`48@$)Y!.6-/FA&@@3@.!T0_B&H'#20X0C@@+R#92QM<D$3
M!L8A,;./P#SPRKH59&T?"R58EA7,HBB->RJB);CB<I]1RM*9L23C1B!0(R!]
MX$!\!$L,6T,CY[1N($DY@!&)210*Z'"</$D:$@TB@$T*['-)8UA-'H"!N$$@
M`Q7(``4L@($L:6`#'$"E(`ER%Z9\I'\`4!KPV#)%J*2$,]0SB(HRA<US5G0V
MVI0*!1%2`*HE['8,6$!-+ED1<]TQ(QI0``8@\(`#2"!&`HL+'0NR@0T<(``=
MM6A.D_.6P+63(`4`IL!"FIB:L*0!>QHG80["``,<4"C>U&E4@9,`FF#``QOP
ME01D&IHLTD4!OUN;_D(KPB[N>=%<%%#`!&B4@!K:1*Q2A6MDB)<GV'!`9<!A
MJ$_((Y"BGD1I`T!`)C%UM*YVCP,'#(``",`<"I`G`@S(5%GC.MG%B"0`S3P:
MTHJ7,3QE`$]OA0@0$\``!G`0`BZU(2@=0"@54=:ULX%`2"5``0>`3V1(>5=-
M4MF0(*46CPVXC?%>.USB<@1/Z(NC3^I%S-H2)"6@+6YTHP*8`A`-3Q;`K3CS
M=5=B^ND#'S2G=,7;E0DD(+S(065=_MA7GT2/F`7P[@<PL-OQUG=7`F7+`=OC
MV__5+I@.X"(!(FE?`CM%`MS5V0&)NC>>F(N:Q#2:D5*"X`)7V">`87"M_BQ`
M48+HUCG59<EN%N;?8&[@<P29BG8MO.*.3-"GH%+15AN$%P"`^".`80YY2F=1
M;H6LC2P&\DL64%A*M>@A!_SF@STRE9HH0,5>S$`&"7(1R089/.<5F0<X[*8"
MR(\AF?HF3CLR2AE7E%PTJ;*5E9-74EUERV4Z4$3`W$V67"1E&O%G]XYJ)*3$
M5\U_KHB*W@>J!MC8(>0!$@""RA$[EYDA1^41='_2OHRR&=!`KD"&294^B+3O
M0(O>"$$'#1$`/'D_].5)J@K2MTNW&B)(D325\E.1$\>%OQDAZ!HCPH!H-JX#
M%B#BR7R"95='%8VNNG-$D+PVEABNH/&!H.[P_C7!8E=[(7XT=9(`0^P9HY*]
M'B&>ER/R0=UE0`%ON4JLK?WG9!/:T`ZQ]0>`>!)6U5C3$5%1"1O'7B.OV]\#
M>8"8%Q6BC/05H2I]P`,<(+H%)$!O!N"HCRJ@@-$2Q@`6F$H$/C<@C7Q5=P*-
M"[?__6=M@<J]$6F45%QIG&>VW"8<UP@I[<8!<O5[Y-8VG*X#15KA;=`L&@R`
M/AL`@0A4$:43M\`%&'`!HDO`D5L"`!8]H@"!IXTF7_G6S=<]RDVS.;&WKLA%
MB`R1E(R-:$&4+]BU;F6DC+I.$U#R1LQ5K(W$A0&65E[C/$<0HZU]W3*O$\$]
M<L"Q1X2@V58(8!"__J_;>"EW?J>LNH4(@*JC:=L?*8NC(Q*X-$-$L9EKEJHA
M#QK)N\@#G5](`BJ/)@/072.9ZK5&[C+@CO2Y<0$PT@E'3QM++\H#"R@]AU0T
MTH@8CO8;F<`!W]R0D#:.FP/YH-EW;V&DP-Q-D&;)LSU2TL=O1$6HIUC.)BCR
MZ1.X`V,:N)\S,AD\47@CHUS\0I:;-@-PEP("0'7YI6N!317*7!ZI"9,HNY.X
MB.,#P.53I@#(G@=()OVS,`@`M3(Y`,V[I5&AB=C3B/H3,@,4F0@8@$T2"NES
MP/H:#)TK$W7:"$5+M,TZB<_1-X^(B^!#%@6P,08(@-X;KF$:.0DH`!E<_I`+
MN+>,0+)O$C>-**G"BSD,I)B4")D-B,`1)#`,*(E`"0`.E#-YH32/0`H'Z).7
M$)JG&12^>T(HK*^X*,(DF9./(`^1R!3BXQ^UXP@!4$*!63KO>H"X(T,[T0`<
M9(OYNSZHR@A$<XX`_`B;(+^,H#:BF10)`,0\+),.X,.U.!`33!*,Z8CV02GE
M^XB0XK27D+*?`"C3<X"`&8#5<T3I2@D\1,,QC(CVX0`"H`"!T":UP*J!`@`K
M_":-@@D-T1G=&X@,:$2"B,13#![JJA,<.HFU,8E.\@YS\2.(8[GA2)!ER8JL
MB(`*X``(F"`!Z+Z38*JS"QB;4XA#),9@@@`D_AR11/P(.%F)SRD;!9D`M6`>
M@=@`@KD`\C":P9"`P+J*H.L.-\26"+@`?#FY<APO<WE!'A$`]]N(VUD)G2@U
MA9@@Y5$5J@(\U#%%<.&`BR.(WS!(^[H*=+20.$,=7>1!/(DEPVD`!QB-"^B`
M">"`"*``#ABE,VR))Y&9HR$(<OO(^FH`5NP0CLJ-FD@,`_"X#9"`"JB`"\"`
M#-"`R:``@L$`P[F(J<``]LDL<MR(!FA`>/&2D(F+<8+$GH0V!"20`Q')ASB0
MB"2/ZE(*M6B>#AB@G_0X^:.\^(N(D%N9`"`BG22FJR3+C&"<,H$9'X2<FE`+
M3D&`HPJIJV`8@$$H_C![&`A0@%?\-;6@B98!"J42F4XLR#SR@+0,S()`C3)Y
MG)98&[5X`+YD")OX-0W@RM_[@)^)B\\!OZOI1(<)&3\<S>'R(_6S$1$\BIH0
MB8!KB@MP.@I8*0<`J0+X*EK2(=DJ"@=P/7`YN9`:QMY4G[LPR_L2*>=P`*7A
MI9H0'YIP+`5H@`F:(+!Q`(F"P^RS/G@1@$@"#,/43CR:``'H3K+!"SO2%=:P
M@.HJ*@UHCL1@R3/Z3J+X/X^R@(#II/LD+@4(PHSIJZ2A10-0D?(Z``LZ$'RI
M`)TXB,5:)3.A&)C9#7&$T+C"#@J<%W,KHH*RJP^8C`J0"0T0"N[R`-5!_@`'
M6(D+X)2N'">>&XB\2]')JH`"V$]J08IW8Z,$:!4/\`]%XY@&.`"MQ*,,V`T_
M*E+7`@S@7`S\4@WZT9,`4,`$B)LQS"<5,21DN:JU*(#L68#JW%*+8D`K#8OT
MP@T/^*`8VJ<*V$,*:,H*X!1*+`AVR;\RR<Z(@(`=&X@+8-(YS:D+8-&$>2J_
MN0I")8BARTTZ32Y.251(I9@N&1+G@<IOLRZ"&8SZE``+R#0,^"`@'0@?B3:=
MFC\%8$A0]2%;J[$\\1('L%-P83(-D(`.J$S4B!P/.*J$9*.:P$N*"<6*H``$
MZSM<K:CIL4\E_2HY'0A<)(B2^M4($@I\60"W_J/6';*B")H*`7"`AALCB%NL
M#.JEQ-M4BZ()(Y$`52S7!3G4V('5M`&,3)%#ASN;!FB`[]'%A3@JH`0E"N"X
MILK7$;E6H*"GCQ,?&8W3AJ@`%OV<`?C6!KH`7WD`3'W8X*$`<GV:P%$6=K(`
MF,D3PBFJI&F(`I@H"]&-\(```[#7]QS9S&&ZC%P9/[(E<X$O"E!*###:T5B)
M6VP(ENU&^!C+\/B9&YK#G>T>M$L;AQS$`DB,R4B,/;02#6"GAO@J6W*MSZ1:
MH_A4Y>B`!9C0T'#)T+"UR7@2F_J@N/`C+\F5B&0()MO7'9H`73F`MCW;G["J
M0O$`!F@*!A#-MGC:_HT8(**PM<3PH"5I4Y%8B:_XJC@U(IH`2%":@/LXML'-
M(ZOLD/,@"L"(2'<T(A-C%[-CGP%(VZ>!@$UJ$]$%)3^*7;YX`&UMB;54"R\)
M1HAXJF9M">&LD\/%%XBS75!"T05YF*)@MMFTK8\P')MT"N/XE0&0GPT0V>75
MG0.YU?UH7IY`"JJY"GRM"`28L[`HDEW94X)X*>^UFS9=6H5-#P$S"J38&P]\
M5)1H/K:(NETY1R,QFMR5WUTQE\5-#J3H6[?`WD'T68>X"^M]BN0B%0V()`(0
MW`,^'09H@(@-C04(7I=0$1`[JA%6"`_0.`OH1Q#^B'&IE7/MR-ODX+2I_H`!
M(-[9^(\*IB;"Z5^&N**:2`"!R(#.-8H!H&$>0<Z06=,:CB`*Z-[PT%G-H)H)
MHN`&F52P($E0D0`%8"(.^M)J<N(%>8`7XP\$4%:?0*B!L",[#6#0L-I""0``
M65#%V*/IFR&BH;('F6+-&)4(2`#LJH@(:."GJ`#CI9)(0H`-[@H#EJX<)A4,
M\-+W>(`?]HV^>KYQFPW<"Y2DA(`ARA1[*AYN'6.=J5DL!1(,D)SX!(_G?8JU
M'`CR65PM;8UI"I2:R!2:4!KR+.73R4QGTQ,!F&3DR+JGB%Y8AH@)R&*ZF-<D
M\:/=8#*;L.2<@N212Z?/"8#J\JP/>(`KQHWY_@R7"AT,!E(6KMT`1(8*"ICF
M$9$`8-H`F?R`J5CF7A:8KR(`SBCB1^G7V?!(J$#F#U@`,TZ\(<N3\:SF@<!3
MCU`1=&:0VC6(#Z'GS'&V(JRB]W`XK7!'E:'!`KC&MRFZ:6HXIDB`;.:=3"%3
MI;&T"WBE2W%E;^GC!1D/A`!:!4:3A([HAGBD.)91YWF/B^07!*`ZE\L3.]*3
M"0"LO]+;CLB4&'F`#"@<`#1B!O&82;&U>;YI8(TZGSHL5$Z/.GZ*7<(+238.
MN+&`!Z@`"6`Z#W8`"9``#3"O#+"`"5"9"/@@!$#=)$Z(`RM41F:("N!=#L$M
M`%BCBTCCJ^Y`?9D;_A=FBS?J"J4=B`,AY87`4QR,ZU5;YX9H9K;(8Z)`"B@%
M$`H8#*LV[*<XO^08)5W;QY9N90^Y1=-(B<CFX8*`&8/BZZAXW**8(-.YG;\>
M;<@1BR1=##LR0`48YMG@293!ESWFBQHK"'!6Z*3FD<`NH?Q\8^^E7Y;X"U>1
MV>/C*`M6#M4F[>H>C,+6B@TMB`P0;7J9V@<IWX,X@`APF]XFFK)H:H,X*K,(
MCW'NBI3@F.@H"]XVY@0![<8RV8BX"H86WQ&-9058@/66;VR1G'@EB`$@;]4`
M++#82#NCO`>NBY)2-*0Z"=6CDLH\B,!"P0>G&(*1,0D`;LF8U9T1"9'8_D/+
M*.0[47!VCJ0,R``$P*&:H&D4)Q7<FKP?YPL(["(%L%_^.*K#0%U-$6P@%YE.
MFHH#$`!\R0#T[0D,"-\41/"G`0R\5H]1&H"OVY.:@&TH=Q66S9,#8"L/<XIA
M'-_NF1HEOD8$F"T.-P`L1_-?Z0`J%1U/<@"JN]D69XLN]"*D`//],-K=()8]
MEQEN<>2BZ&<ONHA(AXR4*@B'KJ]GS<.X8.7@2)Q00J`D60!\T5Y'7YE`?X\!
M^/0&V@`47A#%+0@,@'54KY4(0-+T*#E0RFP.*<$9J6TT[U@;N5?%#@OR(28>
MGQ*9S`X)`'`T/V@+>:[P.'`JF7'%\.X145Z"_J!!6\^8P2#TMK"`9R^0FK7C
MRR:0T"XE=/=V4@D`(N\+?SRG&X\4.N+"=D^8T%6.:/?7&N>)`&*3`1-A?!>8
MB2#XA7@``S8`,N+!@U\HY.!DAQ<BK_`)+;FA))=XGMCL6G;P@\]VEA"*`1G"
MC$>6U23YA#@]GZC+ZDGODW<6P7-YH_#J6H]Y*@'1FC<*@BV(!\5Y4O&1GC>*
M",@>$@-Z.]'OHO<)=?R7?8X)I`^-.W9ZGL"`S^VP*(8)?H_ZEV``?\]ZA4@`
M+NKUY#!VG+?$KF>)A2^(",!XU;AVLX^(KVIUMQ\K=1(`JY?[!3%32X]YN2Z(
M4KQ[*KF(L3?[A!N(_I3PYK\OD)30>Y='@%PA"`)(=,1/CP@X<\E/"`,HH0*H
M?,M7#W.)?,YG'R,Q*<XGD=$G?8;X^D?9_-.?#IAIVL6H@&$G)L<FD`]RFJN(
M>];OZ9;OBO$;KY#B>L@@``AX"\K4?0Z9H.`WBE&7KB<GD(^=BZLH\.-7#P9@
M][98^_]9_!$Q%]F/#/4<"-RG_@?9CMF8UJB(%OKK>."0@`P+G_%GD#!J#>87
M+S_R_L7P0_R&_P(9G]:`-8#X('`@P8(&#R),J'`APX8.'T*,*+'@@`,3+V*4
M6*``00(-,H(,*7(DR9(F3Z),J7*ER`X`,+`<J6!!S)HV;Y*T`(`#SIHN_C,(
MY`"`0<^B1H\B3:ITJ<H%`Y@V!*`!*M6J(A5PM`KR@,6!`"YH#2MV+-FR4'4"
M+>N@JTT-'LS"A;AA9UR'"P"\%0C@8]V^?O\"KMM@0EZR`";@Y!EX\0<$#A@;
ME$"@@T`/`!1`SJQY,^>0`&B6G0"`<N?2)+-N!F"!H('5IE_#C@V9`$S#?%=V
M*"R[+(+;F1M\%9@!P.[BQH]7C6!6`UV6N9&/M<R9`-L/`JI#SZY].TD,$M0F
MX,Y]`>C,&()_&$Y`//OV[A=^9@KVX,_WR(5N%C#5:WG[_O]GUT`"&RPUGT$7
M!`"@<0`\H%D`X7E5FX(34F@:<`2*A0`%%<9V_AYIC"6@FE?[<5BBB7]Y9-B)
MKPWP&&12$10`42O26&-8`A`GU@1/G<2!;C;:-!>&BRD`P'=Z20BDDDOV5(!R
M8AF)$@<?,AF3`P)`I@`!BC7V9)5?@GF2!%B&-=>/8?8E@(&`08"70!>(B*:<
M<T[$```;:A4?G7Y9@)U?!K!%`8-[FL@EH2$=T%Q5%;AYJ$H51$`E2*,MAEYZ
M`+CHZ(22:CJ1`3E:M8`!2VYPIDTZ`5`!26M5FM8'&GC9J:QS(C!C599Q.BNB
M$(YDV9`.D:@4`-5)@*>NQU8IJ%8[(EL6!;S^%2><#39;K8W#:E4`!-9&)``!
MY"60``('$`"`JR,%_F!H70NH.M``VW(;;XD-K%?57.K*FU"1`/#;[P(0_"H2
M!*/^-0"9'U@0:[X+^S=4J`DRW)`&#130KZDA699D7*(.Q)RQ$8,L'@`&Y(I4
MJB$[!!R_!)MD0;U]!="<97ZB7'-QP`6K%',V,Q1BJB5[IK%9#QR@V%P\)^0C
MTIM-`+11#?2W]*L.$!`SOPKX5I($+*N$0<`9D4R0PSRO&=3%4O>%@0#M,D4I
MVA]8W:_<YY840,XG75!V1CJY]@``""!]]MN5,O#U41`<C';3!'F`@=,A.8!9
M70"L7=F@@V,.609*MWTDYA401M`#^([DTMUC55"8QYFS'I@"$`A^DP2*_J+M
MDL4>S`YC2@E(;E;C;@VDGT`=P-NZ\609@%C;MKY=,07,]1L`V^U%<*?8KH',
M`=W'+Q;!RTD)%3O*!=2+@)&/:\?<?#H9SKW[5"$P?5+HHYPH!]`'I?Q[#!9F
M[OO_:T4"/`)@3\HE-[E1RST'*,]PMD?`!Q;E+A#$2040H(`+2(`!$I#``P!F
M'QQA:"Y"FR`)8V*G$D:,7R0*@-Y0Z,*3&``U+^06M@0B&NS-,(<DX<`(=2@K
MR[!M+O+S(1$OTJ@BZLIO`S'?QY#H1(?(Z(FZTA.2I&A%AA3IBIW"`/88H#\M
M@K$C"@MCF-ZBF[F<CHQJ7".0/#"``<0M``-(_L`!!@"`XI6F?6RT#P0"$(`%
M$(!\!/"6'_<($0]`((';&9D!'&`!0?%+`+.+S1<-Z9^Y3,!J`WA``!QG1QQ:
M,B%VU)UVJC>D"^"(417S7"AOTD-9?8H`GX+6T5JYD`=4C'3&@8"?WM*O5]H2
M)>)[3P=TB1&Y(0"/U@EF2H9I%C@QSRO\,B8SN>5,AW1``-XZB*#H1\8-%.!(
M$'C71-(8$3VZ\C('L2/$JNG"`6#@=,JJ)J,`4"\[7:XH`!AC3^!D.'[1S)T/
MS!TH/S!)9EH&`*4:2`8J=A0%]`XIWSJ(Q02*0APIU"`.:&<P`R!#@53OFB:)
MIE$L`+B"0.^(%H4@_@`2D+B!B*LF%3`GYG#T@`Y,A7C\0LH!^(F3EAJ$.7;T
MYDHS%\F#''0EPP'FX(1R0'XU$2<7"*A-A!*U#VS`:D0MZN#,][V!B"8F620@
M!?:E+3-*E*8QL0"^G$H[KOZO7P=Q0(X\T$*1Q.E]&I!06CA`S9C@!RD!4.8'
M.#```S!@JW"56@$.$("O><"GW>$H]X3BIQ`II2)'\8!'#>(!`Q```8I=+-(V
M`,]<N2TE`6`E]Z8UO';=1:TL"6Q1F,.KR'Z``>1["6D!>"4.:,D`"1R.2,\)
MJO>=QT4%().='(B3`S@W)N!\3O6*A-'>_F]F,;.C`V!RE]2>I`$D/=YP_A"@
M-GL*I%Q,7>MQ;Y)2`,0M1`&@*G8'YP'S1:]?`@#M2OP'P+D\=93%18D"ANB3
M"8S+,0EX3`>^6M_C<8X!%.A`)5$R`0>[KP,+2,`"&-``!]SEI$IQR5*@=9[H
M/KAU?R5)E&;X``P;Y8)*X<!MZ+K>%+]M7#6!TX!;-[L>XPW&-V'40`0%9!R'
MC'<UH9<.NPD52QDEGT)9,9*EMK.8Y)6`'O``!;RV5PR4Z\@FH:N806*!WH6U
MRNX;X$K@1,*GZK<JZ#5*!0;P(9VHV7T7R!I*"E!A`&8``18DCP`&$-&EJ,\H
MG-6=$O-\/$S-MKT$O`"*X4?9JD+`<V9R=$AD_KLG#K#V).0BH5,-@H"7=JXH
M'MB`JW1R8TXK)`.CA8VG19(`-J,DHQ.<"V@R`)J8:24!EXZ)!Q:00+]1&=8A
MD[1)TCS!C.DE1W8,"V]Q<N7A,5O92YNV2J)(ZJ%X@%$"*.9.`\BU#Y0Y*FQ+
ME+8SAX&HD@1.R6X=G(]*[1_5^B(Z^1")VSTX-Z=$`"(F804H8($+8``#&=!`
MOB,(K<JLY$$#&:N_D[+J$FD``@V'B$O2_6#+5+HDY^$2HV9=<61Y@`/HS,BU
M=6ARG"Q@V"DYCX3FB1&/GYQ#GUTY1A9<Q,.492X%3<E<V,*O(Z<\YYUZGC"S
M[<([FJ4!,C])HT&J_FNEVZP!YQX)U9"83\/,>U)=)"S6(];ODP0@4SZ$M%DD
M,'"5#.=7H2X[R(IF$G]ZG<]AL<S&+Q(!7H6(YW2OE@86T/>%%&#K.1R;6=H4
M$]%XJ7J#KQF46_)6'5+1+-9;"0?6I*7)K\0#+^=.(L?\T;4?FBQ^$WQ&U"D0
M"Z`:]"39,I`,W/K#Q_7A92'`GV=_+I?`6_;6TDG8%P)[*?X-0!00L0*F+OQJ
MC=X@:GJB2^BK'4;5'+S/CQ?9+W(>*X[L/QUHY$`,H/CM-PL"T2>(^<!_>O80
M&:;O1S_W!#!T'5IF_MSI@`0*$P'GTU^G9`"DU%<!X%I[5(`$W(:A!2"W_K#:
M@R$``&8'HQ3&]S6@M6!%?042@`"50"S7!5I3?;&=?32``!3&!>@?"*J@>U2;
M?<")J^C6"FH&[<D@2'#`IPA``:@=>R05W#@=^M$@8*@<7'C`#A;5OO"+$7)'
M!GQ/^\G@$'8*__46)$&5?R3`AS3`7=4@G3#'^H61W*!3\3$&G%")(FWAH7A`
M`;P="8U2\N!4!GA-N!53!$1`(CF``U3,WR!`#!&`P02``5#``O3&!]333FV`
M!3P2!6P0!DB=/2$AY8#6(!D`U`AB!"B`!A%``D2``X@A4E1`IG#;&3H*SB&-
M6]7;*:)B*O)+W*AB*]9;7+0)]MB<*!X*!]@>_@%AE"OJXB[RHB[&Q7!XB2S1
MHJ9T@&0!4+](C@10C0&JH0((@`+PS@/@$J"X70)L4`-\(@1```=,``54`-08
MT`(D'E>TE`(X0`18``1LS@1T8P54P`9HP,)M``9$@*B,"WSE(N.5Q0O"U%4-
MHYQDG`O9#BG-7+DU';^\&D;4$DB((T%0W#_2B>,]';]HX4A`CQ<>A%M5I$@(
M1?`=T@AJ%D2*I#XA)$L`F$H`6);MS@\Z!`6P&5V-Y)X8X_O`24FNQ$FFA&C8
M)&ZTX,VAQE[$))V08LV<!T6RQ,RH1.ZP)$D<0`HV!`/(T4`<@.X%)9-8H@NA
MRLFPQ`!X9$CXS4ZR_@1!2D0F$01P5"6:T-A$=&*UJ(Q8_D7U\,M,DD1,8<3L
MW$;5G66US"+2C))6=D^_=*7(7=Y#L%O'2&!>ML=&?L`!C-="$(`2UDQ?KB55
MI%3WH80!4.5#8*.[I!YR=$!@(N93*A9SL%Y18.1FM`E\949"M5A-,$="%D0$
M?-&SA&:5:,#Y)40/6@7GO$?NQ!Z?]`MDIH0$342;I$4:9F9MFL@%$$##,<<M
MH@PD'699%")L8LS50029#<0?*B>I=&9"5,!OV@P^32=9#(=1AL0%.!/Y3`0%
M<)1#=2>0;,`:*L0@#@X59H9&8DQ$^!=_/DE]Q&>-3$`!B!1V2DU6:D:__LP=
M2R".1"#`]PA`8P9HA7"G0P2:9Y5FL]3D4L*%U>C=4;:F0YS'?EB&D$WHA*C4
M0@2`&4K-AFH&1GTG2Y@E1-"<5(KGB2J(`$RGVK!.4:8H8(Q2[T5:R)5EXG0=
MCIY(!RBF0-P:O1U=9O2+7`XG;A[$INF%D"*I^%$9<RSHTF#4:1Z%6UDF2PP'
M40W2G7%HEK9'`CBE0.CFV[C59%*%`;'H31P`?2)$6?4.`AR@FOY'TC7$8QK/
M*&6H6.2A<!*;@2:$`TS/C/HIA4P,0Y!FZ[!FH6H%:WZH3<200U#:D"2?TDV)
MS5A`G19$`\0H8ZD0E/*+A-;$O30$!KF*7SZJ_H(P"WS@WL)\2G\&AEN=:DVD
M"$/T%$$D`)7.*GMDD_&E:<VPIG5J14HFITU8X$)`0`*DA4N,:;%R2`$\J]3(
ME:IN7E+,$1:UX-=AJWUTG$)4'N:D5&:D%&A*EZ+&IJ5T8+G:!^Z@&)Z1U\ID
M1DIV*4ZLZ$+L55[,!:+2JX(@0+]*S7FVZ7)$J7RPY#,ZI(D6+`>":;-`C\3"
M!5Q"7=N0ZIMLGE!DZL1FQP;<8H-R#X#UJ5_HI*PFA;,=Q$8(*YZ*;':T7$&D
M:^;8SHW^8K]8JDKL4T*0QT`TSLR6R'"\3SV5IV&`I5*\Z4#\G=@@+-'"!I=<
MP'?^J_OD3M**A5MU_FR402:_A,ORD:O4%D<=<1A^"8U+]&S(N*BW1BT%9=M[
MP2?9(L>&]LL0/>3Q^&B"\DO71MF"_J$""!<#R"S=FD;<A!:SJ:3Q("ADL*:[
MX@1F<>(W,L`#>(U`,,"GW*KA]H50!(`"*,:`,$`&9,!J>=O[K&P@D<L`>-@?
M_LT!Q-``Z""6"A:_K"WG?8L&#-(;N8U.$JGL`2J=\*-P9`"]])31`A`^_8T#
M/``@)1X"\(X@)L`#Z-;/:@6,6H5+E,<!-"];6`#5_"[P$@J_E$>;M$GH8NS;
MK.M#E.Z-Z&M5P(EK&-"W?F7X<NYB0(_GX-*&00@"+"S:T!4`I"Q"/$#A_B+%
M*'U4!Q#5CYC4DJ(KM2@PP@W)5[+J_6K&<#A`ORI1J?!F0W@`[6:$+HW>4,(O
MO_PO2/EM1`3AS5D-E@0PG&T`'VJ3*IZ;Z''`?RZ$4%1D'DJI!3.&1"9$B"0*
M`QR`JBS`:B#&!$S)`UP`X#C`!52/9#1`!FP9:20=!O`$!7C$P27,=X@7`FS`
M_P''=Z&B<D3``W!0!PS6)2Z`!&"``6A``6```Z2A/5$`!P@`!3#``#"<02FP
M`R``@DW`!ER``<13`82O!5"Q`G=`!D!``\RQ.7+`$6^2H.A6`""&6YP-#>)3
M`T`--(X+#L:-`00:IFP./,(A%R6B!-3A`SC`_B<K0"CCR"#)30!00#<F'"IC
MP`580,%-@`(R+P,(<SX6``/PGE]]0!9^;[$Q`/-F6K%P,<)E`*O%#068ULH(
MP`/H1,4(&0+XXT!43#;[L&R4RX)ZP`$\XP5T'AT:0#X>4)&$,W!\2E_VCE#4
M$^+(32S]S2CI1P<\``7<LL%90,)I`*K<!7,>QF6,C!S=1;FLZ%0BD#W="8$`
M#R&^+HY4!+_\;DK*#0'0,K]8P`#,#J1,P"7R"WY9;T'XZ"GZT0`$$J!84![V
MX@%I4R`];[@\8BN6"^_"ETZ98+Q]8P-L0'=QXH-B`!//%T)D4P$T@"Y!D@./
M\U\,!XZ8"@3DX0=X_F.FQ3$'-&?\3,`3@\5W;,X'@$5.C:K&=$!3;PL8;T"I
M)-!;/&._:L!"B0Y,P,1WN`90!(OHE>;HHEL&0&Y0S#4'W#%$*.,TLS+00/&&
M:(`$=`#Y/"MK;@X%/$`%.'(%\%`%/(=:4@9A6\"J`84U:T"$>A9(-08";*Y)
M!!*U(H1!1_5K8,`$&)M"J&'%7L1Y/FL':,GM!H8#Z?%!G$?(?D";3,"U-MT>
M,MMY0$#E&H`!XX1+QPIFM_4'?,8CO;9IS,4@YDT&_/(#^!KA#J91)(`&-8CZ
MJ><WGO:<08=;BAY%><O0?D`E34"#W-5GBP0?>]8JPI&@A*UD.,`FA4@/_L<$
M<S!''[;(9^`C@QCW=0,&&=/T`4$%5.J6.^?7`LAI8.3*!OR9S_"+J5[&(RL`
M.F,-RV+5`$>$@;E$XG;X9VAN@8V&ZS'%(^)(D9A/`]B1^3%X:<@-,3]HOUSX
M2+0E?)TT?&U7`.!(:F]&61D$!Q2`D;MBZ@&T2+P%IS"*2_.++/7E4VWK36"P
M/[?T4,CTU>0X9Z0AJ^4&B2B'!S"<<.-$9''`MAR<0&CCJS0V=,;&!KRM([\>
MI46``$RK!2R8!"C`8U>8_3)$YB%,`YRQTA#(9U(`I27<PI$P1G3`_:';F*O@
MP!*$`U2P1/!:24`305"`]6%ZJ2?$!ECC?*SP_D3(L4!H`!,+^$.X1`&01N28
M^JU+A,*Q2IEEXAFCMTI``&I#<K+B>K&GQW!T^D+`I=WXA-5,NK'?+Y(/3T_8
M-K1;^[5C>[9K^[9?^X]S^[<?1;6#^[B''KF;^[FC>[JK^[JS>[N[^[O#>[S+
M.VKR]KS;^[WC>[[K^[[S>[_[^[\#?,`+_,`3?,$;_,$C_+H74\(S?,,[_,-#
M?,1+_,13O-D]>\7?^@:(.\9S?,=[_,>#?,B+?$1HS\BS^W2;?,JK?+8_@+2O
M_'4;@)V__,S3?,W;_,WC?,[K_,[S?,_[_,\#?=`+_=`3?=$;_=$C?=(K_=(S
M?874^\)<7-.CG-13)'W5=\;%6_U9/GW6<WW7>_W7@WW8B_W8DWW9F_W9HWW:
&\TQ````[
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>f39432xe3943237.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943237.gif
M1TE&.#EAT`*7`_<```````@("!`0$!@8&"$A(2DI*3$Q,3DY.4)"0DI*2E)2
M4EI:6F-C8VMK:W-S<WM[>X2$A(R,C)24E)R<G*6EI:VMK;6UM;V]O<;&QL[.
MSM;6UM[>WN?GY^_O[_?W]_______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````T`*7`P`(_@`_"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRI3IP4,'
M#S-SZMS)LZ?/GT"#"IU9$V=-@D6/BNS`=*C3IU"C2IU*M2I5G`*3%AU8E`-6
MJV##BAU+MJS9LQB5,OQ:DBW:MW#CRIU+UZS;NGCSZMW+MZ_?OX`#"QY,N+#A
MPX@3#[W[DK'BQY`C2YZ\\VO1IHXI:][,N7/*S!8M:P7=EJM1TIZ%HD[-FO-J
MD4FYWCPX^Z/H#[%;+^;Y6K=OQ9DMXS8Z,O>'#ALZ'-S0^V#SEHZ?=U:+>R8'
MKUQ_:W]<VZ!R@3=M_GX/2UWU]0_7QV\ON.&"3>FP*U#(@'V]?<-;LV;/7MXE
M?-G=!<4!!`8<H``"#61P7T$80(#!`Q.H]](&"SCPP`+N+:AA8!Y8X(`$'.`5
M'F\%<1"!`@"DN``$%82XGEL=5,"`!!!(,-,&!QA8``(7;.BC7Q80$``%^OU8
M$&,<7,!`B@`<`,$&^VW'07(#=:"`!14X^%]''DR@``,-#&"!D62*2$$`"Y1I
M$'4=9/"``"D&P`"4/F9`@098=7"!`Q8T**%+%33@P`)CJFDH7#@.0.2APW$5
MP0%P`D!`!'3^J,$%XWD@*`86_*D25A@@($`"!MA8)*.H6B4!``5DL*5O_A<L
M$$"*`CB`@8L^XK2!`PH.E$$#$'!``9VO9M1!`P`8`(`"N*;J[%-L>>#```YX
MJE&Q<7%@`00$I$C``A1@NQD'$S2``4$2).A`!3-AP$"!#6#Z[+Q!,2:M`1I$
M*9>X%27I0+>2-A#N5/SZMRY!&D0@@04+PX25!@]4<,$$%%A+[\7^.4:!`!)8
M3-%[@UG&09AQ\A@5<6-YL$&E'^S9@00V%AS:RADXP`"N,F.LLT3]"81!`004
M*JX'%RAP[DY,Y0S1!**F.``$^2(UU`:WDC7!!`2YF0$&%40MDY<'X+OSV#UU
M$`$`"'@L4081>)U3?J4)E`$#D1+`I]H[;4#!_@/O$@"!TI\--#&>65WP`-41
M.#P0A:PBT"O@9$<>48P'%(#UOBMU*(&RDB[`+E",;3R``@>@2;A86>HG;07E
MN@U3!*4:P(#KDM>>T@4->&FT1Y!#6P'``BA00>\9W673R@X(D*8%#&A9'5@6
M+'"Z!Q@(*L$#M+=$0;`7(`"![>"K5($!T4]Z[6`F%D"K`_6=ZI/*$I"ZP`,=
M/V"``QF*M4$$#;@=P9T)Z)A,.D`!_#U@4>%+($DT,*@!-.EHNGE9`F;%J@D(
MYR?4>T`"#$0Z!5"`::030*E8!I:Y@6@@&I"8FWKDGRKM20(44Z`,;>,S`C``
M10D@H62B10$%.+!)_A!@X4\Z8`&%.4`!"FB`#Q>`@?@I8`$$J-4!`)``"(JE
M>H42"`5N5B.L$,\A'KCA$[,WPS):I`,SJD#I+C<9MK3)`104``-Z]3RB<"`#
M&=``!1:`@`0L0`$.F$`%_,BP`@B```1P$HH$``&\[>8#$?C;0-S5@"R9*B9F
M`\``&#`[,WK2?1'Q0`86T``)&,B*P$'*!DSIM`-(X(L-B=9-VE2!"SG`9@>4
MEYO^!8!1/2`""RC`$Q/0+0,<#98FP4`@"6(!`UP``@M@3DPZ1``#/$!1G_1D
M@"0R@00@0%F7G$P'F/9#HYT.E"R!&(0,$``Y,NP"&MC:`PZ`2`88Z`+)_D$.
M!C20)!0%X'-D`:8TT4.C"5S(D2;A6P00X``=9A-\Q>*``PR`+`5$!BO"4D"D
M7.E0_TB``=U$&P4:@(`<(0`!-"K0`!`0@:XEP`$)@4"*+H=,DZPR`E_AP`(D
MD`$!RH0#$EC`N[)8TX?.BUN#'$#B$I.G/4:J`+SZ%$+T-(']%:``Q`3D`O[X
MKL[=<`$!;.($&`!0@U`@10XH:FE&R;*KC:A="4C`C#IJU+H>A`(HG4`!!C"\
MQTR`@@00WDGL99,,5,`"%)B@`A+0`&!Z$%GM%&8":G0T"%C6`."RUP<P4$PA
MCD4#$*``KCJ@`;IF#C<2H!8#8&K7UBZD`BR=_M8!FF68#BP@108H*TM$V40$
MM-./ZH-:NA#0K0!X<W0#%<AB+7!.A&@``2E:*EFHQP#/ZBLF%AB``.3H*M=Z
MUSN&.Y$`=&L8!P`@``H@8UMZ^,>KTA-H'N2C(0,0@`$L8`(14%\"W%(AAVS@
M30!@;5DX\`#K]H3`!IAL%K_+8($PU+R.4PP&E'4`.O+..3*B40(&4``--LEF
M!<#0`X1T`/I5`$H<@*XQV?*`!]`6(1UR8)K.LH$*6-@GPG(`BURDU@:3::L-
MZ%9:\0,>\P*`O![AP*5H]``%"'.U#4B`C#B,`$/>[X/S,<C9&*D<4+74(1R8
M(@*22Y;!"06--NR?_H\9O"?+"N``J"2,!QZ0HN]]A"G:`B8]!1``[S&@I4U&
MP``PJ]T4S38A%^A6-!EDX*DB2U$]-HD':!1IGMU62&Q<LVLG5LL&+-@P9P/`
MS2"R&@]4X)8%,``!"E`!"0A:2`+@,`,&H-0[6F"*!&BTSRCLNMYX(`)P6D"E
M2S)2'O\D`I.5ZXTU;=1)H_2)RQZ,!685X>:0]IE"E<`%GKG!$&YRK*ZTP`-F
MY3D'"-,!!Q"P3`,0`6O]&@$N]LYW0.,!"JA/;&=)H7II<AP(H-33S/9N,Z<(
M@`9XL3`4HB\"&T*N`Y6.595S\K(XN=@#0B`!6(4AU#Z@1@ONC4YT;E*T_L&3
M`3)S'`&=E-J1GBNI"B`T*B;"P,%[,DH-,C'@K9VT`.;;[L.\#$X-@`@'&!!9
M`V#V7P,P$`6X-H&@>K-``29(#SM5@14A-@'G3<#('1,]`S`42J2Y;:U>+)8!
M84\H&2`FM5Z.\X<,&S`:`*EY<WW=M\-DG`Z$,XR/]`'FZ7BA6B<08REJLT@F
M0``(P,"!A/A?)_GVJ@BZH04NJ)`.O/0#&;`<4CK@%;8LJ<_[MHI$D;P3B1Z`
MH1&Z+E/_XH'VJ8EZ.EY2O`VC@2D.()P)(2(%/EJY5:,\Z01G5;LGC3_J14"(
M&@@3O)<.S^N0F4HJ!X\$!#NRE-?[0'/*"K?._GN`T%=%4YGV20=T/%9G4J;U
M)M?+-M440`^0JD=NL7MC<`/LJ//].!?8FY.!9O1!&X#/`A`!;G);`'`Y&!`!
MYS)6$:`[@$0!%F!:HM0`!Q`O#)(O&5`J6+$!&'=$Q&5HEY,N%Z=)<68U#S""
M1($;<]-8"J!KB%$3Z]=V,7$]$W!;#"`AXN$4+Q@:/T-%QL,\[,0DYS4C&O1_
M`/``#Z,^#Y`5YH9N$ZA$\V."=60BBT5*+*(<%H``"\`_BS80W?1$#*`^<J(`
M$O`H[!)JX5<6QY*$"R%_`C$!@=1JW@>#X?-HDA)^K<>&8,0!;!=+M<<JRZ8!
M6-=+A98L"R,!J=9D_E[C`="5`!H03PU07W\V`5#H7)YS'*:$``X8B,:5/5@Q
M`>?5`&`E5\JQ*@5G6L5!$A#``/=W'!JPAR)!+GC5<W*831-031BW`-U5&+=5
M:P61?,(D`7O$)`1P>+6R`;2%=0&0:O=#'T?Q'#\C-#'RA13D3-'1=]W"(W9"
M.!4`)Q561V510,TE.`A`>BPQ2B>U<+-81AT``7"6/`(F-]KV%T9&`#Y5.`_0
M*=;H+1""3P=A9)B(`::X=P)1>U:$',P#)V.V$!D`7:UR'+Z"=0*`CFW1,QZA
M`3!D@QG0=&WCC=KC=0=PANDH0W$72;1V-&SC9"`Y%UA!`0#3`#CS`?]%_B<X
M<E[LHQ`3X$!IDQ$78'X&<8$B1V^015ZA)ETH09$>L45_XB4,)#0O@0&DH@#?
M$I`A&3D=DFX-$#R'I40-0#\8X(ICL0$H`@#2PR`1!I/^E)*3A&LCYQ!Z(@$.
M8#)K`I$XM1">"`#!H@$6,`%8LB3V-UAK.&\9`5LZQ#SE<D)2Q8JQ<DC%-613
M64::4B/$E4AS-7Y5A(<L860%8%U7V"L$!B>J6'E+TI`4,4Y5)H9D)RTJ0GD$
M40$I$D`00#H,@(S+0G8M<1T%8P&5:1#1`P'`LEL]%4SU16MYEXN-J4#2`@'(
M]DW'IT1(!%)=MA>A]D\$82+9AQN_0T6T*3A@_A*'")%Y+JF':X(;+-DDV:E%
M3&(T*_,!%)!TR7),TV24$A$KHF40&L!$;^EZ)I%:U00T`927"D!1Y5F<8R-*
MYK9JR4@JHU,!C\*"<K&-T25UN0D>#-E7X8D;*^.5`VD^"[$!T$5W#)**2`0P
M8HD!B\(_ZPD`1#E-'*$W$J!#!!1:$R!)*6&(.R5H![!3#0`TF\2=`GHQ3IDL
MP8-N!0!#_S>6>Y%V*6)P`]E?!2%V#_"<:7$0'*``<[D0NRA)2S8H@#1BHX)6
M-3-]::6(8AD7R6=A>7)\O\*C&T%@"O`K@W92JS9%>M>C"I1H]*1M"T!1@C91
M*5H7'1!R$5:?#:!#_L@RFR-Q+&K&D00!J!2P)WU4(3T"6C;F0#=S`>JCBAZ`
M(CGY%AQ*>AL0H_BEIAIQA:>V(T$F0MZ4>G2:0`MY7B*D`.VT@FA4DWMQ)IK$
M4W_T:6U83*+*$$E3)6])CH*C+/3E3040-=2#4C"I+`B@A__Y4HK7GI;Y$2F&
MEB35/1))$MI2=3O2--*ZJL9I;V]6.6YY8K#3IW6!`77S9S)W$#LI*0PJ$>N8
M`!'`8_EE9PH1*K124HJR,GN4>E,J*6,B,!W0(-WR-!@J%"-#CA;06+>D($6E
M)V9C``X4/"<U<^!J.R9B(!OV)%=8`,'2%YEG:!?0+-$B=O58H:O8C\M"_DI=
MB2PSIA":TIH6T+"#\H.4(A#7Z22+@E>S@EX!6A4O,WD)P32@A:\@P1;*]``-
M0*P)$"'<LI89JS,8M5!`<P!7]Z1\@1,C`R=JJ*@"L6Y:QQ&UZ(9)9#]4M&Q&
M47(?4)<*H!RCY"THYR#(07!RXH9[Q20&()4$@R7$8A`8`"X,`U"`@QQ$!$4;
M]20"<6L--;5B`9]BP7(4NX(<LH,QFQ!!TDN?1DOMBAX8T)4,T4U@%S\5P@!?
MBQ0R<C/3)K`?`(A^LS7X12,0H#Y`6+N:1+1G(4K'EQ!$PVH>DK`,(2R-%47%
M='8#82*)%WV.^Q2DU:LG<TW=,J>`$69HDWX$_@&6*8*.%*`L8WDL`8"UI*$D
MJ?<>$F519G6C`S`!EIHB[+*31#EGYV6[MBL`LV<7&0`!NCJ=+&50^)AD["@D
M3'(`^<-,!;!@.;B\[],4<@$[?$2_@[$D0:-9QU&HTB4M"7`A!\`N'0!='$,:
MH'4X!<&._1@T67B_=39I!P`E110!LR:_\@MZ:.$!<8=[1Q(KQ]>FQ5,E;M*!
MN`4!Q(DP*Q(B*(/`&(,5YLB2`8"6=+&2#F2$"Q%JZ37!4E:W26A;*<(`I$%`
M520W[,(T@_DEYK,!ZA-B%"LH\^7":"R=N0N6Z%H0JV4V$Q"TO%L0;/-PN&4K
M,JM&-$S$)R,7%)#!_BBRA7_!H=BY$!<`)]*Y4%DD5]:I/H>V$#_3(X$20"Q<
M,0;QKJHX86B\R>=EBR(JHV:A4TB+$*<V+`R0K6LQG7I$,N=5``#GJSL"F'P\
M-O]5(;CTDGO!`5@W`%"H*T0'`,."M03A`(D*P9U;H<]5`17P)20U(R%;$'HR
M``0`BA3$R?+K2B5G9&+IO$/1/`V!;'LDBSPCPZ]Y`!5;8FY#&K/6QK-,+Q*5
MQ'_5?8&Q)`'H,>,$)Z*%PP/!/[UR-K>G-AL`4J_)4Z;[*R1D(A/42Y%BS;;[
M-#CA@+78GF`+%HW%<,"T/:@LD!P7941XJZW8'!,V8]/:SH0Q8:'%3C3E_A>D
M&,7Y>HV6U2P/8D''\HE"K!`>`C,)UJ;N%ZENR0""5LV;S&=0-6*"TBWTBT>!
M`B6R`@![+!80(K.^XCF1A#=L\2NJMM`\@J%.-M(D71C+7",!$#2`80'J(P#Q
MFF*&]L,?P"U1AL@&<&-XA'E-MW0),+"20@$LB2`;QM!,4BMX77)%Y!6%RB[V
MUF%-!'1O03]LN444D"42S!49"5U.HUV"3&IMZ$K`V]4:`@$?`ETU^!=(RM0+
M<2QP8@`O5I=Q<EYCTGI>P3<63$\2:(3KBTA\#83)B'A"=&IT4I>-],=/!`$3
M`"<)(,=2X0#L;!`<*D@($'H<T%M,,BL&0`'U_HI.;/D`QZK99,..$!``;TW=
M*FED+EEY$>!`F>D6U?-$4/2@__4D#X``[M>HM'9(]`34#$U?)(L["J"7K]E(
MBTMNJ:A+C\@JPEH5'^)V8P4L((P0`R*BWXM#$QT1ZSDPV*TS$C#-_]?4>$&*
MR<N[?6A<-Z8R*V,B:#4Q]B3=*V@`J4;??'U2\#H^R1(B6\2.Y\5$NI+0F,B*
M`*9)QTW@&.X<%O)<YW(7@U3-*Y@!&XP`&[&3N#CA.A.X]*IJDS@7%U"Q&3T0
MD@T`+,08G`5Q6#AH]`0IM7U>TCQ9$Q!W:',NQHP>$BA';FDS2[<`<$(M#;"5
MG)W0GVD6?Q9+`\$P_AIP-2:[10"S4CFKL_0J+B82D4RN,]'S*-7K%W$W*Z-\
M$)?H`/N&`<''W0O-UT#S9O]3Y@-!.M/G)N<UEV]B9WU..O3D+7\$(5"ROH]<
M%GD.X82B`&J800O]M+T&17S+$!K088F.,>NXZ0&0LGFQCI[)<+B,W+\<YN<U
M*P=@XN@H2MZS`02P>[.27KO2C5-R*3[T@P5<(@PI+]#"$`4>$;^C+`10YGI%
M*U#54=M-H16!$W]:7;].+[T+=67)%Q8@W-[W&NO+[.C=-@U"7K6'4GRER2`[
M@Q_9L(DDAALPL@7L1AUJR3B(&A4=$0$=*1SV5#Y,D;_#TA=1;]94[_1"_D0+
ME2),J1<:T"W5OA$LQ]!BJ$2&55*BU6)KXFI8B">0U4X#8%P6(@$54#7N=ZLH
M2"?K%MY<S;NH4>X1L;JV;2ZTB5%P5.5NYP$%0MPD?Q]?X6I8UXU\H<MHM:9T
M@\8&BN6;%70S^)J_8KY'PCK]K.I@HKXD]&MP\K:!\F=%Q/)17MQ*7*$9L-##
MJ*JJ5T/Y?A&S&^E9'S(G,=#*\K9\L8X.Q/88$2,B&B>8Y3=X52HMTZQ@@@&*
MX@`1BDYG)6H0R'+'R@`5PE@YFB(]?C+2TO<(L3&]Y$%8;XD!\(X3D2=\)(=)
M'\-%Q4#"4P##OK5D39X;,9/)R/+LPBL;D#OT_MI##&0@?%5UH-R=X<X0*%+`
M9(4;#T*[M"H6?TKUSA'<10@?'3",_/(HUIOX?J'`)I%8^(59F7T56%?>UX)U
MY`-;Z?L!?/(@I@80#QXTJ'`A`@,)'#A`:-#APT.($3]L:!``P`2)&3\X`"!`
M00(+#SU\B&#Q``:-*56N9-G2I40/&AI0>"E10X($%VIF1(!@P\Z5%11,<#@2
MZ%&D294N9=JTIH<.1IU.I5IUJ@>I5E-RF$!P`0&=6L56-<I1``0.5!L`,("!
M@@4(#S`XF#!!`0,#""!(<)#!0P:''R842+O20P4!`!RTY`@`P(`*$2M8%!!Y
M[&65'C`\"/D48H:A_DH?%)#`U*@&!@<R8&;=VO5KD5%ASZ;M,FMKHQL,.%``
M0,%JD;6%0ZQ```""M+>34A`@8(%JF0LD0(!@%X$$#1@06(;X8`!*EAJ,)P@,
M\32%"`D(&##00$/$"P4<8QRNM0,%"<`]/VS0H/!1#=A3#BD/'@"`N_HR2W!!
M!L?"JD$(M=K@N03D8^"G"&'C8(''P',J`P0>&Z"Z_F1Z0*(.#BCM@PXLF.`K
M"LK;JK<"PK*I`0,.F.F"]\S[@(/&(,B0J0X>F."_`7_D0,:',F@@`J48&.`"
M)I,J#JTA8<IRR_V&>Y!+,)_*(`$'(.@(P3"UXB@`-(_*BL,`%%B`@0C>_FN`
M`12E^\`#"\AL0(`'_DNI`S,'H"DC";9+;B3E*'"LH31KXJ"!"9*,B`(';(SH
M@04L94DH"*I$:@,(&/`P2ZP\C735V51E-<P*[@RQ`5=?W6D"QT(-3JD-QNR(
M`@TTX&`D!QAXD"L(%'C`@PTCX,`"`Q+0;U`)!@"``4$?>B`!5S&P-H$>;<UH
M)`X2.'3<B#1XCH+;,&``RZ,(16Y/(BTXX-PM:Q5W7W[[=<H#!0B@H``!\/5W
MIY$LL%:!<`U328,(%#@@,0'H@\B"3!^*``$'"$```PP.>*^#""!3T(.!.U+V
M5`<2<$F#W@CH3%\P-T"@LXDH>,#@AR"(DX$C_O=DUH$"IMT)6@MH7FF#`DY$
M]6"HHY9Z*08(P,""`A10>FKM'@MK:Y%\=LRQ`*3=,P,+."V-@@0B`,UC!Q)J
M<@`HT0T[,<?:DP"#GQY`P"4.(DC,Z:@I6HV#"QBPZ+N,)KA.S@@FD$"""!QH
M`,.C*$K@5*4`OG!JT$,7?54*%HB,Z$I'9VE2QU9D*28,L@6RN1RMG?(#=0D(
MH&D.$&C@(9L!(`^B<AT8><G;0$ML``4N@*"`MC6WS0+CYJ777PT@X/L!XQP;
MX/.((%C@H;D4,%\!"41]J8,)SIHJ`M-5EW]^^FNK8`%UC\NV_H<<!8!6AXV)
M`(&2B`46T)<B.48G_A0X0`4FD``$S,E&$6B`IDBV``A48&/N"4X&,%B7_$!E
M`Q50SP`6`S@#`$`U8,L2119@`(L`H&E2PAF+&!(;A2A$-DK1`/0:II0+'`!/
M_"-B$8U((!91$`$#&,#ECOB!"U@$7"S9``,<4S0?9:!,#K&`8RH@%'9]H%#X
M4@A,.*"`W32@0J[S0`3:(K2(=&`N#N!<9A+PF`BPT"IZ?$@')""?O,E%,P=P
MP'\NX`">704"!G!=YSQ@@`)\Z8F3I"0ERU4`!!A``#CCHZTR<```R(R*H'R,
MT4AEMD^R10%U^T`&Z(0DE5A``A;`0'2`(P$560HJ3YG`PCIIFJUEI455_KOB
M`RX@E0M<!R+%4E]3F&6`\>TJ*1"XV2\K>4ULK@IE!X!>`9QH1"!9A)4J6<NO
M?/2!XNCD)HX98E,XP``$9`!FG5(0PCIP1P/LKU4#\I0'-G`![WAO`9J"R`(:
MHID$"`DS#3B)4S3`S&Q&5**BJTA>"#!._MW'6K]CR01BB`""9J``&+F)12S6
ME.(\QP&8.R=$.K"DEEXO(E:T6H)T&9&L8&`!UNI(`H*F$8#F1X@LI0HR%0!`
M(C&`,!-E:E/[53("Z.XW1\2`<;3&D@ND4(4,P!?,(N"00QI/IDAD$=L:J!%)
M0A$"-=0(!WK$D0&DSZ8[60@@54B!#33S`Q)H_L[FI"F611:FDW\DJ%,->]@L
M94!\.2*`0HO8@=ZHYJ\1V1`[2^6`"HR$9'5ZB$*LB=,+7"!;3FI>1"A"@`0P
M@#O^W,!!(E"!N*0P`(4<4DP:L``/<4`"O7$,(>NHI=9J;[+_\B?:0N2LIM@+
M7HAE;G,9Y($)K"<`".C19\'$*`D$0``24)69%,,!$C+@`95K``1^6%0M/017
MBI&(HS*)ENPPI#<!8`"'QD8`VF:H0`A(0`/X)A2+3%>X.$V)=<,S'0403(9&
M&Q4$_.I<"$>8-A@PP``PJ:LN[>LP\EF`7C_@/^K^Z($"0.U/9^,_!;#471S`
M0`0D4+7FL+-C`K`P_@)VYN':>`"S%N`O`A(3@(L:F"J#F5@!)L8FIU0UD1)F
M<I.OTEH'^N0I:167!D!Y`*)FY`+=HT\'.K`!Y)'E)1>PUAOIM0$'6*`!!8"A
M8PBP``0<(%I[`W.J$KN`YL10``RP`(Z%TTLV'Z!"`<AC4S(@``<(V<F+9C)7
M*&!%_XRYD?SB$`'\LA*86>2$KI&<8#-2V8M$Q(`\]2F'%L#B!MCXMPV22@="
M-+8$5"#+$:JB=MDC109GSJ"Y9G2O?;TZ:A(L`.?RE`;[991"R34S'A7>K(%B
MJ1&^6``!<&Q&M&.<!E(@63G*I(JJ*(`$#&2)*M)`!=C*Z@N\V,T*,&^D_G!%
MX@,J8``G34H'2$CO7^=;WQ(A8;@)P(#SCFL#`;=5!:RU`&=_QEH%./?K5A(5
MMZ*M<DHU27DZD!VW!$R3`-#N`0XP``),X+**&X`F"[!P.K:,2A#R9P0`&2<*
MZ'-+!C?```_)7G?N9M\[YWG_Y%*U23N\7R!:\"@?$_26W`8K%W]+LN1MJIB$
MR`!][D`&7E0`W07@``3(,Y(%IT:\D1A]%E``QT+U3BP_%W&\!;*R606:C_?7
M(J<>[D[DI.B>Y_V)[*O0M80>M0Y8$<E+>S7A[/8Z#$A@`6PN@-;]!A(6P>D`
M<"9``>QJ$:RS>0`'0*,!'"=#CAW0`A&#(%A:_ED!/VLE*Q=(,-D&BG?6L"\Q
M!#CJ;9<,%`>`M.YZYSUS^?J\`.!;?A%P3*%50K*#MR1Q#+!1<2G0``<\8"]L
MNVC5#>"T!7PD`%KEN@$4X(#%PQ.3%@Y``.Z4F`9D``,)&`!.>`H`\#"J/A50
MZMA,ASG87X8K$:!`[,X83:;0J4WK/0*$,+*#`**)I]V;&O]!.,/8@"N3.8CP
M+@;(`.=1(S3ZGV,BGW#C"@$X@-"*H`DXB+RHD+C!E-V0M\I#`(_!`)'##C%J
MO-GBC>]+CAVB#3X)J%!"GX3KE]1(/9;`"]C(OP(LPM90&!<K``>L'PM(#`,H
M+)@(D1K1*_]AI`C0_AWF88`.#)_4&@`@\YT#0``*<*7LDS,MY":V0``V<X`(
MR""HB`HY`CF)H:5:*HQR(\+)>BD)Z![F:1-Q29)%"B.F(!H,`$+3V("\,D)%
MC)0-B+7VJ:GZ"1G'N#V(N","<#N-H+!)Q)WR&A828JL'6C,#B(#T($5(JCR"
MT1W'F#;?X2P6V0P&>!(**+FOT$*.29H/2S37,`I[P[/>0KWY8:`',,24,"!=
MP4/@>0`%\,-%;,8&Z8#<2X"/&\:Q$ITJRA7&X+A(4PE0PX@B60"_`#^4P(`*
MT!D,NI\/3+#UJ+#Z^QX&8``VK(!A^:<&D).C<@!-^A,@$P`;FQCID)("_HB^
M4S&P5G,C/A2D9[.5]4,`8M0(U"B`'B2+^_$F"60T9'3&HFK$```Y`V#&T$&,
M:U$524R[C$";6,$;CMJ0!%```<B:!,@+'Q,`_WJULN&XU]H`"NB)M1J)#7#!
M4KD+Z0.6/T*MTK,6D1,P+80^KFHQENHDJ="`1].S"FK(V'@5!Q``@GL)HQ`<
MCU0]JXNS[(.@!XA(Q!H6C&05HQ`I`-@IW:.?'CH.7MN4CNB,+[L`#:H0_EI)
M/+J:!:",.U*ACR,;:4P`.!L]O3@->((`"Y0`-4(`>&R88IF`'/D(W:$3\<H`
M#@"SGBRWU%JUI.``ML$;Z,$7L(&*BYR*]LFL_J;(*N1B#:D`F,=@#^;)2N:*
MB8H\R[^;#0GP/.-8C-,<#BM[C-LS"@EPC`7HOPJ8,8L8(`V0HQ`I.2/S.`R*
MH)P<`!I+#+10OY&H@`.0BU8*D99$K0C``.68D/1!@-W9.@BBE+',Q`BB3:'#
M"B?!F^F*D7]YE62"`+)L"0\2*]<`K]PS'D:Y3>:Z0=Q$F`WXS8APDKZSGAQS
MC5KSNXX:&QGZN,92G`H`F1>AG*-2K`5X`"EQS.[!+9`9EB\YC)JK+PKE';12
MO)#0@.FH&@/0'@@0`./#J0VIM@S+@-T<&\^#*6?RI'>$3Y=`LX'ZS^>!.@4]
M4*<R3>'`@%(A@`$P_CS:>!8"78K`20R1\11-Q"0YVPUJ&J#1@R0+R$ESV:GR
M$P#O>P`)F`#:Y!/%^SX'8"+S2;^,8!JDRAT$&`H_`H!&RJDQY!4'"$P9&L\E
M9;D?622=Z*3[.("&4[WLN%(F[;U#11$7\X[;<1BQ0!RJ?(K@+`#51"L660L)
MZ$EJ*A4:NXA>XD?TY#@+X[RZP,6:L,`-X*N1H@`Y"541.RN(L"(Q+"\W^JIJ
M[",B;2G0_,M02K.(VC+A.XH,8*1=++<1G)RZ@(`ZJ=1)=492L1SY^)@"DYJU
M.`L/RZZ0:"/"7"+TZU&RJ;P%L`"S5`JB(X#(T!PWY4!=%8P!V`Z"*9:;_LF,
M,'L)KE"<*U*`1YVD<EDNI>B`ZW,-O@M#]1B;D\#6;&U&#5BB"@,`:AP7B:T*
MOA*>;+D-@UL6!N(+K,N1FK.H)L*`2VN*X+%1D;"+OO@P`_@A7(I%D(.G`%@1
MY8#*/A,Z#C`06-O`B0J<=ITLFH&L_")"9D'$JKO*`#C28]O8B7V5OU@`Z>"O
MPF*63LT0:)$A^%08`X"GB]*`"0A#=]D.C$M0JK"WWB3//4FFHWJ7;*&_EN$Z
M,MDN;L0/F7M-Q_DHO)):5.%.I'LVAHA+L=B`@1C#K7VN#;"`8IW:;$J610(`
MC.HCP'4*R'J,\_*`"Z"`KK`K$K.QOP2:QR40_@X`)9`J#[B(JL(BF9K[29*1
M&[0"J![T4+Q!`+<Y+&8I`#RY&EIZ3:U,G&:UBF<9C:>]`+=8V7V1(TF%W&LR
MH)=DBU6[W*8(5^T!&0LH4_$Q'S4L.3?KWD`S7,R%$X0MDNX\+PK0ND<;*0=K
M&WW"``[2B%HE)1F*V>:J.;YP`/VM#L],K][A*,PX#!R)JNN`G_9T7@0FB]U:
ML[6<G^*,34@".=0:+]1S);+#(_Y36<!PS7(J@%/1`(-H&]&2#-I3C_+K"(Z[
M5Q9)FUE#&9[ZM_YE*@9PCKJH@-T2HAC."$%KC1:)5:+)H+I0VP0>XN2ZBP98
M#Z$5G2"B4,>H)CMS_A(-,)`!Z%D[:XUR"H`:NA/UJYIE@8CT)3%!^PH(.@M/
MPYT)B#FTZMIY:]YL>K322)4O8X#2J@F)V4]@@JVGRQ@BWF/3N(#G<`P'8!*E
MXY=KY#AE>4F"DHD1M!`V=JB_W$:`\4T09HC.V$TFRJ">P(OMFMME5)_@$24)
M`XT![*QB`0Y7V98D'HLJ"K=RQ..,Y6-8]HS]BC,""+C$L^/:>H@'9IA60A^)
M"!R.Z8W*`)[%K0EH!.3D<!($(16@08]%TKK4`#^0BS2IP-4>Y!"Z:>1K\@!X
M,E80M>,*X)@%9(J?'2"UQ0J\*-U87F?-D`[B$U:7$@K*14N@FKO"P!B#_A$I
M@<B5#F"]"D)&F9B[]YB4",@RQ8,F-X+8$:RP)Z0L<V.)M8@3=<XFHGE740/5
M6KF)`\!#U(#$"109>EYGY]J0Z%-3NFRM3!H`_!GGIYF,4.(.OW%7HR@7SWT4
M"[`BX3'EL2`4O!&2^&A6>WFSB:F\N-*IW5DN"X!"B7A@`Q#?IG(Y7%PZA4@4
M$X-H`RCFEK@2A4!$!KHJD?[JEL``-%*`V6*1T;@^OB#8,.&G0]*JANZC"!"T
MF/NRA(*`A=.@XSB`X:4*F&&G#-@8I?X`=YG1P40MOM"NE7Y#^5.)XO`:)A,*
M^LB`YZLYCG'J";0TUD"<C;E.!*AJ,+%HL#:-_OE)#PB(*OT=CP@P$@RJ)PAI
M$1IL,\?@9>*9`$Y9@`H9H)Q\%"LJN:X,4GOQN,@`829YEGK,/N,AH1C:"[(1
M+8)8[)5HC,$]K%-Z`-X0K^JP`"%V"<GL6=;8&/'BKXFN#P,-;=$.G9'(`!`]
MLK%1K3'$,QWUI\``7#ZY$[MB8@7,"O`JE83"3._ZOLK+B=:8BPSRW!YQ*PW2
M7RW\/C06H_8;J>Q*H?33'AQ+F+G#Y4JJYNV+&\=U$RCZT.08"]#TY5:R'+>=
M*.IMJO&6&I+!NKXCX`@HTQD&01%RP66$D'=BXB]\R?*+;HFHJK6$+?'!,,Q`
MC>?Q#0>BCA?2D?PP_H]AV2W^G0#Q:LD<[O$4,KUA-:PF[.*E0%QO=9"!`3B(
M&(P4"^G+8)8$3G&I2:58#,@'.`#M*H#QW*T1TG&,C9`'?@SH`<;@'.6'N2,5
MF8ZHVNNI(#.R`3DCHR.+YDF1HSSGB!V,60]*S$12$O2F"AG9[9Q>*EB6+16C
MP57NSB8S=U[G#IW`82+_4HCTP*SS7@`H9S/LC)`H3JA::LX^VBGP"0]0`C+>
M%:<R%XEJB;6WJ"6'T`"I@!\WG[884@SG(37E;8G\`0`=12R>I&Y-'S.\5>6.
M8:L]!,:(\B?RYI?<:(`1$>R(T8L,X-$*20V.8Z<3_Y$-MHGZHI-Q#B>V_BB]
M;XJIJ:@Z\`:M=FTMWJJYX]`@-[^7"I"/*07MEDA?W[!P(U*.`B$`7N4A'6'X
MI_#C_K)6$/4=8I>HF%"=*C8L-'<-[0@W-P>RR4N``,,D2')S2`D3W5HK+7P)
MQ"6`!J`>%1D];I\*#K!`3+%:C^.N%@-1X^!=-0S(SE5KF9VZO3*R63+$`.D(
M2L<F?[H`N)"/@B'GEJGVI#B-ZLX^O=#F^?'VI/M#(#6LLL=!^UH/%G0S]H@S
MSJ@`5^)Q"/%CG<`1(+1MD<H1VA%$K32C@8-2G*`8D[><[G%5?IP`88\X[&XE
M*>VS!\(Z*9,4@07@27+X-_RGYRO\G,;W]:$`_FC%#6'I++"7'U?9)0V3]@0I
M^,;J$XX#,O2A@!'^LN_#:LQ8B`3XB8JNB><@%1:$'O"+^JUHL:VCF)9Q&S3%
MF[Q),PU(T)'`E,[-&`R0#P5@&[Q0(0LO]09FJL;5M@3(,[+Y.+JY<JW4C6AW
MD(3A*MJ7FM+?Q5'_=I?H@$H[B(`T-\!@$N1-_[&@)ES\(_MT"1P!"`L+"`@X
MX&##`P<>/C!LZ/#A!PX4)"PX8`"!`@(&%"2PD!'!@`($%#Q@`($"!@X//2Q0
MT($#@PD='@``T&"#1P06-T!DN+`GA`$`$'3H:?0HTJ1*ES)-FH'"A`8@!PBH
M"2#``@D5,EP8D*"G_H4'%)AV(-"@*=J?8!%$4(GV+=RX<GL6G6NWIP>U=_'N
M[>OW+^"E:C$T4(#R@EN('CA<X!GXKEH.$!)4:'@AP0+'1W].2!"ALP`"##Y@
M4#!!;T\.%BY$:,``@8,#`W1>-$```8.*LPT\^(#:YP8%""PPE``A@P0$`ASX
MSIB``8:&OQUFL`"!0$T#&*8_[L[T=P<,$B(X`!G`:M4"#B10T/Q!@8&B'2H\
M:%#2*W>(&^L&[I`!0P8;<*`!!A@P0(!,WBGHG0?\+?A=8/D]."&%%$KHDP8-
M3%#A6QV$%4`"&&B@TDP%9,"4!@XPX($$5!U`P0,(//";!QM<\%\$"AP`_@`!
M"0S7@$8`R!;`C@IHL$$$/CHP`08;H-8!!05$T)`%,7E80`)/*7`5`P?AY8$&
M%E1`@0,^'E#5`!$XR"&;OG&P`08P(F!530($P-L$#Q#7DP0&31`!`P<<P(`$
M"BAP84.!5O;8!A*4],`$$##`0`(.9(!HFYGZM*:FOC'(::>ABFH4I@Y%\(`&
MH_:$P0*8)6#``A&D2D$`%Y#E``&LB71```$P<*FG-188@5DZ+A!``0<0D*Q0
M`8BF0`0>$'L6!YY1L&P#P#8DT794P@:F`05(D$!&``PPP)Z>=D!@!0L(,(`!
M,6'0P0(U+9"8JG)QEU>#83E@`)WG#0`M!.D>_I7!G#T:7$$#H/8TP0$0=-<!
M:PPHT``$#CQP@</Y9KJ8Q]YMH&W()><KH0<6G&CR!QUL\/+($U1$@04!C.43
M4AXX`$`!(!D`@6$-A8E!!0D(H(`#4BH`+YTU(3!!H:;E-8$`!5S@00(2?)!!
M!DEJ[9,%[3W$0'P4"/7<:P01X(!;&E#`P+E85;`5!VXU4-,![K%L%P802$70
M>>@UH)6`'=`($0,"-*87!0TSA0%NW>75`>4-5B><WGM7"++F?;U4:N>A3^B!
MI+:*'MZI"_R<>4\7``R`HP<4_4"<#U2T``15>19:X'<>X-D$)V)`0`002-R!
M;,0-^A-.9"I@P01&_B(^P)L0V(;`VP$@D$`"#3C0*@((#+XV4&A&)SI?$''0
M=V$&5&75>:914$'FB$I@(D2%-L4!1H^I%=X$',"1K'0,?1%BG0$%D\`%:LH#
M%2#``A:8@0;\SG1)<5U-'."W<1G``%0IDY``<+0Y\2Q\$+A`DQJR@3)Q`$@+
MV=)I$N(>#MA.)PVXVD,D8("Q:,!H!4`2`#IX'BP](`)[BM'*''*!'05`30Q4
MWU.^1T*K#(``!]"0!!#8%`L89(8/D%A35,<!T)'%.@@8"0-XEJHG+JA&;'PC
M'$G5)M*!,8$:*(``%J44"%B%`3#*#78&0($("*`JMA$`;A"SQH<\X`"S_EJ`
MK>ZV@'5M17T&2(`&M#*BGV@``KVQ@%!,1('W(>L!:W*`K_#%D#0&0'H,7,R;
M*E"FP-6DBCV:0"7]LL(#G*\X$%CD4AY0@`J0<2DKQ(Y-+B"`%<51<JIL)C2C
MR:#Y%7-4&7#?S91"`7MAX`(/@&`"K&*6'`F*;0LYYT,HD+6%9``"$DC9)9OD
MO8?02P$GN@!\(N`DWVP@51@`F``>,*[00.!4B+OB`_1&$YY9$'T-PD!"C-:T
MV5"`:_NL)E(J,(`-,80#)'E+GT[S&)<5+23FXJ@T_5+`E+)45/S25`06H,?3
M7:`!YV&`6R2$@0+P"`%X=%H$(E``>WIH`5AR_J)B/!"^NK!(`2J!'D\6$,%M
M%6I1_DD2`B20*@YXZ0$#\)X%!"*`#A[*(1XP">1>Y)"%`F"FJN(.!\B)1UJ>
MRP&KT<!*[Y*!`MSK`Y?Y55,64C2D^L]&%X"*`A9`LI;&!:.,?:SD'+L7"T@@
MB:/ZS8`N("GXT+*.2-F`3:^B$0+X:B$0@.36C/<VW`&3(3F:Z00,X!C#?:!5
M2GR17AQ8T`ND:`!:FX#V9+>!<-:D`(O4V4T^P#`%3,I[.ZK)E$*5GWYJME7O
MJU-!"F:!9WIG/AAQ5`-ZV90,Y*8HDFU*G,8(V;CD=;WN?>Q3Z'?>[C1*JJ]K
M&@"^<B$/C#*(Q:,4_@2*(@&%96A#%[#8>BS@&`T$S2'7:BV@NO4!Z^!++6%R
MEUJW>96"D9"O%:C+M;[&D`F$;WLEJ8H"M-BF=7$M1PG@J3A_MZ3@L>DG'#"`
MKRB`T18.P+)^48T$)D"!(4\`,>]]2X..K&0E_U,[\^T+OSC03EI>)0"A.9.0
M]IF4.^:W4!5A0*KX&`!3MLK&N)*1!C*@0;U5P`!6+0H-RWJ!AJY$`P^X"`2B
MTQ4>+>`!WP2`'R'PU$KQA#O!X9'!%#2=R?TG>@C`,14UD@`*<*"]BE9F`LZ+
M2AU["LI1.@!/D>6^!'!WR8HIM:E3W4P.C"<OJEI?NZ@2L.W)*D/FXG12_OC'
MLP0$0"B\_``?!3`E\FAF?9T)'_X>DB(C248"T4G.8NQC5H?0BP%A+<^1>&K%
MBWV3+5FZ``(6T%J(;("5V1R=6=<GS$+2U5`4.)*3GKP7#VQ$.G&9@&\MS90-
M^(TKX8M.`PH@857C!=4$/_@"Y^-611N%*XT4"9UZ)"^\,H2/`%!(SB*R)0.0
M9P$8F8!'1;@AAM'Y)7<#`+3<`R7MT$M<'XA2!OSLL!2-M54)D)T$:G(>`2P@
M<0/8T6V.,VV(=(!J`.@-A\)S`9E9Y+K:6X`#WJT!>0.&`QKQ\5LLL+9"RQN?
MT?4D0RS0$7V_UXT(]PO5S_Z="A0L[2BJ@`2D_@+CFO2HYQ55I0-Y2A2E=`"5
MRUS20!;PMMN<AJO,-&L#?J:B6.%P:P:P@,ZD](%RZ\0!-\I+/S%@@0B`1.>U
M3``R\]N`/I.VSPQH"U,R@!T%3"@\8:/@3\79O>"I=V^+48Z(XP(Y!$3'U7LI
M359)?``)5&DX;H\CYR)TY..KG2D'9EL;*<>5"N3HNE=!@"<IG90.;(D`XB55
M!6!,+H`1`"6-D^D'(A`?L[[F?*PZ@`(J2[GP?J!/"H@.<#%FP@GD"=0:4=95
M%,"Y#-6K"(`$7$:2$$\Q;0#`:`?.H-VZS!D$8%G$'0!&4`#9C<J`C<9<:``#
M%$"BW0648`:EA!NE_H`9\S53"CX@8[U4\W$(832`P:7%M'E`!OP)`E#959"+
MT#5%&@G;2ME@`U[+HQ'`B?00`"R`!T",9GA(5BG;G1G`!(R,2M`*`$2+!%B;
MK0E)?0B@`\0)!,R)%!Y@@UR`2/#:2%B$!%18KM5+`'A68`W=0A#(N`A%TXB&
M']4>"X8.!UB@77`5`2S<7KC,&#6([[U@A;A,!B90DB$B!.9'AAS`#&9<:EQ`
MW+F/'=(=`T#*D90:=["2N"7%8@#=J>Q(`6Q(7+G&FVRB8UR3*:W$FT!4N&"2
MKDW)/^&.`IQ'`B"&YET*Y1!-!E!.772`^\A&`9Q'();*0G2`!%0%!\8A_M%9
M(N<10"::BZ'DV<NLX.@\FF1U0`0``$H!AC8Z8LXLQCBZ%#FBG1Q5P!5-8OJ8
M%0;DR8M9'\I]D8(M8D-\(X]\GU&PTJ1)!02,7,\(DC<F%X.%B%$8F_<,![`I
M0,$XP``X"VD=W5MLR7G$BVT\0&+H(:E8@-[]A#FBA7C$E`!2&;=9@`907#09
M%4>^Q05<W#FN1#K.))+1I'=`P##A(T.\A(T$T'/IG%=\#P2H&%ID0#AYWU)<
M"X^0AT-F1LZ=QTU$3ZK<V?>I1>,$SV4(WNB9!_R\2PC*I$-`0*]D#6D4@,`Y
MT/?0F6)LP)R8R#*VI/K$29Y`&IW`2@/H$V0I_H``#!Q<;`!?$:5<A`=?VB1A
M%J:FO,U@BJ(P8L"I'$A7%H!]:-]C$(LKY=J6+(?/Y!&2;$F6:-WEA*-TO,2X
M0%U&6!E!4%%(7(QD;M%M.$:;"5ONU$3N'46]#(!&YLPOLMU/5EE!0)U:MI0'
MZ*4$Z&3+6`P_UB1$7,`"R*!A-J=S5L@--IX<41M4W%F5B9,#5(`%&,XA`H:=
M.<"X&<7)8<9R0D?+A)\`4)IBE811\)OJ4$7-`0RR"."+J(PA%M,=Q4??X-C/
M"<58'2=$+!0"A.=.BH?U]$I=NL84&N*1B1US!N9D".)>4$#$$.=S7BB&'H4&
MR,I+&)QX"!`U4AGV_IU0(3*(M_QF3^R,31"-?21(!52%*<D=20"6-WD<50!-
M1`J%K#D+ST#>?'%FYW&)H?"?2ER(V8A0:V52`S3`/-(2`1315KR,A3(B0T".
M;,W%RD674NP75QR62$!>AH:IF$)C1UE/`#&7E_B&?PP2!>E@`7Q1!&#=A*C>
MN2&%Q4$'L9@E#Z71:/1-00F'`U1?<5F>>"A`LIQ>D.5)G<Z%/E[?X*1DJM"6
M4B`A[`P(!60,K]%)(25`0(+IV7&`NZ"H8)CA6;SCP8S)I5H,N6!&@HRIJ[XJ
M76Q>H5C9`C0+.'(`?3R`1*''4/G95W)(M0SG4CP0CTB*N6R4;\3638P,_HQ\
MSYE`9J#RA%N$A70&1@8,Q/`!)E*H:+SH9<1A"_]IZY(]0``0TUS<V%1MZ?J(
MR9"5"??`G_>L1V+$)*S28+TFD!F*DW`(BD58C/7URC)I!;TJ15SU8%*4&W3A
MVZ00![U@Q'+R&K+<20$\H[W>19A4FKW!1<XU32$)`&54P!H-K$.ADDC-Q>],
M#G?RRV+T$QV"WKD81`2P1WAJH\C>J\VVB0;42TU`1V=<T618WP+\"<A*JJI0
M3`,L*ECJXZ28RQN&G7P.T=REF*CXQP-(*%.\*/Q@#PIM`'?2).G8ICL>!9-"
M!;F\6X&$A0!NZF?P'TI66N6@V\UVR)3&;84L_MM7&<X%"!#&"`7VS,_4S>W$
M0`M3U$P0Y:!0N(3+/$!Z9,>7R2E8*I]/6$Q.P851U@1E.&[-L@QJF*$]!29,
MA`0R\14#N`;&&`\$#"W1KAC@AFDCTBT?3H8@,43.SL;=H$L"05WJ`<R@A%O/
M08J-*(MQ9,7Z'%_KBF3/)>92=(#%,<?CVD5W/E%N#4@$"$KO"4:#:(#,)$`U
MFLO:5I3)4([KDFGX[HW64:1OV)1A;(_CLDQ].(:$K%"7V4>[Y)<&/)!QC6-(
MPH78)=2Z]).6*44%6.[Z.B]</A%C6(``^8C5#)U1>,AI;6\A75SG9.[X5G!W
MT!"@;0M4I$S\)5#C_EBM69G-`&@,V2!C!FC4E79..SU%SW71XPA%(.[A(!8P
M`T6`5QR-^N61=#RO0X!6N(2;BMC)I%B>!1?Q^+80HC4$^+(EQ8;.!"&=4JC>
M4"1-2(2;5I!-FDH.9%0:<CA`=EJ:!CP7'/X%#S-03=D'_.$*`)P;RA"(B`A(
M<!A`W6@9!1NQ'3-6T55%J3Z$T=!,!7",#'M,83#%C9E+S_F-23B*C^!4IVE.
M>!R)OG%55:0K3:Y0O)"6'2*MJ9K*5]RQ)\=M(3<Q0]3+,EG1KWI,C'R'SCY-
MWF))N0S``@!HR%2'N)K5!6"'(]4Q^FQ3U7C0><RFQCK5)P_SO::1$DJ'_I1M
M27Z=AP.D;LE,``/\[V:T"(\DA'((#&D%`/397G``,R$#':[1I%&^(43Q%!3#
MQ4)TQF(1,SMC:&PAP*)XP(?.'=YX*LOTC;E&\8[`LEE:A.6I68\,L*C$U1<&
MLBC.24"M+F-=ZYL^!78XSEQ0`/8H=#M7]'IQ!G;\#`5-Y`Y6BJ$^*,LHKS`;
M]$Z&TW#(K);=,IAM3ASRVQIF;/.RG^52-#J2,7"%!@$01.=&=%;1M$7_-&.U
MV41AQM%FP-2!6PH_8E\@(6$AQ=T4``9V5/VV!E_)\JC$E9Q:FE(:UTP.A@`:
M@(9X'`@#,*>&+5"?M>:4\5W`!+*,E5UQ"L(H_@Y@O.U>8)``G')8%M>\N%C@
MY+0F>\?ZS(M2-`J^O(1U:!7?U6:K&M!^49U$2*8.>?-X34HMH[5EAXQ:W\4'
MCL=V&H49-A%%9S9:]!UT):6R!(#WY'15O$M5@.:\M8R44D[=Q!6\=#9,;TOP
MF)=J)-YYW(R$B%DTBP[HN.!<3T`!C#%:\!LF739S+Q#SR3/'M*1>M,@VZ_)1
M*.TDI@@>%4"X8`>"6(#X"#0Z5X!R6)$%=I`'F4N`Y=I3^!GQ+0TR_;5#:!3]
MIG5C2<Y.[7%CZ9!X-[=_/Q;H?&-EFLR>&8"H*A$)48:8V`K_'+B^3)!_XE>=
M7%&@6""AA)5UC!^:_D":>HQU1-R9(?6WJ#!F/C>07[*>79B-5?\WBU]TSDQ`
M3CMXC?6PSDJVO2TAN="99!3I2"T=F?@(7?+([X":6;J*182>#BY3D:%0-\W9
MD32$AND<7N?+=2`WE'V'`1S`>8V2A[=XBUOWB@&7EIJ,!\)H(W_6J0%RZ]F(
M`,'?=O9OI3'&]S"7NZ@'T)R'LX`:VK0$N6@0_8`WE058@W1HI8&Y0SC*BE/(
MBQ&H\Q'`.WDYI..%3W>.!BR'YBBE38AO1T5%96NZ;TQ.W8!DL*CL?&2-2F``
M#`^G?SB*GR4$I8C$]N87+D&-!#C`T>J-:&LQ<?L/4[R&B!O%/]UFI`_[_FV7
MW3:Y1*?HA91YD\7,7015TT(<V(=UCAGNXA8*P(88R,4,#M<>20/,!GD@><^$
MCX]@A)F@=[+@CA^/B5:8-63\18&@18QT^<%<#*/;I*$3NZG)\ZL0AW4K]Z/I
MX`'(^&9<@#TG.U*\9'ZYZZLH`'D?@%0]FF(QQ*/UGC+CS9`-F7:R:4M(E<=[
MC\UQ3\]Y<6Y(U84#2).OAKLK2$JB1?38^%)X8"Q?:+[KNZH1BY57"&A)>(\0
MP)0W+XO0NZA<DPC%'Z0833@]P`WFB)#4E*\TQ,G5A'['=#]MGO%\!J!4Q+*8
MY48T5VX,T$E`!?])`-EO14K&>:@SG/-USQ_J_NK/.V+-V_R2?>TY9\KPZ%RO
M03RE.1LZMTP&"*[HT!!I00O\:=L:'[I9(E(O1?U0_#I2O$3*WJ"*=(FMUX=L
MV`F"(LLF8LQ$!-5V%7JH+%$G!Z8%[)!SQKW<SSVJ4W*FY*S39"=>Y44N)7>!
MD"$#EPPS8H>SV,95[(AG><!"C;G%X<WYG!<Z;<IL)_^;6")[Q.P?1P6HD7NX
M]$Q"A0H&^"&6EKYK-R?JISZ`\Y&6DW2$H),-FD0&Z"'P$WP.R932DQC(=0Z4
M"`S/&-4`P,V`*Q,X2D<:41',*TCE`(0'#Q\^<,A@H8(%"Q<J4)#0H``%@A,I
M5K1X$6/&#QX6&.B@_A&D!PP#((`T>1)E2I4K47)@^1)F3)DS:=:T>1-G3HP>
M*A0P4$'GQ($6!5+D,)1BAP025UJ0L`'#A@D)(%!P&92F!PT+$"`0,("!`0$,
M.I84"@$``PP2'#`8```NW`1(:]*U.4&`!*PH&Q#8('/#@`=["1?6>-1P8L6+
M&3=VS)+"@09VZ[Y$BD&!A964"T:@\''C8XIV/41(8&"`@0-O"SPHP&!B!PX4
MOA:(>QM`@,DT98,FV,'W2<X?-C@H`#2TXP8#,@P7?F"P:.DR.SB??AT[=NO9
M]UXX@&`[2J0>@K/<(.&I30V>B2JVON$`7`,-(B#(W1<V<0IA`^".*\``_J9H
MTJ""#(32((/R7N*@/LVD8R"`"A1,R8,$&KB*NPPQFE###CW\$,24T")``YW"
M:X\@"@RX8*;Q.-A@O,>*JHBGU"[X"RT`"`B`@+96ZP^W`19PH*KFA*(.N-$X
M7(E!!!P4+0(")EC2)`\82(#%$#L\4<LNO22*RR]?R@"!`BX(4SB9*E@``M_0
MS(B#!AZ0H,3&.)#@``<H@T\`IC`@P+^X"%!@3@DFL$`##JCL\,X#''S3I@H0
MB`!#ECR```$!Q=R4TTXSG-'3%B>RX``)*MU)HPX0LF#1C#K`(((#%&CU(LZ.
MTL`!0`=`KC#R,J@@@@80(.`!RC2(+X&/HKQ-_H`"#F"S@K]"G8B#"7Z:S@($
M&I#6,@H4F&#:<,4=UT1R:;)``03J;&\X@3C@`((!P.)V)<P&.`"""VX\,J7>
M/#C/VV:_TC1-\<C#P`(*$A@@``,F<$G!#A0`(($,(B@`R``FC<I<@F:[5KH+
M$$A@W9<L6$"OY#I>F>66^749)0T8("!+HJI362@+&(@O+0,MRP`"#"S&C]Z6
M,'@@WZD(0(!G`*(3U2*#'B!@4`(2L&"#CS3`X"('`"A`@C(-@.L`%D$EMP.%
MGWP,,Y)ERH!0F.6>6SH/$*.[,`H"(%BHLSMHR($R^XNHY,UD(VB#7QUPP.>4
M*B#@@`(&$``N`2Q<_N!KKC.BS+H,+IA@`0(*`+3'"BK5>0*[:$N+/[@*6%N\
M+JM5H.;'<%57)@X.2`#OWJ<[VU.!(/6]):\A.'&#J0&-:\67:4J><2XO3<NV
MI2&0``,/+EB@@<8QPF!Q5C'Z-=C(NS+@VX8T]PW>I8*S0"RP&J`<+K,6/)6[
M:AO07#0.'CB@<"SI"O$(N!CA%1"!)\G`PA00P)=5@'YP&4`"^*<37&W+>5&3
M@(7H<P$,O2IAO,((`P3P+&F1IP,9<,C,=)0`!40``T<!C4LJ`*ZA="`"#'C*
MBSSP@`&,;@$4F``"^I.?EVR@:/F;``0<N)@.0,``%7R)`Y*50"M>$8ON_JF`
M`HX3D@_@)2XDH95,,$#!E%@@`;KY"`K7,H&+@4<C#'``!A9@H`T@9(@`$,`"
MOJ.I@53E`R6B`..2,@$B&:H^.GH``U@4@;<LP#):V@`$F'@=VCQI(#$B2"9#
MP\D'-)"3613E*$EILK<P93B37)Z.4F<8GF!@C!DX0``"P(`5&@"7S:(8B@AB
M@0:<!@(/$(L!`B``!;1)`TC[0($V0`$/9.!%"U`(!%H9FPY<@)H-8(`V%S``
M!TQ@>0B`$<LV$($'-'$Q$QB`@%"H(('(1E%(=(D#!D`I#:"SE/D<C3ZM6!P`
M-"`CD^S*`Y;8`!%"K2(=:.:5=O>93<*I`?U1_LW2WB(DMP"0,TB<@&T`()F.
M#"IHS=2`0C_P``H<[44(LLH'),"`4/Y&`U!)G`_3<@$%#,Z9Y'P`(>L&`8TQ
M0`$*`*H"%E!4LB1@9$3E(P,8@(`%"'."7)'`\/A95:NV+`,#$*=%SJ.``S"`
M5T.A:JT2AX'/-4`!;XE+1!;E`0LP;`"#XHH!$N``A05`3QO1@+XF<"4^&@`!
M!D#:!#1@@:MX@'%_NV,&"KLU]C2G`G.A$8TB`)<%:`"<]\'J-O%IF`X\`#<9
M`P##<B.OW$@NL`;@HP!X])8$)/&JUP%>;&EKDV>.+JP<.)JS^&9!81U@1W$)
M`&D!L`#\<75L`$``_ID*T(`%]*FRQU&A`XJ*,<L9@%(72)N`.*"!9W[@9)I)
MW`8J\#EP.>`"ZPF/!0!E``D\#BZX6YG,&."]QU!`<@1030(*4`"A?A(!1%J`
M3X0*@0B@)ZT"&!D!&-#9VKKG;@^6<(LP0,R4?0`#PF*`!5Z*E0QP]#8!H,I-
M.WK<BG!@8L659;.TB@$,V.<K\R'2H6`Y`:#`Z)T3`)H#NHO$F'ZV>UC:Y`2X
M1IJ+:("(!(``>^%"+!.'BK[V;8RO*F!6"4#``9ZQ`)8;0*0"E-``!)!FE`@P
M@`:@$0)&FO#OUMQFF)`'R;!!(P'.[-W8`2;%<&$`-3=@$/L00(H7^6Q__A[0
MS`58Z`%,.[1=,1#3K!4E*ANH[T;^]8$+/(4"!BW(!YSKO\1)!"DI?._FP)F7
MK(8QT.'2@#93?1/IN>M%BOH7$I%HU@P@+,T=H"*X+%V@L;H9V,%NC-<.C8`'
MV/?7P@&:G"8PSHDP0(\YU8A;`;4`)!H'`5Y-<Z+@5)`&Q'0"+.I`3+>FX[1]
M(`(+("GXD-A2H(X-DCO90`($D&;\QB4"XJ*+S(0<E-FZFBS[2<!3,M``P8Y1
MV`E7.%;L@F0].L#!H_EW3D"K&]B.9@-_QC(1<W/AR4X$*AG(F@:P[(%P3])N
M2*14!B0`S0LTX*M\A%P"0A?OV#`6FY&AV$DA_@27!N*,4UH92-HB</&L#"\\
M=AL;U5*3+D`9<>%1WU2RR46>#30@-\?;3(1Q0I?*`B"*)\%<`$:'RS(_X,D3
MN<">W?HJ=;\W6[K5;@P-0H%XZ7$`"FCY52XPQ^H8Q)<1R%7HO@;%!/",``?M
M5`:D69`>*^IF.:$Z1G2G,>`"M]X(\+C4.1\BX$P^7(SW"2T?@/!]%J8"%:U=
M1G*$I9UNCR0FP6'I:2>R1+VH`J'&P"!3^X`+0#/REE8`>J=2`,T?Y5>V,<"5
MU`J7S7<J]1X-:@(20-"T;X8PVONJ+P\M5&$]O_/A_Q3HQ407_SU+`A>@0%>N
M3Z&<X'`^1D^..D?+_E0V80[J&>FKJH["HGNF/-,.CX\2("%B:'P6IME4B`(6
MT,::*<S0"^OBXFE"I0)T9`'(@JDRL-4\1"DPZ)YN+:;81/RRB/Q&T%(J`GRX
M8G\FP@$$0,HLI01!+@*:[21>S.<&K,P"`/PL8C^`(Z:>B8JVB2N^`V4B0/&`
M#BT:0,?(RP'2ST#(1+G.XS8<0%PL```@+@.R\)XPP'3$!'X4+YH<P/1,L&-B
M4$O,,$3^Q5NL9FU0#`"J*2;(P]]>;@,KPFN<1E@4@&K:9#M4:*&&#ZD,@,#R
M90PO@,X4P*`.+"H0)FQR8P(FH&GL)U3@)N*V1.UTZ%1415@*C0P+:.*Z_JX3
M*8^.C"E['@K#Q@:#0*2,8"<C)$""J&(_]G!S-NF:ID:/E.SWQI`BOM`"FL,E
M+B`!1"<"(N`!22XN]`(-$T,K0".3.BQ$KBX!\&<VA"G?0M$3K=&5*"(RC(]2
M*"-M%,",*B,GX(/73*("^B,`YB3,Y,(Z=(;ZMJDJ8N@3%8@L(*`"$JV\:,P#
M**"B4",N($`J=#$[X.5Z#NS`%L>A/@0IPB;W+&+M,F#/L+'SDE&4*&.+G"H"
M."PC,&"6>BM_O@4E;/`-+6"XF(8!EH0#[".(HD(@,V+5[(H"8$A1)D(#$B!0
M"B!H*)(P7D4"%ND"(4!8'$#^LD-F))$B,`MN_JI1(J-N'IG2`A)M4DZ%,F0)
M`.Q')U_BB4P%Z*(F`H_I-((*[>@BU(9E]6SB3A!`+78BL[KB-C`J5-Q*`D[J
M`AK-.*Q-2SI@2#B$`Q8"`8QR*86M);>2G^QFB`I`*%'BB<:B_41#51Z`%6M%
M`H!$[S!&Q.RL/0RI#F>11C8`08Z&<AC@XMQJ`?`J1RH'[4*%`]JBV11%9_)D
M**=C-I8B(UBN`]#R+V_3%&,+*6I2`+H'X7B"^LJ2._YE`902)##`-AR%'\/,
M3+PQAB;`]VR"CL*,1Q[@`;H0(T3&S!()+@)``1;30^QFBY9F=/:'ZSJ$(]G)
M(@Z'^EX3-\6O*44I_K+$+%HVXP+$HAS#,\!BQCZ6[ZFZ"2>9T9=HCG'NQ"]K
MA:NL3%C09\DD@%)D#4[4:9TL(((,X`7%).-TI(@",_L0!\OD[P+.*<O>$S?C
MDX#H(L.^8]*.*`($@`I#1*A:(J*4*P(@(!BM1E^N!YL:("[GTJO&4"0ZX@*#
M*OU.ZM;D;RA&`@`B0`.:+R\XM'\@@*B,<)"$ZF%`9`)^3B-4!'5<YBI)5.IT
M;X/RI!)1)#`00$N`,N)4Q39`,W)68X_:(F@J(%$JX,KT*^VL3E^PIP.P+@#L
M4;L^@.4<<Y#:#PH';I72$7^^="8V(%TPJ:4@`#P;(P.(Q"1>3E+R"DPW_M6+
MY(8P%Z:.LL(0+31$UFX'U],^G.0`OH,`%"QU<.B%*(![I%0!U*QO@&,M=@90
M].2FJ+"[TJ;!/(B.VN^SZL\K*B<"@H-1L\+$3-0Q'B`5-0*S,G59E9%3KW7:
M1@4U\N4\WTP"0!)$)"W_-L<^P*8G&XH"3*J9-%*%H+,K[$M_AN5K'#3O*H1Q
M.)-5(NMF]C(\\#(WCFEY7!1#R(/\DO$\"H<GOFU+'/5%02(#FBT!3K(,#1!;
MPZ5:&^.)RB0!KO3C8`("<%)+`B<E_+2^(/$UL`PHQNT!BM,@X\-`=I2+"N"I
M,JU6TX95&J\@T$M5EHE.TRL\H.@KCC4WL.1H_KPJ4Q"*X?@1*$CN(SH`3S+3
M,3Q`J-Q3A2H$H%8F:RK68IVU_'0&L"`N*/#+YC1D*,+&/2UM;`J@KUCK/DI$
MH1Q`[RQ`:!R)J:B/^HZIT41M2CX`.!8@*EA$!%.$R-+U0C<)`S`%2&[#OX;*
M+<8V)H+O_=!",^[3;?\':AEC'Q$@2_JPZ%YHE"[6&NWFU[CV2SI@-:0M-VW"
MX*"4,+:(8T-B[`Q.P>SC`&+(SLP/BNBLRFX7:(@,XEP,+S$@2^_D2M^%,^EH
M]60#02[`-&8IM,!BS^HDAP13)9+$WRA`R<I)R6!E=PIWRH!3(VO0`=#H5'L'
M="62`P(UDEK&;N*F_C"(L10_!!@SXT1`J]ZTJ;P.("]X:=P@IH86XC.4Z4;B
MDB/,:G]$KKNLXE<IH&2D0EB^+'&%"T`D]4C,R4N0<[@HIYA&*UJOXTZ&;U*!
M1E*,,X%(5VNG#7(K<@-0IC"4(@#V]D,F0(^T%%7033X8K*52H]5"3?UD:NUT
M#:".PE`XHA>S[%V\ZR/LE&_WBBV$97(BN'((P#-<2$':PM48[E<6<`$;PF>Q
M8R\_MG;#Y(ZV@H01R!E/>"_.MVZ`L7SK(FPNA'JGPQ5SXP@MP@)LPSO3!4+J
MK:W2%<.@`CQJM%H@((BLI`'2BVO>A3B6:0&@4P%0`XKU:'>"Z'^BY30._HL@
MX.9`R=9+QJTC\O,DL.D#A@2-0]>$Q^5O-,\PXJ0`O'<Z*LSYLC60;')OZN,!
M*(>&75(SXG*+$,8S^BI3+D5A]>H@&`!:,2904@,ML:?/O&UC9TE"0$Z.SO:J
MD.*I6.+EBK*40]%N6#?HT`64@X(C!>`QL^.)X&(W0((#H.T*[Y'>!.`T:_A5
M[B0NEXSE2B+#P.507L0"W(B%`N4K!B4"/.@B:(.Z'&4H2(YVI`Y8ZSB#"B)A
M-FR;N5F-UQA<"2-.UBE$*$`N(@ZT;K&_=D1BC_.;;N\HM()KGI)%+""'4$,`
MV#90>H0"@._?:&/#1,YC'.``4&E<*GHB,L``_K1N)<AKA<-YHL//IV5D[3PR
M)_`KGI/Z(JA2HTV"H\F&C_27C]698T+#SEXD5K(-N"+Y/[YJR;K5(5MUH(\-
M73+%F]VC8PT((R9I17?BN%+HQ=+YJ/.Z_#"CC6V"O1#@<A\C3BAG`C/"$.O'
M._R+:FAEW!SB6XWY2D`L4,AN=QJ``@@:0:-F9BX0[-"RG-W/,8379S!+?!AC
M`_0E0<`KEVLEA065L"(6JLU7K_'FF?`E,3"C3X:31NAO7(^,Q-+LR]"JE6OE
M7WXEF!ZY^0*E<N**KAR`F6#B+!<@Q0[`E2^BNT9J.C9JH1]GM0T#LT8M>:(#
M4KSE`RPU%%M[MEE&_GLF11DI5+QUNR#X4;G:#UXH)X@N#Y<HA=+<9??^6;E#
MJX2:4,<@12S!1\&D-&(#32Q/K*]09E)U(D41H(:,C9HEKZ0`FZK6I$\WN?-F
M,KWE)FU*)3'^IK@Z1*&&*+B:\U(IQS"Q#K`((&54:)&&);C^>ZQY%%$@;_+^
MA&J,;[0<6M"<JP).%W,GHB==S'D'0"M%@XX:UF3J:#_9C&ZP^\-A!CC[6CU&
MIKJO^"(2IP+02E[CXK+"8P,XB@`)RO`<`.9:U<:[LX2,F0)ZT=EJ6"7<2@]C
M;%6=1#B$URTH***<7#&V(KZZ:7>B<LI^XP(QF26V:($XO#`4N7>HO,K9_O=8
M"ILP',"]&'/W`&R5;L,`/OO$1A/L'E%*.UVYAPNP,#+<'KPEF'B1ODP/T7)2
M;@0I]K("[-0Z#0Q:X1%1/DRR&*,F1T>#WXOFRA0GX$7/94(#9KKZ1`.)?,>L
M)SV-E1'%'+WK'`G0TQC.<E2RNQ/5Q8(!P#-M=(6_;'RX?**N)"#'@T*A$L=&
M5XE8<@@<C6TN?T]??*@_R#.N$B`CQZ-,A+-7]FK+OFIG&NR^U#;9#&+>C$M&
M8MM:9<+AI9TH8FHQX$,!1MS%IN*E(UG!^!V)8C*PM2*Y_KO,!F6F3WI&S-!;
MO"J"+$L@)*#,!'$^@#8WXH(*^_>`*,(UK)WA_C:B`T"GKN*7,3"CNQ==`:Z.
MYQ?NE-<3O24>3.`Z,>"6==L%5KBHS!27*R@G0.[I*BP&U&DDSW"CD2G@UA%E
MZBD/L\"2B.@G`-#/)_Y"IZ]$@\7:TNWX68H\H1!DSADC;,XDCD]BB^2.U<71
M=YJ^SMNZE)<^#CL4+S^]!%_%3B$"-P9%CK#F`FSCXBOBRK9\(EITK3BJBQCN
M51SBEX*Q.T<GC+02`GK$40$D@B9XFOK#<4_O6`@`\4,%8:037/0EXN4FVIW>
MWRR\0S?SCLC>+<""0\DC?1\1YIS4OZXG6NC")A$@PBJD[J75)CN*^>*KPF5/
M/ZPS+"*(EDZKOZ3;_K8M[<M8:+APN,H01P(H)]O7<V'\WHI*D+S@!LL5[O>!
M_TNZ^3<`@@.'#AX^&#R(,*%"A!X:=MB0P0*$!0<*$``P@`""#0L['O30X6$%
M"0XN`C@9(*4""A8X>&0`@,"$@A\\:#`@P>-+``$D,%#P(````1%T=J3YT0.'
M"Q0P/#@I(($!`04J'DA`0`$!`0X*.C#@TD*!DP`00)A`H4--#A8<'"!P0,$%
MHP8C#'C@DJ[>O0:1\OT+.+!'#0X4#"@J.+'BQ7S],DY(\+'DR90K6[Z,F6X'
M#"MK5DAP(,(&QX(W6,C@H,"``PU,D@VP0$-@#!(:&!8@@"R`T&<U--3Y_A2`
M`[4?.$!PD"%P\`$*+%00"N#!8XE:LQX(,`"!`0,$A,*F`"'"!`<,#$[\L$$!
M601S"6J`<,#``0=--PS42P%N\LS\^RNV\%9/_@TXV4.D$8A@@@HNR.!B&!R`
M@&\0)/!`81(0I]@&7R&0&T\$-"#!`@`4X(`%&F#XT4*F0<#``1V2-4`#$4AP
M04B.'9@?`&`9)$$"<^V%E`0G#;#`5V0M0->!&3#5P`(,C`5=`!T*0``!"Q#`
MP`:1;=`D5@/\U``")R4@FT$/F#7!:0=&ME`'$S109H,UR7G9!05(60&=>BH$
MTH%[_@EHH(+J50$`$WQ`00`.?(`!A7DIID$"_D,V0$$$#W!D)P./SLGG4A`\
MH,!89`DP0`$-0)"61WY^D(&8`ECP000(Y)GB40E9D-L`$DB0D5`&9$#:C9M1
M,`$$"!`PP(@')"N``AS"M94"&'C`P*+%:2#!L59^"L$&$YQ$`*P&(9!`D@?2
M=&*"'#S`P(^#/A;!4#*]2V^]]MZ+;V88$$`C5AQ-@,`$*"8&`48/.+8!`PQ@
MT%$''&QP001NZ4;EEVA5L.I>,`7`P`1299"N7A!/4`$%Z@&09\D&&#SP00Y#
M'(&Q*0T%8X<$0-!`=AE@4"1("BR`P7@+)+!`!0PCA.M)%!P4P<(Z9:P7U(%M
ML,``"5A@WP;VM9PO_F0-C*AKUV*/37;9]29\T<UJ06#`M(_9.8"X"'$0@0%+
M)V33!.PFJ]N($%R`-67QCNB`3P7,VI=.ZR++<<'"T?0U``ML2A,'%3B`%4]#
M6<3`E2<=`/H"!@B5@%H4(*!``J2^1:$%7&N@G@"TFEDZWG^=VU^D`)SZP*D8
M<#VV!Z=;1*O49A^/?/+*-\9!!F@]RH'Q=&$P>@2D6<#O1Q4TP``"`T!'E@(2
M-!6]G](G=,%%[*''U`+-*;X``A90W_%)"W#T@02^XF_0!A$H4!$J<4<`"&B2
M`08P@-P$``$4V(`&'I";`V`@`PH@(`(>4($*7"`#]UF(!YQ7`?XQRED2_CB?
M[11BH,Q0X"3D2ET#*@"\L66@`;G)R?)NB,,<ZI`AWOK1!2#P-S8M1D.DNML'
M-(`!"WQM`1:(0)-<@Q'.18`"OK$58W0W`'=YX`(+8.*Y&&``6G%/`KDI`,.X
ME!$R;0!4##A33"J($:$PQS`$P.#X+D`3#(BJ2`](4XV29!0,.,!]O&N`;9R6
M.!1>H$1XV]1D/@@!N$C``A:XP`4P,)KEV>DDA]JA)S_9M=_D4`,+*`"L3F>`
MPPGL,1Z8@%"LQ8$6B2DF?$,)`0Q0H@M4P)&9B24G$V*<!>PG<1V0P`%L^('M
M#5(HW7H`NQ#0L1;=Z5@CHN&(")@L`B3`B`SQ_H`#"/B`5$D&*16(G_NT8C\1
M+N0"L#%A8CQ@@04T0)TYS``#L,)-4.ISGW\2)0XO(``&=,!.!Q@)+GDI&`KD
M9@%J@5T`"'"X9&%G`+@\38,<ATR74<HQZ>MD_RR4+`.TIEAP2<!=&F41!"9P
M`<7RI0`>$$,-&,T_#W')X.+6$0YH8$D&0,#1^J,4#0PD>AW00,B6!Y+T((:?
M3&VJ4_FS+]$P(`!YL@`TZ5F:!01`@@;AF0(JP+8/5=(W_E30"H4S,'A.0)T3
MR")"J%8`"/"-*L@2@%"L)+H`&.`G"I@`4?,GE`/$B5-]*>LC3U@!OMW-+QZH
M&UP*4`"/`C5A)(J8_GPP)AAW]J<#(`/*4S\+VM`*1@,(L`B67/*``:S2@W\Q
M#G;$E1[Y82X"0J03!L04(9=5X`&B6P`%\&@0+OIF`C_QWD.A`U'YR(<!%R$2
M`B1`&Q\A1*$\<=>?,B`JZ22$E"\T9HL@0*!&M5$!!EC`A`S@UW<"J3\9"&<!
MRB/:^,IWO@6Q2006((&\5&`F1C'L42R0K'F"[`'E54U&Y500#C1`2@^X@`2(
MVQWD6JLM!^@B%'7S7/(D`)H9^(Q&9(0Y."$D`Y(:P$_Y1*`-5*II?$/`,!E%
MM!\](`&P&9`'A+0T(>5$`PK#JKD`Z9_3-4J[\RURO42I62.C<+`?<=MF_DJV
MP0Q$9`+`U8R(OH0`!\RXPO*T0)(M4\Q<U;)O.@*/J,BLFP.D20+DE4\$9*H=
M+2=`6G[I@$0DX&/^*`4B$_`)^,(7IPX\0+!]N4"R!/OEO80Y)Q'HR08P@#,F
M`VE5'L`D@2K`@!O/3LF<5A6!0%+;3@LF?;0BSKK(=,2JZ16`/4T`!&[4D4AB
M!R/03"\%$K"?1$LF?61.B92\@^:^00<"&``C9',E'P4XP&B/,IY20LU*@OP0
MC+KQ=0(!D%$+/`!8!]F`F`S@9:!.@(!N(6#\]IKG##V70,[30`3D)NIX]T4#
MF:0IM.6]%UP=REL)+@Q'!CJ>[B6P8YMNR+FT_NJ="6!@E_V[[XOEM($#].VY
M#_Y,L/M6@*'IR*2D>I$`2C@0_Z+X(!7HZ4]U?9!XEG)F,`*1T908@4=)S&M8
MLFYFW"V!#%:@DI;\'642S"*;]W+G!P`OOO&M@2H#E28H5_*^X"37O]4M`2($
MB>7N9(!7,^0H/T05!6ZL`/Z1V'IT*D@'(H=?A1L\5A?7B`,4#K%:IN2]EC+`
M4@/#XP/,F&$F])-8JAVCBT7O(!1H@-QZAS>[@+OI=.$`!1X@'HD1^^<I+\"F
M^W,!2F7]Z/A.X648?_2$R3-4U2+O/!&2]`NXDD1R<R?;+M27>.:3095V$E;_
MCI+#+2`"1D.*!W*&_J4(3#$O1:H5:Q7R$V!5*-U;/XA`D$(]LB1@`FCA6BOK
MR#1KO75E8?>/<5*7@,,YBP'<I@R7%-!L]A+;+)QO/^7=_QB`.P`")>LSE=4R
M4`H\*8$!F$D,Z>(MEX(0[))K9><GMW4265<!DG80&L`2+5,M'O1\#7,Z'D4>
M1:5+R0$U,_0`9:)@!=`ADN5!WU(N!C$!=W<0XV8`#%@9%E`6A:<H&0`?#L!\
M@/$_5?1I#H1+\,>#BB%R/0@D#B1E&``X@\49%58A#_`IG@4IO(<A%-0`@^(8
ML',2R&0^A-47'<``1I<0[04!.)@0$4=V/)(`MI$L"9!^*!0<2V,<&!0Y_EQX
M%-@5+@:Q7XE4:*YS.X$A%K!B`6US1.3!@H+!@0JB8A1@=_0">D`H)R&AB(+Q
M(!!%--QQ.%GR`47E0#LE91F@)>JE`2"R*1"@`('H'U+3`0YP$G!X.Z!X>76!
M`*`#`<113'UT)M;U0`I`?[:A=.@A'BF890!0.AM0`$OS+;OS?Y[11I=#`-J'
M-S\X<GI(`'EB)S42`7$ABH!!'@C%'Y@V0R(8*`[#C(UX9(D8>LZ4<\MA7GGA
M;DE8(5OX<("Q1M+"*1WP/WDACI,QC"[6&-U&(O65$%UT`;V#7X^V,A3U=6'8
M$L41,TBAA0"@``:1`47"`0B@5PF`:@#%D&6R_BI]6`"6D@`HF!B,&!@94%X3
M$@#*ECH0@(WY^`$6T%<+D@$1<`$(X)&`TB?@B#SUV&E^D0$^\0`GQF,%H&Q:
MUCO948Q/HT>3@WHL591R8F@8,7MT01@^Y4'B$UR=,V/043M8B!``4R;R*"EA
ME#":\@'&4@`)X#89(''/2!<7$!]OIC62$6K&TP&/)W$8P5(74&]75'1+61D;
MD$$%0&1.A9,V29B*L1E3]2O%$7(K>4&.Q``"D))1PR&291-,9"^1(A1%<3X<
MD!J8A4(,<'</V1T8\8I&H3\E]`%LB0'Y80`S=BC"TQ)(0369J1?8LE;CU(QZ
MP5G9PAQP-QET<P!"_C<@D$9*![9/@UF8R0D8=&,2'Q(JZ,8HK;A8K,(=D9DD
M!'9@'&"+UBDGZY(;RFA%Q5%*#-=\"4.9S:,>`=``Q2@6B,8N'(`!W,,`^543
M%B`!#P=@NQ,U(*F5\2<]"5->%$`LJ6&630<PX>:2DY0`QJE/]Z:<#XH9?J%'
M"UHRE3)&+C&7%$$NK?A>;C-$RH8W%["@1T9="E"4*O8_#>"AUQ,P6ME6NY%G
M_48JJW%&G_)'_=,`^W9?D)<;:-A/<ME6,4<0(5$WH<@8MZ9U_;E9.^5J3X6<
MK/2D$'H\D6$!5(5"?N&`0CE_W-E?YG$`!8D0$]&.@'(3.N*A'I%8KZ40_@^S
MF@1F>2I28B?F06*1'4L5(GTA91]0?(4A3RT2$ZMX.PYZ&?((`*@8`5A2@XJC
M``H0I3KA@!$'GE(*&-\HJ:`U>(8&`3N#`9N:1.6W%E(&$9K(ET91`;>D3IQI
MHO2RD$1!%V>%CR-6&-OA+`*X$#`A`&#J$2263Q.P(Q3@)-Q%6@Q0,J=R$8$9
M&$J!.Y<!.T7G'-I68=787X,DIXVZE;BV@Y6J7MC::=C54]NQ'1#5`'GA/V]!
M+MUQ-9)Q6P60B\G4'*.*(!T``4(!7SI!8B,";YQ)%E%H%`6CGLP'C#;T&Q5P
M`"HF%477`.$T$:A#']SG@YZ6&6X")0R&C<[V_B`SJ:2744Z<8;':RK$]"%#"
M:DDABTD%P6-9=@%&%305-AEU`T-XPY7O<GUE`37&\4O=]@![U*H]6HT<L'GK
M(I.^JFTY:BD"ZE=U4S07L#((`#Q?]C";M9H9A`$[A8/N!#ODUTT*4@%A-Y\=
MBR#4FI/'0V*`FH("@)0(436,1S?2E2()TX%2V`&28D90PTXZ<BJR84^'NAM@
M6)[J00!\YQ&EJ*(5`)3R5"R/5UXPA2V,LBSNDRRF5&?N^A&<Y0`;BQD<(`&B
MD8?%P3;PQCZ#1R`7P`"&B(I<JV>42KKX,E"C`6H/4SXK:0#3ET2_-0$*D&F3
M`8S<B!X=22_\Z@`I_OEH^D-K\F0R5"<I_/)_7*(T5K1%6Z@_9Q(;9)(^=>0M
MH5$2?7,7F\*?X8D0<ZD>">"U_=,[3`82K:IF"(,!GCL@Y00PE'NZCT00WRM:
M\&L9E48!NW*YDO='<PD:J5.69,NE>T$WDU<K;\*Y?U*JNS&FS0.*L^13A`&"
M71$4NT,Y`N%`NU671G>)O-0!18*T%1%SP>D!;),`3W)Q9)NH#L$6GFH0QG$1
MB#:H#G2)](9I(K:]Q>@!O`4HV;(]3]F^\TNZXXL\I(5`D+4=$-*[6=AAQ((J
M_PLD^^*C>&,;D.L?NB,`0@><6UB7`F!T"Y<<.?+$Q8$!3@1`8R90<#4O_@IQ
ML/`4*ABC`+PG*9IS<3HB::0Q4!(P:#08H@MF>?7(O:#CK2`84/0$-3Y1P"?D
M'VS)(>P+LSTL;_);&=CU-Q-$A)L*AMXR`1BI2XGH`;3+-?%T,(*B.RBC$!-P
M,_;1:/;C,@9!6B/B$L662D5G,B/"7/8JN*`H4`J1D!\`$QVC&B`8QQ0CG,`T
MGQ90L`4L:*4"4\HJ,0[`S$KX`-#EKA_$&H'B`1!#E:&$OHRLS1'**@5E$%QC
MN>"7J=NC=U*L$[+"H/DCE=0<.<E,$Q1P`&+)*-"Q@CJY,K!1."<X12$1*@(3
MP?0'`)!6MF]%'O#,$V?VRWV3S!?;`=HQ29F7_J1($58KB!DU)1"M&Q@-K0!C
MVB"KV5BX6R^"NLTCS1@B*1VH<3UNU@!Q(14+(XX80%$=L0''`:T)DB@CHD6B
M\X1\(Q,%L21@!47M4F^?P0!VFRS(D0`.D&59:!KU*W%_EM`8@4X)**<+$2\E
M.-.8.UU7\BKW`IR%+"<6T"Z[1])E/5\PW0`>4`&Y%1+$<3IYDC`+RL2`01%I
MU3]?U4\..4O(!+IW5Z9#,4_Q"2$K?="=\[H0(!%)+1?H(7%HR`&2LIZKZ6=1
M#7@6$15<`A?)>[&IF1T'P46TZI!GD@">22\4X+C&1R?N1@"*;-:M[4D8,!3L
M(@`Y"BHHF4SK,T,Q_H<>-0T8G\TU<_F%FYT@%'2*!T'3;_68DW)'$.,`V>1E
M27>S'6>E9U<6K3P5H9)`+T+9NX&7F?=>9C$XQNI!%8$0H-NV*3@<YCR*1]0[
M(B32Z5LT(^K:\]U4'-!G9_*ZH#'::H%2K7A+\9&,E7N^J.T!"R#>BQ@<M?L!
MIP(9=D$690DKZU(;-?NV.&$!Q/55"9,295@UV[U`4I$;`C#8K827O)5?A2(Y
MW!DFZ'-?\L0]S($O@R:^CIP0^1$!TT??.=Y4,D5)U/=3&5J&O9,Z+5D@(2%3
M]T7:6UDTJ,T@2>.''_#,D$%=/-%&S`P4'8#BZ)=,"^`NI=HL=[+=*#$5_K+S
M?1-BLF^;$_"I%G-K`,&,$-E2D#3A/Q1)-+IK+Q?`A(.":28#TCKNY_!G/A7L
M3+S58H.%%/<UU_RA`4_]:@F#BEND`$*AQ3)8W#`](E';5_81Q@PP9@F=$AD1
M4.4T`'E"`8NB?Z_Y6]NU,@"@R!24E0RQ4Y'[W@ORMFG])[65=`7.VG_.ZSO$
M6.J55/:Y`"]2*B$5S.V%%W^2'D)A%F+"4-TD:"=1`,GQ3:KU=T0Q`6JVTJON
MX5DA/K?F0)@3(3WB>R>4,+FAKT_C$]PICZE"XVUBB.F<(`UQ24HQ5*.QU+VN
M[\<I&3)'7J85$Q*Y%:$1&C%DB%7-('0C47P3_@`SN4D`(&4,,#_E1!95\E#:
MG="S'1X@PQ$\MD99XH8#_;<O^NHH)-8908DZ`8QMGM>,?<1ZXB:#'3_0!),R
MJ>_JO>].U18.$";?\U`*,[D4\56<A5"5XT2R\>X'@5W5]CXH9(H,V4==)2)A
MKANNU@"X5HG;FW,4Z:O.M&PQE$=C06C.EW3W%7ZZ(;;.)R:[/B`/N<XP'\$%
ML#(9MQWKT^LXG_-,%7TQH=\PM)J%MVV-`11)_Q&SQ!QXYA'#J"-H01ZS1/7J
M*1!*7=5V=K#&$AJTD?**(R8RL5,5T#1G_QK0P;["$U"!(@'@!B@?.'=6,FCV
MFO>O+V^FJ!H5(3\1_H,JF6\\Q`76"O+T7]P150H56T'94H(;<0$ELA$!5)+L
MV\N6:0$!$B`;ALC1";$Q"$`1PE:60#'U\AR'MX3WC^0<=MB=K':*S#R[K`K[
MZ6]D]@07/H\;.M)&XM08)/,GFY2J.K$O4'UQ4I(1?74F`%'!@P0``2A@B/"`
M`@()'SYX</AA0X$('SIX@&CAP(6('3UZ@!"@H$@```8<4`#A`H<.'RX8`%#`
M@D>:'Q`0P`"QYDZ>/7TZQ/A3Z%"?'1P@>`#!@`0-'CI(0$"!Z%2J5:U>Q9I5
MZU:N7;U^!1M6K%`,"0(LL#!!@8$##BY8>!"!`U&='.:.)=HA`8`#&GQJ_EA`
MLN1@PH,=<-"086X$`AL^6!#9X,(#`08&3*#I`0$$CQD82+C;$T.!P0@:/+"0
M04/H#QD$F*SP,X*!BGA_ZK1=M4,$!`D8)%B@8,'O`0US'T>>7/ERYLV=/]_I
M@0%?"Q48%-A<H8*$!GZA:YT^8&;TAQ->%P9`8$!)`;U1.WZ\H`&&UC`+7,B@
M(`$$^!Z38J`@KKG@R@"HGB8`[@$,.FB))@L6**``"%C;J8("%/@NPYTZ4"H`
M`0@@(#T&"!``,PU/1#%%%5=D,<,'3$K@``%$$J``!A+JKT6?"`K@@1QKTB#$
MDDXZ@`$*(`B1`-`D4""N!R*$X+`/'"A)*HDZ_L+-I0824.``I"R@(('Q;LO2
M(P["7(`""QI\B*>7#OA1Q]QPZZ"!`0@H((`"%I!@`@08*%!.00<EE,4R"]70
M`P720V"]UP+P+0&Y$*W)`M(,")0G#A`H"=(".T"L`0`$@*`E#RBP+,(!$.`H
M@I(X^\DL"CRXH$L$!+#R4*(XD.``X_)Z0($,=*44*UTY>("`!9!4H#H&&)B`
MPF*GI;9:JXBUMCDJ1QW`0P,,6`N`!+RKEH-%!Z"O)PX:.(^`"#S`P`$-+`1@
M@;D\B*``T#2P`((&%H"I7FEI:H"`F3S@X`('#HB-JC)1G0!;8A&[*%NM6.JL
MMP1"_#:"#C!`P`&+_BG%=F23#92SY.\V6&``X2:@8((+U)S``0K8K-95`'Z-
M[J7T(I!@800@6@```Q9+H.$/.$#2PY(,&),GWF:-2`,,!IX*@P4>P-HBG,D[
MF2ZOS:P`@PLFF,`""2H`==FP!0WJ;;F!4GGNKBP@H"]RYZZ@)`4<*[EH`S;@
M(#RVP\/`N@DZV"!H!WR3``*S=NX)H@H6\#BSK)3ZVB,&P;;;)Z<BJOL##?!K
MP,304XQ[=9,A*AVZV)>C0(`#NJYI]A,O(&T`I7FBDH#8*F`KS:(#8"#DQAVP
MK,F[*EA/9)\R>."!SK5:.#,&ZW9*=Y-!!;VCC[4[`%;73QS]?/71O_X[_@D&
M,&""84/'X("2>-[IQ>+ZO1E`^X<D`+@<8`$.Q(U6(4I``2L7M/9=90,-8$"6
M.J"!F,VO)XUKROJPT@$*."`"";#2^6`G.^]IT%"#*F%N(&`D#&B@@9E1(*$V
MP`"1/$!S'1&5T1CFD`PX@"2DPD!J-M`Y#9"&`%1S$P*.]I5XF0@#$$!``=1C
MHSAY!&\3,B'IB+*!"UR@`@H(H>L\X,+OI#"+9Y2;!+:FIA=^I(VLHX!(%E"Y
M#/QO5`Z00%P@\`!.`8`CE2L:`")8DPU,8`'N>:-/[%(7!]AH`</96L`(D*F=
M7*`RZ3*C^B8C@02H[GP80V,H12F43/J$`A&*_@`!5Y>!2UU@C!2X`,X\4,?!
M&&`XJ?-+WP!0F]PYA`(ANEUF)A"A^222)QR$8`@MA!T(Y,1T]@M`U`C)@.*,
M4B@=F$#J.FE-;G83C1@IY4XF`*X+;""<<N+`7I"'(*,%"C<O*HE,/(*!]=CK
M+YP27IDX$`$%[`TK&_C?'(%B%RQY0%0">!?*/$>!`4@/.>=DS@4DH!AH>=.B
M%UV=!P@7EE,F0#40;1$'`E.0\]RG3.^+IS0UP"D#I"LZZ2Q(`ESJD`Y8QY\.
M7%2]/M(1##S)99/:*5`P((`%@+1RU:*5_/B$4:8V=63=XZ@"4F+!.36'@T(B
MJ:]HDH$^`D`J8W0`_@0LX,,`>+)-9X5G2905-0LPX*97J0`"=76!!&P,6L"9
M:>Z"]3NP/.6/U,)F`RC``+XZU;"';9%1:U(!+E6@BF(I9.84BI=-C4H!$KC`
M"AN$&P@,QH9U6@!P'/`:&\Y2E:2[`(1HQ*64?+6#C\62NBP0`0:\!E,ZP8V%
M?$,!5!T@KQW(``;01H$(.$`!9MV*3F:X`$Q.BP,50!L($8O8BDU7@W%-P&:/
MLRYY+J=H1W3(!AX`&H]4@"0,2)BP+J!$D21@9LGCY0?*<A`^5L0##T#)!&C+
MMJH@#%0298"70C2`4M%$`Q!`,(0B=+`-;``#CJMK@%/RUJTPK0!AG)9I_E$5
M7^MB=(@=3NQ7ALDP8W)%O`^@Y'%$%8`&W"4#G<P2WOQ67`M`Q#SL04GR&F#.
MAT@`4P^18)@`@(#'E@EVC)M9Y%QF`;]$0([]T<EZ;T52`#@`N/[R$@0D8($@
M!A&V6EG(S;*%S1L=`+D@[F;KT!RZ8?Z-6(J-2!TYG)L)K*<`@>(@`A3PUPWL
M950&X%IX'U!/#:SFB2:JP&:P]C$UQ2Y>"4#``0Z9-SQ9R5SI\<X$XT4`D1B`
M`0`+@++&N[6KL:1[:O9*!AK08HMM8(46$.R:93WKY1@5;PFHR>?P4MR\VH:K
M!5':J1B@GP8X8`%8O4]'.)"6O26ZG,GKW.S@_A5<[D1@CQ+`K`)P@H$&&$!>
M'\CA9R1W@(#YC0(2J*T!&J`2#'RY*^_\F\DD2E?\T5K6((4S&JL+9K8X5H(E
MOLH>E2.=@EA/V0_@4H*H.63X8&L##CA*L[3(DRQQ(`/;@4!P%$`:MW8$`GWY
M0&<+D#8_HP=2#=!S`@8HUD(#/+ETK4V^!SZO+Y[9WM;U'FX-&$-[0T37V"M`
M6VH\\=Q4P`$"24YGAYSBB#2H`_9KZ5%[3)NS;O'C!-`SA$*&UZ5-D)H'X.,!
M(I`0THRD1ES"(K(*8$/HU!&])ML`<0/TUYNC&=6]7)H"N;B@I35`FG4/IZ@\
MRO.J.N3C=Y%Y1R9`_J._9TE1Z;$Y31@T>8I+/@+K:8!3GCB3U$;@B=4CS0&D
MV*2P0G-9$5@)5#$"2N?PZ@`8SI8%P(B`.==]NBK#35D8T.!&G<6%9KXYG"U@
M@`+PMSG<=@"4\:*!G.8J.M,QF@,8H""\:Q&W&FA`O3MB7@"P/;404+4"HFB`
MUTAZ)*,*`!Y9SGH40:1^DDV\<FJ%(.V/,OYK9KX@!Q*3;F4>^%6WO:S0`$BS
M`'<#B]R+G^0@B.[["0M`@``X@--P@&0JL76!#9Z8@))@B,?QD$A+`,MX%+80
MB9"IGEB:BOO;B0>RIY.I*02+BFX"%=P)0*J0@`#XFPX8D19BBW2*O!FD_@J-
M$)8,<+FNX!"T0`[($!<*ZPB)4J4-^""D4$*/Z+.28``W:ASR.X`$*``!F)'T
MJ*L8`9$#R)L(D(QB^3BFRQ9^20NJXR;&D4$?'(K1H@\,4``&:`D&&!P$Z$$X
M'`I4,0`*R*#G`(XAK`I6BHGQ\!X)((`JK#R:FH`048`CXP#A,@NBH@"C.Z0!
MN!`]4R)(4S<T'!15,Y^3T:@+J)]1_"8^]`H'0!>7"!F(N(XZVL-&Y$-4T1>J
M:@Y#FL6M8!F1V,7<H8`F(25#/``A5`L%0#D(Q*P,@(NU((D",(`$>(`*6`W"
M([H6J4-"E!-^,<7+PB@4!+$:7(`ONK":@L`-_DC`J2`H570([&LQ</2)!HC$
MW-BGUV@`J>,)_&(-#X`+#%LO*IP`^_F,$(&60]K"IV$`#RH;'KLAN/$3V!L9
MIA&3!B@L?=LW=JR*^BD(OKB`'"H5K5)':_3!"V"`^6#(Y\"`Z7O#K*"5]2C&
MR1J*X?,\+K*V",C"`J+)`!.]DX.TD8)&$$&`X1B@BX#'W+@`D)0;#IB`:1P@
M`-2W#\/(:TFT")DH@G2AI8A*JU`*TW"E#+&0,9$Y@#()"=`=4"DT"+B0A*@K
MAN@V",@F3M/$!Q@M)5DQK,O"+5O):=&:W8/)5IN+8(3(,P*GK+P6!ID+O_(Y
M?3$65>2G:=3&K]``_H@#Q7?SH2J;G0Z`"S`<``9XD'$)FMXAO@`20Y4[@`%X
MC46L`)8@O*)$#B2AN[?!"`XR`%0DS*M@33FIK@Y0S-HD"OV*$A/,$,`@2[SP
M`'I!@#922J!9N`)8#P"8/:,!$>:4$`IHF8V1HI(PLPR`2M>I%2L+G0T`D\L)
MS%"Z3;HHSPS)`-0;(U4:B(A!2M[\B<%2B4#,$`>LO7>KK$DJ&0T8D?/(PB_\
M#>#8"UM2HF(C#2F*0&SK-=<)K;RDELR")8J$3Y9$HPH`.Y#P+8GH#9NHOPGU
MB'$2F;M[#GE\3*%8E"-ZH0Z`IQ[I(9OI(`$`(<;`#M/\%DE3R($Y3^7X_J#Q
M-!FK28RC0ZP<[2;9@P`/<`"<6)KAZ``V]-">"!/.I,_@A("$&@LJ02@9M(#7
M&#G^E$8(T#:[?(T/*0#!XKO86A]X*1\1`I4,$"O#$E)O>A#.>!*.*!Q[V<TF
MY0D*V!(%6%#HX(T2W9$G<\J.J)TA(3\0P3HA&8#-K`#M+*`WE1W30<;)/)D,
MX*T*0`VG$M$)M5#.Z!7Z\(#@X(#_@U2+2C0$2$T524DIR3=:`CF:V``*`AC"
MX$))4R+X48ER*E7T\;&_FQL.V`!+W::F&J-=%24+D,8/X(V<R`\[_#\\W0G=
M,]:J&[[7]`H<'!4^2QSC2H#F_#/?2!XQK*&F_NJ5B+E&V`3/!TA'ID*8:44C
MNMH,&5FWC2N5=3U30<F/?NI+Y_`Y!(O"K("G^;@X@#D/]O@6!0FN)S&)WO!5
M:^HS7%L?;(JP/K46=[TYWND46B5+K/30DI$``;@,!U4.<S$..%M`;A$,DI*0
MC7*(PO$T0+38$WD`YM*@^X(?H()6Q'JN")@`[8`9WAJB.ZU9.6$7/<&B%7D`
M0!$+"_#63C$`TR@;(?R(6&6]F'T.A-D:$Z(KD`VT[Q'9G.VOB%C')>W0N6'9
M[Q!)AU!7$D$`BH6.=<F\?;T*#M@63[,9#-#.>P.*DOS7M['0U_`=4K3:FU/*
M:,&7X(@8#WC/3_I:_K%(VP_P$_48`&N-5(>HE2(-"_%RB](9W!2Y@,O((@N5
MM*2Y6K'HW#5344AYKL$(@(TMV[`Q5I4)2&^AW!,)2+<%V\[@VRRB@")I,%-Y
MM[#-W1:)*P)8G!>90)=9TOO,*#F1@"W40T!=OCWJV^&=#4JUFUHY+ES4"O`Q
MS],%6\J0"R/M"[TP``U(1_#5H.>%E*'3$3DC3ML+R`++HJ-<V(:]EK)DO^%-
M$7;Q"^:[1W";I&?EWP^@%Q8S0'Y]"`3#WMP]DL8=F0P`F-#"W^.`J@)6$0A`
MJ(>C"(0A-W3\1?CT&:1(8-EIH2Q*'T*Y2!,JI`DXL`K&X%#"FP%(@!JQ_H!:
M2;\E#6'>K)]QB6$S*>'<W0#MH+<?OBBZ)8D%N(`0,2FA)45KF2&9.LD8WM05
M45_*>HL*4`ENNF(4#J\CB0#M3(`R)-NPV9YL<4*/J6(C9N.G(*PM9F-#6>/<
MZ`_=?%V2D=[OP%29R6,^[.(T2Y;BJEW;L-@53AE^)<KDF#S5,Q4F+>`5BHOJ
M-2&?^^/<5<H&B``CY`KNF6.KZF,Q4HX.N`">51.?A5F.S<K903<7GN(T6XTX
M7I&W^!AO/$`SE8BKF;48-"&--#N1Z!$/<&3^10B;">)[[6187HY)M("Q@F%U
M#!`$FU()2`BVD:@"J>1$^3GU.;!5*[8)?!:!_I"N0?7CNNE(P8I29%:1:QZ+
MXA2KIH2H%_,0330`]1`77J&^GKO7GN@`!:A(^QL+0Z:)WN73QT7G]N,FHROB
MKFB<8HN+G+),7J,U<%+G:T&,6"VTQ!#"4=UA8W:.T;@/""[HAYIHL+@<;MOH
M+1JT7_:`FL'=D$8."8X0*3+-`,AAX!MIQR5HTW6(!PD99W+I=`;IL&&:?MK.
MKR`>HZ&:E7Z`00:QFR8*#"BWDTL>UV6J,VZ.*4V,H/[I=7;JKC"ZV6KIH8BR
M$7D]*#LW2=YJQT7+6H*`1K4()_Y&YD`Y,1.AX#LLV$F<-/$*"RN)!TB,F1D6
M+=/JM.Y>+5X`,2R`_DZZB&`>7BK9TFSAW*Y&'W9-&'1K9J)@6K62JF_93*/P
MD4*1[+`YL.9\%Y`,[9'I%;#SZ8KUB;.=M3$:;+LYDU4C77&F"CHD-VADBYMH
M`!7][$0)GP*^PB$1B,4=WK)8@-5P:L81G=-VCI?@T5&J;,Z\U@:[:`T@G`+B
M$+_6D1'BWU<Z"CQ9`/EY"#"2VR:]G/%>;6HYDX3"/5G3O086)5YQB^,P19#@
M[A,!5L?#+15V[H[`/JSB$^UTBF$UZ/^>"B8ATT]V#C]Y*P1GCADB,DV=%VN3
M;ZO@(K40@`@2$-M>#L8Q,DK9WY/!V'@*K0/P%=VDS3(Z9KM9B-W+:1E*_@JT
M!C'F86J'G8!HIG'189P,F``\5"NRQ",&7TQD?C&38`LQY$*N(0"V:S^`7I_Z
M$8"NA6S>.6F=%0X/MZ9)/!((V/$+HBT#H.D`*`Y3Z7#";HY2;*&_Q@\/OF/F
M@/!=.:3UMA:C:(`+[S!C"^OYMHM,ONRAJ(#S<(`G\BB@P.381O/^<NWP&B("
M%N8HD@`Z+Y<%<"C`6Z\WGYO8H96$D+BN*'%`.R3XP,&CW>KS[,A9&66_F"$'
M`&9,AT^-T!?@1.U.?^VJ20E$1Y06#Z^@@:`;GPI1GMD\*8CY**!#+_7G@!AP
M$P"!X*H(0N4GAN*$U/)B*4(B%TQ4V7,S%EG`_@X:7[>*`U,B+JP(!S#7D-9U
MCA*[*2D`^L@/5C=NR+:8]!RO<\Z6>"$OO76),2YF:!\*#="O<\/S$P05)QS3
M*2GW@CYWL%B(AFB``OA?9%1<5T>AA%>1/+I$63>9W@WX;T0X[XCSKIB7MP#$
MW`"N8K_R,KI:*(]?K]PF?;2(X8AXV)QV.7'`%B,CB\$-INF.\W8JR?'V;B(<
M?BS#KS@4N]AGB9]L?L68C^<)QO*1A;D`?OD3Q65>:-6+`P!QN?&`_;@WKJIT
MG0569#WYJ8"@K:]Z8J4IIJ^)]9(T$N$2>8UY@[8F'Y<?C!\XO,BF/[>H#I`/
MOU![A8X96.MGK:`3_@08&@4X^[O.(J@F#)H>E7<91YZ?4(@88L>RFW^Q]I7G
MU^$;>S2B'DPV[]P8ME"ETD0?6;7I$[2!&0*2#KWG30W`-C#!==L4B^^[9HK?
M"M[9L7.]J+HXFZ3]>7S,GSEB`/HU_8?B_9<??*N:?6J)*R*[>:N*/\;J2D11
M^;%8EQ^SNPGREVS_B81YBRY:YD2K0DRV]K\/I3.Y$0P(HAR/I7#>58M#?YZH
MGP6X?D*.\:S8)Z6U_O(\"H#(\&$@P8(&#R),J'`APX8.'7KHL(%#!XH=,F#(
M,.$!AH<.*QP(&=*``0("''Q@(,%C0P\>6,*,*7,FS9HV8WJ(,`!```(#_@(`
M$`#!PX&5-X\.?(ET*5.&%Q`LX,!!:5.(50UJ4&"!(-6K7K\.M)``)=BR93U@
M6#!A0@,(%!I(Z*#APH:E%@X@0)!`P8(%"A),\`!X*8>Z9@\C3FSS*0$&"```
M,,```H8.!HPJSJR9)H4""SI<J-`AZ>:O'20TZ'BU*T+62UW#5*I`@>'2MCUF
M*,!@`8`"!08@<)!`-5(.&B9*U*`\0X<.15^/OBU]NM?.#CA8*&#@0G3+F*F#
M+ZUA;X8$"R(\V,V@0OB;@AF4Y9!A@T3F7B/"7BAU@W(,'#YX,$$"[+57X`<9
M'/`33P$,H!T!"A!GDU(;5&!!=`0Y]UU-^1G8_J&'!%4P&`<-P(?A91^BN%H#
M!"S08`&0009!B@\I14$"$=S7P0,*0``!`^M=R)0'&W!X4`<6./"C7Q!^<($!
M%'`U8VGE!2#``0M`(($$$3AP`)1(;0`!`@($X$"0'=PHI9IKPA1B!&@I8":&
MS[%9)TL;\!9`BP,L<,"#%]C)D`,(U"8D!P8(D$"5C6%0)$V.8L4;``102D!E
M)`H4J&(;Z/6C:`-E`-=_2$T00`$*"%"`!52AJ:&FKTHIU@,?8!`GJW3"FFM!
M#0#@90(&3$`!`P,\`"F;&J17*%,2(/#;`8EJL)I'+WE``:(/:%#!`QM8@$"$
MNGZ5@5X40%``E!L,_JM`ID<Y,("%$21`P84=((`CN/=VZ"1P!@``'`)%<5"`
MO?C""H$`"GS0+5XO&J#LJTIA,&"42SW`$P%Y.9"!L?$]8-(#&=AX:F`$?Z6!
M=AA0`,`"`"K0F&$;+^0``=%>H!)5'!PP,,D[VY:!`E4.X%,`54)PJ*L)N<1S
M>!Y`,,!E;Y6DW;8P2^E!!0ML)22]D`E`P(T:3Y>5E0A06D"92E^U@4\05-!`
M!1E<(/.;2Y7['P8,?#F0T6CSK=B1$E!@`06#5R@5`GE/;%!$?4O7P8H'%'#C
M!!#$V2C552]P75,=,""``$$'0!MU&@S*0`)!Q1LDXS9I@$#0#1PG'`,!_CR@
M>DTZ4:`!!`<\<('O].&ZNO"K4<0:!PA,,/R,#1Q0@029HU:`4#Q[D($#R3=U
M]5X.I`JV=!R@MH`$%4"0FO(WA;I3``<P#]R#Z]X405`*PAC`4,&?GS]-&S1`
MDH8X8^\@%-&?;1PW@`1((`&?,PD`R,*S!S3`=C9)CG(H\*GI>*`PT<H*!2Y'
M0()@X$6+^LD"4!:!;]7D*;XQ0$C^-2`/G.B#,O3(B&!D@$819&^MD>`,P<*Y
M`_*+:Y!A@`?5E`$&.+"(&"*2FA(8K1ZRA`-KJ0`5R16!"F!``H!"2O5\AX&,
M9"`#&H@(_J!H1H)DIR@*`-;-8K@0)9[Q(1U(_A(%!("`!CA``@Q0P`1X"*X*
M',Z/'I$('!5#`>0),HYO=-X$)`"_#3&$7D=3Y`P/F3RQ2.!F!PC@HR@I$PU$
M0`(8@%U!"IDB:@$R:YU4TQP78$HS'D>*%!B563K`1T^N;F.`7$FW(#"O!1"(
M)L;!)4PX(*8(*.N5,]J``S(FO`B8CYA1K`A;MEA+8$H31<H<4I$LV:1Z%:0#
MV*Q)1;+Y$&0%AY;#\\!<'*8T,9K3(QN`&P11Z!4T$4B9\5Q*!UZ9P2)9@(7"
M$8!D%L``"W`@7DW19_XXL,<,J)-&L*(*0]E44?UA``(.R-P3W<,0`++DHOM,
M2#_/<B`$#*U*`H!1_NT4@#B<)&ZD!N'`7Y0H4IG.A#4W71T&($@B:\8'6!+]
M``<N8$$,6."1.#7+*S>PD0=$()02Z-$%/*"`8$HHD=F\0`*:5\3%+75I)5TJ
M=@#G-B%I``-$BLA%@,=)ATB``#QIF0(B&E:3/JHB4FF.7C.(O-?<=2`3\`P3
M5QE8VPQ)JY[<P`.`61E^2L!LP5E`5PWPIC(JI'H(4,#L)G?+PU9EKX\%RZ'>
M"MJ:0"``)8K-::D#UK!>``(1F.52)A`TR''-CE55Z$,X,"BX!2!:#4!8:V]2
MU`16("ON9$IIBWN3SIC+KLZ=;GLNHBT(*)4FO)JE`WHU6X%P8)P.X<`#_N(E
M`0!,H`(*:`!U8V,<"S3`;`"@``9F%E33EF:G:X)O2'#8WO^"!TD]HJU5&+*B
METP``:HDZE5)TY`-*$`[O?):=@%LI%'*UTHKN4`!.NH5'5K8(^BY`$3U&^(3
M+X1T"6@`@1GB$D<M@`#_@5=5N2+><\IL?0P`*HH-8H&6$0!R`X#02^[BX;0)
M%3SE)&`$>&2!Y?8XRM-ZR`8H@)X('!EICK)J`00;E8(D]*7C_2)$I8P0^?&D
M1VD:R`44D&6:'"E+-?[`!H1JXFDI5FD3,,"`QFCF/\.D.0W!@`/PB.6E\&8R
MB%HO`U(#TI8D[2"1!C17JS0;R1BFS5`.*9+D_DI04IH,OX!.6%Z2>^>OG'K4
MMQ$T0S(`30<<&BFI]1RE5AJ4N&!6@&QY0(\@\(#T(%/5'T#6LWAR``@`ZBF;
M]DAV)O47N7YF`P68)*!]MDGOV6G2PKX7S"@"/@?8<\H$R0#@".>\"$S`K0Y.
MB`86P*`!!(T`TE.7L"/"K=U!A@`7P$##;M)N`6"K/JZ3P*.WS68$`*NP@4JU
MP3=3)-E^H$=OSFETYOF?I*%)S*V9IQB/LP'^2'?4%WE>`;!H@(E#9#36*10@
M'U!P@W.NK@Q?N-)>?%?=32;6,%TWK>);@#MND:98E8E$&A[.)U?@Y(_ZSV`S
M61!FNOROF97R'!5`_A=3SCPI>99)UE^C[3=VG6`<:#*Z4>YBUC"6`#TQP$\&
MD#Q.#5W2!KE`*"-0OMX9_2"#-?O9/]"9HA5$`PQP^285IVH+4%:48=\0JS^L
M@;$N<P)^1O$%GFSW"K?D(!4S`':+:K`#B/%P/$>:N*K4D\CX-^\#L1;?'6(M
M"(Q1*AR@`(^D+>K%R[!;*"DD[LN"I`YJDR`3(,"""WQ7\!T43,U2%@5XAS.-
M)X2\!V@T`FKF+=47)$3+_L@`4A4UM=,N8$>#?)1[.O@+!GKRB6$XO*B5HJ>0
MLL>SA\`$P+US'T__(!O8R_%$C1`(+T`&))UQ+`![8=_J)<#V-40&Q%B\_LE;
MY,A+DG5%[WT0W45`4FU=*4V%TMP-X`&(AW!.`N+$`.%4S30:[)%*8PB0`A"*
ME]`0`Q!`5`&`EDP?!?80;"28`KI8!EA`!9#8OF'`&-&+__W9!6#)!Y#?#%%%
M0,6=BV5&>?&859"@3,$-XFT+4H20`:@.2*2&Q'R@BV'``20`Y23`GZC:UQ5$
M\^G@0LA%=+!*88B>T7$5`F!1!@[/'&$+3IR:9LD(H#$3!*QA0S1``$0`<PA<
M]?E,\0U:!=!'>BBBE"D'#ZGA381()E&`YC`6(+J1P5G`CBQ`ZQE>+B54'WYA
M0PP3JB&A`^0A),E4%NU(%-9$!:C=`#B`F*S4_JPXU".^4938X(><VFXL%^L]
M5P$4"_.,1JTPP`84GM&%B%;HH,TI3Y/I8F:%G-R%5%*D$J!Y0`)E#N;AA'K]
M1)40XW^$UU;`#(6,T52!8OY`XU=`3LC92"`FQ&`-Q0)H8<*,Q?%`7TX%EK5\
MQ@9"1"]FAN,D@!U.G4%\7$QT2P08)&B]!&,U4[BQEMY8@)9@$4&,1Q,B#9ZH
MBP>TBP-4E$"Z!QHVQ0*8B\=]G`90Q`1\F4TTW0<PSTND1=$LXT(MU5W0H4&*
M)%[5#$,.%=B-VSHJQ8@4I*IA@-U)P#H&&GUP17EH)$+X%K$,!/_$H9#$$V\8
MP!V12%_T#@6T9$WL_AE[,,`!3(4&-`#A$>&C[*2:W`4M5J-TN-]T`))$QL04
MQI2!T<9:#@]C)<`#V!\_D1O9W,@39<53ZM^5K,L1K19TF%-WP<AC$L`$_)@\
M(D1G8$N$68`&"(@#A%I5D&0V38`83@"VM<<\-615,!8#>.,UEB)+<)4#`1H'
M8$`%J,1;#E5.[`2\`04""(3@3:,`,8]1>,`#(`"UG=BPP)IL;8D$2%X\/A=0
MR%6_[$0#29MQLN)(1<#%4`!E(@;<8-!`F`PI&M9$"L8"<&=Q4<1X7"%22$"#
MX,T%/(]J543RT8A9%@!>L)V<<)%,Y45^",AY%D2H_$I>X`54(-0F;EO$_DR;
M4F9&8;1'DQEF+0%2,.FE*%K`9``H5B1(A'@`#$Y`.0X5.ND%9QK?=/V%)(K@
M46301!3&!BIC6IH9<295A>XD5>"19E`%`U9`A2J/!\#7`@#?4426`0*(3"(F
MUF1>DII9H4E0M8B.>XC12VC$=@X;;S6<N"`,CWK(1JRF:0@+@_X7ND"&=;($
M!"`H45%6K?RFBK:F<TE%]$%3AA*$M9@)OP&%U8W'/DK+,JE?=YHD$H'I!^G(
M:F5=9,D+)R:`;SB`G,ZI`1`I07"5:C;8+A+5EC`=PI50)&DIWQB3YMA$LP$B
MKY@DP'&*GEZ%<6PJ$BH<8HAI3\`B+B%>D+:I_E<(7@/89H\16H3Y$E+84@!0
M*8`XB0&\C1=&D@,4@(Q<`*4HP)`525Q25]OP6H_\&MN0&P/<JB`"@"]AP&95
M1%ZT#HPVA06,3(?T7NOTAKZ-E-58G6)X`!ZEZO#<C5SM*E+(XH.@VXHT4/7<
MF$)`0&,(E[NT:\FIFJ0\)F30H;!<ZQO%&-/Q%@,4`(*8:E7,YKMN1NOHR0'0
M)26-B#,=1@=,@$MQF[/6B038VB<R1;?8&H.XW('LF!.2S7_8$G&]YD2>EOGA
MD2KV2&:R9,(NQ.P`R@,4`*`(1@N"JY!0;&D\@`$46J#*$#L=&UYI@`$4"[?U
MJ8$42<6LE,ZH*(7T_@4%V`=:1%.1^,EH9$6)(..V4912>&PRW@0$]$KG/&S-
M"("M)MEA'.UM.,#:9:PG/4\^?07_,,#>K@E^O$K30,6.7H5R*$4&C9+@MDM@
M1(!E#<0#N*![W2V*""`64<"OC<SF\JQ"^`R,.("3]$:C6"G,*0!D@%Y8+0`"
MW)D$8*PVYL<HZ44?`=9!5&1&-,"K&D3$#%D`5!^2`$!1+N5IGI&U#(W:\<0,
MSM_G*@3.85D8-@]1K4?>9<4!+6I8'9)/5H<"S,V?)2&&T%X,WMF@)%<#K"F(
MD`T!;&>+/`G7A6^Z?L#I2)BY4,"05<#D.&_**87/1*B4=>(5H6!8F2G3_D)$
MGQCO73D*#[[%H5IE05`.!1@A[TY,!I$C?>ED-OV30VB'?*A@ZSA`1:[L=;(;
ML1H<-#4*0"[5W43`_CH$!)BP-D(E#S9`-)'P042`8VD%_%YNG<3O0>C&0'`>
M@"S``U2DI]8$!U2`N0T.X(C1Z6Z;F]3LI+(I42'`K!R@WGBE!WY%DGS1#BNI
MZG7`SPV)9Z!%<%P`6[CPW$%.I0C-M)5JWH60I23P#?8M<]6P`9]8!QPE\NB3
MQQ:QKS53N]!&6F1-#]]@P`1`#?=$`RR``.R8!"`Q3:0%"^)%`G355<4Q,ZI=
M]H+6;-1Q]AE`^JH:?$8``@`BF!!LP2;C$9%R_A9GT`%`!E`\)HME22B_&%_A
MATMH0.4V7()=<9>:4]L4[0+RFAZ?6`"[%$-IA`3P6MTAFWSL;A;3"`9,@%1)
ME>1=P`-\Z-8VQWX<AUQ4I<%)0)6T<&MQR5W"A`0\*37#C9N$<E(@57.\A+>Y
MA/6HADVY<QZ%\A'IQ5\<0$EL$H1%;)1YI5K$,R);Y2C%A3H[A(!\B4*O#G;X
M2+`=!?^0Q7R4$J$);FMF4"A*&3L!(1!B`'?T%/>"9<&FRL^-)I*B+9NEUVB-
MYP<%2-`F<0(LY@T[UP9$`!*AWV(<`,+4BL[P\33?R26J8HOUV,T,"Z4$C6^X
M74:=\Z?^!G0^P-M0_D2;O3**_1@#/-X$2715E`>).J&1I$<^WV"'9,OSR.IB
M*,"L]%(IA0H%ZQ_W.,W0:&V4L1.J^,9O=)\`7.`MWX1<Q-:8],0F\3$5<^*8
M6*M'W2"_%;-!E$=D(PV^_/!TC,@JWD2;S0I787%2(!Y=@]DI@]L&M-EP1!GD
M7008P8WO<,<%M$4=IVV;08:P1LS_EM_I"&L\-RU!4,YL]$5P_P4FYT5>O'4M
MEA>]39`*WP;6T:@&O$4J'X41RDA6Z(R/AFU#]+*MCAM.H^(9:1M;E5)8J(1L
M<X5FRC(`0,AMRW%`!PYO0U'4`@!4[)%(\%FAL6!>^(7I#(#3%5(;YLJF_NK.
M>NF<343,<$B``4!(:#P>;(LV0>S?I(;)FMT3?./+D!`G9_V:>BSQ5>.R-<N,
MLY$H>S.C9]#S3N.%<:2DQ\G>:&10&,V>L*KH%ZVQBH:U0Y!;^4@`HX+GZ2`<
MO)'$`,!.6FP1I!S)K[C%(S>`B4T$):%%$-4/9%R/AV]V=`[O!>R5!W`5;O=8
M@@%&U1Y6Z[!7^40(5[G9>'/8N/+CV"5E`=7XC%`$,SUX;\E,@?[+LP0N1[=)
MC#&(:JH::%A9&;(8<VH`DMBN3:1,_;#0@]#7.&^;"8[FC1N(,B[YKP`*^+`3
MGV69D[3UM-`'/U-&[WTFN!Q'&)*IIX=1QX61_EI1R%]Z>N6I%5Y)TVE,+Z2&
M<"AW"PL5=X(,B%8[-`#7,'U)>H%`6+&@2A_!L`5$P,%L^BC'QDOPL9,PP$7D
MCL,Q#@_&%=O6TB7N;;-:>%B%R((AR:H,-D9DA`:(41`J,0,<NL&QA1;9!WK&
MR0?HQ%C`6U<)@'D>!(?-N=91RP98,[E+)H!Q2X*1=7R\14>#QC5+,(E%%7/K
MM51H0`)!B8/&C0.3TP9.6F'4C&;'D7XE35=,`-X4QK`O#5$@3-PDP+_\'!(1
M'.ZB*TN<N/Z]N33)YEMT\[8'[D/X3/==C'D$0(J:&3N-Y:\`QW`-!Y)PQTW`
M[H[:75@TP`GMJ_PQ_F5!!)0"$&YQH?P'&L=>S;R//>RC5#U(:WT$\$Z;2VC+
M.@1CE80M;U2[AW0&6#E/V-IL[>XK/8``B`8+#D0"0<"/;?4ZF=CB=`4#%@#'
M.E=>#`1(E`B=2E!V"#-)3?-$J"2`5<_FDOM^1A]+=C0[:0ES&(=*FGR@=,#F
M/G-4V9UFWGW;#D!'_,M`-)D$B`67]^BWCS="C(>P\GAK$)!>)$P!1&:1F03<
MAX4!1'YK7*"R.]6ZC'YX7)P#8#QSJ1-/VS"E7O:?Y<=+T*:%M"T!"`1E>9DH
M*;89O59BA%!!7E3YG\^A*`#G`(#.U!%W^]@-;<C8J85*P(WMSU"AL^1Z_DH(
M0'SXP,$"A`8,(%CH,%#"@PP"(4:4.)%B18L7,6;4N)%C1X\8/6"(8$%BA@87
M*CA0^'%B!`(8/C!8()#"@@@9%I!DN9-G3Y\_.UI`8$#"!J`1.3P\NI3I10\;
M"BCP`"$``PX>%CX8`('#Q`L%E'[T(+"#!0<)$#A@D$!#4[=OX4+<X,"`@@A=
MCW)P,`!`````!$3XT&$"A+!Q$2=6W)/P@`$4(`H%,.'"@PMC?48H8,'#6JP0
M$D"HH$#G8M-,,9NV8`!!AH6H4Y^6G?$`@@\:&`@8P+I```(57D>\8`!FSP<'
M1E[8L,'U;.?/-U!H,"'XSP<!##BH4*%!`0$3_CQ0,/R<?/FW'C(P`##@084'
M`@(HV,!=0^R=$@`0..#7@('U#RA@X(+G[#//0(D8(("Z`QED"BV!-H!`@8,<
MH*`^BH8KCJ?"C!)(@\L:#/$H#-JKKB<,#C#@`KPXN("`!32@P('#1*S11H@H
M\(^O`1:<8($-"OQHN`$$,."``@AXD0(+&-!PL2!O)#!!PZ",TDJ('HSH*0TP
ML`"XB2PH8,">-,!+H(),O%)-B&*<H`'.CIK```@F8H`!#21PP$F/JES3SXTX
M>.`O`!R`:(([^P3T`@M0JN`"#,K<@,G23/,@T3_=RE&!##!($],:QSH@`8&P
MZB"#"A(L@($.(ZI`_@!*6=I`@PY:9&[!3]>T8(()%)#`4Y8HL*M.KMS<$]=C
MF\(@@?7V"V#&#VK*X-*-GIK`@0DN+"NGV6A%5K$*$&B`@PU^]=;`#A!0X`/T
M#CU````.6&DB5V']B-8+("#`LEO-M7&A#11P@%6?*DA`,`0?B*X!8RG"S-*(
M.NA@VGYO[(`"`@!(0+D)>BM`@PH6D-:GL3PXSB\!]!W+@FUE>YCBMY050-R7
M6\9H`P,8^`""`O["#H`&+'*U@I&YQ*""MCC`8`*&:7[N`@E2DL!,GRQ(T8&#
M&G#@/:NX8WHB#R[0&NH)@FU@X*9;GAAB"'!N2Z`+%`"`@J[5MDBOO@)&_N!=
M!SJ`N]ZXZD:;(PT24+!<P7\B&:0,"IC)/05ZP_B`"R>B0("A>R+(`J,XF.`!
M"T1&7"Q:`Y^W@0<:^!(H%/L*(`#=,!:WV(TR4$```0Y00($%!K!*]+0#1R]T
MB#K?P$<0?9H@@`,D$(@@`@RHH/:_?U\S`P0.N(#RZI=R^:+A<H9()`8,$``!
MJ><5`#+&-+#`P@P<@)'+J;EWBH.K?.J;@@<@</NGSK/V`/Y!(`*6X4!#:&01
M#9PE`0^0@`1V-;SZ12DUL8G``22X$P@,8$P0D4"OTD.]"=YH-0!8`/)&.#*(
M5`D#:2'5N@0"OP3\"$R/X4EJ#GB!UW3``0JH_@#^4K@46G%``[/:0%<\8*T.
M(H8#%8B`_YP20PR4#H9!?%(&*/`0EW&``AV(0`+HIT$"2-!'(SF)%=7TE0&@
M#XT[F19Z7/@!29%M(;0"$I@41,6)2`QB'Z-`&-O(IZHM0`$(.,ZF/E"!*>:E
M2QJ0508XM:(-1*!_'?$>1_08R(YX\0`4F,H$NO*5IRD`D!_9V=F8]`!K>4V3
MYAF-0QC0``@\X&H):%XK^421='V@A:+J9)\LL,9,?HUX$7C3"W%IR:H5P``$
MT)O!))2PHU3`/P1P#/0,,(`(3-(A'SE@A5YSJ6$FLR(=R-<?$0"C1`*@`L$"
M8D\DL)6Y56`"(`O-_NS(V:""3<<QA<Q/`<0U3C1N``,9N%\!$!"H`6@G7&>3
MB`4(X$FF],V)#;@)!DJ9SXI@H#]#T0_9_+.J$3$@10=8RZ#XEJ<$8D0""3A2
M73"7D0[,2J-`(4P"+,"!!=SI`\%$B7P$2H$`$`E)\`&``<AVQIH:2`,+*$`"
MT&(G`BB``0]8Y%(OP@$(B.H@`&C-`N+55`0`AUP%&LX2@8*;QNW*F*S$JD`P
M0(`$.``!!7A`!S:P`/6Y)6+0<@P".C6!)W*D+`6PJ[7,YU"*F.IP;\6(.<?:
M`3L]Y`("N``%$G!'JO7'2`BHZP!R@BJT.E8VX`J7`I*D@/TD((.D75=3_OV2
MGXQ=H`'0TUL`%D!+U44D3*/UB5:W$@$BT;"*KB45!A@0`>X@,CT,@!-JYG([
M:7;NCQS9P`S#$JQ;&O<M/,S>!ZYFE`Q85@(($.A@BIA>#7#JB"OS+7?CTH$%
M`*``74J``1;0G04T%JL><`"2<+L`7RF-?`,P*0,FY-"JN55(2!I*7P0&7RV!
M*P(7(!]):F>3C%K2>6P30`*J.Y!=*;8B&D``6SQX@`E(F*_=:8]G)5`9`#QM
M5(GQP,I$R&*FU,ZK$H.`@"70N/,Z9\@?40_*),"`0L604:>BP`6:\]#)-:5V
M!-#:`1:F8XBX"`(8:,"<!K*`JFQ8F0E`601B_A.AHA"68P9X@#$'(!\M"W&#
MT+N=-?TRRB(C<X5^FS,3'Y"=L?30>`-`@&;AZP$-\*PO"0@``F@E@?5)IP%=
MY'-/7](4#:"V`5^V"8E=^Y4#.$!K#EF@@,G,$1?]I0`CD4`$]+3`;7J$;<QT
MYGO_+!8FB:J0!F"F`29I7C=N1%LYSK5/KK,JCJK(`>9C\(T4=QJP[<<[?)$/
M?E@K`0$4U0%AA*BQA62D`;AN`)O1LL6:E1,!.L`PY-+(PZK$,=T0"3Y^<8`&
MW@QJBW2@`A)X[K$3%[&(W>]^1H$`I!-SP"P#W"WJT1<"#'RD`"3@JI_"RCL5
M\Y3R+H`RN=-`;2TD_JH,A`G%#P5+4_A]$`):9L\3]``U"^`8!&\;P;B6"%X/
MUR(O[6I7,EH1__1=7(8_9^3!NV20,,,!6*_T*%AI.?<ZL*SR(:EQ!S@J"BW.
MWZ9X@(@T35<'M#)#`-")`EZ%HD"HR?2>;(D#I)NSQ61B)UI"X%$,X)=3^%B1
MV#1Q)?^BY-E+3($(#'Z6$!"/1(<NHC0Q)TB=TQ/@\BYA@!'@R[Z>Z@$HGVH;
M/7TGGOW`!:P.``6TQ0$!B$":*#``M8LE\:1:;P;2*RE(.8"-1ZE,`IBY``@L
M!-\AQL@%"N?K="$`8PG0>NLS7I$O`FDY2,$G\GV2X0Q<@)(%A(`$`,\@_LYO
M_0.U61<%THD7\7C*<L^&?D\@X%P&(/Z&.#+`ZWS]K@7<KT0:T0"L!T^!EO[E
M`4(_?X,:(`!T2&L@)D#,[_\J0BB`1N\`[F9J;%T<YB(J@`!L#@'1;V&<:RE0
MA``BH%/X33T>0.E\CR.TBIDD8/LLD"?V@EP20%T@`NXJ,`4KH@+<1:08$%10
M$"@X`*$^HK=DL"DBH%?`Z2C^RU<<9@>;I-(T+R)09*$J[@</I`$&@%Q.#&*8
M)`:AL%5B;M;^Q%)R\"<8YP$YH@(X*`N/XN#2KP*&K#;2Y&H"I/8L`C/PS0`2
M8+?,T$"DL"MV"F)X!=SNL*<0JHB.KWNJY\8,_F`!.\)R8NH/=X(NSN+N>N(`
M#J!`U,)-0$DC+`8!Z&MHQL6@OI`1*V(O#&H/[^<I(N"$4N@3?X*C(@KK3*-;
MABU*+"`TM$0C%!$4>6(!"$!"N.(H&&"-@N,I\,O++"TCOJ(OIH.6&J!75!$7
M(P("!("`C.35`.1IQJ-^+LE*K@<`>,HYL*@99>,"#.DC;M$9/Z*N,$`E!A$C
M)F``"&#-7BYN?$65-&\6^Z,V3@SB'``<S1$"!N4?X64").`:L=%/_&OTR,/M
M$$<<^\\CA`8!.<_,DFSU/B("X$,_WD]F:,7P-(^((.DCUPM20,(<F0*Y8FGE
MU*+"5&J$^)$G="IZ_G0(^N"H_RQ@S30BF-8'`2.FR!A@K!:`_7["8AH@`1P#
MU3X@/>SP!DG20%+#5#"*>%9I*24"]-@C*5UK6J[G`3Q`%R%`5HZH%`L$)UN2
M)142*$BMJ7H1*)KRR9BP#K</*Z02-3(@`GS-[HR",!8N+H_R(.2%N]0F*SO#
MT$CM^@0H)J<RCR`R&]L/=>#&5Q*'5&!1CO"G=JSR*")3+WWB8@"#+R;N(0P0
M,T4,(?J2M.!R(TRL4!)D_7ZL?%Y$P0S'_Y"OR"1@.A(`/)9B`QY`I`;I(7"B
M&$&3A,:M#O%%$U=%.@XP"V_,`9YH+"T.DS9@U#Y@*`<$K[I$D=)$:)B3_GLX
MSY@F``%.SS(;(&/:8ALG9P,8``Y_4T34@POE*$5>+2_C\M0L)#M_AP-,BI<B
MI8ABPSXF<!'34R(:X(0:ZBB$*[+6)1T!(&%29QW_<S$T($7F97=HB2*;ACY5
M[4@H@T'[2R+L<R:XY`'0X@!^TDO2!/34L$$G8AGA)BW7KOL*H$-2(W?"YCA1
M5#%0)`'LP\+LHBL+\D\X@'PF`-%$Q$+=J`/NL[:VC='R`P$`;S5HE"3SQ`)2
MY[QVT#8F`JJ>KT8/1`-\S43*ZSPK23NC34T^),J&%#9Q4.B,5%TVX%%BQ"\4
M((O,:LJTU(.P+SN6,"-\S:'2"6Z>L$[+8[X6_@!S8@1W+J`P*+1?%#-*M`H"
M%M4\+$5#B:Q`/$!46@7!<M+_,@10!>+-/,"6))4BJ`(!Y"4=!0#[<*H\@@<Y
M%1/TUD/)F@4\/"=16XD?YZ))0A5P'C5$JH0.!P)5_"(G+JM3P$1,`'4LE,P#
MX/.W&"``&D<MRD<!9LHM$Y)(WXKK)`(S<`)C`$-!!B-/GC05G8,@(@#[=#60
MO&\X_L+0<`]/BY56K<A:*>)T="I36S10RH?5NHV7?"@[(X]:Y+40J\14*$DY
MQ@*`X#6(O-`YKBMZB/4MQJ6-/(`UY$A"9$G2*@!TTB1,$C:%VLY&Y@9@(JQ[
MF@@"L.4U,."$`O;=_E864XJL+`\H3)<J`F6#`YII7-XR5[VE2M>E%,G"6M#S
M\TZNOUH6KLK$[H;,>TH3KAB@8YD231/M7SFL(@[(7#&SJ53L3Q]3D]##T%8(
M`UY-)@`DC#:U3L=B;CJ@`1P3*`HHE)1"Z2`I51NTY?K*+29IL#!S90S)%=UH
M:8O6-"[`T&XLR=[E+Z354WQ0+06G:*\&-];V)W"O/A+`=S0@&A?MWWY3:J-$
MUH(.;?Y6(L@0@S#NAASI<T\CKHPO-WK&71J2(B;`LE3(#'O(PIS6(F1"8M*)
M]UKM0<.54[,U+G`3;_4RF`A@-->N3,C)9D>E11Y``=[/JS)`2&GB57ZK_G-;
MCWSTK[5V`JK6Q:3&`BJZ\@!ZUW>;[B(B1&;C$J+,ZV5-MU(<<(762TIS)V@M
MQP\O@H_:EV::5TJ!,A*M%#H'XWR>$PO)%SIF*?L6-W\C`Z%T5BGCD'LR`&=F
M\%K"Z"'--B84(&7OXBA<ZGZPC#I![$'MMX#?XF,NX(07Q4MD!0+0]W=V540V
M+7H:&)->F&9:J/\.M5S]#266ID`L&%!=*@.NSWHU0J\Z;=L.`K4J8`,0@(!)
M>.O"\W9NQW6X$0.N+T_-$$0Q0'KA@H@4>!4/H/^DT#>HF+Y\$R+(T%YKM-,F
MZ8Q[(CP!\B]>):]J]XE_HCL]JY#X0O3"9@1[_M1*/`!RGG(Q+M.%(SAG/@8#
M4O8O*`Z0</)8H_-.!G4IL&A7'H@"Y@D]NM&.:Q;VB*CTKJ[WL!@*<2*#M\?&
M1BB"77!=-F[%5NBA$!-0"8EP[FUK^2PXD`N!.3GC.`:T8.*`@C0+-9<B2`24
M:`KZ'A1HGD83,P:3)6UC?\-WP0ID:GF:!@O?\HLDE*6.=]DEF62H'!5"AA@*
MN6Y:PN:)N!C@GB)<=,8[Y@T^XJQ)B<-W_TMK=+D'K6E`U,,OZBN"Q[>;O4DK
M3.@P\(T]4U!M/$>U'K?UF'@F:&7D'J6@RB0LQ==WMZK+TEDLXF;W[',S-NA.
M_QF@.\(?&9EL9@GV_FB/?A86%VDKYA`2^FXF9[#H,/HF:#'@I0%5V\RG?UD"
M;/#K3&BQ`[*CA;A9I#%IGV_''>TM`^CQ:[Y8=)`K20#K_&PV9[9J?<:BJ4HN
M(M*#B.-R9UA7H`CC'05"0L8D7&[ZGHU:+<U"@!!LIQ``6R+`CY?2PHADGJ'/
M2&?BRX;F:0IKJ\6'27V7.[[L.T<&`YXJ*4042.+*(7":R`#Z>Q-BAI%YO@!C
MA"6L4M4%-)9&%P4KGHO5B:7R1_O"E8'"T:!J[)+(S"Q$L-=Z-@)E:1B@,LU1
MLIRU>,]/LS_`)5[G'[<BC&ZZJ!E1J"Y[*:CI+UZB`A@Y:0Q`K;D/H/G-_@&L
MK@&:BJY)\O::";,EK`K;="#+=?`VIT"(FIY516.ZYVDH`VQ"XR$F,*3MY6,+
M6-'Z3:\`0T7,\Q(QLZ5OQS\9;BP\[WZB:('=&SD_`.A8)G9O+CC@QKE1;G0!
M%6[>Q2]X)*OM;I1_\%,!P[S/[\0\0`($C$M.F%&X6)1\-P)`B7E4,6DH^[6I
MUK+KD"XZY.,P5RJCSNP(D9PJ%4<Y9CVF>#U8-#+P.J=OPF!6/".>.BXY8%F.
M*OU6&=^TEB2;2E_P(I-JV(IVT/@V",3(A@&BHK7"9,!EER@JG,5?YL868"C>
M):*,`C>>W!SW)XLLW*EK"BIP-"4ZJ$40&/1$_GLI42M8W%BDCQPC\`2U4`:P
M-HV_E])'NG*8&S`J>I8C.&K/25(F(@3,03/0'7@O_6.;J#6_K>EH,/U*%*T`
M#F`Y"NXKQX4Y)+J((F0`M+MF:@H"NFV0U[K*#1)_L")"M*=?0;-V5,QX^YM+
MC\JPC,1(4L2P"&#>Z.TO;/-,WRIKF/@$7]O6_<1$%H(R0YU["D("(*7(\^F#
M*J0A[$3)2$UKM(:%"6@@\XO!N<7;7T9W&&?WR+S,LU6KM"<GW)WA*F/,97(<
M265<VHYT%I5PU/A`ZK:F2&IGFGW>/3<#3.BZ)/W"<\,&D8^)"WXCM,:K2?+@
M2`K1&=Y;2&8#K.Q!_B/^!^F21Y&O+!ZOIS7XE1OT%'G%XS_>7(2Z?[X+-'4J
M8V8<X*[GQXV,`:C='!O@`/)ENV;>7)J2Z`<X<ZVNR[+]1E+OU:?2)IX^B'"/
M`@Y`YH_^2B8I:ZJJ(<(S?*7^!W.SK%I/`PQB(8;I4/+]_$A-ITI^Z\TC3.+X
M+T)N["&5>_JM=%N/.S*Z(Z(#V$$3:M#EXL_#V?]3Z0(&=6+I+*_'TEM/ISCP
ME(V<M-Q$`T.F1NU9F[B6T>/2"R_N*_E5N&>CZHG-70P3)$Q?,?2B==M/CB89
M1;6&<4S;QE;6Z5!T`V;3JJ;2M;MP]6UF`>HPIXP<^!$#1/%^CP)$)XS?_G,-
M@@(*P/!A`VHG]=+T4K(&I:*W;&BIY6FY!U_\S;IKT>6Q*G=0+HQE?_V\%8V:
MGWMR!*#<A4X6F$+;/U?.D_I9##V$I2FTINT3#R`8,-B`@,*'@P@3*ES(L*&'
MAA`C2IQ(L:+%BQ@S:MS(,>&$!!`X4$``(>&%`A@H>EC9L67"ARYCRE2(X<`!
M#1M@SMS)D^?##@X>:.B)P<&$GDB3+M2IM.*$"!<85.C8@6G3JUBS:L4Z08%!
M#@TBF#204N)#JUO3JF6HP0`"#CDKHEU+5^*&`T>1-E!0MZ_9JGX]-'"P@4'9
MC2S]*E[,F&<%!1$\7%A0LD.'#Q7(-MYL=B9:_@L&#E3`,!?B6<Y].SP^[)B!
MA=*HLWH`[#>!`H(&8^O>S9LCA0,)(B08`-(!A`V@,_26"=MB\Z46:7\`'6`!
MZ8N)EU]]F('!!`Y*/V[03GXF`P49#H0LS[Y][`D#`,B?#V#`!0P%E+N7ZYG#
M996GF94!>`=UL$``#XR'G4;/[7=09JSU9$$"%S3H($<6)N6!`@,ED-N%((9X
MU081#/8`!"A&$-(%`N@G(D328;C!?Q/-EJ%_"350``49(D;CBPM%<(""275@
M`01#`=E1CU=%(,$&"TSPHY)45NF<?Y:QQ-T#!%IY4'9+QAA1@!AE@$`!%F`P
MI4H5P<4D>Q90MB9/_ATP<,&7J,WFI40/-%#!`9'M^>:>7NI)J&=8P722`1=8
MT&5/'7`P*'D.(!!74QY($$&2>8IYZ$$)'$!!`7D="N:GJ*;J8)T'8/"H3Y\V
MP(!L=9:DVZ0@>K"`=0B42FBDSJDJ[+"*"0G!!7,2N^`'&T`@P58/,,"ILIMY
MP$$$$UA0@`.O6KD!D6.>2NVXY,ZTP``49(!KN1]H"NZ("RBP[G;#+B!JKZ@:
M6B.[_/:[$0>A8H"LOQ<!_&Q:$NR8+,%91>!`414L7.6\#%?L;W=V5M"MQ0IQ
M(`$"4T&7U`8/(#`MQSTQM=(%ZE:@,<HPQTQN!O&.=AJ9*&NP@`.<4BSR_D(7
M,"HSG1MH8#0&%5R@`+<87"JSST-'O9O.>&EPF0=6&PTUH1Q,,+!:S4:@X-8Q
M=T"!`0,00(```A2P0`,+\,@QV5+7K5L&#SA`@080#!;O`0I4"+.U.GFP`04/
M/%"!!'(CM4$#=W;VDMT*71`?``8D4$`"#2`@@*\QTTWYZ&OAG8!K!0`0P'P"
M-"XU!?$9L``!LR[D:4,=7$!!A`<U<'"!EAD]I0>NDHZ0!IMW+E":#`A@0=FB
M&R^]5@8"0$`%#``@P`!H*Z!!](<ZH+VL!*!'P0045&!!!4YBD$$&C6(@,`9&
M9V"T!`<,L$#2&W!@0?H*"([`-,`^"3CK9!W8_M27Q!4Z"@1@`A4(0``<\`$.
M*(``SX.99:;'0?9XX`&TXX#.2*(!"KAN:-9*@/42X``#!*``$F3;``0@P0$4
MH`!J,P`."6``'2+@``5PB^8*(($&T'``\0F`#@42&@=\;7(?L%8&)&8QD@$`
M@MQ[G@,'D,$.>O&+=8D`[3R0@00DH`(;J-1KI$:\!Z0N``<(P``@D#X+-.H^
M%DA3!N2WQSVZ#WX8@`\`1$6:#)AP-'F\P`7Z]ZV%;:`"Z=M81L!WJPD$P`(:
MX%!*TK@`%Z6%DAH"HR@W4R<`(*`#^!$`5`X`@`>`<F+=V97^$*"`IFE`8._+
MP/K<=\=$#G!&%DB;_N\F,(&@:`J3WY),^B!IP+PY8#`1X$#7WB8VYKRR,19X
MH`40("<.Y"UR6[G=*,<ILPP8```)Z,`&+NB`"B"``">460<08(`6*N``)(%`
MM!;`@+W81B`*".@]\9D`RD```?IC@&WH>8!=-0`"$7A`!!;0P]#81(@)H.5Q
M,+``V_`.,==<C`<B6%`!&(``LC+IAZA'Q9:$E)PPU8JV`,``#EP@<1!%``/$
MB;(&R$<`\BE``TZD(HD:1U,22.H$#"@K$S7@G``H@-A&<\L-8,`"$^B;IAZ0
M5`OL42<8..,&BB@!24Y25<&4H]KF$P#G%8J!,8VK=C(358?1D@'GW"GE_B0@
M07M!3IJ6"2R6`EL5RP#6/QX(IBF'LI+&KL2PA*T*F#J0`48VTFX>&)5\X$B<
MO#7@HR)"SG7D2EKRF',`#K@<?0Y@5I1=@(<:>"KH,H(!H"Z@I0!"",42\U+%
M8(!#STS<G6+;Q411#R>E3>YR-&!&##``B`5`0`,.X(#>*JD"`CA`*1_`'X94
M0#Z6@J)NZ0+7/:%R/"(D$'.EI-SVMK<["JA`914I*>1&L6X0P!Q'"?"[C9@3
M<XK+8P70]S+WVLX"1L'MA:YI70/7C0,,*,`#OM/!")BR3OQMB=GV<@`"!-$F
M!4"7@Q,"%PU(P).D*^^(#;PALCA->A$(`%\6_B"`_C(H4AO()?UTZ:$5'\2`
M'&6L]!KLXYAQ(']>)3*58"(!)![H>DHA;I$U8$BI*GG)1<[R!S)```#04<&]
M`=]<&NN1+L/P`.#D26RKZ6.X_`D"8-:RG"L&):D^440X0\IL?@2?'<$M9'2"
M0*NR#.0%%'?.B);:(]&HI$C%62Y6L0H%!'"]"3S@T#(Y6UFS;$<-2/=D%KMR
MHH=&@6A.$4ADWHD^NS27D031`%S"$$,^*-36*M<!G8R;J+6SZU''C&0)>("Z
M8F8`ODAD))=#`(HU\JT-W!2O#2!0@WI-+[]$0`$2Z&3HJ.UKBV$`A/:96Q0U
MX)V)P$X`#&CK;#'R_C@./=<K^TJNB1F`@#2'NMN)CM,!I/)H874@J>_RK@T3
M)N*.9%-[QXF.I`3%[8/,&P&8)EC#\<TP"S`@`L"ZMP6["!OJ*`"'*]6(`TVY
M[(A<``*`7O(B&W.?3*:<XISI@-5@OA5/FVSBL6%N2IZ#@7,:8"]BZ<C(%2!M
MBH`E`=7^Y(P:4TP*!([FL9%YOZ&ND?]^%N>,>8C'$CZ1GL_QJ4'GB`6`F@!0
M2^0Q:U0*X>I"[6)V!;143_$X@S8`Q=EZ7!6@D(5JLJ/XV#@C+"(Y1LPFK:90
M=NI`HA\'0!;WV&!]Q1CP<&4?SY@(&"#@#<$``K2WO;!O9.R"QTAL[>V3_A<3
MJW]MX5;CO4CY$`7-E'`O%[GU2I$*I*X^!/!\U5<W:(Q(!@([UU#KLT),@KS<
M2L,?L8J-%[0)8IY?$$!/AB:-[OB49,^(A8NCU8G>`75I`IZKY4:P'4IVK4];
MZW[1\E=OS7'BQP`:N#NU^'D1*)6=E0<HHJQVY0`&[(J?"J4`Q<0A#[`[#P`<
M$B9_#&%`2>(SUL(P(Y5A;W5?[+=Z&A!'4(%XA&(!#9!^$$$!`]$`JT,?$O1"
M729!F[4]F]56\M%EMK(1>3,3E)5\GT1&]68J%<A^=S%(:4<P#D`8&%$I'0!"
M".`DQ$0!C9)C)G0^#N,`7094JK,ZJ:-[&-$`_@FP->LG+)"D>;&G?CG8>&E4
M3R57+AT`:QD!`8QR;<<A62KS6)&B,[[#3>@#`?]C=A91%!-`@PYR)!!``*KW
MA8"H).VV2'H83NX4<A0A:!?0`+3S?$M!AUO6@`J!*Q6P`(XH/1F050:P'H'8
MB2%2)][S/9RQ:SJ3<$QR4.N$.:(X$?XSABX1-I<X.!`!/Y-!>IYXB^Q1:CFF
M@;*Q%35Q?!21;>16';$X7A3H$Q<`<93S'(K$4150B+@8C0GAA`U``;R8%-*D
M%IF%'AHA`0G0+)PC.!1A-H@H$QR08&RT?!7P@\HHC>ZX'!MP3@TP;*B!(UKQ
M$-]FC1HQ`=$F@MPH_CD?$`$#88PQ04;ME(YC\@$:4$P@`XVXF&J>R%S*1H]Y
MHA84<%O,%B\]!P#R<A$:$`%0L3$4,U2B])%6"(SON!/S8BT\M7K_5E8%!I#&
MI8TELA&6A"X$$``0D"$PD4#$5"$0V1(5`'QXPD$7^5RVF)+MAR&(Y2`.N14<
MH$\L\QQ/*7:^LQ$58$,6$$>N-$D0!C(:@$DS(0'<Y46JH3Z,IY3EAR%5^0$9
M5T4=I345L4%[HE!V.!$6T&4Y:4JFIQ*WY$X!0(4<40%<TI:ZT7\8`#EJZ7@+
M=HU<TV%VI&!T:24=T%!B=U*,R)&\R&4`T``%64%9I8`RHTCDUH6+*7<5_I-)
MO6(!R6*8#!(G!C$I6TDAP_%W&!%6!8"2QWB'WM-!L_&14'::PMD7%M<`7K4F
MKKD10QA-''$!!Y!=:F.;L]80F=$`=[E`%M$L=T8Z0#%#`""=PQF>34$!'N8U
MPY.%0&)!Y6@1R1B%Z-27%O$G!."!!;)PG2$9=K*;E+,!*E10URF>`+H39]-)
M#H!B>78H9924%9$>FS5(L7<^/S*9$P!4X/DE+:D0=;*>=2,8?AB3`?JA2+%-
M"=!DNIDJ&N``;+81%WDF+.0LZ;.$%*!4$0!#<;-4_?<`N@-)!7``$=<2%W!B
M0_9!!"!=KN@OZ`FB_3)3!!!NY.).14H1>R$!_@(!`5GE?P*Q*PJ```B0`#34
M4`MP)OL&@IO23Z:I$2HR/3JC/5?T-,F)I&HQ`:DS``U0C%P34:+9$`X@`,$6
M.WM36>HD3<VF`*[$`?:S1Y)2%;&U(TA1:O8Y.HL759_CII(J$\T279PX+#!A
M<>S5$0^@/=P48E'R@R");1-%`:$R`3HS`8$D-O]C>ZWC$!TQ5A7*:WUA0?7Q
M)%'3II.:%1#0-@GPI.$S)!0#`:M3/F]3`;=T`52&K&%)5]6U.X2:$G"1`6A(
MGQV!/?]Y*]2V(0"P`)NVJQ*7)0^6/?6AH)_"`;L2$Q`P0S:T;Q*0-"[3*'64
MIZVT$/2#')8W6T<*_A'-`H3ML:])H2*:UZ/@2BV&LXI1$UMI@P!EZB44X$0Q
M,:-IDY,!0`#`X4,=]FK1)0$T8I`,``$J]$!+`37XH:&R."!W8;(%2RRZNA:Z
M0BI(@G<40*<3,:,[BD.N\4<XT3^1<@%>@Q;P,P$'LJ;3V1*>=JD>I!@FI#,-
MN[(X2#H4E4SCDHT1JS:`DS<*T`#[%R\*T%'TU"LT<P"A$2K`H0`&4&-*H1H&
M()A#DRT<0"J2VK+]TFLZ@QX4*2RBTV3:DSEFU#=#I4_]UT_Q<0#1DC@_:$SX
M$ZE-48"C(QF*5!!(VC_D)+<7D7<+T"AWBC)Z.X+\94>V9"V$2@$H(ESV_O,2
M8O2=O4@YA`D!UH&D$F"N-`>P2)&,:`:?JKNDYX(YSY0T$-!.V3*A!I$[$R"V
M$D!E1G)#7M9M#P`9N8FD+"-*>[85LML349$Y^MA!#G`;S^6M_[%V"FDO#+`W
MUG*19_L=0@(`;.MC#Q&6"3.K:GFAC6M=,-%K7:,XH\5!!X6N0SIAO1NX#S--
M;+-OK%E"<&,O%-IM\J-Y)2J<E#N*+/N#^L)!3AA6]3$8_==1'(*JBRA'Y_&Q
M96$!#S`[]>IK$M!.D.NT*"P1%]@Z=RL]:,A1<F0=5&8_5@-(K"0674-/$7`=
MWB15W38!'VL`')O"1,P6"C``WN&8_1(!#'O$_@%0$!!P<?]S`8O#H'`F7R9V
M05*11\7C:PG,HT4<Q@FA+0+`,U_T``;P)]I#&#;5-`5(Q?S92N1V'UZS51F5
M``1;9#Y;Q6+<QWR%)DK<+T]U$@7``#9F-=;B:1-$0.^#+%;EC?*1OD7V/]_6
M@WV<PA/Z%O`;-:SK:1?W`/(S8!2P/LQT3@D`04>H5$]!;PN\8OV#'Y(\MY?,
M+B=Q$[9+.0));LES3SAT0SJT;ZE#`&8D4`#X4+H#K"N661(H;K-L?BX47PW<
M%T$CQ*R$.>=Q:2QS5>R3.JM)Q5GUKL*1.NX[8D;S6N-LL-/;S$JB6:(1S74A
M`4"UI/LV5.$+/WBS_C,*($&&3)8_V$\%.*,&D,<^ME1F(M#C<J#J/"S:LB-J
M@JE(0:RJ@T]^XC[2I*P&)+H=5HW\R+_&46I::M`CA@%D&=`)C<+I018-G2]-
MX0`OQ$WUD2YPX3ZW1#]=80#UC(3((5^+>$,JJWS,X@!@7-(KRZ"&D2HB!$H/
MX*L)\$(H$A02M:*Y:],X*LI)XQ^_47A]X<X]$97(+-3AV0$?1S]:O1!"J!2]
MVJXZ90&6)4U&$Y:IXSV&U93_IC:M[&"9E2X*`-)>/9P<]3`30+,7T@%P`TIB
M-`!M51U%>B0*"CM$NQ8"D[G#0F6C<LY[?9I2*E$4=BB6UM4;8;-`%%4M_GP1
M-2&R=)$!>D.0<[M'F6&ME?VOTJ,T(PK9[G$Z36)#%]=#]YN0"Z'(K*T4B-.H
M$I<W?Z+7K;V8%S25A](!P785$I"3Z&*%N7V;!UP770-G'#-OHE%D@>Q[VTTE
MD[FA$09!LDT>_Q9?1=D3$XIN3T5[&Q%YR2O-<QIJTO1;30M3X^T2Z7PHWS(Z
ML36/7>PER/,`W<T0\`%'7;8`\\*?@>D77;-IHI.<9Q$GL#NI8PT1]F@W%K`T
MA#K@C3%2)'T5C%T`MK69"!``E#TRE\L<^NF4B7E&8KS)2.I.'N*A5,(W#CZ>
M:0-^G=D2D4?:M3IA2LR&(K*J:-;'%0Y&S0+*_K<<(G'"V4)7/ID4``V0X%%R
MW\R1F#U=(S`>9E<E`6E<W`YM,>C**%9^*U$T41R^@-EE)N_9$4&3`/6M%(9\
MW@R"VBJ9*)%RD<0=M\`=YCF#-FF2YHI1`7[R4A(P2,R%Z.OBWB^8%C&R.(!-
M7I^$2G`^RV0DZ+QVY"U11G#.FC]S(2&\%?`L+]F#X+&ZKK&L9TU9()K"&T'I
M&=C'UA?``9&7Y>"JZ1/QEA43)]7H*,BGM5MA8:=T((V>$>JD,[G18&C!CYCN
M4OFMPDR((OEG-IO8[&">=;C.$1/P<S9%C[0>Z;I1B;WM4@<1`77W`0O0K1K&
MNGO^Z<N2$'@3:[LA_F:V9TKTID\?6]3JG.VC`\^BTC<<PKIRVN?M45!E+A=0
M@FXT8P!2HC[WBE5)LSY+14S8HCX@&5%G8NLPHD@#!E&A31%GDZW>X@"AHJ4V
M'5&<X^3)S.\Y6._(JSTC>!L@P@&;>(_N5!_\A"V=`QS^MZ0]Y&'QO#D=!D3%
M&D?79R-NZ";:=UD)$58VT6$U]B;KZSL'WQXGR@"58K$#@5U!#7,7?NTSH7G:
M,T.<LS8,#R)&\C`KGC*/8]CHYD:8,T-0F#:&/4,OI!X*4!]'3`#10CO_$Z-+
MF%1Y@S@0%2U_#1?^,0%+6LBS(P&30D;[0RS_1FEH\XWMLCWMGLQ@SQ.__F$]
M&F.J'39!($)N0[P5F5&Q0^I"]0%4,<1"W/2U0"1#ANT`ZI3N<B1',D1#LN]A
M/J^E-B$0/W0`LF+BN`+6&I^>^64<TRX9J77BFX^+8Q5B0['M=H3US]X7YC3A
M*IG4=P]\5D5E.S8@6-,_B-]'N?0?_H.$21,_7,Q'[\-'L].,3K<`,+0Z_[B/
M"B0L_?JC\:V0!P40%CX,)%C0X$&$"14N9-C0X4.($25.I%C1XD6,&35NY,C1
M0P0``S1\8%`@@X4%#49V9(G0PP</%1BL;.ER`X,!`@@H8`"A@@4*%"I0F`!!
M@H0&#R+\K'`A0P8,%BID\-!!ZH4*69G^!!KA_NB$"1(B%`@@X4'4`P@2)#B0
M0`*'BPT@$'Q9TRY%#48K+#A0`>8#`@@RW"5<V/!AQ(D5+UY8M2YCB!H.`%BP
M0<,"`PX*"&!PX3'DBA<<7.B0V(,&!@(&!-C,^@`!`@<,&""@6D``UP82,."M
M`$&$#QP8&$!0X,#Q!`40()`]8``!YZL+)#`P``*%VPPF/&B`H6+="`J\@UZ,
M^O@```DH1"``@,!X\B[CSZ=?W[[=SPP[9"A]'R&&Y"+8X`(&EGO.`0SR\T\A
M"1*`"R,%%?(@@\F<$Z``!XB:0"@+-,B``@DN$`NL""BPX`(-,,#@P0W,DF""
M$RL`"\:GHK(`K`HV_IC0NPH$$""M`0I88#"+-FA`@0@7U.BF````(`#:H%R@
M`/CNZR!));/4<DO%KHRH/RXW6,"]!A)8C34!%.``RRT?0-*BJKQ\R`,,&C!N
M@>$<B+.#*U_J8,T_^134`T(?JXJ#005=L]`]^R/T`PP4:&`!M@Z(`,R*)#"`
M)BXSFM"!`YH,B8`'+$B@2OO8['155ENE2-6"8+UOS`,$<-+))C>5U;\+&@#N
MHD<A\H"#%%$<D$CZ]O/P`F8?O$B#!AC8`"97+>)@.P<<:,"O#0R@H%IPPQ5W
MW(AV!:T#!0ZXP``%N&O`@00<T!%<[IR%T-/YS!5VH`L*^);<.0=R+#@=_C/P
M%V"$$U9X8?(N.("!#BBP=]B)]*W)`P=^C<_B<3G0%E6&&9(`@@L0N(!+CD-6
M>666)[+@``4T<-;0:CVPP`&_6E[PM`/FTEFA!T8S^6>BBS8:X9('8,""E`F2
MD[P.%HB@Z:,W>BRENJ@.-P,-C`1Y03ZK%GOLEC.H;@(,,*U8ZR43$(CL^'J=
M`.X/,NBLTZ?IUGOO5B](X(%@OZ./`PH>0)9OQ1Y@0.RL*2#@7U;91GQRRCF*
M@&0+YB4WT@CL75GRFBA8&O1J-X!``,@K5WUUUKF#X#K/P9U@@)-9OZNN#1Y8
M(/:?]XO`@-IM%WYXN!\8X(`)-"`=,@X@4&#:_I;S7G""`H(W&H.A!LB9>.Z[
M_WF")B/@-%P)%/!,Y\"51$V\JHGJ=WOOXY>?W+HJ4$N"M,E](('Y:\H`@=01
M+0,5*-_7^@>:Y0GL@(B#0'>H1:X;+;`C'K@`](X6*>`)+X&K2I\$JP8>(6%`
M>>0*FP?O!9,-HJP#!#*@"15#N@ZZ\&@1@%(%\B>N%,J0:(2*P`0XT(##32Z&
M&W.)VH#ED"'J<%P>.)W)2*-$**(,1!88FNJ2B$"7K*E+4518!R(@``-DA7=<
M).-!<FC&@70``@5XFQ4C5\;^5:`VR8-C'1$BJ,-P("ICL=[JSJBP/]JQ)<*)
MF1$%6<8.:(XN-<'>_H<&$,!#`NR*D502!H(&%`M2DHQ5&4B*QKBD:4FFC9JD
MWR1)69\)[&8"`CHE%S^#/46RY#3$8D`+*1G(5HZM`NR262[A)BO)!9(#$5B*
MNGRYR'#A\I@2D4!LO)+)9?YLEH11)DPL8X$"P"^:G:KF-B6B`04DX"F&]&;(
MAJ6JEY@R8"UA(@0L0`!MEE.>W$-7]10XS[VIDSP>>``$,$"`4=:GF_@DZ$,J
M,!G!%%1O`RW2!B@4T)TI5**+T10!%E`!<DYTF1<0RI"TM#R&:I2+FFH`![0H
M4EEZ<)47>,#X4A5,?:*TH!`8``(J\,G[A%2:.M4I8=8C.EON$W0QE2D^_FE:
M`/'5S(5RPN6$^'//A''@9@:`*""+>M6#4*``"OA33R?"@2=ZL%"(Z4`%&E!5
MA&U`,VC%:EL7-H':-.!\J]IE4+TW4'[.+609P(K;W/K7E5F`-A1PJ7]PM[_"
M3M0"[F28!D($K3X"5K+DHH#4-'`!G-I'4Q;(J$05QS`.-"52=IUL:;FD.PJ<
M)+/U:<`!O.I"F22HBXMM``$B*]/7FG8CLTN`S'+K$`T\0`)_[<`$&#"S)4J`
M`9.ADFZ=6RV/@?%4G8J``Q([T;I<X'D)^P@"FG2`(**4J,]5$@?&Y*1X+@@!
M#9!L[CKWP'%%"@`"6,!U)3K>E)+7(A1`P&T`_I#>5%4@`7IM:UT`1&!R#1,Z
MTM(O?GY+T*(\``$9?"%$S`N!U6J4GPOPSH,M@@$('&``XFPP.WU;XHJ$-F@0
M@*9_-@#`TIX&`0Z0)#9#8D\4=T1Z.7Y(!QH0@`-X-*(?$"R`V\J`WM(O`N@)
M``)(FQ`/\UBC&%A`DYJ+F($YQ'1`/$R4?Y8!N0`,`^4C@`&>W!`O2UF>U5W`
MC\+KX!TG1+MSO4N<RUC9SK)*`PXP,[#2K.9Y.D`!VK*NEBB0@!;+4@-YAB(&
M1L-H+EF%PQ=!%*`M'1'`0."<$;6D!"!]0D'ZJ7#3^O.<-,`>MB+QTJMVR`,H
MPR4(+,#.[*0D.-_<_BK?3?=5K.:UR`;@K40GBP'LU2\'^AGL+=5E@*D\<Z^=
M[9`)S,:?I39NSDIM0@I:*KXR`NBSO9T1!PS`?"-<$$^0/5D/2"K#6>)`,U/]
M;6>K\W0"4$EY,Y-CE&AL9W$6C00$?%MX>UN=&D``0#^=F+*JI\&/@=>Z7SC6
M@VS``E*AL.UF'7"^;2"<&[@X8R[S7OB2ET"7JAD&.-KG:],'OQ@_6C,/0-@T
MEPS@Y$VEPU6>@900Z-8LYWE!:&JR@Q\F8C-1LZG.K22)W^@`S29;RGL.&@H$
M28P"_<`%+AITP46S11)K%05UA)*=/YWGFI*7!6Q>&,!@O;V3AJJ6H*(!_@NP
M3^!B;T@$SAKR^5R&?]1T.MDZX``6NZJZFIJYFOO.3<2!6`(9B&5\RD>!0/Y)
MGJ?Y&S(_:O<(++W7PSH[XNJB=I8=VKI/K<\"WE28PY--`5S5\P8V$.UWHUBJ
M3!?B2?D&U]XV'C(>N(G&4@]%J_L,;T]95^%SS`&N'9!BDXNVM&R_3[$<'<40
M0`#H&2.CT=)=^P-QG@0V<,/X=(`!D+2TU3WM$;M\2`)"WKX;*7<D&$U`^H8!
MIY&E[`$)(,"^]HF8`OK<?MOYO<(0'0A0K?EH-_-YMKR8/V'IN(G(@*(H-`!\
M.FAY@`]PP,)8E_.+M^?+"`Y@P(BP``;PC;#3_K`)O`M3L<#ZH#(0[+KYR2')
MLYI.`A7-*S`4.L&:<(``6!R!LKXW>BZI`@NX$$`_(L(&&Y,%4!(C1*(EW"&,
M,!(%N)P6]*:LP<'T,P`VXJQ]4IG/**O8NZ5@R@`)<("$<D'/:\(2^Q^3\3XH
MNI;,$:ZIH,*5.PBX,!(GJQDTG*"VLT*.^+$&.`T?9!WA>`"-$Y]`W"2,,+F;
MJ:]JP4`AJA@K=(#T.$3;L0R"X"@@I``(@)<2O"_TX\,/@"LGZCSY*2'3&A;7
M$\%.5$+NR3)0A`BXDK5%BR)33"/G&D)FTZ\^D8@Y?#8("(`%Z$7W&X@-R(H/
M^0D*H$3ELPO12!?:_BLQ8>RUTQ$G1<I#E3.I"S2N"(B7HB!%*-*:1R&4#FB0
M!&!$>+/&8UHCP$''^\B+DJH;?R,LO-.D:+Q`8MF`#\R<JF.`5;PKEF/'AX``
MP^$D*"O%#Y&_X*BT+`'(.=$:\R``XY"-T3"K?NP>940W1U28U^&KC!D*L9`+
M<IN?R[@MAMP]/[L(#`B5G'`2W8@7V2*>7:G'&,O(A)D`GB@)W/"1)A$`IHF?
M/[DL_IJ:>62,8J0`%;$ATO,>G#.`"=#!!*B`->J+BUP9FGQ%A*&0`(B7`I@O
MY@``,RM)U!,1YH``VH"`J803"?"1!.@O!,`P<.&]LX0(#"@."_BQ"?``_NHI
M`-H)0(ZSRJ/!N9UXO2`90P)@`+`LC+)"```H@`<P@/28PIK8@,*1L`+02_MS
MNP;@NL5(275A``"8FPE``*6`S*,Y3+]<B/63E`_8@.,8("$9RD^\'2Q;%P!`
M'L5$@`YDC(]0E\FPE;L$EV%"@"^4P:H[E8^`F+I)+=WSH]/\&0<H,P?@$P08
M@,6JS3_"Q]N912S#@`(@`+$P``&(SL&ILC*Q%0'80.A2@.$RC:I;`(&@``6X
MRV':%F]L3M-R-0`P3`Y(``*@/LJ(2Z=A++NPBOJ<B+*JJ?S+"?&<#[NY#;70
M"?)CE<4R/AW[@,LP`.5:3!#9RC*T3U;[,<Z8_A`\.;0"0+`)R@`%L+:+Z9)F
M"@FO!(#J>S`(6$R()(``N,R/$C_A0PPC@8T`&(`R,8ZU?$8/+:T&\,K728ZT
ML!4:2Z%A.@N&X3WEDHL*Z"<`K9B;R1@(8(`%2,9QP1,LXQ?TP,(?L2C%(;HB
M7;4'*``&H"%<L14`(+:62$D<=96L<3T_6<[%B!..ZP`-^-,EK!^I48Q3BX")
M>Q$!&:;`2]-+(\NS6``$6`#`>X!2L8L*,`G+FT#J*]!R20@-D)%%951`:Z9@
ME,G&&(AA8K!7K!,?B@\RW,3]$]7GN@P"D*MJJDLZP\&ZH***E"6.XBA^E%5`
M>S$SXYT46C_3;"6"_H,\T,#'%JDX8<TQZGD>/>T(T]$W/A0U!7@;G<*`HC"F
M:.6Q`G&`$+E2@Z@NTNPY#[@WR-B`"!"N>@O7')N4"<@19>J)(G4`MEN,"Y`*
MLXA5>94L!W@`9J$*_"!&!EA/OZP+\Z(QQNB`J*"`>`W8!I-8I=#".N-2"L7!
M"."PD`*Q"!@@3J58B7H9>C/8N]B``5!!^WP)CT%.Q8#`L&`EDM4OK;(.<Q68
MN.NP-+4?(L4($22QFB6O"G"`G@C)E@@NFDW3#`"\=+6("]"+D1U:?&J^OKP+
M^^E5`#2P!%0,^`2\(:1:W0J/5JTSY<I9@3N*I\6+!II8L2TMU$+9FC"K_I<4
M54)Q`!,E#.0K'`GLLK<ESDS5&TGDGS^"EV3%)\##LIOIIY;",K15.4O;-+XY
MTB2L,S`5UKH8F:EU"*OX2*T='E/%)U<4F-`%&,U(@*5EB8X=3K]T5[T*I)C(
MF`G@,AVJ2O&RW:.QDP5X"[N8,9(UKLUM#/M!W;YUH=+]VXEX@*R46X_0N+P5
MUDY[W+]`74*4)M-(H,,E+Y-5DT':CI^U0IMI@+5]B!K9#H`M)?;<B$227HW(
M7N^Q`'_CCPW2./0,V%/#J,*H0^<9C.P]7M/`W0I[MHZ5B\]MB/_9V.9\C*8=
MCS/Z5!E!4\!-E3JJ15X#C!!"OVMQ6Y+5CL+0_@`0&</S;0SVQ2=L?#;C\J=J
MI0CM*EM$#$#O/=B!<+3BK8A$<M]6=+:]6!JDS0A-*>"[\E_08@"6Q0_D8UXX
M@4WD/:0(6"\+,&*,@(`$&.%?(AZD\&$T"T7MP-@D!JS*<@"N69[*JE.Q(AZP
M<F*.:,P&Z%!\V>)3<C3Z[`@N#=R`K:;"66($9N."0HIW"=X?VE$\UD-OG;H_
M;BOJ,4P8HH#1P.,_HI,)"*M!OJHU=8#<3#$#`)P?!$69>`#-?.2B0F3\N4@.
MB$_$.TT)"++JY>2B<M?.@:$,"%X'.\W@ZHGQ1652FH`@`[_VY28;CB00@QU:
M5K5HHAX@G64SW$,<_LR`33SE7X:R76X5-R'@9D[37J'4$!YD(%Z@!<"P"HIF
M#_W4H^#=93[5:$H*^)7B<)X3";``Q2-FL8T3;M:2<!,`!SGG2IH2<Z1G,WIG
M+5G3(+EC?#8,J>(.>?GGF6(7"=AA*E2H7L&9QEU8'*ZI%,XE?0X7(W$+#>9#
M`"XM#3`3MRRG77ZMS]`:9,X8=HXW'%Z]^HVF:V9%'.*K,1QH@L8GI9`1<[YA
M8UZ8E6Z(%+EI\MW2:*GFF(XD<HU:H#[-G&8(XSI$O!PV\0WJA/Z`ZA+(NO5'
M&=(IE/#29T&*4'5JOQV>J(6`Y)GH7AM'_<.(J+6[HN;J5Q%KB;@9'U*[_M^#
M7;=:E]_\#J#@*U=6:V;FGA![`-P]:O0#*;9>F'&L)3B1N*#(:[W&Y@&XJ$EF
MB*"(G-(%;#BZFN>%"-/)9L5>[/Y9+I"TF(WF06[*Z`8SBOK,OP>X*<Y>IM3@
M1X[1U^]%F,%>&&-3V'*IDT&[Z-76I.5*":#V@`-@V=D&+$%+F3\1C1G>;=Y>
M@`4@@`DX.`IZRL6N2PG@&,:+6BU6;E)*XW?);H8P$G`.ZL=(I2GT`$W4%D?6
M;DT"#)7(R+F$C^&6K+CS;C3SH@)H:O4FI?!8`,.YX@LL92L>Y+Q([N\.K08(
M[WS*;\3(O&U!:#F3FLT66RIK-@K*%O.EG-%5_O"6:"+,@H@&J6E93:<2<12'
M`#&EV.I\BG`-Y[[*5&:&,#8Y7>W3R)"(&`EWQ>45KR,W.>A=8:D(U>N!%1:3
MPQ[5SG%!<I[KB.C@X(GXUB\+B(`[/I&O+FDC%Q[G.7`'CY4,*$P-WU+,)IQ!
M2^LJEY_R2>W'IHM4NFR]?HGR47*!:1"0&_,[&S9[U0])#5OU1N8X7X@_*9_G
MEG,X.N$Z7P@.0``U7VT*J,$7#Z[@5G%`WQM!2YY/\I-_DR3MVS,4-Z-B1+)-
M?G0H&H[,S#.[2=UQ(>T<NXEW,^^109`F]W26@.($>,>%X%6%4<BGDP"LAC(H
MA\^>='7@$XI</8AQ_JR,*A^6I4`SX]ES7W>AI%@/G+*D7#=RWBC(U=R+;07Q
M96\9M?@)-H'B,S_'M[JHA?C4@9WJ8<QVAT@7F%L(2*4[REZ,INPLQ_()1P\7
M4_=T__.53SHT/_['DL0="DCO6+D`8D)PON$\=)\(OA#B3S*]E6AUUC'-B'%Q
MNKB`"#3X@X=X`)R24%>(]1KC9(OX&%9583?O^*QW'$KXB&```L#6@I`T,3[#
MA0QIBQ2+@'<*N-N0Q4MT%J:<>P=T*/:A$X$*%5&1\DGIU=$`L""*%VGBIWBM
M_<"*HP`*PH(1;+?3+2<5;3&]`ZA,K]A=E`<7"E;YA3!Q!@B`V(`-'P$C_@4(
M<*.1@">!C9PHL\"@\G+)BZW\4;(@%0,X`-;]I0QH;,DTDVV)POUX@)XG^_X)
MF@EH;DW&=05@4Q.Y>L%SDN>&BD.;K]BF-.X4`+3IUP8)`,]O15PG^*8\BKY/
MD04(=@Q7_+KS%>=)K7[UE?7+]-6A`/#\%=[KOBPW#+QT#D_CD[G\$7^&F^;A
M#>.8#?3()OA,?->/GS',BN6`5+VD5-4@T@U*.92@#?Z.EEBWH7320X<X^YZI
M+K#`PHY&HUP&9G'>EXQ`E]EX$K0O@+X/B@5P_N?O'@:0Y'=RDK4'B`(($!"X
M\.$@PH0*%S)DZ*$AQ(@2'4Z,^/"#!00&!@``_A"@(X`"%3I(O%BQY$('!1Q4
M2$!@`0,!!!YL0'GRI$F3-W?R5*C3`X,#&B%$L(#A`0(+%A1@T-GS*=2H4J=2
MK6KU*M:L6K=RM;I@@84)"P(4D'"!PH(!`0A@2.ATZENL<;=NB+GV@%`"`1"T
M?3J7IP0$"1(@*%"`@(```B)8I#@Q)\(.'#IX^"N5,M7)!SU<,$!V`8>#%0PH
MX(#A0(3075>S;NWZ->S8LF=G7>!@PP4$$"I<\-"A`8$#`"Q\\+#A8@<-#SML
M2![:0P4,&S)PL."`0G&?":<?G$[20W4)&"YH^,"A,H?I31'^Y*#9/'@-&FJ"
MW[!!`\D-;<$C-%T^_CM"%"B66GKN17#``A=@D,$'&7Q'TG;X869>!A081=P'
M&$2@@73F65#30APP```!$2RXX`4+$.#`9!HH>$$&#VU``80+>9!!!!-T0,$$
M%XQTP0,15,#`!1Q4<%`&O$E0DWX1-%#4`Q-``,%D'&A@`8\P6L!;!12,=P&8
M&&C(``,-&&1><;A5D,&5/29'P040.#!!EQ5L64$!8$7`0(Q).A"!D^O1-BBA
MA1IZ***)<J4`!!A`(,%#;'Z@@00+%&#043&Z.-V5$$R@085G2:#4`Q1(L%L$
M]*F6G'H98-"CJQTH."11#BR0P`,-,+``:@O^=U!Y%D"@E'089#E>=5-*_B#D
MEA38Z>!!CE)``9O2I6?!`PI8(-E\Q-)I5*CN*;?=<0EU,($%\[')@8\<!,F<
M`A2\)2L$-"*4P04,2("O!A5,8.J&'CC:6T,<.)OA!=R%JB%U<%I9P;($BWC`
MK@084(`"KNHW087I5D`4C\LZT(`#V@X9U)$9+J=@NOV65]V,HQH[ZP86A*8!
M!,HQ>0&@JBGZ,]!!"STTT58Q@``##[`W;@<2?,K!!`QXN:4&/$*P``09"$OG
M!%TW$!JV#C!HY<WHFJA!`PCT"*59$3C@``$@R;W`LA0TAQM+$#0P`:!A)2`U
M!EU*\,"C#@09G:=B4D9!`Q`H(`$%0490;[X#_@DE'`+GS:?!!!)$%Y:$[F6P
M[GWZF;6!E1(P`$%SA-]WW60=?(=0S3Q2X(`!!AQ`W`5\3WOJFI$_+9GL[DUV
MGWSR^9B!>B\Z/L&K$)1*708*(+"``0(`(,#C49YJ@02>N]T`G`]4BD`#3'4@
MIEFRBK<^G,]:6(&=2EV`I9`*^@;JB5BNF>\"&%2T`1*P@`8\X&P<```$4"]T
MZ9%/6+I6-V%%P%0/\%?\:L4G_3@+1ABP@*ON%[Y_G4IZ(]-5X_:DH@!L9`"(
M$0`"YD0_"31@`0I0`/D^YK0&4*R"-*2`N@S'&S&!B7Z1(YGA'G`K!23@``8@
MP``2@YCM/8Y-%NC;_L<(][ME$6YPNG*`!!*P@/$A1FIT@M'H?/0L#@5.`0+0
MWO8L=CUTE0ERGNK<U>"$I6E)$%!34N(-/6.X`R3```MH@&%(=LB55,`!+KE+
M``;@PL$@`"^YJZ0!CL:`J#D):Q::UOP>4*8I64\!N;+D``12``,,1'<'4,`$
MW+4`PMD*)H/Q#`((AL!=\E(NO?PEH52$`$;=BDQE:H"NG#A,71US<C6DFY/<
ME@!3'FT@P_S*(=.G.Y@@TW!DHJ4Q'Q>!![S*:7P3I0+(=(`".)&5-U0`3+!I
M0R;BD`$)6*5@I@G/7>T*GF*\U2QUI3<A[8F$%/"4X_J9M+?="FG(["<3_L5H
M*Z39BDR,2IL8F6A+:Q+&E@_E9R&'J:_!.4`PZ9OF5X[&SLNE$YXP&1E1R&2K
M)S'@;36M8>/^J"M`.?,!A`-4YY+H10DX0*80*!.@G'8J)!IN69"#&)UX9,1I
M=>D"]-J-@L04EE'-QS+`_"I8B^/5L)+5*N,)W`?K9[_[=<D"6043FUSUP?N0
M1VODV:.=ZG<_'UDH3*-S%9NF(U<,&*\XE/&-?L"D1J4PUJU^)>)>E4*_R:HU
M3&_-*O-(1Y+D/&1_'#+*7D&%KRV)*827U8]1DL>OQ=KI?GBE7UQ1=Y\T.LM7
M@B76!]=:)[V.YZ_VL<_H!/M`WX['/NZYC^RX_O7;V#$'N:!2CV@5E+S?CDX^
MLIV,;RJCW>QJ][#(S8GL-E/6\9*U,N0]+WK3J][ULK>][@70>^/KFK'"=X#T
M1=1]&R/?_?*WO_[]+X`#+.`!$[C`!CXP@A.LX`4SN,$.?C"$(RSA"5.XPA:&
M<'XOK.$-<[C#%,ZNAT/,X0R+N,0F/C&*T5NC%+.8P"1N,8S;^^(8T[C&-KXQ
MCG-L(QWSN,<^_G%/9@SD(1.YR!:>D)&3K.0E;]B\/!8RDZ,LY2G'U\E4OC*6
MLUQE*&NYRU[^,IC#+.8Q2YC+9#XSFM.LYC6SN<U5T:Z;XWQ>,\OYO>"A<YWS
M3"@XZYG!>.XSH&/S_N=`KW?0A#XTHA.MZ$4SNM&.?C2D(RWI25.ZTI:^-*8S
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MO.<^_SG0@R[TH1.]Z$8G,\*/KG0$MGSIIVYYS`&>=/9`J.EO=GJW7SSH5R]$
M,G%ICD/*-6ZLNQPS-7=+M7?BGK?06CL-F<NPK4YV7WL],F.GBF]VTG:<W%WN
@<[<WUS]`\JOX_>^7EGIG96QXC..'(6NO[^+)'A```#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>f39432xe3943238.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943238.gif
M1TE&.#EAT`*S`_<```````@("!`0$!@8&"$A(2DI*3$Q,3DY.4)"0DI*2E)2
M4EI:6F-C8VMK:W-S<WM[>X2$A(R,C)24E)R<G*6EI:VMK;6UM;V]O<;&QL[.
MSM;6UM[>WN?GY^_O[_?W]_______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````T`*S`P`(_@`_"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L`/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3*EW*=*&'IE"C2IU*M:K5JP@Y/,7*M:O7
MKV##BAU+MJS9LVC3JEW+MJ"&EA8`5&A+MZ[=NWC#<AAP(:_?OX`#"[:Y@<+@
MPX@3*UY<T2/CQY`C2YY,N;+ERY@S:][,N;/GSZ!#BQY-NK3ITZA3JU[-NK7K
MU[!CRYY-N[;MV[ASZ][-L2_OW\"#"Q].O+CQX\B3*U_.G#2'YM#1=E`0G>G6
MZMC!6GB;O;OW[^##_HL?3[Z\^;L0-IQ?SU[R]?;PX\N?3Q]RA^?U#T-PG+^_
M_[$9O/??@`06:."!"":HX((,-NC@@VM9`.&$%%9HX8489JCAAAQVZ.&'((8H
MXH@DEFCBB2BF:%P'!P#`0`8JQJA@`@#4"(&,.`K5002J4=`B`-3E*.2`#0R`
MP%Q#)ED?!P!L``"/2D:YV@,+U%2C``!(J25J$V1)DP(,"%"``5N629H!5<[D
M08TU<E>2@&;&:18`&-"TI@,`%'`2`G+V>=8#7LX4EP8`P.CGH9<-<"--$@B`
M`9V(1CH9H355P&::DF;*&)8U!<`F?YJ&.E@&`+@9$P(`6&"`;Z*V&I@!_H'*
M-(!``;AJ*V``+"H3FS7>ZBMZ`(#J4EP'H+J`GB0V\&MH8\)DP0``"/!!``YX
MFL"RV*K%)'XK>0`K`(9]$`&;9&9K[IR8HM0!G@`X4)"E+4IX[KQB%9H2`S4R
M@-`%I!)`[[]?15"K11[`:9"3`/BK$`8=-`GPPU@!<&U%6BW40(UU+K3!CX9"
M['%4%)0J4L@`S-K0!`)@&>O'+"LU0+H:9?!MQPT=D`"G+>><U`4`&%R1`C6Z
M&]$%"#`@K\Y(%S7`P!=Q@"H`$E@T;JY)8X:!J1:F>A&^`"A[$:DU"ELU9![0
M?.&CC1$`0`!(9M0BTV/'O1.X`EG@00<78'W0_M-1:\3D!RO++;A-:O/**[(&
M05`CXARQF?'@D,\$*YD%#T2HR0/Q'*W/&'6)9;B1A_X2E`<-T/;%II<4P0'K
MBBWZZS`1:@'0[9[D00`=#*`O[+S'Y&F-!)A-4KZ!]ZY6!ZZ3R'6-H*/4P`-=
M&F\7YQ]2P"ZOY:JD>`$/2._]2!<;'@"LS:.T`:#2?J^^1C_R>H!`#2BL$LHE
M[[[^_12MR28$IL*=$@<LRA[^!@@1"=0(9G]CB=JP1#T".K`@%GC<0*+7D@00
M(`%">Z`&(\(`F*D$2`"8P`9'Z!!(N<12-6H@":D"P!,!@$\QF0`"WK="L.B*
M1&J3B0$H<`$)UA`K_HHST0MWQ:ON_9`K'."6B'H%$W@YR0">4N$1U4>`HZUD
M`J1ZGP:<I#O235&#:&/)HPK@K@8T(`/7&I=ZOKC!(:ZD`QAH``,",*X%U$IQ
M"!`>&^\7%R6FY%&>6UNT4'7#/0XP`IA320)HV"Y."6`#`\B@(0<8@+ZI"UI9
M@J(!$%``"72)B9,<8,B2]Q&G&>YQ;)H:#2TDR5!^)8<E(=GB:F2`!*!*`1MX
M#KB"92$/M`TJ%""E*P5B+Y%D`),E>TM<:L0V@@#@`CP;ILZDJ!`*?F29O++D
M`#)0O@_$Q9K2_-@:+4(UCCRM1K/:`'\,$"2#X&D`Z0OG]P@E3(A\DIFL_EI`
M`CR@MG$:9)<"+(L_Y7F@VEW$`H6KD0@+TB+&'21DXQOH6*A)T/E8RB(:^-8!
MDU=/@:0L3Q7U7M<HHC@VR<\BR+1B2%]'*HDNQ("&8]5%4I4`#\J(HBME";X>
MLH%S\NJD%D&CI3J:FPK8KRDRS>E-#&HQPQFNE1;QE$.%XP$?*A4SXUH(H,1G
M`)6!\J`)*(`;BX/3S\"Q/!YX``.`:AD!')4@V,2>0!K&)B-BY$>)O*IP'L7,
MS01.9DZ%&D':9T*,K`UW>BT.C6IDR<LT`'$<"-]/52J0A/9,(VQJ;&*!\[OB
M4<93$!"K4Q?Z4%Y-#",%*`"E-CL<-NF-,I(U_ASK%F)9C:Q);7ID+6[H&JW,
M'-.I!7"I0<"6+XUX]9>ZO4T%#A``9`)@`:]EC&@-%UV$E!1C&>$9J4B;W-IP
M0&U&-)Q-%7//(D[$N9P;[T%<U"7-=A<VX\H@89\9F8PZE0#570A?:P3#BW@@
M+D![[VQX-I<)E)=-R$6,!1;@U'U>I+89L0`'&("`TWK&`WX4<$*<1*O>'H"Y
M?5W,?$M65H2@L$9VO4@>:R3<S)0XN2T2R%#AQZ:W!N9ZALOPSWBE$0A<0*Q3
MU?!JGB20#""I`\NC;%XJX-P(LBFW%.&5US`2@"XE6,@]"A0!3*:YW@9F:LS,
M&,GZFUT>:P1:/B8J_I9#DR<\70M/#%CL"[V(%0],@`$M1DA<#8#<)W-$SIZ5
M"-!H%.0UGR9/&J"`IPP3UT!#Y3XG+J1"GL4KE\+4T1.1LMO8E``E&_HT#"8=
M<4%*%0TDVK)LRK-`,.!<1R6$35"UB&5?7)"&&<!F9/[T:?@)J0/(T:E2P4"7
M#2>`WP6T(+PVW`0JX+/K;22V8PUJ``A`;5T/V4NT*S:OVKD40!MNC8Y#"&^O
MI-$K"P23[I7(B0T'98A`RU/MMC9HGBL0?'DDKOD=2F>OQ,EBJBR>!`$S\RH;
M0O\5A$T6V6_0/B#:55Z$9S12M;SIH@%:*V1-`WD<H"V^5)-FD'L#89,2_@6.
MW8$4CKL%87"T'\(B7F402PA0<T-"EL")XV7=)?-T11"`.0=D`-4R=PF^\OV!
M#HS/(`EPT_($\F/#'01ACH:U1#I+9A>%Y%,9@4`W;:X4S2D@`QG8@`5010")
M/V1-^M*`<Q7:$^OQ,LI*9%,`MNIT@G2`1K]S>$'H;M6%@,V?";`P1PY@`;%R
MO2X<N(#!@)9NBHR:5P'HNTR2B`$&X*E%?)Y(-`ER8%Y!`)8?P",Q:Y149UXI
MTP<?29<\-67$!UW#3BI]17!>V)IP8`->_98`)D"`UCMD32C_@$\'(-:,#2`!
M%?`4?P`EUN3M5^<?@)7O`<`M5I-D7$'LS.NG_GBQC=SS@C:Y&[07P&"C"N1I
M0<=909`9+KI%'WBUSI.1$D([S^+XX.-T`.)")A`Z6T3.VX<86R=-6Z5C$)$[
MO*)>;]0!%#!=_)4!NF1`:_(TN;80##9<O!)/E@(!GL)L![$\PL5;FH50AN-%
ML<(`/$(`'4``!;!?\?806*)^AW<7/]=,%Z%1)J411)<52.94%8`!$L0S:E-2
M$*$!8I54:'=/_%$C"9!GF'1L`W%I6S%N@L5_,@8W#-`]L+)VL381/`(TYC:#
MTD$C;"41/U=CR/023'(I=&.`@+,V>.<0)%.&'Q`N[/(6=.6&`P%FU54X#U`V
M&<@M`;`H]#80%?.&_L"F$714:/XEADH1,@+`<46W/`R`)%BG$@BP;S4R+K)G
M`1,@`1'@`1F%0@.X=S9R$!>P1K_C5J3&$,N35P1!*(%E-FL2`4#C1P:@`3Z5
M,%]U$>'C?_XE>8[X$QR`)8(W$=<%`#2$`:*%`&9G$<@S`0'060KP``9P,1B0
M``9D,A5P:TZU'1]0`3M8=,S$`.5S,:B&`#O(:UY5BI=V)0;S(Q+U>%P&<(95
M(R\XC%PABPH5`8\E:0O!C\"5``P@B4ZA</C(-EFB-BBC:,S5;YPF`=,U$0F%
M+&BDB4SX$`20/F:&$"IC<`4!`7WG7*T$A11!`7PV`,"HCV"A<DZ%``A@_@`$
M4(EYHV/S50`*T&DGD8S*B"H6("TO]``!L#S%:%(U97J8AA#+XR+0EEEZ6!`U
MYY)A>$_JQBLV]@$$('L$(S(L6186(`$X%EAU10&@&`$NV2L,$'P@<0&6%9.E
MH@$<H#CXTB("X&T`8``%8%,_$H8)89>FM0$04%8+0&9IF!`JEV(+,0'(M``^
M$Q<;02ICDI1=V14B"78C)I8)^`&#.1(/(`#(M&4#@(.PYB)TLH9L0CTP58$,
M\7A=`Y;"R!!$-A#ZTXL$45+0-Q`XEV\!P&T7(0!1LY*3B1:0B&I.%0&RR)<3
ML917(C%+0R.6`H'41R>\.(T2@E`:@W`2\8H9_H%Q!;&%7/DN=]E1IDE+,R>9
M#O$HJ#*.P5D6$Q!X:U-%[\=8L8<10OEO+D)(!H`P&0`!$ED`%0`!7*,R:F-)
M#J,0F(2<!W%/("D1-3<0="<\:W*;]?9M&JF`$>&8YKF>;#$U%V`8>()+!G&(
MUO51O((J0(F5'[`!M608S\0FQ!=,]'6!Q`2<$RH7$@%UU)<1@>,!T`*,U=94
MO/*:")&A#9$EJ**A\)./9X&C4/(T5<(!#_`TB4.B>8*7#5`K''``:,)@'>`H
M:E,XQ%<`_+%:I"(0#$:'`X$PJ@F;F941`E"*!K$F?`E8Z'25#>$`)CD1[2.A
M2*H6.#IE:158&>,`_KS%/85B&$<:`1DPC;#R`2-VC,2T`6K'B[J3E"$6$=.5
MIP6$IHF#IAI`=X,X4[Y'3JC2>'U*%YV5E0AA)--8@Q)S)5B$D0I0;"&#+P7P
M(PL`>@1!7`H@`:$*.%TX$$]38@+G7]*HC`XA`!"Z,7*%$9N7$5/#FZ=J%]"&
M$&RC4:@B5K0#.$`6,D98=Q_`%\0$5Q+99@/5,&I)$#"5K@JQ;D^Y$*950F9#
M=VPRJA4A`!8*$0IP`!0VK7FQ6(SX`9=SJ^4&+H;W`!T0/K3C+LLU$`(P%\!W
M`8WR0@N0KC&V$&NH=P[16?;SKG`%K@SQJQ_@`;NXIA23HQGA)`P&D/[J_J?H
MY'?!@H\`\`#(TB3X,HU9\A[<.7J0AYCK9:JFMZ`6Z*(IBIT,X222I;$)(0$F
M<Y8)HY47,0'26A&*TR)`>RY0&QZ7B!"0A`$VHR=W*4N\`HN`4R<8H#@2L`!9
M6Q`!UA"B):0'\8X']"A2M"840#)">Q"#Z(/#LQ$=()/(RC+JB1TJ`ZG.U"+4
M9CBWA@#UMS>I9(;?N1`D@Z!QZE0.8"E^%%TA`W64NVKB-;@384!PZQ#*8@":
MVK)F`5-Y&ZY70FA::BI^MH=M1B,LJQ"(]!!@8[(&RBL58`$7P"V)MCC6F@`D
M8X\(D0$XM@!*BA$-$*P2H0%=<KJH.Q90=W$$_B`!!(`!"P`J)&A>1>M^`ELC
M'AMRM;M>M%F>1@N]NTBV'U"F3\.IW^JB<,H3*+1ESQB<$P"Z4\$F</HCX7*E
ML!8!''!IQ#2UBB-S3&@`_$FCPE=R$6%:35DRNNL`0+F))F8X]@H4LLB!YYL8
MR[M9S0BOZ'1`$E`^"%<`&1RN/JL0-VNT%SQ2$N%5XG.*L%D!IAFGEJ6T04&O
M=149`:A4[,*IB+@!G,,U!@2O%!$7U*,_QML0L/(T!A`!U>8D*VP0A((!A4,S
M\Z6_-)&-GK)@&)<P"S"_TPL6)[80/_*4/YA]KT9K-JH0X181.&HJ#@`M#@$T
MGS0P10D\[/H3SZ(R_A^0`!S8%T1:QER!8+:[<`QQ47`<@*2RMFT:$>-F85ER
M60SQ-X5#`/3:QT(!*!\@`#QS`%W&Q88\%5M5OOHCO76(:2@KN5;$7PNQ6#I\
M$!G@$;-9KW7H+R'D$&HEMN@TOC^A)\NT`4"C-@-`QJ6,1"\+QQV,;)8\I._Z
M(WT3>!RF$&NHNZ]61`DP`)K,<+/\3Z,E%4^#LVB6S&E1O<Q,7S6<$'AZ$!&0
M?X*4)9M7>P211(B8:7?Y.1]P,<_QK"&K:5(!-*HR1\MLSFA1.'"Z5>Q;$$ZB
M8P16$%TF$'):`1LI5FGB5H[[0G&,NZ1'(WSB)$+S=@IQEKDH%<P&+;/C_B4%
M$`%7:]!=`393*[LIU!"W"-'@&W*O>B,@I5V@!$[]5R@1P`!<D\+[8CA\TG0]
MLP#FIJ*BR<!&@2>I=9=<64N%[-)3(8NKZUH+<0$"X`!#B`$64`'&TC"8DY,>
ML'LSZR7T!)6M+-$SVP"I6"/?[)$_!3CJ84"*!D%:"ERC.Q1RBR6L(IW`O)Y]
M716\]9K?XKPDHR\XJL"(F#$Y^DQQ85<VV@$Q"2-O?'#!LE].D3B&8P%,@T+A
M>&LR7&E2P3,X*#99`@%-[*\<(%8M?17HELA>%G`%>IJA)UC$U"**0RCE4DX$
MX=6(:*1*^\0_Q0'[V4IK(E%.U3SU%U@B6=A#_K%8GV0P.4O/+?NX91$^1,V/
MMKW,R#1M.',`L[+26\4=$.`UEB)"&-H]6;):`K$!Q(R9!1UR;*6)`D&S#L@F
M!Y`!&/#!1H%.OSND`E$`ANL4@]U=&F46$9W.AL)V,@I34Q8F1QQZW?,>_/<H
MT.+>[X<GQ#0!'-!H]&UCQ<5YAK.1@:6\:QL53A*P7E+-$3'`8B@`%;;B5X'(
M"5$X[@).#M/@`@$K0E-S'?`6&,=A0SDM`E%23T'?EHN]*V,I<<$X.!I8`<`O
M.J$!#G"_X@8TW62-<"RL^:JA"@`MG'P5['+@XD)+:P*[4%(X&.Y,ZK$\#6,8
MNTDW"F`83LODO.(8_KL\$`Q`'73U`$0LXF%6OC,!6AC%*P*B`9R:V<5DR"X<
M%N'#J;,Y`+YG,S)6(PEV1H##(\^$<3(**SSBRWKN5$84>,XD-!N`8WLM,4)=
MYC2AVQ91+-"B66JG$(BU:ILAHEM",E7,%?LE3%Z%<NO=`+AJ=Z>I`+I<`$Y3
M=,C"+J*IYWFI+,25Z0X+B^\QLV0QV2M3C`8Z3@VS&089(C`U)QF9$.W#W.(S
M6)4L(5Z");M3ZBE>`12`-3^R%71"5PUD[&6A,BGFT_CG3#^L(!T`X*(1DQ*0
MX%"Q6'E+E>!,H0+AX39*`%6BG/+.W\((4XLB9QY[TV`!9H\SYG#L3_[,_B$8
M1AOMT@"&7A7W!'VXS%#$=P!^2!#A(T+1+N\'L`#*LDT*H3G(XJOW.RY\RD(2
MP#-/\2AY%KF`$]OK"2V<1!8]G,T6K&<UPIL7'UB5>'"W&>D089NRZ15>0C7`
M/:0^%$GF'#(((-U0\3N<>L;IK!Y4>/$&X``,EF$)0-0-K#44L0%BQ8)ATQ5X
MHBSU[9%)U5+)_'E*[Q7.IA`9$(DB?/6R=0"DHXT&L5,*03MAKE42H_9)$6,5
M'LM71LJ.R%MC89J=JQ"[J.<$8%0T8A``SR3"Y-T684!.+16$L@!,(J&9O8?.
MZU_C;D@&=+%A(7470>IB^0`4P%T!D&$%2A"]_O?X6EX0(6/C4@$V'\`SV.SQ
M'^#)(C'D6$:B8L$U`>L04X[!$[``+B4`/CMWE7^ZBQ73#;&1'S'P+?%V,#RD
M:DGCYMQR#8#-4P$0%```&/#!X$&$"14B5##0(0`(#"PL1#A@@4($!`P>@&!0
M`P"*!QL.#%G2((`-)@UFJ`#A@LF6"1MD4%G3YLV#`4">?!`R0(2%&0!PP%G4
MZ%&D294N9=K4Z5.H4:5.50I`P(&=5+4N[>"P`],)#@L8F%@SK$()((4"*$`T
M*\6T`U\:Q0#@:\(,1"LD2%#@H8:M@1=R>`O``T4`$Q!3$-S8\6/(D25/INRX
M`5:@E25O`&Q@H.*E_AX<%JTP],.&N1]0&IB088##U(@'EBUZX>V'"GX?[@;0
M0//4MP(1WU48`,/4P[^5+V?>W/ESG)X+'(<>F,%``TT=IL0)0,)'``1H*D@`
M@.:'"PT[EGQM]:@%D!HR4"C/F[?&ZDD!]#Q8?B$!VA*JZSRH8LOO0`035'#!
MFB`8B#$&G8+/O:0VD,"S@1PH:@(#'M"H/@(>1$B`V]!R*+FB[-N-@@HJ^``\
MPR*L*2WJ#%J@Q`)`6PB![&3T\4<@@Q02*P`@%-(HAP@LBC#>C!+``04.<I`D
MCP;RS22'7%Q210$00$`AW0`[4J$,E%1-H0'X6Z@!(\=T\TTXXZ2J`0G\_I-3
MI?K4+&JMW9#L,B3;4*J)1``2,$HTAP8@3\O_K+Q3`0,=3,@`#2EBH(`[,]5T
M4TX5&BB`3F7#+Z0(""`@`#$/2FN##0@U\(/Z`$"`48-(O&@A@:*T:4)#C:JO
M()4<&$W.AMK\`$"$%KA5ME";=?99!CT+0$=G`RT1H=(<,A8^@\("8-D/$+!*
M`@DH()*[#SQ8;R&L:E3)VJ.F9."#`!?J:B#BX,3*4Q15J@M:@`,6^+?P3&O6
M6BI#>D@A;D\;]@-A7Q7WU<$:2B#?DI(T:H-/;=()@,SBY#AD@X0MZX%U$1L8
MR'Y7=OFY!^QZ\TJ*$!:QI`A.]%3,]FC*V5V$_NRTB41T2ZJOTJ(^)DJED6B.
M<X`>$<J9*`R,]93DEQ'T8.FLNV:N@8&^'+-E@S;0;:`!*%;HWH%2-2@`3#_0
MC:8!G$Y(-*!-2JL`LA.*:U2<VL.:(F_M?E,"8/T>"N.%;"O::\@AXYHR#=R.
MG'`)=`+U3H$<^@FGCV\V**V2!\KKVHIZO2D#G4QB4M"BIE2])!@S[2IJA#I_
M?*'I+O?=L;Y_=XY(\^*LZR'#5;K.*K`!$!,^[DPGS"0'Q$YQ]X1&8EPEMCT>
M"/LQQ84+]4G!%?Y\])W-.0`$M@<20X<LMVG*@CQH7N,/.&",8Y,F.``G#F!`
M`P.PWD(F`)YZ>:]X_LH;B`3BQ($'P.=_%+F1OQ:8/@QF,%.E@<#@?G0!^$$D
M*<?+"@<RL`$.,*XK)FE`W$S2@0QXZV$(P8"7'F*UFA`)<"&)2P&I4H$!$$``
M'F1*B!Y2@`$$3S6XHP@%U*9!*$911@)XC0"$A(%8L<5]-W%(RC+F0(4E+UT9
MT,"43'<0F04M42$:0-YJ$JC$E>1U[5G`%I6215D!(``ZL2)7'A*!Z:!.`AIA
MHD(>H$0I)E*1T!G)?H!THT0]$2?>VF%(8A:2?0GH4KN90`<$L*R=8$`".6-+
M\R"P@"`B988X$T`!(E`N$NE**AD0EWTR8`$*3"Y%$`@BV":8L7F1RGR+_B1F
M,9<#+Q]USB'!;,J$R.>IY*4E-AHXVWGX8I!_G>0`1K1*`6B"*@Q54H'4P@EX
MMM*!$-JG``Z07TF6MQM)=N"7"\&;,>UYS\JTC9D*HD![L*/+I;S.C0OAV$^(
MXZ#D=&!Y`3!0S#*``1)1H)$`,$`!RE*``H2H(:79BYD8V!NEA$@P'+"503H`
M@8SRA@(>&*A!2&F5AY!M`Z#))@7UA$^<YI0JB**4@BK`30#,$RJ$$B-%B.<0
M`F01*^U4T0%D:9!807(@'BA-40FZ2J,,8)^3R8`"".!/BAX0H&<*0`,<@`$#
M>!0A\$G@028P3)W&5:Y*>1TYG>.!6L)&*U/J_F-)<GF0K1UP>0EP4%D2$"`,
M3,"76,'*`,JR@0F%Z'@3P,`&1,,8T:S+`T]=B*OH^LS(:$`"#XC90QQP`0H`
MA@$!V.I"+)`XCMG5(-.;:VUM>Y27YH=C#UE`2YOR.CO6<G8&88#UTD@``VA@
MFP\9P`&J]R"2#D0W(=+-03[2(PV0S(X?(!0153(!0AVH`A8PXT/Z^@$%M+8#
M`>H*^-)[6_C&5V\Z`:-S0G@`6FG%B+(]R/W(Y$(*!$"J5HI9`]Y*(@Y,@``:
MN$"(N.F!E&2H`82"75&$%52<H*8^!WB`6J'#`0ZP]&Q?)10')(F;-/K-JO)E
M\5P!4!?O3F;`PPU,_FF%ZJF$61<_%V@/!1Y@@.]\@"/8N4IO>!,!KFE``"1"
M0$H0D`!$6A*K-7-(`C@+I`TT``$1"!T`%%!9D#'LQA^H:8NU$F4S(ZB=1^D<
M`_)+F0&#5')3/DBV#':0KD!`A@/R,B^E"H&C6H4!<S';!^`W0/J@"P)H1LAN
MBZ029[;V317=@(>0J@#6(*3#"Q%:FJ4R5D\OB-$U\:]F.`!4!8!Z*XB*$4+(
MU9!&<L<"%I!G0YQ*T6_!M*D+<`"K<@>`"]<EHV`3EXL:``$*;#<A#JDO0BY@
M`3X^Y,IO6N%:@<I:[;DVU-N6*PDK4UX"*%LK#LD,!A;J@,,0:5XJ2M1`_B!9
M@/]A``,#P%@,">5`DCS$`HT,70(.H&I-8P<A)U61`6(\I@5(^BOF.D"L!,"`
MRAZDD-RF>#$+A8!I!\:9:/M-:04PI08$Z$8?>\`%,(#*!Z0%;@-1@`)>(P'B
M;,"K)LUK;S1`E(\@BD0&(,`!*%!)!S6;(LZ4-[L'(DXY64X!</T`!=+)%O.`
MK^)3A^)V'L.!+E=`W(%A6^(Z@,<-+,`S1$D`!2)PO/(P@-X9:-F%V5>H[U@.
M`"YB.:S"$X#S'H1C7ER;T54D=#D)F(9\3\C%.K"!"G2Y+P\`.-4=#SG;N.8Q
M1[5H<SX&E`M;B0,#*$U:%E">F+T&`S^N`"+!_DJ1%59`(A"Q<Z$6\A$<5L3O
M>IP[BCLE*X1$N9\T-(Q`0L>`!!S\\<,7F&=.(YB7BHXY`YE27O]7@/OMQC,K
M7C9!EBP_C"-$)T*A$_D@@#2*E-8J=WF`3HSU]4YQ@&904LD`-O<V=V69N222
M@-2)?_].P8CP3L&`XJNSVP?XEZ'PLIH;B`,X``\KB?+;E_)(F:[(%YU`@,L0
M%NH#%(=HO`]H`*:#$P&@#48C#$:)@+S+G8HZJ@[C`/O#/Q5\$R,"/Z>@IB-"
MD`P1BH;@`/@ACP_@+YL@(:`HC;YB@!W""IIX)P]K@(G3OH'`0._H%&$YB.NP
M"0W@#M&PB0M@``@`_BHV&:45W$(X(0CGB8IWLHHU:X[[D<"'F(`3`QWS.PAQ
MZ8@*,X@)^8BO^L*K,@E(VK^#L(U0Z8!#.H@$3`@(Z)$I-(H*P(`*>+H">(FM
MXT)&7([F@0H/""$?.A#2:8L7TSM?"XUO68#)42:%0!3&>@U)@T.3V*TX6HAO
M:18%F*`,V$!/F2`O:XH(0(#5^J,,>+9&S,7J(!0:.XJX,,`_=([769C$NT"F
M@!&WB<1K:8@(8!T!.$0!2)Y>K+YG\HMGV8D.2$,\HR@R`ZVCF`!_VXT'2*U%
MU$5SG`J.Z8`)`#R<0!@$&,/\8#<#<`NGP!`OT@T7K(L%V("*2I-'4X@Q_DL(
M(FFKYBG'(UF`_]D:`!(4;U2*$U*H(_(0/%00=CQ'-X''R!"(GSD*FWFS!?DZ
MAQC'97.*CVFVLQ"697$TL,HQ@]!#O1F(UK*-"PD/%]04_T&Q"KC%UVBKW'NQ
M?W2,KN(-C(2.%+1(>Q*-;-%&/,L\@C#(YR@C[&G(FD`;P%G"#UB+PU"F\,@H
M([JI]W*=C@F)Q)J-3D$`*Q(M`G`0!'"`FE2(`0J/R3B,#O`EHZQ+JF`2"=!!
MA6B]!7N@HBD-I_``(^J5AG%"MC@6U1B-`HB9`OH(;:2SA!"7HCP2$A&I#]@N
M#R`2>DE%S7B`4[1+T%P*\+A%0*FS)H&37^0:_M=K"K99#P!XE=<I/8HZ``2(
MB_,"-IO0C8I,B%GL%`5X/^ORJ`VP,BN#$)>LC$L*3>5D"H$(D012IE/Y%*)H
M'>:8R*DT(OS(I*9`%+[1@&I;B-?0B3G<C;(0'YN("U=$"*D,$CE#B+5TK5?!
MO<K(F>6L3Z5HI#H;HH?`D!IYC>9PRDDI&.*ZH*;@F`1```M@@$+BPREI.@,X
M-)JQQINXE\]T+?GDE`-4SYN8$,TP/OO\4*-HB`YT4*MP@&FI&LYBR2-)`)N)
M/:5("\7("@_0@`=8'@)H`!3Q#I"Q(@LP(J/XF)#HJEI"`-]R$]M(E0"H4(JX
ML,Y<3Q!]TG09BM+@_B:3>BLU<M($\2J'J,!#Z9,/,*,"@#(:0@"IN@`!T`DE
M-8FC40@MLPH%F(#)')/V&)U)+(F)(``7%0S/&#4H!5%"&0`F`X")^!@C>:4$
M`,XQ^8@%F(!WI(I??`B72(@*<`#Q&XCD2].26(N\:P^]S!2X=)BB.(ZPJPSX
M`-`^#<T)X0"_V``&`$*B$98)8*T`.``!X%,%(0P?10Y'@:R%>+J!P`!AB9F`
M-`E60P@9PD`XZ8"[F(B?G)\,O"G(*-53G59ZP@J!>``#4P`KTA\[HS`Y`2J>
M7(K=RI<)<(`&:-7V()$)$E'?"*^C^!CJB#Z>1%8@B570N(X!>(T\S<#\_L%2
MJ)"4[2Q2:GV\/`*`ZR@/,H4(VEN8!RH8?[T)S^BCC4L4#H"/6V&2##"C82V)
MO%K)2Z0GA5@I-S'87[J`"4L7CG6@08S+.!U8^[R.`!"(@_4+J9*(C!K!,7&`
M6&W6I\`W+TR4#8C4DW`0H!B--PVBA\6C\#C4CX46`SB`3.LOI!,)L0F`E@T-
M3*NHS-A8EWU2;Y&;F#&B#1@`([FS+G0F6V4//:(P\WI#N3E+D)B2`ABD`+``
M%U*)#:"`6G0($J&9Q`@8"J``\^R/W22SNZ"`N]V*Y'.(].S:#Y6N7(N`5DD@
M!L#9QX"PJ)@HKA`M(WP(G8``#KBY7L7&G;@?_@MX4)Y5B-"=*.EBG`M]ENE)
MN)'TB:59V<:8T4922L=5SN,9`%XJB8>[$]'H0"Y-"-&:M]T0HL,(BP08PX_E
M&)H@E-9+'A/2`*G*I6]2FR<$F`Z`D`EZ-G%Q'P^8G8>MB="E"!@YPMU]4@]`
MMQ<2/B!Q$`$0B@G]@$=UB`D00=R[#!B-SP)Z@.=KH*^"FZOT@`NX`%9ARL28
M'`:`5H-(3H"Q7H-]B#H-(W3D.QADV/7=8(HHC6#\$=T0@'!S'0^`V8=(``D@
M$9K8-S1Z$0<S$K!QFVRJCTOY4ACA+0'J``(`&N$8#*N$EMWB&&35`.`DJ<9@
M2@,`4@Y>8N.=6B%Q_K16"PJ@HJZ,.`P'N0A1@L6#P`"_:!^.R:]+`L>?O8YT
M$MV#J*!E6S-N#!@Q\0!,/8@#P!HG?@H/@%\F9HH4,L>QI5<9F;N@:I,4VEEM
M,<"WN$)A$:6Z*Q'..$Q/\5F%+12'<+D2H;UE<V"[&Y@W58VA1(`VZ6''\+$&
MT%T,4L@[#I*<R;@CF;L$\`Q(ZC+I.PT4R;D/6("BW<</&`#`$Y<0N0"W\0^V
M(26BO<S;>$(*9$.D"PN!S90'B)+"#(D!P!JSI0KY@SH]LN/T(>52_A'X\,@Q
M(1[6%0#":(`'F``/>`#7U1)<FF60VKUDV0D+\;(-6#B0J$40ZSF_H([:_CL(
M`8`04JHH?'D]@Q68`P"6`TA/16X,^%B7W<IF)I8`5`Z?;S&`Y,`]H9C(!1B5
MALB?!&VZVWA#/F$\PX`C],JU7J'-@X"/R<$`(2H[A;'<VS,NJ=.`2HH`:TX*
MVW`7[3P2#^A4:AU*X1$(G@820EE,&P&)S/P`G8`K$4(C!VQ:C`H*0"J/I0F=
M+J$2P/R`G*EID8CB9RF`]UOFD``OA>"?P&`2!F`IR&1H:A4-K@V2&\D98(F9
MGC!@^S5`[7-!%,0+7>F*X+$`2(H>=_/$D]#`U$59DQ"*?<V4L04L\G$?EX:*
M#'@I*]1JM;9/TMD@AH4/3'$N/,.*!3C=2<ZO_N\[B5$4BB;KK9/8#\^(DH"6
MF[:IBFF\/5FJ49PHL\`@I;2M[&:)0F?IBM@^$H0)"[\&"0?8*D_"JB;D`"#\
M#N>Q3(68`%ZJ`+/*P8D:`$,A"(^XVL91T69Q(O5,H*X8JP0(ZM!0)@%X`)_6
M;1!M0DV9CK'(D+:AK67C)6#CFBGT`!+1D#A&';&#Y*`J6#T:.U+B8XI(L(=(
M9CF)@)2Y:MZKC$")`!81EC=6[R=%XTP)BY+"[T<+,X1XZJ9[C;0R"`7HB%8Q
MB.9A`)^C%YXSNBA9E06HS5]-BLSSC8^PSDQ)BW`UB$`<'ZB0GYQQFNVE\*[-
M`%-5D+<25)!@$HU@_A]7NXVQ)0GQR1D$>(FSR;718`PH06TI*90%,+NP:-RK
MZHW)^51H*8U^Z=&$4+M/-`BMVHJT**#F$O*Z5%8D^>U4-LM;B8NMN=O";E\J
M^8A_RT&0*1AD$UD[W0V=L'.*X)B\86]HR8#$58VB\8!ZP>;`$,Q2@B0PE_/Z
M;,]'\<*)R(X7XX!?`EB"(HQ@>@!,(8S?3,+NB-L)B!E0Z0!N#HE.T_'6AI:O
M,M[@D+IHIHI(UFY.!TTROY,PY*U9?@G;B+U]V3R72BE"=E)$X9H;.9N:GJIE
M4]]-R6F7&I4?5@@!T':GR)F#$N5AK\NST)32DM!:4@V-X'"%*)5C.=,)_BX`
M"CN`]%9/LI0`K`@`^"F*Z]`31W^6RYY=^5Z(WMP*$5TG#,GQ<U].^M64CUC%
M7MDMHI`6A4`ICT7TO#Z*UW%EF"3$HQM/!(\3Q`F)T\62W+Z)NC@.1RGYAZ_+
MU=24%1(A^<!-JSC@Q3P`)(J?Y!,`#&B`!.C#I&`U_-W.&S&`DH(6/J0(!>B`
M"$A/`QC%IA`*!^I;2X]Y*"6`N<B`7HN3!%B`+HD;L#$4VA2-2C4P[I@PSH!$
MAW#XVN#P6`28<$=X/:IU@R!3F_"`M#UV8]1Z*-7PA15W&;$S8*F+NB4`O^#Y
M.J:`#W:*EN#EIR",5+'P9[%\A"@LDTAY*BR*_DJ+@`F8@/$B+\`_U=+0"<\@
M?!EQD`!0DY%K&_S<C")/B```G*D)&-]%C"(]SM+O?79!B09H@`F7$0_H``7`
M*&YZ6@IC@-DO>BU<"MM6#;S/%`MH2^*R3A#R?>U/B+#@I;A([`C9HRY3QE9M
M`&&/B@AH:PM2"`.HX#C)@.+:([=5STB_&T_??M_G#;A?D!26/K$'B```#GPH
M:/`@PH0*%S)4"`$`@0\%`'!HJ/#!@(0%`ECLZ/$CR)`?`$0`@`#``H$=%&Y@
MP."!Q0P)1-*L:?,FSIPZ=_+LZ?,GT*!"AWY@`*""@PM$ER8$X/0I``H&`3A@
M*G*#!P$`,M`\P*"@_@0$)YVNM&H6X<F14#DFE+!@I(>&#1"<K6OW+MZ\>O?R
M-3NA0=^<$Z4B+/#P*=V"`#(&/@B@@,$%93TV&.@4@8(-%`!@:!RT`TJG&P0(
M@)QPP82B`!I:6.WY->S8LF?3YIN`:VV%%PH0@)KP,%0!!7MW]DS@K4$/<4%>
MB)"AXM29N7$>`*!`@(<""E(K+`M@<L(,`#98A3[]//KTZM<W-+U>(-3Q"#?$
M)_NA,N#&&X-69A^RP$1/&0"`!0DQ5E!B"[D6E'CQ<><?A!%*.*%9'228WE@H
M/0#`5PC51\!*FUW(%P`:!+694A0R]!0!$!S6E&/%*;3@3_05H-D')=$8_M@&
M$JCX(Y!!"G428>DI\-14#Q:4```-R&A06H%YL&-/H"$G)$*34?F!DAILJ9A0
MFR$TP)=8FGDFFKE)4"9ME=GW`091'11!1`A1$!9%-FFPW$Y3)L3!!`:`5Y-`
M:2:T@9)P[KB`<`HI4"!0$T&`E`0;LFDHIIEJ:A5]_CT%Z0<.+&:!!AP08!I]
M]34*TI%.L<43C1@L\)1Y-HFZZ0>%.N;C01Y@I1`'E]HT:W`)*(`KLLDJZU,"
M5Z;'I%,>0C6`J/'Q%@!,#5%``&GP79;M3FLRH$"`ON74&D&:%FE0?@@9D.Y\
MPBX[+[WUG@5:HN<!5VM!'9`''W$?D,>O0_59_D=P3E!MY%0!%*28L+Q`CMNK
M0N*1AY"?_`ET;*X`/'P3PO:*/#)Z]/&JWJ<,/=2A8R$++%-\";A\TUCPW0?N
M1P\P`"I"&UZ<*00'@F9B0B7-&-2:"U3PE`-/WC0HR5%++9MX$+!7+<<"+^#5
M5/`6U.E"ED+E=4<=[`E2M.N"M#0`NAY*DJ93\MP0`G4Z!K5.FW766P53\\6G
MWX'_%,#,LT'K,;&T#K=C!J\:-`&9'/K;6[L?;6`!W@H^EMS:)BDV=W3(+O=0
M0R4BA`'@/&T67&^"V^5!X:[+;GD%J9^W)E0-G$T`T3XW9.D`#^!V5JL$$6"W
M08`F-"7+`.!\T*V9_GK`0`#+$9#U0IG_U`%P`W`0`>BSBS]^;`T<J-X%&63P
M\W`R$GA0J?<]M4#X5EU0;8##/^`M2@8=>5!*EL>!`6$O,$0#BIC0AA`"Y$LH
M?6M(!&)'O@E2L$]4"1*-+EB0UK`(`K:S"U1D9IXU`<8"%1A018YR$`LX3@-&
M@<H'L509$UU`6`KPV@4,0!0+7`!W%?PA$/%2/_]8`'D;DH"./*:<QO"O=@<I
M`,YJN*:FD&I`!AM>FB3`*PWHL",`>)`"1M2G"!Q.A><98A#3B*:E`>F+!KE`
MAE*#1KS$"2K(,T`7#?*0$6V@-_4I5U4R]1V11.PF;(/*Q]2HR#0>,"?!_OK1
M`])%`:T@R2!&><VL3L*`/'Y@0T4SS?<,QBVNO!!Y:7+-`.8X%4AYP)0]D94?
MS;A(IFR`?;.4&@,2Z9\:(B!Q%:G,9#;PO\"\4)9WBY?!!C``6ZJED!-:S`=X
ME[-716`I%]#`!$QWRVUR\R-1@A!H8"@CT)RL(/T)3"43<@`"7%,#L8Q/(#4'
M`*MEBB-;01MW(-#`H,2PF_[LYJ2<=A[8<9`D+&298LC&I7T"10-A'(B!R-3(
M#92JC$\1`+<$JA`_ND<W/^H;:$(2K!3V\R9B<XH`M/?/E=XR6NCI0"B=0C_S
M,,D\U5%(G#CI$YDDSBDZ_0`$!&">#?#O*0$8_H``&+J0:CEN>3^Z0&\*V!'Q
MM$:E-<FF`6K)0Y>RM*O<G%)':8.!ZC@%`O4#&Y>:=)`CM<HG'+@`!B+W%`9D
M@)Z_6<`[ZZ-0D`3+*6HS$YTB29.X$$""(:$/%F=E6*\R5GQNI(T#B@D!729$
M`<CI:P0HD`!*/H69-;G`20$@``@@X($C^6M!Z_/7FOBQ<FD:@&L_LK22UD0\
M!X#`!B[05D5V@+:-M<D21^:!"ZCR+AH06],,>\F"U#`^P7/*\T(R@4@ZEZLK
MU*9!.)M.GL12D,X\""^!`CD6*6"U%0SN;]WJV65UX)J>T4`%(G<;PVK`30!8
M#B"#>QF&F!8A$O`6_@%65Z?5*,4#_151OPK"OZ;J1&R+A9`&*&#5ADP8)Z))
M+X;3&*?UVL5+3O$*%AOB`?LNLR"KVZM:%C+%@U```60%0+-,M!H$*"4C4*PA
M^S2`@,B-1*Y.\2TAH8NIUEP`-0>()^SZZZ&'=,!A#VZ(`PC@8PYGN,KKR8!&
MM^>4)_>$`QAPTP`PL-B">G!.42EO@IE$2L[(TV"#O(]$,/``R*S$`RNA+)<Z
MD\*Q_41`0!XL3#>@/@P0EP(4F$`$7-2`:H)$.1S@`$4';0$+'!K1$'C``P8T
M(*TP0"L'"!!I#!`!*Q9@`%:$"D)OTBH_6D`K5GZU8^]K%R\GCJXTL6*J_HVR
M'.?%1RIDBJ>)BVP2J/RWD\*A"X'6]$@/S*3$OHT/@W-23*B4]G(9F$`%%N"`
M"8C%`+Q!@`$`YN9Q&RP!!_#V\01P@**2F]QX[4`V)STE&<^J0:=VU9'<I&2;
M;&@E`YB)>"H,ZX$K*P)2'4I[RT4!*EOD<`>)$ZBTB](/;*:+'L#`O3E3@`4P
M^@/<NT\'#C`3JZG0GAQ@HT4&"!6!?P0X[7XYS&,N\YE7EW\O9AB7%!4`@523
M/DH%B>\"H,/><)G@1C>4!E8EE+?&D@)%S])3W"<=L-2'(U,BT#L#(`&OT04#
M=EM.QR]`D!)-H"IY:DA0H=)(G>".YFY_.]SC_EZ?@VP`-`3H6P6TOI/4HOKH
M?A?9A8?T%`@\?2%6O))\#$*?5GDL`6EW"I,,((`.9>`KPG%>2-<7`61W8-$<
MX,@"[.H1E_?/)V0JE]S7$@`"&)P`>(1`>5V2@090@/1&%>WM<1\``0P``0QH
MP`0D8($'8"`#&JC[!1YF.W<>`#-^3)T%JE.9N_/D>QD@;O%%__?M)\LIP-Z)
M9B+'`):'Q$ULR=A!.%#0T*[&=CK4880I7I0'U'`DPM3A:C!P+`G`%?(-L>B?
M@<1DB,KN%8`#+``"()H$8$#Q'=^C!:!%M!<&:`!,U=E=.,7#),``5(=6M$;'
M<1\(SA+K\00V54OH_A5>1]31@BR(H.6(P=0=;?6(07"%!MA3\F2$CWB84=W4
MBE2+4ZS=-MV<FVD?0Z!@"!YAIK2&3F0`(&59GSE%<30*XY5;1Q``_:V&`@3+
M5ZS&`312!W1`Y!B`"1&-`3BA$$;7+873N)T$&OX&^2$A'&J*G-1$!T@`_DR`
M>0D%606`1;G9NKT90SB``TQ)!Q1``DR`<`B'!LS$`Y#8!A!A`7P@0C3(1:V4
MF'``>J78`Y13'':B^+C0DU&`7#7`&_*$#\9<DQ42WE3`ZCA%V>7AG$&9=JV4
M,:W5:@!A8&0`!'HB+YK%`'V$!R!7<2'<N/'A2M@7?"C=0AR`C-C9HQG5_@=H
M@!.BS;T1X2)M%D/TAGC(1BGF2"]^(U!,B;,`RR(Z17GMHE#D5014`$)18H`P
M0.'@UDADB%-4`)XE1`4`!@4RQ+1!$S?%24.0"<,9'4R!H_@PR4+8V:E)P$#6
M!5F)4?*DS$G@XD$\GO\!V@>8FK;$1S=IT$(4RF,9I$B23`*DC@2`VJ3)QNK\
ME&,\!48\"D,D0&\4P`%PHDU$`(H5Q`28RE/89!J=FT6XFC*.)%':2P?`C"M.
M8U]<'9NP&TL61$G\W&`U1%ZEFH8!XD+TAI=88U%VI55\(5^X$.-9@%)Z1H#L
M&[L\10:T2LA@@%32Q/MD3WP,91!Y9#:N1FQY_J5>+L51Z@4&'(Y/YD8V;4[8
MP-"&V`[W3,GWZ80!0.3CQ`=%4M"L>,2`",Q>7B::;$"M,<!BGH<:,H0.^DCT
M%$0%R(I?^6-/6,!3*@8B#AYOW5-'W)1=8B91&B%L;,!8.04#[*-:I0=8-E/I
M>%\S'<`U081C<"7(8->?S*4BP9@WK08!6"5M&F2(1<@%E)(%L$\OJ0<'E`6Q
M!&8GT8H508",8$`$^`@!3%U#",2?.<!JRD09W:/X#)-'W%0J32=0Y"5^\L2U
M,8UYG=UZ%%1P.L6:I,N:/!=R&*="]&-#ADJ94$!N]F00B4=93L5J2.=^9JAG
MP-M30%%#U!^$;%="_KS0`!`+`GQ9QV6`%=D-!VA`!`C$QCW`6\#C1P`D0_04
M1`'1`>CG0M0;`("GA@:I75"`V!#>A-%'M-&&>5"2]K3=V''(!P@?`2[`!1@+
MG#07AQP<VMRC?9D+!9T3VGR'N0DIF>)%!8A-`O162,1)'L;&9!S>@,)$_W@)
M!TC`NDS+L22=3(Q$!SP`6A;A0=1AQJG=#X7D1ZA$D96IHEI%03D`<GI$@\(&
M[H050IPB=,40<55`WX#(E'2*`!A`)J;@!Z@FZJE*DLH.;\!E5$#IHK8J4%@1
M`G3CPP'H3T3F3J@@A:U%X`7B!QS`E9!'7-C:1V"IFPE`E&TBZE#09J`C_F>]
MI:L^:T-LP(LQ)$]H187&1LHPQ(NIQ<\U0/]%DX]4!`(T9!(9#`(XP`%UX'?9
MRY1(XD=,Q*S()[3.:T(T&7Q(@+/RE0"<:FU`BY8RUU.0E4=08$1$DIAH!9YQ
MP`%(7,#R(/Q,RP0YK$AL&H;2J\4:1-L9H*Q:Q-+D9&W@ZH"ZID4`SDI0A(VN
MT*FX60!4P,6LUE$)1,5.36L\'9D,R*/62ZA>[*8X1699Q6RBAUJ&[(#$['49
MA!BN$+F4JE%5`'A4`$0ZP+YF&OG\+$B<!`8P0+XJ2Z3J;)"T3H6L:V!8D;O:
M(L/\J%7]Z`;D4:9=0`,LC)L5P)\R@&.RDZBH_J?@&`W--(D3<2W?>I)9H*9Z
M#.9J4EQ]S`S@N!/,*<#-&NH,/@;NM6'4>`Q.'`GI\"W?5J99G,2?UL8AS8Q1
M!5P*-H`0&DP!5*="(.1"9-.1D(GL!`"EBL1D;JVRF*[E0HAO1<#Y,`7@ID?0
M,D2&\.E"8``%&("/N9D"Q(]'Q`E%AML'G(0K24TVZ41:U*+4;&[MKL=`+I=9
MK)Y_D!7M%@2.T@@'F%O,"8"\)L2&\&CS>@R!/("MU@OUTH0V_NO(V.;UH@>W
MU(7?K@=9Q2PE(H8")`"[K:%(*&P`P&3(XF[NDLP!+'!-H-`<WN^\5L?&U@3<
MK$=ST65+NAWO20`Z_NI@FY*FPKRNO6S83KB:QTHPF7[3UWK*#S;$H+H9`3A`
M!12>![1B`XO*]W[`D3!)IXTM_([C39")":LPM(J67025?Q!+9QJ$"KJ9!IS-
M37A`\6X%M.0E!$C91`APJU0PEDA93Q2I$?,G$(?C+%F758@'T:KD?C'$$\_5
M-:$C`.V>P01`:]!G-#9`^,;',&;*(_6$ZD[6&(-$`A3'`I`)=RC`\P:%[`J.
M@M9%G'BQ<8DH,HFG[,;3J`TPDISG:?&A^;C9`KB$A(Y,`*@O3623433Q($L+
M8'3I6SB``R.A<UY@",N&']FJ'QD`Z_D>35Q:7KG*K%3+NEG>'CL/EO')_@NE
M\*8HH4^THBJO\N(,TD14"A(_@`8?H>=<H/7.AA6A44F(267$<D)<`!T7(^BU
M*WQ4<0&0)<+HH,@$RY^^+W\U20.L\1B'T]<`0!<9Q09$P#4/Q:/5Y>`.!03P
MZVQPT.`&RXEVC+PH+<YM!05,VK&,[E,HP"9Z$0;:2V\ZE4W4D65!\SQSAY<4
MQV;`FT'SDR3/RZ?EQ>2QQU/8*B4-9EPF!-%PUKTZ!YQ%P'&-6[,H`,OYD3VG
MR?$$A=C0[RK7D'0L38I,9@(-<F]D;6!$SC-/H6XJ1*"<*;%\!4$<`$P0!#U.
M"P/N\(VV\;($2R-[1#$%M1%O6<<41%^Y(#2K_G%R9`"0!@9P-,1@/D`V.6P'
M],T%#$``$-53)("/M,91O2U.XP0ETHOS"(6;_#-(EU%$D!5@L'`(;HO]Z@23
MW)]/3<=+NW%G9X1TM-)BM(V`4!)',*PY:ML,!G`$-'*JP&:R"/!0B(H"\"%(
MKV?486EGH!P2>IT^2[%>N(I6V.UL/(7UMHU,>IK!4)*ODAL#4,`XED0`B)Q`
M)(`\&\0I.J:A!$M*+\1#N$@9Y[;'+0>SR<AHPN$IAM$V\Y-3#,!$3`1W-\9#
MYNI<;85)0,`">(G]]:%H,:!&"<3'3(":>813?#(:RZ$0^T02C3?X76ST=B+?
MQ2]3'%(#V,P'M'=>_AR21<"8+G/&7\B::OM5\K6'K"5$A.MV05!B=NM$SJ))
M$I'W0G#`:I%E42BST<FW^D3Q=U^53\5)G5RK1W2`D!MX@GN(%;%1Y/QR!&#`
M('9$L#CA#,N%-E&BANO$/FJ*3)_O(+N4C$Y%1*0W-CNX76C%D2PR;-RRB*V>
MJ,ATS%2'6$,/"1>$]L[(QW1H-\V*4:BU"GLM5WUJJ)RTT27`N!+:J)DR4:P8
M>@`'9'^J&H^-4T!*#0WT5"RX$Y=)`)$MV,I.:SQS;D^$8BS(`!2L./^=FX%?
M*:9X;<S9W*E,?00PPO1578^$?&+`-0^`)$H6-[6&5I#Y((/Z2,!+`0B'_C]W
MHG5\0&7BBTZH*4V<1&;_!('[]Y%O<'E-F`^5#AJI^@+94C'A^`354"U#,_$J
MF+#3A:++,EV0R0W/-%X(`.3>Q0,H@`+$\%.<[VY]Q)H`J08V!![W#"?J8!^/
M#T!*KHPCQ+H5A$86A`%415/+LL%<N5`D@*\3A?X5<T435\N]L$>(R@+0%E9Z
MR(*GYRP'Z@04^?C,[`2TN!&?!!+M''QE4U6(^1'V1G9V@%$SZL=;A0:(RB]3
MF_#1A(?=_`<$,T-<'24A#.M6\L0Q5FMH`-P6/$)(NW-6;ARB4(8W35],1(]#
M63_6\<T:.61?'1H5U'_-D\<]6JL1O+1`1`6H_KP:E432N;T$!PUQ\][Q``8$
M&#<(#H9,:87<!T6.!L75?K5>U3QW_5BT*N<'&!C//$4UV9Y5MBAP!+PB/027
M0SU"W%`<BF-XCJK:ZX6K_<0)M5LJ.0Q0$(M11["#.O[B/T6[Y*R@M03#P$>X
MWU))-,Z[8SY"+,"<^UT=Y97>@]"FT[0%./3@X:'3#44=#72;:_>/#0C_T"4'
M-`!3!0=\6/H_K4ES\+F0RG&&-[9$?)@Y43K!=<#QL%X%Y'T!F+Q0>!M.T#VY
ML3_$G+A<UF-1:,5*A)P@4K)]D>)(`$0!#Q\B`#`(X$-"A0L9-G3X$&)$B1,I
M5K1X<0(`"PP47/3X_A%D2)$C29;T>`'D!8,0/APX"*"C@@(F:=:T>1-G3I`;
M`"PXN8"!RY<O+PS4*;&`P0H2`3A@<-`#@`<,!1BDP$'#!`(&,RS4`*#KAPHO
M-1PU>_8H!0`3T+9U^Q;N38,-$B;E\`%`@`\/!L3U^Y=BV(L6`@0PV+&M!Z,0
M.X"M2('!TZ$''TR8L/CO`H,S(TI-*.'`AP0)&$J>#$`"0P`0+%00NA)P;-D9
M`!1,+1LW7`\8<NNT`(#N!PX]/R.4(*!W<K@4/#KH*4'"6`!WSW:X';&@Q`H3
M7@^-(&$"RMZT#4I$@("AVO0'$P)8FCUAAXRG\RJWKU,EA`&([_>GB=D__I%^
MNXVGLMH3#;D`%?1+)0-44ZZQI1BZ8($&Z!N@@`(,O.^@#B)2J2'W5#/(0X3:
M@Z`"!>A[:4&<F(M-K0@>0*_%&FT\"P,`"$A(+0L2TNR#`O2ZD4B<ADLPH8P\
M3,XPHS(@C#X%)O!Q0<T`>!$BQQ9JBB$+`?!0``HVZ&[%@P0K$B0$A@1,,\U"
M0Q/..#\:0*JO3(2@/.?DW#,D\A+@P```.%-N`0+P7)$!(M4"X$V(%'"`(3P9
M:@R`!#8PK$SZV.*S(CUE<XXE3D4=-2$O#2(@*H-"^XW45B.JRJ`$&F4,0+/H
M$Z"`",0C,L?R(E)@U@]878B\3*,T:$U7&1IN_E?`'LB+@#.5G;9%"0[20"5?
MQZ*6VX3"^E(B#JAKBP-,81I73E@E&G8A`3ST@%)CAUK`PP>V,JA690%P$+=G
M90JVVX!](ZF!)3]X2F!N&Z/2/H.0Y%-%$SMK**-[Y:VT`@XZ,,#`7@WBE]N,
M>BN(`0H@31CE%CWU:-.4_?LM@OM2E9C/16F$J$(+*)"`SHL!$&`KAA3H"R\H
M]X7(`SJ;11.`I0&SMJI\79X:-P9V_$AJJM_BZ258?;H/@5A%C5<BTRX.K;8#
M%^)Z,I`G/>CA(CE*+J-GM;Z[K0X:$!,##"ZH@(()EFI@4+QO1):`!'`MH&7[
M$C#HNCW9<\B#L'T^_NBN`(Q*>\N?`2@K*7`;FAF`#>!4+SFUU)+0\-9M,G>R
M'1VXVO7::_+`XD3YM#+4A+*]W#N\(M"`-M]#=_O@@PKX>J%G#>*MR,:PS$WD
M#3:T'7N0K,U+@`$((,"``A)=@.CLS;=H3`22:B!L%9F7\Z`*+`=^-0M[1FRH
MJA"`8"J&K#R(80HYR/MLQ("XQ44E!WB*E3ZP@.O)Z8'G2TX$#BA!"WZ@+,R!
MR59\%"@'-,9@<0K=Q02P``2$IB\+,(`!]/(XO5!*`/QC#6.")S2'%2E'66L+
M!6#UDJ>P;D^]NV!OK#5$"S+@25>RF/.&DCP^%>1B,5N(`A+U`-,U\%2<_JM(
M!BIP`0THX("_(1&18(*;#O0*`\,YB-.,.$0*G!`"$XB`C!YP@-"(K(W9,V"O
M(M.314TF(0$@(`[+=,*818LA>%0(%"MXD1*&R"#]JU&@<C,6`B`@8@#,XR;)
MU,2P;9);%=#A>DZ3D$-Y[WMAB0H0F3:42QX@@,`*$;I2U4B+#(=V[1%;C7(4
MPMC41BT],\ST0&G!^2F%>!3P$;LT5LQ113`BQP2+`!!@NB,]1"6^)-)K)`"]
MAN0H1$+$RQA'HD8'8,MC-%.0`*0%&.?D)0.!FDX$@@-!9]8D@AQ@HHX:9P'^
M<&"4]U26!9:GD@`@P(02")TM#U`^-'DI@`WA_LD5%3(`22;$<MK<2=?BUZ(-
MV-(O/QM`:$(W`7&B+Z`"%94%WGF0U*A(I7!BHT=J\[G?6(@Y%6A,LA@2E<;Q
M"G),$6<1%W*HB]9D4?P)$&I2ISS+;46*,1WB[T)C(:D6*:5ERXL%-H`GS0Q$
M,A'Y#;IN1"GD-20!-Q,@0QB9$^D4KC\PI=MI?G/4JV8/`YGT">'NZC*A#``!
M`HA9SVX8D0:<U4:P(BM;)>:2WUSO4.ILGD'46I'?:;0W4:%H;Q3X@`:H<2D_
M[6OKWOB2!X1E9:,-6,$(((&-?6`"PP&6H"8"`&\2R4K$#!%*PM:KHQYDLZ:,
M%00,0X#@,B622]5=_H`BY#W5NFY['_/E`_3B@79:-JO/_:6Q)I+:&]FILB'*
M@/0^0!N>?J`!]53(5H0XGXL<A#1QE>Q?%).E`W!@N7'Q0'RU&YN6Z@A8!>C>
M!R"`G.SVMT@C7!$T&Y*4`_?&(`YU"!49I1##8'8A+KFN52LRG_GBAC;7]0L%
M;KLVU%`R)QRH`.`F(`$Z-L`G47DP@FL"Q=/H)0+GI?&HME<`ZVU`8QUX\%I:
M6;J(Y$C"%`%2EEC9&8/,-#:7Y.5J/+!8FD3W-`,!P(QW7!(.8$`#&]A`!S)@
M.C'!]L-=WM.]1'P1GF#8/T*)ZD-L^Q$M.H0O%NF9:&7S&SA/$#C"T8D&_@(`
M/@,@]"5:_K.:XX(Z1H]J/NH5"8?+^C&)*$#2%/E<1!R09(ALC[\05JJ"\+05
MQ.9$C)[!BY4?C6J0&>P!,]E6JT55+%;3]*0+PI1$O@*!#-PZ1'"N`$B79>GD
M$+5&S@E;?H]B):4:F=8>V<"!@_8!%(L&(7R--I^\-&J1-"9R*C,(@Q-BIX,0
MH,DALNM"<GR1GB6')VV^#YZJDLN<8$#.JB'WMDWB*P,@:6@?P`"Q^;V@0X6:
M)#DZ;H"@N.Z%=!$#&7!`529"`(<G!#X5>1RT+7FRN`"`V7!9.':0=1;+>7Q+
M\B[X2`R#48FUO'@KAY-D`#82[R[(V!5!I$3L_O:0QLRYM@[;F%0,`NR<.)J^
M'H%:G7,2+Y]@)0-^:X_*90X2BF-;(1/?BZ>KWB*HV$1'-Z*3CA\2V(I4!9KU
MF4B8_WN:=!]%LT7*"+[?7A(L3Z9$5.^Z(TTD5_0ZR`+VWON"G"=XDD3EXO;Q
MTJ(_$)6(1D0SMZ741#P\%'P?N@%;R;19!G!J!:GE`@6H^^$G4QC#E.5*@Z<)
MBAFPI@RAU_"J[X^7PFV2K]BH5PA_R%,.[+P!#$!=$)%G_@(@Q0T(.`+G&0"4
M;S+K(HW%`P8PNJVF+_N)F"K"`S#,3/1C?8_N\B8("+E_2E[;?4-D`BI"0+JQ
M/Y0!`,@EY\E6]?N-_O(;_29C#ZFO3BJ`>N^39.-.`SDR[O_ZHU<(+B28JD4L
MQ^@F(+QV0R2("W8.HB,PZU04JRT4)TY`I%(<@OX^H@*V@C>VK`!%0F,&(F,L
MH,H\1`+(K@1Q0XU6`]723#GFH^XB(%!J[L$L``&&[R`,@WP"(-<2XC<TX_&.
MHC%*[$9R1*$8KR0P`/ON@@1?\"84B0H!K6F.XN;NPT\8(@,2P``L1D1"0L%^
ML+CVATY:Z[EH0P/V[RB&#6XH8',^\`H5P@%?9`,NP`)(P_GJL)*^3B<Z$.?"
MKH%D@CYT[]+RXE8N8`(&`,LJ`!%CZBN>I>9,@@,4C$Y"B`#.SP_;Y2`(_JL\
M_*X398-K#(#++$(!`T0H)O`@#L!<*.+NA@*F-*(""D`EV"L#:N^J>`('.3$D
M?L='>$+?1M$.\\5*CHE.8@;9B!$PI$,);^*Q%"2=7D(!HDZ7IN,A,H!]Z","
MY`@OHB*30`[(:&PX,@`"*O$)SRU%U$E+F+'L3*17O)`&W1%'DNLLM&VISBWJ
M?.E>@LLY6+$\$`+D2(>R`$K-AL/^<.("$@!V&,";F(X>(4F`@$X"8B\BS^*=
M+-(F!,`7`6/CQ@_C#$)W&*`!0+%#8&4"`L`'@6\([XD#J*XQ4&0>3:(#_J?H
M\(+YF/'J\(*5&,#S+O(H8O`9;R+F_$.>H.R/_GIH,NQ%`](JDQX@`KRMU:("
M`<#)+3C`<I9"(X"2(>A$@`!D=K@2+BB%SW(B%>]#,H"NW$IR110`WZPE!A%B
M_?8.`!#@<?S"(7E2+->K-G!P7RJ@`0X@9O)L+]N":Q)2)TZ17'+N`RA@&]UO
M+!S``!JJ=`I`V4#.^NHR`89R='`B]0K3)%]"+PJL,/,&N&J',AS`)BFP4!Z`
M-'Q$4,P%)*ON-PJM(^DP(CC`+?%"%R.2`AY%`8"B`1[@`>*((%RP-&M"C=!Q
M:@Q($4U1*"P$`Q9@`PY+$0V"+<YH]&0N1R(F+C(B9F(H.27""L<3)V8&-[FE
M(%BEI?!D+`3`7!K`_M?JD#80$"?&@BVP,3DG8`%T<1G-\R8\!GMT!%E.);(.
M(@(@0#'Y[2O<)?%F$/7*,B)%LR$0!D`#\<D4HB.I)9@$Y=_VQ2!B9D%ESE\2
M0"-S0B5,)P".,"*=@P!"AYCN\D*-),*<,&':1"\,(R?]T&,B\2B^@CD,0.\Z
MT2O;@Y5D:4:A\3"PIS',9B;]$$_HI"5+H@$"(`$4(*TZSS#RDS/=T24$:&D6
M`*Z2U"0,`SFI1L!:<>28L:UTHEA.0X-V=!35#B_$"0)^<B\W="*X1K<,)T<.
MP!H+<V;4\C\PP`(X@`)8YV^TC$7I<<"FKDO&5/7TU"UF!C%[(SU+8DBG_H4`
M[!-.*..7MI,8[X45^X(PR10D?DT>=:0W<V-3[THS;+1(:*,`)`!/24(##L``
MCO`S]U(I\X?`/'44*?4A-$";TG"05.HEO>)&RI%;["0"DI4F#M1IB*PPORP#
M-$!<A&PA6A!5;2)0S.Y;LV1*.65FI+7?UL(Y=.\LR;1*QY4F#.,`UE0V1A24
M'.!,1:4G%L!'2\):SZ,AB@]>D4ZEZ%597M$_B/6>U,)>%Z37..!$18(V0L4G
M&V(`)#0B9%7V)&47709S>J,Z^0TS`V823[7YLG`O#H@`-B\BQB2+GE3U/@E>
M_75R<.-/HXW2NJ4Q'.!2:8)S#F!,"Z!+1R>+_@K@-\*K!+=P9CW",)`6,&BC
M3Q&LEQ)F.#3#:=/UA"),`*HB-<:P(JQE!'>DY^HP9Y<6)#)4.13NT2HL81IC
M`;HOQ<K$)P*`91_B2_&"-`BVC306),AL::S&;$>"LNY#:2E'I<JV6Z*"-&:S
M)#H``C8@@(@G(;#T(CR%2V04J_0+/80Q+0)P`'KG`6X57CT`8]FF/YR+(@S6
M@GAB:%VE4GXF-@P@:B%B[%ZB7/U#=?%)GCZ@,=(";@Z"1K0B<$5"*%HWI.14
MI60P96X69LU25'O*)GO6=31@)=4&)^:#`:X(BNC"9(?WO0CQ/@CPN60V9<;B
M`/X3+GK5([!E==NO_G&F\":VXK@`H"\*@.N\%[E,D?RN-J88=FH:Y'F/HEWO
MZG<"(`1Y2C]OP@`\K5,_`'WQ-^C45SF&PWB+:61=QF/N%RT$=B3X-F"BJU1H
MIC$R=2+^S2%<\0-$$8(G(E7R-3;@4K4>6&#JDTL`0SPG0CKH0W13!OMV5R&*
M4BXJZ"[O=H4KHF;]PT+O*BHJV%7,338LBB(T`*'2"P(40'8E$V/O1C)?(@$D
M8'-T(BG"@\7``S/)MXB#+F)Q0Y#ZBF[OAB?NY2RFA"'Z)DCJ]JXVP,:*CG5S
M(AS=#\W.N"("15@!`]IB:FRI9C@:P`-:U21Z!@$F;H"LC7$K@H1=)@2G_F,X
M=((".L]["L".TLI!D@^0-<U7%B2)DS>+=1;D7/,HQ'`HF.,`T%7_.H`#K$<#
M`#>/RB*3_P+?1EDB/*9ASV)E8\J`#"<J&*``*KFVWL0@Z,4@/P"3:&HRZHF)
M\:9W<R(/'4(#6*(!!AF"K\5&(+*8HN)5IZ4G#F!V2<)M$^*4$^)*+P)/'L`Y
MLJ*&>7=OFU>:$R+6!&A'\-&7'V(KO+D9\=EV&N-!$Z92=O(FHB)4S-B=`_A'
M3,3(RM.(9"PGM$^7%&+`[.6?(P)34CDY!$!Z)2@!)-4A(!I-AF,TJIFFJ.3F
M&`"D%8+#ZE+@$CB/1"=^.:.4OR=8.SI++CB<_CWX;KY"F4EE7S!`@SM8>5U"
M`RH``RK`=`3`CAM".J`(VXIZ:FRZ)NRW+B1&P`B,H"$84Y!W9,(:;SJO=AIC
M1[!:_\J$-*+Y(A['B@YBDL]'JU<O09;,VO3"`?K553I`J+.G*NKZ/HAXB'*$
MK?65`"BZ)G"%48*3)/$5E@E5(I9D`R2`2H)98"8J)PX@0<BW`#I";Q/WJE)%
MEI>*?VTGT%1[^78X)P3@H"N"I;EED9E"82?B<2A@42#``9P'MIC3EU.%L.^#
M@H>HY094+X";)E3SS!2B0CZ"`E""`QH`I1-F[CICMDEY10XFC<_XCZXH=Y-#
M`;I;:PKW;NCW]=[0_I6E+R$.8*K1ZFBR):91QCGH%66A,8X<$P)@+#)\9`&4
M>Y1#YV0TNRTDV':&(YVUYF?2>P8/XP%Z:"`,8+B]I2>NZ`**U';P!,,<CY<!
M')!=PK6)V\#YA)9)(BG.QS#:&>Q4S;F)`ZXKPK"MMW9HX_?@<RC&RVMQ(@*H
M0P,HX$]^),17.&P0@,#A(D?*.6#\['R\\K1%`C\=HCQ&HW+5B5U4>T4TJ)4#
M+2ZYV:1]NOSDQ+RIYIU;1W+?)2,$``IUXBFL#$B0%!5![DD"I<NU)B,<8`+Z
MILS&C#FBXK8EPDNZPB6V-NPXVJ<=0IXFG/PH>W@KYCKA1B?PY+HH:0$4_MWG
M7,E\1GM+L!E?,OH#M@*_DMJ7>R:P>P.Q`3G5:L-<$EPD5`)I:2LR0,(#AE."
ME*0SJILB<F13@#0AF.4X"KTAU$BM-B"[<4.O5_@K"D+!`D#512*2%D.,IL(!
M/!R4?L.^E]TC?N-%<@1Z:`-PS-I[WVE+'OE3$?TCNDG@<$,",`D#[-?:I\8`
M.L(`NOF(741Y3$5W$N"][TGE"AF?U"XIO@4A,-VG0P?<L@A.:".V04*-`C"Q
M[6PS-N-\GH(W#I1.PEOA07$`/(X`(J"Y_=Q$-J!GYM69-@TGDJ*'A,5,]V+.
M_]E4Y!H(1]H_+B#A/Z+]K#6DZ%<!OB+(489._I*Q9QH5&IO,,BLB;(B&3K(V
MM6L'7JBC'6WB=];B=W**O(NXAR-@`\8BWUWF2/#$.8:])/CBT&[Q?'I-(SR;
M?AV@W7$"WV%Q9&6KO;V=6MYT,KI"G&_B`BZ@*WB"=2+`KWUYX\3B.>+=U@,F
M6P#32F.C`W[/<D"=:G*$M]<"5L3WWM*0`0Q&?"B"B&GCBIAE01I^(F+Q)6"3
MK&TBK7R](2RD(Y+/`C#@<6YW:MB&LBQ>+@3E(++>97"'/J;^(]HN1-D975D'
M<Y\%>AIC]/VBR"5BVHKBW#$H`[1L\$OBOTV?(4*G.^ADYE$&`0:@`\P%Z,V"
M`\"C`BR`JR(^`2JD_K?QQ`"^XR@D`P&Z0@(BQD=>'/*8#G;=&>[/.^W=#$L`
MVWKNHF(!XH/`@00+&CR(,*'"A0P;.GP(,:+$B1`-``!`@`.`!Q`$"(!`,:3(
MD0XO>/A00<.$#B1;NGP),^8'``HH6)`Y\*+!"S0_*$#@\*($!``*"%P`(`#.
MI4P+=N"PX<,%!@`&Y)R`\Z+6K3H=&&T*-JS8L2XO&DVP@`&!```TD'T+-Z[<
MN1(!()``8"E5!@<%Y&5PP"&$K5*UWJ2+&"%2KA<%"`2`528!QEJ5/K":.+/F
MS0PG:$5:(`$`!E$YFSZ-.O7,`QP"XRP`X*3!P1\8&("HP>T'#04LL%0]_I=Q
M!@ZP)<PTCO,WPH[`$5YH#IVD1;[1F7K@4#V[:@`'%C18&@$`2(,Z'WS5#KW"
MZ`\=[.;$#B""W`A*T<M&CU_AQ0?Y^_O_3U![!4RUE$8$&.39`A\<<&!F'"@'
MX`8`E":`:QH``-]X,64`P0,/-,```P],8$`"'^!%%P?W`<@B1`,`H&"+,LZ8
M6E7L,641C-A=`!L`&7PP`'\T9H8!A@()<-MC40'@`$6E(?0B93I-X-B05IIF
M@597;LGE6``(@")3!U!6@4`0)-DE7!D`<-@`!VI0I%L`("?1BN1M!68$$A#`
M%P55I@GH6T01@$&@,])F*$Q)?7#>4A<\<!$!_L\-),%WB8JUII0^SO2C3!CX
MI94!V`U4`9J7GAK39*:BFA^3K))TD0:6RF7`K*]FI6FA`$RZ%`4*;(7`CJ[=
M2BQ%>*U7;':P)4L16SK!10%6!U#'[$L89)"!6U%A]QN;8F6IY0/#5DMN0J()
M4&BYJO&D+D1^C1E73PLHT&Y8`)39E`<:$'414`NL&I:*]6:GI:'I^@>`B;<>
M1I%6MGI);P(*0P2!LPD/?-"H`%"PE+YC:J7`80TT*I:=&&_W;*`8^:=`?2<G
MY(%6O))U\4\1B;:1`VS16^Z7W!%@P&1L<0P93A1L-8`&*SK0X,L]?WFI>ZT>
M[/1!A,$5@+_C,E1D_F0"A:>NINL)(-]"H[JXU0$*0,#``DTR5S6Y1XL7-=75
MK15W0CIM+19W'XP,$57D"5EMAQ!((`$%%5APP04L">!U0A`Z%*64']"7=W.3
M,]7CYETZD)=V1V>.4*RL+<7VKV89X!=(7D&DGH:U&9GW`&5O*'$%BRO`0`,-
MR!<FL[KU=W:^SA8?:-;9Q3QSN1X\J5#,>1D`O:*:6N4`P`OAK$".$SO?P5.Y
M96#!200T&9=GI"<[6&RHSEF=:.M;[5CH.&V@P08<J&@G!'PS-)2++$!VU1+;
M=UPE$PTPC"`7X!@%,#._5[W(99>*F>=,$[/JS4]"!\``SW`BL(1$X(,1_ME?
MO22DJ0-2RWH"L4A.\J*>"!+O@@^)T@H390`*UNAA,M0)\A0%E`]0P&X?<,#_
M(F*R9+&D2'3*">%@XL(/6$0V?BF,#//3@21"1"LT[!+S@#,9+:XO*:];"@)M
M5)`"D+`A]A.(!O[4KHV0AV,R$=P'B"(;I%PNB%<\57CN]2J>B!$Q1^M4'X_4
MQJQ0)SX&.<#WHL<89T$PCCSTEDP:$#H$N`R3'U@`'P]I*-!-$E6(.@W\0"D0
MMG"`AR^!T6,(^($$D$PA#;!(`2(P@0,<``&L+"#Z"`)(F2PKEO9+@&,XB4I#
M7>2(B4(69P(`QT.V9T*)5!3/$$@0!3R2(=5L_E<&*H"X^&P`6PE8TB]A\H`J
MV;$VMW'`*)/))9P5*V;#R\R:!CF_6'6S+-=\XE&8B9`N%E!3\JD03B!5@!PI
M8*'ET2$\M_2KIMUJ3?5$#`!Z><7)!$\F?FE;50X0M`#PQS8/!9)9*N.70I$-
M)Z"R'`3>6=(A+>:<KP*=9GX5TV$R16P'`EQ,%3(`6+9$`VI30`8DX``(1"`"
M9<+<3[=$E6C>*JB)N9!`(T@4"?W0)1A@@`,H<+@)*,X"A;I,234H$`S<Y'QR
M41^J0K@^2,'T5?NDF?9`293$P"V9$HH100;#EP%@E"0=\(P`&>;6IUHI1^12
M"UU*65+YW54L$9`H_BHOXK(.1*E,!;CA2U#(%?3%4+%6FLRF"CC8I@"`B,E<
MS"S)(H%M'K)(%YD`S@30*0/XTR73Q&T'-H`S_EA`JJ1ET;&NFJCV--%+?HVI
M5O`5$3J.!%(_G=M%%CB`-;I$--`5"`I1,J'BT@@OQ"76FN!2)-)>+;H5G4@%
M7JN0Y=:F7M.\"-46T-R7(+,@\IO`7,7;G[E]8(')4MM;"'"[F&HD*6@=2W<>
M\H!?J1$!"#A``!R:+$B-9C&2$@@O<<*6@]AT`98%\'\6TX#\)FM78TGL4RW6
MX+!(S"'2HPQ\;Z65R%3`6?(9P"=;J3V<^M3$+.+7*<F5I9(Q4K$U9FU,_B!5
M(0@\R8@0D1"$\,FJB]@)DP=Z0(E;X@#'E,8#)PF`4;Q,Y!;A3+8%9C-,H"G>
MBRA`Q3!1#V/2=::()'A@%]AJ!^@5`/FVA"J:^L!+T\RBCQ&87!MKBD9B#,_&
MU)4DX#)`F7)96T/?^*D?P0GHI&24O2*Z/YEB<;O8M=/(*=:^#$#N1/S2W0'W
MI`%?9H@'&N``5Y]*?P?90%2"M)0L:G&CH\:/:8/9+L?BA-BKS@NAS*@]`73Y
MOPC90.4NHFMEAHZMCZ%7`5*[%!<7&SWU577/:#K4)<=Y>EMM25$.0H`#0>#'
M#'G1`C"``=!AF%CKB5F,)/0=`WA6+*,;=WZ0_J(4+-]*0I">2`#H_-2DM&>G
M7R8`2")07H2HIWJF1NUCZ+2>!\=EM`9'SX7">[+]MB2]1$Y*:R@N$#(_R`(!
M"(Q_(2+NF32O6*Z<B89<B0#MB@75)=>.AJE=+0$,O&'2!;"6)ST2BS$&*-^.
MR$7H2(')P.0I`.K)3`C7$YO%Y0*U+KIJ>E0UC60[(>LT<14[T-ZR:(I>$=CT
M07C"%4,6L)\Y,=$"`,J4"93=[*B1GMXQ5G"1A,?)BJVB4,<2](EDP$VQKA9;
MYE45`Q1@,O[:K5@D1/CL\"MO.1R)U]/\HIDH'(D-$7ND-=6D!M"[)2'^P'4,
MLJ?0QV]E>>OY1`JP_N_B:KT`JW](/>-M'`Y8X*7T^GM),]``I4I`K(MSW-\R
M+I+4F]0@[M1]='X5_.PT'2SMJ7Q#DESL*;K/:)JZ#4D;LABM".#"[\X<XG""
MMYE44]3>%XE)<&)8;E8=:S<2)#<0)P$5&I`!C:,[$S!]19-^JV5W(L$6"?!'
M50$T43%D"Y$4;I)0!]!2XS8<`U$`F(%3!>%4_3<2X_<2?R1H)V,1!J!Y/B,V
M!5-L\`(`!!@4KE$D-V16%,$O<3=JK",0-E40.:>"G`$IX3<C'""$$W$T48(D
MT\(AJZ4_PK8:2[%H]9)7JO45%X(\_%<2%S%9HV9A`G&"!)%X27@:X-)N_C1R
M`8PG$:.SAK;730,P@12Q<_7R*Q8P>V71(.>%@DQH$!VP&'MH</+S`7[A`4^!
M/^#U5\7'ADT1)3I(+#&4)3?!:QK17O%F<$BA'EOH;@T"60+!;`JA82]8<CAC
M.32GAI.H&<>"??62)1Z0)=EU$1DP)NU5@@:G$QL@B5L4`!"0/4R2``C061\P
M`7]H$!O`%H!G<,?2@5MQ($0'BYNA.NO#+B?'&#]$A./F%UV(*X4&-FS4&)K4
M(_77)1!P>*0&==<(%SU2AO6":@[0.UDC`;AT$&<X;L_XCB&1`-KD'34'`;0F
M'^7($%+'&/VW?'LV`80(CV3Q1\PX,`CI$)ID_G!LT0"SV!2Q]1#!6&QAEC:C
M8@%Y&)%B,7JD@WZ#@3YL86X^\8\_56,F:330>)+$)&<Y$CJ">).(\3'KHQ'L
M(34?\%T&H4?CIA7H]ED5P`$2H`'A,P'15R8*8),1"2XI(1`<$(,?0%T]B1C.
M\H0#<UX:82M^L6>SXXNC$9,3(39&L8%>61"UET9Y<8IP23-'%C>H=A$#8`'@
M,GLJAV@^!)(.D8Y;48%%-'@W&3/_HQX50`$0:9>>)A2D<R$#H9,!T(ZIM);.
MU1:T$Q<_&)G`-'`:H3B;&9HN\6D`$Y;)XF)G4P$'P(+:5VRI9XDM(8:1N2B-
MM"OH=YIDT3ZKV2[J_K$B'K",%[%S6H>4>2%T+C$!#N``(*(`0X&,WU&7<@%7
M\T,4X_==O-F;8D%H<E@OZL$2%1!TH8(0.C5J]K5^,E&#RFB:AS28#E%?!$`!
MA,9(UMB=8*%ACX<Q[>$!&K852BE%ZXEH(5:;#,$`O(-)\<$`S2D?CYEF#5>`
MQZ859<-R1`:<P(%VI/-HIJB3<])>\`*.>4&@2V%Q!O&:^4D0&:`6!C`!]X$!
MB:FB+F%G2X<Q%U)1CQ(I!C%_1`8IQ8EV\^@2W$80'CFC"O%&1PH6=O:2)[,F
MAG0?''"6C/*>,B2->*@EN!4655<0$H!T,UJ=2MH2HB&C]<)BTCBE.?&E_O`T
M&1'`:S8(%@2P3<XGI@>!9G6*$]EH`39JIH_!)"EC-57)-0?PD'RR6NIR(41A
M(.LE$P7I.W(&4GS"3OD!C/-CD7CZ$HLQ&`3P(F-"D\UT`!"0`'AS(3\BEU:S
MG!(!6HQ:+:*A.EO!IZ:G*3WUJ:<9IIA*$7:&613:+NV3E,=R;=@T$*=J>IX1
M`$5RH%N"20Y@`1JP8*,1GPQQ`0J`:QRA)Q1``<\!FKCJGG)A?O!(:(MC%W,"
MJ-42?_UR1_&6`!8@`0N0`#N74"_!.V&F(*KX*C&CB,X2``J0K"%QFW5:A]PZ
M$D4Y.K)2I6ER`&$&`9XAI`31E>YV+,_8+I[Q_@`4H(LYME/4EH)VB0&K9X`"
M.Q(_.1.\015K>BH=$`"B@0'L4C$"\3$!8#**2!*K.IGEHA%^\1-<(8JP`E`2
M`)GP6"H@M7D#\"(5)FL@2Z//<A$+>K!<<H$X$P$\X1B3(4L02!"<ZA)K4@`<
M\$W7R2P+UE+&B2UFQ)_*R)$G:624\0$7BK2RRI5)@1$!$*NLPA?\(4@Q\YQT
MHQ[R]8T`Y@%T5"9C<@&9618&H$`6$"T3$`$/<!/<>9H;L+#8NK+RM[:;^88@
M"RY[L@'-JHX8TQ;ZIQ/3U%[B.&I4H3.7*Q+MF0`-.[/1*D.JHP#8@0$FRQZ>
MURZV.R-[&:PE6B[(_EI$F78AYB>SH^87&]"O"<$6`N"!!K!+"(`5"""`D6E8
MEO0!&?"S;9L0M-6Q?'&,%G@RE2D0%LL0:2@2`NHTD_&P,=$>?)I+_[&SQ()W
M&[$B9(>]([$8J-LN00D11UE="U&!K"L1[2&`[Y>?BT%<25J_(:$Z+/@R[4&X
M"&&$,KD0'Y.#R0$`9?B6H>FK`^!5*<8[4G&]"5P0>!?"2O2Y$,:[)O8B-]<K
MB%B$M(L8&9HLTJBV^"G"'WD1T=LN,1,1H".A$4=-=.$`J>J5&_``$E!]&+``
M&O``9=.T"1PE[ULO,2.)I9AF.E&K-TP2-JS%#+%@6;QB"$B83WQ()^BZ_EW<
M$&#SL2U"9LV&OW'TMA`WEP9'%<&+QD:CDU8T)(WX5(9UMF$#DQ=E`1Z28KNU
MB_W()G]\QPY1`:^*$1S#MHM,2_LQ1AUP@5S!0V-RQE<$.N`KR1_I%$P+ISSY
MR0G1/FEZ,I_+>]OCF04Z(5)<R@11/?9I'&W'Q9GSP%MB9Z@\,#'S(ZUL+F3<
M1Q9AO=\:RPOQ:6SB`<B95F5Z,F],(^`"RZ<APX[B(RC4(8^*EV@HS)R,(2=Z
MS!'1`:SX7`.A`3!LE4P1OQQJA69V;0:P.51QO!&$28UCON&\$!-0F!?3LOAL
M$.#"P"=3)`NT3%H$F&F&%SP";OZ<O0NJ%!O+_M"_6ZY.4W[>E2,2L`'65Q`1
M/(0Y6+$1+1([IL<@39291CKWPHV8;)0H-VI$420+3=(*L<;^C$+37"YK@A6)
MLSBR(5N*.FY4\9`Q31$9P!^@]Q\_#$\+AKL#(R%G.17(-A#DBVCA014V+=17
MFQ>.R]`323H\H2&^1L$LZ!E('5-4@11$?-4'(3BW'!/0#(]:$=":D<MRT1Y-
M4FJ8A1!(J,+DNLG^+#B?4C+Y"2YRK!GS;"T3\JP@HW$I#&!LL29EF]8&T0!6
M0<H@#:=I=UH;D,PF31!98MCK\R(.,'V1_1""8]0DC4(`+#F?W1P78C<<P(Y(
MC"`57&R3T0""1]I=_OHE%@,J1J&_6NS"U?-I:-T07-=,B+A51V/5)04;%V`!
MJHW/Y[J0EYK`Q4=;@EHM[=&QE3$`SM*.D$+6)>5"&`#3U9$!K)TWRH=O#/`H
M)B';&"?4A@7&Q*+=M;$`TD@`"F`RX6',Q34F$K*:U>S/MQK+Y9PW]3T05/'`
M10*>BF5DQ$(!Z$TLD)L`#O!#>AW.[>/,7=+@!!$SQD$E6I&P!L""X6&OI"4:
M%K'4,5UC$SW3^"R+R>+6CU$H'PJWU10>+EQ<KSJW($T556NU`J'5#+VC)WWB
M!6$1D*U82($4.@S2)R@AJL;6QVQGA#TPKK(X!0'5+MMHQ485!&"\N4T0_NNT
MS9',T+0E1YESJ!?,'H>QR@-!%$?^5*"34F(^$/NE;@)1V=X5SM)XSV;ZRX$1
M'N'#YOS%V.+UJG$MU!%,-[+<37U=I\[RY^K2'@H2CE('2[\BX7$S&"MLYV:"
M$0K0VP2`))5[U681*!C0W[CA2O:Y%>V(%#/^4(!5`8I<+LMM*`"JME:,Q@^R
M'%KAY`!B`)/N$!+2)`C07!JPAU01W@^%%QQ#D2<#Z4W(`!`05F-5`5C!Z_@<
MOXJ>OX!T,=DRR7.M6.%1DBO^Z6G5S4A;7Z33'CW&%14B7YT\;D118>6=[D)]
MV4Z#MXMH8P8!*;(.3[`V`<2=[U=]<MC-+(MY_B(,0.YX@>NOATD"?O!WS`$Z
MOI=CU*3#P8#93@&P$?')9%H!T.P5W\6VF!!V5L(K]B6DKI`$-6Z3L1@FG^]X
M9^O,@G?+NTMHT3L.P!&(DZUXB,CH3O/Z_N95,P`*_P&_C6A^L0`1T.-%S]"O
MFCDQT^$&(;?%9F1*+_4%'BMY<]`.P8FC)O,AW_6?K*L'OLTN@LZH9!%9(N=G
M'\YHGC=F#A%Q@FC$+/!R3UA[WW]T'S=>-1+Y1V1CT@&$RO>1+3TK3U=^/Q#W
ME&9YQ=*)']//&C<8#A&D*UZBH1%Q3_F2K#K$SBP!L.H/D0">#THXA0!7__F2
MS!9MSRJ>3!),7USR_CSMK0^RJ.XT(E<61._V$LCUN"_"AN$TI^42!P#[]+PK
M&##?PH^]X&+PQ4+@=0$7MX\>D*(X&^[\-\R-NQ_M$X$`-S\2.IXF@W$!`Q#L
MVZ_%C/4RQO\28U]<5#T`UJ_^1RH]WU\L&3RDP4\Z>''Z``'APT""!0T>1)A0
MX4*&#1T^A!A1XD2*%2U>Q)A1XT:.'3T.M`!`I(./)4TV!)#A)``-)UTF!-#A
M)44*`!!\D#E3YTZ>/7W^!!I4:,D%(@%X&)J484B7$P`@U+!!Z42D4PU&L$G@
MJ56N7;U^!1M6;,*0``2T'"O4P("7`#"DA<L0`8`*`$C&Q9M7[UZ^88VJ_NP[
M$T"$EPL"!,8[8+!;Q(T=/X8<6:%(MI([=H@I>,)'#I8O-@"@`($`SZ5-GT8-
M5(#(U!<E+-!Y86M'P*T1<MB@(0.&#`4`2,A0V?9PXL6-&ZS+^OA#NCL!6%AN
MTNAT``=6"T4;7?MV[A45_^Z.L"Y/"@G";WQ07;$"HP;.OX<?7ZA1^0,-2.@Y
MF^$&Z/4)7E!`@J<8$$D#`2KPKSL.<DJPP8TR,,H!!P1"X((/*.#.`_T@J"`#
M"RK(KB,)&G#(-P$B$"``X=XCT$``./!-I`(<I+%&&Q,R0$8`"#3J`.X@T$^`
M!P14SB`/.L!M@]VRVZP#"P?*0"4**#A@+A`9_LA@`@`;H$`""3K00"0@16)`
MK*I\"HF"LK1:C;32I+HQ3CDS,@JSW@!03*#M=BPHI!RI`Q30/P.EKH("!A6)
M@**,(F`ND38```(WPPIQIZ(F`(U'`Z(T[<PY/P75(?K2,P"T`,K4#BL&/P``
MT;D<0`#$!#P@P(`*-BC@``H((!$ZZ#(X<B!/6>U`IJH<D$`!!C1(```",F``
M2-CD8Z```@9(KU4$A@VU6V]3H^^#,)$"X,GH#IC1()$4"*#9,AM@@#304L*J
M*-\@\(`#E3P`T<!FC0H`3Z-BM&M@(7U;P+WX$L#J-^JF_39BB2U;[3`-9VR`
M`#V7"Q-.@A8X`$N1_NIR8#I'"27470`F,*``(!,88`*M-"@S`J2THDZ^N@H(
M&,)6$Z@M3FXG)OJQ9MG*((``)FAVX^-\.P@S&%.:;H!KJT,``0468*`!!QZ`
M(`()U%P-SP\Z,PC"@E;]8%X!WL8POC&=36`U"C#P<4X.ABZZ[[TP`R"`DAD(
MN,CE!HMZ.@W<VWLB#$0R#Z8'B(9P<H_]QCQSKS0TZO$`YM6ON#!A>JXHPBIZ
MW":%0",ZS`<Z<%ISV6<'BO,"BI*`X,N-XYNUHB9O"&V#:A)I@@H>>("!"<X$
M(.[E/."[HI*13Y=VZZ_7">"0&/#```<0C`^T#E8CL:'3#7K\;4"=3^"P_N@Z
MB)ZB]!K8@`#L[\?_(QF)R]<B]CI0#*HZL@#\$.0Y$DL/`ZR6/P8VT"*0LU'3
MG`(QCIRH()R*&(08T!\'=C!S'J@41<)%HT4%3`$>"4G\NA42!13@?!Z$X<0Z
MP,$'`J!Z#L**`;02N8UHZ(5%<PH"6!=#(A)Q?S4BE6)NPI'`::XN%"QB%!O(
M@439B'@1<,`-+Q(F`.RN:*"!P&BD>!`/>'&,1>,<`(#G("`)1`!:E,@%'L">
M5LT.=&P[8QYE%S#WT8A'>+)?1;(%@`;@T6^/,\"DQ((D/382,8!K#HW8LQH(
MP!$B=%PB[1"I&$=VTF]IY&&#BE(F0EID49F<_EV8"&`!2WK2E:$RB@K/0Z0/
M<,TB\UKC[$(R``;\,(\A?"6H2F8V&HUI+N6CR#`%.#LJ]C&8SP05%1]5(]"P
MIS<6R98O,X>9C(42FM^L$1>/8B.Z$*``)ZR(4P``1<V%J4/@A.>-_K6B!$$(
M-`VH'O0ZD)L,=,!#!#D2VC!`)%3*KB87Z%(\%=J@SMGH.W/Y#LHD"H!F70]2
M%:B5%+6YT#D9I:#^D:91\%4!"4S`8PTX`-@B4!0$E*QDK&*GYFI20"FVDJ-Q
M,HKPC+/,ACP.`P*82^PB8KC9U84"#W#F396Z'4>!SSA`DF5!7$2`A%)D3(J4
MG6Q89L:E=I4X\XH._G@@@@$%K.8"NK)(P'0JN\=%X`"A\VI<;6,4IQ(GA1&1
M#:.P"<&*>""7-*+B7>0ZV.$8)::I.4!2&R(@<Y;K(B(Q)$3X9"-(.8`#6"5L
M9BTSPN(<,"(Y+$`!N,H<QE@$2#<2T/?@JEG6.N9/R!S.:252,@)HI:X2@91C
M'^L\-J[S`YAM;7#[\IWC!("F$!GDS"KBLXS4Q$;UFL!'A3O=O/S).)BQZHZ&
M&56$9$MACZ5A@@3D3>HV4`.;<9"CC!,!V$)$0`=0`)`VVI#<1C8BUJF14Q)`
MH/+V-R__0F=AN6N0DK6L>6N%".=&.U3T-J@F=O-OA--"1\6>AHH+5LA!_O/Z
MEHJ(9,`+P<J'EU.7`018PB?VREOIF9H!5-@A6*%`7L,+D?'992.(:U!(?+-B
M%/=8*-LE3B0G,A?\=/$#9LQ``Q;`MJI(\Z][=5!>5>=C*@_E3PHP\6FPLE>!
ML&<#BIE``&134KH:P"D#\$U=>(3AH;8W/H\[P$NK/.>?E`W'J0E`EB/R.U:M
MK`,1N,```%0!#$24,!N0"8?[G#>-R*9!7+0OG25=DO8@N#1&KLBK/J`5@4CI
M`Q,`4P!.!IK7S$@``G*Q:=WL$A$/!5($N,!\)SWK&XND-L"$C&PKHA42J>@#
M#Q!`&#_0(0P8``$$V$!G+`2[#UA@7L?5R&I-_M(XO%!14JFF=;8OHL[2HH8E
M%]%*F;R<$!X]20,(XHT!Q@<LCPQ`L/&AX@,2`&UMU_NQE'EW:1Q]D;F4J6P"
ML,#C")0`(.W,610ED`7*.C*/J*T^F(%`S.P]<8S\R\:H*<"J(\(>!:0'`QR(
M5W7`-)!YS=B`3?1(\^JC(0NTFN(O'XA(6X-IB_RQH@-9`,"?`\D/B)D`"6"=
M#LU2DBW+!U(6$!#,E2Y9HI;&N1A!E&X)TBP*%"Y*B%83?B+@%$65Q&7UL<L"
M@C8Q#RB::&5L+5U38P`]#UDDG_.L01@PI.=P2`&="58M>=L1IL1'0P(QU](%
MCY`TIH:*+C?(OP!^_MN#E`PIZ`H<=4RN$2S+9V7L&7SF$6*4P'L&\QDY&7F-
MQ*?^%012!:`W1P*`^-/@B0%FU[SF"V?IR!2@P1AY*T55GA"6_U%@AS'+L'`M
M/Q[OR0'[CGWL%V53QV!W(T5Y]D(6$($-1``#&[@`M;7"YL<._SC<3'[X-RV2
MR3\&V!M)C@TCM1"5YTLW%["`2IKN$>2'QR8.%__@"W?[S>;;(AJX+/*CO8&0
M,CP1@+<J"L40O8Y8P+`2F?S+O#_9N\@(,?0[`$<[`/O2$-@XMP_P@"<!G+'C
M#.8S#I&3-@BTM]QK/9ZZ"$@)&.5*B`LXIQ)J%J08D\ZC-.YK#0TQ@`WP_C\4
MG#A':3O'@)0!I`C%B!'8*P@/^)R$R*T3Y(@'^*[MD`WI`D+M4$(;^1,1?`P'
M"*2-P`R@8I4AQ`DU`I"6&0!'R2LC9"+^XQB1F`O6N\+(B+0&B1%&DPRIVPC?
MP)DL)`BMV"'D"1OH\`V-\PA(L;_52+TYS#8>$2K'<(J/B)&Y*+\/*(#^&+F"
M$`DVY`@"D#7;.+W,8$1'HC:K6)32(``WQ`AIZH!Y@8`.8(`#0)?:.H!!<0"+
MHPYLZXC1V8XPJ44K',4B*L6IX*(I?`S,P$&,2(X(2`\"P("J6Y<#&(`_.0`.
MXP``E`G,R#B>D#CMH**UP,.OX,1@Q)]A\L/`_M"*C]`0`8!&8&0(SOE$OH/"
MUH"0@#G'J6`\<NR@LGE$Q$C%CU`E5JFJB9"F!BR).-..W/I"?<RV[]!![M"4
M]*DA[*&B`R``,F1(*ALF[WN/;/F`E)I`B-"*)YL)#;A'"[.+!RB^C%0JM-LV
MSDJ0,4D`W*&*!X"1<22[';$6EM2CD]R)+:P1K`"^N'N(DA$UBB+!H@D-DN3)
M&.J`D/P)1V'!^B`2`LE'A:"B`HB;M\,>U4G&INRQ86+*^.`V,8$(A!P(:3HL
MS`D-!5C(TUA$L*01GYE*^:B)&4$`CM1$G?*`N?!)HAD,G(PKEY1+A*`CP=R.
MNK@)OW2(^L.Y>?06_@K(NP]@CPPTQL)$,9$`KOH8LSZ+*@YPPX`)QZE@),?@
MHF;AM@#X2\P4KFRIP_.H"X'0$)=3$L5`3#FA(^H8@+=B32K+%CD,,HKZ@%)Y
MB/0SF0"XRN"ID`J@@`F``+TTCK((H,Z!S-X,KH91`"3)`-W`@$J,CI,1B0>8
M``G`%O5#&2`9I"]A""3A%M#A//GP#0R``'4*`$1<"'VQ3M8"SW6:#LLS"ID9
MF.F`@,))`%P\.*-@@`05C008M>F`E00H%0C0&$3Y2NV0,?>\CH4HEOS4+.*Q
M"0-@@)*9"[]C";=8@+*H"ZVPC@C!&4"#C;@YD@CXDW^)`+<JF`L@$$=!_IZB
M"),8>4CBT`I.(IC7Y%#-(BY6@1#VT,7E@-`2VX"Z>(`+6(`+^#B)>`NTH`#^
MX`"!H(!B.:$V24NSF(NB(-+B8"RHB1'\+-((HZ.!"!/#@"SX\)FG*)<#HXMU
M.JL)&``)\,0YFH[O(J3IR+W(DZ@'P*=`!<[2,``+60R1B,LU;2WBL0_'2H`'
M2%3+R+VW2<#VF`[?:P`+H-((X*"7F8[50(!I-(`$N``$H`!8X0!],<_YXX[M
M04Y`N51(_::&L8^>PPJ#7`X.4(P!4(S$^@#S`(Q#ZZN'T("0.+;BB8\-B!;U
M.YFZQ%7-XJ(/L-$"2(#M@XL)&,L!2@`+L!\)_JC0G0@XG"A3A2BQF3.`!8#.
M:O6J?_%"HVB8=!6*1OD6_@(7`2!3>)TN`RV8.$V+%XD8->()[Z2TIUA2?^TJ
MHQ``F>@,#'"2V_P)"G!'.:E.C>B`Y%P)%\I8AKVI;.'"M-`0BDT0[_&)&7*.
M![`LD`VNLOA8KD@ZS\B`<CT)"+G5A[@`5?P(2"F3U?2*=W79^/@.DTV*BRP-
MZ`D*QZ1#[8K9H84G(OE1JQ!%HA&`G.6*#70`A(7:A6J8?A0+7BP:&32-T*"`
MS837R>RJW'M+N(`OMBS;T719I8TK.EI)L-"0S*F`NPV,ZN``N>W:I>(1>U6*
MB-.<<=JL`XB`M@W<_J7*K:3L"K'"G/'8K`(`N<8=+$?!VI>@W,PI0LL@`'G9
MW&SCV@C[$\(="@18RXEY'-05BZ$S6LSMI#%QW:#H-LT)MLB`E`&H":"%U-)U
M)9G$BQRQGI_2W:$S1-F-IX:IVK%8/^L1`)[]F\#)`,;UBI%5W@8A$INU"K&E
M'2J"#`U1FJ<%BMK-7NT@GHNUBLK#'@4`7N=]([X]WV<JM[AH7DU:6+CHS_F]
M*2F#BPJX3-J17,1X3_[EJ$&:VI\@3OQYG,=P6`/FJ$7YP:Z@(J%52K#%"QL2
M3PA>J"=,BQ%E(*;5BV^T`+3E8%?*%@R>B@%FM01NC8PBX`)`'O[U`.E]_J5L
MB5V=`&'NN(#1?0CP)6#2@,H3=J5_^5:EN#@'"H``C@M5TB$BAJ?DP,BD$&'\
MP3^^P!,(>%0H;J2\4E^A0`#`Q9\T[%O5)%\NCB%E"@M(,=^^.6.E$-^:>%\T
MCB'.F>*=P!<"0UP8*@!J==[FH3DZ]J3DX%[;]6/\L<^]V$0Q%N0\@DFK(!`?
M[A9^Y0NH*>1&)J(U`8LI*Z(KQ@O?D`U)QN2^X2(5KITWGIV5460ZS6%ML^`>
M(Y.O2)@S2I95SA%1'N76B66O"(`AGKC<^IY<[J202C%4KC)Q(@!<%N:(44NO
M4*#8>\)X7.8.@J0V%BX,4&:/"*E#GN8.XAP;_I9=S@F83]G0;A:,E"!BS@F5
M;#9G+H+<QGT[4S9G!E*G=PY<D6@`WYWGKEPG=N9)?);??<:?>?%EY;6A2!9H
MB1C&HA$G[#5HT6+DA.:]S$D=7Y5=9[&`@)9HZ\DM:8;G_-WHO0"AO@@8>?YH
M5@&*5P[IB+!FH)`FC;YG.EUIR;CDKSC2B*GIE5L)JIGI#DJ.+1::;O%H$:(+
MD^YIS$D=HYZU'';AARCIB#YJV5$,H-8V!9C@I$"8/8[J^UD7S6O=KV"-^]UJ
MVH'9V.,EL,ZIL;X?1XR]O/6*D?%GM7X/<9H/F/:D77GK5J%JN9X8+BIHE_BV
MI;I=)*X.8U:H#EC=_J9DQ:"0LZ6JXI1F#;OV*H=N2N+)Z8ZXLZ4:@%;F"'C4
M0[YVHCH!"L/6(PFUBI"R:-">&)&`:J)([6^2#<[66(!1;;*>II^8K+C2UJE0
MY\2N[>C@V`0#C%WN"0A1Z5=R:\+N`'#^[6Z1B;P*@):6")#)K`9@8I^@J,YM
M;K8L)>R6;4<B;8DX$PT8`&9AC>.NUJB(IS22[B64/NOM*@?P;8\X&D#INRA"
M[_E-/\Z('B$CK$3>"4C*&<K>;F\1B>LNB<<A\+"(:X7PF&5-"S+F"3A+"24K
M$((M\+Z9%P204`9``,+@Y@>2[*G8`'B!G`97%^JXXZ08[)<($_XB'@Z8_N,,
MOQ&CX%/J"'''"62\*)O":6WI&-\V2@OOY=S`B;KAI/&^X1R96)G`2<>2J):^
MP`P%4+'@=HFBN!I5'MC\E@@!\?(%8,(237(T@IR`%9@%GP@M5V0"`3:4`PK%
MD(U3BXO&/N=2D8JP'G-=;H^Y0.P`F/'@"6^@D(U!'7&.,(``>!NS@@L-V6N,
MJ(D<&;B`@92FSG/YR"L'Z``$D(#HEE6,@)7``+;<O.J7$'#6CHOD?HG$<A1'
MT8!MJ72)X4,.072SP'#,YO*AB`"M4;/73G#C`=7+'@I]SHB<>!06?O5/X1P(
M."T;6@WFE@BW;`RDT(VS`160[@C%B(`!:&]X_D)QTG50R4NY+R8LHG0.-?)O
M8L2?[PZ_Z9C0[\A"NI4("*'TZ\%FEP!PG>"BMU+W8]<.&6$`"HHLM84(TSXQ
MK<1NBN)U?@<I1Q6,OV:MHN,)D?AJA0<5+LKQF@MTCC+8B'^*<*7X4`D8!,^(
M"Z.RC&\(=S;YCR\.P+'VB=!N%).`'X\VFVATE8>/-$)SBA``^/8OL9:.E:EY
MFS^/9C8).9ZSO=V)GM%JH:<1Z-YV@^`D.O-Y_7D*D6=Z^?B.H)<L*^^O!IZ)
M<=Z]JZ>1U!'WB7@Z25OQC,A0L;<1<9IWA0#1PDS'61G:/P\FSJE&2KMUS0OK
MO6?[N1+.CQ@BN60-_F?\>QJIHH\P+LR4^!8_?/@@DB.FB,=F2/+C^<>W/S?G
MB`HP87(,P<_&_/>PG71F^-!/$)D[83BG*M,'N\`_88E'@*=G_<<@9B*VM=EO
M?:O'7,UT?,V1V*WF2MMO<MG'_<80B:'NVO#<\>+'PJ[V";^O-SB<>N8_#A44
M_DZG_A)T%B@6DZO-_NY0#-V'Y\&`?@>!=Z4H_RO,/:XG1PZ0?*:KBVZ_KK<7
M9I&8;WT<EUK[6WW<]\'B'(!8\&$@P8(&#R),J'`APX8.'T*,*'$BQ8H6(1Z0
M<+&@```?`&C8*'(DR9(F3Z*DZ"$ERY8N7\(T"`"`@I@V;^+,J5.A!X\C_@EX
M!-!A)]&B1H\B3:IT*<0%`!(PC2IU:LL`(47._&B!*M>N7K^"#2N2PTR?8L^B
MC<I!P,BL`%:FC2MW+MVZ(R_,'&!W+]^3`!Q@]3BT+^'"A@]'+8MX,6.#$LQ:
MS!J@0>/*EB]C=CBSID4*4#.#/GJ`[46@'RYP"*UZ-6N[92=$OM!Z-LP,`%);
M#````X*KM'\##UZ4+(``%CT8%ZY\)`/($V<N&"![.?7JUC<V!["AX@(#U[]#
MW!T9@`4.T\&C3X\>0=:*?]7#-P@!@<6.&2)DB(_Y`@;]_A%V),!@$FW@W'_H
M&1@>30=:!A>#!^J6@(,1+?A@>@C01Y%N&3B@_I&%'X+(UTRD260;;IEU<&*(
MFIU'87&WK1BCC&(5,!-L$B60(6@>J#AC0A`DV-"((/E8I)%+S53`1!W`>&1=
M@)EDP80/S92!`!0XF:66-\UTP$0-$+!E<`U0)M%,6(J9IIHE,0D`B0\5..":
MK"7G(@5!SIFGG@D-,-,#$=VY)VL,,&`F`/@).M64B8*677X0"?`9HZ#AF5!9
M`_0XJ5$M:HI97A'UU%^GF$7PII!_$3FJJF(:,).H#EE0Z:J%`5`!1+IAT.2L
MNQ99EIP,$>`AKXQ-(&M!;CTZK+(A]NGE0STMVUB%#744K;4@SN3=0PE(>FUA
MMCW4YP<,_.FMN?`I_D;EHN>ZUJU"-6I`*+OS?O>8>`T]8"R]!FW@FU3@4GN;
M`^6NMM6^!\L$@%X.%>`LPJ[=N-`!'B%0YL,7TPF`D@V1]2K&<N7:$'L<3"#0
M@QW\^G&:"K3'4`1UJBP7`&@JE```^1(<L\Z,S63Q0O?NG!8#82[$L@4F!YVT
M8;H!D&Q"C\W&@<>3WKP04(\)J[36KCW5$`%3AY;!=J,"^?-;%$2\M=IR`:GM
MSVNC!0#2!^F6-MQW.\1!ICHYH#!#3N$=5@5X=C2TPX$C?E`'Z^8T4Z$_^YPX
M50+,71!0@]LJN>9,U6CJ0?K&[&]7&@09P6X:;YXZ4KFVC%"LJG.EP`(+_D@`
MP0<12-`W`,W1#+OO.+%WJ$(`V)VG!F-7-],%$!2[09\:@_Z[]"0%SU/TBTW-
MHP>,M]0!!5<&0!8#"!S.&NDSV5S63`X<8/OT[[O$\L((&;!Q:P04>_E3`.AH
MT^`C9@=]OZD17FP3`)8)!7X*;$F^V.*`!>AN?#8#6V@.J#`()(!I]GM(!YPV
M$7OYA'0#P("[5$.Z`RQ``P(@P`7R!1+B+3"&)>E3`8I5*@8X)5VSL8W`QC4B
MB71P(S:K$0<2T#?.T"8`^<G<!YAD'.[),(JW*LO$#'"!`VS@>]=;3'-:-:(:
M(0\G``#*&,N2,]8TH``VFX`$)M`1CUR@=U*<_N,4!:"!`'1`-Z:+E>=40[L`
M+,`#4"E`!HH'D\%A@``>H`!OA&<2#W3@`IQZ%LHVP`$(9``##HC``0Y0``(0
M8``">.-,(O`!#VP@`AQXP.QR1+[Z@7*43%,?+0'@I00@D8ZZ;$@#%'.G6*D/
MBIBA@/TPP(`!^(8#PH2(!E+4`0D0:G9;L=D"*.,!!]2(`1NPY`4ZL($&,*"%
M"T``!!P`@0(@0`$!F&4M:>F`"G@&`1%8@`"\V,Y[XC.?0WJ1/FD9@5XZ[P,&
MD.,N"WH0!'Z``!9X@`$\(`"$BF5[*=JF!C(@`3E-5`-2NX#8*'"!VD&@`168
M)SV[5(`:W;,!'/BG_@-PZ$I/?G(`Z^PG36MJTYG,4@`HI6*K=`,4W;"3EJT"
M2G2*(P#;6``"WM$+`CIRT0$4B'0.R%6K,M"G]-6REQ)@#Y!L9-"O`L@M!OM`
M`'(%)8.@C""I6:0&(.D`,BU``3DZP``^28!1VE)4&J"`U"+04@8D8`*=7,!)
M[RJ`H/:3E#>]J6+5EX!6-3:?S]/871]C@0#TYG06F`!@@O*!`1C``(B]YT<V
M@*&/F`X"/>E)L2#@0L_6JE@%>.,!=,.>&@4O+S3I$\OLJ;X!#(``$-AF$P=R
MHP-P0$D>>(`'(-B`!T#`M?`$*W4+@A?U/3"WMB1`C?HTVL6"EZ:X/=0`_AK0
MJC4*P`$#0``&!$`6!.+39LUYK`-ZPB1!-J!L`CE`F(2R&Y8UM:O\_&V-6#:X
M6-K&H0,%`)`F=E?HZ89E83+``"S0$?9@LY/\G9CZ=#-*G1*@DW)-`#1AL]:!
MP,62Y?R`V&JR@?Q,X`$/B`#N*$`!"QCL>-7=<4OXZY$#*$"_FV4PD2-`QGQR
M-WP`>,SQV/*6F14(+QZ```.89)O(YJ4YS5&G[;S3-`/4[F:UDIM,YWNS`Q@@
M`0>H``[5YY3.C3&'MJQE4.D:@+H*Q&,3,,`$TMDPEBEU`1H&<@(:,(`@/T`"
M$K"Q!22I`='Q.-(#W-\$#CBQ?#6U+%)E0`$\_@`4NM;RC4X!"@+&&UG%;@"/
M@_M`W\S[T$@AH#F@SLN=@]O)',VN`0[8)`0NFA`/;.5/B68>JR/9QAOS)P./
MUMOB).WL/7FF`.9]0`&&C;8*6``#_4D10E*TE0G(1@*I5``X&?#<!UA`E9+\
M0$4]^.QWPSO>\IXWO>MM;\1`^M[ZWC>_^^WO?P,\X`(?.,$+;O"#(SSA"E\X
MPQON\(=#/.(2GSC%*V[QBV,\XQK?.,<[[O&/@SSD(J<NCT9N\I.C/.4J7SG+
M6^[RE\,\YC*?.<UK;O.;XSSG.M\YSWON\Y\#/>A"'SK1BV[THR,]Z4K?^=Z6
M[O3&8#%P%UCFTZN^I!<*6CWK6M\ZU[ON]:^#/>QB'SO9RV[VLZ,][6I?.]O;
M[O:WPSWN<I\[W4<^UKKC/>]ZWSO+F\[WORL.\((?/.$+;_C#(S[QBE\\XQOO
M^,=#/O*2]W<$"#IYMV/`W4GQ^^77[H$#3++SHA\]Z4MO^M.C/O6J7_W!.)`R
LUL,^]K*?/>UK;_O;XS[WNM\][WOO^]\#/_C"'S[QBV_\XR,_^<HO?$```#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>f39432xe3943239.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943239.gif
M1TE&.#EA[P'A`/<```````@("!`0$!@8&"$A(2DI*3$Q,3DY.4)"0DI*2E)2
M4EI:6F-C8VMK:W-S<WM[>X2$A(R,C)24E)R<G*6EI:VMK;6UM;V]O<;&QL[.
MSM;6UM[>WN?GY^_O[_?W]_______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````[P'A```(_@`_"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!?>C@XDV#-
M@AXR?+@9LZ?/GT"#"AW*<N9-HSB3"N0@8`/1IU"C2IU*5:8#!`0:S+20`$$#
M#A\P3&C``*R'#A$J@.4`8`//JG#CRIU+EVH'`0XR%*#@X<"""@(D?&`P0$)7
M#WT7&!C0@:V&NI`C2YY,.:&'QQ0]$-#@X0&##Q8>4`@\&,*'"P%R-M4PX`*'
M`$XKRYY-NW;0MQ`]#.#L@$$'`P<B$(@PF,+IU!,`'"C0=$-JV]"C2Y_^4S<#
M"@0J:`@@`?`##PDJ_H1-G2&`!@X+-&RGSKZ]>_8>P'+T(*#!`@L[*0"/T*"#
M!*<9+(!8!`,,H$`'O[VGX((,-HB0!UK9)%!-%$[X00=N6>C@AAQV"!UN'H8H
MXHA#>8!!;CNEN--;2%UXXD-Y<6#:AF>1:..-&ND$408,1-"!0*&]B%@%%1CU
M0`$U<2#?0(@Q&<`%'DQPE(0=@1B3DCAF>9*5#7I@P`,&.!`E`0X(<,$'"PAP
MP'`>`!:`>-@9R$%G"A#PXDYF;C`!:!,LH(!3'EC08VP9<4"HEHB^]Z.(%QCP
MP086].4`!PF(F0`#)A8@$`4)G#4`!AL0(`%X9MIDI@4'H"D`!0TH\$$&_@94
MH$"GB=9JJY9<>;"!!G<9D,`!HP(;EJ8?/."J!0`@D$``Q%6*TVZH>L"`:=@5
MBT`%92YZZ[;<<MC!;@LT@"8$$`J&@'$8T/I``A]LAT$&#6``WIXV#<!!M,)B
MYX$#7S[P'75<=BOPK1,8Z!:L`B30`7CBI2L0!`-DX(&?#0R`W[4\W05IJL!Z
M0`$";2;`P00%:!N=R0.GO&V+B#6YXLL7\HK8!!%DB,&2$_)U[P<5Z(3!`Q<N
M,``"=TH7L,I()_W1PBJ['-)E2D<]U=$/4:VEU1=1C;747'OT0-%=7X1S24Z'
M;;9(?1$GV]92L8W1G&?'_72LLV4H]]V)'@K2_K5X]UU7V;6Z+9$'?,\FN-\W
MQE?5X7,A@!_BD$=>V4P)8":YK8!O26)C`%=^^:V9FQ0?XQ^REX".GZ<N=8UK
M(X"ZZK![2#IM7M(;^^T.,BV[`9_-CCNB;G/>GMT=>E"`8&VWB+:&OV.DNT.^
MSQ7]Y`:H#17AM%+))$VY41!!!!.\OCS>TS<_DI?6/^6<`$N.SF394T)OX`$(
M6$PV`@X,7'Y<4.ZD7M@&L-U3#',\@3```0$0V0<BD"8$/`8"#C@=6@PPJK!`
MJ0*/PXFF$`,!`07J`1/X40<TD($)F"4L$H#;62CP&-QT0%XS^=;8;(4@!AF%
M`^)+6E^,<SU@00!3_A\@`*88\!D$'$`##P#9`08@'@@@X`(%*%(%"#`!`>1P
M)W:Z0*-&=8$!..``KL*`<A1P@!\]@``*$`"Y.%``!!1`0`71"_T0A```S(A;
MH3/?7`R00:(XAP`#8)_Q(@5%\`#-.1LX@&EV^`$'B.D#"0``\@S"%@4L@`#F
M^<"]X`6R#-A+-QCX%I2(N,!."J!H$R-7>#0Y`+WI\95H.T`?A_*`(V(@BL:#
M4ZH28)H+".`W^/%2D?B#&`4$()B4',!,.&"G5Q&@*ZG2"Q8O@($![&0"F%I6
M`080@*)]2R<_?!1L8$E.DAQ`/$_AP`!XN"[=)(`K@DD``3)@2?KPL`']_N'C
MF!Q0@#F%DB#JK,DYQ^4!"*3*`AO<C9<NT`%G&;0Q$<#9#B<6`<2TDD1Y+"=E
M^H).HKRP)AVP0`<"X!D>"I&7/[)`;-!3O9T\(%)IH=2A.O#(#TS`-!8P`'#>
MB0%7@<<M)"M``,242`48<6P3.``#^AF?BXX(91I=FV8Z.K5&:FM?\MJ>A>+'
M/.W=I(9=10Q6'O"I"9$01!JH@+:@&M6V6J0OLZ0*3_97D9RXAFUT=6NBL@J3
MO>CUKX!-RCJOUU60<'4C&=5>8!>K$,T(\'P3>0!9'N"`]'V$`Q10P*000P%7
M9J8A6&*L:+4J$"J*;H8-Z2!PII4BELVUM5K=_@K8P!.F!!C@+`HX4V%5I**C
ML(BW.`&.4GZ;U]$63[&-%8C>'/O9B!QN)A`P3DTHP`"UZBHT-:U``QP03$BE
M92=Z68#)-+:3>%WH1Q_,@%,09`&^S&0#%8!`;'(R`0MP1B`8D(#$#K*=`,@'
M,9%ZU'X%$E+4(M>X60I4^"AT,R[=9#O/(]PDG<M6@DS@OAB)``\_8)B/D>N2
M'=1*!M3X@%_2-@((D-(MQ6L3!"B``OOUDG$BH`"((2D"0TW``C0I``8T`$DV
M+4`##@"`.47@`&>\XT`TL%T%B*<O9.H,`BXIL0R@<;`*J3""1P2!`J119TLD
M`,A"P\&%H5@!)\+`_B];O&&<<`!*1KD,TQ17H2;-Q*^9\8`$*NH`'FKFQ0[8
M\0),HX%4!:H")0;+Z:(T(P14U"8=H.X`#@"6`DCL`#HQC)X%M(';!BJMC"&<
M<;:S`:9<>`+L*LBW*"`!G]*M`_/L0`.`=B]**7G+`JN>!JX29%DKTXD7(D`'
M1FPL)%F``+RM'8@06H!YMJN.!1#9!?*W`0<LS`$$8-,'+,TX67?S`]$U2@&0
MW(`]-8`X4_1`HQ8@@4\:X$S\$<BYXXBIL\3*>!)S]@1`)MG+(*D#"#!``X2=
M2W%N``,!\/(;WX(:(S+F`PA8BP`$$,CO='I-0,.U_@*9;7$A`&A=]$`$_MC%
M1LZR2MC'3O9P:&(`"G1@`9B*@`$XP`#_[OLT_][+B)UBZ<PT``!:T?.&'?``
MS(JK1R92Y@/$2P&%$@`_$?C,!VJ<,8OEA`!0,H"\9ITN!(#[,QH@@,<,,,+;
M%DMD$3`QUB_S:"8I(.,)D%(!8F.`#(24+PSX3MZ+J_'V'&!/%MA3H,>T+TQM
M`$G5]/%M<SI7(0/W-``@P&*\KH`]53/27K\\SQBP`/]Z"6P/L4`"T8L!W3XJ
M`0(HP(E>^BI7:6";OLH?`TZT9X%\T60%S;87$;,`B6T@X&(6.;DV@"DV%D"G
MQ&DH`9CSHPIXN3`%\64+.?4;'1D4*U#"CC%+_M9W@4UQB<:QP``&#C((Q$H!
MRF3`@<ZH9Z\71($&V8``(H`!"N`]?Q6`#;`K<-MJOI3@6C<1:C9S[R,A2%%G
M9T$A![A5."%G%5(LXY<=+H,4!58C#T!2`G=#H&(0+3,ARI,3$'!"]0=6D<-W
M9/-XE*$!G340&4!9!X`8_$)TND(`J0<L?0)<#!`@1=)BE1(F']!T$K!$'I,=
MQQ<H6)=V=F<G;A,JFP$4ZF8!H&<9&%`!?(4[T9-88F-8TJ(`)@@3N)$30+.`
M,=-:*-,7`@``=J1J?<(7UT1$8L=A"6!_Y34`"?``?&8YT"-/<",4<_6`'(B"
ML-.%&&&"'C`KR2*(_GQ($2.&A@"0/TIA$QSP+\SCAQ'1`0S@;%01`1+P`.32
M?7\H/1G`B'XVB;`EAE.R@''66ZJ(BJ786JS(B@Q(B0]89SL1*HSX*:;HBAHR
MBX#($(A1,?U#%1"`A@$P8)Y(8'1ABP$``,!Q`$I%1)RG`)8T*PF`3Y;4`)<"
MC7X"<T1$=`S@2`X@`31#,QH&`>8(0FEA?ZP&`1,@`7OV/1``/JQFAS_D%YQW
M*48EC0FPC\J2`+.B+$2T``*IC[-&60Z`3YOHCC+'B`"0`!)``?1(`1/0C@H9
M`1#0`!!@`412`>HXD1=`A1@`*AB@`=1D*+NB`;LR)PAB9@$@)0G8,@D(_EQ<
M-9-4$C\=*)-==7AHV(3'*!EBU)`5<%,6J8D2X`#M&`%$!T&<:([QZ(X.``$*
M:9#^LI24A93G"$';15G^8HX.8$D6Z6,^EI04``$/4`$,($^2MP`'T(QDA`#]
MZ(_2N``)$&VV943TXY;[2$;["!P$P)!*A9?[N);'=WP&('EK4B`"`$@#D&W9
M=GR8%``"`)F127$!L(R5.7$3!YD`$`"`1(.`-'$T*``Z50"D:0!OZ8_*<HW<
MR'E^HH_2N%T'B4\!F7JMN0!&272.-!9022!H^!4].1DTY2A'\UJ?V(O)A2*%
M%3"DHRO+R(P51IRRV(`4(A\8HB2-L9(4D(;J_I$!4&@!%V`!WDE-(5E?$T`!
M&TDDX%D!W[-G[CB1#RD!$%`!"AF/]!F/(`1"ZL@?3RF0@V9,:/B"A/6;#@%P
MMB(!._E?+'%X7%B<K\6+R5F`T8F3LR@MRWAK?(B(4=4!J1(X#XF)QAD2&DJ`
M<1$?"_!8JJ,\$T%7&'I@!/%ZF+,34>2!*=$9`H"'B_,!Y78[)J(KGE4U6C81
M/SH?/8H8;/2A3Q4Q+3$:52@7"C!AJ1-V3!97$.$]&]$!KE(2&>"(!B$6&J``
MZ%$B$842K&,9S;02@-%V=.%H?<,RN\BC]+<3C3$G&[`P*VF="*(D>`J5C:$>
M2L*C*8FG)KDK='H6_@BR`0=BG3")&'2Z,/'!`2MY7AL0J==9:G>*IUEZDB24
M`1E0>AJ9`/675D1B?Q>@J1E``2%Y`>>1`1H`*I'JJ.JUDK"*('&6J!THACL!
M1&*Z$)H1A=RS(G7:6]LYG7=::I$*&`S`&1GBJ&`5'Y$:J5M%JZT(B%8SK?-6
MG$IS2^.6;6L)2&Y9F-F6>L!!F=Q$<1,72)@9`-QTF0"0F9N)F>Y*<6B8F:")
MF.Y:F8%4(/B*KYA)FI`)F8L92)=IKN8:F959L.C*F8N9F`7RF/;Z3(4)L*4I
M>:G'F!3'<<MG`*))L)?9F?HJFMY*FLMW?/O8%4#V$\YQ11PX)ZAZ%63D_J43
M$FC2>%\OYV)NJ2P&P(QJF8WRY&)PY"7\6!;*95N^\BMR21:\)`''ZB,'46H+
M\3P*@0!.BHQ2,VR:JAZ12G\5L`%CZ1EJ*5^^-ZKW@@`G>7#PA4,*P&?AHH(;
M$`$:4!88$DH=<`$B,Z>-,9(;X$0FQ`%'1*@/L`$74&KG@5F"D@%J\;<XU(*J
MVEDCB2#V]Q5S"B^AQ`"[0J@:$"D_XP"1*F>-\43JY18D"2$A"#7TQQF[YG(6
MP`$(``$CV0`D::A0:)8:Z1MYT0`\(HX)%Q2A:%GGPT9E=!IW<AX%(2Z[%5M&
MNA/?LQ`6@+(3TA\-,&&((0'":Q!6:J-OA:M&_C,ZG!%IDBL!'7!AL\9$?ZMN
MYFDH\9*#$Y!?'!!1#K1G7R$!*,EY%_``EI@!%14N.>ARVJ%A+]5>-$>%WQF'
MZ3NXD_*:=_MR/&*H&+``&,"ZO5>B";`!E<-""CR7>2&V#:`?Q`<F&#!["7`!
M7NJI1LD`<KL!"P`FQ$<!BO'`@?<7$_`=7FJJV7&LK@-C"E/"7;D`462'QV9V
MI-C#AP6=7A56SA%@/;R+I$63S--0<[<4>ZB*'%;$C^>@S,,!@D&<#/B(;D&"
M,]'";&H4N_:!1TR\6[6@TS$Q%.``ZODS%R"VE,)N`F!)]`2["GP`;RRW7"&W
M\0M&&(!DCN-`"Z`G_BB\P!M\)!9PP0Q`,Z."C9);/^6+'FU+Q9&8`0D@<R6$
M'A=P'4?BJ==170_`(Q=`NR)\0'_\P)([I_N;=K,2D@'2`5/$`!:@P*.L)T@;
MOY]<?U0X?AJ6``.P`)],`!"`(08@7MMUP070ML2W`=ME92"#IZV*7C`YJ$2Z
M*(G*J';6BM!*AJMB*"BI@N^RJ=^I1>FYD100>!5`3::J1=^ID>?97@Q@1Q\Y
MA1@$A1RPS:I*N)O:S1QP,X:BS>J1J0=W,RB9`?.,DAO`G1J@NMY<>AC@G3T3
MJ?T<J\LD`3?#JMO9>YH:DID5@DI2T"Q$0LQ<J'&ZSYAZSZ=J`8YCC+9!_B2@
MPLH8T)6&ZLGEL2HPYLKT=SH1=RUBVUGR*0`F#1P:P,M'=CJ\S,OQR8EE66XM
M?%/^TE,9X#@630#ID;<OM\&!5FT+G`$9^<<7W+PC!)]:!\K[IB0M5ZJ@XCT9
M7'<-L,:7?'CP%2`_;0%=R4?<:Y8]8JK`LL&)],@JK*%9BBHD'(\8>0`M'8]G
MV)>6N9F2B9D8RQR+&9KY^J^)29H@VVR*:9INM!@&0)B270`,V=F>S9#-N9F(
M_=FD3=JA38RE?=JFC=J'38S-J=JBW=J,>*Z1'9F=#=N,B-NY;;"BS9"3#`&6
M))`^)ED_UF<K*A/>(R]9JP`EI`$FU`")=):[_O;35XT5]X%FF/85Z]:V$-#!
M(LS`''G)9(E^9SR1FLA=>W&L$Y`5AJH!,S?!"7S)#F`QN14ON_G&\7539QP:
ME]S2W`G=>ENZP\8`K885A,L558L!`H<!].<Z$'`!4!E=XWS('0!"V9$7R^'*
MJ">Y.,S<@S8MJI?6"M``O'-LB'V9[HJODN=&A-F,-:N8(!NRS3:9-#X`7O::
MJTD6">1(4PE!_`ES^$064W:0??NW$RF08"2;:N*60A,`"P`^[?A%#TXDY\2)
M$=!>6A1?K#:1ZO@7XPR>WWF^U/12]M=>]@6>&JG`(?DNX)D!J%K"&"2.]D>4
M6(G1(6D!%AGF:_Z1_@]I?QR)Y^]Y`>79'7)N?Q>)DRMBO1]2:^?KYDHE*!=0
MHB9=`&L=DO<Q`8V"`8[SX&A6;I3N)T1SOD>RR:\,X8A&%H@,E=#+>6*QQJJ,
M?O=17>[;>]A2OH("D=B$`>SXCD5Y0-K5TA101H11WVNK`*H'/B]&N[#,UKP\
M>R*\;[*DD1)``)R8O@%DEH?WR;`2()(\,D,VV`:EP>&R`,KAJ*6F0KT5MQ+S
M9A,@)K0XH3>I;D[3(J_!%VXA4CJ"HLEV0O%S`9,D?I;E,4MB;<L4DI5[%JN:
M;`[AJ/&7<4QB.2&X$^CT3PD1OZ\S,BJ%//&Q,)*(7)^<9>XG'2/TG0]`_LL-
M4`'IP4`1MT1ED8/7_7($(-B>>@`7<$Y^PL$5<#HB?``DK)Z?+%(5@RW>(U^J
MJT@*W'3]T1A']$ZG4]^CP5`D_/,0$X<$KHGT-WOP+0'LQDS$5WH<4'GQ*&8=
M_!5/U'1$<T3,32Z:>/+-VR/WLL=CH>D)X]Z[S"/UH6<T9NP!LL:'1P#RYWX>
MTT]`0L;`7?+UH59AU:L3LL!(H?7BYQ0;``#$P:,NLZG$IUX>^&0$4="EF(!=
ME'%[6%#W!1YS=B'B@O#T(N\I:<W1NA-STA<(.B$_,GL%H6%_:!1H+,WQ$6@Z
MP0&L^T!XF!.H!->-!:#3@>7CK%T#8``D7*IZ_I(FA/O3!U?AG7:WZ:(!3W2V
M9J++E$XT/^;'J)K&\7@!$NG<]%>T:\OWVB%/@OTU1$,D$<")LF*>9^P963J6
MJMY!F%M=9HEIAP<0"2AD\+!!P0$,$!P0P,``@P(-&S@8R-"`0P4-"BX\6%"`
MPH,*'0H\L+A@`(0,$`=H:(`AP88$&0YH8$!A0(8($3`TH,!@`P,'%P@H\)"R
M0``,'SYD@-!!J8</'CQPB*K4ZE6L6*%ZT*B4@X<(%3A<@+H!0(6G5K=&Y<#!
MZ0<+&T!:4-NA@P<,'30HW8!!PP`#3CU`>&#UP08/%#P4L*OA0H8%A=-V4.``
M*H<-$3)HF+!`[P2]_HC;;N4@`<*'#@+(4JWZ\P."#%<]+%"LU4(%!PL90(C@
M0`$$PA`F.&#`0(*#"0IB6R68E8*#K+(91*=>W?IU[-FUJQ5+0<*%"@LP++CP
MH?(&"@$8<'B@`<).F`8T(L"`8".%"`L<R*2@8#P%`S1XH+<*,(+```(D,*VG
M"RC8H(`*(MC``@+H6T"#`SIP0(,-^WH@@02XHF"!"BRPP`,$%IC@@0E8NF`"
M^ABP@*"/&/@+`P[H^B`"LB0XX(*Q'EN``P84:,""!%C"P`'O*+A``PH@2$""
MOC:`S3,,"E@@`PH(2,""@Q[(P`$+&DA@``D2B,"`!A1`@`,"%O@`@@+Z_IK*
M`@K>4DJDP+:[RJZG+MA`*8VV>H`L"P"@0#M#J6S.@PD^F,"OBZSJ@``"OHKJ
M,:6&&S0J`[ZBH"T]-ZU@(*PVN``#@CB`L@(,)#!@T+LLN"NBFG*$"K4*$"-`
MS\0$RBH"".R[@+X*(.")@@(C+/$["BCX$JH.,-!1M@:@JXXF/[OU]MMN,9@@
MPKPX>$F#"`:S8(((!.`@W2<5F.``"0K(Z(($&MI(`=6ZI(B\^N25@+WA5F31
M`@7':Z@`!6`"D$,.'$``H@=T7:`WX3AHX`+@)(A``0L>D(""V[@<X``+(/CH
M`88D6``"/#O0>(&05\0,`YT:@("`"U8ED8$)_B8"*H(',"``S&,%L-$GU60\
M(*4+#."X``,FL-H"\I)LH($,!&B@H*2BLB"`7[&*Z%L/6-YU;4`UZ`#(#RY0
MU#G6KHITUSV7BPJOO.#RH`$!"I1JKZT&6SN!NZ3:NRY@U?IJK:HTP*"@GJJZ
MH(,))%B;*JIFZUQL`\)6*ZH$'ICMLD$]2'9=#SIX``*I&MC+/-.KPEM9ZS98
M`&]O(;<=7."WP^NB0R'0J`$%*VI(`/(:Z(`\"<?[\@$+',H`@PIVRP"!GH:+
M@(#LE36-Q0$(B$`"!B"[0`$._&O1@00T^K*`BK"NF:8"(M`@`X_YQZ#J"?3D
M([#R#]$DD#D(["]P_GZ)$@1@U0`#/(!Z#+@`3S[&@/!<@$03$(Z8'N"Z!+2D
M`BC20$R*HY,'L&DG"(``QP(8@0+4RP$&*-V0$("`K'A``GH+GJ4^)1NKO,PJ
M<EM4#K%B%\3(YH?7^\!7[/(``$3``IJ!4F,2\T&E:,!>I\EBI-Z%@2+FS5(5
M$!,/E9(!MXAN,ZI*UP<J`!&[+.8N&7`*!\03'101Q`&#VL``!M6^I'@@-Y,S
MSZ[>8IH,9"!U$FB`=32P.W#M90.640H%9M=#3%)'=QN1RFQX0ZP-5JA!9<K>
MO0@`)3`EZST5,-\#!&``":RK/\A)64X20B`'-&0\.&&`O2XV*X<0J6)!_KI`
M!`(HL@F\J`(9J("9)I!*\AAG``W(W+@,4(`&T2:1MP$1!ZFVHC(%D`$"F,"1
M5&2:+#&@`1'*@`$JD``[%@`!6(,`.1T`IXI,@``<-``"'*"R"S@D)@4XP`("
M(*>X\3%;L\S)`LB32:7@R%9/R8]4*C`WQ?&N*AV`P(2JXA4N>L`"HF,`%"6S
MMW%I8(H<@``'\J*``O"N(A;IY%4BP``]`2E6U^J4!CA0Q*DX1"D3K<"DR&B^
M=D8@*@X1:>V><JC?%`8"#)"BZ[15O0.H2FJWHLH&).<6#[A'`M:!#"9+!5&T
M9B6@0'H1A'C#RC<IH$)E^M@;`RK!AN`&.,*Y_AB,+N"`"IAFGT2+4IF$@H!U
M'N"=&FKG0V`5/WQA8``XLX`#&"DR3!ES8^2ACP%ZDKV4R&6=$V``I,B8'P&$
M!:<10)X'X@>2_!2(`A@X5`:`EIGL$0=KZ.FG@#Q`$?I82601B-^II+8NG12`
M`0LP``,,`!P;3N<#V1J,Y@KBE@Y(1'%H79ND1N@!(MZ%+!_=U%J@@J/1Q:V[
MZ?D5WB[ST:9HH'5Q>DM8(_`Y\O[.O/5MXN>ZF\74J<4#3^,*!S&`D-9=,BIU
MI$S[%)``X*!H;ZI["'@&Y=-=$:0@#CA?=50'R;0*+\39P<R%&H:0GEE`4!\X
M``)XU*(HC>@!`V"7_@082+T#3',"!$4@*:F'$I<BIP$30I)<.D"!D:PJ`PP)
M&DTR,$4*7"W*FGF;Y&BF@`B&)R-E(M+%GL,2CV3@2YY)5]4X!ACDA:0HDFV`
MR&8+GP,8#TEV].D&-A"GD$E@`!@[VG`(,-L!1(8"LBLM!1/P(P`@M)-OBHY>
M-`K1M3FF`@%@UP8B%978".;([L7*D]RK@0`@0+X>4XOF**J@$6:(HLZEFJ:H
MQ#LD/9J0Z]R*Z)C3'-D<@"HGNDL"RM.!L6+%+7!1TP=&=(`$,.DA"Z!781Z=
M%059)SS/'C$>JWV=N_2%*K\Q$8HFQ0`$4*0I-K;Q>"!@F@I<()8)/,QX_HIZ
M0`<<0+.2>Q&1I@H?"4T`)@+J50(C)A(PELA!(YU8,C?0@73G"60E8<F8>#(F
M#&#O/11:Y08"*X$.-*`W&:@Q&?_Z4PX\,WTZ6X\E)R`?<7%@)C![R,@B9FD-
M(*#&*"&.`R*C@"@I1VFH<5.X>0@9`P2=?9-":T`#%12>C:YUF+'XD[,;5MYU
M4E.H:7'GDJ@5J&!1*:6]BH#LO!6,C^5$;#&O4D:HE=FM90/+P5L'#/!?^T2%
M9++!`&)<)I;^?D7-.4K28[I[W0EL)7/47@K7KSUB4X,++P4I"E[B.*?):21H
ML>ED02CXMK&H-`,/4*?1,K<9IC#S>G:.2"+7_F[G:AW<(78>D:O>UE'4MZ4M
M'&N,S,KU@`VY2B)VWE@90][1);5%NR!14,>R6W>.+R"6BES[9OS3%C0N0"+9
M=4!CLA1`"N&H`D^;4XEL]K4-<:1KI7U7X2;C-M)TE+R<3DMZU]9)MWDEJ.,M
MW`0H+_72HS$J?D'-IU2N:LSX"L+ACDTS#(3;%2BQE/>KBO:QBR=Y"V;*+ZBX
M',?XG8BS"ISBB\G9D*6@B>U*BZ!ZD[K#G+:`@,C0'[!B%?E:"LQ`#1T:*_83
MF]/XK_5KOQI,K_:+P?^"G*ACCKNXBP5CE`(H``%XI0(8@``8@"$T@%<R`+(9
M`"@\B@"8P@``@`$H_L(BO$(BG$("(!L",`#`$(`<N\+RP10NI)HEO,)7@D(!
M4,(O)``!*`!,(8`CQ)0HG,,C',(VE$,$R<(D))LMO,(I+)_R8<(V)(`HE$."
M.@`#.(`60P`009"3H<-K@D,H1$0!H,-,))M,%$.J"8`$8,(!0(`XA$,BK,0N
M5"Z':H`B>;`$6(`'*XZ)40`C00#GHD4020!(O*$;<D1'#+IP(Z@S&4($D$-'
M!`PE7,("2`!Y4JY>[">J";>@HQHZ/!-D2X`N_$(P##<$&`I>9$0$T9+(@``H
M+*D'*$;:>(#?4)"<^!@'>!W\R`T.NRD"X##>V"N%>$=;G"IU>IG>()96_LJ6
MD7FN<_0-!2`6X'B6;.F,0&/%-B$`%'L;W*.I+"J^ERF6TL&]W"")K1D0R3`-
M$RRB#F`M5BR.!5`G=?HGC71(O2&MK7F+GRB.Y3K)%ML:=7*OQ-B5AC@`G/L`
M1CJKZO`JGW(]NT"BT`&Y+CD1S&B,R<(1-!K!TM@+B*"6P3BXUOE!D6JC(Y,9
M!YR<M8.DUE&JUI&*.`H9K!S+M-$PF;&3^]H/NZ@LB4B@HH24.Y.(MA@I#8@(
M.[,6')$9V=L]V6N+<BF([`I`Z.N9B$NDS=!+NY0]F7D2Q<Q+TK.S1`K,MO`I
MMQ'*O%S,B`C,HN3*_>&`Z]F,B/.I7DD]O[0S_E>1G(A#OC5*33A1E`,``"I!
M#-L#D@!4E8BHEI+!")4JD-NP&ICQ#JL)H&B)LKDP$0D(+'&1@(.,%@<J$1/I
MF551S@`R3MDB&7HZGP`2N"A#H+W*B]8T/=1(B@[(`"!I'8+0"+]`3Y88"!-1
M,2=I3061BC72+J?0"["J,[W(RZ'$+B"<L*OT2Z:[E8C8S+ISJ;_T*E@)BU[!
MBP:I&^O(.%HL#A"11AIZL&Y$@`/@"73)$\<`B9:*,AS1'XW0(">)"`I`+#L)
M"8L8%QS!D99H"H<(/*:P`-%4N;K3`+$`#V-[G;01*0'Y@`VQ")R:B@^HF,'X
MBC%QB\K($8D0E!1Q_L1D6RX%<"B93$D':`!;5,?X*0X-58`!P#(R;:X%R$64
MC!];!+=&5``&B)_X<=,4.;1&3`!P.X!E]$5'[,4;.C0X)2A:/$D(DL-BK--'
ME,/X<2@WQ4:(=%,NY=(XA46'.DDCV9K<`+<!````$(!$X[SEXDD&&-,,90!&
MY,F38;:@:ZY9Y%!DZ\4]39&97(!P`Q%PT\6"DH]7A,96C,4B:1,L.X`WO5):
M=!-Y6BY(#"&9M$=IQ)1,!,-*#(`XE$-$),,#2,(O3,-2]))=Y,53%(``P%-%
M),0VS,(C5,)K&D(^I)IK2D(L!$,X1)`6HT-,649(9$2"&@!=I*%$I2HW_I44
MJP%*#_L`B?@HTIB*/+D`-)$<DKF>"$(7,H(Y,[$(%_N.%K$1_Q`/O_BGP$F`
M9+DI/P.:``(?X-@)C`B9=/LK&*DL]H":6]PEZ;,(`Z@>F7BDXO@?F*B/AWF[
M=[$.#"B/Z@!"J:B^FH(45Q$48QH5)!HOL/*J@^N`'[E*L/JHI].OR[@D7'N*
M'T2-L0@KF<DH6]D*F.FHJ*L-V5C!JXA-3:V3#P@DJQ#`BS`OQ!C:!6L^`HTC
M^$LD^<JNQORZRG.;K_"JNL-1S@@:]40C_^0]'KVO%<D2E3H2QV"2"_&IPSBX
MAIF*9=)+`5&DB)B*_6'%D;J>NNO9F+@I.G(;_I7J*#I:2E=YG:443Z\*BJY5
MI*6;ODY*'(Q8,+HPI)&L/N=IOX=`FQP)F;8-)!NA$.4;`(T9CNP!$PM`@`P2
MM0,`D`V``)Z4%O;`UR59'SQ1)O*XC0NP%=P8H1UJ#\W9/,VYK[K#*<#".(OZ
M7@%A*<=`/@]0IT=R&^=,FWN2KX.+I0+`GJ])"\H;*I4"VJ=@VUT1VJ=HO*DX
M.-O9C,1(S]^9WK\#P1RDX+5801XDV`6CBF+2E!6DGK1;O[&KX+@9$TT]X709
M%`B.BB0"NPI`@`TP-:EP%8&-EJWX(:@XC@^$BA74KK2HOJJXP+/=FQ':T:<8
M$I<JB,`K`+=0#(%+_A(W;:ED<KOVP!.7JAB$Z5$@:0XIVHR02PRJ0Q@R0XVW
MR9-J:;SLNIP6.:`)&14"6SP5*\^>=:*GN*>HV*,&+HW'"+;SPHOI(#Q-PC#!
MD(JF/1(`41D!.+B\4(P!4DU6\:KS<0OI8Q5%PE&=<HR\C!F_P!&_I:*^N*^U
M##NO(E#LX=PZ*P@5J9;*1",E_93EF]]APS25FPT%R+:^)-#)Y%PTTHO/E!F8
MT8IR0B<6EIS\Q"X[*V+^B3_94+.Q[$_ABPM5B;ULLZ3`W#T[:SK%!%T'T8!K
MJKL2V4S0_5PTJA+2`P]./6$`"``5&REH%DJ\G<MQ!A3%0*)3P=JHN[JK_B`D
MV2`+I]J_K,",P@$OKT+8O'2+%7':HN`20=DCV@`KP8B)RF,\[SB[@G4>33$_
M\+6_3E*5W9F<RI.4'!7`UI'@;-.+!0N\.$H<\+*5M230S0":G@7=!BFFTHI?
M0+:*\=@:GF3&+[Q2DE`(@B)"`>!0="V?)817#JW$,YG%!Q.`7/Q26YS&4'RP
M@S`)60U%1&1&!!A3@F*N1F1"B+PA>)4G2OSJ0SL`I^9&1(S&4>1)1S1#.JR,
M876HD[%36F1%!RB`W%B`H9C48JT07`S%6813AZI26!Q69@S4@RA6$*'J!6#%
M*WW%F91)0<V6;/'6R'@=X"":XM@:S]Y(C22,_@%9``#X)P61QVQY1R/YI)Q0
M",)`YQ-&GGF\*75*;<YC$Z!HKJVQQ:M&5X:!U<@&-S,!BLX^TY/<U0<[4WD:
M5ERL4%F]QE",4YX&``;`E!:CH5#A$0MPCT=JZ\6&2*>&1@[%,HAD1JIAQ&)\
MI4.KUU(=Q7#D4`[%QD?$;F2K:SI$UP/`%,'V4UK,;S>)TV%EQ"L];)E$K)$X
MTS8K*>!8+F`['X!MM'2YE;C=%=GA"I$B+45VB[\**PE`%T6""_S@"MP$C2'#
M(D?CN);2GQ?]"GD9B`PH@,";BI:RO;18J1$JCQ.!$NL"+VH9D@!FEJFH/L60
MBKS($*)#BUU!C&5:_KOA:!(G*ISF^*XFZEH!$QNTQ!M"HA:E(F,;E)DG&[NN
M;9U<`X`*P5,"B-M>(M9PLY4'($(E+$(O`8`&@,4C;-4"4$J^#M?4Z@]TKD+:
M1(FKP&$6%EC*(!S62*`)/)$9EI!7.Y&^6,[R`*_.$9.UH,#RJW*\:&$LMR/A
MNPP)P*'+&)7U$`N"*'58WK\S7A?GV:[+F1/0$)0![8#22HX81Q?'>!O;F>&R
M0PQ+`XW'F8K!P33>L9;$P!P>CYN_P@@$*(BH$`O<4#P*O@KVK>7`HADN^8B`
MXA+TY+B?6A\.`5;;N@@CV8F,@`PDB1`-"1D@OQCLL2W.4!46[14`U2:Y_M`5
M.MJC/;*_CGKA]+DOE:IE#9*<"!C)BV&,<4E2S1"P2&>;HMA?@VMV(+Q=V5`1
MI2BFN-&1@AB4'.<BLYNMJ[@>J4.L<YLBK"4HYOG"`"@6R(BW(TP`VG23P,'3
M`7"`0`N`@U``LGFP+CR,:.&9DQ``EX'M`;@`3NUG[.`*UJ!!&P.BW[D9JV2^
M*N&=H+'-KKNTCQH5M=B`JD'X"GIAIX@+#&D^6^$:1Y>WHE#0HM&)9\IA0%&`
M)3\@R6F=`T".BKD<(0^\KQMXC/@:5LD3'$VNVQBK[&HIEKJ+P%.+"T&,1&J*
M=(&(_1`72T*,F%V1X,%ZOD@7D8(*,INA_`B9_BRY4O6)B>K[I_0)G0N1$1AV
MB/3YW@_IWU49K98"'XL`D%QJ&)S2B-ERB)/LWQU*GQ.1%8>(`/P8F7+'.!LI
MJMB'C-FJG\`((+P@"'&Y"D[!Z;V@X>VJ@",T$?[229]5P*=0#IQN),<QZ1S2
M,//#"PFP0]JNQU/RB*I!D]0B@`;XLP`@0EN$J:&O[PN`\9GO4#P%"`D!""BH
M$```0@0%'BQ`2(&"`@X>.'3PX.$#!0P7/G#\X"'!10X7.'S8</&#!`P>/US8
MT/$B3(X8*H3D8*$#1YH6%KCD&--CA0P=?;Y,,*!BAP@6&BP8T*`"A0P')&C@
M\$`#!@X1-D3`<,!"_@0($B)(N/#`0(()&"),L/"`I@(*%28XT.!@0P,."39(
M:!!!PP(-$B0@V'`APP(,$"B<;9"!+`4(B]<.SM"!@@0+#"XLJ&AQYH8)#`(W
MV,``KX8*""@0P(#!P(3(F#$4@##T-N[;&RA0[`@8YP$-'E8_0"#A`(8%%AQ4
M2`"8@P/$%S10&(#A;((,%B8F4("!008.=B<TL*!A^00)$"Y`,,"`P^"(G3DH
M"'Q:08:Z#R0\\.#@.V.BC0?!!!/L5T`"FDT`00(%9$`!`T\]H-8"#`R@P`0;
M;>#26"=]T$$'>=U6@6TG7?1`2S1Y-`$'$Y!%%$SFF?@2!`UXZ--&0WF`_E-/
MMWG`6T,.#,!:`P%<@$``"$#`0`0#J#8!`E`J,``#!%PP0%\7U*:``PE08(`%
MK5DIP``!T(80``5@0(`%`S@`0`03D43!!AS(M5D%1'6P@$423.`2;R5)T-H'
M&"!`DDP4)("31QU(U-E+'U[0``$1K&1!5LR=)!%'%N2Y4@<&;"B!!QK$>0!Y
MR6EP@5ST(1;980E`,*$#%KAEP6*V5J#>0Q$@\%8$%S"`05X*$.1K!@IHT,!W
MG%F@`*XD6H``>RDY0$$$%1A;U@(+;E#7KXXY,.E,'2BP06(1<*#<N`DDAP%F
M%2CU``:7.9`;OCK>2!1'/'EP0%)J(;!`LAHD_E#<8WH]B^NL>V*0T@,9%*!9
M5!L0N&=:#D207P7#JID`?`S0"0$'"&B`W[`;/^"``1?\">P$%1C0``013$A!
M>HE!8`$'N\J%P9!^2J!M!`;\:$%)PJUT&X@W[C@42>#YF&$&*F:`@*<;5)0!
M7QH,E4'##7C-T8,Z*M<C1W9^\$!D!#P@0`(V;^:V`!.4J>0!#:R&P*\%-#=0
M!NZQ.8!41U)@7)<-,``!F@"(%H$"".0]`6XA,6H>5\GQNW0$#$C0**,^E;IT
M1XC"N!T#'FZ0@:EQ>K2`NN)=M!9%!""%[@,<.-6Q11<XP$$&&'@G@0.9%4#5
M7<5'5D`#XSJ0'GDG_D_J\K3$8@!R7P3C]T`"6*^768$9'$S!4AC4&C$$'DR0
MWW4>;%#!`1DP&S$#'2`F-@/+@<6J`AU4.H$"((`!#50-=_DZX$X\-",/5`!$
M!NC`63;@+N<LH#T:$&!Y%.`[!`C@`A8X0`&F]P"V7<!E#8@-8S"CEK8PRU@,
M$$QS'M0SOIF/,\F)C`5BQH#T8*8!7M(*!4X8'02(3`(X<X"5`#,8QOR+`@+8
MS04\D`'*+<U$)=O(OCSB`0QXH'XPXDBM1#<GN7P@-=NY@*,FDCH/H+%R.GKC
MASK"``44P&X9((#X(K"`!QP@`AUTD@"\XD($1.``"3"``Q"`H0.,,(`&_H``
M`2@0``D4H#H&0$C+*BF``"C`B"_A2TJ^1A/@->`!'6#1AA#E`119)E)#Z0`$
M*N+*DX32`S;B%P<`5KI27:!_'[#51`H0NL=<@``26(!-DA:Q:P7E84?2R(,J
M`)9LD<J#VVD@)5\8)XT$A@(+T-@+28,M>5G,9[%!@#1-69;_&.``%5C64A[3
M@0H$15B`V<!V(D*!59J%1)2$'SVOPBR%O.4!!\07`U6YJ@^T"%X%X!,"($BY
M!"2&)XRY2P,XLZNQ0.!:3FH`A"8PL<$\("Q_.20$R+DSGNSEA158@'.8$YP(
M>)-$!2I`02S`JH==I8@[49`>YR*TXI6*`"E-_M\J(T"`#3S`5E?9P,,\0C*?
MO`\CH?/(T#SR'H]XT"(ZZ@`6^=4!E60D3QQ0DT:\"J,LEO$B'1C;!QKR@,4U
MX(3H),`$$L"`O3+@`0/HGE/^2$G&!4``#G"0D]A4R00P!0+&,8`!`K`3!@C`
M`)$4P'9>,A*GC=4B._2`>8+G`$9IL(TPL=2FN.BZH2S41&>+U%ME^46/".<"
M`3"H1S#`(@$@(`,B`]$+!\B<6S6%=3%;0&0JX+;^["PH&?B(P5JDE_Q8((0@
M78"PHM@@>2V(FMYDC#UKE='_O)!K5RE+1/?)`<5H@`&(7(OY+/"0G7#``+NJ
MJT2^I8$"W.N@N9GG_@8(R$"/=$XS6GL@87()@<3PAP`58(YK4HJN<U7`20;*
M3/&,^"`!FB]8Y*NH!OB8'4\90`/"$=X$/!`L*8KEPAD8BX$F950.,`NYF_D5
M@4AE@-40*X@8T"F;"*#B!EY@)@F@B8H3*H$Z,=1#&6AJ3\Y5Q@.03"5DBPO2
MN#J?KG(D3AN8RJZ$)1/S(5$H*UGE`SUBYK@*P(D7$)4QZVB`M_E1D@P(0`*Z
M%R&].J4``A@480HPF@8(`))7<FPA]58="`A```HXB`.\FH'PY$:^).FOFBGM
MD;PDY5JTA<F.4LQ%'3E'1_%#T8Y.$BR+G:0#!\AOB0Z0(P_,[+`B.0S/_E0R
M$;&LREWE06:&=-O7S3@&`WA9W;FF*$]H=4R/>`1/L!9#T]VX92UU))9IA`56
M!3B&8!4PC6ZQ!5572<"W#T*C!8;&%0,<9SV=2=^ZX(-I__J(:SV)B11!B\>X
M><I!FV%/U<J3D8A5`$4;((!@M,.`.HYE:+[3P,RR);+<O;.WP\)51BF@`3Q:
MJVK[!"!OIKD46]K)=TO!F9>P9>RQ?$!BI`(K@RCYY'?_)(Z'H2(L?UP14^'D
M(EY\6LN'PN33XH0#)HG4=USRDZUY"E%H[-F].Z(E`!26``A2`!\9\E@)/)*B
M!?#S!`R+TX,0(`$`2`!F(QD`"-PV;SB]T)\%_O```BR@[`68I$U<??0/69FA
M)>&=U-TWD0:$D*%P?6X']CIJ3GF&/`LD)*.^[9.U+(U$[G/='1FE/CH)FLN1
MHLZ/J4.`NA!P.N]<7'_L!U9PS=.>`L16:W;H&*@&4=KOT\Z.)H,N\[GF.T_&
M=G1:U++P3$0X'NCD>DWEHCHMX`/U<Q%-&M@`6'Z.WKG)T4OV^0%1'1\PB[)3
M<$5JOFB.BR\&V&<"W+F=I%P@)<_5:02NE1^MI&9'BL2G5XZ-3PA4!5YV2C>+
M:(?VO5B"8`1\15I?54#[J4]P51EH>8`$G!7.[--=L%%8:=&L2<2/+9YZ;56D
M<(KJU-PL$4L6V<^,_FB1T9$12Y3$`I`)`@!6<!P``0R``13``````2!'89')
M``P`W0F&(NU5A922-UV+(BE`?2S`DM&)7_&-0AB``*!6'+V$TUB$F7D(%W&`
M5O3$WH%*%''$2-!'_#2*6VT'GZR$L44*`^%;VGB$,#4*JW1`1*7&IY@(BE1`
M&FX3!%F$!8!-+*7-1%C$QD"0H[B$HZ3.`Y",QHV5$6U@5@S0!?P%3%"$9>S$
M]'%-!+S5>0!<`U%B%PD%&UD`/FU1_,0%>PA>4L"8];V2@!G=%M6+H]`'/F4B
M@9@8!5P`'JZ,9`S&KF`*A$P:7AU&D96;?.&B4*T&^62(IZR<=ES'Q@"/_F*L
M5X`E'U<4V6%,V@!=4-78B6$$6`*D1)%Y@%AHX3O5"8CTH='@BM'UG!;=!*<L
MC65H3=-4A`(8P',Q$$Z,E2M-0!J=&3]^"`:Q"JA=Q'E8A%LYBF<8'50)!44L
M1@=P10:,Q(88AHF!GD9D!59`%:9`V*K,1/"X!E;H5#D6V:J\D_V$!SF^!P9P
M33::V$>BI*/`(KY9Q"E)Q(RP8Q5Y%3M*A$VL3W"8EN;YA`:`2!51#JV!3:G(
M2Q<)QU#*I)S\R,M%($V"2%6<1B9JX8Z`2`/)XT0@Y`"8G!9JS;(P!T)2A-&-
M!)U,I`881FG427A,AUO6"?"LSF&4QD-JQS+._H6AN,Q@I!OD0`D5K>('0!(!
M0%8-IDD`!(!E!0!."<`"R&`!$(!B6I8-[A@($0!FSJ#5^1ED'8!GEMT+=D=]
M3,F.H85G'@#?Y&!WS.#7%8!EM9-GNB:9\"!F?EVCE8EB\B"9$(``U*9K#H0/
MWJ;5:68`U%UA0N'76=T`]"9F-MHF)>8.)N9F(L``',`"7%)U;I)>5<@"(*%1
M4)0#1`ZWZ0T!(,E#(2$"6%9O@I``%(`,;F9D:J8/^B`#>!T-HN8,]F!\9J9[
M^F`[(0!F!@`-1H@`>&8-0I9[>B;?Y-EERN"!0J$"6&=3'$`-QF=KUJ`,]J"`
MZJ8+NB=D#<P!C*9J_N;9:#B`WCP4@H0H$GIF]P3``;1G>@[`UQG``E2(`J"=
M$R)`72E.H[E'Y.Q88AJ`#PJHC$)A#U+=D?*@#V)FF<CH<K;G9K8G9"WI<MY=
MF;#F</8F;)[F<FYH#VXF;PHH;VX2F9)):[KFC.;@ASIAGAF``A@6$NY57550
M6@BFCX@.C%10%ZE/GCPE0V66%JT$^6B5AYP2O\`$/WK5C'SA%AFE1RC=6E&$
M9[B519B$08(:!10E%[W5I6:ET:RE!"UD\.A116BAI++?UJP.$Z&1MJS.>OV8
M$=E*;$#%2Y'/+6)+E]#4`T@0J)IJ>(`(L&X-DGG57#`0=O6'%EF$35;1_H<H
MJD742.X,QT\(GAJ6Q'.]A*L5BE"DSYDQ5.A,9;),I*F.8T:5C$8\Q$K2DS3I
M5`G-!#@&SW0T0`12#W:YAJ<@!E3<(CW9RDZ4T`2T3'6!352<BZG&(HA`%0$1
MT(-%)`&=JF5T*DS4BT><ZHZ8!`2`HD_\!;,JJZ*>V88@A5H99+>N!`B.[(G$
M$1L6CYWFQH_<B%\<'P1EF?UP!/FPU:!^`$ATA,7@2\3@2_45RJ<PU,_>1BCE
MAFWD!MH8($NH2.`A@`<$!@<P`-/@%FY$Q6U0GKNXR-6N&=%>5:&8$D(V@(^0
M"M)F64>LQ9$$&+=VQ&7DR[Y,@-MD!0'@QAGB_L9,^(C1*.">WL94X09BX$9;
MH,2CX(;IC.W;RH4"M-R\<41@^LBG)-Z'."T>:HL;L:S7=L3TL>S0LI9ME(:.
M+!G+'BUN>!"^]"'+1IKF/BT$PE4@>MK*RI85GMF/=,:B8%?K>L1#&.0\SA-O
MU)?(\ERPQN)5'&RGQM(Y9NI4)NNE:MS3=&R*.:M%#"51K,>'O&.R'H!IO`]N
MM1KR^H@HD@Y8?$"D:2T6SAJ,>-&9L4<?%D;S5='GG.#(`D5FT`13.>MZ72H9
MJD336$3D0$"`#4!6,@J?R-*E5LVT#L"$P$6WJABDQ@2K18I2#`=3&<#FD*TK
M?4"*\6T426U^3&OW_GZ@HTJM!Q@3?_RMZ#R(`IW9V)S@/X[@!>\(%_DOZ>QJ
MM;($J!'%6C*K\NJ+%"W-I()5O&&*T8G'CU'+RE88@JJG?A8`DG!;@0[$BTJF
M#`IG#SKIF&KHA4;F@>;G#`IG956HE3XI#7[=E^IG%?.F<EI69O*FD);GA0Z$
M8;(Q"*&%$\9FFB`($GDGW\B@Y%#HURD2W'0/1:6?CEI=>HY&=_J0QHS0"#D`
M@?219$2`)#^F`\`4R^SH:!A+C2+AC7;/'AOH8BI$>E;6<O;@<S+I8MY=%R^G
M9,)Q`C#F)HVQ8KIFA4+G<!KFW3TFWPR`0F!F#19I?/+QBT8H3-6'>[0'_H`B
M\,J8:`,<0(0P14E)1HW4E0-4L]XHP,+UA8\VDGM5\S/+*0,H2?.XS:,5AW4*
MFA":YZR,D%A0@`,P@'4*X2:[UPO6<7KB,HUV<IMRT']R*2BWIG!2)VRJ,9/Z
MIQ.VYVD.-!0F,2VW4P[BF7OF67=TQU>N;+-2A/OPS!!S@%B$R-5DH55PC1%)
M*L76[-/JR4;TW/Z2RHUXQDV`2,P8I#2&I1;"--=HH8E-Y._4-+`^(*C]QVY$
MH*1"U04<0*F8&$\HI$C$TEJR#C;F#U:44"1N#%9TU(_M*_1YT%P4"``9D;I"
M1'D$S^&XQJ1-V@2`:H"-FTYA]+.^;P<LAYR`_HB=*&ML585$\K0/967=:M%>
M7^J&=&O)J+2-3.I@FJ5<&MM8D_6DR6OPO$\(M:MK1(5\R<6^IIM4_]BS7.QT
MU`B_:D2ZS80"VDI4))>GR)JBL&2_4@"J8,N1N4C#.3(\K\P>-<_*H!-/.XIH
M521:BP?/[$7P5H!-IEHL#B554H2)K:2XFF5L(<6D[BWI?(A)\,E-^(AC6'2D
M[.STDLH.!8=/E,4'S`6^I!1'&'5'/`:^(!/+2BWN!B:\7/#:K+".+*X<W<8+
ML43C.A\'N$U(+"X)WND?Q@2)=/?:7H1W;ZP%PT3[E1'_]747P1$#F2WC&I3[
M,,9M@`V^B"VI@8D"_@X`;B``OJB@S@*`<.!$^PY%W\X(0^R+V&`%0QW`R-[2
MQK9O3+Q%2%@>4<#'M'($7[A5`A2*"+M/?W3%2B#K&W46%?9+%DV$I3SW=W\.
M3^@(D3/-DOM(L.!+*Q'N7@]%^QB-B-`WUUJW5>A(E-27JTA=G"Q&>"-O`:C.
ME-_&D^.&N71$@70$6YSWEW=$E+]$XA9%%/D)?=<7%P'YC3Q9>'LM9J3-XMQ(
M4^'+H=Q&>KA/:2PN?6@NA&.PNDB1>MR(6?R7TYI-B=G?OJ1.I66JT*WYZAP?
M;G3Y;3B`B]]&:>ADC]-WOG@X?:?;/"G);2P+OBAEY+8<`XP+C=7*E*^2_DA4
MK>BZ.;Z$^:C36M)F>>E0[6W0U(7#%=3`>(4;E-'XDHXHBW6S%K0_+?DX+<&4
MC@*((ZE3N:Z1MTP<^U"@KX_L.4:<NY_GQKC#>8G+NH=@%TH,[?'ETD28Q^):
MN-%Z[6!TA+Q`.?;=AK;[!/F^5:R_Q+T/Q:(/A2JR!+M'8FY,^FT(*1YFJZFQ
ME;1_3:SO"(8/Q>_D1C.GNJV0S=S>B'I73L3'U15F"]/$/,V2K1RVG+^P1#-?
MU0(81^&6A*C3+5LI.VZDV[]0N^KFAEW@B\96CKM7NY6G&`7O18=?[LIN.E'X
M"01Z@(.\1.J@>6X(^0<(@(>PQWD'/4=X/$H$_N:\X\:PI+?<0[Q)'#K$<X``
M<(JN?TV;FSC!!Z;-*'JE8V[AJIB7L9"/O+R.B/=01,9)&,B-A"_A/KQ/R"!2
MM/I0&,VH7^W#3[K+LA6K4[>N39F/Y'F[AWK?4;C0V3P#'6T']+CF<,1^4>U%
M:,PWZ@;FZXBU0PVT#X5\?4!A*#Q;38K3WSE'9"Z<EWR%?TX!X+>/6'VW@^&\
M?<1;1-+7$W[^L"Q(700`2QV[=X2SKWVKBZ/;W[<<]9V.*'Y1*#R'W+>RM,RJ
M$#]K];U/Y(ZC\X9!A064#SY'+#SC`L0"#A$46&CP`2%"#PX\)'0HH8)##Q,@
M)+P@P>$'"Q0R)E30_C"AAP0%.'SH8`!DP@0I'4:8D%%#`H4=#F9LP!)AAP4'
M.C;`X*&A!@49/?#L^,$#`IP*,"A$4-&AAIH=*T!H2/.#!@(3K@K0(/$EAZ]1
M91YET.$HAP='-7(\@-;A`K@9-T#M*"$#VP9S'79P<-2#!@D=>#+`*;(D6\4=
M,3!TF*!"!*4+\B:L$#GBT0@6$!Y(B<%JQZ)\$W98B3#"!<L8S385S8"M88<,
MODZ0P!(!!I0>(&1PG!!#!,`1QB:D6&'#APH46#[@?%1N1@H",VRX`#LD5M$0
M7">$L!8I!MD6.7;L,%2B@@(-*1C(J!/PA.X(.7CFP$`!>H<W.W)8(),E_@4$
MD*"I#<H*:0&VDL+))Z0\6*"\A#;XZR@+P,L@0:$0TL`!`3#((`,,1%S@`@M,
MM*`Z#"K0+R.ETJ*PHPM>>BNCZ!BS*R,"]2(M)QP=NB""#88:[['B%CM2`_`4
MDH"ACQ*83P,&-L,)(>X:<L^BEU[CT20$$GI`-80DT+*GY,Q+\#66%JB-*X<.
MV("GA@S*R`(?$VJ``Y9L@VLCB9RC\@,;$XJ@`@\LB$"\C-0"5`(C>5O+@PKJ
MS.BBHTQ[3[V&,O`R(R);"E-"I3S`P"^<'.!QH0,5:H"""=`2DB4/6)3(Q?U4
MZZ"#"")$:`,EZ60NJP0I&"H#!1X8(()D'6B`_H$')HC``0><_:X!&#/ZZ"@-
M[$3(@I<0Z(`E_AAC[:[Y9N-R`^PZRF`"#H82M\@CY<T*1P\*X.PC!N83J8'*
M.D(4(2P1P@#8CKX%3#8/)`!U@EU#.A6PWR0",*$U/YC@.84H,RHK=3<,K2,&
M$DN(@@@\B"`#"0I&Z`%_;<))`HPVL`"#J9!2:SB7/WB@@I)&O<VA"GPMS>,/
MZB/@*SB)*CHA"3(>V`"X/!CZ`XB)<@`VEASH+B:BX*T1J=D6L("##71EJ5>V
M^OP@W0\H6"M$#00PTP-P)W@`Z`]DU(`#:Q\#-#BV*O"6-*J12IFM"716R`)`
M,P`Y(PPD,-`#3Q%2_L#,>8E2:(."&V(`7UGI1LK"O!IBB3ND/`N;X+`ELNKT
MD!8:]#D/*`#5]:H32ZEND$%JJ%Z1L\K3]0S.`XD#<1LR^_>0(O"9Y(4]>%PX
MUR=7Z.77(^I`@PBR1DJ##K3DW>T-8O\`@@(BZ!>"ZD%2L?FP,W/]`00*W33^
M!^)OJ`+3);R75!50%T@>@);F3<1F#;$80@2(/:38#'L>4!Y"%H`7#F3`)0[4
M0)M<UY`+<"0PL*F*C"Z``?N%)P$=F%;8+F"^2I%/@H#I``@=Z($2?B!A86M<
M2"14F?,I9V3G(U784B(8(F*O;%-ST!%E-3+-@6\#4=Q`!I"C@>H\CC.&_CE`
M!BS0OPR4*`$4`%&(,'`!,S9`4A:P7Q<)MC41E=&,%6@`S3:@`0QH`(^2"]$%
M&M"NZM`1CU8$$0845T<-;*!L480`'L<HH@M4H$1=O(#]-GB!,1ZRA*LSV@+J
M6,<+0H`#N.H`!TC)@0N$$EQ`H<!@0MF^NIUN`ZG,W0>^QIN(7``"%#`,N$9Y
M02("A9=U$Z5?]%<W"D``D7G,@`:$B2M2:L`"AK1B8U:W@0)8DHX;^)`@0<2]
MACFS;'+T0"PQL(!7BI("I<P34'K'SE3N!3B&`8J#?B(U[*7R=)6;H@8N<IL\
M@4LL#FIF!^Z(*UQ^0#P<&%QD3D7014X..4")_L`"Y/B3E*0R`U3R@$)[&4J@
M<``#>3(GKL+'`;(ETI!D%-$RN4=*#$3QD(P<Y$K-6*+EX(6+7&R8!"+`TP1$
MX`'M<U:T&E``+AW)A`A`0`(2@``!$`"J!BA``+(H00,HE:D*0$``#K"``B3@
M``G8R0$(<%4""&`D!=!J60W0U@.\%0$#,`!3$Y"?`MQ5K@>0:@&P6M:Z%N"J
M@#5`7I4JU:LBP``*2(!A#PO7OBXUK`2XJP'(JM:$<&``2Y7L70GPU@,`5@"A
M%8!<!6L``4S@`LR4P``*((#)$F``DD4`7]]J6L!RE@`!*)2V+A!:UHZVM8QM
MJP%@6P#/OG4`$:(`_E0+L-FH4I:X@(UK;*$J6R\!I;-*16P"RJK7V;J5M8'E
MJP"FXH&V%F```PB```)P5N;"-K0`6*]\`S```20&I/5]:FL%0-_AWA6O@F5O
M;HNSVN:^5JZ2E>IG^2M9^P[V`!JX3`7:&X#UJE<`!FBO:2V<7M=2]ZRC72][
M67M6#>MWM&7%:UD#4%K*EG6I2\V/`ABL5\\JU:]:50\!%,M6QR)`L77-CU@7
MP``&-*`!"C#`!!+P`"=38#D50,D3)>*0#6#D=Z##H>BJ++S<\<],X]FH#QU8
M*`<Z2'\(P1A(P'5FX+69B3]QLVI^!\JL).<S'/`2+V&TO(C$[G0]RPAJ_L,&
M`=C5#8^(1"0I<;6!-3&ZCA#`,D'/$LP.F-F!"F4F]G+9M(SELX,U+,T#Y.(`
MRD4P<[D+'P\3I1!YIF0PKNME8]AI$IWX+(2,YN4%`"W*!\TSE;1IFIE/IP'F
MG$].O*:7H9@32HCP1@'@T@`"'A!M"PC%`-]1'(@2;9U%HC(G/ZOU/.L6Q5H!
M9W\F(5Y@)F`;.\9/(1GE(5(N?42%)/(O)ILWC:B<+7)5*=IKNN_5G.@0"-SJ
MW!N,#:!BB)KYB8@M#TAU2`Q7.9MD%,J=Z@!)"J4`R!G-<.B;>`7(]2R)D`U0
M5AL4<\23@:(-)''FRJ"8?/1!2_GH/@B8``,,_O0>")(,=PAE@*!GYR>-ZK(C
M"M#T!S(`P0XP+2%,4\!7+I"K^0V,3#FJ3%UHTH"==)$C3^?E`]:M;IZ9JV*.
MRWK05&/.['5$,!-*``0J`,WT8;I3@*J+X&AV$*CSN]\PR1M"(&.:^CAQHUL$
ME,2!HDF-K+UB!7>U=^9W&;9@#C`?GSS%2P(1B?#\30THH5V`4JGMS#-ZQJG>
MDA:'$)6CYB5FD\I[).800K>D-TB1$DM,OS26F.8`5NE:7W[.0)VYO,U3B]77
M%(*UI"\``YRA0"VWI?M98KXA#K@Z0JM/H(;T;9*F%I\"RH.!!&2``Q7)IU0B
M$W2%I'E=_W8(!2QP_I)8A3PF3_KRSA,P\2T?)6U$0T5JYO_ZPJ@";]XV(.L>
MI''T1^+N8F52(C5,XD"F!^^(2/.:;TFZXX;F#7W@#2D@YW?^(B7(3B.>9GA6
M`BTZ`$<Z(`-HB(=BS2'6YF)V:%#&`B=@QWD*!2BT12(49I:00D>PQVG,9#D<
M:)0.8R)J2`$LIN<DXN?`3")\0R$J`$U2@LYX2&$H)"70Z'0(\**P`R>>[LRF
M[DO"Y'W^#=::8J-:9N9J\-Y(30'03T6:)3G0[\R"L(A@T/8:!UL<`E*(`C2"
MD.G&Z25X1][.S-@\D)[6`M/8[#0`13%<L.ZBB&"XJ6:0@^=TCMOPJ`*P_L:.
M[NB"[HCNK&.+.LF3N">*JJ-7`DFFK$@^7JH45_&.!.F-KN..0F05ZXAL`@G]
M1NE#*C%=@M&2'.F#(J#_@-$!?/$%0>F02LD2HZ@#8DE\**#-5(;>>M#2X,QD
M7@DIM,^&Y*.A0JEL7@J8@*D#6F@:8^D^&J=N(D,LK@A$%NVERH:+\$B4%/`M
M".I-YM&*O$BEC(<[H'$#/O&5)F280BF=W`F8+.`*P\;+1N70A*D"DH^=).HB
MP44NZL9=*""6\.B">!"@>HD"/+*.$*`!7(E_&,#0ON,!'"`!+"P`%@!O>"I9
M6O(["*4DGV5,!L<"BM&9+G)F#@ES0$J;DD>*_E(*`Q2@`HSQ$U\*D"C@0Z8H
M1%S0BKBI6S#1D702,AY@E=JM6A@@:MXF68YJT(QL`?*CR):*J9SJ/PB``09@
M`<R*`1!`+`4`R.RJR!:`M=Y*`!1KJ9IK`08S`?ZRJ;"*KK)*+0<3J@X``<@*
MLH[+Q6[,,0=KMIJJJ2A++@T@+=4#,`T@R=1RJ0:@+NW2ZQB`KM)R,/\#K-X*
MK![S,1W3-6GLL^9J)!)+JA`KK.IJ-_/R,!%KQFSL`+0*K&:L"6EL,7GS.(/L
ML.IJJ>:*LFCSL)0J/P9`K`:@JXK,R$H3R1C@/Q0`:[R*,[6*`;KJ.*.S"1%@
M)]SJLU2,LBI+L0!S_K'2DJFNJJT>\ZY<LZZ*<S^#;`&T:S^3[#$/,SY5LPGW
M$C6#[*OV$S_54SO1DEFJQ0$ZTT&-C#8!E*[R`\B*[#"%+,C$2@"&<S`5`#4/
M@+62+,F:ZK/"4ZL&0,D6P.M8,SX)0#WSPT)3E`"2##^PYB5?4@'6Q]!<HMTD
MP#W*J"FIK'F2KTH"8R@6P`&`)+6N(L(\$CGZIV]>PC1^YU"(B)D`[9?FHB':
MC3Y0;Z.6R%]ZT'1R(Y_<D0&`Y'0:`&4N8\S"!Y3^8C#@#'EB)8(4@DS]9=UP
MS<T"M2&&*&RB"-E^1`NQYTCS2=YZ<(EFJ6Z0(J@.R-Y0+1&)*#G`M/X\_B<P
M#M6`.LBDTNW+0FU/\RE2^0944LU30>HG@>)0,D=/1373_NRR2'5F,NITF.,`
MRLZ&>.,BQJEO*@`!2F1Z%B*CED/.\(Q_8,D%67!3^*D#!@-EV`91",`"E$XY
M!I4P)+'?7,5V2D\LAD(!G@6UZB17F@IE'@"H+B`M_X(P3D5.L*,#3`1;YBE4
M30D-T4),)T#G%(+0*`":]"T\V.Q;.$A$3N))&R!)YLZ$%$`U7JH#<D,F'`"D
MFD9,J,0!'":B*/`=S<,!7$57FJ)+!0KU/I9/GV=S2H,078];F>DR:N>'D(+:
M$%!!D"EE(^4#@L0UQHEGWV,0>664C`0AV*7N_H*&]ZZ#=X`".;:(.Z22*WYG
ME9;Q`72#`(X*9[DU*MQ.04IB@_",F;BB`,Y4@B3H`#YDAC9B(U2#BAZ`F:`%
M5W#H52]`6D@I,%"I57PB8QV`9A3F,K@C02(5`PKH``-/V7*G+NHF:C3``-*E
M?1KF!3DD/P;G;J(D8KGB`MY"8?XC-":"W,P(:E&O>T[&<HF'3T'04$XG8D,M
MEM:D-T1F7`OB+#8JI/J/,J(M=E!NWJR1;"2"4._CWF"U<PCJE0S%<U\R3]AP
M:IT)=S8JAW(BFJ9P0HJC8H=G8&)'80D&GA)/-F8H*-#N@^8#GX2BZ7;':.8I
MI%#7@[R$`NZEUX#&_H:@YYZ$$$SY0D[\J<K.4:"^Z&0@R2`=Y#2&-@*S8GHV
M+2IPU>6X-?UVIW%$)#D,@)FN#%S6@D1*<B%8T&G*B#=84I_T#:@T@),2@`,`
MEE1$YB?+5J&<)65``Y<D#@&N360HE@.F+/`,1<XN*V4D:&$*P)IZPR6"@Z<<
M0'TL1#"J`T)LQST,Z9A^9Y[:9<R(AXM\AE3&Y(,"HR\NPFSPU("DDB>XAU<D
MS#I?$%Q(-`.R;8L00"C4R@`NX/Q<8B&F2"*X;MY8\$__5@+H-H*:$DQ-8IO@
M8@*2)%H:18-"!"GTC8;-IS2^R($C:"(00%ESHE$"`Y%R(J["]I1X[07-_N5D
M$.4S2BB/)&@"D@-?T6)Z$:KN3`0VIE$P/)+7=(F93(HHIM$&-RHH*I(NYA!*
M@.(%S4-.;0<"HHD%"0`+;3#<U*T_DF,Y5D]MEF><(B@"<B7?#A@!',`W\",!
M4-,!%"#)I&5"^<H[8?("E$YQ"ZC^1BDOG,:*O'*5ID<"(.!N*J?<0`0O9+C?
M0OB17G`E-J-07,6#S4N.0N0[+(`E#>!M,.2;A02U)HIMK".HD((K.N<BU;,`
M\.0`^F4"M,H`O).R&@;U*H!&L9-6IZ8D<.5O23<K&!GZFL3E)F!-4`;Z.,E+
M8/@V3,1D>KF4#RYVTLEH3(+G"&*8.>"3Y2Q/_I870BZ594SM?%N(8$SP<,(F
ME/(P7:ADG8BB.`SH*IJP3(VF_B!BTZ@Z6U#/1LKTE4C7&MD&ET`"D>8B2D")
M.5XB%RUIS4C&?("ZJ9+#T5;P$+F">Q;1(?3L.1I(.2A`D\YC+OH&_HY$4D("
M#UV5#649?-I,=^E-A1ZD`L+H.B!`JOKGI?Z(74-1/-K%9,QXCJ8.^MRF`&P2
M2%!$-RS@JJ1L=JMR`X`9`7U:H#ZU;I"F6,RKI2E`;YME`7C,`LX/<R2@F@?G
MN@89`F2I>:+D=$7"(SF`R!S@`)X6H9J9EI#%)5@.G_3&T33%?S9NBZ"O`0A@
M31)``D0&8*6L"0.%_I3.M'SGJ2D7`H_V-#F4FW<^52$*=TWGC>Z\=)!.!R/T
M5I@%#2)Q=DSU.'=RY=,^X$XIRRJFD4M'22Q/*3)BR74XJ(+Y]#S\1W6A`MY,
M0\S8QI61@CG0C\R*[71R664[B'P$RFVJ9W5CIW!-PO\4@P;9!BWJ;WJ-)]:6
MB3XD8D4DP"X/X'9R4BIY#C5C%P+2\BP8HF4ZLHOXJ8YX8R>O]1,_\0$8@$GN
M0WSE`CGDN=]0EP5YAP$R`*P^H&QI0XSPA%7N:HX0(`/(KEGJQIP@H*DX2S9M
MC*]^&P*01BT&PM&0S`&>HH[6$2E:RSKFR#M'-#X1($>=%$:QS,VGKI>9_J)9
M"B"FV/;\#@*(T6Y*:!ND6`-1%-"*(``]0.*0'`:`)4^A+F<^KDYAS*=G%#`G
M@JK_\"QAFD+.EEF;<H(X2`<M<!6;!4.OXX+7KH*?J.A4O*B,:(F`J9LC11Q,
MXYHQQ`-M5HV'E@ED=)>@GH-8-T28"WC[-((U0OA_:?:R4!TP3`)KO_$^)*-1
M@HKN<M3(+:".I9E4'H1B.;9N&N=)&[8WN.-)!0*98B9B:6-AK$(WUOU(],RD
MP#1%O.0`1(:BL+P[,:!LZRXU&L`ZIW$H&/G*=-C7>"E/)B`E?8+7X(A#'`!:
M*$JI-VXM2*WN4LO8GC$F2"E9,,0D"H!$P&0"_A*K+G3;($##/"OGI:C"6#E'
M8U&&;YYN<CY6G'X=]4Q"/N`N3/0V)T9)4;*1/O#,!:/\`S!G5.X]U`Y5W?G4
M2>?M*N!,-#(*7!)Q+T1$!NDM)[@%**3]\_B(]](I5X`CEOP497SZ.5AE4[W2
M57/'I,)=Y8?6XKUT,4A:JN7%CO#T?GV&(5J8*4UMCN!R`*9(/`@IR=+RMWTC
M'6DR..3XDWNR1!2*8B4-3LU)+F['`O5,X1>#W.X))<HI*9@I$QEB`2"``71^
MVH:2*<9I)5:'`$-B9;)PQ14&(P!JJPD_)0PY@A"@)&+)G47B5E&$1#+6`%R.
M8$P#H'=FQ?D44D7M_OO<#G\)BGNNFIACQ6?:5/%KU8;6)7R:)YKX(Z1(R6U"
MB69(93X`(H.'#P0[-`BP@*#"#Q4Z9+BP\,)`@AX@<)A(T8&&#ATP3)S@H8.&
M#10]*L1(\8/!#R@G=CA)$>-$C!8J;+1`$><%ARQ[SB0X(<+,!"\C:%BX$&,%
MDT@)9F@*E><'"@M<:L!@P`%+K0@J'("PL0*#`!$>'+C`@4&##0PX/,C0@(-%
M#QX27)"`024$#Q8<')@P`<*%P1P^1,`JH<,"!AH6=)"P@0,"J)2C%E;YLL,&
M#PX\8&CPX8""#A0V9."`88+C!AHH=-"H`8'1#0D\*!B800+%#1HXO%S8_A'E
MAZ<2*GSP[4$#W0R:/US(8,'#A@X>*,PLX-&U!Y`>&%2X,($Z`@4;*ECH[;EB
MXP\,3FZF._/RPNC"W:J4F/3#1@P9IN<]BM)&'T#P&U(-")>4<DAYH!N#,M'5
M`40S;50@2]5%L.!`PN4%TT5(15!!2_IUP`%$!-5$78&1*;3!`RS)I]!3335'
M&6\46)B2;Q2XY4&([RE4P0,8LF22!QQ,L*!S",X(06644:=A9R$-U`&&WBVP
M06<:,!"=0PTLT$`%"2AP0`0.9.`:!\HA21=!FS$4XG,/]$@7!2"VM98&`)XV
MF9-/1J;!>1QL$-D&&&#0&P8+6'``H2-M8$$&_@HL=8%%_9FF``6M)9#!`AQ$
MD`"!(F%`**06G#=2A!1RP$$%&S0P@6D9:)"!0!S=^A)\1%Z4%D>]L1H2`H]N
M%I>1&^S$JIH;+-!:;WHN-2A:QV(PZ*`C(;K1E!VUA4&N%FK($GY4FF9AKAU`
MD)=,U'T+(913AL02<Q?!=RNX*H4T+ZL<%9KECKZ5JAR)OD9&(JFL.JJG:13$
M*G"RONE)'T?_3H0<10)Y\!25+*W;)ET81)!BFSV5YI%($/:F&:TD<M`?8[Q!
MD*9R$K[H+KM3%F8D?/#YQJY/R`GL4D@*[!=7`@1P,,"D%P2*@042/!?9P=*5
M6$&MI#('@;RL]J<!_@1X0??QJ7=9`"L$#5"P,&`2,(#`DDYZ@````0P00-UV
M!R"````LH$!6!!1`P`!Y%U!``'\+/D#@`]!M@`(,%-#```<XL,#B@@M`@`&)
M)VYX`9KC+<``@-,]M]YRYYTWXG^O+CCH>2-PP`$&P*[``@$4@'GKJ(>^>.B#
M-Z!``@A@#GCFO"LNN.(%6(X[`0C`+CSR!AA00.RR3T\XWWW_#?@!L!.@``*$
M%V^YZ-.COCH!BF>.0.4)'("\^80;@+GZGENN?O*8+W!`^9D'KKD"((!ZU$,=
M_@1P@`48X$NY$X#='$@W]=GO`.,CP-R<MP`%!L\!M:.>]^`WI@,D0'BQ_AN`
MYJ@W/A(JT(2:4Q_H2N<ZO.&M=WFC'_7^EC<"Q`X!EWL@X0@`@,0A+W3<"UP%
MB:>\]]%-;DP,@`(<(``%"*"%X^L<`((H0!>J#X4WS-P!=N<Y^`'.<XVKW7CZ
M9@`&C*EV"_`:!-KC)Z@,JE0L0PNN#B"!";0'`>_A"$LF4)@JN4LQ$.%`9X12
MG9W@*U?PV<O&NL41",&,.LE:V:T>-1(]12!9M'D)L!+3G4@:R0&L(M6MIL.R
M]LP*`XZ$%\%TMC.5Z$LN%BC/!R0`&4)%:S#3XD\&%!4I#;A*`YP:3D<:4*M9
M78545:O58`[E2V6>B2_5`:3`--.?Y+R)+I4T_I)F'."B2MDKDN[254MPZ1R]
M0,A8$4!E)3733#W1"@&E<0!I&F`!:/[R.0G3I<)PQ1\#1.`"(6J`29"#'EU1
MI`+Z0I$#+'`N#SS@/*7B#<K(J1EL]9,!D-+(`BY@J%JIR4/X\DT'0M0!%YWJ
M`-31C6-^J2'X;$`"#6C`&[_4,9_HK"<]N8R],$(!@7`((RN)(U10\LNDO`4#
M'#T:3PGR``\QP%X/[98"(-"HJ;#IEAE3B"/UDI*!%.>I*I%1CT@R$0ULM2Z,
M'!!=;G,2`GV@ED\U4@$8Y)`FI40#^(%)=<AZ*@V`9@),80E]DC2DE#S@*#"K
M@%X58K*FP.NI#!#(_E[,@U22I$2R%*%*9X*$%`[<*#\,^4F/A#*G3\%D*F3=
MV&AYVA[5+@PE'<`)::M$5HX^YP/V_,D$9+3:KV(61!\X4&5ATIK-*D0"+=E+
ME23J(85$MRF%K$K5#D`7%U5%)0KI5DQH=9'"*C=)MX013P4RT.K\A"5P-&I^
M'L13N-$*+&UK"BDY$BN=5;4#!;!`GP@*'PIPR$+6L5C/)/!:GRE$0)`%;DI1
MHIL/P%4A0_(N4C:`@`Y,E0,17K!9-]M7A0!&`X<TD4)"C)0$LT0!3W$`!BK0
MX8((1(["65MW;',4TAYU01<80%5:M"#S*@2B[**`2R/SV).(+"F:7<B!_K(T
M5Q4O>4$58J^QBEMEYN@X.H8USEL,<X$#F%=-1W414II4D0\\H,DQH8RMG-L!
MECKH-A<8K71F8IJ13#E)M!7)NE*R+[B@)55ZJI58W)L4`\CN>O;[V_,`T(`$
M%`"*UL->X>*W/,ZET6@*\#&9\K>YZLD.=RA<7N`4%\#K46^`932:]YX7NS0J
M('@)B``$;FT6F@X`=M.KG!G/.$)>%R`"!GB``TSX0U#GT&X&R!SAGI>`73_N
M<0FH:0,8P(`,/@#;N'Z`L:U];080@`*\?``"O&WL!<`.V^S.8-]FG4$$,&#7
M$H`<!K77MU=;C]$%2,#L^A>ZR24@`(JV'@'J_G=JT2WN<`(`7``08+3,B2YU
MLIMBYOS=OEF/<(0.P/9?(*``FB[`U@]HP+89X("4U[3=LVZYXPC0@-A-P'FE
MEB#@FDTX[SE[C)53RZX1".M1&T"#+1_AKH,>[0@PH-C.>]_&JP<[5E=0<Y)S
MH=?`5#PRXLYSRW,@WM17Z68#4'("A#7G,F=I%&YN@)+;H>/DC>B%@#>9@\DD
MH?`IJ0P<C3<6W=)I(A,7WTC&`N"9JD8R$`'(L"J?]>*`8W3IJJWUI@&'2::>
M#J5+!F#@F1B@P%N<J8!3.<T"";``!0SPRV0B8%8"YL^A!G,!!5#K(5$=B;5.
M8U+J1*:6"1N)`]"%_IH%X,679)M`!<PC-B,G8`)I6Y@";)J`!RC@`12H0.)/
M]9V:5/_X%9B`V)XYJ60BF%;R?`@TL:5,BSHJ`@IX#@7LJ2^,V1V5*K%`[D."
M2WKM1?`<T13Y"\U7Y+9YFU<!]&0>%-``#G!\-4%0$6!Z$P`>:%-]3R,V?'46
MKE=ZM9(P_'0MTW$:"Z"!Q4%BKA(9#EA*_($V\I1)%]`TY\<?JR=,L0%2(\4!
M]L<R(J%,:@4=',4J!@!RA-=?E+0O-H4R^M(!@0$R$E,J@/1.O@(E\:4?AK$9
M3:8ARQ)WE4%X23$Y6_(!!2!D&G$O&:80[==Y4Z4`!-%]%$%81'6&+Z(5_DEQ
M-DW!'U[%9AN06!IF(B!3%1V0`$@Q&H:18SGQ*KMA9@HA8)2A%2@!(MXU44C!
M95#1'C)163V2`=V'$C5X5,R%%"#H528&%$(F'2KV*>3!%YH(64@"%?:D5,;!
M%QI0B`K1&5"A`3'&$G.R+H"1%*GA9E+6)P2!`(.R$(N%B!-A>NRQ25#%9E,A
M7@H!&ILX$+4T-&<F9`31&:_1$Y[B9P;0$BZF9#@S)Q;P505A6_85B&?6'8A"
MB\,Q55<(%:>BA0S0-QU``,DH821!$@8U$9FR`7H$-T:2`,9!$`8%'`=P$E%E
M(*BX$)U'AW)WAV\8$HJA$O4UAH41`<!U'.WG_ABPXP"TF$>4T8P+(0%B-A`/
M!8=N,V$4D0!Y01U.@Q1H0AFFJ!!V06$*(F*@B`&OR!!\$QT(\(8L@I,*X1A(
MH8`?$!Y<B!3MA108D([@HU<(EA06`!)0D1M(T0':*!%P8UYK01EBR!#6P27S
MHI4+<8B2M8X+$90$D0#E6(^4$5L.20"U8G_:*)8#`",0,`!/L8X0@)`?`&50
M<2!'M1>:!XY-T2EN$W<=>1(,L$EM(Y=^B%:W%)42=B,8T(>341&HR!DF1A<$
M21$N@A(,L)=``9`?P"P,N6!ER2!]&&=)$905B1$<8!<*P#*S2(N#01DW`F$`
M*5&/2(U5%I--@0!Y_F%K$:!B:+(DQ;(0,DD0%2F4],B7.-DIG%(12:8?/XF6
MPN$`-T(=7;,@'YF4Z9AA!7862`%C;A9C(:&-;\)'0CF.SEB+2'(VUA$!`Z"6
MY$89VV66C$2?1[DD-Y8!Z^@!!X`VL3(`KZENT_4!M7%C*X81&="3F^B<$N8!
M#;`TU#D<^#E>B#96*2$`U#)5!B!DT>@4;>@!"X`DG?(!!D`=U9<K#N")&F``
M+.*=`1F:RCB&Y7@!B84!L>@9%;``KL&9,?D2#S!@*L$`L===D4D0%-">"Q&+
M(#E@7W82J@@5C0F4'O$`E:)B!'6?PO%1%&:1$N6<%C`G<D<]8E6F"_:@_@O!
M`%7V`+I1@QF`DR7J9C7:APK1B`LQ`>FXI(E5$)RI&060C&`(%?A)G'!3)*R1
M8IYX$AA*$`>`>`0!HBCQEU"!77!!$5Z8J06"-FV!%.!!IVCX6AK@ITXVC>QA
M$(BB8CFY$*<:1\4A$QW*%AYP5TTAHL=1JW4!$A=0%5=5)0NS%47*AS*Z(-[1
M%-4'E.4(6@31-711$PFZ$P2)$;?A`8<A71P@>W#D&:6*K)*5$`;"4`,1)BCA
M*5NY(%]*(C#SJ:/)GTB!`'5&%Q)@D<5%CWP1FA@@0@0A`6O:ETU1&TA!?42R
MK#'1AH29C@7+6TT*8TN2HTFQFL55`5XH$XHJ_EE.=4L281<Y5IHG\1U;Z:5M
ML@%W1:EN<ZGMU9BT6B`<5:DL41YZ2!$I%2,6&I"^68OLP1NEVB-WRA*EJJ%%
M6A?4TADJ"IR!6!<XDRF<D1`$@"[$-1!K!AR5FA8+$K`I-HZ<""2%R%0#81VV
M01W8999-"US!PE0G1HMHLR1IRHP&L!2\E6`32K/L(1SONATY&II<*EDKRQ*_
MF*.GIYD#HI8$<1<H<0%#IZ\X>0%K.H;"`0&:BC$XJ6%+,HNVZJ1-"H&W6:H<
M(*V;X:BD&:%$L9QY`8(`0K%#5J0G(9$Q"2$;(+1.UI^W(5B;.B4%\&<WPJ/L
MU5M/RB!)ZI%O.R>5_E6,Y`D:$,*S[F5\P"$`_5$5+`6<;):GPF<8MX%M')98
M3KM@55$8]@&PJSJ6I&F19!HC#_I@`9H4U&JMD)6M"U:V3<J,PC%1&0`2#%!@
M%(&WR1FW.$&AB-E=JTH0F_N+K<(6C`H6[1B:$?NO>_JI,ZH0;7IF7T6J23&A
MYNFO&)&G:LBH0^:)=%$`.58!!-`2!NFM$T&D'_"N":R6YG%4)TD0MP$IH5%E
M#?"V4_6ZN#H0:&&5>[J1"``!$6!K$E`3"!9R>@D8$Y$:2T*E3>$BLED3P@%:
M7Q(\['@BY4BK).;"IPN4W5NF!^`1@M4=+`&K4#5=5C@0J@6'ZMNQ,SL?_AV6
M`:O766T3H)_Y$L@$')6EP-#!K?.*IXHK$2_QHT)IDG'K$<Y*BPI)EBV1`)I5
MK5!L$5`!K_/Q?'01%$F)E$ZJN-PQ'#@KL\-!BP$*7!#`KE-1P4M*BR&[`5O+
ME;`8H7!5$1Z1EA/!44DAKT<UOR=9RK7H-NUA`4/"`;++K(WRCQ*8`-LG>H,!
ME9L'E28VE:G(NW4!*:MJ?6G!35<X$4&5%`G`*IPR`+^!$9Y[$L&;DA]`F3[*
MQ78&`508P\<Q)#.Q**NU%!-!2O/Q6AGPKP/QNJ':$^NX(_'%'R&WDO&+AGV;
MP#+!6P/VI05I+R^;$#+QBVIV%ZQX8D.E5%5V_I:<,5UT(AP88UO$"`$+@"B/
MS%.82%H1-A/&)B'N6U>)A1*;9\0\%<(GX8[C9<)REQ`XH[P@Z9L#H5<5\134
M;"$S/1&NTEJ/VZXB`:*;I:0PX2(-S!(%@(H68`!V""XEPQ)BD3%Z5%@#82CC
MI5ZK11`>`7]$>R(6D8B;2QFH\7I[2RV1D0$",%`%0`$%L$_4PBH@B#"O,2AO
M65R,<8898`"N,1(V,1T28Q$7X;ZPE%(-@2L.(7@3>A'KHI2_D1OR+`$<$+Q3
MI7]A#$LA@:\'TAK^4BWH-R\ITA"5)-D#-HD^L4U0.&,\Y:*[F:6;)3(S01<,
M52W)P4?/F*4'0RC!_I1ZYW<!V+<49A,`A!4!%-HT+$@!G'Q\Y/8<:+(495U,
MEP>_F^=,A[$T2S-'5Y$PTO&?AL(;9Q)?(/7:&L(S,V$0&"%G,<%<[:+=Y?$K
M;[$!!]`0A\(LJ-0;FH?;=T8H.D,BJ\=-,*A+?)%[*S,HI)*CA=:_=&$`9`H=
M(&4:D$HK$#@K-H$6M5(J&BA2^P25HE<US+<P$3`!L@$!X%1RV^9OF_2&ZDL9
M$;!H[Z-HT&9TS]$9U3,]+C0X"V<\F1,`3W&3DK&<HH-#811`==-PH3,]'F1#
M!S=#=;,ZA=,[.D0W#:<Y7Q42]D0!R(8[=4,XB^,Y@8,Z?TD:B8-$#6<__D5>
M<8230X*CP.PA.47.:1L7;!!7`&2B:-E&`,9Q$0]0=K#S15-4Y&040#\T/0&0
M8Q4Q.Q`'<0:0`.J61FI$084.<9+F``9%J@?`Z.&S0QL';WRS&-A64Y`Z$:J;
MZ=G6/M;S/!#'/O-#.-2,>)TR/P6$.5-D/7Z.=ID610L1:XOVYZ5&0&W'0]XC
M`-9Q%`U`1C8'/\RS.GP^/=8#N)*Q:`0P0EY$ZJ\V`.]3=ID#CD;B/`3@`&,B
M/@$```600?P#CQ_T1<\C0>1.02+T.*\&<0N0``P@?7ZAPWE$G-6W`7II2!E:
M&>&=4P/1%AS6QC'%$EOK$TX#-[GMPG>ZAES,_DCXUQ.:(?!J=C&+K1\*PA>H
MQ!$`%B^H6#":!RHUXRE&@AZYYWD6@YL:<AZN;5@%_0"1R24/Z1!5,Q)@TQMW
MP7D/,1K=H5:1G7O(<=DY5<\:<@%195HX`ML`?9/K^%`_T1Q%;\B=:6)WX1/Q
M`H6X<94^D8C+R1P0`BP!GB)JPO5J4I8B_-<RM5,\92+5>A%7U9D-?U+O84XY
M(Y3,V@%L[!/>,O4.XHXAH:#3T=2>R:S39TWO<A2L<M-AE??1]5,MEAP3W976
MZ,2DVZH",,HN'*0+\8>MVB3O.E&D]*]/@Z?ER&$L(F7X1%V!V,ZZZQ01IAGE
M[<QL:M-L5AWO=RS._J%B1D$9/]G:K*)Y`/NVG<P>DD*?]AD1O"F6PM'*R'AF
M-$O\)P9W:F;\S=^NP<@4+*GY2](T5%D;K5)<YF5_2S(K2*$!V#$1LUQ<_=E>
MXRQAHUG$!)$U1P7\;2%,;9P4B$L13?*L%SDN!G"30Y%C`'$!08(*$38<0-`@
M@88/#3]PR.!0XH<&'B8ZA.#A@(<.%RQDP#`A0P4%$R0TN)A294,)%R1V**#!
M@0.-%B=6G-@A@0<$#"TXX%"20X0+-AEPL/EAPX.&'CA(N+C`PL66#A=TD%AA
M:D,+4)MV:%!A@X(/21DTA,#0(0<'%1YTV'"A`H2):56>3?H!@DNG!C!(_O1`
M,V]3IH`7;'#J@<)6AQ3^7O3`(*^'!%@U>'BP`?`##BDK/'8H@4'A!Q4F6C"=
MDN9$!A@XF*8P(:?7BW)S5F[:0"W&W1,E1)0X=@.%L@L&-\":4G+#MY0[ESWJ
M&WA.!Q,]*.@P4N?@Y1<[T+P`U4,%!!@,<![@@/$'"JF36H3[`'1#K2H?#'98
MX?KW!1`L7(@`I`4FH*"[E0YD#S&)L.L`@PXVNDB!YR0"JH"(+LA(@0PPP\"F
M!B9\*`*'-DC-H<A<\FTW!Y)K2"2'-)`@J0X8Z*"#!5@K2P+-3/2H,`\P($ZB
M"'K+:C`(-/-`@\,F0M&[ZF[RP`,)-)A@O8>B_O0L0JPL.A*P^4S,8$>'@/1J
M@A(;PL#*QBYJ@*_QK!Q*I0N:;(B#LQP:$K`.\*/ORPT2V("A#@R8C$:5&&L`
M,4`;T@`G$R<@LJ$.[IN(+`<CF^S,B3JT[8,)=FI*LM4:RH`!"%AL"H,V+^(`
M1(DLX/.##A'(8,6+`BP+P8LRH&"Q-!V88,X+-L"`@#3EZTD##3CH`"(%7-L@
MT$`AH,"`"S(0+8,$+,!@KT`U:"T#<<.<@-E6F^6(6<H<K+%=##9@MD&D.$I2
M@W:7:I6#:!W<8$6.:C0NL1JCS,Z"MS[H:()F6]7@(V6E10JNA:/$;,,H,[,H
M8RPSSC6QCC^@T8,)_C;PKV..$-NS1G,OT%=9#3)0H`*0,EC`,6$M"!:##"QP
M[+->_YO3@@@26$"N!AB(C4`@(PC6`J<K@%J"7GLU"0'U(#BI+:B=QB`"#+[^
M&EX.4/M6`V*1J['?#%J%E]C+"&X777I/SBA*#G;ZMU66VW69V`<R>)F!:&F-
M=BQQ7V96YGSU+?P"LQ_'(`'7(&+@@G==UGG<KS68TS$*Y)M@@O+^LT!R!CY*
MT^D)#GA`I`LF:.``R^=\5U_'71[W]9:"YKD""B2`8`("))C)@0<:.)H!`A2(
M8`'G,](5,P,4:``!YQ$8"`$!"$!H@``$&`"!`PP@@`#P`RA@`/()0%^`_@``
M2``!`P1((/P$"MB^??S='\#][P787@',M[T#!,!\`P3?]LK'/@+LSW\`]%X#
M!S"`\@7```4P8``TJ$$">&^""?3?]S"XP0!\D((-+$`!##!!`*@/@"I<7_\T
MJ+X+IG"!"5"``K)W`.Z)3WX("``"%!"^$B*@``?P'P!FF,`%+C"%!H"B`<:'
MO8'@,(?.4P`#%L``Y#'``0O(X@,@,$8=+L`!1T->\1ZPQ@8LX`%;A``#Y(B\
M!LSD`0Q(``3>Z#SG)2`!#%#``N*'/83@T(A/A.+X#$#%!'30B2H4(`"W=\+^
MR5")WQ/A"M/7P11V$I%2/,`!PG<`/R*``$(T_N+X$((0*I+R@@.)HA3C%\H"
M^-&*XCOB`A(92B.>LI$#2,`%%>#'4R(O>Z?,80ZMIT,YBH^5C42E$/FXR#06
MSP%C?$`$M"D!\46`9^UI6*LR4)IXZ:HI",L`NLX9,0\`"`,(R(A^-K`G;WI@
M0Q5XV088$`"&D,1.&V)`!3AP&0=<:V`D2Z<'-C"!)(D-9!3HR,8X0`$.O*N@
M,(+(Z[KF`=3(JC-)<@I0-M2A!EA``]I<'$2>@H'E)$:A<=N8W?9D$XV935T*
M%=?7+M"KK3DM:!CPB,ZNI:VUY6M@&\M54FE:EJ4J]6-,M2?!SEDGG#&U*<]Y
M#L>6:I,]E26KYZ37_DR=.E6.U<A$'`-K6.W6-G/%;6`SI1B6QIHK!R@(JD]%
M:UDVA%>GTA2I>;6J4B*R59M(`"L6,U%3)@-6>*&UJ8F52.BV!)\G;2`"736G
M1(:BEIB"RP,1$(NU=J<8#S0@`SLED-!**X#.=,U.'<+:BB"`O-=T(`(<N-%M
MLWG;M#BN/$FBP,XFNI<C-8`"0(%(!#[GE)UVK",/.8`#,B`;RM"D/,VZ;?4D
M8`!])J>I3K'M8"_S$+MF;&?O24D'*/">91WL`WM=`$0V,%@D66=9+_E+!QBJ
M&)4DIU5E><QB-;#&)'TTJ;L9C,;L*2GHW357<IG7V[Z:5/9,1Z[I5<G&_@#D
M&*S8%BF`>>][(MH`"$0$)"(:D[X:HJ`?982B2M$`/A$KL@G9;3Y8Z=!7*.`M
M'75D7_UJR`4Z,MZ$HA>]%)[J0Y#<,9IPJL,H:E1\,PN9ILRE**4"D'X8(($*
M2&`"MXT``2#0E@=H8#%A&<">?J=/+IDVG<\::(Q@5IG3RJX#0G/)`1@`N+)<
MZP$GN<`#LA@7#K3N;_<9HT4VH*,".(MF^L3M22.`@(%R(%A204F8Q"2!BI[U
M,HYK)T0_L"P,R!G%^&$O;>"CU-(BM6&CU@_"_@79CQ4ZR9!];*X4I,_JV',X
M'YYJ4:8*D1_EBBVZ5@"=/&:O4"LZ6LBQR'UW_L39J2[4.FO)&*PRUH$*-"A(
M;;UV9#";`1%M%<0:&_;:++>7\<+G;8P:K(G4&[+0.4``L!,`A)JRMK)PYIU(
MNHS@3&0VP`#;(E7RT@>PMR?7((RAHX;`;:?<WY0QM="P,L"7@T>!"$B`>:JR
M0)L^Q```,*1;%[B17B@*,S!2"7`:.,##)""!,@<O20A@FK@^$/()M"8SVRK7
M6^J8`,!A2-X1<,H!$I5LX0FN`4!]2CMS6!'LB.DR(`*I9CL#KY>%+D"`5>A[
M_CMPP'`7K"BR29J4-=BBD&A#2-D`K,I"E[/6B=]E[5>T&T"I*)G9(FEZ35SD
MFN`Z.>JI(%8L?)HE_H&_?-8U1+KO@?CRJ`\Q%0/4_NQT/_->6&W(`@JH[X!]
M5O<ZV36Q93YG6CJ#N,2.)U([?Q)3+2?NE7P7*69FU'CV2NO`GI4G"IA*5[]C
MKW'&ZD`##;ZL=O2:IP<4`P=PRY=;9P$"A,X#>P$^!#`0`!,+`)#%`7U="\J`
M&*O*>?I40`$X'BQ%.2!`O1(RSI^N`(1D8"\,F`#H]VP2$Q5:H0:8*`QXEIYH
M(P.P@-,)D`.`'9[PB@]K)P-CF1AK/87)%5[YB..:EQ_Y,!53J)>@EJPJ@`ZY
M/(MXCF9Y+]GHLW92*('"@*NH`$/A`&$K/8[ID"3YB[7)&`I(`!^A$O%H_@H"
MB3;,T+YYBA(AB[OJN!9T>C?VJ`"6>0_,V!*'F`"=^8TH"92&LZ?#HK#(H*ZF
MD"Z(P*P?@0]\*@N(VI,YL1,*$+)VTA%[R95E@1=&40LDB8BM@PB]8`C\>)#&
M*PK'"+X"P8K_$IIYTK4/ZYIK\:N3TBH'R2;!^*QH09B!*C8*RX`",+WLN),!
MH[2)B\3U(@Z:HA*RV+@!,"X'^)T".0#MN[\6'`D!0(RYH("K^`!3?!8'T"$,
MD(\8,P`E>1V%62C_V`!X.JYNL0@)6(!2"48LTXT$B,61B`"ZJY/@@9D]>P"<
M&8##R(PR:Q,(<)X#X``$Z"H+0(H:9(])Z304_N0*!W&("S`5CIB*)%DCDU(H
M96DXAYB4&:,)#K1'@V,4)..8D\(*K7"*'?DL%AG(LD`PEN(TALI#P-@]$BP*
MK7B7[%B67K,()U0R63&-R'L(J!D,QKN2][J<HO@/2U,0M1@HB<$3%>.1ARP+
MN=.K*/'&EUJ=G@,O18,++T&2Y6.Q"-`034$8&8P2EIJ*,Q*<R[I(,R0*#5!'
MO9@GK(O#T$"**C07!]D0IBR5B6S(#Q@?B>@6%!LG`YFRC$$2$D2,^<*:YZN`
MDC+%%3F`D+@`[&@)R>$NQ0B>`7F*`QB770R+L-`C]8B`!T@`Y:H<&MG!ISN2
MC&!&\J,`4L(`!X@<_@>P%M,J"#$IK2P:`)H9L.?K%Z`XD5(S@.;1@)W@.@,#
MK',##-\9KQ%9JJ^9J/WZ"+'2#PY9&R(IR1%!E3NT1Y@D%1:A$F4[O`NXIB5#
M&`1AEJ]X"+(8EB@\37L4DXEHC_YJ2'N1)ZT(DRLI+'S*"WWA*(>PL`/<$UE,
MD@N`M@:)$?*Z"C[A$S.Y-CVQ#KL<J*8@3]-R/PM8@/-<,K,B3A>Q#O>0JC*T
M@`X8@`(PJRCYLFASKXE;L`XHL9$H"[AH@`@PK@X@@`]YBPZ9`#.:%&*D`,2P
MD%[)D,YHB7*)#**H1L7PBY$H-0!9J#T93'$1IP&[BO4BOQ5YE_^8PJ-A_IJ.
M$8M&:0V!1`"**C/YB#:B0#H(J`#CX3?ULB<:R8Z.(9$<8Q02":XY/#`+J"^:
MTAFF7*\0(P"!VD+%:CVP2JKINK6EZBKX$,&.,3/#2RH2'5.S7"H..)6&7+#?
M\1C%TIES`HYY?(@P1!@I=2RX4)`8M"?!:+W',K=9]"Z>(2NHZC10_"N$1#V_
M,BDR=:HF3`H"L3E[00J0H+9<^8VF,#U9:3>O:B?O3"NDB*^$RLDBY#A0F;(8
M\YW3^@R0N-%C+"EMV:FI00W9D0"G(9TJB8D!TZ.*F!%`81;IP@"Q&(\R6T'3
M@HM\Z0F!.I?,8Q<%<`RVB3&F9,.4@8N=T0`(_FB99<&.BN*T9=$;"1"1RX(Z
MN&D6L>D`AEB6N)(W2#P\8X.,C%E-`P6VM<C2F8J;Q7F8_U@[P,'5.0$<U/&(
MGP$)FW$`ZWD:J*&:+C,)=IVY,:)8WZ&:V)`:("$=;DG8M0LJMED8Q@D4A*T1
MP&D7?6FKAP'7=%$9'(R2M8F6MWJK2LN7TMH3B#@M3\V7:!FH:+&IN'G*@;J\
M<4JG:,F;Q2F<E,55;>*=KO!5D!"(V1$6-0R3,#E87&U6K2`=BJ6:BP6>;,(F
M`2@`6QR(\8$A`3@NXX,,0+*B*Q*B`T@?+I(?_/&C8;);4Y(?55HD\0$`^3$?
M`8*B`26?2IJ@!B(`_@!X(N^1I`F*($^JH/*1H1+2($EZ(,U-(+MM'PK"($GZ
M'\5]H0%-(;3MH`$()4<2H`5:(?5QIO%1W00@I6&*GP;(HBR2(RT"(T'RHSJ*
M6"/*MP/0(5?J(/*!(2CBI%/"'BF")5JZGR.2H@5@)>P9IF3:HBU*"/J;@)E`
MHP:8GB_:(BZB(^-1"#!2`%O$HCE"'AVJ(BNR6P-@`%!*(2.:'P)8'X1X(AN*
M(@7:).D-)20"G_D98!CJ)"E2H?ZQW!-Z(O3!7RFB7PE:7!2"H4IRGP%"W/*)
M)56JWO=='@/H(V0Z(@?XHUI*/QPJ@$#B(@8X`##"GOA!)C!2I``>IA=6_H`[
M<K^CN:;0F1H*."74@!2:W;F1X<0P!:N]@S4.,`!,_9*DFLGPB)/,HQC#BJLD
MR95F>:LHT1"M`B]W>3FS68Q\Z99XL9>XH)FY\11FF:=VH1<*T`TLF==_\:ZX
M.BJ5.9=F`0DD?1RS\0C:^0^=X1ENL1S?&9E6*9JQ^8T,Q,X5.RJ3:;?%RE<C
MCHA22Q4[C42R,C(3^1)4H[7!^U/3G)M)A61[=0I_3%.FBDJMFCZ\NC,C5K!.
MQE3BK.)<V3P*X*P`_0!*^9B\RK4CB\)'-;*TB!;;2(K7T;<B3B\"8(IFU0`$
MP`^Q-)%&VSF*>A*@<`BQ;)`Q"1*)6(!(,0B'_H"3"2$W*[RM]5J*E[@3B0.3
MY:I`.C%._-`9&2$65%&)MQ$9%,Q)W5P)H%R+LM`*>IXXI@B/%>,R*M-DK;-,
M5T%FJ2E5CLUF59TR:`R.P>C0]UR`YK&<B2J+<OE7@GS.M>#-.5E-E4#:Y1,9
MFOBZ%9L5AZBK.?S7S-*^&LO#U\O0.*-GJ"F,L4P9B@$K./R,&<$U']E"`O`\
MQD.)TOJH\>#EJV*QINCF+>PVIMHKFW",5"&.ZS0VIM"87H-)LIP+BIDOM!LK
M+@[329T75][E[K0(;2,6K4JR(W,LQ]KEQ(/CC)$-1_V[]>+I[V*U0($J"C0W
M1>TKC#PG,LPK!WS4_BTT3;XBTZ5B/-/@:9!Q:Y.9["TLT`E+L*6JC\V!%^FR
MD0Y4F;(8#K5ZT+Y2,#F.1'6-NY$X,5KIN8(8(PBX'WZ;LN>3(1MJ7<;EGE":
MGQ66(^<A`"M*`./Q7@/"I?0#X>`&I`<P@&MR`-_FH]L5).QA@`&XHM_&7>=N
M(ZPA$`H(I#K"(Q#.(3EB(P2`G0B-``-@5Q+#IC6*6*53IE/JW60J)2]*HY/8
MK6?4H];IX=`)5IWRB(GUF=A`C=W:KC'"79,0HS-*'MZ](ELJ`/$))MZFW-W&
MGPT:8,MM(%*B7?RU6^+E(?6!I`66I!$JW`NZ(`#J(`A*)46"HM8E7C_B_B('
MZ"%2^FV$P-T;=N\$B)WQY5TARJ%!PB%2$B07QB+;W5O[3IXA(IH;)K$[$H`<
M[B(M"B3J`=X'^"(&3QXL"B7;W2'>?G$;.J#@5H`'KO'Z:5W)5?,)4B%.RNT4
M(J4&,B7)35P3DEP#RI\MXV&@6J@(N)/,<@JS"9/(^&/HHY[LD!D#^)W0`9()
M4'0S:0].E8`!B+,I`11NXS*.6P#P`8!.#X#[#!T(B"[C$2,($+-MFKDPXR+@
M28!.=W4`:("9$PUJ,1L@R:,'2,5M`E\OPG(["DQ;M-&,U@`QZQ4#8._8UB8(
M*(#UKJ;GAJ?G_FTYNL8%L!XJPAX!N%X!^+/0_JDWGC(`'E>(T7A&X/$Z9NRI
MQ9`+_V"\EVM6;=6*V?D:=A67-RI"I*,I2YQ7T.L;H94)MU*7I3`;?M<9E@*;
MG.J5XZ'81EL8G1H7;>V5`C`3;2J(W]DNJ>D5T((:"$"`)@P=GNE5`HB-2$_%
MB$-U\WX9!V"\UD`-`M"F"%AVD^CN"<!RUD%VT"H=;_H:U(`:\O`IH,J<#-#+
M.#*.CI&[=B(Z_SA&08_!KW&_GT?86KD6MJH1<!$KOUJ1BC``]2H7+U.2`E@2
M9&Z*4[$(!2ACQ="1!'CK!K,.`A!1HUXO"7&(/\N;C;<)6P,,4'D/!=A4`2@J
M)6:1UZDQ-20>P$`)_KW("9S19?A`@!UY:G\4ZJ2H@(>S#EUFM5'9"(]Q`'O9
M$^1`"X`NBZ,&C"1!,<BR9L@22$^!'@)QV;(H@%!1:*4H?"3#+2IC4-Z3BXS!
MBP\0-IKZ<V@VBEX&_=:3U8W&#^AY1#VR&[*PB.%/*EM;K`3@1Z=.B;'_@)9`
M`*7J-5DY"X/(:0H[4<@8E>TD"_O@`)0X`/VB*#6$Q]?C1$/Q@&[^G&WB@`.`
MC.M/+U?,9>@G4`\`0*-H0(#@<(#"AX(:''3PX.'#0@<+"Q;TL`#BAP<),G1@
M2"!C00L$(6I0X.&!`XH>#!1D\+#@A@@4(!2\L%##@(<,,E"$Z*%!3H@3_B3T
M+-B`8\Z3$5%ZT%#PP`8/'#ZH7`B!J$D$*RE>@-ESY].>$RHP=%F0PM`-&!@6
M>(B@:\X-"8)^V*`R*(>W02M\["!2@H8.$7#:C,B`8=#!<!_`_9!@I0>"'A)&
M?/!P@H>6'S1DL%I0`=R65R$NH*IS[M:W$R8<B+MP9](,%P9SX(`XZ`.P04/3
MM4O;0H,,`YKJ[&#AP87$QG,RZ'K1@8.O%S8@Z-G!P.>"'`8\C3!![L+D@B4H
M1+`!`(6'&P0,,'#@0($#`0@8(%"`P(`!`8A:C!"!H0"B%1A,`%$%BV%0$D0<
M</9!=!1M`$$$!BJ$@08";)#265M1%Y0$0&VE_EE0*!64(6$R043:4$%Y\%9U
M%6C5DP)LZ?2`!05IQQ`%"G0`G`<"/)1`A3UM,!N0I.7$@6%>?;1!`19`IM`%
M'##Y5D(>]M1`=0SQA.(!ZJUGP``(%"``?`6HQQ`&"C3`P'Z7.9129VL6E0",
M.BU&ETC$\?00!QDMA(%*#5Q@8$\.S+@5`Z(5E$&"6SF@P6`#4+#`2AM,T,"%
MQQVWP%,>W/28!Q9(4(%(12[8$P<!<.#!AAK`Y($"/T*UGW#3?914<GO&IM>+
M&\2V@9(K06`54![<)R`%FU8@J@)H(K?951=0X(`$&"BTV@$<+8!3:83E-$%Y
M05T+%X@GZ5GI0REN_@K!G`5U,-%6+%[IXU826"!5@!^\%!%:/:Y;&017&@D7
M!X)VZY@&=EU5(:<0'7!EBE=^L&A/!R3PP`(+($"=0@DEY"X%K@F@U`<79.DJ
M7!BTF--:<%%IDDK2,E!!!YOBYD$&$TV0`<$4$0?7H4%9L/.!#/CI05J?>1#!
MI8E!#-&+"RGPD@0<2,```KH=V/*!`TB`9@49:/6J8!$T^)@`E[(89Z$4U5D0
M!'E6P$%_$+ETKP9!=O`:10@NU'9,TA+`@`;W&IWJ!PW`:I+$%.D'5P*(IO20
M`7RB192(#JP;U^(""HG<E;45M"%#$J3<`0'69HY!YUAEV1/)<'EKD*1P_ND%
MD8@]/0Z7N^"V^D$'?CM->04S]MEZ:D#_6UB_"@+\U@,4`+@!8%::%:B9JX.F
M;5&'5A?HE>T6^`&(52:.:5$*X29^TD!]A:!TI?9$@`(5.%#!!@9D8#2L#4"0
MP%D="``C&.@`!CA$$01\1"<(F%F%'C`7"%@`51"1@&-B@P&"9*!U<;'+J"!2
M0.W8C"(&Z`KB4#0[KQC0)+D[GV$\<(`*7$!D`[P`M1K&D`>4CR7`XQR*B$01
M"'R$7AG!R][&)Z^B!.ED0DO4[DQ"`;MUT#%94POD7`6YB,'%`PCX5P?J9T.3
M%,"`"\A90?P$D1UV)&5LRZ'OM&:=MT#@-=32_LD','"!"<"D-G#*2:.N%"[7
M:9`B[4J;B`S'D)69;RN/@8I"/G"M#@SQ;IN3".T&`,D&6&`#$LC(SQCB@`9T
MQ0,$P,`"#."2%!XRD*+L`)A<I1F;\6B"H'+*!BSPE`SN;4$^O&!S/B.B!HBL
M2!W,"0506:(K;6!W5HE-02BC@0JXD",E!!+6*&(!-8+F2D`,704T)8$(L.5^
MJQ%/4*Q7SB4F)9`3!`QT5K.5!&FQB@N$R^8BLD4/#.\"MW/:2A(@LS*V<'PY
M49WCV-B!M-!E(@Z(@$J*<\/&:(`"$5!55G2G`3]"#@-6"@KX]O-%PEPR<^8[
MUZBBZ1%\80`#.]0+_L!JP@%`/4``B$%`,!UP0E%B(`((K,`>&9*`>^E$4EN2
M2)X^D('33?!KW-(`!S)PI`]P8$$GC`E94$FN@LS35/5LC&VVAZ(-),AT5+G=
M'Q%7G;I<B8A%^4`!,@<!VS3`-F3Y464*D$V@+;&.ZBSC1GOR@`N%))ATC%B/
M&ED4-Q8DKPJ"``:>@@'X140W(S&3S4B#1J-*)BBOJ@Y+@W(S#T!@`A,YUV`6
MDC8/7-"$VLO)9<W(41F!,P$7W=O`V&@^H@QE(==RP`,R$`$-:*");Q080@E%
MOX5H"B+2HD@!YO@!"_34A4MC2&H6N8`CF6XE+I&B[SSP.HC(!:M4P4"E_M;&
MKLEA-7-U@<OPKC35O8WJH)!IYKD\-,VVJ*@G'JG.PW:SD+B&Q2J-Y(!=#PFY
M2L'ENT4)7U`<<"'Z?8LAZV/(HE;8$^$&-3$)V'!&;F2JACVE`P^X:$:"QA*$
MNJZGA)$M1S',DI+41HW!?(F(GP@74,8KHWN-2QS51:5S@3*1*$H)1Q88&PYL
M@(!/9=<P!6G)#Q`J:-#T$*>Z>JH+?4K%@2N*0!EP)*,110(8&=9"7+-'#KAK
MR>0%L+ZTJ);,U6XK$3#O:+C%(+MTH&'.C7"*."*9LU[VCO2$W&^%$J"DP20#
M@!$1CLYYLB5#I)AP86RB$'.N#&Q`*9Q:S7LI_N)#G>Q8,0<PW)FDLR2<!*HX
M%;K`FB@9%)1=I9')E0ZDK5.2N"8O(JW#2P<H8&-#L7%A6RE@9XCSK]W5JT17
M-(XAA<*G%UT`+YETK2"Q:9"CR0A*QR:*`]H:D0(`9V1J-!I0[;D2!K3I`Q.H
MR00;.P$+&$`!DLFI($>[9`VP&IQQX5-6/QV9PW35<T$!:T0XHZ,"'&FT'Y@H
M76KM76B6AM#:(I3;!)MG<P_;VGH]F3'=IBUS#M9W@O*W3[/H8NH"U0+5]-T)
M)S#`B&A@-JZZ$K&#<B)3=9I=)9$`@J&:D+XFBR$9H#-HFNWI*V6@XW&A%P4Z
MT$+&4$;($3E76/CT_J\Y9YH#!:*Z[S)+F-5$]88X,=R)%`*!J:V&`)L:6;F7
MLMK(E:BH&$"H:><HO0=D1`/[64V0RFQGA5#`H8UEB*0:0O753/;K$8D`B=QI
M^,./CEVOM(X[24,9KBN$X>YDB`4T;>?#;7XU8E[(7RMT6J6XQ2:.CPBQ5V^S
MO>M+Z&!9_<))W3MNK4;F;8(\:0XOI,.+)5%^6TB["--Y;A60T[@GS`5#SY"I
MM%G"L,=]V7B.=PXP=69-Y8!V.)"L"HBL6E@R)&,TCWC4XAV2CSER1",@`7T^
M<4,3T`\$_CC2I"0``5MBCP`.H(`%#(`"K`?%)`![,,<GI0D#&``#7,RR_C!`
M`WS2`#!'`9S=-S'``#C(-QD`!8!.BCS`_%7-H>F+`F@%27V3?AB`I4T`!Q``
M$)W&=3D0`B``"4*``FP1<T1``QS`AJB)?D0`!#S``RP@<S1`$3)`"T+@`4#`
M$CX`$#H`$"+`:?S$"=:@=GP?7M"0`F1`2G&A!J34`OC*8V%&!L3?AE3`!!A`
MLNB4MQ33!$B+!#0``C#'`Z!)$-K4`R8@`UX,`3QA$))$$<:;EQ7`=6$,`GC9
MQ20``2R``ASA`B3`(B;`LBB``1B``RA`),[@`6",`33@LB2``S#@)S;``Q2A
M!#Q`!%2,@SAB$'K+!)SB3ZSA#Z8@*^(1!$C+_@YNB(/\(!`JP`&&%@(N0'N(
MC`44@!T2(0,4`,P8XBXZ4-0\D0'\1#3Z6J#4A@7@Q?P]$0*X'P.\#7.@&P$4
MH`SJ'WL,@``8@`"@XY<0P-60"9D0`'R@!SJV(R6R1P`,8)<80`$40`#.8`%D
M3`+D8__E8_YES`&`"9@L``'X(,^=!@5DE9`Y1:[TA;I@@,[D2`9@Q@5(P`)8
M@`5<P`58P`4Q)!M20+)(@$QU4P)$P`-LR!A]TP,<@"UQ2"^Z7]5$#=5L4@0,
MP`(\"7%H@`04@/O-'\)!U=0,P"DR%`*PI$=X"^E$@+PM(11N2'/@D2GR%KIU
M9+1Y)`+(WQCY&EY\_M,2:N-"AM:-C.(<0L!U*<`@>ED#)$`<RB`X7E?@7`QO
M%>,'1L`!S"$#-*%$N5]->N57?I^#?&1*2=L%_%1)5D"H\-3\?*0"1`"+)`!C
M76$">*3*P9!K5.0%N>+0924-W9$#*!H&X(5B;J1'2M2&\!Q?SB$)+L`H-J%-
M%:$2`B)O!6%4.H@!J.9IA)9+I&)4:H?[!<ZH9$:R=&3@3<!/>8MV^)JOH2(3
MIF!;IDD1+N(<-N$2ZE1--J2W7(",8$"F`5>2Q5S>5`#>N=,<?8I,)`6LI(KV
MX=#,J-]"<,"3^(JOM&<&'-KA152T#4ST84G3,(U)](YD@!#XL<I@.47(_OE.
MPX"6MG0'XD&00B29`="54QV+KPF'_PT0!51D_U`$;^5(&W&+TN"+0D"<!A`/
MNTS?YT%`#I$&0IB$=6`/C0C62FS49\B&A/V+8:U6NJGG5LC<0`7<N<!H[.&+
MPK1H6&B/4RQ*[^E$!D!<3T@47.C=WS73CY`7V#5;!X"')S%&G<7>9&313P%'
M!:C3[RB,P@C(VI1$K!G5:IU+EWY>8WR>0>R'-4Z%YW&+M_RDR[GIX1AI1-R>
M3@1=G6J21V@42-CHLB5&JJP$A*B$KQ"&!ISICKE00X3?8['%\_C.<P0`K$!+
M]$%FC&K0$P+18PR33VI?`40+!PK2L`1<B3C7_C$Y&UWLE0<TRF$@$X04@,[H
M";O,7$'@'4>E6TYTY)4X7*Y"Q8\D:41`QQM!#JLEF(H9A,9)`):N"0=`@'>4
M$3R1G+!MA;4M1`$$R+2\C:',3'D6#/'EU?`X#IPU&4A,%/]<'DC4D5]4Y&DX
MU*`07TYTP(ZUU\"]'P5L0,GXCJ`RJG&<2ZY)2DI98P<<:%%8*@4FC6#)R4.,
M44(DQ:<^1&IMWJ@Y7K`**V-EQ,5!!&,YJ)@-70J)6&+%VK_:1FP\AGU!3L`$
M!02\7609%D4X"L9)GDZDVP/`V8Y-`(ELSY6(9F)1RTA\IWP^EL\2$[6.C-)=
MTY5<:QHE1A<5W,Y"_D2<`6DE`46.;"O2B`>E4`!3-=4'%*K7YH2[;D7Z^.N.
M5>DI-AVL=-5?*$1(^@S`N!@^$1U+O!N3M(ZB^%I%0!ZF*(0A9=:FS5F:8-_M
M@=WRK88"7-2U5IX[;>3%0.!O1,0%+$`$=``1I0@FJ<I94-)#Y*4?.@"5#=ZY
M]`EW>1=#T-74X6PS(8!,G-"?19]?<-WH`,;?>9V=::N$%96)ZLOBIFB8$@X=
M?>?RT<B7,L1V/-]L)1E3V!KQ0B]J%0?F15O(58:<XMZQF(F<<IW6*D20ZL3"
M?.E"M!H=@=;;V&$+Z<3>05(09MJG0!QH0:_:YH^51MWRM:SB/899$-`W_O5*
M?0*7Y_[5'3W)D=5G,JE??/I.O8C?QH06)&%P4Q40$&H'`N#%&5I?`R!<`LYJ
M8F3`/IKCEIBC/HJ)`,R@`2!`?3``FEP7`RKBQ3S@#.>?`+PE)ZJ)31TE$R(`
M!/*6!`1.FC@B9#)A$!YEW9Q&!`0E_15`Q=1D`?"/M"Q`$-)?'5XB$1;A)UK-
M:V:QQ23`ER"@`L#CQ0#@)4:B)3X@0([B7](?`F1Q9#;G:42-1WXD2.)%U"SF
M#N(12Y+E`=BA`1!Q'BYB`7@B0<XEPC&@'B[+.JHN$;:'EP6@+<(P'U[-`;CP
MEGR)&B^R`/CC.&8,#,_')1(@0<:'#'K9(5H-_@VNY0=BY]DME`[^H`/,(DD@
M8)H$#@,NRVN"8B5"H!%ZV5HVP`+P%@(,IULV8"4JH`TJ81#",&]!@"DMY!8W
M@';881'JX!/:E"3FWP`0Y'KHGYAX2?_IXP"\8SDJ\B3NGPS&QP'4QVNF99C4
MASG/ARC+QSH.P'R0B7JTASY>3<4LBP^.HA3Z&D9^)).,U/;Y"G!MIJ))RS,9
MIQ[?T;MQ)AM^GS5&6R_NIA1NR$KB)OWQ%@(>($DH(78VH7X$80-0$!#>)G:Z
MW[;B41R3!`<[95H*)4+7I$=@I\NE%`,_T4^\Q!+"HON1Q&EHL1\V89J@22NW
MI3CR91PVM>8FI$E;_F<MZJ)1-^17\N;PE.%(-F<Q(:6#%--'OX2W;+0><Z$%
M-"0-?6<M?29<5R1<>W5'7N8WR=]?2D`?QC1+R]]/+%0QP;1,\YQ8NX1QGF$&
MNA^'DE=S>N09[J)^+`#/E65S4A"+&+9J`E%(^R'I9"`%;4@,6:.BV2>O[$E\
M>DI16%6=%H76-45"=$6.,%![^J>Q"I;4*6R8F@2F6>G^*JAIZ6F,!BKFZ42N
MS:GS6NG?[8FIK,W^NFGONB]O%W>,;MY6_+;#(&B@4O=U&RGM/6DHK=5W*VAR
M=_=M\Y=RF_>?.J]T>S>";J]Q`S=QNW9T!_</G=7LIM1Q7#=[2S='B91N_@OX
M@`\9@0N,@3,-@"+X@C-X@SLXSQC=@TOXA"/X9$44A2.XI>6$!@1E$'87AH,X
M?X?X>#^X@I?XB*-XBANX`R29BKLXBK_4<\7JB_?0E?1%!D0XC4^X=W&MCOOX
MCP-YD"?2B)FXD!MYD0Q&;QVY3L0KB2\Y@_?XDTOYE%/Y@D]+E6,YNX!'S@5Y
M9;AVEB]X4GPYF"]YD9/YD9OYF;_X:A1KA5?W=BN>>JLYE"?LG(?XGQ+0G,1:
MM:SV?`/K8W`$TL!Y>==I]BZWG2/Z@HN8=M.WA.%XUYY&H+\$1I2L+8+3]S)'
M<$5-HG,ZIVO1;$3+Z!!``$A@=]!'/\_(!*#C_JH#$WI!60HUQJJ_A]-%Z0=(
M@`P:I)4D@$.-A$-EP*[+[ENV<@PM;C7+CU*(&&`4:J<S.]/H72,AWFT/;]*]
M9A`Z!<E`'T/0T+M%BQ?>46.5IP8@4&\T>[F3^8Z<3=),Q%'1)P)I$5\T"$J0
MIP"$I*\\F40@MZT?0!<J1KG)6U:>Q3''Q-$<#@#D"?<YP`#P#P;`FR<=0-'J
M(&H!@`T]H;F7^W5#1WTH,L7`!R7",(EHDLUL*^<U@`%$V[YJ@,EC)&\P!-5\
MYV-E,=7,%HA#DL7;O-2=2@!^P+E"X$.(BA85B@8@E4;\R'4PU:^G#&C)B7V>
M1`IQ*K?X!B?-!@MF_DQ5;(H%-,P&_(:U>"J]0UF^W_R<S]?7Y8JG:&P%7X9D
M^,I?'3,'!.ZEK,9W7I>B58!&<>2_]%;%S#R&IWG8FWL'`(`^9<5$]2I(W`>8
M<+R0=`#G7@:IJS,`=$ZLUT<`\(0"I-`%S@>D^(X!4`L!B,P%I(7GGXO:Q41J
M).=Q,Q8T%H"(S:C?N_[>8,RN6P!/$H]]*E)3)*[-[&N$9-+K^_Z+=P"J1$`*
M_HME0L0%;$0",$`QM>!#++[A9(``[$F5.1%G`+IB[)$"3`!P]45B60I2<8KJ
MPX3"8$?I+]Q4Z0<&4(=*\M;ON_]T@_>7&W=]OW_]\ST`8`0""`!,,-1#_O0U
M0'A(4.&#!PP*/B3T0("#AP\9!CC\P(!@PH(/&%A,V*""Q`\+,FA,J&&``0@*
M"2A@<,!`!@T%!S3\@.'`0P$<%":PD*'`S``!(H@4.I1H4:-'D295NI1I4Z=/
MH4:5.I6J2(]5L69MZ@&`!H,!3G8H``%#A`(O$U!(6`&!10Y=$V8@(%&!6HL>
M'A"0\("O!P0)($!XT&%!`PH4(%RP:`!`R`\6YA8D4&'#!PX!9%HP4%#!@X84
M#'BPT-.#`P`.M*:V>E5U:]>O8<>6/9LVTPX8,%RXD`$W;MVZ+02_@*$"!0L4
M+EC`7>%W<`L5H!\V3F%"!0NZK5^'7B$W;]P:_C1DV,`AO(8-X#EDZ."!?8<.
M'-Z[+^B0/GOR[^'#WU"Y?H>"M0$,4,`!"2S00`(S2&"!!!A(0($$&D@`@;\2
M<%`!!198@($-&^C0`0<:<("O$2/`J`$&0`SQ0[X$<R"""`33D($.&5A@P@H5
MN#$!`PHPP(`##B!```$*&(```GSLT<<E@>01@2*/1#+)'_T[4*LJLV+-2J@\
MP&G+J2AP[,LQJZ+O/_;^2U.HJ\Q,TTR)M%1(3HW:](@]UMX\4\V[YM.333++
M5,U+0)V*,RH\7=,2`S&M(M311R&-U%%#)8U-`R\]6$\U@T*BM-%*00U5U%&Q
ME,K34<L<(".#$/BS_J`-M*SL*,T`".`!.^G4R`*$YD35UU^!#598K#@0```,
M9FJU(`QD]8""!83"0-FB/#@@@@XV*``#^C1-B`-8$Y(@`87,.W78<]%-5UU'
M-R```@9$RXBP`0:8X(,+Z"U5`P,$V%8S`Q2C<X!..<`)`P,&0*`A"^AMZ0,(
MQO6``0(*.$#6=3'.6..-ES+7J&S]PD`">"\HH`,-YO)`@I/HK""T#PZP8(*4
M[VI```8>R,"A!"3HP,4/&I!`(+4@:,`#GN"S-D`T.6[:Z:=?*]4I#B*J@(`-
M\7*`O0(JFR`HD7CR8(-6%WKI+FPCF#@##ACJDP,(%!!`,0A0@T``!`X8T``"
MCZ'NV^^_#Y2Z*8C86P``>"E`2`.3/_!:J`Q:/:@@KC6J@/'2(J#ZI9TZ0,`!
M#!:PX&'4)C@@N0FV!5SUU5G_50,%'&(;6K$@T+"@"!)@3:[U"LB@@@/8+*`!
M#B@@`-D$'"B9L@$PH$#OK#]`68+B16_=^NNQ?[3@@C1PL4H-KJ6S>\5&Z]VJ
M"Q((@("@,F4`@5L?,P"!"'K.P+$+4*SH*<&S[]___ZGU*3@I!5>KV9.;YN2J
<J/`/@`UTX`,!Y`&S885O$+3@IBZ80:8$!```.S\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>f39432xe3943240.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 f39432xe3943240.gif
M1TE&.#EA.0`7`/<```````@("!`0$!@8&"$A(2DI*3$Q,3DY.4)"0DI*2E)2
M4EI:6F-C8VMK:W-S<WM[>X2$A(R,C)24E)R<G*6EI:VMK;6UM;V]O<;&QL[.
MSM;6UM[>WN_O[_?W]___________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________RP`````.0`7```(_@`]"!Q(L*#`#AP@:#!8D,.%
M#@PC2C0(D6('!P`:5*PX$"$#`1HXBIPHL0.%#1!'0@@`((`##@<[:F#`D@#*
MCAX04N!(LN,$`A1@'LRP@"6`HP485-B@08.$!`*.(H60H8-5AP<T]C2X80"`
M`088,"!@5*K9`&B1/KA@0&H``0$,1!VP<&O!#@G,ZMV[=P"""E'Y`D#`TZY`
M"F7W)MZ[(`%@P0$FY#1,D`,!P0`""RXP8/'9#)3O-L!,VBUF`T)##YQ0NC7F
M!:H+7O#LNK7DV`,Y-"!@``$#`PV".T!0H,$"`\<;'WB@`$$"!0H6,(@@UL%-
MW`>M3IZ<<B1.[MIC?&+_GI)[S(W;Q9L?+WYD^?+;M://"1\[4>C/I2=@@`#!
M@0,*'(!``P?L)U8"^>%7P`/L"<1:;1`N4%AL%$`(H0/IX::!5Q;JY1F&$ZH&
MP0$&#$!``9P58,"*__6'H`(,1+>`=`<P<`"*$31X7FZIW171?"'J*.201!H6
$$```.S\_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
